FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Pehlivan, E
   Altun, T
AF Pehlivan, Erol
   Altun, Tuerkan
TI Biosorption of chromium(VI) ion from aqueous solutions using walnut,
   hazelnut and almond shell
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE shell; low-cost adsorbent; batch model; chromium; adsorption; Walnut;
   Hazelnut; Almond
ID SULFURIZED ACTIVATED CARBON; AGRICULTURAL BY-PRODUCTS; HEXAVALENT
   CHROMIUM; WASTE-WATER; METAL-IONS; HEAVY-METALS; EXCHANGE-RESINS;
   CITRIC-ACID; BROWN COALS; REMOVAL
AB The potential to remove Cr(VI) ion from aqueous solutions through biosorption using, the shells of Walnut (WNS) (Juglans regia), Hazelnut (HNS) (Corylus avellana) and Almond (AS) (Prunus dulcis) was investigated in batch experiments. The equilibrium adsorption level was determined to be a function of the solution contact time and concentration. Kinetic experiments revealed that the dilute chromium solutions reached equilibrium within 100 min. The biosorptive capacity of the shells was dependent on the pH of the chromium solution, with pH 3.5 being optimal. Adsorption of Cr(VI) ion uptake is in all cases pH-dependent showing a maximum at equilibrium pH values between 2.0 and 3.5, depending on the biomaterial, that correspond to equilibrium pH values of 3.5 for (WNS), 3.5 for (HNS) and 3.2 for (AS). The adsorption data fit well with the Langmuir isotherm model. The sorption process conformed to the Langmuir isotherm with maximum Cr(VI) ion sorption capacities of 8.01, 8.28, and 3.40 mg/g for WNS, HNS and AS, respectively. Percentage removal by WNS, HNS and AS was 85.32, 88.46 and 55.00%, respectively at a concentration of 0.5 mM. HNS presented the highest adsorption capacities for the Cr(VI) ion. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Pehlivan, Erol; Altun, Tuerkan] Selcut Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
RP Altun, T (reprint author), Selcut Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
EM erolpehlivan@gmail.com
CR Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   Bai S, 2001, BIORESOURCE TECHNOL, V79, P73, DOI 10.1016/S0960-8524(00)00107-3
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   Brown PA, 2000, WATER RES, V34, P3907, DOI 10.1016/S0043-1354(00)00152-4
   CHAKRAVARTI AK, 1995, COLLOID SURFACE A, V103, P59, DOI 10.1016/0927-7757(95)03201-N
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   CieslakGolonka M, 1996, POLYHEDRON, V15, P3667, DOI 10.1016/0277-5387(96)00141-6
   CIMINO G, 1990, BIOL WASTE, V33, P201, DOI 10.1016/0269-7483(90)90005-D
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Dean SA, 1999, RESOUR CONSERV RECY, V27, P151, DOI 10.1016/S0921-3449(98)00095-0
   DEFILIPPIS LF, 1994, ALGAE WATER POLLUTIO, P31
   Donmez G, 2002, PROCESS BIOCHEM, V38, P751, DOI 10.1016/S0032-9592(02)00204-2
   Espinola A., 1999, P TMS FALL EXTR PROC, V3, P2057
   Gloaguen V, 1997, J ENVIRON SCI HEAL A, V32, P901, DOI 10.1080/10934529709376585
   Gode F, 2006, ENERG SOURCE PART A, V28, P447, DOI 10.1080/009083190927156
   Gode F, 2005, FUEL PROCESS TECHNOL, V86, P875, DOI 10.1016/j.fuproc.2004.10.006
   Gode F, 2005, J HAZARD MATER, V119, P175, DOI 10.1016/j.jhazmat.2004.12.004
   Gode F, 2003, J HAZARD MATER, V100, P231, DOI 10.1016/S0304-3894(03)00110-9
   Gomez-Serrano V, 1998, WATER RES, V32, P1, DOI 10.1016/S0043-1354(97)00203-0
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Iqbal M, 2002, BIORESOURCE TECHNOL, V81, P151, DOI 10.1016/S0960-8524(01)00126-2
   Juang RS, 2000, J MEMBRANE SCI, V165, P159, DOI 10.1016/S0376-7388(99)00235-5
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Kawamura Y, 1997, WATER SCI TECHNOL, V35, P97, DOI 10.1016/S0273-1223(97)00119-4
   Klimmek S, 2001, ENVIRON SCI TECHNOL, V35, P4283, DOI 10.1021/es010063x
   Lakatos J, 2002, FUEL, V81, P691, DOI 10.1016/S0016-2361(01)00159-4
   Lalvani SB, 1998, CARBON, V36, P1219, DOI 10.1016/S0008-6223(98)00102-X
   Lalvani SB, 2000, ENERG SOURCE, V22, P45, DOI 10.1080/00908310050014207
   LASZLO JA, 1994, J APPL POLYM SCI, V52, P531, DOI 10.1002/app.1994.070520408
   Lee B. G., 2004, Journal of Natural Fibers, V1, P97, DOI 10.1300/J395v01n01_07
   Lee MY, 2005, J APPL POLYM SCI, V96, P44, DOI 10.1002/app.21356
   Lu AH, 2006, ENVIRON SCI TECHNOL, V40, P3064, DOI 10.1021/es052057x
   MaciasGarcia A, 1995, AN QUIM, V91, P547
   MACIASGARCIA A, 1993, CARBON, V31, P1249, DOI 10.1016/0008-6223(93)90083-M
   Maddalone RF, 1996, WATER AIR SOIL POLL, V90, P163, DOI 10.1007/BF00619278
   Madoni P, 1996, WATER RES, V30, P135, DOI 10.1016/0043-1354(95)00124-4
   Madronova L, 2001, REACT FUNCT POLYM, V47, P119, DOI 10.1016/S1381-5148(00)00077-8
   Mahvi A. H., 2005, American Journal of Applied Sciences, V2, P372
   MALTERER T, 1996, MINING ENG, V48, P53
   Marathe RM, 2002, FOOD HYDROCOLLOID, V16, P423, DOI 10.1016/S0268-005X(01)00118-7
   Marshall WE, 2000, ENVIRON TECHNOL, V21, P601, DOI 10.1080/09593332108618075
   MARSHALL WE, 1995, J ENVIRON SCI HEAL A, V30, P241, DOI 10.1080/10934529509376198
   McKay G, 1997, J CHEM TECHNOL BIOT, V69, P309, DOI 10.1002/(SICI)1097-4660(199707)69:3<309::AID-JCTB724>3.0.CO;2-W
   Namasivayam C, 1999, CARBON, V37, P79, DOI 10.1016/S0008-6223(98)00189-4
   Ozdemir G, 2004, CHEM ENG J, V102, P249, DOI 10.1016/j.cej.2004.01.032
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Rengaraj S, 2001, J HAZARD MATER, V87, P273, DOI 10.1016/S0304-3894(01)00291-6
   Ricou-Hoeffer P, 2001, WATER RES, V35, P965, DOI 10.1016/S0043-1354(00)00341-9
   Saeed Asma, 2002, Pakistan Journal of Scientific and Industrial Research, V45, P206
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   TAN WT, 1993, ENVIRON TECHNOL, V14, P277, DOI 10.1080/09593339309385290
   TEIXER AC, 1999, ENVIRON SCI TECHNOL, V33, P489
   UDAYBHASKAR P, 1990, J APPL POLYM SCI, V39, P739, DOI 10.1002/app.1990.070390322
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   Wartelle LH, 2000, ADV ENVIRON RES, V4, P1, DOI 10.1016/S1093-0191(00)00002-2
   Wasay SA, 1999, WATER AIR SOIL POLL, V116, P449, DOI 10.1023/A:1005115820429
   Yan GY, 2001, BIORESOURCE TECHNOL, V78, P243, DOI 10.1016/S0960-8524(01)00020-7
   Yates LM, 1999, ENVIRON SCI TECHNOL, V33, P2076, DOI 10.1021/es980408k
NR 60
TC 124
Z9 137
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JUN 30
PY 2008
VL 155
IS 1-2
BP 378
EP 384
DI 10.1016/j.jhazmat.2007.11.071
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 310TH
UT WOS:000256552800048
PM 18179865
DA 2018-10-19
ER

PT J
AU Song, YW
   Shan, DY
   Han, EH
AF Song, Y. W.
   Shan, D. Y.
   Han, E. H.
TI Electrodeposition of hydroxyapatite coating on AZ91D magnesium alloy for
   biomaterial application
SO MATERIALS LETTERS
LA English
DT Article
DE deposition; hydroxyapatite; coating; biodegradable property; magnesium
   alloy
ID SIMULATED BODY-FLUID; IN-VIVO CORROSION; CALCIUM-PHOSPHATE; BEHAVIOR;
   TI-6AL-4V
AB Magnesium and its alloys are potential biodegradable implant materials due to their attractive biological property. But their poor corrosion resistance may result in the sudden failure of the implants. The bioactive hydroxyapatite (HA) coating was electrodeposited on AZ91D magnesium alloy surface to improve its biodegradation performance. The biodegradable behavior of HA coating was investigated by electrochemical tests and immersion tests. The experimental results indicated that the as-deposited coating consisting of dicalcium phosphate dehydrate ((DCPD, CaHPO4 center dot 2H(2)O) and beta-tricalcium phosphate (beta-TCP, Ca-3 (PO4)(2)) was transformed into uniforryl hydroxyapatite (HA, Calo (PO4)(6)(OH)(2)) coating after immersion in 1 M NaOH solution for 2 h. The HA coating can obviously slow down the biodegradation rate of AZ91 D magnesium alloy in stimulated body fluid (SBF). (c) 2008 Elsevier B.V. All rights reserved.
C1 [Song, Y. W.; Shan, D. Y.; Han, E. H.] Chinese Acad Sci, Inst Met Res, Environm Corros Ctr, Shenyang 110016, Peoples R China.
RP Song, YW (reprint author), Chinese Acad Sci, Inst Met Res, Environm Corros Ctr, 62 Wencui Rd, Shenyang 110016, Peoples R China.
EM ywsong@imr.ac.cn
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cao C.N., 2004, PRINCIPLE CORROSION
   Cao C. N., 2002, INTRO ELECTROCHEMICA
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Liu CL, 2007, THIN SOLID FILMS, V516, P422, DOI 10.1016/j.tsf.2007.05.048
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Park JH, 2005, SURF COAT TECH, V195, P252, DOI 10.1016/j.surfcoat.2004.08.185
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, ELECTROCHIM ACTA, V53, P2135, DOI 10.1016/j.electacta.2007.09.026
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yen S. K., 2002, MAT SCI ENG C-BIO S, V20, P153
   Zhang EL, 2005, T NONFERR METAL SOC, V15, P1199
NR 17
TC 321
Z9 349
U1 16
U2 189
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUN 30
PY 2008
VL 62
IS 17-18
BP 3276
EP 3279
DI 10.1016/j.matlet.2008.02.048
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 314AI
UT WOS:000256780700204
DA 2018-10-19
ER

PT J
AU Cejas, MA
   Kinnney, WA
   Chen, C
   Vinter, JG
   Almond, HR
   Balss, KM
   Maryanoff, CA
   Schmidt, U
   Breslav, M
   Mahan, A
   Lacy, E
   Maryanoff, BE
AF Cejas, Mabel A.
   Kinnney, William A.
   Chen, Cailin
   Vinter, Jeremy G.
   Almond, Harold R.
   Balss, Karin M.
   Maryanoff, Cynthia A.
   Schmidt, Ute
   Breslav, Michael
   Mahan, Andrew
   Lacy, Eilyn
   Maryanoff, Bruce E.
TI Thrombogenic collagen-mimetic peptides: Self-assembly of triple
   helix-based fibrils driven by hydrophobic interactions
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; platelets; structure-function; supramolecular triplex
ID STACKING INTERACTIONS; MOLECULAR-STRUCTURE; FORCE-FIELD; STABILITY;
   ACTIVATION; PROTEINS; INTEGRIN; STRANDS; FLOW; GPVI
AB Collagens are integral structural proteins in animal tissues and play key functional roles in cellular modulation. We sought to discover collagen model peptides (CmPs) that would form triple helices and self-assemble into supramolecular fibrils exhibiting collagen-like biological activity without preorganizing the peptide chains by covalent linkages. This challenging objective was accomplished by placing aromatic groups on the ends of a representative 30-mer CMP, (GPO)(10), as with L-phenylalanine and L-pentafluorophenylalanine in 32-mer la. Computational studies on homologous 29-mers 1a'-d' (one less GPO), as pairs of triple helices interacting head-to-tail, yielded stabilization energies in the order 1a' > 1b, > 1c' > 1d', supporting the hypothesis that hydrophobic aromatic groups can drive CMP self-assembly. Peptides 1a-d were studied comparatively relative to structural properties and ability to stimulate human platelets. Although each 32-mer formed stable triple helices (CID) spectroscopy, only 1a and 1b self-assembled into micrometer-scale fibrils. Light microscopy images for 1a depicted long collagen-like fibrils, whereas images for Id did not. Atomic force microscopy topographical images indicated that 1a and 1b self-organize into microfibrillar species, whereas 1 c and 1d do not. Peptides 1a and 1b induced the aggregation of human blood platelets with a potency similar to type I collagen, whereas 1c was much less effective, and 1d was inactive (EC50 potency: 1a/1b >> 1c > 1d). Thus, 1a and 1b spontaneously self-assemble into thrombogenic collagen-mimetic materials because of hydrophobic aromatic interactions provided by the special end-groups. These findings have important implications for the design of biofunctional CmPs.
C1 [Cejas, Mabel A.; Kinnney, William A.; Chen, Cailin; Almond, Harold R.; Breslav, Michael; Mahan, Andrew; Maryanoff, Bruce E.] Johnson & Johnson Pharmaceut Res & Dev, Res & Early Dev, Spring House, PA 19477 USA.
   [Vinter, Jeremy G.] Cresset BioMol Discovery Ltd, Welwyn Garden City AL7 3AX, Herts, England.
   [Balss, Karin M.; Maryanoff, Cynthia A.] Johnson & Johnson Co, Convergent Product Dev, Spring House, PA 19477 USA.
   [Schmidt, Ute] WITec GmbH, D-89081 Ulm, Germany.
   [Lacy, Eilyn] Centocor Res & Dev, Prot Engn, Radnor, PA 19087 USA.
RP Kinnney, WA (reprint author), Johnson & Johnson Pharmaceut Res & Dev, Res & Early Dev, Spring House, PA 19477 USA.
EM wak@pei3.com; bmaryano@prdus.jnj.com
CR Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364
   BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Binder WH, 2006, ANGEW CHEM INT EDIT, V45, P7324, DOI 10.1002/anie.200602001
   Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868
   Chan WC, 2000, FMOC SOLID PHASE PEP, P41
   Chessari G, 2002, CHEM-EUR J, V8, P2860, DOI 10.1002/1521-3765(20020703)8:13<2860::AID-CHEM2860>3.0.CO;2-N
   Cole DJ, 1999, SURGERY, V126, P510, DOI 10.1067/msy.2099.99675
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Gdaniec M, 2003, ANGEW CHEM INT EDIT, V42, P3903, DOI 10.1002/anie.200351432
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   Hoekstra WJ, 1999, J MED CHEM, V42, P5254, DOI 10.1021/jm990418b
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   KAR K, 2006, J BIOL CHEM, V282, P33283
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s
   Lecut C, 2005, THROMB HAEMOSTASIS, V94, P107, DOI 10.1160/TH04-12-0783
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Lozman OR, 2001, J CHEM SOC PERK T 2, P1446, DOI 10.1039/b103390p
   McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815
   Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434
   Savage B, 1999, BLOOD, V94, P2704
   TRAUB W, 1978, FEBS LETT, V92, P114, DOI 10.1016/0014-5793(78)80734-0
   VINTER JG, 1994, J COMPUT AID MOL DES, V8, P653, DOI 10.1007/BF00124013
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   WHITE P. D., 2000, FMOC SOLID PHASE PEP, P9
   YANG C, 2003, J BIOMED MATER RES B, V69, P18
NR 47
TC 91
Z9 94
U1 2
U2 33
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 24
PY 2008
VL 105
IS 25
BP 8513
EP 8518
DI 10.1073/pnas.0800291105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 319TA
UT WOS:000257185700007
PM 18559857
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Yang, SH
   Wu, XH
   Mei, RC
   Yang, C
   Li, J
   Xu, WH
   Ye, SN
AF Yang, Shuhua
   Wu, Xinghuo
   Mei, Rongcheng
   Yang, Cao
   Li, Jin
   Xu, Weihua
   Ye, Shunan
TI Biomaterial-loaded allograft threaded cage for the treatment of femoral
   head osteonecrosis in a goat model
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE osteonecrosis; core decompression; allograft threaded cage; decalcified
   bone matrix; goat
ID DEMINERALIZED BONE-MATRIX; DONOR-SITE MORBIDITY; CORE DECOMPRESSION;
   AVASCULAR NECROSIS; FIBULAR GRAFTS; HIP; CARTILAGE; REPAIR
AB The purpose of this study was to evaluate the efficacy of core decompression with a biomaterial-loaded allograft threaded cage (ATC) for the treatment of femoral head osteonecrosis in an established goat model. First, bilateral early-stage osteonecrosis was induced. After core decompression, the remaining goats were randomly divided into three groups: Group A, the goats were left without any treatment; Group B, the goats were treated with implanting a composite of autologous bone and decalcified bone matrix (DBM); Group C, the goats were treated using insertion of ATC loaded with DBM and autogenous bone graft. Then radiographic, histological and biomechanical analysis were taken in each group at 5, 10, and 20 weeks postoperation. In Group A, the classical signs of osteonecrosis of the femoral head were identified 10 weeks after the induction. Twenty weeks later, the density, surface and biomechanical stability of the femoral head were normal in Group C, while an irregular surface and an inhomogeneous microstructure or variation of density/hardness were identified in Group B. The specimens revealed a continuous trabaecular bone structure throughout the cage and extensive bone ingrowth and remodeling in Group C, while fibrous tissue was evident in Group B. Core decompression with a biomaterial loaded ATC almost uniformly delays or arrests the progression of the disease before articular collapse, and it could help to get the balance between bone resorption and new bone formation, strengthen structural mechanics of the femoral head, provide structure support of articular cartilage.
C1 [Yang, Shuhua; Wu, Xinghuo; Mei, Rongcheng; Yang, Cao; Li, Jin; Xu, Weihua; Ye, Shunan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Yang, SH (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM shuhua196@yahoo.com.cn
CR AARON RK, 1989, CLIN ORTHOP RELAT R, P209
   Aaron RK, 1998, ADULT HIP, P451
   Aldridge J Mack 3rd, 2004, Am J Orthop (Belle Mead NJ), V33, P327
   Aluisio FV, 1998, CLIN ORTHOP RELAT R, P192
   ASSOULINEDAYAN Y, 2002, BIOTECHNOL BIOENG, V92, P189
   Babyn PS, 1998, J MAGN RESON IMAGING, V8, P717, DOI 10.1002/jmri.1880080331
   Bejar J, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-24
   Beltrame F, 2005, BIOTECHNOL BIOENG, V92, P189, DOI 10.1002/bit.20591
   Conzemius MG, 2002, J ORTHOPAED RES, V20, P303, DOI 10.1016/S0736-0266(01)00108-5
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   Hungerford DS, 2007, J ARTHROPLASTY, V22, P91, DOI 10.1016/j.arth.2007.02.009
   Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2012, DOI 10.2106/JBJS.D.02593
   Lavernia CJ, 2000, J ARTHROPLASTY, V15, P171, DOI 10.1016/S0883-5403(00)90132-3
   Lieberman Jay R, 2003, Instr Course Lect, V52, P337
   Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f
   Magnussen RA, 2005, J ORTHOP RES, V23, P576, DOI 10.1016/j.orthres.2004.12.006
   McCarthy J, 2003, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.0000043045.84315.d9
   Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989
   Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Mont Michael A, 2007, Instr Course Lect, V56, P213
   Ranly DM, 2005, J BONE JOINT SURG AM, V87A, P2052, DOI 10.2106/JBJS.D.02752
   ROSENWASSER MP, 1994, INSTR COURSE LECT, V306, P17
   Russell JL, 2000, TISSUE ENG, V6, P435, DOI 10.1089/107632700418137
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   STEINBERG ME, 1997, OSTEONECROSIS ETIOLO, P293
   TAKAOKA K, 1981, ARCH ORTHOP TRAUM SU, V99, P109, DOI 10.1007/BF00389746
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
NR 33
TC 6
Z9 9
U1 1
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN 15
PY 2008
VL 100
IS 3
BP 560
EP 566
DI 10.1002/bit.21792
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 301GE
UT WOS:000255883600016
PM 18438884
DA 2018-10-19
ER

PT J
AU Schopper, C
   Moser, D
   Spassova, E
   Goriwoda, W
   Lagogiannis, G
   Hoering, B
   Ewers, R
   Redl, H
AF Schopper, C.
   Moser, D.
   Spassova, E.
   Goriwoda, W.
   Lagogiannis, G.
   Hoering, B.
   Ewers, R.
   Redl, H.
TI Bone regeneration using a naturally grown HA/TCP carrier loaded with
   rhBMP-2 is independent of barrier-membrane effects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE BMP; bone regeneration; hydroxyapatite composite; membrane; scaffold
ID MORPHOGENETIC PROTEIN FAMILY; GUIDED TISSUE REGENERATION; TRICALCIUM
   PHOSPHATE; IMPLANTS; RAT; NEOGENESIS; REGULATORS; DEFECTS; MONKEYS;
   SURFACE
AB The present study investigated whether bone regeneration and biomaterial replacement would be improved by loading of biogenous biphasic biomaterial scaffolds (HA/TCP ratio 30/70) with rhBMP-2, and whether the placement of three barrier membranes differing in structure and porosity (prototyped SLA Ti specimens, GORE RESOLUT Adapt specimens, and titanized TiMESH light specimens) would have a synergistic effect. A rabbit calvarial model was used for the implantation studies. Histological specimens were obtained after 12 weeks and evaluated quantitatively for differences between the various material combinations. Loading of the biomaterials with rhBMP-2 significantly enhanced the amount of regenerated bone and caused a pronounced biomaterial replacement. While BMP-induced bone had formed uniformly over the surgical defects, bone regeneration in the absence of BMP depends on bone promotion from the margins of the defects toward the center. No positive effect on bone regeneration was seen for any of the placed barrier membranes. While the present study had shown that rhBMP-2 loading significantly increases bone regeneration using the investigated biomaterial, barrier-membrane placement may be useful in predetermining the final shape of the regenerative site but provides no additional beneficial impact on the amount and quality of the bone regeneration induced by rhBMP-2. (C) 2007 Wiley Periodicals, Inc.
C1 [Schopper, C.; Moser, D.; Goriwoda, W.; Lagogiannis, G.; Ewers, R.] Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
   [Spassova, E.] AlgOss Biotechnol GmbH, Vienna, Austria.
   [Hoering, B.; Redl, H.] Ludwig Boltzmann Inst Expt & Clin Traumatol, Res Ctr Traumatol, Vienna, Austria.
RP Schopper, C (reprint author), Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
EM christian.schopper@meduniwien.ac.at
CR ASPENBERG P, 1991, J ORTHOPAED RES, V9, P20, DOI 10.1002/jor.1100090104
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Buser D., 2001, TITANIUM MED, p[876, 888]
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   DONATH K, 1982, J ORAL PATHOL, V11, P198
   ELIMA K, 1993, ANN MED, V25, P395, DOI 10.3109/07853899309147302
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200
   Hoffmann A, 2001, APPL MICROBIOL BIOT, V57, P294
   Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P245, DOI 10.1034/j.1600-0501.1994.050408.x
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R
   MIYAMOTO S, 1993, J BONE JOINT SURG BR, V75, P107
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Ono I, 1999, J BIOMED MATER RES, V45, P337
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   SCHMID J, 1994, CLIN ORAL IMPLAN RES, V5, P125, DOI 10.1034/j.1600-0501.1994.050302.x
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SEEHERMAN H, 2002, SPINE, V27, P16
   STEENBERGHE D, 2003, CLIN ORAL IMPLAN RES, V14, P63
   Takeishi H, 2001, ORAL DIS, V7, P281, DOI 10.1034/j.1601-0825.2001.00725.x
   URIST MR, 1965, SCIENCE, V150, P839
   VUKICEVIC S, 1995, EUR J CLIN CHEM CLIN, V33, P661
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
NR 41
TC 22
Z9 24
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 954
EP 963
DI 10.1002/jbm.a.31525
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000011
PM 17896771
DA 2018-10-19
ER

PT J
AU van Minnen, B
   van Leeuwen, MBM
   Kors, G
   Zuidema, J
   van Kooten, TG
   Bos, RRM
AF van Minnen, B.
   van Leeuwen, M. B. M.
   Kors, G.
   Zuidema, J.
   van Kooten, T. G.
   Bos, R. R. M.
TI In vivo resorption of a biodegradable polyurethane foam, based on
   1.4-butanediisocyanate: A three-year subcutaneous implantation study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; biodegradation; bioresorption; in vivo test
ID FOREIGN-BODY REACTION; ALIPHATIC POLYESTERS; DEGRADATION; BONE; ACID;
   BIOCOMPATIBILITY; POLY(L-LACTIDE); SCAFFOLDS; FIXATION; RABBITS
AB Degradable polyurethanes (PUs), based on aliphatic diisocyanates, can be very useful in tissue regeneration applications. Their long-term in vivo degradation has not been extensively investigated. In this study a biodegradable PU with copolyester soft segments Of DL-lactide/ F-caprolactone and hard segments synthesized from 1,4-butanediisocyanate was evaluated with regard to tissue response during degradation and, ultimately, the resorption of the material. Highly porous PU foam discs were subcutaneously implanted in rats and rabbits for intervals up to 3 years. A copolymer foam Of DL-lactide and c-caprolactone served as a control. The foams, the surrounding tissues and the draining lymph nodes were evaluated with light and electron microscopy. In the first stages of degradation the number of macrophages and giant cells increased. As the resorption stage set in their numbers gradually decreased. Electron microscopy showed macrophages containing pieces of PU. The size of the intracellular PU particles diminished and cells containing these remnants gradually disappeared after periods from I to 3 years. After 3 years an occasional, isolated macrophage with biomaterial remnants could be traced in both PU and copolymer explants. Single macrophages with biomaterial remnants were observed in the lymph nodes between 39 weeks and 1.5 years following implantation. It is concluded that the PU foam is biocompatible during degradation. After 3 years PU samples had been resorbed almost completely. These results indicate that the PU foam can be safely used as a biodegradable implant. (C) 2007 Wiley Periodicals, Inc.
C1 [van Leeuwen, M. B. M.; van Kooten, T. G.] Univ Groningen, Univ Med Ctr Groningen, Sect Biocompatibil & Biomat, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [van Minnen, B.; Bos, R. R. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, NL-9700 RB Groningen, Netherlands.
   [Kors, G.] Univ Groningen, Univ Med Ctr Groningen, Sect Electron Microscopy, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.
   [Zuidema, J.] Polyganics BV, NL-9713 GX Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Sect Biocompatibil & Biomat, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM kooten@med.umcg.nl
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   AN HA, 2000, BIOMATERIALS, V21, P2635
   AWANG MN, 1988, INT J ORAL MAX SURG, V17, P110, DOI 10.1016/S0901-5027(88)80162-0
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P1169, DOI 10.1002/jbm.820231006
   Cordewener FW, 2000, TISSUE ENG, V6, P413, DOI 10.1089/107632700418119
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   GETTER L, 1972, J ORAL SURG, V30, P344
   Groot J. H., 1996, BIOMATERIALS, V17, P163
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Laitinen O, 2002, J BIOMED MATER RES, V61, P33, DOI 10.1002/jbm.10115
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   SPAANS CJ, 2000, THESIS STATE U GRONI
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   van Minnen B, 2007, J ORAL MAXIL SURG, V65, P218, DOI 10.1016/j.joms.2005.11.120
   van Tienen T, 2004, AM J SPORTS MED, V32, P1182
   VANMINNEN B, 2006, UNPUB 3 YEAR IN VITR
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
NR 32
TC 21
Z9 21
U1 1
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 972
EP 982
DI 10.1002/jbm.a.31574
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000013
PM 17907243
DA 2018-10-19
ER

PT J
AU Faxalv, L
   Tengvall, P
   Lindahl, TL
AF Faxaelv, Lars
   Tengvall, Pentti
   Lindahl, Tomas L.
TI Imaging of blood plasma coagulation and its propagation at surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE coagulation; propagation; image processing; surface; biomaterial
ID QUARTZ-CRYSTAL MICROBALANCE; FREE OSCILLATION RHEOMETRY; WHOLE-BLOOD;
   ARTIFICIAL SURFACES; TIME; ACTIVATION; RESONANCE
AB A new method utilizing image capture and processing was developed for the analysis of blood plasma coagulation at surfaces. The coagulation was detected in a cuvette by time-lapse image capture of light scattering from the developing fibrin network. By image processing and computer analysis of the captured image data, both early detection of coagulation at the surface and the propagation phase of coagulation could be measured in the same experiment. It is possible to use both platelet-rich plasma (PRP) and platelet-free plasma (PFP) with the method, and thereby study the platelet contribution to both surface coagulation and propagation of coagulation. Two well-known model surfaces, hydrophilic and hydrophobic glass, were used in combination with PRP and PFP to illustrate the method. Hydrophilic glass activated coagulation significantly faster (PRP: 7.0 +/- 1.7 min, PFP: 5.9 +/- 1.2 min, n = 16) than hydrophobic glass (PRP: 50 +/- 14 min, PFP: 65+/-32 min, n = 16) in both PRP and PFP. Hydrophilic surfaces showed a faster initial propagation of coagulation adjacent to the surface (mean velocity: 0.14 +/- 0.05 min/minute) compared with the propagation observed further out from the surface (mean velocity: 0.05 +/- 0.01 mm/min). The method is very flexible and can be suitable for screening hemocompatibility of biomaterials. (C) 2007 Wiley Periodicals, Inc.
C1 [Faxaelv, Lars; Lindahl, Tomas L.] Linkoping Univ Hosp, Dept Clin Chem, Lab Med, SE-58185 Linkoping, Sweden.
   [Tengvall, Pentti] Linkoping Univ, Dept Phys Chem & Biol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
RP Faxalv, L (reprint author), Linkoping Univ Hosp, Dept Clin Chem, Lab Med, SE-58185 Linkoping, Sweden.
EM lars.faxalv@ibk.liu.se
CR Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Ranby M, 2003, SCAND J CLIN LAB INV, V63, P397, DOI 10.1080/00365510310002095
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Vikinge TP, 2000, BIOSENS BIOELECTRON, V15, P605, DOI 10.1016/S0956-5663(00)00125-1
   WALSH PN, 2006, HEMOSTASIS THROMBOSI, P1827
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 8
TC 8
Z9 8
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 1129
EP 1134
DI 10.1002/jbm.a.31529
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000030
PM 17907239
DA 2018-10-19
ER

PT J
AU Nakai, M
   Niinomi, M
   Akahori, T
   Ohtsu, N
   Nishimura, H
   Toda, H
   Fukui, H
   Ogawa, M
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Akahori, Toshikazu
   Ohtsu, Naofumi
   Nishimura, Hideki
   Toda, Hiroyuki
   Fukui, Hisao
   Ogawa, Michiharu
TI Surface hardening of biomedical Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V ELI by
   gas nitriding
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; titanium alloy; Ti-29Nb-13Ta-4.6Zr; Ti-6Al-4V; surface
   hardening; nitriding
ID TITANIUM-ALLOY; PERFORMANCE
AB The microstructure and hardness near the surface of a biomedical titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), subjected to gas nitriding at 1023-1223 K was investigated in comparison with the conventional biomedical Ti-6Al-4V ELI (Ti64). After gas nitriding, the microstructure near the specimen surface was observed by optical microscopy, X-ray diffraction (XRD), Auger electron spectroscopy (AES), and X-ray photoelectron spectroscopy (XPS). In both alloys, two types of titanium nitrides (TiN and Ti(2)N) are formed and the a phase is precipitated by gas nitriding. Furthermore, the oxygen impurity in the gas nitriding atmosphere reacts with the titanium nitrides; thus, TiO(2) is formed at the outermost titanium nitride layer. The surface hardening was also evaluated by Vickers hardness measurement. The Vickers hardness near the surface of TNTZ and Ti64 increases significantly by gas nitriding. (c) 2007 Published by Elsevier B.V.
C1 [Nakai, Masaaki; Niinomi, Mitsuo; Akahori, Toshikazu; Ohtsu, Naofumi] Tohoku Univ, Mat Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Nishimura, Hideki; Toda, Hiroyuki] Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   [Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Chikusa Ku, Nagoya, Aichi 4648650, Japan.
   [Ogawa, Michiharu] Daido Steel Co Ltd, R&D Lab, Minami Ku, Nagoya, Aichi 4578545, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Mat Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp
RI Ohtsu, Naofumi/L-6021-2018; Nakai, Masaaki/C-1919-2009; Niinomi,
   Mitsuo/B-5965-2011
OI Ohtsu, Naofumi/0000-0001-7935-3949; 
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   BARIN I., 1989, THERMOCHEMICAL DATA
   BERTOTI I, 1995, APPL SURF SCI, V84, P357, DOI 10.1016/0169-4332(94)00545-1
   DESMAISON J, 1979, OXID MET, V13, P505, DOI 10.1007/BF00812775
   Dong H, 2000, WEAR, V238, P131, DOI 10.1016/S0043-1648(99)00359-2
   Hanawa T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P145
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   KOFSTAD P, 1972, NONSTOICHIOMETRY DIF, P137
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MIZUTA S, 2001, KOTAIDENKIKAGAKU JIK, P84
   MURALEEDHARAN TM, 1992, THIN SOLID FILMS, V221, P104, DOI 10.1016/0040-6090(92)90802-I
   NAKAYAMA T, 1996, KINZOKU, V66, P986
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, TETSU TO HAGANE, V88, P567, DOI 10.2355/tetsutohagane1955.88.9_567
   Ohtsu N, 2007, MATER TRANS, V48, P105, DOI 10.2320/matertrans.48.105
   SWIFT P, 1982, SURF INTERFACE ANAL, V4, P47, DOI 10.1002/sia.740040204
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
NR 21
TC 29
Z9 32
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 15
PY 2008
VL 486
IS 1-2
BP 193
EP 201
DI 10.1016/j.msea.2007.08.065
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 306RX
UT WOS:000256266600029
DA 2018-10-19
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, Ying-Long
   Niinomi, Mitsuo
   Akahori, Toshikazu
TI Changes in mechanical properties of Ti alloys in relation to alloying
   additions of Ta and Hf
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 14th International Conference on the Strength of Materials (ICSMA 14)
CY JUN 04-09, 2006
CL Xian Jiaotong Univ, Xian, PEOPLES R CHINA
SP Inst Met Res, CAS
HO Xian Jiaotong Univ
DE dynamic Young's modulus; tensile property; Ti-Ta alloy; Ti-Hf alloy;
   metallic biomaterial
ID TITANIUM-ALLOYS; YOUNGS MODULUS
AB The effects of Ta and Hf on the dynamic Young's moduli and tensile properties of Ti-Ta and Ti-Hf alloys for biomedical applications are comparatively studied in this paper. It is found that with increasing Hf content, the dynamic Young's modulus of the Ti-Hf alloy gently decreases and its tensile strength keeps on increasing. In contrast, with increasing Ta content, the dynamic Young's modulus of the Ti-Ta alloys first decreases, reaches a minimum value of 69 GPa and then increases. In parallel, the tensile strength first increases, reaches a maximum value of 587 MPa, and then slightly decreases. It is shown that the addition of Hf has a slight influence on the dynamic Young's modulus and a strong influence on the tensile properties of the Ti-Hf alloy, while an increase of Ta content has a strong effect on both the dynamic Young's modulus and tensile properties of the Ti-Ta alloy. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Niinomi, Mitsuo; Akahori, Toshikazu] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi 9808577, Japan.
RP Zhou, YL (reprint author), Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, Foshan 528000, Peoples R China.
EM ylzhou_2@yahoo.com
RI Niinomi, Mitsuo/B-5965-2011
CR Boyer R., 1994, MAT PROPERTIES HDB T
   CUI XZ, 2000, METALLOGRAPHY HEAT T
   Dieter G. E., 1976, MECH METALLURGY
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
NR 12
TC 44
Z9 48
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 15
PY 2008
VL 483-84
SI SI
BP 153
EP 156
DI 10.1016/j.msea.2006.09.173
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 303WH
UT WOS:000256071100037
DA 2018-10-19
ER

PT J
AU Hsiong, SX
   Cooke, PH
   Kong, HJ
   Fishman, ML
   Ericsson, M
   Mooney, DJ
AF Hsiong, Susan X.
   Cooke, Peter H.
   Kong, Hyun-Joon
   Fishman, Marshall L.
   Ericsson, Maria
   Mooney, David J.
TI AFM imaging of RGD presenting synthetic extracellular matrix using gold
   nanoparticles
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE atomic force microscopy (AFM); biomaterials; electron microscopy;
   hydrogels; TEM
ID ATOMIC-FORCE MICROSCOPY; TEMPERATURE ELECTRON-MICROSCOPY; CELL-ADHESION;
   POLYSACCHARIDE ULTRASTRUCTURES; ALGINATE HYDROGELS; STEM-CELLS;
   DIFFERENTIATION; GELS; ORGANIZATION; SURFACES
AB Several high-resolution imaging techniques such as FESEM, TEM and AFM are compared with respect to their application on alginate hydrogels, a widely used polysaccharide biomaterial. A new AFM method applicable to RGD peptides covalently conjugated to alginate hydrogels is described. High-resolution images of RGD adhesion ligand distribution were obtained by labeling biotinylated RGD peptides with streptavidin-labeled gold nanoparticles. This method may broadly provide a useful tool for sECM characterization and design for tissue regeneration strategies.
C1 [Hsiong, Susan X.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Engn Sci Lab, SEAS, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Cooke, Peter H.; Fishman, Marshall L.] Agr Res Serv, Eastern Reg Res Ctr, USDA, Wyndmoor, PA USA.
   [Kong, Hyun-Joon] Univ Illinois, Dept Chem & Biomol Engn, Champaign, IL 61820 USA.
   [Ericsson, Maria] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Engn Sci Lab, SEAS, 325 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   Decho AW, 1999, CARBOHYD RES, V315, P330, DOI 10.1016/S0008-6215(99)00006-3
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Dupres V, 2007, BIOMATERIALS, V28, P2393, DOI 10.1016/j.biomaterials.2006.11.011
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fishman ML, 2007, BIOMACROMOLECULES, V8, P573, DOI 10.1021/bm0607729
   Fishman ML, 2004, BIOMACROMOLECULES, V5, P334, DOI 10.1021/bm0300655
   Franz C M, 2007, SCI STKE, P15
   Harrison D, 1997, Biomed Sci Instrum, V34, P41
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   LIU H, 2006, BIOMATERIALS, V28, P354
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   MORRIS VJ, 2004, ATOMIC FORCE MICROSC
   Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006
   Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P243, DOI 10.1002/bit.10286
   Shao ZF, 1995, ANNU REV CELL DEV BI, V11, P241, DOI 10.1146/annurev.cb.11.110195.001325
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   SMALL JV, 1986, J CELL BIOL, V102, P210, DOI 10.1083/jcb.102.1.210
   Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   Wong M, 2002, TISSUE ENG, V8, P979, DOI 10.1089/107632702320934074
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang HY, 2007, EXP CELL RES, V313, P3497, DOI 10.1016/j.yexcr.2007.08.001
NR 43
TC 4
Z9 4
U1 7
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN 11
PY 2008
VL 8
IS 6
BP 469
EP 477
DI 10.1002/mabi.200700313
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 315QX
UT WOS:000256895600001
PM 18383570
DA 2018-10-19
ER

PT J
AU Yang, Y
   Bolikal, D
   Becker, ML
   Kohn, J
   Zeiger, DN
   Simon, CG
AF Yang, Yanyin
   Bolikal, Durgadas
   Becker, Matthew L.
   Kohn, Joachim
   Zeiger, Diana N.
   Simon, Carl G., Jr.
TI Combinatorial polymer scaffold libraries for screening cell-biomaterial
   interactions in 3D
SO ADVANCED MATERIALS
LA English
DT Article
ID TYROSINE-DERIVED POLYCARBONATES; DEGRADABLE BIOMATERIALS; STEM-CELLS;
   DIFFERENTIATION; MICROARRAYS; SURFACES; CULTURE; BLENDS; LINE
AB A combinatorial method for screening cell-biomaterial interactions in 3D is presented; polymeric, salt-leached scaffolds with varied composition and properties are present in a 96-well plate. Previous high-throughput approaches for screening cell-material interactions have focused on planar 2D surfaces or films. However, biomaterials are commonly used in a 3D scaffold format and cells behave more physiologically when cultured in 3D.
C1 [Yang, Yanyin; Becker, Matthew L.; Zeiger, Diana N.; Simon, Carl G., Jr.] Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Simon, CG (reprint author), Natl Inst Stand & Technol, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011
   DOOLEY CT, 1994, SCIENCE, V266, P2019, DOI 10.1126/science.7801131
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   HORBETT TA, 1982, BIOMATERIALS INTERFA, P233
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOHN J, 2006, MED DEVICE DEV, V1, P35
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   SIMON CG, 2007, REV SCI INSTRUM, V78
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
NR 33
TC 43
Z9 43
U1 1
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUN 4
PY 2008
VL 20
IS 11
BP 2037
EP +
DI 10.1002/adma.200702088
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 317UC
UT WOS:000257044600002
DA 2018-10-19
ER

PT J
AU Yang, TL
   Young, TH
AF Yang, Tsung-Lin
   Young, Tai-Horng
TI The enhancement of submandibular gland branch formation on chitosan
   membranes
SO BIOMATERIALS
LA English
DT Article
DE salivary glands; submandibular gland (SMG); biomaterials; chitosan;
   collagen; branching morphogenesis
ID SALIVARY EPITHELIAL-CELLS; IN-VITRO; ACINAR-CELLS; MORPHOGENESIS;
   COLLAGEN; TISSUE; CHITIN; SULFATE; GROWTH; PROLIFERATION
AB Many glandular organs are developed by branching morphogenesis, an efficient and ubiquitous process for creating a larger cellular area for metabolic requirement. To regenerate a glandular organ, such as salivary glands, recapitulation of branching processes may be requisite. At present, the roles of biomaterials in regenerative branching have never been thoroughly explored. By culturing the embryonal submandibular gland (SMG) on different substrata, including polyvinyl alcohol (PVA), chitosan, and polycarbonate (PC), this study demonstrated for the first time that chitosan was capable of providing a more preferential environment for salivary gland branch formation. After culturing SMG explants on chitosan membranes, secreted extracellular matrices distributed in a reticular manner and formed thicker fibers beyond the extents of cell attachment, which were not found in PVA and PC. In the subsequent culture of explants just on the used chitosan substrates, these conditioned membranes were able to further enhance SMG branching. The fact that the promoting effects were eliminated with collagenase treatment and type I and type III collagen were identified within the adherent fibrillar extracellular matrix raised the possibility that the stimulating factors were collagen-originated. This indicates that, for SMG, chitosan is a bioactive substratum which enables cells to synthesize and deposit essential extracellular matrix, paving an important way for ensuing branch formation. Accordingly, the current study provides a larger scope to use chitosan as a biomaterial for recapitulating branching, which might be useful for the scaffold design of salivary gland regeneration. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Yang, Tsung-Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
EM thyoung@ntu.edu.tw
OI YANG, TSUNG-LIN/0000-0001-6521-8631
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   BARD JBL, 1977, J CELL BIOL, V74, P816, DOI 10.1083/jcb.74.3.816
   Chen MH, 2005, J BIOMED MATER RES A, V74A, P254, DOI 10.1002/jbm.a.30376
   Chen MH, 2005, TISSUE ENG, V11, P526, DOI 10.1089/ten.2005.11.526
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DOANE KJ, 1992, EXP CELL RES, V202, P113, DOI 10.1016/0014-4827(92)90410-A
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GRINNELL F, 1979, CELL, V17, P117, DOI 10.1016/0092-8674(79)90300-3
   GROBSTEIN C, 1965, SCIENCE, V150, P626, DOI 10.1126/science.150.3696.626
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Jaskoll T, 2001, BMC Dev Biol, V1, P5, DOI 10.1186/1471-213X-1-5
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   Joraku A, 2007, DIFFERENTIATION, V75, P318, DOI 10.1111/j.1432-0436.2006.00138.x
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   Kojima K, 1998, CARBOHYD POLYM, V37, P109, DOI 10.1016/S0144-8617(98)00055-1
   KRATOCHWIL K, 1986, DEV BIOL, V117, P596, DOI 10.1016/0012-1606(86)90328-3
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   NAKANISHI Y, 1993, DEV GROWTH DIFFER, V35, P371
   NAKANISHI Y, 1986, J EMBRYOL EXP MORPH, V96, P65
   NAKANISHI Y, 1988, DEVELOPMENT, V104, P51
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Umeda Y, 2001, DEV BIOL, V237, P202, DOI 10.1006/dbio.2001.0351
   Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305
   Warde P, 2002, INT J RADIAT ONCOL, V54, P9, DOI 10.1016/S0360-3016(02)02890-0
   Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123
NR 40
TC 26
Z9 28
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 16
BP 2501
EP 2508
DI 10.1016/j.biomaterials.2008.02.014
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 294TG
UT WOS:000255428100007
PM 18316118
DA 2018-10-19
ER

PT J
AU Kelly, S
   Regan, EM
   Uney, JB
   Dick, AD
   McGeehan, JP
   Mayer, EJ
   Claeyssens, F
AF Kelly, Stephen
   Regan, Edward M.
   Uney, James B.
   Dick, Andrew D.
   McGeehan, Joseph P.
   Mayer, Eric J.
   Claeyssens, Frederik
CA Bristol Biochip Grp
TI Patterned growth of neuronal cells on modified diamond-like carbon
   substrates
SO BIOMATERIALS
LA English
DT Article
DE laser ablation; neural cell; carbon; diamond; micropatterning
ID IMMERSION ION-IMPLANTATION; AMORPHOUS RED PHOSPHORUS; PULSED-LASER
   ABLATION; IN-VITRO; THIN-FILMS; DLC COATINGS; BLOOD COMPATIBILITY;
   ENDOTHELIAL-CELLS; PLATELET-ADHESION; RAMAN-SPECTRA
AB Diamond-like carbon (DLC) has been explored as a biomaterial with potential use for coating implantable devices and surgical instruments. In this study the interaction of DLC with mammalian neuronal cells has been studied along with its modifications to improve its function as a biomaterial. We describe the use of DLC, oxidised DLC and phosphorus-doped DLC to support the growth and survival of primary central nervous system neurones and neuroblastoma cells. None of these substrates were cytotoxic and primary neurones adhered better to phosphorus-doped DLC than unmodified DLC. This property was used to culture cortical neurones in a predetermined micropattern. This raises the potential of DLC as a biomaterial for central nervous system (CNS) implantation. Furthermore, patterned DLC and phosphorus-doped DLC can direct neuronal growth, generating a powerful tool to study neuronal networks in a spatially distinct way. This study reports the generation of nerve cell patterns via patterned deposition of DLC. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Claeyssens, Frederik] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.
   [McGeehan, Joseph P.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England.
   [Regan, Edward M.; Dick, Andrew D.; Mayer, Eric J.] Univ Bristol, Bristol Eye Hosp, Bristol BS1 2LX, Avon, England.
   [Kelly, Stephen; Regan, Edward M.; Uney, James B.] Univ Bristol, Clin Sci S Bristol, Henry Wellcome LINE, Bristol BS8 1TH, Avon, England.
   Univ Bristol, Dept Clin Sci, Bristol BS8 1TH, Avon, England.
   Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England.
   [Bristol Biochip Grp] Univ Bristol, Sch Chem, Bristol BS8 1TH, Avon, England.
RP Claeyssens, F (reprint author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.
EM e.mayer@bristol.ac.uk; f.claeyssens@bristol.ac.uk
RI Kelly, Stephen/A-8307-2010; Claeyssens, Frederik/E-4781-2011
OI Claeyssens, Frederik/0000-0002-1030-939X
FU Engineering and Physical Sciences Research Council [EP/C532066/1];
   Wellcome Trust
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ANTONIUCCI D, 2000, AM J CARDIOL, V86, P171
   Ashfold MNR, 2004, CHEM SOC REV, V33, P23, DOI 10.1039/b207644f
   Ball M, 2004, J BIOMED MATER RES A, V70A, P380, DOI 10.1002/jbm.a.30066
   Bartorelli AL, 2002, CATHETER CARDIO INTE, V55, P150, DOI 10.1002/ccd.10037
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Claeyssens F, 2004, DALTON T, P3085, DOI 10.1039/b402740j
   Claeyssens F, 2004, APPL PHYS A-MATER, V79, P1237, DOI 10.1007/s00339-004-2726-7
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   FASOL G, 1984, SOLID STATE COMMUN, V52, P307, DOI 10.1016/0038-1098(84)90832-9
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Fuge GM, 2004, DIAM RELAT MATER, V13, P1442, DOI 10.1016/j.diamond.2003.11.069
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Gorham J, 2005, J PHYS CHEM B, V109, P20379, DOI 10.1021/jp0521196
   Gross GW, 1999, J INTEL MAT SYST STR, V10, P558, DOI 10.1106/XC9U-BMJ8-FE1A-EUNQ
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Huang LCL, 2004, LANGMUIR, V20, P5879, DOI 10.1021/la0495736
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kumar R.R., 2007, J BIOMEDICAL MAT R B, V83B, P72
   Kumari TV, 2002, BIO-MED MATER ENG, V12, P329
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Kwok SCH, 2006, NEW DIAM FRONT C TEC, V16, P39
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Kwok SCH, 2004, J BIOMED MATER RES A, V70A, P107, DOI 10.1002/jbm.a.30070
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Nurdin N., 2003, EUR CELLS MATER, V5, P26
   Okpalugo TIT, 2004, J BIOMED MATER RES A, V71A, P201, DOI 10.1002/jbm.a.30104
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   OLEGO DJ, 1984, SOLID STATE COMMUN, V52, P311, DOI 10.1016/0038-1098(84)90833-0
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Prawer S, 1996, DIAM RELAT MATER, V5, P433, DOI 10.1016/0925-9635(95)00363-0
   Salahas A, 2007, ANGIOLOGY, V58, P203, DOI 10.1177/0003319707300360
   Schaefer O, 2004, CLIN RADIOL, V59, P1128, DOI 10.1016/j.crad.2004.05.016
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Tran HS, 1999, J INVEST SURG, V12, P133
   Xiao XC, 2006, J BIOMED MATER RES B, V77B, P273, DOI 10.1002/jbm.b.30448
NR 46
TC 46
Z9 47
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 17
BP 2573
EP 2580
DI 10.1016/j.biomaterials.2008.03.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 307JE
UT WOS:000256314400002
PM 18359076
DA 2018-10-19
ER

PT J
AU Peyton, SR
   Kim, PD
   Ghajar, CM
   Seliktar, D
   Putnam, AJ
AF Peyton, Shelly R.
   Kim, Peter D.
   Ghajar, Cyrus M.
   Seliktar, Dror
   Putnam, Andrew J.
TI The effects of matrix stiffness and RhoA on the phenotypic plasticity of
   smooth muscle cells in a 3-D biosynthetic hydrogel system
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); hydrogel; mechanical properties;
   polyethylene oxide; smooth muscle cell
ID PEG HYDROGELS; COLLAGEN MATRIX; MC3T3-E1 CELLS; TISSUE; MIGRATION;
   FIBRINOGEN; ADHESION; TENSION; GTPASES; KINASE
AB Studies using 2-D cultures have shown that the mechanical properties of the extracellular matrix (ECM) influence cell migration, spreading, proliferation, and differentiation; however, cellular mechanosensing in 3-D remains under-explored. To investigate this topic, a unique biomaterial system based on poly(ethylene glycol)-conjugated fibrinogen was adapted to study phenotypic plasticity in smooth muscle cells (SMCs) as a function of ECM mechanics in 3-D. Tuning the compressive modulus between 448 and 5804 Pa modestly regulated SMC cytoskeletal assembly in 3-D3, with spread cells in stiff matrices having a slightly higher degree of F-actin bundling after prolonged culture. However, vinculin expression in all 3-D conditions was qualitatively low and was not assembled into the classic focal adhesions typically seen in 2-D cultures. Given the evidence that RhoA-mediated cytoskeletal contractility represents a critical node in mechanosensing, we molecularly upregulated contractility by inducing SMCs to express constitutively active RhoA. In these cells, F-actin bundling and total vinculin expression increased, and focal adhesion-like structures began to emerge, consistent with RhoA' mechanism of action in cells cultured on 2-D substrates. Furthermore, SMC proliferation in 3-D did not depend significantly on matrix stiffness, and was reduced by constitutive activation of RhoA irrespective of ECM mechanical properties. Conversely, the expression of contractile markers globally increased with constitutive RhoA activation and depended on 3-D matrix stiffness only in cells with heightened RhoA activity. Combined, these data suggest that the synergistic effects of ECM mechanics and RhoA activity on SMC phenotype in 3-D are distinct from those in 2-D, and highlight the importance of studying the mechanical role of cell-matrix interactions in tunable 3-D environments. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Kim, Peter D.; Ghajar, Cyrus M.; Putnam, Andrew J.] Univ Calif Irvine, Dept Biomed Engn, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
   [Peyton, Shelly R.; Putnam, Andrew J.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
   [Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Putnam, AJ (reprint author), Univ Calif Irvine, Dept Biomed Engn, Henry Samueli Sch Engn, 3107 Nat Sci 2, Irvine, CA 92697 USA.
EM aputnam@uci.edu
RI Peyton, Shelly/F-5340-2012; Putnam, Andrew/E-8643-2010
OI Putnam, Andrew/0000-0002-1262-4377; Peyton, Shelly/0000-0002-7364-8727;
   Seliktar, Dror/0000-0001-6964-8567
FU NCRR NIH HHS [P41 RR001192, P41 RR001192-20, #P41-RR01192]
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Bi D, 2005, CIRC RES, V96, P890, DOI 10.1161/01.RES.0000163018.66460.85
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chapados R, 2006, CIRC RES, V99, P837, DOI 10.1161/01.RES.0000246172.77441.f1
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   DIKOVSKY D, 2008, BIOPHYS J
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fung YC, 1993, BIOMECHANICS MECH PR
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Kamiyama Masumi, 2003, J Atheroscler Thromb, V10, P117
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200
   Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A
   Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje
   OSOL G, 1995, J VASC RES, V32, P275, DOI 10.1159/000159102
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578
   Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104
   Sawada N, 2000, CIRCULATION, V101, P2030, DOI 10.1161/01.CIR.101.17.2030
   Schmidt O, 2006, BIOTECHNOL BIOENG, V95, P1061, DOI 10.1002/bit.21072
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005
NR 47
TC 142
Z9 143
U1 4
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 17
BP 2597
EP 2607
DI 10.1016/j.biomaterials.2008.02.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 307JE
UT WOS:000256314400005
PM 18342366
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pham, QP
   Kasper, FK
   Baggett, LS
   Raphael, RM
   Jansen, JA
   Mikos, AG
AF Pham, Quynh P.
   Kasper, F. Kurtis
   Baggett, L. Scott
   Raphael, Robert M.
   Jansen, John A.
   Mikos, Antonios G.
TI The influence of an in vitro generated bone-like extracellular matrix on
   osteoblastic gene expression of marrow stromal cells
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix; gene expression; growth factors; osteoblast;
   scaffold
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; MC3T3-E1 CELLS; DIFFERENTIATION;
   PHENOTYPE; PROTEINS; DECORIN; BINDING; REPAIR; TISSUE
AB The function and development of cells rely heavily on the signaling interactions with the surrounding extracellular matrix (ECM). Therefore, a tissue engineering scaffold should mimic native ECM to recreate the in vivo environment. Previously, we have shown that an in vitro generated ECM secreted by cultured cells enhances the mineralized matrix deposition of marrow stromal cells (MSCs). in this study, MSC expression of 45 bone-related genes using real-time reverse transcriptase polymerase chain reaction (RT-PCR) was determined. Upregulation of osteoblastic markers such as collagen type 1, matrix extracellular phosphoglycoprotein with ASARM motif, parathyroid hormone receptor, and osteocalcin, indicated that the MSCs on plain titanium scaffolds differentiated down the osteoblastic lineage and deposited a mineralized matrix on day 12. Significant mineralized matrix deposition was observed as early as day 4 on ECM-containing scaffolds and was associated with the enhancement in expression of a subset of osteoblast-specific genes that included a 2-fold increase in osteopontin expression at day 1 and a 6.5-fold increase in osteocalcin expression at day 4 as well as downregulation of chondrogenic gene markers. These results were attributed to the cellular interactions with growth factors and matrix molecules that are likely present in the in vitro generated ECM since the genes for insulin-like growth factor 1, insulin-like growth factor 2, vascular endothelial growth factor, dentin matrix protein, collagen type IV, cartilage oligomeric protein, and matrix metalloproteinase 13 were significantly upregulated during ECM construct generation. Overall, the data demonstrate that modulation of MSC differentiation occurs at the transcriptional level and gene expression of bone-related proteins is differentially regulated by the ECM. This study presents enormous implications for tissue engineering strategies, as it demonstrates that modification of a biomaterial with an in vitro generated ECM containing cell-generated bioactive signaling molecules can effectively direct gene expression and differentiation of seeded progenitor cell populations. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Pham, Quynh P.; Kasper, F. Kurtis; Raphael, Robert M.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Baggett, L. Scott] Rice Univ, Dept Stat, Houston, TX 77251 USA.
   [Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM mikos@rice.edu
RI Jansen, John/H-8055-2014; Kasper, Fred/H-5719-2011
FU NCI NIH HHS [CA-16672]; NIAMS NIH HHS [(R01-AR42639]; NIBIB NIH HHS [5
   R01 EB005173-02]; NIDDK NIH HHS [5 T90 DK070121-03]
CR Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6558
   Aubin JE, 1995, BONE, V17, P77
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   BI Y, 2005, J BIOL CHEM
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   HEDBOM E, 1993, J BIOL CHEM, V268, P27307
   Hoshi K, 1999, J BONE MINER RES, V14, P273, DOI 10.1359/jbmr.1999.14.2.273
   HUANG Z, 2007, TISSUE ENG
   Kondo H, 1997, J BONE MINER RES, V12, P2089, DOI 10.1359/jbmr.1997.12.12.2089
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marvanova M, 2004, NEUROPSYCHOPHARMACOL, V29, P1070, DOI 10.1038/sj.npp.1300398
   Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x
   Matsuura T, 2005, EUR J ORAL SCI, V113, P225, DOI 10.1111/j.1600-0722.2005.00208.x
   Monticone M, 2004, J CELL BIOCHEM, V92, P733, DOI 10.1002/jcb.20120
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198
   Ninomiya K, 2007, BIOCHEM BIOPH RES CO, V362, P460, DOI 10.1016/j.bbrc.2007.07.193
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   ROBEY PG, 2002, PRINCIPLES BONE BIOL, P225
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Schiavi SC, 2006, NAT GENET, V38, P1230, DOI 10.1038/ng1106-1230
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Wang PP, 2004, BIOCHEM BIOPH RES CO, V320, P712, DOI 10.1016/j.bbrc.2004.05.213
   Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36
NR 45
TC 98
Z9 102
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 18
BP 2729
EP 2739
DI 10.1016/j.biomaterials.2008.02.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 304YF
UT WOS:000256144300004
PM 18367245
DA 2018-10-19
ER

PT J
AU Bera, T
   Vivek, AN
   Saraf, SK
   Ramachandrarao, P
AF Bera, Tanmay
   Vivek, A. N.
   Saraf, S. K.
   Ramachandrarao, P.
TI Characterization of biomimetically synthesized Hap-Gel nanocomposites as
   bone substitute
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID TRICALCIUM PHOSPHATE; DEFICIENT APATITE; BIOCERAMICS
AB There is an increasing demand for an affordable and easy-to-fabricate material to help patients having a long bone gap. In this paper, we describe the biomimetic synthesis of Hap-Gel in situ nanocomposite powders with varied proportions. Their biocompatibility and bone regeneration abilities were assessed on a rabbit model. The use of Hap crystals and Gel molecule, the soluble form of bone protein, makes the nanocomposites comparable to natural bone in constituents. The application of biomimetic principles improves crystal morphology and the interaction of Hap crystals with the Gel molecules as seen through in vitro characterizations. Out of the various compositions studied, one with 80: 20 proportions of Hap to Gel proved to be closest to the characteristics of natural bone. The immunological response to this composite, assessed through intradermal inoculation, did not reveal any reaction. The in vivo implantation studies in the femoral condyle of the animals, as assessed by serial post-operative follow-up radiography and the histological evaluation, revealed a good biocompatibility and bone-regeneration ability of the material. Thus, nanocomposites of Hap-Gel have a great potential for serving as an effective and affordable biomaterial for bone grafting applications.
C1 [Bera, Tanmay] Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
   [Vivek, A. N.; Saraf, S. K.] Banaras Hindu Univ, Inst Med Sci, Dept Orthoped, Varanasi 221005, Uttar Pradesh, India.
   [Ramachandrarao, P.] Int Adv Res Ctr Powder Metallurgy & New Mat ARCI, Hyderabad 500005, Andhra Pradesh, India.
RP Bera, T (reprint author), Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
EM pramachandra_rao@yahoo.com
CR BERMAN A, 1988, NATURE, V331, P546
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gilbert PUPA, 2005, REV MINERAL GEOCHEM, V59, P157, DOI 10.2138/rmg.2005.59.7
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hao H, 2004, BIOMATERIALS, V25, P431, DOI 10.1016/S0142-9612(03)00550-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KATTHAGEN BD, 1987, BONE REGENERATION BO
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu GP, 2007, BIOMED MATER, V2, P78, DOI 10.1088/1748-6041/2/2/004
   MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Oudadesse H, 2007, BIOMED MATER, V2, pS59, DOI 10.1088/1748-6041/2/1/S09
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RAMACHANDRARAO P, 2003, SADHNA, V28, P657, DOI DOI 10.1007/BF02706452
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
NR 21
TC 9
Z9 9
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2008
VL 3
IS 2
AR 025001
DI 10.1088/1748-6041/3/2/025001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309IN
UT WOS:000256454000002
PM 18458374
DA 2018-10-19
ER

PT J
AU Huang, TH
   Muhlbauer, RC
   Tang, CH
   Chen, HI
   Chang, GL
   Huang, YW
   Lai, YT
   Lin, HS
   Yang, WT
   Yang, RS
AF Huang, Tsang-Hai
   Muehlbauer, Roman C.
   Tang, Chih-Hsin
   Chen, Hsiun-Ing
   Chang, Guan-Liang
   Huang, Yi-Wei
   Lai, Yu-Ting
   Lin, Hsin-Shi
   Yang, Wei-Ting
   Yang, Rong-Sen
TI Onion decreases the ovariectomy-induced osteopenia in young adult rats
SO BONE
LA English
DT Article
DE osteoporosis; phytotherapy; alendronate; osteoclast; menopause
ID BONE-MINERAL DENSITY; MECHANICAL-PROPERTIES; VEGETABLE CONSUMPTION;
   ALENDRONATE TREATMENT; DIETARY PATTERNS; FRUIT; OSTEOPOROSIS;
   METABOLISM; MASS; STRENGTH
AB It has been suggested that fruit and vegetable consumption are associated with good bone health. Onion, in particular, has been verified in its efficacy in bone resorption activity. In this study, we further investigated the effects of an onion-containing diet on ovariectomy-induced bone loss using methods of serum marker assay, bistomorphometric analysis and biomechanical tests. Sixty-four female Wistar rats (14-week-old) with sham operations or ovariectomy were assigned to 6 groups: CON, sham-operated control group; OVX, ovariectomized group; ALN, ovariectomized rats treated with alendronate (1 mg/kg/day, p.o.); and 3% ON, 7% ON and 14% ON, ovariectomized rats fed with diets containing 3%, 7% and 14% (wt/wt) onion powder, respectively. Animals were sacrificed after a six-week treatment course. In the serum marker assay, alendronate and all three onion-enriched diets significantly decreased serum calcium level (p<0.05). Both 14% ON group and the ALN group even showed similarly lower level of serum osteocalcin (p<0.05), suggesting a down-regulation of bone turnover. The histomorphometric analysis showed that ovariectomy markedly decrease bone trabeculae. The ALN and 14% ON rats were 80% and 46% higher, respectively, in BV/TV than the OVX rats (p<0.05), and the rats fed with onion-enriched food showed a lesser ovariectomy-induced bone loss in a dose-dependent manner. Additionally, both ALN and 14% ON groups had significantly more trabecular number, less separated trabeculae, and fewer osteoclasts (p<0.05), but the protective efficacy from the 14% onion-enriched diet was slightly inferior to that of alendronate. Ovariectomy also significantly decreased tissue weight and biomechanical strength in the OVX group (p<0.05). The ALN and 14% ON groups equivalently showed a lesser decrease in tissue weight, though the difference was not significant. On the other hand, both the ALN and 14% ON groups represented similar biomaterial properties of femurs, and both reduced the ovariectomy-induced decrease in bending load and bending energy (p<0.05). The present study further verified that an onion-enriched diet could counteract ovariectomy-induced bone loss and deterioration of biomechanical properties. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Coll Med, Dept Orthopaed, Taipei 100, Taiwan.
   [Huang, Tsang-Hai; Lin, Hsin-Shi] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan.
   [Chen, Hsiun-Ing] Natl Cheng Kung Univ, Dept Physiol, Tainan 701, Taiwan.
   [Chang, Guan-Liang; Yang, Wei-Ting] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
   [Huang, Yi-Wei; Lai, Yu-Ting] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan.
   [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung 404, Taiwan.
   [Muehlbauer, Roman C.] Univ Bern, Dept Clin Res, Bone Biol Grp, CH-3010 Bern, Switzerland.
RP Yang, RS (reprint author), Natl Taiwan Univ & Hosp, Coll Med, Dept Orthopaed, 7 Chung-Shan S Rd, Taipei 100, Taiwan.
EM rsyang@ntuh.gov.tw
RI Tang, Chih Hsin/O-5212-2015
OI Tang, Chih Hsin/0000-0002-7113-8352; Yang, Rong-Sen/0000-0002-0553-4779
CR Alatalo SL, 2003, J BONE MINER RES, V18, P134, DOI 10.1359/jbmr.2003.18.1.134
   Arjmandi BH, 2002, J WOMEN HEALTH GEN-B, V11, P61, DOI 10.1089/152460902753473471
   Arjmandi BH, 1996, J NUTR, V126, P161
   Azuma Y, 1998, J PHARMACOL EXP THER, V286, P128
   Bagi CM, 1997, CALCIFIED TISSUE INT, V61, P336, DOI 10.1007/s002239900344
   Cai DJ, 2005, J BONE MINER RES, V20, P828, DOI 10.1359/JBMR.041236
   Chachra D, 2000, BIOMED SCI INSTRUM, V36, P123
   Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883
   da Paz LHBC, 2001, BRAZ J MED BIOL RES, V34, P1015, DOI 10.1590/S0100-879X2001000800007
   Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b
   Draper CR, 1997, J NUTR, V127, P1795
   Friedman AW, 2006, JCR-J CLIN RHEUMATOL, V12, P70, DOI 10.1097/01.rhu.0000208612.33819.8c
   Frolik CA, 1996, BONE, V18, P621, DOI 10.1016/8756-3282(96)00085-3
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916
   Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Horcajada-Molteni MN, 2000, J BONE MINER RES, V15, P2251, DOI 10.1359/jbmr.2000.15.11.2251
   Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Ito M, 2002, JPN J PHARMACOL, V89, P255, DOI 10.1254/jjp.89.255
   Iwamoto J, 2006, EXP ANIM TOKYO, V55, P357, DOI 10.1538/expanim.55.357
   KALU DN, 1989, ENDOCRINOLOGY, V124, P7, DOI 10.1210/endo-124-1-7
   Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064
   Lindsay R, 1997, OSTEOPOROSIS INT, V7, P1
   Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x
   McGartland CP, 2004, AM J CLIN NUTR, V80, P1019
   MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902
   Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915
   Muhlbauer R. C., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P137
   Muhlbauer RC, 1999, NATURE, V401, P343, DOI 10.1038/43824
   Muhlbauer RC, 2003, J NUTR, V133, P3592
   Muhlbauer RC, 2002, J BONE MINER RES, V17, P1230, DOI 10.1359/jbmr.2002.17.7.1230
   Muhlbauer RC, 2001, J BONE MINER RES, V16, P970, DOI 10.1359/jbmr.2001.16.5.970
   New SA, 2000, AM J CLIN NUTR, V71, P142
   Ogawa K, 2005, J BONE MINER METAB, V23, P351, DOI 10.1007/s00774-005-0612-9
   Okubo H, 2006, AM J CLIN NUTR, V83, P1185
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Peng ZQ, 1997, BONE, V20, P207, DOI 10.1016/S8756-3282(96)00369-9
   Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420
   Reid Ian R, 2002, Expert Opin Drug Saf, V1, P93, DOI 10.1517/14740338.1.1.93
   RUTH EB, 1953, AM J ANAT, V93, P429, DOI 10.1002/aja.1000930306
   Tucker KL, 2002, AM J CLIN NUTR, V76, P245
   Tucker KL, 1999, AM J CLIN NUTR, V69, P727
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311
   van der Meulen MCH, 2001, BONE, V29, P101, DOI 10.1016/S8756-3282(01)00491-4
   Vatanparast H, 2005, AM J CLIN NUTR, V82, P700
   Wetli HA, 2005, J AGR FOOD CHEM, V53, P3408, DOI [10.1021/jf040457i, 10.1021/jf040457l]
   Ye She-Fang, 2003, Endocr Regul, V37, P145
   Yeh IT, 2007, ADV ANAT PATHOL, V14, P17, DOI 10.1097/PAP.0b013e31802ef00f
NR 51
TC 17
Z9 19
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD JUN
PY 2008
VL 42
IS 6
BP 1154
EP 1163
DI 10.1016/j.bone.2008.01.032
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 307PE
UT WOS:000256330000018
PM 18387868
DA 2018-10-19
ER

PT J
AU Nie, M
   Zhang, TP
   Pei, CX
   Quan, DX
   Chen, N
AF Nie Min
   Zhang TianPeng
   Pei ChangXing
   Quan DongXiao
   Chen Nan
TI The U/Omega effect of electricity parameters of the lotus root silk in
   the liquor with different pH values
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE silk of lotus root; biomedicine engineering material; U/Omega effect; pH
   value of liquor
ID TISSUE; CELLS
AB The silk of lotus root is a kind of natural biomaterial with the advantages of easy absorbing and dissolving and poisonless. It may become a new engineering material for clinic and tissue engineering. However, the relationship between its electricity parameters and the pH values of the liquor that the silk is dipped in is unknown presently. The electricity parameters of inductance, capacitance and impedance of the silk were measured in the environment with the temperature ranging from 23 degrees C to 25 degrees C and the humidity ranging from 45% to 55% when it was dipped in the liquor with different pH values for 24 h. The results show that the inductance and impedance vary in Omega shape curves with the liquor pH value, and the capacitance varies in Omega shape curve. The minimal value of the Omega curves and the maximal value of the Omega curve appear at the point where the pH value equals to Omega. The phenomena are called the U/Omega effect. It means that the silk has perfect biocompatibility with human tissues. The study results may imply that the silk have broader potential applications in biomedicine, tissue engineering and bioelectronics.
C1 [Nie Min; Zhang TianPeng; Pei ChangXing; Quan DongXiao; Chen Nan] Xidian Univ, State Key Lab ISN, Xian 710071, Peoples R China.
   [Nie Min] Xian Inst Post & Telecommun, Xian 710061, Peoples R China.
RP Nie, M (reprint author), Xidian Univ, State Key Lab ISN, Xian 710071, Peoples R China.
EM mnie@xidian.edu.cn
CR BLAU HM, 2001, CELL, V105, P8292
   BRIEN FJ, 2005, BIOMATERIALS, V26, P433
   Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025
   Fujita M, 2005, TISSUE ENG, V11, P1346, DOI 10.1089/ten.2005.11.1346
   HAYNES CA, 1992, J PHYS CHEM-US, V96, P905, DOI 10.1021/j100181a069
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin YZ, 2001, ACTA CHIM SINICA, V59, P2110
   MA L, 2001, SPACE MED ENG, V15, P199
   PATRICIA YW, 2005, NAT MATER, V4, P568
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Scott J., 2005, NAT MATER, V4, P518
   VINCENT LV, 1981, J COLLOID INTERF SCI, V79, P548
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WU L, 2005, THESIS NW U AGR FORE
NR 16
TC 0
Z9 0
U1 0
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUN
PY 2008
VL 53
IS 12
BP 1924
EP 1928
DI 10.1007/s11434-008-0260-2
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 316PU
UT WOS:000256963000019
DA 2018-10-19
ER

PT J
AU Tang, CY
   Chen, DZ
   Yue, TM
   Chan, KC
   Tsui, CP
   Yu, PHF
AF Tang, C. Y.
   Chen, D. Z.
   Yue, T. M.
   Chan, K. C.
   Tsui, C. P.
   Yu, Peter H. F.
TI Water absorption and solubility of PHBHV/HA nanocomposites
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE polymer-matrix composites (PMCs); nanostructures; ceramics; thermal
   properties; water absorption
ID MECHANICAL-PROPERTIES; MOISTURE ABSORPTION; COMPOSITES; HYDROXYAPATITE;
   DIFFUSION; NANOINDENTATION; TEMPERATURE; POLYMERS; SORPTION; RESINS
AB A thorough understanding of the influence of bioceramic phase on the water absorption and solubility of biomaterial is of importance in tailoring its degradation and the formation of bone-like apatite for clinical implant applications in a wet environment. The objective of this study was to characterize and quantify the water transport properties and solubility of biomaterial incorporating poly(3-hydroxy-butyrate-co-3-hydroxyvalerate) (PHBHV) and nano-hydroxyapatite (nano-HA) modified with a silane coupling agent. Solubility and transport parameters such as diffusion, permeability, and sorption coefficients were determined at three different temperatures using the weighing method. When the environmental temperature reached 60 degrees C, the water uptake of the nanocomposite reaches equilibrium after a normally fast absorption process, and then decreases as the immersion time is prolonged due to the solubility of the material. Moreover, this phenomenon becomes more significant with increasing the volume fraction of nano-HA. Compared to those for the base resin, the diffusion coefficients for the nanocomposite decrease, whereas the sorption coefficients and the solubility show an opposite tendency. All of the transportation parameters are temperature sensitive and obey the Arrhenius or the van't Hoff relationship. Results from thermodynamic analysis imply that when using a high filler loading level (>= 20 vol%) the sorption of the nanocomposite is mainly dominated by a Langmuir sorption mode giving an exothermic process. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Tang, C. Y.; Chen, D. Z.; Yue, T. M.; Chan, K. C.; Tsui, C. P.] Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
   [Yu, Peter H. F.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.
RP Chen, DZ (reprint author), Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
EM mfdazhu@polyu.edu.hk
RI Chan, K.C./A-2311-2014; TSUI, CP/A-4087-2009
OI Chan, K.C./0000-0002-6173-5532; YUE, Tai Man/0000-0001-9380-5067; TSUI,
   Chi Pong/0000-0001-9239-9386; Tang, Chak Yin/0000-0003-2577-024X
CR Aminabhavi TM, 1996, EUR POLYM J, V32, P1117, DOI 10.1016/0014-3057(96)00021-3
   ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   Balac I, 2006, MATER SCI FORUM, V518, P501, DOI 10.4028/www.scientific.net/MSF.518.501
   Bao LR, 2002, POLYMER, V43, P3987, DOI 10.1016/S0032-3861(02)00189-1
   Becker O, 2004, EUR POLYM J, V40, P187, DOI 10.1016/j.eurpolymj.2003.09.008
   Bond DA, 2005, J COMPOS MATER, V39, P2113, DOI 10.1177/0021998305052030
   BRADEN M, 1976, J DENT RES, V55, P730, DOI 10.1177/00220345760550050501
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chow CPL, 2007, COMPOS SCI TECHNOL, V67, P306, DOI 10.1016/j.compscitech.2006.08.005
   Chuang T. H., 2004, INT J POLYM MATER, V53, P553
   CRANK J, 1957, MATH DIFFUSION, P45
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   Hashimoto M, 2006, MATER RES BULL, V41, P515, DOI 10.1016/j.materresbull.2005.09.014
   Hodzic A, 2004, COMPOS SCI TECHNOL, V64, P2185, DOI 10.1016/j.compscitech.2004.03.011
   Kim JK, 2005, COMPOS SCI TECHNOL, V65, P805, DOI 10.1016/j.compscitech.2004.10.014
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P293, DOI 10.1016/S0142-9612(99)00180-5
   Li HY, 2005, COMPOS SCI TECHNOL, V65, P2226, DOI 10.1016/j.compscitech.2005.04.051
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Malacarne J, 2006, DENT MATER, V22, P973, DOI 10.1016/j.dental.2005.11.020
   Mathieu LM, 2006, COMPOS SCI TECHNOL, V66, P1606, DOI 10.1016/j.compscitech.2005.11.012
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Santos C, 2002, BIOMATERIALS, V23, P1897, DOI 10.1016/S0142-9612(01)00331-3
   Shanahan MER, 1998, POLYMER, V39, P1155, DOI 10.1016/S0032-3861(97)00277-2
   Sideridou I, 2004, BIOMATERIALS, V25, P367, DOI 10.1016/S0142-9612(03)00529-5
   Sreekala MS, 2002, COMPOS PART A-APPL S, V33, P763, DOI 10.1016/S1359-835X(02)00032-5
   Tang CY, 2006, J APPL POLYM SCI, V102, P5388, DOI 10.1002/app.25016
   Uskokovic PS, 2007, J EUR CERAM SOC, V27, P1559, DOI 10.1016/j.jeurceramsoc.2006.04.122
   Vallittu PK, 1999, J ORAL REHABIL, V26, P666, DOI 10.1046/j.1365-2842.1999.00431.x
   Wang YJ, 2007, MATER LETT, V61, P1071, DOI 10.1016/j.matlet.2006.06.042
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
   Yoon JS, 2000, J APPL POLYM SCI, V77, P1716, DOI 10.1002/1097-4628(20000822)77:8<1716::AID-APP8>3.3.CO;2-6
   Zhao JL, 2004, MATER LETT, V58, P163, DOI 10.1016/S0167-577X(03)00437-3
NR 33
TC 27
Z9 29
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JUN
PY 2008
VL 68
IS 7-8
BP 1927
EP 1934
DI 10.1016/j.compscitech.2007.12.003
PG 8
WC Materials Science, Composites
SC Materials Science
GA 304US
UT WOS:000256135200043
DA 2018-10-19
ER

PT J
AU Laib, S
   Petit, M
   Bodio, E
   Fatimi, A
   Weiss, P
   Bujoli, B
AF Laib, Samia
   Petit, Marc
   Bodio, Ewen
   Fatimi, Ahmed
   Weiss, Pierre
   Bujoli, Bruno
TI Labeling of a self-hardening bone substitute using ruthenium
   tris-bipyridine complexes, for the analysis of its in vivo metabolism
SO COMPTES RENDUS CHIMIE
LA English
DT Article; Proceedings Paper
CT GECOM-CONCOORD Conference
CY MAY 20-25, 2007
CL Plancoet, FRANCE
DE labeling; bipyridine; ruthenium; hydrogel; biomaterial; cellulose;
   self-setting scaffold
ID SOLID-PHASE SYNTHESIS; GENERAL-PROPERTIES; REDOX DERIVATIVES;
   BIOMATERIALS; SEPARATION; INGROWTH; LYSINE
AB A self-setting cellulose scaffold, used as a component of an injectable bone substitute, was labeled with ruthenium tris-bipyridine complexes functionalized by triethoxysilane groups. The labeling yield was found to vary according to the number and location of Si(OR)(3) groups present on the ruthenium complex backbone. For label loadings, less than similar to 0.1 wt%, no significant modification of the theological properties of the gel was observed.
C1 [Laib, Samia; Petit, Marc; Bodio, Ewen; Bujoli, Bruno] Univ Nantes, CEISAM, Fac Sci & Tech, F-44322 Nantes 3, France.
   [Laib, Samia; Fatimi, Ahmed; Weiss, Pierre] Univ Nantes, LIOAD, INSERM, UMRS 791, F-44042 Nantes 1, France.
   [Laib, Samia; Petit, Marc; Bodio, Ewen; Bujoli, Bruno] CNRS, UMR 6230, F-44322 Nantes 3, France.
RP Bujoli, B (reprint author), Univ Nantes, CEISAM, Fac Sci & Tech, 2 Rue Houssiniere,BP 92208, F-44322 Nantes 3, France.
EM bruno.bujoli@univ-nantes.fr
RI Fatimi, Ahmed/F-2936-2012; petit, marc/C-8828-2015; Weiss,
   Pierre/P-1372-2014
OI petit, marc/0000-0001-6298-2087; Weiss, Pierre/0000-0002-6159-8590
CR Arnosti C, 2000, MAR CHEM, V71, P321, DOI 10.1016/S0304-4203(00)00061-X
   BARD AJ, 1993, Patent No. 8602734
   Berg KE, 2001, EUR J INORG CHEM, P1019
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Daculsi G, 1999, BONE, V25, P59
   Fraser CL, 1997, J ORG CHEM, V62, P9314, DOI 10.1021/jo971685x
   FURUE M, 1991, B CHEM SOC JPN, V64, P1632, DOI 10.1246/bcsj.64.1632
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   GHOSH PK, 1980, J AM CHEM SOC, V102, P5543, DOI 10.1021/ja00537a021
   Hu X, 2000, INORG CHEM, V39, P2500, DOI 10.1021/ic991078n
   Jones JR, 2006, MATER TODAY, V9, P34, DOI 10.1016/S1369-7021(06)71741-2
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Loiseau A, 2006, MACROMOLECULES, V39, P9185, DOI 10.1021/ma061324w
   MCCAFFERTY DG, 1995, TETRAHEDRON, V51, P1093, DOI 10.1016/0040-4020(94)01018-U
   Nordmark TS, 2000, FOOD HYDROCOLLOID, V14, P579, DOI 10.1016/S0268-005X(00)00037-0
   O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4
   PEEK BM, 1991, INT J PEPT PROT RES, V38, P114
   Savage SA, 1998, J ORG CHEM, V63, P10048, DOI 10.1021/jo981505z
   Schubert US, 1998, TETRAHEDRON LETT, V39, P8643, DOI 10.1016/S0040-4039(98)02041-3
   Smith AP, 2000, TETRAHEDRON LETT, V41, P2787, DOI 10.1016/S0040-4039(00)00264-1
   Telfer SG, 2003, DALTON T, P435, DOI 10.1039/b208934c
   TELSER J, 1989, J AM CHEM SOC, V111, P7221, DOI 10.1021/ja00200a049
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   TRAMP H, 2001, FOOD RES INT, V34, P931
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Will G, 1999, J PHYS CHEM B, V103, P8067, DOI 10.1021/jp990414i
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
NR 28
TC 3
Z9 3
U1 0
U2 10
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0748
J9 CR CHIM
JI C. R. Chim.
PD JUN-JUL
PY 2008
VL 11
IS 6-7
BP 641
EP 649
DI 10.1016/j.crci.2008.01.013
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 313IX
UT WOS:000256735400008
DA 2018-10-19
ER

PT J
AU Yamada, M
   Amoo, M
AF Yamada, Masanori
   Amoo, Mariko
TI Enzymatic collapse of artificial polymer composite material containing
   double-stranded DNA
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE DNA; enzymatic collapse; Micrococcal nuclease; composite materials;
   artificial polymer
ID METAL-IONS; UV-IRRADIATION; ACID; CELLULOSE; COMPLEX
AB Large amounts of DNA-enriched biomaterials, such as salmon milts and shellfish gonads, are discarded as industrial waste around the world. Therefore, the utilizations of DNA with the specific function are important for the biomaterial science and the curce technology. We could convert the discarded DNA to an enzymatic collapsible material by the addition of DNA to the artificial polymer material, such as nylon. Although these DNA-artificial polymer composite materials were stable in water, these materials indicated the collapsibility at the DNA-hydrolyzed enzyme, such as Micrococcal nuclease, condition. Additionally, these collapsibilities under enzyme condition were controlled by the number of imino groups in the components of the artificial polymer. Furthermore, these composite materials could create the fiber form with a highly ordered molecular orientation by the reaction at the liquid/liquid interface. The DNA-artificial polymer composite materials may have the potential utility as a novel bio-, medical-, and environmental materials with the enzymatic collapsibility and degraclability. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Yamada, Masanori; Amoo, Mariko] Okayama Univ Sci, Dept Chem, Fac Sci, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Dept Chem, Fac Sci, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
CR Alberts B., 1971, METHOD ENZYMOL, V21, P198
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Bozkurt A, 2001, SOLID STATE IONICS, V138, P259, DOI 10.1016/S0167-2738(00)00779-7
   Fugetsu B, 2004, B CHEM SOC JPN, V77, P1945, DOI 10.1246/bcsj.77.1945
   Hackl EV, 2005, INT J BIOL MACROMOL, V35, P175, DOI 10.1016/j.ijbiomac.2005.01.011
   Kawahara M, 2000, ELECTROCHIM ACTA, V45, P1395, DOI 10.1016/S0013-4686(99)00349-7
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   NAIR LS, 2006, PROG POLYM SCI, V31, P576
   Nakayama H, 2001, CHEM COMMUN, P2300, DOI 10.1039/b107228e
   Niemeyer CM, 2007, NANO TODAY, V2, P42, DOI 10.1016/S1748-0132(07)70058-0
   Nishida A, 2004, B CHEM SOC JPN, V77, P1783, DOI 10.1246/bcsj.77.1783
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Seeman NC, 2003, BIOCHEMISTRY-US, V42, P7259, DOI 10.1021/bi030079v
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111
   TAJMIRRIAHI HA, 1993, BIOPOLYMERS, V33, P1819, DOI 10.1002/bip.360331208
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yang KG, 2005, DESALINATION, V175, P297, DOI 10.1016/j.desal.2004.08.046
   YU L, 2007, PROG POLYM SCI, V32, P762
   Zhao BD, 2005, INT J BIOL MACROMOL, V37, P143, DOI 10.1016/j.ijbiomac.2005.10.002
NR 24
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN 1
PY 2008
VL 42
IS 5
BP 478
EP 482
DI 10.1016/j.ijbiomac.2008.03.005
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 317SI
UT WOS:000257039600012
PM 18457870
DA 2018-10-19
ER

PT J
AU Xu, L
   Sun, R
   Zhang, LF
   Yang, DJ
   Tan, YF
   Xiong, CD
AF Xu, Liang
   Sun, Rui
   Zhang, Li-Fang
   Yang, De-Juan
   Tan, Yan-Fei
   Xiong, Cheng-Dong
TI Studies on Poly(D, L-lactic acid)/wollastonite composites as a
   blomaterial
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE polylactic acid; wollastonite; biomaterial; mechanical properties;
   biocompatibility
ID WOLLASTONITE MICRO-FIBERS; IN-VITRO; MECHANICAL-PROPERTIES; BONE
   REGENERATION; APATITE FORMATION; SCAFFOLDS; HYDROXYAPATITE;
   BIOMATERIALS; BIOCERAMICS; FABRICATION
AB The aim of the study was to prepare bioactive and bioabsorbable composites of polylactide/wollastonite (PDLLA/W) and evaluate their mechanical properties and biocompatibility in vitro. PDLLA and wollastonite were physically mixed and the mechanical properties of the composition showed the influence of wollastonite, and that a partial composite, e.g., a PDLLA/wollastonite composition with 15 wt% wollastonite (PW-15) has similar mechanical properties compared to pure PDLLA. However, an in vitro biocompatibility testing showed that the composite has no deleterious effects on the osteoblast cells and facilitates both adhesion and proliferation of the osteoblast cells on the PDLLA/wollastonite film surface. The introduction of wollastonite could also induce the deposition of hydroxyapatite (HA) on the surface of the composite in simulated body fluids (SBF) which has important implications on bone regeneration. These mechanical and biocompatibility properties represent PDLLA/wollastonite composites as potential biomaterials.
C1 [Xu, Liang; Sun, Rui; Zhang, Li-Fang; Yang, De-Juan; Xiong, Cheng-Dong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Tan, Yan-Fei] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM luanshikedou@sina.com
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   DUCHEYNE P, 1988, BIOCERAMICS MAT CHAR, V523
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   KOKUBO T, 1993, J MATER SCI-MATER M, V4, P1, DOI 10.1007/BF00122969
   Kokubo T., 1990, J BIOMED MATER RES, V24, P723
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   Li HY, 2005, POLYM DEGRAD STABIL, V87, P301, DOI 10.1016/j.polymdegradstab.2004.09.001
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   LOW NMP, 1994, CEMENT CONCRETE RES, V24, P650, DOI 10.1016/0008-8846(94)90189-9
   LOW NMP, 1994, CEMENT CONCRETE RES, V24, P874, DOI 10.1016/0008-8846(94)90007-8
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Mohammadi Y, 2007, IRAN POLYM J, V16, P57
   Molly M S, 2004, BIOMATERIALS, V25, P887
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   NIIAREN H, 1999, J MATER SCI-MATER M, V10, P707
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P57, DOI 10.1016/0278-2391(94)90016-7
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Tong J, 2003, WEAR, V255, P734, DOI 10.1016/S0043-1648(03)00221-7
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Ye LZ, 2008, J BIOMATER APPL, V22, P465, DOI 10.1177/0885328207079670
   Zhang FM, 2008, J MATER SCI-MATER M, V19, P167, DOI 10.1007/s10856-006-0056-3
   Zhang LF, 2008, MAT SCI ENG C-BIO S, V28, P141, DOI 10.1016/j.msec.2007.01.005
NR 33
TC 8
Z9 9
U1 0
U2 5
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JUN
PY 2008
VL 17
IS 6
BP 407
EP 418
PG 12
WC Polymer Science
SC Polymer Science
GA 324PC
UT WOS:000257529500002
DA 2018-10-19
ER

PT J
AU Arslan, H
   Celikkan, H
   Ornek, N
   Ozan, O
   Ersoy, AE
   Aksu, ML
AF Arslan, Halit
   Celikkan, Hueseyin
   Oernek, Nisa
   Ozan, Oguz
   Ersoy, A. Ersan
   Aksu, M. Levent
TI Galvanic corrosion of titanium-based dental implant materials
SO JOURNAL OF APPLIED ELECTROCHEMISTRY
LA English
DT Article
DE galvanic corrosion; Ti-based dental materials; Tafel plots;
   electrochemical impedance spectroscopy
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; PASSIVE OXIDE-FILM; SURGICAL
   IMPLANTS; ALLOYS; FLUORIDE; BEHAVIOR; BIOMATERIAL; WEAR; TI
AB This paper describes an investigation of the corrosion behavior of Ti-based dental materials with Au, CrNi and CoCr in Ringer solution by the use of Tafel plots, Evans diagrams and EIS Nyguist diagrams. The galvanic potentials and currents obtained for various implant couples are as follows: For, Ti6Al4V/CrNi couple -0.030 V (Ag/AgCl (3 M NaCl)) and 7.94 mu A cm(-2); for Ti6Al4V/CoCr couple -0.020 V (Ag/AgCl (3 M NaCl)) and 7.08 mu A cm(-2); for Ti6Al4V/Au couple -0.020 V (Ag/AgCl (3 M NaCl)) and 5.62 mu A cm(-2). The Ti6Al4V/Au couple was found to be the most suitable one against galvanic corrosion according to both the Tafel method and mixed potential theory. The corrosion behaviors of Ti6Al4V/CoCr and Ti6Al4V/CrNi couples were found to be similar.
C1 [Aksu, M. Levent] Gazi Univ, Gazi Educ Fac, Dept Chem Educ, TR-06500 Ankara, Turkey.
   [Arslan, Halit] Gazi Univ, Arts Sci Fac, Dept Chem, TR-06500 Ankara, Turkey.
   [Celikkan, Hueseyin] Mineral Res & Explorat Inst, Ankara, Turkey.
   [Oernek, Nisa; Ozan, Oguz; Ersoy, A. Ersan] Ankara Univ, Fac Dent, TR-06500 Ankara, Turkey.
RP Aksu, ML (reprint author), Gazi Univ, Gazi Educ Fac, Dept Chem Educ, TR-06500 Ankara, Turkey.
EM maksu@gazi.edu.tr
RI ARSLAN, Halit/A-4121-2016
OI Celikkan, Huseyin/0000-0002-8016-3082
CR BADAWY WA, 1993, J BR CORR, V28, P136
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Frateur I, 2000, J ELECTROANAL CHEM, V482, P202, DOI 10.1016/S0022-0728(00)00050-4
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   HANSON M, 1958, CONSTITUTION BINARY
   HILLE GH, 1966, J MATER, V1, P373
   Hsu RWW, 2004, MATER CHEM PHYS, V86, P269, DOI 10.1016/j.matchemphys.2004.02.025
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   Katzer A, 2003, TOXICOLOGY, V190, P145, DOI 10.1016/S03000-483X(03)00147-1
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   LUCKEY HA, 1983, 796 STP AM SOC TEST
   MACDONALD D, 1981, ASTM SPEC TECH PUB
   MACDONALD DD, 1981, ASTM STP, V727, P110
   Mansfeld F., 1993, 26 SOL SCHLUMB
   Nakagawa M, 2002, DENT MATER J, V21, P83, DOI 10.4012/dmj.21.83
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   POPA MV, 1997, ADV MAT PROCESSING T, V2, P737
   POPA MV, 1997, 9 P INT MET MAT C, V1
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3
   Reclaru L, 2002, BIOMATERIALS, V23, P3479, DOI 10.1016/S0142-9612(02)00055-8
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   ROSCA MJC, 1997, 7 EUR C APPL SURF IN
   SCHUTZ RW, 1986, TITANIUM PROCESS IND
   Souza MEP, 2007, SURF COAT TECH, V201, P7775, DOI 10.1016/j.surfcoat.2007.03.005
   TOMASHOV ND, 1974, ELECTROCHIM ACTA, V19, P159, DOI 10.1016/0013-4686(74)85012-7
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V2
NR 32
TC 23
Z9 23
U1 3
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0021-891X
J9 J APPL ELECTROCHEM
JI J. Appl. Electrochem.
PD JUN
PY 2008
VL 38
IS 6
BP 853
EP 859
DI 10.1007/s10800-008-9523-5
PG 7
WC Electrochemistry
SC Electrochemistry
GA 299JO
UT WOS:000255752100016
DA 2018-10-19
ER

PT J
AU Tamimi, F
   Torres, J
   Bettini, R
   Ruggera, F
   Rueda, C
   Lopez-Ponce, M
   Lopez-Cabarcos, E
AF Tamimi, Faleh
   Torres, Jesus
   Bettini, Ruggero
   Ruggera, Francesca
   Rueda, Carmen
   Lopez-Ponce, Manuel
   Lopez-Cabarcos, Enrique
TI Doxycycline sustained release from brushite cements for the treatment of
   periodontal diseases
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE doxycycline; brushite cement; periodontal pathogens; solid state
   fluorescence; controlled release
ID CALCIUM-PHOSPHATE CEMENTS; DELIVERED DOXYCYCLINE; CREVICULAR FLUID;
   BONE-CEMENT; TETRACYCLINE; SYSTEM; FLUORESCENCE; THERAPY; TEETH
AB Doxycycline (DOXY) is a wide spectrum antibiotic used in the treatment of dental, periodontal, and bone infections. Brushite cements are calcium phosphate biomaterials especially interesting for bone regeneration processes. In this work, we describe the preparation of a brushite cement containing DOXY and the drug release from the cement. DOXY solutions were mixed with the cement powder and after a 50% burst release in the first 12 h, a slow and controlled release was achieved over 3.5 days. The release of DOXY hyclate was controlled by both, diffusion and Ca2+ interaction. Formation of DOXY-Ca2+ chelates was detected in the cement structure using solid state fluorescence. The brushite cement loaded with DOXY hyclate had antibacterial activity against periodontal pathogens: Actinobacilhis actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides frosthytus. This new biomaterial may be helpful for the treatment of periodontal diseases. (C) 2007 Wiley Periodicals, Inc.
C1 [Tamimi, Faleh; Rueda, Carmen; Lopez-Ponce, Manuel; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Dept Quim Fis 2, E-28040 Madrid, Spain.
   [Torres, Jesus] Univ Rey Juan Carlos I, Dept Ciencias Salud 3, Madrid, Spain.
   [Bettini, Ruggero; Ruggera, Francesca] Univ Parma, Dipartimento Farmaceut, I-43100 Parma, Italy.
RP Tamimi, F (reprint author), Univ Complutense Madrid, Dept Quim Fis 2, E-28040 Madrid, Spain.
EM fdamimim@farm.ucm.es
RI Lopez Cabarcos, Enrique/L-5802-2014; Bettini, Ruggero/O-2693-2013
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130; Bettini,
   Ruggero/0000-0002-3857-7476; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
CR Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bokor-Bratic M, 2000, Med Pregl, V53, P266
   CASWELL AH, 1971, BIOCHEM BIOPH RES CO, V43, P625, DOI 10.1016/0006-291X(71)90660-7
   Choi DH, 2004, J PERIODONTAL RES, V39, P20, DOI 10.1111/j.1600-0765.2004.00696.x
   Ciancio Sebastian G., 1999, General Dentistry, V47, P172
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   DAVIES AK, 1985, J DENT RES, V64, P936, DOI 10.1177/00220345850640061701
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Hanes Philip J, 2003, Ann Periodontol, V8, P79, DOI 10.1902/annals.2003.8.1.79
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Jacinto RC, 2003, ORAL MICROBIOL IMMUN, V18, P285, DOI 10.1034/j.1399-302X.2003.00078.x
   Johnson L R, 1999, Compend Contin Educ Dent, V20, P19
   KAITILA I, 1971, BIOCHIM BIOPHYS ACTA, V244, P584, DOI 10.1016/0304-4165(71)90075-4
   Parfitt K, 1999, COMPLETE DRUG REFERE, P203
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Ramamurthy NS, 2002, J PERIODONTOL, V73, P726, DOI 10.1902/jop.2002.73.7.726
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Schneider S, 2003, PHOTOCH PHOTOBIO SCI, V2, P1107, DOI 10.1039/b304523b
   Slots J, 1986, Oral Microbiol Immunol, V1, P48, DOI 10.1111/j.1399-302X.1986.tb00318.x
   SLOTS J, 1982, J CLIN MICROBIOL, V16, P1148
   Song Zhiguo, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P586
   Stoller NH, 1998, J PERIODONTOL, V69, P1085, DOI 10.1902/jop.1998.69.10.1085
   Tomasi C, 2004, J CLIN PERIODONTOL, V31, P589, DOI 10.1111/j.1600-051X.2004.00524.x
   Walker C, 1999, Compend Contin Educ Dent, V20, P4
NR 28
TC 53
Z9 56
U1 4
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2008
VL 85A
IS 3
BP 707
EP 714
DI 10.1002/jbm.a.31610
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296GC
UT WOS:000255530500017
PM 17876778
DA 2018-10-19
ER

PT J
AU Ahmad, Z
   Huang, J
   Thian, ES
   Edirisinghe, MJ
   Jayasinghe, SN
   Best, SM
   Bonfield, W
   Brooks, RA
   Rushton, N
AF Ahmad, Z.
   Huang, J.
   Thian, E. S.
   Edirisinghe, M. J.
   Jayasinghe, S. N.
   Best, S. M.
   Bonfield, W.
   Brooks, R. A.
   Rushton, N.
TI Freeform fabrication of nano-biomaterials using 3D electrohydrodynamic
   print-patterning
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE freeforming; hydroxyapatite; biomaterials; printing; patterning
ID INK-JET PRINTER; ELECTROSTATIC ATOMIZATION; HYDROXYAPATITE SCAFFOLDS;
   IMPLANT MATERIALS; BONE-FORMATION; SUSPENSION; CELLS; CERAMICS;
   DROPLETS; VITRO
AB An electrohydrodynamic jet in conjunction with a computer-controlled collecting device has been used to form micro-scale structures. From a nano-scale particle suspension of a biomaterial a variety of patterning was produced in the x,y axis by the collection of fine droplets resulting from the jetting process. By over-printing these patterns repeatedly, whilst controlling the deposition in the z axis, structures can be formed to the desired height. The merits and limiting factors of this freeform fabrication method are discussed alongside some of the key developments and future aims in this area.
C1 [Ahmad, Z.; Huang, J.; Edirisinghe, M. J.; Jayasinghe, S. N.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Thian, E. S.; Best, S. M.; Bonfield, W.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Brooks, R. A.; Rushton, N.] Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
RP Ahmad, Z (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
RI Jayasinghe, Suwan/C-1799-2008
OI Ahmad, Zeeshan/0000-0001-8863-6211; Thian, Eng San/0000-0001-6925-6811;
   Jayasinghe, Suwan/0000-0002-7125-2219
CR AHAMD Z, 2006, J BIOMED NANOTECHNOL, V2, P201
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   CLOUPEAU M, 1994, J AEROSOL SCI, V25, P1021, DOI 10.1016/0021-8502(94)90199-6
   de Sousa FCG, 2005, ADV APPL CERAM, V104, P30, DOI 10.1179/174367605225011025
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Dimitrov D, 2006, RAPID PROTOTYPING J, V12, P136, DOI 10.1108/13552540610670717
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Eagles PAM, 2006, BIOCHEM J, V394, P375, DOI 10.1042/BJ20051838
   Gao C, 2004, J INORG MATER, V19, P714
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   HARTMAN RPA, 1999, ELECTROSTATICS 1999, V163, P115
   Huang J, 2004, J MATER SCI, V39, P1029, DOI 10.1023/B:JMSC.0000012937.85880.7b
   Jayasinghe SN, 2002, J MATER SCI LETT, V21, P371, DOI 10.1023/A:1014998916149
   Jayasinghe SN, 2002, MATER RES INNOV, V6, P92, DOI 10.1007/s10019-002-0192-4
   Lee DY, 2006, APPL PHYS A-MATER, V82, P671, DOI 10.1007/s00339-005-3452-5
   Limpanuphap S, 2002, J MATER SCI-MATER M, V13, P1163, DOI 10.1023/A:1021146106442
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MEESTERS GMH, 1992, J AEROSOL SCI, V23, P37, DOI 10.1016/0021-8502(92)90316-N
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Moon J, 2002, J AM CERAM SOC, V85, P755
   NEDOVIC V, 2002, LANDBAUFORSCH VOLK, VSH 241, P11
   Notz PK, 1999, J COLLOID INTERF SCI, V213, P218, DOI 10.1006/jcis.1999.6136
   Park J, 2006, LANGMUIR, V22, P3506, DOI 10.1021/la053450j
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rea SM, 2004, J BIOMED MATER RES B, V70B, P250, DOI 10.1002/jbm.b.30039
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Samarasinghe SR, 2006, GOLD BULL, V39, P48, DOI 10.1007/BF03215276
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sirringhaus H, 2003, MRS BULL, V28, P802, DOI 10.1557/mrs2003.228
   Sirringhaus H, 2001, MRS BULL, V26, P539, DOI 10.1557/mrs2001.127
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   STANKUS JJ, 2006, BIOMATERIALS, V27, P744
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Tay BY, 2003, INT MATER REV, V48, P341, DOI 10.1179/095066003225010263
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Thian ES, 2007, J BIONANOSCI, V1, P60, DOI DOI 10.1166/JBNS.2007.004
   Wang DZ, 2006, J AM CERAM SOC, V89, P1727, DOI 10.1111/j.1551-2916.2006.00936.x
   Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531
   Wang DZ, 2005, J NANOPART RES, V7, P301, DOI 10.1007/s11051-004-7772-8
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yeo LY, 2005, BIOMATERIALS, V26, P6122, DOI 10.1016/j.biomaterials.2005.03.033
   Zhao X, 2003, CERAM INT, V29, P887, DOI 10.1016/S0272-8842(03)00032-4
NR 50
TC 11
Z9 11
U1 1
U2 50
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2008
VL 4
IS 2
BP 185
EP 195
DI 10.1166/jbn.2008.017
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 328JH
UT WOS:000257794200007
DA 2018-10-19
ER

PT J
AU Tanzer, M
   Bobyn, JD
   Krygier, JJ
   Karabasz, D
AF Tanzer, M.
   Bobyn, J. D.
   Krygier, J. J.
   Karabasz, D.
TI Histopathologic retrieval analysis of clinically failed porous tantalum
   osteonecrosis implants
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID FEMORAL-HEAD; BIOMATERIAL
AB Background: An Osteonecrosis Intervention Implant made of porous tantalum was recently developed to provide structural support and a compatible surface for tissue ingrowth in osteonecrotic femoral heads. From an investigational device exemption study that comprised 113 implants, we carried out a retrieval analysis of clinically failed implants.
   Methods: Seventeen porous tantalum implants that had been used for the treatment of Steinberg stage-II osteonecrosis of the hip were retrieved at the time of conversion to a total hip arthroplasty. Fifteen implants that had been transected near the base of the femoral neck with the proximal portion left in situ within the femoral head underwent histopathologic analysis at an average of 13.4 months (range, three to thirty-six months) after implantation.
   Results: Residual osteonecrosis was present in fourteen of the fifteen specimens. Fracture of the subchondral bone of the femoral head was present in all instances, and collapse of the femoral head was present in nine instances (60%). Backscattered scanning electron microscopy confirmed the presence of bone ingrowth in thirteen (87%) of the fifteen specimens. The mean extent of bone ingrowth was 1.9% (range, 0% to 4.4%).
   Conclusions: The retrieved implants were associated with little bone ingrowth and insufficient mechanical support of subchondral bone. The implant design, the surgical technique, its application, and the clinical characteristics of candidates for this procedure should continue to be monitored closely.
   Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
C1 [Tanzer, M.] McGill Univ, Div Orthopaed, Dept Surg, Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
RP Tanzer, M (reprint author), McGill Univ, Div Orthopaed, Dept Surg, Miller Orthopaed Res Lab, 1650 Cedar Ave B5-159, Montreal, PQ H3G 1A4, Canada.
CR Beris AE, 2001, CLIN ORTHOP RELAT R, P64
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BORGSTEDE LL, 2006, T ORTHOP RES SOC, V31, P640
   BUGBEE WD, 1998, ADULT HIP, V2, P1023
   Della Valle AG, 2005, J ARTHROPLASTY, V20, P331, DOI 10.1016/j.arth.2004.05.006
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Peters CL, 1998, ADULT HIP, VII, P993
   Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   ZIMMER, 2005, SURG TECHNIQUES BROC
NR 15
TC 34
Z9 56
U1 0
U2 3
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD JUN
PY 2008
VL 90A
IS 6
BP 1282
EP 1289
DI 10.2106/JBJS.F.00847
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 309JL
UT WOS:000256456400015
PM 18519322
DA 2018-10-19
ER

PT J
AU Busscher, HJ
   Dijkstra, RJB
   Langworthy, DE
   Collias, DI
   Bjorkquist, DW
   Mitchell, MD
   Van der Mei, HC
AF Busscher, Henk J.
   Dijkstra, Rene J. B.
   Langworthy, Don E.
   Collias, Dimitris I.
   Bjorkquist, David W.
   Mitchell, Michael D.
   Van der Mei, Henny C.
TI Interaction forces between waterborne bacteria and activated carbon
   particles
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE AFM; activated carbon; bacterial adhesion; water filtration; interaction
   force; Raoutella terrigena; Escherichiae coli; EPS
ID ADHESION FORCES; STAPHYLOCOCCUS-EPIDERMIDIS; MICROSCOPY; SURFACES;
   BIOFILMS; BIOMATERIAL; ADSORPTION; STRAINS; BINDING; GLASS
AB Activated carbons remove waterborne bacteria from potable water systems through attractive Lifshitz-van der Waals forces despite electrostatic repulsion between negatively charged cells and carbon surfaces. In this paper we quantify the interaction forces between bacteria with negatively and positively charged, mesoporous wood-based carbons, as well as with a microporous coconut carbon. To this end, we glued carbon particles to the cantilever of an atomic force microscope and measured the interaction forces upon approach and retraction of thus made tips. Waterborne Raoultella terrigena and Escherichia coli adhered weakly (1-2 nN) to different activated carbon particles, and the main difference between the activated carbons was the percentage of curves with attractive sites revealed upon traversing of a carbon particle through the bacterial EPS layer. The percentage of curves showing adhesion forces upon retraction varied between 21% and 69%, and was highest for R. terrigena with positively charged carbon (66%) and a coconut carbon (69%). Macroscopic bacterial removal by the mesoporous carbon particles increased with increasing percentages of attractive sites revealed upon traversing a carbon particle through the outer bacterial surface layer. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Busscher, Henk J.; Dijkstra, Rene J. B.; Van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.; Dijkstra, Rene J. B.; Van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.] SASA BV, NL-9797 PC Thesinge, Netherlands.
   [Langworthy, Don E.; Bjorkquist, David W.] Procter & Gamble Co, Cincinnati, OH USA.
   [Collias, Dimitris I.; Mitchell, Michael D.] Procter & Gamble Co, Corp Res & Dev, W Chester, OH 45069 USA.
RP Van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BIFULCO JM, 1989, APPL ENVIRON MICROB, V55, P2214
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Busscher HJ, 2006, ENVIRON SCI TECHNOL, V40, P6799, DOI 10.1021/s061282r
   Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Flemming HC, 2001, WATER SCI TECHNOL, V43, P1
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9
   Liu XL, 2005, RADIOCHIM ACTA, V93, P305, DOI 10.1524/ract.93.5.305.64276
   MENDEZVILAS A, IN PRESS COLLOIDS SU
   Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PAYMENT P, 1988, CAN J MICROBIOL, V34, P1304, DOI 10.1139/m88-228
   Percival SL, 1999, BIOFOULING, V14, P99, DOI 10.1080/08927019909378402
   PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643
   Quinlivan PA, 2005, WATER RES, V39, P1663, DOI 10.1016/j.watres.2005.01.029
   Rabinovich YI, 2000, J COLLOID INTERF SCI, V232, P17, DOI 10.1006/jcis.2000.7168
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Schmitt J, 1999, WATER SCI TECHNOL, V39, P77, DOI 10.1016/S0273-1223(99)00153-5
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Shi ZL, 2007, IND ENG CHEM RES, V46, P439, DOI 10.1021/ie0608096
   Tang GY, 2004, ARCH ORAL BIOL, V49, P727, DOI 10.1016/j.archoralbio.2004.04.003
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   Vadillo-Rodriguez V, 2005, COLLOID SURFACE B, V41, P33, DOI 10.1016/j.colsurfb.2004.10.028
   Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0
   van der Mei HC, 2000, BIOPHYS J, V78, P2668, DOI 10.1016/S0006-3495(00)76810-X
   van Hoogmoed CG, 2006, J DENT RES, V85, P54, DOI 10.1177/154405910608500109
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v
NR 31
TC 14
Z9 14
U1 3
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUN 1
PY 2008
VL 322
IS 1
BP 351
EP 357
DI 10.1016/j.jcis.2008.03.018
PG 7
WC Chemistry, Physical
SC Chemistry
GA 303FY
UT WOS:000256027600046
PM 18405910
DA 2018-10-19
ER

PT J
AU Kramer, FJ
   Sinikovic, B
   Mueller, M
   Rahmstorf, M
   Schierle, H
AF Kramer, Franz-Josef
   Sinikovic, Branko
   Mueller, Michal
   Rahmstorf, Meike
   Schierle, Hannes
TI Experimental application of a biomaterial in bifocal transport
   osteogenesis for craniofacial reconstruction
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE craniofacial; reconstruction; distraction; bifocal transport
   osteogenesis; biomaterial
ID MANDIBULAR DISTRACTION OSTEOGENESIS; DEFECTS
AB Purpose: Bifocal transport osteogenesis is an alternative technique of callus distraction, in which movement of a transport segment results in the formation of new bone in order to close a continuity defect. The aim of this experimental pilot study was to replace a bone graft by a biomaterial as a transport segment. Material and methods: Critical size defects of the calvaria in four adult sheep were treated with transport segments consisting either of an autogenous free bone graft of the calvaria (n = 2) or of the biomaterial (deproteinized bovine cancellous bone; n = 2). Latency period was 5 days; the rate of distraction was I mm per day and was planned for 40 days. The consolidation period was 28 days. Specimens were investigated by conventional radiography, CT-scans and histologically, including immunofluorescence. Results: In both groups, transport osteogenesis resulted in a "de novo" formation of bone, indicating that this biomaterial may contribute successfully to bone formation in bifocal transport osteogenesis. However, volume and thickness of the newly formed bone at the defect site were smaller when using the biomaterial than when using autogenous bonegrafts. Conclusion: The application of a biomaterial as transport segments in bifocal transport osteogenesis in cranial critical size defects resulted in the formation of new bone thus excluding bone graft donor site morbidity. (C) 2008 European Association for Cranio-Maxillofacial Surgery.
C1 [Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, D-37099 Gottingen, Germany.
   [Sinikovic, Branko] Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany.
RP Kramer, FJ (reprint author), Univ Gottingen, Dept Oral & Maxillofacial Surg, Robert Koch Str 40, D-37099 Gottingen, Germany.
EM franz-josef.kramer@med.uni-goettingen.de
CR Aronson J, 1990, Clin Orthop Relat Res, P43
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P1074, DOI 10.1097/00006534-200203000-00046
   Bouletreau PJ, 2002, J CRANIO MAXILL SURG, V30, P1, DOI 10.1054/jems.2001.0263
   Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026
   Costantino PD, 1996, J CRANIOFAC SURG, V7, P404, DOI 10.1097/00001665-199611000-00002
   COSTANTINO PD, 1990, ARCH OTOLARYNGOL, V116, P535
   Costantino Peter D, 2002, Facial Plast Surg, V18, P13, DOI 10.1055/s-2002-19823
   ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Ilizarov G A, 1989, Clin Orthop Relat Res, P249
   ILIZAROV GA, 1980, ACTA CHIR PLAST, V22, P32
   Kondoh T, 2002, INT J ORAL MAX SURG, V31, P675, DOI 10.1054/ijom.2002.0249
   McCarthy JG, 2002, PLAST RECONSTR SURG, V110, P1704, DOI 10.1097/01.PRS.0000036260.60746.1B
   MOLINA F, 1995, PLAST RECONSTR SURG, V96, P825, DOI 10.1097/00006534-199509001-00010
   Paccione MF, 2001, J CRANIOFAC SURG, V12, P175, DOI 10.1097/00001665-200103000-00015
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   StuckiMcCormick SU, 1997, J CRANIOFAC SURG, V8, P48, DOI 10.1097/00001665-199701000-00016
   Swennen G, 2002, INT J ORAL MAX SURG, V31, P123, DOI 10.1054/ijom.2002.0225
NR 19
TC 3
Z9 3
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUN
PY 2008
VL 36
IS 4
BP 218
EP 226
DI 10.1016/j.jcms.2007.12.001
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 312BQ
UT WOS:000256644500005
PM 18314339
DA 2018-10-19
ER

PT J
AU Santos, DT
   Sarrouh, BF
   Rivaldi, JD
   Converti, A
   Silva, SS
AF Santos, Diego T.
   Sarrouh, Boutros F.
   Rivaldi, Juan D.
   Converti, Attilio
   Silva, Silvio S.
TI Use of sugarcane bagasse as biomaterial for cell immobilization for
   xylitol production
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE sugarcane bagasse fibers; biomaterial; cell immobilization;
   bioconversion; xylitol production
ID CANDIDA-GUILLIERMONDII CELLS; FLUIDIZED-BED REACTOR; CA-ALGINATE;
   D-XYLOSE; HEMICELLULOSE HYDROLYSATE; POROUS-GLASS; YEAST-CELLS;
   FERMENTATION; BIOREACTOR; HYDROLYZATE
AB This study provides a preliminary contribution to the development of a bioprocess for the contintious production of xylitol from hemicellulosic hydrolyzate utilizing Candida guilliermondii cells immobilized onto natural sugarcane bagasse fibers. To this purpose, cells of this yeast were submitted to batch tests of "in situ" adsorption onto crushed and powdered sugarcane bagasse after treatment with 0.5 M NaOH. The results obtained on a xylose-based semi-synthetic medium were evaluated in terms of immobilization efficiency, cell retention and specific growth rates of suspended, immobilized and total cells. The first two parameters were shown to increase along the immobilization process, reached maximum values of 50.5% and 0.31 g immobilized cells/g bagasse after 21 h and then sharply decreased. The specific growth rate of suspended cells continuously increased during the immobilization tests, while that of the immobilized ones, after an initial growth, exhibited decreasing values. Under the conditions selected for cell immobilization, fermentation also took place with promising results. The yields of xylitol and biomass on consumed xylose were 0.65 and 0.18 g/g, respectively, xylitol and biomass productivities 0.66 and 0.13 g L-1 h(-1), and the efficiency of xylose-to-xylitol bioconversion was 70.8%. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Santos, Diego T.; Sarrouh, Boutros F.; Rivaldi, Juan D.; Silva, Silvio S.] Univ Sao Paulo, Dept Biotechnol, Sch Engn Lorena, BR-12602810 Lorena, SP, Brazil.
   [Converti, Attilio] Univ Genoa, Dept Chem & Proc Engn, I-16145 Genoa, Italy.
   [Silva, Silvio S.] FATEA, Lorena, SP, Brazil.
RP Silva, SS (reprint author), Univ Sao Paulo, Dept Biotechnol, Sch Engn Lorena, Estrada Municipal Campinho S-N,Cx Postal 116, BR-12602810 Lorena, SP, Brazil.
EM silvio@debiq.eel.usp.br
RI Santos, Diego/G-2922-2011; da Silva, Silvio/H-8960-2012; Oliveira,
   Nadir/H-3532-2015; RIVALDI, JUAN/I-6610-2012; Converti,
   Attilio/C-4368-2013
OI Santos, Diego/0000-0003-1551-3012; da Silva, Silvio/0000-0003-0669-2784;
   RIVALDI, JUAN/0000-0002-2296-2791; Converti, Attilio/0000-0003-2488-6080
CR ABSOLOM SR, 1985, COMPREHENSIVE BIOTEC, V4, P433
   BARBOSA MFS, 1988, J IND MICROBIOL, V3, P241, DOI 10.1007/BF01569582
   Branyik T, 2001, BIOTECHNOL LETT, V23, P1073, DOI 10.1023/A:1010558407475
   Carvalho W, 2005, BIOCHEM ENG J, V25, P25, DOI 10.1016/j.bej.2005.03.006
   Carvalho W, 2003, ENZYME MICROB TECH, V32, P553, DOI 10.1016/S0141-0229(03)00007-3
   CORCORAN E, 1985, TOPICS ENZYME FERMEN, V10, P12
   Cunha M, 2006, WORLD J MICROB BIOT, V22, P65, DOI 10.1007/s11274-005-6812-6
   Dominguez JM, 1996, APPL BIOCHEM BIOTECH, V57-8, P49, DOI 10.1007/BF02941687
   FACCHINI PJ, 1988, APPL MICROBIOL BIOT, V29, P346, DOI 10.1007/BF00265818
   GRANSTROM T, 2002, THESIS HELSINKI U TE
   Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P273, DOI 10.1007/s00253-006-0760-4
   Guo C, 2006, J APPL MICROBIOL, V101, P1096, DOI 10.1111/j.1365-2672.2006.02994.x
   GURGEL PV, 1998, BRAZ J CHEM ENG, V15, P309
   JONES HC, 1969, J BACTERIOL, V99, P316
   Kontiokari T, 1998, J ANTIMICROB CHEMOTH, V41, P563, DOI 10.1093/jac/41.5.563
   Kwon SG, 2006, J BIOSCI BIOENG, V101, P13, DOI 10.1263/jbb.101.13
   Lopez F, 2004, ANTON LEEUW INT J G, V85, P281, DOI 10.1023/B:ANTO.0000020368.37876.1c
   Masako K, 2005, J DERMATOL SCI, V38, P207, DOI 10.1016/j.jdermsci.2005.01.003
   Masako K, 2005, J DERMATOL SCI, V38, P197, DOI 10.1016/j.jdermsci.2005.01.006
   Mathew S, 2005, ENZYME MICROB TECH, V36, P565, DOI 10.1016/j.enzmictec.2004.12.003
   McLean R. J. C., 1994, IMMOBILIZED BIOSYSTE, P289
   MOZES N, 1985, APPL MICROBIOL BIOT, V22, P92
   Naaber P, 1996, FEMS IMMUNOL MED MIC, V14, P205, DOI 10.1016/0928-8244(96)00031-4
   NAVARRO JM, 1977, EUR J APPL MICROBIOL, V4, P243, DOI 10.1007/BF00931261
   NORTON S, 1994, ENZYME MICROB TECH, V16, P365, DOI 10.1016/0141-0229(94)90150-3
   Park JK, 2000, BIOTECHNOL ADV, V18, P303, DOI 10.1016/S0734-9750(00)00040-9
   Pilkington PH, 1998, J I BREWING, V104, P19, DOI 10.1002/j.2050-0416.1998.tb00970.x
   Ramakrishna SV, 1999, CURR SCI INDIA, V77, P87
   ROBERTO IC, 1994, BIOTECHNOL LETT, V16, P1211, DOI 10.1007/BF01020853
   Rodrigues RCLB, 2006, CURR MICROBIOL, V53, P53, DOI 10.1007/s00284-005-0242-4
   Sampaio FC, 2005, PROCESS BIOCHEM, V40, P3600, DOI 10.1016/j.procbio.2005.03.039
   Santos JC, 2005, BIOCHEM ENG J, V23, P1, DOI 10.1016/j.bej.2004.10.001
   Santos JC, 2005, PROCESS BIOCHEM, V40, P113, DOI 10.1016/j.procbio.2003.11.045
   Santos JC, 2003, BIOTECHNOL PROGR, V19, P1210, DOI 10.1021/bp034042d
   Sarrouh Boutros Fouad, 2007, Biotechnology Journal, V2, P759, DOI 10.1002/biot.200600207
   Sene L, 2002, BIORESOURCE TECHNOL, V83, P153, DOI 10.1016/S0960-8524(01)00192-4
   Silva CJSM, 2006, J FOOD ENG, V75, P115, DOI 10.1016/j.jfoodeng.2005.04.001
   SILVA SS, 1994, THESIS U SAO PAULO, P219
   SIMEONOVA DD, 2004, THESIS L PASTEUR U S, P155
   Tischler AS, 1996, TOXICOL APPL PHARM, V140, P115, DOI 10.1006/taap.1996.0204
   Veliky IA, 1994, IMMOBILIZED BIOSYSTE
   WANG YM, 1981, ANNU REV NUTR, V1, P435
   Winkelhausen E, 1998, J FERMENT BIOENG, V86, P1, DOI 10.1016/S0922-338X(98)80026-3
   Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614
NR 44
TC 50
Z9 50
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
J9 J FOOD ENG
JI J. Food Eng.
PD JUN
PY 2008
VL 86
IS 4
BP 542
EP 548
DI 10.1016/j.jfoodeng.2007.11.004
PG 7
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 273GV
UT WOS:000253919300009
DA 2018-10-19
ER

PT J
AU Palsule, AS
   Clarson, SJ
   Widenhouse, CW
AF Palsule, Aniruddha S.
   Clarson, Stephen J.
   Widenhouse, Christopher W.
TI Gamma irradiation of silicones
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Review
DE silicones; polysiloxanes; PDMS; gamma irradiation; gamma sterilization
ID RADIATION-INDUCED POLYMERIZATION; SOLID-STATE POLYMERIZATION;
   ELECTRON-SPIN-RESONANCE; LIQUID-STATE; POLY(DIMETHYL SILOXANE);
   IONIZING-RADIATION; CROSS-LINKING; CHEMISTRY;
   OCTAMETHYLCYCLOTETRASILOXANE; HEXAMETHYLCYCLOTRISILOXANE
AB Silicones in various forms have been utilized in biomedical applications over the past several decades. While silicone elastomers are currently the most common silicone biomaterial, low molar mass cyclic silicones, low molar mass linear silicones, silicone oligomers, silicone polymers and silicone gels have each found applications as biomaterials. For the biomedical applications of silicones, it is required that the materials be sterilized prior to application or implantation. Common methods of sterilization include steam sterilization, ethylene oxide sterilization, electron beam sterilization and gamma sterilization. In this review we will describe the behavior of various silicones upon exposure to gamma radiation.
C1 [Clarson, Stephen J.] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45221 USA.
   [Palsule, Aniruddha S.] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45221 USA.
   [Widenhouse, Christopher W.] Ethicon Endo Surg, Cincinnati, OH 45242 USA.
RP Clarson, SJ (reprint author), Univ Cincinnati, Dept Chem & Mat Engn, 601b ERC,ML 0012, Cincinnati, OH 45221 USA.
EM Stephen.Clarson@UC.Edu
CR ARKLES B, 1983, CHEMTECH, V13, P542
   Basfar AA, 1997, RADIAT PHYS CHEM, V50, P607, DOI 10.1016/S0969-806X(97)00123-0
   Brook M. A., 2000, SILICON ORGANIC ORGA, P459
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   BUECHE AM, 1956, J POLYM SCI, V19, P297, DOI 10.1002/pol.1956.120199206
   CHARLESBY A, 1955, PROC R SOC LON SER-A, V230, P120, DOI 10.1098/rspa.1955.0116
   CHARLESBY A, 1963, PROC R SOC LON SER-A, V273, P117, DOI 10.1098/rspa.1963.0078
   CHAWLA AS, 1972, J POLYM SCI A1, V10, P2691, DOI 10.1002/pol.1972.150100915
   CHAWLA AS, 1972, J APPL POLYM SCI, V16, P1887, DOI 10.1002/app.1972.070160802
   Chien A, 2000, RADIAT PHYS CHEM, V59, P493, DOI 10.1016/S0969-806X(00)00305-4
   Clarson S.J., 1996, POLYM MAT ENCY, V10, P7663
   Clarson S. J., 1993, SILOXANE POLYM
   CLARSON SJ, 2003, ACM S SERIES, V838, P2
   Colas A., 1996, BIOMATERIALS SCI INT, p[80, 697]
   CORFIELD GC, 1984, AM CHEM SOC, V24, P473
   DELIDES CG, 1980, RADIAT PHYS CHEM, V16, P345, DOI 10.1016/0146-5724(80)90228-9
   DEWHURST HA, 1960, J PHYS CHEM-US, V64, P1063, DOI 10.1021/j100837a025
   Hill DJT, 2002, POLYMER, V43, P1051, DOI 10.1016/S0032-3861(01)00711-X
   Hill DJT, 2001, RADIAT PHYS CHEM, V62, P11, DOI 10.1016/S0969-806X(01)00416-9
   HILL DJT, 2000, MACROMOL S, V195, P95
   KNAAP B, 1996, SILICON
   Kowalski JB, 1996, BIOMATERIALS SCI INT, P415
   LAWTON EJ, 1956, J POLYM SCI, V19, P455, DOI 10.1002/pol.1956.120199306
   LAZURKIN IS, 1958, ATOM ENERGY, V4, P365
   LEBRUN JJ, 1984, RADIAT PHYS CHEM, V24, P239, DOI 10.1016/0146-5724(84)90058-X
   LIEBHAFSKY HA, 1978, SILICONES MONOGRAM S
   MARK JE, 1998, RUB CHEM TECH, V71, P941
   Maxwell RS, 2003, POLYM DEGRAD STABIL, V80, P443, DOI 10.1016/S0141-3910(03)00028-4
   MCGREGOR RR, 1954, PHYSL RESPONSE SILIC, P188
   MENHOFER H, 1987, RADIAT PHYS CHEM, V29, P243
   MENHOFER H, 1986, RADIAT PHYS CHEM, V33, P561
   MILLER AA, 1961, J AM CHEM SOC, V83, P31, DOI 10.1021/ja01462a006
   MILLER AA, 1960, J AM CHEM SOC, V82, P3519, DOI 10.1021/ja01499a011
   NAYLOR DM, 1986, J POLYM SCI POL LETT, V24, P319, DOI 10.1002/pol.1986.140240704
   NAYLOR DM, 1991, POLYMER, V32, P1084, DOI 10.1016/0032-3861(91)90596-B
   NAYLOR DM, 1990, POLYMER, V31, P954, DOI 10.1016/0032-3861(90)90063-5
   NAYLOR DM, 1994, POLYMER, V35, P1764, DOI 10.1016/0032-3861(94)90853-2
   Noll W., 1968, CHEM TECHNOLOGY SILI
   NOLL W, 1968, PHYSL BEHAV CHEM TEC, P516
   ORMEROD MG, 1963, POLYMER, V4, P459, DOI 10.1016/0032-3861(63)90059-4
   PARK JB, 1992, STERILIZATION EFFECT, P162
   RICHOW EG, 1946, INTRO CHEM SILICONES
   Rochow E. G., 1987, SILICON SILICONES
   Rogero SO, 2005, NUCL INSTRUM METH B, V236, P521, DOI 10.1016/j.nimb.2005.04.031
   SEMLYEN JA, LARGE RING MOL, P3
   Stevenson I, 2001, POLYMER, V42, P9287, DOI 10.1016/S0032-3861(01)00470-0
   STPIERRE LE, 1960, J PHYS CHEM-US, V64, P1060
   THOMAS J, 2002, ELEMENTS SILICON
   VanDyke ME, 2003, INTRO POLYM BIOMATER, P109
   VISSER SA, 1996, BIOMATERIALS SCI INT, P59
   WARRICK EL, 1990, 40 YEARS 1 RECOLLECT, P184
   WARRICK EL, 1955, IND ENG CHEM, V24, P842
   WARRICK EL, 1990, 40 YEARS 1 RECOLLECT
   WOLF CJ, 1962, J PHYS CHEM-US, V66, P1119
   ZACK JF, 1961, J CHEM ENG DATA, V6, P279
NR 56
TC 35
Z9 35
U1 1
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD JUN
PY 2008
VL 18
IS 2
BP 207
EP 221
DI 10.1007/s10904-008-9205-0
PG 15
WC Polymer Science
SC Polymer Science
GA 285KL
UT WOS:000254775600001
DA 2018-10-19
ER

PT J
AU Yamauchi, K
   Takahashi, T
   Funaki, K
   Yamashita, Y
AF Yamauchi, Kensuke
   Takahashi, Tetsu
   Funaki, Katsuyuki
   Yamashita, Yoshihiro
TI Periosteal expansion osteogenesis using highly purified beta-tricalcium
   phosphate blocks: A pilot study in dogs
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE alveolar augmentation; biomaterial; distraction osteogenesis; periosteum
ID DISTRACTION OSTEOGENESIS; BONE-FORMATION; POROUS HYDROXYAPATITE; RIDGE
   AUGMENTATION; ALVEOLAR RIDGE; LONG-TERM; RECONSTRUCTION; IMPLANTS;
   FRACTURE; DEFECTS
AB Background: In highly atrophic edentulous jaws, the augmentation of the alveolar process is standard treatment for dental implantation because of the lack of alveolar bone height and width. Our aim was to examine periosteal expansion osteogenesis in a dog model, based on the concept of distraction osteogenesis, using a highly purified beta-tricalcium phosphate (beta-TCP) block instead of an original bone segment.
   Methods: Three beagle dogs weighing 10 to 12 kg were used. The beta-TCP block was placed at the lateral surface of the mandibular bone. Two titanium screws were inserted from the lingual aspect to push the block to the buccal side. After a latency period of 8 days, during which primary wound healing occurred, the lingual screws were advanced by similar to 0.5 mm/day for 8 days. Specimens were taken 8 weeks after lingual screw adjustments ceased and were analyzed by hematoxylin and eosin, tartrate-resistant acid phosphatase (TRAP), and Villanueva bone staining.
   Results: The alveolar form at the experimental region was changed dramatically following lateral expansion with the beta-TCP block. Newly formed bone was observed in the gap between the bone and the beta-TCP block, as well as on the lateral surface of the block. Moreover, the replacement of large parts of beta-TCP with newly formed bone was observed in the beta-TCP block area. However, newly formed bone was not observed over the upper parts of the block, and multinucleated TRAP-positive cells were attached to the beta-TCP in the periphery of this area.
   Conclusion: The highly purified beta-TCP block worked as an activator for the soft tissue, including the periosteum, as well as a space maker to induce an osteoblastic response in the periosteum.
C1 [Yamauchi, Kensuke; Takahashi, Tetsu; Funaki, Katsuyuki; Yamashita, Yoshihiro] Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Div Oral & Maxillofacial Reconstruct Surg, Fukuoka, Japan.
RP Yamauchi, K (reprint author), 2-6-1 Manazuru,Kokurakita Ku, Fukuoka 8038580, Japan.
EM k-yama@kyu-dent.ac.jp
CR Estrada JIC, 2007, BRIT J ORAL MAX SURG, V45, P402, DOI 10.1016/j.bjoms.2006.02.005
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   DELLOYE C, 1990, CLIN ORTHOP RELAT R, P34
   Dortbudak O, 2002, J ORAL REHABIL, V29, P835, DOI 10.1046/j.1365-2842.2002.00918.x
   EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   Hikiji H, 2000, J ORAL MAXIL SURG, V58, P1270, DOI 10.1053/joms.2000.16628
   Hirata M, 2006, INT ORTHOP, V30, P510, DOI 10.1007/s00264-006-0156-1
   HOLBEIN O, 1995, J ORTHOP RES, V13, P629, DOI 10.1002/jor.1100130420
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   Ilizarov G A, 1989, Clin Orthop Relat Res, P263
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023
   Kessler P, 2007, BRIT J ORAL MAX SURG, V45, P284, DOI 10.1016/j.bjoms.2006.09.010
   Koepp HE, 2004, J BIOMED MATER RES B, V70B, P209, DOI 10.1002/jbm.b.30034
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   KOSTOPOULOS L, 1995, J CLIN PERIODONTOL, V22, P247
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Ozerdem OR, 1998, ANN PLAS SURG, V41, P148
   POSTACCHINI F, 1995, CLIN ORTHOP RELAT R, P218
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   Schmidt BL, 2002, J ORAL MAXIL SURG, V60, P1170, DOI 10.1053/joms.2002.34993
   Sencimen M, 2007, INT J ORAL MAX SURG, V36, P235, DOI 10.1016/j.ijom.2006.08.016
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291
   Uckan S, 2002, BRIT J ORAL MAX SURG, V40, P393, DOI 10.1016/S0266-4356(02)00211-5
   Yamatuchi K, 2006, INT J ORAL MAX SURG, V35, P493, DOI 10.1016/j.ijom.2006.01.008
NR 30
TC 18
Z9 18
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD JUN
PY 2008
VL 79
IS 6
BP 999
EP 1005
DI 10.1902/jop.2008.070536
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 312CK
UT WOS:000256646500007
PM 18533776
DA 2018-10-19
ER

PT J
AU Molly, L
   Vandromme, H
   Quirynen, M
   Schepers, E
   Adams, JL
   van Steenberghe, D
AF Molly, Liene
   Vandromme, Heleen
   Quirynen, Marc
   Schepers, Evert
   Adams, Jessica L.
   van Steenberghe, Daniel
TI Bone formation following implantation of bone biomaterials into
   extraction sites
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE biomaterials; bone; case series; dental implants; tooth extraction;
   tooth socket
ID TOOTH EXTRACTION; SINUS AUGMENTATION; RIDGE PRESERVATION; HUMANS;
   DEFECTS; MEMBRANE; REGENERATION; BIO-OSS(R); DIMENSIONS; LESIONS
AB Background: Adequate bone volume is imperative for the osseointegration of endosseous implants, but post-extraction resorption and remodeling may challenge implant placement. The use of bone biomaterials has been advocated to fill extraction sites and to enhance primary implant stability during osseointegration. The objective of the case series was to evaluate bone formation histologically and biomechanically in extraction sites following implantation of three commercially available bone biomaterials to compare their ability to allow guided bone regeneration.
   Methods: Thirty-six periodontally involved teeth were extracted from eight healthy non-smoking subjects. At least two bone biomaterials, a synthetic sponge based on poly lactic-polyglycolic acid technology (FIS), bovine porous bone mineral (BPBM), Ora natural coral derivative physically and chemically transformed into a calcium carbonate ceramic (COR), and one non-grafted control were applied to the extraction sockets within each subject and were covered by an expanded polytetrafluoroethylene device. The devices were removed after 2 months, and trephine biopsies were obtained from each site 4 months later. At that time, endosseous implants were placed in 25 of the sites, and healing abutments were placed; measurements were taken 4 to 6 months later with an electronic mobility testing device.
   Results: The percentage of residual biomaterial was 5.6% +/- 8.9% for FIS (P<0.001), 20.2% +/- 17.0% for BPBM (P<0.05), and 12.0% +/- 16.4% for COR (P<0.001). The amount of residual biomaterial after 6 months showed a significant relationship with the insertion torque measurements during the first third of implant insertion (P<0.05) and with values of the electronic mobility testing device at the abutment connection (P = 0.05). Histologically, new bone apposition was seen on BPBM particles. FIS sites showed similar ingrowth of blood vessels and osteocytes as empty controls.
   Conclusion: All sites revealed good primary stability at implant insertion and proper implant rigidity at abutment placement, indicating that early implant osseointegration was not influenced by the application of bone biomaterials used in this study.
C1 [Molly, Liene; Quirynen, Marc; van Steenberghe, Daniel] Catholic Univ Louvain, Dept Periodontol, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, B-3000 Louvain, Belgium.
   [Molly, Liene; Adams, Jessica L.] Univ Maryland, Sch Dent, Dept Periodontol, Baltimore, MD USA.
   [Vandromme, Heleen] Catholic Univ Louvain, Fac Psychol & Educ Sci, Ctr Psychol Learning & Expt Psychopathol, B-3000 Louvain, Belgium.
   [Schepers, Evert] Catholic Univ Louvain, Dept Prosthet Dent, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, B-3000 Louvain, Belgium.
RP Molly, L (reprint author), Catholic Univ Louvain, Dept Periodontol, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM lienemolly@yahoo.com
CR Assenza B, 2001, J Oral Implantol, V27, P287, DOI 10.1563/1548-1336(2001)027<0287:LRAUTM>2.3.CO;2
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Castellon Paulino, 2004, Implant Dent, V13, P42, DOI 10.1097/01.ID.0000116451.04676.7B
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kainulainen VT, 2004, INT J ORAL MAX SURG, V33, P786, DOI 10.1016/j.ijom.2004.01.007
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Mecall R A, 1991, Int J Periodontics Restorative Dent, V11, P8
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   Nair PNR, 2004, ORAL SURG ORAL MED O, V97, P559, DOI 10.1016/j.tripleo.2003.10.013
   Penarrocha Miguel, 2004, Med Oral, V9, P234
   Saldanha JB, 2006, J ORAL MAXIL SURG, V64, P1359, DOI 10.1016/j.joms.2006.05.021
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tatakis DN, 1999, J PERIODONTOL, V70, P542, DOI 10.1902/jop.1999.70.5.542
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   van Steenberghe D, 2003, CLIN ORAL IMPLAN RES, V14, P63, DOI 10.1034/j.1600-0501.2003.140109.x
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zitzmann N U, 2001, Int J Periodontics Restorative Dent, V21, P288
NR 27
TC 51
Z9 52
U1 1
U2 11
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUN
PY 2008
VL 79
IS 6
BP 1108
EP 1115
DI 10.1902/jop.2008.070476
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 312CK
UT WOS:000256646500022
PM 18533791
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AFM techniques for understanding cell-biomaterial interactions
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT News Item
CR MOONEY DJ, MACROMOL BIOSCI, DOI DOI 10.1002/MABI.200700313
NR 1
TC 0
Z9 0
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
EI 1099-0518
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUN 1
PY 2008
VL 46
IS 11
BP A3
EP A3
DI 10.1002/mabi.200700313
PG 1
WC Polymer Science
SC Polymer Science
GA 308KY
UT WOS:000256390100005
DA 2018-10-19
ER

PT J
AU Shyang, CW
   Khim, LY
   Ariffin, A
   Arifin, Z
   Ishak, M
AF Shyang, Chow Wen
   Khim, Loo Yok
   Ariffin, Azlan
   Arifin, Zainal
   Ishak, Mohd
TI Flexural properties of hydroxyapatite reinforced poly(methyl
   methacrylate) composites
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
DE poly(methyl methacrylate); hydroxyapatite; composites
ID POLYETHYLENE COMPOSITES; MECHANICAL-PROPERTIES
AB Poly(methyl methacrylate) (PMMA) filled with hydroxyapatite (HA) filler has been widely used in biomaterial application. Acrylic denture base material was prepared from PMMA filled with HA. This research work attempted to investigate the effects of hydroxyapatite (HA) on the flexural properties of poly(methyl methacrylate). PMMA powder was mixed with a monomer of methyl methacrylate (MMA) stabilized with hydroquinone. Benzoyl peroxide (BPO) and ethylene glycol dimethacrylate (EGDMA) were used as initiator and crosslinking agent, respectively. The PMMA/HA composites were prepared by using heat-processing polymers powder and liquid method. The flexural modulus of PMMA was increased by the addition of HA. This is attributed to the reinforcement effects of HA. However, the flexural strength and strain was decreased in the presence of HA. Experimental data of flexural modulus for PMMA/HA composites was compared with several theoretical models and equations. It was found that the experimental data could be relatively predicted by Hirsch's model.
C1 [Shyang, Chow Wen; Khim, Loo Yok; Ariffin, Azlan; Arifin, Zainal; Ishak, Mohd] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
RP Shyang, CW (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.
EM chowwenshyang@yahoo.com
CR Balac I, 2001, COMP MATER SCI, V20, P275, DOI 10.1016/S0927-0256(00)00182-8
   Balamurugan A, 2004, TRENDS BIOMATER ARTI, V18, P41
   Cheang P, 2003, MAT SCI ENG A-STRUCT, V345, P47, DOI 10.1016/S0921-5093(02)00284-8
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Ferris CF, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-10
   John J, 2001, J PROSTHET DENT, V86, P424, DOI 10.1067/mpr.2001.118564
   LAWRENCE EN, 1994, MECH PROPERTIES POLY, P386
   MCCABE JF, 1998, APPL DENT MAT, P96
   NIDAL WE, 2006, THESIS U SAINS MALAY, P79
   OBRIEN WJ, 2002, DENTAL MAT THEIR SEL, P77
   ONFIELD, 2003, BIOMATERIALS RES DEV, P72
   Pereira Marivalda de Magalhães, 2003, Mat. Res., V6, P311, DOI 10.1590/S1516-14392003000300002
   SAIED HM, 2006, THESIS U SAINS MALAY, P90
   Sakaguchi RL, 2004, DENT MATER, V20, P397, DOI 10.1016/j.dental.2003.11.003
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Yan W, 2006, COMPOS SCI TECHNOL, V66, P2080, DOI 10.1016/j.compscitech.2005.12.022
NR 16
TC 5
Z9 6
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD JUN
PY 2008
VL 27
IS 9
BP 945
EP 952
DI 10.1177/0731684407086506
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 311GJ
UT WOS:000256588400005
DA 2018-10-19
ER

PT J
AU Safran, MR
   Kim, H
   Zaffagnini, S
AF Safran, Marc R.
   Kim, Hubert
   Zaffagnini, Stefano
TI The use of scaffolds in the management of art articular cartilage injury
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; TISSUE-ENGINEERED CARTILAGE; BOVINE
   CHONDROCYTES; REPAIR; DEFECTS; POLYMER; REDIFFERENTIATION; BIOMATERIAL;
   CONSTRUCTS; SURFACES
AB Managing articular cartilage injury continues to be a difficult challenge for the clinician. Although the short- and intermediateterm results of autologous chondrocyte implantation appear to be favorable, resources are being directed toward research to improve the technology. One promising area of investigation is the combination of cultured chondrocytes with scaffolds. Clinicians desire techniques that may be implanted easily, reduce surgical morbidity, do not require harvesting of other tissues, exhibit enhanced cell proliferation and maturation, have easier phenotype maintenance, and allow for efficient and complete integration with surrounding articular cartilage. The characteristics that make scaffolds optimal for clinical use are that they be biocompatible, biodegradable, permeable, reproducible, mechanically stable, noncytotoxic, and capable of serving as a temporary support for the cells while allowing for eventual replacement by matrix components synthesized by the implanted cells. Clinical experience is growing with three scaffold-based cartilage repair techniques, each using a different type of scaffold material: matrix-induced autologous chondrocyte implantation, a hyaluronic acid-based scaffold, and a composite polylactic/polyglycolic acid polymer fleece. Clinical results are encouraging. Future directions in scaffold-based cartilage repair include bioactive and spatially oriented scaffolds.
C1 [Safran, Marc R.; Kim, Hubert] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
   [Zaffagnini, Stefano] Rizzoli Orthopaed Inst, Biomech Lab, Bologna, Italy.
RP Safran, MR (reprint author), Stanford Univ, 300 Pasteur Dr,Edwards R105, Stanford, CA 94305 USA.
CR Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Chen G, 2003, FEBS LETT, V542, P95, DOI 10.1016/S0014-5793(03)00354-5
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   Erggelet C, 2003, ARTHROSCOPY, V19, P108, DOI 10.1053/jars.2003.50025
   GOTI GK, 2003, ARCH OTOLARYNGOL, V129, P889
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   GUILLEN P, 2005, FINAL PROGRAM, P145
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Kim HT, 2006, J ORTHOP SPORT PHYS, V36, P765, DOI 10.2519/jospt.2006.2284
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M., 2005, ANN M AM ORTH SOC SP
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Strauss EJ, 2005, AM J SPORT MED, V33, P1647, DOI 10.1177/0363546505275487
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Zehbe R, 2005, BIO-MED MATER ENG, V15, P445
NR 27
TC 42
Z9 43
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1067-151X
EI 1940-5480
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PD JUN
PY 2008
VL 16
IS 6
BP 306
EP 311
DI 10.5435/00124635-200806000-00002
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 306XC
UT WOS:000256280600002
PM 18524981
DA 2018-10-19
ER

PT J
AU Dutra, CEA
   Pereira, MM
   Serakides, R
   Rezende, CAF
AF Dutra, Carlos E. A.
   Pereira, Marivalda M.
   Serakides, Rogeria
   Rezende, Cleuza A. F.
TI In vivo evaluation of bioactive glass foams associated with
   platelet-rich plasma in bone defects
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterials; bioactive glass foam; sol-gel; bone; osteoconduction
ID REGENERATION; SCAFFOLDS; CERAMICS; GRAFTS; GROWTH
AB The objective of this study was to evaluate the use of bioactive glass foams produced by the sol-gel process, associated or not with platelet-rich plasma (PRP), in the regeneration of bone defects. Mongrel dogs (n = 14) were divided into two groups after having their superior first premolar removed. A small piece of vestibular bone from the alveolus was intentionally removed. The area was filled with bioactive glass foam produced by the sol-gel method. Two groups were tested: group A was the glass foam; group B was the same material associated with PRP, prepared from each animal. The other side of alveolar bone was used as a control group, in which the bone defect did not receive any biomaterial. The thickness of the bone area was measured before and after the intervention. After a period of 60 days implantation, the right and left bones were measured again, and a bone biopsy on both regions was conducted for histological analysis. The findings show an increase of bone thickness for both materials implanted compared to the control group. Group B, implanted with bioactive glass foam associated with PRP, showed a thicker bone area compared to Group A. Histological results indicate bone formation for both materials used. However, the bioactive glass associated with PRP gave rise to a more mature bone formation. These results show that bioactive glass foams processed by a sol-gel method is effective in maintaining the thickness of the alveolar ridge, and the use of PRP associated with the foams improve bone formation. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Dutra, Carlos E. A.] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Marivalda M.] Univ Fed Minas Gerais, Escola Engn, Dept Engn Met, BR-31270901 Belo Horizonte, MG, Brazil.
   [Serakides, Rogeria; Rezende, Cleuza A. F.] Univ Fed Minas Gerais, Escola Med Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Dutra, CEA (reprint author), Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kkdut@hotmail.com
RI Serakides, Rogeria/C-7571-2016
OI Serakides, Rogeria/0000-0001-5374-6242
CR BARTLEY PM, 2001, REV ADM, V5, P283
   BELL E, 1997, PRINCIPLES TISSUE EN, P181
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   Coelho MD, 2005, J BIOMED MATER RES B, V75B, P451, DOI 10.1002/jbm.b.30354
   Cunningham N, 1992, BONE GRAFTS BONE SUB, P93
   Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322
   Froum SJ, 2002, INT J PERIODONT REST, V22, P45
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   GRENNSPAN DC, 1998, P 11 INT S CER MED B, P345
   HAMMADOUCHE M, 2001, J BIOMED MATER RES, V4, P560
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Langer R, 1997, PHARMACEUT RES, V14, P840, DOI 10.1023/A:1012131329148
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   LYNCH SE, 1994, PERIODONTAL REGENERA
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Nevins M L, 2000, Int J Periodontics Restorative Dent, V20, P458
   PEREIRA MM, 1994, THESIS GRADUATE SCH
   PUTNAM JA, 1996, NAT MED, V7, P824
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   URIST MR, 1972, CLIN ORTHOP RELAT R, P132
   XINUS ID, 2000, BIOCHEM BIOPH RES CO, V276, P461
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
NR 27
TC 18
Z9 22
U1 0
U2 2
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2008
VL 2
IS 4
BP 221
EP 227
DI 10.1002/term.86
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 317UI
UT WOS:000257045200007
PM 18493909
DA 2018-10-19
ER

PT J
AU Arias, JI
   Gonzalez, A
   Fernandez, MS
   Gonzalez, C
   Saez, D
   Arias, JL
AF Arias, J. I.
   Gonzalez, A.
   Fernandez, M. S.
   Gonzalez, C.
   Saez, D.
   Arias, J. L.
TI Eggshell membrane as a biodegradable bone regeneration inhibitor
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE eggshell membrane; bone; regeneration; radius curvus; biomaterial; type
   X collagen
ID MOLECULAR WEIGHT COLLAGEN; DISTAL ULNAR PHYSIS; X COLLAGEN; ENDOCHONDRAL
   OSSIFICATION; PREMATURE CLOSURE; CRANIAL DEFECTS; NONUNION MODEL;
   CHONDROCYTES; CARTILAGE; MATRIX
AB The efficiency of chicken eggshell membranes combined with a minimally invasive small osteotomy procedure of the ulna to accomplish an efficient release of the radius so that it can continue to grow in an unstressed manner was tested in rabbits. Eggshell membranes were extracted from chicken eggs, rinsed, dried and sterilized with ethylene oxide for 24 h. For reactivity testing, four separate subcutaneous pockets were created in 10 rats in the paravertebral region by blunt dissection and eggshell membranes were implanted in two of them. After 1-16 weeks, the implants were retrieved with the surrounding soft tissues and submitted to histological examination. Subsequently, 10 rabbits were anaesthetized and a complete 0.5 mm. wide osteotomy was performed in both the right and the left distal ulna. A piece of eggshell membranes was interposed in the osteotomy site of one ulna. The opposite osteotomized ulna was left as a negative control. The rabbits were injected with oxytetracycline at the time of surgery and this was repeated every 7 days for labelling new bone formation. After 1-16 weeks, ulnar osteotomized regions were histologically examined. After histological, fluorescence microcopy and radiological evaluation, we demonstrate here for the first time that eggshell membranes as interpositional material in rabbit osteotomized ulnar experiments acted as an active barrier against bone bridging. The degradation of the eggshell membrane, due to host reaction, appeared sufficiently late to cause the desirable delay of bone healing that is compatible with the time needed for a corrective response. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Arias, J. I.] Univ Austral Chile, Inst Ciencias Clin Vet, Fac Ciencias Vet, Valdivia, Chile.
   [Gonzalez, A.; Fernandez, M. S.; Saez, D.; Arias, J. L.] Univ Chile, Fac Ciencias Vet & Pecuarias, Santiago, Chile.
   [Fernandez, M. S.; Arias, J. L.] Univ Chile, Fac Vet Sci, Ctr Adv Interdisciplinary Res Mat Sci, Santiago, Chile.
   [Gonzalez, C.] Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Med Vet, Santiago, Chile.
RP Arias, JL (reprint author), Univ Chile, Fac Vet Sci, Ctr Adv Interdisciplinary Res Mat Sci, Santa Rosa 11735, Santiago, Chile.
EM jarias@uchile.cl
RI ARIAS, JOSE/H-5489-2013; Arias, Jose/E-1206-2011
OI Arias, Jose Ignacio/0000-0001-6518-2229
CR [Anonymous], 2003, F198399 ASTM INT
   Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211
   ARIAS JL, 1991, MATRIX, V11, P313, DOI 10.1016/S0934-8832(11)80202-7
   ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162
   ARIAS JL, 2007, HDB BIOMINERALIZATIO, V2, P109
   *ASTM INT, 2004, F98104 ASTM INT
   Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549
   CAPASSO O, 1984, MOL CELL BIOL, V4, P1163, DOI 10.1128/MCB.4.6.1163
   CAPASSO O, 1982, EXP CELL RES, V142, P194
   DEBOER HH, 1989, J BONE JOINT SURG BR, V71, P374
   Dupoirieux L, 2001, J CRANIOFAC SURG, V12, P53, DOI 10.1097/00001665-200101000-00009
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Durmus E, 2003, J INT MED RES, V31, P223, DOI 10.1177/147323000303100309
   EGGER EL, 1978, J AM ANIM HOSP ASSOC, V14, P690
   Fernandez MS, 2001, MATRIX BIOL, V19, P793
   Fox DB, 2006, VET SURG, V35, P67, DOI 10.1111/j.1532-950X.2005.00114.x
   GIBSON GJ, 1984, J CELL BIOL, V99, P208, DOI 10.1083/jcb.99.1.208
   GRANT WT, 1987, J BIOL CHEM, V262, P9844
   HABUCHI H, 1985, J BIOL CHEM, V260, P13026
   HAN CS, 1992, J BONE JOINT SURG AM, V74A, P1441, DOI 10.2106/00004623-199274100-00002
   JACENKO O, 1991, CRIT REV EUKAR GENE, V1, P3217
   JIA J, 2007, J BIOMED MAT RES
   KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545
   Kim G, 2007, BIOMED MATER, V2, P250, DOI 10.1088/1748-6041/2/4/007
   KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x
   Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   LAU RE, 1977, J AM ANIM HOSP ASSOC, V13, P609
   LEBOY PS, 1988, J BIOL CHEM, V263, P8515
   LUVALLE P, 1992, MATRIX, V12, P404, DOI 10.1016/S0934-8832(11)80037-5
   MAY JW, 1989, J BONE JOINT SURG AM, V71A, P1422, DOI 10.2106/00004623-198971090-00027
   NEWTON CD, 1974, J AM VET MED ASSOC, V164, P479
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   PIERMATEI DL, 1997, HDB SMALL ANIMAL ORT, P696
   POOLE AR, 1989, ANAT REC, V224, P167
   POOLE AR, 1989, J CELL BIOL, V109, P2547, DOI 10.1083/jcb.109.5.2547
   Russell G, 2007, J INVEST SURG, V20, P249, DOI 10.1080/08941930701481312
   SCHMID TM, 1985, DEV BIOL, V107, P373, DOI 10.1016/0012-1606(85)90319-7
   SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598
   SCHMID TM, 1982, J BIOL CHEM, V257, P2444
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   SOLURSH M, 1986, DEV BIOL, V117, P90, DOI 10.1016/0012-1606(86)90351-9
   TACCHETTI C, 1989, DEV BIOL, V132, P442, DOI 10.1016/0012-1606(89)90240-6
   Upman PJ, 2003, LAB ANIMAL, V32, P26, DOI 10.1038/laban0303-26
   VANDEWATER A, 1982, VET SURG, V11, P92, DOI 10.1111/j.1532-950X.1982.tb00675.x
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   WALKER GD, 1995, J ORTHOPAED RES, V13, P4, DOI 10.1002/jor.1100130104
   Zadik Y, 2007, WILD ENVIRON MED, V18, P230, DOI 10.1580/06-WEME-LE-082R1.1
NR 50
TC 13
Z9 13
U1 0
U2 19
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2008
VL 2
IS 4
BP 228
EP 235
DI 10.1002/term.87
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 317UI
UT WOS:000257045200008
PM 18493912
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Yamamoto, A
   Maruyama, N
   Somekawa, H
   Mukai, T
AF Hiromoto, Sachiko
   Yamamoto, Akiko
   Maruyama, Norio
   Somekawa, Hidetoshi
   Mukai, Toshiji
TI Polarization behavior of pure magnesium under a controlled flow in a
   NaCl solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE pure magnesium; controlled flow; polarization behavior; impedance
   behavior; biomaterial
ID ABSORBABLE METAL; ALLOYS; CORROSION; STENTS
AB Magnesium and its alloys are potential candidates for bioabsorbable stents. The degradation rate of an indwelled magnesium stent is expected to be controlled under a blood flow. The influence of the controlled flow on the polarization and impedance behavior of pure Mg was thus investigated in a 0.6 mass% NaCl solution using a rotating electrode. The existence of a flow caused an increase in the anodic current density as well as a decrease in the impedance for a few hours of immersion, indicating the acceleration of Mg dissolution and the retardation of the growth of the surface hydroxide film. Interestingly, the existence of a flow retarded the breakdown of the surface film. After the surface film was broken down, the impedance did not depend on the rotation speed. To precisely evaluate the degradation rate of magnesium and its alloys for use in stents, the flow rate of the test solution should be controlled.
C1 [Hiromoto, Sachiko; Yamamoto, Akiko; Maruyama, Norio] Natl Inst Mat Sci, Ctr Biomat, Biomet Grp, Tsukuba, Ibaraki 3050044, Japan.
   [Somekawa, Hidetoshi; Mukai, Toshiji] Natl Inst Mat Sci, Struct Met Ctr, Lightweight Alloys Grp, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Ctr Biomat, Biomet Grp, Tsukuba, Ibaraki 3050044, Japan.
EM HIROMOTO.Sachiko@nims.go.jp
RI Mukai, Toshiji/F-9570-2014; HIROMOTO, Sachiko/H-2686-2011; Kobe Univ,
   Engineering/D-2028-2017
OI Mukai, Toshiji/0000-0002-9628-5762; 
CR Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   GULBRANDSEN E, 1992, ELECTROCHIM ACTA, V37, P1403, DOI 10.1016/0013-4686(92)87014-Q
   Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hillis J., 2006, MAGNESIUM TECHNOLOGY, P469
   KAIBARA M, 1999, BIORHEOLOGY, P78
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   McCord Carey P., 1942, INDUST MED [BELOIT], V11, P71
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA, P139
   Stroganov G. B., 1972, [No title captured], Patent No. [3687135, 3, 687, 135]
   SUGAWARA M, 2003, HEMORHEOLOGY BLOOD F, P75
   Takatani Y., 2005, Journal of Japan Institute of Light Metals, V55, P357, DOI 10.2464/jilm.55.357
   TANAKA H, 1995, CHEM REV Q, V27, P3
   WADA G, 1957, DENKI KAGAKU ELECTRO, V25, P164
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
NR 19
TC 15
Z9 15
U1 0
U2 12
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2008
VL 49
IS 6
BP 1456
EP 1461
DI 10.2320/matertrans.MRA2008011
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 333OD
UT WOS:000258160900041
OA Bronze
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AFM techniques for understanding cell-biomaterial interactions
SO PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS
LA English
DT News Item
CR MOONEY DJ, MACROMOL BIOSCI, DOI DOI 10.1002/MABI.200700313
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1862-6254
EI 1862-6270
J9 PHYS STATUS SOLIDI-R
JI Phys. Status Solidi-Rapid Res. Lett.
PD JUN
PY 2008
VL 2
IS 3
BP A3
EP A3
PG 1
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 317TQ
UT WOS:000257043400010
DA 2018-10-19
ER

PT J
AU Man, I
   Pirvu, C
   Demetrescu, I
AF Man, Isabela
   Pirvu, Cristian
   Demetrescu, Ioana
TI Enhancing Titanium stability in Fusayama Saliva using electrochemical
   elaboration of TiO(2) nanotubes
SO REVISTA DE CHIMIE
LA English
DT Article
DE TO(2) nanotubes; Fusayama saliva; cyclic voltametry; atomic force
   microscopy
ID SURFACE OXIDE-FILM; PHYSIOLOGICAL ENVIRONMENT; DENTAL ALLOYS; BEHAVIOR;
   LAYERS; MOCVD
AB Titanium having low density, stability and biocompatibility, is one of the most promising biomaterial of the century even with the natural passive stratum [1,2], but building a nano-tube structure in the last decade using various procedure could lead also to an improvement of a quite large range of properties important in applied chemistry. The aim of the paper is to elaborate electrochemically TiO(2) nanotubes and to evaluate the stability increase of Titanium in Fusayama saliva changing the surface morphology from micro TiO(2) to TiO(2) nanotubes. Anodization at room temperature in a mixture of (NH(4))(2)SO(4) and NH(4)F, was the choice of nanotubes structures elaboration, and cyclic voltammetry was the procedure of stability evaluation. The surface analysis was performed using scanning electron microscopy (SEM), energy-dispersive X-ray microanalysis (EDAX), and atomic force microscopy before and after anodization.
C1 [Man, Isabela; Pirvu, Cristian; Demetrescu, Ioana] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, 1-3 Polizu Str, Bucharest 011061, Romania.
EM l_demetrescu@chim.upb.ro
RI Demetrescu, Ioana/C-5325-2013
OI Pirvu, Cristian/0000-0003-0339-6146
CR Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Balaur E, 2005, ELECTROCHEM COMMUN, V7, P1066, DOI 10.1016/j.elecom.2005.07.014
   Brunette D. M., 2001, TITANIUM MED
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   DYER CK, 1978, J ELECTROCHEM SOC, V125, P23, DOI 10.1149/1.2131391
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   HANAVA T, 1998, BIOMATERIALS, V19, P85
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hazra SK, 2006, MAT SCI ENG B-SOLID, V131, P135, DOI 10.1016/j.mseb.2006.04.004
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Macak JM, 2005, ELECTROCHIM ACTA, V50, P3679, DOI 10.1016/j.electacta.2005.01.014
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Popa MV, 2003, MATER CORROS, V54, P215, DOI 10.1002/maco.200390049
   Popescu S, 2007, REV CHIM-BUCHAREST, V58, P880
   Popescu S, 2007, J MATER SCI-MATER M, V18, P2075, DOI 10.1007/s10856-007-3133-3
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 22
TC 30
Z9 30
U1 1
U2 6
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD JUN
PY 2008
VL 59
IS 6
BP 615
EP 617
PG 3
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 325QY
UT WOS:000257604600002
DA 2018-10-19
ER

PT J
AU Ganio, E
   Marino, F
   Giani, I
   Luc, AR
   Clerico, G
   Novelli, E
   Trompetto, M
AF Ganio, E.
   Marino, F.
   Giani, I.
   Luc, A. Realis
   Clerico, G.
   Novelli, E.
   Trompetto, M.
TI Injectable synthetic calcium hydroxylapatite ceramic microspheres
   (Coaptite) for passive fecal incontinence
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article
DE Fecal incontinence; Bulking agents; Calcium hydroxylapatite; Coaptite
ID RADIOFREQUENCY ENERGY DELIVERY; STRESS URINARY-INCONTINENCE;
   ANAL-SPHINCTER DYSFUNCTION; SILICONE BIOMATERIAL; VESICOURETERAL REFLUX;
   ENDOSCOPIC TREATMENT; PERIANAL INJECTION; BULKING AGENT; COLLAGEN;
   MANAGEMENT
AB Background Passive fecal incontinence is a disabling condition caused by internal anal sphincter dysfunction. The aim of the study was to assess prospectively the effects of calcium hydroxylapatite ceramic microspheres (Coaptite) as a bulking agents to treat patients with passive fecal incontinence. Methods Ten patients with passive fecal incontinence were recruited. All patients were assessed by clinical examination, anal ultrasonography and anal manometry. The severity of incontinence and quality of life were assessed using the Fecal Incontinence Scoring System (FISS) and Fecal Incontinence Quality of Life (FIQoL) questionnaire at baseline and at 3, 6 and 12 months after the Coaptite injection. Results Eight patients (80%) had a marked improvement in continence, with a significant reduction in FISS from 85.6 +/- 9.4 to 28.0 +/- 29.0 (p=0.008) at 12 months. There was an improvement in global quality of life scores, which was significant in three subscales ( lifestyle, coping/behaviour and embarrassment). Manometry showed a significant improvement from baseline in the mean resting anal canal pressure after the Coaptite injection (p=0.018). Conclusions Coaptite is a promising and safe bulking agent for the treatment of passive fecal incontinence.
C1 [Ganio, E.; Marino, F.; Giani, I.; Luc, A. Realis; Clerico, G.; Novelli, E.; Trompetto, M.] Clin S Rita, Colorectal Eporediensis Ctr, Vercelli, Italy.
RP Marino, F (reprint author), Clin S Rita, Colorectal Eporediensis Ctr, Vercelli, Italy.
EM fabio.marino@virgilio.it
CR Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Hetzer FH, 2006, BRIT J SURG, V93, P1411, DOI 10.1002/bjs.5491
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   MAEDA Y, 2007, COLORECTAL DIS, V10, P268
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Mayer R, 2001, UROLOGY, V57, P434, DOI 10.1016/S0090-4295(00)01098-0
   Mayer RD, 2007, UROLOGY, V69, P876, DOI 10.1016/j.urology.2007.01.050
   Merrot T, 2005, PROG UROL, V15, P1114
   Mevorach RA, 2006, J UROLOGY, V175, P288, DOI 10.1016/S0022-5347(05)00013-3
   Mora Durban Miguel Julian, 2006, Archivos Espanoles de Urologia, V59, P493
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
NR 22
TC 21
Z9 22
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1123-6337
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD JUN
PY 2008
VL 12
IS 2
BP 99
EP 102
DI 10.1007/s10151-008-0406-x
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 385VU
UT WOS:000261842500003
PM 18545883
DA 2018-10-19
ER

PT J
AU El-Ayoubi, R
   Eliopoulos, N
   Diraddo, R
   Jacques, G
   Yousef, AM
AF El-Ayoubi, Rouwayda
   Eliopoulos, Nicoletta
   Diraddo, Robert
   Galipeau, Jacques
   Yousefi, Azizeh-Mitra
TI Design and fabrication of 3D porous scaffolds to facilitate cell-based
   gene therapy
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; TISSUE ENGINEERING
   SCAFFOLDS; BIODEGRADABLE POLYMER; POLY(D,L-LACTIC-CO-GLYCOLIC ACID);
   SYSTEMIC DELIVERY; PHASE-SEPARATION; SPINAL-CORD; PORE-SIZE;
   ERYTHROPOIETIN
AB Biomaterials capable of efficient gene delivery by embedded cells provide a fundamental tool for the treatment of acquired or hereditary diseases. A major obstacle is maintaining adequate nutrient and oxygen diffusion to cells within the biomaterial. In this study, we combined the solid free-form fabrication and porogen leaching techniques to fabricate three-dimensional scaffolds, with bimodal pore size distribution, for cell-based gene delivery. The objective of this study was to design micro-/macroporous scaffolds to improve cell viability and drug delivery. Murine bone marrow-derived mesenchymal stromal cells (MSCs) genetically engineered to secrete erythropoietin (EPO) were seeded onto poly-L-lactide (PLLA) scaffolds with different microporosities. Over a period of 2 weeks in culture, an increase in cell proliferation and metabolic activity was observed with increasing scaffold microporosity. The concentration of EPO detected in supernatants also increased with increasing microporosity level. Our study shows that these constructs can promote cell viability and release of therapeutic proteins, and clearly demonstrates their capacity for a dual role as scaffolds for tissue regeneration and as delivery systems for soluble gene products.
C1 [El-Ayoubi, Rouwayda; Diraddo, Robert; Yousefi, Azizeh-Mitra] Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
   [Eliopoulos, Nicoletta; Galipeau, Jacques] McGill Univ, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3A 2T5, Canada.
   [Eliopoulos, Nicoletta; Galipeau, Jacques] McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3A 2T5, Canada.
RP Yousef, AM (reprint author), Natl Res Council Canada, Inst Ind Mat, 75 Mortagne Blvd, Boucherville, PQ J4B 6Y4, Canada.
EM Azizeh.Yousefi@imi.cnrc-nrc.gc.ca
CR Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bursac PM, 1999, J BIOMECH, V32, P1125, DOI 10.1016/S0021-9290(99)00105-0
   Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Chang PL, 1998, ADV DRUG DELIVER REV, V33, P31, DOI 10.1016/S0169-409X(98)00018-0
   Crow BB, 2005, TISSUE ENG, V11, P1077, DOI 10.1089/ten.2005.11.1077
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   Dealy J M, 1990, MELT RHEOLOGY ITS RO
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Diez S, 2006, EUR J PHARM BIOPHARM, V63, P188, DOI 10.1016/j.ejpb.2006.03.007
   Eliopoulos N, 2006, J AM SOC NEPHROL, V17, P1576, DOI 10.1681/ASN.2005101035
   Eliopoulos N, 2004, MOL THER, V10, P741, DOI 10.1016/j.ymthe.2004.07.004
   Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Horwitz EM, 2003, ARCH MED RES, V34, P600, DOI 10.1016/j.arcmed.2003.09.006
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Jelkmann W, 1996, ANN ANAT, V178, P391, DOI 10.1016/S0940-9602(96)80124-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim SS, 1998, ANN SURG, V228, P8, DOI 10.1097/00000658-199807000-00002
   Kim SY, 2002, KOREAN J CHEM ENG, V19, P190, DOI 10.1007/BF02706894
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Leclerc E, 2004, MAT SCI ENG C-BIO S, V24, P349, DOI 10.1016/j.msec.2003.12.004
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Margarett D.M.E., 1998, J BIOMED MATER RES, V40, P621
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mikos AG, 1994, POLYMER, V35, P1069
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Newman KD, 2004, BIOMATERIALS, V25, P5763, DOI 10.1016/j.biomaterials.2004.01.027
   Paek HJ, 2006, TISSUE ENG, V12, P1733, DOI 10.1089/ten.2006.12.1733
   Pfister A, 2004, J POLYM SCI POL CHEM, V42, P624, DOI 10.1002/pola.10807
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pochampally RR, 2005, GENE THER, V12, P1119, DOI 10.1038/sj.gt.3302514
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   Regulier E, 1998, GENE THER, V5, P1014, DOI 10.1038/sj.gt.3300687
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   VACANTI JP, 1999, LANCET S1, V354, pS132
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WEISS L, 1997, INT TECHNOLOGY RES I, V5, P5
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   XU SL, 2001, ANN NY ACAD SCI, V944, P144
   Yamamoto M, 2006, ADV DRUG DELIVER REV, V58, P535, DOI 10.1016/j.addr.2006.03.003
   Yousefi AM, 2007, POLYM ENG SCI, V47, P608, DOI 10.1002/pen.20732
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 68
TC 21
Z9 23
U1 2
U2 16
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2008
VL 14
IS 6
BP 1037
EP 1048
DI 10.1089/ten.tea.2006.0418
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 316SK
UT WOS:000256969800009
PM 19230126
DA 2018-10-19
ER

PT J
AU Pokrywczynska, M
   Drewa, T
   Jundzill, A
   Lysik, J
AF Pokrywczynska, M.
   Drewa, T.
   Jundzill, A.
   Lysik, J.
TI Alginate is not a good material for growth of rapidly proliferating
   cells
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID VESICOURETERAL REFLUX; ENDOSCOPIC TREATMENT; FOLLOW-UP; CHONDROCYTES;
   ISLETS; HYDROGELS; SCAFFOLDS
AB Introduction. Alginate scaffolds are widely used in tissue engineering. The aim of this study was to evaluate alginate as a scaffold for 3D cultures of rapidly proliferating cells.
   Materials and Methods. Murine 3T3 fibroblasts were cultured in an alginate scaffold for 30 days. Cells growing in alginate were observed under the inverted microscope. Pathologic examination by hematoxylin and eosin staining was done at the end of the experiment.
   Results. Migration of rapidly proliferating cells from the 3D scaffold and an inappropriate growth pattern were observed during the experiment. Cells and scaffold did not form a solid graft.
   Conclusions. The results obtained in this study indicated that alginate is not a good biomaterial for a durable implant.
C1 Nicholas Copernicus Univ, Coll Med, Chair Med Biol, Dept Tissue Engn, PL-85090 Bydgoszcz, Poland.
   Ctr Oncol, Dept Oncol & Brachytherapy, Bydgoszcz, Poland.
RP Drewa, T (reprint author), Nicholas Copernicus Univ, Coll Med, Chair Med Biol, Dept Tissue Engn, Karlowicza 24 Str, PL-85090 Bydgoszcz, Poland.
EM tomaszdrewa@wp.pl
RI Pokrywczynska, Marta/E-9323-2014
OI Pokrywczynska, Marta/0000-0003-3259-087X
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Calafiore R, 2006, TRANSPLANT P, V38, P1156, DOI 10.1016/j.transproceed.2006.03.014
   Chertin B, 2002, J UROLOGY, V167, P1443, DOI 10.1016/S0022-5347(05)65340-2
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Elliott RB, 2005, TRANSPL P, V37, P466, DOI 10.1016/j.transproceed.2004.12.198
   Fu SH, 2003, TRANSPLANT P, V35, P496, DOI 10.1016/S0041-1345(02)03902-7
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Kamishina H, 2006, J VET MED SCI, V68, P1239, DOI 10.1292/jvms.68.1239
   Lackgren G, 2001, J UROLOGY, V166, P1887, DOI 10.1016/S0022-5347(05)65713-8
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Stabler C, 2001, BIOMATERIALS, V22, P1301, DOI 10.1016/S0142-9612(00)00282-9
   WENG Y, 2006, TISSUE ENG, V6, P1503
   Zhang WJ, 2001, TRANSPLANT P, V33, P3517, DOI 10.1016/S0041-1345(01)02419-8
NR 20
TC 18
Z9 19
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD JUN
PY 2008
VL 40
IS 5
BP 1664
EP 1667
DI 10.1016/j.transproceed.2008.03.135
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 326YJ
UT WOS:000257695300090
PM 18589169
DA 2018-10-19
ER

PT J
AU Nagele, U
   Kuczyk, MA
   Horstmann, M
   Hennenlotter, J
   Sievert, KD
   Schilling, D
   Walcher, U
   Stenzl, A
   Anastasiadis, AG
AF Nagele, Udo
   Kuczyk, Markus A.
   Horstmann, Marcus
   Hennenlotter, Joerg
   Sievert, Karl-Dietrich
   Schilling, David
   Walcher, Ute
   Stenzl, Arnulf
   Anastasiadis, Aristotelis G.
TI Initial clinical experience with full-length metal ureteral stents for
   obstructive ureteral stenosis
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE ureteral obstruction; endourology; metal stent
ID BIOMATERIAL ENCRUSTATION; WALLSTENTS; MODEL
AB Objectives Long-term ureteral stenting is used to ensure urinary drainage if a reconstructive approach or a release of an extrinsic obstruction is not possible. In this contribution, a long-term experience with a new full-length, metal indwelling stent is presented.
   Methods Fourteen patients with ureteral obstruction received full metal indwelling stents in 18 collecting systems (benign disease in 5 and malignant disease in 13). Stent placement was performed cystoscopically under fluoroscopic guidance. Follow-up was done every 3 months with ultrasonographic examination, creatinine levels, and a visual analog pain score.
   Results Eight stents were removed, whereas eight are still in situ. One patient without stent-related problems died because of progressive rectal cancer 9 months after bilateral stent insertion. Mean stent duration (8 stents still in situ) is 8.6 months, whereas mean stent duration for benign and malignant disease is 11.8 (median 13) and 7.3 (median 6) months, respectively (p < 0.05). All removed stents were extracted endoscopically without any problems and had no incrustation except two. Neither migration nor mechanical damage was observed.
   Conclusion This novel stent is easy to insert and remove. It is an option for patients in which a surgical reconstruction of the obstructed ureter is not possible. Stents have been developed further and are now available in various lengths. This might result in a reduction of problems associated with inadequate stent length and should increase patient comfort and stent durability.
C1 [Nagele, Udo; Kuczyk, Markus A.; Horstmann, Marcus; Hennenlotter, Joerg; Sievert, Karl-Dietrich; Schilling, David; Walcher, Ute; Stenzl, Arnulf; Anastasiadis, Aristotelis G.] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany.
RP Nagele, U (reprint author), Univ Tubingen, Dept Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM Udo.Nagele@med.uni-tuebingen.de
CR Barbalias GA, 2002, EUR UROL, V42, P276, DOI 10.1016/S0302-2838(02)00281-6
   Borin JF, 2006, J ENDOUROL, V20, P300, DOI 10.1089/end.2006.20.300
   Chung SY, 2004, J UROLOGY, V172, P592, DOI 10.1097/01.ju.0000130510.28768.f5
   DOCIMO SG, 1989, J UROLOGY, V142, P277, DOI 10.1016/S0022-5347(17)38729-3
   Hekimoglu B, 1996, EUR RADIOL, V6, P675
   JOSHI HB, 2001, EUR UROL, V39, P6
   Klarskov P, 2005, SCAND J UROL NEPHROL, V39, P169, DOI 10.1080/00365590510007720
   KU JH, 2004, UROLOGY, V64, P5
   Liatsikos EN, 2007, J UROLOGY, V178, P169, DOI 10.1016/j.juro.2007.03.061
   Lugmayr HF, 1996, RADIOLOGY, V198, P105, DOI 10.1148/radiology.198.1.8539359
   PAUER W, 1992, J UROLOGY, V148, P281, DOI 10.1016/S0022-5347(17)36573-4
   THIJSSEN AM, 1994, J UROLOGY, V151, P268, DOI 10.1016/S0022-5347(17)34930-3
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
NR 14
TC 42
Z9 42
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD JUN
PY 2008
VL 26
IS 3
BP 257
EP 262
DI 10.1007/s00345-008-0245-4
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 304EH
UT WOS:000256092300010
PM 18324407
DA 2018-10-19
ER

PT J
AU Bodnar, M
   Kjoniksen, AL
   Molnar, RM
   Hartmann, JF
   Daroczi, L
   Nystrom, B
   Borbely, J
AF Bodnar, MagdoIna
   Kjoniksen, Anna-Lena
   Molnar, Reka M.
   Hartmann, John F.
   Daroczi, Lajos
   Nystrom, Bo
   Borbely, Janos
TI Nanoparticles formed by complexation of poly-gamma-glutamic acid with
   lead ions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE gamma-PGA; lead binding; nanoparticles; complexation
ID POLY(GAMMA-GLUTAMIC ACID); FLOCCULATING ACTIVITY; WASTE-WATER; CHEMICAL
   MODIFICATION; BACILLUS-SUBTILIS; AQUEOUS-SOLUTIONS; ULTRAFILTRATION;
   ASSOCIATION; SURFACTANT; SUSPENSION
AB The present investigation describes the preparation and characterization of novel biodegradable nanoparticles based on complexation of polygarnma-glutamic acid (gamma-PGA) with bivalent lead ion. The prepared nano-systems were stable in aqueous media at low pH, neutral and mild alkaline conditions. The particle size and the size of the complexes were identified by dynamic light scattering (DLS) and transmission electron microscopy (TEM) measurements. It was found that the size of the complexes depended on the pH and concentrations of gamma-PGA and lead ions. Particle sizes measured by TEM revealed that at low concentrations, nanosized particles were formed, however, at high concentrations of gamma-PGA and lead ions, the formation of large aggregates with a broad size distribution was promoted. The size of individual particles was in the range of 40-100 nm measured by TEM. The results from the DLS measurements showed that the low and high pH values in mixtures with high concentrations of gamma-PGA and Pb2+ ions favored the growth of large complexes. The gamma-PGA nanoparticles, composed of a biodegradable biomaterial with high flocculating and heavy metal binding activity, may be useful for various water treatment applications. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Bodnar, MagdoIna; Molnar, Reka M.; Borbely, Janos] Univ Debrecen, Dept Colloid & Environm Chem, H-4010 Debrecen, Hungary.
   [Kjoniksen, Anna-Lena; Nystrom, Bo] Univ Oslo, Dept Chem, N-0315 Oslo, Norway.
   [Hartmann, John F.] ElizaNor Polymer LLC, Princeton Jct, NJ 08550 USA.
   [Daroczi, Lajos] Univ Debrecen, H-4010 Debrecen, Hungary.
   [Borbely, Janos] BBS Nanotechnol Ltd, H-4225 Debrecen 16, Hungary.
RP Borbely, J (reprint author), Univ Debrecen, Dept Colloid & Environm Chem, H-4010 Debrecen, Hungary.
EM jborbely@delfin.unideb.hu
RI Kjoniksen, Anna-Lena/B-9603-2011
OI Kjoniksen, Anna-Lena/0000-0003-4864-4043
CR BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   DEARFIELD KL, 1988, MUTAT RES, V195, P45, DOI 10.1016/0165-1110(88)90015-2
   Denizli A, 2005, MAT SCI ENG C-BIO S, V25, P448, DOI 10.1016/j.msec.2004.12.001
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Kjoniksen AL, 1998, LANGMUIR, V14, P5039, DOI 10.1021/la980391j
   Krecz A, 2001, FOLIA MICROBIOL, V46, P183, DOI 10.1007/BF02818530
   Lauten RA, 2003, COLLOID SURFACE A, V219, P45, DOI 10.1016/S0927-7757(03)00030-X
   Lin WC, 2006, COLLOID SURFACE B, V47, P43, DOI 10.1016/j.colsurfb.2005.11.013
   Llorens J, 2004, J MEMBRANE SCI, V239, P173, DOI 10.1016/j.memsci.2004.02.034
   Maleki A, 2005, J PHYS CHEM B, V109, P12329, DOI 10.1021/jp0514271
   Mark SS, 2006, BIOTECHNOL PROGR, V22, P523, DOI 10.1021/bp060040s
   Molinari R, 2004, WATER RES, V38, P593, DOI 10.1016/j.watres.2003.10.024
   Qi LF, 2004, COLLOID SURFACE A, V251, P183, DOI 10.1016/j.colsurfa.2004.10.010
   Ramelow US, 1996, J HAZARD MATER, V46, P37, DOI 10.1016/0304-3894(95)00104-2
   Rattanakawin C, 2001, COLLOID SURFACE A, V177, P87, DOI 10.1016/S0927-7757(00)00662-2
   Rivas BL, 2003, PROG POLYM SCI, V28, P173, DOI 10.1016/S0079-6700(02)00028-X
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Shih IL, 2001, BIORESOURCE TECHNOL, V78, P267, DOI 10.1016/S0960-8524(01)00027-X
   Solpan D, 2005, COLLOID SURFACE A, V268, P12, DOI 10.1016/j.colsurfa.2005.04.035
   Taniguchi M, 2005, J BIOSCI BIOENG, V100, P207, DOI 10.1263/jbb.100.207
   Taniguchi M, 2005, J BIOSCI BIOENG, V99, P245, DOI 10.1263/jbb.99.245
   Taniguchi M, 2005, J BIOSCI BIOENG, V99, P130, DOI 10.1263/jbb.99.130
   Xu H, 2005, PROCESS BIOCHEM, V40, P519, DOI 10.1016/j.procbio.2003.09.025
   Yang WY, 2004, J COLLOID INTERF SCI, V273, P400, DOI 10.1016/j.jcis.2004.02.002
   Yokoi H, 1996, J FERMENT BIOENG, V82, P84, DOI 10.1016/0922-338X(96)89461-X
NR 25
TC 17
Z9 19
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAY 30
PY 2008
VL 153
IS 3
BP 1185
EP 1192
DI 10.1016/j.jhazmat.2007.09.080
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 296LG
UT WOS:000255544300037
PM 17997032
DA 2018-10-19
ER

PT J
AU Salvay, DM
   Rives, CB
   Zhang, XM
   Chen, F
   Kaufman, DB
   Lowe, WL
   Shea, LD
AF Salvay, David M.
   Rives, Christopher B.
   Zhang, Xiaomin
   Chen, Fei
   Kaufman, Dixon B.
   Lowe, William L., Jr.
   Shea, Lonnie D.
TI Extracellular matrix protein-coated scaffolds promote the reversal of
   diabetes after extrahepatic islet transplantation
SO TRANSPLANTATION
LA English
DT Article
DE islet transplantation; biomaterial; diabetes; PLG; scaffold;
   microenvironment
ID HUMAN PANCREATIC-ISLETS; CELL-MATRIX; BETA-CELLS; INSULIN; APOPTOSIS;
   SECRETION; MELLITUS; TERM; REVASCULARIZATION; MICROENVIRONMENTS
AB Background. The survival and function of transplanted pancreatic islets is limited, owing in part to disruption of islet-matrix attachments during the isolation procedure. Using polymer scaffolds as a platform for islet transplantation, we investigated the hypothesis that replacement of key extracellular matrix components known to surround islets in vivo would improve graft function at an extrahepatic implantation site.
   Methods. Microporous polymer scaffolds fabricated from copolymers of lactide and glycolide were adsorbed with collagen IV, fibronectin, laminin-332 or serum proteins before seeding with 125 mouse islets. Islet-seeded scaffolds were then implanted onto the epididymal fat pad of syngeneic mice with streptozotocin-induced diabetes. Nonfasting glucose levels, weight gain, response to glucose challenges, and histology were used to assess graft function for 10 months after transplantation.
   Results. Mice transplanted with islets seeded onto scaffolds adsorbed with collagen IV achieved euglycemia fastest and their response to glucose challenge was similar to normal mice. Fibronectin and laminin similarly promoted euglycemia, yet required more time than collagen IV and less time than serum. Histopathological assessment of retrieved grafts demonstrated that coating scaffolds with specific extracellular matrix proteins increased total islet area in the sections and vessel density within the transplanted islets, relative to controls.
   Conclusions. Extracellular matrix proteins adsorbed to microporous scaffolds can enhance the function of transplanted islets, with collagen IV maximizing graft function relative to the other proteins tested. These scaffolds enable the creation of well-defined microenvironments that promote graft efficacy at extrahepatic sites.
C1 [Salvay, David M.; Rives, Christopher B.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Transplant Surg, Chicago, IL 60611 USA.
   [Chen, Fei; Lowe, William L., Jr.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Tech E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIBIB NIH HHS [F31 EB 007118, F31 EB007118, R01 EB003806, R01 EB 003806,
   F31 EB007118-02, R01 EB003806-04]; NIDDK NIH HHS [R21 DK 067833, R01 DK
   062641, R01 DK 52919, R21 DK062641, R21 DK067833, R01 DK 063439, R21
   DK063439]
CR Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Balamurugan AN, 2006, PANCREAS, V32, P231, DOI 10.1097/01.mpa.0000203961.16630.2f
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103
   Chen XJ, 2007, TRANSPLANTATION, V84, P122, DOI 10.1097/01.tp.0000266909.58117.e3
   Cheung BWY, 2005, FUND CLIN PHARMACOL, V19, P347, DOI 10.1111/j.1472-8206.2005.00329.x
   Dufrane D, 2006, TRANSPLANTATION, V81, P36, DOI 10.1097/01.tp.0000189712.74495.82
   Eiselein L, 2004, ILAR J, V45, P231, DOI 10.1093/ilar.45.3.231
   EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
   Hamalainen Anu-Maaria, 2002, Curr Diab Rep, V2, P347, DOI 10.1007/s11892-002-0025-2
   Hamamoto Y, 2003, HORM METAB RES, V35, P460
   Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034
   HAYEK A, 1989, IN VITRO CELL DEV B, V25, P146
   Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86
   Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830
   Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/005-1333
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jiang FX, 2002, MOL MED, V8, P763, DOI 10.1007/BF03402081
   Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200
   Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   LUCASCLERC C, 1993, MOL CELL ENDOCRINOL, V94, P9, DOI 10.1016/0303-7207(93)90046-M
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mattsson G, 2003, TRANSPLANTATION, V75, P736, DOI 10.1097/01.TP.0000052592.92966.FE
   Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974
   Nathan D M, 1992, Drugs, V44 Suppl 3, P39
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Olsson R, 2006, TRANSPLANTATION, V82, P340, DOI 10.1097/01.tp.0000229418.60236.87
   Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   Tian B, 2005, J CANCER RES CLIN, V131, P80, DOI 10.1007/s00432-004-0614-3
   Wilson DB, 2005, NATURE, V438, pE5, DOI 10.1038/nature04423
   Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63
NR 41
TC 82
Z9 83
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD MAY 27
PY 2008
VL 85
IS 10
BP 1456
EP 1464
DI 10.1097/TP.0b013e31816fc0ea
PG 9
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 305LS
UT WOS:000256180500017
PM 18497687
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Adamov, GE
   Devyatkov, AG
   Gnatyuk, LN
   Goldobin, IS
   Grebennikov, EP
AF Adamov, G. E.
   Devyatkov, A. G.
   Gnatyuk, L. N.
   Goldobin, I. S.
   Grebennikov, E. P.
TI Bacteriorhodopsin - Perspective biomaterial for molecular nanophotonics
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Symposium on Molecular Photonics
CY JUN 28-JUL 02, 2006
CL St Petersburg, RUSSIA
DE molecular nanophotonics; bacteriorhodopsin; neural networks; multilayer
   structures
ID RECEPTIVE-FIELDS
AB Results of investigation of photochromic protein bacteriorhodopsin (BR) extracted from cellular membranes of Halobacterium salinarum are represented. Basic processes and original approaches of neural networks realization based on bacteriorhodopsin in composition of multilayer structures. Requirements of BR-containing functional films are determined and results of investigation of layers modifications are represented for the purpose of stabilization of extremely high photochromic sensitivity of BR-containing media. The modification of BR-films using bifunctional crosslinking reagents to increase of technological parameters of BR is applied. The influence of 1,4-diaminobenzene, glutaric dialdehyde and lysine on photochromic proper-ties of the bacteriorhodopsin films is investigated. Shown that addition of bifunctional crosslinking reagents increase technological parameters of materials based on bacteriorhodopsin. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Adamov, G. E.; Devyatkov, A. G.; Gnatyuk, L. N.; Goldobin, I. S.; Grebennikov, E. P.] OJSC CSRIT Technomash, Moscow 121108, Russia.
RP Adamov, GE (reprint author), OJSC CSRIT Technomash, Ivan Franko Str 4, Moscow 121108, Russia.
EM ntc_technology@socket.ru
CR ALEXEEV AS, 1992, IOFAN P, V38, P133
   Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n
   CHINAROV V, 1995, 5 INT S BIOEL MOL EL, P243
   DMITRIEV AS, 1993, RADIO ENG ELECT, V38, P18
   GREBENNIKOV EP, 2000, P 2 C MOL PHYS NON S, P235
   GREBENNIKOV EP, 1997, P SOC PHOTO-OPT INS, V3402, P460
   GROSS RB, 1992, P SOC PHOTO-OPT INS, V1662, P186, DOI 10.1117/12.58502
   HARONIAN D, 1991, APPL OPTICS, V30, P597, DOI 10.1364/AO.30.000597
   HWANG SB, 1978, BIOCHIM BIOPHYS ACTA, V509, P300, DOI 10.1016/0005-2736(78)90049-4
   KORCHEMSKAYA EY, 1990, QUANTUM ELECTRON+, V17, P448
   KOYAMA K, 1994, SCIENCE, V265, P762, DOI 10.1126/science.265.5173.762
   MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   OESTERHELT D, 1991, Q REV BIOPHYS, V24, P425, DOI 10.1017/S0033583500003863
   PRIGOZHIN I, 1985, EXISTENT INCIPIENT T
   RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833
   SHELTON DP, 1977, OPT LETT, V22, P1728
   SIEBERT F, 1982, FEBS LETT, V141, P82, DOI 10.1016/0014-5793(82)80021-5
   TAKEI H, 1991, APPL OPTICS, V30, P500, DOI 10.1364/AO.30.000500
   VSEVOLODOV NN, 1988, PHOTOMATERIAL BASED, P224
   Wasserman F., 1992, NEUROCOMPUTER TECHNI, P240
   Zeisel D., 1992, J PHYS CHEM-US, V96, P7787
NR 22
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1010-6030
J9 J PHOTOCH PHOTOBIO A
JI J. Photochem. Photobiol. A-Chem.
PD MAY 20
PY 2008
VL 196
IS 2-3
BP 254
EP 261
DI 10.1016/j.jphotochem.2007.07.027
PG 8
WC Chemistry, Physical
SC Chemistry
GA 302ZM
UT WOS:000256008700020
DA 2018-10-19
ER

PT J
AU Arami, M
   Limaee, NY
   Mahmoodi, NM
AF Arami, Mokhtar
   Limaee, Nargess Yousefi
   Mahmoodi, Niyaz Mohammad
TI Evaluation of the adsorption kinetics and equilibrium for the potential
   removal of acid dyes using a biosorbent
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE biosorbent; acid dye; ESM; isotherms; kinetics; dye removal
ID LOW-COST ADSORBENTS; ACTIVATED CARBON; AQUEOUS-SOLUTIONS; PHOTOCATALYTIC
   DEGRADATION; IMMOBILIZED NANOPARTICLES; FUNDAMENTAL PROPERTIES;
   TITANIUM-DIOXIDE; REACTIVE DYES; ORANGE PEEL; CONGO RED
AB The adsorption of Acid Red 14 (AR14) and Acid Blue 92 (AB92) onto the microporous and mesoporous egg shell membrane (ESM) was investigated in aqueous solution in a batch system with respect to initial dye concentration, pH, contact time, particle size and biosorbent doses at 20 +/- 1 degrees C. The surface area, Fourier transform infrared (FTIR) and scanning electron microscopy (SEM) of ESM were obtained. The surface area of ESM was found to be 2.2098 m(2)/g. The pseudo-first-order, pseudo-second-order kinetics and the intraparticle diffusion models were used to describe the kinetics data. The rate constants at different pH values (2-12) were evaluated. The experimental data fitted well to the pseudo-second-order kinetics model at pH values of 2-8 and pseudo-first-order kinetics model at pH values of 10 and 12 for both dyes. Equilibrium isotherms were analyzed by Langmuir, Freundlich and Redlich-Peterson adsorption models. Maximum desorption of >= 89.6% was achieved for AR14 and 82.8% for AB92 in aqueous solution at pH 12. The results indicate that ESM could be fruitfully employed as effective biomaterial for the removal of residual color from effluents. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Arami, Mokhtar] Amir Kabir Univ Technol, Dept Text Engn, Tehran, Iran.
   [Arami, Mokhtar; Limaee, Nargess Yousefi; Mahmoodi, Niyaz Mohammad] Inst Colorants Paint & Coatings, Dept Organ Colorants, Tehran, Iran.
RP Arami, M (reprint author), Amir Kabir Univ Technol, Dept Text Engn, Tehran, Iran.
EM mokhtar-arami@yahoo.com; nm_-mahmoodi@yahoo.com
OI Mahmoodi, Niyaz Mohammad/0000-0002-3349-3732
CR Akbari A, 2002, CHEM ENG PROCESS, V41, P601, DOI 10.1016/S0255-2701(01)00181-7
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   ALLEN SJ, 2000, P 2 PAC BAS C ADS SC, P46
   ALLEY ER, 2000, WATER QUALITY CONTRO, P125
   Annadurai G, 2002, ADV ENVIRON RES, V6, P191, DOI 10.1016/S1093-0191(01)00050-8
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Arami M, 2006, J HAZARD MATER, V135, P171, DOI 10.1016/j.jhazmat.2005.11.044
   Benefield LD, 1982, PROCESS CHEM WATER W, P191
   Chakraborty S, 2005, DESALINATION, V174, P73, DOI 10.1016/j.desal.2004.08.040
   Chen BN, 2001, CHEM ENG J, V84, P77, DOI 10.1016/S1385-8947(01)00193-0
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   El-Geundi MS, 1997, ADSORPT SCI TECHNOL, V15, P777, DOI 10.1177/026361749701501004
   Fernandes A, 2004, DYES PIGMENTS, V61, P287, DOI 10.1016/j.jdyepig.2003.11.008
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   He J, 2002, APPL CATAL B-ENVIRON, V39, P211, DOI 10.1016/S0926-3373(02)00085-1
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2004, SCIENTOMETRICS, V59, P171
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2001, ADSORPTION, V7, P139, DOI 10.1023/A:1011652224816
   HO YS, 1995, THESIS U BIRMINGHAM
   Hoda N, 2006, J HAZARD MATER, V137, P344, DOI 10.1016/j.jhazmat.2006.02.009
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kim MS, 2006, INT J ENVIRON POLLUT, V27, P247, DOI 10.1504/IJEP.2006.010467
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Langmuir I, 1917, J AM CHEM SOC, V39, P1848, DOI 10.1021/ja02254a006
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mahmoodi NM, 2007, J HAZARD MATER, V145, P65, DOI 10.1016/j.jhazmat.2006.10.089
   Mahmoodi NM, 2007, J PHOTOCH PHOTOBIO A, V189, P1, DOI 10.1016/j.jphotochem.2006.12.025
   Mahmoodi NM, 2007, MATER RES BULL, V42, P797, DOI 10.1016/j.materresbull.2006.08.031
   Mahmoodi NM, 2006, J PHOTOCH PHOTOBIO A, V182, P60, DOI 10.1016/j.jphotochem.2006.01.014
   Mahmoodi NM, 2006, COLLOID SURFACE A, V290, P125, DOI 10.1016/j.colsurfa.2006.05.012
   Mahmoodi NM, 2006, J HAZARD MATER, V133, P113, DOI 10.1016/j.jhazmat.2005.09.057
   Mahmoodi NM, 2006, J COLLOID INTERF SCI, V295, P159, DOI 10.1016/j.jcis.2005.08.007
   Mahmoodi NM, 2005, CHEM ENG J, V112, P191, DOI 10.1016/j.cej.2005.07.008
   Mall ID, 2005, CHEMOSPHERE, V61, P492, DOI 10.1016/j.chemosphere.2005.03.065
   Meshko V, 2001, WATER RES, V35, P3357, DOI 10.1016/S0043-1354(01)00056-2
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   Namasivayam C, 2002, DYES PIGMENTS, V54, P47, DOI 10.1016/S0143-7208(02)00025-6
   Ozcan A, 2005, J HAZARD MATER, V125, P252, DOI 10.1016/j.jhazmat.2005.05.039
   Park SC, 2006, EUR PHYS J B, V50, P327, DOI 10.1140/epjb/e2006-00126-9
   Pavia D. L., 1987, INTRO SPECTROSCOPY G
   Ravikumar K, 2007, DYES PIGMENTS, V72, P66, DOI 10.1016/j.dyepig.2005.07.018
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Sanghi R, 2002, COLOR TECHNOL, V118, P256
   Senthilkumaar S, 2006, BIORESOURCE TECHNOL, V97, P1618, DOI 10.1016/j.biortech.2005.08.001
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Wang SB, 2005, WATER RES, V39, P129, DOI 10.1016/j.watres.2004.09.011
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Woodard F, 2001, IND WASTE TREATMENT, P376
   Yuzhu F., 2002, ADV ENVIRON RES, V7, P239
NR 54
TC 95
Z9 109
U1 1
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAY 15
PY 2008
VL 139
IS 1
BP 2
EP 10
DI 10.1016/j.cej.2007.07.060
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 302WZ
UT WOS:000256002000002
DA 2018-10-19
ER

PT J
AU Sarkar, D
   Yang, JC
   Lopina, ST
AF Sarkar, Debanjan
   Yang, Jui-Chen
   Lopina, Stephanie T.
TI Structure-property relationship of L-tyrosine-based polyurethanes for
   biomaterial applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyurethane; L-tyrosine; FTIR; hydrolytic degradation; morphology
ID CHAIN EXTENDER; ELASTOMERS; COPOLYMERS; RELEASE; DESIGN
AB The structure-property relationship of L-tyrosine-based polyurethanes was demonstrated by using different polyols and diisocyanates. L-tyrosine-based chain extender, desaminotyrosyl tyrosine hexyl ester (DTH), was used, to synthesize a series of polyurethanes. Polyethylene glycol (PEG) or poly caprolactone diol (PCL) was used as the soft segment and hexamethylene diisocyanate (HDI) or dicyclohexylmethane 4,4'-diisocyanate (HMDI) was used with DTH as the hard segment. The polyurethanes were characterized to investigate the effect of structure on different polyurethane properties. From FTIR and DSC, these polyurethanes exhibit a wide range of morphology from phase-mixed to phase-separated structure. The decreasing molecular weight of the PEG soft segment leads to relatively more phase mixed morphology whereas for PCL-based polyurethanes the extent of phase mixing is less with decreasing PCL molecular weight. Results show that PCL-based polyurethanes are mechanically stronger than PEG-based polyurethanes but PCL-based polyurethanes degrade slower and absorb less water compared with PEG-based polyurethanes. The HMDI-based polyurethanes are less crystalline and comparatively more hydrophobic than HDI-based polyurethartes. The characterization results show that the polyurethane properties are directly related to the structure and can be varied easily for a different set of properties that are pertinent for biomaterial applications. (C) 2008 Wiley Periodicals, Inc.
C1 [Sarkar, Debanjan; Yang, Jui-Chen; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
EM lopina@uakron.edu
RI Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hepburn C., 1993, POLYURETHANE ELASTOM
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   Iskakov R, 2000, J APPL POLYM SCI, V75, P35, DOI 10.1002/(SICI)1097-4628(20000103)75:1<35::AID-APP5>3.0.CO;2-2
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LI F, 2000, J APPL POLYM SCI, V75, P1522
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Liaw DJ, 1997, J APPL POLYM SCI, V66, P1251, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1251::AID-APP5>3.0.CO;2-F
   Mallapragada SK, 1997, J BIOMED MATER RES, V36, P125, DOI 10.1002/(SICI)1097-4636(199707)36:1<125::AID-JBM15>3.0.CO;2-H
   Petrovic Z., 1991, J PROG POLYM SCI, V16, P695
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   Rao C.N.R., 1963, CHEM APPL INFRARED S
   SARKAR D, IN PRESS J BIOMED MA
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   SIEGMANN A, 1987, POLYM ENG SCI, V27, P1187, DOI 10.1002/pen.760271512
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SPECKHARD TA, 1986, RUBBER CHEM TECHNOL, V59, P405, DOI 10.5254/1.3538208
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Yeganeh H, 2007, POLYM INT, V56, P41, DOI 10.1002/pi.2107
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 27
TC 31
Z9 35
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 15
PY 2008
VL 108
IS 4
BP 2345
EP 2355
DI 10.1002/app.27637
PG 11
WC Polymer Science
SC Polymer Science
GA 283YQ
UT WOS:000254672800038
DA 2018-10-19
ER

PT J
AU Ban, L
   Chai, XS
   Guo, JQ
   Ban, WP
   Lucia, LA
AF Ban, Lan
   Chai, Xinsheng
   Guo, Jiqiang
   Ban, Weiping
   Lucia, Lucian A.
TI Chemical response of hardwood oligosaccharides as a statistical function
   of isolation protocol
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE hardwoods; hemicelluloses; extraction; pH; temperature
ID XYLAN; EXTRACTION; LIGNOCELLULOSE; HYDROLYSIS
AB Hardwoods contain a substantial amount of hemicellulose-type oligosaccharides, the chemical structures of which are typically categorized in the xylan saccharide class. The efficient and selective isolation of these hemicelluloses is regarded as one of the most critical obstacles to overcome for their eventual biomaterial and bioenergy utilization. Therefore, the objective of the current work was to perform a fundamental exploration of the function of extraction pH, temperature, and time on the final chemical properties of the extracted hemicelluloses. The extraction chemistries employed varied pH and showed that acidic conditions provided a higher extractive yield versus alkaline conditions. An alkaline environment gave higher yields than an acidic environment and also resulted in much higher lignin removal from wood, especially at high temperature. In general, control of the pH chemistry leads to a change in the carboxylic acid groups present in the extracts. When the extraction pH changed from acidic to alkaline, the total carboxylic acid group content in the hemicelluloses removed significantly increased due to more acetic acid group hydrolysis and increased lignin degradation.
C1 [Lucia, Lucian A.] N Carolina State Univ, Dept Wood & Paper Sci, Raleigh, NC 27695 USA.
   [Ban, Lan; Chai, Xinsheng] Georgia Inst Technol, Inst Paper Sci & Technol, Atlanta, GA 03320 USA.
   [Guo, Jiqiang; Ban, Weiping] Dalian Polytech Univ, Dalian 116034, Peoples R China.
RP Lucia, LA (reprint author), N Carolina State Univ, Dept Wood & Paper Sci, Campus Box 8005, Raleigh, NC 27695 USA.
EM lucian.lucia@ncsu.edu
CR Azuma J., 1986, WOOD RES, V72, P1
   BENNANI A, 1991, BIOMASS BIOENERG, V1, P289, DOI 10.1016/0961-9534(91)90041-A
   BIERMANN CJ, 1984, J WOOD CHEM TECHNOL, V4, P111, DOI 10.1080/02773818408062286
   BUCHERT J, 1995, TAPPI J, V78, P125
   Chai XS, 2005, IND ENG CHEM RES, V44, P10013, DOI 10.1021/ie050921o
   Chai XS, 2003, J PULP PAP SCI, V29, P204
   DAVID N, 2001, WOOD CELLULOSIC CHEM
   Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542
   Fang JM, 2000, CELLULOSE, V7, P87, DOI 10.1023/A:1009245100275
   Hromadkova Z, 2005, CHEM PAP-CHEM ZVESTI, V59, P223
   Hromadkova Z, 1999, IND CROP PROD, V9, P101, DOI 10.1016/S0926-6690(98)00020-X
   JUNEL L, 1999, THESIS LUTKDH LUND U
   JUSLIN M, 1984, PHARM PHARM, V36, P256
   LAMPTEY J, 1985, BIOTECHNOL LETT, V7, P531, DOI 10.1007/BF01199874
   Lindstrom T, 1992, NORD PULP PAP RES J, V7, P181
   MAGARA K, 1988, MOKUZAI GAKKAISHI, V34, P462
   OKAMOTO Y, 1984, J AM CHEM SOC, V106, P5357, DOI 10.1021/ja00330a057
   PASZNER L, 1993, ENERGY BIOMASS WASTE, V16, P629
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   PULS J, 1993, 2 TRICEL93 S TRICH R, V8, P51
   Schultz T., 1984, ENERGY BIOMASS WASTE, V8, P1171
   Sjostrom E, 1989, NORD PULP PAP RES J, V4, P90, DOI DOI 10.3183/NPPRJ-1989-04-02-P090-093
   Tenkanen M, 1999, J PULP PAP SCI, V25, P306
   VAZQUEZ MJ, 2001, TRENDS FOOD SCI TECH, V11, P387
NR 24
TC 6
Z9 6
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 14
PY 2008
VL 56
IS 9
BP 2953
EP 2959
DI 10.1021/jf0727037
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 297ZJ
UT WOS:000255655600014
PM 18407651
DA 2018-10-19
ER

PT J
AU Berglin, M
   Olsson, A
   Elwing, H
AF Berglin, Mattias
   Olsson, Adam
   Elwing, Hans
TI The interaction between model biomaterial coatings and nylon
   microparticles as measured with a quartz crystal microbalance with
   dissipation monitoring
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biomaterials; cell attachment; quartz crystal microbalance
   (QCM)
ID IMMUNE COMPLEMENT ACTIVATION; SURFACE-PLASMON RESONANCE; PROTEIN
   ADSORPTION; CELL-ADHESION; CROSS-LINKING; MULTILAYER FILMS; COUPLED
   WATER; BLOOD-PLASMA; QCM-D; QUANTIFICATION
AB The interaction between cells and biomaterials has been mimicked using nylon microparticles as pseudo-cells and PLMA and PIBMA as biomaterial model acrylate polymers. The shift of fundamental resonance frequencies was negative for both polymers, indicating mass-coupling to the sensor surface. The shifts of the 3(rd), 5(th) and 7(th) overtone frequencies were initially positive for both polymers, indicating a particle slip or wobbling on the surface. The OCM technique could discriminate between the two different polymers, showing increased interaction between microparticle and PLMA. The dissipation shift was positive for all overtones on both polymers, but again with faster and more prominent response for PLMA.
C1 [Berglin, Mattias; Olsson, Adam; Elwing, Hans] Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
RP Berglin, M (reprint author), Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
EM mattias.berglin@cmb.gu.se
CR Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Andersson M, 2002, J BIOMAT SCI-POLYM E, V13, P907, DOI 10.1163/156856202320401951
   Berglin M, 2005, J ADHESION, V81, P805, DOI 10.1080/00218460500189059
   Berglin M, 2004, BIOMACROMOLECULES, V5, P2376, DOI 10.1021/bm0496864
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   de Kerchove AJ, 2007, BIOMACROMOLECULES, V8, P113, DOI 10.1021/bm060670i
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Graneli A, 2004, CHEMPHYSCHEM, V5, P729, DOI 10.1002/cphc.200301061
   Holland NB, 1999, J BIOMED MATER RES, V45, P167, DOI 10.1002/(SICI)1097-4636(19990605)45:3<167::AID-JBM2>3.0.CO;2-7
   Hong S, 2006, BIOMATERIALS, V27, P5813, DOI 10.1016/j.biomaterials.2006.07.031
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 2002, ENCY SURFACE COLLOID, P774
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Olofsson AC, 2005, APPL ENVIRON MICROB, V71, P2705, DOI 10.1128/AEM.71.5.2705-2712.2005
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schakenraad J M, 1996, BIOMATERIALS SCI
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Welle A, 2004, J BIOMAT SCI-POLYM E, V15, P357, DOI 10.1163/156856204322977238
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 31
TC 21
Z9 21
U1 1
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 13
PY 2008
VL 8
IS 5
BP 410
EP 416
DI 10.1002/mabi.200700218
PG 7
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 311WZ
UT WOS:000256632400005
PM 18167626
DA 2018-10-19
ER

PT J
AU Ketteler, G
   Ashby, P
   Mun, BS
   Ratera, I
   Bluhm, H
   Kasemo, B
   Salmeron, M
AF Ketteler, G.
   Ashby, P.
   Mun, B. S.
   Ratera, I.
   Bluhm, H.
   Kasemo, B.
   Salmeron, M.
TI In situ photoelectron spectroscopy study of water adsorption on model
   biomaterial surfaces
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; RAY-INDUCED DAMAGE; ALKANETHIOLATE
   MONOLAYERS; ORGANIC-SURFACES; PHOTOEMISSION; MEMBRANE; GOLD;
   IRRADIATION; ELECTRON; POLYMER
AB Using in situ photoelectron spectroscopy at near ambient conditions, we compare the interaction of water with four different model biomaterial surfaces: self-assembled thiol monolayers on Au(111) that are functionalized with methyl, hydroxyl, and carboxyl groups, and phosphatidylcholine (POPC) lipid films on silicon. We show that the interaction of water with biomaterial surfaces is mediated by polar functional groups that interact strongly with water molecules through hydrogen bonding, resulting in adsorption of 0.2-0.3 ML water on the polar thiol films in 700 mTorr water pressure and resulting in characteristic N 1s and P 2p shifts for the POPC films. Provided that beam damage is carefully controlled, in situ electron spectroscopy can give valuable information about water adsorption which is not accessible under ultrahigh vacuum conditions.
C1 [Ketteler, G.; Kasemo, B.] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   [Mun, B. S.] Lawrence Berkeley Natl Labs, Adv Light Source, Berkeley, CA 94720 USA.
   [Mun, B. S.] Hanyang Univ, Dept Appl Phys, Ansan 426791, Kyunggi Do, South Korea.
   [Ratera, I.; Salmeron, M.] Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA 94720 USA.
   [Bluhm, H.] Lawrence Berkeley Natl Labs, Div Chem Sci, Berkeley, CA 94720 USA.
RP Ketteler, G (reprint author), Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
RI Mun, Bongjin/G-1701-2013; Ratera, Imma/E-2353-2014
OI Ratera, Imma/0000-0002-1464-9789
CR BAIN CD, 1989, ANGEW CHEM INT EDIT, V28, P506, DOI 10.1002/anie.198905061
   Bluhm H, 2006, J ELECTRON SPECTROSC, V150, P86, DOI 10.1016/j.elspec.2005.07.005
   DUWEZ AS, 2004, J ELECT SPECTROSC RE, V97, P134
   GRAHAM RL, 1993, J PHYS CHEM-US, V97, P9456, DOI 10.1021/j100139a033
   He Q, 2006, J NANOSCI NANOTECHNO, V6, P1838, DOI 10.1166/jnn.2006.208
   Heister K, 2003, SURF SCI, V529, P36, DOI 10.1016/S0039-6028(03)00299-1
   Heister K, 2001, LANGMUIR, V17, P8, DOI 10.1021/la001101d
   ISRAELICHVILI J, 1992, NATURE, V379, P219
   Lorusso GF, 1997, J PHYS D APPL PHYS, V30, P1794, DOI 10.1088/0022-3727/30/12/017
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Maccarini M, 2005, APPL SURF SCI, V252, P1941, DOI 10.1016/j.apsusc.2005.03.157
   Methivier C, 2003, LANGMUIR, V19, P8807, DOI 10.1021/la0345789
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   Ogletree DF, 2002, REV SCI INSTRUM, V73, P3872, DOI 10.1063/1.1512336
   OTTOVALEITMANNOVA A, 1992, PROG SURF SCI, V41, P337, DOI 10.1016/0079-6816(92)90012-7
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Pijpers AP, 1999, CHEM SOC REV, V28, P233
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang RY, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869414
   Wang T, 2005, COLLOID SURFACE B, V46, P233, DOI 10.1016/j.colsurfb.2005.07.010
   Wen XG, 2004, J PHYS CHEM A, V108, P9673, DOI 10.1021/jp047922z
   Willey TM, 2004, LANGMUIR, V20, P2746, DOI 10.1021/la036073o
   Yang ZH, 1999, LANGMUIR, V15, P1731, DOI 10.1021/la980839g
   Ye SH, 2005, J MEMBRANE SCI, V249, P133, DOI 10.1016/j.memsci.2004.10.006
   YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6
   Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i
   Zharnikov M, 2002, J VAC SCI TECHNOL B, V20, P1793, DOI 10.1116/1.1514665
   Zharnikov M, 1999, PHYS CHEM CHEM PHYS, V1, P3163, DOI 10.1039/a902013f
   Zubavichus Y, 2004, LANGMUIR, V20, P11022, DOI 10.1021/la047980b
   Zubavichus Y, 2004, RADIAT RES, V161, P346, DOI 10.1667/RR3114.1
NR 33
TC 17
Z9 17
U1 2
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD MAY 7
PY 2008
VL 20
IS 18
AR 184024
DI 10.1088/0953-8984/20/18/184024
PG 7
WC Physics, Condensed Matter
SC Physics
GA 298BL
UT WOS:000255661200026
DA 2018-10-19
ER

PT J
AU Deupree, SM
   Schoenfisch, MH
AF Deupree, Susan M.
   Schoenfisch, Mark H.
TI Quantitative method for determining the lateral strength of bacterial
   adhesion and application for characterizing adhesion kinetics
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPE; STAPHYLOCOCCUS-AUREUS ADHESION; SUBSTRATUM
   SURFACE-TOPOGRAPHY; MEDIATED CELL ATTACHMENT; DETACHMENT KINETICS;
   STREPTOCOCCUS-THERMOPHILUS; BIOMATERIAL SURFACES; SOL-GELS; FLOW;
   FIBRINOGEN
AB A quantitative method for measuring the shear force required to detach individual adhered bacteria using atomic force microscopy (AFM) was developed. By determining the total compression of the cantilever during cell detachment events, a more accurate means of calculating the applied lateral force necessary to remove individual cells was achieved compared to previous methods. In addition, a tunable assay for monitoring the dynamics of Pseudomonas aeruginosa and Staphylococcus aureus adhesion strength was employed. The accumulation of force measurements over time allowed for the characterization of adhesion strength kinetics. P. aeruginosa reinforced its adhesion to the surface at a rate 7-fold faster than for S. aureus; the average adhesion strength of P. aeruginosa was larger than that of S. aureus at corresponding time points. Adhered cells of the same species and strain demonstrated a range of adhesion forces that broadened with time, indicating that the change in adhesion strength does not proceed uniformly.
C1 [Deupree, Susan M.; Schoenfisch, Mark H.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
RP Schoenfisch, MH (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
EM schoenfisch@unc.edu
CR An Y. H, 2000, HDB BACTERIAL ADHESI, P1
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   Chin MYH, 2006, J BIOMED MATER RES B, V78B, P401, DOI 10.1002/jbm.b.30501
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P841, DOI 10.1016/S0006-3495(90)82430-9
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   DUDDRIDGE JE, 1982, BIOTECHNOL BIOENG, V24, P153, DOI 10.1002/bit.260240113
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HERMANN M, 1988, J INFECT DIS, V158, P693
   Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0
   Kwon KD, 2006, GEOCHIM COSMOCHIM AC, V70, P3803, DOI 10.1016/j.gca.2006.05.016
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   McWhirter MJ, 2002, COLLOID SURFACE B, V26, P365, DOI 10.1016/S0927-7765(02)00017-6
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   MORRIS EJ, 1984, INFECT IMMUN, V43, P656
   Nablo BJ, 2003, J BIOMED MATER RES A, V67A, P1276, DOI 10.1002/jbm.a.20030
   ORSTAVIK D, 1977, ACTA PATH MICRO IM B, V85, P38
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   SATERBAK A, 1993, BIOPHYS J, V65, P243, DOI 10.1016/S0006-3495(93)81077-4
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Senechal A, 2004, LANGMUIR, V20, P4172, DOI 10.1021/la035847y
   Tang H., 2006, J BIOMED MATER RES A, V80, P885
   Vacheethasanee K., 2000, HDB BACTERIAL ADHESI, P73
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   Vadillo-Rodriguez V, 2004, J COLLOID INTERF SCI, V278, P251, DOI 10.1016/j.jcis.2004.05.045
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   Walker SL, 2005, ENVIRON SCI TECHNOL, V39, P6405, DOI 10.1021/es050077t
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Xu LC, 2006, LANGMUIR, V22, P4720, DOI 10.1021/la053443v
   Xu LC, 2006, COLLOID SURFACE B, V48, P84, DOI 10.1016/j.colsurfb.2006.01.012
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
NR 45
TC 13
Z9 13
U1 3
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 6
PY 2008
VL 24
IS 9
BP 4700
EP 4707
DI 10.1021/la800417g
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 294UP
UT WOS:000255432000045
PM 18399690
DA 2018-10-19
ER

PT J
AU Yang, ZG
   Ding, JD
AF Yang, Zigang
   Ding, Jiandong
TI A thermosensitive and biodegradable physical gel with chemically
   crosslinked nanogels as the building block
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE biodegradable; block copolymers; gelation; hydrogels; sol-gel transition
ID CONTROLLED DRUG-DELIVERY; POLY(ETHYLENE OXIDE); TRIBLOCK COPOLYMERS;
   AQUEOUS-SOLUTIONS; DIBLOCK COPOLYMERS; ALPHA-CYCLODEXTRIN;
   PHASE-TRANSITIONS; HYDROGELS; GELATION; POLYMERIZATION
AB A triblock copolymer, poly(ethylene glycol)-poly(propylene glycol)--poly(ethylene glycol) was end-capped by acryloyl groups using a biodegradable oligolactide as spacer, and such biodegradable amphiphilic macromers could form micelles in water. A nanogel was prepared via polymerizing macromers in a micelle, and a macroscopic physical gelation was found upon heating a concentrated aqueous nanogel suspension. Such a sol-gel transition with a chemically crosslinked nanogel as the building block was thermoreversible. While the hydrogel affords a promising injectable biomaterial; this research reveals new physics of the thermogelling mechanism of amphiphilic block copolymers.
C1 [Yang, Zigang; Ding, Jiandong] Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromol Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromol Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
CR ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Chen L, 2002, MACROMOL RAPID COMM, V23, P171, DOI 10.1002/1521-3927(20020201)23:3<171::AID-MARC171>3.0.CO;2-P
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   Edwards EW, 2007, MACROMOL CHEM PHYSIC, V208, P439, DOI 10.1002/macp.200600655
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Guo K, 2007, BIOMATERIALS, V28, P3284, DOI 10.1016/j.biomaterials.2007.03.031
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hu ZB, 2000, ADV MATER, V12, P1173, DOI 10.1002/1521-4095(200008)12:16<1173::AID-ADMA1173>3.0.CO;2-Z
   Hu ZB, 2004, ADV MATER, V16, P305, DOI 10.1002/adma.200305560
   Huang M, 2007, MACROMOLECULES, V40, P6658, DOI 10.1021/ma062482q
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Kretschmann O, 2006, ANGEW CHEM INT EDIT, V45, P4361, DOI 10.1002/anie.200504539
   Kuroda K, 2002, LANGMUIR, V18, P3780, DOI 10.1021/la011454s
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Lu WQ, 2006, MACROMOLECULES, V39, P7433, DOI 10.1021/ma061356j
   Lu Y, 2007, MACROMOL CHEM PHYSIC, V208, P254, DOI 10.1002/macp.200600534
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutz JF, 2007, MACROMOLECULES, V40, P2503, DOI 10.1021/ma062925q
   Nagasaki Y, 2001, MACROMOL RAPID COMM, V22, P1124, DOI 10.1002/1521-3927(20011001)22:14<1124::AID-MARC1124>3.0.CO;2-4
   Namkung S, 2007, J BIOMAT SCI-POLYM E, V18, P901, DOI 10.1163/156856207781367701
   Oh JK, 2007, J AM CHEM SOC, V129, P5939, DOI 10.1021/ja069150l
   Park SY, 2007, MACROMOL RAPID COMM, V28, P1172, DOI 10.1002/marc.200600914
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Sugihara S, 2004, MACROMOLECULES, V37, P336, DOI 10.1021/ma035037t
   Tanodekaew S, 1997, MACROMOL CHEM PHYSIC, V198, P3385, DOI 10.1002/macp.1997.021981105
   Tomatsu I, 2006, MACROMOL RAPID COMM, V27, P238, DOI 10.1002/marc.200500793
   Van Tomme SR, 2006, BIOMATERIALS, V27, P4141, DOI 10.1016/j.biomaterials.2006.03.023
   Wang B, 2007, MACROMOL RAPID COMM, V28, P567, DOI 10.1002/marc.200600730
   Wang C, 2004, ADV MATER, V16, P1074, DOI 10.1002/adma.200306516
   Wehnert F, 2006, MACROMOL RAPID COMM, V27, P1865, DOI 10.1002/marc.200600482
   Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7
   Yamamoto N, 1996, MACROMOL RAPID COMM, V17, P313, DOI 10.1002/marc.1996.030170505
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
NR 47
TC 34
Z9 36
U1 4
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAY 2
PY 2008
VL 29
IS 9
BP 751
EP 756
DI 10.1002/marc.200700872
PG 6
WC Polymer Science
SC Polymer Science
GA 306EL
UT WOS:000256231000008
DA 2018-10-19
ER

PT J
AU Balas, F
   Manzano, M
   Colilla, M
   Vallet-Regi, M
AF Balas, Francisco
   Manzano, Miguel
   Colilla, Montserrat
   Vallet-Regi, Maria
TI L-Trp adsorption into silica mesoporous materials to promote bone
   formation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE bioactive silica; bone-healing; peptides; adsorption; controlled release
ID RAY PHOTOELECTRON-SPECTROSCOPY; HORMONE-RELATED PROTEIN; DRUG-DELIVERY;
   CONTROLLED-RELEASE; MOLECULAR-SIEVES; DISSOLUTION; COPOLYMER; TRIBLOCK;
   MATRICES; SYSTEM
AB The properties of ordered mesoporous silicas as bioactive materials, able to induce bone-tissue regeneration, have been combined with their abilities to host and release specific biomolecules in a controlled fashion. The possibility of locally deliver peptides and proteins is of great scientific importance because it opens new paths for the design of implantable biomaterials than can promote bone formation where needed. These biomaterials can host such biofactors, and their adsorption can be enhanced by chemically modifying the silica surface, with the aim of encouraging host-guest interaction and, thereby, increasing the loading capacity of the biomaterial matrix. L-Tryptophan (L-Trp) is a hydrophobic amino acid present in the three-dimensional structure of numerous proteins, and it is used here as model system to predict peptide delivery systems. Unmodified, silanol-rich, bioactive SBA-15 ordered mesoporous silica has been found to be incapable of confining L-Trp in its mesopores due to the hydrophobic character of this molecule. Organically modifying SBA-15 with quaternary amines results in approximately two-thirds of the silica surface being functionalized, increases the surface hydrophobicity allowing an increased L-Trp loading, and also induces different release kinetics. The control of the L-Trp release is the first step in controlled and localized protein delivery technologies, and opens novel perspectives for designing bioactive silica-based devices suitable for bone-healing applications. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Balas, Francisco; Manzano, Miguel; Colilla, Montserrat; Vallet-Regi, Maria] Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Colilla, Montserrat/N-4628-2014; Manzano, Miguel/K-3719-2014;
   Vallet-Regi, Maria/M-3378-2014; Balas, Francisco/K-7799-2014
OI Colilla, Montserrat/0000-0003-1961-4160; Manzano,
   Miguel/0000-0001-6238-6111; Vallet-Regi, Maria/0000-0002-6104-4889;
   Balas, Francisco/0000-0001-5512-0075
CR Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Crank J, 1975, MATH DIFFUSION
   Cuthbertson RM, 1999, BBA-PROTEIN STRUCT M, V1432, P64, DOI 10.1016/S0167-4838(99)00078-3
   Doadrio JC, 2006, J MATER CHEM, V16, P462, DOI 10.1039/b510101h
   ESCARD J, 1974, INORG CHEM, V13, P695, DOI 10.1021/ic50133a036
   Frenning G, 2003, INT J PHARM, V250, P137, DOI 10.1016/S0378-5173(02)00539-2
   GREGG SJ, 1982, ADSORPTION SURFACE A
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hernandez R, 2004, J AM CHEM SOC, V126, P3370, DOI 10.1021/ja039424u
   Horcajada P, 2006, SOLID STATE SCI, V8, P1243, DOI 10.1016/j.solidstatesciences.2006.04.016
   Ikeo N., 1991, HDB XRAY PHOTOELECTR
   Iler R, 1979, CHEM SILICA
   Inagaki S., 1993, CHEM COMMUN, P680
   KALLURY KMR, 1994, LANGMUIR, V10, P492, DOI 10.1021/la00014a025
   Koyano KA, 1997, J PHYS CHEM B, V101, P9436, DOI 10.1021/jp9724941
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kruk M, 2000, MICROPOR MESOPOR MAT, V35-6, P545, DOI 10.1016/S1387-1811(99)00249-8
   Kruk M, 2002, J PHYS CHEM B, V106, P4732, DOI 10.1021/jp0137423
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lei CH, 2002, J AM CHEM SOC, V124, P11242, DOI 10.1021/ja026855o
   Maria Chong AS, 2003, J PHYS CHEM B, V107, P12650
   MOSES PR, 1978, ANAL CHEM, V50, P576, DOI 10.1021/ac50026a010
   MULYE NV, 1995, DRUG DEV IND PHARM, V21, P943, DOI 10.3109/03639049509026658
   SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618
   Thomas JM, 2003, ACCOUNTS CHEM RES, V36, P20, DOI 10.1021/ar990017q
   Valin A, 1997, J CELL PHYSIOL, V170, P209, DOI 10.1002/(SICI)1097-4652(199702)170:2<209::AID-JCP13>3.3.CO;2-Y
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi M, 2007, SOLID STATE SCI, V9, P768, DOI 10.1016/j.solidstatesciences.2007.03.026
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VALLETREGI M, 2007, PROG SOLID STATE CHE
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   Walcarius A, 2003, CHEM MATER, V15, P2161, DOI 10.1021/cm021310e
   Wei Q, 2006, J SOL-GEL SCI TECHN, V39, P103, DOI 10.1007/s10971-006-9171-3
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 38
TC 62
Z9 64
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 514
EP 522
DI 10.1016/j.actbio.2007.11.009
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500006
PM 18234569
DA 2018-10-19
ER

PT J
AU Le Guehennec, L
   Lopez-Heredia, MA
   Enkel, B
   Weiss, P
   Amouriq, Y
   Layrolle, P
AF Le Guehennec, Laurent
   Lopez-Heredia, Marco-Antonio
   Enkel, Benedicte
   Weiss, Pierre
   Amouriq, Yves
   Layrolle, Pierre
TI Osteoblastic cell behaviour on different titanium implant surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cell-biomaterial interaction; osteoblasts; surface roughness; titanium;
   dental implant
ID ENHANCED BONE APPOSITION; IN-VITRO; ENDOSSEOUS IMPLANTS;
   OSSEOINTEGRATION; PROLIFERATION; ROUGHNESS; TOPOGRAPHY; ENERGY;
   ACTIVATION; ATTACHMENT
AB The osseointegration of oral implants is related to the early interactions between osteoblastic cells and titanium surfaces. The behaviour of osteoblastic MC3T3-E1 cells was compared on four different titanium surfaces: mirror-polished (Smooth-Ti), alumina grit-blasted (Alumina-Ti) or biphasic calcium phosphate ceramic grit-blasted (BCP-Ti) and a commercially available implant surface (SLA). Scanning electron microscopy and profilometry showed distinct microtopographies. The BCP-Ti group had higher average surface roughness (R-a = 2.5 mu m) than the other grit-blasted groups. Hydrophilicity and surfaces energies were determined on the different substrates by dynamic contact angle measurements. The most hydrophilic surface was the Alumina-Ti discs, while SLA was the most hydrophobic. The titanium surfaces were all oxidized as TiO2 and polluted by carbon contaminants, as determined by X-ray photoelectron spectroscopy. Alumina-Ti samples also exhibited aluminium peaks as a result of the blasting. The BCP-Ti discs contained traces of calcium and phosphorus. MC3T3-E1 cells attached, spread and proliferated on the substrates. For both the SLA and BCP-Ti groups, the entire surface was covered with a layer of osteoblastic cells after 2 days. At high magnification, the cells exhibited cytoplasmic extensions and filopodia. Compared with plastic, cell viability was similar with the Smooth-Ti, slightly lower with the Alumina-Ti and superior with the SLA and BCP-Ti groups. Alkaline phosphatase activity increased with the culture time whatever the substrate. This study shows that BCP-blasting produces rough titanium implants without surface contaminants. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Le Guehennec, Laurent; Lopez-Heredia, Marco-Antonio; Enkel, Benedicte; Weiss, Pierre; Amouriq, Yves; Layrolle, Pierre] Univ Nantes, INSERM, U791, Lab Osteoarticular & Dent Tissue Engn,Fac Dent Su, F-44042 Nantes, France.
RP Layrolle, P (reprint author), Univ Nantes, INSERM, U791, Lab Osteoarticular & Dent Tissue Engn,Fac Dent Su, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.
EM pierre.layrolle@nantes.inserm.fr
RI LE GUEHENNEC, Laurent/P-6301-2014; LABOUX, OLIVIER/A-8270-2015;
   Layrolle, Pierre/K-9257-2015; Weiss, Pierre/P-1372-2014
OI Layrolle, Pierre/0000-0001-9800-5210; Weiss, Pierre/0000-0002-6159-8590
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito Marco, 2005, Eur J Prosthodont Restor Dent, V13, P15
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Giordano C, 2006, INT J ARTIF ORGANS, V29, P772
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Ivanoff CJ, 2003, INT J ORAL MAX IMPL, V18, P341
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   Kim MJ, 2006, BIOMATERIALS, V27, P5502, DOI 10.1016/j.biomaterials.2006.06.023
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   MARINUCCI L, 2007, INT J ORAL MAXILLOF, V22, P19
   Marinucci L, 2006, INT J ORAL MAX IMPL, V21, P719
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Novaes AB, 2002, INT J ORAL MAX IMPL, V17, P377
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x
   Sanz A, 2001, Implant Dent, V10, P126
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sul YT, 2005, INT J ORAL MAX IMPL, V20, P349
   Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 42
TC 122
Z9 122
U1 1
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 535
EP 543
DI 10.1016/j.actbio.2007.12.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500008
PM 18226985
DA 2018-10-19
ER

PT J
AU Yang, ZP
   Si, SH
   Zeng, XM
   Zhang, CJ
   Dai, HJ
AF Yang, Zhengpeng
   Si, Shihui
   Zeng, Xiaoming
   Zhang, Chunjing
   Dai, Hongjuan
TI Mechanism and kinetics of apatite formation on nanocrystalline TiO2
   coatings: A quartz crystal microbalance study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nanocrystalline TiO2 coatings; apatite; QCM; mechanism; kinetics
ID SIMULATED BODY-FLUID; BIOMIMETIC DEPOSITION; BIOACTIVE MATERIALS;
   TITANIUM-DIOXIDE; ADSORPTION; GROWTH; BIOSENSOR; SURFACES; ALLOY; QCM
AB Apatite (Ca-5(PO4)(3)OH) has long been considered as an excellent biomaterial to promote bone repairs and implant. Apatite formation induced by negatively charged nanocrystalline TiO2 coatings soaked in simulated body fluid (SBF) was investigated using in situ quartz crystal microbalance (QCM), scanning electron microscopy (SEM), Fourier-transformed infrared spectroscopy (FTIR), X-ray diffraction (XRD) and energy-dispersive X-ray spectroscopy (EDX) techniques, and factors affecting its formation such as pH, size of TiO2 particles and thickness of TiO2 coatings, were discussed in detail. Two different stages were clearly observed in the process of apatite precipitation, indicating two different kinetic processes. At the first stage, the calcium ions in SBF were initially attracted to the negatively charged TiO2 surface, and then the calcium titanate formed at the interface combined with phosphate ions, consequently forming apatite nuclei. After the nucleation, the calcium ions, phosphate ions and other minor ions (i.e. CO32- and Mg2+) in supersaturated SBF deposited spontaneously on the original apatite coatings to form apatite precipitates. In terms of the in situ frequency shifts, the growth-rate constants of apatite (K-1 and K-2) were estimated, respectively, at two different stages, and the results were (1.96 +/- 0.14) x 10(-3) s(-1) and (1.28 +/- 0.10) x 10(-4) s(-1), respectively, in 1.5 SBF solution. It was found that the reaction rate at the first stage is obviously higher than that at the second stage. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yang, Zhengpeng; Si, Shihui; Zhang, Chunjing; Dai, Hongjuan] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
   [Zeng, Xiaoming] Hunan Bur Qual & Tech Supervis, Changsha 410007, Peoples R China.
RP Si, SH (reprint author), Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
EM sishihui@mail.esu.edu.cn
CR Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272
   BenDov I, 1997, ANAL CHEM, V69, P3506, DOI 10.1021/ac970216s
   Cosnier S, 1999, J ELECTROANAL CHEM, V469, P176, DOI 10.1016/S0022-0728(99)00223-5
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Dutta PK, 2004, J COLLOID INTERF SCI, V278, P270, DOI 10.1016/j.jcis.2004.06.015
   FAWCETT NC, 1998, ANAL CHEM, V70, P287
   Gu YW, 2005, BIOMATERIALS, V26, P6916, DOI [10.1016/j.biomaterials.2005.04.051, 10.1016/j.biomaterials.2005.04.51]
   Hayakawa S, 2000, J NON-CRYST SOLIDS, V263, P409, DOI 10.1016/S0022-3093(99)00649-3
   He YR, 2007, INT J HEAT MASS TRAN, V50, P2272, DOI 10.1016/j.ijheatmasstransfer.2006.10.024
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hianik T, 2005, BIOORG MED CHEM LETT, V15, P291, DOI 10.1016/j.bmcl.2004.10.083
   JOOS P, 1995, J COLLOID INTERF SCI, V171, P399, DOI 10.1006/jcis.1995.1196
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Keshmiri M, 2003, J NON-CRYST SOLIDS, V324, P289, DOI 10.1016/S0022-3093(03)00363-6
   Koenig Bernd, 1994, Analytical Chemistry, V66, P341, DOI 10.1021/ac00075a005
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOSSLINGER C, 1992, BIOSENS BIOELECTRON, V7, P397, DOI 10.1016/0956-5663(92)85038-C
   Lin CM, 2006, MAT SCI ENG C-BIO S, V26, P54, DOI 10.1016/j.msec.2005.06.048
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Liu SQ, 2005, LANGMUIR, V21, P8409, DOI 10.1021/la050875x
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Lori JA, 2001, CORROS SCI, V43, P2111, DOI 10.1016/S0010-938X(01)00003-8
   Nunalee FN, 2006, ANAL CHEM, V78, P1158, DOI 10.1021/ac0515226
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Park IS, 2004, BIOSENS BIOELECTRON, V19, P667, DOI 10.1016/S0956-5663(03)00268-9
   Ratner B. D., 2001, TITANIUM MED, P1
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shen ZH, 2007, ANAL CHEM, V79, P2312, DOI 10.1021/ac061986j
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Stanley S, 2003, ANAL CHEM, V75, P1573, DOI 10.1021/ac0257546
   Su XL, 2005, BIOSENS BIOELECTRON, V21, P840, DOI 10.1016/j.bios.2005.01.021
   SURI CR, 1994, BIOSENS BIOELECTRON, V9, P325, DOI 10.1016/0956-5663(94)80031-6
   Tanahashi M, 1996, J BIOMED MATER RES, V31, P243, DOI 10.1002/(SICI)1097-4636(199606)31:2<243::AID-JBM11>3.0.CO;2-M
   Towery RB, 2001, BIOSENS BIOELECTRON, V16, P1, DOI 10.1016/S0956-5663(00)00126-3
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang XX, 2003, BIOMATERIALS, V24, P4631, DOI 10.1016/S0142-9612(03)00357-0
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Xie Y., 2006, SURF SCI, V600, P651
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yang ZP, 2007, THIN SOLID FILMS, V515, P3344, DOI 10.1016/j.tsf.2006.09.018
   Zhang HZ, 1999, J PHYS CHEM B, V103, P4656, DOI 10.1021/jp984574q
   Zhu PX, 2003, J AM CERAM SOC, V86, P782, DOI 10.1111/j.1151-2916.2003.tb03375.x
NR 43
TC 42
Z9 45
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 560
EP 568
DI 10.1016/j.actbio.2007.10.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500011
PM 18053780
DA 2018-10-19
ER

PT J
AU Gomes, PS
   Santos, JD
   Fernandes, MH
AF Gomes, P. S.
   Santos, J. D.
   Fernandes, M. H.
TI Cell-induced response by tetracyclines on human bone marrow colonized
   hydroxyapatite and Bonelike (R)
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tetracyclines; osteoblasts; hydroxyapatite; bonelike
ID GLASS-REINFORCED-HYDROXYAPATITE; OSTEOBLAST PHENOTYPE; TISSUE
   REGENERATION; INDUCED OSTEOPENIA; DIFFERENTIATION; DOXYCYCLINE;
   PROLIFERATION; COMPOSITES; SCAFFOLDS; GROWTH
AB Semi-synthetic tetracyclines are commonly used antibiotics that also seem to play an important role in the modulation of the immuno-inflammatory imbalance, verified in several bone diseases. The association of a therapeutic agent (that prevents bacterial infection and induces tissue formation) to a biomaterial aiming to repair/regenerate bone defects could contribute to a more predictable clinical outcome. The present study intends to evaluate the proliferation and functional activity of osteoblast-induced human bone marrow cells, cultured on the surface of hydroxyapatite (HA) and Bonelike (R), in the presence of therapeutic concentrations of doxycycline and minocycline. First passage bone marrow cells were cultured for 35 days on the surface of HA and Bonelike (R) discs, in the absence or presence of 1 mu g ml(-1) doxycycline and minocycline. Cultures performed in standard tissue culture plates were used as control.
   Doxycycline or minocycline induced cell proliferation and increased the extent of matrix mineralization in osteoblastic cell cultures established in the three substrates. Also, an improved biological behavior was verified in seeded Bonelike (R) compared with HA. The results suggest that the local delivery of tetracyclines might associate the antimicrobial activity in implant-related bone infection with an eventual induction of osteoblastic proliferation and maintenance of the characteristic biological activity of these cells. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Gomes, P. S.; Fernandes, M. H.] Univ Porto FMDUP, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, P-4200392 Oporto, Portugal.
   [Santos, J. D.] Univ Porto, Seccao Mat, DEMM, Fac Engn, P-4200465 Oporto, Portugal.
   [Santos, J. D.] Inst Engn Biomed INEB, Lab Biomat, P-4150180 Oporto, Portugal.
RP Fernandes, MH (reprint author), Univ Porto FMDUP, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, Rua Dr Manuel Pereira Silva,S-N, P-4200392 Oporto, Portugal.
EM mhrf@portugalmail.pt
RI Fernandes, Maria Helena/K-6917-2014; Gomes, Pedro/K-2433-2014
OI Gomes, Pedro/0000-0001-5365-2123; Santos, Jose
   Domingos/0000-0002-6871-9850; Fernandes, Maria
   Helena/0000-0001-9391-9574
CR Alkan A, 2002, J ORAL MAXIL SURG, V60, P898, DOI 10.1053/jams.2002.33859
   Beardmore AA, 2005, J BONE JOINT SURG AM, V87A, P107, DOI 10.2106/JBJS.C.01670
   Bettany J T, 1998, Adv Dent Res, V12, P136
   Brause BD, 2000, MANDELL DOUGLAS BENN, P1196
   BUCHTER A, 2004, BRIT J ORAL MAX SURG, V42, P452
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Caton J G, 1999, Compend Contin Educ Dent, V20, P451
   Chambers HF, 2006, GOODMAN GILMANS PHAR, P1173
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Costa MA, 2004, KEY ENG MAT, V254-2, P821, DOI 10.4028/www.scientific.net/KEM.254-256.821
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   DUARTE F, 2004, MATER SCI FORUM, V370, P455
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   GERSTENFELD LC, 1988, J CELL BIOL, V106, P979, DOI 10.1083/jcb.106.3.979
   GIANNOUDIS P, 2005, INT J CARE INJURED, V365, P220
   GOLUB LM, 1984, J PERIODONTAL RES, V19, P651, DOI 10.1111/j.1600-0765.1984.tb01334.x
   GOLUB LM, 1994, J AM DENT ASSOC, V125, P163, DOI 10.14219/jada.archive.1994.0261
   GOLUB LM, 1990, RES COMMUN CHEM PATH, V68, P27
   Gomes PS, 2007, ARCH ORAL BIOL, V52, P251, DOI 10.1016/j.archoralbio.2006.10.005
   Gurkan A, 2005, J CLIN PERIODONTOL, V32, P244, DOI 10.1111/j.1600-051X.2005.00663.x
   Gutierres M, 2006, J ORTHOP RES, V24, P953, DOI 10.1002/jor.20117
   GUTIERRES M, 2005, KEY ENG MATER, V1041, P284
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Holmes SG, 2004, BONE, V35, P471, DOI 10.1016/j.bone.2004.02.028
   Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005
   KARIMBUX N, 1998, J PERIODONTOL, V69, P39
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   KIMA HW, 2005, BIOMATERIALS, V26, P4395
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lin LY, 2001, J CARDIOVASC ELECTR, V12, P26, DOI 10.1046/j.1540-8167.2001.00026.x
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   POLSON A, 2005, J APPL RES CLIN DENT, P32
   Pytlik M, 2004, CALCIFIED TISSUE INT, V75, P225, DOI 10.1007/s00223-004-0097-x
   RAMAMURTHY N, 2003, P 10 WORLD C NEW YOR, P236
   Ramamurthy N, 2005, J PERIODONTOL, V73, P726
   Sakellari D, 2000, J CLIN PERIODONTOL, V27, P53, DOI 10.1034/j.1600-051x.2000.027001053.x
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   SANTOS JD, 1995, J MATER SCI-MATER M, V6, P348, DOI 10.1007/BF00120303
   Schwartz Z, 2000, J PERIODONTOL, V71, P586, DOI 10.1902/jop.2000.71.4.586
   Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Vallet Regi M, 2007, DRUG METABOL LETT, V1, P37
   Williams S, 1999, ANN NY ACAD SCI, V878, P191, DOI 10.1111/j.1749-6632.1999.tb07684.x
   Williams S, 1998, Adv Dent Res, V12, P71
   Williams S, 1996, BONE, V19, P637, DOI 10.1016/S8756-3282(96)00302-X
   WOESSNER JF, 2000, MATRIX METALLOPROTEI, P109
   YAMAGUCHI A, 1990, J BIOL CHEM, V265, P4809
   YU Z, 1993, J PERIODONTAL RES, V28, P420
   Yukna R A, 1982, Int J Periodontics Restorative Dent, V2, P8
   ZHANG Y, 2001, KEY ENG MATER, V192, P643
   Zucchelli G, 1999, J PERIODONTOL, V70, P239, DOI 10.1902/jop.1999.70.3.239
NR 58
TC 29
Z9 30
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 630
EP 637
DI 10.1016/j.actbio.2007.12.006
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500018
PM 18291737
DA 2018-10-19
ER

PT J
AU Kelch, S
   Choi, NY
   Wang, ZG
   Lendlein, A
AF Kelch, Steffen
   Choi, Nok-Young
   Wang, Zhonggang
   Lendlein, Andreas
TI Amorphous, elastic AB copolymer networks from acrylates and
   poly[(L-lactide)-ran-glycolide]dimethacrylates
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID SHAPE-MEMORY POLYMER; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS;
   ANGIOGENESIS; IMPLANTATION; BIOMATERIAL; DEGRADATION; MICE
C1 [Kelch, Steffen] Sik Technol AG, CH-8048 Zurich, Switzerland.
   [Lendlein, Andreas] GKSS Forschungszentrum Geesthacht GmbH, Polymer Res Inst, D-14513 Teltow, Germany.
   [Choi, Nok-Young] BASF AG, D-67056 Ludwigshafen, Germany.
   [Wang, Zhonggang] Dalian Univ Technol, Sch Chem Engn, Dept Polymer Sci & Mat, Dalian 116012, Peoples R China.
RP Kelch, S (reprint author), Sik Technol AG, Tuffenwies 16, CH-8048 Zurich, Switzerland.
EM andreas.lendlein@gkss.de
RI Wang, Zhonggang/L-1555-2014; Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Alcoutlabi M, 1999, J MATER SCI, V34, P2361, DOI 10.1023/A:1004546228825
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113
   Charlesby A, 1960, ATOMIC RAD POLYM
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   GRULKE EA, 1989, POLYM HDB
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   KINE BB, 1985, ENCY POLYM SCI ENG, V1, P274
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A., 2005, ENCY MAT SCI TECHNOL
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Min CC, 2005, POLYM ADVAN TECHNOL, V16, P608, DOI 10.1002/pat.624
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Reyntjens WG, 1999, MACROMOL RAPID COMM, V20, P251, DOI 10.1002/(SICI)1521-3927(19990501)20:5<251::AID-MARC251>3.0.CO;2-2
   Rickert D, 2005, CLIN HEMORHEOL MICRO, V32, P117
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
NR 26
TC 53
Z9 53
U1 1
U2 26
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2008
VL 10
IS 5
BP 494
EP 502
DI 10.1002/adem.200700339
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 310VF
UT WOS:000256558100013
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Uskokovic, D
AF Ignjatovic, N.
   Uskokovic, D.
TI Biodegradable composites based on nanocrystalline calcium phosphate and
   bioresorbable polymers
SO ADVANCES IN APPLIED CERAMICS
LA English
DT Article
DE composite biomaterials; injectable paste; nanocrystalline calcium
   phosphate; resorbable polymer
ID HARD-TISSUE REPLACEMENT; BONE TISSUE; HAP/PLLA COMPOSITE; IN-VIVO;
   BIOMATERIALS; BIOCOMPOSITE; RECONSTRUCTION; OSTEOGENESIS; SUBSTITUTION;
   SPECTROSCOPY
AB Nanocrystalline calcium phosphates (NC CP) are suitable for the synthesis of CP/bioresorbable polymer composite biomaterials for the application in bone engineering. There are different forms of NC CP/ bioresorbable polymers composite biomaterials. Calcium phosphate was synthesised in highly NC form. A NC calcium phosphate/poly-DL-lactide-co-glycolide (CP/DLPLG) composite biomaterial in filler forms was synthesised in the shape of spherical granules (150-200 mu m in diameter) and nanoparticles (30-40 nm in diameter). Each CP granule or nanoparticle was coated with amorphous DLPLG polymer. Using NC and nanosized CP/ DLPLG composite materials, an injectable composite biomaterial was prepared. By hot pressing of highly porous NC CP/ bioresorbable polymer composite biomaterials at the polymer's melting temperature, blocks were obtained with relatively uniform distribution of phases. Designing of the properties of CP/ bioresorbable polymers composite biomaterial block was provided by combining high pressure, temperature and time.
C1 [Ignjatovic, N.; Uskokovic, D.] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade 11000, Serbia.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Knez Mihailova 35-IV, Belgrade 11000, Serbia.
EM uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Ajdukovic Z, 2007, J BIOMATER APPL, V21, P317, DOI 10.1177/0885328207073760
   Albee FH, 1920, ANN SURG, V71, P32
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   GERLACH KI, 2004, QUINTESSENZ, V66, P603
   Grigor'ian A S, 2000, Stomatologiia (Mosk), V79, P9
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2005, MATER SCI FORUM, V494, P519, DOI 10.4028/www.scientific.net/MSF.494.519
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2004, SPECTROSC-INT J, V18, P553, DOI 10.1155/2004/917656
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic N, 2003, BIO-MED MATER ENG, V13, P401
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Kandic L, 2006, MATER SCI FORUM, V518, P507, DOI 10.4028/www.scientific.net/MSF.518.507
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lu LC, 1996, MRS BULL, V21, P28
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Meneghini C, 2003, BIOPHYS J, V84, P2021, DOI 10.1016/S0006-3495(03)75010-3
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Osman MA, 2006, POLYMER, V47, P2357, DOI 10.1016/j.polymer.2006.01.085
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Soriano I, 2000, J CONTROL RELEASE, V68, P121, DOI 10.1016/S0168-3659(00)00251-0
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   YAMAMURA K, 1992, J BIOMED MATER RES, V26, P1053, DOI 10.1002/jbm.820260807
NR 46
TC 8
Z9 9
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-6753
EI 1743-6761
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD MAY
PY 2008
VL 107
IS 3
BP 142
EP 147
DI 10.1179/174367608X263421
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 333EY
UT WOS:000258137000004
DA 2018-10-19
ER

PT J
AU Du, CL
   Wang, MQ
   Liu, JY
   Pan, ML
   Cai, YR
   Yao, JM
AF Du, Chunling
   Wang, Mingqi
   Liu, Jinying
   Pan, Mingli
   Cai, Yurong
   Yao, Juming
TI Improvement of thermostability of recombinant collagen-like protein by
   incorporating a foldon sequence
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE collagen; recombinant protein; fibritin; foldon; thermostability; cell
   biocompatibility
ID BACTERIOPHAGE-T4 FIBRITIN; TERMINAL DOMAIN; EXPRESSION; PEPTIDES; CHAIN
AB Collagen is a popular biomaterial in many specific biological interactions as well as a structural element. In this work, the recombinant collagen-like proteins were synthesized using Escherichia coli expression system. A foldon sequence, GYIPEAPRDGQAYVRKDGEWVLLSTFL, derived from the native T4 phage fibritin was incorporated at the C-terminal of collagen-like protein molecules to stabilize the triple helix formed in the proteins. The differential scanning calorimetry and thermogravimetric analysis measurements showed that the thermostability of the recombinant collagen-like proteins was significantly improved when compared with those without the foldon sequence at the C-terminal. Fourier transform infrared and scanning electron microscopy observations indicated that the collagen-like proteins forms the triple helix structure and prefer to aggregate as fibrils, same as the native collagen. Moreover, the mice fibroblasts L929 cells could attach and grew very well on the recombinant collage-like proteins. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the cell biocompatibility of collagen-like proteins produced in this work was even better than that of native collagen, suggesting that the collagen-like proteins may be a satisfactory candidate for the future applications as a biomaterial.
C1 [Du, Chunling; Wang, Mingqi; Liu, Jinying; Pan, Mingli; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR Baez J, 2005, APPL MICROBIOL BIOT, V69, P245, DOI 10.1007/s00253-005-0180-x
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   PERRIS R, 1993, J CELL SCI, V106, P1357
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   SERGEI PB, 2002, EUR J BIOCHEM, V269, P833
   STAATZ WD, 1990, J BIOL CHEM, V265, P4778
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Valluzzi R, 2000, BIOPOLYMERS, V53, P350, DOI 10.1002/(SICI)1097-0282(20000405)53:4<350::AID-BIP7>3.0.CO;2-O
   VANDERZEE E, 1995, J CELL SCI, V108, P3307
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
NR 22
TC 17
Z9 18
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAY
PY 2008
VL 79
IS 2
BP 195
EP 202
DI 10.1007/s00253-008-1427-0
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 292FZ
UT WOS:000255253200004
PM 18379779
DA 2018-10-19
ER

PT J
AU Rice, WL
   Firdous, S
   Gupta, S
   Hunter, M
   Foo, CWP
   Wang, Y
   Kim, HJ
   Kaplan, DL
   Georgakoudi, I
AF Rice, William L.
   Firdous, Shamaraz
   Gupta, Sharad
   Hunter, Martin
   Foo, Cheryl W. P.
   Wang, Yongzhong
   Kim, Hyeon Joo
   Kaplan, David L.
   Georgakoudi, Irene
TI Non-invasive characterization of structure and morphology of silk
   fibroin biomaterials using non-linear microscopy
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; two photon excited fluorescence; second harmonic
   generation; spectral analysis; non-invasive characterization
ID TRYPTOPHAN FLUORESCENCE-SPECTRA; MESENCHYMAL STEM-CELLS; LOG-NORMAL
   COMPONENTS; MARROW STROMAL CELLS; SPIDER DRAGLINE SILK; IN-VIVO
   EVALUATION; 2ND-HARMONIC GENERATION; OSTEOGENIC DIFFERENTIATION;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX
AB Designing biomaterial scaffolds remains a major challenge in tissue engineering. Key to this challenge is improved understanding of the relationships between the scaffold properties and its degradation kinetics, as well as the cell interactions and the promotion of new matrix deposition. Here we present the use of non-linear spectroscopic imaging as a non-invasive method to characterize not only morphological, but also structural aspects of silkworm silk fibroin-based biomaterials, relying entirely on endogenous optical contrast. We demonstrate that two photon excited fluorescence and second harmonic generation are sensitive to the hydration, overall sheet content and molecular orientation of the sample. Thus, the functional content and high resolution afforded by these non-invasive approaches offer promise for identifying important connections between biomaterial design and functional engineered tissue development. The strategies described also have broader implications for understanding and tracking the remodeling of degradable biomaterials under dynamic conditions both ill vitro and ill vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Rice, William L.; Gupta, Sharad; Hunter, Martin; Foo, Cheryl W. P.; Wang, Yongzhong; Kim, Hyeon Joo; Kaplan, David L.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Firdous, Shamaraz] Pakistan Inst Engn & Appl Sci, Dept Phys & Appl Math, Laser Lab, Islamabad, Pakistan.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St,Room 229, Medford, MA 02155 USA.
EM rene.georgakoudi@tufts.edu
RI Firdous, Shamaraz/I-8028-2015; Gupta, Sharad/C-3481-2013
OI Gupta, Sharad/0000-0003-2521-0170
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-03]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T, 2005, BIOMACROMOLECULES, V6, P468, DOI 10.1021/bm049487k
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brehmer B, 2007, UROL INT, V78, P23, DOI 10.1159/000096930
   Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7
   Chandra M, 2006, OPT EXPRESS, V14, P6157, DOI 10.1364/OE.14.006157
   Edwards GA, 1997, J BIOMED MATER RES, V34, P291
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Gonzalez S, 2003, CLIN DERMATOL, V21, P359, DOI 10.1016/j.clindermatol.2003.08.007
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gubler U, 2002, NAT MATER, V1, P209, DOI 10.1038/nmat781
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Ko HJ, 2006, TISSUE ENG, V12, P63, DOI 10.1089/ten.2006.12.63
   LEE HS, 2006, TISSUE ENG
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Ntziachristos V, 2001, BREAST CANCER RES, V3, P41, DOI 10.1186/bcr269
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Ramanujam N, 2000, NEOPLASIA, V2, P89, DOI 10.1038/sj.neo.7900077
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xu C. C., 2006, TISSUE ENG
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
NR 58
TC 48
Z9 50
U1 1
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 13
BP 2015
EP 2024
DI 10.1016/j.biomaterials.2007.12.049
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315BO
UT WOS:000256853100003
PM 18291520
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, XH
   Baughman, CB
   Kaplan, DL
AF Zhang, Xiaohui
   Baughman, Cassandra B.
   Kaplan, David L.
TI In vitro evaluation of electrospun silk fibroin scaffolds for vascular
   cell growth
SO BIOMATERIALS
LA English
DT Article
DE silk; electrospinning; endothelial cells; smooth muscle cells; vascular
ID BIODEGRADABLE POLYMER; PULMONARY-ARTERY; TUBE FORMATION; COLLAGEN;
   ANGIOGENESIS; CONSTRUCTS; FIBROBLAST; NANOFIBER; INVITRO; TISSUES
AB Human aortic endothelial (HAEC) and human coronary artery smooth muscle cell (HCASMC) responses on electrospun silk fibroin scaffolds were studied to evaluate potential for vascular tissue engineering. Cell proliferation studies supported the utility of this biomaterial matrix by both HAECs and HCASMCs. Alignment and elongation of HCASMCs on random non-woven nanofibrous silk scaffolds was observed within 5 days after seeding based on SEM and confocal microscopy. Short cord-like structures formed from HAECs on the scaffolds by day 4, and a complex interconnecting network of capillary tubes with identifiable lumens was demonstrated by day 7. The preservation of cell phenotype on the silk fibroin scaffolds was confirmed by the presence of cell-specific markers, including CD 146, VE-cadherin, PECAM-1 and vWF for HAECs, and SM-MHC2 and SM-actin for HCASMCs at both protein and transcription levels using immunocytochemistry and real-time RT-PCR, respectively. Formation of ECM was also demonstrated for the HCASMCs, based on the quantification of collagen type I expression at protein and transcription levels. The results indicate a favorable interaction between vascular cells and electrospun silk fibroin scaffolds. When these results are factored into the useful mechanical properties and slow degradability of this protein biomaterial matrix, potential utility in tissue-engineered blood vessels can be envisioned. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Baughman, Cassandra B.; Kaplan, David L.] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Zhang, Xiaohui/C-4569-2013
FU PHS HHS [P41]; NIBIB NIH HHS [P41 EB002520, P41 EB002520-05]
CR AUERBACH R, 1991, PHARMACOL THERAPEUT, V51, P1, DOI 10.1016/0163-7258(91)90038-N
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808
   Conte MS, 1998, FASEB J, V12, P43
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931
   HERRING MB, 1991, J VASC SURG, V13, P731
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LEAH S, IN PRESS J BIOMATER
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Montanez Eloi, 2002, Angiogenesis, V5, P167, DOI 10.1023/A:1023837821062
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 31
TC 206
Z9 239
U1 3
U2 122
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 14
BP 2217
EP 2227
DI 10.1016/j.biomaterials.2008.01.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289PH
UT WOS:000255065900007
PM 18279952
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zeugolis, DI
   Khew, ST
   Yew, ESY
   Ekaputra, AK
   Tong, YW
   Yung, LYL
   Hutmacher, DW
   Sheppard, C
   Raghunath, M
AF Zeugolis, Dimitrios I.
   Khew, Shih T.
   Yew, Elijah S. Y.
   Ekaputra, Andrew K.
   Tong, Yen W.
   Yung, Lin-Yue L.
   Hutmacher, Dietmar W.
   Sheppard, Colin
   Raghunath, Michael
TI Electro-spinning of pure collagen nano-fibres - Just an expensive way to
   make gelatin?
SO BIOMATERIALS
LA English
DT Editorial Material
DE collagen denaturation; gelatin; denaturation temperature; second
   harmonic generation; transmission electron microscopy; circular
   dichroism
ID TISSUE ENGINEERING SCAFFOLDS; 2ND-HARMONIC GENERATION; FIBRIL FORMATION;
   MECHANICAL-PROPERTIES; CIRCULAR-DICHROISM; MOLECULAR PACKING; I
   COLLAGEN; CROSS-LINKING; RAT TENDON; INVITRO
AB Scaffolds manufactured from biological materials promise better clinical functionality, providing that characteristic features are preserved. Collagen, a prominent biopolymer, is used extensively for tissue engineering applications, because its signature biological and physico-chemical properties are retained in in vitro preparations. We show here for the first time that the very properties that have established collagen as the leading natural biomaterial are lost when it is electro-spun into nano-fibres out of fluoroalcohols such as 1,1,1,3,3,3-hexafluoro-2-propanol or 2,2,2-trifluoroethanol. We further identify the use of fluoroalcohols as the major culprit in the process. The resultant nano-scaffolds lack the unique ultra-structural axial periodicity that confirms quarter-staggered supramolecular assemblies and the capacity to generate second harmonic signals, representing the typical crystalline triple-helical structure. They were also characterised by low denaturation temperatures, similar to those obtained from gelatin preparations (p > 0.05). Likewise, circular dichroism spectra revealed extensive denaturation of the electro-spun collagen. Using pepsin digestion in combination with quantitative SDS-PAGE, we corroborate great losses of up to 99% of triple-helical collagen. In conclusion, electro-spinning of collagen out of fluoroalcohols effectively denatures this biopolymer, and thus appears to defeat its purpose, namely to create biomimetic scaffolds emulating the collagen structure and function of the extracellular matrix. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zeugolis, Dimitrios I.; Raghunath, Michael] Natl Univ Singapore, Tissue Modulat Lab, Singapore 117510, Singapore.
   [Zeugolis, Dimitrios I.; Yew, Elijah S. Y.; Ekaputra, Andrew K.; Tong, Yen W.; Hutmacher, Dietmar W.; Sheppard, Colin; Raghunath, Michael] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117576, Singapore.
   [Zeugolis, Dimitrios I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Immunol Programme, Singapore 117456, Singapore.
   [Khew, Shih T.; Tong, Yen W.; Yung, Lin-Yue L.] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
   [Hutmacher, Dietmar W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117597, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
RP Raghunath, M (reprint author), Natl Univ Singapore, Tissue Modulat Lab, Singapore 117510, Singapore.
EM bierm@nus.edu.sg
RI Yung, Lanry/B-6515-2009; Sheppard, Colin/B-9593-2008; Tong, Yen
   Wah/D-4602-2009; Khew, Shih Tak/H-1828-2011; Raghunath,
   Michael/E-6483-2010
OI Yung, Lanry/0000-0001-7579-6347; Sheppard, Colin/0000-0002-0792-4607;
   Tong, Yen Wah/0000-0002-6004-6284; Raghunath,
   Michael/0000-0002-2138-6614; zeugolis, dimitrios/0000-0002-7599-5191;
   Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   BEAR RS, 1952, ADV PROTEIN CHEM, V7, P69, DOI 10.1016/S0065-3233(08)60018-2
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   BIRK DE, 1990, J CELL SCI, V95, P649
   BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   CHU FH, 1974, BIOPOLYMERS, V13, P1427, DOI 10.1002/bip.1974.360130713
   COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004
   Cort JR, 1997, BIOCHEM BIOPH RES CO, V233, P687, DOI 10.1006/bbrc.1997.6524
   Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2
   COX G, 2003, P SPIE
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   DOYLE BB, 1978, BIOCHIM BIOPHYS ACTA, V535, P25
   FINCH A, 1974, BIOCHIM BIOPHYS ACTA, V365, P400, DOI 10.1016/0005-2795(74)90012-9
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   GROSS J, 1954, P NATL ACAD SCI USA, V40, P679, DOI 10.1073/pnas.40.8.679
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   HIGHBERGER JH, 1951, P NATL ACAD SCI USA, V37, P286, DOI 10.1073/pnas.37.5.286
   Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t
   HORMANN H, 1971, BIOCHEMISTRY-US, V10, P932
   HSU S, 1994, BIORHEOLOGY, V31, P21
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang YF, 2001, EXP EYE RES, V73, P521, DOI 10.1006/exer.2001.1057
   Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49
   HULMES DJS, 1985, J MOL BIOL, V184, P473, DOI 10.1016/0022-2836(85)90295-5
   HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0
   HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C
   KOPP J, 1989, Matrix, V9, P443
   Kundu A, 2004, BIOPOLYMERS, V73, P405, DOI 10.1002/bip.20014
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   LIGHT ND, 1985, METHODS SKIN RES, P559
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   Paul R Gordon, 2003, ScientificWorldJournal, V3, P138
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   SILVER FH, 1984, INT J BIOL MACROMOL, V6, P125, DOI 10.1016/0141-8130(84)90052-7
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Theodossiou TA, 2006, BIOPHYS J, V91, P4665, DOI 10.1529/biophysj.106.093740
   Tsereteli G. I., 1991, POLYM SCI, V33, P2112
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Van Der Rest Michel, 1993, V6, P1
   VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Wess TJ, 1998, J MOL BIOL, V275, P255, DOI 10.1006/jmbi.1997.1449
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   ZEUGOLIS DI, J BIOMEDICAL MAT R A
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 78
TC 298
Z9 304
U1 7
U2 108
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2293
EP 2305
DI 10.1016/j.biomaterials.2008.02.009
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700001
PM 18313748
DA 2018-10-19
ER

PT J
AU Gupta, S
   Hunter, M
   Cebe, P
   Levitt, JM
   Kaplan, DL
   Georgakoudi, I
AF Gupta, Sharad
   Hunter, Martin
   Cebe, Peggy
   Levitt, Jonathan M.
   Kaplan, David L.
   Georgakoudi, Irene
TI Non-invasive optical characterization of biomaterial mineralization
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; tissue engineering; polarization; light scattering
ID MORI SILK FIBROIN; LIGHT-SCATTERING SPECTROSCOPY; AIR-WATER-INTERFACE;
   BIOLOGICAL TISSUE; CRYSTAL-STRUCTURE; TRANSITION; DYSPLASIA; PROTEINS;
   MINERALS; APATITE
AB Current approaches to study biomaterial mineralization are invasive and prevent dynamic characterization of this process within the same sample. Polarized light scattering spectroscopy (LSS) may offer a non-invasive alternative for assessing the levels of mineralization as well as some aspects of the organization of the mineral deposits. Specifically, we used LSS to characterize the formation of hydroxyapatite deposits on three types of silk films (water-annealed, methanol-treated and polyaspartic acid (PAA)-mixed) following 1, 3, 5 and 7 cycles of mineralization. We found that the total light scattering intensity provided a quantitative measure of the degree of mineralization as confirmed by thermal gravimetric analysis (TGA). The PAA-mixed silk films yielded the highest level of mineral deposition and the water-annealed ones the least, consistent with the beta sheet content of the films prior to the onset of mineralization. The wavelength dependence of the singly backscattered light was consistent with a self-affine fractal morphology of the deposited films within scales in the range of 150-300 nm; this was confirmed by Fourier analysis of scanning electron microscopy (SEM) images of the corresponding films. The deposits of minerals in the water-annealed films were predominantly flake-like, with positively correlated density fluctuations (Hurst parameter, H > 0.5), whereas methanol-treated and PAA-mixed silk films resulted in densely-packed, bulk mineral deposits with negatively correlated density fluctuations (H < 0.5). Therefore, LSS could serve as a valuable tool for understanding the role of biomaterial properties in mineral formation, and, ultimately, for optimizing biomaterial designs that yield mineral deposits with the desired organization. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Gupta, Sharad; Hunter, Martin; Levitt, Jonathan M.; Kaplan, David L.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colgby St, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
RI Gupta, Sharad/C-3481-2013
OI Gupta, Sharad/0000-0003-2521-0170; Cebe, Peggy/0000-0002-8721-644X
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-04]
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325
   Backman V, 2000, NATURE, V406, P35
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Dougherty G, 2001, MED ENG PHYS, V23, P369, DOI 10.1016/S1350-4533(01)00057-1
   Drezek R, 2001, PHOTOCHEM PHOTOBIOL, V73, P636, DOI 10.1562/0031-8655(2001)073<0636:AMOFCT>2.0.CO;2
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Frankel RB, 2003, REV MINERAL GEOCHEM, V54, P95, DOI 10.2113/0540095
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hunter M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138102
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Mandelbrot B B, 2000, FRACTAL GEOMETRY NAT
   MANN S, 1983, STRUCT BOND, V54, P125
   MANN S, 2001, BIORNINERALIZATION P
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Perelman LT, 1998, PHYS REV LETT, V80, P627, DOI 10.1103/PhysRevLett.80.627
   POWER WL, 1991, J GEOPHYS RES-SOLID, V96, P415, DOI 10.1029/90JB02107
   Schmitt JM, 1996, OPT LETT, V21, P1310, DOI 10.1364/OL.21.001310
   SIMUKANGA S, 1995, FERT RES, V41, P159, DOI 10.1007/BF00750758
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   VOSS RF, 1986, PHYS SCRIPTA, VT13, P27, DOI 10.1088/0031-8949/1986/T13/004
   Wallace MB, 2000, GASTROENTEROLOGY, V119, P677, DOI 10.1053/gast.2000.16511
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   YOUNGJUAN R, 2007, FRONT MAT SCI CHINA, V1, P258
NR 35
TC 10
Z9 10
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2359
EP 2369
DI 10.1016/j.biomaterials.2008.01.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700007
PM 18313137
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yang, Q
   Peng, J
   Guo, QY
   Huang, JX
   Zhang, L
   Yao, J
   Yang, F
   Wang, SG
   Xu, WJ
   Wang, AY
   Lu, SB
AF Yang, Qiang
   Peng, Jiang
   Guo, Quanyi
   Huang, Jingxiang
   Zhang, Li
   Yao, Jun
   Yang, Fei
   Wang, Shenguo
   Xu, Wenjing
   Wang, Aiyuan
   Lu, Shibi
TI A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo
   cartilage tissue engineering with PKH26-labeled chondrogenic bone
   marrow-derived mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE cartilage tissue engineering; ECM (extracellular matrix); fluorescence;
   decellularization; scaffolds
ID ARTICULAR-CARTILAGE; CROSS-LINKING; MODEL; REPAIR; DIFFERENTIATION;
   RECONSTRUCTION; BIOMATERIALS; IMPLANTATION
AB We developed a natural, acellular, 3-D interconnected porous scaffold derived from cartilage extracellular matrix (ECM). Human cartilage was physically shattered, then decellularized sequentially with use of hypotonic buffer, TritonX-100, and a nuclease solution and made into a suspension. The scaffold was fabricated by simple freeze-drying and cross-linking techniques. On histology, scaffolds showed most of the ECM components after removal of the cell fragments, and scanning electron microscopy revealed a 3-D interconnected porous structure. Cellular viability assay revealed no cytotoxic effects. In vitro study showed that the novel scaffold could provide a suitable 3-D environment to support the adheration, proliferation and differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) to chondrocytes in culture with chondrogenic medium after 21 days. Chondrogenically induced BMSCs labeled with fluorescent dye PKH26 were then grown on scaffolds and implanted subcutaneously into nude mice. Four weeks later, cartilage-like tissue formed, with positive staining for Safranin 0, tuoluidine blue and collagen H. Cells in the samples seemed to confirm that they originated from the labeled BMSCs, as confirmed by in vivo fluorescent imaging and immunofluorescence examination. In conclusion, the cartilage ECM-derived porous scaffold shows potential as biomaterial for cartilage tissue engineering, and PKH26 fluorescent labeling and in vivo fluorescent imaging can be useful for cell tracking and analyzing cell-scaffold constructs in vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Yang, Qiang; Peng, Jiang; Guo, Quanyi; Huang, Jingxiang; Zhang, Li; Yao, Jun; Xu, Wenjing; Wang, Aiyuan; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Key Lab People Liberat Army, Beijing 100853, Peoples R China.
   [Yang, Fei; Wang, Shenguo] Chinese Acad Sci, Inst Chem, BNLMS State Key Lab Polymer Phys & Chem, Beijing 100080, Peoples R China.
RP Lu, SB (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Key Lab People Liberat Army, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM shibilu301@gmail.com
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   de Boer J, 2006, BIOMATERIALS, V27, P1851, DOI 10.1016/j.biomaterials.2005.09.034
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Grogan SP, 2002, J PATHOL, V198, P5, DOI 10.1002/path.1169
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Iyer M, 2002, MOL THER, V6, P555, DOI 10.1006/mthe.2002.0700
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Kelley TF, 2002, OTOLARYNG HEAD NECK, V127, P265, DOI 10.1067/mhn.2002.128344
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Quintavalla J, 2002, BIOMATERIALS, V23, P109, DOI 10.1016/S0142-9612(01)00086-2
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6
   Wu JC, 2002, CIRCULATION, V105, P1631, DOI 10.1161/01.CIR.0000014984.95520.AD
   Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209
NR 32
TC 154
Z9 184
U1 7
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2378
EP 2387
DI 10.1016/j.biomaterials.2008.01.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700009
PM 18313139
DA 2018-10-19
ER

PT J
AU Park, KM
   Bae, JW
   Joung, YK
   Shin, JW
   Park, KD
AF Park, Kyung Min
   Bae, Jin Woo
   Joung, Yoon Ki
   Shin, Jung Woog
   Park, Ki Dong
TI Nanoaggregate of thermosensitive chitosan-pluronic for sustained release
   of hydrophobic drug
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE chitosan; pluronic; nanoaggregate; sustained release; indomethacin
ID POLYMERIC MICELLES; POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; IN-VITRO;
   DELIVERY; BEHAVIOR; NANOPARTICLES; BIOMATERIAL; CARRIERS; DESIGN
AB A thermo-sensitive chitosan-Pluromic copolymer (CP) was prepared by grafting mono-carboxyl Pluronic onto the chitosan using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS). Indomethacin (IMC)-loaded nanoaggregate (NA) was prepared using the synthesized CP by the direct dissolution method. The critical aggregate concentration (CAC), hydrodynamic size and surface morphology of the prepared CP nanoaggregate (CPNA) were characterized by fluorescence spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM), respectively. The resulting CAC and the average diameter of CPNA were about 0.31 g/l and 120 nm, indicating high structural stability of CPNA and size favorable for intravenous delivery of drugs. In vitro release test of the IMC encapsulated into CPNA showed sustained release rate of IMC as compared with that from Pluronic micelle. Therefore, we can conclude that our CPNA can be a novel type of superior drug carrier for sustained delivery of hydrophobic drugs. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Park, Kyung Min; Bae, Jin Woo; Joung, Yoon Ki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Shin, Jung Woog] Inje Univ, Dept Biomed Engn, Gimhae 621749, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, 5 Wonchon, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
OI joung, yoon ki/0000-0001-8661-481X
CR ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Bae JW, 2006, MACROMOL RES, V14, P461, DOI 10.1007/BF03219111
   Cha J, 2006, MACROMOL RES, V14, P573, DOI 10.1007/BF03218726
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   Gan ZH, 1999, MACROMOLECULES, V32, P590, DOI 10.1021/ma981121a
   Hong SW, 2005, MACROMOL RES, V13, P397, DOI 10.1007/BF03218472
   KABANOV AV, 1995, MACROMOLECULES, V28, P2303, DOI 10.1021/ma00111a026
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kalyanasundoram K., 1988, J AM CHEM SOC, V99, P2039
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim IS, 2000, INT J PHARM, V205, P165, DOI 10.1016/S0378-5173(00)00501-9
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   KOSSOVSK N, 1997, BIOL TECHNOL, V11, P1534
   Lee JH, 2003, INT J PHARM, V251, P23, DOI 10.1016/S0378-5173(02)00582-3
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Martin H., 2005, J CONTROL RELEASE, V103, P137
   MIYAZAKI S, 1981, CHEM PHARM BULL, V29, P3067
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   PRASAD KN, 1982, J COLLOID INTERF SCI, V90, P303
   Soga O, 2005, J CONTROL RELEASE, V103, P341, DOI 10.1016/j.jconrel.2004.12.009
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Sugimoto H, 2005, POLYMER, V46, P10800, DOI 10.1016/j.polymer.2005.09.005
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
NR 30
TC 48
Z9 50
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2008
VL 63
IS 1
BP 1
EP 6
DI 10.1016/j.colsurfb.2007.10.024
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 293JU
UT WOS:000255332400001
PM 18314312
DA 2018-10-19
ER

PT J
AU Goda, T
   Matsuno, R
   Konno, T
   Takai, M
   Ishihara, K
AF Goda, Tatsuro
   Matsuno, Ryosuke
   Konno, Tomohiro
   Takai, Madoka
   Ishihara, Kazuhiko
TI Photografting of 2-methacryloyloxyethyl phosphorylcholine from
   polydimethylsiloxane: Tunable protein repellency and lubrication
   property
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE polydimethylsiloxane; phosphorylcholine; photografting; protein
   adsorption; lubrication
ID LIVING GRAFT-POLYMERIZATION; PDMS MICROFLUIDIC CHANNELS;
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); PHOSPHOLIPID POLYMER;
   MOLECULAR-DYNAMICS; WATER INTERACTION; ADHERENT CELLS; SURFACE;
   ADSORPTION; COPOLYMERS
AB The phosphorylcholine group functional methacrylate monomer, 2-methacryloyloxyethyl phosphory1choline (MPC), was graft polymerized from the polydimethylsiloxane (PDMS) substrate using ultraviolet irradiation and using benzophenone as a photoinitiator. The varying monomer concentrations and irradiation times were investigated in order to verify the relationships between graft density and protein resistance under specific biological conditions. The ellipsometry analysis revealed that the layer thickness of the grafted polymer depended on the monomer concentrations after the irradiation for 1 min, however, it stabilized thereafter in all the specified conditions. The curve fitting of the C Is spectrum obtained by X-ray photoelectron spectroscopy analysis showed that the amount of grafted polymer increased with an increase in both monomer concentration and irradiation time. Atomic force microscopic images revealed that the terminations among the graft chains became dominant due to magnified chain mobility followed by growth of their length. In vitro albumin and fibrinogen adsorption results indicated that the resistance to protein adsorption was easily tuned by the specified conditions due to the controlled graft density. Lubrication was dramatically enhanced by the grafting and it was further promoted by an increase in the graft density in good solvents, indicating that the interactions between the graft chains and the solvents resulted in the lubrication system. These basic findings regarding the grafted PDMS surface are important for versatile applications, including its use as a biomaterial and microfluidic device. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Goda, Tatsuro; Matsuno, Ryosuke; Konno, Tomohiro; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Goda, Tatsuro; Matsuno, Ryosuke; Konno, Tomohiro; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@mpc.t.u-tokyo.ac.jp
RI Goda, Tatsuro/B-6484-2011; Konno, Tomohiro/E-5244-2011
OI Goda, Tatsuro/0000-0003-2688-8186; Konno, Tomohiro/0000-0002-7814-3306
CR BEAMSON G, 1992, HDB HIGH RESOLUTION, pCH15
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b
   Ebara M, 2006, LAB CHIP, V6, P843, DOI 10.1039/b515128g
   Eteshola E, 2001, SENSOR ACTUAT B-CHEM, V72, P129, DOI 10.1016/S0925-4005(00)00640-7
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Feng W, 2006, BIOINTERPHASES, V1, P50, DOI 10.1116/1.2187495
   Goda T, 2007, COLLOID SURFACE B, V54, P67, DOI 10.1016/j.colsurfb.2006.09.006
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Hu SW, 2004, ANAL CHEM, V76, P1865, DOI 10.1021/ac049937z
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 2007, COLLOID SURFACE B, V57, P226, DOI 10.1016/j.colsurfb.2007.02.007
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Kato K, 2003, PROG POLYM SCI, V28, P209, DOI 10.1016/S0079-6700(02)00032-1
   Kiritoshi Y, 2002, J BIOMAT SCI-POLYM E, V13, P213, DOI 10.1163/156856202317414384
   KIRITOSHI Y, 2003, ADV MATER, V4, P93
   Kitano H, 2005, LANGMUIR, V21, P11932, DOI 10.1021/la0515571
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Kyomoto M, 2007, J BIOMED MATER RES A, V82A, P10, DOI 10.1002/jbm.a.31134
   Kyomoto M, 2007, BIOMATERIALS, V28, P3121, DOI 10.1016/j.biomaterials.2007.03.010
   Lam JKW, 2004, J CONTROL RELEASE, V100, P293, DOI 10.1016/j.jconrel.2004.08.028
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Matsuda Y, 2006, CHEM LETT, V35, P1310, DOI 10.1246/cl.2006.1310
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Muller MT, 2005, MACROMOLECULES, V38, P3861, DOI 10.1021/ma047468x
   OGIWARA Y, 1981, J POLYM SCI POL LETT, V19, P457, DOI 10.1002/pol.1981.130190905
   OSTER G, 1957, J POLYM SCI, V26, P233, DOI 10.1002/pol.1957.1202611311
   Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302
   Pu QS, 2007, LANGMUIR, V23, P1577, DOI 10.1021/la062662t
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Sawada SI, 2006, J BIOMED MATER RES A, V79A, P476, DOI 10.1002/jbm.a.30820
   SEIBER RP, 1975, J APPL POLYM SCI, V19, P2187, DOI 10.1002/app.1975.070190812
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   SMITH PK, 1985, ANAL BIOCHEM, V150, P6
   Tamai Y, 1996, MACROMOLECULES, V29, P6750, DOI 10.1021/ma951635z
   Tamai Y, 1996, MACROMOLECULES, V29, P6761, DOI 10.1021/ma960961r
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Ulbricht M, 1997, J MEMBRANE SCI, V136, P25, DOI 10.1016/S0376-7388(97)00151-8
   Wang YL, 2006, LANGMUIR, V22, P2719, DOI 10.1021/la053188e
   WRIGHT AN, 1967, NATURE, V215, P953, DOI 10.1038/215953a0
   Yang WT, 1996, MACROMOLECULES, V29, P3308, DOI 10.1021/ma9515543
   YAO ZP, 1990, J APPL POLYM SCI, V41, P1469, DOI 10.1002/app.1990.070410710
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 55
TC 36
Z9 37
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2008
VL 63
IS 1
BP 64
EP 72
DI 10.1016/j.colsurfb.2007.11.014
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 293JU
UT WOS:000255332400010
PM 18226507
DA 2018-10-19
ER

PT J
AU Ma, LJ
   Wen, HP
AF Ma, Lijuan
   Wen, Jianping
TI Biocomposite of double-walled carbon nanotube-doped alginate gel for
   biomaterial immobilization
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE carbon nanotubes; hybrid composites; mechanical properties; scanning
   electron microscopy (SEM); transmission electron microscopy (TEM)
ID ENZYME IMMOBILIZATION; BIOCOMPATIBILITY; MICROCAPSULES; ADSORPTION;
   MECHANISM
AB An efficient support for biomaterial immobilization, double-walled carbon nanotube-doped alginate gel (DWCNT-ALG) hybrid composite, was studied in this work. DWCNTs were cut by mixed acids to get a homogeneous dispersion in an aqueous solution. Fourier transform infrared spectroscopy (FTIR) was employed to analyze the structure of shortened DWCNTs. Bovine serum albumin (BSA), the model biomaterial, was immobilized in DWCNT-ALG composites. Mixture of DWCNTs and BSA were suspended in ALG homogenously and then added into a calcium chloride solution dropwise to form biocomposite beads. Transmission and scanning electron microscope (TEM and SEM) images confirmed the adsorption of BSA on DWCNTs and the uniform distribution of DWCNTs in ALG, respectively. Water loss and BSA leakage from the BSA-DWCNT-ALG biocomposites were reduced to 46.48% and 19.28%, respectively, compared with those from BSA-ALG biocomposites. These DWCNT-ALG biocomposites showed high efficiency in BSA immobilization. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Ma, Lijuan; Wen, Jianping] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China.
RP Wen, HP (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China.
EM jpwen@tju.edu.cn
CR Asuri P, 2006, J AM CHEM SOC, V128, P1046, DOI 10.1021/ja0573965
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bunger CM, 2003, J BIOMED MATER RES A, V67A, P1219, DOI 10.1002/jbm.a.10094
   Cheng H, 2001, J AM CHEM SOC, V123, P5845, DOI 10.1021/ja0155231
   Endo M, 2004, NANO LETT, V4, P1451, DOI 10.1021/nl0492483
   Jiang ZY, 2006, J BIOMAT SCI-POLYM E, V17, P21, DOI 10.1163/156856206774879144
   Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h
   Kim YJ, 2000, J APPL POLYM SCI, V78, P1797, DOI 10.1002/1097-4628(20001205)78:10<1797::AID-APP110>3.0.CO;2-M
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   Marshall MW, 2006, CARBON, V44, P1137, DOI 10.1016/j.carbon.2005.11.010
   Miyamoto J, 2006, J AM CHEM SOC, V128, P12636, DOI 10.1021/ja064744+
   Ren WC, 2005, J PHYS CHEM B, V109, P7169, DOI 10.1021/jp0448088
   Seifert DB, 1997, BIOTECHNOL PROGR, V13, P562, DOI 10.1021/bp9700723
   Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046
   Tang DS, 2006, CARBON, V44, P2155, DOI 10.1016/j.carbon.2006.03.023
   Tapia C, 2005, BIOMACROMOLECULES, V6, P2389, DOI 10.1021/bm050227s
   Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034
   Wang Q, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045403
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
   Wei JQ, 2006, ADV MATER, V18, P1695, DOI 10.1002/adna.200501841
   Xu SW, 2006, J MOL CATAL B-ENZYM, V43, P68, DOI 10.1016/j.molcatb.2006.06.026
   Zhang J, 2003, J PHYS CHEM B, V107, P3712, DOI 10.1021/jp027500u
   Zhang L, 2004, J APPL POLYM SCI, V92, P878, DOI 10.1002/app.13708
NR 24
TC 11
Z9 11
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD MAY
PY 2008
VL 68
IS 6
BP 1297
EP 1303
DI 10.1016/j.compscitech.2007.12.009
PG 7
WC Materials Science, Composites
SC Materials Science
GA 300AQ
UT WOS:000255797100007
DA 2018-10-19
ER

PT J
AU Sato, H
   Yamada, K
   Pezzotti, G
   Nawa, M
   Ban, S
AF Sato, Hideo
   Yamada, Kiyotaka
   Pezzotti, Giuseppe
   Nawa, Masahiro
   Ban, Seiji
TI Mechanical properties of dental zirconia ceramics changed with
   sandblasting and heat treatment
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE zirconia; sandblasting; heat treatment
ID RAMAN MICROPROBE SPECTROSCOPY; TETRAGONAL ZIRCONIA; FLEXURAL STRENGTH;
   RESIDUAL-STRESSES; SURFACE; TRANSFORMATION; RELIABILITY; NANOCOMPOSITE;
   POLYCRYSTALS; BIOMATERIAL
AB Two types of tetragonal zirconia polycrystals (TZP), a ceria-stabilized TZP/Al2O3 nanocomposite (CZA) and a conventional yttria-stabilized TZP (Y-TZP), were sandblasted with 70-mu m alumina and 125-mu m SiC powders, then partially annealed at 500-1200 degrees C for five minutes. Monoclinic ZrO2 content was determined by X-ray diffractometry and Raman spectroscopy. Biaxial flexure test was conducted on the specimens before and after the treatments. Monoclinic ZrO2 content and biaxial flexure strength increased after sandblasting, but decreased after heat treatment. However, in both cases, the strength of CZA was higher than that of Y-TZP. Raman spectroscopy showed that a compressive stress field was introduced on the sample surface after sandblasting. It was concluded that sandblasting induced tetragonal-to-monoclinic phase transformation and that the volume expansion associated with such a phase transformation gave rise to an increase in compressive stress on the surface of CZA. With the occurrence of such a strengthening mechanism in the microstructure, it was concluded that CZA was more susceptible to stress-induced transformation than Y-TZP.
C1 [Sato, Hideo; Ban, Seiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8908544, Japan.
   [Yamada, Kiyotaka; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
   [Yamada, Kiyotaka; Pezzotti, Giuseppe] Kyoto Inst Technol, Res Inst Nanosci, Sakyo Ku, Kyoto 6068585, Japan.
   [Nawa, Masahiro] Matsushita Elect Works Ltd, Cent Res Lab, Osaka 5718686, Japan.
RP Ban, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM sban@denta.hal.kagoshima-u.ac.jp
CR ANUSAVICE KJ, 2003, PHILIPS SCI DENT MAT, P680
   Ban S, 2007, KEY ENG MATER, V330-332, P353, DOI 10.4028/www.scientific.net/KEM.330-332.353
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   Chevalier J, 1999, J AM CERAM SOC, V82, P3129
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Denry IL, 2006, J BIOMED MATER RES B, V76B, P440, DOI 10.1002/jbm.b.30382
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Filser F, 2001, Int J Comput Dent, V4, P89
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hasegawa H, 2003, J CERAM SOC JPN, V111, P252, DOI 10.2109/jcersj.111.252
   Katagiri G, 1988, ADV CERAM, V24, P537
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Kosmac T, 2004, KEY ENG MAT, V254-2, P683, DOI 10.4028/www.scientific.net/KEM.254-256.683
   KOSMAC T, 1981, J AM CERAM SOC, V64, pC72
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MIYAZAKI T, 2007, DENTISTRY JAPAN, V43, P189
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Pezzotti G, 2003, J BIOMED MATER RES A, V65A, P229, DOI 10.1002/jbm.a.10447
   Pezzotti G, 1999, J RAMAN SPECTROSC, V30, P867
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REED JS, 1977, MATER RES BULL, V12, P949, DOI 10.1016/0025-5408(77)90017-4
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   Studart AR, 2007, BIOMATERIALS, V28, P2695, DOI 10.1016/j.biomaterials.2006.12.033
   SWAIN MV, 1980, J MATER SCI, V15, P1577, DOI 10.1007/BF00752140
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Yamada K, 2007, KEY ENG MATER, V330-332, P373, DOI 10.4028/www.scientific.net/KEM.330-332.373
   Yu MQ, 2003, KEY ENG MAT, V249, P167, DOI 10.4028/www.scientific.net/KEM.249.167
   VITA VM9 WORKING INS
NR 31
TC 124
Z9 132
U1 0
U2 23
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KAMAGOME TS BDG, KOMAGONE, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD MAY
PY 2008
VL 27
IS 3
BP 408
EP 414
DI 10.4012/dmj.27.408
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 330XV
UT WOS:000257977000011
PM 18717169
OA Bronze
DA 2018-10-19
ER

PT J
AU Jakubowicz, J
AF Jakubowicz, J.
TI Formation of porous TiOx biomaterials in H3PO4 electrolytes
SO ELECTROCHEMISTRY COMMUNICATIONS
LA English
DT Article
DE titanium oxide; biomaterials; atomic force microscopy; corrosion;
   etching
ID NANOTUBES; ALLOYS
AB In this work, formation of porous TiOx layers and theirs corrosion behavior were studied. Application of H3PO4 electrolytes results in porous TiOx formation. The process is enhanced by small amount of HF content in the electrolyte. The HF results in higher current density, enhancing dissolution. Small 0.5% HF concentration results in nanopores formation, with pore diameter of about 45 nm. Increase of HF concentration up to 10% results in pores with average diameter of about 5.2 mu m. An increase of etching time results in larger pore diameter, but between large 2-5 mu m diameter pores smallest ones were observed with diameter below 200 nm. In the initial etching process a remnants of the flat surface are presents with initial cracks in the surface, indicating places for growth of the pores.
   The TiOx layers can be used as a biomaterial. The corrosion behavior of the layer investigated in Ringer's solution, revealed an excellent corrosion resistance, with respect to pure Ti. (C) 2008 Elsevier B.V. All rights reserved.
C1 Poznan Tech Univ, Inst Mat Sci & Engn, PL-60965 Poznan, Poland.
RP Jakubowicz, J (reprint author), Poznan Tech Univ, Inst Mat Sci & Engn, M Sklodowska Curie 5 Sq, PL-60965 Poznan, Poland.
EM jaroslawjakubowicz@put.poznan.pl
RI Jakubowicz, Jaroslaw/F-7836-2014
OI Jakubowicz, Jaroslaw/0000-0001-6339-0796
CR Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Brusatori MA, 2003, BIOSENS BIOELECTRON, V18, P1269, DOI 10.1016/S0956-5663(03)00079-4
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Macak JM, 2005, ELECTROCHIM ACTA, V50, P3679, DOI 10.1016/j.electacta.2005.01.014
   Munoz AG, 2007, ELECTROCHIM ACTA, V52, P4167, DOI 10.1016/j.electacta.2006.11.035
   Sgambato A, 2003, MAT SCI ENG C-BIO S, V23, P419, DOI 10.1016/S0928-4931(02)00314-4
   Tsuchiya H, 2005, ELECTROCHEM COMMUN, V7, P576, DOI 10.1016/j.elecom.2005.04.008
   Tsuchiya H, 2006, ELECTROCHIM ACTA, V52, P94, DOI 10.1016/j.electacta.2006.03.087
   Varghese OK, 2003, SENSOR ACTUAT B-CHEM, V93, P338, DOI 10.1016/S0925-4005(03)00222-3
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
NR 10
TC 33
Z9 35
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1388-2481
J9 ELECTROCHEM COMMUN
JI Electrochem. Commun.
PD MAY
PY 2008
VL 10
IS 5
BP 735
EP 739
DI 10.1016/j.elecom.2008.02.027
PG 5
WC Electrochemistry
SC Electrochemistry
GA 311BN
UT WOS:000256575100014
DA 2018-10-19
ER

PT J
AU Merle, M
   Lallemand, B
   Lim, A
   Gantois, G
AF Merle, M.
   Lallemand, B.
   Lim, A.
   Gantois, G.
TI Experimental and clinical evaluation of an absorbable biomaterial
   inducing an anti-adhesive barrier (Divide (R))
SO EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY
LA English
DT Article
ID OXIDIZED REGENERATED CELLULOSE; POTENTIAL MECHANISM; PREVENT ADHESIONS;
   INTERCEED; REDUCTION; MACROPHAGES; SURGERY
AB We evaluated the efficacy of a biomaterial composed of oxidised regenerated cellulose ( Divide) in decreasing the formation of peri-tendinous adhesions in an experimental and clinical study. The experimental study was carried out in 47 New Zealand white rabbits whose Achilles tendons were subjected to a crush injury. The left Achilles tendon served as a control, while the right tendon was wrapped in a sheet of Divide (R). Six weeks later the range of motion at the ankle was measured, the tendons were histologically analysed for peri-tendinous adhesions, the tendon sheath was examined using a scanning electron microscope for determining resorption of the biomaterial and the mechanical properties evaluated. The clinical study was performed on 22 patients; 16 requiring post-traumatic extensor tenolysis and six who underwent dorsal synovectomy for rheumatoid arthritis. A sheet of Divide (R) was placed either between the periosteum and the tendon or around the tendon in all patients. Total active motion and grip strength was evaluated in all patients pre-operatively and at regular intervals post-operatively. The experimental study showed that ankle range of motion was similar between the control and Divide (R) treated groups in two rabbits, better in the Divide (R) group in seven rabbits and better in the control group in two rabbits. The results were not statistically significant (P <= 0.262) since the numbers were quite low. Histological analysis showed that the treated tendon had a better gliding surface and minimal inflammation/reaction compared to the control group. Scanning electron microscopy on the 10th post-operative day revealed the formation of a new tendon sheath in the Divide (R) group. The mechanical properties of both the control and experimental Achilles tendon were similar and comparable to a human tendon. The clinical study demonstrated that Divide (R) was completely resorbed, perfectly biocompatible and non-allergenic. The mean T. A. M. improved from 159.4 degrees to 187.3 degrees (P <= 0.074) and grip strength from -26.7 kgF to 10.7 kgF on the 84th post-op day in the extensor tenolysis group ( 16 digits), while mean return of function to pre-operation level was achieved at 42nd post-operative day and grip strength increased from -3.4 kgF in the immediate, post-operative period to +5.7 kgF at the 84th day in the rheumatoid arthritis group.
C1 [Merle, M.; Lallemand, B.] Inst Europeen Main, F-54320 Maxeville Nancy, France.
   [Merle, M.; Lim, A.; Gantois, G.] Univ Henri Poincare, Inst Europeen Biomat & Microchirurg, F-54506 Vandoeuvre Les Nancy, France.
   [Lim, A.] Natl Univ Singapore, Natl Univ Hosp, Dept Orthopaed Surg, Yong Loo Lin Sch Med, Singapore 119074, Singapore.
RP Merle, M (reprint author), Inst Europeen Main, 13 Rue Blaise Pascal, F-54320 Maxeville Nancy, France.
EM mmerle@pt.lu
CR Diamond MP, 1997, AM J OBSTET GYNECOL, V177, P1320
   DIAMOND MP, 1991, J GYNECOL SURG, V7, P1, DOI 10.1089/gyn.1991.7.1
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   GELBERMAN RH, 1986, J ORTHOPAED RES, V4, P119, DOI 10.1002/jor.1100040116
   Hwang JM, 1999, BRIT J OPHTHALMOL, V83, P788, DOI 10.1136/bjo.83.7.788
   IKEDA K, 2002, J HAND SURG, V7, P11
   Loick J, 1997, Handchir Mikrochir Plast Chir, V29, P209
   MAINARD D, 1988, PROGR RECENT BIOMATE, P193
   MEISLIN RJ, 1990, J APPL BIOMATER, V1, P13, DOI 10.1002/jab.770010104
   Merle M, 1995, 6TH CONGRESS OF THE INTERNATIONAL FEDERATION OF SOCIETIES FOR SURGERY OF THE HAND (IFSSH), P1025
   MERLE M, 1997, HAND SURG CURRENT CO, P33
   Reddy S, 1997, AM J OBSTET GYNECOL, V177, P1315, DOI 10.1016/S0002-9378(97)70070-X
   SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3
   STANLEY JT, COMMUNICATION
   STICKLAND JW, 2000, J HAND SURG-AM, V25, P214
   TEMIZ A, 2007, INT ORTHOP      0309
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
NR 17
TC 7
Z9 7
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1633-8065
J9 EUR J ORTHOP SURG TR
JI Eur. J. Orthop. Surg. Traumatol.
PD MAY
PY 2008
VL 18
IS 4
BP 255
EP 263
DI 10.1007/s00590-008-0294-9
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 315FG
UT WOS:000256862900001
OA Other Gold
DA 2018-10-19
ER

PT J
AU Luo, YF
   Wang, YH
   Niu, XF
   Shang, JF
AF Luo, Yanfeng
   Wang, Yuanhang
   Niu, Xufeng
   Shang, Juanfang
TI Evaluation of the cytocompatibility of butanediamine- and RGDS-grafted
   poly(DL-lactic acid)
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE poly(DL-lactic acid); biomimetic material; butanediamine; RGDS;
   cytocompatibility
ID OSTEOBLAST ADHESION; SURFACE-CHEMISTRY; MEDIATED ADHESION;
   GENE-EXPRESSION; CELL-GROWTH; BONE-MATRIX; POLYMER; DIFFERENTIATION;
   BIOMATERIALS; HYALURONAN
AB Butanediamine-grafted polylactic acid (BDPLA) is a well-established poly(DL-lactic acid) (PDLLA) based biomaterial with pendant carboxyl groups and amino groups. It has been proved out that BDPLA possesses highly improved hydrophilicity and reduced acidity of degrading products compared with PDLLA. RGDS-PLA is a BDPLA-based biomimetic material obtained by covalently incorporating RGDS adhesion peptide. The objective of this study was to evaluate the cytocompatibility of BDPLA and RGDS-PLA with PDLLA as control. Rat calvarial osteoblasts (ROBs) were seeded on various polymer films, and the morphology, adhesion and spreading, and viability and proliferation of ROBs were assessed by scanning electronic microscopy (SEM), micropipette aspiration system and methylthiazolyl tetrazolium assay (MTT assay), respectively. ALP activity and extracellular calcium production were exploited to characterize the differentiation of ROBs on various polymer films. The affecting mechanisms of BDPLA and RGDS-PLA on the cytocompatibility were extensively explained. The results revealed that the introduction of butanediamine to PDLLA is obviously beneficial to the adhesion, spreading, growth and differentiation of ROB, and the introduction of RGDS adhesive peptide can further improve the cytocompatibility of PDLLA. These results suggest that, in terms of cytocompatibility, BDPLA and RGDS-PLA are promising biomaterials for tissue engineering and other biomedical applications, and RGDS-PLA is a better one. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Luo, Yanfeng; Wang, Yuanhang; Niu, Xufeng; Shang, Juanfang] Chongqing Univ, Res Ctr Bioinspired Mat Sci & Engn, Dept Bioengn, Chongqing 400030, Peoples R China.
   [Niu, Xufeng] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
RP Luo, YF (reprint author), Chongqing Univ, Res Ctr Bioinspired Mat Sci & Engn, Dept Bioengn, Chongqing 400030, Peoples R China.
EM yfluo@cqu.edu.cn
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   BOHNER M, 2002, J BIOMAT SCI-POLYM E, V13, P732
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   CURTIS A, 1987, J CELL SCI, V87, P609
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Igarashi M, 2004, J MOL HISTOL, V35, P3
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594
   Kim H, 2003, J BONE MINER METAB, V21, P311, DOI 10.1007/s00774-003-0426-6
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Luo YF, 2007, EUR POLYM J, V43, P3856, DOI 10.1016/j.eurpolymj.2007.06.022
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   NEBE B, 2007, BIOMOL ENG, DOI DOI 10.1016/J.BIOENG.2007.07.004
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Niu XF, 2005, CHINESE CHEM LETT, V16, P1035
   NIU XF, 2005, J MATER SCI TECHNOL, V20, P571
   Perinpanayagam H, 2006, ARCH ORAL BIOL, V51, P406, DOI 10.1016/j.archoralbio.2005.09.004
   Ponec M, 2002, ADV DRUG DELIVER REV, V54, pS19, DOI 10.1016/S0169-409X(02)00112-6
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Salih V, 2001, BIOMATERIALS, V22, P2817, DOI 10.1016/S0142-9612(01)00026-6
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Taguchi K, 1988, MACROMOLECULES, V21, P3338
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 51
TC 18
Z9 23
U1 2
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAY
PY 2008
VL 44
IS 5
BP 1390
EP 1402
DI 10.1016/j.eurpolymj.2008.01.043
PG 13
WC Polymer Science
SC Polymer Science
GA 306MR
UT WOS:000256253000012
DA 2018-10-19
ER

PT J
AU Bordenave, L
   Menu, P
   Baquey, C
AF Bordenave, Laurence
   Menu, Patrick
   Baquey, Charles
TI Developments towards tissue-engineered, small-diameter arterial
   substitutes
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; bioreactor; endothelial cell; scaffold; small-diameter
   vascular substitution; stem cell; vascular graft; vascular tissue
   engineering
ID KNEE FEMOROPOPLITEAL BYPASS; EMBRYONIC STEM-CELLS; VASCULAR GRAFTS;
   IN-VITRO; ENDOTHELIAL-CELLS; BLOOD-VESSELS; PROGENITOR CELLS;
   SHEAR-STRESS; MECHANICAL-PROPERTIES; CLINICAL-EXPERIENCE
AB This article reviews the present state of small-diameter vascular substitution, the mechanisms of graft failure and the ongoing matters of graft design, with particular attention to small-caliber grafts. Tissue engineering of blood vessels with the mechanical properties of native vessels and with the antithrombotic properties required is really a great challenge. Recent advances, however, indicate that the goal of providing a tissue-engineered vascular graft that will remain patent in vivo for substantial periods of time, is achievable. This review describes the specific requirements of the successful replacement artery from a biomaterial- and tissue-engineering perspective, as well as various approaches in vascular tissue engineering including cells and cell sources, scaffolds and their improvements as well as bioreactors and signaling.
C1 [Bordenave, Laurence] Univ Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
   [Bordenave, Laurence] CHU Bordeaux, F-33604 Pessac, France.
   [Bordenave, Laurence] INSERM, CIC IT 802, Bordeaux, France.
   [Menu, Patrick] Nancy Univ, UMR 7563, F-54505 Vandoeuvre Les Nancy, France.
RP Bordenave, L (reprint author), Univ Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
EM laurence.bordenave@u-bordeaux2.fr; patrick.menu@medecine.uhp-nancy.fr;
   charles.baquey@bordeaux.inserm.fr
CR Abbott W M, 1995, Semin Vasc Surg, V8, P236
   Abbott WM, 1997, J VASC SURG, V25, P19, DOI 10.1016/S0741-5214(97)70317-3
   ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Adham M, 1996, J SURG RES, V64, P32, DOI 10.1006/jsre.1996.0302
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   BAQUEY C, 1989, C INSERM, P177
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   BOCK AK, 2003, 21000 JRCIPTS EUR EN
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campbell JH, 1999, CIRC RES, V85, P1173
   CHIEN S, 2005, J PHYSL HEART CIRC P, V292, pH1209
   Conte MS, 1998, FASEB J, V12, P43
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Farber A, 2003, J VASC SURG, V38, P15, DOI 10.1016/S0741-5214(03)00330-6
   Fernandez P, 2006, TISSUE ENG, V12, P1, DOI 10.1089/ten.2006.12.1
   Fernandez P, 2005, BIOMATERIALS, V26, P5042, DOI 10.1016/j.biomaterials.2005.01.011
   Fernandez P, 2007, TISSUE ENG, V13, P1607, DOI 10.1089/ten.2006.0399
   Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201
   Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012
   FOSTER ED, 1989, CIRCULATION, V79, P34
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726
   Harris DT, 2007, EXPERT OPIN BIOL TH, V7, P1311, DOI 10.1517/14712598.7.9.1311
   HERRING M, 1985, J VASC SURG, V2, P727, DOI 10.1067/mva.1985.avs0020727
   HERRING M, 1978, SURGERY, V84, P498
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   HONGDEWU MH, 1995, J VASC SURG, V21, P862
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kashyap Vikram S, 2002, Vasc Endovascular Surg, V36, P255
   Kerdjoudj H, 2007, CLIN HEMORHEOL MICRO, V37, P89
   Kerdjoudj H, 2007, ADV FUNCT MATER, V17, P2667, DOI 10.1002/adfm.200600795
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Levenberg S, 2005, CURR OPIN BIOTECH, V16, P516, DOI 10.1016/j.copbio.2005.08.007
   Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marois Y, 1999, ANN VASC SURG, V13, P130, DOI 10.1007/s100169900231
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Moby V, 2007, BIOMACROMOLECULES, V8, P2156, DOI 10.1021/bm070348n
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Naito Y, 2003, J THORAC CARDIOV SUR, V125, P419, DOI 10.1067/mtc.2003.134
   NEREM RM, 1984, BIORHEOLOGY, V21, P565
   NIKLASON LE, 1985, SURGERY, V98, P816
   Opitz F, 2007, TISSUE ENG, V13, P2505, DOI 10.1089/ten.2006.0424
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Quinones-Baldrich W J, 1991, Ann Vasc Surg, V5, P163, DOI 10.1007/BF02016750
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   ROBERTS PN, 1977, BRIT MED J, V2, P1190, DOI 10.1136/bmj.2.6096.1190-a
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Sales KM, 2005, TRENDS BIOTECHNOL, V23, P461, DOI 10.1016/j.tibtech.2005.06.006
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Song YC, 2000, NAT BIOTECHNOL, V18, P296
   SPARKS CH, 1972, AM J SURG, V124, P244, DOI 10.1016/0002-9610(72)90021-9
   Stanke F, 1998, J VASC SURG, V28, P273, DOI 10.1016/S0741-5214(98)70163-6
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Tiaw KS, 2007, BIOMACROMOLECULES, V8, P807, DOI 10.1021/bm060832a
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Trommelmans L, 2007, TISSUE ENG, V13, P667, DOI 10.1089/ten.2006.0089
   Vacanti JP, 2007, TISSUE ENG, V13, P231, DOI 10.1089/ten.2006.0351
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WILSON GJ, 1983, T AM SOC ART INT ORG, V29, P260
   Wusteman M. C., 2000, Cell and Tissue Banking, V1, P295, DOI 10.1023/A:1010167604609
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yow KH, 2006, BRIT J SURG, V93, P652, DOI 10.1002/bjs.5343
NR 102
TC 44
Z9 49
U1 0
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAY
PY 2008
VL 5
IS 3
BP 337
EP 347
DI 10.1586/17434440-5.3-337
PG 11
WC Engineering, Biomedical
SC Engineering
GA 343FB
UT WOS:000258837200018
PM 18452384
DA 2018-10-19
ER

PT J
AU Santin, M
   Ambrosio, L
AF Santin, Matteo
   Ambrosio, Luigi
TI Soybean-based biornaterials: preparation, properties and tissue
   regeneration potential
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biodegradable biomaterial; bone filler; isoflavone; soybean; wound
   dressing
ID HEPATOCYTE GROWTH-FACTOR; BONE FILLERS; GLYCINE-MAX; GENISTEIN; CELLS;
   DIFFERENTIATION; EXTRACTION; EXPRESSION; INHIBITOR; VARIETIES
AB Future successes in regenerative medicine will depend on the development of new biodegradable biomaterials able to control tissue regeneration in vitro and in vivo. None of the products currently available to surgeons can combine all the essential characteristics for biodegradable biomaterials, which are tunable degradation rate, controlled inflammatory reaction, no toxicity and stimulation of tissue regeneration. These clinical features should be provided, together with ease of handling during surgery and cost-effective production. Here, an overview is presented of a novel class of soybean-based biomaterials, which can be manufactured as different hydrogel formulations, all tailored for specific clinical applications. In vitro and in vivo studies have ascertained their activity on various biochemical and cellular components of regenerating tissues. Beyond their use, the ascertained bioactivity of some of the soybean components may open new investigations and commercial routes in regenerative medicine.
C1 [Santin, Matteo] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Ambrosio, Luigi] Inst Composite & Biomed Mat IMCB CNR, I-80130 Naples, Italy.
RP Santin, M (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Cockcroft Bldg Lewes Rd, Brighton BN2 4GJ, E Sussex, England.
EM m.santin@brighton.ac.uk; ambrosio@unina.it
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   Brynin Rona, 2002, Altern Med Rev, V7, P317
   Deak NA, 2007, J AM OIL CHEM SOC, V84, P137, DOI 10.1007/s11746-006-1017-1
   Demirbas A, 2007, INT J GREEN ENERGY, V4, P15, DOI 10.1080/15435070601015395
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   FINI M, 2007, P 21 EUR SOC BIOM C
   Fiorellini JP, 2007, INT J PERIODONT REST, V27, P287
   Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176
   Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hollung K, 2005, J AGR FOOD CHEM, V53, P9112, DOI 10.1021/jf051438r
   Hwang K, 2001, J HISTOTECHNOL, V24, P95
   ILLSLEY MS, 2007, P 21 EUR SOC BIOM C
   Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8
   Kanellakis P, 2004, ATHEROSCLEROSIS, V176, P63, DOI 10.1016/j.atherosclerosis.2004.05.003
   KESANI AK, 2007, ORTHOPAEDICS REL RES, V464, P210
   Klein SL, 2002, MOL MED, V8, P742, DOI 10.1007/BF03402038
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lee JH, 2006, FOOD SCI BIOTECHNOL, V15, P392
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   LHORCINE L, 2007, CRIT REV FOOD SCI NU, V47, P127
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P1858, DOI 10.1021/bm070157k
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   *MED HEALTHC PROD, 2004, MDA2004047 MED HEALT
   *MED HEALTHC PROD, 1999, AN199901 MED HEALTHC
   *MED HEALTHC PROD, 2000, 200005 HN MED HEALTH
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Mo XQ, 2006, J AGR FOOD CHEM, V54, P7589, DOI 10.1021/jf060780g
   Morris C, 2006, J NUTR, V136, P1166
   Newman SA, 2003, J PERIODONTOL, V74, P1191, DOI 10.1902/jop.2003.74.8.1191
   Ni YW, 2007, PLANTA MED, V73, P1260, DOI 10.1055/s-2007-990225
   Nodar MD, 2002, FOOD SCI TECHNOL INT, V8, P337, DOI 10.1106/108201302031651
   Okada M, 2000, J HYPERTENS, V18, P1825, DOI 10.1097/00004872-200018120-00017
   Pandjaitan N, 2000, J FOOD SCI, V65, P399, DOI 10.1111/j.1365-2621.2000.tb16015.x
   Pesic MB, 2007, SENSORS-BASEL, V7, P67, DOI 10.3390/s7010067
   Ramirez-Suarez JC, 2003, MEAT SCI, V65, P899, DOI 10.1016/S0309-1740(02)00297-8
   Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539
   SANTIN M, 2005, P 19 EUR C BIOM SORR
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Schmidt V, 2005, POLYM DEGRAD STABIL, V87, P25, DOI 10.1016/j.polymdegradstab.2004.07.003
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Smith PC, 2004, J PERIODONTAL RES, V39, P380, DOI 10.1111/j.1600-0765.2004.00753.x
   STANDEN G, 2005, P 19 EUR SOC BIOM C
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Vignes JR, 2007, J CRANIO MAXILL SURG, V35, P185, DOI 10.1016/j.jcms.2007.04.002
   World Health Organization, GLOB STRAT DIET PHYS
   Zhang EJ, 2007, J AGR FOOD CHEM, V55, P6940, DOI 10.1021/jf0708903
   Zhang LX, 2002, AGRON J, V94, P1163, DOI 10.2134/agronj2002.1163
NR 50
TC 33
Z9 37
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAY
PY 2008
VL 5
IS 3
BP 349
EP 358
DI 10.1586/17434440.5.3.349
PG 10
WC Engineering, Biomedical
SC Engineering
GA 343FB
UT WOS:000258837200019
PM 18452385
DA 2018-10-19
ER

PT J
AU Wei, N
   Wang, M
   Lin, Y
   Gong, P
   Yao, YY
   Li, XY
   Lin, YH
   Wu, DC
   Man, Y
AF Wei, Na
   Wang, Min
   Lin, Yi
   Gong, Ping
   Yao, Yong-Yi
   Li, Xiao-Yu
   Lin, Yin-He
   Wu, Da-Cheng
   Man, Yi
TI Cyto-compatibility of polyethersulphone nanofibres prepared by
   gas-jet/electrospinning
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE electrospinning; polyethersulphone; gas-jet; cyto-compatibility;
   nanofibres
ID NORMAL HUMAN KERATINOCYTES; HOLLOW-FIBER MEMBRANES; SMOOTH-MUSCLE-CELL;
   IN-VITRO; SCAFFOLDS; COLLAGEN; HEMODIALYSIS; FIBROBLASTS; ADHESION;
   MATRIX
AB Polymeric nanofibres that mimic the structure and function of the natural extracellular matrix (ECM) are produced by electrospinning and have attracted great interests in biomedical applications in the last several years. Electrospinning is an efficient process whereby polymeric nanofibres are formed in a high-voltage electrostatic field. Compared to the conventional electrospinning, the gas-jet/electrospinning method can generate thinner and more uniform nanofibres with higher efficiency. Recently, polyethersulphone (PES) has drawn significant attention as a commercially available material with unique properties, which make it extremely suitable for fabrication of some biomedical materials. In this paper, the cyto-compatibility of a novel nanofibrous scaffold made of PIES was examined by culturing human umbilical vein endothelial cells and rat osteoblasts. This scaffold was prepared by gas-jet/electrospinning and was made up of ultrafine fibres with the average diameter 126 nm and well-interconnected pores. Cell attachment and proliferation and cell-matrix interaction were assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) analysis, Vi CELL automated cell counter and scanning electron microscopy (SEM) imaging. The results of cell behaviour on the nanofibrous structure showed that both ECV-304 endothelial cells and osteoblasts adhered and proliferated well on the PIES nanofibrous matrix. In addition, the cells maintained a normal phenotypic shape on the nanofibres. This may result from the cyto-compatibility of PES and the three-dimensional structure of electrospun nanofibres. Overall, these results strongly support the cyto-compatibility of the gas-jet/electrospun PES nanofibrous structure and suggest potential uses of this biomaterial matrix as scaffolds for biomedical applications.
C1 [Wei, Na; Wang, Min; Gong, Ping; Lin, Yin-He; Man, Yi] Sichuan Univ, W China Coll Stomatol, Chengdu 610064, Peoples R China.
   [Lin, Yi; Yao, Yong-Yi; Wu, Da-Cheng] Sichuan Univ, Textile Coll, Chengdu 610065, Peoples R China.
   [Li, Xiao-Yu] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Gong, P (reprint author), Sichuan Univ, W China Coll Stomatol, Chengdu 610064, Peoples R China.
EM gp602002@163.com
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   David S, 2003, CONTRIB NEPHROL, V138, P43
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Jalili R, 2005, IRAN POLYM J, V14, P1074
   Khulbe KC, 2000, J MEMBRANE SCI, V167, P263, DOI 10.1016/S0376-7388(99)00296-3
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Locatelli F, 2003, CONTRIB NEPHROL, V138, P55
   Long L, 2006, J BIOMED MATER RES B, V78B, P409, DOI 10.1002/jbm.b.30502
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Moce-Llivina L, 2003, J VIROL METHODS, V109, P99, DOI 10.1016/S0166-0934(03)00046-6
   Mohammadi Y, 2007, IRAN POLYM J, V16, P57
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   PAUL D, 2002, TRIVANDRUM RES SIGNP, P179
   SOURIRAJAN S, 1985, 24188 NAT RES COUNC
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   WAN JL, 2006, ACTA BIOMATER, V2, P377
   Wan YQ, 2006, IRAN POLYM J, V15, P265
   YAO YY, 2005, ACTA POLYM SIN, V5, P687
   ZHONG S, 2006, MATER SCI ENG, V27, P262
   ZHU DD, 2005, J YUNNAN U, V27, P231
NR 34
TC 5
Z9 5
U1 0
U2 2
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD MAY
PY 2008
VL 17
IS 5
BP 333
EP 343
PG 11
WC Polymer Science
SC Polymer Science
GA 312RZ
UT WOS:000256689800003
DA 2018-10-19
ER

PT J
AU Koc, A
   Emin, N
   Elcin, AE
   Elcin, YM
AF Koc, Aysel
   Emin, Nuray
   Elcin, A. Eser
   Elcin, Y. Murat
TI In vitro osteogenic differentiation of rat mesenchymal stem cells in a
   microgravity bioreactor
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE bone tissue engineering; mesencyhmal stem cells; stroma; MSCs; PLGA;
   mineralization; osteogenic differentiation; microgravity bioreactor
ID PERIODONTAL-LIGAMENT FIBROBLASTS; MARROW STROMAL CELLS; BONE-MARROW;
   EXTRACELLULAR-MATRIX; BIOMIMETIC PROCESS; PERFUSION CULTURE;
   GENE-EXPRESSION; SCAFFOLDS; PROLIFERATION; MICROSPHERES
AB Mesenchymal stem cells (MSCs) are multipotent progenitor cells with the ability to differentiate into osteoblasts, chondroblasts, myocytes, and adipocytes. They have potential for bone tissue engineering by the utilization of in vitro expanded cells with osteogenic capacity and their delivery to the appropriate sites via biomaterial scaffolds. The objective was to evaluate the potential of rat bone marrow MSCs to form 3D bone-like tissue by the use of mineralized poly(DL-lactic-co-glycolic acid) (PLGA) foam and osteoinductive medium under rotating culture conditions. PLGA foams were prepared by solvent casting and particulate leaching, then mineralized by incubating in simulated body fluid. MSCs isolated from the bone marrow of young Wistar rats were expanded and seeded on the mineralized scaffolds. The cell-polymer constructs were then cultured in a slow turning lateral vessel-type rotating bioreactor for 4 weeks under the effect of osteogenic inducers, P-glycerophosphate, ascorbic acid and dexamethasone. Mineralization was evaluated using FT-IR and increases in dry mass; morphology changes of the mineralized foams and cell adhesion was characterized by SEM; cell viability was monitored by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). Osteogenic differentiation was determined by using immunohistochemistry (anti-osteopontin). Results indicate the feasibility of bone tissue engineering with MSCs and mineralized PLGA scaffolds supporting cell adhesion, viability and osteogenic differentiation properties of cells in hybrid structures under appropriate bioreactor conditions.
C1 [Koc, Aysel; Emin, Nuray; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
   [Koc, Aysel; Emin, Nuray; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Inst Biotechnol, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
   [Elcin, A. Eser] Gazi Univ, GEF, Div Biol Educ, TR-06100 Ankara, Turkey.
RP Elcin, YM (reprint author), Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
EM elcin@science.ankara.edu.tr
RI Koc Demir, Aysel/G-7889-2016; Emin, Nuray/H-1546-2017
OI Emin, Nuray/0000-0002-0859-2536; Elcin, Yasar Murat/0000-0003-1037-0825
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   BURG KJL, 2000, J BIOMED MATER RES, V51, P562
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Carmeliet G, 1999, FASEB J, V13, pS129
   Chaubey A, 2008, J BIOACT COMPAT POL, V23, P20, DOI 10.1177/0883911507085534
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591
   Conconi MT, 2006, TISSUE ENG, V12, P811, DOI 10.1089/ten.2006.12.811
   Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dominici M, 2001, J BIOL REG HOMEOS AG, V15, P28
   Elcin YM, 2003, TISSUE ENG, V9, P1047, DOI 10.1089/107632703322495682
   ELCIN YM, 2003, TISSUE ENG STEM CELL, V534
   *FDA, 1997, DIV GEN REST DEV CAL
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P1387, DOI 10.1016/j.biomaterials.2005.08.017
   Inanc B, 2006, TISSUE ENG, V12, P257, DOI 10.1089/ten.2006.12.257
   Inanc B, 2007, J BIOMED MATER RES A, V82A, P917, DOI 10.1002/jbm.a.31213
   Jiao YP, 2007, J BIOACT COMPAT POL, V22, P492, DOI 10.1177/0883911507082161
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2007, J BIOACT COMPAT POL, V22, P89, DOI 10.1177/0883911506073363
   Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Merzlikina N. V., 2004, J GRAVIT PHYSL, V11, P193
   Odgren P.R., 2002, PRINCIPLES BONE BIOL, P3
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164
   Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120
   Sibonga JD, 2000, BONE, V27, P535, DOI 10.1016/S8756-3282(00)00352-5
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 42
TC 22
Z9 24
U1 0
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2008
VL 23
IS 3
BP 244
EP 261
DI 10.1177/0883911508091828
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 299UQ
UT WOS:000255780900003
DA 2018-10-19
ER

PT J
AU Maus, U
   Andereya, S
   Gravius, S
   Ohnsorge, JAK
   Niedhart, C
AF Maus, Uwe
   Andereya, Stefan
   Gravius, Sascha
   Ohnsorge, Joerg A. K.
   Niedhart, Christopher
TI BMP-2 incorporated in a tricalcium phosphate bone substitute enhances
   bone remodeling in sheep
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE BMP-2; bone substitute; TCP; calcium phosphate; osteogenesis;
   osteoinduction; osseous defect
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; NORIAN SRS;
   HISTOLOGICAL-EVALUATION; BIOMATERIAL CARRIERS; GRAFT SUBSTITUTES;
   CALCIUM; CEMENT; DEFECTS; RHBMP-2
AB Bone morphogenetic protein-2 (BMP-2) is a well-known osteoinductive protein, which requires a carrier for local application. As an alternative to the previously described carriers, an in situ hardening, resorbable, and osteoconductive beta-tricalcium phosphate cement (TCP) is tested. Trepanation defects in the bovine distal femoral epiphysis are filled with a composite consisting of TCP and 200 mu g rhBMP-2 per cm(3) TCP, autologous bone graft, pure TCP, or left empty. A radiological follow-up is performed after 7 weeks and 3 months. The sheep are euthanized and bone samples are analyzed by microradiography, histology, and histomorphometry. Microradiography and histology show similar results for pure TCP and the composite. The defects are filled with trabecular bone and newly formed bone is in close contact with the remaining TCP-particles. The majority of the cement is resorbed, in the composite group the amount of remaining cement particles is reduced. Defects treated with autologous bone graft are filled completely, while untreated defects shows only a small amount of bone originating from the rim of the defect. Histomorphometry of the defects treated with pure TCP shows a significantly increased bone content in comparison to defects treated with the composite or autologous bone graft. Analysis of the remaining cement particles shows significantly less cement in the TCP/rhBMP-2 group in comparison to pure TCP. The sum of bone and cement content in the rhBMP-2 group shows amounts comparable to the calcified structures found following autologous bone grafting. The addition of rhBMP-2 to the TCP leads to faster remodeling of the defect comparable to autologous bone graft, while defects treated with pure TCP are not completely remodeled.
C1 [Maus, Uwe; Andereya, Stefan; Gravius, Sascha; Ohnsorge, Joerg A. K.; Niedhart, Christopher] Univ Aachen, Dept Orthoped Surg, D-52074 Aachen, Germany.
RP Maus, U (reprint author), Univ Aachen, Dept Orthoped Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM umaus@ukaachen.de
CR AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Allegrini S, 2004, J BIOMED MATER RES B, V68B, P127, DOI 10.1002/jbm.b.20006
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   BROWN CE, 1987, CEMENTS RES PROGR 19, P352
   Cassidy C, 2003, J BONE JOINT SURG AM, V85A, P2127, DOI 10.2106/00004623-200311000-00010
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GOULET A, 1997, CLIN ORTHOP RELAT R, V339, P76
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   ISHKAWA K, 1995, J MATL SCI MATL MED, V6, P528
   Jubel A, 2004, ORTHOPADE, V33, P919, DOI 10.1007/s00132-004-0664-x
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Manjubala I, 2005, J BIOMATER APPL, V19, P341, DOI 10.1177/0885328205048633
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Niedhart C, 2004, J BIOMED MATER RES B, V71B, P123, DOI 10.1002/jbm.b.30071
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Ohyama T, 2004, NEUROL MED-CHIR, V44, P234, DOI 10.2176/nmc.44.234
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Parikh SN, 2002, ORTHOPEDICS, V25, P1301
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   Tomford William W., 2000, Cell and Tissue Banking, V1, P105, DOI 10.1023/A:1010158731885
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Weibrich G, 1999, Mund Kiefer Gesichtschir, V3, P92, DOI 10.1007/s100060050103
   Welkerling H, 2003, J BONE JOINT SURG BR, V85B, P238, DOI 10.1302/0301-620X.85B2.13255
   Wolff KD, 2004, J CRANIO MAXILL SURG, V32, P71, DOI 10.1016/S1010-5182(03)00134-3
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 44
TC 34
Z9 36
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2008
VL 22
IS 6
BP 559
EP 576
DI 10.1177/0885328207083311
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296VG
UT WOS:000255573300005
PM 18194994
DA 2018-10-19
ER

PT J
AU Ng, AMH
   Tan, KK
   Phang, MY
   Aziyati, O
   Tan, GH
   Isa, MR
   Aminuddin, BS
   Naseem, M
   Fauziah, O
   Ruszymah, BHI
AF Ng, Angela M. H.
   Tan, K. K.
   Phang, M. Y.
   Aziyati, O.
   Tan, G. H.
   Isa, M. R.
   Aminuddin, B. S.
   Naseem, M.
   Fauziah, O.
   Ruszymah, B. H. I.
TI Differential osteogenic activity of osteoprogenitor cells on HA and
   TCP/HA scaffold of tissue engineered bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; hydroxyapatite; tricalcium phosphate; fibrin;
   periosteum
ID CALCIUM-PHOSPHATE BIOCERAMICS; MESENCHYMAL STEM-CELLS; PHYSICOCHEMICAL
   CHARACTERIZATION; CERAMICS; HYDROXYAPATITE; REGENERATION; IMPLANTATION;
   SUBSTITUTES; POROSITY; SURFACE
AB Biomaterial, an essential component of tissue engineering, serves as a scaffold for cell attachment, proliferation, and differentiation; provides the three dimensional (313) structure and, in some applications, the mechanical strength required for the engineered tissue. Both synthetic and naturally occurring calcium phosphate based biomaterial have been used as bone fillers or bone extenders in orthopedic and reconstructive surgeries. This study aims to evaluate two popular calcium phosphate based biomaterial i.e., hydroxyapatite (HA) and tricalcium phosphate/hydroxyapatite (TCP/HA) granules as scaffold materials in bone tissue engineering. In our strategy for constructing tissue engineered bone, human osteoprogenitor cells derived from periosteum were incorporated with human plasma-derived fibrin and seeded onto HA or TCP/HA forming 3D tissue constructs and further maintained in osteogenic medium for 4 weeks to induce osteogenic differentiation. Constructs were subsequently implanted intramuscularly in nude mice for 8 weeks after which mice were euthanized and constructs harvested for evaluation. The differential cell response to the biomaterial (HA or TCP/HA) adopted as scaffold was illustrated by the histology of undecalcified constructs and evaluation using SEM and TEM. Both HA and TCP/HA constructs showed evidence of cell proliferation, calcium deposition, and collagen bundle formation albeit lesser in the former. Our findings demonstrated that TCP/HA is superior between the two in early bone formation and hence is the scaffold material of choice in bone tissue engineering. (C) 2007 Wiley Periodicals, Inc.
C1 [Ng, Angela M. H.; Ruszymah, B. H. I.] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
   [Ng, Angela M. H.; Ruszymah, B. H. I.] Hosp Univ Kebangsaan Malaysia, Tissue Engn Lab, Kuala Lumpur, Malaysia.
   [Tan, K. K.; Tan, G. H.] Univ Kebangsaan Malaysia, Fac Med, Dept Orthoped & Traumatol, Kuala Lumpur, Malaysia.
   [Phang, M. Y.; Aziyati, O.; Fauziah, O.] Univ Putra Malaysia, Microscopy Imaging & Nanosci Unit, Inst Biosci, Selangor, Malaysia.
   [Phang, M. Y.; Aziyati, O.; Fauziah, O.] Univ Putra Malaysia, Fac Med & Hlth Sci, Selangor, Malaysia.
   [Isa, M. R.] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.
   [Aminuddin, B. S.] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Kuala Lumpur, Malaysia.
   [Naseem, M.] Inst Med Res, Lab Anim Resource Unit, Kuala Lumpur 50588, Malaysia.
RP Ruszymah, BHI (reprint author), Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
EM ruszy@medic.ukm.my
RI Idrus, Ruszymah/F-1521-2010; Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR ANGELA MH, 2005, J ORTHO SCI, V10, P192
   ANGELA MH, 2005, P 8 ANN M TISS ENG S
   ANGELA MH, 2005, 4 MAL IND MED SCI C
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Culling C.F.A., 1974, HDB HISTOPATHOLOGICA
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ferrera D, 2002, BONE, V30, P718, DOI 10.1016/S8756-3282(02)00691-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   Hoshi K, 2000, CALCIFIED TISSUE INT, V66, P430, DOI 10.1007/s002230010087
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leng Y, 2003, BIOMATERIALS, V24, P2125, DOI 10.1016/S0142-9612(03)00036-X
   Livingston AT., 2005, BIOMATERIALS, V26, P3631
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   Phang M.Y., 2004, J MICROSC-OXFORD, V1, P73
   Tan K K, 2004, Med J Malaysia, V59 Suppl B, P43
   TEMENOFF JS, 2004, ORTHOPAEDIC TISSUE E, P77
NR 27
TC 44
Z9 44
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 301
EP 312
DI 10.1002/jbm.a.31324
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700003
PM 17688285
DA 2018-10-19
ER

PT J
AU Ricci, JL
   Grew, JC
   Alexander, H
AF Ricci, John L.
   Grew, John C.
   Alexander, Harold
TI Connective-tissue responses to defined biomaterial surfaces. I. Growth
   of rat fibroblast and bone marrow cell colonies on microgrooved
   substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE microgroove; in vitro; cell-surface interactions; fibroblasts; bone
   marrow
ID OSTEOBLAST-LIKE CELLS; TITANIUM IMPLANT MATERIALS; TOTAL JOINT
   ARTHROPLASTY; HUMAN-ENDOTHELIAL CELLS; LACTIC ACID IMPLANTS; GROOVED
   SUBSTRATA; EPITHELIAL TISSUE; MICROSCOPIC OBSERVATION; MICROTEXTURED
   SURFACES; TOPOGRAPHICAL CONTROL
AB Surface microgeometry plays a role in tissue-implant surface interactions, but our understanding of its effects is incomplete. Substrate microgrooves strongly influence cells in vitro, as evidenced by contact guidance and cell alignment. We studied "dot" colonies of primary fibroblasts and bone marrow cells that were grown on titanium-coated, microgrooved polystyrene surfaces that we designed and produced. Rat tendon fibroblast and rat bone marrow colony growth and migration varied (p < 0.01) by microgroove dimension and slightly by cell type. We observed profoundly altered morphologies, reduced growth rates, and directional growth in colonies grown on microgrooved substrates, when compared with colonies grown on flat, control surfaces (p < 0.01). The cells in our colonies grown on microgrooved surfaces were well aligned and elongated in the direction parallel to the grooves and colonies. Our "dot" colony is an easily reproduced, easily measured and artificial explant model of tissue-implant interactions that better approximates in vivo implant responses than culturing isolated cells on biomaterials. Our results correlate well with in vivo studies of titanium dioxide-coated polystyrene, titanium, and titanium alloy implants with controlled microgeometries. Microgrooves and other surface features appear to directionally or spatially organize cells and matrix molecules in ways that contribute to improved stabilization and osseointegration of implants. (C) 2007 Wiley Periodicals, Inc.
C1 [Grew, John C.] New Jersey City Univ, Dept Biol, Jersey City, NJ 07305 USA.
   [Ricci, John L.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10003 USA.
   [Alexander, Harold] Orthogen Corp, Springfield, NJ 07081 USA.
RP Grew, JC (reprint author), New Jersey City Univ, Dept Biol, 2039 Kennedy Blvd, Jersey City, NJ 07305 USA.
EM jGrew@NJCU.edu
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   Albrektsson Tomas, 2005, J Can Dent Assoc, V71, P327
   ALEXANDER H, 2007, J BIOMED MAT  B 0423
   ALHABBAB R, 2005, T SOC BIOMATER, V28, P123
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cameron HU, 1997, CAN J SURG, V40, P278
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B., 1995, P813
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   Evans MDM, 2005, BIOMATERIALS, V26, P1703, DOI 10.1016/j.biomaterials.2004.05.023
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   FRENKEL SR, 1998, T SOC BIOMATER, V21, P66
   FRENKEL SR, 1999, T ORTHOP RES SOC, V22, P891
   Gemmell CH, 2000, BONE ENG, P108
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Goessl A, 2001, J BIOMED MATER RES, V57, P15, DOI 10.1002/1097-4636(200110)57:1<15::AID-JBM1136>3.0.CO;2-N
   GREW JC, IN PRESS J BIOMED MA
   GREW JC, 1998, T SOC BIOMATER, V21, P40
   GREW JC, 1997, T SOC BIOMATER, V20, P32
   HADDAD RJ, 1987, J BONE JOINT SURG AM, V69A, P1459
   Healy K E, 1991, ASAIO Trans, V37, pM150
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HONG HL, 1987, J CELL SCI, V87, P259
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Millenium Research Group, 2003, IMPLANT DENT, V12, P108
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   *NAT CTR HLTH STAT, 2003, NUMB RAT SURG NONS P
   Ozawa N, 2002, J BIOMED MATER RES, V62, P579, DOI 10.1002/jbm.10281
   Parker JATC, 2003, TISSUE ENG, V9, P117, DOI 10.1089/107632703762687591
   Parker JATC, 2002, J BIOMED MATER RES, V61, P91, DOI 10.1002/jbm.10170
   Parker JATC, 2002, BIOMATERIALS, V23, P3887, DOI 10.1016/S0142-9612(02)00134-5
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Ricci J, 2000, BONE ENG, P282
   RICCI JL, 1990, B HOSP JOINT DIS ORT, V50, P126
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   RICCI JL, 1991, J BIOMED MATER RES, V25, P651, DOI 10.1002/jbm.820250508
   RICCI JL, 1995, T SOC BIOMATER, V18, P115
   RICCI JL, 1992, TISSUE INDUCING BIOM, P221
   Ricci JL, 1994, SURFACE MODIFICATION, VVII, P491
   RICCI JL, 1996, T WORLD BIOMATER C, V6, P937
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Salvi GE, 2001, CRIT REV ORAL BIOL M, V12, P262, DOI 10.1177/10454411010120030501
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Sennerby L, 1998, INT J PROSTHODONT, V11, P408
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2
   Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.3.CO;2-E
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   Walboomers XF, 2005, J BIOMED MATER RES A, V74A, P381, DOI 10.1002/jbm.a.30337
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
   Walboomers XF, 2002, J BIOMED MATER RES, V60, P445, DOI 10.1002/jbm.1290
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037
   WEINER S, IN PRESS IMPLANT DEN
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 115
TC 36
Z9 36
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 313
EP 325
DI 10.1002/jbm.a.31379
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700004
PM 17688290
DA 2018-10-19
ER

PT J
AU Grew, JC
   Ricci, JL
   Alexander, H
AF Grew, John C.
   Ricci, John L.
   Alexander, Harold
TI Connective-tissue responses to defined biomaterial surfaces. II.
   Behavior of rat and mouse fibroblasts cultured on microgrooved
   substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE microgroove; in vitro; cell-surface interactions; fibroblasts;
   cytoskeleton
ID OSTEOBLAST-LIKE CELLS; CAPILLARY ENDOTHELIAL-CELLS; MESSENGER-RNA
   EXPRESSION; QUANTITATIVE-ANALYSIS; GROOVED SUBSTRATA; CYCLE PROGRESSION;
   CONTACT GUIDANCE; MICROSCOPIC OBSERVATION; DIFFERENT DIMENSIONS;
   TITANIUM SUBSTRATA
AB Surface microgeometry strongly influences the shapes, orientations, and growth characteristics of cultured cells, but in-depth, quantitative studies of these effects are lacking. We investigated several contact guidance effects in cells within "dot" colonies of primary fibroblasts and in cultures of a transformed fibroblast cell line, employing titanium-coated, microgrooved polystyrene surfaces that we designed and produced. The aspect ratios, orientations, densities, and attachment areas of rat tendon fibroblasts (RTF) colony cells, in most cases, varied (p < 0.01) by microgroove dimension. We observed profoundly altered cell morphologies, reduced attachment areas, and reduced cell densities within colonies grown on microgrooved substrates, compared with cells of colonies grown on flat, control surfaces. 3T3 fibroblasts cultured on microgrooved surfaces demonstrated similarly altered morphologies. Fluorescence microscopy revealed that microgrooves alter the distribution and assembly of cytoskeletal and attachment proteins within these cells. These findings are consistent with previous results, and taken together with the results of our in vivo and cell colony growth studies, enable us to propose a unified hypothesis of how microgrooves induce contact guidance. (C) 2007 Wiley Periodicals, Inc.
C1 [Grew, John C.] New Jersey City Univ, Dept Biol, Jersey City, NJ 07305 USA.
   [Ricci, John L.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10003 USA.
   [Alexander, Harold] Orthogen Corp, Springfield, NJ 07081 USA.
RP Grew, JC (reprint author), New Jersey City Univ, Dept Biol, 2039 Kennedy Blvd, Jersey City, NJ 07305 USA.
EM jGrew@NJCU.edu
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   ALEXANDER H, 2007, IN PRESS J BIOMED MA
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, NATURE, V392, P730
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Dike LE, 1996, J CELL SCI, V109, P2855
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DUNN GA, 1986, J CELL SCI, V83, P313
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   GREW JC, 1998, T SOC BIOMATER, V21, P40
   GREW JC, 1997, T SOC BIOMATER, V20, P32
   HONG HL, 1987, J CELL SCI, V87, P259
   Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   INGBER DE, 1986, ENDOCRINOLOGY, V119, P1768, DOI 10.1210/endo-119-4-1768
   Kato S, 2001, J BIOMED MATER RES, V54, P366, DOI 10.1002/1097-4636(20010305)54:3<366::AID-JBM80>3.3.CO;2-I
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Ricci J, 2000, BONE ENG, P282
   RICCI JL, 1990, B HOSP JOINT DIS ORT, V50, P126
   RICCI JL, 1995, T SOC BIOMATER, V18, P115
   Ricci JL, 1994, SURFACE MODIFICATION, VVII, P491
   RICCI JL, 1996, T WORLD BIOMATER C, P937
   RICCI JL, IN PRESS J BIOMED MA
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   SARBER R, 1981, MECH AGEING DEV, V17, P107, DOI 10.1016/0047-6374(81)90077-4
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEINER S, IN PRESS IMPLANT DEN
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 69
TC 27
Z9 28
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 326
EP 335
DI 10.1002/jbm.a.31378
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700005
PM 17688289
DA 2018-10-19
ER

PT J
AU Rousseau, M
   Boulzaguet, H
   Biagianti, J
   Duplat, D
   Milet, C
   Lopez, E
   Bedouet, L
AF Rousseau, Marthe
   Boulzaguet, Helene
   Biagianti, Julie
   Duplat, Denis
   Milet, Christian
   Lopez, Evelyne
   Bedouet, Laurent
TI Low molecular weight molecules of oyster nacre induce mineralization of
   the MC3T3-E1 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE MC3T3-E1 preosteoblast; mineralization; nacre; metabolites; osteopontin;
   Runx2
ID OSTEOBLASTS MAINTAINED INVITRO; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION;
   TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; PINCTADA-MAXIMA; ORGANIC
   MATRIX; BONE-FORMATION; IN-VIVO; DIFFERENTIATION
AB The nacre layer from the pearl oyster shell is considered as a promising osteoinductive biomaterial. Nacre contains one or more signal molecules capable of stimulating bone formation. The identity and the mode of action of these molecules on the osteoblast differentiation were analyzed. Water-soluble molecules from nacre were fractionated according to dialysis, solvent extraction, and reversed-phase HPLC. The activity of a fraction composed of low molecular weight molecules in the mineralization of the MC3T3-E1 extracellular matrix was investigated. Mineralization of the preosteoblast cells was monitored according to alizarin red staining, Raman spectroscopy, scanning electron microscopy, and quantitative RT-PCR. Molecules isolated from nacre, ranging from 50 to 235 Da, induced a red alizarin staining of the preosteoblasts extracellular matrix after 16 days of culture. Raman spectroscopy demonstrated the presence of hydroxyapatite (HA) in samples treated with these molecules. Scanning electron microscopy pictures showed at the surface of the treated cells the occurrence of clusters of spherical particles resembling to HA. The treatment of cells with nacre molecules accelerated expression of collagen I and increased the mRNA expression of Runx2 and osteopontin. This study indicated that the nacre molecules efficient in bone cell differentiation are certainly different from proteins, and could be useful for in vivo bone repair. (C) 2007 Wiley Periodicals, Inc.
C1 [Rousseau, Marthe; Boulzaguet, Helene; Biagianti, Julie; Duplat, Denis; Milet, Christian; Lopez, Evelyne; Bedouet, Laurent] Museum Natl Hist Nat, CNRS MNHN Biol Organismes Marine & Ecosyst, ERT Valorisat Mol Bioact Origine Marine, Dept Milieux & Peuplements Aquat,UMR 5178, F-75231 Paris 05, France.
RP Rousseau, M (reprint author), Museum Natl Hist Nat, CNRS MNHN Biol Organismes Marine & Ecosyst, ERT Valorisat Mol Bioact Origine Marine, Dept Milieux & Peuplements Aquat,UMR 5178, CP 26,43 Rue Cuvier, F-75231 Paris 05, France.
EM rousseam@gmx.net
RI MNHN/CNRS/UPMC/IRD, UMR BOREA/B-2312-2012
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   CARIOLOU MA, 1988, J COMP PHYSIOL B, V157, P717, DOI 10.1007/BF00691002
   Carter EA, 2001, INFRARED RAMAN SPECT, P421
   Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200
   Javed A, 1999, MOL CELL BIOL, V19, P7491
   Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0180
   Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020
   Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 2004, ARGOS SPINE NEWS, V8, P32
   MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   PEREIRAMOURIES L, 2002, COMP BIOCH PHYSL, V132, P217
   Rousseau M, 2003, COMP BIOCHEM PHYS A, V135, P271, DOI 10.1016/S1095-6433(03)00070-9
   Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064
   Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   SUDO H, 1983, J CELL BIOL, V96, P194
   VANDESOMPELE J, 2002, GENOME BIOL, V3, DOI [DOI 10.1186/GB-2002-3-7-RESEARCH0034, DOI 10.1186/GB-2002-2-7-RESEARCH0034]
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 36
TC 30
Z9 31
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 487
EP 497
DI 10.1002/jbm.a.31553
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700023
PM 17729263
DA 2018-10-19
ER

PT J
AU Broekhuizen, CAN
   de Boer, L
   Schipper, K
   Jones, CD
   Quadir, S
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   de Boer, Leonie
   Schipper, Kim
   Jones, Christopher D.
   Quadir, Shan
   Vandenbroucke-Grauls, Christina M. J. E.
   Zaat, Sebastian A. J.
TI Staphylococcus epidermidis is cleared from biomaterial implants but
   persists in peri-implant tissue in mice despite rifampicin/vancomycin
   treatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Staphylococcus epidermidis; experimental biomaterial-associated
   infection; vancomycin; rifampicin; tissue colonization
ID FOREIGN-BODY INFECTION; SUBCUTANEOUS ABSCESS FORMATION; CATHETER-RELATED
   INFECTIONS; IN-VIVO; POUCH MODEL; VANCOMYCIN; RIFAMPIN; AUREUS;
   BIOFILMS; SUSCEPTIBILITY
AB Infections associated with implanted biomedical devices (BAI) are predominantly caused by Staphylococcus epidermidis. We previously observed in murine experimental BAI that S. epidermidis persists in peri-implant tissue rather than on the implanted biomaterial itself (Boelens et al., J Infect Dis 2000;181:1337-1349; Broekhuizen et al., Infect Immun 2007;75:1129-1136). To investigate the efficacy of rifampicin/vancomycin to clear S. epidermidis from implants and peri-implant tissues, mice with two implants were challenged with 10(7) cfu S. epidermidis per implant and received daily injections of rifampicin (25 mg/kg) and vancomycin (50 mg/kg). On the day of termination, implants and peri-implant tissue were collected and processed for culture and histology. After 1 and 8 days, implants of control mice were culture positive in 14/18 and 5/16 cases, respectively, and tissue biopsies were all culture positive. In the antibiotic-treated mice, bacteria were recovered from only 1/18 and 1/16 implants after 1 and 8 days, respectively, whereas the tissues were culture positive in 14/18 and 7/16 biopsies, respectively. In microscopy, bacteria were seen in the tissue at a distance of several cell layers from the tissue-implant interface, colocalized with host cells. Thus, although a regimen of rifampicin/vancomycin sterilized the implants, S. epidermidis persisted in peri-implant tissue, which might be an as yet unrecognized reservoir in the pathogenesis of BAI (C) 2007 Wiley Periodicals, Inc.
C1 [Broekhuizen, Corine A. N.; de Boer, Leonie; Schipper, Kim; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Inflammat Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [Jones, Christopher D.; Quadir, Shan] Emergent Prod Dev UK Ltd Microsci Ltd, Wokingham RG41 5TU, Berks, England.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Inflammat Amsterdam CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR BLASER J, 1995, ANTIMICROB AGENTS CH, V39, P1134, DOI 10.1128/AAC.39.5.1134
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BROEKHUIZEN CAN, 2006, 106 ASM GEN M WASH D
   BROEKHUIZEN CAN, 2007, UNPUB TISSUE CATHETE
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Burns CA, 2006, SCAND J INFECT DIS, V38, P133, DOI 10.1080/00365540500277292
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   DAROUICHE RO, 1994, ANTIMICROB AGENTS CH, V38, P1059, DOI 10.1128/AAC.38.5.1059
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   DWORKIN R, 1990, ANTIMICROB AGENTS CH, V34, P1014, DOI 10.1128/AAC.34.6.1014
   El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2
   Gagnon R F, 1992, ASAIO J, V38, pM596, DOI 10.1097/00002480-199207000-00106
   Garrison JR, 1997, ASAIO J, V43, P8, DOI 10.1097/00002480-199701000-00003
   Ghiselli R, 2002, EUR J VASC ENDOVASC, V24, P230, DOI 10.1053/ejvs.2002.1713
   Giacometti A, 2003, J ANTIMICROB CHEMOTH, V52, P724, DOI 10.1093/jac/dkg396
   HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409
   Isiklar Z U, 1999, Bull Hosp Jt Dis, V58, P79
   KARCHMER AW, 1983, ANN INTERN MED, V98, P447, DOI 10.7326/0003-4819-98-4-447
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
   Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9
   Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   SCHAAD HJ, 1994, ANTIMICROB AGENTS CH, V38, P1703, DOI 10.1128/AAC.38.8.1703
   Stein GE, 2005, ANN PHARMACOTHER, V39, P427, DOI 10.1345/aph.1E484
   Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vesely JJK, 1998, PHARMACOTHERAPY, V18, P345
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   von Eiff C, 1999, INFECTION, V27, pS7, DOI 10.1007/BF02561610
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Walsh C., 2003, ANTIBIOTICS ACTIONS
   WEHRLI W, 1983, REV INFECT DIS S, V3, pS407
   Wilcox MH, 2001, J ANTIMICROB CHEMOTH, V47, P171, DOI 10.1093/jac/47.2.171
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 48
TC 17
Z9 17
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 498
EP 505
DI 10.1002/jbm.a.31528
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700024
PM 17729261
DA 2018-10-19
ER

PT J
AU Rodriguez, A
   Voskerician, G
   Meyerson, H
   MacEwan, SR
   Anderson, JM
AF Rodriguez, Analiz
   Voskerician, Gabriela
   Meyerson, Howard
   MacEwan, Sarah R.
   Anderson, James M.
TI T cell subset distributions following primary and secondary implantation
   at subcutaneous biomaterial implant sites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rat cage system; flow cytometry; T cell; synthetic biomaterials;
   secondary host response
ID IN-VIVO BIOCOMPATIBILITY; FOREIGN-BODY RESPONSE; IMMUNE-RESPONSE;
   VASCULAR PROSTHESES; SURFACE-CHEMISTRY; ANTIBODY-RESPONSE; ADHESION;
   VITRO; RATS; MECHANISMS
AB Synthetic biomaterials are considered to be non-immunogenic. Therefore, the role that adaptive immunity may play in the host response to implanted synthetic biomaterials has not been extensively studied. Cardinal features of adaptive immunity include specificity and T cell responses, which are greater and more effective with upregulation of activation receptors upon rechallenge. We compared the primary and secondary in vivo host response to three synthetic biomaterials: Elasthane 80A, silicone rubber, and polyethylene terephthalate using a cage implant model in Sprague Dawley rats. The synthetic biomedical polymers were subcutaneously implanted in cages for 14 days. Following explantation of the cages and a 2 week healing period, rats were implanted with cages containing the biomedical polymers for an additional 2 weeks. The cellular exudates within the cages were analyzed 4, 7, and 14 days post primary and secondary implantation by flow cytometry for the following cell types: T cells (inclusive of CD8(+), CD4(+), and CD4(+)/CD25(+) subsets), B cells, granulocytes, and macrophages. At day 14 following secondary implantation, there was an increase in T cells, granulocytes, and macrophages in the exudates when compared with primary implantation for all groups inclusive of the empty cage control. However, CD4(+)/CD8(+) ratios, the percentage of CD4(+)CD25(+) T cells, and the macrophage surface adhesion/fusion did not vary significantly upon secondary implantation. Despite a quantitative increase in T cells following secondary biomaterial exposure, T cell subset distribution did not change, indicating nonspecific recruitment rather than an adaptive immune response. (C) 2007 Wiley Periodicals, Inc.
C1 [Rodriguez, Analiz; Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Voskerician, Gabriela] Proxy Biomed Ltd, Galway, Ireland.
   [MacEwan, Sarah R.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Wolstein Res Bldg 5104, Cleveland, OH 44106 USA.
EM jma6@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [R01 EB000282, EB-000282]
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x
   D'Ambrosio D, 2006, SEMIN CANCER BIOL, V16, P91, DOI 10.1016/j.semcancer.2005.11.002
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   DJIKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263
   Granchi D, 2002, BIOMATERIALS, V23, P1033, DOI 10.1016/S0142-9612(01)00215-0
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUANG B, 1992, BIOMATERIALS, V13, P209, DOI 10.1016/0142-9612(92)90186-R
   Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016
   JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117
   Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446
   JONES JA, 2007, J BIOMED MAT RE 0514
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   LANZAVECCHIA A, 2000, SCIENCE, V290, P8063
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245
   Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003
   RHODES NP, 1994, J MATER SCI-MATER M, V5, P666, DOI 10.1007/BF00120353
   Rozalska B, 1996, IMMUNOL LETT, V49, P99, DOI 10.1016/0165-2478(95)02489-1
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   Schlosser M, 2002, J BIOMED MATER RES, V61, P450, DOI 10.1002/jbm.10096
   SCHLOSSER M, 1994, HORM METAB RES, V26, P534, DOI 10.1055/s-2007-1001751
   Schuster M, 2001, TRANSPLANT P, V33, P1960, DOI 10.1016/S0041-1345(00)02754-8
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   Yi HF, 2006, CELL MOL IMMUNOL, V3, P189
   ZIEGLER M, 1994, BIOMATERIALS, V15, P859, DOI 10.1016/0142-9612(94)90043-4
   Zippel R, 2001, EUR J VASC ENDOVASC, V21, P202, DOI 10.1053/ejvs.2000.1298
NR 37
TC 26
Z9 26
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 556
EP 565
DI 10.1002/jbm.a.31562
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700030
PM 17729264
DA 2018-10-19
ER

PT J
AU Zhu, AP
   Pan, YN
   Liao, TQ
   Zhao, F
   Chen, T
AF Zhu, Aiping
   Pan, Yingnan
   Liao, Tianqing
   Zhao, Feng
   Chen, Tian
TI The synthesis and characterization of polymerizable and Biocompatible
   N-maleic acyl-chitosan
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitosan; maleic acyl-chitosan; polymeric activity; cytocompatibility
ID ADHESION CONTACT DYNAMICS; O-CARBOXYMETHYLCHITOSAN; POLY(ETHYLENE
   GLYCOL); PCL DIACRYLATE; CELL VIABILITY; ACID; SCAFFOLDS; HYDROGELS;
   POLYSACCHARIDES; COMPATIBILITY
AB Biocompatible and polymerizable natural macromolecules have been found to provide great advantages in the preparation of hydrogels, which have wide applications in the fields of tissue engineering and polymeric drug delivery systems. To develop a new biocompatible polymerizable chitosan derivative, N-maleic acyl-chitosan (NMCS) was synthesized in this study. This novel biomaterial was designed from the N-acylation of chitosan with maleic anhydride introducing functional carboxyl and vinylated (-C=C-) groups. The structure of NMCS was characterized by FTIR, H-1 NMR, element analysis, and X-ray diffraction (XRD). NMCS can be dissolved into water because of its decreased crystallinity compared with chitosan. The NMCS's multiporous and microgel morphology was revealed by transmission electron microscope (TEM). Crosslinked hydrogel films can be successfully obtain through the macromolecular polymerization of NMCS. Subsequently, 3T3 fibroblasts were cultured onto the surface of the polymerized NMCS (P-NMCS) films to examine the capability of cell attachment and proliferation. Results from the cell culture demonstrate that P-NMCS films provide significant improvement in cell attachment and proliferation over unmodified chitosan. The improved P-NMCS cytocompatibility is expected to provide substantial contributions to tissue engineering in the future.(c) 2007 Wiley Periodicals, Inc.
C1 [Zhu, Aiping; Pan, Yingnan; Chen, Tian] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
   [Liao, Tianqing; Zhao, Feng] Florida State Univ, Dept Chem & Biomed Engn, Tallahassee, FL 32310 USA.
RP Zhu, AP (reprint author), Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
EM apzhu@yzu.edu.cn
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Dureja H, 2001, INT J PHARM, V213, P193, DOI 10.1016/S0378-5173(00)00666-9
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim SH, 2000, J BIOMED MATER RES, V49, P517, DOI 10.1002/(SICI)1097-4636(20000315)49:4<517::AID-JBM10>3.0.CO;2-8
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   PARK JW, 1983, B KOR CHEM SOC, V4, P68
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Tanaka M, 2007, J NANOSCI NANOTECHNO, V7, P763, DOI 10.1166/jnn.2007.514
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu AP, 2006, J BIOMED MATER RES B, V76B, P76, DOI 10.1002/jbm.b.30348
   Zhu AP, 2006, CARBOHYD POLYM, V63, P89, DOI 10.1016/j.carbpol.2005.08.006
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
   Zhu AP, 2005, COLLOID SURFACE B, V43, P143, DOI 10.1016/j.colsurfb.2005.04.009
   Zhu AP, 2005, J BIOMAT SCI-POLYM E, V16, P301, DOI 10.1163/1568562053654149
   Zhu AP, 2003, POLYM INT, V52, P81, DOI 10.1002/pi.1026
   Zhu YB, 2003, J BIOMED MATER RES A, V67A, P1367, DOI 10.1002/jbm.a.20058
NR 25
TC 14
Z9 14
U1 0
U2 23
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2008
VL 85B
IS 2
BP 489
EP 495
DI 10.1002/jbm.b.30970
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 291GB
UT WOS:000255180900022
PM 18161835
DA 2018-10-19
ER

PT J
AU Lyu, S
   Schley, J
   Loy, B
   Luo, L
   Hobot, C
   Sparer, R
   Untereker, D
   Krzeszak, J
AF Lyu, SuPing
   Schley, James
   Loy, Brian
   Luo, Lian
   Hobot, Chris
   Sparer, Randall
   Untereker, Darrel
   Krzeszak, Jason
TI In vitro biostability evaluation of polyurethane composites in acidic,
   basic, oxidative, and neutral solutions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE composite; biostabillity; oxidation; chemical resistance; hydration;
   biomaterial
ID MATRIX INTERFACIAL BOND; STRUCTURAL BIOMATERIALS; STRESS CRACKING;
   SURFACE DAMAGE; BIODEGRADATION; CARBON; ENVIRONMENTS; REPLACEMENT;
   COMPONENTS; DEGRADATION
AB New and improved properties can often be achieved by compounding two or more different but compatible materials. But, can failure possibility also be increased by such a compounding strategy? In this article, we compared the in vitro biostability of composites with that of the pure polymer. We tested three model composites in oxidative, acidic, basic, and neutral solutions. We found that oxidation degradation was much more profound in the composites than in the corresponding pure polymer. This degradation seemed to be an intrinsic property of composite materials. We also observed the well documented interfacial debonding between filler and matrix and its effects on the mechanical reinforcement of the hydrated composites. The improvements in acid and base resistance were also observed. (c) 2007 Wiley Periodicals, Inc.
C1 [Lyu, SuPing; Schley, James; Loy, Brian; Luo, Lian; Hobot, Chris; Sparer, Randall; Untereker, Darrel; Krzeszak, Jason] Medtron Corp Sci & Technol, Minneapolis, MN 55432 USA.
RP Lyu, S (reprint author), Medtron Corp Sci & Technol, 710 Medtron Pkwy, Minneapolis, MN 55432 USA.
EM suping.lyu@medtronic.com
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   Byrd C L, 1983, Pacing Clin Electrophysiol, V6, P869
   Casas J, 1999, J BIOMED MATER RES, V46, P475, DOI 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   COURY A, 2004, BIOMATERIALS SCI INT, P411
   HALCOMB FJ, 1981, T AM SOC ART INT ORG, V27, P364
   LATOUR RA, 1992, J BIOMED MATER RES, V26, P593, DOI 10.1002/jbm.820260504
   LATOUR RA, 1993, J BIOMED MATER RES, V27, P1281, DOI 10.1002/jbm.820271008
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   MEYER MR, 1994, J BIOMED MATER RES, V28, P1221, DOI 10.1002/jbm.820281012
   Migliaresi C., 2004, BIOMATERIALS SCI INT, P181
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Stokes KS, 1988, J BIOMATER APPL, V3, P229
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Wiggins MJ, 2003, J BIOMED MATER RES A, V66A, P463, DOI 10.1002/jbm.a.10584
   Wiggins MJ, 2003, J BIOMED MATER RES A, V65A, P524, DOI 10.1002/jbm.a.10565
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   WRIGHT TM, 1986, CLIN ORTHOP RELAT R, P67
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P1312, DOI 10.2106/00004623-198870090-00006
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P926, DOI 10.2106/00004623-198870060-00019
   Wright-Charlesworth DD, 2006, J BIOMED MATER RES A, V78A, P541, DOI 10.1002/jbm.a.30767
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 24
TC 6
Z9 6
U1 2
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2008
VL 85B
IS 2
BP 509
EP 518
DI 10.1002/jbm.b.30973
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 291GB
UT WOS:000255180900025
PM 18076092
DA 2018-10-19
ER

PT J
AU Batory, D
   Blaszczyk, T
   Clapa, M
   Mitura, S
AF Batory, D.
   Blaszczyk, T.
   Clapa, M.
   Mitura, S.
TI Investigation of anti-corrosion properties of Ti : C gradient layers
   manufactured in hybrid deposition system
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT International Conference on Surfaces, Coatings and Nanostructured
   Materials (NanoSMat)
CY 2007
CL Algarve, PORTUGAL
SP Soc Nanosci & Nanotechnol
ID STAINLESS-STEEL; MAGNESIUM ALLOY; DLC COATINGS; CORROSION; WEAR;
   BIOMATERIAL; FRICTION; BEHAVIOR; FILMS
AB Excellent properties of hard carbon layers and especially, the unique combination of tribological, chemical and physical properties make them a popular coating material for use on surgical prosthesis, biomedical implants, and machine tools. However, their well-known poor adhesion and high internal stress disqualifies them in many possibilities of industrial applications. These drawbacks were improved by deposition of Ti buffer layer. By a combination of Radio Frequency Plasma Assisted Chemical Vapor Deposition (RFPACVD) and DC magnetron sputtering methods, thick carbon films were manufactured on Rex 734 steel. Structure and chemical composition of deposited layers was determined by scanning electron microscope and energy dispersive spectrometer analysis. The main purpose of this work was to determine the corrosion properties of Rex 734 alloy in a typical 0.5 M NaCl solution and to find the influence of Ti:C gradient layers on these properties. Anti-corrosion behavior was measured by the detection of corrosion potential in open circuit and the registration of potentiodynamic characteristics according to Stern-Geary and Tafel methods. Five different types of samples were studied: for full analysis the investigation was conducted for every structural component of the layer: for pure Ti deposited on Rex 734 as well as for Ti containing carbon layer and carbon layer deposited subsequently, and finally the corrosion resistance of Rex 734 steel was measured for comparison. As a result of the investigation it was noticed that the Ti-C interlayer enables to maximize the thickness of DLC films and Ti:C gradient layers have the good influence on the corrosion features of Rex 734 alloy.
C1 [Batory, D.; Clapa, M.; Mitura, S.] Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
   [Blaszczyk, T.] Univ Lodz, Dept Gen & Inorgan Chem, PL-90136 Lodz, Poland.
RP Batory, D (reprint author), Tech Univ Lodz, Inst Mat Sci & Engn, 1 Stefanowskiego St, PL-90924 Lodz, Poland.
EM damian.batory@p.lodz.pl
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748
CR Batoty D., 2006, INZYNIERIA MATERIALO, V5, P868
   BLASZCZYK T, 2006, ENG BIOMATER, V65, P58
   BURNAT B, 2007, ENG BIOMATER RYTRO, P66621
   Choi J, 2007, DIAM RELAT MATER, V16, P1361, DOI 10.1016/j.diamond.2006.11.088
   Clapa M., 2007, J ACHIEVEMENTS MAT M, V20, P415
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   Dorner-Reisel A, 2004, SURF COAT TECH, V177, P830, DOI 10.1016/j.surfcoat.2003.06.015
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Huang GF, 2003, DIAM RELAT MATER, V12, P1406, DOI 10.1016/S0925-9635(03)00168-7
   Huang LY, 2001, DIAM RELAT MATER, V10, P1448, DOI 10.1016/S0925-9635(00)00501-X
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   MITURA S, 2000, NANOTECHNOLOGY MAT S, P66621
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Reclaru L, 2002, BIOMATERIALS, V23, P3479, DOI 10.1016/S0142-9612(02)00055-8
   SCHOLL H, 2006, NEW TECHNOLOGIES MED, P66621
   SUNDARAM VS, 2006, DIAM RELAT MATER, V201, P2707
   Yamauchi N, 2005, SURF COAT TECH, V193, P277, DOI 10.1016/j.surfcoat.2004.07.056
   Yamauchi N, 2003, SURF COAT TECH, V174, P465, DOI 10.1016/S0257-8972(03)00406-7
   2004, G10289, P66621
NR 20
TC 12
Z9 12
U1 5
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY
PY 2008
VL 43
IS 10
BP 3385
EP 3391
DI 10.1007/s10853-007-2393-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 288CQ
UT WOS:000254964200005
DA 2018-10-19
ER

PT J
AU Pan, YS
   Xiong, DS
   Gao, F
AF Pan, Yusong
   Xiong, Dangsheng
   Gao, Fei
TI Viscoelastic behavior of nano-hydroxyapatite reinforced poly(vinyl
   alcohol) gel biocomposites as an articular cartilage
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FRICTION CHARACTERISTICS; PVA-HYDROGEL; STARCH GELS; BIOMATERIAL
AB Nanohydroxyapatite reinforced poly(vinyl alcohol) gel (nano-HA/PVA gel) composites has been proposed as an articular cartilage repair biomaterial. In this paper, nano-HA/PVA gel composites were prepared by in situ synthesis nano-HA particles in PVA solution and accompanied with freeze/thaw method. The influence of nano-HA content, PVA concentration, test frequency and freeze/thaw cycle times on the viscoelastic behavior of nano-HA/PVA gel composites were evaluated using dynamic mechanical thermal analysis (DMTA). The results showed that both storage modulus and loss modulus firstly increased and then presented decreasing trend with the rise of nano-HA content. Their maximum values were obtained while nano-HA content was 6%. Furthermore, the G' and G '' of the composites improve with the increase of PVA concentrations and freeze/thaw cycle times. This effect was more distinct at low freeze/thaw cycles. The phase angle (tan delta) of the pure PVA gel is larger than that of the nano-HA/PVA composites at the test frequency spectra, but all the phase angle values of the tested composites were close to that of nature bone.
C1 [Pan, Yusong; Xiong, Dangsheng; Gao, Fei] Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nan Jing 21009, Peoples R China.
RP Pan, YS (reprint author), Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nan Jing 21009, Peoples R China.
EM xiongds@163.com
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Arvind S., 2007, MAT SCI ENG C, V27, P70
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hernandez R, 2002, POLYMER, V43, P5661, DOI 10.1016/S0032-3861(02)00470-6
   Hisatoshi K., 2004, MAT SCI ENG C, V24, P729
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   JOAO FM, 2005, MAT SCI ENG C-BIO S, V25, P145
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KONG LX, 2005, SYNTHETIC MET, V152, P25
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Michailova V, 1999, COLLOID SURFACE A, V149, P515, DOI 10.1016/S0927-7757(98)00608-6
   Mondragon M, 2006, CARBOHYD POLYM, V65, P314, DOI 10.1016/j.carbpol.2006.01.011
   Moresi M, 2004, J FOOD ENG, V64, P179, DOI 10.1016/j.jfoodeng.2003.09.030
   Nebahat D., 2006, COLLOID SURFACE B, V48, P42
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   PAN YS, 2007, MAT SCI, V42, P5129
   [潘育松 Pan Yusong], 2006, [摩擦学学报, Tribology], V26, P188
   Pan YS, 2007, KEY ENG MATER, V330-332, P1297, DOI 10.4028/www.scientific.net/KEM.330-332.1297
   REBECA H, 2004, POLYMER, V46, P5543
   REBECCAH JC, 2003, WEAR, V25, P1064
   Rosa R., 2003, POLYMER, V44, P3375
   SHIGO M, 2004, MAT SCI ENG C-BIO S, V24, P425
   SU FL, 2005, ACTA MAT COMPOSITES, V22, P27
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3
   ZHANG P, 2004, SYNTHETIC MET, V152, P25
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 29
TC 34
Z9 39
U1 4
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2008
VL 19
IS 5
BP 1963
EP 1969
DI 10.1007/s10856-007-3280-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277HC
UT WOS:000254202300013
PM 17943417
DA 2018-10-19
ER

PT J
AU Venugopal, J
   Low, S
   Choon, AT
   Kumar, TSS
   Ramakrishna, S
AF Venugopal, J.
   Low, Sharon
   Choon, Aw Tar
   Kumar, T. S. Sampath
   Ramakrishna, S.
TI Mineralization of osteoblasts with electrospun collagen/hydroxyapatite
   nanofibers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE; HUMAN BONE; HYDROXYAPATITE; COLLAGEN; MATRIX; CELLS;
   COMPOSITE; SCAFFOLDS; IMPLANTS; BIOMATERIALS
AB Regeneration of fractured or diseased bones is the challenge faced by current technologies in tissue engineering. The major solid components of human bone consist of collagen and hydroxyapatite. Collagen (Col) and hydroxyapatite (HA) have potential in mimicking natural extracellular matrix and replacing diseased skeletal bones. More attention has been focused on HA because of its crystallographic structure similar to inorganic compound found in natural bone and extensively investigated due to its excellent biocompatibility, bioactivity and osteoconductivity properties. In the present study, electrospun nanofibrous scaffolds are fabricated with collagen (80 mg/ml) and Col/HA (1:1). The diameter of the collagen nanofibers is around 265 +/- 0.64 nm and Col/HA nanofibers are 293 +/- 1.45 nm. The crystalline HA (29 +/- 7.5 nm) loaded into the collagen nanofibers are embedded within nanofibrous matrix of the scaffolds. Osteoblasts cultured on both scaffolds and show insignificant level of proliferation but mineralization was significantly (p < 0.001) increased to 56% in Col/HA nanofibrous scaffolds compared to collagen. Energy dispersive X-ray analysis (EDX) spectroscopy results proved the presence of higher level of calcium and phosphorous in Col/HA nanocomposites than collagen nanofibrous scaffolds grown osteoblasts. The results of the present study suggested that the designed electrospun nanofibrous scaffold (Col/HA) have potential biomaterial for bone tissue engineering.
C1 [Venugopal, J.; Ramakrishna, S.] Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   [Low, Sharon; Choon, Aw Tar] StemLife Sdn BhD, Kuala Lumpur 50450, Malaysia.
   [Kumar, T. S. Sampath] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
RP Venugopal, J (reprint author), Natl Univ Singapore, Div Bioengn, Block E3,05-14,9 Engn Dr 1, Singapore 117576, Singapore.
EM engjrv@nus.edu.sg
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   De Bruijn J. D., 1998, BIOMATERIALS SURG, P77
   Derkx P, 1998, BONE, V22, P367, DOI 10.1016/S8756-3282(97)00299-8
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GEORGE J, 2006, BIOTECHNOL BIOENG, V95, P405
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Hsu SH, 2007, J BIOMED MATER RES B, V80B, P519, DOI 10.1002/jbm.b.30626
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JOHANSEN E, 1960, J BIOPHYS BIOCHEM CY, V7, P743, DOI 10.1083/jcb.7.4.743
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li Xiang-Ru, 2005, Journal of Software, V16, P365, DOI 10.1360/jos160365
   Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21
   MENDES SC, 2000, BONE ENG, P505
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   MIZUNO M, 2001, J BIOCHEM-TOKYO, V129, P129
   MURUGAN R, 2002, BIOCH BIOPHYS RES, V292, P1
   Nishikawa Tetsunari, 2005, Implant Dent, V14, P252, DOI 10.1097/01.id.0000173628.00705.d0
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Scabbia A, 2004, J CLIN PERIODONTOL, V31, P348, DOI 10.1111/j.1600-051X.2004.00483.x
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   WEINER S, 1989, TISSUE RES, V221, P589
   WEINREB M, 1990, J BONE MINER RES, V5, P831
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 41
TC 114
Z9 114
U1 1
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2008
VL 19
IS 5
BP 2039
EP 2046
DI 10.1007/s10856-007-3289-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277HC
UT WOS:000254202300022
PM 17957448
DA 2018-10-19
ER

PT J
AU Mangano, C
   Piattelli, A
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Piattelli, Adriano
   Perrotti, Vittoria
   Iezzi, Giovanna
TI Dense hydroxyapatite inserted into postextraction sockets: A histologic
   and histomorphometric 20-year case report
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE case report; histology; hydroxyapatite; long-term study
ID LONG-TERM; POROUS HYDROXYAPATITE; ALVEOLAR RIDGE; TRICALCIUM PHOSPHATE;
   EXTRACTION SOCKETS; CERAMIC IMPLANTS; MAXILLARY SINUS; DOG FEMORA;
   IN-VIVO; BONE
AB Background: The biologic behavior, i.e., the degradation of hydroxyapatite (HA) in the human body, is of relevance for clinicians. The present investigation is a long-term (20-year) histologic and histomorphometric evaluation of dense HA used in postextraction sockets.
   Methods: Dense HA particles were used in a patient in postextraction alveolar sockets to maintain the alveolar ridge height. The patient returned after 20 years for implant treatment. A ridge remodeling was necessary during implant insertion surgery, and the HA/bone tissue was harvested with bone-cutting forceps from the canine and premolar area. The specimen was processed for histology and histomorphometry at the Implant Retrieval Centre, Dental School, University of Chieti-Pescara.
   Results: Most of the particles (56%) were surrounded partially by bone, whereas some particles (39%) were surrounded completely. At higher magnification, bone was in close contact with the particles, and neither gaps nor flbrous tissues were present at the bone-biomaterial interface. Microscopically, the particles had a dense appearance. In only a few fields, it was possible to observe that the outer part of some particles had detached from the original particles' surface. Histomorphometry showed that bone represented 25.4% +/- 3.2%, marrow spaces represented 41.3% +/- 5.2%, and residual HA particles represented 38.1% +/- 4.1%.
   Conclusions: Intimate binding between bone and HA particles was present after a long-term implantation period (20 years). The fact that HA particles were surrounded closely by bone is very promising for the long-term stability of the augmentation.
C1 [Mangano, Carlo] Univ Varese, Sch Dent, Dept Biomat Sci, Varese, Italy.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Dept Oral Med & Pathol, Chieti, Italy.
   [Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Dept Stomatol & Oral Sci, Chieti, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
CR Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CARRANZA FA, 1987, J PERIODONTOL, V58, P682, DOI 10.1902/jop.1987.58.10.682
   DENISSEN HW, 1984, J BIOMED MATER RES, V18, P147, DOI 10.1002/jbm.820180205
   DENISSEN HW, 1985, HYDROXYAPATITE IMPLA, P63
   DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8
   DONATH K, 1990, OSSEOINTEGRATED IMPL, P99
   ELDEEB M, 1991, J ORAL MAXIL SURG, V49, P257, DOI 10.1016/0278-2391(91)90215-8
   Goto T, 2001, J Orthop Sci, V6, P444, DOI 10.1007/s007760170013
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Haas R, 2003, INT J ORAL MAX IMPL, V18, P691
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KENT JN, 1986, DENT CLIN N AM, V30, P231
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KWONG CH, 1989, BIOMATERIALS, V10, P579, DOI 10.1016/0142-9612(89)90110-5
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   Mercier P, 1996, J ORAL MAXIL SURG, V54, P960, DOI 10.1016/S0278-2391(96)90392-4
   OGUCHI H, 1995, BIOMATERIALS, V16, P33, DOI 10.1016/0142-9612(95)91093-E
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Proussaefs P, 2002, J PROSTHET DENT, V87, P481, DOI 10.1037/mpr.2002.122961
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   SCHEER P, 1987, J AM DENT ASSOC, V114, P594
   SHERER AD, 1987, J PROSTHET DENT, V57, P331, DOI 10.1016/0022-3913(87)90308-8
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Ye F, 2007, J MATER SCI-MATER M, V18, P2173, DOI 10.1007/s10856-007-3215-2
NR 29
TC 17
Z9 17
U1 0
U2 0
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2008
VL 79
IS 5
BP 929
EP 933
DI 10.1902/jop.2008.070245
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 302IH
UT WOS:000255961500021
PM 18454673
DA 2018-10-19
ER

PT J
AU Schoenfeld, AJ
   Battula, S
   Sahai, V
   Vrabec, GA
   Corman, S
   Burton, L
   Njus, GO
AF Schoenfeld, Andrew J.
   Battula, Suneel
   Sahai, Vivek
   Vrabec, Gregory A.
   Corman, Steven
   Burton, Lyndsey
   Njus, Glen O.
TI Pullout strength and load to failure properties of self-tapping cortical
   screws in synthetic and cadaveric environments representative of healthy
   and osteoporotic bone
SO JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
LA English
DT Article
DE osteoporosis; biomaterial properties; self-tapping screws; biomechanical
   testing
AB Background: The parameters of self-tapping screw (STS) performance in normal and osteoporotic bone have been defined in representative environments, but the question remains as to the clinical application of such findings. The goal of this study was to analyze the biomechanical performance of STSs in cadaveric and synthetic environments representative of healthy and osteoporotic bone.
   Methods: Ninety-six Synthes STSs were inserted into cadaveric and synthetic models representative of osteoporotic and healthy bone. Screws were inserted to depths of 1 mm short of the far cortex, flush and 1 nun and 2 mm beyond the far cortex. Screws were tested with an Instron 8511 material testing system utilizing axial pullout forces. A SAS procedure was used to conduct analysis of variance for unbalanced datasets.
   Results: Substantial differences were appreciated with respect to screw performance between osteoporotic and healthy bone specimens. Although a similar pattern of increased pullout strength and loading energy with increasing depth of insertion was demonstrated, absolute values were lower in osteoporotic specimens. Although performance trends were similar in cadaveric and synthetic testing models for both osteoporotic and healthy bone, values obtained during testing were different. Incomplete insertion of STSs resulted in a 21.5% and 37% reduction of biomechanical properties in osteoporotic and normal bone, respectively.
   Conclusions: These results indicate that previously published findings on the performance of STSs in synthetic models cannot reasonably be applied to the clinical realm. Although trends may be similar, screw performance in synthetic, as compared with cadaveric, models is markedly different.
C1 [Schoenfeld, Andrew J.; Vrabec, Gregory A.] Northeastern Ohio Univ Coll Med & Pharm, Dept Orthopaed Surg, Akron, OH USA.
   [Schoenfeld, Andrew J.; Sahai, Vivek; Vrabec, Gregory A.; Corman, Steven] Akron Gen Med Ctr, Dept Orthopaed Surg, Akron, OH USA.
   [Battula, Suneel; Njus, Glen O.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Burton, Lyndsey] Northeastern Ohio Univ Coll Med & Pharm, Rootstown, OH USA.
RP Schoenfeld, AJ (reprint author), Northeastern Ohio Univ Coll Med & Pharm, Dept Orthopaed Surg, 400 Wabash Ave, Akron, OH USA.
EM ajschoen@neoucom.edu
OI Schoenfeld, Andrew/0000-0002-3691-1215
CR *ASTM, 1996, BOOK ASTM STAND, P1
   Battula S, 2006, CLIN BIOMECH, V21, P533, DOI 10.1016/j.clinbiomech.2005.12.020
   Berkowitz R, 2005, J ORTHOP TRAUMA, V19, P462, DOI 10.1097/01.bot.0000161544.72757.95
   CHANDLER RW, 2001, ROCKWOOD GREENS FRAC, P181
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Gonzalez J V, 1997, J Foot Ankle Surg, V36, P422
   LANE J, 2003, SKELETAL TRAUMA, P287
   MAZZOCCA AD, 2003, SKELETAL TRAUMA BASI, P195
   MCDONALD DE, 1994, VET SURG, V23, P488, DOI 10.1111/j.1532-950X.1994.tb00510.x
   Murphy TP, 2001, VET SURG, V30, P253, DOI 10.1053/jvet.2001.23344
   ROSEN H, 1990, ORTHOP CLIN N AM, V21, P725
   Yerby S, 2001, J ORTHOP TRAUMA, V15, P216, DOI 10.1097/00005131-200103000-00012
NR 12
TC 24
Z9 24
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5282
J9 J TRAUMA
JI J. Trauma-Injury Infect. Crit. Care
PD MAY
PY 2008
VL 64
IS 5
BP 1302
EP 1307
DI 10.1097/TA.0b013e318169cd71
PG 6
WC Critical Care Medicine; Surgery
SC General & Internal Medicine; Surgery
GA 301SH
UT WOS:000255915400027
PM 18469654
DA 2018-10-19
ER

PT J
AU Roller, J
   Laschke, MW
   Sethi, S
   Herrmann, M
   Menger, MD
AF Roller, Jonas
   Laschke, Matthias W.
   Sethi, Shneh
   Herrmann, Mathias
   Menger, Michael D.
TI Prolene-Monocryl-composite meshes do not increase microvascular
   Staphylococcus aureus adherence and do not sensitize for leukocytic
   inflammation
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Article
DE surgical mesh; infection; Staphylococcus aureus; dorsal skinfold
   chamber; intravital fluorescence microscopy
ID COMPARATIVE IN-VIVO; FIBRONECTIN-BINDING PROTEINS; HERNIA REPAIR;
   INGUINAL-HERNIA; STRIATED-MUSCLE; POLYPROPYLENE MESH; INCISIONAL HERNIA;
   CHAMBER TECHNIQUE; STAINLESS-STEEL; INFECTION
AB Background and aims Mesh implantation for hernia repair bears the risk of bacterial mesh infection. In this study, we analyzed whether this complication is supported by an increased interaction of bacteria and leukocytes with the microvascular endothelium at the implantation site.
   Materials and methods Ultrapro meshes were implanted into the dorsal skinfold chamber of Syrian golden hamsters. After 12 days, fluorescein isothiocyanate (FITC)-labeled staphylococci were injected in the animals. Subsequently, we analyzed bacterial adherence, leukocyte-endothelial cell interaction, and microhemodynamics in venules of the mesh border zone and of distant control tissue under baseline conditions and during TNF-alpha-induced inflammation using intravital fluorescence microscopy. The results were compared to animals which did not receive any bacteria.
   Results Under baseline conditions, leukocyte-endothelial cell interaction and bacterial adherence were not affected by the implanted biomaterial. TNF-alpha-induced inflammation significantly increased numbers of adherent leukocytes and bacteria in venules located in direct vicinity to the mesh however without any differences to control tissue. Comparable results were found for the leukocyte-endothelial cell interaction when animals were not exposed to bacteria.
   Conclusion Implanted Ultrapro meshes do neither increase microvascular Staphylococcus aureus adherence nor sensitize for leukocytic inflammation. Thus, we suggest that a mesh-induced increase of bacterial adherence in vessels of the implantation site cannot be considered as a primary cause for the development of mesh infection.
C1 [Roller, Jonas; Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Sethi, Shneh; Herrmann, Mathias] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uniklinik-saarland.de
RI Herrmann, Mathias/B-6475-2013; Sethi, Shneh/F-1796-2013
CR AINSCOW DAP, 1984, J BONE JOINT SURG BR, V66, P580
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461
   Burger JWA, 2004, ANN SURG, V240, P578
   Cobb WS, 2003, AM SURGEON, V69, P784
   Collaboration EH, 2000, BRIT J SURG, V87, P854
   Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005
   Delikoukos S, 2007, Hernia, V11, P15, DOI 10.1007/s10029-006-0131-1
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x
   Foschi D, 1998, SURG ENDOSC-ULTRAS, V12, P455, DOI 10.1007/s004649900704
   Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0
   Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42
   Holzheimer RG, 2007, EUR J MED RES, V12, P1
   HOMER V, 2007, INT J INFECT DIS SUP, V11, pS17
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Kerdudou S, 2006, THROMB HAEMOSTASIS, V96, P183, DOI 10.1160/TH-06-02-0116
   Klosterhalfen B, 2003, EUR SURG, V35, P16
   Kraft CN, 2005, J BIOMED MATER RES A, V75A, P31, DOI 10.1002/jbm.a.30407
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Laschke MW, 2005, J INFECT DIS, V191, P435, DOI 10.1086/427193
   LASCHKE MW, 2007, IN PRESS J BIOMED MA
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MALMROS C, 1994, WORLD J SURG, V18, P811, DOI 10.1007/BF00299071
   Mann DV, 1998, AM J SURG, V176, P12, DOI 10.1016/S0002-9610(98)00094-4
   Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Nienhuijs S, 2007, AM J SURG, V194, P394, DOI 10.1016/j.amjsurg.2007.02.012
   PAPENFUSS HD, 1979, MICROVASC RES, V18, P311, DOI 10.1016/0026-2862(79)90039-6
   Rios A, 2001, Hernia, V5, P148
   Rosch R, 2003, EUR SURG RES, V35, P161, DOI 10.1159/000070045
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1006/jsre.2002.6559
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor SG, 1999, BRIT J SURG, V86, P562
   Vallien G, 2000, MICROCIRCULATION, V7, P249, DOI 10.1080/713773980
   Yerdel MA, 2001, ANN SURG, V233, P26, DOI 10.1097/00000658-200101000-00005
NR 47
TC 12
Z9 12
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1435-2443
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD MAY
PY 2008
VL 393
IS 3
BP 349
EP 357
DI 10.1007/s00423-008-0295-5
PG 9
WC Surgery
SC Surgery
GA 278CH
UT WOS:000254260600015
PM 18322695
DA 2018-10-19
ER

PT J
AU Yaguchi, S
   Nishihara, H
   Kambhiranond, W
   Stanley, D
   Apple, DJ
AF Yaguchi, Shigeo
   Nishihara, Hitoshi
   Kambhiranond, Waraporn
   Stanley, Daniel
   Apple, David J.
TI Light scatter on the surface of AcrySof (R) intraocular lenses: Part II.
   Analysis of lenses following hydrolytic stability testing
SO OPHTHALMIC SURGERY LASERS & IMAGING
LA English
DT Article
AB BACKGROUND AND OBJECTIVE: To investigate the surface light scatter and optical quality of AcrySof lenses (Alcon Laboratories, Inc., Fort Worth, TX) following simulated aging of 20 years.
   MATERIALS AND METHODS: AcrySof lenses were exposed to exaggerated thermal conditions to simulate up to 20 years of aging and were tested for surface light scatter and optical quality (modulation transfer function).
   RESULTS: There were no significant differences from baseline for either the surface light scatter or optical quality of the lenses over time.
   CONCLUSION: The current study demonstrated that surface light scatter on AcrySof lenses did not increase under conditions simulating 20 years of aging. Because the simulated aging environment contained no protein, this work indirectly supports the finding that surface light scatter is due to the deposition of a biomaterial on the lens surface rather than changes in the material. Optical performance integrity of the test lenses was maintained under severe environmental conditions.
C1 [Yaguchi, Shigeo; Nishihara, Hitoshi] Showa Univ, Fujigaoka Hosp, Dept Ophthalmol, Kanagawa 2278501, Japan.
   [Kambhiranond, Waraporn; Stanley, Daniel] Alcon Res Ltd, Ft Worth, TX USA.
   [Apple, David J.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA.
RP Yaguchi, S (reprint author), Showa Univ, Fujigaoka Hosp, Dept Ophthalmol, 1-30 Fujigaoka, Kanagawa 2278501, Japan.
CR *INT ORG STAND, 1197922000 ISO 2
   *INT ORG STAND, 1197962000 ISO 6
   Learning DV, 2004, J CATARACT REFR SURG, V30, P892
   Nishihara H, 2003, J CATARACT REFR SURG, V29, P1385, DOI 10.1016/S0886-3350(02)01994-6
   Yaguchi S, 2008, OPHTHAL SURG LAS IM, V39, P209, DOI 10.3928/15428877-20080501-22
NR 5
TC 7
Z9 7
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 1542-8877
J9 OPHTHAL SURG LAS IM
JI Ophthalmic Surg. Lasers Imaging
PD MAY-JUN
PY 2008
VL 39
IS 3
BP 214
EP 216
PG 3
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 299QE
UT WOS:000255769300007
PM 18556942
DA 2018-10-19
ER

PT J
AU Patel, M
   Fisher, JP
AF Patel, Minal
   Fisher, John P.
TI Biomaterial scaffolds in pediatric tissue engineering
SO PEDIATRIC RESEARCH
LA English
DT Review
ID BONE-MARROW-CELLS; RANDOMIZED-TRIAL; THICKNESS BURNS; HEART-VALVES;
   CARTILAGE; REGENERATION; DEGRADATION; REPAIR; TRANSPLANTATION; EXPANDERS
AB This article reviews recent developments and major issues in the use and design of biomaterials for use as scaffolds in pediatric tissue engineering. A brief history of tissue engineering and the limitations of current tissue-engineering research with respect to pediatric patients have been introduced. An overview of the characteristics of an ideal tissue-engineering scaffold for pediatric applications has been presented, including a description of the different types of scaffolds. Applications of scaffolds materials have been highlighted in the fields of drug delivery, bone, cardiovascular, and skin tissue engineering with respect to the pediatric population. This review highlights biomaterials as scaffolds as an alternative treatment method for pediatric surgeries due to the ability to create a functional cell-scaffold environment.
C1 [Patel, Minal; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
OI Fisher, James/0000-0001-7851-9222
CR Andriani E, 2000, Minerva Pediatr, V52, P15
   Bendoriene Jolanta, 2006, Eye Contact Lens, V32, P104, DOI 10.1097/01.icl.0000174755.50802.15
   Cassidy C, 2005, BURNS, V31, P890, DOI 10.1016/j.burns.2005.04.029
   Chalasani R, 2007, SURV OPHTHALMOL, V52, P145, DOI 10.1016/j.survophthal.2006.12.007
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cohen AJ, 2004, J CRANIOFAC SURG, V15, P469, DOI 10.1097/00001665-200405000-00025
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Demann Eric T K, 2005, J Long Term Eff Med Implants, V15, P687
   Drewa T, 2005, J PEDIATR SURG, V40, P317, DOI 10.1016/j.jpedsurg.2004.10.019
   Earthman James C, 2006, Dent Clin North Am, V50, P229, DOI 10.1016/j.cden.2005.11.010
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Esposito G, 2007, PLAST RECONSTR SURG, V119, P2346, DOI 10.1097/01.prs.0000261076.40549.cf
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Frimberger D, 2006, REGEN MED, V1, P425, DOI 10.2217/17460751.1.4.425
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Idrus RBH, 2005, INT J PEDIATR OTORHI, V69, P1489, DOI 10.1016/j.ijporl.2005.04.026
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kobus KF, 2007, J PLAST RECONSTR AES, V60, P414, DOI 10.1016/j.bjps.2006.01.053
   Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x
   Lang EM, 2005, ANN PLAS SURG, V55, P485, DOI 10.1097/01.sap.0000182652.88669.a6
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Martinez L, 2002, Cir Pediatr, V15, P97
   Maurer BJ, 2007, CLIN CANCER RES, V13, P3079, DOI 10.1158/1078-0432.CCR-06-1889
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2437, DOI 10.1016/S0142-9612(03)00112-1
   Nikitin A A, 2005, Stomatologiia (Mosk), V84, P40
   Norbury WB, 2005, CRIT CARE, V9, P533, DOI 10.1186/cc3881
   Ozawa T, 2004, CELL TRANSPLANT, V13, P169, DOI 10.3727/000000004773301852
   Patel M, 2006, TISSUE ENG, V12, P3189, DOI 10.1089/ten.2006.12.3189
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Richards SK, 2005, PEDIATR TRANSPLANT, V9, P627, DOI 10.1111/j.1399-3046.2005.00312.x
   Roh JD, 2007, J PEDIATR SURG, V42, P198, DOI 10.1016/j.jpedsurg.2006.09.054
   Schittkowski MP, 2006, BRIT J OPHTHALMOL, V90, P1173, DOI 10.1136/bjo.2006.092478
   Schmidt D, 2004, ANN THORAC SURG, V78, P2094, DOI 10.1016/j.athoracsur.2004.06.052
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   STUART JD, 1987, AM FAM PHYSICIAN, V36, P139
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   SUNIL B, 2006, J PEDIATR SURG, V41, pE5
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Tuggle DW, 2004, J PEDIATR SURG, V39, P626, DOI 10.1016/j.jpedsurg.2003.12.032
   Vacanti JP, 1999, LANCET, V354, pSI32
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Velardi F, 2006, CHILD NERV SYST, V22, P1158, DOI 10.1007/s00381-006-0100-0
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
NR 56
TC 38
Z9 41
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2008
VL 63
IS 5
BP 497
EP 501
DI 10.1203/01.PDR.0b013e318165eb3e
PG 5
WC Pediatrics
SC Pediatrics
GA 293CH
UT WOS:000255311900008
PM 18427294
OA Bronze
DA 2018-10-19
ER

PT J
AU Gunaydin, S
   McCusker, K
   Sari, T
   Onur, MA
   Gurpinar, A
   Sevim, H
   Atasoy, P
   Yorgancioglu, C
   Zorlutuna, Y
AF Gunaydin, S.
   McCusker, K.
   Sari, T.
   Onur, M. A.
   Gurpinar, A.
   Sevim, H.
   Atasoy, P.
   Yorgancioglu, C.
   Zorlutuna, Y.
TI Clinical impact and biomaterial evaluation of autologous platelet gel in
   cardiac surgery
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT Annual Seminar of the American-Academy-of-Cardiovascular-Perfusion
CY JAN 25-28, 2008
CL Orlando, FL
SP Amer Acad Cardiovasc Perfus
DE extracorporeal circulation; platelet activation; platelet gel; platelet
   rich plasma; surgical hemostasis
ID RICH PLASMA; GLUE
AB We compared the clinical efficacy of autologous platelet gel (APG) and gelatine (CONT), including biomaterial evaluation. In a prospective, randomized, controlled trial, 64 patients undergoing complex coronary artery bypass graft (CABG) surgery and/ or aortic surgery, in whom the surgeon was able to identify a bleeding site for which conventional means to stop bleeding were impractical or proved unsuccessful, were enrolled. Aortic punch biopsy from each patient was harvested in explant cell (EC) culture media. Hemostasis success for the "oozing" category was 89% in APG and 60% in CONT (p < 0.05). For the "heavy bleeding" category, the success rates were 92% in APG and 45% in CONT (p < 0.01). Contact of gelatine inhibited EC proliferation and APG increased cell cycling and EC quantity. Phagocytic capacity (PC) was significantly higher in the APG group (p < 0.001). APG was significantly better than CONT with respect to hemostatic success rate, effects on wound healing and increased resistance to infection (PC). Perfusion (2008) 23, 179-186.
C1 [McCusker, K.] New York Med Coll, New York, NY USA.
   [Onur, M. A.; Gurpinar, A.; Yorgancioglu, C.] Hacettepe Univ, Ankara, Turkey.
RP Gunaydin, S (reprint author), Univ K Kale, Dept CV Surg, Angora Evleri G-8 Bl 1, TR-06800 Beysukent Ankara, Turkey.
EM sgunaydin@isnet.net.tr
RI ONUR, MEHMET/G-9137-2013
OI ONUR, MEHMET/0000-0002-3630-7982
CR Beck LH, 2004, DIFFERENTIATION, V72, P162, DOI 10.1111/j.1432-0436.2004.07204004.x
   Borzini P, 2005, CURR OPIN HEMATOL, V12, P473, DOI 10.1097/01.moh.0000177831.70657.e8
   Borzini P, 2005, TRANSFUSION, V45, P1759, DOI 10.1111/j.1537-2995.2005.00600.x
   EVERTS, 2006, JECT, V38, P174
   Everts PA, 2007, SURG ENDOSC, V21, P2063, DOI 10.1007/s00464-007-9293-x
   Everts PAM, 2006, GROWTH FACTORS, V24, P165, DOI 10.1080/08977190600821327
   Giannini G, 2004, TRANSFUS APHER SCI, V30, P139, DOI 10.1016/j.transci.2003.11.009
   Green DM, 1998, PLAST RECONSTR SURG, V101, P1161, DOI 10.1097/00006534-199804040-00067
   Khatafi RS, 2008, EUR J CARDIO-THORAC, V34, P360, DOI 10.1016/j.ejcts.2008.04.026
   Krasna M, 2007, ACTA DERMATOVEN ALP, V16, P105
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Trowbridge Cody C, 2005, J Extra Corpor Technol, V37, P381
   Vang See N, 2007, J Extra Corpor Technol, V39, P31
NR 13
TC 10
Z9 12
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
EI 1477-111X
J9 PERFUSION-UK
JI Perfusion-UK
PD MAY
PY 2008
VL 23
IS 3
BP 179
EP 186
DI 10.1177/0267659108097783
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 375KY
UT WOS:000261114000007
PM 19029269
DA 2018-10-19
ER

PT J
AU Yao, L
   Liu, JY
   Andreadis, ST
AF Yao, Lan
   Liu, Jinyu
   Andreadis, Stelios T.
TI Composite fibrin scaffolds increase mechanical strength and preserve
   contractility of tissue engineered blood vessels
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE cardiovascular tissue engineering; composite materials; contractility;
   fibrin; smooth muscle
ID SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-KINASE; IN-VITRO; GROWTH-FACTOR;
   MEDIA-EQUIVALENTS; CYCLIC STRAIN; VASCULAR CONSTRUCTS;
   CONTROLLED-RELEASE; ENDOTHELIAL-CELLS; PULMONARY-ARTERY
AB Purpose: We recently demonstrated that fibrin-based tissue engineered blood vessels (TEV) exhibited vascular reactivity, matrix remodeling and sufficient strength for implantation into the veins of an ovine animal model, where they remained patent for 15 weeks. Here we present an approach to improve the mechanical properties of fibrin-based TEV and examine the relationship between mechanical strength and smooth muscle cell (SMC) function.
   Materials and Methods: To this end, we prepared TEV that were composed of two layers: a cellular layer containing SMC embedded in fibrin hydrogel to provide contractility and matrix remodeling; and a second cell-free fibrin layer composed of high concentration fibrinogen to provide mechanical strength.
   Results: The ultimate tensile force of double-layered TEV increased with FBG concentration in the cell-free layer in a dose-dependent manner. Double-layered TEV exhibited burst pressure that was ten-fold higher than single-layered tissues but vascular reactivity remained high even though the cells were constricting an additional tissue layer.
   Conclusions: These results showed that mechanical strength results largely from the biomaterial but contractility requires active cellular machinery. Consequently, they may suggest novel approaches for engineering biomaterials that satisfy the requirement for high mechanical strength while preserving SMC function.
C1 [Yao, Lan; Liu, Jinyu; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Buffalo, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Buffalo, NY 14260 USA.
EM sandread@eng.buffalo.edu
CR Bader A, 2000, TRANSPLANTATION, V70, P7
   Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   BROWN SL, 1994, CARDIOVASC RES, V28, P1815, DOI 10.1093/cvr/28.12.1815
   Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95
   CLARK RAF, 1995, J CELL SCI, V108, P1251
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Drury J K, 1987, Ann Vasc Surg, V1, P542, DOI 10.1016/S0890-5096(06)61437-4
   DVORAK HF, 1987, LAB INVEST, V57, P673
   GAUDINO M, 2005, CIRCULATION, V112, P265
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Geer DJ, 2004, TISSUE ENG, V10, P1006, DOI 10.1089/ten.2004.10.1006
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hudlett P, 2005, J HYPERTENS, V23, P1559, DOI 10.1097/01.hjh.0000174607.18780.62
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Ishibashi K, 1994, ASAIO J, V40, pM284, DOI 10.1097/00002480-199407000-00009
   Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li W, 2003, J CELL PHYSIOL, V195, P202, DOI 10.1002/jcp.10230
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Martineau Laurie, 2007, Angiogenesis, V10, P269, DOI 10.1007/s10456-007-9079-8
   MATSUDA T, 1995, J THORAC CARDIOV SUR, V110, P988, DOI 10.1016/S0022-5223(05)80166-7
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PASIC M, 1995, CIRCULATION, V92, P2605, DOI 10.1161/01.CIR.92.9.2605
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Smith JD, 2001, ENDOTHELIUM-NEW YORK, V8, P41, DOI 10.3109/10623320109063156
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   THIE M, 1991, EUR J CELL BIOL, V55, P295
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 60
TC 24
Z9 24
U1 0
U2 11
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD MAY
PY 2008
VL 25
IS 5
BP 1212
EP 1221
DI 10.1007/s11095-007-9499-6
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 286MJ
UT WOS:000254849700024
PM 18092140
DA 2018-10-19
ER

PT J
AU Yu, O
   Jez, JM
AF Yu, Oliver
   Jez, Joseph M.
TI Nature's assembly line: biosynthesis of simple phenylpropanoids and
   polyketides
SO PLANT JOURNAL
LA English
DT Review
DE phenylpropanoid; polyketide; metabolic engineering; stilbene;
   isoflavone; catechin
ID SOYBEAN ISOFLAVONE SYNTHASE; PHENYLALANINE AMMONIA-LYASE; CHAIN-LENGTH
   CONTROL; CHALCONE SYNTHASE; PROANTHOCYANIDIN BIOSYNTHESIS; ENZYMATIC
   FORMATION; REACTION-MECHANISM; PLANT POLYKETIDES; CELL-CULTURES;
   LIFE-SPAN
AB Plants produce large amounts of phenylpropanoids, both in terms of molecular diversity and absolute quantity of these compounds. The phenylpropanoids, and the related plant polyketides, have multiple biological functions. They serve to attract pollinators, support secondary cell-wall growth, provide protection against various plant diseases, and interact with beneficial soil microbes. Their basic chemical properties also make them useful in the biofuel and biomaterial industries. Phenylpropanoid metabolism begins with the amino acid phenylalanine, which feeds into various biosynthetic pathways that generate a wide range of structurally related polyphenolic compounds. This review focuses on four sub-groups of these polyphenolic compounds - polyketides, stilbenes, isoflavones and catechins. We discuss the biosynthesis of these molecules, their physiological role in plants, and their striking pharmacological and physiological effects on humans. This review also highlights metabolic engineering efforts aimed at increasing or decreasing the amounts of each class of compound in various model plants and crops.
C1 [Yu, Oliver; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.
RP Yu, O (reprint author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.
EM oyu@danforthcenter.org
CR Abe I, 2006, ORG LETT, V8, P499, DOI 10.1021/ol052912h
   Abe I, 2006, FEBS J, V273, P208, DOI 10.1111/j.1742-4658.2005.05059.x
   Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v
   Abe I, 2005, J AM CHEM SOC, V127, P1362, DOI 10.1021/ja0431206
   Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x
   Abe I, 2004, PHYTOCHEMISTRY, V65, P2447, DOI 10.1016/j.phytochem.2004.08.005
   Abe I, 2004, FEBS LETT, V562, P171, DOI 10.1016/S0014-5793(04)00230-3
   Abe I, 2003, ORG LETT, V5, P1277, DOI 10.1021/ol0300165
   Abe I, 2002, ORG LETT, V4, P3623, DOI 10.1021/ol0201409
   Abe I, 2007, J AM CHEM SOC, V129, P5976, DOI 10.1021/ja0703751
   Akashi T, 2005, PLANT PHYSIOL, V137, P882, DOI 10.1104/pp.104.056747
   Akiyama T, 1999, EUR J BIOCHEM, V263, P834, DOI 10.1046/j.1432-1327.1999.00562.x
   Albertazzi P, 2002, CLIMACTERIC, V5, P190, DOI 10.1080/713605224
   Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X
   Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121
   Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5
   Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024
   Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Bomati EK, 2005, J BIOL CHEM, V280, P30496, DOI 10.1074/jbc.M502239200
   Bringmann G, 2007, J ORG CHEM, V72, P3247, DOI 10.1021/jo062566x
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288
   Das S, 2006, J NAT PROD, V69, P499, DOI 10.1021/np0504659
   Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200
   Dewick PM, 2002, MED NATURAL PRODUCTS
   Dixon RA, 1998, ADV EXP MED BIOL, V439, P55
   Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7
   Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x
   Eckermann C, 2003, PHYTOCHEMISTRY, V62, P271, DOI 10.1016/S0031-9422(02)00554-X
   Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652
   Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775
   Graham TL, 2007, PLANT PHYSIOL, V144, P728, DOI 10.1104/pp.107.097865
   HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0
   Halls C, 2008, TRENDS BIOTECHNOL, V26, P77, DOI 10.1016/j.tibtech.2007.11.002
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013
   Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s
   Jez JM, 2000, NAT STRUCT BIOL, V7, P786, DOI 10.1038/79025
   Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266
   Jez JM, 2001, J IND MICROBIOL BIOT, V27, P393, DOI 10.1038/sj.jim.7000188
   Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200
   Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499
   Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7
   Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200
   Jez JM, 2001, BIOCHEMISTRY-US, V40, P14829, DOI 10.1021/bi015621z
   Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f
   Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671
   Klingauf P, 2005, PHYTOCHEMISTRY, V66, P139, DOI 10.1016/j.phytochem.2004.11.003
   Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772
   Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668
   Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x
   Liu BY, 2004, PLANTA, V218, P492, DOI 10.1007/s00425-003-1144-y
   Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x
   Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099
   Lozovaya VV, 2007, PLANTA, V225, P665, DOI 10.1007/s00425-006-0368-z
   Lukacin R, 2005, PHYTOCHEMISTRY, V66, P277, DOI 10.1016/j.phytochem.2004.11.023
   MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018
   MACLAGAN TJ, 1876, LANCET, V1, P342, DOI DOI 10.1016/S0140-6736(02)46434-3
   Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7
   Martin Jan H J, 2007, Future Oncol, V3, P307, DOI 10.2217/14796694.3.3.307
   Medina-Bolivar F, 2007, PHYTOCHEMISTRY, V68, P1992, DOI 10.1016/j.phytochem.2007.04.039
   Messina MJ, 2001, J NUTR, V131, p3095S, DOI 10.1093/jn/131.11.3095S
   Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003
   NONOMURA S, 1963, Yakugaku Zasshi, V83, P988
   Oguro S, 2004, BIOCHEM BIOPH RES CO, V325, P561, DOI 10.1016/j.bbrc.2004.10.057
   Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326
   Paniego NB, 1999, EUR J BIOCHEM, V262, P612, DOI 10.1046/j.1432-1327.1999.00444.x
   Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n
   Peters D, 2007, ADV BIOCHEM ENG BIOT, V105, P1, DOI 10.1007/10_031
   Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502
   Rosler J, 1997, PLANT PHYSIOL, V113, P175, DOI 10.1104/pp.113.1.175
   Sawada Y, 2002, PLANT J, V31, P555, DOI 10.1046/j.1365-313X.2002.01378.x
   Schroder G, 2004, PHYTOCHEMISTRY, V65, P1085, DOI 10.1016/j.phytochem.2004.02.010
   Schroder J, 1998, BIOCHEMISTRY-US, V37, P8417, DOI 10.1021/bi980204g
   Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x
   Schwekendiek A, 2007, J AGR FOOD CHEM, V55, P7002, DOI 10.1021/jf070509e
   Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432
   Shomura Y, 2005, PROTEINS, V60, P803, DOI 10.1002/prot.20584
   SPAINK HP, 1994, ANTON LEEUW INT J G, V65, P81, DOI 10.1007/BF00871750
   Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k
   Springob K, 2007, FEBS J, V274, P406, DOI 10.1111/j.1742-4658.2006.05588.x
   Sreevidya VS, 2006, J EXP BOT, V57, P1957, DOI 10.1093/jxb/erj143
   Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238
   Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025
   Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036
   Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257
   Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006
   Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x
   Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x
   Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200
   Tian L, 2006, PLANTA, V224, P496, DOI 10.1007/s00425-006-0233-0
   TROPF S, 1994, J MOL EVOL, V38, P610
   Turck D, 2007, CURR OPIN CLIN NUTR, V10, P360, DOI 10.1097/MCO.0b013e3280fa821b
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x
   Vatanparast H, 2007, NUTR REV, V65, P294, DOI 10.1301/nr.2007jun.294-299
   Wanibuchi K, 2007, FEBS J, V274, P1073, DOI 10.1111/j.1742-4658.2007.05656.x
   Wellmann F, 2006, FEBS LETT, V580, P1642, DOI 10.1016/j.febslet.2006.02.004
   Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5
   Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x
   Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.026553.x
   Xie DY, 2005, PHYTOCHEMISTRY, V66, P2127, DOI 10.1016/j.phytochem.2005.01.008
   Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540
   Yu O, 2000, PLANT PHYSIOL, V124, P781, DOI 10.1104/pp.124.2.781
   Yu O, 2003, PHYTOCHEMISTRY, V63, P753, DOI 10.1016/S0031-9422(03)00345-5
   Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094
NR 110
TC 64
Z9 68
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7412
EI 1365-313X
J9 PLANT J
JI Plant J.
PD MAY
PY 2008
VL 54
IS 4
BP 750
EP 762
DI 10.1111/j.1365-313X.2008.03436.x
PG 13
WC Plant Sciences
SC Plant Sciences
GA 299KR
UT WOS:000255755000017
PM 18476876
OA Bronze
DA 2018-10-19
ER

PT J
AU Bhatti, IA
   Lee, J
   Jang, YD
   Kim, KS
   Kwon, JH
AF Bhatti, Ijaz A.
   Lee, Jeongeun
   Jang, Yun-Deuk
   Kim, Kyong-Su
   Kwon, Joong-Ho
TI Analysis of shellfish by thermoluminescence and X-ray diffraction
   methods: Knowledge of gamma-ray treatment and mineral characterization
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
DE shellfish; irradiation; thermoluminescence; minerals; X-ray diffraction
ID INTERNATIONAL INTERLABORATORY TRIAL; CONTAMINATING MINERALS; IRRADIATED
   SHELLFISH; LUMINESCENCE; FOODS; IDENTIFICATION; ORIGINS
AB To investigate the detection of irradiated shellfish, seven kinds of shellfish samples were gamma irradiated at 3 and 6 kGy. The first-glow curves for all the control and irradiated shellfish samples were recorded between temperatures of 50 and 400 degrees C at I heating rate of 5 degrees C/s. All the samples, the first glow curves (TL1) of which have been recorded, were re-irradiated at 1 kGy for the normalization of results. Their second glow curves (TL,) were obtained at the same conditions in order to achieve the thermoluminescence (TL) ratios (TL1/TL2). The TL method proactively identified the whole shellfish samples by using the calcite, aragonite and quartz minerals that are present in the shells. The X-ray diffraction spectroscopy has been used as all analytical tool for the characterization of minerals that are present in the shells as inorganic materials along with biomaterial. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Lee, Jeongeun; Kwon, Joong-Ho] Kyungpook Natl Univ, Dept Food Sci & Technol, Taegu 702701, South Korea.
   [Bhatti, Ijaz A.] Univ Agr Faisalabad, Dept Chem, Faisalabad, Pakistan.
   [Jang, Yun-Deuk] Kyungpook Natl Univ, Dept Geol, Taegu 702701, South Korea.
   [Kim, Kyong-Su] Chosun Univ, Dept Food Sci & Nutr, Kwangju 501759, South Korea.
RP Kwon, JH (reprint author), Kyungpook Natl Univ, Dept Food Sci & Technol, Taegu 702701, South Korea.
EM jhkwon@knu.ac.kr
RI Bhatti, Ijaz Ahmad/I-8043-2015; Kim, Kyong Su/F-8576-2014
OI Kim, Kyong Su/0000-0002-2394-857X
CR ANGEL JP, 1992, RECENT ADV DETECTION, P186
   [Anonymous], 1996, 1788 EN EUR COMM STA
   Carmichael LA, 2000, FOOD CHEM, V68, P233, DOI 10.1016/S0308-8146(99)00200-9
   Choi ID, 2004, FOOD SCI BIOTECHNOL, V13, P151
   DAVID C, 1994, ENV INDICATORS SHELL, P1
   Engin B, 2000, RADIAT MEAS, V32, P253, DOI 10.1016/S1350-4487(99)00284-X
   FIELDS P, 1996, METHYL BROMIDE ALTER
   Khan HM, 1999, J RADIOANAL NUCL CH, V242, P739, DOI 10.1007/BF02347388
   Khan HM, 1998, RADIAT PHYS CHEM, V52, P145, DOI 10.1016/S0969-806X(98)00064-4
   Kwon JH, 2002, RADIAT PHYS CHEM, V63, P415, DOI 10.1016/S0969-806X(01)00590-4
   Pinnioja S, 1999, RADIAT PHYS CHEM, V54, P505, DOI 10.1016/S0969-806X(97)00284-3
   Pinnioja S, 1999, RADIAT PHYS CHEM, V55, P743, DOI 10.1016/S0969-806X(99)00222-4
   Pinnioja S, 1998, RADIAT MEAS, V29, P651, DOI 10.1016/S1350-4487(98)00073-0
   Sanderson D. C. W., 1996, DETECTION METHODS IR, P139
   SANDERSON DCW, 1989, RADIAT PHYS CHEM, V34, P915
   Sanderson DCW, 2003, J AOAC INT, V86, P983
   Sanderson DCW, 2003, J AOAC INT, V86, P976
   Sanderson DCW, 2003, J AOAC INT, V86, P971
   SANDERSON DCW, 1990, PUBLICATION ROYAL SO, V86, P25
   Thayer DW, 1996, RAD PASTEURIZATION F
   Urbina M, 1998, J LUMIN, V79, P21, DOI 10.1016/S0022-2313(98)00015-5
   2006, FOOD IRRADIATION UPD
   2005, IRRADIATION OYSTERS
NR 23
TC 7
Z9 9
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAY
PY 2008
VL 77
IS 5
BP 663
EP 668
DI 10.1016/j.radphyschem.2007.12.009
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 291PU
UT WOS:000255210100020
DA 2018-10-19
ER

PT J
AU Benesch, J
   Hungerfod, G
   Suhling, K
   Tavares, C
   Lewitt, JA
   Mano, JF
   Reis, RL
AF Benesch, J.
   Hungerfod, G.
   Suhling, K.
   Tavares, C.
   Lewitt, J. A.
   Mano, J. F.
   Reis, R. L.
TI Application of fluorescence techniques to the study of protein
   adsorption and packing on biomaterial surfaces
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Benesch, J.; Mano, J. F.; Reis, R. L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Braga, Portugal.
   [Benesch, J.; Mano, J. F.; Reis, R. L.] IBB Inst Biotechnol & Bioengn, PT Govt Associated lab, Braga, Portugal.
   [Hungerfod, G.; Suhling, K.; Lewitt, J. A.] Kings Coll London, Dept Phys, London WC2R 2LS, England.
   [Tavares, C.] Univ Minho, Dept Phys, Guimaraes, Portugal.
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Benesch,
   Johan/C-6593-2014; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Benesch,
   Johan/0000-0003-3991-7433; Reis, Rui L./0000-0002-4295-6129
NR 0
TC 0
Z9 0
U1 1
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP18
BP 700
EP 700
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800030
DA 2018-10-19
ER

PT J
AU Longin, F
   Schwach-Abdellaoui, K
AF Longin, F.
   Schwach-Abdellaoui, K.
TI New biosynthetic bacillus-derived hyaluronic acid as an attractive
   potential biomaterial for tissue engineering applications
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Longin, F.; Schwach-Abdellaoui, K.] Novozymes Biopolymer AS, DK-2880 Bagsvaerd, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP203
BP 760
EP 761
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800215
DA 2018-10-19
ER

PT J
AU Marcacci, M
   Kon, E
   Zaffagnini, S
   Filardo, G
   Pressato, D
   Arcangeli, E
   Quarto, R
   Parma, B
   Tampieri, A
   Delcogliano, M
AF Marcacci, M.
   Kon, E.
   Zaffagnini, S.
   Filardo, G.
   Pressato, D.
   Arcangeli, E.
   Quarto, R.
   Parma, Bruna
   Tampieri, A.
   Delcogliano, M.
TI Novel nano-composite biomaterial for osteochondral tissue engineering:
   Pilot clinical study
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Marcacci, M.; Kon, E.; Zaffagnini, S.; Filardo, G.; Delcogliano, M.] Ist Ortoped Rizzoli, Bologna, Italy.
   [Pressato, D.; Arcangeli, E.] Fin Ceram SPA, Faenza, Italy.
   [Quarto, R.] Univ Genoa, Adv Biotechnol Ctr, Stem Cells Lab, Genoa, Italy.
   [Parma, Bruna] Opocrin SpA, Modena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP214
BP 764
EP 764
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800226
DA 2018-10-19
ER

PT J
AU Alves, A
   Pinho, ED
   Neves, NM
   Mano, JF
   Sousa, RA
   Reis, RL
AF Alves, A.
   Pinho, E. D.
   Neves, N. M.
   Mano, J. F.
   Sousa, R. A.
   Reis, R. L.
TI Ulvan: a new natural derived biomaterial obtained from renewable marine
   resources
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN 22-26, 2008
CL Oporto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Alves, A.; Pinho, E. D.; Neves, N. M.; Mano, J. F.; Sousa, R. A.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   [Alves, A.; Pinho, E. D.; Neves, N. M.; Mano, J. F.; Sousa, R. A.; Reis, R. L.] Inst Biotechnol & Bioengn, Braga, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Alves,
   Anabela/C-2729-2011; Mano, Joao/A-4418-2009; Neves, Nuno/B-4685-2008
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Alves,
   Anabela/0000-0002-6878-0766; Mano, Joao/0000-0002-2342-3765; Neves,
   Nuno/0000-0003-3041-0687
NR 0
TC 0
Z9 0
U1 0
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP305
BP 793
EP 793
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800317
DA 2018-10-19
ER

PT J
AU Edwards, FC
   Di, Y
   Dann, SC
   Clayton, EA
   Dye, JF
AF Edwards, F. C.
   Di, Y.
   Dann, S. C.
   Clayton, E. A.
   Dye, J. F.
TI Calcium phosphate formation causes an inflammatory response to a
   prototype biomaterial scaffold
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P57
BP 816
EP 817
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800388
DA 2018-10-19
ER

PT J
AU Caissie, R
   Tomasetig, F
   Grenier, M
   Landry, PE
   Berthod, F
AF Caissie, R.
   Tomasetig, F.
   Grenier, M.
   Landry, P. E.
   Berthod, F.
TI Evaluation of nerve regeneration across using a fibroblast nerve conduit
   filled with a collagen-based biomaterial to bridge peripheral nerve gaps
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Caissie, R.; Tomasetig, F.; Grenier, M.; Berthod, F.] Hop St Sacrement, CHAUQ, LOEX, Quebec City, PQ, Canada.
   [Caissie, R.; Landry, P. E.] Univ Laval, Dept Chirurg, Quebec City, PQ, Canada.
   [Caissie, R.; Landry, P. E.] Hop Enfants Jesus, CHAUQ, Dept Oral & Maxillofacial Surg, Quebec City, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P162
BP 850
EP 850
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800493
DA 2018-10-19
ER

PT J
AU Myllymaa, K
   Myllymaa, S
   Korhonen, H
   Kouri, VP
   Konttinen, YT
   Lappalainen, R
AF Myllymaa, K.
   Myllymaa, S.
   Korhonen, H.
   Kouri, V-P.
   Konttinen, Y. T.
   Lappalainen, R.
TI Osteoblast attachment studied using microtextured thin film biomaterial
   surfaces
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Myllymaa, K.; Myllymaa, S.; Korhonen, H.; Lappalainen, R.] Univ Kuopio, Dept Phys, Kuopio, Finland.
   [Kouri, V-P.; Konttinen, Y. T.] Univ Helsinki, Biomedicum, Helsinki, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P303
BP 894
EP 894
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800633
DA 2018-10-19
ER

PT J
AU Scaglione, S
   Zerega, B
   Cavaliere, A
   De Faveri, S
   Ilengo, C
   Quarto, R
AF Scaglione, S.
   Zerega, B.
   Cavaliere, A.
   De Faveri, S.
   Ilengo, C.
   Quarto, R.
TI Three-dimensional system (bioreactor-biomaterial) to engineer ligament
   tissue
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Scaglione, S.; Zerega, B.; Ilengo, C.; Quarto, R.] Adv Biotechnol Ctr, Stem Cell Lab, Genoa, Italy.
   [Scaglione, S.; Cavaliere, A.; De Faveri, S.] Univ Genoa, Dept Commun Comp & Syst Sci, Genoa, Italy.
   [Quarto, R.] Univ Genoa, Dept Chem & Food & Pharmaceut Technol, Genoa, Italy.
RI Scaglione, Silvia/B-7124-2014
OI Scaglione, Silvia/0000-0002-9464-3554
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P383
BP 919
EP 920
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800713
DA 2018-10-19
ER

PT J
AU Kluge, JA
   Rabotyagova, U
   Leisk, GG
   Kaplan, DL
AF Kluge, Jonathan A.
   Rabotyagova, Uena
   Leisk, Gary G.
   Kaplan, David L.
TI Spider silks and their applications
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID GENETICALLY-ENGINEERED SILK; DRAGLINE SILK; MECHANICAL-PROPERTIES;
   ESCHERICHIA-COLI; PROTEIN; FIBROIN; EXPRESSION; BIOMATERIAL; SCAFFOLDS;
   FIBERS
AB Spider silks are characterized by remarkable diversity in their chemistry, structure and functions, ranging from orb web construction to adhesives and cocoons. These unique materials have prompted efforts to explore potential applications of spider silk equivalent to those of silkworm silks, which have undergone 5000 years of domestication and have a variety of uses, from textiles to biomedical materials. Recent progress in genetic engineering of spider silks and the development of new chimeric spider silks with enhanced functions and specific characteristics have advanced spider silk technologies. Further progress in yields of expressed spider-silk proteins, in the control of self-assembly processes and in the selective exploration of material applications is anticipated in the future. The unique features of spider silks, the progress and challenges in the cloning and expression of these silks, environmentally triggered silk assembly and disassembly and the formation of fibers, films and novel chimeric composite materials from genetically engineered spider silks will be reviewed.
C1 [Kluge, Jonathan A.; Rabotyagova, Uena; Leisk, Gary G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn Chem & Mech Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn Chem & Mech Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIDCR NIH HHS [R01 DE017207]; NIBIB NIH HHS [R01 EB014283]
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Barr LA, 2004, MOL BREEDING, V13, P345, DOI 10.1023/B:MOLB.0000034089.92263.ff
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Corsini P, 2007, J POLYM SCI POL PHYS, V45, P2568, DOI 10.1002/polb.21255
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gellynck K., 2005, EUR CELLS MATER, V10, P45
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karatzas C. N., 2003, BIOPOLYMERS POLYAMID, P500
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewis R, 1996, BIOSCIENCE, V46, P636, DOI 10.2307/1312891
   McGrath K. P., 1997, PROTEIN BASED MAT
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu Y, 2005, J MATER SCI, V40, P5355, DOI 10.1007/s10853-005-4301-9
   Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zuo BQ, 2007, J APPL POLYM SCI, V106, P53, DOI 10.1002/app.26653
NR 62
TC 150
Z9 168
U1 5
U2 195
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAY
PY 2008
VL 26
IS 5
BP 244
EP 251
DI 10.1016/j.tibtech.2008.02.006
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 300MJ
UT WOS:000255827600004
PM 18367277
DA 2018-10-19
ER

PT J
AU Kim, HS
   Park, WI
   Kim, Y
   Jin, HJ
AF Kim, H. -S.
   Park, W. -I.
   Kim, Y.
   Jin, H. -J.
TI Silk fibroin films crystallized by multiwalled carbon nanotubes
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Impact Engineering
CY SEP 16-19, 2007
CL Daejeon, SOUTH KOREA
DE silk fibroins; carbon nanotubes; nanocomposites; crystallization
ID MECHANICAL-PROPERTIES; COMPOSITES; NUCLEATION; REINFORCEMENT; NYLON-6
AB Silk films prepared from regenerated silk fibroin are normally stabilized by beta-sheet formation through the use of solvents (methanol, water etc.). Herein, we report a new method of preparing water-stable films without a beta-sheet conformation from regenerated silk fibroin solutions by incorporating a small amount (0.2 wt%) of multiwalled carbon nanotubes (MWCNTs). To extend the biomaterial utility of silk proteins, forming water-stable silk-based materials with enhanced mechanical properties is essential. Scanning electron microscopy and transmission electron microscopy were used to observe the morphology of the MWCNT-incorporated silk films. The wide-angle X-ray diffraction provided clear evidence of the crystallization of the silk fibroin induced by MWCNT in the composite films without any additional annealing processing. The tensile modulus and strength of the composite films were improved by 108% and 51%, respectively, by the incorporation of 0.2 wt% of MWCNTs, as compared with those of the pure silk films. The method described in this study will provide an alternative means of crystallizing silk fibroin films without using an organic solvent or blending with any other polymers, which may be important in biomedical applications.
C1 [Kim, H. -S.; Park, W. -I.; Kim, Y.; Jin, H. -J.] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
EM hjjin@inha.ac.kr
CR ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Assouline E, 2003, J POLYM SCI POL PHYS, V41, P520, DOI 10.1002/polb.10394
   Cadek M, 2004, NANO LETT, V4, P353, DOI 10.1021/nl035009o
   Esumi K, 1996, CARBON, V34, P279, DOI 10.1016/0008-6223(96)83349-5
   Grady BP, 2002, J PHYS CHEM B, V106, P5852, DOI 10.1021/jp014622y
   Jin HJ, 2005, CHEM MATER, V17, P4034, DOI 10.1021/cm050500x
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kang M, 2006, POLYMER, V47, P3961, DOI 10.1016/j.polymer.2006.03.073
   Kim HS, 2006, MACROMOL RAPID COMM, V27, P146, DOI 10.1002/marc.200500617
   Kim JY, 2006, POLYMER, V47, P1379, DOI 10.1016/j.polymer.2005.12.042
   Liu TX, 2004, MACROMOLECULES, V37, P7214, DOI 10.1021/ma049132t
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Ryan KP, 2006, SYNTHETIC MET, V156, P332, DOI 10.1016/j.synthmet.2005.12.015
   Ryan KP, 2004, CHEM PHYS LETT, V391, P329, DOI 10.1016/j.cplett.2004.05.025
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang M, 2005, POLYMER, V46, P11510, DOI 10.1016/j.polymer.2005.10.007
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
NR 19
TC 5
Z9 5
U1 1
U2 16
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD APR 30
PY 2008
VL 22
IS 9-11
BP 1807
EP 1812
DI 10.1142/S0217979208047456
PG 6
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 312WH
UT WOS:000256702600120
DA 2018-10-19
ER

PT J
AU Jia, XT
   He, W
   Yang, W
   Zhao, HS
   Zhang, XD
AF Jia, Xingtao
   He, Wen
   Yang, Wei
   Zhao, Hongshi
   Zhang, Xudong
TI Nanomorphological anatase TiO(2): From spongy network to porous
   nanoparticles
SO MATERIALS LETTERS
LA English
DT Article
DE spongy network structure; nanomaterials; sol-gel preparation; TiO(2);
   biomaterial
ID PHOTOCATALYTIC ACTIVITY; NANOTUBE ARRAYS; METAL-OXIDES; THIN-FILMS
AB Nanomorphological anatase TiO(2) from spongy network to porous nanoparticles was synthesized by a modified sol-gel preparation and a post microwave-assisted combustion treatment. The TEM studies showed that the spongy network texture was resulted in sample calcined at lower temperature (360 degrees C) and the structure partially collapsed into solid and porous nanoparticles when calcined at higher temperature (400 degrees C). The photocatalysis study showed that the lower calcinations sample is photo-inactive large adsorbed of methyl orange than P25. The special texture, large adsorption of organ molecular and photo-inactivity of the lower calcinations sample indicated that the materials maybe served as a kind of promising biomimetic material. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Jia, Xingtao; He, Wen; Zhao, Hongshi; Zhang, Xudong] Shandong Inst Light Ind, Dept Mat Sci & Engn, Jinan 250353, Peoples R China.
   [Jia, Xingtao; Yang, Wei] China Univ Petr, Coll Chem & Chem Engn, Dongying 257061, Peoples R China.
RP He, W (reprint author), Shandong Inst Light Ind, Dept Mat Sci & Engn, Jinan 250353, Peoples R China.
EM jiaxingtao@126.com; hewen_sdili@yahoo.com.cn; yangwei@hdpu.edu.cn;
   zhaohongshi@126.com; xdzhang@icm.sdu.edu.cn
RI jia, xingtao/C-8829-2013
CR Alvaro M, 2006, J PHYS CHEM B, V110, P6661, DOI 10.1021/jp0573240
   Chen J, 2003, J AM CHEM SOC, V125, P5284, DOI 10.1021/ja034601c
   Frindell KL, 2004, CHEM MATER, V16, P3524, DOI 10.1021/cm0341989
   GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9
   HOFFMANN MR, 1995, CHEM REV, V95, P96
   Karvinen SM, 2003, IND ENG CHEM RES, V42, P1035, DOI 10.1021/ie020358z
   Kunst M, 2006, SUPERLATTICE MICROST, V39, P376, DOI 10.1016/j.spmi.2005.08.062
   Mitchell JW, 2006, MATER LETT, V60, P1524, DOI 10.1016/j.matlet.2005.11.063
   Mor GK, 2005, NANO LETT, V5, P191, DOI 10.1021/nl048301k
   Nadagouda MN, 2006, SMART MATER STRUCT, V15, P1260, DOI 10.1088/0964-1726/15/5/015
   Park JH, 2006, NANO LETT, V6, P24, DOI 10.1021/nl051807y
   Popovici N, 2006, J NON-CRYST SOLIDS, V352, P1486, DOI 10.1016/j.jnoncrysol.2005.10.036
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Toma SH, 2006, SURF SCI, V600, P4591, DOI 10.1016/j.susc.2006.07.027
   Yang PD, 1998, NATURE, V396, P152
   Yu JC, 2005, CHEM COMMUN, P2704, DOI 10.1039/b502493e
   Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8
NR 17
TC 5
Z9 5
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR 30
PY 2008
VL 62
IS 12-13
BP 1896
EP 1898
DI 10.1016/j.matlet.2007.10.034
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 297JG
UT WOS:000255612400043
DA 2018-10-19
ER

PT J
AU Liu, HT
   Xu, WL
   Zou, HT
   Ke, GZ
   Li, WB
   Ouyang, CX
AF Liu, Hongtao
   Xu, Weilin
   Zou, Hantao
   Ke, Guizhen
   Li, Wenbin
   Ouyang, Chenxi
TI Feasibility of wet spinning of silk-inspired polyurethane elastic
   biofiber
SO MATERIALS LETTERS
LA English
DT Article
DE polyurethane; spandex; silk fibroin; superfine powder; elastic biofiber
ID FIBERS; MORPHOLOGY; BEHAVIOR; FIBROIN
AB Two types of water-insoluble protein from Bombyx mori silkworm, degummed and undegummed superfine silk powders, were prepared through a physical method. Water-soluble superfine silk fibroin powder was obtained from salt-dissolved, dialyzed and freeze-dried silk fibroin. These three types of superfine silk powders were blended with solution of commercially available biomedical grade segmented polyurethane (PU) to prepare elastic biofiber by a wet-spinning process. The objective of the current study was to identify the feasibility of wet spinning of polyurethane/superfine silk powder blend elastic biofiber, and analyse and compare the mechanical properties of the as-spun biofibers. Superfine silk fibroin powders and PU were dispersed in dimethyl formamide (DMF) and the dope solution exhibited good fiber formation in a warm distilled water coagulation bath. The superfine silk powder/PU blend fiber had a smooth surface, dense structure, and considerably high strength with a circular cross-section. The future further investigation will be carried out to analyse in detail the structure and morphology of the as-spun fiber. The silk-inspired biomedical polyurethane biofiber showed potential as a biomaterial for small-diameter artificial vascular scaffolds. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Liu, Hongtao; Xu, Weilin; Zou, Hantao; Ke, Guizhen; Li, Wenbin] Wuhan Univ Sci & Engn, Textile Res Ctr, Wuhan 430073, Peoples R China.
   [Liu, Hongtao] DongHua Univ, Coll Text, Shanghai 201620, Peoples R China.
   [Ouyang, Chenxi] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan 430022, Hubei, Peoples R China.
RP Xu, WL (reprint author), Wuhan Univ Sci & Engn, Textile Res Ctr, Wuhan 430073, Peoples R China.
EM weilin-xu@hotmail.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bhat G, 2001, THERMOCHIM ACTA, V367, P161, DOI 10.1016/S0040-6031(00)00673-0
   Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Ke GZ, 2004, ACTA POLYM SIN, P103
   Ki CS, 2007, INT J BIOL MACROMOL, V41, P346, DOI 10.1016/j.ijbiomac.2007.05.005
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Li Y., 2006, US. Patent, Patent No. 7000858
   Novak S, 2004, POWDER TECHNOL, V139, P140, DOI 10.1016/j.powtec.2003.11.007
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Sanders JE, 2005, BIOMATERIALS, V26, P813, DOI 10.1016/j.biomaterials.2004.03.030
   Smeenk JM, 2005, MACROMOL SYMP, V225, P1, DOI 10.1002/masy.200550701
   Wei YP, 2004, J APPL POLYM SCI, V92, P351, DOI 10.1002/app.20023
   Xia YY, 2007, MATER LETT, V61, P4321, DOI 10.1016/j.matlet.2007.01.095
   Xu WL, 2004, POWDER TECHNOL, V140, P136, DOI 10.1016/j.powtec.2003.12.010
   XU WL, 2006, Patent No. 1268434
NR 16
TC 25
Z9 28
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR 30
PY 2008
VL 62
IS 12-13
BP 1949
EP 1952
DI 10.1016/j.matlet.2007.10.061
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 297JG
UT WOS:000255612400058
DA 2018-10-19
ER

PT J
AU Sander, B
   Raabe, D
AF Sander, B.
   Raabe, D.
TI Texture inhomogeneity in a Ti-Nb-based beta-titanium alloy after warm
   rolling and recrystallization
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE texture; rolling; biomaterial; titanium; crystal plasticity; goss;
   recrystallization; recovery; shear texture
ID AUSTENITIC STAINLESS-STEEL; BIMODAL IMI-834 BILLET; LOW-CARBON STEELS;
   CRYSTALLOGRAPHIC TEXTURE; BCC METALS; GRAIN-GROWTH; ORIENTATION
   DEPENDENCE; MECHANICAL-PROPERTIES; VARIANT SELECTION; ALPHA-PHASE
AB The crystallographic microtexture and microstructure of a beta-titanium, alloy (Ti-35 wt.% Nb-7 wt.% Zr-5 wt.% Ta) is studied after warm rolling and recrystallization. The main observations are the evolution of partially recrystallized microstructures during warm rolling and the formation of strong through-thickness texture and microstructure gradients at larger strains. Both, the recrystallized volume fraction and the texture depend on the thickness reduction. At small reductions (<= 50%) texture gradients are also small showing some alpha(bcc)-fiber (crystallographic axis < 110 > parallel to the rolling direction) and gamma-fiber (crystallographic axis < 111 > parallel to the normal direction) texture components. At larger strains (70-90%) the texture and microstructure gradients are characterized by shear texture components and dynamic recrystallization particularly close to the surface layers and plane strain texture components which are typical of recovered grains in the center layer. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Sander, B.; Raabe, D.] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany.
RP Raabe, D (reprint author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.
EM b.sander@mpie.de; d.raabe@mpie.de
RI Raabe, Dierk/A-6470-2009
OI Raabe, Dierk/0000-0003-0194-6124
CR Aernoudt E, 1993, MATER SCI TECHNOL, V6, P89
   Bache M.R., 2001, INT J FATIGUE, V23, P153
   Bache MR, 2003, INT J FATIGUE, V25, P1079, DOI 10.1016/S0142-1123(03)00145-2
   Bache MR, 2001, MAT SCI ENG A-STRUCT, V319, P409, DOI 10.1016/S0921-5093(00)02034-7
   BEYNON JH, 1988, PROCESS MODEL MET FO, V321
   BOWEN AW, 1977, MATER SCI ENG, V29, P19, DOI 10.1016/0025-5416(77)90141-0
   Bridier F, 2005, ACTA MATER, V53, P555, DOI 10.1016/j.actamat.2004.09.040
   Chen N, 2003, ACTA MATER, V51, P1755, DOI 10.1016/S1359-6454(02)00574-8
   De Gelas B., 1982, TITANIUM TITANIUM AL
   FEDOSSEEV AI, 1994, SCRIPTA METALL MATER, V30, P1, DOI 10.1016/0956-716X(94)90348-4
   Germain L, 2005, ACTA MATER, V53, P3535, DOI 10.1016/j.actamat.2005.03.043
   Gey N, 2000, SCRIPTA MATER, V42, P525, DOI 10.1016/S1359-6462(99)00396-6
   Glavicic MG, 2004, MAT SCI ENG A-STRUCT, V385, P372, DOI 10.1016/j.msea.2004.07.036
   Glavicic MG, 2003, MAT SCI ENG A-STRUCT, V351, P258, DOI 10.1016/S0921-5093(02)00844-4
   HOLSCHER M, 1991, STEEL RES, V62, P567
   HOLSCHER M, 1994, ACTA METALL MATER, V42, P879, DOI 10.1016/0956-7151(94)90283-6
   Humbert M, 2006, MAT SCI ENG A-STRUCT, V430, P157, DOI 10.1016/j.msea.2006.05.047
   Hutchinson W. B., 1984, International Metals Reviews, V29, P25
   HUTCHINSON WB, 1989, ACTA METALL MATER, V37, P1047, DOI 10.1016/0001-6160(89)90101-6
   Inamura T, 2006, MAT SCI ENG A-STRUCT, V438, P865, DOI 10.1016/j.msea.2006.02.092
   Ivasishin OM, 2002, MAT SCI ENG A-STRUCT, V332, P343, DOI 10.1016/S0921-5093(01)01755-5
   Kalinyuk AN, 2003, MAT SCI ENG A-STRUCT, V346, P178, DOI 10.1016/S0921-5093(02)00518-X
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Karthikeyan T, 2005, MAT SCI ENG A-STRUCT, V393, P294, DOI 10.1016/j.msea.2004.10.044
   Kocks U. F., 1998, TEXTURE ANISOTROPY
   Lebensohn RA, 1997, ACTA MATER, V45, P3687, DOI 10.1016/S1359-6454(97)00067-0
   MCLAREN AJ, 1993, P INT C STRIP CAST H, V107
   Peeters B, 2001, SCRIPTA MATER, V45, P1349, DOI 10.1016/S1359-6462(01)01168-X
   Ponsonnet L, 1999, MAT SCI ENG A-STRUCT, V262, P50, DOI 10.1016/S0921-5093(98)01016-8
   RAABE D, 1993, MATER SCI TECH SER, V9, P302, DOI 10.1179/mst.1993.9.4.302
   RAABE D, 1995, MATER SCI TECH SER, V11, P455, DOI 10.1179/mst.1995.11.5.455
   Raabe D, 2007, ACTA MATER, V55, P4475, DOI 10.1016/j.actamat.2007.04.024
   RAABE D, 1994, Z METALLKD, V85, P302
   RAABE D, 1995, PHILOS MAG A, V71, P805, DOI 10.1080/01418619508236221
   RAABE D, 1992, SCRIPTA METALL MATER, V27, P211, DOI 10.1016/0956-716X(92)90115-U
   RAABE D, 1995, SCRIPTA METALL MATER, V33, P735, DOI 10.1016/0956-716X(95)00276-2
   RAABE D, 1993, J PHYS IV, V3, P523, DOI 10.1051/jp4:1993784
   RAABE D, 1995, STEEL RES, V66, P222, DOI 10.1002/srin.199501116
   RAABE D, 1994, MATER SCI FORUM, V157-, P841, DOI 10.4028/www.scientific.net/MSF.157-162.841
   Raabe D, 2002, ACTA MATER, V50, P421, DOI 10.1016/S1359-6454(01)00323-8
   RAABE D, 1995, J MATER SCI, V30, P47, DOI 10.1007/BF00352130
   RAABE D, 1995, METALL MATER TRANS A, V26, P991, DOI 10.1007/BF02649096
   RAABE D, 1992, SCRIPTA METALL MATER, V26, P1221, DOI 10.1016/0956-716X(92)90567-X
   RAABE D, 1995, MAT SCI ENG A-STRUCT, V197, P31, DOI 10.1016/0921-5093(94)09770-4
   RAABE D, 1995, MATER SCI TECH SER, V11, P461, DOI 10.1179/mst.1995.11.5.461
   Raabe D., 1994, MATER SCI TECHNOL, V10, P229
   RAPHANEL JL, 1985, ACTA METALL MATER, V33, P1481, DOI 10.1016/0001-6160(85)90049-5
   Roters F, 2005, MATER SCI FORUM, V495-497, P937, DOI 10.4028/www.scientific.net/MSF.495-497.937
   Semiatin SL, 2001, MAT SCI ENG A-STRUCT, V299, P225, DOI 10.1016/S0921-5093(00)01371-X
   SINGH AK, 1999, MAT SCI ENG A-STRUCT, P225
   Stanford N, 2004, ACTA MATER, V52, P5215, DOI 10.1016/j.actamat.2004.07.034
   Suwas S, 1999, ACTA MATER, V47, P4585, DOI 10.1016/S1359-6454(99)00327-4
   Thomas I, 2003, ADV ENG MATER, V5, P566, DOI 10.1002/adem.200300373
   Toth LS, 1997, METALL MATER TRANS A, V28, P2343, DOI 10.1007/s11661-997-0191-6
   USHIODA K, 1986, MATER SCI TECH SER, V2, P807, DOI 10.1179/mst.1986.2.8.807
   Van Houtte P., 1999, TEXTURE MICROSTRUCT, V31, P109
   Zaefferer S, 2003, MAT SCI ENG A-STRUCT, V344, P20, DOI 10.1016/S0921-5093(02)00421-5
   Zeng L, 2005, MAT SCI ENG A-STRUCT, V392, P403, DOI 10.1016/j.msea.2004.09.072
NR 58
TC 58
Z9 65
U1 1
U2 49
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 25
PY 2008
VL 479
IS 1-2
BP 236
EP 247
DI 10.1016/j.msea.2007.06.077
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 292HE
UT WOS:000255256300028
DA 2018-10-19
ER

PT J
AU Tiwari, A
   Singh, SP
AF Tiwari, Ashutosh
   Singh, S. P.
TI Synthesis and characterization of biopolymer-based electrical conducting
   graft copolymers
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyaniline-graft-guar gum; water soluble; electrical conductivity;
   sensor application
ID MICROWAVE IRRADIATION; SEED-GUMS; POLYANILINE; POLYMERIZATION; POLYMERS;
   ANILINE; POLYACRYLAMIDE; ACID
AB The naturally occurring Guar gum (GG) was chemically modified with polyaniline (PANI) using ammonium persulfate (APS) as oxidant/initiator in acidic condition. The representative graft copolymer was characterized using UV-vis, FTIR, H-1 NMR, XRD, TGA, and SEM taking GG and PANI as reference. The affinity of the upper limit for the graft copolymerization has been extensively studied by varying different chemical and physical parameters. All the findings have been discussed, and proposed a plausible mechanism for the graft copolymerization. The grafted GG exhibited hybrid properties of biopoly- mer as well as PANI, and has electrical conductivity in the range of 1.6 X 10(-2) S/cm at room temperature. The electrical conductivity of the grafted biomaterial was quite sensitive with pH, and it could be interesting to combine a biopolymer, isolated from the natural resources with synthetic polymer from petrochemical origin, and yielded an eco-friendly material of high performance. (C) 2008 Wiley Periodicals, Inc.
C1 [Tiwari, Ashutosh; Singh, S. P.] Natl Phys Lab, Dept Mat Engn, New Delhi 110012, India.
RP Tiwari, A (reprint author), Natl Phys Lab, Dept Mat Engn, New Delhi 110012, India.
EM ashunpl@gmail.com
CR Ahmeda A. A., 2004, SYNTHETIC MET, V144, P29
   Anbarasan R, 2003, J APPL POLYM SCI, V90, P3827, DOI 10.1002/app.13115
   Beadle PM, 1998, SYNTHETIC MET, V95, P29, DOI 10.1016/S0379-6779(98)00028-9
   CAO Y, 1986, SYNTHETIC MET, V16, P305, DOI 10.1016/0379-6779(86)90167-0
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   GANG L, 1997, MACROMOLECULES, V30, P5660
   Gospodinova N, 1998, PROG POLYM SCI, V23, P1443, DOI 10.1016/S0079-6700(98)00008-2
   Hosseini SH, 2001, POLYM ADVAN TECHNOL, V12, P482, DOI 10.1002/pat.107
   Kim SJ, 2005, J APPL POLYM SCI, V96, P867, DOI 10.1002/app.21524
   KOBAYASHI T, 1984, J ELECTROANAL CHEM, V161, P419, DOI 10.1016/S0022-0728(84)80201-6
   LI Z, 1992, ELECTROCHIM ACTA, V37, P1003, DOI 10.1016/0013-4686(92)85215-7
   MacDiarmid AG, 2001, REV MOD PHYS, V73, P701, DOI 10.1103/RevModPhys.73.701
   MACDIARMID AG, 1989, FARADAY DISCUSS, P317
   MANOHAR SK, 1991, SYNTHETIC MET, V41, P711, DOI 10.1016/0379-6779(91)91165-7
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   Singh V, 2007, EXPRESS POLYM LETT, V1, P51, DOI 10.3144/expresspolymlett.2007.10
   Singh V, 2006, POLYMER, V47, P254, DOI 10.1016/j.polymer.2005.10.101
   Singh V, 2005, BIOMACROMOLECULES, V6, P453, DOI 10.1021/bm049518b
   Singh V, 2004, CARBOHYD POLYM, V58, P1, DOI 10.1016/j.carbpol.2004.04.010
   Singh V, 2004, J APPL POLYM SCI, V92, P1569, DOI 10.1002/app.20099
   Singh V, 2003, CARBOHYD POLYM, V54, P523, DOI 10.1016/j.carbpol.2003.05.003
   SINGH V, 2005, R J APPL POLYM SCI, V98, P1652
   Singh V, 2006, REACT FUNCT POLYM, V66, P1306, DOI 10.1016/j.reactfunctpolym.2006.03.013
   SKOTHEIM TA, 1997, HDB CONDUCTING POLYM
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Takeda S, 1999, THIN SOLID FILMS, V343, P313, DOI 10.1016/S0040-6090(98)01591-0
   Tiwari A, 2007, J MACROMOL SCI A, V44, P735, DOI 10.1080/10601320701353116
   Trivedi D. C., 1997, HDB ORGANIC CONDUCTI, V2
   TRIVEDI DC, 1993, POLYM ADVAN TECHNOL, V4, P335
   Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044
   Yang YS, 2005, POLYM ADVAN TECHNOL, V16, P24, DOI 10.1002/pat.541
NR 31
TC 34
Z9 34
U1 3
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2008
VL 108
IS 2
BP 1169
EP 1177
DI 10.1002/app.27789
PG 9
WC Polymer Science
SC Polymer Science
GA 265IO
UT WOS:000253352500060
DA 2018-10-19
ER

PT J
AU Oliveira, WE
   Franca, AS
   Oliveira, LS
   Rocha, SD
AF Oliveira, Waleska E.
   Franca, Adriana S.
   Oliveira, Leandro S.
   Rocha, Sonia D.
TI Untreated coffee husks as biosorbents for the removal of heavy metals
   from aqueous solutions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE biosorption; agricultural waste; toxic pollutants
ID ACTIVATED CARBON; WASTE-WATER; AGRICULTURAL WASTE; HEXAVALENT CHROMIUM;
   BIOSORPTION; ADSORPTION; SORPTION; CADMIUM; BIOMASS; EQUILIBRIUM
AB The objective of this work was to propose an altemative use for coffee husks (CH), a coffee processing residue, as untreated sorbents for the removal of heavy metal ions from aqueous solutions. Biosorption studies were conducted in a batch system as a function of contact time, initial metal ion concentration, biosorbent concentration and pH of the solution. A contact time of 72 It assured attainment of equilibrium for Cu(II), Cd(II) and Zn(II). The sorption efficiency after equilibrium was higher for Cu(II) (89-98% adsorption), followed by Cd(II) (65-85%) and Zn(II) (48-79%). Even though equilibrium was not attained in the case of Cr(VI) ions, sorption efficiency ranged from 79 to 86%. Sorption performance improved as metal ions concentrations were lowered. The experimental sorption equilibrium data were fitted by both Langmuir and Freundlich sorption models, with Langmuir providing the best fit (R-2 > 0.95). The biosorption kinetics was determined by fitting first and second-order kinetic models to the experimental data, being better described by the pseudo-second-order model (R-2 > 0.99). The amount of metal ions sorbed increased with the biosorbent concentration in the case of Cu(H) and Cr(VI) and did not present significant variations for the other metal ions. The effect of the initial pH in the biosorption efficiency was verified in the pH range of 4-7, and the results showed that the highest adsorption capacity occurred at distinct pH values for each metal ion. A comparison of the maximum sorption capacity of several untreated biomaterial-based residues showed that coffee husks are suitable candidates for use as biosorbents in the removal of heavy metals from aqueous solutions. (C) 2007 Elsevier B.V All rights reserved.
C1 [Oliveira, Waleska E.; Franca, Adriana S.; Oliveira, Leandro S.; Rocha, Sonia D.] Univ Fed Minas Gerais, Dept Engn Quim, BR-30160030 Belo Horizonte, MG, Brazil.
RP Oliveira, LS (reprint author), Univ Fed Minas Gerais, Dept Engn Quim, 35 Sexto Andar, BR-30160030 Belo Horizonte, MG, Brazil.
EM leandro@deq.ufmg.br
RI Franca, Adriana/N-8870-2013; Oliveira, Leandro/O-2671-2017
OI Franca, Adriana/0000-0003-0967-8451; Oliveira,
   Leandro/0000-0001-6977-7625
CR Agrawal A, 2004, COLLOID SURFACE A, V237, P133, DOI 10.1016/j.colsurfa.2004.01.034
   Al-Degs YS, 2006, WATER RES, V40, P2645, DOI 10.1016/j.watres.2006.05.018
   Annadurai A., 2002, WATER SCI TECHNOL, V47, P185
   Bansal RC, 1988, ACTIVE CARBON
   Basci N, 2004, DESALINATION, V164, P135, DOI 10.1016/S0011-9164(04)00172-9
   Brown P, 2000, ADV ENVIRON RES, V4, P19, DOI 10.1016/S1093-0191(00)00004-6
   Chen JP, 2005, IND ENG CHEM RES, V44, P9931, DOI 10.1021/ie050678t
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   Conrad K, 2007, BIORESOURCE TECHNOL, V98, P89, DOI 10.1016/j.biortech.2005.11.018
   Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X
   Doyurum S, 2006, J HAZARD MATER, V138, P22, DOI 10.1016/j.jhazmat.2006.03.071
   Evans MJB, 1999, CARBON, V37, P269, DOI 10.1016/S0008-6223(98)00174-2
   Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Kumar YP, 2006, J HAZARD MATER, V137, P1211, DOI 10.1016/j.jhazmat.2006.04.006
   Leyva-Ramos R, 2005, SEP PURIF TECHNOL, V45, P41, DOI 10.1016/j.seppur.2005.02.005
   Lodeiro P, 2005, BIORESOURCE TECHNOL, V96, P1796, DOI 10.1016/j.biortech.2005.01.002
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Meunier N, 2003, BIORESOURCE TECHNOL, V90, P255, DOI 10.1016/S0960-8524(03)00129-9
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   Mohan D, 2005, IND ENG CHEM RES, V44, P1027, DOI 10.1021/ie0400898
   Montanher SF, 2005, J HAZARD MATER, V117, P207, DOI 10.1016/j.jhazmat.2004.09.015
   Namane A, 2005, J HAZARD MATER, V119, P189, DOI 10.1016/j.jhazmat.2004.12.006
   Nasernejad B, 2005, PROCESS BIOCHEM, V40, P1319, DOI 10.1016/j.procbio.2004.06.010
   Nuhoglu Y, 2003, PROCESS BIOCHEM, V38, P1627, DOI 10.1016/S0032-9592(03)00055-4
   Pagnanelli F, 2002, WASTE MANAGE, V22, P901, DOI 10.1016/S0956-053X(02)00086-7
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   PINTO LC, 2003, QUANTIKOV IMAGE ANAL
   POLLARD SJT, 1992, SCI TOTAL ENVIRON, V116, P31, DOI 10.1016/0048-9697(92)90363-W
   Puigdom'enech I., 2004, MEDUSA
   Rajeshwarisivaraj, 2001, BIORESOURCE TECHNOL, V80, P233
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Saenger M, 2001, RENEW ENERG, V23, P103, DOI 10.1016/S0960-1481(00)00106-3
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P994, DOI 10.1016/j.biortech.2005.04.043
   Singh KK, 2005, J HAZARD MATER, V121, P51, DOI 10.1016/j.jhazmat.2004.11.002
   Titus E, 2003, COLLOID SURFACE A, V223, P55, DOI 10.1016/S0927-7757(03)00131-6
   Valdes H, 2002, LANGMUIR, V18, P2111, DOI 10.1021/la010920a
   Yu LJ, 2003, J HAZARD MATER, V100, P53, DOI 10.1016/S0304-3894(03)00008-6
NR 40
TC 121
Z9 128
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 15
PY 2008
VL 152
IS 3
BP 1073
EP 1081
DI 10.1016/j.jhazmat.2007.07.085
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 291FZ
UT WOS:000255180600024
PM 17804159
DA 2018-10-19
ER

PT J
AU Jewrajka, SK
   Kennedy, JP
AF Jewrajka, Suresh K.
   Kennedy, J. P.
TI Networks and conetworks of PIB-based cyanoacrylate-telechelic
   prepolymers: Synthesis, characterization, and properties
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biomaterial; bulk polymerization; conetwork; crosslinking;
   cyanoacrylate; network; polyisobutylene; reaction injection molding
ID ETHYL CYANOACRYLATE; COPOLYMERIZABILITY; POLYMERIZABILITY;
   POLYISOBUTYLENE
AB Novel networks and conetworks were prepared by the instantaneous polymerization of cyanoacrylate-telechelic three-arm star polyisobutylene [phi(PIB-CA)(3)] and the copolymerization of phi(PIB-CA)(3)/2,4,4-trimethylpentane cyanoacrylate (TMP-CA) mixtures, respectively, by means of strong nucleophiles, such as NEt2-telechleic linear or three-arm star PIBs [phi(PIB-NEt2)(2) or 3]. The reactants were combined in the bulk in double-barrel syringes by reaction injection molding (RIM). The chemical and mechanical properties of products prepared in the bulk and by conventional solution techniques were characterized by various techniques (swelling, extractables, FTIR and NMR spectroscopies, Instron, microhardness, oxidative resistance, DSC, DMTA). Conditions for the preparation of rubbery materials for possible biomedical applications were developed. (c) 2008 Wiley Periodicals, Inc.
C1 [Jewrajka, Suresh K.; Kennedy, J. P.] Univ Akron, Inst Polymer Sci, Akron, OH 44325 USA.
RP Kennedy, JP (reprint author), Univ Akron, Inst Polymer Sci, Akron, OH 44325 USA.
EM josep19@uakron.edu
CR Costa G, 1997, MACROMOL RAPID COMM, V18, P891, DOI 10.1002/marc.1997.030180918
   FICHT K, 1993, MAKROMOL CHEM-RAPID, V14, P6669
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   JEWRAJKA SK, IN PRESS J BIOMED A
   JEWRAJKA SK, UNPUB
   Klemarczyk P, 2001, POLYMER, V42, P2837, DOI 10.1016/S0032-3861(00)00618-2
   Kwon Y, 2007, POLYM ADVAN TECHNOL, V18, P800, DOI 10.1002/pat.969
   Kwon Y, 2007, POLYM ADVAN TECHNOL, V18, P808, DOI 10.1002/pat.968
   MATSUMOTO T, 1972, MED EXAMINATION PUBL, P5
   PAPATHEOFANIS FJ, 1989, J BIOMED MATER RES, V23, P661, DOI 10.1002/jbm.820230609
   TUNCEL A, 1995, J BIOMED MATER RES, V29, P721, DOI 10.1002/jbm.820290608
   ZUMPANO BJ, 1982, SURG NEUROL, V18, P452, DOI 10.1016/0090-3019(82)90186-0
NR 12
TC 9
Z9 9
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD APR 15
PY 2008
VL 46
IS 8
BP 2612
EP 2623
DI 10.1002/pola.22591
PG 12
WC Polymer Science
SC Polymer Science
GA 288IB
UT WOS:000254978600002
DA 2018-10-19
ER

PT J
AU Pishko, MV
AF Pishko, Michael V.
TI POLY 630-Hyperbranched polymer thin films on nanostructured biomaterial
   surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 235th American-Chemical-Society National Meeting
CY APR 06-10, 2008
CL New Orleans, LA
C1 [Pishko, Michael V.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77845 USA.
EM mpishko@tamu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 6
PY 2008
VL 235
MA 630-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 519XJ
UT WOS:000271802800338
DA 2018-10-19
ER

PT J
AU Wang, S
   Bao, HM
   Yang, PY
   Chen, G
AF Wang, Sheng
   Bao, Huimin
   Yang, Pengyuan
   Chen, Gang
TI Immobilization of trypsin in polyaniline-coated nano-Fe3O4/carbon
   nanotube composite for protein digestion
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE composite; Fe3O4; polyaniline; carbon nanotube; proteomics; trypsin
ID CARBON NANOTUBES; SOL-GEL; NANOPARTICLES; REACTOR; MICROCHIP; ANILINE;
   POLYMERIZATION; IDENTIFICATION; SEPARATION; PROTEOMICS
AB In this report, a four-component nanocomposite, trypsin-immobilized polyaniline-coated Fe3O4/carbon nanotube composite, was synthesized for highly efficient protein digestion. Fe3O4 was deposited by the chemical coprecipitation of Fe2+ and Fe3+ in an alkaline solution containing carbon nanotubes (CNTs) to prepare nano-Fe3O4/CNT composite. Subsequently, polyaniline (PA) was assembled on the Fe3O4/CNT composite by the in situ polymerization of aniline in the presence of trypsin to obtain trypsin-immobilized PA/Fe3O4/CNT nanocomposite. The novel 1D superparamagnetic biomaterial has been characterized by TEM, SEM, XRD, and magnetometric analysis. The feasibility and performance of the unique magnetic biomaterial have been demonstrated by the tryptic digestion of bovine serum albumin, myoglobin, and lysozyme within 5 min. The digests were identified by MALDI-TOF MS with sequence coverages that were comparable to those obtained from the conventional in-solution tryptic digestion. The present biocomposite offers considerable promise for protein analysis due to its high magnetic responsivity and excellent dispersibility. it can be easily isolated from the digests with the aid of an external magnetic field. Because the enzyme-immobilized nanocomposite can be prepared by a simple two-step deposition approach at low cost, it may find a wide range of biological applications including proteome research. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Chen, Gang] Fudan Univ, Sch Pharm, Shanghai 200032, Peoples R China.
   Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China.
RP Chen, G (reprint author), Fudan Univ, Sch Pharm, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.
EM gangchen@fudan.edu.cn
RI Wang, Sheng/I-2066-2015
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   AMANKWA LN, 1993, ANAL CHEM, V65, P2693, DOI 10.1021/ac00067a025
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   BIKOVA Z, 2006, ELECTROPHORESIS, V27, P1811
   Choi JW, 2002, LAB CHIP, V2, P27, DOI [10.1039/b107540n, 10.1039/b1077540n]
   Cooper JW, 2003, ANAL CHEM, V75, P1067, DOI 10.1021/ac025768b
   Deng JG, 2003, SYNTHETIC MET, V139, P295, DOI 10.1016/S0379-6779(03)00166-8
   Deng YH, 2005, COLLOID SURFACE A, V262, P87, DOI 10.1016/j.colsurfa.2005.04.009
   Ding Y, 1999, J POLYM SCI POL CHEM, V37, P2569, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2569::AID-POLA30>3.0.CO;2-N
   Downs C, 1999, ADV MATER, V11, P1028, DOI 10.1002/(SICI)1521-4095(199908)11:12<1028::AID-ADMA1028>3.0.CO;2-N
   Fan HZ, 2007, PROTEOMICS, V7, P3445, DOI 10.1002/pmic.200700505
   Ghosh P, 1999, EUR POLYM J, V35, P699, DOI 10.1016/S0014-3057(98)00157-8
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kryszewski M, 1998, SYNTHETIC MET, V94, P99, DOI 10.1016/S0379-6779(97)04152-0
   Li Y, 2007, J PROTEOME RES, V6, P2367, DOI 10.1021/pr060558r
   Li YM, 1998, ACTA POLYM SIN, P177
   Lion N, 2003, ELECTROPHORESIS, V24, P3533, DOI 10.1002/elps.200305629
   Liu Y, 2006, ANAL CHEM, V78, P801, DOI 10.1021/ac051463w
   Lu XF, 2005, NANOTECHNOLOGY, V16, P1660, DOI 10.1088/0957-4484/16/9/043
   Lu XF, 2006, J SOLID STATE CHEM, V179, P2609, DOI 10.1016/j.jssc.2006.04.029
   Peng XJ, 2005, CARBON, V43, P880, DOI 10.1016/j.carbon.2004.11.009
   Qu HY, 2004, ANAL CHEM, V76, P6426, DOI 10.1021/ac049466g
   Qu S, 2007, TALANTA, V71, P1096, DOI 10.1016/j.talanta.2006.06.003
   Righetti PG, 2004, EUR J MASS SPECTROM, V10, P335, DOI 10.1255/ejms.600
   Sakai-Kato K, 2003, ANAL CHEM, V75, P388, DOI 10.1021/ac026240+
   Slysz GW, 2005, ANAL CHEM, V77, P1572, DOI 10.1021/ac048698c
   Xu XQ, 2007, J PROTEOME RES, V6, P3849, DOI 10.1021/pr070132s
   Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O
   Zhu WZ, 2003, MATER CHEM PHYS, V82, P638, DOI 10.1016/S0254-0584(03)00341-9
NR 29
TC 61
Z9 66
U1 2
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD APR
PY 2008
VL 612
IS 2
BP 182
EP 189
DI 10.1016/j.aca.2008.02.035
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 289IX
UT WOS:000255049300009
PM 18358864
DA 2018-10-19
ER

PT J
AU Meek, MF
   Coert, JH
AF Meek, M. F.
   Coert, J. H.
TI US Food and Drug Administration/Conformit Europe-approved absorbable
   nerve conduits for clinical repair of peripheral and cranial nerves
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE NeuraGen; NeuroMatrix; Neurotube; Neurolac; absorbable nerve conduit;
   clinical
ID POLYGLYCOLIC ACID CONDUITS; RAT SCIATIC-NERVE; COLLAGEN TUBE;
   REGENERATION; RECONSTRUCTION; GUIDE; TUBULIZATION; BIOMATERIAL; DEFECTS
AB Several absorbable nerve conduits are approved by the US Food and Drug Administration (FDA) and Conformit Europe (CE) for clinical repair of peripheral and cranial nerves. Surgeons are often not aware of the different (bio)materials of these conduits when performing nerve repair. An overview of these FDA- and CE-approved absorbable nerve conduits for clinical use is presented. PubMed. MEDLINE, and the companies selling the conduits were consulted. The available FDA and CE absorbable nerve conduits for peripheral and cranial nerve repair are 2 collagen- and 2 synthetic-polyester-based conduits. The available clinical data, the price, the length, and the composition of the tube show significant differences. Based on the available data in this paper at this moment, we favor the PGA (Neurotube) nerve conduit for repair of peripheral and cranial nerve defects because of its advantages in length, price, and availability of clinical data. However, no prospective studies comparing the available nerve conduits have been published.
C1 [Meek, M. F.] Derbyshire Royal Infirm, Pulvertaft Hand Ctr, Derby DE1 2QY, England.
   [Coert, J. H.] Erasmus Univ, Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.
RP Meek, MF (reprint author), Derbyshire Royal Infirm, Pulvertaft Hand Ctr, London Rd, Derby DE1 2QY, England.
EM marcelfineek@hotmail.com
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Berger A, 1994, Handchir Mikrochir Plast Chir, V26, P44
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   BUNGE MB, 1989, DEV NEUROSCI-BASEL, V11, P348, DOI 10.1159/000111911
   Casanas J, 2000, J HAND SURG B, V25, P44
   Chamberlain LJ, 2000, J COMP NEUROL, V417, P415, DOI 10.1002/(SICI)1096-9861(20000221)417:4<415::AID-CNE3>3.0.CO;2-9
   CRAWLEY WA, 1992, PLAST RECONSTR SURG, V90, P300, DOI 10.1097/00006534-199290020-00022
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DENDUNNEN WFA, 1996, THESIS U GRONINGEN
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Ducic I, 2005, J RECONSTR MICROSURG, V21, P29, DOI 10.1055/s-2005-862777
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hagiwara Akeo, 2002, Gan To Kagaku Ryoho, V29, P2202
   Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   KEELEY RD, 1991, J RECONSTR MICROSURG, V7, P93, DOI 10.1055/s-2007-1006766
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   LAQUERRIERE A, 1994, MICROSURG, V15, P203, DOI 10.1002/micr.1920150312
   LaRosa G, 2003, RIV ITAL CHIR PLASTI, V35, P125
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   LOHMEYER J, 2007, DER CHIRURG, V78, P142
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MATHUR A, 1983, SCAN ELECT MICROSC, V2, P975
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 2006, J RECONSTR MICROSURG, V22, P149, DOI 10.1055/s-2006-939959
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MEEK MF, 2007, DER CHIRUR, V78, P1152
   MEEK MF, 2000, THESIS U GRONINGEN
   MERRELL JC, 1986, ANN PLAS SURG, V17, P49, DOI 10.1097/00000637-198607000-00010
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   ROSEN J M, 1989, Journal of Rehabilitation Research and Development, V26, P1
   ROSEN JM, 1983, ANN PLAS SURG, V11, P397, DOI 10.1097/00000637-198311000-00007
   Rosner BI, 2003, ANN BIOMED ENG, V31, P1383, DOI 10.1114/1.1626118
   Scherman P, 2001, J NEUROSURG, V95, P316, DOI 10.3171/jns.2001.95.2.0316
   Strauch B, 2000, HAND CLIN, V16, P123
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Yuen D., 2003, T SOC BIOMATERIALS, P228
NR 46
TC 101
Z9 105
U1 1
U2 41
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2008
VL 60
IS 4
BP 466
EP 472
DI 10.1097/SAP.0b013e31804d441c
PG 7
WC Surgery
SC Surgery
GA 281ML
UT WOS:000254501600028
PM 18437784
DA 2018-10-19
ER

PT J
AU Rodas, ACD
   Maizato, MJS
   Leirner, AA
   Pitombo, RNM
   Polakiewicz, B
   Beppu, MM
   Higa, OZ
AF Rodas, Andrea C. D.
   Maizato, Marina J. S.
   Leirner, Adolfo A.
   Pitombo, Ronaldo N. M.
   Polakiewicz, Bronislaw
   Beppu, Marisa M.
   Higa, Olga Z.
TI Cytotoxicity and genotoxicity of bovine pericardium preserved in
   glycerol
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 4th Latin American Congress for Artificial Organs and Biomaterials
CY AUG 08-11, 2006
CL Caxambu, BRAZIL
DE cytotoxicity; genotoxicity; glycerol; pericardium
ID MECHANISMS
AB Bovine pericardium is a widely utilized biomaterial. Usually, after harvesting, it is advantageous that the pericardium be immersed in glycerol to improve its shelf life. This can induce some degree of toxicity in the material. The studies were performed in compliance with the rules of ISO 10993 and OECD 487, in the biological evaluation of medical devices. The material was prepared without previous washing. After sterilization by gamma radiation the pericardium was immersed in RPMI 1640 culture medium to fulfill the extraction condition. The same extract was employed in the cytotoxic and genotoxic tests. The procedures were carried out with Chinese hamster ovary cell line and to determine the cytotoxicity, a colorimetric method with the tetrazolium compound MTS was used. For the genotoxicity, following the in vitro micronucleus assay, the test was developed with and without metabolic activation. The Cytotoxicity Index was graphically estimated at the extract concentration of 78%. In the genotoxicity test, the average value of cell proliferation index was found to be 1.62 +/- 0.02 with S9 metabolic activator and 1.91 +/- 0.01 without S9 metabolic activator. Both values are similar to the negative control value in the micronucleus assay. We observed that although the pericardium preserved in glycerol shows a certain level of cytotoxicity, it does not show any genotoxicity.
C1 [Rodas, Andrea C. D.; Higa, Olga Z.] IPEN CNEN SP, Ctr Biotechnol, BR-05508900 Sao Paulo, Brazil.
   [Maizato, Marina J. S.; Leirner, Adolfo A.] HC FMUSP, Inst Coracao InCor, Div Bioengn, Sao Paulo, Brazil.
   [Pitombo, Ronaldo N. M.; Polakiewicz, Bronislaw] Univ Sao Paulo, FCF, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil.
   [Beppu, Marisa M.] Univ Estadual Campinas, Escola Engn Quim, Campinas, Brazil.
RP Rodas, ACD (reprint author), IPEN CNEN SP, Ctr Biotechnol, Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM arodas@ipen.br
RI Biofabris, Inct/I-2418-2013; Rodas, Andrea/E-1130-2012; BEPPU,
   MARISA/E-1057-2012
CR BRAILE DM, 1990, THESIS EPM SP
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DIDISHEIM P, 1996, BIOMATERIALS SCI
   Garriott ML, 2002, MUTAT RES-GEN TOX EN, V517, P123, DOI 10.1016/S1383-5718(02)00059-1
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   International Standardization Organization, 1992, 109935 ISO
   MAIZATO MJS, 2003, THESIS UNICAMP CAMPI
   *ORG EC COOP DEV, 487 OECD
NR 9
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD APR
PY 2008
VL 32
IS 4
BP 272
EP 276
DI 10.1111/j.1525-1594.2008.00542.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 280GE
UT WOS:000254412900004
PM 18370940
DA 2018-10-19
ER

PT J
AU Theiszova, M
   Jantova, S
   Letasiova, S
   Valik, L
   Palou, MT
AF Theiszova, Marica
   Jantova, Sona
   Letasiova, Silvia
   Valik, Lubos
   Palou, Martin T.
TI Comparative study of a new composite biomaterial fluor-hydroxyapatite on
   fibroblast cell line NIH-3T3 by direct test
SO BIOLOGIA
LA English
DT Article
DE fluor-hydroxyapatite composite; fluorapatite; hydroxyapatite; NIH-3T3
   fibroblasts; contact basal cytotoxicity
ID IN-VITRO CYTOTOXICITY; CALCIUM-PHOSPHATE; HYDROXYLAPATITE; INVITRO;
   TISSUE; DAMAGE
AB The number of biomaterials used in biomedical applications has rapidly increased in the past two decades. Fluorapatite (FA) is one of the inorganic constituents of bone or teeth used for hard tissue repairs and replacements. Fluor-hydroxyapatite (FHA) is a new synthetically prepared composite that in its structure contains the same molecular concentration of OH- groups and F- ions. The aim of this experimental investigation was to use the embryonal mouse fibroblast cell line NIH-3T3 for comparative study of basal cytotoxicity of fluoridated biomaterials FHA and FA discs. Hydroxyapatite (HA) disc, high-density polyethylene as negative control and polyvinyl chloride (PVC) containing organotin stabilizer as positive control were used as standard biomaterials. The appropriateness of the use of NIH-3T3 cells and their sensitivity for tested biomaterials were evaluated on the basis of five cytotoxic end points: cell proliferation, cell morphology, lactate dehydrogenase (LDH) released, protein and DNA cell content. The basal cytotoxicity of FHA, FA and HA discs was measured by direct contact method. FHA composite, FA and HA demonstrated in cell line NIH-3T3 nearly similar basal cytotoxicity increasing with the time of treatment. After 72 h of biomaterials treatment, about 25% inhibition of cell number, unchanged morphology of dividing cells, 6.31-0.16% increase of released LDH, about 10% inhibition of cell protein content and about 20% inhibition of DNA content was found. On the other hand, from the growth rates it resulted that NIH-3T3 cells, affected by tested biomaterials, divided about 20% slowlier than the control (untreated cells). Using the linear regression analysis we found out that deviations in measurements of cytotoxicity by four methods were as follows: less than 10% for cell number, protein and DNA content methods and 12.4% for released LDH method. Based on a good correlation of the cytotoxicity of biomaterials obtained from all end points we could conclude that fibroblast NIH-3T3 cell line was appropriate for measuring the basal cytoxicity of tested biomaterials.
C1 [Theiszova, Marica; Jantova, Sona; Letasiova, Silvia; Valik, Lubos] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, SK-81237 Bratislava, Slovakia.
   [Palou, Martin T.] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Inorgan Chem Technol & Mat, SK-81237 Bratislava, Slovakia.
RP Theiszova, M (reprint author), Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Radlinskeho 9, SK-81237 Bratislava, Slovakia.
EM marica.theiszova@stuba.sk
RI Valik, Lubomir/A-9971-2008
OI Valik, Lubomir/0000-0001-8681-3616
CR ASTERN P, 1998, PHARM WORLD SCI, V20, P214
   BARANYI J, 1993, FOOD MICROBIOL, V10, P43, DOI 10.1006/fmic.1993.1005
   BARILE FA, 1994, INTRO VITRO CYTOTOXI
   Bergmeier H. U., 1970, METHODEN ENZYMATISCH
   FARLEY JR, 1983, SCIENCE, V222, P330
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.3.CO;2-1
   HONGSLO JK, 1974, J DENT RES, V53, P410, DOI 10.1177/00220345740530023801
   IGNAJATOVIC N, 2006, MICROSC RES TECHNIQ, V69, P976
   JARCHO M, 1977, J BIOENG, V1, P79
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KUZIELOVA E, 2006, BOOK ABSTR, V28, P99
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LANG H, 1990, J ORAL MAXIL SURG, V48, P606, DOI 10.1016/S0278-2391(10)80475-6
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Leroy N., 2001, European Cells & Materials, V2, P36
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARUGAN R, 2002, MATER LETT, V57, P429
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Nablo BJ, 2005, BIOMATERIALS, V26, P4405, DOI 10.1016/j.biomaterials.2004.11.015
   Ning Congqin, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P550
   OGURO A, 1983, J DENT HLTH, V31, P453
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   REJDA BV, 1977, J BIOENG, V1, P93
   Ribeiro Daniel Araki, 2006, Braz. Dent. J., V17, P91, DOI 10.1590/S0103-64402006000200001
   Ribeiro Daniel Araki, 2004, Braz. oral res., V18, P192, DOI 10.1590/S1806-83242004000300003
   RICE RM, 1978, J BIOMED MATER RES, V12, P43, DOI 10.1002/jbm.820120105
   Shan KR, 2004, TOXICOLOGY, V200, P169, DOI 10.1016/j.tox.2004.03.013
   Tadashi K, 2003, BIOMATERIALS, V24, P2161
   Vallittu PK, 1999, J ORAL REHABIL, V26, P666, DOI 10.1046/j.1365-2842.1999.00431.x
   Wang AG, 2004, BIOMED ENVIRON SCI, V17, P217
   Xu W, 2006, MATER LETT, V60, P1575, DOI 10.1016/j.matlet.2005.11.072
NR 34
TC 4
Z9 4
U1 1
U2 12
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0006-3088
EI 1336-9563
J9 BIOLOGIA
JI Biologia
PD APR
PY 2008
VL 63
IS 2
BP 273
EP 281
DI 10.2478/s11756-008-0043-x
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 275BA
UT WOS:000254045700025
OA Other Gold
DA 2018-10-19
ER

PT J
AU Coutinho, DF
   Pashkuleva, IH
   Alves, CM
   Marques, AP
   Neves, NM
   Reis, RL
AF Coutinho, Daniela F.
   Pashkuleva, Iva H.
   Alves, Catarina M.
   Marques, Alexandra P.
   Neves, Nuno M.
   Reis, Rui L.
TI The effect of chitosan on the in vitro biological performance of
   chitosan-poly(butylene succinate) blends
SO BIOMACROMOLECULES
LA English
DT Article
ID OSTEOBLAST ADHESION; BIOMATERIALS; FIBRONECTIN; ADSORPTION; SCAFFOLDS;
   PROTEINS; SURFACES; BINDING; CHITIN; ENERGY
AB Chitosan blends with synthetic biodegradable polymers have been proposed for various biomedical applications due to their versatile mechanical properties and easier processing. However, details regarding the main surface characteristics that may benefit from the blending of these two types of materials are still missing. Hence, this work aims at investigating the surface properties of chitosan-based blends, illustrating the way these properties determine the material-proteins interactions and ultimately the behavior of osteoblast-like cells. The surface characteristics of modified and nonmodified blends were assessed using complimentary techniques such as optical microscopy, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR-ATR), X-ray photoelectron spectroscopy (XPS), contact angle measurements and surface energy calculations. The adsorption of human serum albumin (HSA) and human plasma fibronectin (HFN) onto the different surfaces was quantified by association of an indirect method with a colorimetric assay. It was found that the presence of chitosan on the surface promoted the adsorption of proteins. Moreover, a preferential adsorption of albumin over fibronectin was registered. The in vitro biological performance of the studied materials was further investigated by a direct contact assay with an osteoblastic-like cell line (SaOs-2). A synergistic effect of the two components of the blend was observed. While the synthetic polyester promoted the adhesion of SaOs-2, the presence of chitosan significantly enhanced the osteoblastic activity of these cells. This work further confirmed the interest in designing polymeric blends with natural polymers as a successful strategy to enhance the biological performance of a biomaterial.
C1 [Coutinho, Daniela F.; Pashkuleva, Iva H.; Alves, Catarina M.; Marques, Alexandra P.; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   [Coutinho, Daniela F.; Pashkuleva, Iva H.; Alves, Catarina M.; Marques, Alexandra P.; Neves, Nuno M.; Reis, Rui L.] IBB, PT Govt Assoc Lab, Braga, Portugal.
RP Coutinho, DF (reprint author), Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM d.coutinho@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Alves, Catarina/B-3632-2018; Pashkuleva,
   Iva/B-5590-2008; Neves, Nuno/B-4685-2008; Marques,
   Alexandra/B-1238-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Alves, Catarina/0000-0001-6003-9159;
   Pashkuleva, Iva/0000-0001-6818-3374; Neves, Nuno/0000-0003-3041-0687;
   Marques, Alexandra/0000-0002-3222-0310; Reis, Rui L./0000-0002-4295-6129
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Briggs D., 1998, SURFACE ANAL POLYM X
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chatterjee S, 2005, J COLLOID INTERF SCI, V288, P30, DOI 10.1016/j.jcis.2005.02.055
   Correlo VM, 2007, MACROMOL BIOSCI, V7, P354, DOI 10.1002/mabi.200600233
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   Lee I. -S., 2007, Current Applied Physics, V7, pe6, DOI 10.1016/j.cap.2006.11.004
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rege PR, 1999, CARBOHYD RES, V321, P235, DOI 10.1016/S0008-6215(99)00172-X
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 27
TC 43
Z9 47
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2008
VL 9
IS 4
BP 1139
EP 1145
DI 10.1021/bm701268s
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 288JP
UT WOS:000254983000009
PM 18330991
DA 2018-10-19
ER

PT J
AU Lawrence, BD
   Cronin-Golomb, M
   Georgakoudi, I
   Kaplan, DL
   Omenetto, FG
AF Lawrence, Brian D.
   Cronin-Golomb, Mark
   Georgakoudi, Irene
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Bioactive silk protein biomaterial systems for optical devices
SO BIOMACROMOLECULES
LA English
DT Article
ID BOMBYX-MORI SILK; PHOTONIC CRYSTAL FIBERS; SENSITIVE HOLOGRAPHIC
   SENSORS; MECHANICAL-PROPERTIES; ABSORPTION-SPECTRA; FIBROIN MEMBRANE;
   GLUCOSE-OXIDASE; HEME-PROTEINS; IN-VITRO; IMMOBILIZATION
AB Silk-based biomaterial systems have been previously explored for a variety of medical and nonmedical materials needs. The unique biophysical features of silks provide options to generate highly tailored structures and morphologies with this unique family of fibrous proteins. To exploit these features, we have optimized the all aqueous processing of silk fibroin into novel surface nanopatterned protein materials. We have exploited control of this nanomorphology to optimize the optical features of these silk protein systems. We demonstrate control of surface morphology down to 125 nm, with fidelity over large length scales. This surface nanopatterning allows the silk protein to be formed into diffractive optics such as diffraction gratings, pattern generators, and lenses due to novel aqueous processing into optically clear materials via control of beta sheet crystallinity. Further, we incorporate biological components, such as hemoglobin and the enzyme peroxidase, during the process of forming the silk diffraction gratings. The ambient processing of the silk protein in water, in combination with these bioactive components, allows these entrained molecules to retain activity and provide added functions and selectivity to the optically active silk films. Thus, combinations of biochemical and optical readout is feasible and provides in a single, disposable/all degradable element with both spectral discrimination and biological function. These new surface nanopatterned, bioactive silk protein-based material systems offer a unique combination of features potentially useful for a range of biosensor needs, particularly when considered in concert with the remarkable mechanical properties of these proteins, their biocompatibility, and controllable biodegradation.
C1 [Lawrence, Brian D.; Cronin-Golomb, Mark; Georgakoudi, Irene; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 01225 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Ctr Sci & Technol, Dept Phys, Medford, MA 01225 USA.
RP Omenetto, FG (reprint author), Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 01225 USA.
EM fiorenzo.omenetto@tufts.edu
RI Cronin-Golomb, Mark/A-5430-2012
OI Cronin-Golomb, Mark/0000-0002-8936-4358
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   DEMURA M, 1989, BIOTECHNOL BIOENG, V33, P598, DOI 10.1002/bit.260330513
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   DEMURA M, 1989, J BIOTECHNOL, V10, P113, DOI 10.1016/0168-1656(89)90033-3
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Horecker BL, 1943, J BIOL CHEM, V148, P173
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lee MC, 2004, ANAL CHEM, V76, P5748, DOI 10.1021/ac049334n
   LLEWELLYNSMITH IJ, 1993, J NEUROSCI METH, V46, P27, DOI 10.1016/0165-0270(93)90138-H
   Marshall AJ, 2003, ANAL CHEM, V75, P4423, DOI 10.1021/ac020730k
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Omenetto FG, 2006, OPT EXPRESS, V14, P4928, DOI 10.1364/OE.14.004928
   PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022
   Russell P, 2003, SCIENCE, V299, P358, DOI 10.1126/science.1079280
   Sartain FK, 2006, ANAL CHEM, V78, P5664, DOI 10.1021/ac060416g
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wadsworth WJ, 2002, J OPT SOC AM B, V19, P2148, DOI 10.1364/JOSAB.19.002148
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   WEINBERG RJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1143, DOI 10.1177/39.8.1906909
   WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2
   Wu YH, 2006, ANAL CHIM ACTA, V558, P179, DOI 10.1016/j.aca.2005.11.031
   Xia YN, 1996, CHEM MATER, V8, P1558, DOI 10.1021/cm9602196
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 32
TC 174
Z9 181
U1 5
U2 128
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2008
VL 9
IS 4
BP 1214
EP 1220
DI 10.1021/bm701235f
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 288JP
UT WOS:000254983000019
PM 18370418
DA 2018-10-19
ER

PT J
AU Pan, H
   Jiang, HL
   Chen, WL
AF Pan, Hui
   Jiang, Hongliang
   Chen, Weiliam
TI The biodegradability of electrospun Dextran/PLGA scaffold in a
   fibroblast/macrophage co-culture
SO BIOMATERIALS
LA English
DT Article
DE fibroblasts; macrophages; co-culture; biodegradation; enzyme; receptor
ID MACROPHAGE ACTIVATION; ALVEOLAR MACROPHAGES; BETA-GLUCOSIDASE;
   GAUCHER-DISEASE; IN-VIVO; DEGRADATION; POLYURETHANES; FIBROBLASTS;
   PARTICLES; LYSOZYME
AB Fibroblast and macrophage are 2 dominant cell types respond cooperatively to degrade implanted biomaterials. Using an electrospun Dextran/Poly-lactide-co-glycolide (PLGA) scaffold as a model, an in vitro fibroblast/macrophage co-culture system was developed to investigate the degradability of implantable biodegradable materials. SEM showed that both fibroblasts and macrophages were able to degrade the scaffold, separately or cooperatively. Under the synergistic coordination of macrophages and fibroblasts, scaffolds showed faster degradation rate than their counterparts incubated with a single type of cells as well as in PBS or cell culture medium. Lysozyme, non-specific esterase (NSE), gelatinase, hyaluronidase-1 and alpha-glucosidase were up-regulated in the presence of the scaffold, suggesting their roles in the cell-mediated scaffold degradation. In addition, the expressions of cell surface receptors CD204 and Toll like receptor 4 (TLR4) were elevated I week after cell seeding, implying that these receptors might be involved in scaffold degradation. The results of in vivo subdermal implantation of the scaffold further confirmed the biodegradability of the Dextran/PLGA scaffold. The fibroblast/macrophage co-culture model adequately mimicked the in vivo environment and could be further developed into an in vitro tool for initial biomaterial evaluation. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Pan, Hui] SUNY Stony Brook, Dept Biomed Engn, Hlth Sci Ctr, Stony Brook, NY 11794 USA.
   [Jiang, Hongliang] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Chen, WL (reprint author), SUNY Stony Brook, Dept Biomed Engn, Hlth Sci Ctr, T18-030, Stony Brook, NY 11794 USA.
EM weiliam.chen@stonybrook.edu
FU NIDDK NIH HHS [DK068401, R01 DK068401, R01 DK068401-04]
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Arlein WJ., 1998, AM J PHYSIOL, V275, P1041
   Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058
   BRANCHAUD RM, 1993, PATHOBIOLOGY, V61, P154, DOI 10.1159/000163784
   Calvo P, 1997, BIOMATERIALS, V18, P1305, DOI 10.1016/S0142-9612(97)00061-6
   Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044
   Chiu RK, 1995, J NEURO-ONCOL, V26, P231, DOI 10.1007/BF01052626
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091
   Fujikawa Yosuke, 2005, Mod Rheumatol, V15, P346
   Girard N, 2002, BRIT J HAEMATOL, V119, P199, DOI 10.1046/j.1365-2141.2002.03733.x
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200
   HASILIK A, 1980, J BIOL CHEM, V255, P4937
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LEE JS, 2006, AM J PATHOL, V168, P290
   Lord MS, 2006, BIOMATERIALS, V27, P1341, DOI 10.1016/j.biomaterials.2005.09.007
   MANO JF, 2007, J R SOC INTERFAC, P999
   MEIER B, 1990, BIOL CHEM H-S, V371, P1021, DOI 10.1515/bchm3.1990.371.2.1021
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   PAN H, UNPUB FIBROBLAST MAC
   RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899
   Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95
   Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xia Z, 2006, BIOMED MATER, V1, P1
   YOMOTA C, 1990, YAKUGAKU ZASSHI, V110, P442, DOI 10.1248/yakushi1947.110.6_442
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 42
TC 44
Z9 47
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 11
BP 1583
EP 1592
DI 10.1016/j.biomaterials.2007.12.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268ZS
UT WOS:000253619900004
PM 18192003
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Scuderi, N
   Onesti, MG
   Bistoni, G
   Ceccarelli, S
   Rotolo, S
   Angeloni, A
   Marchese, C
AF Scuderi, Nicolo
   Onesti, Maria G.
   Bistoni, Giovanni
   Ceccarelli, Simona
   Rotolo, Sabrina
   Angeloni, Antonio
   Marchese, Cinzia
TI The clinical application of autologous bioengineered skin based on a
   hyaluronic acid scaffold
SO BIOMATERIALS
LA English
DT Article
DE autologous cell; co-culture; hyaluronic acid scaffold; transplantation
ID FULL-THICKNESS BURNS; CONGENITAL NEVOCELLULAR NEVUS; MALIGNANT-MELANOMA;
   MELANOCYTIC NEVI; ARTIFICIAL SKIN; SUBSTITUTES; TISSUE; RISK;
   BIOCOMPATIBILITY; RECONSTRUCTION
AB The aim of this work was to generate an in vitro skin substitute harbouring autologous fibroblasts, keratinocytes and melanocytes, to establish a new one-step clinical method in problems associated with skin disorders. Here we present a case of a nine-year-old girl with a congenital giant nevus treated by surgical approach, with primary co-cultures of keratinocytes, melanocytes and fibroblasts obtained from autologous skin biopsy. Generally these lesions need to be removed to avoid the risk of transformation into malignant melanoma. With this purpose we analyzed the melanocytes contained in the new skin substitute for the presence of genetic alterations correlated to increased risk for melanoma. The organotypical cultures were designed including an engineered scaffold of a non-woven mesh of hyaluronic acid (HYAFF (R) 11). This biomaterial has been previously demonstrated to be the most suitable to maintain polarity and to support the in vitro constructs. Six dermal-epidermal skin substitutes were transplanted and 14 days after surgery the re-epithelialized area was about 90%. Our results suggest that this new dermal-epidermal construct not only reduces hospitalization time and ameliorates scar retraction, but might also represent a solution for the high risk of developing a tumour derived from the original nevus. (c) 2007 Elsevier Ltd. All fights reserved.
C1 [Ceccarelli, Simona; Rotolo, Sabrina; Angeloni, Antonio; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy.
   [Scuderi, Nicolo; Onesti, Maria G.; Bistoni, Giovanni] Univ Roma La Sapienza, Dept Plast & Reconstruct Surg, I-00161 Rome, Italy.
RP Marchese, C (reprint author), Univ Roma La Sapienza, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.
EM cinzia.marchese@uniromal.it
RI Scuderi, Nicolo/J-2711-2018; Angeloni, Antonio/J-9392-2018; Ceccarelli,
   Simona/J-4086-2018
OI Scuderi, Nicolo/0000-0002-2458-0498; Angeloni,
   Antonio/0000-0003-4969-9548; Ceccarelli, Simona/0000-0001-8789-7719;
   MARCHESE, CINZIA/0000-0002-9280-8917; ONESTI, Maria
   Giuseppina/0000-0003-3403-2433
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARONS MS, 1983, PLAST RECONSTR SURG, V72, P355, DOI 10.1097/00006534-198309000-00019
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016
   Boyce ST, 1999, J BURN CARE REHABIL, V20, P453, DOI 10.1097/00004630-199920060-00006
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   DONATI L, 1994, P WORKSH HELD ANN M, P52
   DONATI L, 1995, WOUND REPAIR REGEN, V3, P363
   Earle SA, 2005, J CRANIOFAC SURG, V16, P904, DOI 10.1097/01.scs.0000180485.20043.d5
   Fargnoli MC, 1998, J INVEST DERMATOL, V111, P1202, DOI 10.1046/j.1523-1747.1998.00412.x
   Flores JF, 1996, CANCER RES, V56, P5023
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   KAPLAN EN, 1974, PLAST RECONSTR SURG, V53, P421, DOI 10.1097/00006534-197404000-00007
   Liu Y, 2007, CELL BIOL INT, V31, P985, DOI 10.1016/j.cellbi.2007.03.009
   Marghoob AA, 1996, ARCH DERMATOL, V132, P170, DOI 10.1001/archderm.132.2.170
   Myers S. R., 1997, Journal of Burn Care and Rehabilitation, V18, P214, DOI 10.1097/00004630-199705000-00007
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   QUABA AA, 1986, PLAST RECONSTR SURG, V78, P174, DOI 10.1097/00006534-198608000-00004
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   RHODES AR, 1981, PLAST RECONSTR SURG, V67, P782, DOI 10.1097/00006534-198106000-00012
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   RUDOLPH R, 1976, SURG GYNECOL OBSTET, V142, P49
   RUIZMALDONADO R, 1992, J PEDIATR-US, V120, P906, DOI 10.1016/S0022-3476(05)81958-4
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   SIMONETTI O, 1995, ARCH DERMATOL RES, V287, P465, DOI 10.1007/BF00373430
   SOBER AJ, 1995, CANCER, V75, P645, DOI 10.1002/1097-0142(19950115)75:2+<645::AID-CNCR2820751405>3.0.CO;2-1
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Stark HJ, 2004, EUR J CELL BIOL, V83, P631, DOI 10.1078/0171-9335-00435
   Stark HJ, 2004, BIOL PROCED ONLINE, V6, P55, DOI DOI 10.1251/BP072
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Tannous ZS, 2005, J AM ACAD DERMATOL, V52, P197, DOI 10.1016/j.jaad.2004.07.020
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 39
TC 33
Z9 35
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 11
BP 1620
EP 1629
DI 10.1016/j.biomaterials.2007.12.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268ZS
UT WOS:000253619900008
PM 18201759
DA 2018-10-19
ER

PT J
AU Rebollar, E
   Frischauf, I
   Olbrich, M
   Peterbauer, T
   Hering, S
   Preiner, J
   Hinterdorfer, P
   Romanin, C
   Heitz, J
AF Rebollar, Esther
   Frischauf, Irene
   Olbrich, Michael
   Peterbauer, Thomas
   Hering, Steffen
   Preiner, Johannes
   Hinterdorfer, Peter
   Romanin, Christoph
   Heitz, Johannes
TI Proliferation of aligned mammalian cells on laser-nanostructured
   polystyrene
SO BIOMATERIALS
LA English
DT Article
DE cell proliferation; cell morphology; laser manufacturing;
   nanotopography; polystyrene
ID SMOOTH-MUSCLE-CELLS; IN-VITRO; POLYETHYLENE-TEREPHTHALATE;
   SURFACE-CHEMISTRY; CONTACT GUIDANCE; EPITHELIAL-CELLS; PLASMA TREATMENT;
   ADHESION; GROWTH; TOPOGRAPHY
AB Biomaterial surface chemistry and nanoscale topography are important for many potential applications in medicine and biotechnology as they strongly influence cell function, adhesion and proliferation. In this work, we present periodic surface structures generated by linearly polarized KrF laser light (248 nm) on polystyrene (PS) foils. These structures have a periodicity of 200-430 nm and a depth of 30-100 nm, depending on the angle of incidence of the laser beam. The changes in surface topography and chemistry were analysed by atomic force microscopy (AFM), advancing water contact-angle measurements, Fourier-transform infrared spectroscopy using an attenuated total reflection device (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS). We show that the surface laser modification results in a significantly enhanced adhesion and proliferation of human embryonic kidney cells (HEK-293) compared to the unmodified polymer foil. Furthermore, we report on the alignment of HEK-293 cells, Chinese hamster ovary (CHO-K1) cells and skeletal myoblasts along the direction of the structures. The results indicate that the presence of nanostructures on the substrates can guide cell alignment along definite directions, and more importantly, in our opinion, that this alignment is only observed when the periodicity is above a critical periodicity value that is cell-type specific. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Rebollar, Esther; Olbrich, Michael; Heitz, Johannes] Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria.
   [Frischauf, Irene; Preiner, Johannes; Hinterdorfer, Peter; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria.
   [Peterbauer, Thomas; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria.
RP Heitz, J (reprint author), Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria.
EM johannes.heitz@jku.at
RI Heitz, Johannes/O-8637-2015; Romanin, Christoph/D-5399-2009;
   Hinterdorfer, Peter/C-4235-2013; Peterbauer, Thomas/A-8001-2008;
   Rebollar, Esther/N-4065-2014
OI Heitz, Johannes/0000-0002-5608-5133; Romanin,
   Christoph/0000-0003-3756-4136; Peterbauer, Thomas/0000-0002-2362-5711;
   Rebollar, Esther/0000-0002-1144-7102; Frischauf,
   Irene/0000-0003-0661-2932; Preiner, Johannes/0000-0002-6755-6543
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   ARENHOLZ E, 1996, SPIE P, V2777, P90
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511
   Bauerle D., 2000, LASER PROCESSING CHE
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   BOLLE M, 1992, APPL PHYS LETT, V60, P674, DOI 10.1063/1.106588
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951
   CLARK P, 1991, J CELL SCI, V99, P73
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Csete M, 1998, APPL SURF SCI, V133, P5, DOI 10.1016/S0169-4332(98)00192-5
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Duncan AC, 2007, COLLOID SURFACE B, V54, P150, DOI 10.1016/j.colsurfb.2006.09.013
   Gejo JL, 2006, PHOTOCH PHOTOBIO SCI, V5, P948, DOI 10.1039/b611874g
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   Kim KH, 2001, NUCL INSTRUM METH B, V175, P542, DOI 10.1016/S0168-583X(00)00650-9
   LAZARE S, 1993, J APPL PHYS, V74, P4953, DOI 10.1063/1.354333
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lopez-Gejo J, 2005, PHOTOCHEM PHOTOBIOL, V81, P777, DOI 10.1562/2004-11-30-RA-387R.1
   Lu HW, 2004, MATER LETT, V58, P29, DOI 10.1016/S0167-577X(03)00408-7
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mikulikova R, 2005, BIOMATERIALS, V26, P5572, DOI 10.1016/j.biomaterials.2005.02.010
   Mirzadeh H, 2003, RADIAT PHYS CHEM, V67, P381, DOI 10.1016/S0969-806X(03)00071-9
   Morra M, 2002, PLASMAS POLYM, V7, P89, DOI 10.1023/A:1016250718123
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   ONYIRIUKA EC, 1994, J ADHES SCI TECHNOL, V8, P1, DOI 10.1163/156856194X00014
   Peterbauer T, 2006, LAB CHIP, V6, P857, DOI 10.1039/b601803c
   Rademacher A, 2001, INT J ARTIF ORGANS, V24, P235
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Rockova-Hlavackova K, 2004, NUCL INSTRUM METH B, V225, P275, DOI 10.1016/j.nimb.2004.05.004
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Svorcik V, 2004, NUCL INSTRUM METH B, V217, P307, DOI 10.1016/j.nimb.2003.09.036
   Svorcik V, 2004, NUCL INSTRUM METH B, V215, P366, DOI 10.1016/j.nimb.2003.08.030
   Svorcik V, 2001, J MATER SCI LETT, V20, P1941, DOI 10.1023/A:1013130617983
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 58
TC 150
Z9 150
U1 7
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 12
BP 1796
EP 1806
DI 10.1016/j.biomaterials.2007.12.039
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284TV
UT WOS:000254729800007
PM 18237776
DA 2018-10-19
ER

PT J
AU Velzenberger, E
   Vayssade, M
   Legeay, G
   Nagel, MD
AF Velzenberger, Elodie
   Vayssade, Muriel
   Legeay, Gilbert
   Nagel, Marie-Danielle
TI Study of cell behaviour on a cellulose anti-adhesive substratum
SO CELLULOSE
LA English
DT Article
DE carboxymethylcellulose; hydroxypropylmethylcellulose; three-dimensional
   culture; cell adhesion; cell proliferation; apoptosis
ID ANCHORAGE-INDEPENDENT GROWTH; MELANOMA-CELLS; DIFFERENTIAL EXPRESSION;
   EXTRACELLULAR-MATRIX; APOPTOTIC CELLS; DRUG-DELIVERY; T-LYMPHOCYTES;
   IN-VITRO; SURVIVAL; ADHESION
AB Carboxymethylcellulose (CMC) is used as an anti-adhesive in several biomaterial applications. We have shown that an original bi-layered hydroxypropylmethylcellulose (HPMC)-CMC-coated substratum (CEL) is suitable for studying the molecular mechanisms underlying cell-substratum and cell-cell interactions. The present work was carried out to assess the anti-adhesive properties of a CEL substratum by analysing the behaviour of three types of adherent cells (Swiss 3T3 fibroblasts, MC-3T3-E1 pre-osteoblasts and B16F10 highly metastatic melanoma cells). Tissue culture polystyrene (tPS) was used as an adhesive control and poly(2-hydroxyethyl methacrylate) PolyHEMA as an anti-adhesive control. Cell morphology, growth, cell cycle analysis and apoptosis were compared. The proliferation of cells on CEL was significantly decreased, cells were arrested in the G1 phase and underwent apoptosis (except for melanoma cells) 48 h post-seeding. We conclude that CEL is an effective anti-adhesive cellulose biomaterial that gives reproducible and demonstratable results, especially for apoptosis. Its advantage as a coating for culture devices is its long shelf-live. It may therefore also be a very good candidate for other biomedical applications requiring adhesion-resistant substrata.
C1 [Velzenberger, Elodie; Vayssade, Muriel; Nagel, Marie-Danielle] Univ Technol Compiegne, CNRS, UMR Domaine Biomat Biocompatibil 6600, F-60205 Compiegne, France.
   [Legeay, Gilbert] Ctr Transfert Technol Mans, Dept Mat, Le Mans, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR Domaine Biomat Biocompatibil 6600, 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
CR Barbucci R, 2004, J BIOMAT SCI-POLYM E, V15, P607, DOI 10.1163/156856204323046870
   Beck D E, 1997, Eur J Surg Suppl, P49
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x
   Buckenmaier CC, 2000, AM SURGEON, V66, P1041
   Caruso DM, 2006, J BURN CARE RES, V27, P298, DOI 10.1097/01.BCR.0000216741.21433.66
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chiumiento A, 2006, J MATER SCI-MATER M, V17, P427, DOI 10.1007/s10856-006-8470-0
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   DEPAUWGILLET MCAJ, 1988, ANTICANCER RES, V8, P153
   Diaz-Montero CM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-39
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   FADOK VA, 1992, J IMMUNOL, V148, P2207
   Faucheux N, 2004, BIOMATERIALS, V25, P2501, DOI 10.1016/j.biomaterials.2003.09.036
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   FAUCHEUX N, 2006, BEHAV CELLS CULTURED, P35
   FEDERMENGUS C, 2007, BR J CANC
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frankfurt OS, 2001, J HISTOCHEM CYTOCHEM, V49, P369, DOI 10.1177/002215540104900311
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gekas J, 2004, FEBS LETT, V563, P103, DOI 10.1016/S0014-5793(04)00276-5
   Ghosh S, 2005, ANN SURG, V242, P851, DOI 10.1097/01.sla.0000189571.84213.b0
   Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723
   Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431
   Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857
   Guest JF, 2005, CURR MED RES OPIN, V21, P281, DOI 10.1185/030079905X25532
   Guest JF, 2005, CURR MED RES OPIN, V21, P81, DOI 10.1185/030079904X15219
   Hindie A, 2005, BIOMOL ENG, V22, P205, DOI 10.1016/j.bioeng.2005.07.002
   Hindie M, 2006, J CELL BIOCHEM, V99, P96, DOI 10.1002/jcb.20833
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Jorgensen K, 2005, BIOCHEM BIOPH RES CO, V329, P266, DOI 10.1016/j.bbrc.2005.01.143
   Krylov SN, 2000, ELECTROPHORESIS, V21, P767, DOI 10.1002/(SICI)1522-2683(20000301)21:4<767::AID-ELPS767>3.3.CO;2-5
   LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2
   Liu LS, 2007, CELLULOSE, V14, P15, DOI 10.1007/s10570-006-9095-7
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Mousavi-Shafaei P, 2006, ANTI-CANCER DRUG, V17, P1031, DOI 10.1097/01.cad.0000231474.77159.e3
   Ravenscroft MJ, 2006, ANN ROY COLL SURG, V88, P18, DOI 10.1308/003588406X82989
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shiras A, 2002, CLIN EXP METASTAS, V19, P445, DOI 10.1023/A:1016305611858
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   Tsuchimochi K, 2005, MOL CELL BIOL, V25, P7344, DOI 10.1128/MCB.25.16.7344-7356.2005
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang LH, 2004, MT SINAI J MED, V71, P361
   Wu PC, 1998, DRUG DEV IND PHARM, V24, P179, DOI 10.3109/03639049809085604
   Zhan M, 2004, HISTOL HISTOPATHOL, V19, P973, DOI 10.14670/HH-19.973
   Zhang XD, 2004, MOL CANCER THER, V3, P187
NR 55
TC 11
Z9 11
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD APR
PY 2008
VL 15
IS 2
BP 347
EP 357
DI 10.1007/s10570-007-9182-4
PG 11
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 267QR
UT WOS:000253524800017
DA 2018-10-19
ER

PT J
AU Islek, C
   Sinag, A
   Akata, I
AF Islek, Cemil
   Sinag, Ali
   Akata, Ilgaz
TI Investigation of biosorption behavior of methylene blue on Pleurotus
   ostreatus (Jacq.) P. Kumm.
SO CLEAN-SOIL AIR WATER
LA English
DT Article
DE Pleurotus ostreatus (Jacq.) P. Kumm.; methylene blue; adsorption;
   Langmuir; biosorption; wastewater
ID ACTIVATED CARBON; HEAVY-METALS; ADSORPTION; KINETICS; REMOVAL;
   MECHANISM; SORPTION; DYES; EQUILIBRIUM; COPPER
AB The effect of varying parameters such as dye concentration, adsorbent dose, pH and temperature on the adsorption capacity of Pleurotus ostreatus is investigated. The commonly available white rot fungus Pleurotus ostreatus is investigated as a viable biomaterial for the biological treatment of synthetic basic methylene blue effluents. The results obtained from the batch experiments reveal the ability of the fungus to remove methylene blue. The performance is dependent on the dye concentration, pH, and fungal biomass. The equilibrium and kinetics of adsorption are investigated and the Langmuir equation is used to fit the equilibrium isotherm. The adsorption isotherm of methylene blue follows only the Langmuir model with a correlation coefficient of ca. 0.96-0.99. The maximum adsorption capacity is ca. 70 mg of dye per g of dry fungus at pH 11, 70 mg L(-1) dye, and 0.1 g L(-1) fungus concentration, respectively. This study demonstrates that the fungus could be used as an effective biosorbent for the treatment of dye-containing wastewater streams.
C1 [Sinag, Ali] Ankara Univ, Fac Sci, Dept Chem, TR-06100 Ankara, Turkey.
   [Islek, Cemil; Akata, Ilgaz] Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey.
RP Sinag, A (reprint author), Ankara Univ, Fac Sci, Dept Chem, TR-06100 Ankara, Turkey.
EM sinag@science.ankara.edu.tr
OI Akata, Ilgaz/0000-0002-1731-1302
CR CEDENO VMA, 2002, WORLD J MICROB BIOT, V18, P201
   Dogan M, 2004, J HAZARD MATER, V109, P141, DOI 10.1016/j.jhazmat.2004.03.003
   El Qada EN, 2006, CHEM ENG J, V124, P103, DOI 10.1016/j.cej.2006.08.015
   FINDON A, 1993, J ENVIRON SCI HEAL A, VA28, P173, DOI 10.1080/10934529309375870
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kargi F, 2004, ENZYME MICROB TECH, V35, P267, DOI 10.1016/j.enzmictec.2004.05.002
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Meshko V, 2001, WATER RES, V35, P3357, DOI 10.1016/S0043-1354(01)00056-2
   Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402
   Namasivayam C, 1996, BIORESOURCE TECHNOL, V57, P37, DOI 10.1016/0960-8524(96)00044-2
   PLATT MW, 1984, APPL MICROBIOL BIOT, V20, P150
   Quek SY, 1998, WATER SA, V24, P251
   Sarin V., 2006, BIORESOURCE TECHNOL, V97, P5
   Shaobin W., 2005, J COLLOID INTERF SCI, V284, P440
   SOLAK H, 1996, THESIS DOKUZ EYLUL U
   Soo SK, 1998, BIOTECHNOL LETT, V20, P569
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vasanth KK, 2005, BIOCH ENG J, V27, P83, DOI DOI 10.1016/J.BEJ.2005.08.004
   Walker GM, 1999, WATER RES, V33, P1895, DOI 10.1016/S0043-1354(98)00388-1
   Walker GM, 1997, WATER RES, V31, P2093, DOI 10.1016/S0043-1354(97)00039-0
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
NR 22
TC 15
Z9 15
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1863-0650
J9 CLEAN-SOIL AIR WATER
JI Clean-Soil Air Water
PD APR
PY 2008
VL 36
IS 4
BP 387
EP 392
DI 10.1002/clen.200700167
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Marine
   & Freshwater Biology; Water Resources
SC Science & Technology - Other Topics; Environmental Sciences & Ecology;
   Marine & Freshwater Biology; Water Resources
GA 293OP
UT WOS:000255344900021
DA 2018-10-19
ER

PT J
AU Oliveira, NTC
   Guastaldi, AC
AF Oliveira, N. T. C.
   Guastaldi, A. C.
TI Electrochemical behavior of Ti-Mo alloys applied as biomaterial
SO CORROSION SCIENCE
LA English
DT Article
DE titanium alloys; cyclic voltammetry; passivation; anodic films; pitting
   corrosion
ID IN-VITRO CORROSION; TITANIUM-ALLOYS; BIOCOMPATIBLE ALLOYS; ANODIC
   OXIDES; FILM; STABILITY; ZIRCONIUM; LAYERS; MEDIA; WEAR
AB Electrochemical investigation on the as-cast Ti-Mo alloys (4-20 Mo wt.%) applied as biomaterials in Na2SO4 and Ringer physiological solutions is reported. Analyses of the open-circuit potential indicated that all alloys present spontaneous passivation. SEM and cyclic voltammograms obtained in the Ringer solution showed that the samples studied do not present pitting corrosion at potentials up to 8 V (SCE), indicating high corrosion resistance. Open-circuit potential profiles of the anodic oxides growth in both solutions show that the presence of chloride ions during the anodization does not influence the oxides' chemical stability, and also clearly indicate that adding Mo to pure Ti improves the stability of the anodic oxides. All these results suggest Ti-Mo alloys promissory to be applied as biomaterials. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Oliveira, N. T. C.; Guastaldi, A. C.] Univ Estadual Paulista, Grp Biomat, Dept Quim Fis, Inst Quim, BR-14081970 Araraquara, SP, Brazil.
RP Guastaldi, AC (reprint author), Univ Estadual Paulista, Grp Biomat, Dept Quim Fis, Inst Quim, Rua Francisco Degni S-N,POB 355, BR-14081970 Araraquara, SP, Brazil.
EM guastald@iq.unesp.br
RI Oliveira, Nilson/G-4429-2015; Guastaldi, Antonio/O-7379-2014
OI Guastaldi, Antonio/0000-0002-6433-3555
CR ARVIA AJ, 1979, ISRAEL J CHEM, V18, P89
   BANEMARK PI, 1997, OSSEOINTEGRATED IMPL
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   CAMARA OR, 1984, ELECTROCHIM ACTA, V29, P1111, DOI 10.1016/0013-4686(84)87163-7
   DAlkaine CV, 1997, J ELECTROCHEM SOC, V144, P3331, DOI 10.1149/1.1838014
   DALKAINE CV, 1993, CORROS SCI, V34, P129, DOI 10.1016/0010-938X(93)90264-H
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guastaldi A. C., 2003, METALURGIA MAT, V59, P442
   Guo H, 2002, ACTA MATER, V50, P929, DOI 10.1016/S1359-6454(01)00392-5
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   HEAKAL FE, 1987, CORROS SCI, V27, P453, DOI 10.1016/0010-938X(87)90089-8
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kuroda D., 1995, J BIOMED MATER RES, V29, P943
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   LIU Y, 2003, J CENTRAL S U TECHNO, V2, P81
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2002, SURF INTERFACE ANAL, V33, P570, DOI 10.1002/sia.1422
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Marcus P, 1998, ELECTROCHIM ACTA, V43, P109, DOI 10.1016/S0013-4686(97)00239-9
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Maurice V, 1996, J ELECTROCHEM SOC, V143, P1182, DOI 10.1149/1.1836616
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira EM, 2000, ELECTROCHEM COMMUN, V2, P254, DOI 10.1016/S1388-2481(00)00018-7
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Oliveira NTC, 2005, J BIOMED MATER RES A, V74A, P397, DOI 10.1002/jbm.a.30352
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   OLIVEIRA NTC, 2007, J MAT SCI ENG A, V452, P727
   Popa MV, 2005, REV CHIM-BUCHAREST, V56, P908
   SAKAGUCHI S, 1999, MET MATER INT, V2, P193
   Schmidt H, 1998, MATER SCI TECH-LOND, V14, P592, DOI 10.1179/mst.1998.14.6.592
   Sugano M., 1998, MAT SCI ENG A-STRUCT, V1-2, P163
   WILLIAMS DF, 1981, CRC SERIES BIOCOMPAT, V1, P24
   Yoshimitsu D, 2003, MAT SCI ENG A-STRUCT, V1-3, P133
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
   Zhang LC, 2005, J MATER SCI, V40, P2833, DOI 10.1007/s10853-005-2426-5
   ZHANG LC, 2005, APPL PHYS LETT, V87, P3
NR 41
TC 88
Z9 91
U1 2
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD APR
PY 2008
VL 50
IS 4
BP 938
EP 945
DI 10.1016/j.corsci.2007.09.009
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 293JA
UT WOS:000255330400004
DA 2018-10-19
ER

PT J
AU Oilo, M
   Gjerdet, NR
   Tvinnereim, HM
AF Oilo, Marit
   Gjerdet, Nils Roar
   Tvinnereim, Helene M.
TI The firing procedure influences properties of a zirconia core ceramic
SO DENTAL MATERIALS
LA English
DT Article
DE dental ceramics; zirconia; heat treatment; flexural strength;
   microhardness; fractography
ID FIXED PARTIAL DENTURES; Y-TZP-ZIRCONIA; FRACTURE-SURFACE-ANALYSIS;
   DENTIN THICKNESS RATIO; FLEXURAL STRENGTH; HEAT-TREATMENT; IN-VITRO;
   RELIABILITY; PERFORMANCE; BIOMATERIAL
AB Objectives. High-strength ceramics for dental restoration are used as an understructure (core) that subsequently is covered by veneering ceramic. The veneering process involves a firing procedure at high temperatures at least once, usually two to five times. The aim of this study was to investigate whether these firing procedures affect the mechanical properties of a zirconia ceramic.
   Methods. Thirty-three specimens of an industrially sintered yttria -stabilized zirconia ceramic (DC Zircon, DCS Dental AG, Allschwil, Switzerland) were cut into bars (1.2 mm x 4 mm x 20 mm). one set of specimens (n = 13) remained untreated (controls). Another set of specimens (n = 10) was heat-treated once, corresponding to the first step of the veneering process. The third set of specimens (n = 10) was heat-treated five times to mimic the full veneering process. Flexural strength, microhardness, dimensions and surface roughness were measured. The fracture patterns were assessed by light microscopy.
   Results. The untreated specimens showed a statistically significant higher flexural strength (20%) and microhardness (9%) than both of the test groups (p <= 0.001). No significant differences were found for fracture patterns, dimensions or surface roughness.
   Significance. The heat treatment associated with the veneering procedure on a zirconia core material reduced the flexural strength of the core after the first firing. Subsequent firings were not detrimental to the properties measured. (C) 2007 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Oilo, Marit; Gjerdet, Nils Roar; Tvinnereim, Helene M.] Univ Bergen, Dept Oral Sci, N-5009 Bergen, Norway.
RP Oilo, M (reprint author), Univ Bergen, Dept Oral Sci, Arstadveien 17, N-5009 Bergen, Norway.
EM marit.oilo@odont.uib.no
OI Oilo, Marit/0000-0002-7134-6485
CR Alcala J, 2000, J AM CERAM SOC, V83, P1977
   ALCALA J, 1977, J AM CERAM SOC, V80, P2759
   [Anonymous], 1995, 6872 ISO
   BADWAL SPS, 1995, SOLID STATE IONICS, V76, P67, DOI 10.1016/0167-2738(94)00236-L
   Balkaya MC, 2005, J PROSTHET DENT, V93, P346, DOI 10.1016/j.prosdent.2005.02.003
   Cattell MJ, 2002, J DENT, V30, P161, DOI 10.1016/S0300-5712(02)00013-1
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Fleming GJP, 2006, DENT MATER, V22, P771, DOI 10.1016/j.dental.2005.11.005
   Fleming GJP, 2005, DENT MATER, V21, P164, DOI 10.1016/j.dental.2004.01.005
   Fleming GJP, 2004, DENT MATER, V20, P142, DOI 10.1016/S0109-5641(03)00085-X
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2004, INT J PROSTHODONT, V17, P142
   Guazzato M, 2004, BIOMATERIALS, V25, P2153, DOI 10.1016/j.biomaterials.2003.08.056
   Hull D., 1999, FRACTOGRAPHY OBSERVI
   Hummel R E, 2004, UNDERSTANDING MAT SC
   Isgro G, 2005, DENT MATER, V21, P557, DOI 10.1016/j.dental.2004.08.006
   KELLY JR, 1989, J PROSTHET DENT, V62, P536, DOI 10.1016/0022-3913(89)90075-9
   KELLY JR, 1995, J DENT RES, V74, P1253, DOI 10.1177/00220345950740060301
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quinn JB, 2005, DENT MATER, V21, P920, DOI 10.1016/j.dental.2005.01.006
   Studart AR, 2007, DENT MATER, V23, P115, DOI 10.1016/j.dental.2005.12.009
   STUDART AR, 2006, DENT MATER, V23, P177
   Sundh A, 2005, DENT MATER, V21, P476, DOI 10.1016/j.dental.2004.07.013
   Taskonak B, 2006, J DENT RES, V85, P277, DOI 10.1177/154405910608500314
   WHALEN PJ, 1989, J AM CERAM SOC, V72, P319, DOI 10.1111/j.1151-2916.1989.tb06124.x
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
NR 33
TC 24
Z9 28
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2008
VL 24
IS 4
BP 471
EP 475
DI 10.1016/j.dental.2007.04.008
PG 5
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 279TM
UT WOS:000254377600005
PM 17651794
DA 2018-10-19
ER

PT J
AU Salgueiredo, E
   Vila, M
   Silva, MA
   Lopes, MA
   Santos, JD
   Costa, FM
   Silva, RF
   Gomes, PS
   Femandes, MH
AF Salgueiredo, E.
   Vila, M.
   Silva, M. A.
   Lopes, M. A.
   Santos, J. D.
   Costa, F. M.
   Silva, R. F.
   Gomes, P. S.
   Femandes, M. H.
TI Biocompatibility evaluation of DLC-coated Si3N4 substrates for
   biomedical applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on New Diamond and Nano Carbons
CY MAY 28-31, 2007
CL Osaka, JAPAN
SP New Energy & Ind Technol Dev Org, Japan New Diamond Forum, Elsevier, Seki Technotron, Natl Inst Ind Sci & Technol, Element Six
DE DLC coatings; biomedical applications; cell cultures
ID DIAMOND-LIKE CARBON; SURFACE FREE-ENERGY; FILMS; OSTEOBLASTS; COATINGS;
   PROTEINS; BEHAVIOR
AB DLC coatings are of enormous interest for biotribological applications due to their biocompatibility, auto-lubricious, and non-stick properties. The most demanding implant is the hip joint. Alternative materials to metal alloys are being increasingly investigated aiming low wear debris volume, in any case innocuous wear particles. Silicon nitride (Si3N4) ceramics are light, tough, mechanical resistant, inert materials, turning them suitable for high-load medical applications. In this study, Si3N4 polished substrates were coated with adherent DLC coatings grown by DC magnetron sputtering to reduce of the friction forces against any antagonist material. Surface characterization results showed that the developed material is quite hydrophobic, with a total surface tension of 45.7 mN/m (polar component: 9.1 mN/m; dispersive component: 36.6 mN/m), and a zeta potential of -35.0 +/- 1.3 mV. In vitro testing using an acellular simulated body fluid (SBF) showed no apatite layer formation ability, as confirmed by SEM observation and analysis of the solution ions concentration with immersion time. MG63 osteoblast-like cells showed poor adhesion on the DLC films but the adherent cells displayed a normal morphology and, as compared to standard polystyrene tissue culture plates, exhibited a higher cell growth rate, suggesting no indication of cytotoxicity. Results suggested that the novel DLC-coated Si3N4 biomaterial should be adequate to be used for articular prostheses medical application. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Salgueiredo, E.; Vila, M.; Silva, R. F.] Univ Aveiro, Glass & Ceram Eng Dept, CICECO, P-3810193 Aveiro, Portugal.
   [Silva, M. A.; Lopes, M. A.; Santos, J. D.] Inst Biomed Engn, Lab Biomat, Oporto, Portugal.
   [Lopes, M. A.; Santos, J. D.] Univ Porto, Fac Engn, Dep Eng Met & Mat, Oporto, Portugal.
   [Costa, F. M.] Univ Aveiro, Dept Phys, P-3810193 Aveiro, Portugal.
   [Gomes, P. S.; Femandes, M. H.] Univ Porto, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, Oporto, Portugal.
RP Silva, RF (reprint author), Univ Aveiro, Glass & Ceram Eng Dept, CICECO, P-3810193 Aveiro, Portugal.
EM rsilva@cv.ua.pt
RI Universidade Aveiro, Departamento Fisica/E-4128-2013; Lopes,
   Cristina/A-4241-2010; Costa, Florinda/J-4345-2013; Lopes, Maria
   A./P-4442-2014; Gomes, Pedro/K-2433-2014; Silva, Rui/B-8208-2008
OI Costa, Florinda/0000-0001-8729-714X; Lopes, Maria
   A./0000-0003-4105-8148; Gomes, Pedro/0000-0001-5365-2123; Silva,
   Rui/0000-0002-2584-1792; Silva, Marta/0000-0002-4833-3686; Santos, Jose
   Domingos/0000-0002-6871-9850; Vila, Mercedes/0000-0002-8473-0881;
   Fernandes, Maria Helena/0000-0001-9391-9574
CR Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Fairbrother F., 1924, J CHEM SOC, V75, P2318
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Narayan RJ, 2005, MAT SCI ENG C-BIO S, V25, P405, DOI 10.1016/j.msec.2005.01.026
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Petzow G., 2002, HIGH PERFORMANCE NON, P47
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Schulz H, 2005, SURF COAT TECH, V200, P1123, DOI 10.1016/j.surfcoat.2005.02.019
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STROM G, 1987, J COLLOID INTERF SCI, V119, P352, DOI 10.1016/0021-9797(87)90280-3
   Vila M, 2006, THIN SOLID FILMS, V515, P2192, DOI 10.1016/j.tsf.2006.07.083
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhao Q, 2004, J COLLOID INTERF SCI, V280, P174, DOI 10.1016/j.jcis.2004.07.004
NR 16
TC 54
Z9 58
U1 3
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-MAY
PY 2008
VL 17
IS 4-5
SI SI
BP 878
EP 881
DI 10.1016/j.diamond.2007.08.019
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 312BE
UT WOS:000256643300103
DA 2018-10-19
ER

PT J
AU Kaplan, D
AF Kaplan, David
TI Protein biomaterial systems for tissue engineering strategies
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Kaplan, David] Tufts Univ, Dept Bioengn, Melfor, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467800743
DA 2018-10-19
ER

PT J
AU Kaplan, DL
AF Kaplan, David L.
TI Protein Biomaterial Systems for Tissue Engineering Strategies
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467800741
DA 2018-10-19
ER

PT J
AU Shah, M
   Kelso, BG
   Caplan, MR
AF Shah, Miti
   Kelso, Bret G.
   Caplan, Michael R.
TI Mathematical modeling and systems biology approach to study biomaterial
   composition-mediated inflammatory signals in endothelial cells
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Shah, Miti; Kelso, Bret G.; Caplan, Michael R.] Arizona State Univ, Dept Bioengn, Tempe, AZ USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467803017
DA 2018-10-19
ER

PT J
AU Stoop, R
AF Stoop, Reinout
TI Smart biomaterials for tissue engineering of cartilage
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Review
DE biomaterials; tissue engineering; drug delivery; chondrocytes
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2 RHBMP-2; FULL-THICKNESS
   DEFECTS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; POLY(ETHYLENE GLYCOL)
   HYDROGELS; FIBROBLAST-GROWTH-FACTOR; SCAFFOLDS IN-VITRO;
   ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; CONTROLLED-RELEASE
AB Biological regeneration using cartilage tissue engineering in which cells are grown on biomaterial scaffolds and then implanted into the cartilage defects could provide new treatment options for articular cartilage defects. This review aims to give an overview of the wide variety of biomaterials that are currently developed as scaffolds for cartilage tissue engineering. Emphasis will be placed on the current development of the materials that are able to direct cell differentiation and metabolism. These so-called "smart" biomaterials are produced by modifying the physical properties of the scaffolds using peptide sequences and most importantly by developing materials that can deliver proteins to enhance tissue regeneration. Besides providing drug delivery systems, the materials respond to environmental stimuli or release their cargo on cellular demand. However, critical issues remain, such as the transferability of basic science insights to clinical products and the applicability of certain data sets to human patients.
C1 [Stoop, Reinout] TNO Qual Life, NL-2301 CE Leiden, Netherlands.
   [Stoop, Reinout] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany.
RP Stoop, R (reprint author), TNO Qual Life, POB 2215, NL-2301 CE Leiden, Netherlands.
EM reinout.stoop@tno.nl
OI , Reinout/0000-0002-8773-8248
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ALTMAN RD, 1992, ANN RHEUM DIS, V51, P1056, DOI 10.1136/ard.51.9.1056
   Andereya S, 2006, Z ORTHOP GRENZGEB, V144, P272, DOI 10.1055/s-2006-933445
   Appel B, 2006, INT J PHARM, V314, P170, DOI 10.1016/j.ijpharm.2005.11.049
   Barbucci R, 2005, BIOMATERIALS, V26, P7596, DOI 10.1016/j.biomaterials.2005.05.090
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BRANDSTEDT S, 1980, EUR SURG RES, V12, P12, DOI 10.1159/000128105
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   CHOU CH, 2007, J BIOMED MAT RES A
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cook SD, 2003, J BONE JOINT SURG AM, V85A, P116, DOI 10.2106/00004623-200300003-00018
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   DEFRERE J, 1992, ACTA CHIR BELG, P217
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Fan H, 2006, INT J ARTIF ORGANS, V29, P602
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   GARCIA AJ, 2002, BIOMIMETIC MAT DESIG, P29
   Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gordon TD, 2004, TISSUE ENG, V10, P1287, DOI 10.1089/1076327041887763
   HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   Harbers G. M., 2002, BIOMIMETIC MAT DESIG, P55
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   HOFMANN S, 2006, TISSUE ENG
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171
   HUNZIKER EB, 2001, CLIN ORTHOP S, V391, pS182
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Im GI, 2001, J BONE JOINT SURG BR, V83B, P289, DOI 10.1302/0301-620X.83B2.10495
   Kang SW, 2006, J BIOMAT SCI-POLYM E, V17, P925, DOI 10.1163/156856206777996862
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   KAPLONYI G, 1988, INJURY, V19, P267, DOI 10.1016/0020-1383(88)90043-5
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LARNO S, 1985, LIFE SCI, V36, P2069, DOI 10.1016/0024-3205(85)90458-8
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee KY, 2000, NATURE, V408, P998
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811
   Lohmann CH, 2000, BIOMATERIALS, V21, P49, DOI 10.1016/S0142-9612(99)00132-5
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   Mahmood TA, 2005, TISSUE ENG, V11, P1244, DOI 10.1089/ten.2005.11.1244
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marlovits S, 2005, KNEE SURG SPORT TR A, V13, P451, DOI 10.1007/s00167-004-0535-3
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   Miot S, 2006, J ORTHOP RES, V24, P1078, DOI 10.1002/jor.20098
   Na K, 2007, J BIOTECHNOL, V128, P412, DOI 10.1016/j.jbiotec.2006.09.025
   Na K, 2006, BIOMATERIALS, V27, P5951, DOI 10.1016/j.biomaterials.2006.08.012
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   POOLE CA, 1990, CONNECT TISSUE RES, V24, P319, DOI 10.3109/03008209009152158
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   STOOP R, 2004, CELL BIOMATERIAL REA
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   TERRELL TG, 1993, INT REV EXP PATHOL, V34, P43
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   Veilleux N, 2005, OSTEOARTHR CARTILAGE, V13, P278, DOI 10.1016/j.joca.2004.12.013
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WANG TW, 2007, J BIOMED MAT RES B
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 119
TC 43
Z9 46
U1 0
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD APR
PY 2008
VL 39
SU 1
BP S77
EP S87
DI 10.1016/j.injury.2008.01.036
PG 11
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 293UW
UT WOS:000255361900011
PM 18313475
DA 2018-10-19
ER

PT J
AU Araujo, M
   Linder, E
   Wennstrom, J
   Lindhe, J
AF Araujo, Mauricio
   Linder, Elena
   Wennstrom, Jan
   Lindhe, Jan
TI The influence of Bio-Oss Collagen on healing of an extraction socket: An
   experimental study in the dog
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID MAXILLARY SINUS AUGMENTATION; DIFFERENT GRAFTING MATERIALS; GUIDED BONE
   REGENERATION; TOOTH EXTRACTION; DENTAL IMPLANTS; BIOACTIVE GLASS; PART
   1; TISSUE; BIO-OSS(R); PLACEMENT
AB The objective of the present experiment was to evaluate the effect on hard tissue modeling and remodeling of the placement of a xenograft in fresh extraction sockets in dogs. Five mongrel dogs were used. Two mandibular premolars (P-4(4)) were hemisected in each dog, and the distal roots were carefully removed. In one socket, a graft consisting of Bio-Oss Collagen (Geistlich) was placed, whereas the contralateral site was left without grafting. After 3 months of healing, the dogs were euthanized and biopsies sampled. From each experimental site, four ground sections (two from the mesial root and two from the healed socket) were prepared, stained, and examined under the microscope. The presence of Bio-Oss Collagen failed to inhibit the processes of modeling and remodeling that took place in the socket walls following tooth extraction. However, it apparently promoted de novo hard tissue formation, particularly in the cortical region of the extraction site. Thus, the dimension of the hard tissue was maintained and the profile of the ridge was better preserved. The placement of a biomaterial in an extraction socket may promote bone modeling and compensate, at least temporarily, for marginal ridge contraction.
C1 [Araujo, Mauricio] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Linder, Elena; Wennstrom, Jan; Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, M (reprint author), Rua Silva Jardim,15 Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR AMLER MH, 1960, J AM DENT ASSOC, V61, P46
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Donath K, 1993, PREPARATION HISTOLOG
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Mellonig J T, 1993, Int J Periodontics Restorative Dent, V13, P108
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P198
   Slotte C, 1999, CLIN ORAL IMPLAN RES, V10, P468, DOI 10.1034/j.1600-0501.1999.100605.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 35
TC 159
Z9 169
U1 0
U2 14
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD APR
PY 2008
VL 28
IS 2
BP 123
EP 135
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 292FO
UT WOS:000255252100003
PM 18546808
DA 2018-10-19
ER

PT J
AU Sawa, Y
   Tatsumi, E
   Funakubo, A
   Horiuchi, T
   Iwasaki, K
   Kishida, A
   Masuzawa, T
   Matsuda, K
   Nishimura, M
   Nishimura, T
   Tomizawa, Y
   Yamaoka, T
   Watanabe, H
AF Sawa, Y.
   Tatsumi, E.
   Funakubo, A.
   Horiuchi, T.
   Iwasaki, K.
   Kishida, A.
   Masuzawa, T.
   Matsuda, K.
   Nishimura, M.
   Nishimura, T.
   Tomizawa, Y.
   Yamaoka, T.
   Watanabe, H.
TI Journal of Artificial Organs 2007: the year in review
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE artificial heart (basic); artificial heart (clinical); cardiopulmonary
   bypass; artificial lung; blood vessel prosthesis; pacemaker; artificial
   valve; biomaterial; tissue engineering; dialysis; apheresis; artificial
   liver; artificial pancreas; artificial skin; artificial muscle;
   artificial bone; artificial neuron
ID VENTRICULAR ASSIST DEVICE; EXTRACORPOREAL MEMBRANE-OXYGENATION;
   CORONARY-ARTERY-BYPASS; FULMINANT MYOCARDITIS; VALVE; SYSTEM; PUMP;
   IMPLANTATION; CYTOTOXICITY; PATIENT
C1 [Sawa, Y.] Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Tatsumi, E.] Natl Cardiovasc Ctr, Res Inst, Dept Artificial Organs, Adv Med Engn Ctr, Suita, Osaka 565, Japan.
   [Funakubo, A.] Tokyo Denki Univ, Dept Elect & Comp Engn, Sch Sci & Engn, Tokyo 101, Japan.
   [Horiuchi, T.] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 514, Japan.
   [Iwasaki, K.] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.
   [Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki, Japan.
   [Matsuda, K.] Univ Yamanashi Hosp, Chuo, Japan.
   [Nishimura, M.] Tottori Univ, Fac Med, Div Organ Regenerat Surg, Yonago, Tottori 683, Japan.
   [Nishimura, T.] Tokyo Univ Hosp, Tokyo 113, Japan.
   [Tomizawa, Y.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan.
   [Yamaoka, T.] Natl Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 565, Japan.
   [Watanabe, H.] Niigata Univ, Div Thorac & Cardiovasc Surg, Grad Sch Med & Dent Sci, Niigata, Japan.
RP Sawa, Y (reprint author), Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM sawa@surg1.medo.osaka-u.ac.jp
CR Abe Y, 2007, J ARTIF ORGANS, V10, P60, DOI 10.1007/s10047-006-0368-6
   Aiba M, 2007, J ARTIF ORGANS, V10, P165, DOI 10.1007/s10047-007-0387-y
   Akagawa E, 2007, J ARTIF ORGANS, V10, P85, DOI 10.1007/s10047-007-0378-z
   Bayrakci B, 2007, J ARTIF ORGANS, V10, P6, DOI 10.1007/s10047-006-0359-7
   Fukunaga K, 2007, J ARTIF ORGANS, V10, P77, DOI 10.1007/s10047-007-0375-2
   Hata K, 2007, J ARTIF ORGANS, V10, P129, DOI 10.1007/s10047-006-0371-y
   Hirata I, 2007, J ARTIF ORGANS, V10, P212, DOI 10.1007/s10047-007-0391-2
   Hoshino A, 2007, J ARTIF ORGANS, V10, P149, DOI 10.1007/s10047-007-0379-y
   Ishiguro H, 2007, J ARTIF ORGANS, V10, P133, DOI 10.1007/s10047-007-0381-4
   Iwai S, 2007, J ARTIF ORGANS, V10, P29, DOI 10.1007/s10047-006-0360-1
   Journal of Artificial Organs Editorial Committee, 2006, J ARTIF ORGANS, V9, P1
   Kataoka G, 2007, J ARTIF ORGANS, V10, P218, DOI 10.1007/s10047-007-0392-1
   Kato T, 2007, J ARTIF ORGANS, V10, P42, DOI 10.1007/s10047-006-0362-z
   Kimura T, 2007, J ARTIF ORGANS, V10, P104, DOI 10.1007/s10047-006-0367-7
   Komoda T, 2007, J ARTIF ORGANS, V10, P124, DOI 10.1007/s10047-007-0374-3
   Lee H, 2007, J ARTIF ORGANS, V10, P181, DOI 10.1007/s10047-007-0382-3
   Lee Hwansung, 2006, J Artif Organs, V9, P154, DOI 10.1007/s10047-006-0332-5
   Liu HJ, 2007, J ARTIF ORGANS, V10, P223, DOI 10.1007/s10047-007-0395-y
   Mitsumune N, 2007, J ARTIF ORGANS, V10, P231, DOI 10.1007/s10047-007-0388-x
   Morsi YS, 2007, J ARTIF ORGANS, V10, P109, DOI 10.1007/s10047-006-0369-5
   Morsi YS, 2007, J ARTIF ORGANS, V10, P96, DOI 10.1007/s10047-006-0365-9
   Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1
   Ninomiya S, 2007, J ARTIF ORGANS, V10, P201, DOI 10.1007/s10047-007-0396-x
   NISHINAKA T, 151 DAYS CONTINUOUS, V40
   Nishinaka T, 2007, J ARTIF ORGANS, V10, P236, DOI 10.1007/s10047-007-0389-9
   Niwayama J, 2007, J ARTIF ORGANS, V10, P36, DOI 10.1007/s10047-006-0357-9
   Ohata T, 2007, J ARTIF ORGANS, V10, P92, DOI 10.1007/s10047-007-0377-0
   Ohata T, 2007, J ARTIF ORGANS, V10, P228, DOI 10.1007/s10047-007-0393-0
   Okamoto E, 2007, J ARTIF ORGANS, V10, P158, DOI 10.1007/s10047-007-0380-5
   Reiss N, 2007, J ARTIF ORGANS, V10, P195, DOI 10.1007/s10047-007-0394-z
   Sacar M, 2007, J ARTIF ORGANS, V10, P177, DOI 10.1007/s10047-007-0383-2
   Saito S, 2007, J ARTIF ORGANS, V10, P118, DOI 10.1007/s10047-007-0373-4
   Sakamoto Y, 2007, J ARTIF ORGANS, V10, P206, DOI 10.1007/s10047-007-0397-9
   Sawa Y, 2007, J ARTIF ORGANS, V10, P53, DOI 10.1007/s10047-007-0386-z
   Sugiki Hiroshi, 2006, J Artif Organs, V9, P42, DOI 10.1007/s10047-005-0319-7
   Sugiki H, 2007, J ARTIF ORGANS, V10, P16, DOI 10.1007/s10047-006-0364-x
   Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y
   Tatsumi E, 2007, J ARTIF ORGANS, V10, P1, DOI 10.1007/s10047-006-0356-x
   Tatsumi E, 2007, J ARTIF ORGANS, V10, P187, DOI 10.1007/s10047-007-0384-1
   Tokunaga S, 2007, J ARTIF ORGANS, V10, P115, DOI 10.1007/s10047-006-0366-8
   Tomizawa Y, 2007, J ARTIF ORGANS, V10, P122, DOI 10.1007/s10047-006-0372-x
   Tomo T, 2007, J ARTIF ORGANS, V10, P47, DOI 10.1007/s10047-006-0358-8
   Tsutsui N, 2007, J ARTIF ORGANS, V10, P143, DOI 10.1007/s10047-007-0385-0
   Watanabe T, 2007, J ARTIF ORGANS, V10, P10, DOI 10.1007/s10047-006-0361-0
   YAMANE Y, 2007, J ARTIF ORGANS, V10, P71
NR 45
TC 13
Z9 13
U1 2
U2 7
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD APR
PY 2008
VL 11
IS 1
BP 4
EP 11
DI 10.1007/s10047-008-0404-9
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 290MH
UT WOS:000255126400002
PM 18414986
DA 2018-10-19
ER

PT J
AU Stark, Y
   Bruns, S
   Stahl, F
   Kasper, C
   Wesemann, M
   Grothe, C
   Scheper, T
AF Stark, Yvonne
   Bruns, Stephanie
   Stahl, Frank
   Kasper, Cornelia
   Wesemann, Maike
   Grothe, Claudia
   Scheper, Thomas
TI A study on polysialic acid as a biomaterial for cell culture
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE peripheral nerve regeneration; polysialic acid; surface coating;
   biomaterials; differentiation
ID ADHESION MOLECULE; INTERNEURON PRECURSORS; NERVE REGENERATION;
   BETA-GLUCAN; GROWTH; NCAM; ATTACHMENT; POLYMER; AXONS; POLYSIALYLATION
AB Polysialic acid (PSA) was investigated for its applicability as coating material for mammalian cell cultivation. PSA is involved in post-translational modification of the vertebrate neural cell adhesion molecule (NCAM). It is biocompatible and degradation-controlled. Thus, it becomes interesting for use as a coating and scaffold material for tissue engineering applications, especially for peripheral nerve regeneration. As a preliminary study of the use of PSA as scaffold material it was tested in its soluble form as coating material. The cytotoxicity was investigated and compared to another polysaccharide beta-glucan, to widely used coating substances (collagen 1, poly-L-lysine, hyaluronic acid) and uncoated tissue culture plastic material. The interactions between the modified cell culture surface and the cells were investigated using a model liver cell line Hep-G2 and a neurobiological cell line PC-12. The PSA coating itself was analyzed by immunoanalysis. Viability of the cells was investigated by the MTT assay. The number and distribution of adhered cells were studied by cell nuclei staining. Furthermore, the differentiation status of the PC-12 cells was monitored, as well as glucose and lactate levels in the cell culture medium from the Hep-G2 cells. Comparable viability and similar numbers of attached cells were observed. Growth in cell clusters was observed for PSA, P-glucan, and hyaluronic acid coated materials. In general, the results indicate that PSA is comparable to other well-established coating materials (e.g. collagen I, hyaluronic acid, and poly-L-lysine). Moreover, as a key substance in vertebrate development it offers interesting features for nerve regeneration, especially as an insoluble, modified scaffold material. (c) 2007 Wiley Periodicals, Inc.
C1 [Stark, Yvonne; Bruns, Stephanie; Stahl, Frank; Kasper, Cornelia; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
   [Wesemann, Maike; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, D-30623 Hannover, Germany.
RP Scheper, T (reprint author), Leibniz Univ Hannover, Inst Tech Chem, Callinstr 3, D-30167 Hannover, Germany.
EM scheper@iftc.uni-hannover.de
RI Scheper, Thomas/H-8143-2013
CR ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143
   Aykin-Burns N, 2005, ARCH ENVIRON CON TOX, V49, P119, DOI 10.1007/s00244-004-0025-0
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Bork K, 2005, FEBS LETT, V579, P5079, DOI 10.1016/j.febslet.2005.08.013
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M
   Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O
   LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J
   Leckband D, 2004, CURR OPIN STRUC BIOL, V14, P524, DOI 10.1016/j.sbi.2004.09.002
   MATSUMOTO S, 1981, J MOL BIOL, V152, P501, DOI 10.1016/0022-2836(81)90255-2
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481
   Miura T, 1999, FEMS IMMUNOL MED MIC, V24, P131
   Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Oberdoerster J, 1998, J PHARMACOL EXP THER, V287, P359
   ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0
   Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807
   RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842
   RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G
   SAKAGAMI H, 1989, In Vivo (Attiki), V3, P243
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x
   TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W
   TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5
   Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   WANG KK, 1993, J RECONSTR MICROSURG, V9, P39, DOI 10.1055/s-2007-1006637
   Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   WOLK M, 1985, MED BIOL, V63, P73
   Yashiki S, 2001, J BIOSCI BIOENG, V92, P385, DOI 10.1263/jbb.92.385
   YIN XH, 1995, DEVELOPMENT, V121, P3439
   Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1
NR 42
TC 5
Z9 5
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 1
EP 13
DI 10.1002/jbm.a.31406
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000001
PM 17618519
DA 2018-10-19
ER

PT J
AU de Guzman, RC
   VandeVord, PJ
AF de Guzman, Roche C.
   VandeVord, Pamela J.
TI Variations in astrocyte and fibroblast response due to biomaterial
   particulates in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE reactive astrocyte; fibroblast; proliferation; cytotoxicity; biomaterial
   particles
ID CENTRAL-NERVOUS-SYSTEM; HUMAN BREAST-CANCER; SPINAL-CORD-INJURY;
   UP-REGULATION; REACTIVE ASTROCYTES; DOSE-RESPONSE; GLIAL SCAR;
   ADULT-RATS; BRAIN; EXPRESSION
AB The possible involvement of orthopedic biomaterial particles such as cobalt-chrome alloy (Co-Cr), ultrahigh molecular weight polyethylene (UHMWPE), titanium alloy (Ti-6Al-4V), and polymethyl methacrylate (PMMA) in the formation of glial and meningeal scars was investigated using an in vitro system. Cell lines were used as models for astrocytes and meningeal fibroblasts. They were incubated with varying concentrations of particle suspensions, after which proliferative and cytotoxic responses were quantified using MTT assay and Live/Dead microscopy. It was determined that relative particulate toxicity (arranged in decreasing order) to astrocytes is Co-Cr > Ti-6AI-4V > PMMA > UHMWPE, and toxicity to fibroblasts is PMMA > Co-Cr > Ti-6AI-4V > UHMWPE. Cell death caused by PMMA was mainly due to necrosis, while the rest of the particles induced apoptosis. Low quantities of Co-Cr and Ti-6Al-4V stimulate increased astrocyte proliferation rate. However, only the cells treated with titanium alloy caused upregulated transcription of reactive astrocyte markers such as glial fibrillary acidic protein, vimentin, nestin, and type IV collagen, suggesting the potential of titanium alloy alone to trigger glial scarring. None of the biomaterials tested promoted proliferation in fibroblasts implying that biomaterial particles are not directly involved in meningeal scar development. (c) 2007 Wiley Periodicals, Inc.
C1 [de Guzman, Roche C.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
RP de Guzman, RC (reprint author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
EM roche@wayne.edu
RI VandeVord, Pamela/B-4606-2012; de Guzman, Roche/K-8832-2015
OI de Guzman, Roche/0000-0001-6051-4765
CR AlAli SY, 1996, J ANAT, V188, P257
   Anteby EY, 2005, EUR J OBSTET GYN R B, V118, P174, DOI 10.1016/j.ejogrb.2004.04.029
   BURKE JM, 1987, ARCH OPHTHALMOL-CHIC, V105, P404, DOI 10.1001/archopht.1987.01060030124041
   Cazaubon S, 1997, J NEUROSCI, V17, P6203
   Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174
   CHUANG CF, 1994, FEBS LETT, V346, P229, DOI 10.1016/0014-5793(94)00480-3
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515
   Hirano S, 2004, BIOCHEM BIOPH RES CO, V317, P437, DOI 10.1016/j.bbrc.2004.03.049
   Kalmar B, 2001, NEUROCHEM INT, V38, P453, DOI 10.1016/S0197-0186(00)00090-5
   Kawai K, 2002, VIRCHOWS ARCH, V441, P584, DOI 10.1007/s00428-002-0636-7
   Kim JK, 1999, J TOXICOL ENV HEAL A, V58, P437, DOI 10.1080/009841099157160
   KRUGER S, 1986, J COMP NEUROL, V249, P103, DOI 10.1002/cne.902490108
   LEIBNITZ L, 1985, J HIRNFORSCH, V26, P601
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x
   Liesi P, 2002, EXP NEUROL, V173, P31, DOI 10.1006/exnr.2001.7800
   Lightfoot HM, 2004, BREAST CANCER RES TR, V88, P109, DOI 10.1007/s10549-004-1022-8
   Liu F, 2003, SPINE, V28, P1666, DOI 10.1097/00007632-200308010-00007
   Mhawech-Fauceglia P, 2006, EJSO, V32, P439, DOI 10.1016/j.ejso.2006.01.018
   Mofid MM, 1997, PLAST RECONSTR SURG, V100, P14, DOI 10.1097/00006534-199707000-00003
   Mohanty M, 2003, J BIOMATER APPL, V18, P109, DOI 10.1177/088532803034746
   Murai Nozomu, 1997, Neurologia Medico-Chirurgica, V37, P201, DOI 10.2176/nmc.37.201
   Nicholas AP, 2002, NEUROSCI LETT, V323, P85, DOI 10.1016/S0304-3940(01)02534-4
   Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   Pentreath VW, 2000, HUM EXP TOXICOL, V19, P641, DOI 10.1191/096032700676221595
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Renner R, 2004, ENVIRON SCI TECHNOL, V38, p90A, DOI 10.1021/es040410d
   SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7
   Scholl FA, 2005, CANCER LETT, V230, P1, DOI 10.1016/j.canlet.2004.12.013
   Schulte-Hermann R, 2000, MUTAT RES-GEN TOX EN, V464, P13, DOI 10.1016/S1383-5718(99)00162-X
   Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Tansey FA, 1998, NEUROSCI LETT, V248, P159, DOI 10.1016/S0304-3940(98)00373-5
   Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236
   Verlaan JJ, 2006, BIOMATERIALS, V27, P290, DOI 10.1016/j.biomaterials.2005.07.028
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.0.CO;2-8
   Yao Qing, 2004, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V20, P328
   Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.3.CO;2-W
   YTURRASPE DJ, 1975, J NEUROSURG, V42, P47, DOI 10.3171/jns.1975.42.1.0047
   YUEN TGH, 1987, BIOMATERIALS, V8, P138, DOI 10.1016/0142-9612(87)90103-7
NR 45
TC 7
Z9 7
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 14
EP 24
DI 10.1002/jbm.a.31516
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000002
PM 17668862
DA 2018-10-19
ER

PT J
AU Tanihara, M
   Kajiwara, K
   Ida, K
   Suzuki, Y
   Kamitakahara, M
   Ogata, S
AF Tanihara, Masao
   Kajiwara, Kazumi
   Ida, Keiko
   Suzuki, Yoshihisa
   Kamitakahara, Masanobu
   Ogata, Shin-ichi
TI The biodegradability of poly(Pro-Hyp-Gly) synthetic polypeptide and the
   promotion of a dermal wound epithelialization using a poly(Pro-Hyp-Gly)
   sponge
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE synthetic polypeptide; poly(Pro-Hyp-Gly); biodegradability; wound
   repair; epithelialization
ID COLLAGEN GEL; IN-VIVO; REGENERATION; PEPTIDES; BIOMATERIAL; STABILITY;
   SCAFFOLDS; DELIVERY; ELASTIN; LAMININ
AB Collagens are widely used in medical applications, but animal-derived collagens have several drawbacks, such as low thermal stability, nonspecific cell attachment, and susceptibility to contamination by infectious pathogens, such as prions, which may transfect humans. We have previously reported the chemical synthesis of polypeptides consisting of a Pro-Hyp-Gly sequence and the high thermostability of their triple-helical structure. To clarify the biomaterial characteristics of the poly(Pro-Hyp-Gly) polypeptide, we assessed its biodegradability and its capability for skin regeneration. Eight weeks after implantation, a poly(Pro-Hyp-Gly) freeze-dried sponge embedded subcutaneously into a rat dorsal area degraded at the same rate as Terudermis (R)), which is made from bovine type I atelocollagen and is used as an artificial dermis. Surprisingly, compared with Terudermis, the poly(Pro-Hyp-Gly) sponge significantly promoted epithelialization of a full-thickness wound on a rabbit's ear pad. This chemically synthesized polypeptide may be useful as a scaffold for tissue engineering and tissue regeneration. (c) 2007 Wiley Periodicals, Inc.
C1 [Tanihara, Masao; Kajiwara, Kazumi; Ida, Keiko; Kamitakahara, Masanobu; Ogata, Shin-ichi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.
   [Suzuki, Yoshihisa] Kyoto Univ, Grad Sch Med, Div Surg, Sakyo Ku, Kyoto 6068507, Japan.
RP Tanihara, M (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Nara 6300192, Japan.
EM mtanihar@ms.naist.jp
CR Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   Ochi K, 2003, J CELL PHYSIOL, V194, P45, DOI 10.1002/jcp.10185
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rothenburger M, 2002, ASAIO J, V48, P586, DOI 10.1097/01.MAT.0000033637.90113.1E
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Toba T, 2002, INT J ARTIF ORGANS, V25, P230
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Yoshii S, 2002, BRAIN RES, V949, P202, DOI 10.1016/S0006-8993(02)03149-9
NR 26
TC 16
Z9 16
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 133
EP 139
DI 10.1002/jbm.a.31496
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000013
PM 17688259
DA 2018-10-19
ER

PT J
AU Hsiong, SX
   Carampin, P
   Kong, HJ
   Lee, KY
   Mooney, DJ
AF Hsiong, Susan X.
   Carampin, Paolo
   Kong, Hyun-Joon
   Lee, Kuen-Yong
   Mooney, David J.
TI Differentiation stage alters matrix control of stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; extracellular matrix; cell differentiation; stem cells;
   osteoblasts
ID MARROW STROMAL CELLS; CONTROLLED SCAFFOLD DEGRADATION; BONE-MARROW;
   OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; EXTRACELLULAR-MATRIX;
   ALGINATE HYDROGELS; FOCAL ADHESIONS; SUBSTRATE; TISSUE
AB Cues from the material to which a cell is adherent (e.g., adhesion ligand presentation, substrate elastic modulus) clearly influence the phenotype of differentiated cells. However, it is currently unclear if stem cells respond similarly to these cues. This study examined how the overall density and nanoscale organization of a model cell adhesion ligand (arginine-glycine-aspartic acid [RGD] containing peptide) presented from hydrogels of varying stiffness regulated the proliferation of a clonally derived stem cell line (D1 cells) and preostcoblasts (MC3T3-E1). While the growth rate of MC3T3-E1 preosteoblasts was responsive to nanoscale RGD ligand organization and substrate stiffness, the D1 stem cells were less sensitive to these cues in their uncommitted state. However, once the D1 cells were differentiated towards the osteoblast lineage, they became more responsive to these signals. These results demonstrate that the cell response to material cues is dependent on the stage of cell commitment or differentiation, and these findings will likely impact the design of biomaterials for tissue regeneration. (c) 2007 Wiley Periodicals, Inc.
C1 [Hsiong, Susan X.; Carampin, Paolo; Kong, Hyun-Joon; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Kong, Hyun-Joon] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Lee, Kuen-Yong] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Lee, Kuen Yong/0000-0002-5759-5952
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   NAKATANI Y, 1984, BIOCHEM BIOPH RES CO, V123, P894, DOI 10.1016/S0006-291X(84)80219-3
   Patel N, 1998, FASEB J, V12, P1447
   Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603
   VACANTI JP, 1998, ADV DRUG DELIV REV, V33, P165, DOI DOI 10.1016/SO169-409X(98)00025-8
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yanai T, 2001, J BONE MINER METAB, V19, P345, DOI 10.1007/s007740170003
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
NR 52
TC 68
Z9 69
U1 2
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 145
EP 156
DI 10.1002/jbm.a.31521
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000015
PM 17688260
DA 2018-10-19
ER

PT J
AU Narayanan, R
   Seshadri, SK
   Kwon, TY
   Kim, KH
AF Narayanan, R.
   Seshadri, S. K.
   Kwon, T. Y.
   Kim, K. H.
TI Calcium phosphate-based coatings on titanium and its alloys
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE titanium; calcium phosphate; hydroxyapatite; coating
ID SPRAYED HYDROXYAPATITE COATINGS; SIMULATED BODY-FLUID; PULSED-LASER
   DEPOSITION; BONELIKE APATITE FORMATION; METAL-ION RELEASE; OXIDE-FILMS;
   IN-VITRO; ELECTROPHORETIC DEPOSITION; OSTEOBLAST ADHESION; POROUS
   TITANIUM
AB Use of titanium as biomaterial is possible because of its very favorable biocompatibility with living tissue. Titanium implants having calcium phosphate coatings on their surface show good fixation to the bone. This review covers briefly the requirements of typical biomaterials and narrowly focuses on the works on titanium. Calcium phosphate ceramics for use in implants are introduced and various methods of producing calcium phosphate coating on titanium substrates are elaborated. Advantages and disadvantages of each type of coating from the view point of process simplicity, cost-effectiveness, stability of the coatings, coating integration with the bone, cell behavior, and so forth are highlighted. Taking into account all these factors, the efficient method(s) of producing these coatings are indicated finally. (c) 2007 Wiley Periodicals, Inc.
C1 [Narayanan, R.; Seshadri, S. K.] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   [Narayanan, R.; Kwon, T. Y.; Kim, K. H.] Kyungpook Natl Univ, Sch Dent, Dept Dent Biomat, Taegu, South Korea.
RP Narayanan, R (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM rnarayan69@hotmail.com
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Ban S, 1998, J BIOMED MATER RES, V42, P387, DOI 10.1002/(SICI)1097-4636(19981205)42:3<387::AID-JBM6>3.3.CO;2-Q
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Bao QH, 2006, MAT SCI ENG A-STRUCT, V429, P25, DOI 10.1016/j.msea.2006.04.003
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Baszkiewicz J, 2003, VACUUM, V70, P163, DOI 10.1016/S0042-207X(02)00636-X
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BROWN PW, 1992, J AM CERAM SOC, V75, P17, DOI 10.1111/j.1151-2916.1992.tb05435.x
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Chen MF, 2007, SURF COAT TECH, V201, P5688, DOI 10.1016/j.surfcoat.2006.07.057
   Chou BY, 2001, SCRIPTA MATER, V45, P487, DOI 10.1016/S1359-6462(01)01064-8
   Cleries L, 2000, BIOMATERIALS, V21, P1861, DOI 10.1016/S0142-9612(00)00060-0
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   CORTEZ PM, 2005, MATER LETT, V58, P1336
   de Andrade MC, 2002, J EUR CERAM SOC, V22, P505
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   DEARNALEY G, 1986, VACUUM, V36, P807, DOI 10.1016/0042-207X(86)90116-8
   Dearnley PA, 2004, WEAR, V256, P469, DOI 10.1016/S0043-1648(03)00557-X
   DELPLANCKE JL, 1982, SURF TECHNOL, V16, P153, DOI 10.1016/0376-4583(82)90033-4
   Deram V, 2003, SURF COAT TECH, V166, P153, DOI 10.1016/S0257-8972(02)00855-1
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   DUNN D, 1992, SURF COAT TECH, V50, P223, DOI 10.1016/0257-8972(92)90005-U
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Erkmen ZE, 1999, J BIOMED MATER RES, V48, P861, DOI 10.1002/(SICI)1097-4636(1999)48:6<861::AID-JBM15>3.0.CO;2-H
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Feng B, 2002, J BIOMED MATER RES, V59, P12, DOI 10.1002/jbm.1211
   Fernandez-Pradas JM, 2000, APPL PHYS A-MATER, V71, P37
   Fernandez-Pradas JM, 1999, J MATER RES, V14, P4715, DOI 10.1557/JMR.1999.0638
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fujihara T, 2004, VACUUM, V73, P629, DOI 10.1016/j.vacuum.2003.12.082
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Gledhill HC, 2001, BIOMATERIALS, V22, P1233, DOI 10.1016/S0142-9612(00)00273-8
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   Grassmann O, 2000, J BIOMED MATER RES, V53, P685, DOI 10.1002/1097-4636(2000)53:6<685::AID-JBM11>3.3.CO;2-2
   Gross KA, 2002, BIOMATERIALS, V23, P4731, DOI 10.1016/S0142-9612(02)00222-3
   Hamagami J, 2004, SOLID STATE IONICS, V172, P331, DOI 10.1016/j.ssi.2004.02.046
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.3.CO;2-L
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1988, BIOCERAMICS MAT CHAR, P54
   Herranen M, 2001, CORROS SCI, V43, P365, DOI 10.1016/S0010-938X(00)00079-2
   -Hukovic M. M., 2003, SURF COAT TECH, V165, P40
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   HWANG BJ, 1993, J APPL ELECTROCHEM, V23, P1056, DOI 10.1007/BF00266129
   Ichinose S, 2003, J MATER SCI-MATER M, V14, P79, DOI 10.1023/A:1021557605458
   Inagaki M, 2001, THIN SOLID FILMS, V382, P69, DOI 10.1016/S0040-6090(00)01772-7
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Ishizawa H, 1999, J MATER SCI, V34, P5893, DOI 10.1023/A:1004739108534
   Ishizawa H, 1996, J MATER SCI, V31, P6279, DOI 10.1007/BF00354450
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kameyama T, 1999, B MATER SCI, V22, P641, DOI 10.1007/BF02749980
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kido H, 1996, J LONG-TERM EFF MED, V6, P119
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Krupa D, 2003, J MATER PROCESS TECH, V143, P158, DOI 10.1016/S0924-0136(03)00398-4
   Krupa D, 2001, VACUUM, V63, P715, DOI 10.1016/S0042-207X(01)00263-9
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Latysh V, 2006, CURR APPL PHYS, V6, P262, DOI 10.1016/j.cap.2005.07.053
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Lee IS, 2002, MAT SCI ENG C-BIO S, V22, P15, DOI 10.1016/S0928-4931(02)00107-8
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li F, 2002, SURF COAT TECH, V154, P88, DOI 10.1016/S0257-8972(01)01710-8
   Liang B, 2003, BIOMATERIALS, V24, P4959, DOI 10.1016/S0142-9612(03)00421-6
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Lin HY, 2004, APPL SURF SCI, V225, P21, DOI 10.1016/j.apsusc.2003.09.027
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   Marcelo H., 2003, J MATER SCI-MATER M, V14, P511
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503
   Meng XW, 2006, KEY ENG MAT, V309-311, P639, DOI 10.4028/www.scientific.net/KEM.309-311.639
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Mohammadi Z, 2007, APPL SURF SCI, V253, P4960, DOI 10.1016/j.apsusc.2006.11.002
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Murugan R, 2004, MATER LETT, V58, P230, DOI 10.1016/S0167-577X(03)00451-8
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   Onoki T, 2006, SURF COAT TECH, V200, P6801, DOI 10.1016/j.surfcoat.2005.10.016
   Peng P, 2006, J BIOMED MATER RES A, V76A, P347, DOI 10.1002/jbm.a.30514
   Pezzatini S, 2006, J BIOMED MATER RES A, V76A, P656, DOI 10.1002/jbm.a.30524
   Pham MT, 2000, J MATER SCI LETT, V19, P1029, DOI 10.1023/A:1006782818468
   Pham MT, 2000, J MATER SCI LETT, V19, P443, DOI 10.1023/A:1006759309358
   Pham MT, 2000, SURF COAT TECH, V128, P313, DOI 10.1016/S0257-8972(00)00593-4
   Piveteau LD, 2000, BIOMATERIALS, V21, P2193, DOI 10.1016/S0142-9612(00)00160-5
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   ROSTLUND T, 1989, BIOMATERIALS, V10, P176, DOI 10.1016/0142-9612(89)90020-3
   ROYER P, 1991, SURF COAT TECH, V45, P171, DOI 10.1016/0257-8972(91)90220-Q
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Sampathkumaran U, 2001, ADV ENG MATER, V3, P401, DOI 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   SHARMA AK, 1992, THIN SOLID FILMS, V208, P48, DOI 10.1016/0040-6090(92)90946-9
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P90, DOI 10.1007/BF00120414
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   SILVA MHP, 2001, SURF COAT TECH, V137, P270
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sousa SR, 1996, BIOMATERIALS, V17, P397, DOI 10.1016/0142-9612(96)89655-4
   Stewart M, 2004, J BIOMED MATER RES A, V69A, P1, DOI 10.1002/jbm.a.20071
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Thian ES, 2007, MAT SCI ENG C-BIO S, V27, P251, DOI 10.1016/j.msec.2006.05.016
   Thian ES, 2001, BIOMATERIALS, V22, P1225, DOI 10.1016/S0142-9612(00)00272-6
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   WEBSTER T, 2005, NANOMED-NANOTECHNOL, V1, P251
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Wie H, 1998, INT J ORAL MAX IMPL, V13, P837
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V1, P11
   Willmann G, 1999, ADV ENG MATER, V1, P95
   WOLKE JGC, 1992, J THERM SPRAY TECHN, V1, P75
   Xue WC, 2005, J BIOMED MATER RES A, V74A, P553, DOI 10.1002/jbm.a.30323
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang Y, 2003, J Oral Implantol, V29, P270, DOI 10.1563/1548-1336(2003)029<0270:CADBOS>2.3.CO;2
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yang YZ, 2003, BIOMATERIALS, V24, P5131, DOI 10.1016/S0142-9612(03)00459-9
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Yousefpour M, 2006, J ELECTROANAL CHEM, V589, P96, DOI 10.1016/j.jelechem.2006.01.020
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
   Zhang CG, 2001, BIOMATERIALS, V22, P1357, DOI 10.1016/S0142-9612(00)00289-1
   Zhang YM, 2002, BIOMOL ENG, V19, P57, DOI 10.1016/S1389-0344(02)00011-4
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhu XL, 2003, J MATER SCI-MATER M, V14, P629, DOI 10.1023/A:1024079109073
NR 164
TC 171
Z9 175
U1 6
U2 74
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2008
VL 85B
IS 1
BP 279
EP 299
DI 10.1002/jbm.b.30932
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 280SB
UT WOS:000254445400036
PM 17853421
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Crosslinking of scleral collagen in the rabbit using glyceraldehyde
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID MYOPIA PROGRESSION; MAILLARD REACTION; KERATOCONUS; RIBOFLAVIN;
   GLYCATION; PRODUCTS; DELIVERY; UVA
AB PURPOSE: To strengthen rabbit sclera in vivo using chemical crosslinking with glyceraldehyde for a scleral-based treatment of progressive myopia.
   SETTING: Department of Ophthalmology, Martin-Luther-University, Halle, Germany.
   METHODS: Five chinchilla rabbits were treated with sequential sub-Tenon injections of 0.15 mL 0.5 M glyceraldehyde into the superonasal quadrant of the right eye 5 times during 14 days. The rabbits were humanely killed and biomechanical stress-strain measurements of scleral strips from the treatment area were performed and compared with nontreated contralateral control sclera using a microcomputer-controlled biomaterial tester. The treated eyes were examined histologically by light microscopy to exclude possible adverse effects.
   RESULTS: Following the crosslinking treatment, the ultimate stress was 15.8 MPa +/- 6.0 (SD) versus 3.1 +/- 0.3 MPa in the controls (increase of 409.7%; P<.02), the Young modulus was 129.6 +/- 53.7 MPa versus 11.5 +/- 1.8 MPa in the controls (increase of 1027%, P<.01), and ultimate strain was 19.8% +/- 2.6% MPA versus 38.2% +/- 5.1% MPA in the controls (decrease of 48.2% P<.05). Histologically, mild side effects were found in the peripheral cornea adjacent to the treatment area, with some inflammatory infiltrate and moderate loss of keratocytes.
   CONCLUSIONS: Glyceraldehyde crosslinking of scleral collagen increased the scleral biomechanical rigidity efficiently. Glyceraldehyde can be easily applied by sequential parabulbar injections. There were no side effects on the retina, so the new method might become a treatment modality for strengthening scleral tissue to prevent progressive myopia.
C1 [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
   [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   Bergman L, 1996, OPHTHALMIC SURG LAS, V27, P106
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   Edwards MH, 1996, ACTA OPHTHALMOL SCAN, V74, P213
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gerrard JA, 2002, FOOD CHEM, V79, P343, DOI 10.1016/S0308-8146(02)00174-7
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Kumar CM, 2003, EYE, V17, P1003, DOI 10.1038/sj.eye.6700501
   MCBRIEN BA, 2003, PROG RETIN EYE RES, V22, P307
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Robinson MR, 2006, EXP EYE RES, V82, P479, DOI 10.1016/j.exer.2005.08.007
   SADY C, 1995, BIOCHEM BIOPH RES CO, V214, P793, DOI 10.1006/bbrc.1995.2356
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Saw SM, 2002, OPHTHALMOLOGY, V109, P422
   Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111
   SNYDER AA, 1972, AM J OPHTHALMOL, V74, P73
   Spoerl E, 2005, INVEST OPHTH VIS SCI, V46, P1286, DOI 10.1167/iovs.040978
   Taylor CR, 1999, ARCH DERMATOL, V135, P540, DOI 10.1001/archderm.135.5.540
   Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668
   Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737
   Touzeau O, 2004, J FR OPHTALMOL, V27, P765, DOI 10.1016/S0181-5512(04)96211-0
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Wildsoet CF, 1999, OPTOMETRY VISION SCI, V76, P341, DOI 10.1097/00006324-199906000-00001
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
NR 34
TC 27
Z9 31
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2008
VL 34
IS 4
BP 651
EP 656
DI 10.1016/i.jcrs.2007.12.030
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 283TW
UT WOS:000254660400027
PM 18361989
DA 2018-10-19
ER

PT J
AU Pedraza, CE
   Chien, YC
   Mckee, MD
AF Pedraza, Claudio E.
   Chien, Yung-Ching
   Mckee, Marc D.
TI Calcium oxalate crystals in fetal bovine serum: Implications for cell
   culture, phagocytosis and biomineralization studies in vitro
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE fetal bovine serum; calcium oxalate; cell culture; biomineralization;
   phagocytosis
ID RENAL EPITHELIAL-CELLS; MONOHYDRATE CRYSTALS; ETHYLENE-GLYCOL; VASCULAR
   CALCIFICATION; GLYCOPROTEIN/FETUIN-A; DIHYDRATE CRYSTALS; PROTEIN;
   MATRIX; URINE; ACID
AB Cell culture methods and models are key investigative tools for cell and molecular biology studies. Fetal bovine serum (FBS) is commonly used as an additive during cell culture since its constituents promote cell survival, proliferation and differentiation. Here we report that commercially available FBS from different major suppliers consistently contain precipitated, calcium oxalate crystals-either in the monohydrate (COM) or dihydrate (COD) form. Mineral structure and phase identification of the crystals were determined by X-ray diffraction, chemical composition by energy-dispersive X-ray microanalysis, and imaging and measurement of crystal growth steps by atomic force microscopy-all identified and confirmed crystallographic parameters for COM and COD. Proteins binding to the crystals were identified by immunoblotting, revealing the presence of osteopontin and fetuin-A (alpha 2HS-glycoprotein)-known regulators of crystal growth found in serum. Macrophage cell cultures exposed to calcium oxalate crystals showed internalization of the crystals by phagocytosis in a process that induced disruption of cell-cell adhesion, release of reactive oxygen species and membrane damage, events that may be linked to the release of inflammatory cytokines by these cells into the culture media. in conclusion, calcium oxalate crystals found in commercially available FBS are toxic to cells, and their presence may confound results from in vitro studies where, amongst others, phagocytosis, biomineralization, renal cell and molecular biology, and drug and biomaterial testing are being examined.
C1 [Pedraza, Claudio E.; Chien, Yung-Ching; Mckee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Mckee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
RP Mckee, MD (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM marc.mckee@mcgill.ca
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   AKBARIEH M, 1987, SCANNING MICROSCOPY, V1, P1397
   Bautista DS, 1996, J CELL BIOCHEM, V61, P402, DOI 10.1002/(SICI)1097-4644(19960601)61:3<402::AID-JCB7>3.0.CO;2-X
   Belliveau J, 2001, ANAL BIOCHEM, V291, P69, DOI 10.1006/abio.2001.5002
   Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152
   BURNS JR, 1980, INVEST UROL, V18, P174
   Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x
   Cheung HS, 2005, CURR OPIN RHEUMATOL, V17, P336, DOI 10.1097/01.bor.0000155362.83990.80
   CHIRIBOGA J, 1963, BIOCHEM BIOPH RES CO, V11, P277, DOI 10.1016/0006-291X(63)90557-6
   de Water R, 2001, AM J KIDNEY DIS, V38, P331, DOI 10.1053/ajkd.2001.26098
   El-Shall H, 2004, CRYST RES TECHNOL, V39, P222, DOI 10.1002/crat.200310174
   ELLIOT JS, 1980, J UROLOGY, V123, P324, DOI 10.1016/S0022-5347(17)55918-2
   FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106
   Greene EL, 2005, UROL RES, V33, P340, DOI 10.1007/s00240-005-0491-5
   Hassoun EA, 1999, J BIOCHEM MOL TOXIC, V13, P179, DOI 10.1002/(SICI)1099-0461(1999)13:3/4<179::AID-JBT8>3.0.CO;2-4
   Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200
   HONN KV, 1975, P SOC EXP BIOL MED, V149, P344
   KASHTOCK M, 1980, J ASSOC OFF ANA CHEM, V63, P168
   Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554
   Khan SR, 2004, NEPHRON EXP NEPHROL, V98, pE55, DOI 10.1159/000080257
   KNIGHT AP, 2003, GUIDE PLANT POISONIN
   Konya E, 2003, EUR UROL, V43, P564, DOI 10.1016/S0302-2838(03)00088-5
   Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200
   LASAGA AC, 1998, THEORY CRYSTALS GROW
   LEPAGE L, 1982, J PHARM SCI, V71, P1059, DOI 10.1002/jps.2600710927
   LIESKE JC, 1994, P NATL ACAD SCI USA, V91, P6987, DOI 10.1073/pnas.91.15.6987
   LIESKE JC, 1992, AM J PHYSIOL, V262, pF622
   MARSH ME, 1995, J BONE MINER RES, V10, P1635
   MCKEE MD, 1995, J BONE MINER RES, V10, P1913
   McMartin KE, 2005, TOXICOL SCI, V84, P195, DOI 10.1093/toxsci/kfi062
   Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98
   Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200
   Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200
   Rolleston W B, 1999, Dev Biol Stand, V99, P79
   Ryall RL, 2005, BJU INT, V96, P654, DOI 10.1111/j.1464-410X.2005.05701.x
   Ryall RL, 2004, NEPHRON PHYSIOL, V98, pp37
   Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI200317202
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   SORENSEN ES, 1993, J DAIRY RES, V60, P535, DOI 10.1017/S0022029900027886
   STAINES D, 2003, MANAGING SERUM REQUI, P1
   Thamilselvan S, 2000, J UROLOGY, V164, P224, DOI 10.1016/S0022-5347(05)67499-X
   THRALL MA, 1985, VET PATHOL, V22, P625, DOI 10.1177/030098588502200618
   Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140
   Walton RC, 2005, BBA-GEN SUBJECTS, V1723, P175, DOI 10.1016/j.bbagen.2005.02.014
   Webb MA, 1999, PLANT CELL, V11, P751
NR 49
TC 15
Z9 15
U1 0
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR 1
PY 2008
VL 103
IS 5
BP 1379
EP 1393
DI 10.1002/jcb.21515
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 285HP
UT WOS:000254768200005
PM 17879965
DA 2018-10-19
ER

PT J
AU Lauto, A
   Mawad, D
   Foster, LJR
AF Lauto, Antonio
   Mawad, Damia
   Foster, L. John R.
TI Adhesive biomaterials for tissue reconstruction
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE glues; tissue engineering; lasers; wound closure; biomaterials
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; RANDOMIZED MULTICENTER TRIAL;
   AUTOLOGOUS FIBRIN GLUE; POLYGLYCOLIC ACID MESH; SOLID PROTEIN SOLDER;
   RAT SCIATIC-NERVE; IN-VITRO; DURAL REPAIR; PHYSICOCHEMICAL
   CHARACTERISTICS; PHOTOCROSSLINKABLE CHITOSAN
AB Tissue reconstruction and wound closure rely on sutures, staples and clips in current surgical procedures. These traditional devices are nonetheless unable to prevent leakage of fluids from a variety of tissue including blood vessels and dura mater. Furthermore, sutures are usually difficult to apply during minimal invasive surgery and often induce detrimental scarring that may impair healing. To overcome these disadvantages, biocompatible and biodegradable glues based on fibrin, polyethylene glycol (PEG) and cyanoacrylate have recently been used in patients to seal and repair tissue wounds. Cyanoacrylate glues create typically very strong tissue bonds but have mostly been applied externally for skin wound closure because of their residual cytotoxicity. Other adhesive biomaterials are also emerging; these glues and adhesives are usually based on proteins such as albumin and collagen or polysaccharides like chitosan; these are irradiated with coherent or non-coherent light to trigger their adhesion to tissue. These biomaterial based devices offer significant advantages over sutures, such as their sealing or repairing ability, easy application modality and delivery in situ of compounds for accelerating wound healing. This paper reviews different tissue reconstruction strategies employing adhesive biomaterials currently used in surgical and experimental procedures. (c) 2007 Society of Chemical Industry.
C1 [Lauto, Antonio] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
   [Mawad, Damia] Univ Lyon, ESCPE, UMR 5007, Lab Automat & Genie Procedes,LAGEP, F-69622 Villeurbanne, France.
RP Lauto, A (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
CR Aigner C, 2006, ANN THORAC SURG, V81, P1275, DOI 10.1016/j.athoracsur.2005.11.037
   BASS LS, 1994, SURGERY, V115, P398
   Belboul A, 2004, EUR J CARDIO-THORAC, V26, P1187, DOI 10.1016/j.ejcts.2004.08.009
   Berger A, 2001, BREAST CANCER RES TR, V67, P9, DOI 10.1023/A:1010671209279
   Breasted JH, 2006, E SMITH SURG PAPYRUS
   Chelala E, 2007, SURG ENDOSC, V21, P391, DOI 10.1007/s00464-006-9014-x
   Christenson JT, 2004, THORAC CARDIOV SURG, V52, P225, DOI 10.1055/s-2004-821078
   Cimador M, 2004, UROL INT, V73, P320, DOI 10.1159/000081592
   Cooley BC, 1996, MICROSURG, V17, P198, DOI 10.1002/(SICI)1098-2752(1996)17:4<198::AID-MICR6>3.0.CO;2-H
   Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52
   Cuomo BE, 2000, J UROLOGY, V163, P634, DOI 10.1016/S0022-5347(05)67949-9
   DUBUISSON AS, 1993, MICROSURG, V14, P398, DOI 10.1002/micr.1920140609
   EIFERMAN RA, 1983, ARCH OPHTHALMOL-CHIC, V101, P958
   Fasol R, 2004, ANN THORAC SURG, V77, P1070, DOI 10.1016/S0003-4975(03)01175-5
   Forer B, 2006, LARYNGOSCOPE, V116, P1002, DOI 10.1097/01.mlg.0000217241.01388.2d
   Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97
   Grayeli AB, 2005, EUR ARCH OTO-RHINO-L, V262, P404, DOI 10.1007/s00405-004-0829-6
   Hida K, 2006, SURG NEUROL, V65, P136, DOI 10.1016/j.surneu.2005.07.059
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hwang K, 2005, J CRANIOFAC SURG, V16, P1102, DOI 10.1097/01.scs.0000179740.60671.e5
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JACKSON RM, 2001, AM J SURG, V182, pS36
   Kawahara M, 1996, DIS COLON RECTUM, V39, P556, DOI 10.1007/BF02058711
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kirman I, 1999, LASER SURG MED, V25, P438, DOI 10.1002/(SICI)1096-9101(1999)25:5<438::AID-LSM11>3.0.CO;2-T
   Kirsch AJ, 1996, UROLOGY, V48, P616, DOI 10.1016/S0090-4295(96)00243-9
   Kirsch AJ, 2001, J UROLOGY, V165, P574, DOI 10.1097/00005392-200102000-00073
   KJAERGARD HK, 1994, EUR SURG RES, V26, P273, DOI 10.1159/000129346
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 2004, LASER SURG MED, V35, P140, DOI 10.1002/lsm.20081
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   Li CL, 2003, J BIOMED MATER RES B, V66B, P439, DOI 10.1002/jbm.b.10025
   Loose HW, 1998, BRIT J RADIOL, V71, P1255, DOI 10.1259/bjr.71.852.10318997
   Lumsden AB, 2006, J VASC SURG, V44, P1002, DOI 10.1016/j.jvs.2006.06.039
   Maitz PKM, 1999, PLAST RECONSTR SURG, V104, P1726, DOI 10.1097/00006534-199911000-00017
   Manzano RPD, 2006, CORNEA, V25, P350
   Marcovich R, 2001, UROLOGY, V57, P806, DOI 10.1016/S0090-4295(00)01075-X
   Martinowitz U, 1996, Curr Opin Hematol, V3, P395
   McNally KM, 2000, LASER SURG MED, V27, P147, DOI 10.1002/1096-9101(2000)27:2<147::AID-LSM6>3.0.CO;2-P
   Menovsky T, 2003, MICROSURG, V23, P109, DOI 10.1002/micr.10100
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   Menovsky T, 1996, LASER SURG MED, V19, P152, DOI 10.1002/(SICI)1096-9101(1996)19:2<152::AID-LSM5>3.0.CO;2-R
   Merrifield BF, 2006, GASTROINTEST ENDOSC, V63, P710, DOI 10.1016/j.gie.2005.11.018
   MILLESI H, 1982, SCAND J PLAST RECONS, V19, P25
   Murray KD, 2002, CHEST, V122, P2146, DOI 10.1378/chest.122.6.2146
   Nageris BI, 2004, OTOLARYNG HEAD NECK, V131, P856, DOI 10.1016/j.otohns.2004.08.002
   Nakamura H, 2005, SPINE, V30, pE347, DOI 10.1097/01.brs.0000167820.54413.8e
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Ong CCP, 2002, PEDIATR SURG INT, V18, P553, DOI 10.1007/s00383-002-0728-0
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Oskoui P, 2003, LASER SURG MED, V32, P346, DOI 10.1002/lsm.10173
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Paez JMG, 2004, J MATER SCI-MATER M, V15, P109, DOI 10.1023/B:JMSM.0000011810.12031.c6
   Pecha RE, 1998, GASTROINTEST ENDOSC, V48, P299, DOI 10.1016/S0016-5107(98)70196-8
   Petratos PB, 2002, WOUND REPAIR REGEN, V10, P252, DOI 10.1046/j.1524-475X.2002.10409.x
   Pini R, 2001, PROC SPIE, V4244, P266, DOI 10.1117/12.427800
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   Proano CE, 2004, INVEST OPHTH VIS SCI, V45, P2177, DOI 10.1167/iovs.03-1066
   Pruthi RS, 2004, BJU INT, V93, P813, DOI 10.1111/j.1464-410X.2004.04742.x
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Ren Z, 2004, J CLIN LASER MED SUR, V22, P81, DOI 10.1089/104454704774076118
   Rutgeerts P, 1997, LANCET, V350, P692, DOI 10.1016/S0140-6736(97)03233-9
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Schievink WI, 2004, J NEUROSURG, V100, P1098, DOI 10.3171/jns.2004.100.6.1098
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   SHAFFREY CI, 1990, NEUROSURGERY, V26, P207, DOI 10.1227/00006123-199002000-00004
   Sharma A, 2003, OPHTHALMOLOGY, V110, P291, DOI 10.1016/S0161-6420(02)01558-0
   Sheffy N, 2006, J AM COLL SURGEONS, V203, P297, DOI 10.1016/j.jamcollsurg.2006.05.010
   Shimada Y, 2006, J ORTHOP SCI, V11, P454, DOI 10.1007/s00776-006-1044-7
   Sierra DH, 2000, J BIOMED MATER RES, V52, P534, DOI 10.1002/1097-4636(20001205)52:3<534::AID-JBM12>3.0.CO;2-7
   Silecchia G, 2006, OBES SURG, V16, P125, DOI 10.1381/096089206775565249
   Sin AH, 2006, J NEUROSURG-SPINE, V5, P224, DOI 10.3171/spi.2006.5.3.224
   Spotnitz WD, 2001, AM J SURG, V182, p8S, DOI 10.1016/S0002-9610(01)00771-1
   Stewart RB, 2002, LASER SURG MED, V31, P36, DOI 10.1002/lsm.10071
   Stone CA, 2000, BRIT J PLAST SURG, V53, P601, DOI 10.1054/bjps.2000.3412
   Sweeney T, 2002, SURGERY, V131, P185, DOI 10.1067/msy.2002.119492
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Taylor LM, 2003, J VASC SURG, V38, P766, DOI 10.1016/S0741-5214(03)00474-9
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Torchiana DF, 2003, J CARDIAC SURG, V18, P504, DOI 10.1046/j.0886-0440.2003.00305.x
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   van den Ende ED, 2004, J PEDIATR SURG, V39, P1249, DOI 10.1016/j.jpedsurg.2004.04.013
   VONSEGESSER LK, 1995, ANN THORAC SURG, V60, P511, DOI 10.1016/0003-4975(95)00536-T
   Vote BJT, 2000, CLIN EXP OPHTHALMOL, V28, P437, DOI 10.1046/j.1442-9071.2000.00351.x
   Wain JC, 2001, ANN THORAC SURG, V71, P1623, DOI 10.1016/S0003-4975(01)02537-1
   Xie H, 2004, LASER SURG MED, V35, P201, DOI 10.1002/lsm.20092
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
NR 92
TC 46
Z9 46
U1 5
U2 66
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD APR
PY 2008
VL 83
IS 4
BP 464
EP 472
DI 10.1002/jctb.1771
PG 9
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 285GB
UT WOS:000254764200006
DA 2018-10-19
ER

PT J
AU Dinnes, DLM
   Marcal, H
   Raftery, MJ
   Labow, RS
   Mahler, SM
AF Dinnes, Donna Lee M.
   Marcal, Helder
   Raftery, Mark J.
   Labow, Rosalind S.
   Mahler, Stephen M.
TI The macrophage-biomaterial interface: a proteomic analysis of the
   conditioned medium environment
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE macrophage; secretome; biomaterial; polycarbonate-urethane; proteomics;
   conditioned medium
ID POLYCARBONATE-BASED POLYURETHANES; ENZYME-INDUCED BIODEGRADATION;
   MONOCYTE-DERIVED MACROPHAGES; MEDIATED BIODEGRADATION; CHOLESTEROL
   ESTERASE; SURFACE-CHEMISTRY; PROTEIN-KINASE; CELLS; INFLAMMATION;
   DEPENDENCE
AB well as extracellular microenvironments. However, proteomics has not been extensively applied to examine cell-material interface dynamics or the conditioned medium (CM) that ensues. Monocyte-derived macrophages (MDM) are of particular interest as they are the predominant cell type contributing to chronic inflammation at long-term implant sites. The current study compares the CM generated when MDM were adherent to tissue culture polystyrene (TCPS) or a model polycarbonate-urethane (PCNU). Two-dimensional electrophoresis and either matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or liquid chromatography Fourier transform mass spectrometry were used for protein identification to begin to assess how the CM is altered when MDM are in contact with a degradable PCNU material relative to a typical tissue culture surface.
   RESULTS: Proteomic analysis of CM samples identified regulatory molecules associated with specific activation pathways, such as interferon-gamma, and degradative proteins, such as matrix metalloproteinases and chitinase-like proteins, suggesting their involvement in the MDM response to PCNU materials. Furthermore, this study illustrates the challenges in analysing CM protein profiles against a background of intracellular protein, originating from lysed cells or cell fragments, and cell culture additives such as fetal bovine serum.
   CONCLUSIONS: The microenvironment surrounding an MDM-biomaterial interface is complex, containing proteins that relate to intracellular signalling pathways, cytoskeletal remodelling, degradation as well as the presence of serum factors necessary for cell attachment. The use of proteomics to determine the CM protein profile should continue to aid in the elucidation of cell-material interactions. (c) 2008 Society of Chemical Industry.
C1 [Mahler, Stephen M.] Univ Queensland, Dept Chem Engn, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Dinnes, Donna Lee M.; Labow, Rosalind S.] Univ Ottawa, Inst Heart, Cardiac Surg Div, Ottawa, ON, Canada.
   [Dinnes, Donna Lee M.; Labow, Rosalind S.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   [Marcal, Helder] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.
   [Marcal, Helder; Mahler, Stephen M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia.
   [Labow, Rosalind S.] Univ Ottawa, Fac Med, Dept Surg, Ottawa, ON, Canada.
RP Mahler, SM (reprint author), Univ Queensland, Dept Chem Engn, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM s.mahler@uq.edu.au
RI Mahler, Stephen/B-4824-2009; Marcal, Helder/A-7690-2008
CR AJIKUMAR R, 2007, LANGNMIR, V23, P5670
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024
   Cordwell SJ, 2002, MICROBIOL-SGM, V148, P2765, DOI 10.1099/00221287-148-9-2765
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DINNES DL, 2007, IN PRESS DIFFERENTIA
   DINNES DL, 2007, BIOMED MATER RES A, V80, P895
   Dinnes DLM, 2005, BIOMATERIALS, V26, P3881, DOI 10.1016/j.biomaterials.2004.09.064
   Dinnes DLM, 2008, J CELL PHYSIOL, V214, P136, DOI 10.1002/jcp.21171
   Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028
   Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809
   Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Ishikawa I, 2006, AM J NEPHROL, V26, P372, DOI 10.1159/000094779
   JONES JA, 2007, BIOINED MATER RES A, V83, P585
   Jones JA, 2007, J BIOMED MATER RES, V84, P158
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LEE TL, 1993, J CELL SCI, V105, P167
   Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4
   Lopez MF, 2000, ELECTROPHORESIS, V21, P3673, DOI 10.1002/1522-2683(200011)21:17<3673::AID-ELPS3673>3.0.CO;2-M
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   MATHESON LA, 2007, BIOTECHNIQUES, V744, P746
   McBane JE, 2005, J BIOMED MATER RES A, V74A, P1, DOI 10.1002/jbm.a.30311
   McBane JE, 2007, J BIOMED MATER RES A, V82A, P984, DOI 10.1002/jbm.a.31263
   Mehul B, 1997, J CELL SCI, V110, P1169
   Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb901
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   STEIN JM, 1974, BIOCHEM J, V7, P381
   Sturge J, 2007, J LEUKOCYTE BIOL, V82, P585, DOI 10.1189/jlb.0107053
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   VANGINDERACHTER JA, 1911, IMMUNOBIOLOGY, V211, P487
   WILLIAMS DF, 1976, MED PROG TECHNOL, V4, P31
   Wong CK, 2005, AM J RESP CELL MOL, V33, P186, DOI 10.1165/rcmb.2005-0034OC
   Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336
NR 49
TC 3
Z9 3
U1 3
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD APR
PY 2008
VL 83
IS 4
BP 482
EP 495
DI 10.1002/jctb.1854
PG 14
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 285GB
UT WOS:000254764200008
DA 2018-10-19
ER

PT J
AU Chen, XB
   Li, MG
   Ke, H
AF Chen, X. B.
   Li, M. G.
   Ke, H.
TI Modeling of the flow rate in the dispensing-based process for
   fabricating tissue scaffolds
SO JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE
   ASME
LA English
DT Article
ID DEPOSITION; CARTILAGE; CHITOSAN
AB Made from biomaterials,tissue scaffolds are three-dimensional (3D) constructs with highly interconnected pore networks for facilitating cell growth and flow transport of nutrients and metabolic waste. To fabricate the scaffolds with complex structures, dispensing-based rapid prototyping technique has been employed recently. In such a fabrication process, the flow rate of biomaterial dispensed is of importance since it directly contributes to the pore size and porosity of the scaffold fabricated. However the modeling of the flow rate has proven to be a challenging task due to its complexity. This paper presents the development of a model for the flow rate in the scaffold fabrication process based on the fundamentals of fluid mechanics. To verify the effectiveness of the developed model, experiments were carried out, in which the chitosan solution (2% w/v) in acetic acid was used for dispensing under different applied pressures (50 kPa, 100 kPa, 150 kPa, 200 kPa, and 250 kPa) and needle heater temperatures (25 degrees C, 35 degrees C, 50 degrees C, and 65 degrees C). The measured flow rates were used to identify the flow behavior of the solution and were compared to the predictions from the developed model to illustrate the model effectiveness. Based on the developed model, simulations were carried out to identify the effects of the needle size and the flow behavior on the flow rate in the scaffold fabrication process. The developed model was also applied to determine the dispensing conditions for fabricating 3D scaffoldsfrom a 50% chitosan-hydroxyapatite colloidal gel. As an example, a scaffold fabricated with a well-controlled internal structure of diameters of 610 +/- 43 mu m and pore sizes of 850 +/- 75 mu m in the horizontal plane and of 430 +/- 50 mu m in the vertical direction is presented in this paper to illustrate the promise of the developed model as applied to the 3D scaffold fabrication.
C1 [Chen, X. B.; Li, M. G.; Ke, H.] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
RP Chen, XB (reprint author), Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
EM xbc719@mail.usask.ca
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Calvert P, 1998, MAT SCI ENG C-BIO S, V6, P167, DOI 10.1016/S0928-4931(98)00046-0
   Chen XB, 2006, IEEE T ELECTRON PACK, V29, P75, DOI 10.1109/TEPM.2006.874964
   Chhabra R.P., 1999, NON NEWTONIAN FLOW P
   Holdsworth S. D., 1993, Food and Bioproducts Processing, V71, P139
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KE H, 2006, 2006 ASME SUMM BIOEN
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
NR 16
TC 13
Z9 14
U1 1
U2 10
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1087-1357
J9 J MANUF SCI E-T ASME
JI J. Manuf. Sci. Eng.-Trans. ASME
PD APR
PY 2008
VL 130
IS 2
AR 021003
DI 10.1115/1.2789725
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 300SU
UT WOS:000255846300004
DA 2018-10-19
ER

PT J
AU Wang, W
   Huang, Y
   Grujicic, M
   Chrisey, DB
AF Wang, Wei
   Huang, Yong
   Grujicic, Mica
   Chrisey, Douglas B.
TI Study of impact-induced mechanical effects in cell direct writing using
   smooth particle hydrodynamic method
SO JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE
   ASME
LA English
DT Article
DE direct writing; cell; hydrogel; impact; smooth particle hydrodynamic
   method
ID LIVING CELLS; MAMMALIAN-CELLS; HYDROGEL; SPH; SIMULATION; TRAUMA; INJURY
AB Biomaterial direct-write technologies have been receiving more and more attention as rapid prototyping innovations in the area of tissue engineering, regenerative medicine, and biosensor/actuator fabrication based on computer-aided designs. However cell damage due to the mechanical impact during cell direct writing has been observed and is a possible hurdle for broad applications of fragile cell direct writing. The objective of this study is to investigate the impact-induced cell mechanical loading profile in cell landing in terms of stress, acceleration, and maximum shear strain component during cell direct writing using a mesh-free smooth particle hydrodynamic method. Such cell mechanical loading profile information can be used to understand and predict possible impact-induced cell damage. It is found that the cell membrane usually undergoes a relatively severe deformation and the cell mechanical loading profile is dependent on the cell droplet initial velocity and the substrate coating thickness. Two important impact processes may occur during cell direct writing: the first impact between the cell droplet and the substrate coating and the second impact between the cell and the substrate. It is concluded that the impact-induced cell damage depends not only on the magnitudes of stress, acceleration, and/or shear strain but also the loading history that a cell experiences.
C1 [Wang, Wei; Huang, Yong; Grujicic, Mica] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
   [Chrisey, Douglas B.] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
RP Wang, W (reprint author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
CR [Anonymous], 2006, LS DYNA THEOR MAN
   Barbee KA, 2005, ANN NY ACAD SCI, V1066, P67, DOI 10.1196/annals.1363.006
   Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Ellero M, 2005, J NON-NEWTON FLUID, V132, P61, DOI 10.1016/j.jnnfm.2005.08.012
   Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193
   GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375
   Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817
   Johnson GR, 1996, COMPUT METHOD APPL M, V139, P347, DOI 10.1016/S0045-7825(96)01089-4
   Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008
   Lin DC, 2004, J BIOMECH ENG-T ASME, V126, P104, DOI 10.1115/1.1645529
   Liu MB, 2003, SHOCK WAVES, V12, P509, DOI 10.1007/s00193-003-0185-2
   Liu MB, 2002, SHOCK WAVES, V12, P181, DOI 10.1007/s00193-002-0163-0
   LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164
   LYSNE PC, 1970, J GEOPHYS RES, V75, P4375, DOI 10.1029/JB075i023p04375
   Malvern L E, 1969, INTRO MECH CONTINUOU
   MONAGHAN JJ, 1983, J COMPUT PHYS, V52, P374, DOI 10.1016/0021-9991(83)90036-0
   Nam K, 2005, POLYMER, V46, P4704, DOI 10.1016/j.polymer.2005.03.087
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Ringeisen Bradley R., 2006, Biotechnology Journal, V1, P930, DOI 10.1002/biot.200600058
   ROEDER BA, 2002, ASME, V124, P214, DOI DOI 10.1115/1.1449904
   Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje
   Smith AE, 2000, CHEM ENG SCI, V55, P2043, DOI 10.1016/S0009-2509(99)00501-1
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Svaldo Lanero T, 2006, J BIOTECHNOL, V124, P723, DOI 10.1016/j.jbiotec.2006.02.016
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Wang W, 2007, T NAMRI SME, V35, P217
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Xu T, 2004, BIOTECHNOL BIOENG, V85, P29, DOI 10.1002/bit.10768
   Young CD, 1998, BIOMATERIALS, V19, P1745, DOI 10.1016/S0142-9612(98)00083-0
   Young D, 2001, APPL PHYS LETT, V78, P3169, DOI 10.1063/1.1372200
NR 33
TC 32
Z9 32
U1 2
U2 11
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1087-1357
J9 J MANUF SCI E-T ASME
JI J. Manuf. Sci. Eng.-Trans. ASME
PD APR
PY 2008
VL 130
IS 2
AR 021012
DI 10.1115/1.2896118
PG 10
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 300SU
UT WOS:000255846300013
DA 2018-10-19
ER

PT J
AU Negroiu, G
   Piticescu, RM
   Chitanu, GC
   Mihailescu, IN
   Zdrentu, L
   Miroiu, M
AF Negroiu, Gabriela
   Piticescu, Roxana M.
   Chitanu, Gabrielle C.
   Mihailescu, Ion N.
   Zdrentu, Livia
   Miroiu, Marimona
TI Biocompatibility evaluation of a novel hydroxyapatite-polymer coating
   for medical implants (in vitro tests)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 21st European Conference on Biomaterials
CY SEP 09-13, 2007
CL Brighton, ENGLAND
ID BONE; TITANIUM; FLUORAPATITE; DEGRADATION; INHIBITION; COPOLYMERS;
   TOXICITY; GROWTH; ALLOY; CELLS
AB Nanocomposites consisting of hydroxyapatite (HA) and a sodium maleate copolymer (maleic polyelectrolyte), synthesized by hydrothermal method and deposited on titanium substrates by Matrix Assisted Pulsed Laser Evaporation (MAPLE) technique were tested for the biological properties. Coating bioanalysis was carried out by triple staining of actin, microtubules and nuclei followed by immunofluorescence microscopy. Within 24 h cells that occupied the biomaterial surface displayed the morphology and cytoskeleton pattern similar to the controls. Cells grown on nanocomposite coated surfaces had a higher proliferation rate than their counterparts grown on Ti coated with HA alone, indicating that maleic polyelectrolyte improved surface bio-adhesive characteristics. The capacity to induce cell attachment, spreading and proliferation demonstrated the potential of Ti coated with HA-polymer nanocomposites to be used as scaffolds in dental or orthopedic implantology.
C1 [Negroiu, Gabriela; Zdrentu, Livia] Acad Romana, Inst Biochem, Bucharest, Romania.
   [Piticescu, Roxana M.; Mihailescu, Ion N.; Miroiu, Marimona] Natl R&D Inst Nonferrous & Rare Metals, Ilfov, Romania.
   [Chitanu, Gabrielle C.] Inst Macromol Chem, Iasi 700487, Romania.
RP Negroiu, G (reprint author), Acad Romana, Inst Biochem, Sector 6, Bucharest, Romania.
EM gnegroiu@biochim.ro; gabrielanegroiu@yahoo.com
RI Negroiu, Gabriela/G-4649-2016; MIROIU, Floralice Marimona/C-5044-2011;
   Mihailescu, Ion/A-5403-2011; Sima, Livia/C-2882-2011
OI Sima, Livia/0000-0002-3404-4162
CR Adya N., 2005, J INDIAN PROSTHODONT, V5, P126, DOI DOI 10.4103/0972-4052.17104
   AMJAD Z, 1998, BIOL IND SYSTEMS
   Bajpai AK, 2004, J MACROMOL SCI PURE, VA41, P1135, DOI 10.1081/MA-200026560
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Bouropoulos K, 1998, J UROLOGY, V159, P1755, DOI 10.1097/00005392-199805000-00107
   Chitanu GC, 2005, REV ROUM CHIM, V50, P589
   CHITANU GC, 2006, CARPOV REV ROUM CHIM, V51, P915
   Eason R., 2006, PULSED LASER DEPOSIT
   FERRIS BB, 1987, J BONE JOINT SURG BR, V69, P234
   Geurtsen W, 2002, CRIT REV ORAL BIOL M, V13, P71, DOI 10.1177/154411130201300108
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.3.CO;2-1
   Hallab NJ, 2001, MOL CELL BIOCHEM, V222, P127, DOI 10.1023/A:1017979710992
   HENNING L, 2002, ACTA ODONTOL SCAND, V60, P1
   Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903
   Kikuchi M, 2007, KEY ENG MATER, V342-343, P277, DOI 10.4028/www.scientific.net/KEM.342-343.277
   KLEPETSANIS KP, 1998, ACS SYM SER, P117
   Knabe C, 2002, BIOMATERIALS, V23, P3235, DOI 10.1016/S0142-9612(02)00078-9
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200
   Overgaard S, 1998, J BIOMED MATER RES, V39, P141, DOI 10.1002/(SICI)1097-4636(199801)39:1<141::AID-JBM16>3.0.CO;2-I
   Park EK, 2004, BIOMATERIALS, V25, P3403, DOI 10.1016/j.biomaterials.2003.10.031
   Piticescu R.M., 2004, ANN TRANSPL, V9, P20
   PITICESCU RM, 2005, T TECH PUBLICATIONS, V47
   Rees SG, 2002, BIOMATERIALS, V23, P481, DOI 10.1016/S0142-9612(01)00130-2
   SABURO S, 1993, JPN PHOSPHORUS RES B, V3, P7
   Sampathkumaran U, 2001, ADV ENG MATER, V3, P401, DOI 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L
   Teng SH, 2006, COMPOS SCI TECHNOL, V66, P1532, DOI 10.1016/j.compscitech.2005.11.021
   WAHL DA, 2006, CELL MAT, V11, P43
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 31
TC 31
Z9 33
U1 2
U2 41
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2008
VL 19
IS 4
BP 1537
EP 1544
DI 10.1007/s10856-007-3300-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274BG
UT WOS:000253976200013
PM 17990076
DA 2018-10-19
ER

PT J
AU Balmayor, ER
   Tuzlakoglu, K
   Marques, AP
   Azevedo, HS
   Reis, RL
AF Balmayor, Elizabeth Rosado
   Tuzlakoglu, Kadriye
   Marques, Alexandra P.
   Azevedo, Helena S.
   Reis, Rui L.
TI A novel enzymatically-mediated drug delivery carrier for bone tissue
   engineering applications: combining biodegradable starch-based
   microparticles and differentiation agents
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 21st European Conference on Biomaterials
CY SEP 09-13, 2007
CL Brighton, ENGLAND
ID IN-VITRO; BIOCOMPATIBILITY; BIOMATERIALS; DEGRADATION; PARTICLES;
   SCAFFOLDS; RELEASE; BLENDS; CELLS
AB In many biomedical applications, the performance of biomaterials depends largely on their degradation behavior. For instance, in drug delivery applications, the polymeric carrier should degrade under physiological conditions slowly releasing the encapsulated drug. The aim of this work was, therefore, to develop an enzymatic-mediated degradation carrier system for the delivery of differentiation agents to be used in bone tissue engineering applications. For that, a polymeric blend of starch with polycaprolactone (SPCL) was used to produce a microparticle carrier for the controlled release of dexamethasone (DEX). In order to investigate the effect of enzymes on the degradation behavior of the developed system and release profile of the encapsulated osteogenic agent (DEX), the microparticles were incubated in phosphate buffer solution in the presence of alpha-amylase and/or lipase enzymes (at physiological concentrations), at 37 degrees C for different periods of time. The degradation was followed by gravimetric measurements, scanning electron microscopy (SEM) and Fourier transformed infrared (FTIR) spectroscopy and the release of DEX was monitored by high performance liquid chromatography (HPLC). The developed microparticles were shown to be susceptible to enzymatic degradation, as observed by an increase in weight loss and porosity with degradation time when compared with control samples (incubation in buffer only). For longer degradation times, the diameter of the microparticles decreased significantly and a highly porous matrix was obtained. The in vitro release studies showed a sustained release pattern with 48% of the encapsulated drug being released for a period of 30 days. As the degradation proceeds, it is expected that the remaining encapsulated drug will be completely released as a consequence of an increasingly permeable matrix and faster diffusion of the drug. Cytocompatibility results indicated the possibility of the developed microparticles to be used as biomaterial due to their reduced cytotoxic effects.
C1 [Balmayor, Elizabeth Rosado; Tuzlakoglu, Kadriye; Marques, Alexandra P.; Azevedo, Helena S.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, P-4710057 Braga, Portugal.
RP Balmayor, ER (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM erosado@dep.uminho.pt
RI Azevedo, Helena/A-8298-2011; Reis, Rui L./A-8938-2008; Marques,
   Alexandra/B-1238-2012; Group, 3Bs/E-4374-2012; Rosado Balmayor,
   Elizabeth/N-9283-2015
OI Azevedo, Helena/0000-0002-5470-1844; Reis, Rui L./0000-0002-4295-6129;
   Marques, Alexandra/0000-0002-3222-0310; Group, 3Bs/0000-0002-5195-3456;
   Rosado Balmayor, Elizabeth/0000-0002-0484-4847
CR Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Azevedo HS, 2005, BIODEGRADABLE SYSTEM, P178
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   BALMAYOR ER, 2006, P EUR MAT RES SOC FA, P219
   Bissery M-C, 1984, MICROSPHERES DRUG TH, P217
   Boesel LF, 2003, BIODEGRADABLE POLYMERS AND PLASTICS, P243
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Kamyshny A, 2000, COLLOID SURFACE B, V18, P13, DOI 10.1016/S0927-7765(99)00123-X
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MALAFAYA PB, 2007, DRUG DELIV, V59, P207
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P195, DOI 10.1016/j.msec.2005.01.009
   Reis R.L., 2001, ENCY MAT SCI TECHNOL, V11, P8810
   Reis RL, 1997, POLYM INT, V43, P347
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Shinkai M, 2002, J BIOSCI BIOENG, V94, P606, DOI 10.1016/S1389-1723(02)80202-X
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P4, DOI 10.1002/term.2
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Silva GA, 2005, MAT SCI ENG C-BIO S, V25, P237, DOI 10.1016/j.msec.2005.01.012
   Silva GA, 2005, J BIOMED MATER RES A, V73A, P234, DOI 10.1002/jbm.a.30287
   Tuncel A, 1996, J POLYM SCI POL CHEM, V34, P45, DOI 10.1002/(SICI)1099-0518(19960115)34:1<45::AID-POLA4>3.0.CO;2-2
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 26
TC 39
Z9 40
U1 2
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2008
VL 19
IS 4
BP 1617
EP 1623
DI 10.1007/s10856-008-3378-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274BG
UT WOS:000253976200024
PM 18214645
DA 2018-10-19
ER

PT J
AU Calvet, JL
   Grafahrend, D
   Klee, D
   Moller, M
AF Calvet, Julia Lleixa
   Grafahrend, Dirk
   Klee, Doris
   Moeller, Martin
TI Sterilization effects on starPEG coated polymer surfaces:
   characterization and cell viability
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 21st European Conference on Biomaterials
CY SEP 09-13, 2007
CL Brighton, ENGLAND
ID SOLID-SURFACES; ADSORPTION; PROTEINS; OXIDE
AB Sterilization is frequently an issue for polymeric biomaterials including hydrogels, where autoclaving needs to be discarded, and gamma-irradiation and low temperature hydrogen peroxide gas plasma sterilization are already important alternatives. Coatings based on poly(ethylene glycol) are a well-known strategy to reduce unspecific protein interactions on biomaterial surfaces. Dense, ultrathin coatings of isocyanate terminated star-shaped poly(ethylene glycol) (starPEG) molecules have proven to be resistant to unspecific adsorption of proteins and enable direct biofunctionalization. The effectivity and stability of the starPEG coatings on poly(vinylidene fluoride) (PVDF) were studied after gamma-irradiation (normed dosis 25 kGy) and plasma sterilization (Sterrad 100S). The selected surface properties determined were: surface composition (X-ray photoelectron spectroscopy, XPS), wettability (sessile drop contact angle) and protein adsorption by fluorescence microscopy (Avidin-TexasRed, Bovine Serum Albumin-Rhodamin). Preliminary cell experiments with the cell line L929 were performed prior and after sterilization to investigate the cell repellence of the starPEG coatings as well as cell viability and specific cell adhesion on GRGDS-modified coatings. The starPEG coating undergoes a slight oxidation due to plasma and gamma-sterilization; this represents a minor variation confirmed by XPS and contact angle results. The non-sterilized starPEG and the plasma-sterilized coatings are protein repellent, however the protein adsorption on starPEG coated substrates is much stronger after gamma-sterilization for both avidin and bovine serum albumin. The cell experiments indicate that the starPEG coatings are appliable homogeneously by incubation and are non-cell adherent. Moreover, after both sterilization processes the starPEG coatings remain cell repellent and the GRGDS-modified coatings presented vital cells. Thus we conclude that the plasma sterilization is more convenient for the starPEG coatings and GRGDS-modified starPEG coatings.
C1 [Moeller, Martin] DWI eV, D-52056 Aachen, Germany.
   Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
RP Moller, M (reprint author), DWI eV, RWTH Aachen Pauwelsstr 8, D-52056 Aachen, Germany.
EM moeller@dwi.rwth-aachen.de
RI Moller, Martin/F-7860-2015
OI Moller, Martin/0000-0002-5955-4185
CR Amirgoulova EV, 2004, CHEMPHYSCHEM, V5, P552, DOI 10.1002/cphc.200400024
   BIALASIEWICZ AA, 1995, OPHTHALMIC RES, V27, P124, DOI 10.1159/000267857
   BOSETAL GW, 1999, J BIOMED MATER RES, V44, P330
   Buijs J, 1997, J COLLOID INTERF SCI, V190, P171, DOI 10.1006/jcis.1997.4876
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Groll J, 2005, BIOMACROMOLECULES, V6, P956, DOI 10.1021/bm049350u
   GROLLETAL J, 2005, J BIOMED MATER RES A, V607, P123
   HARRIS JM, 1992, POLY CHEM BIOTECHNIC
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Johnson R, 1997, Biomed Sci Instrum, V34, P47
   Kelly-Wintenberg K, 1999, J VAC SCI TECHNOL A, V17, P1539, DOI 10.1116/1.581849
   KIDANEETAL A, 1999, J BIOMED MATER RES, V44, P640
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Norde W, 1996, MACROMOL SYMP, V103, P5, DOI 10.1002/masy.19961030104
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   THE TC, 1996, BIOMATERIALS, V17, P1273
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
NR 19
TC 10
Z9 10
U1 2
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2008
VL 19
IS 4
BP 1631
EP 1636
DI 10.1007/s10856-008-3381-x
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274BG
UT WOS:000253976200026
PM 18228118
DA 2018-10-19
ER

PT J
AU Douglas, T
   Heinemann, S
   Hempel, U
   Mietrach, C
   Knieb, C
   Bierbaum, S
   Scharnweber, D
   Worch, H
AF Douglas, Timothy
   Heinemann, Sascha
   Hempel, Ute
   Mietrach, Carolin
   Knieb, Christiane
   Bierbaum, Susanne
   Scharnweber, Dieter
   Worch, Hartmut
TI Characterization of collagen II fibrils containing biglycan and their
   effect as a coating on osteoblast adhesion and proliferation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 21st European Conference on Biomaterials
CY SEP 09-13, 2007
CL Brighton, ENGLAND
ID LEUCINE-RICH PROTEOGLYCANS; CHONDROITIN-SULFATE; IN-VITRO; TITANIUM
   IMPLANTS; CELL-ADHESION; GROWTH-PLATE; HUMAN BONE; DIFFERENTIATION;
   CHONDROCYTES; DECORIN
AB Collagen has been used as a coating material for titanium-based implants for bone contact and as a component of scaffolds for bone tissue engineering. In general collagen type I has been used, however very little attention has been focussed on collagen type II. Collagen-based coatings and scaffolds have been enhanced by the incorporation of the glycosaminoglycan chondroitin sulphate (CS), however the proteglycan biglycan, which is found in bone and contains glycosaminoglycan chains consisting of CS, has not been used as a biomaterial component. The study had the following aims: firstly, five different collagen II preparations were compared with regard to their ability to bind CS and biglycan and the changes in fibril morphology thereby induced. Secondly, the effects of biglycan on the adhesion of primary rat osteoblasts (rO) as well as the proliferation of rO, primary human osteoblasts (hO) and the osteoblast-like cell line 7F2 were studied by culturing the cells on surfaces coated with collagen II fibrils containing biglycan. Fibrils of the collagen II preparation which bound the most biglycan were used to coat titanium surfaces. Bare titanium, titanium coated with collagen II fibrils and titanium coated with collagen II fibrils containing biglycan were compared. It was found that different collagen II preparations showed different affinities for CS and biglycan. In four of the five preparations tested, biglycan reduced fibril diameter, however the ability of a preparation to bind more biglycan did not appear to lead to a greater reduction in fibril diameter. Fibrils containing biglycan promoted the formation of focal adhesions by rO and significantly enhanced the proliferation of hO but not of rO or 7F2 cells. These results should encourage further investigation of biglycan as a component of collagen-based scaffolds and/or coatings.
C1 [Douglas, Timothy; Heinemann, Sascha; Knieb, Christiane; Bierbaum, Susanne; Scharnweber, Dieter; Worch, Hartmut] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Hempel, Ute; Mietrach, Carolin] Ctr Theoret Med, Inst Phys Chem, D-01307 Dresden, Germany.
RP Douglas, T (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
EM Timothy.Douglas@mailbox.tu-dresden.de
RI Scharnweber, Dieter/B-3382-2010
OI Scharnweber, Dieter/0000-0003-0369-5189; Douglas,
   Timothy/0000-0002-6661-3120
CR Alini M, 2001, MATRIX BIOL, V19, P805, DOI 10.1016/S0945-053X(00)00129-3
   Ameye L, 2002, GLYCOBIOLOGY, V12, p107R
   Ballock RT, 2003, J BONE JOINT SURG AM, V85A, P715, DOI 10.2106/00004623-200304000-00021
   Banu N, 2007, J BIOMED MATER RES A, V80A, P257, DOI 10.1002/jbm.a.30931
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bi YM, 2006, BONE, V38, P778, DOI 10.1016/j.bone.2005.11.005
   BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Douglas T, 2007, BIOMACROMOLECULES, V8, P1085, DOI 10.1021/bm0609644
   Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746
   EINHORN TA, 2001, FOLIA TRAUMATOLOGICA, P86
   FEDARKO NS, 1990, J BIOL CHEM, V265, P12200
   Fischer U, 2003, BIOMATERIALS, V24, P2631, DOI 10.1016/S0142-9612(03)00068-1
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527
   INGRAM RT, 1993, J BONE MINER RES, V8, P1019
   Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615
   Mundy G R, 1996, Clin Orthop Relat Res, P24, DOI 10.1097/00003086-199603000-00004
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   NEGROIU G, 1992, Revue Roumaine de Biochimie, V29, P23
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   OBRINK B, 1973, EUR J BIOCHEM, V33, P387, DOI 10.1111/j.1432-1033.1973.tb02695.x
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   POGANY G, 1994, ARCH BIOCHEM BIOPHYS, V313, P102, DOI 10.1006/abbi.1994.1365
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150
   Schliephake H, 2005, CLIN ORAL IMPLAN RES, V16, P563, DOI 10.1111/j.1600-0501.2005.01143.x
   Schliephake H, 2005, J BIOMED MATER RES B, V73B, P88, DOI 10.1002/jbm.b.30183
   SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776
   STADLINGER B, 2007, J BIOMED MAT RES B
   Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Vynios DH, 2001, BIOCHIMIE, V83, P899, DOI 10.1016/S0300-9084(01)01332-3
   Waddington R. J., 2003, European Cells & Materials, V6, P12
   Wolf-Brandstetter C, 2006, J BIOMED MATER RES A, V79A, P882, DOI 10.1002/jbm.a.30826
   WOLFBRANDSTETTE.C, 2004, THESIS TECHNISCHE U
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   YANG CL, 1995, BIOCHEM J, V306, P871, DOI 10.1042/bj3060871
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 53
TC 17
Z9 18
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2008
VL 19
IS 4
BP 1653
EP 1660
DI 10.1007/s10856-007-3250-z
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274BG
UT WOS:000253976200029
PM 17851735
DA 2018-10-19
ER

PT J
AU Peng, HT
   Martineau, L
   Hung, A
AF Peng, Henry T.
   Martineau, Lucie
   Hung, Andy
TI Hydrogel-elastomer composite biomaterials: 4. Experimental optimization
   of hydrogel-elastomer composite fibers for use as a wound dressing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 21st European Conference on Biomaterials
CY SEP 09-13, 2007
CL Brighton, ENGLAND
ID INTERPENETRATING POLYMER NETWORKS; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; CELLULOSE-ACETATE; GELATIN
   FIBERS; SILK FIBROIN; BLEND FIBERS; POLYACRYLONITRILE; SCAFFOLDS
AB We report a novel 3-D cavity wound dressing based on a hydrogel-elastomer Interpenetrating Polymer Network (IPN) fabricated into an open-mesh architecture. IPN fibers used to form the dressing were produced by a wet spinning method and optimized in two steps. A factorial experiment was first conducted to identify key parameters that controlled fiber properties. We observed that gelatin wt% played a major role in determining fiber yield, swelling, strength and stability. Other contributing factors included coagulation solution composition, gelatin type, and pre- and post-UV irradiation time. The key factors were then further evaluated individually to achieve a condition that provided a combination of good swelling, mechanical properties and stability. The concentration of the gelatin/HydroThane (TM) extrusion solution significantly affected fiber formation and properties, presumably due to the changes in solution viscosity. The effects of pre-UV irradiation were also ascribed to its impact on the solution viscosity and became negligible at higher concentrations when viscosity is mainly controlled by concentration. The composition of the coagulation bath influenced the fiber swelling and wet stress. These results, taken together with our previous studies, suggest that our biomaterial would provide a combination of mechanical and swelling properties suitable for wound dressing applications.
C1 [Peng, Henry T.; Hung, Andy] Def Res & Dev Canada Toronto, Toronto, ON M3M 3B9, Canada.
   [Martineau, Lucie] Def Res & Dev Canada Valcartier, Toronto, ON G3J 1X5, Canada.
RP Peng, HT (reprint author), Def Res & Dev Canada Toronto, 1133 Sheppard Ave W, Toronto, ON M3M 3B9, Canada.
EM henry.peng@drdc-rddc.gc.ca
OI Peng, Henry/0000-0001-5276-9573
CR Bak H, 2002, CHEM ENG SCI, V57, P913, DOI 10.1016/S0009-2509(01)00392-X
   Barani H, 2007, J APPL POLYM SCI, V103, P2000, DOI 10.1002/app.25326
   Bellincampi LD, 1997, J APPL POLYM SCI, V63, P1493, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1493::AID-APP11>3.0.CO;2-3
   Djagny KB, 2001, CRIT REV FOOD SCI, V41, P481, DOI 10.1080/20014091091904
   FAN L, 2006, J APPL POLYM SCI, V96, P1625
   Fei JQ, 2002, J APPL POLYM SCI, V85, P2423, DOI 10.1002/app.10888
   Garcia JM, 2005, DYSPHAGIA, V20, P325, DOI 10.1007/s00455-005-0034-9
   Gisselfalt K, 2002, BIOMACROMOLECULES, V3, P951, DOI 10.1021/bm025535u
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   LI M, 2006, BIOMATERIALS, V26, P5999
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Marsano E, 2007, J APPL POLYM SCI, V104, P2187, DOI 10.1002/app.24856
   Miller RG, 1998, J BIOMED MATER RES, V41, P237, DOI 10.1002/(SICI)1097-4636(199808)41:2<237::AID-JBM8>3.0.CO;2-J
   Nagura M, 2002, POLYM J, V34, P761, DOI 10.1295/polymj.34.761
   Nam CW, 2001, J APPL POLYM SCI, V82, P1620, DOI 10.1002/app.2001.abs
   Nam CW, 1999, J APPL POLYM SCI, V74, P2258, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2258::AID-APP15>3.3.CO;2-0
   Oh YS, 1997, J APPL POLYM SCI, V64, P1937, DOI 10.1002/(SICI)1097-4628(19970606)64:10<1937::AID-APP8>3.3.CO;2-1
   Peng HT, 2007, J MATER SCI-MATER M, V18, P975, DOI 10.1007/s10856-006-0088-8
   Peng HT, 2007, J MATER SCI-MATER M, V18, P1025, DOI 10.1007/s10856-006-0072-3
   PENG HT, IN PRESS J MAT SCI M
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   TSAI JS, 1991, J MATER SCI LETT, V10, P1253, DOI 10.1007/BF00720937
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Um IC, 2004, INT J BIOL MACROMOL, V34, P89, DOI 10.1016/j.ijbiomac.2004.03.007
   Um IC, 2004, INT J BIOL MACROMOL, V34, P107, DOI 10.1016/j.ijbiomac.2004.03.011
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yang RD, 2005, J APPL POLYM SCI, V96, P144, DOI 10.1002/app.21416
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   YUAN M, IN PRESS TECHNOMETRI
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zheng H, 2003, KEY ENG MAT, V249, P437, DOI 10.4028/www.scientific.net/KEM.249.437
NR 37
TC 10
Z9 10
U1 7
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2008
VL 19
IS 4
BP 1803
EP 1813
DI 10.1007/s10856-007-3324-y
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274BG
UT WOS:000253976200048
PM 18058199
DA 2018-10-19
ER

PT J
AU Liu, YJ
   Yao, DJ
   Lin, HC
   Chang, WY
   Chang, HY
AF Liu, Yi-Ju
   Yao, Da-Jeng
   Lin, Hung-Chia
   Chang, Wei-You
   Chang, Hwan-You
TI DNA ligation of ultramicro volume using an EWOD microfluidic system with
   coplanar electrodes
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID ELECTROWETTING-BASED ACTUATION; DIGITAL MICROFLUIDICS; LIQUID DROPLETS
AB An automatic ultramicro-volume DNA ligation process using a coplanar electrode type of electrowetting-on-dielectric (EWOD) microfluidic system was designed for economy of reagent. The droplets, containing DNA, a ligation enzyme and a multi-salt reaction buffer, served to complete the ligation using a developed EWOD system. Droplets of ultramicro volume (0.3 mu L) were successfully generated from reservoirs between one plate with coplanar electrodes and another plate with a hydrophobic surface free of electrodes. In one successful cloning, the total usage of reagents in an ultramicro-volume EWOD chip was 2.1 mu L; no volume was wasted, in comparison with 85% waste with the standard protocol and 80% waste with a free-cover coplanar EWOD chip. The results also show that the entire process was accomplished without damage to the chip surface and without biomaterial annulment. With a design consisting of electrode pathways in a flexible pattern and multiplex reservoirs, an EWOD digital microfluidic system with coplanar electrodes would be improved as an efficient parallel DNA-cloning system in the construction of an artificial library or expression library.
C1 [Liu, Yi-Ju; Yao, Da-Jeng; Lin, Hung-Chia; Chang, Wei-You] Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu 30013, Taiwan.
   [Chang, Hwan-You] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 30013, Taiwan.
RP Liu, YJ (reprint author), Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu 30013, Taiwan.
EM djyao@mx.nthu.edu.tw
CR Chang YH, 2006, BIOMED MICRODEVICES, V8, P215, DOI 10.1007/s10544-006-8171-y
   Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467
   Cooney CG, 2006, MICROFLUID NANOFLUID, V2, P435, DOI 10.1007/s10404-006-0085-8
   *EPICENTRE, 2007, FAST LINK DNA LIG SC
   GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N
   LIU YJ, 2007, IEEE INT C NAN MOL M
   Paik P, 2003, LAB CHIP, V3, P28, DOI 10.1039/b210825a
   Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534
   SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794
   SPECTROM C, 2004, ANAL CHEM, V76, P4833
   Srinivasan V, 2004, ANAL CHIM ACTA, V507, P145, DOI 10.1016/j.aca.2003.12.030
   Wheeler AR, 2005, ANAL CHEM, V77, P534, DOI 10.1021/ac048754+
   YI UC, 2005, 13 INT C SOL STAT SE, P89
   Yi UC, 2006, J MICROMECH MICROENG, V16, P2053, DOI 10.1088/0960-1317/16/10/018
NR 14
TC 41
Z9 41
U1 2
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD APR
PY 2008
VL 18
IS 4
AR 045017
DI 10.1088/0960-1317/18/4/045017
PG 7
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 276OL
UT WOS:000254151800017
DA 2018-10-19
ER

PT J
AU El Kassaby, A
   AbouShwareb, T
   Atala, A
AF El Kassaby, AbdelWahab
   AbouShwareb, Tamer
   Atala, Anthony
TI Randomized comparative study between buccal mucosal and acellular
   bladder matrix grafts in complex anterior urethral strictures
SO JOURNAL OF UROLOGY
LA English
DT Article
DE urethra; urethral stricture; reconstructive surgical procedures
ID TUNICA VAGINALIS; SUBSTITUTION URETHROPLASTY; COLLAGEN MATRIX; DORSAL;
   RECONSTRUCTION; REPAIR; HYPOSPADIAS; FLAP; SKIN
AB Purpose: Urethral strictures have been a reconstructive dilemma for many years due to the limited availability of tissue substitutes and incidence of recurrence. Buccal mucosal grafts have been a favored material in instances where penile skin is unavailable due to its durability and excellent graft survival. Recently collagen based matrices derived from the bladder have been used successfully in patients with stricture disease and hypospadias. We performed a randomized comparative study to assess the outcome of the acellular bladder matrix compared to buccal mucosa in patients with complex urethral strictures.
   Materials and Methods: Human demineralized bone matrix, obtained from cadaveric donors, was processed and prepared for use as an off-the-shelf material. Thirty patients with stricture 21 to 59 years old (mean 36.2) were enrolled and assessed using a standard protocol. The stricture length ranged from 2 to 18 cm (mean 6.9), of which 11 patients had bulbar, 7 had pendulous and 12 had combined bulbopendulous strictures. Of the 30 patients 7 had received no previous intervention while the remaining 23 had undergone 1 to 7 procedures (mean 1.9). All patients were randomized and alternatively assigned to receive either buccal mucosa or demineralized bone matrix and underwent an onlay procedure.
   Results: All patients except 2 who were lost during followup were followed for 18 to 36 months (mean 25). In patients with a healthy urethral bed (less than 2 prior operations) the success rate of buccal mucosa grafts (10 of 10) was similar to the bladder matrix grafts (8 of 9) in terms of patency. In patients with an unhealthy urethral bed (more than 2 prior operations) only 2 of 6 patients with a bladder matrix graft were successful, whereas all 5 patients with a buccal mucosa graft had a patent urethra. Postoperative uroflowmetry showed significant voiding improvement in both groups. Histology of the graft biopsies showed normal urethral tissue characteristics.
   Conclusions: This study demonstrates that the use of acellular bladder matrix is a viable option for urethral repair. Demineralized bone matrix as an off-the-shelf biomaterial achieves the best results in patients with a healthy urethral bed, no spongiofibrosis and good urethral mucosa.
C1 Wake Forest Univ Hlth Serv, Dept Urol, Winston Salem, NC USA.
   Wake Forest Univ Hlth Serv, Inst Regenerat Med, Winston Salem, NC USA.
   [El Kassaby, AbdelWahab] Ain Shams Univ, Cairo, Egypt.
RP Atala, A (reprint author), Wake Forest Inst Regenerat Med, Dept Urol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM aatala@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Andrich DE, 2001, J UROLOGY, V165, P1131, DOI 10.1016/S0022-5347(05)66447-6
   Ariyoshi A, 1967, Nihon Hinyokika Gakkai Zasshi, V58, P417
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Barbagli G, 2004, J UROLOGY, V172, P1365, DOI 10.1097/01.ju.0000139727.70523.30
   Barbagli G, 1998, J UROLOGY, V160, P1307, DOI 10.1016/S0022-5347(01)62522-9
   Barbagli G, 2006, CURR OPIN UROL, V16, P391, DOI 10.1097/01.mou.0000250277.44990.ab
   Bellinzoni Piera, 2002, Arch Ital Urol Androl, V74, P117
   Bhandari M, 2001, BJU INT, V88, P39, DOI 10.1046/j.1464-410x.2001.02257.x
   Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2004.04723.x
   Bhargava S, 2004, BJU INT, V93, P1191, DOI 10.1111/j.1464-410X.2004.04860.x
   Braga LHP, 2007, J UROLOGY, V178, P1693, DOI 10.1016/j.juro.2007.03.166
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   El-Kassaby AW, 2008, EUR UROL, V53, P420, DOI 10.1016/j.eururo.2007.06.002
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   ELKASABY AW, 1993, J UROLOGY, V149, P276, DOI 10.1016/S0022-5347(17)36054-8
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Gupta NP, 2004, BJU INT, V93, P1287, DOI 10.1111/j.1464-410X.2004.04822.x
   Kane CJ, 2002, J UROLOGY, V167, P1314, DOI 10.1016/S0022-5347(05)65289-5
   KIRKALI Z, 1990, BRIT J UROL, V65, P530, DOI 10.1111/j.1464-410X.1990.tb14802.x
   Morey Allen F, 2005, J Urol, V174, P1858
   Ozgok Y, 2000, INT J UROL, V7, P355, DOI 10.1046/j.1442-2042.2000.00210.x
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   QUARTEY JKM, 1993, ANN UROL, V27, P228
   Santucci Richard A., 2005, Int. braz j urol., V31, P192, DOI 10.1590/S1677-55382005000300002
   SIEVERT KD, 2007, INT BRAZ J UROL, V33, P447
   SNOW BW, 1992, UROLOGY, V40, P442, DOI 10.1016/0090-4295(92)90460-E
   Theodorescu D, 1998, J UROLOGY, V159, P1708, DOI 10.1097/00005392-199805000-00098
   Venn SN, 1998, BRIT J UROL, V81, P735
   Wessells H, 1996, J UROLOGY, V155, P1912, DOI 10.1016/S0022-5347(01)66045-2
NR 29
TC 97
Z9 109
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2008
VL 179
IS 4
BP 1432
EP 1436
DI 10.1016/j.juro.2007.11.101
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 276WS
UT WOS:000254175000058
PM 18295282
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Akahori, T
   Nakai, M
AF Niinomi, Mitsuo
   Akahori, Toshikazu
   Nakai, Masaaki
TI In situ X-ray analysis of mechanism of nonlinear super elastic behavior
   of Ti-Nb-Ta-Zr system beta-type titanium alloy for biomedical
   applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Advanced Processing of Biomaterials
CY OCT 15-19, 2006
CL Cincinnati, OH
SP Amer Ceram Soc, Assoc Iron & Steel Technol, ASM Int, Minerals, Met & Mat Soc
DE beta type titanium alloy; elastic plastic deformation; super elasticity;
   X-ray analysis; biomaterial
ID TENSILE DEFORMATION-BEHAVIOR; SIMULATED BODY ENVIRONMENT;
   MICROSTRUCTURE; TI-29NB-13TA-4.6ZR; MODULUS
AB Ti-XNb-10Ta-5Zr (mass %) alloys based on nominal compositions of Ti-35Nb-IM-5Zr,Ti-30Nb-10Ta-5Zr, and Ti-25Nb-10Ta-5Zr were fabricated through powder metallurgy and forging and swaging processes for biomedical applications. The tensile deformation mechanisms of the Ti-25Nb-10Ta-5Zr, Ti-30Nb-10Ta-5Zr, and Ti-35Nb-10Ta-5Zr alloys were investigated in situ by X-ray diffraction analysis under several loading conditions.
   Under the loading conditions, the X-ray diffraction peaks of all the specimens shifted to higher angles than those obtained under the unloading conditions. For the Ti-30Nb-10Ta-5Zr alloy, the elastic deformation is considered to progress continuously in a different crystal direction although after the elastic strain reaches elastic limit in the crystal direction where the elastic limit is the smallest, slip deformation occurs in that crystal direction. The elastic modulus of this alloy appears to decrease in terms of strain over the proportional limit. Thus, the elastic deformation behavior of the Ti-30Nb-10Ta-5Zr alloy does not obey Hooke's law. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Niinomi, Mitsuo; Akahori, Toshikazu; Nakai, Masaaki] Tohoku Univ, Dept Biomat Sci, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Niinomi, M (reprint author), Tohoku Univ, Dept Biomat Sci, Inst Mat Res, Aoba Ku, Tohoku Univ 2-1-1, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.toholcu.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
CR Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   KRENN CR, 2003, MAT SCI ENG A-STRUCT, P111
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   MONDOLFO LF, 1976, ALUMINUM ALLOYS STRU, P72
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, TETSU TO HAGANE, V88, P567, DOI 10.2355/tetsutohagane1955.88.9_567
   Niinomi M, 2002, TETSU TO HAGANE, V88, P553, DOI 10.2355/tetsutohagane1955.88.9_553
   OHMORI Y, 2001, MAT SCI ENG A-STRUCT, V321, P182
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   Sakaguchi N, 2004, J JPN I MET, V68, P1076, DOI 10.2320/jinstmet.68.1076
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
NR 16
TC 30
Z9 33
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 1
PY 2008
VL 28
IS 3
BP 406
EP 413
DI 10.1016/j.msec.2007.04.028
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 295BX
UT WOS:000255451100015
DA 2018-10-19
ER

PT J
AU Schmahl, WW
   Griesshaber, E
   Merkel, C
   Kelm, K
   Deuschle, J
   Neuser, RD
   Goetz, AJ
   Sehrbrock, A
   Mader, W
AF Schmahl, W. W.
   Griesshaber, E.
   Merkel, C.
   Kelm, K.
   Deuschle, J.
   Neuser, R. D.
   Goeetz, A. J.
   Sehrbrock, A.
   Mader, W.
TI Hierarchical fibre composite structure and micromechanical properties of
   phosphatic and calcitic brachiopod shell biomaterials - an overview
SO MINERALOGICAL MAGAZINE
LA English
DT Article
DE biomineralization; hierarchical architecture; nano-indentation; EBSD;
   amorphous calciumphosphate; ACP; hydroxylapatite; HAP; nacre;
   palaeoclimate
ID FRACTURE-MECHANICS; HARD TISSUES; NACRE; MICROSTRUCTURE; DESIGN;
   NANOSTRUCTURE; DELTA-O-18; DELTA-C-13; EVOLUTION; PATTERNS
AB Brachiopods are a phylum of shell-forming sessile marine invertebrates which have existed since the early Cambrian. Two very different biomaterial design strategies for their shells evolved early in their history. Both strategies use hybrid fibre composites, however, one is based oil mineral fibres embedded in similar to 2 wt.% of organic biopolymer sheaths and the inorganic fibres are calcite single crystals. In the second strategy the fibres are biopolymers and are reinforced with Ca-phosphate nanoparticles to form a fibrous nanocomposite. Here the organic component (chitin) dominates. The Ca-phosphate nanoparticle-reinforcement strategy is not unlike that in vertebrate hone, however, the microscale Structure is laminated with alternating laminae which have a different degree of mineralization. The calcitic shells feature all outer compact layer of calcite micro- and nanoparticles protecting the inner fibrous layer from the outside. Transmission electron microscopy of the fibrous layer reveals intercrystalline and intracrystalline biopolymers. The calcitic shell material is stiff with nano-indentation E-moduli of 63 +/- 8 GPa and relatively hard (Vickers microhardness up to 400 HV 0.0005/10 and nanohardness 4 +/- 0.5 GPa). Compared to inorganic calcite the microhardness is doubled and the nanohardness increases by 60%. We attribute this increased hardness to intracrystalline biopolymers. The nano-indentation E-moduli of the chitinophosphatic shells range from 3 to 55 GPa as a result Of the varying degree of mineralization between their laminae, and similarly their nanohardness varies between 0.1 and 3 GPa. For brachiopods burrowing inside the sediment, the alternation of non-mineralized laminae with thin, more strongly mineralized laminae provides abrasion-resistance. hardness and longitudinal stiffness while it preserves the flexibility provided by the organic component for bending movements.
C1 [Schmahl, W. W.; Griesshaber, E.; Merkel, C.; Goeetz, A. J.] Ludwig Maximilians Univ Munchen, GeoBioctr, D-80333 Munich, Germany.
   [Schmahl, W. W.; Griesshaber, E.; Merkel, C.; Goeetz, A. J.] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, D-80333 Munich, Germany.
   [Kelm, K.; Mader, W.] Univ Bonn, Inst Anorgan Chem, D-53117 Bonn, Germany.
   [Deuschle, J.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany.
   [Neuser, R. D.] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44801 Bochum, Germany.
   [Sehrbrock, A.] Forschungszentrum CAESAR, D-53175 Bonn, Germany.
RP Schmahl, WW (reprint author), Ludwig Maximilians Univ Munchen, GeoBioctr, Theresienstr 41, D-80333 Munich, Germany.
EM wolfgang.schmahl@lrz.uni-muenchen.de
RI Schmahl, Wolfgang/J-7571-2012
OI Schmahl, Wolfgang/0000-0002-0165-5952
FU German Research Council (DFG)
FX We are indebted to E. Kessler, T. Westphal and D. Dettmer, Ruhr
   Universitat Bochum for the skillful preparation of the samples with
   surfaces of superb quality, without which this work would not have been
   possible. Thanks to U. Brand (University of St. Catherines, Canada) and
   A. Logan (University of New Brunswick, Canada) for providing the
   brachiopod specimens and to R. Hochleitner (Mineralogische
   Staatssammlung Munchen) for providing inorganic reference minerals. We
   acknowledge fruitful discussion on brachiopod anatomy with G.
   Haszprunar, LMU Munich. Thanks to J. Veizer, J. Mutterlose and J.
   Steffahn (Bochum) for their constant help with paleontologic
   terminology. We would like to thank the German Research Council (DFG)
   for financial support.
CR ALEXANDER RR, 2001, PALEONTOLOGICAL SOC, V7, P17
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9
   CARPENTER SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P3749, DOI 10.1016/0016-7037(95)00291-7
   Currey J.D., 1990, P11
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURREY JD, 1974, J ZOOL, V173, P395
   Currey JD, 1999, J EXP BIOL, V202, P3285
   Currey JD, 2006, BONES STRUCTURE MECH
   Engler O., 2000, INTRO TEXTURE ANAL
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gay D., 2007, COMPOSITE MAT DESIGN
   GOTZ A, EUROPEAN J MIN UNPUB
   Griesshaber E, 2005, MATER RES SOC SYMP P, V844, P99
   Griesshaber E., 2006, MAT RES SOC S P E, V989E
   Griesshaber E, 2007, AM MINERAL, V92, P722, DOI 10.2138/am.2007.2220
   Grossman EL, 1996, J SEDIMENT RES, V66, P1011
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kamat S, 2000, NATURE, V405, P1036
   Katti K, 2005, J MATER SCI, V40, P1749, DOI 10.1007/s10853-005-0678-8
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   LOWENSTAM HA, 1961, J GEOL, V69, P241, DOI 10.1086/626740
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144
   Merkel C, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000253
   Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002
   Perez-Huerta A, 2007, J R SOC INTERFACE, V4, P33, DOI 10.1098/rsif.2006.0150
   REINDL S, 1995, J SUBMICR CYTOL PATH, V27, P543
   Rowell A.J., 1987, P445
   Rudwick M. J. S., 1970, LIVING FOSSIL BRACHI
   Samtleben C, 2001, CHEM GEOL, V175, P61, DOI 10.1016/S0009-2541(00)00364-8
   SARIKAYA M, 1995, BIOMIMETRICS DESIGN
   Schmahl WW, 2004, EUR J MINERAL, V16, P693, DOI 10.1127/0935-1221/2004/0016-0693
   SCHMIDT NH, 1989, CAN MINERAL, V27, P15
   Song F, 2002, INT J NONLINEAR SCI, V3, P257
   TAYLOR W, 1949, AM MINERAL, V28, P718
   THAYER CW, 1975, LETHAIA, V8, P209, DOI 10.1111/j.1502-3931.1975.tb00925.x
   Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Williams A., 1968, Special Papers in Palaeontology, VNo. 2, P1
   WILLIAMS A, 1992, PHILOS T ROY SOC B, V337, P83, DOI 10.1098/rstb.1992.0086
   Williams A, 1998, SCIENCE, V279, P2094, DOI 10.1126/science.279.5359.2094
   Williams A, 1999, J STRUCT BIOL, V126, P227, DOI 10.1006/jsbi.1999.4117
   Williams A, 1998, PHILOS T ROY SOC B, V353, P2005, DOI 10.1098/rstb.1998.0350
   WILLIAMS A, 1994, PHILOS T ROY SOC B, V346, P223, DOI 10.1098/rstb.1994.0143
   WILLIAMS A, 2000, TREATISE INVERTEBR H, V2, P1
NR 48
TC 42
Z9 43
U1 5
U2 35
PU MINERALOGICAL SOC
PI TWICKENHAM
PA 12 BAYLIS MEWS, AMYAND PARK ROAD,, TWICKENHAM TW1 3HQ, MIDDLESEX,
   ENGLAND
SN 0026-461X
J9 MINERAL MAG
JI Mineral. Mag.
PD APR
PY 2008
VL 72
IS 2
BP 541
EP 562
DI 10.1180/minmag.2008.072.2.541
PG 22
WC Mineralogy
SC Mineralogy
GA 358TC
UT WOS:000259939400002
DA 2018-10-19
ER

PT J
AU McDermott, SL
   Walsh, JE
   Howard, RG
AF McDermott, S. L.
   Walsh, J. E.
   Howard, R. G.
TI A comparison of the emission characteristics of UV-LEDs and fluorescent
   lamps for polymerisation applications
SO OPTICS AND LASER TECHNOLOGY
LA English
DT Article
DE UV-LEDs; fluorescent lamps; photopolymerisation
ID LIGHT-EMITTING-DIODES; DENTAL COMPOSITES
AB Ultraviolet (UV) fluorescent lamps are widely used in the manufacturing process of biomaterials. The possibility of replacing these lamps with ultraviolet light emitting diodes (UV-LEDs) was investigated and the results are presented here. A number of emission characteristics, including the spectral output and intensity of both light sources were measured and compared. The warm up time of the UV-LED was found to be faster than that of the fluorescent lamp while their stabilities were found to be comparable. The ability of each source to initiate photopolymerisation in a biomaterial sample was monitored using Fourier Transform Infrared spectroscopy and the percentage polymerisation calculated. The results presented here show that UV-LEDs are a viable alternative to UV fluorescent lamps in the manufacturing process of biomaterials. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [McDermott, S. L.; Walsh, J. E.; Howard, R. G.] Dublin Inst Technol, FOCAS Inst, Sch Phys, Dublin, Ireland.
RP McDermott, SL (reprint author), Dublin Inst Technol, FOCAS Inst, Sch Phys, Kevin St, Dublin, Ireland.
EM sharon.mcdermott@dit.ie
CR Acharya YB, 2005, OPT LASER TECHNOL, V37, P547, DOI 10.1016/j.optlastec.2004.08.008
   Berntsen A, 1998, OPT MATER, V9, P125, DOI 10.1016/S0925-3467(97)00082-7
   Csele M, 2004, FUNDAMENTALS LIGHT S
   Dodabalapur A, 1997, SOLID STATE COMMUN, V102, P259, DOI 10.1016/S0038-1098(96)00714-4
   Elenbaas W, 1972, LIGHT SOURCES
   FORSTER R, 2005, LIGHT EMITTING DIODE
   Fouassier J.-P., 1993, RAD CURING POLYM SCI
   FUJIBAYASHI K., 1998, DENT JPN, V34, P49
   Gardner C, 2006, OPT LASER TECHNOL, V38, P366, DOI 10.1016/j.optlastec.2005.06.022
   Kim SW, 1996, POLYM TEST, V15, P559, DOI 10.1016/0142-9418(96)00018-9
   KIM YH, 2002, OPT MATER, V21, P175
   MILLS RW, 1995, BRIT DENT J, V178, P169, DOI 10.1038/sj.bdj.4808693
   Mills RW, 2002, BIOMATERIALS, V23, P2955, DOI 10.1016/S0142-9612(02)00024-8
   Narendran N, 2004, J CRYST GROWTH, V268, P449, DOI 10.1016/j.jcrysgro.2004.04.071
   *OC OPT, OC OPT 2006 PROD CAT, P121
   *PHIL LIGHT, 2007, 9W102P PLS UNP
   PRITCHARD DC, 1992, LIGHTING
   *ROITHN LAS, LED3756660110 ROITHN
   Rosillo FG, 2004, RENEW ENERG, V29, P961, DOI 10.1016/j.renene.2003.11.005
   *ROTH LAS, UVTOP255 LED DAT SHE
   RUEGGEBERG FA, 1996, J DENT RES, V75, P380
   Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712
   Sliney DH, 1997, RADIAT PROT DOSIM, V72, P197, DOI 10.1093/oxfordjournals.rpd.a032091
   *SOL LIGHT, PMA 2107 UVA B DAT S
   Stahl F, 2000, BIOMATERIALS, V21, P1379, DOI 10.1016/S0142-9612(00)00029-6
   Uhl A, 2003, BIOMATERIALS, V24, P1809, DOI 10.1016/S0142-9612(02)00585-9
   Yoon TH, 2002, J ORAL REHABIL, V29, P1165, DOI 10.1046/j.1365-2842.2002.00970.x
NR 27
TC 13
Z9 13
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0030-3992
J9 OPT LASER TECHNOL
JI Opt. Laser Technol.
PD APR
PY 2008
VL 40
IS 3
BP 487
EP 493
DI 10.1016/j.optlastec.2007.07.013
PG 7
WC Optics; Physics, Applied
SC Optics; Physics
GA 242TA
UT WOS:000251747700010
DA 2018-10-19
ER

PT J
AU Pradel, W
   Tausche, E
   Gollogly, J
   Lauer, G
AF Pradel, Winnie
   Tausche, Eve
   Gollogly, James
   Lauer, Guenter
TI Spontaneous tooth eruption after alveolar cleft osteoplasty using
   tissue-engineered bone: a case report
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID MORPHOGENETIC PROTEIN-2; ALLOGENEIC BONE; AUGMENTATION; REGENERATION;
   SURGERY; GRAFTS; REPAIR; PALATE; LIP
AB To bridge the cleft in the alveolar bone and to allow for physiologic eruption of the canine teeth, alveolar bone grafting is often necessary in patients with cleft lips and palates. Instead of autogenous bone, biomaterial seeded with autogenous osteogenic cells has found some clinical application. However, so far no real functional proof has been available to demonstrate that this technique also allows further physiologic features such as tooth eruption to occur. This report describes the results of grafting tissue-engineered bone into the alveolar cleft of a 10-year-old boy. Immediate postoperative healing was uneventful. Eight months after grafting, erupting teeth had moved into the newly formed bone. Eighteen months postoperatively at the site where the tissue-engineered graft had been inserted, the canine had erupted spontaneously in its proper place. The data suggest that tissue-engineered bone can lead to the ossification of the alveolar cleft and allow for physiologic spontaneous tooth eruption.
C1 [Lauer, Guenter] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.
   [Pradel, Winnie] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, D-01307 Dresden, Germany.
   [Tausche, Eve] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Orthodont, D-01307 Dresden, Germany.
   [Gollogly, James] Tech Univ Dresden, Childrens Surg Ctr Kien Khleang, D-01307 Dresden, Germany.
RP Lauer, G (reprint author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Ctr Regenerat Therapies Dresden, Fetscherstr 74, D-01307 Dresden, Germany.
EM guenter.lauer@uniklinikum-dresden.de
CR AMANAT N, 1991, J CRANIO MAXILL SURG, V19, P7, DOI 10.1016/S1010-5182(05)80265-3
   BERGLAND O, 1986, CLEFT PALATE J, V23, P175
   Choi BH, 2004, J CRANIO MAXILL SURG, V32, P51, DOI 10.1016/j.jcms.2003.08.006
   da Silva Filho O G, 2000, Angle Orthod, V70, P174
   FEINBERG SE, 1989, ARCH ORAL BIOL, V34, P975, DOI 10.1016/0003-9969(89)90055-1
   FREIHOFER HPM, 1993, J CRANIO MAXILL SURG, V21, P143, DOI 10.1016/S1010-5182(05)80102-7
   Hibi H, 2006, INT J ORAL MAX SURG, V35, P551, DOI 10.1016/j.ijom.2005.12.007
   Hogan L, 2003, AUST DENT J, V48, P119, DOI 10.1111/j.1834-7819.2003.tb00020.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Hubner U., 1999, OSTEOLOGIE, V8, P179
   Hutmacher D.W., 2002, IMPLANTOLOGIE, V10, P143
   Kitamura A, 2002, CLEFT PALATE-CRAN J, V39, P449, DOI 10.1597/1545-1569(2002)039<0449:TEITNG>2.0.CO;2
   KRAUT RA, 1987, ORAL SURG ORAL MED O, V64, P278, DOI 10.1016/0030-4220(87)90003-X
   LAROSSA D, 1995, PLAST RECONSTR SURG, V96, P789, DOI 10.1097/00006534-199509001-00004
   Matsui K, 2005, CLEFT PALATE-CRAN J, V42, P309, DOI 10.1597/03-113.1
   MAXSON BB, 1990, J ORAL MAXIL SURG, V48, P933, DOI 10.1016/0278-2391(90)90005-M
   Mayer M, 1996, PLAST RECONSTR SURG, V98, P247, DOI 10.1097/00006534-199608000-00006
   Ochs MW, 1996, J ORAL MAXIL SURG, V54, P83, DOI 10.1016/S0278-2391(96)90311-0
   Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Seto I, 2001, J ORAL MAXIL SURG, V59, P53, DOI 10.1053/joms.2001.19286
   STRIETZEL FP, 2004, INT J ORAL MAXILLOF, V21, P131
   Ueda M, 2005, INT J PERIODONT REST, V25, P129
   VANDERAS AP, 1987, CLEFT PALATE J, V24, P216
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
   Zeitler D., 2000, ORAL MAXILLOFACIAL S, V6, P75
NR 27
TC 20
Z9 20
U1 0
U2 8
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD APR
PY 2008
VL 105
IS 4
BP 440
EP 444
DI 10.1016/j.tripleo.2007.07.042
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 281WV
UT WOS:000254530500009
PM 18206405
DA 2018-10-19
ER

PT J
AU Pramanik, N
   Mohapatra, S
   Alam, S
   Pramanik, P
AF Pramanik, Nabakumar
   Mohapatra, Sasmita
   Alam, Sarfaraz
   Pramanik, Panchanan
TI Synthesis of hydroxyapatite/poly(vinyl alcohol phosphate) nanocomposite
   and its characterization
SO POLYMER COMPOSITES
LA English
DT Article
ID POLY(VINYL PHOSPHONATE) COMPOSITES; POLYETHYLENE COMPOSITES; COUPLING
   AGENTS; PARTICLES; ACID
AB Hydroxyapatite (HAp)/poly(vinyl alcohol phosphate) (PVAP) nanocomposite has been prepared using a solution-based method varying HAp from 10 to 60% (w/ w). X-ray diffraction, Fourier transform infrared absorption spectra (FTIR), and thermal analysis have indicated the presence of bonding between HAp particles and PVAP matrix. Transmission electron microscope analysis shows the needle-like crystals of HAp powder having a diameter of 6-10 nm and a length of 26-38 nm. The surface roughness and the homogeneous dispersion of HAP particles in the polymer matrix have been observed by scanning electron microscopy. Particle size distribution analysis shows the narrow distribution of hydrodynamic particles in the polymer matrix. The tensile stress-strain curves show the improvement in mechanical properties of the composites with increase in amount of HAP particles loading. The composites along with polymer are highly hemocompatible. The use of PVAP promotes the homogeneous distribution of particles on the polymer matrix along with strong particle-polymer interfacial bonding, which has supported the improvement in mechanical properties of the composites. The prepared HAp/PVAP composite with uniform microstructure would be effective to act as a potential biomaterial.
C1 [Pramanik, Nabakumar; Mohapatra, Sasmita; Pramanik, Panchanan] Indian Inst Technol Kharagpur, Dept Chem, Kharagpur 721302, W Bengal, India.
   [Alam, Sarfaraz] DMSRDE, Kanpur, Uttar Pradesh, India.
RP Pramanik, P (reprint author), Indian Inst Technol Kharagpur, Dept Chem, Kharagpur 721302, W Bengal, India.
EM pramanik@chem.iitkgp.ernet.in
CR Abboud M, 1997, J MATER CHEM, V7, P1527, DOI 10.1039/a700573c
   AKAMATSU N, 1993, ASIAN MED J, V36, P621
   Carotenuto G, 1999, J MATER SCI-MATER M, V10, P671, DOI 10.1023/A:1008952111545
   Chowdhury SKR, 2004, WEAR, V256, P1026, DOI 10.1016/S0043-1648(03)00535-0
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ELLIS J, 1991, POLYM INT, V24, P221, DOI 10.1002/pi.4990240404
   FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0
   Greish YE, 2002, J AM CERAM SOC, V85, P1738
   Greish YE, 2001, BIOMATERIALS, V22, P807, DOI 10.1016/S0142-9612(00)00243-X
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hussain M, 1996, MATER LETT, V26, P299, DOI 10.1016/0167-577X(95)00253-7
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Liu Q, 1998, J BIOMED MATER RES, V40, P358
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   MISRA DN, 1985, J DENT RES, V64, P1405, DOI 10.1177/00220345850640121701
   Mohapatra S, 2006, J NANOSCI NANOTECHNO, V6, P823, DOI 10.1166/jnn.2006.117
   OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003
   Pramanik N, 2006, POLYM COMPOSITE, V27, P633, DOI 10.1002/pc.20246
   SUGAMA T, 1995, PROG ORG COAT, V25, P205, DOI 10.1016/0300-9440(94)00507-W
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   XAVIER SF, 1990, J MATER SCI, V25, P2428, DOI 10.1007/BF00638037
   Yonggang Y., 2003, EUR POLYM J, V39, P411
NR 26
TC 18
Z9 18
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0272-8397
J9 POLYM COMPOSITE
JI Polym. Compos.
PD APR
PY 2008
VL 29
IS 4
BP 429
EP 436
DI 10.1002/pc.20410
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 280FX
UT WOS:000254412200012
DA 2018-10-19
ER

PT J
AU Wincup, CJ
   Santin, M
   Salvage, J
AF Wincup, Christopher J.
   Santin, Matteo
   Salvage, Jon
TI Comparative in vivo study of the bone regeneration potential between a
   novel soy-based biomaterial and a commercially available bone filler
SO RHEUMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the British-Society-Rheumatology/Spring Meeting of
   British Health Professional in Rheumatology
CY APR 22-25, 2008
CL Liverpool, ENGLAND
SP British Soc Rheumatol
C1 [Wincup, Christopher J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
   [Santin, Matteo; Salvage, Jon] Univ Brighton, Brighton, E Sussex, England.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD APR
PY 2008
VL 47
SU 2
BP II60
EP II60
PG 1
WC Rheumatology
SC Rheumatology
GA 284BT
UT WOS:000254680900205
DA 2018-10-19
ER

PT J
AU Anderson, JM
   Rodriguez, A
   Chang, DT
AF Anderson, James M.
   Rodriguez, Analiz
   Chang, David T.
TI Foreign body reaction to biomaterials
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE foreign body reaction; macrophages; foreign body giant cells;
   biodegradation; cytokines; biomaterials
ID GIANT-CELL FORMATION; POLY(ETHER URETHANE) BIODEGRADATION;
   POLYCARBONATE-BASED POLYURETHANES; ACUTE INFLAMMATORY RESPONSES; MANNOSE
   RECEPTOR-ACTIVITY; FOCAL ADHESION DYNAMICS; IN-VIVO BIOSTABILITY;
   MACROPHAGE FUSION; SURFACE-CHEMISTRY; HUMAN-MONOCYTES
AB The foreign body reaction composed of macrophages and foreign body giant cells is the end-stage response of the inflammatory and wound healing responses following implantation of a medical device, prosthesis, or biomaterial. A brief, focused overview of events leading to the foreign body reaction is presented. The major focus of this review is on factors that modulate the interaction of macrophages and foreign body giant cells on synthetic surfaces where the chemical, physical, and morphological characteristics of the synthetic surface are considered to play a role in modulating cellular events. These events in the foreign body reaction include protein adsorption, monocyte/macrophage adhesion, macrophage fusion to form foreign body giant cells, consequences of the foreign body response on biomaterials, and cross-talk between macrophages/foreign body giant cells and inflammatory/wound healing cells. Biomaterial surface properties play an important role in modulating the foreign body reaction in the first two to four weeks following implantation of a medical device, even though the foreign body reaction at the tissue/material interface is present for the in vivo lifetime of the medical device. An understanding of the foreign body reaction is important as the foreign body reaction may impact the biocompatibility (safety) of the medical device, prosthesis, or implanted biomaterial and may significantly impact shortand long-term tissue responses with tissue-engineered constructs containing proteins, cells, and other biological components for use in tissue engineering and regenerative medicine. Our perspective has been on the inflammatory and wound healing response to implanted materials, devices, and tissue-engineered constructs. The incorporation of biological components of allogeneic or xenogeneic origin as well as stem cells into tissue-engineered or regenerative approaches opens up a myriad of other challenges. An in depth understanding of how the immune system interacts with these cells and how biomaterials or tissue-engineered constructs influence these interactions may prove pivotal to the safety, biocompatibility, and function of the device or system under consideration. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Anderson, James M.; Rodriguez, Analiz] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.; Chang, David T.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd,WRB Room 5105, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [R01 EB000282-12, R01 EB000282, EB-000282, R56 EB000282,
   EB-000275]; NIGMS NIH HHS [T32 GM07250, T32 GM007250]
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x
   CHANG DT, 2007, IN PRESS J BIOMED A
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033
   Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952
   Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013
   DONNELLY RP, 1990, J IMMUNOL, V145, P569
   DOUSSIS IA, 1992, J CLIN PATHOL, V45, P398, DOI 10.1136/jcp.45.5.398
   Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N
   Ebert M, 2005, J BIOMED MATER RES A, V75A, P175, DOI 10.1002/jbm.a.30396
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   FENTON MJ, 1992, J IMMUNOL, V149, P1283
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   KADOYA Y, 1994, BONE MINER, V27, P85, DOI 10.1016/S0169-6009(08)80211-5
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keegan AD, 2001, CYTOKINE REFERENCE
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200
   Kopydlowski KM, 1999, J IMMUNOL, V163, P1537
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Marx J, 2006, SCIENCE, V312, P1868, DOI 10.1126/science.312.5782.1868
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McKenzie ANJ, 2001, CYTOKINE REFERENCE
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 2007, IN PRESS J BIOMED A
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Neale SD, 1999, ACTA ORTHOP SCAND, V70, P452, DOI 10.3109/17453679909000980
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676
   Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x
   Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877
   QUINN JMW, 1991, HISTOCHEMISTRY, V96, P169, DOI 10.1007/BF00315989
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x
   Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   Shive MS, 2002, J BIOMED MATER RES, V62, P163, DOI 10.1002/jbm.10225
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   Ward B, 2006, J BIOMED MATER RES A, V77A, P380, DOI 10.1002/jbm.a.30553
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 157
TC 1666
Z9 1702
U1 61
U2 802
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD APR
PY 2008
VL 20
IS 2
BP 86
EP 100
DI 10.1016/j.smim.2007.11.004
PG 15
WC Immunology
SC Immunology
GA 291KM
UT WOS:000255195900002
PM 18162407
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jones, KS
AF Jones, Kim S.
TI Effects of biomaterial-induced inflammation on fibrosis and rejection
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE biomaterial; combination products; fibrosis; adjuvant; transplant
   rejection
ID DELAYED-TYPE HYPERSENSITIVITY; IDIOPATHIC PULMONARY FIBROSIS; DENDRITIC
   CELL MATURATION; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; TGF-BETA;
   TRANSPLANTATION TOLERANCE; MINOR COMPONENT; KAPPA-B; COMPLEMENT
AB Evidence is emerging that biomaterials cause inflammation by ligating innate immune receptors on antigen presenting cells. Although inflammation is usually viewed as detrimental, it has unexpected and potentially beneficial effects on fibrosis and transplant rejection. For example, the magnitude of inflammation due to a biomaterial is not predictive of the extent of fibrosis. Similarly, biomaterials do not always show adjuvancy. Some biomaterials suppressed T cell rejection responses in vivo and in vitro, while others non-specifically stimulated T cell proliferation. Understanding these complex inter-relationships is the key to designing a biomaterial that stimulates regeneration and induces tolerance in tissue engineering applications. (c) 2007 Elsevier Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x
   Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Ardehali A, 2002, TRANSPLANTATION, V73, P1805, DOI 10.1097/00007890-200206150-00018
   Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bickerstaff AA, 2000, TRANSPLANTATION, V69, P1517, DOI 10.1097/00007890-200004150-00055
   Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390
   BUDZYNSKI W, 1994, IMMUNOPHARM IMMUNOT, V16, P319, DOI 10.3109/08923979409007097
   Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x
   Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31
   Carrodeguas L, 1999, HUM IMMUNOL, V60, P640, DOI 10.1016/S0198-8859(99)00002-6
   Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043
   Delhalle S, 2004, ANN NY ACAD SCI, V1030, P1, DOI 10.1196/annals.1329.002
   Derks RA, 2005, CURR OPIN IMMUNOL, V17, P560, DOI 10.1016/j.coi.2005.07.011
   Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2
   Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661
   Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054
   Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF
   Geissler F, 2001, TRANSPLANT P, V33, P1377, DOI 10.1016/S0041-1345(00)02517-3
   GILL RG, 1992, TRANSPLANT P, V24, P642
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOULMY E, 1989, TRANSPLANTATION, V48, P559, DOI 10.1097/00007890-198910000-00004
   Guardino AE, 2006, CYTOTHERAPY, V8, P277, DOI 10.1080/14653240600735701
   Hamilton JA, 2003, J LEUKOCYTE BIOL, V73, P702, DOI 10.1189/jlb.0103037
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Jones KS, 2004, TRANSPLANTATION, V78, P1454, DOI 10.1097/01.TP.0000142094.63083.FB
   Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007
   Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341
   Kolb M, 2002, AM J RESP CELL MOL, V27, P141, DOI 10.1165/ajrcmb.27.2.4674
   Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mazariegos GV, 2003, AM J TRANSPLANT, V3, P689, DOI 10.1034/j.1600-6143.2003.00109.x
   McGettrick AF, 2007, BRIT J HAEMATOL, V139, P185, DOI 10.1111/j.1365-2141.2007.06802.x
   Mcguigan AP, 2007, TISSUE ENG, V13, P1079, DOI 10.1089/ten.2006.0245
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333
   Otsuka H, 2006, EUR CELLS MATER, V12, P36, DOI 10.22203/eCM.v012a04
   Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Stocum D.L., 2004, ADV ANAT EMBRYOL CEL, P176
   Strieter RM, 2002, AM J RESP CRIT CARE, V165, P1206, DOI 10.1164/rccm.2202055
   Strober S, 2000, TRANSPLANTATION, V69, P1549
   Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2
   VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171
   Xu QY, 2007, J IMMUNOL, V178, P3983, DOI 10.4049/jimmunol.178.6.3983
   YANG D, IN PRESS J BIOMED A
   Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zhao Y, 2007, TRENDS IMMUNOL, V28, P376, DOI 10.1016/j.it.2007.07.001
NR 58
TC 61
Z9 62
U1 2
U2 39
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD APR
PY 2008
VL 20
IS 2
BP 130
EP 136
DI 10.1016/j.smim.2007.11.005
PG 7
WC Immunology
SC Immunology
GA 291KM
UT WOS:000255195900007
PM 18191409
DA 2018-10-19
ER

PT J
AU Swartz, MA
   Hubbell, JA
   Reddy, ST
AF Swartz, Melody A.
   Hubbell, Jeffrey A.
   Reddy, Sai T.
TI Lymphatic drainage function and its immunological implications: From
   dendritic cell homing to vaccine design
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE immunotherapy; engineering; lymph node; biomaterials; lymphatic
   morphogenesis; adjuvant; complement; chemotaxis; flow
ID SECONDARY LYMPHOID ORGANS; ANTIGEN-PRESENTING CELLS;
   MONOPHOSPHORYL-LIPID-A; INTERSTITIAL FLOW; HUMAN SKIN; COMPLEMENT
   ACTIVATION; INDUCED INFLAMMATION; ANTITUMOR IMMUNITY; DEC-205 RECEPTOR;
   CUTTING EDGE
AB The slow interstitial flow that drains fluid from the blood capillaries into the lymphatic capillaries provides transport of macromolecular nutrients to cells in the interstitium. We discuss herein how this flow also provides continuous access to immune cells residing in the lymph nodes of antigens from self or from pathogens residing in the interstitium. We also address mechanisms by which dendritic cells in the periphery sense interstitial flow to home efficiently into the lymphatics after activation, and how lymphatic endothelium can be activated by this flow, including how it can act as a lymphatic morphoregulator. Further, we present concepts on how interstitial flow can be exploited with biomaterial systems to deliver antigen and adjuvant molecules directly into the lymphatics, to target dendritic cells residing in the lymph nodes rather than in the peripheral tissues., using particles that are small enough to be carried along by flow through the network structure of the interstitium. Finally, we present recent work on lymphatic and lymphoid tissue engineering, including how interstitial flow can be used as a design principle. Thus, an understanding of the physiological processes that govern transport in the interstitium guides new understanding of both immune cell interactions with the lymphatics as well as therapeutic interventions exploiting the lymphatics as a target. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Swartz, Melody A.; Hubbell, Jeffrey A.; Reddy, Sai T.] Ecole Polytech Fed Lausanne, Inst Bioengn, SV IBI LMBM, Stn 15, CH-1015 Lausanne, Switzerland.
RP Swartz, MA (reprint author), Ecole Polytech Fed Lausanne, Inst Bioengn, SV IBI LMBM, Stn 15, CH-1015 Lausanne, Switzerland.
EM melody.swartz@epfl.ch
RI Swartz, Melody/B-7633-2009; Swartz, Melody/F-9563-2011; Reddy,
   Sai/B-4190-2012; Hubbell, Jeffrey/A-9266-2008
OI Reddy, Sai/0000-0002-9177-0857; Hubbell, Jeffrey/0000-0003-0276-5456
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005
   Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BENOIT JN, 1992, AM J PHYSIOL, V262, pG199
   Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761
   Boardman KC, 2003, CIRC RES, V92, P801, DOI 10.1161/01.RES.0000065621.69843.49
   Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220
   Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928
   Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104
   BRAND CU, 1992, ARCH DERMATOL RES, V284, P123, DOI 10.1007/BF00372702
   Breslin JW, 2007, AM J PHYSIOL-HEART C, V293, pH709, DOI 10.1152/ajpheart.00102.2007
   CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385
   Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007
   Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628
   Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098
   Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447
   Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   DRAKE RE, 1991, AM J PHYSIOL, V260, P668
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Fischer M, 1996, AM J PHYSIOL-HEART C, V270, pH358
   Fleury ME, 2006, BIOPHYS J, V91, P113, DOI 10.1529/biophysj.105.080192
   Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227
   Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78
   Goldman J, 2007, AM J PHYSIOL-HEART C, V292, pH2176, DOI 10.1152/ajpheart.01011.2006
   Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRANGER DN, 1988, GASTROENTEROLOGY, V94, P673, DOI 10.1016/0016-5085(88)90238-7
   Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451
   Harzstark AL, 2007, EXPERT OPIN BIOL TH, V7, P1275, DOI 10.1517/14712598.7.8.1275
   Helm CLE, 2007, BIOTECHNOL BIOENG, V96, P167, DOI 10.1002/bit.21185
   HELM CE, 2007, P NATL ACAD SCI USA, V44, P15779
   Hemmi H, 2000, NATURE, V408, P740
   Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758
   Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0
   Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.simm.2007.02.011
   Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759
   Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243
   Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994
   Knutson KL, 2002, CURR OPIN MOL THER, V4, P403
   KOIZUMI T, 1993, LUNG, V171, P19, DOI 10.1007/BF02656255
   Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373
   Kuroshima S, 2004, MICROVASC RES, V67, P90, DOI 10.1016/j.mvr.2003.09.005
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Kwon YJ, 2005, J CONTROL RELEASE, V105, P199, DOI 10.1016/j.jconrel.2005.02.027
   LEAK LV, 1971, J CELL BIOL, V50, P300, DOI 10.1083/jcb.50.2.300
   LEAK LV, 1976, FED PROC, V35, P1863
   Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694
   Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424
   Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nishioka Y, 2001, ADV DRUG DELIVER REV, V47, P55, DOI 10.1016/S0169-409X(00)00121-6
   Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014
   Okamoto N, 2007, J CLIN INVEST, V117, P997, DOI 10.1172/JCI30379
   Oussoren C, 2001, ADV DRUG DELIVER REV, V50, P143, DOI 10.1016/S0169-409X(01)00154-5
   Patel DD, 2001, CLIN IMMUNOL, V99, P43, DOI 10.1006/clim.2000.4997
   Quick CM, 2007, AM J PHYSIOL-REG I, V292, pR1510, DOI 10.1152/ajpregu.00258.2006
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P1
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037
   Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3
   Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0
   Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007
   Rutkowski JM, 2006, AM J PHYSIOL-HEART C, V291, pH1402, DOI 10.1152/ajpheart.00038.2006
   Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009
   Saeki H, 1999, J IMMUNOL, V162, P2472
   Salerno-Goncalves R, 2006, TRENDS MICROBIOL, V14, P536, DOI 10.1016/j.tim.2006.10.004
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013
   Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017
   Sozzani S, 1998, J IMMUNOL, V161, P1083
   SPIEGEL M, 1992, AM J PHYSIOL, V262, pH1208
   STACHOWIAK AN, 2007, J BIOMED MAT RES A
   Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205
   Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annure/bioeng.9.060906.151850
   Tammela T, 2007, CIRC RES, V100, P1468, DOI 10.1161/01.RES.0000269043.51272.6d
   Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517
   Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005
   Trzewik J, 2001, FASEB J, V15, P1711, DOI 10.1096/fj.01-0067com
   Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9
   von der Weid PY, 2004, INT J BIOCHEM CELL B, V36, P1147, DOI 10.1016/j.biocel.2003.12.008
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang RF, 2002, NAT BIOTECHNOL, V20, P149, DOI 10.1038/nbt0202-149
   Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
NR 107
TC 72
Z9 73
U1 0
U2 27
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD APR
PY 2008
VL 20
IS 2
BP 147
EP 156
DI 10.1016/j.smim.2007.11.007
PG 10
WC Immunology
SC Immunology
GA 291KM
UT WOS:000255195900009
PM 18201895
OA Green Published
DA 2018-10-19
ER

PT J
AU Wilshaw, SP
   Kearney, J
   Fisher, J
   Ingham, E
AF Wilshaw, Stacy-Paul
   Kearney, John
   Fisher, John
   Ingham, Eileen
TI Biocompatibility and potential of acellular human amniotic membrane to
   support the attachment and proliferation of allogeneic cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PORCINE HEART-VALVES; PERACETIC-ACID; MATRIX; DECELLULARIZATION;
   TRANSPLANTATION; RECELLULARIZATION; RECONSTRUCTION; ALLOGRAFTS; SKIN
AB The aim of this study was to determine the biocompatibility of an acellular human amniotic membrane biomaterial, which may have clinical utility for cell delivery. Human amniotic membrane was decellularized using 0.03% (w/v) sodium dodecyl sulfate (SDS), with hypotonic tris buffer and protease inhibitors and nuclease treatment. The membrane was terminally sterilized using an optimal concentration of peracetic acid. Residual SDS present within the acellular membrane was quantified using radio-labeled C 14 SDS. In vivo biocompatibility was assessed by implantation of acellular human amniotic membrane subcutaneously into mice for 3 months and comparison with fresh and glutaraldehyde-fixed tissue. Cellular infiltrate into the explanted tissues was characterized using monoclonal antibodies against the following cell surface markers: CD3, CD4, CD34, and F4/80. Calcification was determined using the Von Kossa's stain. The potential of acellular human amniotic membrane to support the attachment and proliferation, and maintain viability of primary human dermal fibroblasts and primary human dermal keratinocytes was assessed in vitro, using a static culture system. Peracetic acid at a concentration of 0.1% (v/v) was sufficient for the sterilization of acellular amniotic membrane. Levels of SDS present within the acellular tissue were 0.62 +/- 0.13 mu g/mg. Analysis of explanted samples from the mice indicated that acellular amniotic membrane contained low numbers of T-cells and high numbers of fibroblastic cells, macrophages, and endothelial cells, indicative of a wound-healing response. There was no evidence of calcification present within explanted acellular amniotic membrane compared to explanted glutaraldehyde-fixed amniotic membrane. Acellular amniotic membrane was shown to be capable of supporting the attachment and proliferation of primary human fibroblasts and keratinocytes. The viability of the cells was maintained for up to 4 weeks. Cell-seeded acellular amniotic membrane has the potential for delivering autologous or allogeneic cells to treat a variety of conditions, including diabetic foot ulcers, corneal defects, and severe skin burns.
C1 [Wilshaw, Stacy-Paul; Ingham, Eileen] Univ Leeds, Fac Biol Sci, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   [Kearney, John] Natl Blood Serv, Tissue Serv, Liverpool, Merseyside, England.
   [Fisher, John] Univ Leeds, Fac Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Wilshaw, SP (reprint author), Univ Leeds, Fac Biol Sci, Inst Med & Biol Engn, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.
EM S.Wilshaw@leeds.ac.uk
OI Wilshaw, Stacy-Paul/0000-0002-7599-8165
FU Biotechnology and Biological Sciences Research Council [BB/D524875/1]
CR BOURNE GL, 1960, AM J OBSTET GYNECOL, V79, P1070, DOI 10.1016/0002-9378(60)90512-3
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hodde J, 2002, BIOTECHNOL BIOENG, V79, P211, DOI 10.1002/bit.10281
   Huang QH, 2004, WOUND REPAIR REGEN, V12, P276, DOI 10.1111/j.1067-1927.2004.012312.x
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lomas RJ, 2003, BURNS, V29, P515, DOI 10.1016/S0305-4179(03)00137-2
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   MOHAMAD H, 2001, ANATOMY EMBRYOLOGY H
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Sokal R. R., 2001, BIOMETRY
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Ueta M, 2002, CLIN EXP IMMUNOL, V129, P464, DOI 10.1046/j.1365-2249.2002.01945.x
   von Versen-Hoeynck Frauke, 2004, Cell and Tissue Banking, V5, P45, DOI 10.1023/B:CATB.0000022276.47180.96
   von Versen-Wynck Frauke, 2004, Cell and Tissue Banking, V5, P57, DOI 10.1023/B:CATB.0000022222.41304.de
   Wilcox HE, 2005, J HEART VALVE DIS, V14, P228
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
NR 23
TC 55
Z9 57
U1 2
U2 17
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2008
VL 14
IS 4
BP 463
EP 472
DI 10.1089/tea.2007.0145
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 292DZ
UT WOS:000255248000001
PM 18370928
DA 2018-10-19
ER

PT J
AU Grayson, WL
   Chao, PHG
   Marolt, D
   Kaplan, DL
   Vunjak-Novakovic, G
AF Grayson, Warren L.
   Chao, Pen-Hsiu Grace
   Marolt, Darja
   Kaplan, David L.
   Vunjak-Novakovic, Gordana
TI Engineering custom-designed osteochondral tissue grafts
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE
   REPAIR; FIBROBLAST-GROWTH-FACTOR; IN-VITRO; SILK FIBROIN; CHONDROGENIC
   DIFFERENTIATION; PERFUSION CULTURE; 3-D SCAFFOLDS; BONE
AB Tissue engineering is expected to help us outlive the failure of our organs by enabling the creation of tissue substitutes capable of fully restoring the original tissue function. Degenerative joint disease, which affects one-fifth of the US population and is the country's leading cause of disability, drives current research of actively growing, functional tissue grafts for joint repair. Toward this goal, living cells are used in conjunction with biomaterial scaffolds (serving as instructive templates for tissue development) and bioreactors; (providing environmental control and molecular and physical regulatory signals). In this review, we discuss the requirements for engineering customized, anatomically-shaped, stratified grafts for joint repair and the challenges of designing these grafts to provide immediate functionality (load bearing, structural support) and long-term regeneration (maturation, integration, remodeling).
C1 [Grayson, Warren L.; Chao, Pen-Hsiu Grace; Marolt, Darja; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,1210 Amsterdam Ave, New York, NY 10027 USA.
EM gv2131@columbia.edu
RI vunjak-novakovic, gordana/J-9279-2012; Chao, Pen-hsiu Grace/F-4845-2012
OI Chao, Pen-hsiu Grace/0000-0001-8520-4800; Marolt,
   Darja/0000-0003-3638-4619; Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-04, P41 EB002520-049002, EB
   002520]; NHLBI NIH HHS [R01 HL076485-04, HL 076485, R01 HL076485]; NIDCR
   NIH HHS [DE 16525-01, R01 DE016525, R01 DE016525-03]
CR Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   *CDCP, 2007, TARG ARTHR RED DIS N
   Chang CH, 2004, J BIOMED MATER RES B, V71B, P313, DOI 10.1002/jbm.b.30090
   Chao PHG, 2007, J ORTHOP SCI, V12, P398, DOI 10.1007/s00776-007-1147-9
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Feinberg SE, 2001, CELLS TISSUES ORGANS, V169, P309, DOI 10.1159/000047896
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Fukuda A, 2005, BIOMATERIALS, V26, P4301, DOI 10.1016/j.biomaterials.2004.11.007
   Gavenis K, 2006, IN VITRO CELL DEV-AN, V42, P159
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   GLEGHORN JP, 2007, J BIOMED MAT RES
   HENDRIKS J, 2005, T ANN M ORTH RES SOC, V30
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Horan RL, 2006, J BIOMECH, V39, P2232, DOI 10.1016/j.jbiomech.2005.07.007
   Huang X, 2007, BIOMATERIALS, V28, P3091, DOI 10.1016/j.biomaterials.2007.03.017
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   LIMA EG, 2004, T ANN M ORTH RES SOC, V29
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   MAUCK RL, 2006, T ANN M ORTH RES SOC, V31
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pound JC, 2006, TISSUE ENG, V12, P2789, DOI 10.1089/ten.2006.12.2789
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Saadat E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2040
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Tuan RS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2310
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Vunjak-Novakovic G, 2005, BASIC ORTHOPAEDIC BI, P343
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   White A, 2001, CURR BIOL, V11, pR589, DOI 10.1016/S0960-9822(01)00359-1
NR 69
TC 92
Z9 94
U1 1
U2 23
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD APR
PY 2008
VL 26
IS 4
BP 181
EP 189
DI 10.1016/j.tibtech.2007.12.009
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 292KZ
UT WOS:000255266200004
PM 18299159
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Dunn, AC
   Cobb, JA
   Kantzios, AN
   Lee, SJ
   Sarntinoranont, M
   Tran-Son-Tay, R
   Sawyer, WG
AF Dunn, Alison C.
   Cobb, Jessica A.
   Kantzios, Ana N.
   Lee, Sung Jin
   Sarntinoranont, Malisa
   Tran-Son-Tay, Roger
   Sawyer, W. Gregory
TI Friction coefficient measurement of hydrogel materials on living
   epithelial cells
SO TRIBOLOGY LETTERS
LA English
DT Article
DE biotribology; hydrogel; friction
ID SOFT CONTACT-LENSES; INTEGRIN BINDING; PROTEIN ADSORPTION; ADHESION;
   SPECIFICITY; DYNAMICS; WEAR
AB Soft biomaterials are often used in applications that involve contact and relative motion against biological tissues, as well as complicated and variable environments. The friction coefficient of these contacts involving living human cells is of key importance in the analysis and success of these devices. This work measures the contacting friction coefficient between soft hydrogel biomaterial surfaces against live human corneal epithelial cells using a custom micro-tribometer. The friction coefficients were of the order of mu = 0.03 for contacts that did not cause gross destruction of the cell layer. Damage to the confluent cell layer was assessed using a Trypan blue stain with optical microscopy. This damage was quantified statistically using image-processing software. The damage was also correlated to in situ friction measurements, with the lowest friction values seen on undamaged cells and higher friction on damaged regions.
C1 [Dunn, Alison C.; Kantzios, Ana N.; Lee, Sung Jin; Sarntinoranont, Malisa; Tran-Son-Tay, Roger; Sawyer, W. Gregory] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.
   [Cobb, Jessica A.; Lee, Sung Jin; Sarntinoranont, Malisa; Tran-Son-Tay, Roger] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Sawyer, WG (reprint author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.
EM wgsawyer@ufl.edu
RI Dunn, Alison/K-6039-2014; Sawyer, Wallace/A-7983-2008
OI Dunn, Alison/0000-0002-4841-1293; Sawyer, Wallace/0000-0002-4461-7227
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bajpai AK, 2002, J BIOMAT SCI-POLYM E, V13, P237, DOI 10.1163/156856202320176501
   BRASH JL, 1987, ACS SYM SER, V343, P490
   Chen XM, 2007, J BIOMECH ENG-T ASME, V129, P156, DOI 10.1115/1.2472373
   COBB JA, IN PRESS BIOTECHNOL
   Dickrell PL, 2006, TRIBOL LETT, V24, P85, DOI 10.1007/s11249-006-9162-0
   Dickrell PL, 2005, TRIBOL LETT, V18, P59, DOI 10.1007/s11249-004-1752-0
   Dunn AC, 2007, TRIBOL LETT, V27, P233, DOI 10.1007/s11249-007-9230-0
   Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p
   Gonzalez-Meijome JM, 2006, J BIOMED MATER RES B, V76B, P412, DOI 10.1002/jbm.b.30387
   Grunheid T, 2005, ARCH ORAL BIOL, V50, P829, DOI 10.1016/j.archoralbio.2005.01.005
   Holden BA, 2001, OPTOMETRY VISION SCI, V78, P9, DOI 10.1097/00006324-200101010-00008
   HUNG G, 1977, AM J OPTOM PHYS OPT, V54, P678
   Joo JH, 2005, MOL VIS, V11, P133
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   NAIRN JA, 1995, ANTEC 95 - THE PLASTICS CHALLENGER: A REVOLUTION IN EDUCATION, CONFERENCE PROCEEDINGS, VOLS I-III, P3384
   Pascovici MD, 2003, TRIBOL INT, V36, P791, DOI 10.1016/S0301-679X(03)00095-1
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rennie AC, 2005, TRIBOL LETT, V18, P499, DOI 10.1007/s11249-005-3610-0
   Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004
   Willcox MDP, 2001, BIOMATERIALS, V22, P3235, DOI 10.1016/S0142-9612(01)00161-2
NR 23
TC 30
Z9 30
U1 0
U2 21
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1023-8883
J9 TRIBOL LETT
JI Tribol. Lett.
PD APR
PY 2008
VL 30
IS 1
BP 13
EP 19
DI 10.1007/s11249-008-9306-5
PG 7
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 277ZM
UT WOS:000254253200002
DA 2018-10-19
ER

PT J
AU Ramage, G
   Wickes, BL
   Lopez-Ribot, JL
AF Ramage, Gordon
   Wickes, Brian L.
   Lopez-Ribot, Jose L.
TI A seed and feed model for the formation of Candida albicans biofilms
   under flow conditions using an improved modified Robbins device
SO REVISTA IBEROAMERICANA DE MICOLOGIA
LA English
DT Article
DE Candida albicans; Biofilm; flow-through; Robbins device
ID IN-VITRO; MICROBIAL ADHESION; INFECTION; MATRIX; VIVO; RESISTANCE
AB A variety of manifestations of Candida albicans infections are associated with the formation of biofilms on the surface of biomaterials. In order to maintain their niche these adherent populations need to withstand the continuous bathing action of physiological fluids (saliva, blood), which also provide water and nutrients to the fungal cells. Thus, it was the aim of this study to examine and further characterize the development of C. albicans biofilms under shear forces and a flow of replenishing nutrients, emulating the conditions that fungal cells would normally encounter within the host. An improved modified Robbins device (MRD) was designed to hold six poly methyl methacrylate (PMMA) plugs of 25 mm in diameter. A "seed and feed" model of biofilm formation was then implemented for which the apparatus was initially seeded with a C. albicans cell suspension to allow initial adhesion of fungal cells to the biomaterial. Following this initial step, sterile medium was then pumped through the MRD at a constant flow rate. Scanning electron microscopy (SEM) and confocal scanning laser microscopy (CSLM) demonstrated a high degree of heterogeneity associated with the structure of biofilms formed under flowing conditions using the MRD. In addition, these biofilms displayed a complex three dimensional architecture and increased production of exopolymeric material.
C1 [Lopez-Ribot, Jose L.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.
   [Ramage, Gordon] Univ Glasgow, Sect Infect & Immun, Glasgow Dent Hosp & Sch, Glasgow G12 8QQ, Lanark, Scotland.
   [Wickes, Brian L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78249 USA.
   [Lopez-Ribot, Jose L.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.
RP Lopez-Ribot, JL (reprint author), Univ Texas San Antonio, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.
EM jose.lopezribot@utsa.edu
RI Lopez-Ribot, Jose/D-2048-2010
CR Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0
   Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004
   Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397
   Bernhardt H, 1999, MYCOSES, V42, P29, DOI [10.1111/j.1439-0507.1999.tb00009.x, 10.1046/j.1439-0507.1999.00259.x]
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dijk F, 2000, J BIOMED MATER RES, V51, P408, DOI 10.1002/1097-4636(20000905)51:3<408::AID-JBM15>3.0.CO;2-M
   Douglas L. Julia, 2002, Revista Iberoamericana de Micologia, V19, P139
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004
   Hawser SP, 1998, J MED MICROBIOL, V47, P253, DOI 10.1099/00222615-47-3-253
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07
   Raad I, 2007, ANTIMICROB AGENTS CH, V51, P78, DOI 10.1128/AAC.00154-06
   Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005
   Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001
   Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002
   Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Sbarbati A, 2001, SCANNING, V23, P376
   Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004
NR 23
TC 25
Z9 29
U1 0
U2 4
PU ASOCIACION ESPANOLA MICOLOGIA-AEM
PI BILBAO
PA C/O DR GUILLERMO QUINDOS, EDITOR-IN-CHIEF, DEPT INMUNOLOGIA,
   MICROBIOLOGIA Y PARASITOLO, BILBAO, 00000, SPAIN
SN 1130-1406
J9 REV IBEROAM MICOL
JI Rev. Iberoam. Micol.
PD MAR 31
PY 2008
VL 25
IS 1
BP 37
EP 40
DI 10.1016/S1130-1406(08)70009-3
PG 4
WC Mycology
SC Mycology
GA 305RW
UT WOS:000256196500009
PM 18338926
DA 2018-10-19
ER

PT J
AU Garcia-Contreras, L
   Wong, YL
   Muttil, P
   Padilla, D
   Sadoff, J
   DeRousse, J
   Germishuizen, WA
   Goonesekera, S
   Elbert, K
   Bloom, BR
   Miller, R
   Fourie, PB
   Hickey, A
   Edwards, D
AF Garcia-Contreras, Lucila
   Wong, Yun-Ling
   Muttil, Pavan
   Padilla, Danielle
   Sadoff, Jerry
   DeRousse, Jessica
   Germishuizen, Willem Andreas
   Goonesekera, Sunali
   Elbert, Katharina
   Bloom, Barry R.
   Miller, Rich
   Fourie, P. Bernard
   Hickey, Anthony
   Edwards, David
TI Immunization by a bacterial aerosol
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DELIVERY; VACCINE; TUBERCULOSIS; PARTICLES
AB By manufacturing a single-particle system in two particulate forms (i.e., micrometer size and nanometer size), we have designed a bacterial vaccine form that exhibits improved efficacy of immunization. Microstructural properties are adapted to alter dispersive and aerosol properties independently. Dried "nanomicroparticie" vaccines possess two axes of nanoscale dimensions and a third axis of micrometer dimension; the last one permits effective micrometer-like physical dispersion, and the former provides alignment of the principal nanodimension particle axes with the direction of airflow. Particles formed with this combination of nano- and micrometer-scale dimensions possess a greater ability to aerosolize than particles of standard spherical isotropic shape and of similar geometric diameter. Here, we demonstrate effective application of this biomaterial by using the live attenuated tuberculosis vaccine bacille Calmette-Guerin (BCG). Prepared as a spray-dried nanomicroparticle aerosol, BCG vaccine exhibited high-efficiency delivery and peripheral lung targeting capacity from a low-cost and technically simple delivery system. Aerosol delivery of the BCG nanomicroparticle to normal guinea pigs subsequently challenged with virulent Mycobacterium tuberculosis significantly reduced bacterial burden and lung pathology both relative to untreated animals and to control animals immunized with the standard parenteral BCG.
C1 [Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Miller, Rich] Manta, Cambridge, MA 02142 USA.
   [Germishuizen, Willem Andreas; Fourie, P. Bernard] Med Res Council 1, ZA-0002 Pretoria, South Africa.
   [Sadoff, Jerry] Aeras Global Tuberculosis Vaccine Fdn, Rockville, MD 20850 USA.
   [Wong, Yun-Ling; DeRousse, Jessica; Elbert, Katharina; Edwards, David] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Garcia-Contreras, Lucila; Muttil, Pavan; Padilla, Danielle; Hickey, Anthony] Univ N Carolina, Chapel Hill, NC 27599 USA.
RP Bloom, BR (reprint author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
EM bbloom@hsph.harvard.edu; ahickey@unc.edu; dedwards@deas.harvard.edu
CR BELL JH, 1971, J PHARM SCI, V60, P1559, DOI 10.1002/jps.2600601028
   Bivas-Benita M, 2005, J CONTROL RELEASE, V107, P1, DOI 10.1016/j.conrel.205.05.028
   CHAN HK, 1989, J AEROSOL SCI, V20, P157, DOI 10.1016/0021-8502(89)90041-4
   CONCESSIO NM, 1997, ADV DRUG DELIV REV, V26, P29
   Crowder TM, 2002, PHARMACEUT RES, V19, P239, DOI 10.1023/A:1014426530935
   DAVIES CN, 1979, J AEROSOL SCI, V10, P477, DOI 10.1016/0021-8502(79)90006-5
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010
   FUCHS NA, 1964, MECHANICS AEROSOLS, P1
   Fults K A, 1997, Pharm Dev Technol, V2, P67, DOI 10.3109/10837459709022610
   GONDA I, 1985, AEROSOL SCI TECH, V4, P233, DOI 10.1080/02786828508959051
   HARRIS RL, 1977, INHALED PARTICLES, V4, P75
   Hickey A., 1992, J BIOPHARM SCI, V3, P107
   KOTTRAPPA P, 1970, 3 INT C ENV TOX, V14, P249
   LAGRANDERIE M, 1993, TUBERCLE LUNG DIS, V74, P38, DOI 10.1016/0962-8479(93)90067-8
   Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213
   ROSENTHAL S R, 1968, Journal of Asthma Research, V5, P309, DOI 10.3109/02770906809100348
   Wong YL, 2007, P NATL ACAD SCI USA, V104, P2591, DOI 10.1073/pnas.0611430104
NR 18
TC 82
Z9 85
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 25
PY 2008
VL 105
IS 12
BP 4656
EP 4660
DI 10.1073/pnas.0800043105
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 285JI
UT WOS:000254772700024
PM 18344320
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Landa, N
   Miller, L
   Feinberg, MS
   Holbova, R
   Shachar, M
   Freeman, I
   Cohen, S
   Leor, J
AF Landa, Natali
   Miller, Liron
   Feinberg, Micha S.
   Holbova, Radka
   Shachar, Michal
   Freeman, Inbar
   Cohen, Smadar
   Leor, Jonathan
TI Effect of injectable alginate implant on cardiac remodeling and function
   after recent and old infarcts in rat
SO CIRCULATION
LA English
DT Article
DE collagen; heart failure; myocardial infarction; remodeling; tissue;
   tissue engineering
ID ASSEMBLING PEPTIDE NANOFIBERS; MYOCARDIAL-INFARCTION; NEOVASCULATURE
   FORMATION; ISCHEMIC-MYOCARDIUM; CELL THERAPY; PDGF-BB; DELIVERY;
   BIOMATERIALS; INJECTION; MOLECULES
AB Background-Adverse cardiac remodeling and progression of heart failure after myocardial infarction are associated with excessive and continuous damage to the extracellular matrix. We hypothesized that injection of in situ-forming alginate hydrogel into recent and old infarcts would provide a temporary scaffold and attenuate adverse cardiac remodeling and dysfunction.
   Methods and Results-We developed a novel absorbable biomaterial composed of calcium-crosslinked alginate solution, which displays low viscosity and, after injection into the infarct, undergoes phase transition into hydrogel. To determine the outcome of the biomaterial after injection, calcium-crosslinked biotin-labeled alginate was injected into the infarct 7 days after anterior myocardial infarction in rat. Serial histology studies showed in situ formation of alginate hydrogel implant, which occupied up to 50% of the scar area. The biomaterial was replaced by connective tissue within 6 weeks. Serial echocardiography studies before and 60 days after injection showed that injection of alginate biomaterial into recent (7 days) infarct increased scar thickness and attenuated left ventricular systolic and diastolic dilatation and dysfunction. These beneficial effects were comparable and sometimes superior to those achieved by neonatal cardiomyocyte transplantation. Moreover, injection of alginate biomaterial into old myocardial infarction (60 days) increased scar thickness and improved systolic and diastolic dysfunction.
   Conclusions-We show for the first time that injection of in situ-forming, bioabsorbable alginate hydrogel is an effective acellular strategy that prevents adverse cardiac remodeling and dysfunction in recent and old myocardial infarctions in rat.
C1 [Landa, Natali; Miller, Liron; Feinberg, Micha S.; Holbova, Radka; Leor, Jonathan] Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
   [Shachar, Michal; Freeman, Inbar; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Leor, J (reprint author), Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
EM scohen@bgu.ac.il; leorj@post.tau.ac.il
RI COHEN, SMADAR/F-1901-2012; Leor, Jonathan/O-2930-2017
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Amsalem Y, 2007, CIRCULATION S1, V116, pI38, DOI DOI 10.1161/CIRCULATIONAHA.106.680231
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2001.1391
   Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005
   Gaudette GR, 2006, CIRCULATION, V114, P2575, DOI 10.1161/CIRCULATIONAHA.106.668707
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   KOFIDIS T, 2005, CIRCULATION S1, V112
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   LEOR J, 2000, CIRCULATION S3, V102
   Leor J., 2006, CIRCULATION, V114, pI94
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Migrino RQ, 1997, CIRCULATION, V96, P116
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
NR 26
TC 257
Z9 271
U1 6
U2 88
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD MAR 18
PY 2008
VL 117
IS 11
BP 1388
EP 1396
DI 10.1161/CIRCULATIONAHA.107.727420
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 275IN
UT WOS:000254065200006
PM 18316487
OA Bronze
DA 2018-10-19
ER

PT J
AU Wan, ACA
   Tai, BCU
   Schumacher, KM
   Schumacher, A
   Chin, SY
   Ying, JY
AF Wan, Andrew C. A.
   Tai, Benjamin C. U.
   Schumacher, Karl M.
   Schumacher, Annegret
   Chin, Sau Yin
   Ying, Jackie Y.
TI Polyelectrolyte complex membranes for specific cell adhesion
SO LANGMUIR
LA English
DT Article
ID BONE DEFECTS; HYDROGELS; PROTEIN; ATTACHMENT; SUBSTRATE; ULTRATHIN;
   PEPTIDES; ALGINATE; CHITOSAN; SULFATE
AB The presentation of bioactive ligands on biomaterial surfaces is often confounded by the adsorption of proteins present in the biological milieu, rendering any type of cellular response nonspecific. We have engineered a polyelectrolyte complex membrane that demonstrates specific adhesion of various cell types for both two-dimensional (2D) and three-dimensional (3D) cell culture systems. Specific cell adhesion is achieved by a three-tiered structure: a silica cross-linked polycation as the bottom (first) tier, a nonfouling polyanion-poly(ethylene glycol) (PEG) conjugate as the intermediate (second) tier, and the cell-adhesion ligand as the top (third) tier. Each tier of the membrane was characterized in terms of chemical composition and dimensions. Epithelial cells (primary human cortical renal cells and a hepatocellular carcinoma cell line) cultured on the membranes exhibited little cell attachment on the polyanion - PEG second tier and good cell adhesion on the RGD-modified third tier. Thus, the second tier allowed the effect of cell adhesion due to the ligand (third tier) to be isolated and distinguished from nonspecific cell attachment to the first tier. For the culturing of cells in three dimensions, the three-tiered membrane system was applied using a highly swellable chitosan membrane as the first tier. The resulting cell-membrane construct was uniformly dispersed and centrifuged to form a matrix that interacted intimately with cells in the form of a pellet. Presentation of RGD in the latter format enhanced the viability of human mesenchymal stem cells (hMSCs) over controls without RGD.
C1 [Wan, Andrew C. A.; Tai, Benjamin C. U.; Schumacher, Karl M.; Schumacher, Annegret; Chin, Sau Yin; Ying, Jackie Y.] Inst Bioengn & Nanotechnol, Nanos 138669, Singapore.
RP Wan, ACA (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way, Nanos 138669, Singapore.
EM awan@ibn.a-star.edu.sg; jyying@ibn.a-star.edu.sg
RI Ying, Jackie/A-8402-2012; Wan, Andrew/B-8525-2014
OI Ying, Jackie/0000-0001-6938-2113; 
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   AJURIA JL, 2004, PRINCIPLES PRACTICE
   Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Bernkop-Schnurch A, 2001, J CONTROL RELEASE, V71, P277, DOI 10.1016/S0168-3659(01)00227-9
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Stavropoulos F, 2004, CLIN ORAL IMPLAN RES, V15, P435, DOI 10.1111/j.1600-0501.2004.01029.x
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Vermette P, 2003, J COLLOID INTERF SCI, V259, P13, DOI 10.1016/S0021-9797(02)00185-6
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
NR 28
TC 11
Z9 12
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 18
PY 2008
VL 24
IS 6
BP 2611
EP 2617
DI 10.1021/la7025768
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 273OM
UT WOS:000253941000050
PM 18260679
DA 2018-10-19
ER

PT J
AU Bai, LQ
   Zhu, LJ
   Min, SJ
   Liu, L
   Cai, YR
   Yao, JM
AF Bai, Liqiang
   Zhu, Liangjun
   Min, Sijia
   Liu, Lin
   Cai, Yurong
   Yao, Juming
TI Surface modification and properties of Bombyx mori silk fibroin films by
   antimicrobial peptide
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Bombyx mori silk; silk fibroin film; surface modification; Cecropin B;
   antimicrobial activity; antimicrobial peptide
ID POLYELECTROLYTE MULTILAYER FILMS; CHEMICAL CROSS-LINKING;
   ANTHERAEA-PERNYI; CECROPIN-B; ANTIBACTERIAL PROPERTIES; 3-D SCAFFOLDS;
   IN-VITRO; CHITOSAN; BEHAVIOR; NANOPARTICLES
AB The Bombyx mori silk fibroin films (SFFs) were modified by a Cecropin B (CB) antimicrobial peptide, (NH2)-NGIVKAGPAIAVLGEAAL-CONH2, using the carbodiimide chemistry method. In order to avoid the dissolution of films during the modification procedure, the SFFs were first treated with 60% (v/v) ethanol aqueous solution, resulting a structural transition from unstable silk I to silk II. The investigation of modification conditions showed that the surface-modified SFFs had the satisfied antimicrobial activity and durability when they were activated by EDC center dot HCl/NHS solution followed by a treatment in CB peptide/PBS buffer (pH 6.5 or 8) solution at ambient temperature for 2 h. Moreover, the surface-modified SFFs showed the smaller contact angle due to the hydrophilic antimicrobial peptides coupled on the film surface, which is essential for the cell adhesion and proliferation. AFM results indicated that the surface roughness of SFFs was considerably increased after the modification by the peptides. The elemental composition analysis results also suggested that the peptides were tightly coupled to the surface of SFFs. This approach may provide a new option to engineer the surface-modified implanted materials preventing the biomaterial-centered infection (BCI). (C) 2007 Elsevier B.V. All rights reserved.
C1 [Bai, Liqiang; Liu, Lin; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Minist Educ, Coll Mat & Text, Hangzhou 310018, Peoples R China.
   [Zhu, Liangjun; Min, Sijia] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Minist Educ, Coll Mat & Text, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR ASAKURA T, 2004, BIOMATERIALS, V25, P61724
   BAI LQ, 2007, J CHIN U, V28, P1593
   BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dai JH, 2002, NANO LETT, V2, P497, DOI 10.1021/nl0255471
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kawahara Y, 2006, MACROMOL MATER ENG, V291, P458, DOI 10.1002/mame.200500350
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon HY, 1999, J APPL POLYM SCI, V73, P2887, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2887::AID-APP12>3.0.CO;2-I
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Moulder J.F., 1995, HDB XRAY PHOTOELECTR, P42
   MULLER WS, 1993, LANGMUIR, V9, P1857, DOI 10.1021/la00031a038
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nichols RL, 1999, DIAGN MICR INFEC DIS, V33, P121, DOI 10.1016/S0732-8893(98)00144-8
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   QU XM, 1982, EUR J BIOCHEM, V127, P219, DOI 10.1111/j.1432-1033.1982.tb06858.x
   RHEE SK, 1997, HANGUK NONGHWA HAKHO, V40, P541
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Sharma A, 2000, FEBS LETT, V484, P7, DOI 10.1016/S0014-5793(00)02106-2
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   VAARA M, 1994, ANTIMICROB AGENTS CH, V38, P2498, DOI 10.1128/AAC.38.10.2498
   VandeVord PJ, 2005, J ORTHOP RES, V23, P1059, DOI 10.1016/j.orthres.2004.12.004
   Wang W, 1999, BBA-GEN SUBJECTS, V1473, P418, DOI 10.1016/S0304-4165(99)00200-7
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Zhang W, 2006, POLYMER, V47, P931, DOI 10.1016/j.polymer.2005.12.009
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou L, 2006, BIOPOLYMERS, V82, P144, DOI 10.1002/bip.20472
NR 39
TC 78
Z9 82
U1 7
U2 87
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 15
PY 2008
VL 254
IS 10
BP 2988
EP 2995
DI 10.1016/j.apsusc.2007.10.049
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 277VV
UT WOS:000254243700013
DA 2018-10-19
ER

PT J
AU Mansur, HS
   Costa, HS
AF Mansur, Herman S.
   Costa, Hermes S.
TI Nanostructured poly(vinyl alcohol)/bioactive glass and poly (vinyl
   alcohol)/chitosan/bioactive glass hybrid scaffolds for biomedical
   applications
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE hybrids; bioceramic scaffold; nanocomposite; bioactive glass; polyvinyl
   alcohol; bone tissue engineering; cytotoxicity
ID SOL-GEL METHOD; BIOACTIVE GLASS; COMPOSITE SCAFFOLDS; CHITOSAN
   HYDROGELS; POLYVINYL ALCOHOL; BIOMATERIAL; CERAMICS; DESIGN; MEMBRANES
AB Bone tissue engineering is the field of intense research for developing new 3D scaffolds with hierarchical and highly interconnected porous structure. which should match the properties of the tissue that is to be replaced. These materials need to be biocompatible, ideally osteoinductive, osteoconductive and mechanically well-matched. In the present study, we report the development and characterization of novel hybrid macroporous scaffolds of poly(vinyl) alcohol (PVA)/bioactive glass (BaG) through the sol-gel route. The organic-inorganic hybrids with three concentrations of PVA (80, 70 and 60 wt%) and bioactive glass (58SiO(2)-33CaO-9P(2)O(5)) were synthesized by foaming a mixture of polymer solution and bioactive glass via sol-gel precursor solution. PVA with two degree of hydrolysis, 98.5% (high degree) and 80% (low degree) was also investigated, in order to evaluate the influence of residual acetate group present in polymer chain on the final structure and properties of 3D porous nanocomposites produced (PVA/BaG). Bioartificial polymeric hybrids were also investigated in this work by blending PVA with chitosan (chi) and then reacting with bioactive glass reagents using sol-gel processing route (PVA/Chi/BaG). The microstructure, morphology and crystallinity of the hybrid porous scaffolds were characterized through synchrotron small-angle X-ray scattering (SAXS), X-ray diffraction (XRD), fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) analysis. In addition, mechanical properties of hybrids were evaluated by uni-axial compression tests. Biocompatibility, cytotoxicity and cell viability assays were also performed by the MTT method with VERO cell culture. The results have given strong evidence that both hybrid systems of PVA/bioactive glass and PVA/chitosan/bioactive glass were successfully produced and extensively characterized with hierarchical macroporous 3D structure. FTIR spectroscopy associated with XRD and SAXS has proven to be important technique for investigating the formation of PVA/BaG and PVA/Chi/BaG hybrids as organic-inorganic network at micro-nanostructure order. Finally, the developed hybrids have presented suitable mechanical, morphological and cell viability properties for potential biological applications. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Mansur, Herman S.; Costa, Hermes S.] Univ Fed Minas Gerais, Lab Biomat & Tissue Engn, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Lab Biomat & Tissue Engn, Dept Met & Mat Engn, R Espirito Santo 35, BR-30160030 Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X
CR ALMEIDA RM, 1990, J APPL PHYS, V68, P4225, DOI 10.1063/1.346213
   Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Cho JD, 1999, MACROMOLECULES, V32, P6236, DOI 10.1021/ma9908402
   COATA J, 2000, ENCY ANAL CHEM INTER, P10811
   Costa HS, 2008, J MATER SCI, V43, P494, DOI 10.1007/s10853-007-1875-4
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   JONES RJ, 2005, BIOMATERIALS, V27, P964, DOI DOI 10.1016/J.BIOMATERIALS.2005.07.017
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Liu YL, 2004, POLYMER, V45, P6831, DOI 10.1016/j.polymer.2004.08.006
   Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Maria V. R., 2004, PROG SOLID STATE CHE, V32, P1
   MARIA VR, 2006, DALTON T, P5211
   Martin AI, 2005, J EUR CERAM SOC, V25, P3533, DOI 10.1016/j.jeurceramsoc.2004.09.030
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   MONTSERRAT C, 2006, CHEM MATER, V18, P5676
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Padilla S, 2007, J BIOMED MATER RES A, V81A, P224, DOI 10.1002/jbm.a.30934
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   Pereira MM, 2005, J MATER SCI-MATER M, V16, P1045, DOI 10.1007/s10856-005-4758-8
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roman J, 2003, CHEM MATER, V15, P798, DOI 10.1021/cm021325c
   SANCHEZ C, 1994, NEW J CHEM, V18, P1007
   Shi DL, 1998, MAT SCI ENG C-BIO S, V6, P175, DOI 10.1016/S0928-4931(98)00048-4
   Silva SS, 2005, J MATER CHEM, V15, P3952, DOI 10.1039/b505875a
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Tang YF, 2007, CARBOHYD POLYM, V67, P491, DOI 10.1016/j.carbpol.2006.06.015
   Tao W., 2004, POLYM INT, V53, P911
   Wang LC, 2007, J MATER SCI-MATER M, V18, P1125, DOI 10.1007/s10856-007-0159-5
   WILLI P, 2006, AM J BIOCH BIOTECHNO, V2, P41
   YAMAOKA T, 1995, J PHARM PHARMACOL, V47, P479, DOI 10.1111/j.2042-7158.1995.tb05835.x
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang YY, 2007, COLLOID POLYM SCI, V285, P855, DOI 10.1007/s00396-006-1630-4
NR 46
TC 93
Z9 96
U1 3
U2 64
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 15
PY 2008
VL 137
IS 1
BP 72
EP 83
DI 10.1016/j.cej.2007.09.036
PG 12
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 274TK
UT WOS:000254023900010
DA 2018-10-19
ER

PT J
AU Gelinsky, M
   Welzel, PB
   Simon, P
   Bernhardt, A
   Konig, U
AF Gelinsky, M.
   Welzel, P. B.
   Simon, P.
   Bernhardt, A.
   Koenig, U.
TI Porous three-dimensional scaffolds made of mineralised collagen:
   Preparation and properties of a biomimetic nanocomposite material for
   tissue engineering of bone
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE biomimetic; porous; scaffold; hydroxyapatite; calcium phosphate;
   collagen; nanocomposite; calorimetry
ID BIOACTIVE COMPOSITE-MATERIALS; MESENCHYMAL STEM-CELLS; CROSS-LINKED
   COLLAGEN; MARROW STROMAL CELLS; IN-VITRO; THERMAL STABILIZATION;
   OSTEOGENIC DIFFERENTIATION; DENATURATION TEMPERATURE;
   MECHANICAL-PROPERTIES; LINKING
AB For healing of bone defects and as matrix for tissues engineering, porous scaffolds are required that can be easily pre-seeded with cells in the lab and invaded by tissue after implantation. We have developed porous 3D scaffolds consisting of mineralised collagen type I-a nanocomposite, which mimics the composition of extracellular matrix of healthy bone tissue. The steps of material processing as well as the physico-chemical, structural and mechanical properties of this biomaterial are described in detail. The technology of differential scanning calorimetry, which provides an excellent possibility to investigate collagen-based materials, was used to characterise the final scaffold and all its intermediates in situ. Furthermore, the interconnecting porosity of the scaffolds with pore diameters of about 200 mu m has been shown to be highly suitable for homogenous cell seeding, demonstrated with human marrow stromal cells. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Gelinsky, M.; Bernhardt, A.; Koenig, U.] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat Dresden, D-01069 Dresden, Germany.
   [Welzel, P. B.] Leibniz Inst Polymer Res Dresden eV, Max Bergmann Ctr Biomat Dresden, Dresden, Germany.
   [Simon, P.] Max Planck Inst Chem Phys Solids, Dresden, Germany.
RP Gelinsky, M (reprint author), Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat Dresden, Budapesterstr 27, D-01069 Dresden, Germany.
EM michael.glinsky@tu-dresden.de
RI Bernhardt, Anne/O-1242-2015; Umlauf, Ursula/D-3356-2014; Gelinsky,
   Michael/A-9680-2012
OI Bernhardt, Anne/0000-0002-1903-1929; Gelinsky,
   Michael/0000-0001-9075-5121
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BAILEY AJ, 1967, RADIAT RES, V31, P206, DOI 10.2307/3572321
   BERNAL VM, 1987, J FOOD SCI, V52, P876, DOI 10.1111/j.1365-2621.1987.tb14231.x
   BERNHARDT A, IN PRESS J BIOMED MA
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   BIGI A, 1991, CONNECT TISSUE RES, V25, P171, DOI 10.3109/03008209109029154
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BURTH R, 1999, TECH TEXTILE, V8, P20
   Chakraborty J, 2007, J AM CERAM SOC, V90, P1258, DOI 10.1111/j.1551-2916.2007.01596.x
   Domaschke H, 2006, TISSUE ENG, V12, P949, DOI 10.1089/ten.2006.12.949
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   Gelinsky M, 2007, INT J MATER RES, V98, P749, DOI 10.3139/146.101520
   Goldstein SA, 1993, CALCIF TISSUE INT S1, V53, P127
   HAYASHI T, 1979, BIOCHEMISTRY-US, V18, P4182, DOI 10.1021/bi00586a022
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Kronick PL, 1996, CONNECT TISSUE RES, V33, P275, DOI 10.3109/03008209609028885
   Kubisz L, 2003, INT J BIOL MACROMOL, V33, P89, DOI 10.1016/S0141-8130(03)00071-0
   LODE A, 2006, P INT C BIOM REG MED, V6, P167
   Lou X, 1999, J BIOMATER APPL, V14, P184, DOI 10.1177/088532829901400204
   Marzec E, 1996, INT J BIOL MACROMOL, V18, P27, DOI 10.1016/0141-8130(95)01052-1
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   Miles CA, 2000, J BIOL CHEM, V275, P33014, DOI 10.1074/jbc.M002346200
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   Mu CD, 2007, BIOPOLYMERS, V86, P282, DOI 10.1002/bip.20742
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7161, DOI 10.1021/bi00444a005
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Reinstorf A, 2004, J MATER SCI-MATER M, V15, P451, DOI 10.1023/B:JMSM.0000021119.14870.3d
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Safinia L, 2006, LANGMUIR, V22, P3235, DOI 10.1021/la051762g
   SCHOLZ M, UNPUB EUR SPINE J
   SEN M. K., 2007, INJURY S1, V38, P75
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n
   Trebacz H, 2005, INT J BIOL MACROMOL, V37, P257, DOI 10.1016/j.ijbiomac.2005.04.007
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
NR 53
TC 93
Z9 95
U1 1
U2 35
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 15
PY 2008
VL 137
IS 1
BP 84
EP 96
DI 10.1016/j.cej.2007.09.029
PG 13
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 274TK
UT WOS:000254023900011
DA 2018-10-19
ER

PT J
AU Fathima, NN
   Suresh, R
   Rao, JR
   Nair, BU
   Ramasami, T
AF Fathima, Nishtar Nishad
   Suresh, Raju
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
   Ramasami, Thirumalachari
TI Effect of UV irradiation on stabilized collagen: Role of chromium(III)
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE collagen; UV radiation; circular dichroism (CD); viscosity;
   fluorescence; absorption
ID RAT TAIL TENDON; ULTRAVIOLET IRRADIATION; CIRCULAR-DICHROISM;
   DENATURATION TEMPERATURE; HYDROLYTIC OLIGOMERS; CROSS-LINKING;
   RADIATION; LIGHT; HELIX; MACROMOLECULES
AB Research on the effect of UV radiation on stabilized collagen is an area of potential interest owing to the fact that collagen is an important biomaterial finding immense use in various fields. In this present study, effect of UV irradiation on collagen stabilized using chromium(III) has been studied. The physical and optical properties affected by UV irradiation have been detailed. Viscosity measurements have shown that chromium(III) treated collagen has better stability against UV radiation than native collagen. Circular dichroic studies indicate that increase in concentration of chromium(III) does not affect the conformation of collagen however, the duration of irradiation has profound impact on the conformation of collagen. The fluorescence intensity of native collagen has been found to decrease more than that of chromium(III) treated collagen. The difference absorption spectra also shows that chromium(III) treatment brings about more stability to collagen against UV irradiation. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Fathima, Nishtar Nishad; Suresh, Raju; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni; Ramasami, Thirumalachari] Cent Leather Res Inst, Chem Lab, Madras 20, Tamil Nadu, India.
RP Rao, JR (reprint author), Cent Leather Res Inst, Chem Lab, Madras 20, Tamil Nadu, India.
EM clrichem@mailcity.com; clrichem@mailcity.com
RI Fathima, Nishad/B-7919-2009; Rao, Jonnalagadda/B-8486-2009; Thangarasu,
   Kandasamy/B-8503-2009; Nair, Balachandran/D-1508-2010
CR BAILEY AJ, 1967, RADIAT RES, V31, P206, DOI 10.2307/3572321
   BROWN FR, 1972, J MOL BIOL, V63, P85, DOI 10.1016/0022-2836(72)90523-2
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   COOPER DR, 1965, BIOCHEM J, V97, P139, DOI 10.1042/bj0970139
   COOPER DR, 1966, BIOCHEM J, V98, P655, DOI 10.1042/bj0980655
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fathima NN, 2003, J INORG BIOCHEM, V95, P47, DOI 10.1016/S0162-0134(03)00071-0
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X
   FUJIMORI E, 1965, BIOPOLYMERS, V3, P115, DOI 10.1002/bip.360030202
   FUJIMORI E, 1966, BIOCHEMISTRY-US, V5, P1034, DOI 10.1021/bi00867a032
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   GOTSIS T, 1992, J SOC LEATH TECH CH, V76, P195
   GUSTAVSON KH, 1952, J AM CHEM SOC, V74, P4608, DOI 10.1021/ja01138a050
   HAYASHI T, 1979, BIOCHEMISTRY-US, V18, P4182, DOI 10.1021/bi00586a022
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x
   LOVELL WW, 1972, T ST JOHNS HOSP DERM, V59, P166
   MAJEWSKI AJ, 2002, PHYS REV E, V65, P1
   Miles CA, 2000, J BIOL CHEM, V275, P33014, DOI 10.1074/jbc.M002346200
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   NIYIBIZI C, 1989, CONNECT TISSUE RES, V20, P247, DOI 10.3109/03008208909023894
   RAAB WP, 1969, EXPERIENTIA, V25, P624, DOI 10.1007/BF01896553
   Ramachandran G.N., 1967, TREATISE COLLAGEN
   Rao JR, 1999, BBA-GEN SUBJECTS, V1472, P595
   Rao JR, 1997, J SOC LEATH TECH CH, V81, P234
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V82, P9, DOI 10.1016/j.photobiol.2005.08.003
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Sionkowska A, 2004, INT J BIOL MACROMOL, V34, P9, DOI 10.1016/j.ijbiomac.2003.10.001
   SWALLOW AJ, 1973, RAD CHEM, P243
   TIFFANY ML, 1968, BIOPOLYMERS, V6, P1767, DOI 10.1002/bip.1968.360061212
   Torikai A, 1999, J APPL POLYM SCI, V73, P1259, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1259::AID-APP20>3.0.CO;2-#
   VENKATACHALAPATHI K, 1982, J CHEM SOC DALTON, P291, DOI 10.1039/dt9820000291
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 37
TC 14
Z9 16
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 15
PY 2008
VL 62
IS 1
BP 11
EP 16
DI 10.1016/j.colsurfb.2007.09.006
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 297NG
UT WOS:000255622800003
PM 17945471
DA 2018-10-19
ER

PT J
AU Churchley, DP
   Barbu, E
   Ewen, RJ
   Shen, Z
   Kim, Y
   McHugh, MA
   Zhang, ZY
   Nevell, TG
   Rees, GD
   Tsibouklis, J
AF Churchley, David P.
   Barbu, Eugen
   Ewen, Richard J.
   Shen, Zhihao
   Kim, Yongchul
   McHugh, Mark A.
   Zhang, Zhong Yi
   Nevell, Thomas G.
   Rees, Gareth D.
   Tsibouklis, John
TI Synthesis and characterization of low surface energy fluoropolymers as
   potential barrier coatings in oral care
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fluoropolymers; low surface energy; dental care
ID SUPERCRITICAL CARBON-DIOXIDE; MOLECULAR DESIGN REQUIREMENTS; BACTERIAL
   ADHESION; PROTEIN ADSORPTION; CONTACT-ANGLE; BIOMATERIAL SURFACES;
   DIBLOCK COPOLYMERS; POLYMER SURFACES; BLOCK-COPOLYMERS; FILM STRUCTURES
AB A series of low surface energy fluorinated homopolymers and copolymers has been synthesized and characterized using thermal, optical, spectroscopic, and chromatographic techniques. Their utility as barrier technologies in oral care has been considered, and aqueous nanosuspensions of the materials have been deposited as films on model dental hard surfaces in the presence and absence of a salivary pellicle. Calcium hydroxyapatite has been used as a model for enamel, as has PMMA due to its widespread use in denture fabrication. Surface energy determinations, combined with XPS studies, have provided insights into the molecular-level organization at the surface of the film structures. Studies of solubility in supercritical carbon dioxide have identified the polymers that are suitable for processing in this medium. (C) 2007 Wiley Periodicals, Inc.
C1 [Churchley, David P.; Barbu, Eugen; Nevell, Thomas G.; Tsibouklis, John] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Ewen, Richard J.] Univ W England, Fac Sci Appl, Bristol BS16 1QY, Avon, England.
   [Shen, Zhihao; Kim, Yongchul; McHugh, Mark A.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Zhang, Zhong Yi] Univ Portsmouth, Reg Ctr Mfg Ind, Dept Mech & Design Engn, Portsmouth PO1 3DJ, Hants, England.
   [Rees, Gareth D.] GlaxoSmithKline R&D, Surrey KT13 0DE, England.
RP Tsibouklis, J (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM john.tsibouklis@port.ac.uk
RI Barbu, Eugen/A-5554-2012
OI Barbu, Eugen/0000-0002-2053-4136; Tsibouklis, John/0000-0001-5300-357X
CR Ameduri B, 2001, PROG POLYM SCI, V26, P105, DOI 10.1016/S0079-6700(00)00044-7
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Andrade J. D., 1988, POLYM SURFACE DYNAMI
   Andruzzi L, 2002, J MATER CHEM, V12, P1684, DOI 10.1039/b200891b
   Baradie B, 2004, MACROMOLECULES, V37, P7799, DOI 10.1021/ma049384u
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brady RF, 1997, CHEM IND-LONDON, P219
   BRADY RF, 1994, NATURE, V368, P16, DOI 10.1038/368016a0
   Brady RF, 1999, PROG ORG COAT, V35, P31, DOI 10.1016/S0300-9440(99)00005-3
   Byun HS, 2000, J CHEM ENG DATA, V45, P810, DOI 10.1021/je990308+
   Ciardelli F, 1996, PAINTS VARNISHES, V72, P21
   CLARE AS, 1992, INVERTEBR REPROD DEV, V22, P67, DOI 10.1080/07924259.1992.9672258
   Cowie J. M. G., 1993, POLYM CHEM PHYS MODE
   Cunliffe D, 2000, BIOTECHNOL LETT, V22, P141, DOI 10.1023/A:1005622424821
   Dardin A, 1998, J PHYS CHEM B, V102, P1775, DOI 10.1021/jp972127p
   Dardin A, 1997, MACROMOLECULES, V30, P3593, DOI 10.1021/ma961917e
   DIGUET R, 1985, BER BUNSEN PHYS CHEM, V89, P800, DOI 10.1002/bbpc.19850890715
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   EVANS LV, 1993, J APPL BACTERIOL, V74, pS119, DOI 10.1111/j.1365-2672.1993.tb04348.x
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Fried JR, 2003, POLYMER, V44, P4363, DOI 10.1016/S0032-3861(03)00285-4
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Hauthal WH, 2001, CHEMOSPHERE, V43, P123, DOI 10.1016/S0045-6535(00)00332-5
   Holland NB, 1998, NATURE, V392, P799
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   Ito H, 2004, J COLLOID INTERF SCI, V276, P290, DOI 10.1016/j.jcis.2004.03.046
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jones FH, 2001, SURF SCI REP, V42, P79
   Kameo A, 2003, COLLOID SURFACE A, V215, P181, DOI 10.1016/S0927-7757(02)00439-9
   KAYE GWC, 1992, TABLE PHYS CHEM CONS
   Kazarian SG, 1996, J AM CHEM SOC, V118, P1729, DOI 10.1021/ja950416q
   Kirby CF, 1999, CHEM REV, V99, P565, DOI 10.1021/cr970046j
   Krupers M, 1997, MACROMOL CHEM PHYSIC, V198, P2163, DOI 10.1002/macp.1997.021980714
   Krupers MJ, 1998, POLYM BULL, V40, P211, DOI 10.1007/s002890050244
   Li D, 2003, IND ENG CHEM RES, V42, P6499, DOI 10.1021/ie021063o
   Lindner E, 1992, BIOFOULING, V6, P193, DOI 10.1080/08927019209386222
   McHugh MA, 2002, MACROMOLECULES, V35, P6479, DOI 10.1021/ma012169i
   MEILCHEN MA, 1991, MACROMOLECULES, V24, P4874, DOI 10.1021/ma00017a025
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Mertdogan CA, 1996, MACROMOLECULES, V29, P6548, DOI 10.1021/ma9605513
   Miyazawa H, 2005, J FLUORINE CHEM, V126, P301, DOI 10.1016/j.fluchem.2004.10.016
   MORRA M, 1990, ADV COLLOID INTERFAC, V32, P79, DOI 10.1016/0001-8686(90)80012-O
   Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PARK IJ, 1994, J APPL POLYM SCI, V54, P1449, DOI 10.1002/app.1994.070541008
   RAYNOR MW, 1993, J SUPERCRIT FLUID, V6, P39, DOI 10.1016/0896-8446(93)90008-L
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rindfleisch F, 1996, J PHYS CHEM-US, V100, P15581, DOI 10.1021/jp9615823
   SCHIERS J, 1997, MODERN FLUROPOLYMERS
   SEN YL, 1990, J SUPERCRIT FLUID, V3, P91, DOI DOI 10.1016/0896-8446(90)90013-C
   SHULL KR, 1991, MACROMOLECULES, V24, P2748, DOI 10.1021/ma00010a017
   Stansbury JW, 1999, DENT MATER, V15, P166, DOI 10.1016/S0109-5641(99)00028-7
   Storsberg J, 2002, MACROMOL CHEM PHYS, V203, P812, DOI 10.1002/1521-3935(20020401)203:5/6<812::AID-MACP812>3.0.CO;2-6
   Thomas RR, 1997, MACROMOLECULES, V30, P2883, DOI 10.1021/ma9618686
   Tsibouklis J, 2000, MACROMOLECULES, V33, P8460, DOI 10.1021/ma0008185
   Tsibouklis J, 1999, LANGMUIR, V15, P7076, DOI 10.1021/la990411x
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Tsibouklis J, 2003, ADV MATER, V15, P647, DOI 10.1002/adma.200301638
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vrolijk N.H., 1990, Biofouling, V2, P39
   Wang JG, 1997, MACROMOLECULES, V30, P1906, DOI 10.1021/ma961412o
   Yoshino N, 1998, REACT FUNCT POLYM, V37, P271, DOI 10.1016/S1381-5148(97)00114-4
NR 68
TC 9
Z9 9
U1 1
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2008
VL 84A
IS 4
BP 994
EP 1005
DI 10.1002/jbm.a.31462
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 264LB
UT WOS:000253287700016
PM 17647242
DA 2018-10-19
ER

PT J
AU Kotch, FW
   Guzei, IA
   Raines, RT
AF Kotch, Frank W.
   Guzei, Ilia A.
   Raines, Ronald T.
TI Stabilization of the collagen triple helix by O-methylation of
   hydroxyproline residues
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID PROTEIN-STRUCTURE; STABILITY; HYDRATION; PEPTIDE; DERIVATIVES
AB Collagen is the most abundant protein in animals, including humans. The prevalent (2S,4R)-4-hydroxyproline (Hyp) residues of collagen are known to confer great stability upon its triple-helical conformation. The basis for that stability has been attributed to hydration of the pendant hydroxyl groups. Here, that attribution is shown to be incorrect. Replacement of the natural Hyp residues with synthetic (2S,4R)-4-methoxyproline (Mop) residues is shown by circular dichronism spectroscopy and differential scanning calorimetry to increase the conformational stability of the collagen triple helix. The thermodynamic parameters indicate that, as expected, O-methylation decreases the hydration of the triple helix. Apparently, hydration of Hyp residues is deleterious, rather than advantageous, to the collagen triple helix. The crystal structure of Ac-Mop-OMe reveals the manifestation of two stereoelectronic effects: a gauche effect and an n -> infinity* interaction, which preorganize the main-chain atoms properly for triple helix formation. Thus, the conformational stability conferred upon the collagen triple helix by O-methylation provides strong evidence that the hydroxyl group of Hyp acts primarily through stereoelectronic effects and that is hydration provides no benefit. This information could have practical utility, as Mop could be prepared in situ by the O-methylation of Hyp residues in natural collagen. Such a semisynthetic collagen could have superior properties as a biomaterial.
C1 [Kotch, Frank W.; Guzei, Ilia A.; Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
   [Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
RP Raines, RT (reprint author), Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
EM rtraines@wisc.edu
RI Raines, Ronald/A-5009-2013
OI Raines, Ronald/0000-0001-7164-1719
FU NCRR NIH HHS [S10 RR013790, RR13790]; NIAMS NIH HHS [R01 AR044276,
   AR050881, F32 AR050881-03, F32 AR050881, AR044276, R01 AR044276-12]
CR Alabugin IV, 2002, J AM CHEM SOC, V124, P3175, DOI 10.1021/ja012633z
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904
   Dyck M, 2005, PHYS CHEM CHEM PHYS, V7, P150, DOI 10.1039/b410863a
   FENG Y, 1996, J AM CHEM SOC, V118, P10355
   Gorske BC, 2007, J AM CHEM SOC, V129, P8928, DOI 10.1021/ja071310l
   Hinderaker MP, 2003, PROTEIN SCI, V12, P1188, DOI 10.1110/ps.0241903
   HINE J, 1975, J ORG CHEM, V40, P292, DOI 10.1021/jo00891a006
   Hodges JA, 2006, ORG LETT, V8, P4695, DOI 10.1021/ol061569t
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806
   Janesko BG, 2003, J PHYS CHEM A, V107, P1655, DOI 10.1021/jp027576q
   Jenkins CL, 2005, BIOPOLYMERS, V80, P1, DOI 10.1002/bip.20164
   KRAPCHO J, 1988, J MED CHEM, V31, P1148, DOI 10.1021/jm00401a014
   Kumin M, 2007, J AM CHEM SOC, V129, P466, DOI 10.1021/ja067148o
   Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w
   Miles CA, 2001, BIOPHYS J, V80, P1480, DOI 10.1016/S0006-3495(01)76120-6
   Naduthambi D, 2006, J AM CHEM SOC, V128, P12430, DOI 10.1021/ja0648458
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   PANASIK N, 1994, INT J PEPT PROT RES, V44, P262
   PERISKOV AV, 2003, J AM CHEM SOC, V125, P1150
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Petukhov M, 2004, PROTEIN SCI, V13, P2120, DOI 10.1110/ps.04748404
   Raines RT, 2006, PROTEIN SCI, V15, P1219, DOI 10.1110/ps.062139406
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   SHOULDERS MD, 2008, BIOPOLYMERS, V89
   Werkmeister J. A., 1992, COLLAGEN BIOMATERIAL
   Zielenkiewicz A, 1998, J SOLUTION CHEM, V27, P235, DOI 10.1023/A:1022636218154
NR 32
TC 71
Z9 71
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 12
PY 2008
VL 130
IS 10
BP 2952
EP 2953
DI 10.1021/ja800225k
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 272IZ
UT WOS:000253854400035
PM 18271593
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Van De Keere, I
   Willaert, R
   Hubin, A
   Vereeckent, J
AF Van De Keere, Isabel
   Willaert, Ronnie
   Hubin, Annick
   Vereeckent, Jean
TI Interaction of human plasma fibrinogen with commercially pure titanium
   as studied with atomic force microscopy and X-ray photoelectron
   spectroscopy
SO LANGMUIR
LA English
DT Article
ID SCANNING PROBE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; SURFACE SCIENCE
   ASPECTS; PROTEIN ADSORPTION; CONFORMATIONAL-CHANGES; IONIC-STRENGTH;
   AQUEOUS CONDITIONS; PLATELET-ADHESION; POLYMER SURFACES; OXIDE SURFACES
AB The surface of a biomaterial interacts with the body fluid upon implantation in the human body. The biocompatibility of a material is strongly influenced by the adsorption of proteins onto the surface. Titanium is frequently used as a biomaterial for implants in orthopedics and cardiovascular devices. Understanding the biocompatibility is very important to improve implants. The surface chemistry of an implant material and its influence on the interaction with body fluid is crucial in that perspective. The main goal of this study was to investigate the conformation of human plasma fibrinogen (HPF) adsorbed on commercially pure titanium (CP Ti) on a molecular level by means of ex situ atomic force microscopy (AFM). With X-ray photoelectron spectroscopy combined with argon ion beam depth profiling it was shown that the oxide layer present at the surface was mainly composed of TiO(2), with a small percentage of Ti(2)O(3). Ex situ AFM imaging showed the conformation of HPF on CP Ti. Single molecules and aggregates of fibrinogen were observed. The trinodular structure of single HPF molecules (two spherical D domains at the distal ends of the extended molecule and the central spherical E domain) adsorbed onto CP Ti was visualized. Aggregate formation through the connection of the D domains of the HPF molecules was observed on CP Ti. The alpha C domains of HPF were not visible on CP Ti. The ex situ AFM images indicated conformational changes of HPF upon adsorption onto CP Ti. The conformation of the adsorbed HPF molecules was different on mica and titanium. The difference in wettability between both substrates caused a larger spread of the protein on the CP Ti surface and thus resulted in a larger perturbation to the native structure of HPF as compared to mica.
C1 [Van De Keere, Isabel; Hubin, Annick; Vereeckent, Jean] Vrije Univ Brussel VIB, Dept Met Electrochem & Mat Sci, B-1050 Brussels, Belgium.
   [Willaert, Ronnie] Vrije Univ Brussel VIB, Dept Ultrastruct, B-1050 Brussels, Belgium.
RP Van De Keere, I (reprint author), Vrije Univ Brussel VIB, Dept Met Electrochem & Mat Sci, Pleinlaan 2, B-1050 Brussels, Belgium.
EM ivdkeere@vub.ac.be
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Bearinger JP, 2001, SURF SCI, V491, P370, DOI 10.1016/S0039-6028(01)01300-0
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   Briggs D, 2003, SURFACE ANAL AUGER X
   BRUNETTE DM, 2001, TITANIMUM MED MAT SC
   BRUNETTE DM, 2001, TITANIUM MED MAT SCI, pCH7
   Busalmen JP, 2001, J IND MICROBIOL BIOT, V26, P303, DOI 10.1038/sj.jim.7000133
   Cacciafesta P, 2002, CHEM MATER, V14, P777, DOI 10.1021/cm0112183
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CARLEY AF, 1990, SURF SCI, V225, pL39, DOI 10.1016/0039-6028(90)90441-A
   Chen XY, 1996, ANAL CHEM, V68, P1451, DOI 10.1021/ac950844e
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   FENG L, 1995, ACS SYM SER, V602, pCH5
   Gettens RTT, 2007, J BIOMED MATER RES A, V81A, P465, DOI 10.1002/jbm.a.30995
   Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218
   GILBERT JL, 2003, MED DEVICE MAT, P139
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   HALBRITTER J, 1991, J ANAL CHEM+, V341, P320
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   HAN SP, 1999, EUROMAT 99
   HANSON SR, 1993, CARDIOVASC PATHOL, V2, pS157
   Hantgan RR, 1994, HEMOSTASIS THROMBOSI, P277
   Henrich V. E., 1994, SURFACE SCI METAL OX
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Horbett TA, 1995, ACS S SERIES, V602
   Ingo GM, 2004, SURF INTERFACE ANAL, V36, P1147, DOI 10.1002/sia.1862
   Jandt KD, 2000, COLLOID SURFACE B, V19, P301, DOI 10.1016/S0927-7765(00)00139-9
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   Jeyachandran YL, 2006, MAT SCI ENG A-STRUCT, V431, P277, DOI 10.1016/j.msea.2006.06.020
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1985, OSSEOINTEGRATION CLI, pCH4
   KESEMO B, 1999, ADV DENTAL RES, V13, P1
   LANGNER KD, 1990, BEHRING I MITT, V86, P146
   Lin Y, 2005, ULTRAMICROSCOPY, V105, P129, DOI 10.1016/j.ultramic.2005.06.028
   Lin Y, 2003, LANGMUIR, V19, P10000, DOI 10.1021/la0350251
   Lu FH, 2000, SURF COAT TECH, V130, P290, DOI 10.1016/S0257-8972(00)00710-6
   LU FH, 1999, THIN SOLID FILMS, V374, P355
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   Mackova A, 2004, SURF INTERFACE ANAL, V36, P1171, DOI 10.1002/sia.1868
   MAJERUS PW, 1990, PHARMACOL BASIS THER, P1131
   Man HC, 2002, APPL SURF SCI, V199, P293, DOI 10.1016/S0169-4332(02)00866-8
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   MAYER JT, 1995, J ELECTRON SPECTROSC, V73, P1, DOI 10.1016/0368-2048(94)02258-5
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   NIEUWENHUIZEN W, 2001, FIBRINOGEN, V936
   Notley SM, 2004, PHYS CHEM CHEM PHYS, V6, P2379, DOI 10.1039/b401376j
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   PARSEGIAN VA, 1983, J PROSTHET DENT, V49, P838, DOI 10.1016/0022-3913(83)90360-8
   Pearson W. B., 1967, HDB LATTICE SPACINGS, V2
   PRIETO P, 1995, J VAC SCI TECHNOL A, V13, P2819, DOI 10.1116/1.579711
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Radhakrishnan G, 2000, THIN SOLID FILMS, V358, P131, DOI 10.1016/S0040-6090(99)00681-1
   RASMUSSON JR, 1994, SCANNING MICROSCOPY, V8, P481
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rock G, 1997, CRIT REV CL LAB SCI, V34, P475, DOI 10.3109/10408369709006423
   SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465
   Sheller NB, 1998, LANGMUIR, V14, P4535, DOI 10.1021/la970916s
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   Taatjes DJ, 1997, CELL BIOL INT, V21, P715, DOI 10.1006/cbir.1997.0216
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tsapikouni TS, 2007, COLLOID SURFACE B, V57, P89, DOI 10.1016/j.colsurfb.2007.01.011
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   Verklich Y. J., 1993, J BIOL CHEM, V268, P13577
   Vesel A, 2006, APPL SURF SCI, V253, P2941, DOI 10.1016/j.apsusc.2006.06.033
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WEISEL JW, 1981, NATURE, V289, P263, DOI 10.1038/289263a0
   WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
NR 87
TC 23
Z9 24
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 4
PY 2008
VL 24
IS 5
BP 1844
EP 1852
DI 10.1021/1a7016566
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 266TP
UT WOS:000253460200046
PM 18193901
DA 2018-10-19
ER

PT J
AU Chen, BY
   Xu, FJ
   Fang, N
   Neoh, KG
   Kang, ET
   Chen, WN
   Chan, V
AF Chen, Beiyi
   Xu, F. J.
   Fang, Ning
   Neoh, K. G.
   Kang, E. T.
   Chen, Wei Ning
   Chan, Vincent
TI Engineering cell de-adhesion dynamics on thermoresponsive
   poly(N-isopropylacrylamide)
SO ACTA BIOMATERIALIA
LA English
DT Article
DE de-adhesion; kinetics; SMC; poly(N-isopropylacrylamide); collagen
ID SMOOTH-MUSCLE-CELLS; POLY N-ISOPROPYLACRYLAMIDE; EXTRACELLULAR-MATRIX;
   ACTIN CYTOSKELETON; CONTACT DYNAMICS; SURFACE; DETACHMENT; PLASMA;
   COPOLYMERS; HYDROGELS
AB Poly(N-isopropylacrylamide) (PIPAAm) has been demonstrated as an effective thermoresponsive polymer for non-invasive cell regeneration/recovery. However, little is known about the intricate relationship between the biophysical response of cells and physiochemical properties of PIPAAm during cell recovery. In this study, the de-adhesion kinetics of smooth muscle cell (SMC) on PIPAAm surfaces is probed with unique biophysical techniques. Water-immersion atomic force microscope (AFM) first showed that the nanotopology of PIPAAm surfaces is dependent on the polymerization time and collagen coating. It is found that the initial rate of cell de-adhesion increases with the increase in polymerization time. Moreover, the degree of cell deformation (a/R) and average adhesion energy are reduced with the increase of grafted PIPAAm density during 40 min of cell de-adhesion. It has been shown that collagen coating regulates cell adhesion on biomaterial surface. Interestingly, lower collagen density on PIPAAm leads to higher adhesion energy per cell during the initial 20 min compared with as-prepared PIPAAm, while the initial rate of cell de-adhesion remains unchanged. In contrast, higher collagen density leads to 50% reduction in the initial rate of cell de-adhesion and higher adhesion energy per cell during the entire 90 min. Furthermore, immunostaining of actin provides supporting evidence that the de-adhesion kinetics is correlated with the cytoskeleton transformation during cell de-adhesion below the lower solution critical temperature (LCST). (C) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xu, F. J.; Neoh, K. G.; Kang, E. T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
   [Chen, Beiyi; Fang, Ning; Chen, Wei Ning; Chan, Vincent] Nanyang Technol Univ, Ctr Biotechnol, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Xu, F. J.] Natl Univ Singapore, Div Bioengn, Singapore 119260, Singapore.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
EM chenkg@nus.edu.sg; mvchan@ntu.edu.sg
RI Xu, Fu-Jian/U-8024-2017; Chan, Vincent/G-6197-2010; Kang,
   En-Tang/G-8522-2012
OI Chan, Vincent/0000-0003-2149-4479; Kang, En-Tang/0000-0003-0599-7834;
   Neoh, Koon Gee/0000-0002-2700-1914
CR Alberts B, 1994, MOL BIOL CELL
   Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839
   Callewaert M, 2004, J COLLOID INTERF SCI, V276, P299, DOI 10.1016/j.jcis.2004.03.063
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Chee CK, 2001, POLYMER, V42, P5079, DOI 10.1016/S0032-3861(00)00821-1
   Chen BY, 2007, BIOMATERIALS, V28, P1503, DOI 10.1016/j.biomaterials.2006.11.027
   Chen CH, 2006, BIOMACROMOLECULES, V7, P736, DOI 10.1021/bm0506400
   Cheng XH, 2005, LANGMUIR, V21, P7833, DOI 10.1021/la050417o
   Crowther HM, 1998, COLLOID POLYM SCI, V276, P46, DOI 10.1007/s003960050207
   Curti PS, 2005, APPL SURF SCI, V245, P223, DOI 10.1016/j.apsusc.2004.10.019
   Feng Z, 2007, J BIOMED MATER RES A, V82A, P788, DOI 10.1002/jbm.a.31123
   Fultz ME, 2000, J MUSCLE RES CELL M, V21, P775, DOI 10.1023/A:1010396429297
   Gao CY, 2006, COLLOID SURFACE A, V272, P203, DOI 10.1016/j.colsurfa.2005.07.023
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Gurdak E, 2006, J COLLOID INTERF SCI, V302, P475, DOI 10.1016/j.jcis.2006.06.064
   Huang J, 2003, J APPL POLYM SCI, V89, P3180, DOI 10.1002/app.12562
   Kim YS, 2005, TISSUE ENG, V11, P30, DOI 10.1089/ten.2005.11.30
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lin Z, 2006, RADIAT PHYS CHEM, V75, P532, DOI 10.1016/j.radphyschem.2005.10.018
   Liu HC, 2003, J BIOMED MATER RES A, V67A, P1424, DOI 10.1002/jbm.a.20004
   Moran MT, 2007, J BIOMED MATER RES A, V81A, P870, DOI 10.1002/jbm.a.31089
   Morikawa N, 2002, J BIOMAT SCI-POLYM E, V13, P167, DOI 10.1163/156856202317414357
   Nagayama K, 2006, J BIOMECH, V39, P293, DOI 10.1016/j.jbiomech.2004.11.019
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Schmaljohann D, 2004, LANGMUIR, V20, P10107, DOI 10.1021/la034653f
   Shiroyanagi Y, 2004, BJU INT, V93, P1069, DOI 10.1111/j.1464-410X.2004.04783.x
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Wan KT, 2001, MED BIOL ENG COMPUT, V39, P605, DOI 10.1007/BF02345154
   Wei H, 2007, BIOMATERIALS, V28, P99, DOI 10.1016/j.biomaterials.2006.08.030
   Xu FJ, 2006, BIOMATERIALS, V27, P2787, DOI 10.1016/j.biomaterials.2006.01.003
   Xu FJ, 2006, BIOMATERIALS, V27, P1236, DOI 10.1016/j.materials.2005.09.012
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   YARMUSH ML, 1992, ANN NY ACAD SCI, V665, P238, DOI 10.1111/j.1749-6632.1992.tb42588.x
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhang DH, 2004, J MUSCLE RES CELL M, V25, P167, DOI 10.1023/B:JURE.0000035898.10847.a1
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu PW, 2000, PHYS REV E, V61, P6866, DOI 10.1103/PhysRevE.61.6866
NR 41
TC 19
Z9 20
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2008
VL 4
IS 2
BP 218
EP 229
DI 10.1016/j.actbio.2007.09.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275KB
UT WOS:000254069200002
PM 17964872
DA 2018-10-19
ER

PT J
AU Sunkara, BK
   Misra, RDK
AF Sunkara, B. K.
   Misra, R. D. K.
TI Enhanced antibactericidal function of W4+-doped titania-coated nickel
   ferrite composite nanoparticles: A biomaterial system
SO ACTA BIOMATERIALIA
LA English
DT Article
DE antimicrobial function; composite nanoparticles
ID REVERSE MICELLE TECHNIQUE; SEMICONDUCTOR PHOTOCATALYSIS; TIO2
   NANOPARTICLES; MAGNETIC CORE; DINITROGEN PHOTOREDUCTION; OXIDATION;
   WATER; DIOXIDE; POWDERS; SHELL
AB The study demonstrates a distinct enhancement of antimicrobial activity of W4+-doped titania that is coated on nickel ferrite nanoparticles in comparison to undoped titania. The composite nanoparticles were synthesized by uniquely combining reverse micelle and chemical hydrolysis synthesis methods [Rana S, Rawat J, Misra RDK, Acta Biomater 2005;1:691]. The superior antimicrobial activity of W4+-doped titania is related to the inhibition of electron-hole recombination and decrease in the band gap energy of titania. The function of the ferrite is to facilitate the removal of nanoparticles from the sprayed surface using a small magnetic field. The coating of ferrite nanoparticles with titania retains superparamagnetic character and magnetic strength of composite nanoparticles signifying non-deterioration of magnetic properties and promoting their use as removable antimicrobial photocatalyst nanoparticles. (C) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Misra, R. D. K.] Univ SW Louisiana, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
   Univ SW Louisiana, Dept Chem Engn, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ SW Louisiana, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
RI Dom, Rekha/B-7113-2012
CR Adachi M, 2003, J ELECTROCHEM SOC, V150, pG488, DOI 10.1149/1.1589763
   BORGARELLO E, 1982, J AM CHEM SOC, V104, P2996, DOI 10.1021/ja00375a010
   CHEN F, 1910, CHEMOSPHERE, V24, P1159
   CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038
   DO YR, 1994, J SOLID STATE CHEM, V108, P198, DOI 10.1006/jssc.1994.1031
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   GRATZEL M, 1990, J PHYS CHEM-US, V94, P2566
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   HARRIS GD, 1987, WATER RES, V21, P687, DOI 10.1016/0043-1354(87)90080-7
   Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   HUANG Z, 2000, J PHOTOCH PHOTOBIO A, V130, P163, DOI DOI 10.1016/S1010-6030(99)00205-1
   KELLER V, 2003, J CATAL, V215, P219
   Kwon YT, 2000, J CATAL, V191, P192
   Lachheb H, 2002, APPL CATAL B-ENVIRON, V39, P75, DOI 10.1016/S0926-3373(02)00078-4
   Li W, 2003, APPL PHYS LETT, V83, P4143, DOI 10.1063/1.1627962
   LUO ZH, 1992, J PHOTOCH PHOTOBIO A, V63, P367, DOI 10.1016/1010-6030(92)85202-6
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Marci G, 2003, ANN CHIM-ROME, V93, P639
   Martinez B, 1998, PHYS REV LETT, V80, P181, DOI 10.1103/PhysRevLett.80.181
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   MATSUNAGA T, 1995, ENVIRON SCI TECHNOL, V29, P501, DOI 10.1021/es00002a028
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   MILLS A, 1993, CHEM SOC REV, V22, P417, DOI 10.1039/cs9932200417
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   MU W, 1989, CATAL LETT, V3, P73, DOI 10.1007/BF00765057
   NAVIO JA, 1991, J PHOTOCH PHOTOBIO A, V55, P319, DOI 10.1016/1010-6030(91)87033-R
   Ollis D.F., 1993, PHOTOCATALYTIC PURIF
   PALMISANO L, 1988, J PHYS CHEM-US, V92, P6710, DOI 10.1021/j100334a044
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   RILEY DP, 1984, J AM CHEM SOC, V106, P3179, DOI 10.1021/ja00323a020
   Rincon AG, 2001, J PHOTOCH PHOTOBIO A, V139, P233, DOI 10.1016/S1010-6030(01)00374-4
   Shah SI, 2002, P NATL ACAD SCI USA, V99, P6482, DOI 10.1073/pnas.052518299
   SORIA J, 1991, J PHYS CHEM-US, V95, P274, DOI 10.1021/j100154a052
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Wang CY, 2003, J MATER CHEM, V13, P2322, DOI 10.1039/b303716a
   Wang YQ, 2000, J MOL CATAL A-CHEM, V151, P205, DOI 10.1016/S1381-1169(99)00245-9
   Yun CY, 2004, WATER SCI TECHNOL, V49, P177
NR 43
TC 109
Z9 110
U1 5
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2008
VL 4
IS 2
BP 273
EP 283
DI 10.1016/j.actbio.2007.07.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275KB
UT WOS:000254069200007
PM 17720641
DA 2018-10-19
ER

PT J
AU Gutierres, M
   Lopes, MA
   Hussain, NS
   Lemos, AF
   Ferreira, JMF
   Afonso, A
   Cabral, AT
   Almeida, L
   Santos, JD
AF Gutierres, M.
   Lopes, M. A.
   Hussain, N. Sooraj
   Lemos, A. F.
   Ferreira, J. M. F.
   Afonso, A.
   Cabral, A. T.
   Almeida, L.
   Santos, J. D.
TI Bone ingrowth in macroporous Bonelike (R) for orthopaedic applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bonelike (R); porous materials; bone graft; orthopaedic
ID GLASS-REINFORCED-HYDROXYAPATITE; PROXIMAL TIBIAL OSTEOTOMY; POROUS
   HYDROXYAPATITE; CORALLINE HYDROXYAPATITE; STARCH CONSOLIDATION; GRAFT
   SUBSTITUTES; CALCIUM-PHOSPHATE; CANCELLOUS BONE; LONG-TERM; COMPOSITES
AB The aim of this study was to evaluate the biological behaviour of porous scaffold structures of Bonelike(R) which is suitable for either direct clinical use or tissue engineering applications. Porous cylindrical specimens 8 x 10 mm were implanted in the lateral aspect of the tibia of 13 patients (mean age 54 years), during osteotomy surgery for the treatment of medial compartment osteoarthritis of the knee. Implanted cylinders were retrieved at the same time as the removal of the blade plates at 3, 6, 9 and 12 months. Scanning electron microscopy and histological evaluations were performed to observe the biological responses of human bone tissue to porous Bonelike(R). The penetration depth was determined for all implantation periods, and after 6 months it was already possible to see new bone in the centre of the implanted cylinders, which gives 100% of penetration depth for all implantations periods except for 3 months when bone could only be seen in the peripherical region. Regarding the percentage of the area covered by new bone calculated from two-dimensional histological sections, values of 53 +/- 15, 76 +/- 12 and 88 +/- 9% were achieved for 6, 9 and 12 months, respectively. Due to its structural features porous Bonelikee permitted effective vascularization and bone ingrowth, and therefore was fully osteointegrated as shown in the histological surveys. A slow biomaterial degradation with implantation time is envisaged since the material has displayed surface degradation. Bonelike(R) scaffolds show potential for complete ingrowth of osseous tissue and restoration of vascularization throughout the defected site. (C) 2007 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Lopes, M. A.; Hussain, N. Sooraj; Santos, J. D.] Univ Porto, Fac Engn, FEUP, P-4200465 Oporto, Portugal.
   [Gutierres, M.; Cabral, A. T.; Almeida, L.] Univ Porto, Hosp Sao Joao, Fac Med, FMUP, P-4200 Oporto, Portugal.
   [Lopes, M. A.; Hussain, N. Sooraj; Santos, J. D.] Inst Biomed Engn INEB, Lab Biomat, P-4150180 Oporto, Portugal.
   [Lemos, A. F.; Ferreira, J. M. F.] Univ Aveiro, UIMC, Dep De Eng Ceramica Vidro, P-3800 Aveiro, Portugal.
   [Afonso, A.] Univ Porto, Fac Med Dent, FMDUP, P-4200393 Oporto, Portugal.
RP Santos, JD (reprint author), Univ Porto, Fac Engn, FEUP, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.
EM jdsantos@fe.up.pt
RI Lopes, Maria A./P-4442-2014; Lopes, Cristina/A-4241-2010
OI Lopes, Maria A./0000-0003-4105-8148; Gutierres,
   Manuel/0000-0003-0491-1736; Santos, Jose Domingos/0000-0002-6871-9850;
   Afonso, Americo/0000-0001-7579-1407; Lemos,
   Alexandra/0000-0002-0065-7606; Ferreira, Jose/0000-0002-7520-2809;
   Nandyala, Sooraj/0000-0002-2736-5224
CR Akamatsu Y, 1997, CLIN ORTHOP RELAT R, P207
   Ayers RA, 1999, J BIOMED MATER RES, V47, P54, DOI 10.1002/(SICI)1097-4636(199910)47:1<54::AID-JBM7>3.3.CO;2-G
   BENISSAN B, 2003, CURR OPIN SOLID ST M, V7, P283
   COVENTRY MB, 1993, J BONE JOINT SURG AM, V75A, P196, DOI 10.2106/00004623-199302000-00006
   COVENTRY MB, 1985, J BONE JOINT SURG AM, V67A, P1136, DOI 10.2106/00004623-198567070-00025
   COVENTRY MB, 1979, ORTHOP CLIN N AM, V10, P191
   COVENTRY MB, 1965, J BONE JOINT SURG AM, VA 47, P984, DOI 10.2106/00004623-196547050-00008
   da Silva MHP, 2002, KEY ENG MAT, V230-2, P483
   da Silva MHP, 2002, J NON-CRYST SOLIDS, V304, P286, DOI 10.1016/S0022-3093(02)01036-0
   Duarte F, 2004, MATER SCI FORUM, V455-456, P370, DOI 10.4028/www.scientific.net/MSF.455-456.370
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   Ferraz MP, 2001, J MATER SCI-MATER M, V12, P629, DOI 10.1023/A:1011245828046
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GUTIERRES M, 2005, KEY ENG MATER, V17, P1041
   HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332
   Hernigou P, 2001, KNEE, V8, P103, DOI 10.1016/S0968-0160(00)00061-2
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   Hui PW, 1996, J BIOMECH, V29, P123, DOI 10.1016/0021-9290(95)00010-0
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Komlev VS, 2002, BIOMATERIALS, V23, P3449, DOI 10.1016/S0142-9612(02)00049-2
   Koshino T, 2003, J BONE JOINT SURG AM, V85A, P78, DOI 10.2106/00004623-200301000-00013
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Lemos AF, 2004, MATER SCI FORUM, V455-456, P361, DOI 10.4028/www.scientific.net/MSF.455-456.361
   Lemos AF, 2004, KEY ENG MAT, V254-2, P1041, DOI 10.4028/www.scientific.net/KEM.254-256.1041
   Lemos AF, 2004, KEY ENG MAT, V254-2, P1033, DOI 10.4028/www.scientific.net/KEM.254-256.1033
   Lemos AF, 2000, MAT SCI ENG C-BIO S, V11, P35, DOI 10.1016/S0928-4931(00)00134-X
   Lobato JV, 2006, THIN SOLID FILMS, V515, P279, DOI 10.1016/j.tsf.2005.12.151
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1905, DOI 10.1016/S0142-9612(00)00068-5
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Lopes MA, 1999, J BIOMED MATER RES, V48, P734, DOI 10.1002/(SICI)1097-4636(1999)48:5<734::AID-JBM20>3.0.CO;2-2
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   LU JX, 1999, MAT MED, V10, P111
   Milosevski M, 1999, CERAM INT, V25, P693, DOI 10.1016/S0272-8842(99)00003-6
   Peng HX, 2000, J EUR CERAM SOC, V20, P807, DOI 10.1016/S0955-2219(99)00229-0
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   RUBIN PAD, 1994, OPHTHALMIC PLAST REC, V10, P96, DOI 10.1097/00002341-199406000-00005
   SANTOS JD, 1999, Patent No. 1189851
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Shors C, 1993, INTRO BIOCERAMICS, P181
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
NR 50
TC 24
Z9 27
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2008
VL 4
IS 2
BP 370
EP 377
DI 10.1016/j.actbio.2007.06.009
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275KB
UT WOS:000254069200017
PM 17716960
DA 2018-10-19
ER

PT J
AU Thibeault, SL
   Duflo, S
AF Thibeault, Susan L.
   Duflo, Suzy
TI Inflammatory cytokine responses to synthetic extracellular matrix
   injection to the vocal fold lamina propria
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE biomaterial; inflammation; tissue engineering; vocal fold
ID HYALURONIC-ACID; IN-VIVO; PHYSIOLOGY; REPAIR
AB Objectives: We determined cytokine profiles for tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6, IL-1 alpha, and IL-1 beta after injection of a synthetic extracellular matrix into the vocal fold lamina propria.
   Methods: Transcript expression of inflammatory cytokines was measured with real-time polymerase chain reaction on postoperative days 1, 3, 5, 10, and 21 in 25 rabbits that underwent bilateral vocal fold biopsy with Extracel-LG (Carbylan-GSX 5%) immediately injected into the wound in the left vocal fold and saline solution injected into the wound in the right vocal fold. Two unwounded normal rabbit larynges were also harvested for controls.
   Results: Significantly elevated levels of TNF-alpha, IL-1 beta, and IL-6 were measured on day 3 in a comparison between Extracel-LG-injected vocal folds and saline solution-injected control vocal folds and between Extracel-LG-injected vocal folds and normal vocal folds. All cytokine levels returned to baseline by day 21.
   Conclusions: A mild short-term inflammatory response was measured early after injection of a synthetic extracellular matrix into the vocal fold lamina propria.
C1 [Thibeault, Susan L.] Univ Wisconsin, Sch Med Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53792 USA.
   [Duflo, Suzy] Hop Enfants La Timone, Fed Otorhinolaryngol Head & Neck Surg, Marseille, France.
RP Thibeault, SL (reprint author), Univ Wisconsin, Sch Med Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, K4-709,600 Highland Ave, Madison, WI 53792 USA.
FU NIDCD NIH HHS [R01 DC4336]
CR Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105
   Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   HUNT TK, 1988, ANN EMERG MED, V17, P1265, DOI 10.1016/S0196-0644(88)80351-2
   Lawrence WT, 1998, CLIN PLAST SURG, V25, P321
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Liu YC, 2004, J BIOMED MATER RES A, V68A, P142, DOI 10.1002/jbm.a.10142
   Prestwich GD, 2006, ADV EXP MED BIOL, V585, P125
   SHU XZ, 2006, BIOMED MAT RES A, V79, P902
   Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7
NR 12
TC 26
Z9 26
U1 0
U2 6
PU ANNALS PUBL CO
PI ST LOUIS
PA 4507 LACLEDE AVE, ST LOUIS, MO 63108 USA
SN 0003-4894
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD MAR
PY 2008
VL 117
IS 3
BP 221
EP 226
DI 10.1177/000348940811700310
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 275XE
UT WOS:000254104700010
PM 18444483
DA 2018-10-19
ER

PT J
AU Guicheteau, J
   Argue, L
   Emge, D
   Hyre, A
   Jacobson, M
   Christesen, S
AF Guicheteau, J.
   Argue, L.
   Emge, D.
   Hyre, A.
   Jacobson, M.
   Christesen, S.
TI Bacillus spore classification via surface-enhanced Raman spectroscopy
   and principal component analysis
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE surface-enhanced Raman spectroscopy; SERS; Bacillus anthracis; bacteria;
   principal component analysis; PCA
ID SINGLE BACTERIAL-CELLS; SILVER ELECTRODE; CHEMICAL-COMPOSITION; SPECTRA;
   SCATTERING; DISCRIMINATION; IDENTIFICATION; PYRIDINE
AB Surface-enhanced Raman spectroscopy (SERS) can provide rapid fingerprinting of biomaterial in a nondestructive manner. The adsorption of colloidal silver to biological material suppresses native biofluorescence while providing electromagnetic surface enhancement of the normal Raman signal. This work validates the applicability of qualitative SER spectroscopy for analysis of bacterial species by utilizing principal component analysis (PCA) to show discrimination of biological threat simulants, based upon multivariate statistical confidence limits bounding known data clusters. Gram-positive Bacillus spores (Bacillus atrophaeus, Bacillus anthracis, and Bacillus thuringiensis) are investigated along with the Gram-negative bacterium Pantoea agglomerans.
C1 [Guicheteau, J.; Argue, L.; Emge, D.; Hyre, A.; Jacobson, M.; Christesen, S.] USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD 21010 USA.
RP Guicheteau, J (reprint author), USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD 21010 USA.
EM guiclietcau@us.army.mil
CR ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071
   COTTON TM, 1980, J AM CHEM SOC, V102, P7960, DOI 10.1021/ja00547a036
   Driks A, 2003, P NATL ACAD SCI USA, V100, P3007, DOI 10.1073/pnas.0730807100
   FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1
   GALLAGHER NC, 1981, IEEE T ACOUST SPEECH, V29, P1136, DOI 10.1109/TASSP.1981.1163708
   Goeller LJ, 2007, APPL SPECTROSC, V61, P679, DOI 10.1366/000370207781393217
   Gonster KR, 2004, P SOC PHOTO-OPT INS, V5585, P136, DOI 10.1117/12.577591
   Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127
   Huang WE, 2004, ANAL CHEM, V76, P4452, DOI 10.1021/ac049753k
   Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c
   JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6
   Kahraman M, 2007, APPL SPECTROSC, V61, P479, DOI 10.1366/000370207780807731
   Laucks ML, 2005, APPL SPECTROSC, V59, P1222, DOI 10.1366/000370205774430891
   LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   MARTINEZ WL, 2001, COMPUTATIONAL STAT H
   MATZ LL, 1970, J BACTERIOL, V101, P196
   McCreery R. L., 2000, RAMAN SPECTROSCOPY C
   Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157
   Pearman WF, 2006, APPL SPECTROSC, V60, P356, DOI 10.1366/000370206776593744
   Peters CJ, 2002, LANCET, V359, P710, DOI 10.1016/S0140-6736(02)07792-9
   Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n
   PRIEBE CE, 1994, J AM STAT ASSOC, V89, P796
   ROGER MJ, 2006, FARADAY DISCUSS, V132, P281
   Schuster KC, 2000, ANAL CHEM, V72, P5529, DOI 10.1021/ac000718x
   SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014
   SOLKA JL, 1995, J COMPUTATIONAL GRAP, V4, P180
   Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389
   Xie C, 2005, ANAL CHEM, V77, P4390, DOI 10.1021/ac0504971
   Zeiri L, 2004, APPL SPECTROSC, V58, P33, DOI 10.1366/000370204322729441
NR 30
TC 57
Z9 57
U1 1
U2 42
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA 201B BROADWAY ST, FREDERICK, MD 21701 USA
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD MAR
PY 2008
VL 62
IS 3
BP 267
EP 272
DI 10.1366/000370208783759623
PG 6
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA 272XT
UT WOS:000253895700002
PM 18339232
DA 2018-10-19
ER

PT J
AU Kim, GH
   Min, T
   Park, SA
   Kim, WD
AF Kim, Geun Hyung
   Min, Taijin
   Park, Su A.
   Kim, Wan Doo
TI Coaxially electrospun micro/nanofibrous
   poly(epsilon-caprolactone)/eggshell-protein scaffold
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article
ID EGGSHELL MEMBRANE-PROTEIN; SURFACE; MATRIX
AB Eggshell membrane (ESM) has potential as a natural scaffold because of its highly porous structure and good biocompatibility. To mimic its structure and surface properties, soluble eggshell membrane protein (SEP) was extracted from ESM and electrospun with a biodegradable polymer, poly(epsilon-caprolactone) (PCL). SEP/PCL micro/nanofibers were fabricated using a coaxial electrospinning process with a dual nozzle and an auxiliary cylindrical electrode. The fiber web was characterized using the water contact angle, pore-size distribution, mechanical properties and cellular behavior. The SEP/PCL web, which demonstrated the feasibility of producing a scaffold with adequate hydrophilicity, suitable pore size and good mechanical properties compared to a pure PCL micro/nanofiber web, exhibits the ability to mimic a natural biomaterial.
C1 [Kim, Geun Hyung; Min, Taijin; Park, Su A.; Kim, Wan Doo] Korea Inst Machinery & Mat, Div Nanomachinery, Nat Inspired Biomech Team, Taejon 305343, South Korea.
RP Kim, GH (reprint author), Korea Inst Machinery & Mat, Div Nanomachinery, Nat Inspired Biomech Team, 171 Jang Dong, Taejon 305343, South Korea.
EM gkim@kimm.re.kr
CR Bar-Cohen Y, 2003, P SOC PHOTO-OPT INS, V5051, P14, DOI 10.1117/12.484379
   Benyus J. M., 1997, INNOVATION INSPIRED
   Bergshoef MM, 1999, ADV MATER, V11, P1362, DOI 10.1002/(SICI)1521-4095(199911)11:16<1362::AID-ADMA1362>3.0.CO;2-X
   BUCKLEY CT, 2004, TOPICS BIOMECHANICAL, P147
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Dersch R, 2005, POLYM ADVAN TECHNOL, V16, P276, DOI 10.1002/pat.568
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   Kim G, 2007, J BIOMED MATER RES B, V81B, P104, DOI 10.1002/jbm.b.30642
   Kitimasak Wachira, 2003, ScienceAsia, V29, P95, DOI 10.2306/scienceasia1513-1874.2003.29.095
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Yi F, 2006, J APPL POLYM SCI, V99, P1340, DOI 10.1002/app.22222
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Yi F, 2003, MACROMOL BIOSCI, V3, P234, DOI 10.1002/mabi.200390030
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 22
TC 18
Z9 21
U1 2
U2 33
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD MAR
PY 2008
VL 3
IS 1
AR 016006
DI 10.1088/1748-3182/3/1/016006
PG 8
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 310FO
UT WOS:000256514500008
PM 18364565
DA 2018-10-19
ER

PT J
AU Tsapikouni, TS
   Allen, S
   Missirlis, YF
AF Tsapikouni, Theodora S.
   Allen, Stephanie
   Missirlis, Yannis F.
TI Measurement of interaction forces between fibrinogen coated probes and
   mica surface with the atomic force microscope: The pH and ionic strength
   effect
SO BIOINTERPHASES
LA English
DT Article
ID PROTEIN ADSORPTION; MOLECULAR-INTERACTIONS; MEMBRANE SURFACES; MUSCOVITE
   MICA; DOUBLE-LAYER; ADHESION; RECOGNITION; SILICA; BIOMOLECULES;
   BIOMATERIAL
AB The study of protein-surface interactions is of great significance in the design of biomaterials and the evaluation of molecular processes in tissue engineering. The authors have used atomic force microscopy (AFM) to directly measure the force of attraction/adhesion of fibrinogen coated tips to mica surfaces and reveal the effect of the surrounding solution pH and ionic strength on this interaction. Silica colloid spheres were attached to the AFM cantilevers and, after plasma deposition of poly (acrylic acid), fibrinogen molecules were covalently bound on them with the help of the cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) in the presence of N-hydroxysulfosuccinimide (sulfo-NHS). The measurements suggest that fibrinogen adsorption is controlled by the screening of electrostatic repulsion as the salt concentration increases from 15 to 150 mM, whereas at higher ionic strength (500 mM) the hydration forces and the compact molecular conformation become crucial, restricting adsorption. The protein attraction to the surface increases at the isoelectric point of fibrinogen (pH 5.8), compared with the physiological pH. At pH 3.5, apart from fibrinogen attraction to the surface, evidence of fibrinogen conformational changes is observed, as the pH and the ionic strength are set back and forth, and these changes may account for fibrinogen aggregation in the protein solution at this pH. (c) 2008 American Vacuum Society.
C1 [Tsapikouni, Theodora S.; Missirlis, Yannis F.] Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26504, Greece.
   [Allen, Stephanie] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RP Missirlis, YF (reprint author), Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26504, Greece.
EM misirlis@mech.upatras.gr
OI Tsapikouni, Theodora/0000-0001-7964-6610; Allen,
   Stephanie/0000-0001-5384-2998
CR Alexander MR, 2004, J MATER CHEM, V14, P408, DOI 10.1039/b311256j
   Bajpai AK, 2005, POLYM INT, V54, P304, DOI 10.1002/pi.1673
   BHUSHAN B, 2004, HDB NANOTECHNOLOGY, pCH15
   Candan S, 1998, J VAC SCI TECHNOL A, V16, P1702, DOI 10.1116/1.581288
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   Czajkowsky DM, 2003, J MICROSC-OXFORD, V211, P1, DOI 10.1046/j.1365-2818.2003.01208.x
   DOOLITTLE RF, 1992, PROTEIN SCI, V1, P1563, DOI 10.1002/pro.5560011204
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Frank BP, 2003, J MEMBRANE SCI, V212, P205, DOI 10.1016/S0376-7388(02)00502-1
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Gibson CT, 2004, REV SCI INSTRUM, V75, P565, DOI 10.1063/1.1642750
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Heinz WF, 1999, BIOPHYS J, V76, P528, DOI 10.1016/S0006-3495(99)77221-8
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIU, pCH3
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Hunter R. J., 1987, FDN COLLOID SCI
   Hurley CR, 2006, LANGMUIR, V22, P4179, DOI 10.1021/la053176t
   ISRAELACHIVILI JN, 1992, INTERMOLECULAR SURFA, pCH4
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kidoaki S, 2001, LANGMUIR, V17, P1080, DOI 10.1021/la000003p
   KOUTSOUKOS PG, 1982, COLLOID SURFACE, V5, P93, DOI 10.1016/0166-6622(82)80065-6
   Leckband D, 1999, COLLOID SURFACE B, V14, P83, DOI 10.1016/S0927-7765(99)00027-2
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   Matsumoto H, 2003, J COLLOID INTERF SCI, V264, P82, DOI 10.1016/S0021-9797(03)00417-X
   MCCORMACK D, 1995, J COLLOID INTERF SCI, V169, P177, DOI 10.1006/jcis.1995.1019
   McGurk SL, 1999, LANGMUIR, V15, P5136, DOI 10.1021/la981788q
   Meagher L, 2002, COLLOID SURFACE B, V23, P125, DOI 10.1016/S0927-7765(01)00234-X
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   Osman MA, 1999, J COLLOID INTERF SCI, V209, P232, DOI 10.1006/jcis.1998.5878
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   PASHLEY RM, 1981, J COLLOID INTERF SCI, V83, P531, DOI 10.1016/0021-9797(81)90348-9
   Roiter Y, 2006, POLYMER, V47, P2493, DOI 10.1016/j.polymer.2005.11.096
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   Su TJ, 1998, J COLLOID INTERF SCI, V203, P419, DOI 10.1006/jcis.1998.5545
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Tsapikouni TS, 2007, COLLOID SURFACE B, V57, P89, DOI 10.1016/j.colsurfb.2007.01.011
   Valle-Delgado JJ, 2004, J PHYS-CONDENS MAT, V16, pS2383, DOI 10.1088/0953-8984/16/26/011
   Valle-Delgado JJ, 2004, J PHYS CHEM B, V108, P5365, DOI 10.1021/jp0374197
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Verklich Y. J., 1993, J BIOL CHEM, V268, P13577
   Verma A, 2004, LANGMUIR, V20, P4178, DOI 10.1021/la036183v
   Wagner P, 1998, FEBS LETT, V430, P112, DOI 10.1016/S0014-5793(98)00614-0
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Willemsen OH, 1999, BIOPHYS J, V76, P716, DOI 10.1016/S0006-3495(99)77238-3
   Zhang HL, 2005, J BIOMED MATER RES A, V74A, P59, DOI 10.1002/jbm.a.30364
NR 51
TC 17
Z9 18
U1 1
U2 28
PU AVS
PI RESEARCH TRIANGLE PARK
PA EDITORIAL OFFICE, 100 PARK DR, STE 105, CALLER BOX 13994, RESEARCH
   TRIANGLE PARK, NC 27709 USA
SN 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD MAR
PY 2008
VL 3
IS 1
BP 1
EP 8
DI 10.1116/1.2840052
PG 8
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 306RZ
UT WOS:000256266800001
PM 20408656
OA Bronze
DA 2018-10-19
ER

PT J
AU Yunoki, S
   Matsuda, T
AF Yunoki, Shunji
   Matsuda, Takehisa
TI Simultaneous processing of fibril formation and cross-linking improves
   mechanical properties of collagen
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOMATERIAL; INVITRO
AB In vitro "simultaneous processing" was investigated in which fibril formation of collagen and cross-linking occur simultaneously in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) as a cross-linking reagent. Fibril formation in simultaneous processing was monitored using turbidity. The EDC in simultaneous processing increased T-1/2 (time required for half of the plateau value in turbidity) and decreased the degree of the fibril formation dose dependently. The reduced fibril formation rate (T-1/2 > 60 s) suggests the introduction of intrafibrillar cross-linking during fibril formation. The collagen gels prepared using simultaneous processing had a compressive modulus that was 6-fold higher than that using sequential processing, which is an advantage of simultaneous processing. Atomic force microscopy images acquired under water on the wet gels demonstrated that the simultaneous processing provided a unique double-network structure: intrafibrillarly cross-linked collagen fibrils among which nonfibrous collagens act as interfibrillar cross-linkages.
C1 [Yunoki, Shunji; Matsuda, Takehisa] Kanazawa Inst Technol, Genome Biotechnol Lab, Hakusan City, Ishikawa 9240838, Japan.
RP Yunoki, S (reprint author), Kanazawa Inst Technol, Genome Biotechnol Lab, Yatsukaho 3-1, Hakusan City, Ishikawa 9240838, Japan.
EM yunoki@neptune.kanazawa-it.ac.jp
CR Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   NIMNI ME, 1988, COLLAGEN
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wikesjo UME, 2004, CLIN ORAL IMPLAN RES, V15, P194, DOI 10.1111/j.1600-0501.2004.00971.x
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P1369, DOI 10.1007/s10856-007-0121-6
NR 16
TC 22
Z9 22
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2008
VL 9
IS 3
BP 879
EP 885
DI 10.1021/bm7012058
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 273JO
UT WOS:000253926400017
PM 18260634
DA 2018-10-19
ER

PT J
AU Onishi, E
   Fujibayashi, S
   Takemoto, M
   Neo, M
   Maruyama, T
   Kokubo, T
   Nakamura, T
AF Onishi, Eijiro
   Fujibayashi, Shunsuke
   Takemoto, Mitsuru
   Neo, Masashi
   Maruyama, Takayuki
   Kokubo, Tadashi
   Nakamura, Takashi
TI Enhancement of bone-bonding ability of bioactive titanium by
   prostaglandin E2 receptor selective agonist
SO BIOMATERIALS
LA English
DT Article
DE prostaglandin; titanium; biomaterial; animal experiment
ID BETA-TRICALCIUM PHOSPHATE; MORPHOGENETIC PROTEIN-2; PROSTANOID
   RECEPTORS; SODIUM REMOVAL; FEMORAL STEMS; KNOCKOUT MICE; EP4;
   HYDROXYAPATITE; E-2; RATS
AB Systemic administration of prostaglandin E2 receptor (EP4) selective agonist increases both bone formation and resorption, and consequently leads to an increase in bone mass. Although previous Studies have reported that EP4 agonist enhanced bone remodeling and fracture healing, it was not known if EP4 agonist activates the bone-biomaterial interface. Bioactive titanium prepared by chemical and thermal treatment can bond to living bone and is suitable for use in clinical applications in cementless fixation devices. Therefore, we examined whether the administration of EP4 agonist enhances the bonding strength between bone and bioactive titanium. Bioactive titanium plates were inserted into the tibia bone of rabbits and examined histologically and biomechanically at 4, 8, and 16 weeks. EP4 agonist was administrated systernically every 2 weeks after surgery. A non-administrated control group, a low-dose group (10 mu g/kg body weight (BW)), and a high-dose group (100 mu g/kg BW) were compared. The bonding strength of bioactive titanium in the EP4 agonist groups was significantly higher than that in the control group at both 4 and 8 weeks, and enhanced bone remodeling and direct bonding around the bioactive titanium plates was observed only in the EP4 agonist groups at 4 weeks. EP4 agonist enhanced bone formation around the bioactive titanium plate, and achieved early direct bone bonding. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Onishi, Eijiro; Fujibayashi, Shunsuke; Takemoto, Mitsuru; Neo, Masashi; Nakamura, Takashi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   [Maruyama, Takayuki] Ono Pharmaceut Co, Minase Res Inst, Shimamoto, Osaka 6188585, Japan.
   [Kokubo, Tadashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan.
RP Nakamura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.
EM nta.ka@kuhp.kyoto-u.ac.jp
OI Neo, Masashi/0000-0001-9208-6419
CR BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Collier J P, 1993, J Arthroplasty, V8, P389, DOI 10.1016/S0883-5403(06)80037-9
   D'Antonio JA, 2001, CLIN ORTHOP RELAT R, P101
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   GOTO J, 1986, DRUG EXP CLIN RES, V12, P917
   Hagino H, 2005, BONE, V36, P444, DOI 10.1016/j.bone.2004/12.013
   Hayashi K, 2005, J BONE JOINT SURG BR, V87B, P1150, DOI 10.1302/0301-620X.87B8.15886
   HENCH LL, 1993, INTRO BIOCERAMICS
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   Li M, 2005, BONE, V37, P46, DOI 10.1016/j.bone.2005.03.016
   Machwate M, 2001, MOL PHARMACOL, V60, P36
   Marui A, 2006, J THORAC CARDIOV SUR, V131, P587, DOI 10.1016/j.jtcvs.2005.10.026
   Masuzawa M, 2005, J ORTHOP SCI, V10, P308, DOI 10.1007/s00776-005-0890-z
   Miyaura C, 2000, J BIOL CHEM, V275, P19819, DOI 10.1074/jbc.M002079200
   NAKAMURA T, 2000, TENSILE TESTING BONE
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Narumiya S, 1999, PHYSIOL REV, V79, P1193
   Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9
   Overgaard S, 1997, J BONE JOINT SURG BR, V79B, P654, DOI 10.1302/0301-620X.79B4.7670
   Sasaoka R, 2004, BIOCHEM BIOPH RES CO, V318, P704, DOI 10.1016/j.bbrc.2004.04.080
   Shamir D, 2004, BONE, V34, P157, DOI 10.1016/j.bone.2003.09.008
   Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963
   Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Tanaka M, 2004, BONE, V34, P940, DOI 10.1016/j.bone.2004.01.002
   Weinreb M, 2001, BONE, V28, P275, DOI 10.1016/S8756-3282(00)00447-6
   Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399
NR 27
TC 8
Z9 8
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2008
VL 29
IS 7
BP 877
EP 883
DI 10.1016/j.biomaterials.2007.10.028
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260MK
UT WOS:000253014200011
PM 18045684
DA 2018-10-19
ER

PT J
AU Wang, X
   Zhang, X
   Castellot, J
   Herman, I
   Iafrati, M
   Kaplan, DL
AF Wang, Xianyan
   Zhang, Xiaohui
   Castellot, John
   Herman, Ira
   Iafrati, Mark
   Kaplan, David L.
TI Controlled release from multilayer silk biomaterial coatings to modulate
   vascular cell responses
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; stent; heparin; paclitaxel; clopidogrel
ID CORONARY-ARTERY-DISEASE; DRUG-ELUTING STENTS; BALLOON ANGIOPLASTY;
   COATED STENTS; FIBROIN; RESTENOSIS; HEPARIN; IMPLANTATION; SCAFFOLDS;
   INTERVENTION
AB A multilayered silk fibroin protein coating system was employed as a drug carrier and delivery system to evaluate vascular cell responses to heparin, paclitaxel, and clopidogrel. The results demonstrated that the silk coating system was an effective system for drug-eluting coatings. such as for stent applications, based on its useful micromechanical properties and biological outcomes. Cell attachment and viability studies with human aortic endothelial cells (HAECs) and human coronary artery smooth muscle cells (HCASMCs) on the drug-incorporated silk coatings demonstrated that paclitaxel and clopidogrel inhibited smooth muscle cell (SMC) proliferation and retarded endothelial cell proliferation. Heparin-loaded silk multilayers promoted HAEC proliferation while inhibiting HCASMC proliferation, desired outcomes for the prevention of restenosis. The preservation of the phenotype of endothelial cells on silk and heparin-loaded silk coatings was confirmed with the presence of endothelial markers CD-31, CD-146, vWF and VE-Cadherin using immunocytochemistry assays. A preliminary in-vivo study in a porcine aorta showed integrity of the silk coatings after implantation and the reduction of platelet adhesion on the heparin-loaded silk coatings. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Wang, Xianyan; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Castellot, John; Herman, Ira; Kaplan, David L.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.
   [Iafrati, Mark] Tufts Univ, Dept Med, Boston, MA 02111 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NHLBI NIH HHS [HL049973, R01 HL049973]; NIBIB NIH HHS [R01 EB003210-04,
   EB003210, EB002520, P41 EB002520-03, R01 EB003210, P41 EB002520]
CR Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3
   Babapulle MN, 2002, CIRCULATION, V106, P2734, DOI 10.1161/01.CIR.0000038982.49640.70
   Bauters C, 1996, EUR HEART J, V17, P1671
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Chen MC, 2005, J CONTROL RELEASE, V108, P178, DOI 10.1016/j.jconrel.2005.07.022
   Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1
   Fischell TA, 1996, CIRCULATION, V94, P1494, DOI 10.1161/01.CIR.94.7.1494
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gieck K., 1997, ENG FORMULAS
   Hardhammar PA, 1996, CIRCULATION, V93, P423, DOI 10.1161/01.CIR.93.3.423
   Hermann A, 2002, THROMB RES, V105, P173, DOI 10.1016/S0049-3848(01)00403-0
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Houerou V. L., 2003, J NONCRYST SOLIDS, V316, P54
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   JONES F, 2004, MACH HDB
   KIM DW, 2000, KOREAN J CARDIOVASC, V1, P119
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KLEINSOYER C, 1994, J CELL PHYSIOL, V160, P316, DOI 10.1002/jcp.1041600213
   KUNTZ RE, 1993, J AM COLL CARDIOL, V21, P15, DOI 10.1016/0735-1097(93)90712-A
   LAKE AC, 2003, CELL COMMUN SIGNAL, V1, DOI DOI 10.1186/1478-811X-1-5
   Lev EI, 2004, AM J CARDIOL, V93, P741, DOI 10.1016/j.amjcard.2003.11.067
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ong ATL, 2005, NAT CLIN PRACT CARD, V2, P647, DOI 10.1038/ncpardio0378
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Tartivel R, 2007, J NON-CRYST SOLIDS, V353, P108, DOI 10.1016/j.jnoncrysol.2006.10.009
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B
NR 36
TC 79
Z9 86
U1 9
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2008
VL 29
IS 7
BP 894
EP 903
DI 10.1016/j.biomaterials.2007.10.055
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260MK
UT WOS:000253014200013
PM 18048096
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Spencer, NJ
   Cotanche, DA
   Klapperich, CM
AF Spencer, Nathaniel J.
   Cotanche, Douglas A.
   Klapperich, Catherine M.
TI Peptide- and collagen-based hydrogel substrates for in vitro culture of
   chick cochleae
SO BIOMATERIALS
LA English
DT Article
DE biomimetic material; hydrogel; organ culture; cell morphology;
   epithelium
ID HAIR-CELL REGENERATION; INNER-EAR; EXTRACELLULAR-MATRIX; SENSORY
   EPITHELIA; SUPPORTING CELLS; BASILAR PAPILLA; ORGAN-CULTURES; HYALINE
   CELLS; AVIAN COCHLEA; NOISE DAMAGE
AB The overall goal of this work is to improve the culture of the auditory organ of birds for the dual use of developing a hair cell regeneration model and charting a pathway to the eventual replacement of the hearing organ. In doing so, we develop a protocol for removing the auditory organ from its basement membrane in the inner ear, attach the organ to a series of artificial basement membranes, and conduct qualitative and quantitative analysis of how cell morphology, viability and function change with time. Native matrix cultures, where the epithelium was floating in media with the basement membrane and accessory structures attached, were used as a basis of comparison. PuraMatrix (TM), collagen I, collagen I/chondroitin-sulfate and Matrigel (TM) were chosen to encompass a diverse range of mechanical properties and macromolecule moieties. Surprisingly, we find that PuraMatrix (TM) outperformed the other matrices as a scaffold for sensory organ culture. PuraMatrix (TM), a self-assembled peptide hydrogel, is a biochemically specific culture substrate that contains none of the extracellular matrix (ECM) molecules and growth factors contained in the inner ear's basement membrane. Rheological measurements reveal that PuraMatrix (TM) may be a closer approximation to the stiffness of the soft tissue supporting the auditory organ. Cell density on the PuraMatrix (TM) substrate is comparable to that of the native matrix cultures, despite the absence of the basement membrane and accessory structures. Further studies show that PuraMatrix (TM) supports the culture of functional hair cells over a 72 h period, with a significant increase in the number of functional hair cells in comparison to the organ cultured without a matrix. This is the first example of adhesion of the adult auditory epithelium to a biomaterial for an extended period of time. With further optimization, this system will enable the performance of many novel biophysical and pharmacological studies involving hair cells and supporting cells. Published by Elsevier Ltd.
C1 [Spencer, Nathaniel J.; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02115 USA.
   [Spencer, Nathaniel J.; Cotanche, Douglas A.] Childrens Hosp, Dept Otolaryngol, Lab Cellular & Mol Hearing Res, Boston, MA 02115 USA.
   [Klapperich, Catherine M.] Boston Univ, Dept Mfg Engn, Boston, MA 02115 USA.
RP Spencer, NJ (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02115 USA.
EM nspencer@bu.edu
RI Klapperich, Catherine/D-5533-2011
OI Cotanche, Douglas/0000-0001-7972-0446; Klapperich,
   Catherine/0000-0001-6103-849X
FU NIDCD NIH HHS [R01 DC001689-14, R01 DC001689-15, R01 DC001689-16A1]
CR CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100
   Cotanche DA, 1999, AUDIOL NEURO-OTOL, V4, P271, DOI 10.1159/000013852
   Cotanche DA, 1995, HEARING RES, V91, P148, DOI 10.1016/0378-5955(95)00185-9
   COTANCHE DA, 1992, J COMP NEUROL, V324, P353, DOI 10.1002/cne.903240306
   DALLOS P, 1996, COCHLEA HOMEOSTASIS, pCH6
   DUAN M, 2004, GENE THER S, V1, pS51
   Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114
   Frenz DA, 1998, ACTA OTO-LARYNGOL, V118, P651
   Hess A, 2002, BRAIN RES, V956, P236, DOI 10.1016/S0006-8993(02)03545-X
   Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103
   Kimitsuki T, 1996, HEARING RES, V101, P75, DOI 10.1016/S0378-5955(96)00134-7
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030
   Mazurek B, 2006, HEARING RES, V215, P31, DOI 10.1016/j.heares.2006.02.010
   Meyers JR, 2003, J NEUROSCI, V23, P4054
   Naidu RC, 2007, J ACOUST SOC AM, V121, P994, DOI 10.1121/1.2404916
   Oesterle EC, 2000, J COMP NEUROL, V424, P307, DOI 10.1002/1096-9861(20000821)424:2<307::AID-CNE9>3.0.CO;2-M
   OESTERLE EC, 1993, HEARING RES, V70, P85, DOI 10.1016/0378-5955(93)90054-5
   OLSON ES, 1991, J ACOUST SOC AM, V89, P1262, DOI 10.1121/1.400535
   Schumacher K, 2007, TISSUE ENG, V13, P197, DOI 10.1089/ten.2006.0046
   Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021
   Stone JS, 1996, J NEUROSCI, V16, P6157
   Stone JS, 2000, P NATL ACAD SCI USA, V97, P11714, DOI 10.1073/pnas.97.22.11714
   STONE JS, 1992, J CELL SCI, V102, P671
   TILNEY LG, 1983, J CELL BIOL, V96, P807, DOI 10.1083/jcb.96.3.807
   Torchinsky C, 1999, J NEUROCYTOL, V28, P913, DOI 10.1023/A:1007082424477
   Warchol ME, 1996, J NEUROSCI, V16, P5466
   Warchol ME, 2002, J NEUROSCI, V22, P2607, DOI 10.1523/JNEUROSCI.22-07-02607.2002
   White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849
   WUE CC, 2007, P NATL ACAD SI, V104, P1254
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
NR 34
TC 18
Z9 19
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2008
VL 29
IS 8
BP 1028
EP 1042
DI 10.1016/j.biomaterials.2007.11.006
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260MM
UT WOS:000253014400008
PM 18037163
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Desormeaux, A
   Moreau, ME
   Lepage, Y
   Chanard, J
   Adam, A
AF Desormeaux, Anik
   Moreau, Marie Eve
   Lepage, Yves
   Chanard, Jacques
   Adam, Albert
TI The effect of electronegativity and angiotensin-converting enzyme
   inhibition on the kinin-forming capacity of polyacrylonitrile dialysis
   membranes
SO BIOMATERIALS
LA English
DT Article
DE haemodialysis membrane; biocompatibility; electroactive polymer;
   hypersensitivity
ID ANAPHYLACTOID REACTIONS; HEMODIALYSIS MEMBRANES; BRADYKININ; GENERATION;
   ACTIVATION; PLASMA; QUANTIFICATION; IMMUNOASSAY; ADSORPTION
AB The combination of negatively-charged membranes and angiotensin I-converting enzyme inhibitors (ACEi) evokes hypersensitivity reactions (HSR) during hemodialysis and bradykinin (BK)-related peptides have been hypothesized as being responsible for these complications. In this study, we tested the effects of neutralizing the membrane electronegativity (zeta potential) of polyacrylonitrile AN69 membranes by coating a polyethyleneimine layer (AN69-ST membranes) over the generation of kinins induced by blood contact with synthetic membranes. We used minidialyzers with AN69 or AN69-ST membranes in an ex vivo model of plasma and we showed that plasma dialysis with AN69 membranes led to significant BK and des-Arg(9)-BK release, which was potentiated by ACEi. This kinin formation was dramatically decreased by AN69-ST membranes, even in the presence of an ACEi, and kinin recovery in the dialysates was also significantly lower with these membranes. High molecular weight kininogen and factor XII detection by immunoblotting of the protein layer coating both membranes corroborated the results: binding of these proteins and contact system activation on AN69-ST membranes were reduced. This ex vivo experimental model applied to the plasma, dialysate and dialysis membrane could be used for the characterization of the kinin-forming capacity of any biomaterial potentially used in vivo in combination with drugs which modulate the pharmacological activity of kinins. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Desormeaux, Anik; Moreau, Marie Eve; Adam, Albert] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada.
   [Lepage, Yves] Univ Montreal, Dept Math & Stat, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada.
   [Chanard, Jacques] Ctr Hosp & Univ, ARPDD, Nephrol Hemodial Transplantat Serv, Reims, France.
   [Chanard, Jacques] CNRS, FRE 2534, Reims, France.
RP Adam, A (reprint author), Univ Montreal, Fac Pharm, 2900 Blvd E Montpetit, Montreal, PQ H3T 1J4, Canada.
EM albert.adam@umontreal.ca
FU NHLBI NIH HHS [R01 HL079184-04, R01 HL079184, 1 R01 HL 079184]
CR Adam A, 2004, Bull Mem Acad R Med Belg, V159, P307
   ADAM A, 1985, CLIN CHEM, V31, P423
   ADAM A, 2004, B MEM ACAD R MED BEL, V159, P314
   BOMMER J, 1985, LANCET, V2, P1382
   Chanard J, 1987, ASAIO Trans, V33, P551
   Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252
   Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275
   Decarie A, 1996, PEPTIDES, V17, P1009
   DECARIE A, 1994, PEPTIDES, V15, P511, DOI 10.1016/0196-9781(94)90214-3
   Duan QL, 2005, AM J HUM GENET, V77, P617, DOI 10.1086/496899
   FINK E, 1994, BRAZ J MED BIOL RES, V27, P1975
   GRANOWITZ EV, 1991, LANCET, V338, P1423, DOI 10.1016/0140-6736(91)92725-H
   Molinaro G, 2006, KIDNEY INT, V70, P1823, DOI 10.1038/sj.ki.5001873
   Molinaro G, 2005, BIOCHEM J, V385, P389, DOI 10.1042/BJ20040849
   Moreau ME, 2007, TRANSFUSION, V47, P410, DOI 10.1111/j.1537-2995.2007.01097.x
   MULVIHILL J, 1992, BIOMATERIALS, V13, P527, DOI 10.1016/0142-9612(92)90104-V
   RAYMOND P, 1995, J IMMUNOL METHODS, V180, P247, DOI 10.1016/0022-1759(94)00320-V
   Sabourin T, 2001, BRIT J PHARMACOL, V133, P1154, DOI 10.1038/sj.bjp.0704158
   SCHAEFER RM, 1994, CLIN NEPHROL, V42, pS44
   SCHULMAN G, 1993, J AM SOC NEPHROL, V3, P1563
   Thomas M, 2000, INT J ARTIF ORGANS, V23, P20
   VERRESEN L, 1994, KIDNEY INT, V45, P1497, DOI 10.1038/ki.1994.195
NR 22
TC 25
Z9 26
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2008
VL 29
IS 9
BP 1139
EP 1146
DI 10.1016/j.biomaterials.2007.11.019
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268EY
UT WOS:000253563000001
PM 18078988
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mondalek, FG
   Lawrence, BJ
   Kropp, BP
   Grady, BP
   Fung, KM
   Madihally, SV
   Lin, HK
AF Mondalek, Fadee G.
   Lawrence, Benjamin J.
   Kropp, Bradley P.
   Grady, Brian P.
   Fung, Kar-Ming
   Madihally, Sundar V.
   Lin, Hsueh-Kung
TI The incorporation of poly (lactic-co-glycolic) acid nanoparticles into
   porcine small intestinal submucosa biomaterials
SO BIOMATERIALS
LA English
DT Article
DE scaffold; small intestinal submucosa; porosity; nanoparticle;
   biocompatibility
ID TISSUE REPLACEMENT APPLICATIONS; BLADDER REGENERATION; IN-VIVO;
   MOLECULAR-WEIGHT; AUGMENTATION; DELIVERY; RELEASE; REPAIR; CELLS; DOG
AB Small intestinal submucosa (SIS) derived from porcine small intestine has been intensively studied for its capacity in repairing and regenerating wounded and dysfunctional tissues. However, SIS suffers from a large spectrum of heterogeneity in microarchitecture leading to inconsistent results. In this study, we introduced nanoparticles (NPs) to SIS with an intention of decreasing the heterogeneity and improving the consistency of this biomaterial. As determined by scanning electron microscopy and urea permeability, the optimum NP size was estimated to be between 200 nm and 500 nm using commercial monodisperse latex spheres. The concentration of NPs that is required to alter pore sizes of SIS as determined by urea permeability was estimated to be 1 mg/ml 260 nm poly (lactic-co-glycolic) acid (PLGA) NPs. The I mg/ml PLGA NPs loaded in the SIS did not change the tensile properties of the unmodified SIS or even alter pH values in a cell culture environment. More importantly, PLGA NP modified SIS did not affect human mammary endothelial cells (HMEC-1) morphology or adhesion, but actually enhanced HEMC-1 cell growth. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Mondalek, Fadee G.; Kropp, Bradley P.; Lin, Hsueh-Kung] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA.
   [Mondalek, Fadee G.; Grady, Brian P.] Univ Oklahoma, Dept Chem Biol & Mat Engn, Norman, OK 73019 USA.
   [Lawrence, Benjamin J.; Madihally, Sundar V.] Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
   [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA.
   [Fung, Kar-Ming; Lin, Hsueh-Kung] Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA.
RP Lin, HK (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, 920 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.
EM hk-lin@ouhsc.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
FU NIDDK NIH HHS [R21 DK074858, 1 R21 DK 074858-01A2, R21 DK074858-01A2]
CR ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   Androjna C, 2007, TISSUE ENG, V13, P233, DOI 10.1089/ten.2006.0050
   Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   Gubbels SP, 2006, OTOLARYNG HEAD NECK, V134, P1028, DOI 10.1016/j.otohns.2005.12.034
   Hillaireau H, 2006, J NANOSCI NANOTECHNO, V6, P2608, DOI 10.1166/jnn.2006.453
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 2002, J UROLOGY, V168, P1742, DOI 10.1097/01.ju.0000028154.79247.ca
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lamprecht A, 2006, NANOTECHNOLOGY, V17, P3673, DOI 10.1088/0957-4484/17/15/009
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Leo E, 2006, J NANOSCI NANOTECHNO, V6, P3070, DOI 10.1166/jnn.2006.408
   Mondalek Fadee G, 2006, J Nanobiotechnology, V4, P4, DOI 10.1186/1477-3155-4-4
   Musumeci T, 2006, INT J PHARM, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352
   Shakweh M, 2006, J NANOSCI NANOTECHNO, V6, P2811, DOI 10.1166/jnn.2006.438
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Wendorf J, 2006, J PHARM SCI-US, V95, P2738, DOI 10.1002/jps.20728
   Yi F, 2006, J CLIN PHARM THER, V31, P43, DOI 10.1111/j.1365-2710.2006.00702.x
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zweers MLT, 2006, J CONTROL RELEASE, V114, P317, DOI 10.1016/j.jconrel.2006.05.021
NR 41
TC 29
Z9 32
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2008
VL 29
IS 9
BP 1159
EP 1166
DI 10.1016/j.biomaterials.2007.11.020
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268EY
UT WOS:000253563000003
PM 18076986
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Thimm, BW
   Unger, RE
   Neumann, HG
   Kirkpatrick, CJ
AF Thimm, Benjamin W.
   Unger, Ronald E.
   Neumann, Hans-Georg
   Kirkpatrick, C. James
TI Biocompatibility studies of endothelial cells on a novel calcium
   phosphate/SiO(2)-xerogel composite for bone tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID HOLLOW-FIBER MEMBRANES; IN-VITRO; ADHESION MOLECULE; GENE-REGULATION;
   VASCULARIZATION; GRAFTS; GROWTH; ANGIOGENESIS; EXPRESSION; CERAMICS
AB The bone biomaterial BONITmatrix (R), a nanoporous, granular scaffold composed of hydroxylapatite, calcium phosphate and SiO(2), linked by a dense collagen mesh, was tested for its biocompatibility using endothelial cells (EC) in the form of macrovascular HUVEC, microvascular HDMEC and the endothelial cell line ISOHAS-1. Cells were examined for their adherence and growth on the biomaterial and this was followed by confocal laser scanning microscopy after vital staining or immunocytochemical reactions, as well as by scanning electron microscopy. Macro- and microvascular ECs predominantly spread on BONITmatrixR (R)-collagen mesh-covered surfaces and fibres and maintained their typical morphology. As ECs in vivo must build up a functional vasculature, the seeded cells were further tested for proinflammatory expression markers and cytokine expression after lipopolysaccharide stimulation. Protein-coating studies revealed that BONITmatrixR (R)-collagen scaffolds needed human blood serum coating to successfully support the growth of ECs. All cells expressed endothelium-specific surface marker proteins such as PECAM-1, VE-cadherin and vWF. The in vitro data support recent in vivo studies and indicate that this calcium phosphate/SiO(2)-xerogel composite could be a useful scaffold material for tissue engineering.
C1 [Thimm, Benjamin W.; Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   [Neumann, Hans-Georg] DOT GmbH, D-18059 Rostock, Germany.
RP Thimm, BW (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM runger@uni-mainz.de
RI Thimm, Benjamin/G-7410-2012
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   ALBELDA SM, 1990, J CELL BIOL, V110, P1227, DOI 10.1083/jcb.110.4.1227
   ANDERSON JS, 1987, SURGERY, V101, P577
   BECKER P, 2004, BIOMATERIALIEN, V5, P10
   Bienengraber V, 2004, MATERIALWISS WERKST, V35, P234, DOI 10.1002/mawe.200400733
   BULNHEIM U, 2006, BIOMATERIALIEN, V7, P56
   Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Freed L E, 1988, ASAIO Trans, V34, P732
   GERBER T, 2001, OSTEOLOGIE, V10, P175
   HENKEL KO, 2004, MUND KIEFER GESICHTS, V5, P277
   HENKEL KO, 2004, OSTEOLOGIE, V13, P57
   HOPP M, 2005, IMPLANTOLOGIE, V13, P301
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius AA, 2001, J BIOMED MATER RES, V55, P285, DOI 10.1002/1097-4636(20010605)55:3<285::AID-JBM1016>3.3.CO;2-T
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446
   Nachtigal P, 2001, Acta Medica (Hradec Kralove), V44, P83
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
NR 36
TC 17
Z9 18
U1 0
U2 13
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2008
VL 3
IS 1
AR 015007
DI 10.1088/1748-6041/3/1/015007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 290BC
UT WOS:000255096700008
PM 18458494
DA 2018-10-19
ER

PT J
AU Park, D
   Yun, YS
   Lee, HW
   Park, JM
AF Park, Donghee
   Yun, Yeoung-Sang
   Lee, Hae Woo
   Park, Jong Moon
TI Advanced kinetic model of the Cr(VI) removal by biomaterials at various
   pHs and temperatures
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE hexavalent chromium; reduction; biomaterial; pine needle; kinetics
ID DEAD FUNGAL BIOMASS; LENTINUS-SAJOR-CAJU; HEXAVALENT CHROMIUM; ACTIVATED
   CARBONS; AQUEOUS-SOLUTIONS; WASTE-WATER; BIOSORPTION; ADSORPTION;
   REDUCTION; MECHANISM
AB Recently, a new and simple kinetic model was derived from a basic concept of the redox reaction between Cr(VI) and biomaterials, and successfully described the removal behavior of Cr(VI) under various Cr(VI) and biomaterial concentrations. However, this model did not consider the effects of pH and temperature on the Cr(VI) removal by biomaterials. In this study, a new efficient biomaterial, pine needle, capable of removing Cr(VI) was used as a model one to study the Cr(VI) removal by biomaterials. Analysis of chromium species in aqueous and solid phases revealed that the removal mechanism of Cr(VI) by pine needle was its reduction into Cr(III). The removal rate of Cr(VI) increased with a decrease in pH or with an increase of temperature. Finally, an advanced kinetic model in the form of -d[Cr(VI)]/dt = Ae(Ea/RT) [H+](n)[Cr(VI)][OCs] was derived, and successfully predicted the time-dependent Cr(VI) concentration at various pHs (2-4) and temperatures (10-55 degrees C). (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Park, Donghee; Lee, Hae Woo; Park, Jong Moon] Pohang Univ Sci & Technol, Dept Chem Engn, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, Pohang 790784, South Korea.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Res Inst Ind Technol, Div Environm & Chem Engn, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, San 31 Hyoja Dong, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
CR Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   AKSU Z, J HAZARD MAT
   Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008
   Arica MY, 2005, COLLOID SURFACE A, V253, P203, DOI 10.1016/j.colsurfa.2004.11.012
   BARAL SS, 2006, BIOCH ENG J, V13, P216
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087
   DUBEY SP, IN PRESS J HAZARD MA
   Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003
   Kiran B, 2007, J HAZARD MATER, V141, P662, DOI 10.1016/j.jhazmat.2006.07.026
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Mohanty K, 2006, CHEM ENG J, V117, P71, DOI 10.1016/j.cej.2005.11.018
   Oguz E, 2005, COLLOID SURFACE A, V252, P121, DOI 10.1016/j.colsurfa.2004.10.004
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   RAMIREZ CM, IN PRESS J HAZARD MA
   Singh KK, 2005, J COLLOID INTERF SCI, V290, P61, DOI 10.1016/j.jcis.2005.04.011
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Wittbrodt PR, 1996, ENVIRON SCI TECHNOL, V30, P2470, DOI 10.1021/es950731c
   Zhou M, 2007, WORLD J MICROB BIOT, V23, P43, DOI 10.1007/s11274-006-9191-8
   ZIAGOVA M, IN PRESS BIORESOURCE
NR 27
TC 70
Z9 71
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD MAR
PY 2008
VL 99
IS 5
BP 1141
EP 1147
DI 10.1016/j.biortech.2007.02.025
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 263XX
UT WOS:000253250900032
PM 17416519
DA 2018-10-19
ER

PT J
AU Maeda, Y
   Vaizey, CJ
   Kamm, MA
AF Maeda, Y.
   Vaizey, C. J.
   Kamm, M. A.
TI Pilot study of two new injectable bulking agents for the treatment of
   faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Article
DE passive faecal incontinence; injection; hydrogel; polyacrylamide;
   porcine dermal collagen
ID SILICONE BIOMATERIAL; AUTOLOGOUS FAT; INJECTION
AB Objective The use of injectable bulking agents for passive faecal incontinence appears to provide reasonable short-term results. However experience with different agents is limited. We report on the outcome of injections with new bulking agents.
   Method Each patient received injections of either Bulkamid(TM) (hydrogel cross-linked with polyacrylamide) or Permacol(TM) (porcine dermal collagen). Assessment included clinical evaluation, anorectal physiological testing, endoanal ultrasonography and questionnaires including the St Mark's Incontinence Score, one week bowel diary card, the Faecal Incontinence Quality of Life Scale and the Short Form-36 (SF-36) health survey. Follow up was at 6 weeks and 6 months, with a further telephone review at a median of 19 months (range 14-22).
   Results Ten patients (nine female), median age 68 years (range 45-79), were enrolled. St Mark's incontinence score (0 = best, 24 = worst) was 15 (range 11-24) at baseline, 12.5 (range 3-18) at 6 weeks and 14 (range 6-22) at 6 months. A 1-week bowel diary and SF-36 forms also showed temporary improvement but this was not sustained beyond 6 weeks.
   Conclusion Bulkamid((TM)) and Permacol((TM)) injections did not have a major effect on faecal incontinence.
C1 [Maeda, Y.; Vaizey, C. J.; Kamm, M. A.] St Marks Hosp, Harrow HA1 3UJ, Middx, England.
RP Vaizey, CJ (reprint author), St Marks Hosp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM carolynne.vaizey@nwlh.nhs.uk
RI Maeda, Yasuko/B-6123-2016
OI Maeda, Yasuko/0000-0002-4081-4741
CR Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037
   LOSE G, 2004, 34 ANN M PAR FRANC
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P16, DOI DOI 10.1007/BF02237236]
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   TEO R, 2004, 34 ANN M PAR FRANC
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 16
TC 28
Z9 29
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD MAR
PY 2008
VL 10
IS 3
BP 268
EP 272
DI 10.1111/j.1463-1318.2007.01318.x
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 258UW
UT WOS:000252896000012
PM 17655723
DA 2018-10-19
ER

PT J
AU Thevenot, P
   Hu, WJ
   Tang, LP
AF Thevenot, Paul
   Hu, Wenjing
   Tang, Liping
TI Surface chemistry influences implant biocompatibility
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE functional groups; biomaterials; biocompatibility; proteins; cells
ID SELF-ASSEMBLED MONOLAYERS; PLASMA-PROTEIN ADSORPTION; ENDOTHELIAL-CELL
   GROWTH; FUNCTIONAL-GROUPS; IN-VITRO; CONFORMATIONAL-CHANGES; FIBRINOGEN
   ADSORPTION; ADSORBED FIBRINOGEN; PLATELET-ADHESION; DRUG-DELIVERY
AB Implantable medical devices are increasingly important in the practice of modern medicine. Unfortunately, almost all medical devices suffer to a different extent from adverse reactions, including inflammation, fibrosis, thrombosis and infection. To improve the safety and function of many types of medical implants, a major need exists for development of materials that evoked desired tissue responses. Because implant-associated protein adsorption and conformational changes thereafter have been shown to promote immune reactions, rigorous research efforts have been emphasized on the engineering of surface property (physical and chemical characteristics) to reduce protein adsorption and cell interactions and subsequently improve implant biocompatibility. This brief review is aimed to summarize the past efforts and our recent knowledge about the influence of surface functionality on protein: cell: biomaterial interactions. It is our belief that detailed understandings of bioactivity of surface functionality provide an easy, economic, and specific approach for the future rational design of implantable medical devices with desired tissue reactivity and, hopefully, wound healing capability.
C1 [Thevenot, Paul; Hu, Wenjing; Tang, Liping] Univ Texas Arlington, Biomed Engn Program, Dept Bioengn, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Biomed Engn Program, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIBIB NIH HHS [R01 EB007271-01A2, R01 EB007271]; NIGMS NIH HHS [R01
   GM074021]
CR Abraham GA, 2001, BIOMATERIALS, V22, P1971, DOI 10.1016/S0142-9612(00)00381-1
   ABSOLOM DR, 1983, T AM SOC ART INT ORG, V29, P146
   Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   ALTMAN JJ, 1986, DIABETES, V35, P625, DOI 10.2337/diabetes.35.6.625
   AMON M, 1994, INT OPHTHALMOL, V18, P9, DOI 10.1007/BF00919407
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ARCHER J, 1980, J SURG RES, V28, P77, DOI 10.1016/0022-4804(80)90086-4
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2005, BIOMATERIALS, V26, P3021, DOI 10.1016/j.biomaterials.2004.09.002
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Butler K, 1997, Biomed Sci Instrum, V34, P18
   Carro LP, 1999, ARTHROSCOPY, V15, P103, DOI 10.1053/ar.1999.v15.015010
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Choi SW, 2003, J DISPER SCI TECHNOL, V24, P475, DOI 10.1081/DIS-120021803
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   CHUANG WH, 2007, IN PRESS J BIOMED MA
   Clark HR, 1999, BIOTECHNOL PROGR, V15, P259, DOI 10.1021/bp990003j
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   CLAYTON HA, 1993, ACTA DIABETOL, V30, P181, DOI 10.1007/BF00569928
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Dyshlovenko S, 2006, SURF COAT TECH, V201, P2248, DOI 10.1016/j.surfcoat.2006.03.034
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218
   Haeffner-Cavaillon N, 1988, Contrib Nephrol, V62, P86
   HENRY CH, 1993, J ORAL MAXIL SURG, V51, P352, DOI 10.1016/S0278-2391(10)80343-X
   Hess H., 2001, REV MOL BIOTECHNOL, V82, P67, DOI DOI 10.1016/S1389-0352(01)00029-0
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Holzapfel V, 2006, J PHYS-CONDENS MAT, V18, pS2581, DOI 10.1088/0953-8984/18/38/S04
   HORBETTL TA, 1994, J BIOMAT SCI-POLYM E, V33, P6
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kaar JL, 2007, BIOMATERIALS, V28, P3131, DOI 10.1016/j.biomaterials.2007.03.021
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAMATH S, 2007, IN PRESS J BIOMED MA
   Kannan S, 2004, J BIOMAT SCI-POLYM E, V15, P311, DOI 10.1163/156856204322977201
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kryshtalskyj B, 1996, Ont Dent, V73, P40
   Ladam G, 2002, BIOMOL ENG, V19, P273, DOI 10.1016/S1389-0344(02)00031-X
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Lin JC, 2000, J BIOMED MATER RES, V51, P413, DOI 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Lorenz MR, 2006, BIOMATERIALS, V27, P2820, DOI 10.1016/j.biomaterials.2005.12.022
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   LUI L, 1994, J BIOMED MATER RES, V28, P767
   LUI L, 1996, J BIOMED MATER RES, V30, P535
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   NISHI O, 1991, J CATARACT REFR SURG, V17, P471, DOI 10.1016/S0886-3350(13)80854-1
   Ohya Y, 2004, J BIOMAT SCI-POLYM E, V15, P111, DOI 10.1163/156856204322752264
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Piana C, 2007, DIFFERENTIATION, V75, P308, DOI 10.1111/j.1432-0436.2006.00141.x
   Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Redhead HM, 2001, J CONTROL RELEASE, V70, P353, DOI 10.1016/S0168-3659(00)00367-9
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   RINSCH CL, 1995, ACS POLYM PREPR, V36, P95
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Ruckenstein E, 2005, ADV COLLOID INTERFAC, V113, P43, DOI 10.1016/j.cis.2004.07.009
   Ryu GH, 2005, SURF COAT TECH, V193, P60, DOI 10.1016/j.surfcoat.2004.07.062
   SAFRANJ A, 1991, BIOTECHNOL PROGR, V7, P173, DOI 10.1021/bp00008a012
   SAVAGE CR, 1991, CHEM MATER, V3, P575, DOI 10.1021/cm00016a005
   SAVAGE CR, 1993, ADV CHEM SER, V236, P745
   SCHAAF P, 1988, COLLOID SURFACE, V31, P89, DOI 10.1016/0166-6622(88)80184-7
   SCHIAVONE PA, 1993, KNEE SURG SPORT TR A, V1, P9
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Schroven I T, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P214, DOI 10.1007/BF01845590
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Sheu MS, 1995, ENCY HDB BIOMATERI A, V1, P865
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   Shikata F, 2002, EUR J PHARM BIOPHARM, V53, P57, DOI 10.1016/S0939-6411(01)00198-9
   Smolarczyk K, 2005, ARTERIOSCL THROM VAS, V25, P2679, DOI 10.1161/01.ATV.0000189305.84297.8b
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   SPERLING C, 2007, IN PRESS BIOMATERIAL
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Takahara A, 2002, COLLOID SURFACE B, V23, P141, DOI 10.1016/S0927-7765(01)00231-4
   TANG L, 1999, TISSUE ENG PROSTHETI, P207
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Tantipolphan R, 2007, INT J PHARM, V337, P40, DOI 10.1016/j.ijpharm.2006.12.021
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   THORNHILL TS, 1990, BIOMATERIALS, V11, P69
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Timmons R B, 1999, US Patent Specification, Patent No. [US 5876753, 5876753]
   TRUMPY IG, 1993, J ORAL MAXIL SURG, V51, P624, DOI 10.1016/S0278-2391(10)80259-9
   Tsai MY, 2007, J COLLOID INTERF SCI, V308, P474, DOI 10.1016/j.jcis.2007.01.015
   Tsai MY, 2001, J BIOMED MATER RES, V55, P554, DOI 10.1002/1097-4636(20010615)55:4<554::AID-JBM1049>3.0.CO;2-V
   TURNER RFB, 1991, BIOMATERIALS, V12, P361, DOI 10.1016/0142-9612(91)90003-S
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493
   Vandamme TF, 2005, J CONTROL RELEASE, V102, P23, DOI 10.1016/j.jconrel.2004.09.015
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 139
TC 326
Z9 329
U1 13
U2 148
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD MAR
PY 2008
VL 8
IS 4
BP 270
EP 280
PG 11
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 275NH
UT WOS:000254078400002
PM 18393890
DA 2018-10-19
ER

PT J
AU Vasita, R
   Shanmugam, K
   Katti, DS
AF Vasita, Rajesh
   Shanmugam, Kirubanandan
   Katti, Dhirendra S.
TI Improved biomaterials for tissue engineering applications: Surface
   modification of polymers
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE tissue engineering; biomaterial; growth factor; protein immobilization;
   biocompatibility; surface modification; protein delivery systems
ID GROWTH-FACTOR-DELIVERY; EXTRACELLULAR-MATRIX; DRUG-DELIVERY; COVALENT
   IMMOBILIZATION; BIODEGRADABLE POLYMERS; POLY(L-LACTIC ACID); PROTEIN
   ADSORPTION; ADHESION PEPTIDES; PLASMA TREATMENT; CELL ATTACHMENT
AB Tissue engineering approaches that combine biomaterial-based scaffolds with protein delivery systems have provided a potential strategy for improved regeneration of damaged tissue. The success of polymeric scaffolds is determined by the response it elicits from the surrounding biological environment. This response is governed, to a large extent, by the surface properties of the scaffold. Surfaces of polymeric scaffolds have a significant effect on protein and cell attachment. Multiple approaches have been developed to provide micrometer to nanometer scale alterations in surface architecture of scaffolds to enable improved protein and cell interactions. Chemical modification of polymeric scaffold surfaces is one of the upcoming approaches that enables enhanced biocompatibility while providing a delivery vehicle for proteins. Similarly, physical adsorption, radiation mediated modifications, grafting, and protein modifications are other methods that have been employed successfully for alterations of surface properties of polymeric scaffolds. The goal of this review is to provide an overview of the role of surface properties/chemistry in tissue engineering and briefly discuss some of the methods of surface modification that can provide improved cell and protein interactions. It is hoped that these improved polymeric scaffolds will lead to accelerated and functional tissue regeneration.
C1 [Vasita, Rajesh; Shanmugam, Kirubanandan; Katti, Dhirendra S.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Katti, DS (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM dsk@iitk.ac.in
OI Shanmugam, Kirubanandan/0000-0002-3461-9958
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   ATALA A, 2002, METHODS TISSUE ENG
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Banu Nasreen, 2005, J Artif Organs, V8, P184, DOI 10.1007/s10047-005-0302-3
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Boxus T, 1998, BIOORGAN MED CHEM, V6, P1577, DOI 10.1016/S0968-0896(98)00083-2
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Crommelin DJA, 2003, J CONTROL RELEASE, V87, P81, DOI 10.1016/S0168-3659(03)00014-2
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   DOMB A, 2007, DRUG DELIV, V59, P185
   Edlund U, 2005, J AM CHEM SOC, V127, P8865, DOI 10.1021/ja052073u
   Fodor W.L, 2003, REPROD BIOL ENDOCRIN, V1, P1
   Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875
   GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X
   GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guisan J. M., 2006, IMMOBILIZATION ENZYM
   Haberal M, 2004, TRANSPL P, V36, P1219, DOI 10.1016/j.transproceed.2004.05.035
   Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   IMANISHI Y, 1994, MAT SCI ENG C-BIOMIM, V1, P143, DOI 10.1016/0928-4931(94)90046-9
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   ITO Y, 1994, MAT SCI ENG C-BIOMIM, V2, P67, DOI 10.1016/0928-4931(94)90031-0
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KHADEMHOSSEINI A, 2006, TISSUE ENG, V103, P2480
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kitajima T, 2007, BIOMATERIALS, V28, P1989, DOI 10.1016/j.biomaterials.2006.12.022
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Lee SG, 2007, SURF COAT TECH, V201, P5128, DOI 10.1016/j.surfcoat.2006.07.040
   Lin Y, 2006, ACTA BIOMATER, V2, P155, DOI 10.1016/j.actbio.2005.10.002
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   Means GE, 1990, BIOCONJUGATE CHEM, V1, P2, DOI 10.1021/bc00001a001
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   PLEUVRY BJ, 2006, INTENS CARE MED, V7, P193
   Qiu LY, 2006, PHARM RES, V23, P1, DOI 10.1007/s11095-005-9046-2
   RATNER BD, 2004, BIOMATERIALS SCI INT, P201
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sato T, 2004, MAT SCI ENG C-BIO S, V24, P365, DOI 10.1016/j.msec.2003.12.010
   SCHAKENRAAD J M, 1991, Clinical Materials, V7, P253, DOI 10.1016/0267-6605(91)90067-P
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Schmitz JP, 1997, TISSUE ENG, V3, P257, DOI 10.1089/ten.1997.3.257
   Schroeder-Tefft JA, 1997, J CONTROL RELEASE, V49, P291, DOI 10.1016/S0168-3659(97)10055-4
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   TABATA Y, 1986, BIOMATERIALS, V7, P234, DOI 10.1016/0142-9612(86)90110-9
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ungaro F, 2006, J CONTROL RELEASE, V113, P128, DOI 10.1016/j.jconrel.2006.04.011
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Wang SG, 2005, ANAL BIOANAL CHEM, V381, P547, DOI 10.1002/s00216-004-27712
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   WOGLER EA, 2004, BIOMATERIALS SCI INT, P59
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zhu HG, 2004, BIOMATERIALS, V25, P109, DOI 10.1016/S0142-9612(03)00481-2
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 106
TC 90
Z9 94
U1 3
U2 71
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD MAR
PY 2008
VL 8
IS 4
BP 341
EP 353
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 275NH
UT WOS:000254078400008
PM 18393896
DA 2018-10-19
ER

PT J
AU Choi, HW
   Dauskardt, RH
   Lee, SC
   Lee, KR
   Oh, KH
AF Choi, Heon Woong
   Dauskardt, Reinhold H.
   Lee, Seung-Cheol
   Lee, Kwang-Ryeol
   Oh, Kyu Hwan
TI Characteristic of silver doped DLC films on surface properties and
   protein adsorption
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE diamond-like carbon (DLC); protein adsorption; surface energy;
   wettability
ID DIAMOND-LIKE CARBON; ION IMPLANTATION-DEPOSITION; AMORPHOUS-CARBON;
   BLOOD COMPATIBILITY; MECHANICAL-PROPERTIES; THIN-FILMS; ACTIVATION;
   COATINGS; HEMOCOMPATIBILITY; BIOCOMPATIBILITY
AB Ag-incorporated diamond-like carbon (DLC) films were prepared on Si substrate using a hybrid deposition system composed of an end-Hall-type hydrocarbon ion gun and a silver DC magnetron sputter source. Ag was selected due to their potential values of biomaterial. The concentration of Ag in the films was varied from 0.1 to 9.7 at.% by controlling the fraction of Ar in the reaction gas mixture with benzene. In order to understand the influence of incorporated Ag on wettability, the surface energy and the protein adsorption as an indirect haemo-compatibility were measured. The surface energy of the Ag-incorporated DLC film decreased gradually with the increase of the Ag concentration. The haemo-compatibility was examined by the adsorption ratio of albumin/fibrinogen as an indirect method and improved with the increase of Ag concentration. The surface and biological behaviors of the films will be discussed in terms of the atomic bond characteristic and microstructure induced by Ag incorporation. Our results demonstrate that the Ag-incorporated DLC films are potentially useful as biomedical devices having good haemo-compatibility and hydrophobic characteristics. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Choi, Heon Woong; Oh, Kyu Hwan] Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151744, South Korea.
   [Choi, Heon Woong; Dauskardt, Reinhold H.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Lee, Seung-Cheol; Lee, Kwang-Ryeol] Korea Inst Sci & Technol, Future Technol Res Div, Seoul 130650, South Korea.
RP Choi, HW (reprint author), Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151744, South Korea.
EM joiner03@snu.ac.kr
RI Lee, Kwang-Ryeol/E-1242-2011; oh, kyuhwan/H-5265-2018
OI Lee, Kwang-Ryeol/0000-0002-8211-3257; 
CR Chen JS, 2001, THIN SOLID FILMS, V398, P110, DOI 10.1016/S0040-6090(01)01455-9
   Chen JS, 2001, J APPL PHYS, V89, P7814, DOI 10.1063/1.1375808
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Eun KY, 1996, SURF COAT TECH, V86-7, P569, DOI 10.1016/S0257-8972(96)02966-0
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KIM HG, 2005, THIN SOLID FILM, V1, P299
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Kwok C.H., 2007, DIAM RELAT MATER, V16, P1353
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Meunier C, 2006, SURF COAT TECH, V200, P6346, DOI 10.1016/j.surfcoat.2005.11.028
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Okpalugo TIT, 2004, DIAM RELAT MATER, V13, P1088, DOI 10.1016/j.diamond.2003.10.064
   Onate JI, 2001, SURF COAT TECH, V142, P1056, DOI 10.1016/S0257-8972(01)01074-X
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   SCHROEDER A, 1999, THESIS ETH ZURICH
   Schulz H, 2005, SURF COAT TECH, V200, P1123, DOI 10.1016/j.surfcoat.2005.02.019
   Shin JK, 2001, APPL PHYS LETT, V78, P631, DOI 10.1063/1.1343840
   Sui JH, 2006, DIAM RELAT MATER, V15, P1720, DOI 10.1016/j.diamond.2006.03.004
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Wang AY, 2006, CARBON, V44, P1826, DOI 10.1016/j.carbon.2005.12.045
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Young T., 1805, PHILOS T R SOC LOND, V9, P255
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
NR 28
TC 75
Z9 77
U1 6
U2 40
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR
PY 2008
VL 17
IS 3
BP 252
EP 257
DI 10.1016/j.diamond.2007.12.034
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 295LF
UT WOS:000255475300007
DA 2018-10-19
ER

PT J
AU Dinnes, DLM
   Santerre, JP
   Labow, RS
AF Dinnes, Donna Lee M.
   Santerre, J. Paul
   Labow, Rosalind S.
TI Influence of biodegradable and non-biodegradable material surfaces on
   the differentiation of human monocyte-derived macrophages
SO DIFFERENTIATION
LA English
DT Article
DE monocyte; macrophage; differentiation; biomaterial; polyurethane;
   cytoskeleton; biodegradation; foreign body response
ID POLYCARBONATE-BASED POLYURETHANES; GIANT-CELL FORMATION; IN-VIVO;
   MEDIATED BIODEGRADATION; CHOLESTEROL ESTERASE; HUMAN NEUTROPHILS;
   DENDRITIC CELLS; EXPRESSION; CHEMISTRY; ADHESION
AB Monocyte-derived macrophages (MDM) and multinucleated foreign body giant cells (FBGC) are the primary cell types that remain at the cell-material interface of polyurethane (PU)-based medical devices as a result of chronic inflammatory responses. In vitro studies have demonstrated that MDM possess degradative potential toward PU, which can result in device failure. Because most studies have followed the degradation potential, morphology, and function of these cells only once fully differentiated, the current study investigated the influence of a non-degradable control tissue culture-grade polystyrene (TCPS) surface relative to two degradable model polycarbonate-urethanes (PCNU), of different chemistry, on various parameters of MDM morphology and function during a 14-day differentiation time course. The differentiation of human monocytes isolated from whole blood on PCNU materials resulted in increased cell attachment, decreased multinucleation, and significant decreases in cell spreading when compared with cells differentiated on TCPS. Actin-stained podosome-like cell adhesion structures were increased in PCNU-adherent cells, accompanied by an alteration in beta-actin and vinculin protein expression. The expression of the CD68 macrophage marker was reduced when cells were adherent to the PCNU materials and compared with TCPS, suggesting altered cell activation by the degradable relative to non-degradable materials. The degradative potential of these cells was altered by the material surface they were exposed to as measured by esterase activity and protein expression of monocyte-specific esterase. This was also supported by physical material breakdown evident in scanning electron microscopy images that illustrated holes in the PCNU films generated by the presence of differentiating MDM. It was concluded from these studies that PCNU materials significantly alter the function and morphology of differentiating MDM. This must be taken into consideration when studying cell-material interactions because these cells will receive cues from their immediate environment (including the biomaterial) upon differentiation, thereby affecting their resulting phenotype.
C1 [Dinnes, Donna Lee M.; Labow, Rosalind S.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   [Dinnes, Donna Lee M.; Labow, Rosalind S.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Santerre, J. Paul] Univ Toronto, Fac Dent, Inst Biomat & Biomed Engn, Toronto, ON M5G 1G6, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Fac Med, Dept Surg, Ottawa, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM rlabow@ottawaheart.ca
CR Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Bailly M, 2003, TRENDS CELL BIOL, V13, P163, DOI 10.1016/S0962-8924(03)00030-8
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002
   Christenson EM, 2005, J BIOMED MATER RES A, V74A, P141, DOI 10.1002/jbm.a.30317
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Dinnes DLM, 2005, BIOMATERIALS, V26, P3881, DOI 10.1016/j.biomaterials.2004.09.064
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Fadeel B, 2004, ANTIOXID REDOX SIGN, V6, P269, DOI 10.1089/152308604322899332
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243
   Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090
   Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jeras M, 2005, TRANSPL IMMUNOL, V14, P231, DOI 10.1016/j.trim.2005.03.012
   Kruger M, 1996, IMMUNOLOGY, V89, P89, DOI 10.1046/j.1365-2567.1996.d01-707.x
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LEE TL, 1993, J CELL SCI, V105, P167
   Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Matheson LA, 2007, BIOTECHNIQUES, V42, P744, DOI 10.2144/000112460
   McBane JE, 2005, J BIOMED MATER RES A, V74A, P1, DOI 10.1002/jbm.a.30311
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Mehul B, 1997, J CELL SCI, V110, P1169
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   Revenko I, 2001, SURF SCI, V491, P346, DOI 10.1016/S0039-6028(01)01298-5
   Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   TAMAKI Y, 2007, J BIOMED MAT RES B
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4
   WILLIAMS DF, 1976, MED PROG TECHNOL, V4, P31
   ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4
   Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819
NR 53
TC 19
Z9 20
U1 0
U2 8
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0301-4681
J9 DIFFERENTIATION
JI Differentiation
PD MAR
PY 2008
VL 76
IS 3
BP 232
EP 244
DI 10.1111/j.1432-0436.2007.00221.x
PG 13
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 268VV
UT WOS:000253608900002
PM 17924965
DA 2018-10-19
ER

PT J
AU Kumar, NA
   Ganapathy, HS
   Kim, JS
   Jeong, YS
   Jeong, YT
AF Kumar, Nanjundan Ashok
   Ganapathy, Hullathy Subban
   Kim, Jong Su
   Jeong, Yong Seok
   Jeong, Yeon Tae
TI Preparation of poly 2-hydroxyethyl methaerylate functionalized carbon
   nanotubes as novel biomaterial nanocomposites
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE carbon nanotubes; polyHEMA; surface functionalization; polymer-CNT
   nanocomposites
ID POLYMERIZATION; BIOCOMPATIBILITY; IMMOBILIZATION; MICROSPHERES;
   METHACRYLATE; COMPOSITES
AB We report a simple method for the functionalization of multi-walled carbon nanotubes (MWNTs) with a biomedically important polymer, poly(2-hydroxyethyl methacrylate) (poly(HEMA)), by chemical grafting of HEMA monomer followed by free radical polymerization. The nanotubes were first oxidized with a mixture of cone. nitric acid and Sulfuric acid (1:3), in order to obtain carboxylic acid functionalized MWNTs. Then the grafting of HEMA oil to the surface of MWNTs was carried by chemical functionalization of HEMA with acid chloride-bound nanotubes by esterification reaction. FT-IR was used to identify functionalization of -COOH and HEMA groups attached to the surface of the nanotubes. The presence of poly(HEMA) oil the nanotubes were confirmed by FESEM, TEM, and TGA analyses. Additionally, the dispersibility of the polymer functionalized nanotubes in methanol was also demonstrated. Considering the biomedical importance of poly(HEMA) and the recent successful in vivo studies oil CNTs, in future, these materials are expected to be useful in the pharmaceutical industry as novel biomaterials composites with potential applications in drug delivery. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Kumar, Nanjundan Ashok; Ganapathy, Hullathy Subban; Kim, Jong Su; Jeong, Yong Seok; Jeong, Yeon Tae] Pukyong Natl Univ, Div Imaging Sci & Informat Engn, Pusan 608739, South Korea.
RP Jeong, YT (reprint author), Pukyong Natl Univ, Div Imaging Sci & Informat Engn, Pusan 608739, South Korea.
EM ytjeong@pknu.ac.kr
RI Nanjundan, Ashok Kumar/A-6639-2008
OI Nanjundan, Ashok Kumar/0000-0001-6502-0844
CR Abraham S, 2005, BIOMATERIALS, V26, P4767, DOI 10.1016/j.biomaterials.2005.01.031
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Baskaran D, 2005, MACROMOL RAPID COMM, V26, P481, DOI 10.1002/marc.200400564
   Baskaran D, 2004, ANGEW CHEM INT EDIT, V43, P2138, DOI 10.1002/anie.200353329
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Cadotte J., 2005, J NEURAL ENG, V2, P114
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492
   Demirelli K, 1999, POLYM INT, V48, P1244
   Gomez FJ, 2003, CHEM COMMUN, P190, DOI 10.1039/b211194b
   Kim B, 2004, LANGMUIR, V20, P8239, DOI 10.1021/la049424n
   Krizova J, 2005, J CHROMATOGR A, V1064, P247, DOI 10.1016/j.chroma.2004.12.014
   Lin Y, 2002, J PHYS CHEM B, V106, P1294, DOI 10.1021/jp013501v
   Lin Y, 2007, J MATER CHEM, V17, P1143, DOI 10.1039/b618344a
   Marshall MW, 2006, CARBON, V44, P1137, DOI 10.1016/j.carbon.2005.11.010
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   PAUL C, 2006, P NATL ACAD SCI USA, V103, P50
   Pei XW, 2007, J PHYS CHEM C, V111, P2947, DOI 10.1021/jp0673213
   Punyani S, 2007, J APPL POLYM SCI, V103, P3334, DOI 10.1002/app.25496
   Ramanathan T, 2005, CHEM MATER, V17, P1290, DOI 10.1021/cm048357f
   Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7
   Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Sreenivasan K, 1999, J APPL POLYM SCI, V74, P113
   Yavuz H, 2002, BIOCHEM ENG J, V10, P1, DOI 10.1016/S1369-703X(01)00146-2
NR 27
TC 58
Z9 59
U1 2
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAR
PY 2008
VL 44
IS 3
BP 579
EP 586
DI 10.1016/j.eurpolymj.2007.12.009
PG 8
WC Polymer Science
SC Polymer Science
GA 297GH
UT WOS:000255604600003
DA 2018-10-19
ER

PT J
AU Innocenti, M
   Civinini, R
   Villano, M
   Carulli, C
AF Innocenti, M.
   Civinini, R.
   Villano, M.
   Carulli, C.
TI New biomaterial in total knee arthroplasty for hemophilic arthropathy
SO HAEMOPHILIA
LA English
DT Meeting Abstract
C1 [Innocenti, M.; Civinini, R.; Villano, M.; Carulli, C.] Univ Florence, Orthopaed Clin 2, Florence, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1351-8216
J9 HAEMOPHILIA
JI Haemophilia
PD MAR
PY 2008
VL 14
IS 2
BP 401
EP 402
PG 2
WC Hematology
SC Hematology
GA 269CC
UT WOS:000253626100040
DA 2018-10-19
ER

PT J
AU Cegielski, M
   Izykowska, I
   Podhorska-Okolow, M
   Zabel, M
   Dziegiel, P
AF Cegielski, Marek
   Izykowska, Ilona
   Podhorska-Okolow, Marzena
   Zabel, Maciej
   Dziegiel, Piotr
TI Development of foreign body giant cells in response to implantation of
   Spongostan (R) as a scaffold for cartilage tissue engineering
SO IN VIVO
LA English
DT Article
DE Spongostan (R); foreign body giant cells; cartilage tissue engineering;
   rabbit
ID FUSION
AB Spongostan (R) a gelatinous haemostatic sponge, is used in surgety. Moreover, Spongostano (R) may serve as a scaffold for proteins or cells implanted into defects. At the site of biomaterial implantation, foreign body giant cells (FBGCs) may develop which are responsible for Spongostano degradation. The purpose of the present study was to examine whether Spongostano may serve as a scaffold in allogenic grafting of chondrocytes developed from rabbit auricular cartilage. The obtained results indicate that Spongostano fulfils its,function as a cell scaffold, induces no inflammatory reaction and involves development of foreign body giant cells which participate in the process of its degradation. Microscopic observation showed that FBGCs manifest presence of cytoplasmic projections and lysosomes, which participate in phagocytosis of the applied scaffold.
C1 [Cegielski, Marek; Izykowska, Ilona; Podhorska-Okolow, Marzena; Zabel, Maciej; Dziegiel, Piotr] Univ Sch Med, Dept Histol & Embryol, Wroclaw, Poland.
   [Zabel, Maciej] Med Univ, Dept Histol & Embryol, Poznan, Poland.
RP Cegielski, M (reprint author), Wroclaw Med Univ, Dept Histol & Embryol, Chalubinskiego 6A, PL-50368 Wroclaw, Poland.
EM marcel@hist.am.wroc.pl
CR Alpaslan C, 1997, BRIT J ORAL MAX SURG, V35, P129, DOI 10.1016/S0266-4356(97)90689-6
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kos Marcin, 2003, Polim Med, V33, P25
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Maluf-Meiken LCV, 2006, J MATER SCI-MATER M, V17, P481, DOI 10.1007/s10856-006-8476-7
   Paganelli C, 2006, J ORAL REHABIL, V33, P625, DOI 10.1111/j.1365-2842.2005.01594.x
   Riegels-Nielsen P, 1986, Acta Orthop Belg, V52, P46
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   ZACZYNSKA E, 2003, POLIM MED, V33, P14
NR 11
TC 16
Z9 16
U1 0
U2 3
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
J9 IN VIVO
JI In Vivo
PD MAR-APR
PY 2008
VL 22
IS 2
BP 203
EP 206
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 286NG
UT WOS:000254852000006
PM 18468404
DA 2018-10-19
ER

PT J
AU Singanan, M
   Vinodhini, S
   Abebaw, A
AF Singanan, M.
   Vinodhini, S.
   Abebaw, A.
TI Biosorption of Cr (III) from aqueous solutions using indigenous
   biomaterials
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH
LA English
DT Article
DE wastewater; biosorption; biomaterials; chromium (III); medicinal plants;
   Tridax procumbens
ID REMOVAL; CHROMIUM; ADSORPTION; CADMIUM; CHARCOAL; CARBON
AB In the present study, an indigenous medicinal plant, Tridax procumbens (Asteraceae) was used as bioadsorbent for the removal of Cr (III) ions from synthetic wastewater and the method was also applied for real sample analysis. The biosorption of Cr (III) was a two-stage batch reactor process. In the first stage, raw biomaterial was used to the conversion of Cr (VI) into Cr (III). The amount of the biomaterial was 2.5g. The percent conversion was 100. The second stage involved the biosorption of Cr (III) onto the activated carbon of the biomaterial. The result indicated that, the biosorption of Cr (III) was 98.5 % at the optimum pH of 3.2. The experiments were carried out at the temperature of 25 +/- 2 degrees C. The optimum contact time was 150 min and the adsorbent dose was 2.5g of activated carbon. The effect of concentration was also studied for the design of the treatment systems and this methodology is highly suitable for the treatment of chromium containing wastewater.
C1 [Singanan, M.; Abebaw, A.] Jimma Univ, Dept Appl Chem, Ambo Coll, Ambo Town, Western Shoa, Ethiopia.
   [Vinodhini, S.] Jimma Univ, Dept Appl Biol, Ambo Coll, Ambo Town, Western Shoa, Ethiopia.
RP Singanan, M (reprint author), Jimma Univ, Dept Appl Chem, Ambo Coll, POB 19, Ambo Town, Western Shoa, Ethiopia.
EM msinganan@yahoo.com
CR Bai R.S., 2001, BIORESOURCE TECHNOL, V79, P73, DOI DOI 10.1016/S0960-8524(00)00107-3
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Dupont L, 2003, J COLLOID INTERF SCI, V263, P35, DOI 10.1016/S0021-9797(03)00241-8
   EPA (Environmental Protection Agency), 1990, EPA625590025
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   FREELAND GN, 1974, ENVIRON SCI TECHNOL, V8, P953
   GOSSET T, 1986, WATER RES, V20, P21, DOI 10.1016/0043-1354(86)90209-5
   HUANG CP, 1975, J WATER POLLUT CON F, V47, P2437
   INBARAJ BS, 2003, P INT C WAT ENV WE 2, P22
   Lee MY, 2005, J APPL POLYM SCI, V96, P44, DOI 10.1002/app.21356
   Qadeer R, 2005, SEPAR SCI TECHNOL, V40, P845, DOI 10.1081/SS-200028819
   Santhy K, 2004, SEPAR SCI TECHNOL, V39, P3331, DOI 10.1081/SS-200036561
   Singanan M., 2006, INDIAN J ENV PROT, V26, P385
   SWAMIAPPAN N, 1984, RES IND, V29, P293
   TAN WT, 1993, ENVIRON TECHNOL, V14, P277, DOI 10.1080/09593339309385290
   Upatham ES, 2002, INT J PHYTOREMEDIAT, V4, P73, DOI 10.1080/15226510208500074
   Verwilghen C, 2004, ENVIRON CHEM LETT, V2, P15, DOI 10.1007/s10311-003-0050-7
   Villaescusa I, 2000, J CHEM TECHNOL BIOT, V75, P812, DOI 10.1002/1097-4660(200009)75:9<812::AID-JCTB284>3.3.CO;2-2
   Zhao M, 1997, BIOTECHNOL APPL BIOC, V26, P179
NR 19
TC 4
Z9 4
U1 0
U2 1
PU UNIV TEHRAN
PI TEHRAN
PA GRADUATE FAC ENV, NO 20 GHODS ST, ENGHELAB AVE, PO BOX 14155-6135,
   TEHRAN, 00000, IRAN
SN 1735-6865
J9 INT J ENVIRON RES
JI Int. J. Environ. Res.
PD SPR
PY 2008
VL 2
IS 2
BP 177
EP 182
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 303DD
UT WOS:000256018900010
DA 2018-10-19
ER

PT J
AU Yoshihashi-Suzuki, S
   Sato, I
   Awazu, K
AF Yoshihashi-Suzuki, Sachiko
   Sato, Izuru
   Awazu, Kunio
TI Wavelength dependence of matrix-assisted laser desorption and ionization
   using a tunable mid-infrared laser
SO INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE IR-MALDI; tunable mid-infrared laser; group vibration mode; C=O
   stretching mode; IR absorption
ID DESORPTION/IONIZATION MASS-SPECTROMETRY; FREE-ELECTRON LASER; OPTICAL
   PARAMETRIC OSCILLATOR; 3 MU-M; INFRARED-LASER; POLYACRYLAMIDE-GEL; LARGE
   BIOMOLECULES; SINGLE-CRYSTAL; ABSORPTION; PROTEINS
AB Matrix-assisted laser desorption and ionization by infrared laser (IR-MALDI) is expected to be an effective methods for soft-ionization of high-molecular weight proteins and intracellular proteins. IR-MALDI is not widely used because its low sensitivity, complexity, high cost, and as it does not work well on commercial MALDI time-of-flight mass spectrometers (TOFMSs). We employed a tunable mid-infrared (MIR) laser as a light source for MALDI to investigate the IR-MALDI. The laser wavelength can be tuned within a range from 5.5 to 10.0 mu m, and included several biomaterial group vibration modes. We evaluated the wavelength dependence of ionization in IR-MALDI for four matrices: succinic acid, urea, 3,5-dimethoxy-4-hydroxycinnamic acid (sinapic acid) and 2,5-dihydroxybenzoic acid (DHB). These matrices contained various groups of vibration modes, and absorbed an infrared (IR) energy at a specific wavelength. The mass spectra of angiotensin 11 was obtained at a specific wavelength corresponding to the C=O stretching and benzene ring vibration mode. In IR-MALDI, we considered the strong molecular bond attracting an electron from a neighboring hydrogen atom, possibly protonating the hydrogen atom. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Yoshihashi-Suzuki, Sachiko; Sato, Izuru; Awazu, Kunio] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan.
RP Yoshihashi-Suzuki, S (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM suzuki-s@see.eng.osaka-u.ac.jp
CR Baltz-Knorr M, 2002, J MASS SPECTROM, V37, P254, DOI 10.1002/jms.295
   Berkenkamp S, 1996, P NATL ACAD SCI USA, V93, P7003, DOI 10.1073/pnas.93.14.7003
   Berkenkamp S, 1997, RAPID COMMUN MASS SP, V11, P1399
   BERKENKAMP S, 1998, P 46 ASMS C MASS SPE, P7
   Caldwell KL, 1998, APPL SURF SCI, V127, P242, DOI 10.1016/S0169-4332(97)00638-7
   Caldwell KL, 1997, J MASS SPECTROM, V32, P1374, DOI 10.1002/(SICI)1096-9888(199712)32:12<1374::AID-JMS600>3.0.CO;2-Y
   Cramer R, 1997, INT J MASS SPECTROM, V169, P51, DOI 10.1016/S0168-1176(97)00223-1
   Cramer R, 1996, J AM SOC MASS SPECTR, V7, P1187, DOI 10.1016/S1044-0305(96)00111-0
   Dreisewerd K, 2003, INT J MASS SPECTROM, V226, P189, DOI 10.1016/S1387-3806(02)00977-6
   EHRING H, 1992, ORG MASS SPECTROM, V27, P472, DOI 10.1002/oms.1210270419
   Finsterbusch K, 2004, APPL PHYS B-LASERS O, V79, P457, DOI 10.1007/s00340-004-1581-8
   Haidar S, 1999, APPL OPTICS, V38, P1798, DOI 10.1364/AO.38.001798
   Hess WP, 1998, APPL SURF SCI, V127, P235, DOI 10.1016/S0169-4332(97)00637-5
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   Laboy JL, 2004, APPL SPECTROSC, V58, P451, DOI 10.1366/000370204773580301
   Laiko VV, 2002, J AM SOC MASS SPECTR, V13, P354, DOI 10.1016/S1044-0305(02)00341-0
   Little MW, 2007, J PHYS CHEM C, V111, P1412, DOI 10.1021/jp063154v
   Menzel C, 2001, INT J MASS SPECTROM, V207, P73, DOI 10.1016/S1387-3806(01)00363-3
   Menzel C, 2002, J AM SOC MASS SPECTR, V13, P975, DOI 10.1016/S1044-0305(02)00397-5
   Naito Y, 2005, INT J MASS SPECTROM, V241, P49, DOI 10.1016/j.ijms.2004.11.001
   Naito Y, 2004, NUCL INSTRUM METH A, V528, P609, DOI 10.1016/j.nima.2004.04.112
   OVERBERG A, 1990, RAPID COMMUN MASS SP, V4, P293, DOI 10.1002/rcm.1290040808
   OVERBERG A, 1991, RAPID COMMUN MASS SP, V5, P128, DOI 10.1002/rcm.1290050308
   Sheffer JD, 1998, RAPID COMMUN MASS SP, V12, P1685, DOI 10.1002/(SICI)1097-0231(19981130)12:22<1685::AID-RCM389>3.0.CO;2-S
   Sheffer JD, 2000, J MASS SPECTROM, V35, P95, DOI 10.1002/(SICI)1096-9888(200001)35:1<95::AID-JMS914>3.0.CO;2-V
   STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008
   Vodopyanov KL, 2000, OPT LETT, V25, P841, DOI 10.1364/OL.25.000841
   Vodopyanov KL, 1999, APPL PHYS LETT, V75, P1204, DOI 10.1063/1.124642
   Xu YC, 2006, J AM SOC MASS SPECTR, V17, P469, DOI 10.1016/j.jasms.2005.12.003
   Xu YC, 2004, ANAL CHEM, V76, P1078, DOI 10.1021/ac034879n
   Yoshihashi-Suzuki S., 2003, Review of Laser Engineering, V31, P835, DOI 10.2184/lsj.31.835
NR 31
TC 5
Z9 5
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-3806
EI 1873-2798
J9 INT J MASS SPECTROM
JI Int. J. Mass Spectrom.
PD MAR 1
PY 2008
VL 270
IS 3
BP 134
EP 138
DI 10.1016/j.ijms.2007.12.003
PG 5
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA 269OG
UT WOS:000253657900005
DA 2018-10-19
ER

PT J
AU Leite, FRM
   Ramalho, LTD
AF Manzolli Leite, Fabio Renato
   de Oliveira Ramalho, Lizeti Toledo
TI Bone regeneration after demineralized bone matrix and castor oil
   (Ricinus communis) polyurethane implantation
SO JOURNAL OF APPLIED ORAL SCIENCE
LA English
DT Article
DE bone regeneration; Ricinus communis; bone substitutes
ID MORPHOGENETIC PROTEIN; BIO-OSS; DEFECTS
AB Innocuous biocompatible materials have been searched to repair or reconstruct bone defects. Their goal is to restore the function of live or dead tissues. This study compared connective tissue and bone reaction when exposed to demineralized bovine bone matrix and a polyurethane resin derived from castor bean (Ricinus communis). Forty-five rats were assigned to 3 groups of 15 animals (control, bovine bone and polyurethane). A cylindrical defect was created on mandible base and filled with bovine bone matrix and the polyurethane. Control group received no treatment. Analyses were performed after 15, 45 and 60 days (5 animals each). Histological analysis revealed connective tissue tolerance to bovine bone with local inflammatory response similar to that of the control group. After 15 days, all groups demonstrated similar outcomes, with mild inflammatory reaction, probably due to the surgical procedure rather than to the material. In the polymer group, after 60 days, scarce multinucleated cells could still be observed. In general, all groups showed good stability and osteogenic connective tissue with blood vessels into the surgical area. The results suggest biocompatibility of both materials, seen by their integration into rat mandible. Moreover, the polyurethane seems to be an alternative in bone reconstruction and it is an inexhaustible source of biomaterial.
C1 [Manzolli Leite, Fabio Renato] Sao Paulo State Univ, Dent Sch Araraquara, Dept Diag & Surg, Araraquara, SP, Brazil.
   [de Oliveira Ramalho, Lizeti Toledo] Sao Paulo State Univ, Dent Sch Araraquara, Dept Morphol, Araraquara, SP, Brazil.
RP Leite, FRM (reprint author), Av Altino Correia Almeida Moraes, BR-14801080 Araraquara, SP, Brazil.
EM leite.fabio@gmail.com
RI Leite, Fabio/G-5709-2013
OI Leite, Fabio/0000-0002-8053-4517
CR ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   Boyne PJ, 1997, OSSEOUS RECONSTRUCTI
   Cornell C.N., 1998, CLIN ORTHOP S, V355, P267
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   HENNING E, 1989, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V22, P204
   Hurzeler MB, 1998, INT J ORAL MAX SURG, V27, P315, DOI 10.1016/S0901-5027(05)80623-X
   Konig B, 1999, ANN ANAT, V181, P581, DOI 10.1016/S0940-9602(99)80071-5
   LAMANOCARVALHO TL, 1997, INT J ORAL MAXILLOF, V26, P149
   LAMANOCARVALHO TL, 1997, J BIOMED MATER RES, V37, P449
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P154
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
NR 17
TC 14
Z9 14
U1 0
U2 5
PU UNIV SAO PAULO FAC ODONTOLOGIA BAURU
PI BAURU-SP
PA AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL
SN 1678-7757
J9 J APPL ORAL SCI
JI J. Appl. Oral Sci.
PD MAR-APR
PY 2008
VL 16
IS 2
BP 122
EP 126
DI 10.1590/S1678-77572008000200008
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 314FU
UT WOS:000256795700008
PM 19089203
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rose, SL
   Babensee, JE
AF Rose, Stacey L.
   Babensee, Julia E.
TI Smooth muscle cell phenotype alters cocultured endothelial cell response
   to biomaterial-pretreated leukocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; endothelial cells; smooth muscle cells; leukocytes;
   coculture
ID MESSENGER-RNA EXPRESSION; TREATED BLOOD-CELLS; FLUID SHEAR-STRESS;
   NITRIC-OXIDE; TISSUE FACTOR; IN-VITRO; PROLIFERATION; ACTIVATION;
   MIGRATION; ADHESION
AB Model in vitro culturing systems were developed to analyze roles of biomaterial-induced leukocyte activation on endothelial cell (EC) and smooth muscle cell (SMC) phenotype, and their crosstalk. Isolated monocytes or neutrophils were pretreated with model biomaterial beads and applied directly to "more secretory" (cultured in media containing 5% fetal bovine serum) or forced contractile (serum and growth factor starved) human aortic SMCs (HASMCs), or to the human aortic EC (HAEC) surface of HAEC/HASMC cocultures (HASMC phenotype varied to be "more or less secretory") for 5 or 24 h of static culture. Surface expression of proinflammatory [ICAM-1, VCAM-1, E-selectin], procoagulant (tissue factor), and anticoagulant (thrombomodulin) markers, as well as HAEC proliferation, were assessed by flow cytometry. Incubation of HAEC with biomaterial-pretreated monocytes (and neutrophils to lesser degree) suppressed HAEC proliferation and induced a proinflammatory/procoagulant HAEC phenotype. This HAEC phenotype was amplified in coculture with "more secretory" HASMCs and subdued in coculture with "less secretory" HASMCs. Direct incubation of biomaterial-pretreated monocytes or neutrophils with "more secretory" HASMCs further increased HASMC ICAM-1 and tissue factor expression. Direct incubation of biomaterial-pretreated monocytes or neutrophils with forced contractile HASMCs upregulated ICAM-1, VCAM-I, and tissue factor expression above the presence of serum-containing media alone. (C) 2007 Wiley Periodicals, Inc. J Biomed Mater Res.
C1 [Rose, Stacey L.; Babensee, Julia E.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.
RP Babensee, JE (reprint author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30322 USA.
EM julia.babensee@bme.gatech.edu
CR BUZBY JS, 1994, EXP HEMATOL, V22, P122
   CAMPBELL GR, 1995, VASCULAR SMOOTH MUSC, P3
   Chiu JJ, 2004, J BIOMECH, V37, P531, DOI 10.1016/j.jbiomech.2003.08.012
   Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560
   CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929
   Cucina A, 2003, J SURG RES, V109, P16, DOI 10.1006/jsre.2002.6565
   Cullen JP, 2004, THROMB RES, V114, P57, DOI 10.1016/j.thromres.2004.05.003
   DE CR, 1995, J CLIN INVEST, V96, P60
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   Farb A, 2003, CIRCULATION, V108, P1701, DOI 10.1161/01.CIR.0000091115.05480.B0
   FILLINGER MF, 1993, J VASC SURG, V17, P1058, DOI 10.1016/0741-5214(93)90676-D
   Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583
   Imberti B, 2002, ENDOTHELIUM-NEW YORK, V9, P11, DOI 10.1080/10623320210714
   Kereiakes Dean J, 2004, Rev Cardiovasc Med, V5, P9
   Kladakis SM, 2004, ENDOTHELIUM-J ENDOTH, V11, P29, DOI 10.1080/10623320490432461
   Lester EA, 2003, J BIOMED MATER RES A, V64A, P397, DOI 10.1002/jbm.a.10378
   Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338
   Nackman GB, 1998, SURGERY, V124, P353, DOI 10.1016/S0039-6060(98)70141-2
   Nackman GB, 1996, SURGERY, V120, P418, DOI 10.1016/S0039-6060(96)80318-7
   RABAUSCH K, 2005, CIRC RES, V96, P1
   Rainger GE, 2001, J IMMUNOL METHODS, V255, P73, DOI 10.1016/S0022-1759(01)00427-6
   RODGERS C, 1995, CIRCULATION, V91, P2995
   Rolfe BE, 2000, ATHEROSCLEROSIS, V149, P99, DOI 10.1016/S0021-9150(99)00322-6
   Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222
   ROSE SL, UNPUB ANN BIOMED ENG
   Schecter AD, 2000, CIRC RES, V87, P126, DOI 10.1161/01.RES.87.2.126
   SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791
   SUEN Y, 1994, BLOOD, V84, P4125
   TACHIYAMA G, 1986, THROMB RES, V137, P309
   Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004
   Vouyouka AG, 2003, J SURG RES, V110, P344, DOI 10.1006/jsre.2003.6614
   Wang BY, 1996, J AM COLL CARDIOL, V28, P1573, DOI 10.1016/S0735-1097(96)00337-3
   Yao L, 2002, J LEUKOCYTE BIOL, V71, P47
   ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980
   Zhang JC, 1999, J VASC RES, V36, P126, DOI 10.1159/000025635
NR 38
TC 10
Z9 10
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2008
VL 84A
IS 3
BP 661
EP 671
DI 10.1002/jbm.a.31305
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260DE
UT WOS:000252990200011
PM 17635014
DA 2018-10-19
ER

PT J
AU Pushpakanth, S
   Srinivasan, B
   Sastry, TP
   Mandal, AB
AF Pushpakanth, Sujatha
   Srinivasan, Balaji
   Sastry, Thotapalli P.
   Mandal, Asit Baran
TI Biocompatible and antibacterial properties of silver-doped
   hydroxyapatite
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE silver hydroxyapatite; nanocomposite; antibacterial
ID NANOPARTICLES; REDUCTION; SURFACE; PHOSPHATE; TITANIUM; FILMS;
   RESISTANCE; CATALYSTS; COLLOIDS; NITRATE
AB We describe here new biomaterial silver-hydroxyapatite nanocomposite and its biocompatible properties for medical application, which was synthesized by ex-situ method.
C1 [Mandal, Asit Baran] Cent Leather Res Inst, Chem Lab, Phys & Inorgan Chem Div, Madras 600020, Tamil Nadu, India.
   [Pushpakanth, Sujatha; Srinivasan, Balaji; Sastry, Thotapalli P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Mandal, AB (reprint author), Cent Leather Res Inst, Chem Lab, Phys & Inorgan Chem Div, Madras 600020, Tamil Nadu, India.
RI Mandal, Asit Baran/B-9977-2009
CR Choudary BM, 2005, J AM CHEM SOC, V127, P9948, DOI 10.1021/ja0436594
   CLEARFIELD A, 1988, CHEM REV, V88, P125, DOI 10.1021/cr00083a007
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   GUTIERREZ M, 1993, J PHYS CHEM-US, V97, P11368, DOI 10.1021/j100146a003
   Khanna PK, 2003, MATER LETT, V57, P2242, DOI 10.1016/S0167-577X(02)01203-X
   Kim JW, 2004, POLYMER, V45, P4741, DOI 10.1016/j.polymer.2004.04.062
   Kolar M, 2001, INT J ANTIMICROB AG, V17, P357, DOI 10.1016/S0924-8579(01)00317-X
   Krupa D, 2001, BIOMATERIALS, V22, P2139, DOI 10.1016/S0142-9612(00)00405-1
   Leopold N, 2003, J PHYS CHEM B, V107, P5723, DOI 10.1021/jp027460u
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   MATIJEVIC E, 1993, CHEM MATER, V5, P412, DOI 10.1021/cm00028a004
   Mori K, 2002, J AM CHEM SOC, V124, P11572, DOI 10.1021/ja020444q
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nickel U, 2000, LANGMUIR, V16, P9087, DOI 10.1021/la000536y
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sondi I, 2003, J COLLOID INTERF SCI, V260, P75, DOI 10.1016/S0021-9797(02)00205-9
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   SUJATHA KA, 2006, J BIO MED NANOTECHNO, V2, P1
   Sun RWY, 2005, CHEM COMMUN, P5059, DOI 10.1039/b510984a
   Tarasevich BJ, 2003, J PHYS CHEM B, V107, P10367, DOI 10.1021/jp027445p
   Thiel J, 2007, SMALL, V3, P799, DOI 10.1002/smll.200600481
   Timlin JA, 2000, ANAL CHEM, V72, P2229, DOI 10.1021/ac9913560
   Wang QF, 2006, CHEM MATER, V18, P1988, DOI 10.1021/cm052654i
   Wang QF, 2005, CHEM MATER, V17, P3563, DOI 10.1021/cm050646w
   Yamaguchi K, 2000, J AM CHEM SOC, V122, P7144, DOI 10.1021/ja001325i
NR 25
TC 11
Z9 12
U1 0
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2008
VL 4
IS 1
BP 62
EP 66
DI 10.1166/jbn.2008.009
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 265DQ
UT WOS:000253339700007
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Boudesocque, S
   Guillon, E
   Aplincourt, M
   Martel, F
   Noel, S
AF Boudesocque, Stephanie
   Guillon, Emmanuel
   Aplincourt, Michel
   Martel, Frederic
   Noel, Sandrine
TI Use of a low-cost biosorbent to remove pesticides from wastewater
SO JOURNAL OF ENVIRONMENTAL QUALITY
LA English
DT Article
ID SUGAR-INDUSTRY WASTE; BAGASSE FLY-ASH; LIGNOCELLULOSIC SUBSTRATE; WHEAT
   BRAN; ADSORPTION; SORPTION; CARBON; SURFACTANT; RESIDUE; SYSTEM
AB A lignocellulosic substrate (LS) obtained from our local agroindustry was used as a low-cost and effective adsorbent for the removal of pesticides from wastewaters. The studied pesticides were terbumeton (N-(1,1-dimethyl)-N'ethyl-6-methoxy-1,3,5-triazine-2,4-diamine), desethyl terbumeton (N-(1,1-dimethylethyl)-6-methoxy-1,3,5-triazine-2,4-diamine), dimetomorph (4-[3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl) acryloyl]morpholine), and isoproturon (3-(4-isopropylphenyl)-1,1-dimethylurea). Batch and column experiments were conducted as a function of pH and pesticide concentration under laboratory and industrial conditions. The concentration range studied for the pesticides varied from 2 x 10(-7) to 3 x 10(-4) mol L-1. The influence of organic and inorganic pollutants was assessed by studying the retention of pesticide in the presence of copper(II) and a surfactant. These experiments indicated that LS is an efficient adsorbent toward the investigated pesticides and has little influence of the other pollutants. The kinetic adsorptions are fast, and the amounts of adsorbed pesticide varied from 1 to 8 g kg(-1) of LS. These retention capacities show that LS can provide a simple, effective, and cheap method for removing pesticides from contaminated waters. Thus, this biomaterial may be useful for cleaning up polluted waters.
C1 [Boudesocque, Stephanie; Guillon, Emmanuel; Aplincourt, Michel] Univ Reims, GRECI, F-51687 Reims 2, France.
   [Martel, Frederic; Noel, Sandrine] ARD Soc Agro Ind Rech & Dev, F-51110 Pomacle, France.
RP Boudesocque, S (reprint author), Univ Reims, GRECI, BP 1039, F-51687 Reims 2, France.
EM stephanie.boudesocque@univ-reims.fr
CR Abiven D, 2006, ENVIRON CHEM, V3, P53, DOI 10.1071/EN05060
   Bacaoui A, 2002, ENVIRON SCI TECHNOL, V36, P3844, DOI 10.1021/es010305t
   BARAK E, 1983, PESTIC SCI, V14, P213, DOI 10.1002/ps.2780140302
   Beigel C, 1998, PESTIC SCI, V54, P52, DOI 10.1002/(SICI)1096-9063(199809)54:1<52::AID-PS779>3.3.CO;2-Q
   Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Bras IP, 1999, ENVIRON SCI TECHNOL, V33, P631, DOI 10.1021/es980402v
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cruz-Guzman M, 2005, J AGR FOOD CHEM, V53, P7502, DOI 10.1021/jf058048p
   Dai SG, 2001, WATER RES, V35, P2286, DOI 10.1016/S0043-1354(00)00491-7
   Esumi K, 1998, COLLOID SURFACE A, V135, P59, DOI 10.1016/S0927-7757(97)00217-3
   FLOGEAC K, 2005, EUR J INORG CHEM, V8, P1552
   Gao JP, 1998, WATER RES, V32, P1662, DOI 10.1016/S0043-1354(97)00377-1
   Gupta V. K., 2006, ENCY SURFACE COLLOID, P149
   Gupta VK, 2002, WATER RES, V36, P2483, DOI 10.1016/S0043-1354(01)00474-2
   Gupta VK, 2001, WATER RES, V35, P33, DOI 10.1016/S0043-1354(00)00232-3
   Hamadi NK, 2004, J HAZARD MATER, V112, P133, DOI 10.1016/j.jhazmat.2004.04.011
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hsieh TL, 1998, J HAZARD MATER, V58, P275, DOI 10.1016/S0304-3894(97)00138-6
   Hwang ES, 2001, J AGR FOOD CHEM, V49, P5689, DOI 10.1021/jf0106650
   IglesiasJimenez E, 1996, CHEMOSPHERE, V32, P1771, DOI 10.1016/0045-6535(96)00094-X
   Kyriakopoulos GL, 2003, J ENVIRON SCI HEAL B, V38, P157, DOI 10.1081/PFC-120018446
   Largergren S, 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Martin-Gullon I, 2001, WATER RES, V35, P516, DOI 10.1016/S0043-1354(00)00262-1
   MASON YZ, 1990, WATER RES, V24, P11, DOI 10.1016/0043-1354(90)90059-F
   Merdy P, 2002, ANAL CHIM ACTA, V459, P133, DOI 10.1016/S0003-2670(02)00078-8
   PIER GD, 1997, TALANTA, V45, P425
   POLLARD SJT, 1992, SCI TOTAL ENVIRON, V116, P31, DOI 10.1016/0048-9697(92)90363-W
   Sannino F, 1997, PESTIC SCI, V51, P429
   Sayen S, 2006, COLLOID SURFACE A, V289, P126, DOI 10.1016/j.colsurfa.2006.04.020
   Sheals J, 2003, J COLLOID INTERF SCI, V262, P38, DOI 10.1016/S0021-9797(03)00207-8
   Sheals J, 2001, INORG CHEM, V40, P4302, DOI 10.1021/ic000849g
   Sudhakar Y, 1999, J ENVIRON SCI HEAL B, V34, P97, DOI 10.1080/03601239909373186
   Van Beinum W, 2006, ENVIRON SCI TECHNOL, V40, P494, DOI 10.1021/es051940s
   Wang N, 2005, CHEMOSPHERE, V59, P545, DOI 10.1016/j.chemosphere.2004.12.009
   WANG Z, 1992, ENVIRON SCI TECHNOL, V26, P560, DOI 10.1021/es00027a019
   Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a
   Yang YN, 2004, LANGMUIR, V20, P6736, DOI 10.1021/la049363t
NR 37
TC 24
Z9 24
U1 1
U2 11
PU AMER SOC AGRONOMY
PI MADISON
PA 677 S SEGOE RD, MADISON, WI 53711 USA
SN 1537-2537
J9 J ENVIRON QUAL
JI J. Environ. Qual.
PD MAR-APR
PY 2008
VL 37
IS 2
BP 631
EP 638
DI 10.2134/jeq2007.0332
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 273KR
UT WOS:000253929600041
PM 18396550
DA 2018-10-19
ER

PT J
AU Jiang, LY
   Li, YB
   Zhang, L
   Liao, JG
AF Jiang Liuyun
   Li Yubao
   Zhang Li
   Liao Jianguo
TI Preparation and properties of a novel bone repair composite:
   nano-hydroxyapatite/chitosan/carboxymethyl cellulose
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CARDIAC-VALVE BIOPROSTHESES; CARBOXYMETHYL CELLULOSE; BOVINE
   PERICARDIUM; IN-VITRO; HYDROXYAPATITE; CHITOSAN; CALCIFICATION;
   BIOMATERIAL; SCAFFOLDS; GRAFT
AB Nano-hydroxyapatite/chitosan/carboxymethyl cellulose (n-HA/CS/CMC) composites with weight ratios of 70/10/20, 70/15/15 and 70/20/10 were prepared through a co-solution method. The properties of the composites were characterized by means of burn-out test, IR, XRD, TEM and universal material testing machine. The degradation and bioactivity were also investigated by in vitro test in a simulated body fluid (SBF) for 8 weeks. The results showed that n-HA particles were dispersed uniformly in organic phase, and strong chemical interactions formed among the three phases. Moreover, the composites were similar to natural bone in morphology and size. In addition, the compressive strength was improved compared with n-HA/CS composite. The biodegradation rate was controllable by altering weight ratio of the CS/CMC. Meanwhile, the composites could induce apatite particles to deposit in SBF. All the above results indicate that the novel composites of n-HA/CS/CMC have a promising prospect used for bone repair materials in view of the good mechanical property, adjustable biodegradation rate and bioactivity in SBF. Additionally, the study would provide a good guide to exploit clinical application of natural cellulose.
C1 [Jiang Liuyun; Li Yubao; Zhang Li; Liao Jianguo] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
EM nic7504@scu.edu.cn
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   ARGUELLESMONAL W, 1988, MAKROMOL CHEM-RAPID, V9, P693
   Beck DE, 1997, EUR J SURG, V163, P49
   Biswal DR, 2004, CARBOHYD POLYM, V57, P379, DOI 10.1016/j.carbpol.2004.04.020
   Burns JW, 1997, EUR J SURG, V163, P40
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   FUKUDA H, 1979, MAKROMOL CHEM, V180, P1631
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   He DL, 2000, TALANTA, V50, P1267, DOI 10.1016/S0039-9140(99)00229-5
   Hong ZK, 2004, POLYMER, V45, P6699, DOI 10.1016/j.polymer.2004.07.036
   Huang M, 2003, J MATER SCI-MATER M, V14, P655, DOI 10.1023/A:1024087410890
   ITO HS, 2001, J BIOMED MATER RES, V54, P445
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Just E.K., 1989, ENCY POLYM SCI ENG, V3, P226
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   LAHIJI A, 2000, J BIOMED MATER RES, V49, P301
   MARCOLONGO M, 1998, J MATER SCI-MATER M, V39, P61
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   MORITZ A, 1991, EUR J CARDIO-THORAC, V5, P155, DOI 10.1016/1010-7940(91)90214-5
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Qiu QQ, 2000, J BIOMED MATER RES, V52, P66, DOI 10.1002/1097-4636(200010)52:1<66::AID-JBM9>3.0.CO;2-2
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SIEGER CHN, 1995, CARBOHYD POLYM, V27, P137, DOI 10.1016/0144-8617(95)00039-A
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   Watanabe Y, 2001, ACTA MATER, V49, P775, DOI 10.1016/S1359-6454(00)00384-0
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   WON KH, 2005, J BIOMED MATER RES, V72, P136
   WU L, 2006, MATER SCI FORUM, V938, P510
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhang Li, 2004, High Technology Letters (English Language Edition), V10, P48
NR 38
TC 35
Z9 38
U1 6
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2008
VL 19
IS 3
BP 981
EP 987
DI 10.1007/s10856-007-3208-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269HS
UT WOS:000253640700003
PM 17665104
DA 2018-10-19
ER

PT J
AU Fei, ZQ
   Hu, YY
   Wu, DC
   Wu, H
   Lu, R
   Bai, JP
   Song, HX
AF Fei, Zhengqi
   Hu, Yunyu
   Wu, Daocheng
   Wu, Hong
   Lu, Rong
   Bai, Jianping
   Song, Hongxun
TI Preparation and property of a novel bone graft composite consisting of
   rhBMP-2 loaded PLGA microspheres and calcium phosphate cement
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIODEGRADABLE POLYMER MICROPARTICLES; GROWTH-FACTOR BETA-1; IN-VIVO;
   HYDROXYAPATITE CEMENT; IMPLANTS; CHONDROGENESIS; OSTEOGENESIS;
   MACROPORES; CERAMICS; INGROWTH
AB Calcium phosphate cement (CPC) is a highly promising bone substitute and an excellent carrier for delivering growth factors. Yet, the lack of macro-porosity and osteoinductive ability, limit its use. This study is aimed at developing a novel biodegradable biomaterial for bone repair with both highly osteoconductive and osteoinductive properties. RhBMP-2 loaded PLGA microspheres were incorporated into rhBMP-2/CPC for macropores for bone ingrowth. The compressive strength, crystallinity, microscopic structure, and bioactivity of the composites were investigated. The results showed that with the incorporation of rhBMP-2 loaded PLGA microspheres, the compressive strength was decreased from (29.48 +/- 6.42) MPa to (8.26 +/- 3.58) MPa. X-ray diffraction revealed that the crystallinity pattern of HA formed by CPC had no significant change. Inside the composite, the microspheres distributed homogeneously and contacted intimately with the HA matrix, as observed by scanning electron microscopy (SEM). When the PLGA microspheres dissolved after having been emerged in PBS for 56 days, macropores were created within the CPC. The rhBMP-2/PLGA/CPC composite, showing a 4.9% initial release of rhBMP-2 in 24 h, followed by a prolonged release for 28 days, should have a greater amount of rhBMP-2 released compared to the CPC delivery system. When rabbit marrow stromal cells were cocultured with the composite, the alkaline phosphatase (ALP) and osteocalcin (OC) showed a dose response to the rhBMP-2 released from the composite, indicating that the activity of rhBMP-2 was retained. This study shows that the new composite reveals more rhBMP-2 release and osteogenic activity. This novel BMP/PLGA/CPC composite could be a promising synthetic bone graft in craniofacial and orthopedic repairs.
C1 [Fei, Zhengqi; Hu, Yunyu; Lu, Rong; Bai, Jianping; Song, Hongxun] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopead, Xian 710032, Peoples R China.
   [Wu, Daocheng; Wu, Hong] Fourth Mil Med Univ, Div Pharmchem, Xian 710032, Peoples R China.
RP Hu, YY (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopead, Changle W Rd, Xian 710032, Peoples R China.
EM Orthol@fmmu.edu.cn
OI Wu, Daocheng/0000-0002-6183-539X
CR Blom EJ, 2002, J BIOMED MATER RES, V59, P265, DOI 10.1002/jbm.1241
   Constantino PD, 1992, PLAST RECONSTR SURG, V90, P174
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   FEI ZQ, 2006, IN PRESS BIOMED ENG, V10
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Ikenaga M, 1998, J BIOMED MATER RES, V40, P139, DOI 10.1002/(SICI)1097-4636(199804)40:1<139::AID-JBM16>3.0.CO;2-J
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MARTIN RB, 1989, BIOMATERIALS, V10, P481, DOI 10.1016/0142-9612(89)90090-2
   Nicolai B K, 2002, BIOMOL ENG, V19, P227
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   Takagi S, 2001, J MATER SCI-MATER M, V12, P135, DOI 10.1023/A:1008917910468
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
NR 22
TC 47
Z9 54
U1 1
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2008
VL 19
IS 3
BP 1109
EP 1116
DI 10.1007/s10856-007-3050-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269HS
UT WOS:000253640700018
PM 17701313
DA 2018-10-19
ER

PT J
AU Gyorgy, E
   Axente, E
   Mihailescu, IN
   Predoi, D
   Ciuca, S
   Neamtu, J
AF Gyoergy, E.
   Axente, E.
   Mihailescu, I. N.
   Predoi, D.
   Ciuca, S.
   Neamtu, J.
TI Creatinine biomaterial thin films grown by laser techniques
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SECONDARY STRUCTURE; DEPOSITION; MATRIX; EVAPORATION; PROTEIN
AB Creatinine thin films were synthesised by matrix assisted pulsed laser deposition (PLD) techniques for enzyme-based biosensor applications. An UV KrF* (lambda = 248 nm, tau similar to 10 ns) excimer laser source was used for the irradiation of the targets at incident fluence values in the 0.3-0.5 J/cm(2) range. For the matrix assisted PLD the targets consisted on a frozen composite obtained by dissolving the biomaterials in distilled water. The surface morphology, chemical composition and structure of the obtained biomaterial thin films were investigated by scanning electron microscopy, Fourier transform infrared spectroscopy, and electron dispersive X-ray spectroscopy as a function of the target preparation procedure and incident laser fluence.
C1 [Gyoergy, E.; Axente, E.; Mihailescu, I. N.] Natl Inst Lasers Plasma & Radiat Phys, Bucharest 77125, Romania.
   [Gyoergy, E.] Inst Ciencia Mat Barcelona, Consejo Super Invest Cient, Bellaterra 08193, Spain.
   [Predoi, D.] Natl Inst Phys Mat, Bucharest, Magurele, Romania.
   [Ciuca, S.] Univ Politehn Bucuresti, Bucharest 77204, VI, Romania.
   [Neamtu, J.] Univ Med & Pharm Craiova, Fac Pharm, Dept Phys, Craiova 1100, Romania.
RP Gyorgy, E (reprint author), Natl Inst Lasers Plasma & Radiat Phys, POB MG 36, Bucharest 77125, Romania.
EM eniko@ifin.nipne.ro
RI Ciuca, Sorin/E-8786-2015; Gyorgy, Eniko/C-4620-2012; AXENTE,
   Emanuel/C-4812-2011; Neamtu, Johny/G-2494-2016; Predoi,
   Daniela/C-4294-2011; Mihailescu, Ion/A-5403-2011
OI Ciuca, Sorin/0000-0002-4343-5704; Neamtu, Johny/0000-0002-1460-7386;
   Predoi, Daniela/0000-0003-3024-6290; AXENTE, Emanuel/0000-0003-1946-5863
CR Bauerle D., 1996, LASER PROCESSING CHE
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Gutierrez-Llorente A, 2004, ORG ELECTRON, V5, P29, DOI 10.1016/j.orgel.2003.11.003
   Hashioka S, 2004, APPL PHYS LETT, V85, P687, DOI 10.1063/1.1772523
   Mihailescu IN, 1999, TRENDS OPTICS PHOTON, P201
   Pique A, 1998, MATER RES SOC SYMP P, V526, P421, DOI 10.1557/PROC-526-421
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Sagawa J, 2005, APPL SURF SCI, V244, P611, DOI 10.1016/j.apsusc.2004.09.162
   Stamatin L, 2005, APPL SURF SCI, V248, P422, DOI 10.1016/j.apsusc.2005.03.060
   Taketani I, 2005, APPL SURF SCI, V244, P623, DOI 10.1016/j.apsusc.2004.09.167
   Toftmann B, 2004, THIN SOLID FILMS, V453, P177, DOI 10.1016/j.tsf.2003.11.099
   Tsuboi Y, 2001, J APPL PHYS, V89, P7917, DOI 10.1063/1.1371266
   von Allmen M. B., 1995, LASER BEAM INTERACTI
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 16
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2008
VL 19
IS 3
BP 1335
EP 1339
DI 10.1007/s10856-007-3254-8
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269HS
UT WOS:000253640700046
PM 17914621
DA 2018-10-19
ER

PT J
AU Schmitt, SC
   Wiedmann-Al-Ahmad, M
   Kuschnierz, J
   Al-Ahmad, A
   Huebner, U
   Schmelzeisen, R
   Gutwald, R
AF Schmitt, Sandra C.
   Wiedmann-Al-Ahmad, Margit
   Kuschnierz, Jens
   Al-Ahmad, Ali
   Huebner, Ute
   Schmelzeisen, Rainer
   Gutwald, Ralf
TI Comparative in vitro study of the proliferation and growth of ovine
   osteoblast-like cells on various alloplastic biomaterials manufactured
   for augmentation and reconstruction of tissue or bone defects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIODEGRADABLE POLYMER SCAFFOLDS; HUMAN OSTEOGENIC PROTEIN-1; POROUS
   HYDROXYAPATITE; TRANSPLANTATION; SURGERY; SHEEP; COMPOSITES; ROUGHNESS;
   CARTILAGE; MAXILLARY
AB In this in vitro study ovine osteoblast-like cells were cultured on seven different alloplastic biomaterials used for augmentation and for reconstruction of bone defects in dental and craniomaxillofacial surgery. The aim of this study was to examine the growth behaviour (viability, cell density and morphology) of ovine osteoblast-like cells on the investigated biomaterials to get knowledge which biomaterial is qualified to act as a cell carrier system in further in vivo experiments. The biomaterials were either synthetically manufactured or of natural origin. As synthetically manufactured biomaterials Ethisorb(R), MakroSorb(R), Palacos(R)R, and PDS(R) film were used. As biomaterials of natural origin Beriplast(R)P, Bio-Oss(R) and Titanmesh were investigated. The cell proliferation and cell colonization were analyzed by a proliferation assay and scanning electron microscopy. Osteoblast-like cells proliferated and attached on all biomaterials, except on Beriplast(R). On Ethisorb(R) the highest cell proliferation rate was measured followed by Palacos(R)R. Both biomaterials offer suitable growth and proliferation conditions for ovine osteoblast-like cells. The proliferation rates of Bio-Oss(R), MakroSorb(R), PDS(R)-film and Titanmesh were low and SEM examinations of these materials showed less spread osteoblast-like cells. The results showed that ovine osteoblast-like cells appear to be sensitive to substrate composition and topography. This in vitro study provides the basis for further in vivo studies using the sheep model to examine the biocompatibility and the long-term interaction between the test material and tissue (bone regeneration).
C1 [Schmitt, Sandra C.; Wiedmann-Al-Ahmad, Margit; Kuschnierz, Jens; Huebner, Ute; Schmelzeisen, Rainer; Gutwald, Ralf] Univ Freiburg, Klin Mund Kiefer & Gesichtschirurg, D-79106 Freiburg, Germany.
   [Al-Ahmad, Ali] Univ Freiburg, Abt Zahnerhaltungskunde & Parodontol, Univ Klin Zahn Mund & Kieferheilkunde, D-79106 Freiburg, Germany.
RP Wiedmann-Al-Ahmad, M (reprint author), Univ Freiburg, Klin Mund Kiefer & Gesichtschirurg, Hugstetterstr 55, D-79106 Freiburg, Germany.
EM wiedmannalahmad@t-online.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BLOCK MS, 1993, J AM DENT ASSOC, V124, P139, DOI 10.14219/jada.archive.1993.0127
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BOYAN BD, 1999, OSTEOLOGIE, V8, P123
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Christgau M, 2002, J CLIN PERIODONTOL, V29, P710, DOI 10.1034/j.1600-051X.2002.290808.x
   CORNWALL GB, 2003, PROTECTED BONE REGEN
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Gerber I., 2001, European Cells & Materials, V2, P10
   Grizon F, 2002, J DENT, V30, P195, DOI 10.1016/S0300-5712(02)00018-0
   GROB D, 1989, BONE TRANSPLANTATION, P32
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Hausamen J E, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P163
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   HURZELER MB, 1997, CLIN ORAL IMPLAN RES, V8, P467
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KRUBLER NR, 1997, MUND KIEFER GESICHTS, V1, P2
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   LEE DD, 1999, CLIN ORTHOP RELAT R, V367, P396
   Malekzadeh R, 1998, J PERIODONTOL, V69, P1256, DOI 10.1902/jop.1998.69.11.1256
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   SALYER KE, 1987, CLIN PLAST SURG, V14, P27
   Schmelzeisen R, 1998, J CRANIO MAXILL SURG, V26, P1, DOI 10.1016/S1010-5182(98)80028-0
   Schmelzeisen R, 1998, INT J ORAL MAX SURG, V27, P377, DOI 10.1016/S0901-5027(98)80069-6
   Schneider U, 1998, ORTHOPADE, V27, P143
   Schratt HE, 1996, UNFALLCHIRURG, V99, P679, DOI 10.1007/s001130050042
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   STARK GB, 1998, BIOL MATRICES TISSUE
   SUGAR AW, 1992, INT J ORAL MAX SURG, V21, P140, DOI 10.1016/S0901-5027(05)80780-5
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Torricelli P, 2000, J BIOMED MATER RES, V52, P177, DOI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   WATTS P, 1995, J HEPATOL, V23, P605, DOI 10.1016/0168-8278(95)80069-7
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, J BONE MINER RES, V15, P1147, DOI 10.1359/jbmr.2000.15.6.1147
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 54
TC 20
Z9 20
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2008
VL 19
IS 3
BP 1441
EP 1450
DI 10.1007/s10856-007-3238-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269HS
UT WOS:000253640700060
PM 17914632
DA 2018-10-19
ER

PT J
AU Chevalier, E
   Chulia, D
   Pouget, C
   Viana, M
AF Chevalier, Emilie
   Chulia, Dominique
   Pouget, Christelle
   Viana, Marylene
TI Fabrication of porous substrates: A review of processes using pore
   forming agents in the biomaterial field
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE pore former; porosity; texture; compaction; casting; foaming;
   bioceramics; biomaterials; powder technology; processing
ID CALCIUM-PHOSPHATE CEMENT; DRUG-DELIVERY SYSTEM; SPHERICAL HYDROXYAPATITE
   GRANULES; IN-VIVO; ALUMINA CERAMICS; MECHANICAL-PROPERTIES; EXTRUSION
   METHOD; STARCH CONSOLIDATION; SIZE DISTRIBUTION; BONE-REPLACEMENT
AB This paper is a review of solid and casting manufacturing processes able to create porous materials, mainly in the biomaterial field. The considered methods are based on pore forming agents that are removed either by heating or by dissolution. All techniques lead to products presenting pores with amount, size, and shape are close to those of the initial pore formers. Porosities up to 90% with pores ranging from 1 to 2000 mu m are reported. Major differences concern macrointerconnections that are more frequently obtained using foams, or porogens which undergo a melting stage during firing. Casting methods combined with solid free form fabrication are promising for the design of porous network through the manufacturing of 3D scaffolds corresponding to the desired porosity. (C) 2007 Wiley-Liss, Inc.
C1 [Chevalier, Emilie; Chulia, Dominique; Pouget, Christelle; Viana, Marylene] Fac Pharm, GEFSOD ES 2631, F-87025 Limoges, France.
RP Viana, M (reprint author), Fac Pharm, GEFSOD ES 2631, 2 Rue Docteur Marcland, F-87025 Limoges, France.
EM marylene.viana@unilim.fr
CR Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Bae CJ, 2006, J MATER SCI-MATER M, V17, P517, DOI 10.1007/s10856-006-8934-2
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Beruto DT, 2002, BIOMATERIALS, V23, P2509, DOI 10.1016/S0142-9612(01)00385-4
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Chandrappa GT, 2002, NATURE, V416, P702, DOI 10.1038/416702a
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Charriere E, 2003, BIOMATERIALS, V24, P809, DOI 10.1016/S0142-9612(02)00406-4
   Chen CH, 2005, J EUR CERAM SOC, V25, P3257, DOI 10.1016/j.jeurceramsoc.2004.08.019
   Chen CH, 2005, J EUR CERAM SOC, V25, P385, DOI 10.1016/j.jeurceramsoc.2004.03.016
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Collin I, 2005, ITBM RBM, V26, P247
   COLLIN I, 2006, THESIS U NANTES NANT
   CORBIN SF, 1999, J AM CERAM SOC, V82, P693
   da Silva MHP, 2002, J NON-CRYST SOLIDS, V304, P286, DOI 10.1016/S0022-3093(02)01036-0
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L
   FABBRI M, 1994, BIOMATERIALS, V15, P474, DOI 10.1016/0142-9612(94)90228-3
   Falamaki C, 2004, J EUR CERAM SOC, V24, P3195, DOI 10.1016/j.jeurceramsoc.2003.10.041
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   GREGOROVA E, 2006, IN PRESS CERAM INT
   Han YS, 2003, MATER RES BULL, V38, P373, DOI 10.1016/S0025-5408(02)01026-7
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047
   Herath H M T U, 2005, J Appl Biomater Biomech, V3, P192
   Hilbrig F, 2012, KEY ENG MATER, V1, p283 
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUBBARD W, 1974, THESIS MARUETTE U MI, P169
   Hulbert SF, 1971, J BIOMED MATER RES, V5, P269
   Ioku K, 2006, J MATER SCI, V41, P1341, DOI 10.1007/s10853-006-7338-5
   Isobe T, 2006, J EUR CERAM SOC, V26, P2213, DOI 10.1016/j.jeuceramsoc.2005.04.014
   Isobe T, 2006, J EUR CERAM SOC, V26, P957, DOI 10.1016/j.jeurceramsoc.2004.11.015
   Isobe T, 2007, J EUR CERAM SOC, V27, P61, DOI 10.1016/j.jeurceramsoc.2006.05.079
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, J MATER SCI, V38, P3783, DOI 10.1023/A:1025988301542
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Komlev VS, 2003, SCI TECHNOL ADV MAT, V4, P503, DOI 10.1016/j.stam.2003.11.007
   Komlev VS, 2003, J MATER SCI LETT, V22, P1215, DOI 10.1023/A:1025300617681
   Komlev VS, 2002, J MATER SCI-MATER M, V13, P295, DOI 10.1023/A:1014015002331
   Komlev VS, 2002, BIOMATERIALS, V23, P3449, DOI 10.1016/S0142-9612(02)00049-2
   KRAJWSKI A, 2000, J MATER SCI-MATER M, V12, P763
   Lee JS, 2003, CERAM INT, V29, P271, DOI 10.1016/S0272-8842(02)00115-3
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Lemos AF, 2000, MAT SCI ENG C-BIO S, V11, P35, DOI 10.1016/S0928-4931(00)00134-X
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   LUI DM, 1997, J MAT SCI MAT, V8, P227
   Lyckfeldt O, 1998, J EUR CERAM SOC, V18, P131, DOI 10.1016/S0955-2219(97)00101-5
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Miao X, 2004, MATER LETT, V58, P397, DOI 10.1016/S0167-577X(03)00510-X
   Milosevski M, 1999, CERAM INT, V25, P693, DOI 10.1016/S0272-8842(99)00003-6
   Montanaro L, 1998, J EUR CERAM SOC, V18, P1339, DOI 10.1016/S0955-2219(98)00063-6
   Netz DJA, 2001, INT J PHARM, V213, P117, DOI 10.1016/S0378-5173(00)00659-1
   OHASHI H, 1994, J MATER SCI-MATER M, V5, P237, DOI 10.1007/BF00121095
   OLIVEIRA JM, 2006, BIOMATERIALS, V27, P613
   Otsuka M, 1998, J CONTROL RELEASE, V52, P281, DOI 10.1016/S0168-3659(97)00264-2
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   Otsuka M, 2000, ADV DRUG DELIVER REV, V42, P249, DOI 10.1016/S0169-409X(00)00065-X
   OTSUKA M, 1994, J PHARM SCI, V83, P255, DOI 10.1002/jps.2600830229
   Padilla S, 2002, J MATER SCI-MATER M, V13, P1193, DOI 10.1023/A:1021162626006
   Palazzo B, 2005, MAT SCI ENG C-BIO S, V25, P207, DOI 10.1016/j.msec.2005.01.011
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   Prabhakaran K, 2007, CERAM INT, V33, P77, DOI 10.1016/j.ceramint.2005.07.020
   Rivera-Munoz E, 2001, J MATER SCI-MATER M, V12, P305, DOI 10.1023/A:1011290919642
   RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x
   SCHMITT M, 2000, THESIS U NANTES NANT
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Slosarczyk A, 1999, J MATER SCI LETT, V18, P1163, DOI 10.1023/A:1006677806537
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Takagi S, 2001, J MATER SCI-MATER M, V12, P135, DOI 10.1023/A:1008917910468
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tancret F, 2006, J EUR CERAM SOC, V26, P3647, DOI 10.1016/j.jeurceramsoc.2005.12.015
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   Wang C, 2005, J MATER SCI-MATER M, V16, P739, DOI 10.1007/s10856-005-2611-8
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Xu HHK, 2004, J BIOMED MATER RES A, V68A, P725, DOI 10.1002/jbm.a.20093
   Xu HHK, 2001, J BIOMED MATER RES, V57, P457, DOI 10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Yang L, 2007, CERAM INT, V33, P483, DOI 10.1016/j.ceramint.2005.10.014
   Yao XM, 2005, J MATER SCI, V40, P4939, DOI 10.1007/s10853-005-3875-6
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zeng T, 2007, CERAM INT, V33, P395, DOI 10.1016/j.ceramint.2005.09.022
   Zhang HL, 2007, ACTA MATER, V55, P171, DOI 10.1016/j.actamat.2006.07.032
NR 106
TC 99
Z9 100
U1 7
U2 100
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-3549
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAR
PY 2008
VL 97
IS 3
BP 1135
EP 1154
DI 10.1002/jps.21059
PG 20
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 268DB
UT WOS:000253557400009
PM 17688274
DA 2018-10-19
ER

PT J
AU Petter-Puchner, AH
   Fortelny, RH
   Walder, N
   Mittermayr, R
   Ohlinger, W
   van Griensven, M
   Redl, H
AF Petter-Puchner, Alexander H.
   Fortelny, Rene H.
   Walder, Nadja
   Mittermayr, Rainer
   Ohlinger, Wolfgang
   van Griensven, Martijn
   Redl, Heinz
TI Adverse effects associated with the use of porcine cross-linked collagen
   implants in an experimental model of incisional hernia repair
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE porcine cross-linked collagen; biocompatibility; rat model; hernia
   repair
ID ACELLULAR DERMAL MATRIX; SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL
   HERNIAS; FIBRIN GLUE; MESH; DEFECTS
AB Background. Porcine cross-linked collagen (PermaCol, PCL; TSL, Aldershot, United Kingdom) has been proposed as permanent biomaterial in incisional. hernia repair. We evaluated the biocompatibility of PCL in an established animal model.
   Material and methods. In 10 Sprague Dawley rats, two hernias per animal were created in the abdominal wall left and right of the linea alba (1.5 cm in diameter), and the peritoneum was spared. The lesions were left untreated for 10 days, until incisional hernias developed. These defects were covered with non-perforated (out-of-the-box, n = 12) or perforated (modified; n = 8) PCL (2 x 2 cm). In a first step, 12 non-perforated implants were tested in a short-term observation period of 17 days. Eight of these non-perforated implants were fibrin sealed (0.3 mL, Tissucol; Baxter, Vienna, Austria), whereas four non-perforated implants were sutured with non-resorbable material. In a second step, perforations were added as modification to PCL to facilitate drainage of fluids, cell ingrowth, and transgression of fibrin sealant. All perforated implants were fibrin sealed and included in a long-term observation period of 3 months. The observation periods allowed the evaluation of the complete degradation of the fibrin sealant fixation after 2 weeks and of the implant integration in a chronic timeframe. Implant sites were analyzed macroscopically and histologically.
   Results. All PCL samples elicited strong local inflammation with signs of foreign body reaction. Integration of perforated PCL appeared limited after 3 months. Three animals had to be euthanized prior to intended time points because of transcutaneous migration of implants.
   Conclusions. In an experimental model of incisional hernia repair, PCL does not integrate well in the abdominal wall and shows poor biocompatibility. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Petter-Puchner, Alexander H.; Walder, Nadja; Mittermayr, Rainer; Ohlinger, Wolfgang; van Griensven, Martijn; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Fortelny, Rene H.] Wilhelminenspital Stadt Wien, Dept Surg, Vienna, Austria.
RP Petter-Puchner, AH (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM alexander.petter@lbitrauma.org
RI van Griensven, Martijn/F-5808-2012
OI van Griensven, Martijn/0000-0001-5104-9881
CR Alwitry A, 2006, ORBIT, V25, P253, DOI 10.1080/01676830600575568
   Armellino Mariano Fortunato, 2006, Chir Ital, V58, P627
   Belcher HJCR, 2001, J HAND SURG-BRIT EUR, V26, P159, DOI 10.1054/jhsb.2001.0554
   Benizri E I, 2006, Hernia, V10, P389, DOI 10.1007/s10029-006-0112-4
   Cappabianca P, 2006, SURG NEUROL, V65, P144, DOI 10.1016/j.surneu.2005.08.023
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   CATENA F, 2006, HERNIA
   Cheung D, 2004, OPHTHAL PLAST RECONS, V20, P257, DOI 10.1097/01.IOP.0000129019.24879.C2
   Dunne JR, 2003, J SURG RES, V111, P78, DOI 10.1016/S0022-4804(03)00000-0
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Jansen PL, 2004, SURGERY, V136, P1, DOI 10.1016/j.surg.2004.01.004
   Kim H, 2006, AM J SURG, V192, P705, DOI 10.1016/j.amjsurg.2006.09.003
   Klinge U, 2001, J INVEST SURG, V14, P47
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Lovisetto F, 2007, ANN SURG, V245, P222, DOI 10.1097/01.sla.0000245832.59478.c6
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   Novik B, 2006, SURG ENDOSC, V20, P462, DOI 10.1007/s00464-005-0391-3
   Olmi Stefano, 2005, Chir Ital, V57, P753
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Petter-Puchner AH, 2006, SURG ENDOSC, V20, P942, DOI 10.1007/s00464-005-0568-9
   Petter-Puchner Alexander H, 2005, Hernia, V9, P322, DOI 10.1007/s10029-005-0009-7
   Poulose BK, 2005, J SURG RES, V123, P262, DOI 10.1016/j.jss.2004.08.011
   Ringley CD, 2006, AM J SURG, V192, P767, DOI 10.1016/j.amjsurg.2006.08.042
   Rosch R, 2003, EUR SURG RES, V35, P445, DOI 10.1159/000072230
   SanchezManuel FJ, 2004, COCHRANE DB SYST REV
   Schmidbauer S, 2005, EUR J MED RES, V10, P247
   Schug-Pass C, 2006, SURG ENDOSC, V20, P402, DOI 10.1007/s00464-004-8277-3
   Schuster R, 2006, AM J SURG, V192, P594, DOI 10.1016/j.amjsurg.2006.08.017
   Soiderer EE, 2004, J SURG RES, V118, P161, DOI 10.1016/S0022-4804(03)00352-4
   van Tuil Cornelia, 2006, Hernia, V10, P41
NR 31
TC 46
Z9 47
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD MAR
PY 2008
VL 145
IS 1
BP 105
EP 110
DI 10.1016/j.jss.2007.03.090
PG 6
WC Surgery
SC Surgery
GA 264WJ
UT WOS:000253320800015
PM 17628597
DA 2018-10-19
ER

PT J
AU Xu, JY
   Liu, ZS
   Erhan, SZ
AF Xu, Jingyuan
   Liu, Zengshe
   Erhan, Sevim Z.
TI Viscoelastic properties of a biological hydrogel produced from soybean
   oil
SO JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
LA English
DT Article
DE biodegradable material; hydrogel; rheology; soybean oil; viscoelastic
   properties
AB Hydrogels formed from biopolymers or natural sources have special advantages because they may have biodegradable and biocompatible properties. The viscoelastic properties of a newly developed biological hydrogel made from epoxidized soybean oil (ESO) were investigated. The material called HPESO is a hydrolytic product of polymerized ESO (PESO). HPESO exhibited viscoelastic solid or gel behavior above 2% (wt. %) concentration at room temperature and viscous liquid behavior at 55 degrees C. The thermal assembly disassembly reassembly function of the HPESO hydrogel was completely reversible. The viscoelastic properties of HPESO were dependent on concentration. Analysis of modulus and concentration dependence and stress relaxation measurement indicated that HPESO was a physical gel where the cross-linkers between the molecules were physical junctions. HPESO hydrogel also exhibited fast initial recovery of its viscoelastic properties after being subjected to mechanical shear disruption. The function and behavior of the HPESO hydrogel suggest that this biomaterial may be suitable for applications in drug delivery and scaffolds of bioengineering and tissue engineering.
C1 [Xu, Jingyuan; Liu, Zengshe; Erhan, Sevim Z.] USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
RP Xu, JY (reprint author), USDA ARS, Natl Ctr Agr Utilizat Res, 1815 N Univ St, Peoria, IL 61604 USA.
EM james.xu@ars.usda.gov
CR Cicchetti S, 2002, Minerva Chir, V57, P53
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Liu ZS, 2002, J APPL POLYM SCI, V85, P2100, DOI 10.1002/app.10763
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Sprung P, 1998, Ostomy Wound Manage, V44, P36
   WOOL RP, 1998, 216 ACS NAT M BOST 2
   Xu JY, 2002, J AM OIL CHEM SOC, V79, P593, DOI 10.1007/s11746-002-0528-0
   Xu JY, 2001, CEREAL CHEM, V78, P181, DOI 10.1094/CCHEM.2001.78.2.181
NR 9
TC 13
Z9 13
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0003-021X
J9 J AM OIL CHEM SOC
JI J. Am. Oil Chem. Soc.
PD MAR
PY 2008
VL 85
IS 3
BP 285
EP 290
DI 10.1007/s11746-008-1193-2
PG 6
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 265YR
UT WOS:000253398400012
DA 2018-10-19
ER

PT J
AU Seki, I
   Kimura, H
   Inoue, A
AF Seki, Ichiro
   Kimura, Hisamichi
   Inoue, Akihisa
TI Thermal stability and mechanical properties of Ti47.4Cu42Zr5.3TM5.3(TM =
   Co, Fe) metallic glass sheets prepared by twin-roller casting method
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE nickel-free metallic glass; bending fracture strain; thermal stability
ID AMORPHOUS-ALLOYS; STRUCTURAL RELAXATION; FORMING ABILITY; BEHAVIOR;
   CRYSTALLIZATION; EMBRITTLEMENT; ENTHALPY; NI; SI
AB Since Ti-based glassy alloys have high strength and high corrosion resistance, it is useful for an application field of substitution material for biomaterials such as living body bone. For the biomaterial use, the glassy alloys are required to substitute the harmful elements for the human body such as Ni. In the present study, we prepared the Ti47.4Cu42Zr5.3TM5.3(TM = Co, Fe) glassy alloy sheets by a twin-roller casting method, and investigated their thermal stability and mechanical properties. The prepared alloy sheets had flat surfaces with highly white luster, and exhibited a distinct glass transition typical to a glassy phase. The super-cooled liquid region Delta Tx defined by the difference between the glass transition temperature (Tg) and the onset temperature for crystallization (Tx) is 50 K for the Ni-containing alloy, 36 K for the Co-containing alloy and 32 K for the Fe-containing alloy. All the alloy sheets exhibit good bending ductility and their Vickers hardness is in the range of 590 to 600.
C1 [Seki, Ichiro; Kimura, Hisamichi; Inoue, Akihisa] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Seki, I (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI 関, 一郎/C-4211-2015; Inoue, Akihisa/E-5271-2015; Kimura,
   Hisamichi/D-5449-2012
CR CHEN HS, 1981, J APPL PHYS, V52, P1868, DOI 10.1063/1.329554
   Hattori Masami, 1996, Aichi-Gakuin Dental Science, V9, P15
   INOUE A, 1985, J MATER SCI, V20, P2323, DOI 10.1007/BF00556062
   INOUE A, 1978, J JPN I MET, V42, P303, DOI 10.2320/jinstmet1952.42.3_303
   INOUE A, 1985, J MATER SCI, V20, P4057, DOI 10.1007/BF00552399
   KAWASHIMA A, 1980, CORROSION, V36, P577, DOI 10.5006/0010-9312-36.10.577
   Ma C, 2004, MATER TRANS, V45, P3223, DOI 10.2320/matertrans.45.3223
   *MAR CO LTD, 2000, RIK NENP, P561
   Men H, 2005, MATER TRANS, V46, P2218, DOI 10.2320/matertrans.46.2218
   Qin FX, 2006, MATER TRANS, V47, P1934, DOI 10.2320/matertrans.47.1934
   Seki I, 2007, MATER TRANS, V48, P2459, DOI 10.2320/matertrans.MRA2007033
   Seki I, 2007, MATER TRANS, V48, P821, DOI 10.2320/matertrans.48.821
   Seki I, 2006, MATER TRANS, V47, P1926, DOI 10.2320/matertrans.47.1926
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhu SL, 2007, MATER TRANS, V48, P163, DOI 10.2320/matertrans.48.163
NR 15
TC 3
Z9 3
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2008
VL 49
IS 3
BP 498
EP 501
DI 10.2320/matertrans.MBW200738
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 295NY
UT WOS:000255482400021
OA Bronze
DA 2018-10-19
ER

PT J
AU Zavan, B
   Abatangelo, G
   Mazzoleni, F
   Bassetto, F
   Cortivo, R
   Vindigni, V
AF Zavan, Barbara
   Abatangelo, Giovanni
   Mazzoleni, Francesco
   Bassetto, Franco
   Cortivo, Roberta
   Vindigni, Vincenzo
TI New 3D hyaluronan-based scaffold for in vitro reconstruction of the rat
   sciatic nerve
SO NEUROLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT Conference on Long Lasting Denervated Muscle
CY APR, 2007
CL Padua, ITALY
DE biocompatibility; cytotoxicity; endothelial cell; hyaluronic acid;
   peripheral nerve; Schwann cell; tissue engineering
ID HUMAN ENDOTHELIAL-CELLS; PERIPHERAL-NERVE; SCHWANN-CELLS; SPINAL-CORD;
   ARTERIAL DIFFERENTIATION; ADULT-RAT; REGENERATION; FIBRONECTIN; MATS;
   BIOCOMPATIBILITY
AB Objective: For peripheral nerve regeneration, three-dimensional distribution and growth of cells within the porous scaffold are of clinical significance. The put-pose of this study was to test in vitro a novel hyaluronic acid-based tubular conduit (HYAFF-11 biomaterials: 1 x 10 mm) as a nerve guide.
   Methods: Human fibroblasts, RN22 Schwann cell lines, human, umbilical vein endothelial cells and primary nerve cells, obtained from neonatal rat sciatic nerve, were harvested and seeded on HYAFF-11 devices. Histologic (hematoxylin-eosin), immunohistochemical (antibodies to S100, CD31 and Von Willebrand factor) and PCR analyses were performed after 7 and 14 days from cell seeding onto biomaterials. MTT-based (thiazolyl blue) and DELFIA cell proliferation kit tests were performed to observe the biocompatibility of the cells cultured within the biomaterial devices.
   Results: We concluded that the conduits were not cytotoxic and demonstrated that cultured RN22 Schwann cells and rat Schwann cells grow in vitro on new artificial nerve conduits. We thus inferred that the HYAFF-11 conduit was a suitable biomaterial able to support nerve cell growth in vitro and after 14 days of cultivation, remained circular with a round lumen, maintaining the size and shape of its original architecture. Finally, attachment and proliferation of endothelial cells attested to the feasibility of developing a coculture system to promote in vivo integration of a microvascularized nerve substitute.
   Discussion: HYAFF-11 pre-seeded with Schwann and endothelial cells has the potential to be an alternative to autografting for the repair of long peripheral nerve defects.
C1 [Zavan, Barbara; Abatangelo, Giovanni] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   [Mazzoleni, Francesco; Bassetto, Franco; Cortivo, Roberta; Vindigni, Vincenzo] Univ Padua, Unit Plast & Reconstruct Surg, I-35100 Padua, Italy.
RP Zavan, B (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Via G Colombo 3, I-35100 Padua, Italy.
EM barbara.zavan@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   Evans GRD, 2003, CLIN PLAST SURG, V30, P559, DOI 10.1016/S0094-1298(03)00073-7
   Fansa H, 2004, NEUROL RES, V26, P167, DOI 10.1179/016164104225013842
   Geuna S, 2004, NEUROL RES, V26, P139, DOI 10.1179/016164104225013752
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906
   JAFFE EA, 1978, J EXP MED, V147, P1779, DOI 10.1084/jem.147.6.1779
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   Lohmeyer JA, 2007, INT J ARTIF ORGANS, V30, P64
   Miller G, 2002, SCIENCE, V296, P2121
   Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2
   Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Weber RV, 2005, CLIN PLAST SURG, V32, P605, DOI 10.1016/j.cps.2005.05.003
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yoshii S, 2004, NEUROL RES, V26, P145, DOI 10.1179/016164104225013770
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
   Zhang M, 2005, ADV BIOCHEM ENG BIOT, V94, P67, DOI 10.1007/b100000
NR 35
TC 14
Z9 18
U1 0
U2 10
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
J9 NEUROL RES
JI Neurol. Res.
PD MAR
PY 2008
VL 30
IS 2
BP 190
EP 196
DI 10.1179/174313208X281082
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 291OA
UT WOS:000255205500014
PM 18397612
DA 2018-10-19
ER

PT J
AU Branford, OA
   Mudera, V
   Brown, RA
   McGrouther, DA
   Grobbelaar, AO
AF Branford, Olivier A.
   Mudera, Vivek
   Brown, Robert A.
   McGrouther, Duncan A.
   Grobbelaar, Adriaan O.
TI A novel biomimetic material for engineering postsurgical adhesion using
   the injured digital flexor tendon-synovial complex as an in vivo model
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID PROTECTED PASSIVE MOBILIZATION; EARLY ACTIVE MOBILIZATION; ANTIADHESIVE
   SITE; FIBRONECTIN; REPAIR; RABBIT; MATRIX; ATTACHMENT; HEPARIN;
   PROLIFERATION
AB Background: Many surgical procedures are complicated by adhesions. These restrictive fibrotic bands form between normally separate gliding tissue layers, potentially impairing function. The authors tested the adhesion-modifying effect of a novel fibronectin-derived biomimetic biomaterial in a tendon-synovial complex injury model.
   Methods: The deep flexor tendons of digits 2 and 4 in the right forepaw of 15 New Zealand White rabbits were subjected to 5-mm-long partial tenotomies. Animals were randomized to receive biomaterial tubes enveloping the tendon injuries or left untreated. Digits, amputated at 2 weeks, were randomized to mechanical pullout assessments of adhesion strength or to quantitative histologic cellularity and immunohistochemical proliferation (Ki67) assessments.
   Results: The mean peak pullout force required to break the adhesions was reduced from 7.70 N (n = 6) in untreated digits to 0.31 N (n = 7) in biomaterial-treated digits (p = 0.001). The mean structural stiffness of the adhesions was also significantly reduced (p = 0.001). Histologically, treated and untreated digits demonstrated an equal incidence of adhesions. The treated adhesions were 55 percent less cellular at their surface than the untreated injured controls (p = 0.003). Treated tendons were 8 percent more cellular (with equal numbers of proliferating cells) at their surface and significantly more cellular within their bulk than positive controls (p <= 0.05).
   Conclusion: This study suggests a significant reduction in the restrictive nature of postsurgical adhesions following treatment with the antiadhesive biomaterial without compromising tendon cellularity.
C1 [Branford, Olivier A.] Mt Vernon Hosp, RAFT, Northwood HA6 2RN, Middx, England.
   UCL, Tissue Repair & Engn Ctr, Inst Orthoped, London WC1E 6BT, England.
   Univ Manchester Plast & Reconstruct Surg Res, Manchester, Lancs, England.
RP Branford, OA (reprint author), Mt Vernon Hosp, RAFT, Leopold Muller Bldg, Northwood HA6 2RN, Middx, England.
EM olivier.branford@totalise.co.uk
RI Mudera, Vivek/C-9383-2009
OI Branford, Olivier/0000-0003-3711-3394
CR Akali A, 1999, PLAST RECONSTR SURG, V103, P151, DOI 10.1097/00006534-199901000-00024
   ASHLEY F L, 1964, Plast Reconstr Surg, V33, P411, DOI 10.1097/00006534-196405000-00001
   AUSTIN RT, 1979, INJURY, V10, P211, DOI 10.1016/0020-1383(79)90011-1
   BRANFORD OA, UNPUB J HAND SURG
   BRIGMAN BE, 1994, J ORTHOPAED RES, V12, P253, DOI 10.1002/jor.1100120215
   BROWN RA, 1983, LANCET, V2, P1058
   DJERKOVIC GS, 2005, INT J ARTIF ORGANS, V28, P284
   Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416
   Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189
   GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107
   GELBERMAN RH, 1991, J HAND SURG-AM, V16A, P686, DOI 10.1016/0363-5023(91)90195-H
   GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5
   GELBERMAN RH, 1981, HAND, V13, P120, DOI 10.1016/S0072-968X(81)80051-4
   GELBERMAN RH, 1991, CLIN ORTHOP RELAT R, V264, P189
   Greiling D, 1997, J CELL SCI, V110, P861
   HAGBERG L, 1992, J HAND SURG-AM, V17A, P935, DOI 10.1016/0363-5023(92)90474-4
   Harrison RK, 2003, J HAND SURG-AM, V28A, P987, DOI 10.1016/S0363-5023(03)00380-0
   Jones ME, 2003, J HAND SURG-AM, V28A, P221, DOI 10.1053/jhsu.2003.50044
   Jones ME, 2002, J HAND SURG-BRIT EUR, V27B, P278, DOI 10.1054/jhsb.2002.0752
   Kakar S, 1998, J HAND SURG-BRIT EUR, V23B, P627, DOI 10.1016/S0266-7681(98)80017-X
   Khan U, 1996, J HAND SURG-BRIT EUR, V21B, P813, DOI 10.1016/S0266-7681(96)80199-9
   Khan U, 2000, J BONE JOINT SURG BR, V82B, P1054, DOI 10.1302/0301-620X.82B7.9892
   Kitsis CK, 1998, J HAND SURG-BRIT EUR, V23B, P344, DOI 10.1016/S0266-7681(98)80055-7
   Kubota H, 1996, J HAND SURG-AM, V21A, P456, DOI 10.1016/S0363-5023(96)80363-7
   KULICK MI, 1984, ANN PLAS SURG, V13, P459, DOI 10.1097/00000637-198412000-00001
   LEE H, 1990, J HAND SURG-AM, V15A, P953, DOI 10.1016/0363-5023(90)90022-J
   LORENZ HP, 2003, SURG SCI BASIS CURRE
   MANSKE PR, 1984, J BONE JOINT SURG AM, V66A, P385, DOI 10.2106/00004623-198466030-00011
   MANSKE PR, 1984, CLIN ORTHOP RELAT R, P297
   MATTHEWS P, 1976, J BONE JOINT SURG BR, V58, P230
   MEISLIN RJ, 1990, J APPL BIOMATER, V1, P13, DOI 10.1002/jab.770010104
   Mentzel M, 2000, J HAND SURG-BRIT EUR, V25B, P590, DOI 10.1054/jhsb.2000.0385
   MESSINA A, 1992, J HAND SURG-AM, V17A, P137, DOI 10.1016/0363-5023(92)90129-D
   Oharazawa H, 2005, OPHTHAL RES, V37, P191, DOI 10.1159/000086595
   Peck FH, 1998, J HAND SURG-BRIT EUR, V23B, P41, DOI 10.1016/S0266-7681(98)80216-7
   PHILLIPS GF, 1985, J HAND SURG-BRIT EUR, V10B, P337, DOI 10.1016/S0266-7681(85)80056-5
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217, DOI 10.2106/00004623-196345060-00009
   POTENZA AD, 1982, J HAND SURG-AM, V7, P196, DOI 10.1016/S0363-5023(82)80088-9
   RIEDERERHENDERSON MA, 1983, IN VITRO CELL DEV B, V19, P127
   Ruoslahti E, 1980, Prog Clin Biol Res, V41, P821
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SAVAGE R, 1989, J HAND SURG-BRIT EUR, V14B, P396, DOI 10.1016/0266-7681(89)90154-X
   SCOTT RJ, 1991, J PATHOL, V165, P173, DOI 10.1002/path.1711650213
   SHIMOOKA T, 1988, CELL STRUCT FUNCT, V13, P515, DOI 10.1247/csf.13.515
   Sottile J, 2000, J CELL SCI, V113, P4287
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Strick MJ, 2004, J HAND SURG-AM, V29A, P15, DOI 10.1016/j.jhsa.2003.09.003
   Strickland J W, 1985, Hand Clin, V1, P167
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   TAKAI S, 1991, J ORTHOP RES, V9, P705, DOI 10.1002/jor.1100090510
   Underwood S, 2001, BIOTECHNOL BIOENG, V73, P295, DOI 10.1002/bit.1062
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r
   WILLIAMS DF, 1992, BIOMATERIAL TISSUE I
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   Yamada KM, 2000, J CLIN INVEST, V105, P1507, DOI 10.1172/JCI10119
   YAMADA KM, 1996, MOL CELLULAR BIOL WO
   ZLATOPOL'SKII A D, 1989, Biokhimiya, V54, P74
   ZLATOPOLSKY AD, 1992, BIOCHEM BIOPH RES CO, V183, P383, DOI 10.1016/0006-291X(92)90492-4
NR 60
TC 11
Z9 11
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAR
PY 2008
VL 121
IS 3
BP 781
EP 793
DI 10.1097/01.prs.0000299373.25294.65
PG 13
WC Surgery
SC Surgery
GA 268GA
UT WOS:000253566000009
PM 18317128
DA 2018-10-19
ER

PT J
AU Hermawan, H
   Alamdari, H
   Mantovani, D
   Dube, D
AF Hermawan, H.
   Alamdari, H.
   Mantovani, D.
   Dube, Dominique
TI Iron-manganese: new class of metallic degradable biomaterials prepared
   by powder metallurgy
SO POWDER METALLURGY
LA English
DT Article
DE Fe-Mn alloy; degradable biomaterial; sintering; microstructure;
   mechanical properties; magnetic susceptibility; corrosion behaviour;
   Hank's solution
ID FE-MN ALLOYS; AUSTENITIC STAINLESS-STEEL; MARTENSITIC-TRANSFORMATION;
   MAGNESIUM ALLOYS; NICKEL-TITANIUM; STENT; RECRYSTALLIZATION;
   BIOCOMPATIBILITY; NUCLEATION; CORROSION
AB An Fe-35 wt-%Mn alloy, aimed to be used as a metallic degradable biomaterial for stent applications, was prepared via a powder metallurgy route. The effects of processing conditions on the microstructure, mechanical properties, magnetic susceptibility and corrosion behaviour were investigated and the results were compared to those of the SS316L alloy, a gold standard for stent applications. The Fe35Mn alloy was found to be essentially austenitic with fine MnO particles aligned along the rolling direction. The alloy is ductile with a strength approaching that of wrought SS316L. It exhibits antiferromagnetic behaviour and its magnetic susceptibility is not altered by plastic deformation, providing an excellent MRI compatibility. Its corrosion rate was evaluated in a modified Hank's solution, and found superior to that of pure iron ( slow in vivo degradation rate). In conclusion, the mechanical, magnetic and corrosion characteristics of the Fe35Mn alloy are considered suitable for further development of a new class of degradable metallic biomaterials.
C1 [Hermawan, H.; Alamdari, H.; Mantovani, D.; Dube, Dominique] Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1V 0A6, Canada.
   Univ Laval, Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
RP Dube, D (reprint author), Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Pavillon Adrien Pouliot,1065 Ave Med,Local 1745D, Quebec City, PQ G1V 0A6, Canada.
EM Dominique.Dube@gmn.ulaval.ca
RI Hermawan, Hendra/G-5892-2010
OI Hermawan, Hendra/0000-0002-5596-9949; Mantovani,
   Diego/0000-0001-9672-895X
CR [Anonymous], 2003, G5997 ASTM
   *ASTM, 2006, D197602 ASTM
   *ASTM, 2006, E101903 ASTM
   *ASTM, 2006, E804 ASTM
   Bhargava B, 2006, CATHETER CARDIO INTE, V67, P698, DOI 10.1002/ccd.20698
   Bliznuk VV, 2002, MAT SCI ENG A-STRUCT, V338, P213, DOI 10.1016/S0921-5093(02)00060-6
   BOGACHEV IN, 1969, PHYS METALS METALLOG, V28, P125
   Brandes E. A., 1992, SMITHELLS METALS REF, P8
   BRANDES EA, 1992, SMITHELLS METALS REF, P11
   BRANDES EA, 1992, SMITHELLS METALS REF, pCH14
   Cotes SM, 2004, METALL MATER TRANS A, V35A, P83, DOI 10.1007/s11661-004-0111-y
   Deevi SC, 2000, INTERMETALLICS, V8, P679, DOI 10.1016/S0966-9795(99)00129-6
   GARTSTEIN E, 1979, ACTA METALL MATER, V27, P1053, DOI 10.1016/0001-6160(79)90193-7
   GAUZZI F, 1983, J MATER SCI, V18, P3661, DOI 10.1007/BF00540738
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   ISHIKAWA Y, 1968, J APPL PHYS, V39, P1318, DOI 10.1063/1.1656274
   Keen CL, 2000, MET IONS BIOL SYST, V37, P89
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lee YK, 1997, ISIJ INT, V37, P1023, DOI 10.2355/isijinternational.37.1023
   Li YH, 2003, MAT SCI ENG A-STRUCT, V363, P356, DOI 10.1016/S0921-5093(03)00629-4
   Martinez J, 2005, MAT SCI ENG A-STRUCT, V408, P26, DOI 10.1016/j.msea.2005.06.019
   MATSOKIN VP, 1994, POWDER METALL MET C+, V33, P233
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Meszaros I, 2005, J MATER PROCESS TECH, V161, P162, DOI 10.1016/j.jmatprotec.2004.07.020
   *MET POWD IND FED, 1990, 15 MET POWD IND FED
   Migliavacca F, 2005, MED ENG PHYS, V27, P13, DOI 10.1016/j.medengphy.2004.08.012
   Mumtaz K, 2004, J MATER SCI, V39, P85, DOI 10.1023/B:JMSC.0000007731.38154.e1
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   RABINKIN A, 1979, CALPHAD, V3, P77, DOI 10.1016/0364-5916(79)90008-7
   RAJAN K, 1984, METALL TRANS A, V15, P1335, DOI 10.1007/BF02648562
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SCHUMANN H, 1975, PRACT METALLOGR, V12, P511
   SHREIR LL, 2000, CORROSION METAL ENV, V1, P151
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   TRICHTER F, 1978, SCRIPTA METALL MATER, V12, P431, DOI 10.1016/0036-9748(78)90251-X
   VOLYNOVA TF, 1984, MET SCI HEAT TREAT+, V26, P476, DOI 10.1007/BF00707724
   VOLYNOVA TF, 1986, POWDER METALL MET C, V25, P999
   VOLYNOVA TF, 1992, POWDER METALL MET C, V31, P570
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Zartner P, 2007, CATHETER CARDIO INTE, V69, P443, DOI 10.1002/ccd.20828
   ZVIGINTSEVA GY, 1970, PHYS METALS METALLOG, V30, P61
NR 44
TC 108
Z9 112
U1 4
U2 70
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0032-5899
J9 POWDER METALL
JI Powder Metall.
PD MAR
PY 2008
VL 51
IS 1
BP 38
EP 45
DI 10.1179/174329008X284868
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 319CW
UT WOS:000257142700019
DA 2018-10-19
ER

PT J
AU Wang, ML
   Massie, J
   Allen, RT
   Lee, YP
   Kim, CW
AF Wang, Mark L.
   Massie, Jennifer
   Allen, Richard T.
   Lee, Yu-Po
   Kim, Choll W.
TI Altered bioreactivity and limited osteoconductivity of calcium
   sulfate-based bone cements in the osteoporotic rat spine
SO SPINE JOURNAL
LA English
DT Article
DE osteoporosis; calcium sulfate; calcium phosphate; OVX rat; micro-CT;
   osteoplasty
ID GRAFT SUBSTITUTE; IN-VITRO; EXPRESSION; 17-BETA-ESTRADIOL; OSTEOLYSIS;
   FRACTURES; CELLS; GP130; IL-6
AB BACKGROUND CONTEXT: Previous studies documenting the osteoconductive nature of calcium sulfate (CaSO4)-based biomaterials have been largely limited to animal models exhibiting nonosteoporotic bone biology. In addition to diminished bone mineral density (BMD) and altered bone microarchitecture, the osteoporosis phenotype is associated with a proinflammatory and proosteolytic state. Thus, osteoporosis may elicit an amplified bioreactivity to common orthopedic biomaterials, potentially limiting their full osteoconductive capabilities in vivo.
   PURPOSE: The purpose of this study is to test the hypothesis that CaSO4-based bone cements exhibit altered bioreactivity and limited osteoconductivity in response to osteoporotic conditions.
   STUDY DESIGN: 1) Microcomputed tomography (micro-CT) radiomorphometry study and 2) histological analysis.
   METHODS: Our laboratory has previously established a preclinical model of osteoporosis using the rodent osteoporotic spine (OS). Caudal vertebral defects were filled with either CaSO4 or CaSO4/CaPO4 (Hybrid) cement for each group (n=4). Over 8 weeks, cement resorption profiles, BMD, average cortical thickness, average trabecular thickness, average trabecular spacing, and diaphyseal bone volume fraction were assessed via micro-CT radiomorphometry. Histological analysis was performed on vertebrae obtained postsurgery and at Week 8.
   RESULTS: Both materials displayed an accelerated cement resorption profile after implantation into the OS vertebrae. Hybrid cement exhibited slower resorption compared with that of CaSO4 under both normal female rats (NL) and OS conditions. The cement-mediated bone augmentation observed in the NL spine was altered under OS conditions.
   CONCLUSIONS: This study suggests that cement bioreactivity is heightened and osteoconductivity may be limited in a preclinical model of the OS. The disparity between the two resorption profiles suggests that this accelerated cement resorption is a material-dependent phenomenon. The proinflammatory and pro-osteolytic bone environment associated with the osteoporosis disease state may contribute to the accelerated resorption and altered osteoconductivity exhibited by both materials. Future study of potential biomaterials intended for use within the OS may necessitate further exploration of the relationship between biomaterial performance and osteoporosis bone biology. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Wang, Mark L.; Massie, Jennifer; Allen, Richard T.; Lee, Yu-Po; Kim, Choll W.] Univ Calif San Diego, Dept Orthoped Surg, San Diego, CA 92103 USA.
   [Massie, Jennifer; Kim, Choll W.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Kim, CW (reprint author), Univ Calif San Diego, Dept Orthoped Surg, 200 W Arbor Dr MC 8894, San Diego, CA 92103 USA.
EM chollkim@ucsd.edu
CR AITKEN JM, 1972, J ENDOCRINOL, V55, P79, DOI 10.1677/joe.0.0550079
   Bonewald L. F., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P101
   CHRISTIANSEN C, 1991, AM J MED, V90, P107
   DEWET JS, 1973, S AFR J SURG, V11, P1
   Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002
   GIRASOLE G, 1992, J CLIN INVEST, V89, P883, DOI 10.1172/JCI115668
   Gitelis S, 2001, ORTHOPEDICS, V24, P162
   Glazer P A, 2001, Spine J, V1, P395, DOI 10.1016/S1529-9430(01)00108-5
   Gu G, 2005, APOPTOSIS, V10, P583, DOI 10.1007/s10495-005-1893-0
   Hadjipavlou AG, 2000, SPINE, V25, P10, DOI 10.1097/00007632-200001010-00004
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   Heymann D, 2000, CYTOKINE, V12, P1455, DOI 10.1006/cyto.2000.0747
   HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7
   Ingram JH, 2005, J BIOMED MATER RES B, V75B, P210, DOI 10.1002/jbm.b.30308
   Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71
   Keating JF, 2003, J BONE JOINT SURG BR, V85B, P68, DOI 10.1302/0301-620X.85B1.12575
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   LI J, 2004, J MOL HISTOL, P723
   Nawrocki B, 1999, J BONE MINER RES, V14, P288, DOI 10.1359/jbmr.1999.14.2.288
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Perry Andrew, 2005, Spine J, V5, P489, DOI 10.1016/j.spinee.2005.03.011
   RAY A, 1994, J BIOL CHEM, V269, P12940
   Rifas L, 1999, CALCIFIED TISSUE INT, V64, P1, DOI 10.1007/s002239900570
   Saito T, 2002, BIOMATERIALS, V23, P2711, DOI 10.1016/S0142-9612(02)00003-0
   SANDERSON C, 1995, BIOTECH HISTOCHEM, V70, P12, DOI 10.3109/10520299509108310
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   Truumees Eeric, 2004, Spine J, V4, P218, DOI 10.1016/j.spinee.2003.08.029
   Turner TM, 2001, J BONE JOINT SURG AM, V83A, P8, DOI 10.2106/00004623-200100021-00003
   Wang ML, 2007, SPINE J, V7, P466, DOI 10.1016/j.spinee.2006.06.400
   1994, NIH CONSENSUS STATEM, V12, P1
NR 30
TC 17
Z9 19
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
J9 SPINE J
JI Spine Journal
PD MAR-APR
PY 2008
VL 8
IS 2
BP 340
EP 350
DI 10.1016/j.spinee.2007.06.003
PG 11
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 277US
UT WOS:000254240800010
PM 17983844
DA 2018-10-19
ER

PT J
AU Van De Keere, I
   Willaert, R
   Tourwe, E
   Hubin, A
   Vereecken, J
AF Van De Keere, Isabel
   Willaert, Ronnie
   Tourwe, Els
   Hubin, Annick
   Vereecken, Jean
TI The interaction of human serum albumin with titanium studied by means of
   atomic force microscopy
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE atomic force microscopy; biomterial surfaces; protein adsorption;
   titanium; human serum albumin
ID CONFORMATIONAL-CHANGES; PROBE MICROSCOPY; IONIC-STRENGTH; ADSORPTION;
   FIBRINOGEN; MOLECULES; SURFACES; PH
AB Titanium is frequently used as a biomaterial for implants in orthopaedics and cardiovascular devices. Understanding the biocompatibility, which is strongly influenced by the adsorption of proteins onto the surface, is very important to improve implants. The surface chemistry of an implant material and its influence on the interaction with body fluid is crucial in that perspective. The main goal of this study was to investigate the conformation of human serum albumin (HSA) with commercially pure titanium (CP Ti) on a molecular level. Both ex situ and in situ AFM imaging showed the conformation of HSA on CP Ti and on mica, which was used as a reference material. Single molecules and aggregates of albumin were observed. HSA can be recognised by the globular shape. The conformation of the adsorbed HSA molecules was different on titanium and mica, for both the ex situ and in situ imaging. The difference in wettability between both substrates caused a larger spread of the protein on the CP Ti surface and thus resulted in a larger perturbation of the native structure of HSA as compared to mica. Copyright (c) 2008 John Wiley & Sons, Ltd.
C1 [Van De Keere, Isabel; Tourwe, Els; Hubin, Annick; Vereecken, Jean] Vrije Univ Brussels, Dept Met Electrochem & Mat Sci, B-1020 Brussels, Belgium.
   [Willaert, Ronnie] Vrije Univ Brussels, Flanders Inst Biotechnol, Dept Ultrastruct, VIB, B-1020 Brussels, Belgium.
RP Van De Keere, I (reprint author), Vrije Univ Brussels, Dept Met Electrochem & Mat Sci, Pleinlaan 2, B-1020 Brussels, Belgium.
EM ivdkeere@vub.ac.be
RI Tourwe, Els/C-4979-2009
CR Aeimbhu A, 2005, SURF INTERFACE ANAL, V37, P1127, DOI 10.1002/sia.2120
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Bearinger JP, 2001, SURF SCI, V491, P370, DOI 10.1016/S0039-6028(01)01300-0
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Busalmen JP, 2001, J IND MICROBIOL BIOT, V26, P303, DOI 10.1038/sj.jim.7000133
   GILBERT J, 2003, DYNAMICS OXIDE FILMS, P139
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO L, 1985, TISSUE INTEGRATED PR, pCH4
   Misawa N, 2006, CHEM PHYS LETT, V419, P86, DOI 10.1016/j.cplett.2005.11.060
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   Notley SM, 2004, PHYS CHEM CHEM PHYS, V6, P2379, DOI 10.1039/b401376j
   Orasanu A, 2003, EUR CELLS MATER, V6, P46
   QUIST AP, 1995, SURF SCI, V325, pL406, DOI 10.1016/0039-6028(94)00809-4
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sheller NB, 1998, LANGMUIR, V14, P4535, DOI 10.1021/la970916s
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Wagner MS, 2003, LANGMUIR, V19, P1708, DOI 10.1021/la0260382
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
NR 24
TC 5
Z9 5
U1 1
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAR-APR
PY 2008
VL 40
IS 3-4
BP 157
EP 161
DI 10.1002/sia.2673
PG 5
WC Chemistry, Physical
SC Chemistry
GA 295PK
UT WOS:000255486200009
OA Bronze
DA 2018-10-19
ER

PT J
AU Kim, WH
   Lee, SB
   Oh, KT
   Moon, SK
   Kim, KM
   Kim, KN
AF Kim, Woo-Hyun
   Lee, Sang-Bae
   Oh, Keun-Taek
   Moon, Seung-Kyun
   Kim, Kwang-Mahn
   Kim, Kyoung-Nam
TI The release behavior of CHX from polymer-coated titanium surfaces
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE chlorhexidine digluconate; PLA coating; dental implant; anodic oxide
   film; surface roughness; UV absorbance
ID BIOMATERIAL; IMPLANTS
AB Titanium has been successfully used in dental implants due to its favorable biological response. However, implant failures caused by infection often occurred with a complex microbial exposure. Chlorhexidine (CHX) is effective against a wide variety of bacteria as well as fungi. The aim of the present study is to investigate the release behavior of CHX from CHX-containing polylactide (PLA)-coated titanium. Commercially, pure titanium was anodized with surfaces exposed to an anodic-forming voltage of 250 V for 3 min. The anodized titanium surfaces were then coated with a PLA/CHX solution. Topographic evaluation was performed using a SEM, and the antibacterial effect was evaluated. The concentrations of CHX were measured using a UV spectrophotometer. In the surface morphology analysis, the uncoated titanium surface showed a porous structure, but the surfaces coated with a polymer displayed nonporous structures and wrinkled surfaces. In addition, there were no differences in the surface roughness between the uncoated and coated surface. On the basis of the comparative analysis of both the UV absorbance of CHX and the surface characteristics, we concluded that the PLA coating can effectively control the release of CHX on anodized titanium surfaces. Copyright (c) 2008 John Wiley & Sons, Ltd.
C1 [Kim, Woo-Hyun; Lee, Sang-Bae; Moon, Seung-Kyun; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept Dent Biomat & Bioengn, BK21 Project, Seoul 120752, South Korea.
   [Oh, Keun-Taek] Biomat Korea Inc, Seoul 150050, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Dept Dent Biomat & Bioengn, BK21 Project, 250 Seongsanno, Seoul 120752, South Korea.
EM kimkn@yuhs.ac
CR Darouiche RO, 1998, INT J ANTIMICROB AG, V10, P83, DOI 10.1016/S0924-8579(98)00017-X
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Kozlovsky A, 2006, J PERIODONTOL, V77, P1194, DOI 10.1902/jop.2006.050401
   KUYYAKANOND T, 1992, MICROBIOL LETT, V15, P211
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   MICHELE E, 2007, COLLOID SURF A, V307, P116
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 10
TC 19
Z9 19
U1 0
U2 9
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAR-APR
PY 2008
VL 40
IS 3-4
BP 202
EP 204
DI 10.1002/sia.2809
PG 3
WC Chemistry, Physical
SC Chemistry
GA 295PK
UT WOS:000255486200019
OA Bronze
DA 2018-10-19
ER

PT J
AU Lou, CW
   Lin, JH
   Yen, KC
   Lu, CT
   Lee, CY
AF Lou, Ching-Wen
   Lin, Jia-Horng
   Yen, Ko-Chung
   Lu, Chao-Tsang
   Lee, Chia-Yi
TI Preparation of polyethylene oxide/chitosan fiber membranes by
   electrospinning and the evaluation of biocompatibility
SO TEXTILE RESEARCH JOURNAL
LA English
DT Article
DE chitosan; polyethylene oxide (PEO); electrospinning
ID CHITOSAN; NANOFIBERS
AB Chitosan is an excellent material for medical use because it is nontoxic, has good biocompatibility, exhibits antimicrobial activity, supports the healing of wounds, etc. Electrospinning yields nanofibers which have wide applications, such as high-performance filters, biomaterial scaffolds for vascular grafts or wound dressings, etc. In this investigation, electrospinning was performed in an electric field of 0.6 kV/cm with a polyethylene oxide to chitosan ratio of 60:40. The polymer nanofibers had diameters that ranged from a few nanometers to several micrometers (approximately 30 nm).
C1 [Lou, Ching-Wen] Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat Sci, Ctr Gen Educ, Taichung, Taiwan.
   [Lin, Jia-Horng; Yen, Ko-Chung] Feng Chia Univ, Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
   [Lu, Chao-Tsang] Cent Taiwan Univ Sci & Technol, Inst Life Sci, Taichung, Taiwan.
   [Lee, Chia-Yi] Feng Chia Univ, Lab Fiber Applicat & Mfg, Dept Fiber & Composite Mat, Taichung 40724, Taiwan.
RP Lou, CW (reprint author), Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat Sci, Ctr Gen Educ, Taichung, Taiwan.
EM cwlou@ctust.edu.tw
OI Yen, Ko-Chung/0000-0001-6276-5912
CR Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Chronakis IS, 2005, J MATER PROCESS TECH, V167, P283, DOI 10.1016/j.jmatprotec.2005.06.053
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
NR 8
TC 18
Z9 18
U1 2
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0040-5175
J9 TEXT RES J
JI Text. Res. J.
PD MAR
PY 2008
VL 78
IS 3
BP 254
EP 257
DI 10.1177/0040517507089752
PG 4
WC Materials Science, Textiles
SC Materials Science
GA 295AN
UT WOS:000255447500008
DA 2018-10-19
ER

PT J
AU Daamen, WF
   Nillesen, STM
   Wismans, RG
   Reinhardt, DP
   Hafmans, T
   Veerkamp, JH
   Van Kuppevelt, TH
AF Daamen, Willeke F.
   Nillesen, Suzan T. M.
   Wismans, Ronnie G.
   Reinhardt, Dieter P.
   Hafmans, Theo
   Veerkamp, Jacques H.
   Van Kuppevelt, Toin H.
TI A biomaterial composed of collagen and solubilized elastin enhances
   angiogenesis and elastic fiber formation without calcification
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID DERMAL SUBSTITUTE; SKIN REGENERATION; CROSS-LINKING; UP-REGULATION;
   MATRIX; PEPTIDES; MICROFIBRILS; FIBRILLIN-1; SCAFFOLDS; PROTEINS
AB Elastin is the prime protein in elastic tissues that contributes to elasticity of, for example, lung, aorta, and skin. Upon injury, elastic fibers are not readily replaced, which hampers tissue regeneration. Incorporation of solubilized elastin (hydrolyzed insoluble elastin fibers or elastin peptides) in biomaterials may improve regeneration, because solubilized elastin is able to promote proliferation as well as elastin synthesis. Porous biomaterials composed of highly purified collagen without and without elastin fibers or solubilized elastin were prepared by freezing and lyophilization. Solubilized elastin formed spherical structures that were incorporated in the collagenous part of the scaffolds and that persisted after chemical crosslinking of the scaffolds. Crosslinked scaffolds were subcutaneously implanted in young Sprague Dawley rats. Collagen-solubilized elastin and collagen scaffolds showed no calcification in this sensitive calcification model, in contrast to scaffolds containing elastin fibers. Collagen-solubilized elastin scaffolds also induced angiogenesis, as revealed by type IV collagen staining, and promoted elastic fiber synthesis, as shown with antibodies against rat elastin and fibrillin-1. It is concluded that scaffolds produced from collagen and solubilized elastin present a non-calcifying biomaterial with a capacity for soft-tissue regeneration, especially in relation to elastic fiber synthesis.
C1 [Daamen, Willeke F.; Nillesen, Suzan T. M.; Wismans, Ronnie G.; Hafmans, Theo; Veerkamp, Jacques H.; Van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands.
   [Reinhardt, Dieter P.] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada.
   [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada.
   [Hafmans, Theo] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis 454, NL-6525 ED Nijmegen, Netherlands.
RP Daamen, WF (reprint author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM w.daamen@ncmls.ru.nl
RI Daamen, Willeke/D-5854-2015; Kuppevelt, A.H.M.S.M./L-4463-2015;
   Reinhardt, Dieter/A-3102-2008
OI Daamen, Willeke/0000-0003-3155-3030; Reinhardt,
   Dieter/0000-0001-6535-9872
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Ashcroft GS, 1997, J PATHOL, V183, P80
   Bailey MT, 2003, J BIOMED MATER RES A, V66A, P93, DOI 10.1002/jbm.a.10543
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   COMPTON CC, 1992, EUR J PEDIATR SURG, V2, P216, DOI 10.1055/s-2008-1063444
   Daamen WF, 2005, TISSUE ENG, V11, P1168, DOI 10.1089/ten.2005.11.1168
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Fulop T, 1998, PATHOL BIOL, V46, P497
   GORG A, 1991, NATURE, V349, P545, DOI 10.1038/349545a0
   Haslik W, 2007, BURNS, V33, P364, DOI 10.1016/j.burns.2006.07.021
   Hinds MT, 2004, J BIOMED MATER RES A, V69A, P55, DOI 10.1002/jbm.a.20109
   Hinek A, 2005, J DERMATOL SCI, V39, P155, DOI 10.1016/j.jdermsci.2005.04.002
   HOLLINGER JO, 1988, CALCIFIED TISSUE INT, V42, P231, DOI 10.1007/BF02553748
   Kadoya K, 2003, BRIT J DERMATOL, V149, P377, DOI 10.1046/j.1365-2133.2003.05382.x
   Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lee JS, 2006, AM J PATHOL, V168, P490, DOI 10.2353/ajpath.2006.050338
   Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   PORATH J, 1959, NATURE, V183, P1657, DOI 10.1038/1831657a0
   Raghunath M, 1996, J INVEST DERMATOL, V106, P1090, DOI 10.1111/1523-1747.ep12339373
   Ramirez F, 1999, INT J BIOCHEM CELL B, V31, P255, DOI 10.1016/S1357-2725(98)00109-5
   Robert L, 1999, CONNECT TISSUE RES, V40, P75, DOI 10.3109/03008209909029103
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Rossi MA, 2003, VIRCHOWS ARCH, V443, P87, DOI 10.1007/s00428-003-0816-0
   SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200
   Truong Anh-Tuan N, 2005, J Burns Wounds, V4, pe4
   VARGA Z, 1989, FEBS LETT, V258, P5, DOI 10.1016/0014-5793(89)81602-3
   WOOD SA, 1986, J BIOMED MATER RES, V20, P315, DOI 10.1002/jbm.820200305
NR 49
TC 39
Z9 40
U1 1
U2 10
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2008
VL 14
IS 3
BP 349
EP 360
DI 10.1089/tea.2007.0076
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 273VZ
UT WOS:000253961300002
PM 18333787
DA 2018-10-19
ER

PT J
AU Wang, ZG
   Pan, H
   Yuan, ZJ
   Liu, JX
   Chen, WL
   Pan, YT
AF Wang, Zhenguo
   Pan, Hui
   Yuan, Zhijia
   Liu, Jingxuan
   Chen, Weiliam
   Pan, Yingtian
TI Assessment of dermal wound repair after collagen implantation with
   optical coherence tomography
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID HUMAN SKIN; IN-VIVO; CONFOCAL MICROSCOPY; HIGH-SPEED
AB We present an animal study to examine the utility and potential limitations of optical coherence tomography (OCT) for noninvasive evaluation of biomaterial scaffold-assisted wound healing. The transverse and axial resolutions of the OCT system at the wavelength of 1.3 mu m were 12 and 10 mu m, respectively. A murine full-thickness transcutaneous wound model was employed, in which a phi 10mm full-thickness wound was created on the back of each male Balb/cJ mouse and a porous collagen scaffold was implanted in the wound bed followed by coverage with a Tegaderm (TM) film. Sequential cross-sectional OCT scans were performed at different time points postsurgical intervention to track morphological changes during wound recovery, and the captured OCT images were validated by their corresponding histological specimens. The results indicated that with removal of the high-scattering skin, OCT was capable of imaging to a depth of over 1.5mm into the wound bed and differentiating various features evolved during wound healing at a high resolution approaching histopathology. OCT was able to not only delineate the epidermis and dermis of normal mouse skin, but also differentiate collagen implant from the underlying subcutaneous tissue; besides, it could track the wound size changes in both lateral and vertical directions. More importantly, OCT was able to detect inflammation, early re-epithelialization, and resorption of the collagen scaffold. These findings suggested the potential of OCT for noninvasive and high-resolution monitoring of assisted wound healing in vivo, longitudinally, and instantaneously.
C1 [Wang, Zhenguo; Pan, Hui; Yuan, Zhijia; Chen, Weiliam; Pan, Yingtian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
   [Liu, Jingxuan] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.
RP Pan, YT (reprint author), SUNY Stony Brook, Dept Biomed Engn, HSC-T18,Room 030B, Stony Brook, NY 11794 USA.
EM yingtian.pan@sunysb.edu
RI yuan, zhijia/F-4314-2011
OI Wang, Zhenguo/0000-0001-7756-1701
FU NIDDK NIH HHS [R01-DK068401, 2R01-DK059265]
CR Aguirre AD, 2003, OPT LETT, V28, P2064, DOI 10.1364/OL.28.002064
   COBB MJ, 2006, J BIOMED OPT, V11, P1
   Ding HF, 2006, PHYS MED BIOL, V51, P1479, DOI 10.1088/0031-9155/51/6/008
   Gladkova ND, 2000, SKIN RES TECHNOL, V6, P6, DOI 10.1034/j.1600-0846.2000.006001006.x
   Hori Y, 2006, OPT EXPRESS, V14, P1862, DOI 10.1364/OE.14.001862
   Masters BR, 2001, OPT EXPRESS, V8, P2, DOI 10.1364/OE.8.000002
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   PAN YT, 2007, JBO LETT, V12, P1
   Pierce MC, 2004, J INVEST DERMATOL, V123, P458, DOI 10.1111/j.0022-202X.2004.23404.x
   Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x
   Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355
   SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523
   Singer AJ, 2007, ACAD EMERG MED, V14, P387, DOI 10.1197/j.aem.2006.11.022
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   Tsai TH, 2006, OPT EXPRESS, V14, P749, DOI 10.1364/OPEX.14.000749
   Wang ZG, 2005, J UROLOGY, V174, P2376, DOI 10.1097/01.ju.0000180413.98752.a1
   Welzel J, 1997, J AM ACAD DERMATOL, V37, P958, DOI 10.1016/S0190-9622(97)70072-0
   Zhao YH, 2000, OPT LETT, V25, P114, DOI 10.1364/OL.25.000114
NR 19
TC 36
Z9 36
U1 0
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PT C-METH
JI Tissue Eng. Part C-Methods
PD MAR
PY 2008
VL 14
IS 1
BP 35
EP 45
DI 10.1089/tec.2007.0285
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 286OC
UT WOS:000254854200005
PM 18454644
DA 2018-10-19
ER

PT J
AU Deng, C
   Weng, J
   Lu, X
   Zhou, SB
   Wan, JX
   Qu, SX
   Feng, B
   Li, XH
   Cheng, QY
AF Deng, C.
   Weng, J.
   Lu, X.
   Zhou, S. B.
   Wan, J. X.
   Qu, S. X.
   Feng, B.
   Li, X. H.
   Cheng, Q. Y.
TI Mechanism of ultrahigh, elongation rate of poly(D,L-lactide)-matrix
   composite biomaterial containing nano-apatite fillers
SO MATERIALS LETTERS
LA English
DT Article
DE nanocomposites; mechanical properties; thin film; elongation rate
ID HYDROXYAPATITE; BLENDS; NANOCOMPOSITES; POLYETHYLENE; REPLACEMENT;
   PARTICLES; POLYMER
AB This study aims to discuss the mechanism of ultrahigh elongation rate of nano-apatite/poly(D,L-lactide) (PDLLA) composite biomaterials prepared by combining traditional solution co-blending and hot pressing techniques. An ultrahigh elongation rate of PDLLA-matrix composite film with nano-apatite fillers was found in our tensile testing experiments. These surprising results could be expressly explained by the structure characteristics of PDLLA-matrix nanocomposites. The linear chains of the PDLLA-matrix materials were cross-linked and fixed by the nano-sized crystallites with high specific surface energy when nano particles were incorporated into PDLLA polymer to form composite. Structure change of the cross-linked PDLLA matrix caused the composite to exhibit high fixation strength between PDLLA molecular chains and nano-apatite particles by a large amount of the cross-link junctions and further brought on larger elastic and plastic deformation than one of pure PDLLA polymer. On the other hand, high nano-apatite contents in composites could lead to the early rupture owing to nano-apatite agglomeration and decrease the elongation rate of the composites. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Deng, C.; Weng, J.; Lu, X.; Zhou, S. B.; Wan, J. X.; Qu, S. X.; Feng, B.; Li, X. H.; Cheng, Q. Y.] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Weng, J (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM jwxm3503@sina.com
RI QU, SHU XIN/H-3036-2011; Feng, Bo/B-3498-2010; Weng, Jie/B-3005-2010;
   LU, xiong/B-3092-2010; zhou, shaobing/B-3148-2010
OI LU, xiong/0000-0001-6367-430X; 
CR BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Deng XM, 2001, J CONTROL RELEASE, V71, P165, DOI 10.1016/S0168-3659(01)00210-3
   FU Q, 1995, POLYMER, V36, P2397, DOI 10.1016/0032-3861(95)97339-H
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu ZH, 1998, POLYMER, V39, P1863, DOI 10.1016/S0032-3861(97)00370-4
   NENAD I, 2004, APPL SURF SCI, V238, P314
   Pukanszky B, 1995, POLYM ENG SCI, V35, P1962, DOI 10.1002/pen.760352408
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Wang M, 2001, J MATER SCI-MATER M, V12, P821, DOI 10.1023/A:1017933220894
   Zhou SB, 2007, CHEM MATER, V19, P247, DOI 10.1021/cm0619398
NR 12
TC 20
Z9 20
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 29
PY 2008
VL 62
IS 4-5
BP 607
EP 610
DI 10.1016/j.matlet.2007.06.014
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 260ST
UT WOS:000253031400015
DA 2018-10-19
ER

PT J
AU Chen, QZ
   Harding, SE
   Ali, NN
   Lyon, AR
   Boccaccini, AR
AF Chen, Qi-Zhi
   Harding, Sian E.
   Ali, Nadire N.
   Lyon, Alexander R.
   Boccaccini, Aldo R.
TI Biomaterials in cardiac tissue engineering: Ten years of research survey
SO MATERIALS SCIENCE & ENGINEERING R-REPORTS
LA English
DT Review
DE tissue engineering; cardiac muscle; biomaterials; polymers; cell
   therapy; bioreactors
ID EMBRYONIC STEM-CELLS; SKELETAL MYOBLAST TRANSPLANTATION; ENDOTHELIAL
   PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; RESPONSIVE CULTURE
   DISHES; BONE-MARROW-CELLS; LEFT-VENTRICULAR GEOMETRY; LONG-TERM
   SURVIVAL; OF-THE-ART; BIODEGRADABLE ELASTOMERIC SCAFFOLDS
AB Driven by enormous clinical need, myocardial tissue engineering has become a prime focus of research within the field of tissue engineering. Myocardial tissue engineering combines isolated functional cardiomyocytes and a biodegradable or nondegradable biomaterial to repair diseased heart muscle. The challenges in heart muscle engineering include cell related issues (such as scale up in a short timeframe, efficiency of cell seeding or cell survival rate, and immune rejection), the design and fabrication of myocardial tissue engineering substrates, and the engineering of tissue constructs in vitro and in vivo. Several approaches have been put forward, and a number of models combining various polymeric biomaterials, cell sources and bioreactors have been developed in the last 10 years for myocardial tissue engineering. This review provides a comprehensive update on the biomaterials, as well as cells and biomimetic systems, used in the engineering of the cardiac muscle. The article is organized as follows. A historic perspective of the evolution of cardiac medicine and emergence of cardiac tissue engineering is presented in the first section. Following a review on the cells used in myocardial tissue engineering (second section), the third section presents a review on biomaterials used in myocardial tissue engineering. This section starts with an overview of the development of tissue engineering substrates and goes on to discuss the selection of biomaterials and design of solid and porous substrates. Then the applications of a variety of biomaterials used in different approaches of myocardial tissue engineering are reviewed in great detail, and related issues and topics that remain challenges for the future progress of the field are identified at the end of each subsection. This is followed by a brief review on the development of bioreactors (fourth section), which is an important achievement in the field of myocardial tissue engineering, and which is also related to the biomaterials developed. At the end of this article, the major achievements and remaining challenges are summarized, and the most promising paradigm for the future of heart muscle tissue engineering is proposed (fifth section). (C) 2007 Elsevier B.V. All fights reserved.
C1 [Chen, Qi-Zhi; Boccaccini, Aldo R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Chen, Qi-Zhi; Harding, Sian E.; Ali, Nadire N.; Lyon, Alexander R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.
RP Chen, QZ (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2AZ, England.
EM qizhi.chen@imperial.ac.uk; a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013
CR Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103
   Akins RE, 1997, IN VITRO CELL DEV-AN, V33, P337
   Alison MR, 2002, J PATHOL, V197, P419, DOI 10.1002/path.1187
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   ALPERT NR, 1979, ANNU REV PHYSIOL, V41, P521, DOI 10.1146/annurev.ph.41.030179.002513
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   ANDERSON JM, 1995, J BIOMED MATER RES, V29, P1473
   Aoki T, 1995, J BIOMAT SCI-POLYM E, V7, P539, DOI 10.1163/156856295X00463
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   ASHIKU SK, 1997, POROUS MAT TISSUE EN, P129
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   ATALA A, 2002, METHODS TISSUE ENG, P681
   ATALA A, 2002, METHODS TISSUE ENG
   BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Baji A, 2006, MATER MANUF PROCESS, V21, P211, DOI 10.1081/AMP-200068681
   Balsam LB, 2004, AM J TRANSPLANT, V4, P469
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   Bartunek J, 2004, CIRCULATION, V110, P69
   Beeres SLMA, 2005, J AM COLL CARDIOL, V46, P1943, DOI 10.1016/j.jacc.2005.07.055
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   Behfar A, 2005, ANN NY ACAD SCI, V1049, P189, DOI 10.1196/annals.1334.018
   Bell E., 2000, PRINCIPLES TISSUE EN, pxxxv
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367
   BING OHL, 1971, CIRC RES, V28, P234, DOI 10.1161/01.RES.28.2.234
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blom AS, 2005, HEART FAIL REV, V10, P125, DOI 10.1007/s10741-005-4640-2
   Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202
   Bouhadir KH, 1998, ABSTR PAP AM CHEM S, V216, pU266
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934
   Brooks A, 2003, HEART, V89, P1255, DOI 10.1136/heart.89.10.1255
   Brown C.D., 2002, METHODS TISSUE ENG, P565
   Bruder SP, 2000, PRINCIPLES TISSUE EN, P683
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BURNS DK, 2003, ROBBINS BASIC PATHOL, P361
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Bursac N, 2003, TISSUE ENG, V9, P1243, DOI 10.1089/10763270360728152
   Calandrelli L, 2004, J BIOACT COMPAT POL, V19, P301, DOI 10.1177/0883911504045234
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Carrier RL, 2002, BIOTECHNOL BIOENG, V78, P617, DOI 10.1002/bit.10245
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Caspi O, 2006, EUR HEART J SUPPL, V8, pE43, DOI 10.1093/eurheartj/sul031
   Chachques JC, 1997, J HEART LUNG TRANSPL, V16, P854
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chaudhry PA, 2001, J CARDIAC SURG, V16, P118, DOI 10.1111/j.1540-8191.2001.tb00496.x
   Cheah CM, 2005, INT J ADV MANUF TECH, V25, P308, DOI 10.1007/s00170-003-1840-6
   Chen Frederick Y, 2002, Cardiol Rev, V10, P326, DOI 10.1097/00045415-200211000-00004
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen Q, 2008, TISSUE ENG USING CER
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   CHEN QZ, 2008, IN PRESS HDB FABRICA
   Chiu R C, 1999, Adv Card Surg, V11, P69
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   CIMA LG, 1991, ASME, V113, P143
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Cowie MR, 2000, HEART, V83, P505, DOI 10.1136/heart.83.5.505
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DEKKER M, 1996, HDB APPL POLYM PROCE
   Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   Dorfman J, 1998, J THORAC CARDIOV SUR, V116, P744, DOI 10.1016/S0022-5223(98)00451-6
   Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2
   Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299
   Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   ELOAKLEY RM, 1994, CIRCULATION, V90, P2085, DOI 10.1161/01.CIR.90.4.2085
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Eschenhagen T, 1997, FASEB J, V11, P683
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   ESCHENHAGEN T, 2005, J BIOTECHNOL, V65, pS65
   Etzion S, 2001, Am J Cardiovasc Drugs, V1, P233, DOI 10.2165/00129784-200101040-00002
   Etzion S, 2002, CIRCULATION, V106, pI125, DOI 10.1161/01.cir.0000032888.55215.b8
   Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2001.1391
   *EUR COMM HLTH CON, 2001, OP STAT ART CONC TIS
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fink C, 2000, FASEB J, V14, P669
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   FUNG YC, 1984, AM ZOOL, V24, P13
   FUNG YC, 1970, J BIOMECH, V3, P381, DOI 10.1016/0021-9290(70)90012-6
   FUNG YC, 1971, J BIOMECH, V4, P289, DOI 10.1016/0021-9290(71)90035-2
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gerecht-Nir S, 2006, INT J DEV BIOL, V50, P233, DOI 10.1387/ijdb.052041sg
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X
   Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo XM, 2006, CIRCULATION, V113, P2229, DOI 10.1161/CIRCULATIONAHA.105.583039
   Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521
   Haider HK, 2005, AM J PHYSIOL-HEART C, V288, pH2557, DOI 10.1152/ajpheart.01215.2004
   Harding SE, 2007, PHARMACOL THERAPEUT, V113, P341, DOI 10.1016/j.pharmthera.2006.08.008
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Haslach HW, 2005, BIOMECH MODEL MECHAN, V3, P172, DOI 10.1007/s10237-004-0055-6
   Hassink RJ, 2003, TRENDS MOL MED, V9, P436, DOI 10.1016/j.molmed.2003.08.002
   Hatakeyama H, 2007, BIOMATERIALS, V28, P3632, DOI 10.1016/j.biomaterials.2007.04.019
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehj826
   Hecker L, 2007, REGEN MED, V2, P125, DOI 10.2217/174607501.2.2.125
   Heng BC, 2005, MED HYPOTHESES, V64, P1085, DOI 10.1016/j.mehy.2004.11.036
   Herreros J, 2003, EUR HEART J, V24, P2012, DOI 10.1016/j.ehj.2003.09.012
   HINRICHS WLJ, 1992, BIOMATERIALS, V13, P585, DOI 10.1016/0142-9612(92)90026-K
   Hirose M, 2000, YONSEI MED J, V41, P803, DOI 10.3349/ymj.2000.41.6.803
   Hosenpud JD, 1999, J HEART LUNG TRANSPL, V18, P611, DOI 10.1016/S1053-2498(99)00037-6
   Hsieh PCH, 2005, CIRCULATION, V112, pU28
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IROH JO, 1999, POLYM DATA HDB, P361
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Itescu S, 2002, INT J ARTIF ORGANS, V25, P647
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Jones JR, 2005, CELLULAR CERAMICS: STRUCTURE, MANUFACTURING, PROPERTIES AND APPLICATIONS, P547, DOI 10.1002/3527606696.ch5h
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawamoto A, 2001, CIRCULATION, V104, P443
   Kawamoto A, 2000, CIRCULATION, V102, P5
   Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kehat I, 2003, HEART FAIL REV, V8, P229, DOI 10.1023/A:1024709332039
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kellomaki M, 2000, J MATER SCI-MATER M, V11, P345, DOI 10.1023/A:1008977806693
   Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853
   Kessler PD, 1999, ANNU REV PHYSIOL, V61, P219, DOI 10.1146/annurev.physiol.61.1.219
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2003, EUR J CARDIO-THORAC, V24, P906, DOI 10.1016/S1010-7940(03)00577-3
   Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0
   Kofidis T, 2003, TISSUE ENG, V9, P517, DOI 10.1089/107632703322066697
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251
   KOH GY, 1993, AM J PHYSIOL, V264, pH1727
   KOH GY, 1993, J CLIN INVEST, V92, P1548, DOI 10.1172/JCI116734
   Kohli SK, 2005, BRIT J HOSP MED, V66, P469, DOI 10.12968/hmed.2005.66.8.18513
   Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005
   Konertz WF, 2001, CIRCULATION, V104, pI270
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   KUMUDINE C, 1999, POLYM DATA HDB
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Kushida A, 2001, J BIOMED MATER RES, V54, P37, DOI 10.1002/1097-4636(200101)54:1<37::AID-JBM5>3.0.CO;2-7
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215
   LAURENCIN CT, 2003, P NATOASI C ANT TURK, V1, P281
   Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611
   Lembcke A, 2006, J HEART LUNG TRANSPL, V25, P90, DOI 10.1016/j.healun.2005.02.025
   Lembcke A, 2005, ROFO-FORTSCHR RONTG, V177, P946, DOI 10.1055/s-2005-857960
   Lembcke A, 2004, ANN THORAC SURG, V78, P900, DOI 10.1016/j.athoracsur.2003.12.051
   Lembcke A, 2004, J HEART LUNG TRANSPL, V23, P11, DOI 10.1016/S1053-2498(03)00066-4
   Lembcke A, 2004, EUR J CARDIO-THORAC, V25, P84, DOI 10.1016/S1010-7940(03)00657-2
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2003, EXPERT OPIN BIOL TH, V3, P1023
   Leor J, 1996, CIRCULATION, V94, P332
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Li RK, 1996, CIRC RES, V78, P283, DOI 10.1161/01.RES.78.2.283
   Li RK, 1997, CIRCULATION, V96, P179
   Lim YM, 2007, J IND ENG CHEM, V13, P21
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Loebe M, 2003, CURR OPIN CARDIOL, V18, P194, DOI 10.1097/00001573-200305000-00004
   Lorusso R, 1997, EUR J CARDIO-THORAC, V11, P363, DOI 10.1016/S1010-7940(96)01038-X
   LU L, 1999, POLYM DATA HDB, P566
   Lu LC, 1996, MRS BULL, V21, P28
   LU LC, 1999, POLYM DATA HDB, P527
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Luo ZP, 2004, BIORHEOLOGY, V41, P247
   LYONS E, 2005, TOPICS TISSUE ENG EB, pCH7
   Madani S, 2006, CARDIOVASC RES, V69, P716, DOI 10.1016/j.cardiores.2005.11.022
   MAGILL JH, 1999, POLYM DATA HDB, P746
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Malchesky PS, 2006, ARTIF ORGANS, V30, P192, DOI 10.1111/j.1525-1594.2006.00206.x
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 2004, J CARD FAIL, V10, P185, DOI 10.1016/j.cardfail.2003.10.007
   MARGOLIN DA, 1993, J VASC SURG, V17, P858, DOI 10.1016/0741-5214(93)90035-K
   MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Martinez C, 2006, AM J GERIATR CARDIOL, V15, P82
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McLachlan CS, 2006, LANCET, V367, P301, DOI 10.1016/S0140-6736(06)68066-5
   Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1
   Menard C, 2004, J CELL BIOCHEM, V93, P681, DOI 10.1002/jcb.20259
   Menasche P, 2005, CORONARY ARTERY DIS, V16, P105, DOI 10.1097/00019501-200503000-00005
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mendias CL, 2005, FASEB J, V19, pA1118
   MESH CL, 1995, J VASC SURG, V22, P142, DOI 10.1016/S0741-5214(95)70108-7
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   MEYHOFER E, 1993, J EXP BIOL, V185, P207
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MILLER BJ, 1953, MED CLIN N AM, P1603
   Min JY, 2006, J THORAC CARDIOV SUR, V131, P889, DOI 10.1016/j.itcvs.2005.12.022
   Min JY, 2005, J THORAC CARDIOV SUR, V130, P547, DOI 10.1016/j.jtcvs.2005.03.017
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101
   Misof K, 1997, J CLIN INVEST, V100, P40, DOI 10.1172/JCI119519
   Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd
   Moainie SL, 2002, ANN THORAC SURG, V74, P753, DOI 10.1016/S0003-4975(02)03827-4
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Murry CE, 2002, COLD SPRING HARB SYM, V67, P519, DOI 10.1101/sqb.2002.67.519
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560
   NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P55, DOI 10.1007/s11746-006-1006-4
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143
   Nerem RM, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P9, DOI 10.1016/B978-0-12-398358-9.00002-1
   Nishikawa N, 2001, J AM COLL CARDIOL, V38, P1539, DOI 10.1016/S0735-1097(01)01548-0
   Noiseux N, 2004, CIRCULATION, V110, P68
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Obradovic B, 1999, BIOTECHNOL BIOENG, V63, P197, DOI 10.1002/(SICI)1097-0290(19990420)63:2<197::AID-BIT8>3.0.CO;2-2
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Oh JH, 1996, J CARDIAC SURG, V11, P194, DOI 10.1111/j.1540-8191.1996.tb00039.x
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   ORLIC D, 2000, HEMATOPOIETIC STEM C, P221
   Ozawa T, 2004, CELL TRANSPLANT, V13, P169, DOI 10.3727/000000004773301852
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   Packer M, 2002, J CARD FAIL, V8, P193, DOI 10.1054/jcaf.2002.128001
   Pagani FD, 2003, J AM COLL CARDIOL, V41, P879, DOI 10.1016/S0735-1097(03)00081-0
   Pagani FD, 2002, CIRCULATION, V106, P463
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Papadaki M, 1999, BASIC APPL MYOL, V9, P151
   Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750
   Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Pezzin APT, 2003, J APPL POLYM SCI, V88, P2744, DOI 10.1002/app.11984
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Pilla JJ, 2005, ANN THORAC SURG, V80, P2257, DOI 10.1016/j.athoracsur.2005.05.089
   Pilla JJ, 2003, J THORAC CARDIOV SUR, V126, P1467, DOI 10.1016/S0022-5223(03)00739-6
   Pilla JJ, 2002, CIRCULATION, V106, pI207, DOI 10.1161/01.cir.0000032871.55215.de
   PINTO JG, 1973, J BIOMECH, V6, P597, DOI 10.1016/0021-9290(73)90017-1
   Pitsch RJ, 1997, J VASC SURG, V26, P70, DOI 10.1016/S0741-5214(97)70149-6
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47
   Polonchuk L, 2000, BIOMATERIALS, V21, P539, DOI 10.1016/S0142-9612(99)00189-1
   Pouzet B, 2000, CIRCULATION, V102, P210
   Radisic M, 2005, J SERB CHEM SOC, V70, P541, DOI 10.2298/JSC0503541R
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Ramakrishna S, 2004, INTRO BIOCOMPOSITES
   RAMSAY BA, 1993, APPL ENVIRON MICROB, V59, P1242
   Rastogi S, 2005, J HEART LUNG TRANSPL, V24, P1619, DOI 10.1016/j.healun.2004.07.022
   Reffelmann T, 2003, HEART FAIL REV, V8, P201, DOI 10.1023/A:1024796912475
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Reinlib L, 2000, CIRCULATION, V101, pE182
   Remppis A, 2004, J GENE MED, V6, P387, DOI 10.1002/jgm.513
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007
   ROEDER BA, 2002, ASME, V124, P214, DOI DOI 10.1115/1.1449904
   Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB
   ROSS DN, 1962, LANCET, V2, P487
   Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sabbah HN, 2005, HEART FAIL REV, V10, P109, DOI 10.1007/s10741-005-4638-9
   Sabbah HN, 2004, J CARD FAIL, V10, pS207, DOI 10.1016/j.cardfail.2004.09.009
   Sabbah HN, 2003, ANN THORAC SURG, V75, pS13, DOI 10.1016/S0003-4975(03)00463-6
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Sakai T, 1999, J THORAC CARDIOV SUR, V118, P715, DOI 10.1016/S0022-5223(99)70018-8
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z
   Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Schmidt D, 2006, SWISS MED WKLY, V136, P618
   Schmidt RE, 2007, J EXOT PET MED, V16, P49, DOI 10.1053/j.jepm.2006.11.009
   SCHMIDT SP, 1985, J VASC SURG, V2, P292, DOI 10.1067/mva.1985.avs0020292
   Scorsin M, 1998, CIRCULATION, V98, P200
   Scorsin M, 1997, CIRCULATION, V96, P188
   Scorsin M, 1996, CIRCULATION, V94, P337
   Scorsin M, 2000, J THORAC CARDIOV SUR, V119, P1169, DOI 10.1067/mtc.2000.104865
   SCORSIN M, 1998, CIRCULATION, V98, P51
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   SENNING A, 1967, J THORAC CARDIOV SUR, V54, P465
   Shachar M, 2003, HEART FAIL REV, V8, P271, DOI 10.1023/A:1024729919743
   Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   SHIMIZU T, 2002, J ARTIF ORGANS, V5, P216
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897
   Siminiak T, 2005, J AM COLL CARDIOL, V45, p57A
   Siminiak T, 2005, EUR HEART J, V26, P1188, DOI 10.1093/eurheartj/ehi159
   Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043
   Singla DK, 2006, J MOL CELL CARDIOL, V40, P195, DOI 10.1016/j.yjmcc.2005.09.001
   Sinkus R, 2006, IEEE T ULTRASON FERR, V53, P2009, DOI 10.1109/TUFFC.2006.141
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stile RA, 2004, J BIOMAT SCI-POLYM E, V15, P865, DOI 10.1163/1568562041271129
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824
   TAIRA M, 2004, J MATER SCI LETT, V20, P1773
   Takahashi T, 1999, NAT MED, V5, P434
   Takamizawa K, 2002, J BIOMAT SCI-POLYM E, V13, P81, DOI 10.1163/156856202753525954
   Takaoka H, 2002, AM J PHYSIOL-HEART C, V282, pH2190, DOI 10.1152/ajpheart.00759.2001
   Tasche C, 1999, AM J PHYSIOL-HEART C, V277, pH2400, DOI 10.1152/ajpheart.1999.277.6.H2400
   Tasche C, 1998, BIOPHYS J, V74, pA350
   Taylor DA, 1998, NAT MED, V4, P1200, DOI 10.1038/2701
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Temenoff J, 2000, BONE ENG, P455
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tomita S, 1999, CIRCULATION, V100, P91
   Tomita S, 1999, CIRCULATION, V100, P247
   TZIAMPAZIS E, 1995, BIOTECHNOL PROGR, V11, P115, DOI 10.1021/bp00032a001
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Vacanti C. A, 2000, PRINCIPLES TISSUE EN, V2nd, P671
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   van Luyn MJA, 2002, BIOMATERIALS, V23, P4793, DOI 10.1016/S0142-9612(02)00230-2
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Varda-Bloom N, 2000, J MOL CELL CARDIOL, V32, P2141, DOI 10.1006/jmcc.2000.1261
   Vats A, 2002, CLIN OTOLARYNGOL, V27, P227, DOI 10.1046/j.1365-2273.2002.00579.x
   Verheggen R, 1997, ACTA NEUROCHIR, V139, P1074, DOI 10.1007/BF01411563
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Vunjak-Novakovic G, 2006, J CHEM TECHNOL BIOT, V81, P485, DOI 10.1002/jctb.1467
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang L, 2007, J MOL CELL CARDIOL, V42, pS97, DOI 10.1016/j.yjmcc.2007.03.210
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Weber KT, 1997, INT J BIOCHEM CELL B, V29, P31, DOI 10.1016/S1357-2725(96)00116-1
   WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Werner L, 2005, J MOL CELL CARDIOL, V39, P691, DOI 10.1016/j.yjmcc.2005.06.015
   WIDMER MS, 1998, FRONTIERS TISSUE ENG, P107
   Wilmut I, 1997, NATURE, V386, P200, DOI 10.1038/386200a0
   Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211
   Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   YAMAZAKI M, 1995, BIOTECHNOL BIOENG, V48, P17, DOI 10.1002/bit.260480105
   YAMAZAKI M, 1994, BIOTECHNOL BIOENG, V44, P38, DOI 10.1002/bit.260440107
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang J, 2005, MRS BULL, V30, P189, DOI 10.1557/mrs2005.51
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   YIN FCP, 1980, CIRC RES, V46, P292, DOI 10.1161/01.RES.46.2.292
   YODA N, 2003, DIE MARKROMOL CHEM, V32, P1
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Yoon J, 2005, ACTA CARDIOL, V60, P277, DOI 10.2143/AC.60.3.2005005
   Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099
   YOST MJ, 2004, ENCY BIOMATERIALS BI, P273
   YOUNG JB, 2004, CLIN MANAGEMENT HEAR
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   ZHANG JC, 1995, J THORAC CARDIOV SUR, V109, P1059, DOI 10.1016/S0022-5223(95)70188-5
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhao YS, 2005, J HEART LUNG TRANSPL, V24, P1091, DOI 10.1016/j.healun.2004.07.010
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 444
TC 190
Z9 193
U1 6
U2 128
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0927-796X
EI 1879-212X
J9 MAT SCI ENG R
JI Mater. Sci. Eng. R-Rep.
PD FEB 29
PY 2008
VL 59
IS 1-6
BP 1
EP 37
DI 10.1016/j.mser.2007.08.001
PG 37
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 284FL
UT WOS:000254692100001
DA 2018-10-19
ER

PT J
AU Tao, W
   Zhou, H
   Zhang, Y
   Li, G
AF Tao, William
   Zhou, Hongyang
   Zhang, Yan
   Li, Gang
TI Novel silsesquioxane mixture-modified high elongation polyurethane with
   reduced platelet adhesion
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE polyurethane; surface modification; island morphology
ID BLOOD COMPATIBILITY; SURFACES; HEMOCOMPATIBILITY; BIOMATERIALS;
   POLYETHYLENE; ADSORPTION; FIBRINOGEN; POLYMERS; GRAFTS; LENGTH
AB We have successfully synthesized a kind of novel silsesquioxane mixture that can be used to modify the surface of biomaterial polyurethane (PU) for the purpose of making silsesquioxane/PU as low-price and high-quality biomaterial. HPLC, FTIR and Si-29 NMR are used to characterize as-synthesized silsesquioxane mixture. XPS figure and SEM images show the silsesquioxane particles really self-assemble on the PU surface. Contact angle measurements verify that there is a large hysteresis loop, which relates to low- and high-surface free energy component on the surface. Platelet adsorption at 90 min of PU/silsesquioxane mixture is lower than that of poly(tetrafluoroethylene) (PTFE) and PU (two-way ANOVA, p < 0.05). Furthermore, SEM images show "island'' morphologic pattern with Cooper grades I platelet adsorption morphology on the smooth PU/silsesquioxane surface, and mechanic test shows that the samples with silsesquioxane mixture can increase mechanic property of PU. On the basis of these results, we conclude that this kind of nanocomposite has promise for application in biomaterials. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Tao, William; Zhang, Yan; Li, Gang] Anhui Univ, Dept Chem, Hefei 230026, Peoples R China.
   [Zhou, Hongyang] USTC China, Hefei, Peoples R China.
   [Tao, William] 9 Middle Sch, Anqing City, Peoples R China.
RP Tao, W (reprint author), Anhui Univ, Dept Chem, Hefei 230026, Peoples R China.
EM williamtao795322@163.com
CR Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Conte MS, 1998, FASEB J, V12, P43
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Jonsson M, 2004, COLLOID SURFACE B, V37, P71, DOI 10.1016/j.colsurfb.2004.06.010
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   KIM YH, 2006, MACROMOLECULES, V2237, P215
   KO TM, 1993, BIOMATERIALS, V14, P657
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   RENE I, 3052350 UMI
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   WANG F, 1998, POLY DIMETHYLSILOXAN
   Xiang KH, 1998, J PHYS CHEM B, V102, P8704, DOI 10.1021/jp981840r
NR 21
TC 9
Z9 10
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2008
VL 254
IS 9
BP 2831
EP 2836
DI 10.1016/j.apsusc.2007.10.027
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 277VU
UT WOS:000254243600042
DA 2018-10-19
ER

PT J
AU Goi, KLS
   Butler, DL
   Jarfors, AEW
   Yong, JMS
   Lim, DCS
AF Goi, K. L. S.
   Butler, D. L.
   Jarfors, A. E. W.
   Yong, J. M. S.
   Lim, D. C. S.
TI Elastic modulus of sintered porous Ti-Si-Zr, using activation by Ti-Si
   mechanically alloyed powder and TiH2 powder
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT International Symposium on Inorganic Interfacial Engineering
CY JUN 20-21, 2006
CL Stockholm, SWEDEN
SP Stockholm Univ, Royal Inst Technol
DE bulk modulus; porous biomaterial; activated sintering; mechanical
   alloying; Ti-Si-Zr alloy
ID TITANIUM-ALLOYS; STRENGTH; DEVICES
AB A novel biomaterial based on Ti-Si-Zr was developed using the sintering process with a composition targeting at a bulk modulus in the same range as that of human bone, i.e. 10-30 GPa. Control of porosity should also be possible to allow for the promotion osseointegration. The sintering procedure involves the use of mechanically alloyed Ti-Si-powder, and TiH2, to promote bonding, but not consolidation. The effect of porosity on the bulk modulus using compression testing is investigated. The influence of sintering temperature, heating rate, and amount and size of the TiH2-activator on porosity are also investigated. The achievable bulk modulus was in the range of 20-55 GPa at porosity levels ranging from 16% to 54%. Porosity had a profound influence on the bulk modulus, and the choice of appropriate processing conditions enables the creation of an engineered porosity and bulk modulus primarily by varying the sintering temperature and the size of the TiH2-powder particles. (C) 2007 Published by Elsevier B.V.
C1 [Jarfors, A. E. W.] KIMAB, S-11428 Stockholm, Sweden.
   [Goi, K. L. S.] Ametek, Singapore, Singapore.
   [Goi, K. L. S.; Butler, D. L.; Lim, D. C. S.] Nanyang Technol Univ, Singapore, Singapore.
   [Butler, D. L.] Singapore Inst Mfg Technol, Singapore, Singapore.
RP Jarfors, AEW (reprint author), KIMAB, Drottnig Kristinas Vag 48, S-11428 Stockholm, Sweden.
EM anders.jarfors@kimab.com
RI Jarfors, Anders/C-6679-2009; Lim,, C.S./A-3863-2011
OI Jarfors, Anders/0000-0002-0101-0062; Butler, David/0000-0001-9952-8670
CR BOBYN JD, 1981, T 7 ANN M SOC BIOM C, P13
   Breme J, 2000, ADV ENG MATER, V2, P270, DOI 10.1002/(SICI)1527-2648(200005)2:5<270::AID-ADEM270>3.0.CO;2-9
   DEWEY JM, 1947, J APPL PHYS, V18, P578, DOI 10.1063/1.1697691
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   Gu YW, 2004, PHYSICA B, V352, P299, DOI 10.1016/j.physb.2004.08.001
   Han FS, 1998, METALL MATER TRANS B, V29, P1315, DOI 10.1007/s11663-998-0055-5
   HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7
   HULBERT S, 1970, AICHE MAT ENG SCI DI, P87
   *I ASM, 1997, FRICT WEAR TEST SOUR
   Kennedy AR, 2002, SCRIPTA MATER, V47, P763, DOI 10.1016/S1359-6462(02)00281-6
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   RATNER B, 2004, COMMUNICATION
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 1999, J COMPUT-AIDED MATER, V6, P355, DOI 10.1023/A:1008762206967
   Thieme M., 1999, Materials Science Forum, V308-311, P374
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   WALPOLE LJ, 1969, J MECH PHYS SOLIDS, V17, P235, DOI 10.1016/0022-5096(69)90014-3
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
   2000, BIOMEDICAL ENG HDB
NR 22
TC 4
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD FEB 25
PY 2008
VL 475
IS 1-2
BP 45
EP 51
DI 10.1016/j.msea.2007.02.129
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 270AW
UT WOS:000253693100010
DA 2018-10-19
ER

PT J
AU Hoffmann, G
   Lutter, G
   Cremer, J
AF Hoffmann, G.
   Lutter, G.
   Cremer, J.
TI Durability of Bioprosthetic Cardiac Valves
SO DEUTSCHES ARZTEBLATT INTERNATIONAL
LA English
DT Review
DE cardiac valve replacement; biomaterial; cardiac surgery; comorbidity;
   guideline; indication
ID HANCOCK-II BIOPROSTHESIS; PORCINE BIOPROSTHESIS; STENTLESS VALVES;
   RANDOMIZED-TRIAL; REPLACEMENT; SURGERY; PREGNANCY; OUTCOMES; WOMEN
AB Introduction: The choice of type of heart valve prosthesis is determined by the patient's age since bioprostheses have a limited lifespan. This article reviews current recommendations and the literature on cardiac valve replacement.
   Methods: Selective literature search in Medline/PubMed back to 1996 and review of current national and international recommendations from specialist societies.
   Results: The recommendations guiding the type of heart valve replacement have been revised in recent years. Of particular interest are the new generation of biological prostheses with extended durability, a growing use of stentless bioprostheses, a decrease in mortality of reoperation and an increase in life expectancy. Comorbidities such as chronic renal insufficiency or chronic atrial fibrillation are no longer contraindications to bioprosthesis. The number of heart valve replacements in recent years rose despite a concomitant increase in valve repairs. Aortic valves are being increasingly replaced by bioprostheses.
   Discussion: The choice of heart valve prosthesis should be tailored to each patient taking into account the patient's age, life expectancy, comorbidities, and life style. Different decisions may be made now than those based on earlier recommendations resulting in an individualized treatment, in patients over the age of 65 or 70. Dtsch Arztebl Int 2008; 105(8): 143-8 DOI: 10.3238/arztebl.2008.0143
C1 [Hoffmann, G.; Lutter, G.; Cremer, J.] Univ Klinikum Schleswig Holstein, Klin Herz & Gefasschirurg, D-24105 Kiel, Germany.
RP Hoffmann, G (reprint author), Univ Klinikum Schleswig Holstein, Klin Herz & Gefasschirurg, Arnold Heller Str 7, D-24105 Kiel, Germany.
EM grischa.hoffmann@gmx.de
RI Cremer, Jochen/E-4171-2010
CR Aupart MR, 2006, J HEART VALVE DIS, V15, P768
   Borger MA, 2006, J HEART VALVE DIS, V15, P49
   Chan V, 2006, ANN THORAC SURG, V81, P857, DOI 10.1016/j.athoracsur.2005.09.009
   Cohen G, 2002, ANN THORAC SURG, V73, P767, DOI 10.1016/S0003-4975(01)03338-0
   COX JL, 1999, J THORAC CARDIOVASC, V118, P883
   Daniel WG, 2006, CLIN RES CARDIOL, V95, P620, DOI 10.1007/s00392-006-0458-8
   David TE, 2001, J THORAC CARDIOV SUR, V121, P268, DOI 10.1067/mtc.2001.112208
   de Kerchove L, 2007, CURR OPIN CARDIOL, V22, P96, DOI 10.1097/HCO.0b013e328014670a
   GRUNKEMEIER GL, 2000, CURR PROB CARDIOLOGY, V25, P75
   Gummert JF, 2006, THORAC CARDIOV SURG, V54, P362, DOI 10.1055/s-2006-924405
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   Jamieson WRE, 2005, J THORAC CARDIOV SUR, V130, P994, DOI 10.1016/j.jtcvs.2005.03.040
   Jamieson WRE, 1998, ANN THORAC SURG, V66, pS49, DOI 10.1016/S0003-4975(98)01127-8
   Mihaljevic T, 2005, J HEART VALVE DIS, V14, P151
   Nagele H, 2000, HERZ, V25, P651, DOI 10.1007/PL00001979
   Neville PH, 1998, ANN THORAC SURG, V66, P143
   Oakley C, 2003, EUR HEART J, V24, P761, DOI 10.1016/S0195-668X(03)00098-8
   Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363
   RAJAPPAN K, 2002, J HEART VALVE DIS, V11, pS60
   Sadler L, 2000, BRIT J OBSTET GYNAEC, V107, P245, DOI 10.1111/j.1471-0528.2000.tb11696.x
   Sidhu P, 2001, ANN THORAC SURG, V71, pS257, DOI 10.1016/S0003-4975(01)02522-X
   SIEVERS H, 2005, DTSCH ARZTEBL, V102, pA2090
   Stassano P, 2006, THORAC CARDIOV SURG, V54, P521, DOI 10.1055/s-2006-924467
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   2006, CIRCULATION, V114, P84
NR 25
TC 28
Z9 30
U1 0
U2 5
PU DEUTSCHER AERZTE-VERLAG GMBH
PI COLOGNE
PA DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY
SN 1866-0452
J9 DTSCH ARZTEBL INT
JI Dtsch. Arztebl. Int.
PD FEB 22
PY 2008
VL 105
IS 8
BP 143
EP 148
DI 10.3238/arztebl.2008.0143
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 475MS
UT WOS:000268364600003
PM 19633780
OA Green Published
DA 2018-10-19
ER

PT J
AU Ismail, YA
   Shin, SR
   Shin, KM
   Yoon, SG
   Shon, K
   Kim, SI
   Kim, SJ
AF Ismail, Yahya A.
   Shin, Su Ryon
   Shin, Kwang Min
   Yoon, Seong Gil
   Shon, Kiwon
   Kim, Sun I.
   Kim, Seon Jeong
TI Electrochemical actuation in chitosan/polyaniline microfibers for
   artificial muscles fabricated using an in situ polymerization
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE electrochemical actuation; chitosan; polyaniline; artificial muscle
ID CONDUCTING POLYMER; ELECTROCHEMOMECHANICAL DEFORMATION;
   AQUEOUS-ELECTROLYTES; DRUG-RELEASE; SEMI-IPN; POLYANILINE; CHITOSAN;
   HYDROGELS; NETWORK; GEL
AB We have fabricated a new type of electroactuating biopolymer hydrogel/polyaniline microfiber by wet spinning a chitosan solution, followed by the in situ chemical polymerization of aniline. This novel biomaterial showed an enhanced chemical and electrochemical actuation in response to pH and an electrical stimulus. The fibers showed a reasonable electrical conductivity of 2.856 x 10(-2) S/cm at room temperature. The strain ratio and response time during electrochemical actuation were highly dependent on the pH of the electrolyte. An isotonic strain of 0.39% during electrochemical actuation in an aqueous HCl solution at pH = 0, along with a strain of 6.73% corresponding to pH actuation was realized in the microfibers. The higher strain ratio at lower pH values is probably due to a faster diffusion rate. Although the electrochemical actuation was due to the polyaniline, the actuation mechanism was different from that in pure polyaniline. EDX analysis showed the presence of polyaniline inside the fibers, which gradually decreased moving towards the center of the fiber. SEM images of the fibers showed an agglomerated granular morphology of polyaniline particles coated on the surface of the chitosan fibers. The electrochemical properties of the fibers were due to polyaniline, as evidenced by cyclic voltammogram. (C) 2007 Elsevier B.V. All rights reserved.
C1 Hanyang Univ, Ctr Bio Artificial Muscle, Seoul 133791, South Korea.
   Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.
RP Kim, SJ (reprint author), Hanyang Univ, Ctr Bio Artificial Muscle, Seoul 133791, South Korea.
EM sjk@hanyang.ac.kr
RI Ismail, Yahya/B-8084-2009
OI Ismail, Yahya/0000-0001-9514-3423
CR Abdelaal MY, 2007, J APPL POLYM SCI, V103, P2864, DOI 10.1002/app.25154
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Dispenza C, 2006, POLYMER, V47, P961, DOI 10.1016/j.polymer.2005.12.071
   Gupta KC, 2001, J MATER SCI-MATER M, V12, P753, DOI 10.1023/A:1017976014534
   Hansen TS, 2006, SYNTHETIC MET, V156, P1203, DOI 10.1016/j.synthmet.2006.08.009
   HUANG WS, 1986, J CHEM SOC FARAD T 1, V82, P2385, DOI 10.1039/f19868202385
   Kaneko M, 1999, SYNTHETIC MET, V102, P1350, DOI 10.1016/S0379-6779(98)00235-5
   Kaneko M, 2001, POLYM J, V33, P104, DOI 10.1295/polymj.33.104
   KANETO K, 1995, SYNTHETIC MET, V71, P2211, DOI 10.1016/0379-6779(94)03226-V
   KIEFER R, 2007, ACTUATORS B, V125, P628
   Kim DH, 2005, IEEE T MAGN, V41, P4158, DOI 10.1109/TMAG.2005.854857
   Kim SJ, 2006, CHEM MATER, V18, P5805, DOI 10.1021/cm060988h
   Kim SJ, 2004, SMART MATER STRUCT, V13, P1036, DOI 10.1088/0964-1726/13/5/008
   Kim SJ, 2006, NAT MATER, V5, P48, DOI 10.1038/nmat1553
   Kim SJ, 2004, J APPL POLYM SCI, V91, P2876, DOI 10.1002/app.13516
   Lu W, 2004, CHEM MATER, V16, P1615, DOI 10.1021/cm0301591
   Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135
   Madden PGA, 2004, IEEE J OCEANIC ENG, V29, P696, DOI 10.1109/JOE.2004.833139
   Mucha M., 2007, E-POLYMERS, V16, P1
   Nakayama M, 1999, ANAL SCI, V15, P259, DOI 10.2116/analsci.15.259
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Pandey SS, 2004, REACT FUNCT POLYM, V58, P103, DOI 10.1016/j.reactfunctpolym.2003.11.011
   Pickup P.G., 1999, MOD ASPECT ELECTROC, V33, P549
   Prakash R, 2002, J APPL POLYM SCI, V83, P378, DOI 10.1002/app.10025
   Qi BH, 2004, J PHYS CHEM B, V108, P6222, DOI 10.1021/jp031092s
   Schreyer HB, 2000, BIOMACROMOLECULES, V1, P642, DOI 10.1021/bm0055571
   Shin SR, 2005, SYNTHETIC MET, V154, P213, DOI 10.1016/j.synthmet.2005.07.054
   Siddhanta SK, 2005, POLYMER, V46, P2993, DOI 10.1016/j.polymer.2005.01.084
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Smela E, 2005, SYNTHETIC MET, V151, P25, DOI 10.1016/j.synthmet.2005.03.009
   Spinks GA, 2007, SENSOR ACTUAT B-CHEM, V121, P616, DOI 10.1016/j.snb.2006.04.103
   Spinks GM, 2002, ADV FUNCT MATER, V12, P437, DOI 10.1002/1616-3028(20020618)12:6/7<437::AID-ADFM437>3.0.CO;2-I
   TRIVEDI DC, 1997, HDB CONDUCTIVE MOL P, V3
   Wei XL, 1996, J AM CHEM SOC, V118, P2545, DOI 10.1021/ja952277i
   Yamauchi T, 2005, SYNTHETIC MET, V152, P45, DOI 10.1016/j.synthmet.2005.07.109
NR 35
TC 86
Z9 87
U1 3
U2 63
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD FEB 22
PY 2008
VL 129
IS 2
BP 834
EP 840
DI 10.1016/j.snb.2007.09.083
PG 7
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 270QC
UT WOS:000253734300048
DA 2018-10-19
ER

PT J
AU Liu, C
   Zhao, Q
   Liu, Y
   Wang, S
   Abel, EW
AF Liu, C.
   Zhao, Q.
   Liu, Y.
   Wang, S.
   Abel, E. W.
TI Reduction of bacterial adhesion on modified DLC coatings
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE biological adhesion; surface modification; contact angles; surface free
   energy
ID DIAMOND-LIKE CARBON; SURFACE FREE-ENERGY; CHEMICAL-VAPOR-DEPOSITION;
   HEAT-TRANSFER SURFACES; AMORPHOUS-CARBON; FILMS; BIOCOMPATIBILITY;
   SILICON
AB The high incidence of infections caused by the use of implanted biomedical devices, including catheters, bone fracture fixation pins and heart valves, etc. has a severe impact on human health and health care costs. Diamond-like carbon (DLC) films as biomaterial for medical devices have been attracting great interest due to their excellent properties such as low friction and chemical inertness. It has been demonstrated that the properties of DLC films can be further improved by the addition of selective elements into DLC films. In this paper Si- and N-doped DLC coatings with various silicon and nitrogen contents on 316 stainless steel substrates were prepared by a magnetron sputtering technique. Bacterial adhesion to the modified DLC coatings was evaluated with Pseudomonas aeruginosa (ATCC 33347) which frequently cause medical device infections. The results showed that the addition of N or Si in DLC coatings had a significant influence on bacterial adhesion. In general the modified DLC coatings with N or Si performed better than the pure DLC coatings in inhibiting bacterial adhesion. The bacterial adhesion mechanism on the modified DLC coatings was explained with thermodynamic theory. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Liu, C.; Zhao, Q.; Liu, Y.; Wang, S.; Abel, E. W.] Univ Dundee, Dept Mech Engn, Dundee DD1 4HN, Scotland.
RP Zhao, Q (reprint author), Univ Dundee, Dept Mech Engn, Dundee DD1 4HN, Scotland.
EM Q.Zhao@dundee.ac.uk
CR Bornhorst A, 1999, HEAT TRANSFER ENG, V20, P6, DOI 10.1080/014576399271529
   Chen LY, 2003, DIAM RELAT MATER, V12, P968, DOI 10.1016/S0925-9635(02)00351-5
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P113, DOI 10.1016/0927-7765(96)01288-X
   Flock JI, 1999, TRENDS MICROBIOL, V7, P140, DOI 10.1016/S0966-842X(99)01483-3
   FRAMCESCJOMO DF, 1992, APPL PHYS LETT, V26, P3229
   Gangopadhyay AK, 1997, TRIBOL INT, V30, P9, DOI 10.1016/0301-679X(96)00017-5
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   HULLERSTEINHAGE.M, 2000, CAN J CHEM ENG, V78, P12
   Ishihara M, 2006, DIAM RELAT MATER, V15, P1011, DOI 10.1016/j.diamond.2005.12.037
   Kim MG, 1999, SURF COAT TECH, V112, P204, DOI 10.1016/S0257-8972(98)00770-1
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Rusop M, 2005, DIAM RELAT MATER, V14, P975, DOI 10.1016/j.diamond.2004.12.040
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Weinstein RA, 2001, CLIN INFECT DIS, V33, P1386, DOI 10.1086/324190
   Wu WJ, 1999, SURF COAT TECH, V111, P134, DOI 10.1016/S0257-8972(98)00719-1
   Yang P, 2006, NUCL INSTRUM METH B, V242, P22, DOI 10.1016/j.nimb.2005.08.081
   Zhao Q, 2005, SURF COAT TECH, V192, P77, DOI 10.1016/j.surfcoat.2004.02.030
   Zhao Q, 2004, J COLLOID INTERF SCI, V280, P174, DOI 10.1016/j.jcis.2004.07.004
   Zhao Q, 2005, CHEM ENG SCI, V60, P4858, DOI 10.1016/j.ces.2005.04.006
NR 28
TC 79
Z9 83
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 15
PY 2008
VL 61
IS 2
BP 182
EP 187
DI 10.1016/j.colsurfb.2007.08.008
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 259DO
UT WOS:000252919500009
PM 17897814
DA 2018-10-19
ER

PT J
AU Vennapusa, R
   Hunegnaw, SM
   Cabrera, RB
   Fernandez-Lahore, M
AF Vennapusa, RamiReddy
   Hunegnaw, Sara M.
   Cabrera, Rosa B.
   Fernandez-Lahore, Marcelo
TI Assessing adsorbent-biomass interactions during expanded bed adsorption
   onto ion exchangers utilizing surface energetics
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE expanded bed adsorption; direct contact; Biomass adhesion; surface
   energetics; sorption performance; biomaterial design
ID SACCHAROMYCES-CEREVISIAE; ELECTROSTATIC ADHESION; BACTERIAL ADHESION;
   CELL DISRUPTION; CONTACT ANGLES; HYDROPHOBICITY; CHROMATOGRAPHY;
   THERMODYNAMICS; BIOSURFACES; POLYSTYRENE
AB Biomass adhesion onto an adsorbent matrix or "interaction" as well as biological particle co-adhesion or "aggregation" can severely affect the overall performance of many direct-contact methods for downstream processing of bioproducts. Studies to quantitatively describe this biomass-adsorbent interaction were developed utilizing surface energetics. An indirect thermodynamic approach via contact angle and zeta potential measurements was utilized. Intact yeast cells, yeast homogenates, and disrupted bacterial paste were employed as model system. Various surfaces that are relevant to biochemical and environmental applications were characterized. The extended Derjaguin, Landau, Verwey, Overbeek (XDLVO) theory was found to appropriately predict biomass adhesion behaviour. It was observed that cell attachment onto anion-exchange supports is promoted by strong and close interaction within a secondary energy minimum followed by moderate multilayer cell aggregation. On the other hand, cell interaction with cation-exchange materials can take place within a reversible secondary energy minimum and at longer separation distance. The influence of particle charge and size, as well as the influence of the nature of the material under study were summarized in the form of energy vs. distance profiles. These investigations lead to many process-related conclusions: (a) process buffer conductivity windows can be recommended for anion-exchange chromatography (AEX) vs. cation-exchange chromatography (CEX) systems, (b) increased hydrodynamic shear is required to prevent biomass attachment onto AEX as compared to CEX, and (c) aggregation phenomena is a function of contact time and biomass concentration. Understanding biomass-adsorbent interaction at the particle (local) level is opening the pave for optimized operation of expanded bed adsorption methods at the process (macro) scale. A universal methodological approach is presented to guide both process and material design. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Vennapusa, RamiReddy; Hunegnaw, Sara M.; Cabrera, Rosa B.; Fernandez-Lahore, Marcelo] Jacobs Univ, Downstream Proc Lab, D-28759 Bremen, Germany.
RP Fernandez-Lahore, M (reprint author), Jacobs Univ, Downstream Proc Lab, Campus Ring 1, D-28759 Bremen, Germany.
EM m.fernandez-lahore@jacobs-university.de
OI Fernandez Lahore, Hector Marcelo/0000-0002-3623-4963
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Anspach FB, 1999, J CHROMATOGR A, V865, P129, DOI 10.1016/S0021-9673(99)01119-X
   Bierau H, 2001, BIOSEPARATION, V10, P73, DOI 10.1023/A:1012054622066
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BRIXIUS PJ, 2003, THESIS
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Dainiak MB, 2002, BIOTECHNOL PROGR, V18, P815, DOI 10.1021/bp0202923
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   Fernandez-Lahore HM, 1999, BIOTECHNOL BIOENG, V64, P484, DOI 10.1002/(SICI)1097-0290(19990820)64:4<484::AID-BIT11>3.0.CO;2-Z
   Fernandez-Lahore HM, 2000, J CHROMATOGR A, V873, P195, DOI 10.1016/S0021-9673(99)01308-4
   Fernandez-Lahore HM, 2001, BIOTECHNOL PROGR, V17, P1128, DOI 10.1021/bp010118z
   Feuser J, 1999, BIOSEPARATION, V8, P99, DOI 10.1023/A:1008071731987
   Gallardo-Moreno AM, 2002, APPL ENVIRON MICROB, V68, P2610, DOI 10.1128/AEM.68.5.2610-2613.2002
   Ganeva V, 2004, BIOTECHNOL LETT, V26, P933, DOI 10.1023/B:bile.0000025906.95694.1a
   *GE HELATHC, 2002, 18114487 GE HEALTHC, P1
   *GE HELATHC, 2001, 18115021 GE HEALTHC, P1
   Henriques M, 2002, BIOTECHNOL LETT, V24, P1111, DOI 10.1023/A:1016083021525
   Hubbuch J, 2005, ADV BIOCHEM ENG BIOT, V92, P101, DOI 10.1007/b98917
   Kang S, 2005, COLLOID SURFACE B, V46, P70, DOI 10.1016/j.colsurfb.2005.08.017
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lin DQ, 2007, BIOTECHNOL PROGR, V23, P162, DOI 10.1021/bp060286x
   Lin DQ, 2006, BIOTECHNOL BIOENG, V95, P185, DOI 10.1002/bit.21011
   Lin DQ, 2003, BIOTECHNOL BIOENG, V83, P149, DOI 10.1002/bit.10654
   Lin DQ, 2001, BIOSEPARATION, V10, P7, DOI 10.1023/A:1012091031567
   Mattiasson B, 1996, J MOL RECOGNIT, V9, P509, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<509::AID-JMR293>3.0.CO;2-Y
   MILLS AL, 1994, APPL ENVIRON MICROB, V60, P3300
   OTTEWILL RH, 1972, J ELECTROANAL CHEM, V37, P133, DOI 10.1016/S0022-0728(72)80221-3
   Sambrook J, 2006, CONDENSED PROTOCOLS
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Strevett KA, 2003, RES MICROBIOL, V154, P329, DOI 10.1016/S0923-2508(03)00038-X
   Theodossiou I, 2001, BIOSEPARATION, V10, P31, DOI 10.1023/A:1012078605874
   THOMMES J, 1995, BIOTECHNOL BIOENG, V48, P367, DOI 10.1002/bit.260480409
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   vanOss CJ, 1997, CURR OPIN COLLOID IN, V2, P503, DOI 10.1016/S1359-0294(97)80099-4
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vergnault H, 2004, BIOTECHNOL PROGR, V20, P1534, DOI 10.1021/bp0499121
   Vergnault H, 2007, PROCESS BIOCHEM, V42, P244, DOI 10.1016/j.procbio.2006.08.009
NR 40
TC 18
Z9 18
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD FEB 15
PY 2008
VL 1181
IS 1-2
BP 9
EP 20
DI 10.1016/j.chroma.2007.11.078
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 267JZ
UT WOS:000253506600002
PM 18199439
DA 2018-10-19
ER

PT J
AU You, YM
   Ludescher, RD
AF You, Yumin
   Ludescher, Richard D.
TI The effect of sodium chloride on molecular mobility in amorphous sucrose
   detected by phosphorescence from the triplet probe erythrosin B
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE sucrose; NaCl; amorphous solid; molecular mobility; phosphorescence;
   erythrosin B
ID DYNAMIC SITE HETEROGENEITY; GLASS-TRANSITION TEMPERATURE; AQUEOUS SUGAR
   SYSTEMS; CAST GELATIN FILMS; ROOM-TEMPERATURE; BIOMATERIAL
   STABILIZATION; ENTHALPY RELAXATION; COLD-CAST; WATER; STATE
AB Phosphorescence from the triplet probe erythrosin B provides spectroscopic characteristics such as emission energy and lifetime that are specifically sensitive to molecular mobility of the local environment. This study used phosphorescence of erythrosin B to investigate how variation in NaCl content modulated the mobility of the amorphous sucrose matrix over the temperature range from 5 to 100 degrees C. Addition of NaCl increased the emission energy and the energy difference with excitation at the absorption maximum and the red edge, and increased the lifetime by reducing the non-radiative decay rate in the glass as well as in the undercooled liquid in a concentration dependent manner, indicating that NaCl decreased the matrix molecular mobility. Emission energy and lifetime increased with increasing NaCl content up to a maximum at NaCl/sucrose mole ratio of similar to 0.5; above 0.5 mole ratio, the effect of NaCl was less significant and appeared to be opposed by increasing plasticization by residual water. Changes in the width of the distribution of the emission energy and lifetime and variation in the lifetime with excitation and emission wavelength indicated that NaCl increased the spectral heterogeneity and thus increased the extent of dynamic site heterogeneity. These results are consistent with a physical model in which sodium and chloride ions interact with sucrose OH by ion-dipole interactions, forming clusters of less mobile molecules within the matrix. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [You, Yumin; Ludescher, Richard D.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
RP Ludescher, RD (reprint author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.
EM ludescher@aesop.rutgers.edu
OI Ludescher, Richard/0000-0003-4795-6520
CR ACCORSI CA, 1989, CARBOHYD RES, V191, P105, DOI 10.1016/0008-6215(89)85050-5
   Buitink J, 2000, BIOPHYS J, V79, P1119, DOI 10.1016/S0006-3495(00)76365-X
   Buitink J, 2004, CRYOBIOLOGY, V48, P215, DOI 10.1016/j.cryobiol.2004.02.011
   CHAN RK, 1986, J PHYS CHEM-US, V90, P6358, DOI 10.1021/j100281a059
   CONNER JM, 1967, J INORG NUCL CHEM, V29, P1953, DOI 10.1016/0022-1902(67)80455-X
   Contreras-Lopez E, 2000, J AGR FOOD CHEM, V48, P1009, DOI 10.1021/jf990816n
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe JH, 2002, INTEGR COMP BIOL, V42, P497, DOI 10.1093/icb/42.3.497
   Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671
   Duchowicz R, 1998, PHOTOCHEM PHOTOBIOL, V68, P494, DOI 10.1562/0031-8655(1998)068<0494:KSOEPA>2.3.CO;2
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   Fennema O. R., 1996, FOOD CHEM, P17
   Fischer CJ, 2002, J AM CHEM SOC, V124, P10359, DOI 10.1021/ja016609x
   FRANKS F, 1992, PURE APPL CHEM, V64, P1667, DOI 10.1351/pac199264111667
   Gangasharan, 1995, J PHYS CHEM-US, V99, P12349
   HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526
   Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI DOI 10.1007/BF01918191
   Izutsu K, 2005, INT J PHARM, V288, P101, DOI 10.1016/j.ijpharm.2004.09.015
   Kawai K, 2005, PHARM RES, V22, P490, DOI 10.1007/s11095-004-1887-6
   Kets EPW, 2004, CRYOBIOLOGY, V48, P46, DOI 10.1016/j.cryobiol.2003.12.002
   Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6
   Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Lu Q, 1997, J PHARM SCI-US, V86, P1374, DOI 10.1021/js970157y
   Lukasik KV, 2006, FOOD HYDROCOLLOID, V20, P96, DOI 10.1016/j.foodhyd.2005.03.007
   Lukasik KV, 2006, FOOD HYDROCOLLOID, V20, P88, DOI 10.1016/j.foodhyd.2005.03.006
   MARONCELLI M, 1987, J CHEM PHYS, V86, P6221, DOI 10.1063/1.452460
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Miller DP, 1999, J PHYS CHEM B, V103, P10243, DOI 10.1021/jp984736i
   MISHRA RG, 1980, INDIAN J CHEM A, V19, P572
   Nack TJ, 2006, FOOD BIOPHYS, V1, P151, DOI 10.1007/s11483-006-9014-3
   Ottenhof MA, 2003, CARBOHYD RES, V338, P2195, DOI 10.1016/S0008-6215(03)00342-2
   PAPP S, 1989, PHOTOCHEM PHOTOBIOL, V49, P775, DOI 10.1111/j.1751-1097.1989.tb05576.x
   PARKER CA, 1968, PHOTOLUMINESCENCE SO, P320
   Pravinata LC, 2005, BIOPHYS J, V88, P3551, DOI 10.1529/biophysj.104.054825
   Richert R, 2000, J CHEM PHYS, V113, P8404, DOI 10.1063/1.1319174
   Richert R, 2001, EUROPHYS LETT, V54, P767, DOI 10.1209/epl/i2001-00320-5
   RICHERT R, 2002, J PHYS CONDENS MATT, V14, pR738
   Robinson R. A., 1970, J CHEM THERMODYN, V2, P745
   Roos Y. H., 1995, PHASE TRANSITIONS FO, P193
   Roos YH, 1996, J THERM ANAL CALORIM, V47, P1437, DOI 10.1007/BF01992838
   Schoorl N, 1923, RECL TRAV CHIM PAY-B, V42, P790
   Shalaev EY, 1996, J PHYS CHEM-US, V100, P1144, DOI 10.1021/jp951052r
   SHALAEV EY, 1995, THERMOCHIM ACTA, V255, P49, DOI 10.1016/0040-6031(94)02180-V
   Shalaev EY, 2002, PHARMACEUT RES, V19, P195, DOI 10.1023/A:1014229001433
   Shamblin SL, 1998, PHARMACEUT RES, V15, P1828, DOI 10.1023/A:1011997721086
   Shirke S, 2005, CARBOHYD RES, V340, P2661, DOI 10.1016/j.carres.2005.08.015
   Shirke S, 2005, J PHYS CHEM B, V109, P16119, DOI 10.1021/jp0521050
   Shirke S, 2006, BIOPHYS CHEM, V123, P122, DOI 10.1016/j.bpc.2006.05.001
   Simon-Lukasik KV, 2004, FOOD HYDROCOLLOID, V18, P621, DOI 10.1016/j.foodhyd.2003.09.006
   Slade L, 1995, Adv Food Nutr Res, V38, P103, DOI 10.1016/S1043-4526(08)60084-4
   Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0
   SUNDARESAN KV, 2007, FOOD HYDROCOLLOIDS, V22, P403
   Urbani R., 2007, THERMOCHIM ACTA, V304, P359
   van den Dries IJ, 2000, J PHYS CHEM B, V104, P9260, DOI 10.1021/jp000074x
   Vavrinecz G., 1958, ELELMEZESI LPAR, V12, P114
   Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3
   Wolkers WF, 1998, BBA-GEN SUBJECTS, V1379, P83, DOI 10.1016/S0304-4165(97)00085-8
   YOU Y, 2007, THESIS RUTGERS U NEW
   You YM, 2006, APPL SPECTROSC, V60, P813, DOI 10.1366/000370206777887107
   Zallen R., 1983, PHYSICS AMORPHOUS SO, P1
NR 61
TC 17
Z9 17
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD FEB 4
PY 2008
VL 343
IS 2
BP 350
EP 363
DI 10.1016/j.carres.2007.11.005
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 260QZ
UT WOS:000253026500020
PM 18048018
DA 2018-10-19
ER

PT J
AU Ousegui, A
   LeBail, A
   Havet, M
AF Ousegui, A.
   LeBail, A.
   Havet, M.
TI Numerical modeling of a high pressure thawing process of a biomaterial
SO AICHE JOURNAL
LA English
DT Article
DE phase change; heat transfer; CFD
ID PHASE-CHANGE; THERMOPHYSICAL PROPERTIES; HEAT-TRANSFER; WATER;
   SIMULATION; ICE; TEMPERATURE; TRANSITIONS; TRANSPORT; SYSTEMS
AB A numerical model for predicting temperature and velocity fields during conjugate heat transfer in a high pressure (HP) (similar to 200 MPa) thawing process presented. This model considers the apparent specific heat formulation to solve the energy equation with phase change and the shift approach to extrapolate thermophysical properties at HP. It does not require the adjustement of the convective heat transfer coefficient. The compressible flow of water in the HP vessel is calculated. It is shown that the fluid motion is dominated by forced convection in the compression phase and by natural convection during the holding phase. A very good agreement between numerical and experimental results is obtained. Additional simulations carried out at various pressures permit to assess the influence of the pressure level on the thawing time. The analysis of the phase change inside the food and of the velocity field inside the vessel clearly demonstrates the great potential of this model to optimize this HP process at an industrial scale. (c) 2007 American Institute of Chemical Engineers.
C1 [Ousegui, A.; LeBail, A.; Havet, M.] ENITIAA, CNRS, UMR GEPEA, UA 6144, F-44322 Nantes 03, France.
RP Havet, M (reprint author), ENITIAA, CNRS, UMR GEPEA, UA 6144, Rue Geraudiere BP 82225, F-44322 Nantes 03, France.
EM havet@enitiaa-nantes.fr
CR Benet G. U., 2004, Innovative Food Science & Emerging Technologies, V5, P413
   BENNON WD, 1987, INT J HEAT MASS TRAN, V30, P2161, DOI 10.1016/0017-9310(87)90094-9
   Bridgman P.W., 1912, P AM ACAD ARTS SCI, V47, P411
   Campanone LA, 2005, INT J HEAT MASS TRAN, V48, P1205, DOI 10.1016/j.ijheatmasstransfer.2004.09.030
   Cheftel JC, 2000, FOOD REV INT, V16, P453, DOI 10.1081/FRI-100102319
   CHIZHOV VE, 1991, P INT ASS HYDR SCI G, V208, P463
   Chourot JM, 1997, J FOOD ENG, V34, P63, DOI 10.1016/S0260-8774(97)00067-8
   Denys S, 1997, BIOTECHNOL PROGR, V13, P416, DOI 10.1021/bp970022y
   Denys S, 2000, BIOTECHNOL PROGR, V16, P447, DOI 10.1021/bp000018d
   Denys S., 2000, Innovative Food Science and Emerging Technologies, V1, P5, DOI 10.1016/S1466-8564(99)00003-X
   Fuchigami M, 1997, J FOOD SCI, V62, P828, DOI 10.1111/j.1365-2621.1997.tb15465.x
   Hartmann C., 2004, Innovative Food Science & Emerging Technologies, V5, P399, DOI 10.1016/j.ifset.2004.07.003
   Hartmann C., 2002, Innovative Food Science and Emerging Technologies, V3, P11, DOI 10.1016/S1466-8564(01)00060-1
   Hartmann C, 2002, BIOTECHNOL BIOENG, V79, P94, DOI 10.1002/bit.10302
   Hendrickx M, 1998, TRENDS FOOD SCI TECH, V9, P197, DOI 10.1016/S0924-2244(98)00039-9
   KADER BA, 1981, INT J HEAT MASS TRAN, V24, P1541, DOI 10.1016/0017-9310(81)90220-9
   KAKAC S, 1987, HDB SINGLE PHASE CON, P13
   KALICHEVSKY MT, 1995, TRENDS FOOD SCI TECH, V6, P253, DOI 10.1016/S0924-2244(00)89109-8
   Knorr D, 1998, FOOD TECHNOL-CHICAGO, V52, P42
   Knorr D., 1993, FOOD TECHNOL, V47, P158
   Kowalczyk W, 2004, INT J HEAT MASS TRAN, V47, P1079, DOI 10.1016/j.ijheatmasstransfer.2003.07.030
   Le Bail A, 2001, J THERM ANAL CALORIM, V66, P243, DOI 10.1023/A:1012408319835
   Li B, 2002, J FOOD ENG, V54, P175, DOI 10.1016/S0260-8774(01)00209-6
   MAKITA T, 1992, FLUID PHASE EQUILIBR, V76, P87, DOI 10.1016/0378-3812(92)85079-N
   Martino MN, 1998, MEAT SCI, V50, P303, DOI 10.1016/S0309-1740(98)00038-2
   MILES CA, 1983, MRI S, V3
   Norris S E, 2000, THESIS U SYDNEY
   Otero L, 2006, FOOD HYDROCOLLOID, V20, P449, DOI 10.1016/j.foodhyd.2005.04.001
   Ousegui A, 2006, AICHE J, V52, P4240, DOI 10.1002/aic.11035
   Patankar S., 1980, NUMERICAL HEAT TRANS
   Rattanadecho P, 2006, CHEM ENG SCI, V61, P4571, DOI 10.1016/j.ces.2006.02.018
   RHIE CM, 1983, AIAA J, V21, P1525, DOI 10.2514/3.8284
   Sanz PD, 2000, BIOTECHNOL PROGR, V16, P1037, DOI 10.1021/bp0001213
   SCHLUTER O, 2003, THESIS BERLIN U TECH
   SCHLUTER O, 1998, HIGH PRESSURE FOOD S, P317
   Tanishita I., 1971, Bulletin of the Japan Society of Mechanical Engineers, V14, P1187
   ZAHO YYR, 1998, J FOOD SCI, V63, P272
   ZHU S, 2003, BIOTECHNOL PROGR, V20, P939
NR 38
TC 2
Z9 2
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0001-1541
J9 AICHE J
JI AICHE J.
PD FEB
PY 2008
VL 54
IS 2
BP 544
EP 553
DI 10.1002/aic.11391
PG 10
WC Engineering, Chemical
SC Engineering
GA 252WV
UT WOS:000252478900019
DA 2018-10-19
ER

PT J
AU Bondar, B
   Fuchs, S
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
AF Bondar, Borys
   Fuchs, Sabine
   Motta, Antonella
   Migliaresi, Claudio
   Kirkpatrick, Charles J.
TI Functionality of endothelial cells on silk fibroin nets: Comparative
   study of micro- and nanometric fibre size
SO BIOMATERIALS
LA English
DT Article
DE nanotopography; endothelial cells; adhesion molecule; stem cell;
   integrins; biomimetic material
ID FOCAL ADHESION KINASE; MESENCHYMAL STEM-CELLS; HUMAN PERIPHERAL-BLOOD;
   COLLAGEN; GROWTH; DIFFERENTIATION; ANGIOGENESIS; CAVEOLIN-1; INTEGRINS;
   MATRIX
AB Biomimetic material design, such as mimicking nanostructured components of the extracellular matrix, is an actual challenge for biomaterial research with a high impact on tissue engineering and regenerative medicine. Thus, understanding the cellular response at the cell biological and molecular level and the consequences of various chemically or physically modified biomaterials is highly important. In the present study we assessed the response of human umbilical vein endothelial cells (HUVEC) and outgrowth endothelial cells (OEC) from endothelial progenitor cells to different variants of nanofibrous silk fibroin nets in comparison to microfibrous silk fibroin scaffolds with regard to cellular morphology, proliferation, formation of intercellular contacts as well as integrin-dependent adhesion. Endothelial cells (ECs) grown on nanometric nets formed a differentiated and interconnected endothelial monolayer with no significant changes in the expression of intercellular contact molecules or proliferation rates compared with cells grown on micrornetric nets. Nevertheless, quantitative real-time PCR revealed a higher expression level of integrin-beta 1 in ECs grown on nanofibrous fibroin nets compared to the microfibrous samples. In addition, single nano-fibres were recognised by the integrin- receptor mechanism supporting the formation of focal adhesion at the interface of ECs and nanometric nets. These findings indicate that the nanometric silk fibroin scaffolds did not interfere with the formation of a differentiated and interconnected EC layer. On the contrary, nanofibre variation of the fibroin net architecture induced changes in ECs at the molecular level in terms of the increased expression of adhesion molecules such as integrin-beta 1. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Bondar, Borys; Fuchs, Sabine; Kirkpatrick, Charles J.] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
RP Fuchs, S (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Bldg 402,Langenbeckstr 1, D-55101 Mainz, Germany.
EM bondar@uni-mainz.de; fuchss@uni-mainz.de; antonella.motta@ing.unitn.it;
   claudio.migliaresi@ing.unitn.it;
   kirkpatrick@pathologie.klinik.uni-mainz.de
OI Motta, Antonella/0000-0003-4893-6863
CR Bajaj P, 2006, INT J NANOMED, V1, P361
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Fuchs S, 2006, CELL TISSUE RES, V326, P79, DOI 10.1007/s00441-006-0222-4
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Heckmann L, 2006, CELLS TISSUES ORGANS, V182, P143, DOI 10.1159/000093964
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Lee TH, 2006, J BIOL CHEM, V281, P40450, DOI 10.1074/jbc.M607525200
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004
   Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Santilman V, 2006, CELL MOTIL CYTOSKEL, V63, P673, DOI 10.1002/cm.20153
   Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020
   Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Unger RE, 2002, IN VITRO CELL DEV-AN, V38, P273
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223
   Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
NR 33
TC 83
Z9 89
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2008
VL 29
IS 5
BP 561
EP 572
DI 10.1016/j.biomaterials.2007.10.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249DL
UT WOS:000252207100005
PM 17942151
DA 2018-10-19
ER

PT J
AU Meyer, F
   Dimitrova, M
   Jedrzejenska, J
   Arntz, Y
   Schaaf, P
   Frisch, B
   Voegel, JC
   Ogier, J
AF Meyer, Florent
   Dimitrova, Maria
   Jedrzejenska, Justyna
   Arntz, Youri
   Schaaf, Pierre
   Frisch, Benoit
   Voegel, Jean-Claude
   Ogier, Joelle
TI Relevance of bi-functionalized polyelectrolyte multilayers for cell
   transfection
SO BIOMATERIALS
LA English
DT Article
DE polyelectrolyte multilayers; transfection; polyplexes; alpha-MSH;
   melanocytes
ID GENE DELIVERY; BETA-CYCLODEXTRIN; IN-VITRO; FILMS; COMPLEXES; DNA;
   ARCHITECTURE; COATINGS; SURFACE; VIVO
AB In an effort to develop new biomaterial coatings, it was shown that polyelectrolyte multilayers constitute a very powerful tool to render surfaces biologically active. The challenge is to multi-functionalize surfaces in a controlled way. We show here, for the first time, that it is possible to functionalize multilayer films simultaneously with two molecules acting in totally different ways on cells, namely plasmid DNA (pDNA), pre-complexed with poly(ethyleneimine) (PEI), and a peptide molecule, NDPMSH. This peptide, grafted to poly (L-glutamic acid) (PGA) was used as a signal molecule for melamona cells B16-F1 and for its ability to enhance gene delivery in a receptor-independent manner. The PGA-NDPMSH chains are embedded in poly-(allylamine hydrochloride)/poly-(sodium 4-styrene sulfonate) multilayers and the pDNA-PEI complexes are deposited on top of the films. It is shown that melanoma cells (B16-F1) are efficiently transfected after 24h of contact with functionalized films. When brought in contact with Huh-7 cells that do not express the peptide receptors, these films trigger significantly the transfection rate, showing that it is possible to enhance the transfection process by incorporating specific peptides into multilayer films. Moreover, transfected cells sorted by flow cytometry produce melanin, demonstrating both activation via the peptide signaling pathway and cell transfection. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Meyer, Florent; Dimitrova, Maria; Arntz, Youri; Voegel, Jean-Claude; Ogier, Joelle] Univ Strasbourg 1, INSERM U 95, F-67085 Strasbourg, France.
   [Jedrzejenska, Justyna; Frisch, Benoit] Fac Pharm, Lab Chim Bioorgan, F-67400 Illkirch Graffenstaden, France.
   [Schaaf, Pierre] Univ Strasbourg 1, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Ogier, J (reprint author), Univ Strasbourg 1, INSERM U 95, 11 Rue Humann, F-67085 Strasbourg, France.
EM joelle.ogier@medecine.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; Meyer, Florent/D-9570-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Meyer, Florent/0000-0002-5275-3421;
   Frisch, Benoit/0000-0002-8378-2508
CR Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Bettinger T, 1999, BIOCONJUGATE CHEM, V10, P558, DOI 10.1021/bc990006h
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Chluba J, 2001, BBA-BIOMEMBRANES, V1510, P198, DOI 10.1016/S0005-2736(00)00348-5
   Derbal L, 2003, BIOMACROMOLECULES, V4, P1255, DOI 10.1021/bm034070k
   Erbacher P, 1999, J GENE MED, V1, P210
   Froidevaux S, 2005, J NUCL MED, V46, P887
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Kursa M, 2003, BIOCONJUGATE CHEM, V14, P222, DOI 10.1021/bc0256087
   LI S, 2000, AM J PHYSIOL-LUNG C, V278, P504
   Meyer F, 2006, BBA-BIOMEMBRANES, V1758, P419, DOI 10.1016/j.bbamem.2005.11.015
   Michel M, 2004, LANGMUIR, V20, P4835, DOI 10.1021/la049736q
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Schaffer DV, 1998, J BIOL CHEM, V273, P28004, DOI 10.1074/jbc.273.43.28004
   Thierry B, 2005, J AM CHEM SOC, V127, P1626, DOI 10.1021/ja045077s
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   UEDA Y, 1994, NEUROSCI LETT, V165, P203, DOI 10.1016/0304-3940(94)90745-5
   Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057
   Ward CM, 2002, J GENE MED, V4, P536, DOI 10.1002/jgm.296
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zuber G, 2003, ANGEW CHEM INT EDIT, V42, P2666, DOI 10.1002/anie.200250446
NR 26
TC 30
Z9 30
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2008
VL 29
IS 5
BP 618
EP 624
DI 10.1016/j.biomaterials.2007.10.027
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249DL
UT WOS:000252207100011
PM 17996296
DA 2018-10-19
ER

PT J
AU Garcia-Fuentes, M
   Giger, E
   Meinel, L
   Merkle, HP
AF Garcia-Fuentes, Marcos
   Giger, Elisabeth
   Meinel, Lorenz
   Merkle, Hans P.
TI The effect of hyaluronic acid on silk fibroin conformation
SO BIOMATERIALS
LA English
DT Article
DE silk; hyaluronic acid; crystallization; secondary structure; mechanical
   properties
ID PHYSICAL-PROPERTIES; BLEND FILMS; MECHANICAL-PROPERTIES;
   STRUCTURAL-CHANGES; BIOMATERIALS; TRANSITION; MEMBRANES; PROTEINS;
   SEQUENCE; POLYMER
AB The molecular conformation of silk fibroin drastically changes the physical properties of this biomaterial. Herein, we investigated the capacity of hyaluronic acid to modify the conformational transition of silk fibroin into its crystalline beta-sheet form. For this aim, matrices composed of these two polymers were prepared and studied. Instrumental analysis confirmed the presence of two intermixed phases: one of pure hyaluronic acid, and another consisting of a molecular dispersion of silk fibroin and hyaluronic acid. Studies performed with silk fibroin/hyaluronic acid matrices indicated that hyaluronic acid induces molecular transition of silk fibroin into a beta-sheet structure when incubated in water, and that it synergistically enhances beta-sheet formation together with methanol treatment. The enhancement of beta-sheet content observed for silk fibroin/hyaluronic acid matrices correlated with improved mechanical properties: blended matrices had higher compressive moduli and higher breaking strengths than pure silk fibroin matrices. These new properties, together with the capacity of silk fibroin/hyaluronic acid to form partially insoluble matrices without any treatment with organic solvents, make this blend composition an interesting material for biomedical applications. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Garcia-Fuentes, Marcos; Giger, Elisabeth; Meinel, Lorenz; Merkle, Hans P.] ETH, Dept Chem & Appl Biosci, Drug Formulat & Delivery Grp, CH-8093 Zurich, Switzerland.
RP Garcia-Fuentes, M (reprint author), Univ Santiago de Compostela, NANOBIOFAR Grp, Dept Pharmaceut Technol, Sch Pharm, Campus, Santiago De Compostela 15782, Spain.
EM redrum@usc.es
RI Garcia-Fuentes, Marcos/B-4218-2012; Merkle, Hans/A-4381-2014; Meinel,
   Lorenz/D-9997-2015
OI Garcia-Fuentes, Marcos/0000-0002-6393-6469; Meinel,
   Lorenz/0000-0002-7549-7627
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Dai LX, 2002, J APPL POLYM SCI, V86, P2342, DOI 10.1002/app.11260
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KRAUSE S, 1989, POLYM HDB, P347
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Moore M. L., 1992, SYNTHETIC PEPTIDES U, P9
   Nishioka N, 1998, J APPL POLYM SCI, V69, P2133, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2133::AID-APP4>3.0.CO;2-H
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   Remiro PM, 1999, J MATER SCI, V34, P2627, DOI 10.1023/A:1004609001449
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Rusa CC, 2005, MACROMOLECULES, V38, P5640, DOI 10.1021/ma050340a
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   STAUFFER SL, 1994, J ARACHNOL, V22, P5
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka T, 1997, POLYM INT, V42, P107, DOI 10.1002/(SICI)1097-0126(199701)42:1<107::AID-PI686>3.0.CO;2-9
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 31
TC 36
Z9 36
U1 5
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2008
VL 29
IS 6
BP 633
EP 642
DI 10.1016/j.biomaterials.2007.10.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249ON
UT WOS:000252238400002
PM 17996295
DA 2018-10-19
ER

PT J
AU Wan, YQ
   Feng, G
   Shen, FH
   Laurencin, CT
   Li, XD
AF Wan, Yuqing
   Feng, Gang
   Shen, Francis H.
   Laurencin, Cato T.
   Li, Xudong
TI Biphasic scaffold for annulus fibrosus tissue regeneration
SO BIOMATERIALS
LA English
DT Article
DE polycaprolactone; biphasic scaffold; tissue engineering; intervertebral
   disc; annulus fibrosus
ID BOVINE ARTICULAR-CARTILAGE; INTERVERTEBRAL DISC; IN-VITRO; MICROPOROUS
   POLY(L-LACTIDE-CO-EPSILON-CAPROLACTONE); CHONDROCYTE BIOSYNTHESIS;
   COMPRESSION FORCE; NUCLEUS PULPOSUS; CELL AFFINITY; COMPOSITES;
   ATTACHMENT
AB Intervertebral disc (IVD) degeneration is the major cause of lower back pain, while the currently available treatments are symptomatic rather than curative. Tissue engineering is a powerful therapeutic strategy that can restore the normal biomechanical motion of the human spine. The ability of a biphasic elastic scaffold to structurally and elastically simulate the annulus fibrosus (AF) tissue of the IVD was explored. The outer phase of the scaffold was a ring-shaped denineralized bone matrix gelatin (BMG) extracted from cortical bone, which mimicks the type I collagen structure and ligamentous properties of outer AF. The inner phase of the scaffold was a bio-biomaterial poly(polycaprolactone triol malate) (PPCLM) orientated in concentric sheets and seeded with chondrocytes to recapitulate the inner layer of the AF, which is rich in type II collagen and proteoglycan. The mechanical properties and degradation of PPCLM could be adjusted by controlling the post-polymerization time of the pre-polymer. PPCLM also demonstrated good biocompatibility in a foreign body response in vivo assay. Incorporation of BMG into the scaffold enhanced the compressive strength compared with PPCLM alone. In addition, the tensile stress of the BMG/PPCLM scaffold was 50-fold greater than that of PPCLM alone, and close to that of normal rabbit AF. Finally, the biphasic scaffold supported the growth of rabbit chondrocytes, as confirmed by Safranin-O and type 11 collagen immunostaining. The excellent mechanical properties and biocompatibility of the BMG/PPCLM scaffold make it a promising candidate for AF repair. Published by Elsevier Ltd.
C1 [Wan, Yuqing; Feng, Gang; Shen, Francis H.; Laurencin, Cato T.; Li, Xudong] Univ Virginia, Sch Med, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
   [Laurencin, Cato T.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Laurencin, Cato T.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.
   [Feng, Gang] Second Clin Hosp, N Sichuan Med Coll, Core Lab, Nanchong 637000, Sichuan Prov, Peoples R China.
RP Li, XD (reprint author), Univ Virginia, Sch Med, Orthopaed Res Lab, PO Box 800374, Charlottesville, VA 22908 USA.
EM XL2N@VlRGINIA.EDU
CR Banu Nasreen, 2005, J Artif Organs, V8, P184, DOI 10.1007/s10047-005-0302-3
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Goins Maurice L, 2005, Spine J, V5, p317S, DOI 10.1016/j.spinee.2005.02.021
   He B, 2004, BIOMATERIALS, V25, P5239, DOI 10.1016/j.biomaterials.2003.12.030
   Jin M, 2003, ARCH BIOCHEM BIOPHYS, V414, P223, DOI 10.1016/S0003-9861(03)00195-4
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   LA GA, 2005, MACROMOL BIOSCI, V5, P1108
   Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/b0502457
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Park S, 2006, J BIOMECH ENG-T ASME, V128, P623, DOI 10.1115/1.2206201
   Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Studer A, 2002, EUR SPINE J, V11, pS154, DOI 10.1007/s00586-002-0443-5
   Sun DDN, 2004, ANN BIOMED ENG, V32, P92, DOI 10.1023/B:ABME.0000007794.87408.1e
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Wang H, 2004, J MOL MED-JMM, V82, P126, DOI 10.1007/s00109-003-0507-y
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Xie J, 2006, TISSUE ENG, V12, P1811, DOI 10.1089/ten.2006.12.1811
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
NR 30
TC 83
Z9 105
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2008
VL 29
IS 6
BP 643
EP 652
DI 10.1016/j.biomaterials.2007.10.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249ON
UT WOS:000252238400003
PM 17997480
DA 2018-10-19
ER

PT J
AU Kodjikian, L
   Beby, F
   Rabilloud, M
   Bruslea, D
   Halphen, I
   Fleury, J
   Grange, JD
   Garweg, JG
AF Kodjikian, L.
   Beby, F.
   Rabilloud, M.
   Bruslea, D.
   Halphen, I.
   Fleury, J.
   Grange, J-D
   Garweg, J. G.
TI Influence of intraocular lens material on the development of acute
   endophthalmitis after cataract surgery?
SO EYE
LA English
DT Article
DE endophthalmitis; cataract surgery; intraocular lens material;
   biomaterial
ID SCANNING-ELECTRON-MICROSCOPY; NATIONAL PROSPECTIVE SURVEY;
   STAPHYLOCOCCUS-EPIDERMIDIS; RISK-FACTORS; POSTOPERATIVE ENDOPHTHALMITIS;
   IN-VITRO; BACTERIAL ADHERENCE; WESTERN-AUSTRALIA; ADHESION; POPULATION
AB Purpose To investigate the causal relationship between acute postoperative endophthalmitis (POE) after cataract surgery and the biomaterial properties of the intraocular lens (IOLs) implanted.
   Methods This retrospective cohort study included all patients who had undergone cataract surgery with IOL implantation at the Lyon Croix-Rousse University Hospital between 1st January 1994 and 31st December 2004. Details respecting the type of IOL implanted (material and manufacturer) were meticulously recorded. The number of patients presenting with POE within 6 weeks of cataract surgery was documented together with their medical characteristics. These data were then compared, and Fisher's exact test was used to establish the significance of any apparent associations.
   Results Eight of the 5837 eyes manifested acute POE (0.14%). Seven of these were composed of polymethylmethacrylate (PMMA) and one of heparinized PMMA. Patients with PMMA IOLs carried a higher risk of developing POE than did those implanted with either heparinized PMMA (P=0.001), hydrophilic acrylic, or hydrophobic acrylic IOLs (P=0.002).
   Conclusions The incidence of acute POE after cataract surgery in our hospital is similar to that currently reported for other institutions in developed countries. Our results add further evidence that IOL material and type are factors contributing to the risk to develop an acute POE after cataract surgery, and that PMMA IOLs may be associated with an increased risk of POE.
C1 [Kodjikian, L.; Beby, F.; Bruslea, D.; Halphen, I.; Fleury, J.; Grange, J-D] Univ Lyon 1, Hop Croix Rousse, Dept Ophthalmol, F-69004 Lyon, France.
   [Garweg, J. G.] Swiss Eye Inst, Wabern, Switzerland.
   [Rabilloud, M.] Hosp Civils Lyon, Dept Biostat, Lyon, France.
RP Kodjikian, L (reprint author), Univ Lyon 1, Hop Croix Rousse, Dept Ophthalmol, Claude Bernard,EA 3090,103,Grande Rue Croix Rouss, F-69004 Lyon, France.
EM kodjikian.laurent@wanadoo.fr
CR AbuElAsrar AM, 1997, INT OPHTHALMOL, V21, P71, DOI 10.1023/A:1005835013581
   Agrawal V, 1997, J CATARACT REFR SURG, V23, P588, DOI 10.1016/S0886-3350(97)80220-9
   ALFONSO EC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1369, DOI 10.1001/archopht.1995.01100110029018
   Bainbridge JWB, 1998, BRIT J OPHTHALMOL, V82, P1312, DOI 10.1136/bjo.82.11.1312
   Burillon C, 2002, DRUG DEV IND PHARM, V28, P95, DOI 10.1081/DDC-120001490
   CUSUMANO A, 1994, ARCH OPHTHALMOL-CHIC, V112, P1015, DOI 10.1001/archopht.1994.01090200017002
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   KIENAST A, 2006, GRAEFES ARCH CLIN EX, V2, P1
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2004, BIO-MED MATER ENG, V14, P395
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4382, DOI 10.1167/iovs-03-0185
   Li JH, 2004, INVEST OPHTH VIS SCI, V45, P1321, DOI 10.1167/iovs.03-1000
   Mayer E, 2003, BRIT J OPHTHALMOL, V87, P867, DOI 10.1136/bjo.87.7.867
   MENIKOFF JA, 1991, OPHTHALMOLOGY, V98, P1761
   Merritt K, 1991, J Biomater Appl, V5, P185, DOI 10.1177/088532829100500304
   Montan P, 2002, ACTA OPHTHALMOL SCAN, V80, P258, DOI 10.1034/j.1600-0420.2002.800305.x
   Montan PG, 1998, OPHTHALMOLOGY, V105, P2171, DOI 10.1016/S0161-6420(98)91211-8
   Nagaki Y, 2003, J CATARACT REFR SURG, V29, P20, DOI 10.1016/S0886-3350(02)01483-9
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   Ng JQ, 2005, OPHTHALMOLOGY, V112, P1199, DOI 10.1016/j.ophtha.2005.01.050
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Pinna A, 2000, OPHTHALMOLOGY, V107, P2162, DOI 10.1016/S0161-6420(00)00408-5
   RASKIN EM, 1993, ARCH OPHTHALMOL-CHIC, V111, P250, DOI 10.1001/archopht.1993.01090020104032
   Schmidt H, 1998, ZBL BAKT-INT J MED M, V287, P135, DOI 10.1016/S0934-8840(98)80159-X
   Semmens JB, 2003, CLIN EXP OPHTHALMOL, V31, P213, DOI 10.1046/j.1442-9071.2003.00647.x
   Somani S, 1997, CAN J OPHTHALMOL, V32, P303
   VINE AK, 1995, ARCH OPHTHALMOL-CHIC, V113, P1479
   Wejde G, 2005, J HOSP INFECT, V61, P251, DOI 10.1016/j.jhin.2005.04.016
   Wejde G, 2005, ACTA OPHTHALMOL SCAN, V83, P7, DOI 10.1111/j.1600-0420.2004.00377.x
   Wong TY, 2004, BRIT J OPHTHALMOL, V88, P29, DOI 10.1136/bjo.88.1.29
   Wong TY, 2004, OPHTHALMOLOGY, V111, P699, DOI 10.1016/j.ophtha.2003.07.014
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 34
TC 8
Z9 9
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
J9 EYE
JI Eye
PD FEB
PY 2008
VL 22
IS 2
BP 184
EP 193
DI 10.1038/sj.eye.6702544
PG 10
WC Ophthalmology
SC Ophthalmology
GA 262IE
UT WOS:000253141400004
PM 16980932
OA Bronze
DA 2018-10-19
ER

PT J
AU Yumusak, C
   Alekberov, V
AF Yumusak, Cigdem
   Alekberov, Vilayet
TI The effects of electrical discharge on the mechanical properties of
   Bombyx mori silk fibroin
SO FIBERS AND POLYMERS
LA English
DT Article
DE silk fibroin; electrical discharge; mechanical properties; mechanical
   stress; crosslinking
ID BIOMATERIAL; FILMS
AB Bombyx Mori is a representative of natural fibers which is known for its mechanical stability. In this study, electrical discharge of the fibers exposed to different voltages for certain periods was examined and mechanical lifetime was measured and also the structure parameters U-o and gamma were calculated. We observed that crosslinks might be formed at the silk fibers exposed to high voltages and as a result, fibers become more resistant to mechanical effects.
C1 [Yumusak, Cigdem; Alekberov, Vilayet] Yildiz Tech Univ, Fac Sci & Arts, Dept Phys, TR-34210 Istanbul, Turkey.
   [Alekberov, Vilayet] Azerbaijan Acad Sci, Inst Phys, Baku 370143, Azerbaijan.
RP Yumusak, C (reprint author), Yildiz Tech Univ, Fac Sci & Arts, Dept Phys, Davutpasa Campus, TR-34210 Istanbul, Turkey.
EM yumusak@yildiz.edu.tr
RI Yumusak, Cigdem/F-4074-2015
OI Yumusak, Cigdem/0000-0001-7207-1121
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ASAKURA T, 1994, ENCY AGR SCI, V1, P1
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   BUNNING TJ, 1994, ACS SYM SER, V544, P2
   Furuhata Ken-Ichi, 1997, Journal of Sericultural Science of Japan, V66, P11
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   TAGER A, 1978, PHYSL CHEM POLYMERS, P156
   Tamada Y, 1999, J BIOMAT SCI-POLYM E, V10, P787, DOI 10.1163/156856299X00649
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   ZHURKOV SN, 1984, THEOR APPL FRAC MECH, P271
NR 16
TC 5
Z9 5
U1 0
U2 3
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD FEB
PY 2008
VL 9
IS 1
BP 15
EP 20
DI 10.1007/s12221-008-0003-7
PG 6
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 267YX
UT WOS:000253546200003
DA 2018-10-19
ER

PT J
AU Gingras, M
   Beaulieu, MM
   Gagnon, V
   Durham, HD
   Berthod, F
AF Gingras, Marie
   Beaulieu, Marie-Michele
   Gagnon, Vicky
   Durham, Heather D.
   Berthod, Francois
TI In vitro study of axonal migration and myelination of motor neurons in a
   three-dimensional tissue-engineered model
SO GLIA
LA English
DT Article
DE Schwann cells; nerve regeneration; biomaterial; peripheral nervous
   system; axon guidance
ID SPINAL MUSCULAR-ATROPHY; PERIPHERAL-NERVE REGENERATION;
   MARIE-TOOTH-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL
   GROWTH-FACTOR; CELL-ADHESION MOLECULES; NEUROTROPHIC FACTOR;
   SCHWANN-CELLS; DIFFERENTIAL REGULATION; COLLAGEN SPONGE
AB Primary motor neurons are difficult to study in conventional culture systems because of their short-term survival without trophic support from glia. In addition, axonal migration on a two-dimensional Petri dish does not reflect the three-dimensional (3D) environment in vivo. A unique in vitro 3D model of motor nerve regeneration was developed to study motor neuron axonal migration and myelination. Mouse spinal cord motor neurons were seeded on a collagen sponge populated with Schwann cells and fibroblasts. This fibroblast-populated sponge was intended to mimic the connective tissue through which motor axons have to elongate in vivo. Addition of conventional neurotrophic supplements was not required for motor neuron survival but was necessary to promote deep neurite outgrowth, as assessed by immunostaining of neurofilament M. A vigorous neurite elongation was detected inside the sponge after only 14 days of neuron culture, reaching more than 850 mu m. The model also allowed the maturation of motor fibers as one-third of them were positive for neurofilament H. Neurites growing in the sponge were subject to myelination when Schwann cells were present, as shown by myelin basic protein immunostaining and electron microscopy. We demonstrated in this model the spontaneous formation of numerous thick myelin sheaths surrounding motor fibers after long-term culture (28 days). Thus, this model might be a valuable tool to study the effect of various cells and/or attractive or repulsive molecules on motor neurite outgrowth in vitro and also for the study of myelination and pathogenesis of motor neuron diseases. (C) 2007 Wiley-Liss, Inc.
C1 [Gingras, Marie; Beaulieu, Marie-Michele; Gagnon, Vicky; Berthod, Francois] Hop St Sacrement, CHAUQ, LOEX, Quebec City, PQ G1S 4L8, Canada.
   [Gingras, Marie; Beaulieu, Marie-Michele; Gagnon, Vicky; Berthod, Francois] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
   [Durham, Heather D.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
RP Berthod, F (reprint author), Hop St Sacrement, CHAUQ, LOEX, 1050 Chemin St Foy, Quebec City, PQ G1S 4L8, Canada.
EM francois.berthod@chg.ulaval.ca
CR ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2
   ARAKAWA Y, 1990, J NEUROSCI, V10, P3507
   Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y
   Avossa D, 2006, NEUROSCIENCE, V138, P1179, DOI 10.1016/j.neuroscience.2005.12.009
   Bearden SE, 2004, MICROCIRCULATION, V11, P633, DOI 10.1080/10739680490517659
   Becker E, 1998, J NEUROSCI, V18, P7903
   Berthod F, 1996, J BIOMED MATER RES, V32, P87, DOI 10.1002/(SICI)1097-4636(199609)32:1<87::AID-JBM10>3.0.CO;2-F
   Berthod F, 2006, J CELL PHYSIOL, V207, P491, DOI 10.1002/jcp.20584
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353
   Bohn MC, 2004, EXP NEUROL, V190, P263, DOI 10.1016/j.expneurol.2004.08.012
   Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511
   Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S
   BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273
   Caissie R, 2006, BIOMATERIALS, V27, P2988, DOI 10.1016/j.biomaterials.2006.01.014
   CARDEN MJ, 1987, J NEUROSCI, V7, P3489
   CLARK EA, 1991, J NEUROSCI RES, V30, P116, DOI 10.1002/jnr.490300113
   Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071
   Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   CULHEIM S, 1999, SPINAL CORD, V37, P811
   D'MELLO SR, 1992, J NEUROSCI RES, V33, P519, DOI 10.1002/jnr.490330404
   DASILVA CF, 1985, BRAIN RES, V342, P307, DOI 10.1016/0006-8993(85)91130-8
   Elliott JL, 1999, NEUROBIOL DIS, V6, P310, DOI 10.1006/nbdi.1999.0266
   GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7
   Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje
   Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024
   Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013
   Greensmith L, 1997, NEUROMUSCULAR DISORD, V7, P369, DOI 10.1016/S0960-8966(97)00047-3
   Griffin JW, 1999, ANN NY ACAD SCI, V883, P77, DOI 10.1111/j.1749-6632.1999.tb08571.x
   Guettier-Sigrist S, 2001, FUNDAM CLIN PHARM, V15, P31, DOI 10.1046/j.1472-8206.2001.00006.x
   Hanson MG, 1998, J NEUROSCI, V18, P7361
   KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M
   Komiyama T, 2003, J NEUROSCI METH, V122, P195, DOI 10.1016/S0165-0270(02)00320-5
   KREIDER B, 1988, J NEUROCHEM, V51, P566, DOI 10.1111/j.1471-4159.1988.tb01076.x
   Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270
   LEE HJ, 1991, BRAIN RES, V558, P197, DOI 10.1016/0006-8993(91)90769-R
   Maggi SP, 2003, CLIN PLAST SURG, V30, P109, DOI 10.1016/S0094-1298(02)00101-3
   Maier M, 2002, J ANAT, V200, P357, DOI 10.1046/j.1469-7580.2002.00044.x
   Maki Y, 2005, SCAND J PLAST RECONS, V39, P257, DOI 10.1080/0284431051006510
   Maragakis NJ, 2003, NEUROSCI LETT, V338, P107, DOI 10.1016/S0304-3940(02)01386-1
   Martini R, 1997, GLIA, V19, P298
   Martini R, 1998, MICROSC RES TECHNIQ, V41, P403
   MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439
   Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001
   OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0
   Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8
   Padilla F, 1999, J NEUROSCI RES, V58, P270
   Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180
   Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002
   Robinson GA, 2006, EXP NEUROL, V197, P341, DOI 10.1016/j.expneurol.2005.10.007
   SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E
   Sendtner M, 2001, CURR OPIN NEUROL, V14, P629, DOI 10.1097/00019052-200110000-00012
   SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0
   Sendtner M, 1991, J Cell Sci Suppl, V15, P103
   Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743
   Shy ME, 2004, CURR OPIN NEUROL, V17, P579, DOI 10.1097/00019052-200410000-00008
   Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999
   Stoll G, 1999, BRAIN PATHOL, V9, P313
   SUGIHARA T, 1994, BBA-MOL CELL RES, V1224, P365, DOI 10.1016/0167-4889(94)90269-0
   Tanaka Yosuke, 2002, Trends Genet, V18, pS39, DOI 10.1016/S0168-9525(02)02839-1
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   TOMASELLI KJ, 1988, J NEUROSCI RES, V21, P275, DOI 10.1002/jnr.490210220
   TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137
   Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603
   WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7
   WOOD SJ, 1990, EUR J NEUROSCI, V2, P650, DOI 10.1111/j.1460-9568.1990.tb00454.x
   YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0
   Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1
NR 72
TC 43
Z9 44
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0894-1491
J9 GLIA
JI Glia
PD FEB
PY 2008
VL 56
IS 3
BP 354
EP 364
DI 10.1002/glia.20617
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 254KQ
UT WOS:000252585900010
PM 18098124
DA 2018-10-19
ER

PT J
AU Tsukiyama, S
   Matsushita, M
   Tanaka, M
   Tamura, H
   Todo, S
   Yamamoto, S
   Shimomura, M
AF Tsukiyama, Shusaku
   Matsushita, Michiaki
   Tanaka, Masaru
   Tamura, Hitoshi
   Todo, Satoru
   Yamamoto, Sadaaki
   Shimomura, Masatsugu
TI Enhanced cell survival and yield of rat small hepatocytes by
   honeycomb-patterned films
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Molecular Electronics and Bioelectronics
CY MAR 14-16, 2007
CL Tokyo, JAPAN
DE honeycomb; hepatocyte; scaffold; cell adhesion; cell survival; cell
   yield; cell function
ID SELF-ORGANIZED HONEYCOMB; HEPATIC NONPARENCHYMAL CELLS; BIODEGRADABLE
   POLYMER; EXTRACELLULAR-MATRIX; BLOOD COMPATIBILITY; WATER-STRUCTURE;
   FABRICATION; ADHESION; PROLIFERATION; BIOREACTOR
AB Surface designing of substrate to regulate cell adhesion and function in nano and micro scale is a critical issue in biomaterial science. In this study, we describe the fabrication of highly regular patterned porous films (honeycomb-patterned film) formed by a simply casting technique, and the culture of mature hepatocytes and small hepatocytes on the films. The pore size of the honeycomb-patterned films used was 6, 12, and 16 pm. We evaluated the effect of the honeycomb-patterned films on the morphology, cell yield, survival and the differentiated hepatic function (albumin production) of the both hepatocytes. Both hepatocytes attached on the flat films appeared to spread well, showing a typical monolayer morphology. They peeled off from the films at 7 days in culture on the flat films. On the other hand, spreading of the each hepatocytes was restricted on the honeycomb-patterned films at 3 and 7 days in culture. The cell yield and survival of the each hepatocytes increased with increasing culture time. Small hepatocyte on the pore sizes of 16 pm showed the highest cell yield (approximately 3 times). Albumin production of mature hepatocyte on the pore sizes of 16 mu m (224.1.3 +/- 157 ng ml(-1) well(-1) at 1 day in culture, 369.5 +/- 222 ng ml(-1) well(-1) at 3 days in culture) was higher than that of the hepatocytes on the flat films (119.3 +/- 9.3 ng ml(-1) well(-1) at 1 day in culture, 262.8 +/- 47.3 ng ml(-1) well(-1) at 3 days in culture), although that of small hepatocytes on the honeycomb-patterned films (pore size: 16 mu m) was similar on the flat film. These results indicated that both the surface topography and the pore size of the honeycomb-patterned film affected the hepatic metabolic function.
C1 [Tsukiyama, Shusaku; Yamamoto, Sadaaki] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   [Matsushita, Michiaki; Tamura, Hitoshi; Todo, Satoru] Hokkaido Univ, Grad Sch Med, Dept Surg 1, Kita Ku, Sapporo, Hokkaido 0608648, Japan.
   [Tanaka, Masaru; Shimomura, Masatsugu] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Tsukiyama, Shusaku; Matsushita, Michiaki; Tanaka, Masaru; Todo, Satoru; Yamamoto, Sadaaki; Shimomura, Masatsugu] Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan.
RP Tsukiyama, S (reprint author), Hokkaido Univ, Kita Ku, N21,W10, Sapporo, Hokkaido 0010021, Japan.
EM tukiyama@med.hokudai.ac.jp
RI Shimomura, Masatsugu/E-5091-2010
OI Tanaka, Masaru/0000-0002-1115-2080
CR Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   CLARK P, 1993, J CELL SCI, V105, P203
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   Endo M, 2002, ARTIF ORGANS, V26, P806, DOI 10.1046/j.1525-1594.2002.06997.x
   Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8
   Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   Gutsche AT, 1996, BIOMATERIALS, V17, P387, DOI 10.1016/0142-9612(96)85577-3
   Harada K, 2003, J HEPATOL, V39, P716, DOI 10.1016/S0168-8278(03)00412-4
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hong JT, 2000, TOXICOL IN VITRO, V14, P177, DOI 10.1016/S0887-2333(00)00009-6
   IIJIMA H, 1998, J BIOMAT SCI-POLYM E, V9, P765
   Kam L, 2001, BIOMATERIALS, V22, P1049, DOI 10.1016/S0142-9612(00)00352-5
   KAMACHI H, 2002, J ARTIF ORGANS, V5, P24
   Karthaus O, 2000, LANGMUIR, V16, P6071, DOI 10.1021/la0001732
   Luttringer O, 2002, BIOCHEM PHARMACOL, V64, P1637, DOI 10.1016/S0006-2952(02)01382-5
   MARUYAMA N, 1998, THIN SOLID FILMS, V854, P327
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   Murakami S, 2004, INT J ARTIF ORGANS, V27, P118
   Nagaki M, 2001, DIGEST DIS SCI, V46, P1046, DOI 10.1023/A:1010714112675
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nishikawa T, 2002, LANGMUIR, V18, P5734, DOI 10.1021/la011451f
   Nishimura S, 1997, J AM CHEM SOC, V119, P10555, DOI 10.1021/ja971786c
   Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Sato K, 2002, INT J NANOSCI SER, V1, P689, DOI 10.1142/S0219581X02000905
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   Sunami H, 2006, COLLOID SURFACE A, V284, P548, DOI 10.1016/j.colsurfa.2005.11.041
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tanaka M, 2004, BIO-MED MATER ENG, V14, P439
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2007, J NANOSCI NANOTECHNO, V7, P763, DOI 10.1166/jnn.2007.514
   Tanaka M, 2006, COLLOID SURFACE A, V284, P464, DOI 10.1016/j.colsurfa.2005.11.098
   Torok E, 2006, TISSUE ENG, V12, P1881, DOI 10.1089/ten.2006.12.1881
   Tsuruma A, 2005, E-J SURF SCI NANOTEC, V3, P159, DOI 10.1380/ejssnt.2005.159
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WATANABE FD, 1997, ANN SURG, V225, P491
   Yabu H, 2003, LANGMUIR, V19, P6297, DOI 10.1021/la034454w
   Yabu H, 2005, LANGMUIR, V21, P3235, DOI 10.1021/la050013w
   Yamamoto S, 2006, SURF SCI, V600, P3785, DOI 10.1016/j.susc.2006.01.085
   Yamashita Y, 2003, CELL TRANSPLANT, V12, P101, DOI 10.3727/000000003108746687
NR 45
TC 8
Z9 8
U1 1
U2 18
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD FEB
PY 2008
VL 47
IS 2
BP 1429
EP 1434
DI 10.1143/JJAP.47.1429
PN 2
PG 6
WC Physics, Applied
SC Physics
GA 288XR
UT WOS:000255020000063
DA 2018-10-19
ER

PT J
AU Marsich, E
   Borgogna, M
   Donati, I
   Mozetic, P
   Strand, BL
   Salvador, SG
   Vittur, F
   Paoletti, S
AF Marsich, Eleonora
   Borgogna, Massimiliano
   Donati, Ivan
   Mozetic, Pamela
   Strand, Berit L.
   Salvador, Santiago Gomez
   Vittur, Franco
   Paoletti, Sergio
TI Alginate/lactose-modified chitosan hydrogels: A bioactive biomaterial
   for chondrocyte encapsulation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE alginate; chitosan; lactose; chitlac; chondrocytes; cell encapsulation;
   polyanion-polycation mixture
ID LACTOSE-MODIFIED CHITOSAN; ARTICULAR-CARTILAGE; IN-VITRO;
   EXTRACELLULAR-MATRIX; CHEMICAL-COMPOSITION; CALCIUM-ALGINATE;
   MOLECULAR-WEIGHT; AGAROSE GELS; TISSUE; BEADS
AB A new bioactive scaffold was prepared from a binary polysaccharide mixture composed of a polyanion (alginate) and a polycation (a lactose-modified chitosan, chitlac). Its potential use for articular chondrocytes encapsulation and cartilage reconstructive surgery applications has been studied. The hydrogel combines the ability of alginate to act as a 3D supporting structure with the capability of the second component (chitlac) to provide interactions with porcine articular chondrocytes. Physico-chemical characterization of the scaffold was accomplished by gel kinetics and compression measurements and demonstrated that alginate-chitlac mixture (AC-mixture) hydrogels exhibit better mechanical properties when compared with sole alginate hydrogels. Furthermore, biochemical and biological studies showed that these 3D scaffolds are able to maintain chondrocyte phenotype and particularly to significantly stimulate and promote chondrocyte growth and proliferation. In conclusion, the present study can be considered as a first step towards an engineered, biologically active scaffold for chondrocyte in vitro cultivation, expansion, and cell delivery. (c) 2007 Wiley Periodicals, Inc.
C1 [Marsich, Eleonora; Borgogna, Massimiliano; Donati, Ivan; Mozetic, Pamela; Vittur, Franco; Paoletti, Sergio] Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   [Strand, Berit L.] Norwegian Univ Sci & Technol, Inst Biotechnol, N-7491 Trondheim, Norway.
   [Salvador, Santiago Gomez] Univ Cadiz, Fac Med, Dept Pathol Anat, SP-11003 Cadiz, Spain.
RP Marsich, E (reprint author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, Via Licio Giorgieri 1, I-34127 Trieste, Italy.
EM emarsich@units.it
RI Strand, Berit Lokensgard/O-3999-2015; Donati, Ivan/C-3725-2017
OI Strand, Berit Lokensgard/0000-0002-9951-0355; Paoletti,
   Sergio/0000-0001-5944-8182; Mozetic, Pamela/0000-0001-8641-0526;
   MARSICH, ELEONORA/0000-0002-0700-4464
CR Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1211, DOI 10.1177/002215540104901003
   De Ceuninck F, 2004, METH MOLEC MED, V100, P15
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   DONATI I, 2007, IN PRESS BIOMACROMOL
   Donati I, 2007, BIOMACROMOLECULES, V8, P957, DOI 10.1021/bm060856h
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gerard C, 2005, J MATER SCI-MATER M, V16, P541, DOI 10.1007/s10856-005-0530-3
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   Homandberg GA, 1997, OSTEOARTHR CARTILAGE, V5, P309, DOI 10.1016/S1063-4584(97)80035-0
   Hortelano G, 1996, BLOOD, V87, P5095
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   Kikuchi T, 2001, OSTEOARTHR CARTILAGE, V9, P351, DOI 10.1053/joca.2000.0395
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   LI Z, J BIOMED MAT RES A, V75, P485
   Liu HX, 1998, BBA-GEN SUBJECTS, V1425, P505, DOI 10.1016/S0304-4165(98)00105-6
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Marcon P, 2005, BIOMATERIALS, V26, P4975, DOI 10.1016/j.biomaterials.2005.01.044
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   POUND JC, 2006, TISSUE ENG
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P79, DOI 10.3891/acta.chem.scand.26-0079
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stove J, 2002, J ORTHOPAED RES, V20, P551, DOI 10.1016/S0736-0266(01)00141-3
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
NR 46
TC 68
Z9 76
U1 2
U2 24
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2008
VL 84A
IS 2
BP 364
EP 376
DI 10.1002/jbm.a.31307
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247ZU
UT WOS:000252121900009
PM 17618521
DA 2018-10-19
ER

PT J
AU Beloti, MM
   de Oliveira, PT
   Tagliani, MM
   Rosa, AL
AF Beloti, Marcio Mateus
   de Oliveira, Paulo Tambasco
   Tagliani, Marcela Martini
   Rosa, Adalberto Luiz
TI Bone cell responses to the composite of Ricinus communis polyurethane
   and alkaline phosphatase
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE stem cells; osteoblast differentiation; Ricinus comniunis polyurethane;
   alkaline phosphatase; composite
ID ASCORBIC-ACID; BIOCOMPATIBILITY; DIFFERENTIATION; MARROW; SUBSTITUTES;
   POLYMER; SURFACE
AB The aim of this study was to evaluate the response of osteoblastic cells to the composite of Ricinus cominunis polyurethane (RCP) and alkaline phosphatase (ALP) incubated in synthetic body fluid (SBF). RCP pure (RCPp) and RCP blended with ALP 6 mg/mL polymer (RCP+ALP) were incubated in SBF for 17 days. Four groups of RCP were tested: RCPp, RCP+ALP, and RCPp and RCP+ALP incubated in SBF (RCPp/SBF and RCP+ALP/SBF). Stem cells from rat bone marrow were cultured in conditions that allowed osteoblastic differentiation on RCP discs and were evaluated: cell adhesion, culture growth, cell viability, total protein content, ALP activity, and bone-like nodule formation. Data were compared by ANOVA or Kruskal-Wallis test. The group RCP-A P was highly cytotoxic and, therefore, was not considered here. Cell adhesion (p = 0.14), culture growth (p = 0.39), viability (p = 0.46) and total protein content (p = 0.12) were not affected by either RCP composition or incubation in SBE ALP activity was affected (p = 0.0001) as follows: RCPp < RCPp/SBF < RCP+ALP/SBF. Bone-like nodule formation was not observed on all evaluated groups. The composite RCP+ALP prior to SBF incubation is cytotoxic and must not be considered as biomaterial, but the incorporation of ALP to the RCP followed by SBF incubation could be a useful alternative to improve the biological properties of the RCP. (c) 2007 Wiley Periodicals, Inc.
C1 [Tagliani, Marcela Martini; Rosa, Adalberto Luiz] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Sao Carlos, SP, Brazil.
   [Beloti, Marcio Mateus; de Oliveira, Paulo Tambasco] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Stomatol & Physiol, Sao Carlos, SP, Brazil.
RP Rosa, AL (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Sao Carlos, SP, Brazil.
EM adalrosa@forp.usp.br
RI Tambasco de Oliveira, Paulo/F-9749-2010; Beloti, Marcio/E-7473-2012;
   Rosa, Adalberto/A-6314-2008
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Beloti,
   Marcio/0000-0003-0149-7189; Rosa, Adalberto/0000-0002-6495-2778
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Aubin Jane E., 1993, P1
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barros VMR, 2003, J BIOMED MATER RES A, V67A, P235, DOI 10.1002/jbm.a.10105
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Beloti MM, 2003, J BIOMED MATER RES A, V64A, P171, DOI 10.1002/jbm.a.10435
   Carvalho TLL, 1997, INT J ORAL MAX SURG, V26, P149, DOI 10.1016/S0901-5027(05)80838-0
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Costantino Peter D, 2002, Facial Plast Surg, V18, P13, DOI 10.1055/s-2002-19823
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R., 1996, Cells and Materials, V6, P11
   Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5
   FRANCINO LF, 1998, THESIS FACULDADE MED
   Gehron-Robey P, 1996, OSTEOPOROSIS, P95
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   HABAL MB, 1994, CLIN PLAST SURG, V21, P349
   Kamei S, 1997, J BIOMED MATER RES, V37, P384
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KOJIMA KE, 1995, ACTA ORTOP BRAS, V3, P62
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ludwig SC, 2000, EUR SPINE J, V9, pS119, DOI 10.1007/PL00008317
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   OWEN TA, 1999, J CELL PHYSL, V143, P357
   Rosa Adalberto Luiz, 2005, Braz. Dent. J., V16, P225, DOI 10.1590/S0103-64402005000300010
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Stancu IC, 2004, J BIOMED MATER RES A, V69A, P584, DOI 10.1002/jbm.a.30036
   Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang JY, 2003, J BIOMED MATER RES A, V67A, P389, DOI 10.1002/jbm.a.10015
NR 36
TC 2
Z9 2
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2008
VL 84A
IS 2
BP 436
EP 441
DI 10.1002/jbm.a.31344
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247ZU
UT WOS:000252121900016
DA 2018-10-19
ER

PT J
AU Hu, K
   Cui, FZ
   Lv, Q
   Ma, J
   Feng, QL
   Xu, L
   Fan, DD
AF Hu, Kun
   Cui, Fuzhai
   Lv, Qiang
   Ma, Jun
   Feng, Qingling
   Xu, Li
   Fan, Daidi
TI Preparation of fibroin/recombinant human-like collagen scaffold to
   promote fibroblasts compatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibroin; RHLC; freeze drying method; porous scaffold; fibroblasts
ID INSOLUBLE FIBROIN FILMS; POROUS SILK FIBROIN; POLYMERIC SCAFFOLDS;
   DRUG-DELIVERY; SKIN COLLAGEN; IN-VITRO; TISSUE; CELLS; BIOMATERIAL;
   FABRICATION
AB Recombinant human-like collagen (RHLC) was added to fibroin solution to prepare a novel hybrid scaffold material for skin tissue engineering. The morphology of the scaffold had highly homogeneous and interconnected pores with pore sizes 136 +/- 32 mu m measured by scanning electron microscopy (SEM). FTIR analysis indicated intermolecular crosslinkages between fibroin and RHLC formed. The viscosity of the blend solution increased because of the interaction between fibroin and RHLC, and then it restrained the unwanted fibroin aggregation in freezing process that generally appeared in fibroin scaffold preparation with freeze drying method. After methanol treatment the fibroin/RHLC scaffold became water-stable. The porosity of scaffolds was >90%, the compressive strength and modulus were up to 662 +/- 32 KPa and 7.8 +/- 0.64 MPa, respectively. Fibroblasts cultured within fibroin/RHLC scaffolds were investigated by SEM, laser scanning confocal microscopy (LSCM), and MTT assay, which showed that the adding of RHLC significantly enhanced the cells adhesion, proliferation, and viability compare with fibroin scaffolds. These results suggest that the hybrid scaffolds have favorable characteristics for skin tissue engineering. (c) 2007 Wiley Periodicals, Inc.
C1 [Hu, Kun; Cui, Fuzhai; Lv, Qiang; Ma, Jun; Feng, Qingling; Xu, Li] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Fan, Daidi] NW Univ Xian, Dept Chem Engn, Xian 710069, Peoples R China.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
RI Fan, daidi/J-1128-2017; Ma, Jun/K-2084-2012
OI Ma, Jun/0000-0001-5167-1750
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Annuar N, 2004, Med J Malaysia, V59 Suppl B, P204
   BARONVANEVERCOOREN A, 1982, J CELL BIOL, V93, P211, DOI 10.1083/jcb.93.1.211
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   El Ghalbzouri A, 2004, BIOMATERIALS, V25, P2987, DOI 10.1016/j.biomaterials.2003.09.098
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Giraud-Guille MM, 2000, BIOMATERIALS, V21, P899, DOI 10.1016/S0142-9612(99)00244-6
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liu YM, 2005, BIOMATERIALS, V26, P4597, DOI 10.1016/j.biomaterials.2004.11.033
   Lu Q, 2004, CHEM J CHINESE U, V25, P1752
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shao JZ, 2005, J APPL POLYM SCI, V96, P1999, DOI 10.1002/app.21346
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
   Yeong WY, 2006, RAPID PROTOTYPING J, V12, P229, DOI 10.1108/13552540610682741
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 48
TC 32
Z9 33
U1 5
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2008
VL 84A
IS 2
BP 483
EP 490
DI 10.1002/jbm.a.31440
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247ZU
UT WOS:000252121900022
PM 17618493
DA 2018-10-19
ER

PT J
AU Sollazzo, V
   Palmieri, A
   Pezzetti, F
   Bignozzi, CA
   Argazzi, R
   Massari, L
   Brunelli, G
   Carinci, F
AF Sollazzo, Vincenzo
   Palmieri, Annalisa
   Pezzetti, Furio
   Bignozzi, Carlo Alberto
   Argazzi, Roberto
   Massari, Leo
   Brunelli, Giorgio
   Carinci, Francesco
TI Genetic effect of zirconium oxide coating on osteoblast-like cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE genetic profiling; cDNA microarray; zirconia; coating(s);
   biocompatibility/hard tissue
ID MICROARRAY TECHNOLOGY; COMPOSITE COATINGS; IMPLANT; CERAMICS; COLLAGEN;
   BINDING; LEPTIN
AB Zirconium is widely used as material for prosthetic devices because its good mechanical and chemical properties. When exposed to oxygen, zirconium becomes zirconium oxide (ZrO2), which is biocompatible. ZrO2 can be also prepared as a colloidal suspension and then used to coat surfaces. Zirconium oxide coating (ZrO2C) can potentially have specific biologic effects, and among them is bone formation related to implant osseointegration. How this biomaterial alters osteoblast activity to promote bone formation is poorly understood. We therefore attempted to address this question by using microarray techniques to identify genes that are differently regulated in osteoblasts exposed to ZrO2C. By using DNA microarrays containing 20,000 genes, we identified in osteoblast-like cell lines (MG-63) cultured with ZrO2C several genes whose expression was significantly upregulated or downregulated. The differentially expressed genes cover a broad range of functional activities: (a) cell cycle regulation, (b) signal transduction, (c) immunity, and (d) cytoskeleton component. The data reported are, to our now knowledge, the first genetic portrait of ZrO2C effects. They can be relevant to better understand the molecular mechanism of bone regeneration and as a model for comparing other materials with similar clinical effects. (C) 2007 Wiley Periodicals, Inc.
C1 [Palmieri, Annalisa; Brunelli, Giorgio; Carinci, Francesco] Univ Ferrara, Dept Head & Neck Surg, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
   [Sollazzo, Vincenzo] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
   [Pezzetti, Furio] Univ Bologna, Inst Histol, I-40126 Bologna, Italy.
   [Bignozzi, Carlo Alberto; Argazzi, Roberto] Univ Ferrara, Dept Chem, I-44100 Ferrara, Italy.
RP Palmieri, A (reprint author), Univ Ferrara, Dept Head & Neck Surg, Sect Maxillofacial Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM annalisapalm@hotmail.com
RI Argazzi, Roberto/C-4819-2015
OI Argazzi, Roberto/0000-0002-2619-6860; Bignozzi, Carlo
   Alberto/0000-0002-7882-3694
CR Ahmad I, 1998, INT J PERIODONT REST, V18, P455
   Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Carinci F, 2004, CLIN ORAL IMPLAN RES, V15, P180, DOI 10.1111/j.1600-0501.2004.00997.x
   Carinci F, 2004, J PERIODONTOL, V75, P66, DOI 10.1902/jop.2004.75.1.66
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156
   Gu YW, 2004, BIOMATERIALS, V25, P3177, DOI 10.1016/j.biomaterials.2003.09.101
   Heegaard AM, 1997, J BONE MINER RES, V12, P2050, DOI 10.1359/jbmr.1997.12.12.2050
   Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   LEE TM, 2004, BIOMATERIALS, V4, P652
   Merlo GR, 2000, INT J DEV BIOL, V44, P619
   Piattelli A, 1996, BIOMATERIALS, V17, P791, DOI 10.1016/0142-9612(96)81416-5
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
NR 26
TC 15
Z9 15
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2008
VL 84B
IS 2
BP 550
EP 558
DI 10.1002/jbm.b.30903
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 252UU
UT WOS:000252472900031
PM 17638321
DA 2018-10-19
ER

PT J
AU Marx, G
   Hotovely-Salomon, A
   Levdansky, L
   Gaberman, E
   Snir, G
   Sievner, Z
   Klauzner, Y
   Silberklang, M
   Thomas, D
   Hoffman, N
   Luke, S
   Lesnoy, D
   Gorodetsky, R
AF Marx, Gerard
   Hotovely-Salomon, Anna
   Levdansky, Lila
   Gaberman, Elena
   Snir, Ganit
   Sievner, Zaki
   Klauzner, Yakir
   Silberklang, Melvin
   Thomas, Dolly
   Hoffman, Nataly
   Luke, Sunny
   Lesnoy, Daniel
   Gorodetsky, Raphael
TI Haptide-coated collagen sponge as a bioactive matrix for tissue
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE collagen; haptide; fibrinogen; wound-healing; tissue-augmentation
ID SMALL-INTESTINE SUBMUCOSA; CHEMICAL MODIFICATION; SKIN SUBSTITUTES;
   ARTIFICIAL SKIN; GROWTH-FACTOR; WOUND MATRIX; LEG ULCERS; CELL;
   FIBRINOGEN; APOPTOSIS
AB We previously described a new class of conserved, cell adhesive (haptotactic) peptides, termed Haptides, based on sequences first identified in fibrinogen. Here, we describe a new biomaterial, Haptide-coated Collagen, in which the carbodiimide reagent, EDC, was used to covalently couple a Haptide (preC gamma), equivalent to the carboxy terminus of the fibrinogen gamma chain, to a cross-linked sponge composed of bovine collagen type I. The dose response of Haptide bound to collagen on cell attachment response reached a plateau at a concentration of 5-10 mg Haptide/g collagen. The Haptized-collagen was more stable to 1N NaOH, with a degradation half-time (T-1/2) of 1.7 h, compared to 0.9 h for untreated control. Haptized collagen discs could be loaded with similar to 30% more human dermal fibroblasts or bovine aortic endothelial cells than unmodified collagen discs (p < 0.001). After a proliferation phase, Haptized collagen discs contained similar to 45% more fibroblasts than non-Haptized discs (p < 0.01). Histological analysis following sub-dermal implantation in rats, indicated that at day 8, Haptized collagen sponge was less degraded than unmodified collagen sponge, attracted more endogenous fibroblasts with newly deposited collagen, and provoked less inflammatory or other adverse reactions. These results suggest potential clinical applications for Haptized collagen sponge for tissue regeneration, soft tissue augmentation, skin repair, and wound healing. (C) 2007 Wiley Periodicals, Inc.
C1 [Marx, Gerard; Hotovely-Salomon, Anna; Snir, Ganit; Klauzner, Yakir; Gorodetsky, Raphael] Hapto Biotech Israel Ltd, Jerusalem, Israel.
   [Levdansky, Lila; Gaberman, Elena; Gorodetsky, Raphael] Hadassah Hebrew Univ Med Ctr, Lab Biotechnol & Radiobiol, Hadassah, Israel.
   [Sievner, Zaki] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.
   [Silberklang, Melvin; Thomas, Dolly; Hoffman, Nataly; Luke, Sunny; Lesnoy, Daniel] Ortec Int Inc, New York, NY USA.
RP Gorodetsky, R (reprint author), Hapto Biotech Israel Ltd, Jerusalem, Israel.
EM gmarx@hapto.co.il; rafi@hadassah.org.il
CR Beele H, 2002, INT J ARTIF ORGANS, V25, P163
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chu CS, 2002, J TRAUMA, V52, P122, DOI 10.1097/00005373-200201000-00021
   DIAMOND AM, 1991, MATRIX, V11, P321, DOI 10.1016/S0934-8832(11)80203-9
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Eisenberg M, 1998, BRIT J PLAST SURG, V51, P608, DOI 10.1054/bjps.1998.9997
   Eisenbud D, 2004, WOUNDS, V16, P2
   FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581
   Gorodetsky R, 2004, J CONTROL RELEASE, V95, P477, DOI 10.1016/j.jconrel.2003.12.023
   Gorodetsky R, 2003, EXP CELL RES, V287, P116, DOI 10.1016/S0014-4827(03)00120-4
   Griffiths M, 2004, TISSUE ENG, V10, P1180, DOI 10.1089/ten.2004.10.1180
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Hadden Helene Levrey, 2000, American Journal of Respiratory and Critical Care Medicine, V162, P1553
   Hanks T, 2004, BIOMATERIALS, V25, P4831, DOI 10.1016/j.biomaterials.2003.12.007
   Hansen S L, 2001, Adv Skin Wound Care, V14, P37, DOI 10.1097/00129334-200101000-00016
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Kim JE, 2003, ONCOGENE, V22, P2045, DOI 10.1038/sj.onc.1206269
   King WWK, 1997, BURNS, V23, pS30
   Klein AW, 2001, DERMATOL CLIN, V19, P491, DOI 10.1016/S0733-8635(05)70290-4
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   Lipkin S, 2003, WOUNDS, V15, P230
   Machens HG, 2000, CELLS TISSUES ORGANS, V167, P88, DOI 10.1159/000016772
   Martin LK, 2002, ADV SKIN WOUND CARE, V15, P262
   Martin LK, 2002, ADV SKIN WOUND CARE, V15, P264
   Martin Lucy K, 2002, Adv Skin Wound Care, V15, P264, DOI 10.1097/00129334-200211000-00006
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Marx G, 2004, THROMB HAEMOSTASIS, V91, P43, DOI 10.1160/TH03-05-0277
   Mitra A, 2005, J CONTROL RELEASE, V102, P191, DOI 10.1016/j.jconrel.2004.09.023
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Nishizawa Y, 1998, APOPTOSIS, V3, P407, DOI 10.1023/A:1009606502160
   Omar AA, 2004, EUR J VASC ENDOVASC, V27, P666, DOI 10.1016/j.ejvs.2004.03.001
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Phillips T, 2002, ARCH DERMATOL, V138, P1079, DOI 10.1001/archderm.138.8.1079
   Poulose BK, 2005, J SURG RES, V123, P262, DOI 10.1016/j.jss.2004.08.011
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Soiderer EE, 2004, J SURG RES, V118, P161, DOI 10.1016/S0022-4804(03)00352-4
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Young JJ, 2004, J BIOMAT SCI-POLYM E, V15, P767, DOI 10.1163/156856204774196153
   Zangi L, 2006, TISSUE ENG, V12, P2343, DOI 10.1089/ten.2006.12.2343
   Zanin-Zhorov A, 2003, J IMMUNOL, V171, P5882, DOI 10.4049/jimmunol.171.11.5882
   Zhang LH, 2005, J BIOMED MATER RES A, V73A, P468, DOI 10.1002/jbm.a.30363
NR 52
TC 9
Z9 9
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2008
VL 84B
IS 2
BP 571
EP 583
DI 10.1002/jbm.b.30905
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 252UU
UT WOS:000252472900033
PM 17680668
DA 2018-10-19
ER

PT J
AU Roh, C
   Lee, SH
   Francois, V
AF Roh, Changhyun
   Lee, Sea-Hoon
   Francois, Villatte
TI Novel precursor-derived Si-C-N ceramic material for purification
   application
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE Si-C-N; precursor-derived ceramics; purification; biomaterial
ID SILICON-NITRIDE; MECHANICAL-PROPERTIES; MICROBIAL DIVERSITY;
   ENVIRONMENTAL DNA; MATRIX COMPOSITES; SOIL METAGENOME; EXTRACTION;
   HYDROXYAPATITE; ADSORPTION; REMOVAL
AB Metagenomic DNA (gDNA) is an important research topic because uncultivated microorganisms represent an interesting reservoir of genes with potential biotechnological applications. Here we describe a novel Si-C-N chromatography approach of gDNA extraction from environmental samples. Amorphous Si-C-N ceramic was obtained by the pyrolysis of a polymer precursor (polycarbosilazane) at 1350 degrees C in Ar. The purified gDNA fragments were at least 12 kilo base pairs in size and were sufficiently free of contaminants, thus were applicable to both restriction enzyme digestion using five different enzymes and polymerase chain reaction amplification for detecting phylogenetic groups of native microorganisms in environmental samples. This Si-C-N material produces pure gDNA that can be utilized in some of the most common molecular biological procedures applied in the purification step. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Roh, Changhyun; Francois, Villatte] Univ Stuttgart, Inst Tech Biochem, D-70569 Stuttgart, Germany.
   [Roh, Changhyun] Seoul Natl Univ, Inst Mol Biol & Genet, Sch Chem & Biol Engn, Seoul, South Korea.
   [Lee, Sea-Hoon] Max Planck Inst Met Res, D-70569 Stuttgart, Germany.
   [Lee, Sea-Hoon] Inst Nichtmet Anorgan Mat, Pulvermet Lab, D-70569 Stuttgart, Germany.
RP Roh, C (reprint author), Univ Stuttgart, Inst Tech Biochem, Allmandring 31, D-70569 Stuttgart, Germany.
EM chroh2l@snu.ac.kr
OI Roh, Changhyun/0000-0002-0542-4828
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   BAHLOUL D, 1992, CERAM INT, V18, P1, DOI 10.1016/0272-8842(92)90055-I
   Baldus P, 1999, SCIENCE, V285, P699, DOI 10.1126/science.285.5428.699
   Bencina K, 2007, J CHROMATOGR A, V1160, P176, DOI 10.1016/j.chroma.2007.05.034
   Bill J, 1996, J EUR CERAM SOC, V16, P1115, DOI 10.1016/0955-2219(96)00025-8
   Butt DP, 1996, J AM CERAM SOC, V79, P2809, DOI 10.1111/j.1151-2916.1996.tb08712.x
   Courtois S, 2001, ENVIRON MICROBIOL, V3, P431, DOI 10.1046/j.1462-2920.2001.00208.x
   Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005
   EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843
   El-Ghannam A, 2001, J BIOMED MATER RES, V55, P387, DOI 10.1002/1097-4636(20010605)55:3<387::AID-JBM1027>3.0.CO;2-V
   Gabor EM, 2003, FEMS MICROBIOL ECOL, V44, P153, DOI 10.1016/S0168-6496(02)00462-2
   Galassi C, 2000, J MATER RES, V15, P155, DOI 10.1557/JMR.2000.0026
   Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002
   Hackley VA, 1997, J AM CERAM SOC, V80, P1781
   Hanai T, 2003, J CHROMATOGR A, V989, P183, DOI 10.1016/S0021-9673(02)02017-4
   HANDELSMAN J, 1998, CHEM BIOL, V5, P245, DOI DOI 10.1016/S1074-5521(98)90108-9
   HOLBEN WE, 1994, ISOLATION PURIFICATI, P727
   Howeler M, 2003, J MICROBIOL METH, V54, P37, DOI [10.1016/S0167-7012(03)00006-X, 10.1016/S0167-70123(03)00006-X]
   Katsumata H, 2004, ENVIRON ENG SCI, V21, P341, DOI 10.1089/109287504323066987
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kennedy T, 1997, J EUR CERAM SOC, V17, P1917, DOI 10.1016/S0955-2219(97)00060-5
   Kroke E, 2000, MAT SCI ENG R, V26, P97, DOI 10.1016/S0927-796X(00)00008-5
   Lee SH, 2005, J AM CERAM SOC, V88, P3024, DOI 10.1111/j.1551-2916.2005.00587.x
   LI R, 2001, THESIS U STUTTGART S, P62
   Liden E., 1991, Journal of the European Ceramic Society, V7, P361, DOI 10.1016/0955-2219(91)90059-9
   LORENZ P, 2002, J MOL CATAL B-ENZYM, P19
   Miller DN, 2001, J MICROBIOL METH, V44, P49, DOI 10.1016/S0167-7012(00)00228-1
   Moreira D, 1998, NUCLEIC ACIDS RES, V26, P3309, DOI 10.1093/nar/26.13.3309
   NISHIZAWA K, 1993, J FERMENT BIOENG, V75, P435, DOI 10.1016/0922-338X(93)90091-L
   ODA K, 1992, NIPPON SERAM KYO GAK, V100, P714
   Orsini M, 2001, LETT APPL MICROBIOL, V33, P17, DOI 10.1046/j.1472-765X.2001.00938.x
   Peric-Concha N, 2003, DRUG DISCOV TODAY, V8, P1078, DOI 10.1016/S1359-6446(03)02901-5
   Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905
   Rezwan K, 2005, BIOMATERIALS, V26, P4351, DOI 10.1016/j.biomaterials.2004.11.017
   Robe P, 2003, EUR J SOIL BIOL, V39, P183, DOI 10.1016/S1164-5563(03)00033-5
   Roh C, 2005, ELECTROPHORESIS, V26, P3055, DOI 10.1002/elps.200410328
   Rondon MR, 1999, TRENDS BIOTECHNOL, V17, P403, DOI 10.1016/S0167-7799(99)01352-9
   Seitz J, 1996, J MATER SCI LETT, V15, P391
   STREIT WR, 2004, CURR OPIN BIOTECH, V15, P1
   Suttor D, 1997, J AM CERAM SOC, V80, P1831
   Tien CC, 1999, J APPL MICROBIOL, V86, P937, DOI 10.1046/j.1365-2672.1999.00775.x
   Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7
   TOSHEVA L, 2004, J AM CHEM SOC, V126, P13264
   Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003
   WANG LM, 1995, J CERAM SOC JPN, V103, P434, DOI 10.2109/jcersj.103.434
   WHITE TJ, 1990, GUIDE METHODS APPL, P315
   WHITMAN PK, 1986, ADV CERAM MATER, V1, P366
   Yeates C, 1997, LETT APPL MICROBIOL, V25, P303, DOI 10.1046/j.1472-765X.1997.00232.x
   Yeates C., 1998, Biological Procedures Online, V1, P40, DOI 10.1251/bpo6
   YOUNG CC, 1993, APPL ENVIRON MICROB, V59, P1972
   Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999
   Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316
NR 52
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD FEB 1
PY 2008
VL 1179
IS 2
BP 145
EP 151
DI 10.1016/j.chroma.2007.11.080
PG 7
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 260JI
UT WOS:000253006200009
PM 18093604
DA 2018-10-19
ER

PT J
AU Ozcelik, O
   Haytac, MC
   Seydaoglu, G
AF Ozcelik, Onur
   Haytac, Mehmet Cenk
   Seydaoglu, Gulsah
TI Enamel matrix derivative and low-level laser therapy in the treatment of
   intra-bony defects: a randomized placebo-controlled clinical trial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Review
DE enamel matrix derivative; low-level laser/therapy; periodontal
   regeneration; surgical periodontal therapy; wound healing
ID GUIDED TISSUE REGENERATION; HUMAN PERIODONTAL-LIGAMENT; HUMAN GINGIVAL
   FIBROBLASTS; PAPILLA PRESERVATION FLAP; HUMAN INFRABONY DEFECTS;
   IN-VITRO; DIODE-LASER; POSTOPERATIVE MORBIDITY; PROMOTES PROLIFERATION;
   SURGICAL APPROACH
AB Aim: The aim of this study was to evaluate the immediate post-operative pain, wound healing and clinical results after the application of an enamel matrix protein derivative (EMD) alone or combined with a low-level laser therapy (LLLT) for the treatment of deep intra-bony defects.
   Material and Methods: This study was an intra-individual longitudinal test of 12 months' duration conducted using a blinded, split-mouth, placebo-controlled and randomized design. In 22 periodontitis patients, one intra-bony defect was randomly treated with EMD + LLLT, while EMD alone was applied to the contra-lateral defect site. LLLT was used both intra- and post-operatively. Clinical measurements were performed by a blinded periodontist at the time of surgery, in the first week and in the first, second, sixth and 12th month. Visual analogue scale (VAS) scores were recorded for pain assesment.
   Results: The results have shown that the treatment of intra-bony defects with EMD alone or EMD + LLLT leads to probing depth reduction and attachment-level gain. In addition, EMD + LLLT had resulted in less gingival recession (p < 0.05), less swelling (p < 0.001) and less VAS scores (p < 0.02) compared with EMD alone.
   Conclusion: This study shows that EMD is an effective, safe and predictable biomaterial for periodontal regeneration and LLLT may improve the effects of EMD by reducing post-operative complications.
C1 [Ozcelik, Onur; Haytac, Mehmet Cenk] Cukurova Univ, Fac Dent, Dept Periodontol, TR-01330 Adana, Turkey.
   [Seydaoglu, Gulsah] Cukurova Univ, Fac Med, Dept Biostat, TR-01330 Adana, Turkey.
RP Ozcelik, O (reprint author), Cukurova Univ, Fac Dent, Dept Periodontol, TR-01330 Adana, Turkey.
EM oozcelik@cu.edu.tr
RI Haytac, Cenk/G-5256-2018
CR ABERGEL RP, 1984, J AM ACAD DERMATOL, V11, P1142, DOI 10.1016/S0190-9622(84)80194-2
   Abramovitch-Gottlib L, 2005, LASER MED SCI, V20, P138, DOI 10.1007/s10103-005-0355-9
   Almeida-Lopes L, 2001, LASER SURG MED, V29, P179, DOI 10.1002/lsm.1107
   ARMIDA MMT, 1989, PRACT ODONTOL, V10, P9
   BALBONI G C, 1986, Archivio Italiano di Anatomia e di Embriologia, V91, P179
   BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9
   BASFORD JR, 1989, LASER SURG MED, V9, P1, DOI 10.1002/lsm.1900090103
   BISHT D, 1994, INDIAN J MED RES, V100, P43
   Bosshardt DD, 2005, J PERIODONTAL RES, V40, P158, DOI 10.1111/j.1600-0765.2005.00785.x
   BOUNEKO JM, 2000, P 3 C WORLD ASS LAS, P79
   Brett PM, 2002, J DENT RES, V81, P776, DOI 10.1177/154405910208101111
   Carinci F, 2006, ORAL DIS, V12, P329, DOI 10.1111/j.1601-0825.2005.01204.x
   Cattaneo V, 2003, J PERIODONTAL RES, V38, P568, DOI 10.1034/j.1600-0765.2003.00690.x
   Chano L, 2003, J PERIODONTAL RES, V38, P164, DOI 10.1034/j.1600-0765.2003.00003.x
   Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x
   Cortellini P, 1999, INT J PERIODONT REST, V19, P589
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   Cortellini P, 2001, J PERIODONTOL, V72, P1702, DOI 10.1902/jop.2001.72.12.1702
   Cortellini P, 2000, PERIODONTOL 2000, V22, P104, DOI 10.1034/j.1600-0757.2000.2220108.x
   CORTELLINI P, 1993, J PERIODONTOL, V64, P254, DOI 10.1902/jop.1993.64.4.254
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x
   Davenport DR, 2003, J CLIN PERIODONTOL, V30, P125, DOI 10.1034/j.1600-051X.2003.00150.x
   Dortbudak O, 2000, CLIN ORAL IMPLAN RES, V11, P540, DOI 10.1034/j.1600-0501.2000.011006540.x
   Enwemeka CS, 2004, PHOTOMED LASER SURG, V22, P323, DOI 10.1089/pho.2004.22.323
   Amorim JCF, 2006, PHOTOMED LASER SURG, V24, P588
   Francetti L, 2004, J CLIN PERIODONTOL, V31, P52, DOI 10.1111/j.0303-6979.2004.00437.x
   Grayson RE, 2006, BIOMATERIALS, V27, P2926, DOI 10.1016/j.biomaterials.2005.12.026
   Hagenaars S, 2004, J CLIN PERIODONTOL, V31, P850, DOI 10.1111/j.1600-051X.2004.00571.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   Harrel SK, 2005, J PERIODONTOL, V76, P380, DOI 10.1902/jop.2005.76.3.380
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Hoang AM, 2000, J PERIODONTOL, V71, P1270, DOI 10.1902/jop.2000.71.8.1270
   HUJOEL PP, 1988, J PERIODONTAL RES, V23, P378, DOI 10.1111/j.1600-0765.1988.tb01616.x
   Jakse N, 2007, CLIN ORAL IMPLAN RES, V18, P517, DOI 10.1111/j.1600-0501.2007.01369.x
   Kawakami T, 1989, Higashi Nihon Shigaku Zasshi, V8, P57
   Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.3.CO;2-O
   Keila S, 2004, J DENT RES, V83, P134, DOI 10.1177/154405910408300210
   Khadra M, 2005, CLIN ORAL IMPLAN RES, V16, P168, DOI 10.1111/j.1600-0501.2004.01092.x
   Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x
   Khadra M., 2005, SWED DENT J S, V172, P1
   Kilic AR, 1997, J CLIN PERIODONTOL, V24, P372, DOI 10.1111/j.1600-051X.1997.tb00200.x
   KOZLOV VI, 1995, P SPIE 1984, P253
   Kreisler M, 2003, J CLIN PERIODONTOL, V30, P353, DOI 10.1034/j.1600-051X.2003.00001.x
   Kreisler M, 2002, LASER SURG MED, V30, P365, DOI 10.1002/lsm.10060
   Kreisler M, 2001, J PERIODONTOL, V72, P1312, DOI 10.1902/jop.2001.72.10.1312
   Laurell L, 2006, J CLIN PERIODONTOL, V33, P596, DOI 10.1111/j.1600-051X.2006.00951.x
   Linares A, 2006, J CLIN PERIODONTOL, V33, P351, DOI 10.1111/j.1600-051X.2006.00911.x
   LOEVSCHALL H, 1994, LASER SURG MED, V14, P347, DOI 10.1002/lsm.1900140407
   Lyngstadaas SP, 2001, J CLIN PERIODONTOL, V28, P181, DOI 10.1034/j.1600-051x.2001.028002181.x
   Mirastschijski U, 2004, WOUND REPAIR REGEN, V12, P100, DOI 10.1111/j.1524-475X.2004.tb00001.x
   Mirsky N, 2002, ANTIOXID REDOX SIGN, V4, P785, DOI 10.1089/152308602760598936
   Myhre AE, 2006, J PERIODONTAL RES, V41, P208, DOI 10.1111/j.1600-0765.2005.00863.x
   Narukawa M, 2007, J PERIODONTAL RES, V42, P131, DOI 10.1111/j.1600-0765.2006.00926.x
   NASCIMENTO PM, 2004, PHOTOMED LASER SURG, V22, P513, DOI DOI 10.1089/PHO.2004.22.513
   Neiburger E J, 1999, J Mass Dent Soc, V48, P8
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Oates TW, 2001, J PERIODONTOL, V72, P324, DOI 10.1902/jop.2001.72.3.324
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   OLIVER RC, 1969, J PERIODONTOL, V40, P201, DOI 10.1902/jop.1969.40.4.201
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   Ozawa Y, 1997, LASER SURG MED, V21, P456, DOI 10.1002/(SICI)1096-9101(1997)21:5<456::AID-LSM7>3.0.CO;2-P
   Ozcelik O, 2007, J CLIN PERIODONTOL, V34, P788, DOI 10.1111/j.1600-051X.2007.01120.x
   Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016
   Pourzarandian A, 2005, J PERIODONTOL, V76, P187, DOI 10.1902/jop.2005.76.2.187
   Qadri T, 2005, J CLIN PERIODONTOL, V32, P714, DOI 10.1111/j.1600-051X.2005.00749.x
   Reddy GK, 2004, J CLIN LASER MED SUR, V22, P141, DOI 10.1089/104454704774076208
   Rincon JC, 2003, J PERIODONTAL RES, V38, P290, DOI 10.1034/j.1600-0765.2003.00610.x
   Rubinov AN, 2003, J PHYS D APPL PHYS, V36, P2317, DOI 10.1088/0022-3727/36/19/002
   Saito S, 1997, AM J ORTHOD DENTOFAC, V111, P525, DOI 10.1016/S0889-5406(97)70152-5
   Sanz M, 2004, J PERIODONTOL, V75, P726, DOI 10.1902/jop.2004.75.5.726
   SATO T, 1994, ACUPUNCTURE ELECTRO, V19, P141, DOI 10.3727/036012994816357312
   Schaffer M, 2000, J PHOTOCH PHOTOBIO B, V54, P55, DOI 10.1016/S1011-1344(99)00155-4
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P111, DOI 10.1111/j.1600-051X.2004.00635.x
   Sculean A, 2004, J CLIN PERIODONTOL, V31, P545, DOI 10.1111/j.1600-051X.2004.00518.x
   Sculean A, 2003, INT J PERIODONT REST, V23, P345
   Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x
   Sculean A, 2006, J PERIODONTOL, V77, P1879, DOI 10.1902/jop.2006.060002
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P507, DOI 10.1111/j.1600-051X.2007.01084.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P72, DOI 10.1111/j.1600-051X.2006.01007.x
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   Slavkin HC, 2006, PERIODONTOL 2000, V41, P9, DOI 10.1111/j.1600-0757.2006.00172.x
   Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161
   Sun Grace, 2004, Dent Clin North Am, V48, P1061, DOI 10.1016/j.cden.2004.05.004
   TONETTI MS, 1993, J PERIODONTOL, V64, P269, DOI 10.1902/jop.1993.64.4.269
   Tonetti MS, 1998, J PERIODONTOL, V69, P1183, DOI 10.1902/jop.1998.69.11.1183
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P1092, DOI 10.1111/j.1600-051X.2004.00615.x
   Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P770, DOI 10.1111/j.1600-051X.2004.00562.x
   Tsitoura E, 2004, J CLIN PERIODONTOL, V31, P643, DOI 10.1111/j.1600-051X.2004.00555.x
   TSUCHIYA K, 1994, BRAIN RES BULL, V34, P369, DOI 10.1016/0361-9230(94)90031-0
   Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492
   Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377
   Tuner J, 1998, J CLIN LASER MED SUR, V16, P245, DOI 10.1089/clm.1998.16.245
   Van der Pauw MT, 2000, J PERIODONTOL, V71, P31, DOI 10.1902/jop.2000.71.1.31
   van der Pauw MTM, 2002, J PERIODONTAL RES, V37, P317, DOI 10.1034/j.1600-0765.2002.00349.x
   Walsh LJ, 1997, AUST DENT J, V42, P247, DOI 10.1111/j.1834-7819.1997.tb00129.x
   Webb C, 1998, LASER SURG MED, V22, P294, DOI 10.1002/(SICI)1096-9101(1998)22:5<294::AID-LSM6>3.0.CO;2-K
   Wennstrom JL, 2002, J CLIN PERIODONTOL, V29, P9, DOI 10.1034/j.1600-051x.2002.290102.x
   Windisch P, 2002, J PERIODONTOL, V73, P409, DOI 10.1902/jop.2002.73.4.409
   Woodruff LD, 2004, PHOTOMED LASER SURG, V22, P241, DOI 10.1089/1549541041438623
   Yilmaz S, 2002, LASER SURG MED, V30, P60, DOI 10.1002/lsm.10010
   YU W, 1993, J PHOTOCH PHOTOBIO B, V59, P167
   Yuan K, 2003, J CLIN PERIODONTOL, V30, P732, DOI 10.1034/j.1600-051X.2003.00413.x
   Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752
   Zeichner-David M, 2006, PERIODONTOL 2000, V41, P196, DOI 10.1111/j.1600-0757.2006.00162.x
NR 105
TC 35
Z9 37
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD FEB
PY 2008
VL 35
IS 2
BP 147
EP 156
DI 10.1111/j.1600-051X.2007.01176.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 250SF
UT WOS:000252320100008
PM 18081859
DA 2018-10-19
ER

PT J
AU Lu, Q
   Feng, QL
   Hu, K
   Cui, F
AF Lu, Qiang
   Feng, Qingling
   Hu, Kun
   Cui, Fuzhai
TI Preparation of three-dimensional fibroin/collagen scaffolds in various
   pH conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MORI SILK FIBROIN; FILMS; CELLS; GROWTH; SPECTROSCOPY; ATTACHMENT;
   GELATIN; NET
AB Three dimensional (3-D) fibroin/collagen scaffolds are the novel fibroin based scaffolds derived from aqueous solution. In this article, we investigated the effect of pH on the formation of fibroin/collagen scaffolds. In the range of pH from 4 to 8.5, the fibroin/collagen scaffolds with good porous structures can be prepared using freeze-drying method, which would facilitate the adding of other biopolymers. The structures of different fibroin-based scaffolds were investigated with FTIR and DSC, which indicated that the interaction of fibroin and collagen affected the methanol-induced transformation of fibroin from random-coil to beta-sheet conformation. The mechanical properties were also studied. The results mean that all the fibroin-based scaffolds prepared in various pH values had better mechanical properties than other reported fibroin scaffolds. Since the fibroin/collagen scaffolds can be prepared in the range of pH from 4 to 8.5, it is very easy to prepare different multifunctional scaffolds such as fibroin/collagen/chitosan scaffolds and fibroin/collagen/heparin scaffolds in acidic or neutral conditions. These new fibroin-based blend materials extend the range of biomaterial properties that can promote the use in biomedical applications such as drug release and tissue engineering.
C1 [Lu, Qiang; Feng, Qingling; Hu, Kun; Cui, Fuzhai] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
RP Feng, QL (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Feng, Qingling/0000-0003-1288-300X
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Lu Q, 2004, CHEM J CHINESE U, V25, P1752
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao JZ, 2005, J APPL POLYM SCI, V96, P1999, DOI 10.1002/app.21346
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Xiao HR, 2005, SPECTROCHIM ACTA A, V61, P2840, DOI 10.1016/j.saa.2004.10.032
NR 23
TC 28
Z9 30
U1 2
U2 37
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2008
VL 19
IS 2
BP 629
EP 634
DI 10.1007/s10856-007-3180-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259YF
UT WOS:000252976100020
PM 17619968
DA 2018-10-19
ER

PT J
AU Huhtala, A
   Pohjonen, T
   Salminen, L
   Salminen, A
   Kaarniranta, K
   Uusitalo, H
AF Huhtala, Anne
   Pohjonen, Timo
   Salminen, Lotta
   Salminen, Antero
   Kaarniranta, Kai
   Uusitalo, Hannu
TI In vitro biocompatibility of degradable biopolymers in cell line
   cultures from various ocular tissues: extraction studies
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COPOLYMERS; TOXICITY; POLYMERS
AB In vitro biocompatibility of 50:50 PDLGA, 85:15 PDLGA, and Inion GTR (TM) membrane was evaluated in cell line cultures from various ocular tissues, in human corneal epithelial cells (HCE), rabbit stromal fibroblasts (SIRC), bovine corneal endothelial cells (BCE), human conjunctival epithelial cells (IOBA-NHC), and human retinal pigment epithelial cells (ARPE-19). To study the toxicity of degradation products, the biomaterials were extracted in phosphate buffered saline at 70 degrees C for 24 h. The cell cultures were exposed to biomaterial extract diluted in medium (1:1-1:8) and the biocompatibility was evaluated by the WST-1 cytotoxicity/cell proliferation test. In all experiments without pH neutralization, cell viability increased with decreasing biomaterial extract volume. The highest extraction ratio 1:1 of PDLGA 50:50 decreased viability from 5-20%, from the control level, depending on the cell type. The corresponding cell viability values for PDLGA 85:15 and Inion GTR membrane ranged from 47-87% and 66-92%, respectively. When the pH of biomaterial extract was neutralized, Inion GTR membrane and PDLGA 85:15 had no effect on viability. BCE, HCE, and IOBA-NHC appeared to the most sensitive cell types, while SIRC and ARPE-19 were more resistant. The results of our in vitro studies suggest that the polymers tested are satisfactorily biocompatible.
C1 [Huhtala, Anne; Salminen, Lotta; Uusitalo, Hannu] Univ Tampere, Sch Med, Tampere 33014, Finland.
   [Huhtala, Anne; Salminen, Lotta; Uusitalo, Hannu] Tampere Univ Hosp, Dept Ophthalmol, Tampere 33521, Finland.
   [Pohjonen, Timo] Inion Ltd, Tampere 33520, Finland.
   [Salminen, Lotta; Kaarniranta, Kai] Univ Kuopio, Dept Neurosci, FIN-70211 Kuopio, Finland.
   [Kaarniranta, Kai; Uusitalo, Hannu] Univ Kuopio, Dept Ophthalmol, FIN-70211 Kuopio, Finland.
RP Huhtala, A (reprint author), Univ Tampere, Sch Med, Tampere 33014, Finland.
EM anne.huhtala@uta.fi
OI Kaarniranta, Kai/0000-0003-2600-8679; Huhtala, Anne/0000-0001-7862-3564
CR Andrieu-Soler C, 2005, MOL VIS, V11
   Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bejjani R, 2005, MOL VIS, V11, P124
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Diebold Y, 2003, INVEST OPHTH VIS SCI, V44, P4263, DOI 10.1167/iovs.03-0560
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   GOSPODAROWICZ D, 1977, EXP EYE RES, V25, P75, DOI 10.1016/0014-4835(77)90248-2
   *INT ORG STAND, 1996, BIOL EV MED DEV 12, P5
   *INT SOC PHARM ENG, 1999, BAS EUR ENG GUID STE, P3
   Kidd KR, 2005, TISSUE ENG, V11, P1379, DOI 10.1089/ten.2005.11.1379
   LEERHOY J, 1965, SCIENCE, V149, P633, DOI 10.1126/science.149.3684.633
   Lu LC, 2001, BIOMATERIALS, V22, P3345, DOI 10.1016/S0142-9612(01)00172-7
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   ULREICH JB, 1983, IN VITRO TOXICITY TE, P102
   Yasukawa T, 2001, ADV DRUG DELIVER REV, V52, P25, DOI 10.1016/S0169-409X(01)00192-2
   Yasukawa Tsutomu, 2006, Expert Opin Drug Deliv, V3, P261, DOI 10.1517/17425247.3.2.261
   Zange R, 1998, J CONTROL RELEASE, V56, P249, DOI 10.1016/S0168-3659(98)00093-5
   Zhu KJ, 2003, J MICROENCAPSUL, V20, P731, DOI 10.1080/02652040310001600785
NR 21
TC 13
Z9 14
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2008
VL 19
IS 2
BP 645
EP 649
DI 10.1007/s10856-007-3192-5
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259YF
UT WOS:000252976100022
PM 17619963
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Tanner, KE
AF Zhang, Y.
   Tanner, K. E.
TI Effect of filler surface morphology on the impact behaviour of
   hydroxyapatite reinforced high density polyethylene composites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TOUGHNESS
AB Instrumented falling weight impact tests have been carried out to characterize the impact behaviour of hydroxyapatite reinforced high-density polyethylene composite (HA-HDPE) in order to use this biomaterial in skull implants. The effects of HA filler surface morphology and volume fraction on the fracture toughness were studied, and fracture mechanism investigated. Impact resistance was found to be markedly improved by using a sintered grade HA filler with smooth particle surface instead of spray dried grade HA with rough surface. SEM examination of impacted fracture surfaces revealed that the improvement of impact resistance was due to the stronger interfacial bonding between smooth HA particles and HDPE polymer matrix compared with that between rough HA and HDPE, which results in more energy absorption during impact and hence better fracture resistance.
C1 [Zhang, Y.; Tanner, K. E.] Univ London Queen Mary & Westfield Coll, Dept Mat, London E1 4NS, England.
RP Zhang, Y (reprint author), Univ London Queen Mary & Westfield Coll, Dept Mat, Mile End Rd, London E1 4NS, England.
EM y.zhang@qmul.ac.uk
RI Tanner, Elizabeth/E-9242-2010
OI Tanner, Elizabeth/0000-0003-2257-0218
CR Bonfield W, 1997, MATER WORLD, V5, P18
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   Dornhoffer JL, 1998, LARYNGOSCOPE, V108, P531, DOI 10.1097/00005537-199804000-00013
   Eniwumide JO, 2004, J MATER SCI-MATER M, V15, P1147, DOI 10.1023/B:JMSM.0000046398.17027.97
   Fekete E, 1999, J MACROMOL SCI PHYS, VB38, P885, DOI 10.1080/00222349908248146
   FU Q, 1993, J APPL POLYM SCI, V49, P673, DOI 10.1002/app.1993.070490412
   GLADSTONE HB, 1995, OTOLARYNG CLIN N AM, V28, P381
   Joseph R, 2005, BIOMACROMOLECULES, V6, P1021, DOI 10.1021/bm0493180
   Kausch HH, 2000, MECH COMPOS MATER, V36, P177, DOI 10.1007/BF02681868
   Kishore S. M., 2002, POLYM INT, V51, P1378
   Mallick PK, 2000, COMPREHENSIVE COMPOS, V2, P291
   Meijer AGW, 2002, ORL J OTO-RHINO-LARY, V64, P173, DOI 10.1159/000058021
   Savadori A, 1996, MACROMOL SYMP, V108, P183, DOI 10.1002/masy.19961080116
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   Wang Y, 1996, J APPL POLYM SCI, V60, P1779, DOI 10.1002/(SICI)1097-4628(19960613)60:11<1779::AID-APP1>3.0.CO;2-I
   Wang Y, 1997, J APPL POLYM SCI, V64, P1275, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1275::AID-APP5>3.0.CO;2-G
   Zhang Y, 2003, J MATER SCI-MATER M, V14, P63, DOI 10.1023/A:1021553504549
   Zuiderduin WCJ, 2003, POLYMER, V44, P261, DOI 10.1016/S0032-3861(02)00769-3
NR 18
TC 11
Z9 12
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2008
VL 19
IS 2
BP 761
EP 766
DI 10.1007/s10856-007-3119-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259YF
UT WOS:000252976100036
PM 17619972
DA 2018-10-19
ER

PT J
AU Liporaci, JL
   Rosa, AL
   Marcio, MB
   Johnson, A
   van Noort, R
   da Rocha Barros, VM
AF Luiz Jacob Liporaci, Jorge, Jr.
   Luiz Rosa, Adalberto
   Mateus Beloti, Marcio
   Johnson, Anthony
   van Noort, Richard
   Mallet da Rocha Barros, Valdemar
TI In vitro osteogenesis on fluorcanasite glass-ceramic with three
   different chemical compositions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-MARROW; CELLS; BIOCOMPATIBILITY
AB This study aimed at investigating in vitro osteogenesis on three fluorcanasite glass-ceramic compositions with different solubilities (K3, K5, and K8). Osteoblastic cells were obtained from human alveolar bone fragments and cultured under standard osteogenic condition until subconfluence. First passage cells were cultured on K3, K5, and K8 and on Bioglass (R) 45S5 (45S5-control). Cell adhesion was evaluated at 24 h. For proliferation and viability, cells were cultured for 1, 4, and 10 days. Total protein content and alkaline phosphatase (ALP) activity were measured at 7, 14, and 21 days. Cultures were stained with Alizarin red at 21 days, for detection of mineralized matrix. Data were compared by ANOVA followed by Duncan's test. Cell adhesion, cell proliferation, viability, total protein content, and ALP activity were not affected by fluorcanasite glass-ceramic composition and solubility. Bone-like formation was similar on all fluorcanasite-glass ceramics and was reduced compared to 45S5. The changes in the chemical composition and consequently solubility of the fluorcanasite glass-ceramics tested here did not significantly alter the in vitro osteogenesis. Further modifications of the chemical composition of the fluorcanasite glass-ceramic would be required to improve bone response, making this biomaterial a good candidate to be employed as a bone substitute.
C1 [Luiz Jacob Liporaci, Jorge, Jr.; Luiz Rosa, Adalberto; Mallet da Rocha Barros, Valdemar] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, BR-14040904 Ribeirao Preto, Brazil.
   [Mateus Beloti, Marcio] Univ Sao Paulo, Sch Dent Ribeirao Preto, Div Oral Histol, BR-14049 Ribeirao Preto, Brazil.
   [Johnson, Anthony; van Noort, Richard] Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn, Sheffield, S Yorkshire, England.
RP da Rocha Barros, VM (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ave Cafe S-N, BR-14040904 Ribeirao Preto, Brazil.
EM vmbarros@forp.usp.br
RI Rosa, Adalberto/A-6314-2008
OI Rosa, Adalberto/0000-0002-6495-2778
CR Anusavice KJ, 1998, J DENT RES, V77, P1553, DOI 10.1177/00220345980770071101
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barros VMD, 2002, BIOMATERIALS, V23, P2895, DOI 10.1016/S0142-9612(01)00417-3
   BEALL GH, 1992, ANNU REV MATER SCI, V22, P91, DOI 10.1146/annurev.ms.22.080192.000515
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Bitar M, 2004, BIOMATERIALS, V25, P2283, DOI 10.1016/j.biomaterials.2003.08.054
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Burridge K, 1987, J Cell Sci Suppl, V8, P211
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Costantino Peter D, 2002, Facial Plast Surg, V18, P13, DOI 10.1055/s-2002-19823
   Dias AG, 2005, J BIOMED MATER RES A, V74A, P347, DOI 10.1002/jbm.a.30357
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   HABAL MB, 1994, CLIN PLAST SURG, V21, P349
   Hench L. L., 1993, INTRO BIOCERAMICS, P386
   Johnson A, 1998, DENT MATER, V14, P412, DOI 10.1016/S0300-5712(99)00015-9
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x
   Miller CA, 2002, J BIOMED MATER RES, V59, P473, DOI 10.1002/jbm.10018
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   STOKES CW, 2002, GLASS TECHNOL C, V43, P229
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   WOLCOTT CC, 1994, Patent No. 5336642
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 27
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2008
VL 19
IS 2
BP 833
EP 838
DI 10.1007/s10856-007-3081-y
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259YF
UT WOS:000252976100045
PM 17665118
DA 2018-10-19
ER

PT J
AU Das, I
   Singh, Y
   Agrawal, NR
   Ansari, SA
   Mishra, SK
AF Das, Ishwar
   Singh, Yogendra
   Agrawal, Namita R.
   Ansari, Shoeb A.
   Mishra, Surabhi Kirti
TI Physico-chemical studies on nanosized material from glucose-cupric
   sulphate reaction
SO JOURNAL OF THE INDIAN CHEMICAL SOCIETY
LA English
DT Article
DE glucose; cupric sulphate; nanosized material; growth morphology;
   biomaterial
ID PERIODIC PRECIPITATION; CRYSTAL-GROWTH; MORPHOLOGY; STABILITY; SYSTEM;
   ACID; GEL
AB Glucose reacts with cupric sulphate to form a new product as evident by growth morphologies, UV-Vis spectra, XRD and DSC studies. Reaction between glucose and cupric sulphate is also evident by conductivity measurements which showed a decrease in electrical conductivity on addition of glucose. There was also a decrease in glucose concentration on addition of cupric sulphate. Glucose crystallizes as fractal in agar-agar matrix, which on addition of cupric sulphate crystallizes rhythmically. Surface morphology of the product was studied by Atomic Force Microscopy (AFM), which revealed the formation of nanosized material. The average thickness of the particle aggregates was in the range of 50-115 nm.
C1 [Das, Ishwar; Ansari, Shoeb A.] DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
   [Singh, Yogendra] UP Coll, Dept Chem, Varanasi, Uttar Pradesh, India.
   [Agrawal, Namita R.] St Andrews Coll, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
   [Mishra, Surabhi Kirti] Meerut Univ, Jaipuria Inst, Dept Biotechnol, Meerut 250001, Uttar Pradesh, India.
RP Das, I (reprint author), DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
EM ishwar_das@rediffmail.com
CR DAS I, 1987, J CRYST GROWTH, V84, P231, DOI 10.1016/0022-0248(87)90135-7
   DAS I, 1987, J CRYST GROWTH, V82, P361, DOI 10.1016/0022-0248(87)90326-5
   DAS I, 1989, J PHYS CHEM-US, V93, P7435, DOI 10.1021/j100358a036
   DAS I, 1991, IND J EXPT BIOL, V39, P1109
   DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337
   FAMILY F, 1989, PHYSICA D, V38, P98, DOI 10.1016/0167-2789(89)90178-4
   FLEURY V, 1994, NATURE, V367, P435, DOI 10.1038/367435a0
   FUGIKAWA H, 1989, J PHYS SOC JPN, V58, P3875
   IWAMOTO K, 1984, J COLLOID INTERF SCI, V102, P477, DOI 10.1016/0021-9797(84)90250-9
   MARENTETTE JM, 1993, J CHEM EDUC, V70, P435, DOI 10.1021/ed070p435
   Trigueros PP, 1993, FRACTALS, V1, P439, DOI 10.1142/S0218348X93000460
   Ribeiro ACF, 2006, J CARBOHYD CHEM, V25, P173, DOI 10.1080/07328300600732469
   SANDER LM, 1986, NATURE, V322, P789, DOI 10.1038/322789a0
   Tabassum S, 2005, J CARBOHYD CHEM, V24, P865, DOI 10.1080/07328300500446483
   VISHNOI NK, 1982, ADV PRACTICAL ORGANI, P438
NR 15
TC 2
Z9 2
U1 0
U2 0
PU SCIENTIFIC PUBL-INDIA
PI JODHPUR
PA 5-A, NEW PALI RD, PO BOX 91, NEAR HOTEL TAJ HARI MAHAL, JODHPUR, 342
   003, INDIA
SN 0019-4522
J9 J INDIAN CHEM SOC
JI J. Indian Chem. Soc.
PD FEB
PY 2008
VL 85
IS 2
BP 171
EP 175
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 273UT
UT WOS:000253957900009
DA 2018-10-19
ER

PT J
AU Haleblian, G
   Kijvikai, K
   de la Rosette, J
   Premingert, G
AF Haleblian, George
   Kijvikai, Kittinut
   de la Rosette, Jean
   Premingert, Glenn
TI Ureteral stenting and urinary stone management: A systematic review
SO JOURNAL OF UROLOGY
LA English
DT Review
DE ureter; stents; lithotripsy; complications; ureteroscopy
ID SHOCK-WAVE LITHOTRIPSY; RANDOMIZED CONTROLLED-TRIAL; HOLMIUM LASER
   LITHOTRIPSY; QUALITY-OF-LIFE; URETEROSCOPIC LITHOTRIPSY; LATE
   COMPLICATIONS; CALCULI; HYDRONEPHROSIS; FRAGMENTATION; NEPHROSTOMY
AB Purpose: Ureteral stents are widely used in many urological procedures. We evaluated the recent literature, providing an update on materials and stent designs, and indications for stent placement and stent complications, including the management of such stent related problems.
   Materials and Methods: A thorough literature search on ureteral stents was performed. Pertinent new and review/updated articles published in the English literature from 2000 through 2006 were systematically reviewed.
   Results: Following uncomplicated ureteroscopy or shock wave lithotripsy routine stenting does not appear to affect the stone-free rate. However, stent related morbidity is often seen. Patients at greatest risk for complications are those undergoing bilateral stentless ureteroscopy, those with recent or recurrent urinary tract infections and pregnant patients. The placement of indwelling stents in these patients should be considered. The development of stent materials and designs has been directed toward decreasing stent related morbidity, such as pain, discomfort, bladder irritability, infection and encrustation. Changes in stent design and materials show great promise. Initial evaluations suggest improvements in patient comfort as well as decreased encrustation. Forgotten stents can lead to significant morbidity as a result of severe encrustation. Most cases can be managed endoscopically, often requiring multiple procedures.
   Conclusions: Stenting is not mandatory after uncomplicated simple ureteroscopy and shock wave lithotripsy. Patients with stents seem to have significantly more bladder and lower urinary tract symptoms than those in whom stents are not placed. However, there is a subgroup of patients who likely benefit from stenting following a procedure because of the increased risk of complications. The ideal ureteral stent biomaterial has yet to be discovered and an area of promising development is the drug eluting stent to prevent infection and encrustation.
C1 [Haleblian, George; Premingert, Glenn] Duke Univ, Med Ctr, Div Urol, Comprehens Kidney Stone Ctr, Durham, NC 27710 USA.
   [Kijvikai, Kittinut] Mahidol Univ, Ramathibodi Hosp, Dept Urol, Bangkok 10700, Thailand.
   [Kijvikai, Kittinut; de la Rosette, Jean] Univ Amsterdam, Dept Urol, Acad Med Ctr, Amsterdam, Netherlands.
RP Premingert, G (reprint author), Duke Univ, Med Ctr, Div Urol, Comprehens Kidney Stone Ctr, Box 3167,Room 1572D,White Zone, Durham, NC 27710 USA.
EM glenn.preminger@duke.edu
CR Akpinar H, 2006, J ENDOUROL, V20, P107, DOI 10.1089/end.2006.20.107
   Al-Awadi KA, 1999, BJU INT, V84, P618
   Al-Busaidy SS, 2003, J UROLOGY, V169, P629, DOI 10.1097/01.ju.0000047231.36474.57
   Ather M H, 2000, Tech Urol, V6, P189
   Auge Brian K, 2002, Curr Opin Urol, V12, P217, DOI 10.1097/00042307-200205000-00007
   Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2
   Borboroglu PG, 2001, J UROLOGY, V166, P1651, DOI 10.1016/S0022-5347(05)65646-7
   Breau RH, 2001, J UROLOGY, V166, P890, DOI 10.1016/S0022-5347(05)65858-2
   Bultitude MF, 2003, UROLOGY, V62, P622, DOI 10.1016/S0090-4295(03)00506-5
   Byrne RR, 2002, J ENDOUROL, V16, P9, DOI 10.1089/089277902753483646
   Cadieux PA, 2006, J UROLOGY, V175, P2331, DOI 10.1016/S0022-5347(06)00252-7
   CASS AS, 1992, UROLOGY, V39, P446, DOI 10.1016/0090-4295(92)90244-Q
   Chandhoke PS, 2002, J UROLOGY, V167, P1981, DOI 10.1016/S0022-5347(05)65067-7
   Chen YT, 2002, J UROLOGY, V167, P1977, DOI 10.1016/S0022-5347(05)65066-5
   Cheung MC, 2003, J UROLOGY, V169, P1257, DOI 10.1097/01.ju.0000053763.30693.ef
   Chew BH, 2004, NAT CLIN PRACT UROL, V1, P44, DOI 10.1038/ncpuro0014
   Damiano R, 2004, EUR UROL, V46, P381, DOI 10.1016/j.eururo.2004.04.004
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   Delakas D, 2001, J ENDOUROL, V15, P675, DOI 10.1089/08927790152596226
   Denstedt JD, 2001, J UROLOGY, V165, P1419, DOI 10.1016/S0022-5347(05)66320-3
   Dunn MD, 2000, J ENDOUROL, V14, P195, DOI 10.1089/end.2000.14.195
   El-Assmy A, 2006, J UROLOGY, V176, P2059, DOI 10.1016/j.juro.2006.07.022
   Gofrit ON, 2001, J UROLOGY, V166, P1862, DOI 10.1016/S0022-5347(05)65707-2
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Harmon WJ, 1997, J UROLOGY, V157, P28, DOI 10.1016/S0022-5347(01)65272-8
   Hollenbeck BK, 2003, J UROLOGY, V170, P103, DOI 10.1097/01.ju.0000069546.53896.6a
   Hollenbeck BK, 2001, UROLOGY, V57, P639, DOI 10.1016/S0090-4295(01)00917-7
   Hosking DH, 1999, J UROLOGY, V161, P48, DOI 10.1016/S0022-5347(01)62058-5
   Jeong H, 2004, BJU INT, V93, P1032, DOI 10.1111/j.1464-410X.2004.04776.x
   Joshi HB, 2003, J UROLOGY, V169, P1060, DOI 10.1097/01.ju.0000049198.53425.1d
   Joshi HB, 1999, BJU INT, V84, P264
   Joshi HB, 2001, J ENDOUROL, V15, P151, DOI 10.1089/089277901750134421
   Joshi HB, 2001, BJU INT, V88, P329, DOI 10.1046/j.1464-410X.2001.02356.x
   Knudsen BE, 2004, UROL CLIN N AM, V31, P173, DOI 10.1016/S0094-0143(03)00091-0
   Kumar M, 1999, UROL INT, V62, P114, DOI 10.1159/000030370
   Lam JS, 2002, J ENDOUROL, V16, P733, DOI 10.1089/08927790260472881
   McCahy P J, 1995, J R Coll Surg Edinb, V40, P326
   Mokhmalji H, 2001, J UROLOGY, V165, P1088, DOI 10.1016/S0022-5347(05)66434-8
   MONGA M, 1995, J UROLOGY, V153, P1817, DOI 10.1016/S0022-5347(01)67319-1
   NAKADA SY, 1995, UROLOGY, V46, P649, DOI 10.1016/S0090-4295(99)80294-5
   Netto NR, 2001, J UROLOGY, V166, P1252, DOI 10.1016/S0022-5347(05)65747-3
   Pearle MS, 1998, J UROLOGY, V160, P1260, DOI 10.1016/S0022-5347(01)62511-4
   Ringel A, 2000, EUR UROL, V38, P41, DOI 10.1159/000020250
   Schierholz JM, 2002, INT J ANTIMICROB AG, V19, P511, DOI 10.1016/S0924-8579(02)00096-1
   SIEGEL JF, 1993, J ENDOUROL, V7, P151, DOI 10.1089/end.1993.7.151
   Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6
   Singh V, 2005, INT UROL NEPHROL, V37, P541, DOI 10.1007/s11255-004-4704-6
   Srivastava A, 2003, J ENDOUROL, V17, P871, DOI 10.1089/089277903772036172
   Waterman BJ, 2006, AUA UPDATE SERIES, V25
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
NR 50
TC 108
Z9 118
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD FEB
PY 2008
VL 179
IS 2
BP 424
EP 430
DI 10.1016/j.juro.2007.09.026
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 251JP
UT WOS:000252369600006
PM 18076928
DA 2018-10-19
ER

PT J
AU Lee, SH
   Nomura, N
   Chiba, A
AF Lee, Sang-Hak
   Nomura, Naoyuki
   Chiba, Akihiko
TI Significant improvement in mechanical properties of biomedical Co-Cr-Mo
   alloys with combination of N addition and Cr-enrichment
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; biomaterial; casting; nitrogen
ID MICROSTRUCTURE; IMPLANTS; NITROGEN; STEELS; CAST
AB An improvement in the mechanical properties of a biomedical Ni-free Co-Cr-Mo alloy under as-cast condition has been examined by means of tensile tests and microstructure observations. The solubility of N in Co-Cr-Mo alloys increases with increasing Cr content from 29 to 34 mass%. This results in a significant improvement in mechanical properties such as yield stress, tensile strength, and fracture elongation. The improvement in the mechanical properties results from the gamma phase stabilization and inhibition of the a phase formation due to N addition. Increasing the Cr content also has contributed to the improved mechanical properties.
C1 [Lee, Sang-Hak] Iwate Ind Promot Ctr, Morioka, Iwate 0200852, Japan.
   [Nomura, Naoyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   [Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Lee, SH (reprint author), Iwate Ind Promot Ctr, Morioka, Iwate 0200852, Japan.
RI Chiba, Akihiko/D-1326-2011
CR BLOSSEY RG, 1966, T METALL SOC AIME, V236, P28
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Gupta KP, 2005, J PHASE EQUILIB DIFF, V26, P87, DOI 10.1361/15477030522608
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   HERO H, 1984, BIOMATERIALS, V5, P201, DOI 10.1016/0142-9612(84)90016-4
   Horovitz MB, 1996, ISIJ INT, V36, P840, DOI 10.2355/isijinternational.36.840
   Huang P, 1999, MATER SCI TECH SER, V15, P1324, DOI 10.1179/026708399101505284
   KLAWITTER JJ, 1977, J DENT RES, V56, P474, DOI 10.1177/00220345770560050501
   KLINER T, 1987, J MATER SCI, V22, P565
   KLINER T, 1987, J MATER SCI, V22, P575
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   RAJAN K, 1983, J MATER SCI, V18, P257, DOI 10.1007/BF00543833
   Salinas-Rodriguez A, 1999, AM SOC TEST MATER, V1365, P108
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   SILVERMAN R, 1956, T ASM, V49, P805
   Wang KK, 1999, AM SOC TEST MATER, V1365, P89, DOI 10.1520/STP14265S
   ZHUANG LZ, 1989, J MATER SCI, V24, P4324, DOI 10.1007/BF00544506
NR 19
TC 65
Z9 66
U1 1
U2 11
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2008
VL 49
IS 2
BP 260
EP 264
DI 10.2320/matertrans.MRA2007220
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 276JX
UT WOS:000254138200005
OA Bronze
DA 2018-10-19
ER

PT J
AU Xia, W
   Chang, J
AF Xia, Wei
   Chang, Jiang
TI Preparation and the phase transformation behavior of amorphous
   mesoporous calcium silicate
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE mesoporous materials; phase transformation; calcium silicate
ID IN-VITRO BIOACTIVITY; DRUG-DELIVERY SYSTEM; SIMULATED BODY-FLUID;
   WOLLASTONITE; GLASSES; POWDERS; SURFACE; MCM-41; TRANSITION; PARTICLES
AB Calcium silicate is not only an important substance in the ceramic and cement industries but also a novel biomaterial for bone repair due to the good bioactivity and degradability/resolvability. In this study, the well-ordered amorphous mesoporous calcium silicate (MCS) was synthesized and its abnormal phase transformation behavior was investigated. The results illustrated an abnormal phase transformation phenomenon of CaSiO3, which was closely related to the mesoporous structure of the materials. When the amorphous mesoporous calcium silicate was calcined, the low-temperature phase beta-CaSiO3 did not appear with the increase of the temperature and high-temperature phase alpha-CaSiO3 was obtained at 800 degrees C, which was 325 degrees C lower than the normal temperature for the formation of alpha-CaSiO3. Our results indicated that mesoporous structure could influence the phase transformation behavior of materials, which can effectively decrease the preparation temperature of high-temperature ceramics. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Xia, Wei; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   [Xia, Wei] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR Alemany MI, 2005, J NON-CRYST SOLIDS, V351, P1716, DOI 10.1016/j.jnoncrysol.2005.04.062
   Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   Deer W. A., 1963, CHAIN SILICATES, V167
   Diao JK, 2003, NAT MATER, V2, P656, DOI 10.1038/nmat977
   Dick K, 2002, J AM CHEM SOC, V124, P2312, DOI 10.1021/ja017281a
   Doadrio AL, 2004, J CONTROL RELEASE, V97, P125, DOI 10.1016/j.jcornel.2004.03.005
   Du YL, 2002, SOLID STATE COMMUN, V124, P113, DOI 10.1016/S0038-1098(02)00493-3
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   HALL BD, 1991, PHYS REV B, V43, P3906, DOI 10.1103/PhysRevB.43.3906
   HENMI C, 1983, AM MINERAL, V68, P156
   Kondo Y, 1999, PHYS REV LETT, V82, P751, DOI 10.1103/PhysRevLett.82.751
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   LOPEZNORIEGA A, 2006, CHEM MATER, V18, P3173
   MARKS LD, 1984, PHILOS MAG A, V49, P81, DOI 10.1080/01418618408233431
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Niu HJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.027002
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Stein A, 2003, ADV MATER, V15, P763, DOI 10.1002/adma.200300007
   Vallet-Regi M, 2005, SOLID STATE SCI, V7, P233, DOI 10.1016/j.solidstatesciences.2004.10.038
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vollath D, 2004, ADV ENG MATER, V6, P117, DOI 10.1002/adem.200300568
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yang H, 1996, NATURE, V379, P703, DOI 10.1038/379703a0
   YEH TS, 1988, J AM CERAM SOC, V71, P841, DOI 10.1111/j.1151-2916.1988.tb07533.x
   Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao WY, 2004, MATER LETT, V58, P2350, DOI 10.1016/j.matlet.2004.02.045
   Zhu YF, 2005, ANGEW CHEM INT EDIT, V44, P5083, DOI 10.1002/anie.200501500
   1964, PHASE DIAGRAMS CERAM, V1, P104
NR 36
TC 36
Z9 39
U1 1
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD FEB 1
PY 2008
VL 108
IS 1-3
BP 345
EP 351
DI 10.1016/j.micromeso.2007.04.013
PG 7
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 253PF
UT WOS:000252529400040
DA 2018-10-19
ER

PT J
AU Cribb, RC
   Haddadin, FT
   Lee, JS
   Webb, K
AF Cribb, Rebecca C.
   Haddadin, Fuad T.
   Lee, Jeoung Soo
   Webb, Ken
TI Baculovirus expression and bioactivity of a soluble 140 kDa
   extracellular cleavage fragment of L1 neural cell adhesion molecule
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE cell adhesion molecule; baculovirus; neural regeneration
ID NEURITE OUTGROWTH; HOMOPHILIC BINDING; INSECT CELLS; SPINAL-CORD; N-CAM;
   PURIFICATION; RECOGNITION; DOMAINS; PROTEIN; FAMILY
AB L1 neural cell adhesion molecule is the founding member of the L1 subfamily of the immunoglobulin superfamily and plays an important role in the overall development of both the central and peripheral nervous systems, making it an attractive candidate for promoting neural regeneration following injury. Currently, L1 used for experimental studies is primarily mammalian-derived; however, the insect cell expression system described here provides an alternative source of recombinant L1 with equivalent bioactivity. A 140 kDa L1 fragment based on a physiological plasmin cleavage site in the extracellular domain was cloned and expressed with a C-terminal 6x histidine tag. Recombinant insect cell-derived L1 was analyzed by Western blot using an antibody to human L1 to confirm immunogenicity and to optimize infection conditions for recombinant L1 production. The recombinant protein was secreted by insect cells, efficiently purified under non-denaturing conditions using dialysis followed by metal affinity chromatography, and analyzed by SDS-PAGE to produce a single band of the expected approximate 140 kDa size. The bioactivity of insect cell-derived L1 was compared to mammalian-derived L1-Fc and poly-L-lysine (PLL) using chick embryonic forebrain neurons. The results show comparable, robust neurite outgrowth at 24 h on insect cell-derived L1 and mammalian-derived L1-Fc, with significantly longer neurites than those observed on PLL. Future studies will examine the immobilization of L1 to biomaterial surfaces in physiologically appropriate orientation via the C-terminal 6x histidine tag and will investigate their application in promoting axonal regeneration in the injured nervous system. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Cribb, Rebecca C.; Haddadin, Fuad T.; Lee, Jeoung Soo; Webb, Ken] Clemson Univ, Dept Bioengn, Micro Environm Engn Lab, Clemson, SC 29634 USA.
RP Webb, K (reprint author), Clemson Univ, Dept Bioengn, Micro Environm Engn Lab, 501 Rhodes Res Ctr, Clemson, SC 29634 USA.
EM kwebb@clemson.edu
CR Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951
   APPEL F, 1993, J NEUROSCI, V13, P4764
   Beer S, 1999, J CELL SCI, V112, P2667
   Brank AS, 2002, PROTEIN EXPRES PURIF, V25, P31, DOI 10.1006/prep.2001.1606
   BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   Chiba A, 1996, DEV BIOL, V180, P424, DOI 10.1006/dbio.1996.0316
   Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X
   DAVIS JQ, 1994, J BIOL CHEM, V269, P27163
   DAVIS TR, 1993, IN VITRO CELL DEV-AN, V29A, P388
   DAVIS TR, 1992, BIO-TECHNOL, V10, P1148, DOI 10.1038/nbt1092-1148
   FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x
   Gouveia RM, 2007, PROTEIN EXPRES PURIF, V52, P182, DOI 10.1016/j.pep.2006.10.008
   Haspel J, 2003, FRONT BIOSCI, V8, pS1210, DOI 10.2741/1108
   Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O
   Heidemann SR, 2003, METHOD CELL BIOL, V71, P51, DOI 10.1016/S0091-679X(03)01004-5
   Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809
   Hortsch M, 1996, NEURON, V17, P587, DOI 10.1016/S0896-6273(00)80192-0
   Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052
   KADMON G, 1998, DEV IMMUNOL, V6, P2025
   Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702
   Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879
   Kenwrick S, 1996, J MED GENET, V33, P59, DOI 10.1136/jmg.33.1.59
   KOBAYASHI S, 1995, NEUROSCI LETT, V188, P191, DOI 10.1016/0304-3940(95)11429-Z
   Kuhn J, 2003, BIOCHEM BIOPH RES CO, V312, P537, DOI 10.1016/j.bbrc.2003.10.157
   LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753
   LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2
   MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439
   Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099
   Mohajeri MH, 1996, EUR J NEUROSCI, V8, P1085, DOI 10.1111/j.1460-9568.1996.tb01276.x
   MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0
   Nayeem N, 1999, J CELL SCI, V112, P4739
   NYBROE O, 1990, INT J DEV NEUROSCI, V8, P273, DOI 10.1016/0736-5748(90)90033-X
   OREILLY DR, 1994, BACULOVIRUS EXPRESSI, P127
   POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9
   RATHJEN FG, 1984, EMBO J, V3, P1
   Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809
   Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485
   Sugawa M, 1997, NEUROREPORT, V8, P3157, DOI 10.1097/00001756-199709290-00030
   Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7
   Wong EV, 1995, NEUROSCI LETT, V200, P155, DOI 10.1016/0304-3940(95)12100-I
   ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413
NR 42
TC 3
Z9 3
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD FEB
PY 2008
VL 57
IS 2
BP 172
EP 179
DI 10.1016/j.pep.2007.10.006
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 259YJ
UT WOS:000252976500009
PM 18060806
DA 2018-10-19
ER

PT J
AU Olteanu, M
   Achimescu, D
   Vuluga, Z
   Trandafir, V
AF Olteanu, Mihaela
   Achimescu, Diana
   Vuluga, Zina
   Trandafir, Viorica
TI MEASUREMENT AND INTERPRETATION OF WETTING PROPERTIES OF NEW
   COLLAGEN-SILICATE BIOMATERIAL
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
DE collagen-silicate biomaterials; wettability; nanocomposites
AB New nontoxic, biocompatible, collagen-natural silicate membranes were prepared. The morphology of nanostructured materials (partially exfoliated, exfoliated or intercalated) depends on the preparation method. The incorporation of a bioactive drug (gentamycine) in the silicate before the membranes casting induces an intercalated nanostructure. The used silicate was montmorillonite, a purified natural bentonite (Bentonite of Chioar Valley Roumania). Through contact angle measurements of membrane/air and membrane/polyethylene support, the surface tension (gamma(s)), electron acceptor (gamma(+)(s)) and electron donor (gamma(-)(s)) surface components of biomaterial samples were calculated using the Lifishitzvan der Waals/Lewis acid-base interaction model. The dynamic contact angle was used to determine the surface porosity, partial soaking and the rate of water diffusion in the membrane, which was found to reflect the nanostructured morphology.
   The nanocomposite morphology was studied using X-Ray diffraction and SEM methods whose results are in good agreement with the wettability data. The new membranes are promising transdermal biomaterials.
C1 [Olteanu, Mihaela; Achimescu, Diana] Univ Bucharest, Fac Chem, Bucharest 030018, Romania.
   [Vuluga, Zina] Inst Chem Res, Bucharest 060021, Romania.
   [Trandafir, Viorica] Natl Inst Res & Dev Text & Leather, ICPI Div, Bucharest, Romania.
RP Olteanu, M (reprint author), Univ Bucharest, Fac Chem, B Dul Regina Elisabeta 4-12, Bucharest 030018, Romania.
EM oltmi@gw-chimie.math.unibuc.ro
CR ALBU B, 2005, J COLLOID SURFACE CH, V5, P13
   Bico J, 1999, EUROPHYS LETT, V47, P220, DOI 10.1209/epl/i1999-00548-y
   BREN L, 2004, J ADHES SCI TECHNOL, V18, P1911
   BROTHER E, 1998, HDB BIOMATERIAL EVAL
   DUMITRIU S, 2002, POLYM BIOMATERIALS, P169
   Helmy AK, 2003, J COLLOID INTERF SCI, V268, P263, DOI 10.1016/j.jcis.2003.07.007
   Lazovic G, 2005, Ann Burns Fire Disasters, V18, P151
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Uricanu V, 2004, MATER CHEM PHYS, V85, P120, DOI 10.1016/j.matchemphys.2003.12.024
   Uricanu VI, 2005, J SOL-GEL SCI TECHN, V34, P23, DOI 10.1007/s10971-005-1259-7
   VANOSS CJ, 1995, CLAY CLAY MINER, V43, P474, DOI 10.1346/CCMN.1995.0430411
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1994, INTERFACIAL FORCES A, P400
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
NR 16
TC 7
Z9 7
U1 0
U2 1
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD FEB
PY 2008
VL 53
IS 2
BP 157
EP 163
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 367EC
UT WOS:000260534300010
DA 2018-10-19
ER

PT J
AU Su, HL
   Han, J
   Wang, N
   Dong, Q
   Zhang, D
   Zhang, CF
AF Su, Huilan
   Han, Jie
   Wang, Na
   Dong, Qun
   Zhang, Di
   Zhang, Chunfu
TI In situ synthesis of lead sulfide nanoclusters on eggshell membrane
   fibers by an ambient bio-inspired technique
SO SMART MATERIALS & STRUCTURES
LA English
DT Article
ID MULTIPLE EXCITON GENERATION; PBS QUANTUM DOTS; NANOPARTICLES;
   NANOCRYSTALS; PROTEIN; CDS; MATRIX; FILMS
AB An ambient aqueous soakage technique is successfully developed to prepare PbS nanoclusters on eggshell membrane (ESM) fibers containing some active functional groups (hydroxyl, amine, imine, etc). Based on the biomaterial ESM serving as the reactive substrate and some ESM biomacromolecules acting as the surfactant, PbS nanocrystallites are in situ formed and further assembled into well-distributed nanoparticle aggregations. This moderate bio-inspired strategy would be of great value in preparing novel functional nanomaterials. The as-prepared hybrid PbS/ESM nanocomposites could have great potential for applications in semiconductor industries, optoelectronic fields, and nanostructured devices.
C1 [Su, Huilan; Han, Jie; Wang, Na; Dong, Qun; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   [Zhang, Chunfu] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM hlsu@sjtu.edu.cn
RI Zhang, Chunfu/P-7553-2014
CR Ahmad A, 2002, J AM CHEM SOC, V124, P12108, DOI 10.1021/ja0272960o
   Ajikumar PK, 2003, BIOMACROMOLECULES, V4, P1321, DOI 10.1021/bm034101b
   Bai HJ, 2006, BIOTECHNOL LETT, V28, P1135, DOI 10.1007/s10529-006-9063-1
   Brumer M, 2005, ADV FUNCT MATER, V15, P1111, DOI 10.1002/adfm.200400620
   DAMERON CT, 1990, INORG CHEM, V29, P1343, DOI 10.1021/ic00332a011
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   DONG Q, 2007, J SOLID STATE CHEM, V180, P959
   Dong Q, 2006, NANOTECHNOLOGY, V17, P3968, DOI 10.1088/0957-4484/17/15/060
   Dong Q, 2006, SCRIPTA MATER, V55, P799, DOI 10.1016/j.scriptamat.2006.07.012
   Ellingson RJ, 2005, NANO LETT, V5, P865, DOI 10.1021/nl0502672
   Flores-Acosta M, 2003, SOLID STATE COMMUN, V128, P407, DOI 10.1016/j.ssc.2003.09.008
   GADENNE P, 1989, J APPL PHYS, V66, P3019, DOI 10.1063/1.344187
   GONG HM, 2006, J CHEM PHYS, V125, P1
   Hens Z, 2005, NANOTECHNOLOGY, V16, P339, DOI 10.1088/0957-4484/16/4/001
   Holmes JD, 1997, MICROBIOL-UK, V143, P2521, DOI 10.1099/00221287-143-8-2521
   Krauss TD, 1997, PHYS REV B, V55, P9860, DOI 10.1103/PhysRevB.55.9860
   Levina L, 2005, ADV MATER, V17, P1854, DOI 10.1002/adma.200401197
   Lim WP, 2004, J PHYS CHEM B, V108, P13093, DOI 10.1021/jp0481781
   Malyarevich AM, 2001, PHYS STATUS SOLIDI B, V224, P253, DOI 10.1002/1521-3951(200103)224:1<253::AID-PSSB253>3.0.CO;2-#
   MUKHERJEE M, 1994, APPL PHYS LETT, V64, P1159, DOI 10.1063/1.110838
   Murphy JE, 2006, J AM CHEM SOC, V128, P3241, DOI 10.1021/ja0574973
   Okuda M, 2005, NANO LETT, V5, P991, DOI 10.1021/nl050556q
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Shenton W, 1999, ADV MATER, V11, P253, DOI 10.1002/(SICI)1521-4095(199903)11:3<253::AID-ADMA253>3.0.CO;2-7
   SUBRAMANIAN V, 1994, P SOC PHOTO-OPT INS, V2274, P219, DOI 10.1117/12.189234
   Talapin DV, 2001, J PHYS CHEM B, V105, P12278, DOI 10.1021/jp012229m
   Wu QS, 2000, CHEM J CHINESE U, V21, P1471
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yang L, 2005, MATER LETT, V59, P2889, DOI 10.1016/j.matlet.2005.04.036
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
NR 30
TC 19
Z9 19
U1 1
U2 14
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0964-1726
J9 SMART MATER STRUCT
JI Smart Mater. Struct.
PD FEB
PY 2008
VL 17
IS 1
AR 015045
DI 10.1088/0964-1726/17/1/015045
PG 5
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA 276XE
UT WOS:000254176200046
DA 2018-10-19
ER

PT J
AU Ali, AQ
   Kannan, TP
   Ahmad, A
   Samsudin, AR
AF Ali, Abdulaziz Qaid
   Kannan, Thirumulu Ponnuraj
   Ahmad, Azlina
   Samsudin, Ab. Rani
TI In vitro genotoxicity tests for polyhydroxybutyrate - A synthetic
   biomaterial
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE polyhydroxybutyrate; Salmonella test; mutagenicity; gene expression;
   p53; c-myc; bcl-xl; bcl-xs
ID DENTIN BONDING AGENTS; MUTAGENICITY TEST; MAMMALIAN-CELLS; ORTHOPEDIC
   USE; BCL-2 PROTEIN; BREAST-CANCER; EXPRESSION; ASSAY; CARCINOGENS;
   POLYMER
AB The aims of this study are to determine the mutagenicity of a locally produced polyhydroxybutyrate (PHB) using Salmonella mutagenicity test and to find out if PHB altered the expression of p53 and c-myc proto-oncogenes and bcl-xl and bcl-xs anti-apoptotic genes in the human fibroblast cell line, MRC-5. Different concentrations of PHB were incubated with special genotypic variants of Salmonella strains (TA1535, TA1537, TA1538, TA98 and TA100) carrying mutations in several genes both with and without metabolic activation (S9) and the test was assessed based on the number of revertant colonies. The average number of revertant colonies per plate treated with PHB was less than double as compared to that of negative control. For the gene expression analyses, fibroblast cell lines were treated with PHB at different concentrations and incubated for 1, 12, 24 and 48 It separately. The total RNA was isolated and analysed for the expression of p53, c-myc, bcl-xl and bcl-xs genes. The PHB did not show over or under expression of the genes studied. The above tests indicate that the locally produced PHB is non-genotoxic and does not alter the expression of the proto-oncogenes and anti-apoptotic genes considered in this study. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Ali, Abdulaziz Qaid; Kannan, Thirumulu Ponnuraj; Ahmad, Azlina; Samsudin, Ab. Rani] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian 16150, Kelantan, Malaysia.
RP Kannan, TP (reprint author), Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian 16150, Kelantan, Malaysia.
EM tpkaniian@kb.usm.my
RI Azlina, Ahmad/B-1273-2011
OI Azlina, Ahmad/0000-0002-1393-5775
CR AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782
   AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1
   AMES BN, 1971, CHEMICAL MUTAGENS PR, V1, P267
   *ASTM, 1987, ANN BOOK ASTM STAND, P323
   Chauvel-Lebret DJ, 2001, BIOMATERIALS, V22, P1795, DOI 10.1016/S0142-9612(00)00351-3
   Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914
   Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0
   Crawford RAF, 1998, BRIT J CANCER, V78, P210, DOI 10.1038/bjc.1998.466
   Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   Gahyva Sérgio Márcio Motta, 2005, J. Appl. Oral Sci., V13, P387, DOI 10.1590/S1678-77572005000400014
   GATEHOUSE D, 1994, MUTAT RES, V312, P217, DOI 10.1016/0165-1161(94)90037-X
   Glosl S, 2004, FOOD CHEM TOXICOL, V42, P1487, DOI 10.1016/j.fct.2004.04.011
   Hai T, 2001, MICROBIOL-SGM, V147, P3047, DOI 10.1099/00221287-147-11-3047
   HELLEMANS P, 1995, BRIT J CANCER, V72, P354, DOI 10.1038/bjc.1995.338
   Hocking P. J., 1994, CHEM TECHNOLOGY BIOD, P48
   Huang FM, 2003, BIOMATERIALS, V24, P157, DOI 10.1016/S0142-9612(02)00273-9
   *ISO INT ORG STAND, 1982, 109933 ISO, P1
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1993, J MED ENG TECHNOL, V17, P129, DOI 10.3109/03091909309087593
   Lee WH, 2004, POLYM DEGRAD STABIL, V84, P129, DOI 10.1016/j.polymdegradstab.2003.10.003
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   Li RH, 2005, J VIROL METHODS, V129, P162, DOI 10.1016/j.jviromet.2005.05.019
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Lootz D, 2001, BIOMATERIALS, V22, P2447, DOI 10.1016/S0142-9612(00)00245-3
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151
   MATSUSHIMA T, 2000, MICROSOMES DRUG OXID, V48, P1093
   MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135
   Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   NEAL FC, 1996, MUTAT RES, V369, P3
   OECD, 1986, GUID TEST CHEM GUID, P1
   *OECD ORG EC COOP, 1997, BACTERIAL REVERSE MU
   Peng T, 1996, BIOMATERIALS, V17, P685, DOI 10.1016/0142-9612(96)86738-X
   PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003
   Ramires PA, 2005, J BIOMED MATER RES B, V72B, P230, DOI 10.1002/jbm.b.30157
   Raouf A A, 2004, Med J Malaysia, V59 Suppl B, P101
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   SAWAI J, 1995, J CHEM ENG JPN, V28, P352, DOI 10.1252/jcej.28.352
   Schweikl H, 1997, J BIOMED MATER RES, V36, P284, DOI 10.1002/(SICI)1097-4636(19970905)36:3<284::AID-JBM2>3.0.CO;2-A
   Schweikl H, 1996, BIOMATERIALS, V17, P1451, DOI 10.1016/0142-9612(96)87289-9
   SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834
   SHILPI K, 2004, PROCESS BIOCHEM, V40, P607
   SHINYA K, 2000, BIOMATERIALS, V21, P521
   SILVESTRINI R, 1994, J NATL CANCER I, V86, P499, DOI 10.1093/jnci/86.7.499
   SIMON FW, 1999, INT J BIOL MACROMOL, V25, P111
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   van Kooten TG, 2000, J BIOMED MATER RES, V52, P199, DOI 10.1002/1097-4636(200010)52:1<199::AID-JBM26>3.0.CO;2-Z
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   WENING JV, 1995, BIOMATERIALS, V16, P337, DOI 10.1016/0142-9612(95)93262-C
   Xi TF, 2006, J BIOMED MATER RES A, V78A, P283, DOI 10.1002/jbm.a.30619
   YAHAGI T, 1975, CANCER LETT, V1, P91, DOI 10.1016/S0304-3835(75)95563-9
   Yu SK, 2004, FOOD CHEM TOXICOL, V42, P1677, DOI 10.1016/j.fct.2004.06.004
   Zhang H, 2004, FOOD CHEM TOXICOL, V42, P2021, DOI 10.1016/j.fct.2004.07.016
NR 60
TC 12
Z9 12
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD FEB
PY 2008
VL 22
IS 1
BP 57
EP 67
DI 10.1016/j.tiv.2007.08.001
PG 11
WC Toxicology
SC Toxicology
GA 258YU
UT WOS:000252907100007
PM 17892925
DA 2018-10-19
ER

PT J
AU Dahiya, S
   Tripathi, RM
   Hegde, AG
AF Dahiya, Sudhir
   Tripathi, R. M.
   Hegde, A. G.
TI Biosorption of heavy metals and radionuclide from aqueous solutions by
   pre-treated arca shell biomass
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE copper; lead; nickel; cesium; cobalt; lagergren; Langmuir; Freundlich
   isotherm
ID MARINE-ALGAE; REMOVAL; COPPER(II); ADSORPTION; SORPTION; CU(II);
   EQUILIBRIUM; NICKEL; WASTE; IONS
AB In this study biosorption potential of pre-treated arca shell biomass for lead, copper, nickel, cobalt and cesium was explored from the artificially prepared solution containing known amount of metals. The effects of pH, initial concentration, biosorbent dosage and contact time were studied in batch experiments. Effects of common ions like sodium, potassium, calcium and magnesium on the sorption capacity of pre-treated arca biomasses were also studied. To analyse the homogeneity of the biomaterial, experiments were performed for eight lots arca shell biomass for all the studies elements and it was observed that relative standard deviation in uptake capacity was within 10% for all elements. At equilibrium, the maximum total uptake by shell biomaterial was 18.33 +/- 0.44, 17.64 +/- 0.31, 9.86 +/- 0.17, 3.93 +/- 0.11 and 7.82 +/- 0.36 mg/g for lead, copper, nickel, cesium and cobalt, respectively, under the optimised condition of pH, initial concentration, biosorbent dose and contact time. Effect of all the common ions jointly up to concentration of 50 ppm was negligible for all the elements but at higher levels the cations affects the uptake capacity. Sorption isotherms were studied to explain the removal mechanism of both elements by fitting isotherms data into Lagergren, Freundlich and Langmuir equations. Halls separation factor estimated under optimised condition also favours the sorption potential of these elements using area shell biomass. Arca shell biomass can be effectively and efficiently employed for removal of studied elements after optimisation of parameters. (c) 2007 Published by Elsevier B.V.
C1 [Dahiya, Sudhir; Hegde, A. G.] Bhabha Atom Res Ctr, Div Hlth Phys, Environm Studies Sect, Bombay 400085, Maharashtra, India.
   [Tripathi, R. M.] Bhabha Atom Res Ctr, Environm Assessment Div, Bombay 400085, Maharashtra, India.
RP Dahiya, S (reprint author), Bhabha Atom Res Ctr, Div Hlth Phys, Environm Studies Sect, Bombay 400085, Maharashtra, India.
EM sdahiya@barc.gov.in
CR Akar T, 2006, BIORESOURCE TECHNOL, V97, P1780, DOI 10.1016/j.biortech.2005.09.009
   Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Al-Qunaibit M, 2005, CHEMOSPHERE, V60, P412, DOI 10.1016/j.chemosphere.2004.12.040
   ALDOR I, 1995, CAN J CHEM ENG, V73, P516, DOI 10.1002/cjce.5450730412
   Antunes WM, 2003, ELECTRON J BIOTECHN, V6, P174, DOI 10.4067/S0717-34582003000300003
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   BILQUES AS, 1999, INDIAN J ENV PROT, V19, P846
   Can MY, 2006, BIORESOURCE TECHNOL, V97, P1761, DOI 10.1016/j.biortech.2005.07.017
   Carson B. L., 1986, TOXICOLOGY BIOL MONI, P133
   Casas JM, 2000, CHEM ENG SCI, V55, P6223, DOI 10.1016/S0009-2509(00)00421-8
   Chojnacka K, 2005, J HAZARD MATER, V121, P167, DOI 10.1016/j.jhazmat.2005.02.004
   Conrad K, 2007, BIORESOURCE TECHNOL, V98, P89, DOI 10.1016/j.biortech.2005.11.018
   CORAPCIOGLU MO, 1987, WATER RES, V21, P1031, DOI 10.1016/0043-1354(87)90024-8
   DAHIYA S, 2005, ENV GEOCHEM, V8, P349
   DAHIYA S, 2005, NATL C REC TRENDS SU, P14
   DAHIYA S, 2003, NATL S ENV P, V12, P400
   DAHIYA S, 2003, RAD PROT ENV, V26, P468
   Faust S. D., 1987, ADSORPTION PROCESS W, P15
   FERGUSON MR, 1989, P 1989 SME S BIOT MI, V24, P201
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Gulnaz O, 2005, J HAZARD MATER, V120, P193, DOI 10.1016/j.jhazmat.2005.01.003
   Gupta R, 2000, CURR SCI INDIA, V78, P967
   HALL KR, 1966, IND ENG CHEM FUND, V5, P213
   Ho YS, 2005, BIORESOURCE TECHNOL, V96, P1285, DOI 10.1016/j.biortech.2004.10.021
   HONEYMAN BD, 1988, ENVIRON SCI TECHNOL, V22, P862, DOI 10.1021/es00173a002
   *ICRP, 1998, REPL ICRP PUBL, V54, P78
   ISABEL V, 2000, J CHEM TECHNOL BIOT, V75, P812
   Jalali-Rad R, 2004, J HAZARD MATER, V116, P125, DOI 10.1016/j.jhazmat.2004.08.022
   Karthikeyan S, 2007, BIORESOURCE TECHNOL, V98, P452, DOI 10.1016/j.biortech.2006.01.010
   KIPLING JJ, 1965, ADSORPTION SOLUTIONS, P113
   Lezcano J.M., 2001, BIOHYDROMETALL FUN B, P217
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MELO JS, 2001, NATL S ENV, P293
   Mercer B. W., 1978, ZEOLITE ION EXCHANGE, P451
   NAGENDRA CR, 1993, J ENV ENG, V119, P369
   Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026
   Pagnanelli F, 2005, WATER RES, V39, P1639, DOI 10.1016/j.watres.2005.01.019
   Pamukoglu Y, 2007, BIORESOURCE TECHNOL, V98, P1155, DOI 10.1016/j.biortech.2006.05.027
   PANDAY KK, 1985, WATER RES, V19, P869, DOI 10.1016/0043-1354(85)90145-9
   PARFITT GD, 1983, ADSORPTION SOLUTION, P7
   Periasamy K, 1996, CHEMOSPHERE, V32, P769, DOI 10.1016/0045-6535(95)00332-0
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SANGURDEKAR PR, 2007, P NATL S ENV, P298
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Sharma P, 2007, BIORESOURCE TECHNOL, V98, P474, DOI 10.1016/j.biortech.2005.12.016
   Song KC, 1997, SEP PURIF TECHNOL, V12, P215, DOI 10.1016/S1383-5866(97)00045-2
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Topallar H, 1999, TURK J CHEM, V23, P193
   Treybal R.E., 1980, MASS TRANSFER OPERAT, P447
   Underwood E, 1977, TRACE ELEMENTS HUMAN
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
   Vijayaraghavan K, 2005, CHEMOSPHERE, V60, P419, DOI 10.1016/j.chemosphere.2004.12.016
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   *WHO, 1991, INT PROGR CHEM SAF E, V108, P286
   *WHO, 1984, HLTH CRIT OTH SUPP I, V2, P126
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
NR 61
TC 105
Z9 108
U1 3
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JAN 31
PY 2008
VL 150
IS 2
BP 376
EP 386
DI 10.1016/j.jhazmat.2007.04.134
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 260LG
UT WOS:000253011200019
PM 17590505
DA 2018-10-19
ER

PT J
AU Su, HL
   Han, J
   Dong, Q
   Zhang, D
   Guo, QX
AF Su, Huilan
   Han, Jie
   Dong, Qun
   Zhang, Di
   Guo, Qixin
TI In situ synthesis and photoluminescence of QD-CdS on silk fibroin fibers
   at room temperature
SO NANOTECHNOLOGY
LA English
DT Article
ID QUANTUM DOTS; SEMICONDUCTOR CRYSTALLITES; AQUEOUS-SOLUTIONS;
   NANOPARTICLES; COPOLYMER; NANOCLUSTERS; TEMPLATES; PARTICLES; MECHANISM;
   MICELLES
AB A convenient room-temperature bioinspired technique has been developed to synthesize hybrid nanocomposites consisting of well-dispersed CdS quantum dots (QD) and the substrate silk fibroin fibers (SFF). The biomaterial SFF provides both a supporting substrate and functional sites for the in situ generation of QD-CdS, which is supported by FTIR and PL measurements. The solid QD-CdS/SFF nanocomposites could be useful in photocatalyst, novel luminescence and photoelectron transfer devices. The QD-CdS/silk fibroin (SF) colloid, in which SF acts as both an inherent biocompatibilizer and an efficient passivator of trap sites on the QD-CdS surface, is also available for some potential applications in the biological fields. The bioinspired method and relevant ideas could extend to fabricating other functional hybrid materials.
C1 [Su, Huilan; Han, Jie; Dong, Qun; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   [Guo, Qixin] Saga Univ, Dept Elect & Elect Engn, Saga 8408502, Japan.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM hlsu@sjtu.edu.cn
CR Ahmad A, 2002, J AM CHEM SOC, V124, P12108, DOI 10.1021/ja0272960o
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Behrens S, 2004, CHEM MATER, V16, P3085, DOI 10.1021/cm049462s
   BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218
   Chen S, 2007, LANGMUIR, V23, P850, DOI 10.1021/la062210g
   DAMERON CT, 1989, NATURE, V338, P596, DOI 10.1038/338596a0
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Du H, 2002, CHEM MATER, V14, P4473, DOI 10.1021/cm010622z
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Gerstel P, 2006, CHEM MATER, V18, P179, DOI 10.1021/cm051542o
   HENGLEIN A, 1989, CHEM REV, V89, P1861, DOI 10.1021/cr00098a010
   Huang JG, 2003, J AM CHEM SOC, V125, P11834, DOI 10.1021/ja037419k
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kumar A, 2002, PHOTOCH PHOTOBIO SCI, V1, P737, DOI 10.1039/b206301h
   Liang HJ, 2003, J AM CHEM SOC, V125, P11786, DOI 10.1021/ja036529o
   Lipovskii A, 1997, APPL PHYS LETT, V71, P3406, DOI 10.1063/1.120349
   Ma YR, 2003, LANGMUIR, V19, P9079, DOI 10.1021/la034994t
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Meldrum FC, 2000, CHEM COMMUN, P29, DOI 10.1039/a907074e
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Sapra S, 2001, CHEM COMMUN, P2188, DOI 10.1039/b106420g
   TIAN YC, 1994, J PHYS CHEM-US, V98, P4913, DOI 10.1021/j100069a024
   Wang CW, 2004, LANGMUIR, V20, P11784, DOI 10.1021/la048390g
   WANG Y, 1991, J PHYS CHEM-US, V95, P525, DOI 10.1021/j100155a009
   Warner JH, 2006, NANOTECHNOLOGY, V17, P3035, DOI 10.1088/0957-4484/17/12/037
   WEI J, 2004, TEXTILE AUXILIARIES, V21, P51
   Winiarz JG, 1999, J AM CHEM SOC, V121, P5287, DOI 10.1021/ja983559w
   Xi YY, 2005, CHEM PHYS LETT, V412, P60, DOI 10.1016/j.cplett.2005.06.087
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhao HY, 2002, CHEM MATER, V14, P1418, DOI [10.1021/cm011581+, 10.1021/cm011581]
   Zhao HY, 2001, LANGMUIR, V17, P8428, DOI 10.1021/la011348q
NR 32
TC 15
Z9 17
U1 6
U2 37
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JAN 16
PY 2008
VL 19
IS 2
AR 025601
DI 10.1088/0957-4484/19/02/025601
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 257WG
UT WOS:000252828900012
PM 21817543
DA 2018-10-19
ER

PT J
AU Khew, ST
   Tong, YW
AF Khew, Shih Tak
   Tong, Yen Wah
TI Template-assembled triple-helical peptide molecules: Mimicry of collagen
   by molecular architecture and integrin-specific cell adhesion
SO BIOCHEMISTRY
LA English
DT Article
ID N-ISOBUTYLGLYCINE NLEU; PRO-HYP SEQUENCES; CIRCULAR-DICHROISM;
   OPTICAL-ROTATION; CONFORMATIONAL-ANALYSIS; ULTRAVIOLET ABSORBENCY;
   MIMETIC PEPTIDE; BINDING; IDENTIFICATION; MODEL
AB Most proteins fold into specific structures to exert their biological functions, and therefore the creation of protein-like molecular architecture is a fundamental prerequisite toward realizing a novel biologically active protein-like biomaterial. To do this with an artificial collagen, we have engineered a peptide template characterized by its collagen-like primary structure composed of Gly-Phe-Gly-Glu-Glu-Gly sequence to assemble (Pro-Hyp-Gly)(n) (n = 3 and 5) into triple-helical conformations that resemble the native structure of collagen. The peptide template has three carboxyl groups connected to the N-termini of three collagen peptides. The coupling was accomplished by a simple and direct branching protocol without complex strategies. A series of biophysical studies, including melting curve analyses and CD and NMR spectroscopy, demonstrated the presence of stable triple-helical conformation in the template-assembled. (Pro-Hyp-Gly)(3) and (Pro-Hyp-Gly)(5) solution. Conversely, nontemplated peptides showed no evidence of assembly of triple-helical structure. A cell binding sequence (Gly-Phe-Hyp-Gly-Glu-Arg) derived from the collagen alpha(1)(I) chain was incorporated to mimic the integrin-specific cell adhesion of collagen. Cell adhesion and inhibition assays and immunofluorescence staining revealed a correlation of triple-helical conformation with cellular recognition of collagen mimetics in an integrin-specific way. This study offers a robust strategy for engineering native-like peptide-based biomaterials, fully composed of only amino acids, by maintaining protein conformation integrity and biological activity.
C1 [Khew, Shih Tak; Tong, Yen Wah] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119077, Singapore.
   [Tong, Yen Wah] Natl Univ Singapore, Div Bioengn, Singapore 119077, Singapore.
RP Tong, YW (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore.
EM chetyw@nus.edu.sg
RI Tong, Yen Wah/D-4602-2009; Khew, Shih Tak/H-1828-2011
OI Tong, Yen Wah/0000-0002-6004-6284; 
CR Bacakova L, 2000, J BIOMED MATER RES, V49, P369, DOI 10.1002/(SICI)1097-4636(20000305)49:3<369::AID-JBM10>3.0.CO;2-W
   Bacakova L, 2000, BIOMATERIALS, V21, P1173, DOI 10.1016/S0142-9612(00)00009-0
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423
   BROWN FR, 1972, J MOL BIOL, V63, P85, DOI 10.1016/0022-2836(72)90523-2
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451
   Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   FIELDS CG, 1995, ANAL BIOCHEM, V231, P57, DOI 10.1006/abio.1995.1503
   FIELDS CG, 1993, J BIOL CHEM, V268, P14153
   FIELDS CG, 1993, BIOPOLYMERS, V33, P1695, DOI 10.1002/bip.360331107
   FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Goodman M, 1996, J AM CHEM SOC, V118, P5156, DOI 10.1021/ja954132h
   Grab B, 1996, J BIOL CHEM, V271, P12234, DOI 10.1074/jbc.271.21.12234
   GREICHE Y, 1979, BIOPOLYMERS, V18, P2359, DOI 10.1002/bip.1979.360180923
   GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x
   Hojo H, 1997, TETRAHEDRON, V53, P14263, DOI 10.1016/S0040-4020(97)00994-0
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 1990, FIBRONECTINS
   Jefferson EA, 1998, J AM CHEM SOC, V120, P7420, DOI 10.1021/ja9810134
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   Kajiyama K, 1995, CHEM PHYS LETT, V247, P299, DOI 10.1016/0009-2614(95)01211-5
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KOBAYASHI Y, 1970, BIOPOLYMERS, V9, P415, DOI 10.1002/bip.1970.360090404
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007
   Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146
   Melacini G, 1996, J AM CHEM SOC, V118, P10359, DOI 10.1021/ja9612615
   MILES AJ, 1994, J BIOL CHEM, V269, P30939
   Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529
   MUTTER M, 1992, J AM CHEM SOC, V114, P1463, DOI 10.1021/ja00030a049
   Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   RIPPON WB, 1971, BIOPOLYMERS, V10, P1207, DOI 10.1002/bip.360100710
   ROTH W, 1980, BIOPOLYMERS, V19, P1909, DOI 10.1002/bip.1980.360191017
   RUBIN K, 1981, CELL, V24, P463, DOI 10.1016/0092-8674(81)90337-8
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SAKAKIBARA S, 1968, B CHEM SOC JPN, V41, P1273, DOI 10.1246/bcsj.41.1273
   SAKAKIBARA S, 1972, J MOL BIOL, V65, P371, DOI 10.1016/0022-2836(72)90288-4
   SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   THAKUR S, 1986, BIOPOLYMERS, V25, P1081, DOI 10.1002/bip.360250608
   VANDYKE TE, 1999, J INT ACAD PERIODONT, V1, P3
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WOOD GC, 1963, BIOCHEM BIOPH RES CO, V13, P95, DOI 10.1016/0006-291X(63)90170-0
   Yamazaki S, 2001, J CHEM SOC PERK T 1, P1870, DOI 10.1039/b103887g
NR 58
TC 19
Z9 19
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JAN 15
PY 2008
VL 47
IS 2
BP 585
EP 596
DI 10.1021/bi702018v
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 249DB
UT WOS:000252206100010
PM 18154308
DA 2018-10-19
ER

PT J
AU Yuen, CWM
   Ku, SKA
   Kan, CW
AF Yuen, C. W. M.
   Ku, S. K. A.
   Kan, C. W.
TI Use of a biomaterial as a thickener for textile ink-jet printing
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; surface; fibers
ID CHITOSAN
AB The feasibility of using chitosan as a thickener in the pretreatment print paste for textile ink-jet printing was explored. An orthogonal analysis was used to determine the optimum conditions for using chitosan as a thickener in the pretreatment print paste and the effects of different process factors for achieving the best color yield in textile ink-jet printing. With the help of the orthogonal analysis, the importance of different process factors was found to be in the order of (1) the amount of urea used, (2) the amount of chitosan used, (3) the amount of sodium bicarbonate used, and (4) the steaming time. On the basis of the results of the orthogonal analysis, the optimum conditions for using chitosan as a thickener for the pretreatment print paste were concluded to be 40 mL of chitosan, 10 g of urea, 8 g of sodium bicarbonate, and 5 min of steaming. According to an analysis of the results of different color fastness tests, chitosan could principally work as a pretreatment print paste thickener. However, the final color yield obtained from chitosan-containing cotton fabrics depended greatly on the stage of the chitosan application. Nevertheless, the color fastness properties and the outline sharpness of the prints of cotton fabric were greatly improved by the chitosan treatment. A two-bath chitosan treatment was developed to separate the chitosan from sodium bicarbonate and urea before it was padded onto the fabric surface to minimize the neutralization effect. On the basis of the results for the highest color yield obtained on the cotton fabric, it was confirmed that the two-bath chitosan treatment was successfully developed. In addition, chitosan could impart higher antibacterial properties with a slight reduction in the tensile strength of the cotton fabric. (C) 2007 Wiley Periodicals, Inc.
C1 Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
RP Kan, CW (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
EM tccwk@inet.polyu.edu.hk
OI Kan, Chi-wai/0000-0002-7668-2410
CR ASTON SO, 1993, J SOC DYERS COLOUR, V109, P147
   Bahmani SA, 2000, J SOC DYERS COLOUR, V116, P94
   BANDYOPADBYAY BN, 2001, BTRA SCAN, V31, P5
   Bandyopadhyay BN, 1998, INT DYE, V183, P39
   CHOI PSR, 2005, TEXT ASIA, V35, P50
   Gupta S, 2001, INDIAN J FIBRE TEXT, V26, P156
   Kan C. W., 2005, Textile Asia, V36, P28
   Lam H L I, 1998, RES J TEXTILES APPAR, V2, P21
   Oktem T, 2003, COLOR TECHNOL, V119, P241
   Qin Y., 2004, TEXT MAG, V31, P14
   SCHULZ G, 2002, INT TEXT REP ENGL ED, V83, P30
   SUI S, 1994, J NW I TEXTILE SCI T, V2, P165
   VANPARYS M, 2002, INT TEXT REP ENGL ED, V83, P96
   Yeung K. W., 1997, J HONG KONG I TEXTIL, V1, P10
   Yuen C. W. M., 2003, RES J TEXT APPAREL, V7, P43
   Yuen CWM, 2004, FIBER POLYM, V5, P117, DOI 10.1007/BF02902924
   Zhou X., 2002, INT TEXTILE B, V48, P64
NR 17
TC 6
Z9 7
U1 2
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 15
PY 2008
VL 107
IS 2
BP 1057
EP 1065
DI 10.1002/app.26968
PG 9
WC Polymer Science
SC Polymer Science
GA 229RR
UT WOS:000250822400043
DA 2018-10-19
ER

PT J
AU Ma, PX
AF Ma, Peter X.
TI Biomimetic materials for tissue engineering
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE biomimetic; tissue engineering; regeneration; polymer scaffold; matrix;
   biomaterial; nano; controlled release
ID BIODEGRADABLE POLYMER SCAFFOLDS; POLY(L-LACTIC ACID) SCAFFOLDS;
   NANO-FIBROUS SCAFFOLDS; MESENCHYMAL STEM-CELLS; IN-VITRO; COMPOSITE
   SCAFFOLDS; SURFACE MODIFICATION; MOLECULAR ARCHITECTURE;
   SUSTAINED-RELEASE; BLOCK-COPOLYMERS
AB Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for transplantation. Biomaterials play a pivotal role as scaffolds to provide three-dimensional templates and synthetic extracellular matrix environments for tissue regeneration. It is often beneficial for the scaffolds to mimic certain advantageous characteristics of the natural extracellular matrix, or developmental or wound healing programs. This article reviews current biomimetic materials approaches in tissue engineering. These include synthesis to achieve certain compositions or properties similar to those of the extracellular matrix, novel processing technologies to achieve structural features mimicking the extracellular matrix on various levels, approaches to emulate cell-extracellular matrix interactions, and biologic delivery strategies to recapitulate a signaling cascade or developmental/wound healing program. The article also provides examples of enhanced cellular/tissue functions and regenerative outcomes, demonstrating the excitement and significance of the biomimetic materials for tissue engineering and regeneration. (c) 2007 Elsevier B.V All rights reserved.
C1 [Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Ma, PX (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM mapx@umich.edu
RI Ma, Peter/E-4895-2011
FU NIGMS NIH HHS [R21 GM075840, R21 GM075840-01, GM075840, R21
   GM075840-02]; NIDCR NIH HHS [R01 DE015384-04, R21 DE014755-02, DE017689,
   R01 DE015384, R01 DE017689-02, R21 DE014755, R01 DE017689-01A1, R01
   DE017689, R01 DE015384-03, R21 DE014755-01A1, DE014755, DE015384]
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Catledge SA, 2004, J NANOSCI NANOTECHNO, V4, P986, DOI 10.1166/jnn.2004.137
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chen VJ, 2006, BIOMATERIALS, V27, P3708, DOI 10.1016/j.biomaterials.2006.02.020
   Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   CHEN VJ, 2006, SCAFFOLDING TISSUE E, P121
   CHEN VJ, 2005, HDB NANOSTRUCTURED B, V2, P415
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007
   Deitzel JM, 2002, POLYMER, V43, P1025, DOI 10.1016/S0032-3861(01)00594-8
   Duan B, 2007, J BIOMAT SCI-POLYM E, V18, P95, DOI 10.1163/156856207779146105
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Formhals A., 1934, U. S. Patent, Patent No. [1,975,504, 1975504]
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hay ED, 1991, CELL BIOL EXTRACELLU
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hu Y, 2001, J DRUG TARGET, V9, P431, DOI 10.3109/10611860108998777
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kennedy JH, 1998, J THORAC CARDIOV SUR, V115, P545
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   LAURENCIN CT, 1989, BONE, V19, pS93
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Liu DJ, 2003, MACROMOLECULES, V36, P8489, DOI 10.1021/ma0348573
   Liu DJ, 2002, LANGMUIR, V18, P2385, DOI 10.1021/la011270d
   Liu XH, 2006, BIOMATERIALS, V27, P3980, DOI 10.1016/j.biomaterials.2006.03.008
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu XH, 2005, J BIOMED NANOTECHNOL, V1, P54, DOI 10.1166/jbn.2005.013
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Ma PX, 1995, MATER RES SOC SYMP P, V394, P99, DOI 10.1557/PROC-394-99
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma PX, 2006, SCAFFOLDING TISSUE E
   MA PX, 2001, Patent No. 6281257
   MA PX, 2000, Patent No. 6146892
   MA PX, 2005, ENCY POLYM SCI TECHN, V12, P261
   MA PX, 2005, Patent No. 6867240
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   MORTON WJ, 1902, Patent No. 705691
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Perutz MF, 1999, BRAIN RES BULL, V50, P467, DOI 10.1016/S0361-9230(99)00137-9
   Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   PITT CG, 1981, BIOMATERIALS, V2, P215
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rice MA, 2005, OTOLARYNG CLIN N AM, V38, P199, DOI 10.1016/j.otc.2004.10.010
   ROEMER D, 1977, NATURE, V268, P547, DOI 10.1038/268547a0
   Ruckenstein E, 2005, ADV COLLOID INTERFAC, V113, P43, DOI 10.1016/j.cis.2004.07.009
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   SCHNUR JM, 1987, THIN SOLID FILMS, V152, P181, DOI 10.1016/0040-6090(87)90416-0
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shinoka T, 1997, CIRCULATION, V96, P102
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   SMITH LA, 2006, NANOTECHNOLOGIES LIF, V9, P188
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wei GB, 2004, BIOMATERIALS, V25, P345, DOI 10.1016/S0142-9612(03)00528-3
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Wei GB, 2006, J BIOMED MATER RES A, V78A, P306, DOI 10.1002/jbm.a.30704
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Zhang JY, 2000, BIOMATERIALS, V21, P1247, DOI 10.1016/S0142-9612(00)00005-3
   Zhang R., 2001, METHODS TISSUE ENG, P715
   Zhang R, 2000, POLYM PREPR, V41, P1618
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
NR 142
TC 718
Z9 765
U1 35
U2 501
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 14
PY 2008
VL 60
IS 2
BP 184
EP 198
DI 10.1016/j.addr.2007.08.041
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 254BY
UT WOS:000252562600009
PM 18045729
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Omelon, S
   Baer, A
   Coyle, T
   Pilliar, RM
   Kandel, R
   Grynpas, M
AF Omelon, Sidney
   Baer, Andrew
   Coyle, Tom
   Pilliar, Robert M.
   Kandel, Rita
   Grynpas, Marc
TI Polymeric crystallization and condensation of calcium polyphosphate
   glass
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE ceramics; crystal growth; infrared spectroscopy; nuclear magnetic
   resonance; X-ray diffraction
ID BONE SUBSTITUTE APPLICATIONS; PHOSPHATE GLASSES; IN-VITRO; NMR; SPECTRA;
   SPECTROSCOPY; SCAFFOLDS; IMPLANTS
AB Calcium polyphosphate (Ca(PO3)(2))(n) (CPP) is under investigation as a resorbable bone biomaterial. Sintering CPP glass particles in humid air produces a porous, interconnected, degradable, crystalline construct that is suitable for connective tissue engineering applications. Porous CPP constructs sintered at 585 degrees C dissolved in water more rapidly than those sintered at 950 degrees C. FTIR, P-31 NMR. powder XRD, and density data for CPP glass and fully crystalline fibers were compared with data for the as-sintered and partially dissolved constructs sintered at 585 or 950 degrees C. The results suggest that condensation continues during sintering, and CPP glass crystallizes in a process analogous to the crystallization of linear organic polymers. During sintering, water vapor caused hydrolytic degradation of the surface polyphosphate chains, forming a surface layer with different dissolution properties than the particle interior. Thus, sintering CPP glass results in a heterogeneous crystalline product that impacts the dissolution rate of CPP as a degradable biomaterial. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Omelon, Sidney; Coyle, Tom; Pilliar, Robert M.; Grynpas, Marc] Univ Toronto, Toronto, ON, Canada.
   [Omelon, Sidney; Grynpas, Marc] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
   [Baer, Andrew] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada.
   [Baer, Andrew] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
RP Grynpas, M (reprint author), Univ Toronto, 184 Coll St, Toronto, ON, Canada.
EM grynpas@mshri.on.ca
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913
CR Abe Y., 1983, TOPICS PHOSPHORUS CH, V11, P19
   BROW RK, 1991, J AM CERAM SOC, V74, P1287, DOI 10.1111/j.1151-2916.1991.tb04099.x
   BROW RK, 1990, J NON-CRYST SOLIDS, V116, P39, DOI 10.1016/0022-3093(90)91043-Q
   CALLISTER WD, 2003, MAT SCI ENG INTRO J, P470
   DUNCAN TM, 1984, CHEM PHYS, V87, P339, DOI 10.1016/0301-0104(84)85115-0
   Durif A., 1995, CRYSTAL CHEM CONDENS
   Fahad MK, 1996, J MATER SCI, V31, P3723, DOI 10.1007/BF00352786
   FLETCHER JP, 1993, J CHEM SOC FARADAY T, V89, P3297, DOI 10.1039/ft9938903297
   Gomez F, 1997, J NON-CRYST SOLIDS, V222, P415, DOI 10.1016/S0022-3093(97)90144-7
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   HINOKI T, 2003, 27 INT COC BEACH C A, P34
   HOLAND W, 2002, GLASS CERAMIC TECHNO, P67
   Kasuga T, 2001, CHEM LETT, P820
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   MCINTOSH AO, 1956, ANAL CHEM, V28, P1424, DOI 10.1021/ac60117a019
   Meyer K, 1997, J NON-CRYST SOLIDS, V209, P227, DOI 10.1016/S0022-3093(96)00563-7
   MEYER K, 1994, VIB SPECTROSC, V6, P323, DOI 10.1016/0924-2031(93)E0055-7
   NOURUZIKHARASAN.A, 1996, METAL CAST SURF FINI, P34
   Palavit G, 1998, J AM CERAM SOC, V81, P1521
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   ROPP RC, 1992, INORGANIC POLYM GLAS, V15, P116
   ROTHAMMEL W, 1989, ACTA CRYSTALLOGR C, V45, P551, DOI 10.1107/S0108270188012922
   SALES BC, 1987, PHYS REV LETT, V59, P1718, DOI 10.1103/PhysRevLett.59.1718
   SCHNEIDER M, 1985, Z ANORG ALLG CHEM, V527, P99, DOI 10.1002/zaac.19855270810
   SCHULTZ JM, 2001, POLYM CRYSTALLIZATIO, P1
   Seguin CA, 2004, SPINE, V29, P1299, DOI 10.1097/01.BRS.0000127183.43765.AF
   SMITH BC, 1999, INFRARED SPECTRAL IN, P6
   Statton W.O., 1963, J APPL POLYM SCI, V7, P803, DOI 10.1002/app.1963.070070302
   Talbot D. E. J., 1975, International Metallurgical Reviews, V20, P166
   VANWAZER JR, 1955, J AM CHEM SOC, V77, P4945, DOI 10.1021/ja01623a091
   VANWAZER JR, 1950, J AM CHEM SOC, V72, P644
   VANWAZER JR, 1958, PHOSPHORUS ITS COMPU, V1
   WAKELIN JH, 1959, J APPL PHYS, V30, P1654, DOI 10.1063/1.1735031
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   WANTANABE A, 1986, J AM CERAM SOC, V69, pC31
   WANTANABE A, 1989, J AM CERAM SOC, V72, P1499
   Witter R, 1998, SOLID STATE NUCL MAG, V13, P189, DOI 10.1016/S0926-2040(98)00088-5
NR 39
TC 15
Z9 16
U1 2
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
J9 MATER RES BULL
JI Mater. Res. Bull.
PD JAN 8
PY 2008
VL 43
IS 1
BP 68
EP 80
DI 10.1016/j.materresbull.2007.02.015
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 250YD
UT WOS:000252336300009
DA 2018-10-19
ER

PT S
AU Aldea, E
   Dicu, MM
   Gleizes, A
   Demetrescu, I
AF Aldea, E.
   Dicu, M. M.
   Gleizes, A.
   Demetrescu, I.
BE Katashev, A
   Dekhtyar, Y
   Spigulis, J
TI The Modification of Titanium Dioxide MOCVD Coating in TiAlNb after
   Immersion in Artificial Saliva
SO 14TH NORDIC-BALTIC CONFERENCE ON BIOMEDICAL ENGINEERING AND MEDICAL
   PHYSICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 14th Nordic-Baltic Conference an Biomedical Engineering and Medical
   Physics
CY JUN 16-20, 2008
CL Riga, LATVIA
SP Siemens, Grindex, Arbor Med Corp, Philips, AB Technol Corp, IFMBE, Latvian Council Sci
DE TiAlNb alloy; MOCVD; artificial saliva; Scanning Electronic Microscopy;
   contact angle; infrared technique
ID TIO2 THIN-FILMS; NB ALLOYS; TI-6AL-4V; IMPLANTS; GROWTH
AB The paper aim is to observed the modification of passive coating obtained on TiAlNb with a Metal-Organic Chemical Vapor Deposition (MOCVD) [1, 2] procedure after immersion in artificial saliva (Fusayama) with calcium content. Two temperatures [T] (400 degrees C and 500 degrees C), two pressures [p] (I and 20 torr) and variable molecular fracetion [chi] from 76 to 5000 were used in MOCVD coating procedures. The X-ray spectrum confirms the dense and uniform deposition of TiO2 film on TiAlNb alloy surface. The results of analyses used in the present paper contribute of the extended research in the biomaterial domain.
C1 [Aldea, E.; Dicu, M. M.; Demetrescu, I.] Univ Polytech Bucharest, Dept Gen Chem, Polizu 1, Bucharest, Romania.
   [Gleizes, A.] CNRS, Centre Interuniv Recherche Ingenierie Mat, UMR 5085, ENSIACET INPT, Toulouse, France.
RP Aldea, E (reprint author), Univ Polytech Bucharest, Dept Gen Chem, Polizu 1, Bucharest, Romania.
EM Aldea_E@Yahoo.Ca
RI Demetrescu, Ioana/C-5325-2013
CR ALDEA E, 2005, UPB SCI B SERIES B, V67, P27
   Battiston GA, 2000, MATER SCI FORUM, V352, P151, DOI 10.4028/www.scientific.net/MSF.352.151
   Boehlert CJ, 2008, MAT SCI ENG C-BIO S, V28, P323, DOI 10.1016/j.msec.2007.04.003
   Brevet A, 2005, J CRYST GROWTH, V275, pE1263, DOI 10.1016/j.jcrysgro.2004.11.081
   Elias KL, 2007, J PROSTHET DENT, V97, P357, DOI 10.1016/S0022-3913(07)60024-9
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Ionita D, 2008, KEY ENG MATER, V361-363, P733, DOI 10.4028/www.scientific.net/KEM.361-363.733
   Li SJ, 2008, MAT SCI ENG A-STRUCT, V480, P101, DOI 10.1016/j.msea.2007.06.070
   Maekawa T, 2008, SURF COAT TECH, V202, P3067, DOI 10.1016/j.surfcoat.2007.11.017
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Monoy A, 2006, THIN SOLID FILMS, V515, P687, DOI 10.1016/j.tsf.2005.12.237
   OSHIDA Y, 2001, Patent No. 6183255
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Sovar MM, 2008, KEY ENG MATER, V361-363, P1131, DOI 10.4028/www.scientific.net/KEM.361-363.1131
   Xu LJ, 2008, J ALLOY COMPD, V453, P320, DOI 10.1016/j.jallcom.2006.11.144
   Zaveri N, 2008, ELECTROCHIM ACTA, V53, P5022, DOI 10.1016/j.electacta.2008.01.086
NR 17
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-69366-6
J9 IFMBE PROC
PY 2008
VL 20
BP 8
EP +
PG 3
WC Engineering, Biomedical; Robotics; Neurosciences; Surgery
SC Engineering; Robotics; Neurosciences & Neurology; Surgery
GA BIM08
UT WOS:000260668000003
DA 2018-10-19
ER

PT S
AU Bossert, J
   Keller, T
AF Bossert, J.
   Keller, T.
BE Katashev, A
   Dekhtyar, Y
   Spigulis, J
TI Investigation of the Bone Cartilage Interface by CLSM
SO 14TH NORDIC-BALTIC CONFERENCE ON BIOMEDICAL ENGINEERING AND MEDICAL
   PHYSICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 14th Nordic-Baltic Conference an Biomedical Engineering and Medical
   Physics
CY JUN 16-20, 2008
CL Riga, LATVIA
SP Siemens, Grindex, Arbor Med Corp, Philips, AB Technol Corp, IFMBE, Latvian Council Sci
DE bone; cartilage; interface; CLSM
ID HUMAN ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; CALCIFIED CARTILAGE;
   PARTICLES; ZONE
AB A common problem for implants is the stress and the strain at the interface of implant and tissue. The reason for are different mechanical properties of biomaterial and tissue. This mechanical incompatibility might lead to the loosening of the implant. There are several strategies dealing with improving the interface of biomaterial and implants. Here we present data of the architecture of a natural interface that might serve to develop advanced surfaces for solid implants.
   From partially decalcified human tali the cartilage could be peeled off. Both, the cartilage and the bone were investigated by Confocal Laser Scanning Microscopy (CLSM). The images give an impression of the roughness and structure of the interface. The resulting three dimensional pictures were quantified by the help of quantitative image analyse software. The quantitative analyse gives information about the real interface area, which is higher than the planar geometrical area, the ratio of bone and cartilage of the transition zone, and about the morphological structure of the interface.
   Quantitative data on the amount and structure of the graded interface can be used to model the mechanical properties of the interface and finally might help to create a micro design of the implant surface ideal for osteointegration and optimal load transfer.
C1 [Bossert, J.; Keller, T.] Univ Jena, Inst Mat Sci & Technol, Jena, Germany.
RP Bossert, J (reprint author), Univ Jena, Inst Mat Sci & Technol, Lobdergraben 32, Jena, Germany.
EM P5jobo@uni-jena.de
CR ANDERSON DD, 1993, CLIN ORTHOP RELAT R, P298
   Geerdink CH, 2006, ACTA ORTHOP, V77, P719, DOI 10.1080/17453670610012890
   Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102
   Keinan-Adamsky K, 2005, J ORTHOP RES, V23, P109, DOI 10.1016/j.orthres.2004.06.005
   MENTE PL, 1994, J ORTHOPAED RES, V12, P637, DOI 10.1002/jor.1100120506
   MINNS RJ, 1977, J ANAT, V123, P437
   Mollenhauer J, 2003, CONNECT TISSUE RES, V44, P201, DOI 10.1080/03008200390244005
   MOLLENHAUER JA, 2007, ADV ENG MATER, V12, P1097
   Muehleman C, 2004, OSTEOARTHR CARTILAGE, V12, P97, DOI 10.1016/j.joca.2003.10.001
   Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   WAGNER A, 2006, PHYS MED BIOL, P11313
   Wang Y, 2007, BIO-MED MATER ENG, V17, P241
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 15
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-69366-6
J9 IFMBE PROC
PY 2008
VL 20
BP 16
EP 18
PG 3
WC Engineering, Biomedical; Robotics; Neurosciences; Surgery
SC Engineering; Robotics; Neurosciences & Neurology; Surgery
GA BIM08
UT WOS:000260668000005
DA 2018-10-19
ER

PT S
AU Locs, J
   Berzina-Cimdina, L
   Zhurinsh, A
AF Locs, J.
   Berzina-Cimdina, L.
   Zhurinsh, A.
BE Katashev, A
   Dekhtyar, Y
   Spigulis, J
TI Development of Biomorphic SiC Ceramics for Biomaterial Purposes
SO 14TH NORDIC-BALTIC CONFERENCE ON BIOMEDICAL ENGINEERING AND MEDICAL
   PHYSICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 14th Nordic-Baltic Conference an Biomedical Engineering and Medical
   Physics
CY JUN 16-20, 2008
CL Riga, LATVIA
SP Siemens, Grindex, Arbor Med Corp, Philips, AB Technol Corp, IFMBE, Latvian Council Sci
DE wood; SiC; biomorphic; biomaterial
ID SILICON-CARBIDE CERAMICS; MECHANICAL-PROPERTIES; POROUS CERAMICS; WOOD;
   MICROSTRUCTURE; INFILTRATION; NANORODS
AB Microstructure of several wooden breeds was investigated and discussed as perspective biomorphic SiC ceramics precursor for biomaterial purposes. Pine tree (Pinus silvestris) with shaped sample dimensions of 20 x 20 x 5mm (axial) was selected as raw material. SiO2 sol-gel solution was prepared using ethanol, tetraetoxysilane, distilled water and hydrochloric acid. Samples were impregnated under vacuum and pressure conditions. Impregnation and drying procedures were repeated several times, to increase SiO2 amount introduced in the samples. SEM microphotograps of samples were taken and are demonstrating the localization Of SiO2 in wood. Impregnated samples were processed using high temperature and inert atmosphere and porous biomorphic SiC ceramics were obtained. Microstructure, crystalline phase composition and chemical functional groups of biomorphic SiC ceramics were investigated.
C1 [Locs, J.; Berzina-Cimdina, L.] Riga Tech Univ, Riga Biomat Innovat & Dev Ctr, Pulka St 3-3, LV-1007 Riga, Latvia.
   [Zhurinsh, A.] Latvian State Inst Wood Chem, Riga 1006, Latvia.
RP Locs, J (reprint author), Riga Tech Univ, Riga Biomat Innovat & Dev Ctr, Pulka St 3-3, LV-1007 Riga, Latvia.
EM janis.locs@rtu.lv
OI Locs, Janis/0000-0003-3162-7431
FU European Social Fund within the National Program; Riga Technical
   University
FX This work has been partly supported by the European Social Fund within
   the National Program Support for carrying out doctoral study programs
   and post-doctoral researches project Support for the development of
   doctoral studies at the Riga Technical University.
CR Borrajo JP, 2005, APPL SURF SCI, V248, P355, DOI 10.1016/j.apsusc.2005.03.051
   Castro V, 2004, KEY ENG MAT, V264-268, P2267, DOI 10.4028/www.scientific.net/KEM.264-268.2267
   Esposito L, 2004, J EUR CERAM SOC, V24, P533, DOI 10.1016/S0955-2219(03)00195-X
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   Guanjun Q, 2002, J MATER PROCESS TECH, V120, P107
   Herzog A, 2004, J AM CERAM SOC, V87, P784, DOI 10.1111/j.1551-2916.2004.00784.x
   Klingner R, 2003, HOLZFORSCHUNG, V57, P440, DOI 10.1515/HF.2003.065
   Munoz A, 2002, J EUR CERAM SOC, V22, P2727, DOI 10.1016/S0955-2219(02)00138-3
   Ota T, 1995, J AM CERAM SOC, V78, P3409, DOI 10.1111/j.1151-2916.1995.tb07988.x
   Qian JM, 2006, J EUR CERAM SOC, V26, P1311, DOI 10.1016/j.jeurceramsoc.2005.03.229
   Rowell RM, 2005, HDB WOOD CHEM WOOD C
   Shin Y, 2007, MATER LETT, V61, P2814, DOI 10.1016/j.matlet.2006.10.035
   Singh M, 2002, J EUR CERAM SOC, V22, P2709, DOI 10.1016/S0955-2219(02)00136-X
   Vogli E, 2002, J EUR CERAM SOC, V22, P2663, DOI 10.1016/S0955-2219(02)00131-0
   Vogt U, 2002, KEY ENG MAT, V206-2, P1941, DOI 10.4028/www.scientific.net/KEM.206-213.1941
   Zawrah MF, 2007, MATER CHEM PHYS, V106, P330, DOI 10.1016/j.matchemphys.2007.06.010
   Zollfrank C, 2004, J EUR CERAM SOC, V24, P479, DOI 10.1016/S0955-2219(03)00202-4
NR 17
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-69366-6
J9 IFMBE PROC
PY 2008
VL 20
BP 48
EP +
PG 2
WC Engineering, Biomedical; Robotics; Neurosciences; Surgery
SC Engineering; Robotics; Neurosciences & Neurology; Surgery
GA BIM08
UT WOS:000260668000014
DA 2018-10-19
ER

PT S
AU Ozolins, V
   Ozolanta, I
   Smits, L
   Lacis, A
   Kasyanov, V
AF Ozolins, V.
   Ozolanta, I.
   Smits, L.
   Lacis, A.
   Kasyanov, V.
BE Katashev, A
   Dekhtyar, Y
   Spigulis, J
TI Biomechanical Properties of Glutaraldehyde Treated Human Pericadium
SO 14TH NORDIC-BALTIC CONFERENCE ON BIOMEDICAL ENGINEERING AND MEDICAL
   PHYSICS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 14th Nordic-Baltic Conference an Biomedical Engineering and Medical
   Physics
CY JUN 16-20, 2008
CL Riga, LATVIA
SP Siemens, Grindex, Arbor Med Corp, Philips, AB Technol Corp, IFMBE, Latvian Council Sci
DE Autologous pericardium; glutaraldehyde; biomechanical properties;
   proteolytic degradation; congenital heart defect
ID BOVINE PERICARDIUM; AUTOLOGOUS PERICARDIUM; BIOPROSTHETIC VALVES;
   CALCIFICATION; FIXATION; BEHAVIOR; PATCH
AB Autologous pericardium, for repair of congenital heart defects, can be used in its fresh non-treated state, or after chemical fixation with glutaraldehyde solution as a biomaterial for surgical repair of congenital heart anomalies. The aim of this experimental study is to investigate changes of biornechanical properties and resistance to proteolytic degradation of human pericardium, after harvesting with glutaraldehyde solution.
   After taken out of a pericardiurn from anterior part of pericardial sac at the time of operation it was fixed with 0.2% solution of glutaraldehyde for 6 minutes.
   Some glutaraldehyde treated and untreated samples were incubated in collagenase solution (100 Uml(-1) for 2 hours at 37 degrees C and proteolytic effect was estimated with gravimetric method. For investigation of biornechanical properties uniaxial tensile tests were performed with testing machine Zwick-Roell Z010. There were set up 18 pieces of fresh human pericardium and 11 pieces of glutaraidehyde-treated human pericardium. There is difference (p<0.05) of ultimate strain (epsilon(max)) between fresh pericardium epsilon(max)=0.119 +/- 0.037 and glutaraldehyde treated human pericardium epsilon(max)=0.098 +/- 0.015, respectively.
   There is difference (p<0.05) of ultimate stress (sigma(max)) between non-treated pericardiurn sigma(max)=3.114 +/- 0.70 MP9 and glutaraldehyde treated human pericardium sigma(max)=6.20 +/- 11.47 MPa. There is difference (p<0.05) of tangential modulus of elasticity (E) between non-treated and glutaraldehyde treated human pericardium: 98.67 +/- 20.75 MPa and 50.25 +/- 16.04 MPa, respectively. Gravimetric data demonstrated that glutaraldehyde treatment resulted in statistically significant improvement in resistance of human pericardium to proteolytic degradation.
   Material became stiffer and stronger after treatment with glutaraldehyde solution as well as more resistant to proteolytic degradation then non-treated one.
   These biomechanical differences could be explained by formation of collagen crosslink after glutaraldehyde treatment. We conclude that treating with glutaraldehyde improve the application of autologous human pericardium as the plastic material for surgical repair of congenital heart anomalies by improving its biomechanical properties and increasing resistance to proteolytic degradation.
C1 [Ozolins, V.; Ozolanta, I.; Smits, L.; Lacis, A.; Kasyanov, V.] Riga Stradins Univ, Riga, Latvia.
RP Ozolins, V (reprint author), Riga Stradins Univ, Dzirciema 16, Riga, Latvia.
EM dr_ozolins@inbox.lv
CR Boughner DR, 2000, J HEART VALVE DIS, V9, P752
   Butera G, 2001, Ital Heart J, V2, P317
   Chanda J, 1997, J THORAC CARDIOV SUR, V114, P512, DOI 10.1016/S0022-5223(97)70211-3
   Cheung DT, 1999, J THORAC CARDIOV SUR, V118, P998, DOI 10.1016/S0022-5223(99)70093-0
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Duncan AC, 1997, J THORAC CARDIOV SUR, V113, P302, DOI 10.1016/S0022-5223(97)70327-1
   Gross J. M., 2003, J THORAC CARDIOVASC, V125, pS6
   HJELMS E, 1981, J THORAC CARDIOV SUR, V81, P120
   HUMPHREY JD, 1990, AM J PHYSIOL, V259, pH101
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   KAWASHIMA Y, 1974, J THORAC CARDIOV SUR, V68, P209
   Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019
   Ng CK, 2001, ANN THORAC SURG, V71, P78, DOI 10.1016/S0003-4975(00)02327-4
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Paez JMG, 1999, J BIOMATER APPL, V13, P351, DOI 10.1177/088532829901300404
   RUBINO M, 2007, INTERACT CARDIOVASC
   Sharma CP, 2001, J BIOMATER APPL, V15, P359, DOI 10.1106/YY8L-M4DD-AGW1-QAGU
   Srivatsa SS, 1997, J CLIN INVEST, V99, P996, DOI 10.1172/JCI119265
   Stacchino C, 1998, J HEART VALVE DIS, V7, P190
   Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043
   Vincentelli A, 1998, J HEART VALVE DIS, V7, P24
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-69366-6
J9 IFMBE PROC
PY 2008
VL 20
BP 143
EP 145
PG 3
WC Engineering, Biomedical; Robotics; Neurosciences; Surgery
SC Engineering; Robotics; Neurosciences & Neurology; Surgery
GA BIM08
UT WOS:000260668000039
DA 2018-10-19
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Magenes, Giovanni
GP IEEE
TI Electromagnetically enhanced coating of a sintered titanium grid with
   human SAOS-2 osteoblasts and extracellular matrix
SO 2008 30TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY, VOLS 1-8
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 30th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 20-24, 2008
CL Vancouver, CANADA
SP DEVICIX, Green Coll, Natl Inst Hlth, NIBIB, NSF, PLEXON Inc, UBC Engn Biomed Engn, Univ Washington, Coll Engn, Bentham Sci Publ Ltd, Recent Patents Biomed Engn, Recent Patents Engn
ID FIBER MESH; BONE-FORMATION; IN-VITRO; CELLS; OSTEOPONTIN; COLLAGEN;
   FIBRILLOGENESIS; ULTRASOUND; IMPLANTS; GROWTH
AB The surface modification of a sintered titanium scaffold could play an important role in bone tissue engineering. In this study we have followed a biomimetic strategy where electromagnetically stimulated human SAOS-2 osteoblasts proliferated and built their extracellular matrix on a sintered titanium grid. In comparison with control conditions (standard cell culture incubator, where no electromagnetic stimulus was detectable), the electromagnetic stimulus (magnetic field, 2 mT; frequency, 75 Hz) increased the cell proliferation and the surface coating with decorin, osteopontin, and type-I collagen. The electromagnetic stimulus aimed at obtaining a better surface coating of the sintered titanium grid in terms of cell colonization and bone matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, CIT, Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   giovanni.magenes@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Magenes,
   Giovanni/0000-0002-7558-1490
FU Fondazione Cariplo; Italian Ministry MUR; FIRB [RBIP06FH7J]
FX This work was supported by Fondazione Cariplo Grant (2004) to F. B., by
   PRIN Grant (2004) from Italian Ministry MUR to L. V., and by FIRB Grant
   (CINECA no. RBIP06FH7J)from Italian Ministry MUR.
CR BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   GERICKE A, 2005, CALCIF TISSUE IN JUL
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Luan YJ, 2000, COMP BIOCHEM PHYS A, V126, P213, DOI 10.1016/S1095-6433(00)00200-2
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
NR 22
TC 10
Z9 10
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-1814-5
J9 IEEE ENG MED BIO
PY 2008
BP 3582
EP +
DI 10.1109/IEMBS.2008.4649980
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BIS22
UT WOS:000262404502089
PM 19163483
DA 2018-10-19
ER

PT B
AU Oh, SJ
   Maeng, I
   Kim, HM
   Chong, J
   Lee, DK
   Yoo, O
   Lee, DH
   Huh, YM
   Suh, JS
   Son, JH
AF Oh, Seung Jae
   Maeng, Inhee
   Kim, Hyeoung Mun
   Chong, Joonggun
   Lee, Dong Kyu
   Yoo, Ocki
   Lee, Dong-Hee
   Huh, Yong-Min
   Suh, Jin-suck
   Son, Joo-Hiuk
GP IEEE
TI Terahertz Dynamics of Electrolytes in Aqueous Biological Media
SO 2008 33RD INTERNATIONAL CONFERENCE ON INFRARED, MILLIMETER AND TERAHERTZ
   WAVES, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 33rd International Conference on Infrared, Millimeter and Terahertz
   Waves
CY SEP 15-19, 2008
CL Pasadena, CA
SP IEEE
AB We measured the dynamics of aqueous biomaterial mixtures using terahertz time-domain spectroscopy. The mixtures were divided into water and other electrolyte parts in mass fractions for analysis. The optical constants of the electrolytes, excluding water, were obtained by applying the ideal mixture equation and fined with the modified double Debye model. We found that the reorientation and hydrogen-bond formation-decomposition times decreased as the electrolyte concentration increased.
C1 [Oh, Seung Jae] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
   [Maeng, Inhee; Kim, Hyeoung Mun; Chong, Joonggun; Lee, Dong Kyu; Son, Joo-Hiuk] Univ Seoul, Dept Phys, Seoul 130743, South Korea.
   [Yoo, Ocki; Lee, Dong-Hee] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea.
   [Huh, Yong-Min; Suh, Jin-suck] Yonsei Univ, Coll Med, Dept Radiol, Seoul 120752, South Korea.
RP Oh, SJ (reprint author), Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
EM joohiuk@uos.ac.kr
CR Kang C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085410
   OH SJ, 2007, J APPL PHYS, V102, P5
NR 2
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-2119-0
PY 2008
BP 773
EP +
PG 2
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA BIV57
UT WOS:000263160700404
DA 2018-10-19
ER

PT B
AU Ran, P
   Wang, BQ
AF Ran, Ping
   Wang, Baoqiang
GP IEEE
TI Design Method of An Automatic Machine Set for TCM Manufacture
SO 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23
LA English
DT Proceedings Paper
CT 7th World Congress on Intelligent Control and Automation
CY JUN 25-27, 2008
CL Chongqing, PEOPLES R CHINA
SP Chongqing Univ, Chongqing Inst Technol, Chongqing Univ Sci & Technol, Xihua Univ, SW Univ Sci & Technol, IEEE Robot & Automat Soc, IEEE Control Syst Soc, Beijing Chapter, Chinese Assoc Automat, Chinese Assoc Artificial Intelligence, Natl Nat Sci Fdn, Chongqing Municipal Sci & Technol Comm, Chongqing Municipal Assoc Sci & Technol, KC Wong Educ Fdn
DE Automatic Production Line; Acoustic Extraction; Porous Risen-assisted
   Purification; Chinese Tradition Medicine Manufacture
AB As a biomaterial processing technology, the macro-porous resin purification has been used in biomaterial extraction for a few years. Acoustic cavitation could bring up huge energy in micro-space and be used to extract medicine materials from Traditional Chinese Medicine (TCM). In the paper, how to improve and combine ultrasonic technique with macro-porous resin purification for medicine extraction are discussed. Firstly, the characteristics of ultrasound propagation in the mixture of biomaterials and liquor are researched for TCM extraction. Secondly, for overcoming some shortages of existing resin purification cylinder used for biomaterial extraction, a new design method assisted with ultrasound is introduced. Then, a new manufacture set of ultrasonic cylinder and adsorbing cylinder with porous resin has been integrated and applied in Chinese traditional medicine production. It was examined via practice that there are many advantages with the design: (1) In all over the cylinder, the ultrasound intensity is strong and symmetrical; (2) The cavitation yield is stronger relative to what in existing ultrasonic processors and automatic circum-rotation is realized in the ultrasonic cylinder; (3) The adsorbing efficiency is greatly improved with the new adsorbing cylinders of porous resin for medicine material adsorption and purification from complex prescription of TCM.
C1 [Ran, Ping; Wang, Baoqiang] Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610041, Sichuan Prov, Peoples R China.
RP Ran, P (reprint author), Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610041, Sichuan Prov, Peoples R China.
EM pingping_311@yahoo.com.cn
CR BAO QW, 2004, IEEE P ICIMA, P763
   Doche ML, 2003, ULTRASON SONOCHEM, V10, P357, DOI 10.1016/S1350-4177(03)00099-3
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   Liu CZ, 2003, PROCESS BIOCHEM, V39, P45, DOI 10.1016/S0032-9592(02)00294-7
   LIU ZL, 2001, CHINESE J PHARM, P13
   SEONGNAM, 2007, ULTRASONICS SONO CHE, V10, P2003
   Suslick KS., 1998, ULTRASOUND ITS CHEM
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   WANG BQ, 2007, IEEE P ICEMI 07, P225
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   YOKIO R, 2002, IEEE T ULTRASONICS, V49, P1260
NR 11
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-2113-8
PY 2008
BP 1579
EP 1583
DI 10.1109/WCICA.2008.4593153
PG 5
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Computer Science, Cybernetics; Engineering, Electrical & Electronic;
   Robotics
SC Automation & Control Systems; Computer Science; Engineering; Robotics
GA BIJ02
UT WOS:000259965701071
DA 2018-10-19
ER

PT B
AU Ioanid, A
   Ciuceanu, RM
AF Ioanid, Ana
   Ciuceanu, Radu Mircea
BE Iantovics, BL
   Enachescu, C
   Filip, FG
TI Simulation of the Growth Process of a Silicium Nanotubes Structure as
   Biomaterial in the Porozity of Zeolite AFI
SO 2008 COMPLEXITY & INTELLIGENCE OF THE ARTIFICIAL & NATURAL COMPLEX
   SYSTEMS, MEDICAL APPLICATIONS OF THE COMPLEX SYSTEMS, BIOMEDICAL
   COMPUTING
LA English
DT Proceedings Paper
CT International Conference on Complexity and Intelligence of the
   Artificial and Natural Complex Systems - Medical Applications of the
   Complex Systems Biomedical Computing
CY NOV 08-10, 2008
CL Petu Maior Univ Targu, Targu Mures, ROMANIA
SP Romanian Acad, Bucharest & Petru Maior Univ Targu Mures
HO Petu Maior Univ Targu
DE biomaterials; zeolite; interconnected pores; adsorption; nanotube
   structure
ID ADSORPTION
AB Hydroxyapatite (HA,Ca-10(PO4)(6)(OH)(2)), that the principal mineral component of the bone tissue, has remarkable precursor of growth properties in the porous structure sort with strongly interconnected pores. The interconnection of the pores is an essential condition assuring high quality of bone implants. We suggest the experimentation of a silicon nanotubes structure (SiNT) as support to enhance the growth of a high quality HA. We propose a model obtaining a silicon nanotubes structure, by silicon atoms adsorption, from vapour phase, in the pores of AlPO4 (AFI) zeolite. A collection of 3D interconnected nanotubes of the deposited silicium can be obtained after matrix removal.
C1 [Ioanid, Ana] Univ Bucharest, Bucharest, Romania.
   [Ciuceanu, Radu Mircea] Univ Politehn Bucuresti, Bucharest, Romania.
RP Ioanid, A (reprint author), Univ Bucharest, Bucharest, Romania.
EM ana_ioanid@yahoo.com; raduciuceanu@yahoo.com
CR ABRAHAMSON AA, 1969, PHYS REV, V178, P76, DOI 10.1103/PhysRev.178.76
   Aoyama N, 2007, FLUID PHASE EQUILIBR, V257, P212, DOI 10.1016/j.fluid.2007.01.039
   Derevianko A, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052704
   Fekkar-Nemmiche N, 2007, EUR PHYS J-SPEC TOP, V141, P45, DOI [10.1140/epjst/e2007-00014-2, 10.1141/epjst/e2007-00008-0]
   HOSONO H, 1992, J NON-CRYST SOLIDS, V139, P90, DOI 10.1016/S0022-3093(05)80810-5
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Llewellyn PL, 2005, ADSORPTION, V11, P73, DOI 10.1007/s10450-005-5901-z
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Wang N, 2000, NATURE, V408, P50, DOI 10.1038/35040702
NR 10
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-3937-9
PY 2008
BP 225
EP +
DI 10.1109/CANS.2008.34
PG 3
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BOP74
UT WOS:000277249300028
DA 2018-10-19
ER

PT S
AU Kuhn, S
   Measor, P
   Lunt, EJ
   Hawkins, AR
   Schmidt, H
AF Kuehn, Sergei
   Measor, Philip
   Lunt, Evan J.
   Hawkins, Aaron R.
   Schmidt, Holger
GP IEEE
TI Particle Manipulation with Integrated Optofluidic Traps
SO 2008 DIGEST OF THE LEOS SUMMER TOPICAL MEETINGS
SE Digest of the LEOS Summer Topical Meetings
LA English
DT Proceedings Paper
CT IEEE/LEOS Summer Topical Meetings
CY JUL 21-23, 2008
CL Acapulco, MEXICO
SP IEEE
AB On an integrated optofluidic waveguide platform we implement two complementary types of traps, in a transverse and a novel axial geometry. The traps are characterized and used to manipulate and study biomaterial.
C1 [Kuehn, Sergei; Measor, Philip; Schmidt, Holger] Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
   [Lunt, Evan J.; Hawkins, Aaron R.] Brigham Young Univ, Dept Elect & Comp Engn, Provo, UT 84602 USA.
RP Kuhn, S (reprint author), Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
EM skuehn@soe.ucsc.edu
OI Hawkins, Aaron/0000-0002-3882-0771
CR ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156
   Cran-McGreehin S, 2006, LAB CHIP, V6, P1122, DOI 10.1039/b605237a
   Measor P, 2008, OPT LETT, V33, P672, DOI 10.1364/OL.33.000672
   Schmidt H, 2008, MICROFLUID NANOFLUID, V4, P3, DOI 10.1007/s10404-007-0199-7
NR 4
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1099-4742
BN 978-1-4244-1925-8
J9 DIGEST LEOS SUM TOP
PY 2008
BP 187
EP +
DI 10.1109/LEOSST.2008.4590552
PG 2
WC Nanoscience & Nanotechnology; Optics; Telecommunications
SC Science & Technology - Other Topics; Optics; Telecommunications
GA BIJ48
UT WOS:000260073000094
DA 2018-10-19
ER

PT B
AU Wang, BQ
   Li, XB
   Ran, P
AF Wang, Baoqiang
   Li, Xiaobo
   Ran, Ping
GP IEEE
TI Innovative Manufacture Techniques of Chinese Medicine with Ultrasound
   and Porous Resin
SO 2008 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY, VOLS 1-5
LA English
DT Proceedings Paper
CT IEEE International Conference on Industrial Technology
CY APR 21-24, 2008
CL Chengdu, PEOPLES R CHINA
SP IEEE
DE Chinese tradition Medicine Manufacture; Ultrasonic Extraction; Porous
   Risen-assisted Purification; Automatic Production
AB Ultrasound could be used to extract medicine materials from traditional Chinese herbs. And the macro-porous resin purification is an obvious biomaterial technology. The characteristics of ultrasound propagation in the mixture of biomaterials and liquor are researched for Chinese medicine extraction. And how to combine ultrasonic technique with macro-porous resin purification is discussed in the paper. To overcome some shortages of existing ultrasonic processors used for biomaterial extraction, a new structure and design method so-called self-circumrotation are introduced. A new machine system of multi-frequency and self-circumrotated ultrasonic cylinder, combined with the adsorbing cylinder of porous resin, has been integrated and applied in Chinese traditional medicine manufacture. It was examined via practice that there are three advantages with the design: (A) The ultrasound intensity is strong and symmetrical in all over the cylinder; and the cavitation yield is 1.3-2.8 times relative to what of ordinary processors; (B) The medium circumrotation is automatically realized in the cylinder; (C) The static and active adsorbing cylinders of porous resin are more effective for medicine material adsorption and purification from complex prescription of traditional Chinese medicine.
C1 [Wang, Baoqiang; Li, Xiaobo; Ran, Ping] Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610041, Sichuan Prov, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610041, Sichuan Prov, Peoples R China.
CR Doche ML, 2003, ULTRASON SONOCHEM, V10, P357, DOI 10.1016/S1350-4177(03)00099-3
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   Liu CZ, 2003, PROCESS BIOCHEM, V39, P45, DOI 10.1016/S0032-9592(02)00294-7
   LIU ZL, 2001, CHINESE J PHARM, P13
   SEONGNAM SK, 2003, ULTRASON SONOCHEM, V10, P139
   Suslick KS., 1998, ULTRASOUND ITS CHEM
   WANG BQ, 2007, IEEE P ICEMI, P763
   WANG BQ, 2004, IEEE P ICIMA, P763
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   YOKIO R, 2002, IEEE T ULTRASONICS, V49, P1260
NR 11
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-1705-6
PY 2008
BP 1202
EP 1206
PG 5
WC Automation & Control Systems; Computer Science, Hardware & Architecture;
   Engineering, Industrial
SC Automation & Control Systems; Computer Science; Engineering
GA BIR17
UT WOS:000262125900227
DA 2018-10-19
ER

PT S
AU Richards, MS
   Rubin, JM
   Jeong, CG
   Hollister, SJ
   Kim, K
AF Richards, Michael S.
   Rubin, Jonathan M.
   Jeong, Claire G.
   Hollister, Scott J.
   Kim, Kang
GP IEEE
TI Three Dimensional Elastic Modulus Reconstruction for Non-invasive,
   Quantitative Monitoring of Tissue Scaffold Mechanical Property Changes
SO 2008 IEEE ULTRASONICS SYMPOSIUM, VOLS 1-4 AND APPENDIX
SE Ultrasonics Symposium
LA English
DT Proceedings Paper
CT IEEE Ultrasonics Symposium
CY NOV 02-05, 2008
CL Beijing, PEOPLES R CHINA
SP IEEE
DE Tissue scaffold; Ultrasound elasticity; Strain; Elastic modulus
   reconstruction; Tissue engineering
AB The field of tissue engineering requires improved methods to monitor tissue growth and function as well as the degradation of biomaterial scaffolds following implantation. Invasive methods of monitoring, such as histology or direct mechanical measurements, are less than ideal. Non-invasive imaging techniques, such as magnetic resonance imaging (MRI), X-ray computed tomography (CT) or conventional ultrasound (US) might only provide morphological information. However, US Elasticity Imaging (UEI) can provide mechanical property information, in the form of elastic modulus images, as well as morphological information. 3D UEI will provide the spatial distribution in 3D of the mechanical property information. This information can be used to characterize and monitor the internal structure and composition of the tissue and scaffold. In order to determine the feasibility of using quantitative 3D UEI to monitor tissue scaffolds, experiments were designed to image Poly (1, 8 Octanediol-co-Citrate) (POC) scaffolds before and following chemically induced weight degradation. In the absence of tissue in growth, the amount degradation is directly related to the scaffold's elastic modulus. For each degradation state, the scaffolds were imbedded in gelatin and imaged with a 3D US scanning system while undergoing a quasi-static compression. A novel US image registration algorithm was used to estimate the displacement field and an elastic modulus reconstruction algorithm was then applied to the estimated displacements. The reconstructed elastic modulus images compared well with direct mechanical measurements and the amount of degradation.
C1 [Richards, Michael S.; Rubin, Jonathan M.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.
   [Jeong, Claire G.; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Kim, Kang] Univ Pittsburgh, Cardiovasc Inst, Dept Bioengn, Pittsburgh, PA 15260 USA.
RP Richards, MS (reprint author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.
EM msrichar@umich.edu
FU BRS US group at the University of Michigan; Boston University;
   Rensselaer Polytechnic Institute
FX The authors would like to acknowledge the support of the BRS US group at
   the University of Michigan. They would also like to thank the support of
   Larry Mo at Zonare for his system support. In addition, the authors
   acknowledge the continued collaboration with Paul Barbone at Boston
   University and Assad Oberai at Rensselaer Polytechnic Institute.
CR Cohn NA, 2000, IEEE T ULTRASON FERR, V47, P956, DOI 10.1109/58.852079
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   KIM K, 2007, NONINVASIVE MONITORI
   KIM K, 2007, IEEE INT ULTR S OCT
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Lubinski MA, 1999, IEEE T ULTRASON FERR, V46, P82, DOI 10.1109/58.741427
   Oberai AA, 2003, INVERSE PROBL, V19, P297, DOI 10.1088/0266-5611/19/2/304
   RICHARDS MS, 2007, THESIS BOSTON U
   Spalazzi JP, 2006, J ORTHOP RES, V24, P2001, DOI 10.1002/jor.20260
NR 9
TC 2
Z9 2
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 978-1-4244-2428-3
J9 ULTRASON
PY 2008
BP 536
EP +
DI 10.1109/ULTSYM.2008.0130
PG 2
WC Acoustics; Engineering, Electrical & Electronic; Physics, Applied;
   Imaging Science & Photographic Technology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Engineering; Physics; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BKP07
UT WOS:000268845800130
DA 2018-10-19
ER

PT B
AU Yu, CC
   Wang, HS
   He, CL
   Mo, XM
AF Yu Chuan-chuan
   Wang Hong-sheng
   He Chuang-long
   Mo Xiu-mei
TI Influence of Initial Seeding Density on Morphological Characteristics of
   Porcine Iliac Artery Endothelial Cells
SO 2008 INTERNATIONAL SYMPOSIUM ON FIBER BASED SCAFFOLDS FOR TISSUE
   ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Symposium on Fiber Based Scaffolds for Tissue Engineering
CY DEC 08-09, 2008
CL Donghua Univ, Ahanghai, PEOPLES R CHINA
SP Coll Textiles, Minist Educ Key Lab Textile Sci & Technol, Minist Educ Engn Res Ctr Tech Textiles, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fibres & Polymer Mat
HO Donghua Univ
DE Endothelial cells; Seeding density; Morphological characteristics;
   Confluence; Tissue engineering
ID BOVINE CORPUS-LUTEUM; DIFFERENT PHENOTYPES
AB A crucial factor in the tissue engineering of vascular is an effective cell seeding with uniform cell distribution on tubular scaffolds to eventually form functional tissue constructs in vitro. In the present study, we investigate the influence of initial seeding density on the morphological characteristics of porcine iliac artery endothelial cells (PIECs). The morrphological characteristics of cells was observed in the 6th, 10th, 12th generations, with three initial seeding densities :2500/well, 5000/well and 10000/well. The result reveals that different generations have different morrphological characteristics: tubule-like structures is not observed in the 6(th) generation while observed in 10(th) and 12(th) generations; PIECs formed tubule-like structures in the 12(th) generation at the first place then moved to the centre of the ring before confluence. Our data suggests that cells with a higher density tend to form a a uniform single layer, while a lower density to form a ununiform layer This work may offer a new way to select proper factors in the study of cellular compatibility on biomaterial for tissue-engineered vascular.
C1 [Yu Chuan-chuan; Wang Hong-sheng; He Chuang-long; Mo Xiu-mei] Donghua Univ, Coll Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
RP Mo, XM (reprint author), Donghua Univ, Coll Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
EM xmm@dhu.edu.cn
RI mo, xiumei/C-9340-2013; He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
CR Birchall IE, 2001, J BIOMED MATER RES, V56, P437, DOI 10.1002/1097-4636(20010905)56:3<437::AID-JBM1113>3.0.CO;2-8
   KAJI T, 2001, CONNECT TISSUE, V33, P1
   SPANELBOROWSKI K, 1990, CELL TISSUE RES, V261, P35, DOI 10.1007/BF00329436
   SPANELBOROWSKI K, 1991, CELL TISSUE RES, V266, P37, DOI 10.1007/BF00678709
   WANG PW, 2008, ZHONGGUO ZUZHI GONGC, V12, P5
NR 5
TC 0
Z9 0
U1 0
U2 0
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-561-1
PY 2008
BP 290
EP 292
PG 3
WC Biotechnology & Applied Microbiology; Cell Biology; Chemistry, Applied;
   Nanoscience & Nanotechnology; Polymer Science
SC Biotechnology & Applied Microbiology; Cell Biology; Chemistry; Science &
   Technology - Other Topics; Polymer Science
GA BLF73
UT WOS:000270079600056
DA 2018-10-19
ER

PT J
AU Pannier, AK
   Wieland, JA
   Shea, LD
AF Pannier, Angela K.
   Wieland, Julie A.
   Shea, Lonnie D.
TI Surface polyethylene glycol enhances substrate-mediated gene delivery by
   nonspecifically immobilized complexes
SO ACTA BIOMATERIALIA
LA English
DT Article
DE gene delivery; reverse transfection; atomic force microscopy (AFM);
   self-assembled monolayers
ID SELF-ASSEMBLED MONOLAYERS; TRANSFECTED CELL MICROARRAYS; DNA DELIVERY;
   PROTEIN ADSORPTION; PLASMID DNA; IN-VITRO; POLY(ETHYLENE GLYCOL);
   BIOLOGICAL-PROPERTIES; PEGYLATION; ADHESION
AB Substrate-mediated gene delivery describes the immobilization of gene therapy vectors to a biomaterial, which enhances gene transfer by exposing adhered cells to elevated DNA concentrations within the local microenvironment. Surface chemistry has been shown to affect transfection by nonspecifically immobilized complexes using self-assembled monolayers (SAMs) of alkanethiols on gold. In this report, SAMs were again used to provide a controlled surface to investigate whether the presence of oligo(ethylene glycol) (EG) groups in a SAM could affect complex morphology and enhance transfection. EG groups were included at percentages that did not affect cell adhesion. Nonspecific complex immobilization to SAMs containing combinations of EG- and carboxylic acid-terminated alkanethiols resulted in substantially greater transfection than surfaces containing no EG groups or SAMs composed of EG groups combined with other functional groups. Enhancement in transfection levels could not be attributed to complex binding densities or release profiles. Atomic force microscopy imaging of immobilized complexes revealed that EG groups within SAMs affected complex size and appearance and could indicate the ability of these surfaces to preserve complex morphology upon binding. The ability to control the morphology of the immobilized complexes and influence transfection levels through surface chemistry could be translated to scaffolds for gene delivery in tissue engineering and diagnostic applications. (C) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Pannier, Angela K.] Northwestern Univ, Dept Interdept Biol Sci, Evanston, IL 60208 USA.
   [Wieland, Julie A.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM 1-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIGMS NIH HHS [R01 GM066830, R01 GM066830-01A1, R01 GM066830-05]
CR Ademovic Z, 2006, J MATER SCI-MATER M, V17, P203, DOI 10.1007/s10856-006-7306-2
   Banerjee P, 2006, BIOCONJUGATE CHEM, V17, P125, DOI 10.1021/bc050083e
   Bengali Z, 2005, MRS BULL, V30, P659, DOI 10.1557/mrs2005.193
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Cooper E, 1997, J MATER CHEM, V7, P435, DOI 10.1039/a607204f
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   Delehanty JB, 2004, BIOSENS BIOELECTRON, V20, P773, DOI 10.1016/j.bios.2004.04.016
   Dunlap DD, 1997, NUCLEIC ACIDS RES, V25, P3095, DOI 10.1093/nar/25.15.3095
   Erbacher P, 1999, J GENE MED, V1, P210
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Guo Y, 2004, MOL PHARMACEUT, V1, P477, DOI 10.1021/mp0499205
   Hansma HG, 1998, NUCLEIC ACIDS RES, V26, P2481, DOI 10.1093/nar/26.10.2481
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637
   Korobko AV, 2006, J PHYS CHEM B, V110, P14550, DOI 10.1021/jp057363b
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Ledley FD, 1996, PHARMACEUT RES, V13, P1595, DOI 10.1023/A:1016420102549
   Lee M, 2005, PHARM RES, V22, P1, DOI 10.1007/s11095-004-9003-5
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lin AJ, 2000, J DRUG TARGET, V8, P13, DOI 10.3109/10611860009009206
   Mannisto M, 2002, J CONTROL RELEASE, V83, P169, DOI 10.1016/S0168-3659(02)00178-5
   Manuel WS, 2001, J DRUG TARGET, V9, P15, DOI 10.3109/10611860108995629
   Mao SR, 2006, BIOCONJUGATE CHEM, V17, P1209, DOI 10.1021/bc060129j
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Merdan T, 2005, BIOCONJUGATE CHEM, V16, P785, DOI 10.1021/bc049743q
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Neu M, 2006, BIOMACROMOLECULES, V7, P3428, DOI 10.1021/bm060788z
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ogris M, 2001, AAPS PHARMSCI, V3, part. no.
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477
   Petersen H, 2002, BIOCONJUGATE CHEM, V13, P845, DOI 10.1021/bc025529v
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Rackstraw BJ, 2001, LANGMUIR, V17, P3185, DOI 10.1021/la001456x
   Reinisalo M, 2006, J CONTROL RELEASE, V110, P437, DOI 10.1016/j.jconrel.2005.10.003
   Ross PC, 1999, BBA-BIOMEMBRANES, V1421, P273, DOI 10.1016/S0005-2736(99)00132-7
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sung SJ, 2003, BIOL PHARM BULL, V26, P492
   Toncheva V, 1998, BBA-GEN SUBJECTS, V1380, P354, DOI 10.1016/S0304-4165(98)00004-X
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   van der Veen M, 2004, COLLOID SURFACE B, V35, P33, DOI 10.1016/j.colsurfb.2004.02.005
   Volcke C, 2006, J BIOTECHNOL, V125, P11, DOI 10.1016/j.jbiotec.2006.02.010
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   Zhang F, 2001, J BIOMAT SCI-POLYM E, V12, P515, DOI 10.1163/156856201300194252
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
NR 63
TC 37
Z9 37
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2008
VL 4
IS 1
BP 26
EP 39
DI 10.1016/j.actbio.2007.08.008
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243DB
UT WOS:000251774000004
PM 17920004
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Vetterl, V
   Hason, S
   Tuononen, H
   Silvennoinen, M
   Myller, K
   Vanek, J
   Silvennoinen, R
AF Vetterl, Vladimir
   Hason, Stanislav
   Tuononen, Heikki
   Silvennoinen, Martti
   Myller, Kari
   Vanek, Jiri
   Silvennoinen, Raimo
BE Myllyla, R
   Priezzhev, AV
   Kinnunen, M
   Pustovoy, VI
   Kirillin, MY
   Popov, AP
TI Diffractive optical element spectroscopy of biomaterial surface
SO ADVANCED LASER TECHNOLOGIES 2007
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Advanced Laser Technologies
CY SEP 03-07, 2007
CL Levi, FINLAND
SP Univ Oulu, VTT Tech Res Ctr Finland, General Phys Inst, Ctr Laser Technol & Mat Sci GPI, Moscow State Univ, Int Laser Ctr, Acad Finland, Russian Fdn Basic Res, SPIE Russian Chapter, Infotech Oulu, Univ Joensuu, LEOS, Italian Chapter, Finnish Opt Soc, Hindawi Publishing Corp, Network Excellence MicroOpt
DE diffractive optical element; complex refractive index; optical
   roughness; specular gloss; titanium; biomaterial; ellipsometry
ID PHASE TRANSIENTS; TITANIUM-OXIDE; ADSORPTION; FIBRINOGEN; ADENOSINE;
   CERAMICS; ADHESION; BLOOD
AB Optical properties of different type of surface treatments of titanium biomaterial as polishing, grinding, and chemical etching are investigated in details. The main aim of this study is in sensing the organisation of nano-scale fibrinogen and oligonugleotides adhered on biomaterial surface. Thus permittivity change and the fluctuation in optical roughness of treated titanium surface, when titanium surface is subjected to the contamination of buffer fractions as well as to the contamination of human plasma fibrinogen fraction, are investigated through optical window of a cuvette by using diffiractive optical element based sensor, During the progress of this work also optical ellipsometry as a corroborative method was used to verify the attachment of the molecules on the biomaterial surface.
C1 [Vetterl, Vladimir; Hason, Stanislav] Acad Sci Czech Republic, Inst Biophys, Vvi Kralovopolska 135, CZ-61265 Brno, Czech Republic.
   [Vetterl, Vladimir; Vanek, Jiri] Masaryk Univ, Stomatol Res Ctr, Fac Med, CZ-66243 Brno, Czech Republic.
   [Tuononen, Heikki; Silvennoinen, Martti; Silvennoinen, Raimo] Univ Joensuu, Dept Phys & Math, FI-80101 Joensuu, Finland.
   [Myller, Kari] MGM Devices Ltd, FI-80101 Joensuu, Finland.
RP Vetterl, V (reprint author), Acad Sci Czech Republic, Inst Biophys, Vvi Kralovopolska 135, CZ-61265 Brno, Czech Republic.
EM raimo.silvennoinen@joensuu.fi
RI Hason, Stanislav/H-1930-2014
OI Hason, Stanislav/0000-0003-4959-8552
FU Ministry of Education and Sport of the Czech Republic [1M0528]; Academy
   of Sciences of the Czech Republic [KAN200040651]; Ministry of Education
   of the Czech Republic [LC06035]; institutional research plan [AVOZ
   50040507]
FX This work was supported by the Ministry of Education and Sport of the
   Czech Republic (1M0528 to J.V.), the Academy of Sciences of the Czech
   Republic (KAN200040651 to S.H.), the Ministry of Education of the Czech
   Republic (LC06035), and by an institutional research plan (AVOZ
   50040507).
CR Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   Boozer C, 2006, LANGMUIR, V22, P4694, DOI 10.1021/la052908e
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Hason S, 2004, J ELECTROANAL CHEM, V568, P65, DOI 10.1016/j.jelechem.2003.12.043
   Hason S, 2003, ELECTROCHIM ACTA, V48, P651, DOI 10.1016/S0013-4686(02)00735-1
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Jansson E, 2004, COLLOID SURFACE B, V35, P45, DOI 10.1016/j.colsurfb.2004.02.007
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Nee SM, 2002, OPT ENG, V41, P994, DOI 10.1117/1.1467359
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Palecek E, 2005, PERSP BIOANAL, V1, P1
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   Silva Ricardo M A, 2007, 7th International Conference on Hybrid Intelligent Systems, HIS 2007, P101
   SILVENNOINEN R, 2007, P 3 RUSS FINN M PALS, P35
   SILVENNOINEN R, 1999, INT TRENDS OPTICS 6, V4, P281
   SILVENNOINEN R, SPECULAR GL IN PRESS
   VETTERL V, 2007, EUR BIOPHYS J S1, V36, pS168
   VETTERL V, 2007, EUR BIOPHYS J S1, V36, pS204
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WILLNER I, 2002, ELECTROANALYTICAL ME, P43
NR 22
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7235-9
J9 PROC SPIE
PY 2008
VL 7022
AR 702203
DI 10.1117/12.803903
PG 11
WC Optics; Imaging Science & Photographic Technology
SC Optics; Imaging Science & Photographic Technology
GA BIF90
UT WOS:000259260300002
DA 2018-10-19
ER

PT S
AU Costa, HS
   Mansur, AAP
   Barbosa-Stancioli, EF
   Pereira, MM
   Mansur, HS
AF Costa, Hermes S.
   Mansur, Alexandra A. P.
   Barbosa-Stancioli, Edel Figueiredo
   Pereira, Marivalda M.
   Mansur, Herman S.
BE Marques, AT
   Silva, AF
   Baptista, APM
   Sa, C
   Alves, FJLA
   Malheiros, LF
   Vieira, M
TI Hybrid Bioactive Glass-Polyvinyl Alcohol Prepared by Sol-Gel
SO ADVANCED MATERIALS FORUM IV
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 13th Conference of the Sociedade-Portuguesa-de-Materiais/4th
   International Materials Symposium
CY APR 01-04, 2007
CL Oporto, PORTUGAL
DE biomaterial; bioceramic; polymer; tissue engineering; hydrids; bioactive
   glass; sot-gel
ID COMPOSITE SCAFFOLDS; BONE; HYDROGELS; POLYMERS
AB Bioactive glasses are materials that have been used for the repair and reconstruction of diseased bone tissues. as they exhibit direct bonding with human bone tissues. However, bioactive lasses have low mechanical properties compared to cortical and cancellous bone. On the other hand, composite materials of biodegradable polymers with inorganic bioactive glasses are of particular interest to engineered scaffolds because they often show an excellent balance between strength and toughness and usually improved characteristics compared to their individual components. Composite bioactive glass-polyvinyl alcohol foams for use as scaffolds in tissue engineering were previously developed using the sol-gel route. The goal of this work was the synthesis of composite foams modified with higher amounts of . Samples were characterized by morphological and chemical analysis. The mechanical behavior of the obtained materials was also investigated. The degree of hydrolysis of PVA. concentration of PVA solution and different PVA-bioactive glass composition ratios affect the synthesis procedure. Foams with up to 80 wt% polymer content were obtained. The hybrid scaffolds obtained exhibited macroporous structure with pore sire varying Prom 50 to 600 fan and improved mechanical properties.
C1 [Costa, Hermes S.; Mansur, Alexandra A. P.; Pereira, Marivalda M.; Mansur, Herman S.] Univ Fed Minas Gerais, Lab Biomat & Tissue Engn, Dept Met & Mat Engn, R Espirito Santo 35, BR-30160030 Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, BR-31270 Belo Horizonte, MG, Brazil.
RP Costa, HS (reprint author), Univ Fed Minas Gerais, Lab Biomat & Tissue Engn, Dept Met & Mat Engn, R Espirito Santo 35, BR-30160030 Belo Horizonte, MG, Brazil.
EM hermessc@bol.com.br; aapiscitelli@uol.com.br; edelfb@mono.icb.ufmg.br;
   mpereira@demet.ufmg.br; hmansur@demet.ufmg.br
OI Mansur, Alexandra/0000-0003-1526-2508; Pereira,
   Marivalda/0000-0001-8867-682X; Mansur, Herman/0000-0002-3032-495X
FU CNPq/FAPEMIG/CAPES
FX The authors acknowledge CNPq/FAPEMIG/CAPES for the financial support on
   this project. We are also grateful to Prof. Dr. Dagoberto B. Santos for
   the facilities of Electronic Microscopy Laboratory and Prof. Dr. Wander
   L Vasconcelos for the FTIR spectroscopy Laboratory.
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Costa Vilma Conceição, 2007, Mat. Res., V10, P21, DOI 10.1590/S1516-14392007000100006
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Herath H M T U, 2005, J Appl Biomater Biomech, V3, P192
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Jones JR, 2004, KEY ENG MAT, V254-2, P981, DOI 10.4028/www.scientific.net/KEM.254-256.981
   JONES RJ, 2005, BIOMATERIALS, V27, P964, DOI DOI 10.1016/J.BIOMATERIALS.2005.07.017
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Li HY, 2005, J BIOMATER APPL, V20, P137, DOI 10.1177/0885328205049472
   Lin WC, 2006, COLLOID SURFACE B, V47, P43, DOI 10.1016/j.colsurfb.2005.11.013
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Soppimath KS, 2000, J BIOMAT SCI-POLYM E, V11, P27, DOI 10.1163/156856200743472
   YAMAOKA T, 1995, J PHARM PHARMACOL, V47, P479, DOI 10.1111/j.2042-7158.1995.tb05835.x
NR 21
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2008
VL 587-588
BP 62
EP +
DI 10.4028/www.scientific.net/MSF.587-588.62
PG 2
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BII83
UT WOS:000259898200013
DA 2018-10-19
ER

PT S
AU Henriques, VAR
   Galvani, ET
   Cairo, CAA
   Taddei, EB
AF Henriques, V. A. R.
   Galvani, E. T.
   Cairo, C. A. A.
   Taddei, E. B.
BE Salgado, L
   filho, FA
TI Ti-13Nb-13Zr FOAMS FOR SURGICAL IMPLANTS
SO ADVANCED POWDER TECHNOLOGY VI
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Latin American Conference on Power Technology
CY NOV 07-10, 2007
CL Assoc Brasileira Ceram, Buzios, BRAZIL
SP Inst Pesquisas Energet Nucl, Metallum Eventos Tecn Cientif
HO Assoc Brasileira Ceram
DE powder metallurgy; titanium alloys; porosity; space holder; foams;
   implants
ID MICROSTRUCTURAL EVOLUTION; TITANIUM-ALLOYS
AB The use of titanium and its alloy as biomaterial is increasing due to their low modulus, superior biocompatibility and enhanced corrosion resistance when compared to more conventional stainless steel and cobalt-based alloys. Ti-13Nb-13Zr is a titanium alloy specifically developed for surgical implants. In this work, highly porous titanium foams, with porosities above from 50%, are reached using an efficient powder metallurgical process, which includes the introduction of a selected spacer into the starting powders. Samples were produced by mixing of initial metallic powders followed by uniaxial and cold isostatic pressing with subsequent densification by sintering. The samples presented a Widmanstatten-like microstructure in an open cellular morphology with pore size between 200-500 mu m.
C1 [Henriques, V. A. R.; Cairo, C. A. A.] CTA, IAE, Div Mat, AMR, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
   [Galvani, E. T.] USP Loreana, EEL, DEMAR, Loreana, SP, Brazil.
   [Taddei, E. B.] CTA, ITA, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
RP Henriques, VAR (reprint author), CTA, IAE, Div Mat, AMR, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
EM vinicius@iae.cta.br; eduardotgalvani@yahoo.com.br; ccairo@iae.cta.br;
   elisataddei@gmail.com
RI Henriques, Vinicius/G-2465-2012
FU FAPESP [Proc.04/07664-2]; EEL-USP Lorena
FX To FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (Proc.04/07664-2), for the technician-scientific and financial support
   and EEL-USP Lorena for the niobium supplying.
CR Davidson J.A., 1994, US Patent, Patent No. [5.545.227, 5545227]
   Froes F.H., 1985, POWDER METALLURGY IN, V17, P47
   German R. M., 1996, SINTERING THEORY PRA
   Henriques V.A.R., 2003, METALURGIA MAT, V59, P7
   Henriques VAR, 2005, MATER SCI FORUM, V498-499, P40, DOI 10.4028/www.scientific.net/MSF.498-499.40
   Henriques VAR, 2003, MAT SCI ENG A-STRUCT, V347, P315, DOI 10.1016/S0921-5093(02)00604-4
   HENRIQUES VAR, 2001, J MATER PROCESS TECH, V5267, P1
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
NR 10
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2008
VL 591-593
BP 24
EP +
DI 10.4028/www.scientific.net/MSF.591-593.24
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BIT18
UT WOS:000262481100005
DA 2018-10-19
ER

PT S
AU de Oliveira, MV
   Moreira, AC
   Pereira, LC
   de Medeiros, WS
   Appoloni, CR
AF de Oliveira, Marize V.
   Moreira, Anderson C.
   Pereira, Luiz C.
   de Medeiros, Waleria S.
   Appoloni, Carlos R.
BE Salgado, L
   filho, FA
TI Porosity Characterization of Sintered Titanium Scaffolds for Surgical
   Implants
SO ADVANCED POWDER TECHNOLOGY VI
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Latin American Conference on Power Technology
CY NOV 07-10, 2007
CL Assoc Brasileira Ceram, Buzios, BRAZIL
SP Inst Pesquisas Energet Nucl, Metallum Eventos Tecn Cientif
HO Assoc Brasileira Ceram
DE Titanium; scaffold; implant; gamma-ray transmission; X-ray
   microtomography
ID FOAMS
AB Porosity and pore size are critical features for biomaterial scaffolds as they play an essential role in bone formation and bone ingrowth in vivo. Therefore, techniques for scaffolds evaluation are of great importance for their design and processing. Porous titanium has been used for grafts and implant coatings as it allows the mechanical interlocking of the pores and bone. In this study, porous titanium samples were manufactured by powder metallurgy. The porosity quantification was assessed by optical quantitative metallographic analysis, and non-destructive gamma-ray transmission and X-ray microtomography techniques, in order to compare their efficacy for porosity evaluation. Pore morphology and surface topography were characterized via scanning electron microscopy. These techniques have demonstrated to be suitable for titanium scaffolds evaluation, and micro-CT was the one that allowed the three-dimensional porosity assessment.
C1 [de Oliveira, Marize V.] INT DPCM, Inst Nacl Tecnol, Av Venezuela 82-602, BR-20081312 Rio De Janeiro, Brazil.
   [Moreira, Anderson C.; Appoloni, Carlos R.] Univ Estadual Londrina, Ctr Ciencias Exatas, Dept Fis, BR-86051990 Londrina, PR, Brazil.
   [Pereira, Luiz C.] Univ Fed Rio de Janeiro, COPPE, Programa Engn Met Mat, BR-21941972 Rio De Janeiro, Brazil.
   [Pereira, Luiz C.] Cidade Univ, CEP, BR-21941972 Rio De Janeiro, Brazil.
   [de Medeiros, Waleria S.] Univ Fed Fluminense, Fac Med, Programa Pos Grad Pathol, CEP, BR-24033 Niteroi, RJ, Brazil.
RP de Oliveira, MV (reprint author), INT DPCM, Inst Nacl Tecnol, Av Venezuela 82-602, BR-20081312 Rio De Janeiro, Brazil.
EM marizeva@int.gov.br; anderson@lmpt.ufsc.br; lula@metalmat.ufrj.br;
   waleria_medeiros@ig.com.br; appoloni@uel.br
RI Camargo Moreira, Anderson/O-1943-2018
OI Camargo Moreira, Anderson/0000-0003-1229-3616
FU CENPES/PETROBRAS/RJ; (INT); (UFRJ); (CTA)
FX The authors wish to thank CENPES/PETROBRAS/RJ, Rone Felipe da Silva
   (INT), Elizabete Fatima Nunes, Laercio R. Guzela (UFRJ) and Jose Luiz de
   Oliveira (CTA) for valuable technical support.
CR Appoloni CR, 2004, APPL RADIAT ISOTOPES, V61, P1133, DOI 10.1016/j.apradiso.2003.12.013
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Gerward L, 2001, RADIAT PHYS CHEM, V60, P23, DOI 10.1016/S0969-806X(00)00324-8
   Jones FH, 2001, SURF SCI REP, V42, P79
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Li H., 2007, JAP MAT T, V45-4, P1124
   Olevsky EA, 2007, ACTA MATER, V55, P1351, DOI 10.1016/j.actamat.2006.09.039
   Oliveira MV, 2006, MATER SCI FORUM, V530-531, P22
   Oliveira M. V., 2006, P 17 C BRAS ENG CIEN
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   SHEN H, 2005, MECH MAT         JAN, P1
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
NR 12
TC 1
Z9 1
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2008
VL 591-593
BP 36
EP +
DI 10.4028/www.scientific.net/MSF.591-593.36
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BIT18
UT WOS:000262481100007
DA 2018-10-19
ER

PT S
AU de Medeiros, WS
   de Oliveira, MV
   Granjeiro, JM
AF de Medeiros, W. S.
   de Oliveira, M. V.
   Granjeiro, J. M.
BE Salgado, L
   filho, FA
TI Evaluation of Biomimetic Solution for Coating Powder Metallurgy Porous
   Titanium Samples
SO ADVANCED POWDER TECHNOLOGY VI
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Latin American Conference on Power Technology
CY NOV 07-10, 2007
CL Assoc Brasileira Ceram, Buzios, BRAZIL
SP Inst Pesquisas Energet Nucl, Metallum Eventos Tecn Cientif
HO Assoc Brasileira Ceram
DE Powder Metallurgy; Porous Titanium; Biomimetic Coating
ID HEAT-TREATMENT; IMPLANTS; OSTEOCONDUCTIVITY; FABRICATION; ABILITY;
   ALKALI
AB In order to improve implant-bone attachment, porous titanium has been used to achieve the ingrowth of bone tissue within the porous structure. Although this biomaterial has shown efficient bone adhesion for orthopedic and dental implants, the ideal surface must have chemical bonds at the implant-bone interface. In this work, samples of pure porous titanium were produced by powder metallurgy technique and submitted to biomimetic process in order to evaluate the material's bioactivity and to enhance its osteoconductivity. The samples were immersed in modified simulated body fluid (mSBF) which induces the nucleation and growth of a calcium phosphate bioactive film and a chemical bond with titanium. SEM, EDX and FTIR analyses showed that a calcium phosphate deposition occurred without the need of pre-treatments to increase the surface bioactivity. As a result, this research revealed the potential for obtaining a bonelike apatite film on this porous titanium by biomimetic method.
C1 [de Medeiros, W. S.; Granjeiro, J. M.] Ctr HUAP UFF, Rua Marques Parana 303-4, BR-24033900 Niteroi, RJ, Brazil.
   [de Oliveira, M. V.] INT, BR-20081312 Rio De Janeiro, Brazil.
RP de Medeiros, WS (reprint author), Ctr HUAP UFF, Rua Marques Parana 303-4, BR-24033900 Niteroi, RJ, Brazil.
EM waleria_medeiros@ig.com.br; marizeva@int.gov.br; jmgranjeiro@vm.uff.br
RI Granjeiro, Jose/D-8289-2012
OI Granjeiro, Jose/0000-0002-8027-8293
CR Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Biasotto M, 2003, J Appl Biomater Biomech, V1, P172
   GERMAN RM, 1994, METAL POWDER IND FED, P406
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Jones FH, 2001, SURF SCI REP, V42, P79
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee WH, 2007, J MATER PROCESS TECH, V189, P219, DOI 10.1016/j.jmatprotec.2007.01.025
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Medeiros WS, 2006, MATER SCI FORUM, V530-531, P569
   Nguyen HQ, 2004, BIOMATERIALS, V25, P865, DOI 10.1016/S0142-9612(03)00607-0
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Oliveira MV, 2006, MATER SCI FORUM, V530-531, P22
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
NR 16
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2008
VL 591-593
BP 703
EP +
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BIT18
UT WOS:000262481100120
DA 2018-10-19
ER

PT S
AU de Oliveira, MV
   Schaerer, MM
   Santos, SRA
   Caminha, IMV
   Rossi, AM
AF de Oliveira, Marize V.
   Schaerer, Magna M.
   Santos, Silvia R. A.
   Caminha, Ieda Maria V.
   Rossi, Alexandre M.
BE Salgado, L
   filho, FA
TI Microstructural and Mechanical Characterization of Sintered
   Hydroxyapatite Samples
SO ADVANCED POWDER TECHNOLOGY VI
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Latin American Conference on Power Technology
CY NOV 07-10, 2007
CL Assoc Brasileira Ceram, Buzios, BRAZIL
SP Inst Pesquisas Energet Nucl, Metallum Eventos Tecn Cientif
HO Assoc Brasileira Ceram
DE biomaterial; hydroxyapatite; ceramic; microstructure; compressive test
AB Despite of the wide use of hydroxyapatite (HA) for bone repair and regeneration, its brittleness has limited clinical application to less stressed body parts. Thus, evaluation of HA mechanical properties has been an important research matter. The aim of this study is to assess the compressive strength of a stoichiometric HA with 1.66 Ca/P molar ratio, synthesized by hydrothermal method. Cylindrical samples were processed by uniaxial compacting, followed by sintering. Compressive strength of cylindrical samples with 2.0 medium diameter/height ratio was measured according to ASTM C 1424. Load to failure divided by the cross-sectional area of the samples were reported and microstructural characterization was made by MEV-EDS. The compression strength results were compared to values reported in the literature.
C1 [de Oliveira, Marize V.; Schaerer, Magna M.; Caminha, Ieda Maria V.] INT, Av Venezuela 82-602, BR-20081312 Rio De Janeiro, Brazil.
   [Santos, Silvia R. A.; Rossi, Alexandre M.] CBPF, Rio De Janeiro, Brazil.
RP de Oliveira, MV (reprint author), INT, Av Venezuela 82-602, BR-20081312 Rio De Janeiro, Brazil.
EM marizeva@int.gov.br; magna@int.gov.br; silvia@cbpf.br;
   iedamari@int.gov.br; rossi@cbpf.br
CR Aoki H, 1994, MED APPL HYDROXYAPAT
   DEWITH G, 1981, J MATER SCI, V16, P1592
   HENCH LL, 1993, INTRO BIOCERAMICS WO
   Kothapalli CR, 2005, J MATER SCI-MATER M, V16, P441, DOI 10.1007/s10856-005-6984-5
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   Pontier C, 2001, EUR J PHARM BIOPHARM, V51, P249, DOI 10.1016/S0939-6411(01)00137-0
   RAO WR, 1974, J DENT RES, V53, P1351, DOI 10.1177/00220345740530061001
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
NR 8
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2008
VL 591-593
BP 717
EP +
DI 10.4028/www.scientific.net/MSF.591-593.717
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BIT18
UT WOS:000262481100123
DA 2018-10-19
ER

PT S
AU Verran, J
   Airey, P
   Packer, A
   Whitehead, KA
AF Verran, Joanna
   Airey, Paul
   Packer, Adele
   Whitehead, Kathryn A.
BE Laskin, AI
   Sariaslani, S
   Gadd, GM
TI Microbial retention on open food contact surfaces and implications for
   food contamination
SO ADVANCES IN APPLIED MICROBIOLOGY, VOL 64
SE Advances in Applied Microbiology
LA English
DT Review; Book Chapter
ID ATOMIC-FORCE MICROSCOPY; SITU HYBRIDIZATION FISH; STAINLESS-STEEL;
   LISTERIA-MONOCYTOGENES; BACTERIAL ADHESION; PHYSICOCHEMICAL PROPERTIES;
   PSEUDOMONAS-AERUGINOSA; SUBSTRATUM TOPOGRAPHY; BIOMATERIAL SURFACES;
   CANDIDA-ALBICANS
C1 [Verran, Joanna; Airey, Paul; Packer, Adele; Whitehead, Kathryn A.] Manchester Metropolitan Univ, Sch Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England.
RP Verran, J (reprint author), Manchester Metropolitan Univ, Sch Biol Chem & Hlth Sci, Chester St, Manchester M1 5GD, Lancs, England.
OI Whitehead, Kathryn A./0000-0001-6001-6686
CR Airey P, 2007, J HOSP INFECT, V67, P271, DOI 10.1016/j.jhin.2007.09.002
   AIREY P, 2006, FOULING CLEANING DIS, P92
   Allison DG, 2000, J BASIC MICROB, V40, P3, DOI 10.1002/(SICI)1521-4028(200002)40:1<3::AID-JOBM3>3.3.CO;2-C
   Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839
   Arnold JW, 2004, J MICROSC-OXFORD, V216, P215, DOI 10.1111/j.0022-2720.2004.01415.x
   BACK JP, 1991, J APPL BACTERIOL, V71, P51
   Barnes BI, 1996, LETT APPL MICROBIOL, V23, P325, DOI 10.1111/j.1472-765X.1996.tb00200.x
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000
   BoulangePetermann L, 1997, BIOFOULING, V11, P201, DOI 10.1080/08927019709378331
   BoulangePetermann L, 1996, BIOFOULING, V10, P275, DOI 10.1080/08927019609386287
   Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   Boyd RD, 2001, APPL SURF SCI, V172, P135, DOI 10.1016/S0169-4332(00)00840-0
   Boyd RD, 2001, J FOOD PROTECT, V64, P87, DOI 10.4315/0362-028X-64.1.87
   Boyd RD, 2000, J ADHES SCI TECHNOL, V14, P1195, DOI 10.1163/156856100743176
   CALLOW ME, 1994, INT BIODETER BIODEGR, V34, P333, DOI 10.1016/0964-8305(94)90092-2
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x
   CHARACKLIS WG, 1990, STRUCTURE FUNCTION B
   Cousins BG, 2007, J APPL MICROBIOL, V102, P757, DOI 10.1111/j.1365-2672.2006.03124.x
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Declerck P, 2003, WATER SCI TECHNOL, V47, P143
   EGINTON PJ, 1995, J IND MICROBIOL, V15, P305, DOI 10.1007/BF01569984
   Flint S. H., 1996, STAINLESS STEEL WELD, P1
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Flint SH, 1997, BIOFOULING, V11, P81, DOI 10.1080/08927019709378321
   Frank JF, 1997, J FOOD PROTECT, V60, P43, DOI 10.4315/0362-028X-60.1.43
   Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011
   Gibbons I, 2006, FOOD MICROBIOL, V23, P359, DOI 10.1016/j.fm.2005.05.008
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Hanarp P, 1999, NANOSTRUCT MATER, V12, P429, DOI 10.1016/S0965-9773(99)00151-8
   Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5
   HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225
   HOLAH JT, 1990, J APPL BACTERIOL, V69, P599, DOI 10.1111/j.1365-2672.1990.tb01554.x
   HOLAH JT, 1990, LETT APPL MICROBIOL, V11, P255, DOI 10.1111/j.1472-765X.1990.tb00175.x
   HOLAH JT, 1988, J APPL BACTERIOL, V65, P215, DOI 10.1111/j.1365-2672.1988.tb01888.x
   HOLAH JT, 2000, FFE377A00
   HOOD SK, 1995, FOOD CONTROL, V6, P9, DOI 10.1016/0956-7135(95)91449-U
   Hooper RJ, 2006, FOOD BIOPROD PROCESS, V84, P353, DOI 10.1205/fbp06038
   JEONG DK, 1994, J FOOD PROTECT, V57, P576, DOI 10.4315/0362-028X-57.7.576
   Kim T, 2005, J RAPID METH AUT MIC, V13, P127, DOI 10.1111/j.1745-4581.2005.00014.x
   Korber DR, 1997, APPL ENVIRON MICROB, V63, P3352
   KULKARNI SM, 1975, J DAIRY SCI, V58, P1095, DOI 10.3168/jds.S0022-0302(75)84687-X
   Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9
   LANGEVELD LP, 1972, NETH MILK DAIRY J, V26, P149
   Li XQ, 2004, BIOCHEM ENG J, V22, P11, DOI 10.1016/j.bej.2004.07.011
   Maller RR, 1998, TRENDS FOOD SCI TECH, V9, P28, DOI 10.1016/S0924-2244(97)00004-6
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Mendez-Vilas A, 2007, ULTRAMICROSCOPY, V107, P617, DOI 10.1016/j.ultramic.2006.12.002
   Mettler E, 1998, J FOOD PROTECT, V61, P57, DOI 10.4315/0362-028X-61.1.57
   Miettinen H, 2003, J FOOD PROTECT, V66, P1832, DOI 10.4315/0362-028X-66.10.1832
   Milledge J. J., 1980, IFST Proceedings, V13, P57
   Moore G, 2002, FOOD MICROBIOL, V19, P65, DOI 10.1006/fmic.2001.0464
   Navratilova P, 2004, VET MED-CZECH, V49, P243, DOI 10.17221/5701-VETMED
   Obee P, 2007, J HOSP INFECT, V65, P35, DOI 10.1016/j.jhin.2006.09.010
   Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1
   PACKER A, 2007, SOC VACUUM COATERS 5, P90
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Redsven I, 2007, APPL SURF SCI, V253, P5536, DOI 10.1016/j.apsusc.2006.12.078
   Saikhwan Phanida, 2007, Food Manufacturing Efficiency, V1, P35, DOI 10.1616/1750-2683.0013
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tide C, 1999, J FOOD ENG, V42, P85, DOI 10.1016/S0260-8774(99)00109-0
   Tresse O, 2007, J FOOD PROTECT, V70, P1569, DOI 10.4315/0362-028X-70.7.1569
   VANHAECKE E, 1990, APPL ENVIRON MICROB, V56, P788
   Verran J, 2006, FOOD BIOPROD PROCESS, V84, P260, DOI 10.1205/fbp06036
   Verran J., 1991, Biofouling, V3, P183
   Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3
   Verran J, 2005, INT J ARTIF ORGANS, V28, P1138
   Verran J, 2002, FOOD BIOPROD PROCESS, V80, P292, DOI 10.1205/096030802321154808
   Verran J, 2003, INT BIODETER BIODEGR, V51, P221, DOI 10.1016/S0964-8305(02)00176-2
   Verran J, 2001, BIOFOULING, V17, P59, DOI 10.1080/08927010109378465
   Verran J, 2002, BIOFOULING, V18, P167, DOI 10.1080/08927010290006736
   Verran J, 2001, J FOOD PROTECT, V64, P1377, DOI 10.4315/0362-028X-64.9.1377
   Verran J, 2000, INT BIODETER BIODEGR, V46, P99, DOI 10.1016/S0964-8305(00)00070-6
   VERRAN J, 2004, HYGIENIC COATINGS SU
   Verran J, 2000, IND BIOFOULING DETEC, P145
   VERRAN J, 2006, FOULING CLEANING DIS, P1
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Whitehead KA, 2007, INT BIODETER BIODEGR, V60, P74, DOI 10.1016/j.ibiod.2006.11.009
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Wilks SA, 2005, INT J FOOD MICROBIOL, V105, P445, DOI 10.1016/j.ijfoodmicro.2005.04.021
   WIRTANEN G, 2000, BIOFILMS, V2
   YU FP, 1995, APPL ENVIRON MICROB, V61, P3367
   2004, LIVE DEAD BACLIGHT V
   1988, BS11341 BRIT STAND 1
NR 89
TC 28
Z9 28
U1 1
U2 20
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2164
BN 978-0-12-374338-1
J9 ADV APPL MICROBIOL
JI Adv. Appl. Microbiol.
PY 2008
VL 64
BP 223
EP 246
DI 10.1016/S0065-2164(08)00408-5
PG 24
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA BHU59
UT WOS:000256527800008
PM 18485287
DA 2018-10-19
ER

PT S
AU Sakamoto, Y
   Moriyama, S
   Endo, M
   Kawakami, Y
AF Sakamoto, Yuki
   Moriyama, Shigeaki
   Endo, Masahiro
   Kawakami, Yuji
BE Lee, HS
   Yoon, IS
   Aliabadi, MH
TI Mechanical Property of Porous Titanium Produced by Spark Plasma
   Sintering
SO ADVANCES IN FRACTURE AND DAMAGE MECHANICS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th International Conference on Fracture and Damage Mechanics
CY SEP 09-11, 2008
CL Seoul, SOUTH KOREA
SP COEX Convent Ctr
DE Titanium powder; Mechanical properties; SPS (Spark plasma sintering);
   Biomaterial
AB Titanium has widely been used as a biomaterial because of its excellent corrosion resistance and biocompatibility. However, problems with respect to biological reaction and fitness of elastic modulus for human bone or tooth have yet to be solved. Porous titanium is expected to be a promising material to solve these problems. The aim of this study is to clarify the effect of the porous structure of this material on the biomechanical compatibility. The spherical pure titanium powder, with an average particle size of 100 mu m, was sintered by spark plasma sintering. The sintered porous titanium compacts had a porosity of 33%. The specimens were machined from the sintered compacts for the evaluation of the mechanical properties. The elastic modulus indicated a value close to human bone, while the tensile and compressive strengths showed lower values than those of human bone.
C1 [Sakamoto, Yuki; Moriyama, Shigeaki; Endo, Masahiro] Fukuoka Univ, Dept Mech Engn, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.
   [Kawakami, Yuji] Ind Technol Ctr Saga, Saga 8480932, Japan.
RP Sakamoto, Y (reprint author), Fukuoka Univ, Dept Mech Engn, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.
EM ysak@fukuoka-u.ac.jp; moriyama@fukuoka-u.ac.jp; endo@fukuoka-u.ac.jp;
   Kawakami@saga-itc.go.jp
FU Central Research Institute of Fukuoka University [081501]
FX This work was supported by funds (No. : 081501) from the Central
   Research Institute of Fukuoka University.
CR BILLOTTE WG, 2000, BIOMEDICAL ENG HDB
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Ishizaki K., 1998, POROUS MAT PROCESS T
   NILLES JL, 1974, J BIOMED MATER RES, V8, P319, DOI 10.1002/jbm.820080411
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
NR 5
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 385-387
BP 637
EP +
DI 10.4028/www.scientific.net/KEM.385-387.637
PG 2
WC Engineering, Civil; Engineering, Mechanical
SC Engineering
GA BIR18
UT WOS:000262126000160
DA 2018-10-19
ER

PT J
AU Cook, JL
   Fox, DB
   Kuroki, K
   Jayo, M
   Deyne, PG
AF Cook, James L.
   Fox, Derek B.
   Kuroki, Keiichi
   Jayo, Manuel
   De Deyne, Patrick G.
TI In vitro and in vivo comparison of five biomaterials used for orthopedic
   soft tissue augmentation
SO AMERICAN JOURNAL OF VETERINARY RESEARCH
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; LARGE MENISCAL DEFECTS;
   EXTRACELLULAR-MATRIX; GROWTH-FACTOR; REPAIR; SCAFFOLD; DOGS;
   REGENERATION; BIOCOMPATIBILITY; GLUTARALDEHYDE
AB Objective - To compare biomaterials used in orthopedics with respect to in vitro cell viability and cell retention and to in vivo tissue healing and regeneration.
   Animals - 65 adult female Sprague-Dawley rats and synovium, tendon, meniscus, and bone marrow specimens obtained from 4 adult canine cadavers.
   Procedures - Synovium, tendon, meniscus, and bone marrow specimens were used to obtain synovial fibroblasts, tendon fibroblasts, meniscal fibrochondrocytes, and bone marrow-derived connective tissue progenitor cells for culture on 5 biomaterials as follows: cross-linked porcine small intestine (CLPSI), non-cross-linked human dermis, cross-linked porcine dermis, non-cross-linked porcine small intestine (NCLPSI), and non-cross-linked fetal bovine dermis. After 1 week of culture, samples were evaluated for cell viability, cell density, and extracellular matrix production. Biomaterials were evaluated in a 1-cm(2) abdominal wall defect in rats. Each biomaterial was subjectively evaluated for handling, suturing, defect fit, and ease of creating the implant at the time of surgery, then grossly and histologically 6 and 12 weeks after surgery.
   Results - All biomaterials allowed for retention of viable cells in culture; however, CLPSI and NCLPSI were consistently superior in terms of cell viability and cell retention. Cell infiltration for NCLPSI was superior to other biomaterials. The NCLPSI appeared to be replaced with regenerative tissue most rapidly in vivo and scored highest in all subjective evaluations of ease of use.
   Conclusions and Clinical Relevance - These data suggested that NCLPSI and CLPSI have favorable properties for further investigation of clinical application in orthopedic tissue engineering.
C1 [Cook, James L.; Fox, Derek B.; Kuroki, Keiichi] Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   [Jayo, Manuel] Tengion Labs, Winston Salem, NC 27103 USA.
   [De Deyne, Patrick G.] DePuy Spine, Raynham, MA 02767 USA.
RP Cook, JL (reprint author), Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Beatty MW, 2002, TISSUE ENG, V8, P955, DOI 10.1089/107632702320934056
   Belcher HJCR, 2001, J HAND SURG-BRIT EUR, V26, P159, DOI 10.1054/jhsb.2001.0554
   Beniker D, 2003, ORTHOPEDICS, V26, pS591
   BOON ME, 1995, BIOMATERIALS, V16, P1089, DOI 10.1016/0142-9612(95)98905-T
   Cook James L, 2006, J Knee Surg, V19, P159
   Cook JL, 2005, CLIN ORTHOP RELAT R, P88, DOI 10.1097/01.blo.0000165735.49510.a9
   Cook JL, 1997, AM J VET RES, V58, P419
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Cook JL, 2006, AM J SPORT MED, V34, P32, DOI 10.1177/0363546505278702
   Crow BD, 2007, J ORTHOP RES, V25, P396, DOI 10.1002/jor.20232
   Dahlgren LA, 2002, J ORTHOPAED RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   Fox DB, 2004, TISSUE ENG, V10, P129, DOI 10.1089/107632704322791772
   Fox DB, 2006, TISSUE ENG, V12, P1526
   Harding ML, 2003, KNEE, V10, P43, DOI 10.1016/S0968-0160(02)00043-1
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Ramires PA, 2002, J MATER SCI-MATER M, V13, P119, DOI 10.1023/A:1013667426066
   Rodkey W G, 1999, Clin Orthop Relat Res, pS281, DOI 10.1097/00003086-199910001-00027
   Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Vecchia L, 1999, J PEDIATR SURG, V34, P167
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 38
TC 23
Z9 24
U1 3
U2 19
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0002-9645
EI 1943-5681
J9 AM J VET RES
JI Am. J. Vet. Res.
PD JAN
PY 2008
VL 69
IS 1
BP 148
EP 156
DI 10.2460/ajvr.69.1.148
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA 246AU
UT WOS:000251980700020
PM 18167101
DA 2018-10-19
ER

PT S
AU Reinhart-King, CA
AF Reinhart-King, Cynthia A.
BE Cheresh, DA
TI Endothelial cell adhesion and migration
SO ANGIOGENESIS: IN VITRO SYSTEMS
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID EXTRACELLULAR-MATRIX; TRACTION FORCES; SUBSTRATE; DYNAMICS;
   ANGIOGENESIS; HYDROGELS; SURFACES; RIGIDITY; MORPHOGENESIS; INTEGRINS
AB Endothelial cell adhesion and migration is fundamental to a number of physiologic processes, including vascular development and angiogenesis. it has been investigated in a variety of contexts, including tumorigenesis, wound heating, tissue engineering, and biomaterial design. The chemical and mechanical extracellular environments are critical regulators of these processes, affecting integrin-matrix binding, cell adhesion strength, and cell migration. Understanding the synergy between matrix chemistry and mechanics will ultimately lead to precise control over adhesion and migration. Moreover, a better understanding of endothelial cell adhesion is critical for development of therapeutics and biomaterials for the treatment of endothelial cell dysfunction and the progression of vascular disease. This chapter will focus on the specific interactions between endothelial cells and the extracellular matrix that mediate adhesion and migration. Several engineering methods used to probe and quantify encdothelial cell adhesion and migration will be discussed.
C1 Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
RP Reinhart-King, CA (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
RI Reinhart-King, Cynthia/A-9264-2016
OI Reinhart-King, Cynthia/0000-0001-6959-3914
CR Asthagiri AR, 1999, J BIOL CHEM, V274, P27119, DOI 10.1074/jbc.274.38.27119
   Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   DOBEREINER HG, 2004, PHYS REV LETT, V93, P1
   Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0
   Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0
   FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j
   Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0
   King MR, 2006, J COLLOID INTERF SCI, V296, P374, DOI 10.1016/j.jcis.2005.08.063
   Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2
   Kumar G, 2005, LANGMUIR, V21, P9267, DOI 10.1021/la050332n
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975
   Miranti CK, 2002, METHOD CELL BIOL, V69, P359, DOI 10.1016/S0091-679X(02)69023-5
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PLESS DD, 1983, J BIOL CHEM, V258, P2340
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Schaff UY, 2007, LAB CHIP, V7, P448, DOI 10.1039/b617915k
   Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007
   STOKES CL, 1991, J CELL SCI, V99, P419
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wu MM, 2006, APPL ENVIRON MICROB, V72, P4987, DOI 10.1128/AEM.00158-06
   YANG JT, 1993, DEVELOPMENT, V119, P1093
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 48
TC 44
Z9 44
U1 2
U2 26
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-374315-2
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2008
VL 443
BP 45
EP +
DI 10.1016/S0076-6879(08)02003-X
PG 21
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BIH31
UT WOS:000259483400003
PM 18772010
DA 2018-10-19
ER

PT J
AU Meek, MF
   Coert, JH
AF Meek, M. F.
   Coert, J. H.
TI US Food and Drug Administration/Conformit Europe-approved absorbable
   nerve conduits for clinical repair of peripheral and cranial nerves
SO ANNALS OF PLASTIC SURGERY
LA English
DT Review
DE NeuraGen; NeuroMatrix; Neurotube; Neurolac; absorbable nerve conduit;
   clinical
ID POLYGLYCOLIC ACID CONDUITS; RAT SCIATIC-NERVE; COLLAGEN TUBE;
   REGENERATION; RECONSTRUCTION; GUIDE; TUBULIZATION; BIOMATERIAL; DEFECTS
AB Several absorbable nerve conduits are approved by the US Food and Drug Administration (FDA) and Conformit Europe (CE) for clinical repair of peripheral and cranial nerves. Surgeons are often not aware of the different (bio)materials of these conduits when performing nerve repair. An overview of these FDA- and CE-approved absorbable nerve conduits for clinical use is presented. PubMed. MEDLINE, and the companies selling the conduits were consulted. The available FDA and CE absorbable nerve conduits for peripheral and cranial nerve repair are 2 collagen- and 2 synthetic-polyester-based conduits. The available clinical data, the price, the length, and the composition of the tube show significant differences. Based on the available data in this paper at this moment, we favor the PGA (Neurotube) nerve conduit for repair of peripheral and cranial nerve defects because of its advantages in length, price, and availability of clinical data. However, no prospective studies comparing the available nerve conduits have been published.
C1 [Meek, M. F.] Derbyshire Royal Infirm, Pulvertaft Hand Ctr, Derby DE1 2QY, England.
   [Coert, J. H.] Erasmus Univ, Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.
RP Meek, MF (reprint author), Derbyshire Royal Infirm, Pulvertaft Hand Ctr, London Rd, Derby DE1 2QY, England.
EM marcelfmeek@hotmail.com
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Berger A, 1994, Handchir Mikrochir Plast Chir, V26, P44
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   BUNGE MB, 1989, DEV NEUROSCI-BASEL, V11, P348, DOI 10.1159/000111911
   Casanas J, 2000, J HAND SURG B, V25, P44
   Chamberlain LJ, 2000, J COMP NEUROL, V417, P415, DOI 10.1002/(SICI)1096-9861(20000221)417:4<415::AID-CNE3>3.0.CO;2-9
   CRAWLEY WA, 1992, PLAST RECONSTR SURG, V90, P300, DOI 10.1097/00006534-199290020-00022
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DENDUNNEN WFA, 1996, THESIS U GRONINGEN N
   Ducic I, 2005, J RECONSTR MICROSURG, V21, P29, DOI 10.1055/s-2005-862777
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hagiwara Akeo, 2002, Gan To Kagaku Ryoho, V29, P2202
   Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   KEELEY RD, 1991, J RECONSTR MICROSURG, V7, P93, DOI 10.1055/s-2007-1006766
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   LAQUERRIERE A, 1994, MICROSURG, V15, P203, DOI 10.1002/micr.1920150312
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   LOHMEYER J, 2007, DER CHIRURG, V78, P142
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MATHUR A, 1983, SCAN ELECT MICROSC, V2, P975
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   MEEK MF, 2000, THESIS U GRONINGEN N
   MERRELL JC, 1986, ANN PLAS SURG, V17, P49, DOI 10.1097/00000637-198607000-00010
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   ROSEN J M, 1989, Journal of Rehabilitation Research and Development, V26, P1
   ROSEN JM, 1983, ANN PLAS SURG, V11, P397, DOI 10.1097/00000637-198311000-00007
   Rosner BI, 2003, ANN BIOMED ENG, V31, P1383, DOI 10.1114/1.1626118
   Scherman P, 2001, J NEUROSURG, V95, P316, DOI 10.3171/jns.2001.95.2.0316
   Strauch B, 2000, HAND CLIN, V16, P123
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Yuen D., 2003, T SOC BIOMATERIALS, P228
NR 40
TC 67
Z9 71
U1 1
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD JAN
PY 2008
VL 60
IS 1
BP 110
EP 116
DI 10.1097/SAP.0b013e31804d441c
PG 7
WC Surgery
SC Surgery
GA 243UL
UT WOS:000251822700024
PM 18281807
DA 2018-10-19
ER

PT S
AU Qiu, JH
   Wang, GX
   Jiang, T
AF Qiu, Juhui
   Wang, Guixue
   Jiang, Tao
BE Peng, Y
   Weng, X
TI Preparation and Biocompatibility of a Novel Scaffold Made from Small
   Intestinal Submucosa Powders
SO APCMBE 2008: 7TH ASIAN-PACIFIC CONFERENCE ON MEDICAL AND BIOLOGICAL
   ENGINEERING
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 7th Asia-Pacific Conference on Medical and Biological Engnieering
CY APR 22-25, 2008
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Biomed Engn
DE Scaffold; Small intestine submucosa; Sponge; biocompatibility
ID BIOMATERIALS; REGENERATION; PRINCIPLES
AB Three-dimensional porous scaffolds play a critical role in both cell targeting and cell transplantation strategies. Small intestine submucosa (SIS) has been recommended as a cell-free, biocompatible and with minimum immune response biomaterial. However, the three-dimensional structure of SIS isn't very suit for tissue regeneration and tissue engineering. So, we tried to prepare SIS sponges and got a kind of novel scaffold. Scanning electron microscope showed that SIS sponge had interconnected network structure and comparably regular pore. The pore diameter was around 100-150 mu m. In vivo implantation test, the sponges were implanted in dorsal muscle of rats for 4 weeks and the results suggest that the SIS sponges had good biocompatibility and also could completely degrade in vivo. So we conclude that the SIS sponges maybe are available scaffolds for injury repair.
C1 [Qiu, Juhui; Wang, Guixue; Jiang, Tao] Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China.
RP Wang, GX (reprint author), Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China.
OI Guixue, Wang/0000-0002-9192-8757
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Zhang Y, 2000, J UROLOGY, V164, P934
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 15
TC 0
Z9 0
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-79038-9
J9 IFMBE PROC
PY 2008
VL 19
BP 40
EP 43
PG 4
WC Engineering, Biomedical
SC Engineering
GA BIL11
UT WOS:000260456700011
DA 2018-10-19
ER

PT J
AU Joyce, TJ
AF Joyce, T. J.
TI Calculation of theoretical lubrication regimes in two-piece first
   metatarsophalangeal prostheses
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE metatarsophalangeal; lubrication regimes; metal-on-metal;
   ceramic-on-ceramic; metal-on-polymer
ID METAL RESURFACING ARTHROPLASTY; LOW-FRICTION ARTHROPLASTY; HIP-JOINT
   REPLACEMENTS; FOLLOW-UP; ELASTOHYDRODYNAMIC LUBRICATION; FORCES; WEAR;
   GAIT; POLYETHYLENE; PREDICTION
AB The key joint of the forefoot during gait is the first metatarsophalangeal joint. It plays an important role in propelling the human form but can be subject to a number of diseases which can lead to its replacement with an artificial joint. Some of these designs of prosthesis employ a two-piece ball and socket arrangement and are available with a range of biomaterial couples including ceramic-on-ceramic, metal-on-metal and metal-on-polymer. Calculation of predicted lubrication regimes applicable to these implant designs was undertaken. Modelling the ball and socket implant as an equivalent ball-on-plane model and employing elastohydrodynamic theory allowed the minimum film thickness to be calculated and in turn the lambda ratio to indicate the lubrication regime. The calculations were undertaken for a 50 to 1500 N range of loading values, a 0 to 30 mm/s range of entraining velocities, and a 3 to 15 mm radius range of sizes. Calculations showed that the ceramic-on-ceramic and metal-on-metal implants could operate under fluid film lubrication, whereas the metal-on-polymer combination operated in the boundary lubrication regime. It was also recognized that manufacturing capabilities are critical to the radial clearances and values of surface roughness that can be achieved, and thus the predicted lubrication regime.
C1 Newcastle Univ, Sch Mech & Syst Engn, Ctr Rehabil & Engn Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP Joyce, TJ (reprint author), Newcastle Univ, Sch Mech & Syst Engn, Ctr Rehabil & Engn Studies, Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM t.j.joyce@ncl.ac.uk
RI Joyce, Thomas/G-3689-2013
OI Joyce, Thomas/0000-0002-8497-5790
CR Back DL, 2005, J BONE JOINT SURG BR, V87B, P324, DOI 10.1302/0301-620X.87B3.15556
   BOMMIREDDY R, 2003, FOOT, V13, P151
   *BURG MED, MOJ MTP IMPL
   Edidin AA, 2001, WEAR, V250, P152, DOI 10.1016/S0043-1648(01)00616-0
   Elfick APD, 1999, J BIOMED MATER RES, V48, P712, DOI 10.1002/(SICI)1097-4636(1999)48:5<712::AID-JBM17>3.0.CO;2-R
   GRANBERRY WM, 1991, J BONE JOINT SURG AM, V73A, P1453, DOI 10.2106/00004623-199173100-00002
   HAMROCK BJ, 1978, J LUBRIC TECH-T ASME, V100, P236, DOI 10.1115/1.3453152
   Hanyu T, 2001, J Orthop Sci, V6, P141, DOI 10.1007/s007760100062
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HASSAN K, 2006, FOOT, V16, P142
   Hungerford DS, 2005, J ARTHROPLASTY, V20, P68, DOI 10.1016/j.arth.2005.03.023
   Jacob HAC, 2001, CLIN BIOMECH, V16, P783, DOI 10.1016/S0268-0033(01)00070-5
   Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0
   JOHNSON KL, 1972, WEAR, V19, P91, DOI 10.1016/0043-1648(72)90445-0
   Joyce TJ, 2005, EXPERT REV MED DEVIC, V2, P453, DOI 10.1586/17434440.2.4.453
   JOYCE TJ, 2006, J BIOMECH, V39, pS525
   MCBRIDE ID, 1991, FOOT ANKLE, V11, P282, DOI 10.1177/107110079101100505
   MINAMIKAWA Y, 1994, J HAND SURG-AM, V19A, P567, DOI 10.1016/0363-5023(94)90258-5
   Nawoczenski DA, 1999, J BONE JOINT SURG AM, V81A, P370, DOI 10.2106/00004623-199903000-00009
   Nercessian OA, 2005, J ARTHROPLASTY, V20, P162, DOI 10.1016/j.arth.2004.07.006
   Older J, 2002, J ARTHROPLASTY, V17, P675, DOI 10.1054/arth.2002.31973
   Olms K, 1999, INT ORTHOP, V23, P240, DOI 10.1007/s002640050360
   PAVIER J, 2005, FOOT, V15, P47
   PEIMER CA, 1991, J HAND SURG-AM, V16A, P835, DOI 10.1016/S0363-5023(10)80146-7
   Pylios T, 2004, J BIOMECH, V37, P405, DOI 10.1016/S0021-9290(03)00265-3
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   Schmalzried TP, 2005, J ARTHROPLASTY, V20, P70, DOI 10.1016/j.arth.2005.03.007
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   Scholes SC, 2000, WEAR, V241, P209, DOI 10.1016/S0043-1648(00)00377-X
   Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237
   Smith SL, 2001, P I MECH ENG J-J ENG, V215, P483, DOI 10.1243/1350650011543718
   STOKES IAF, 1979, J ANAT, V129, P579
   Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030
   Udofia IJ, 2003, J BIOMECH, V36, P537, DOI 10.1016/S0021-9290(02)00422-0
   Villar R, 2004, J BONE JOINT SURG BR, V86B, P157, DOI 10.1302/0301-620X.86B2.15231
   Wroblewski BM, 2002, J BONE JOINT SURG BR, V84B, P540, DOI 10.1302/0301-620X.84B4.10293
NR 36
TC 1
Z9 1
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2008
VL 18
IS 1
BP 45
EP 51
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 262TI
UT WOS:000253170500005
PM 18198406
DA 2018-10-19
ER

PT J
AU Moby, V
   Kadi, A
   de Isla, N
   Stoltz, JF
   Menu, P
AF Moby, V.
   Kadi, A.
   de Isla, N.
   Stoltz, J. F.
   Menu, P.
TI Polyelectrolyte multilayer films: Effect of the initial anchoring layer
   on the cell growth
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Polyelectrolyte multilayer films; surface modification; tissue
   engineering; stem cells
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELL; WETTABILITY; POLYSTYRENE;
   ADHESION; GLASS
AB In tissue engineering, surface characteristics of a biomaterial are one of most important factors determining the compatibility with the environment. They influence attachment and growth of cells onto the material. In many cases, the surface should to be modified and engineered in the desired direction. The modification of non-adhesive surfaces with polyelectrolyte multilayer films (PMF) was recently depicted as a powerful technique to promote the growth of different cell lines. In this study, we evaluated the possible use of two different PMF as surface modification for the culture of mesenchymal stem cells (MSC). We used two types of PMF which differed by the nature of the initial anchoring layer which was poly( ethylenimine) (PEI) or poly(allylamine hydrochloride) (PAH). This initial polyelectrolytes adsorption was followed by the alternated deposition of poly(sodium 4-styrenesulfonate) (PSS) and (PAH) in order to obtain a PEI-(PSS-PAH)(3) film or a PAH-(PSS-PAH)(3) film. In order to control the behaviour of MSC, the cell viability was evaluated by Alamar Blue assay and the actin cytoskeleton was labelled and visualised in a confocal microscope. The behaviour of cells on the two PMF was compared to cells cultivated on surfaces treated with fibronectin. The results showed that PAH-(PSS-PAH)(3) PMF improve the growth of cells, inducing a higher cell viability compared to PEI-(PSS-PAH)(3) PMF and fibronectin at 2, 3 and 7 days of culture. Moreover, those cells showed a well-organized actin cytoskeleton. In conclusion, PAH-(PSS-PAH)(3) polyelectrolyte multilayer film seems to constitute an excellent material for MSC seeding.
C1 [Moby, V.; Kadi, A.; de Isla, N.; Stoltz, J. F.; Menu, P.] Univ Nancy 1, Fac Med, CNRS 7563, Grp Mecan & Ingn Cellulaire & Tissulair, F-54505 Vandoeuvre Les Nancy, France.
   [Stoltz, J. F.] CHU Nancy, Unite Therapie Cellulaire & Tissus, Vandoeuvre Les Nancy, France.
RP Moby, V (reprint author), Univ Nancy 1, Fac Med, CNRS 7563, Grp Mecan & Ingn Cellulaire & Tissulair, F-54505 Vandoeuvre Les Nancy, France.
EM vanessa.moby@medecine.uhp-nancy.fr
CR Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   BOURA C, 2006, BIOMED MAT ENG, V16, P115
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Donath E, 1997, LANGMUIR, V13, P5294, DOI 10.1021/la970090u
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   Ho M, 2006, BIOMATERIALS, V27, P4333, DOI 10.1016/j.biomaterials.2006.03.037
   Kadner A, 2002, EUR J CARDIO-THORAC, V21, P1055, DOI 10.1016/S1010-7940(02)00079-9
   Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x
   Kolasinska M, 2005, BIOELECTROCHEMISTRY, V66, P65, DOI 10.1016/j.bioelechem.2004.03.009
   Kolasinska M, 2007, J COLLOID INTERF SCI, V305, P46, DOI 10.1016/j.jcis.2006.09.035
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Moby V, 2007, BIOMACROMOLECULES, V8, P2156, DOI 10.1021/bm070348n
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   Zhu HG, 2004, BIOMACROMOLECULES, V5, P1933, DOI 10.1021/bm049753u
NR 18
TC 13
Z9 13
U1 0
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2008
VL 18
IS 4-5
BP 199
EP 204
DI 10.3233/BME-2008-0525
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 394MO
UT WOS:000262451000006
PM 19065022
DA 2018-10-19
ER

PT J
AU Facca, S
   Gillet, P
   Stoltz, JF
   Netter, P
   Mainard, D
   Voegel, JC
   Benkirane-Jessel, N
AF Facca, S.
   Gillet, P.
   Stoltz, J. -F.
   Netter, P.
   Mainard, D.
   Voegel, J. -C.
   Benkirane-Jessel, N.
TI Three-dimensional sprayed active biological gels and cells for tissue
   engineering application
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Active gel; LbL films; tissue engineering; sprayed gel; sprayed cells
ID POLYELECTROLYTE MULTILAYERS; POLYSACCHARIDES; CYCLODEXTRIN; INTERFACES;
   COATINGS; DELIVERY; SULFATE; FILMS
AB Complex three-dimensional structures can "a priori" be built layer-by-layer with a large number of different components, including various cell types, polyelectrolytes, drugs, proteins, peptides or DNA. Our approach is based on the spraying of such elements in order to form a highly functionalized and structured biomaterial. The proposed route will allow the control at the surface and in depth the distribution of the different included elements (matrix and cells).
   The main objective of this work concerns the buildup of biomaterials aimed to reconstruct biological tissue. The proposed ways are highly innovative and consist in a simple and progressive spraying of all the elements constituting finally the biomaterial.
   We report here that it is possible (i) to build an alginate gel by alternate spraying of alginate and Ca(2+); (ii) to spray active alginate gel and cells; (iii) to build layer-by-layer an active reservoir under and on the top of this sprayed gel and cells; (iv) to follow the activity of these sprayed cells with time; ( v) to propose a three-dimensional sprayed structure for tissue engineering application.
C1 [Facca, S.; Voegel, J. -C.; Benkirane-Jessel, N.] INSERM, Unite 595, Fac Med, F-67085 Strasbourg, France.
   [Gillet, P.; Stoltz, J. -F.; Netter, P.; Mainard, D.] Univ Nancy 1, Fac Med, CNRS, UMR 7561, F-54506 Vandoeuvre Les Nancy, France.
RP Benkirane-Jessel, N (reprint author), INSERM, Unite 595, Fac Med, 11 Rue Humann, F-67085 Strasbourg, France.
EM nadia.jessel@medecine.u-strasbg.fr
RI Benkirane-Jessel, Nadia/H-6438-2016
OI Benkirane-Jessel, Nadia/0000-0003-3059-3559
CR Akaike T., 1997, ADV POLYM BIOMATERIA
   BAKER R, 1987, CONTROLLED RELEASE B
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   BENKIRANEJESSEL N, 2003, ADV MATER, V15, P692
   BENKIRANEJESSEL N, 2004, ADV FUNCT MATER, V14, P963
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   Gangloff SC, 2006, BIOMATERIALS, V27, P1771, DOI 10.1016/j.biomaterials.2005.10.001
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   GROSSIN L, 2008, ADV MAT IN PRESS
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   HELLER J, 1993, ADV DRUG DELIVER REV, V10, P163, DOI 10.1016/0169-409X(93)90047-8
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Knoll W, 1996, CURR OPIN COLLOID IN, V1, P137, DOI 10.1016/S1359-0294(96)80054-9
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   MENDEZGARZIA J, 2005, LANGMUIR, V21, P12372
   PARK K, 1993, BIODEGRADABLE HYDROG
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Sato K, 2003, LANGMUIR, V19, P7406, DOI 10.1021/la030163b
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   Wang DY, 2002, NANO LETT, V2, P857, DOI 10.1021/nl025624c
NR 28
TC 5
Z9 5
U1 1
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2008
VL 18
IS 4-5
BP 231
EP 235
DI 10.3233/BME-2008-0530
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 394MO
UT WOS:000262451000011
PM 19065027
DA 2018-10-19
ER

PT J
AU Lu, J
   Laudinet, J
   Williams, S
AF Lu, Jing
   Laudinet, Jacques
   Williams, Sandy
TI Mechanical stimulation and evaluation of hydrogel biomaterial
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
C1 [Lu, Jing; Laudinet, Jacques; Williams, Sandy] Bose Corp ElectroForce Syst Grp, Jacques Laudinet, Eden Prairie, MN 55344 USA.
RP Williams, S (reprint author), Bose Corp ElectroForce Syst Grp, Jacques Laudinet, 10250 Valley View Rd,Suite 113, Eden Prairie, MN 55344 USA.
EM Sandy_Williams@bose.com
NR 0
TC 2
Z9 2
U1 2
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2008
VL 18
IS 4-5
BP 335
EP 337
DI 10.3233/BME-2008-0549
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 394MO
UT WOS:000262451000028
PM 19065044
DA 2018-10-19
ER

PT S
AU Kim, SR
   Kim, YH
   Kwon, WT
   Kim, HS
   Choi, YM
   Ha, SM
   Kim, HJ
AF Kim, S. R.
   Kim, Y. H.
   Kwon, W. T.
   Kim, H. S.
   Choi, Y. M.
   Ha, S. M.
   Kim, H. J.
BE Daculsi, G
   Layrolle, P
TI Biocompatibility evaluation of porous Si-containing hydroxyapatite
   derived from coral
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE porous hydroxyapatite; silicon; coral; biocompatibility evaluation
ID SUBSTITUTED HYDROXYAPATITE
AB A porous silicon-containing hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Silicon content is ranged from 0.5wt% to 1wt% by weight. The porous silicon-containing hydroxyapatite blocks were inserted into the 5mm diameter of drill holes made through the lateral femoral condyles of New Zealand white rabbits. The new bony formation did not begin after I week. At 3 week, bony ongrowth to the inserted porous silicon-containing hydroxyapatite block could be found, and the new bone surrounded the inserted block entirely after 24weeks. Based on in-vivo test, Si-containing porous hydroxyapatite derived from coral possesses high biodegradability and can be considered a useful material for bone implants.
C1 [Kim, S. R.; Kim, Y. H.; Kwon, W. T.] Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
   [Kim, H. S.] Seoul Natl Univ, Dept Orthopaed Surg, Seoul 110744, South Korea.
   [Choi, Y. M.; Ha, S. M.; Kim, H. J.] Meta Biomed Co Ltd, Choongbuk, South Korea.
RP Kim, SR (reprint author), Korea Inst Ceram Engn & Technol, Seoul 153801, South Korea.
EM srkim@kicet.re.kr; yhkokim@kicet.re.kr
FU Next Generation Project (Development of Biological Hybrid Materials) of
   Ministry of Commerce, Industry and Energy, Korea [N11-A08-1402-07-1-3]
FX Financial support of this work was provided by Next Generation Project
   (Development of Biological Hybrid Materials) of Ministry of Commerce,
   Industry and Energy, Korea under contract No. N11-A08-1402-07-1-3.
CR Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LOPEZ JG, 2001, J RAMAN SPECTROSC, V32, P255
   Mayer I, 2000, J CRYST GROWTH, V219, P98, DOI 10.1016/S0022-0248(00)00608-4
   OKAZAKI M, 1995, BIOMATERIALS, V16, P703, DOI 10.1016/0142-9612(95)99698-L
   Skrtic D, 2002, J BIOMED MATER RES, V59, P597, DOI 10.1002/jbm.10017
NR 7
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 131
EP +
DI 10.4028/www.scientific.net/KEM.361-363.131
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200034
DA 2018-10-19
ER

PT S
AU Shi, XC
   Jiang, HZ
   Xue, J
   Liao, YM
   Xiao, LY
   Bao, CY
   Li, W
AF Shi, X. C.
   Jiang, H. Z.
   Xue, J.
   Liao, Y. M.
   Xiao, L. Y.
   Bao, C. Y.
   Li, W.
BE Daculsi, G
   Layrolle, P
TI Antibacterial effects of sol-gel derived zinc-containing hydroxyapatite
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE antimicrobial; coatings; hydroxyapatite sol-gel route; Streptococcus
   mutans; Zinc-containing
ID COATINGS; IMPLANTS
AB In order to modify the biological properties of pure hydroxyapatite (HAp), two kinds of zinc-containing HAp, which had zinc content of 5.10wt% and 2.54wt%, respectively, were synthesized via sol-gel technique. The obtained coatings were characterized by X-ray diffraction (XRD) and scanning electron microscope (SENT). Then the antibacterial effects were evaluated through bacteriostatic test on Streptococcus mutans (S.mutans) in vitro and zinc ions releasing ability was investigated through detecting the zinc ions concentration by inductively coupled plasma-atomic emission spectroscopy (ICP-AES). The obtained coatings were observed to possess typical apatite peaks in XRD patterns and high homogeneous and porous surfaces in SENT morphology. The coating layer demonstrated good releasing ability in Brain Heart Infusion (BHI) liquid and obviously inhibitory effects to the growth and proliferation of S. mutans. Based on the results obtained above, it is concluded that the sol-gel derived zinc-containing hydroxyapatite could be applied as an antibacterial effective biomaterial.
C1 [Shi, X. C.; Jiang, H. Z.; Xue, J.; Liao, Y. M.; Xiao, L. Y.; Bao, C. Y.; Li, W.] Sichuan Univ, Minist Hlth, Key Lab Oral Biomed Engn, Chengdu 610041, Sichuan, Peoples R China.
RP Shi, XC (reprint author), Sichuan Univ, Minist Hlth, Key Lab Oral Biomed Engn, Chengdu 610041, Sichuan, Peoples R China.
CR ALEXIA GL, 2006, BIOMATER, V27, P3195
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BIGI A, 1995, J INORG BIOCHEM, V58, P49, DOI 10.1016/0162-0134(94)00036-A
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   GEESINK RGT, 1990, CLIN ORTHOP RELAT R, P39
   HIDAKA S, 1994, J BIOMED MATER RES, P175
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   OKAMOTO Y, 1994, J BIOMED MATER RES, V28, P1403, DOI 10.1002/jbm.820281204
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   William R. L., 1993, HYDROXYAPATITE COATI, P223
NR 12
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 361-363
BP 139
EP 142
DI 10.4028/www.scientific.net/KEM.361-363.139
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200036
DA 2018-10-19
ER

PT S
AU Kim, JJ
   Kim, HJ
   Lee, KS
AF Kim, Jung-Jae
   Kim, Hae-Jung
   Lee, Kang-Sik
BE Daculsi, G
   Layrolle, P
TI Evaluation of biocompatibility of pProus hydroxyapatite developed from
   edible cuttlefish bone
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE hydroxyapatite; edible cuttle bone; aragonite; scaffold
ID IN-VITRO; PARTICLES
AB A edible cuttlefish(Zoological name : Sepia esculenta) bone has a porous structure with all pores interconnected The purpose of this research is to develop porous hydroxyapatite prepared by hydrothermal treatment from cuttlefish bone and evaluate the biocompatibility using undecalcified materials through the in-vivo test of rabbits. In this study, the phase and substructure of a porous hydroxyapatite, prepared by hydrothermal treatment using edible cuttlefish bone as a calcium source, has been confirmed by X-ray diffractometer and scanning electronic microscope. After preparing the specimens with 5mm diameter and 7mm length, the specimens were implanted into the femoral condyles of rabbits. Each rabbits were sacrificed at each time period of 1, 2, 3, 4 weeks after operation, respectively and the stained section was examined by a transmission light microscope. The X-ray diffraction patterns of the edible cuttlefish bone was confirm for aragonite phase and of the sample after hydrothermal treatment showed mostly into hydroxyapatite phase. There was more bone density increase in porous HA rod around implant site than natural edible cuttlefish bone. Because the edible cuttlefish bone is a very pure and good calcium source, porous hydroxyapatite developed from this study is expected to be a biomaterial having a good biocompatibility to be used as a suitable bone substitute.
C1 [Kim, Jung-Jae; Lee, Kang-Sik] ASAN Med Ctr, Dept Orthoped Surg, Seoul, South Korea.
   [Kim, Hae-Jung] Meta Biomed Co Ltd, Choongbuk 363880, South Korea.
RP Kim, JJ (reprint author), ASAN Med Ctr, Dept Orthoped Surg, Seoul, South Korea.
EM jjkim2@amc.seoul.kr; meta2120@hanmail.net; knifebrd@hanmail.net
FU Asan Institute for Life Sciences, Seoul, Korea [2007-175]
FX This study was supported by a grant (NO. 2007-175) from the Asan
   Institute for Life Sciences, Seoul, Korea.
CR Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
NR 4
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 155
EP +
DI 10.4028/www.scientific.net/KEM.361-363.155
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200040
DA 2018-10-19
ER

PT S
AU Tofighi, A
   Schaffer, K
   Palazzolo, R
AF Tofighi, A.
   Schaffer, K.
   Palazzolo, R.
BE Daculsi, G
   Layrolle, P
TI Calcium phosphate cement (CPC): A critical development path
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE calcium phosphate; bone cement; characterization; competitors
ID BONE
AB The first generation of synthetic bone substitute materials (BSM) was initially investigated in the mid 1970s using hydroxyapatite (HA) as a biomaterial for remodeling of bone defects. The concepts established by CPC pioneers in the early 1980s were used as a platform to initiate a second generation of BSM for commercialization. Since then, advances have been made in composition, performance and manufacturing.
   A self-setting and injectable calcium phosphate cement (CPC) based on amorphous calcium phosphate (ACP) with calcium to phosphate (Ca/P) atomic ratio less than 1.5, combined with dicalcium phosphate dihydrate (DCPD or brushite.. seeded with apatite), is proposed. Amorphization of raw material was observed following high energy mechano-chemical processing. Upon hydration, the cement hardened in less than 3 minutes at 37 degrees C and reached a maximum compressive strength of about 50 MPa.
   The final product was a low crystalline calcium deficient carbonated apatite similar to the composition and structure of bone mineral.
   In vivo performance of this cement in mediating bone healing was compared to alpha-BSM (R) in a rabbit femoral defect model.
   Performance characteristics of some commercially available CPC products are compared. The concerns of CPC designers and the needs of product users (surgeons) are discussed.
C1 [Tofighi, A.; Schaffer, K.; Palazzolo, R.] ETEX Corp, Cambridge, MA 02139 USA.
RP Tofighi, A (reprint author), ETEX Corp, Univ Pk MIT, Cambridge, MA 02139 USA.
CR BROWN WE, 1983, J DENT RES, V62, P672
   CATALANO PJ, 2007, ENG MAT, V330, P799
   Chow LC, 2001, J RES NATL INST STAN, V106, P1029, DOI 10.6028/jres.106.053
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   JARCHO M, 1977, J BIOENG, V1, P79
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   REDDI AH, 2001, JBJS A S1, V83
   Rey C, 2002, ACTUALITES BIOMATERI, P27
   TOFIGHI A, 2007, ORS AAOS, P124
   Van Landuyt P, 1999, BONE, V25, p95S, DOI 10.1016/S8756-3282(99)00142-8
   2006, LAST ADV BONE SUBSTI
NR 11
TC 16
Z9 16
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 361-363
BP 303
EP 306
DI 10.4028/www.scientific.net/KEM.361-363.303
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200076
DA 2018-10-19
ER

PT S
AU Fatimi, A
   Tassin, JF
   Axelos, MAV
   Weiss, P
AF Fatimi, A.
   Tassin, J. F.
   Axelos, M. A. V.
   Weiss, P.
BE Daculsi, G
   Layrolle, P
TI Sedimentation study of biphasic calcium phosphate particles
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE biphasic calcium phosphate; cellulose ether derivatives; sedimentation;
   viscosity
ID THERMAL GELATION; METHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE;
   KINETICS; WATER
AB Injectable calcium phosphate (CaP) biomaterial is considered as an injectable bone substitute (IBS). It was developed to minimize invasive surgery in various applications in orthopedic and dental surgery. The IBS considered of a polymer solution mixed with biphasic calcium phosphate (BCP) ceramic particles. Two particle sizes of BCP (40-80 and 80-200 mu m) were used and the weight ratio was 40%. This study investigated the influence of polymer solution on the OF BCP particles stability. Effects of particles size and limiting viscosity of polymer on the sedimentation were studied. The polymer concentration and particles size can be adapted to provide the best stability and storage of IBS.
C1 [Fatimi, A.; Weiss, P.] Univ Nantes, LIOAD, INSERM, U791, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.
   [Tassin, J. F.] Univ Maine, CNRS, UMR6120, Polymeres Colloides Interfaces, F-72085 Le Mans, France.
   [Axelos, M. A. V.] INRA, UR1268, Biopolymeres Interact Assemblages, F-44300 Nantes, France.
RP Fatimi, A (reprint author), Univ Nantes, LIOAD, INSERM, U791, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.
EM ahmed.fatimi@univ-nantes.fr; jean-francois.tassin@univ-lemans.fr;
   monique.axelos@nantes.inra.fr; pierre.weiss@univ-nantes.fr
RI Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590
FU CPER "Biomateriaux S3"; Region Pays de la Loire
FX This work was supported by CPER "Biomateriaux S3" 2004-2008, Region Pays
   de la Loire. The help of Paul Pilet (Center of Electronic Microscopy,
   INSERM U791 CHU Nantes) for the image observations and granulometry
   analysis is acknowledged with gratitude.
CR ALLAIN C, 1993, ADV COLLOID INTERFAC, V46, P129, DOI 10.1016/0001-8686(93)80038-D
   Balastre M, 2002, COLLOID SURFACE A, V211, P145, DOI 10.1016/S0927-7757(02)00240-6
   Bosco J, 2007, KEY ENG MATER, V330-332, P847, DOI 10.4028/www.scientific.net/KEM.330-332.847
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Clasen C, 2001, PROG POLYM SCI, V26, P1839, DOI 10.1016/S0079-6700(01)00024-7
   DACULSI G, 2009, BONE, V25, pS59
   HAQUE A, 1993, CARBOHYD POLYM, V22, P161, DOI 10.1016/0144-8617(93)90137-S
   Kobayashi K, 1999, MACROMOLECULES, V32, P7070, DOI 10.1021/ma990242n
   SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420
   SARKAR N, 1995, CARBOHYD POLYM, V26, P195, DOI 10.1016/0144-8617(94)00107-5
   SARKAR N, 1995, CARBOHYD POLYM, V27, P177, DOI 10.1016/0144-8617(95)00061-B
   Shojaei A, 2006, CHEM ENG SCI, V61, P7565, DOI 10.1016/j.ces.2006.08.050
   Tritt-Goc J, 2002, J CONTROL RELEASE, V80, P79, DOI 10.1016/S0168-3659(01)00556-9
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
NR 14
TC 4
Z9 4
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 365
EP +
DI 10.4028/www.scientific.net/KEM.361-363.365
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200091
DA 2018-10-19
ER

PT S
AU Bernstein, A
   Nobell, D
   Mayr, HO
   Gildenhaar, R
   Berger, G
   Ploska, U
   Brandt, J
AF Bernstein, A.
   Noebell, D.
   Mayr, H. O.
   Gildenhaar, R.
   Berger, G.
   Ploska, U.
   Brandt, J.
BE Daculsi, G
   Layrolle, P
TI Influence of calcium zirconium phosphate containing coatings on
   mineralization of bone
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE ceramics; coating; biomaterial; bone; biocompatibility; surface reaction
AB Bioactive ceramics such as hydroxypatite (HA) promote and enhance biological fixation. There is still a discussion oil the desired longevity of the coating. Stable coatings require an optimum between resorption rate, flexural strength and adhesive strength of the coating. Ceramic coatings containing fluorapatite (FA, Ca5(PO4)(3)F) and calcium zirconium phosphate (CZP, CaZr4(PO4)(6)) promise lower resorption rates than conventional HA coatings in the biological milieu. It is hoped that they can improve the long-term stability of implants by eliminating the detrimental resorption of coating material. For the in vivo studies plasma sprayed coatings were generated. The materials were implanted into the distal femur epiphysis of rabbits and investigated after 2, 4, 6, 12, and 24 weeks postoperatively. Histological analysis was preformed on the areas surrounding the implant. The amount of osseointegration was determined by using the automatically image analysis. The bonding strengths were compared with HA coating and uncoated titanium alloy. According to available data, there is inhibition of mineralization of bone at the interface of calcium zirconium phosphate ceramics of the described composition.
C1 [Bernstein, A.; Noebell, D.; Mayr, H. O.; Brandt, J.] Univ Halle, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle, Germany.
   [Gildenhaar, R.; Berger, G.; Ploska, U.] Fed Inst Mat Res & Testing, D-12200 Berlin, Germany.
RP Bernstein, A (reprint author), Univ Halle, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle, Germany.
EM anke.bernstein@medizin.uni-halle.de; georg.berger@bam.de
FU German Research Foundation [BE1964/2-1, 2, BE1339/10-1, 2]
FX Financial support by the German Research Foundation (DFG Grant. No.
   BE1964/2-1, 2 and BE1339/10-1, 2) is gratefully acknowledged.
CR ALAMO J, 1993, SOLID STATE IONICS, V63-5, P547, DOI 10.1016/0167-2738(93)90158-Y
   ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P141, DOI 10.3109/17453679209154809
   Berger G, 2003, KEY ENG MAT, V240-2, P607, DOI 10.4028/www.scientific.net/KEM.240-242.607
   BERNSTEIN A, 2007, UNPUB J BIOMED MAT R
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   FLASCHKA H, 1956, J ANAL CHEM+, V150, P339
   PEASRE AGE, 1968, HISTOCHEMISTRY THEOR
   SENBHAGARAMAN S, 1993, J MATER CHEM, V3, P309, DOI 10.1039/jm9930300309
NR 8
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 641
EP +
DI 10.4028/www.scientific.net/KEM.361-363.641
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200159
DA 2018-10-19
ER

PT S
AU Ionita, D
   Aldea, E
   Stanciu, G
   Demetrescu, I
AF Ionita, D.
   Aldea, E.
   Stanciu, G.
   Demetrescu, I.
BE Daculsi, G
   Layrolle, P
TI Evaluation and characterization of TiAlZr alloys coated with apatite or
   albumin-apatite composite
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE hydroxyapatite layer; surface morphology; albumin-apatite;
   biocompatibility; wettability
ID BIOMEDICAL APPLICATIONS; TITANIUM; PHOSPHATE; CALCIUM; LAYER
AB The aim of this paper was to find and establish the contact: biomaterial implant (TiAlZr) - coated with biologically active molecules; and the correlation between surface characteristics and their efficiency.
C1 [Ionita, D.; Aldea, E.; Demetrescu, I.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
   [Stanciu, G.] Univ Politehn Bucuresti, Ctr Microscopy Microanal & Informat Proc, Bucharest 011061, Romania.
RP Ionita, D (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
EM md_ionita@yahoo.com; aldea_e@yahoo.ca; stanciu@physics.pub.ro;
   i_demetrescu@chim.pub.ro
CR Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Guillemot F, 2002, J COLLOID INTERF SCI, V255, P75, DOI 10.1006/jcis.2002.8623
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   IONITA D, 2007, KEY ENG MATER, V330, P557
   KARLSSON M, 2004, ACTA U UPSALIENSIS
   Lima J, 2001, J BIOMED MATER RES, V55, P45, DOI 10.1002/1097-4636(200104)55:1<45::AID-JBM70>3.0.CO;2-0
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   OSHIDA Y, 2001, Patent No. 6183255
   Textor M., 2001, TITANIUM MED, P171
NR 10
TC 4
Z9 4
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 733
EP +
DI 10.4028/www.scientific.net/KEM.361-363.733
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200182
DA 2018-10-19
ER

PT S
AU Garmendia, N
   Bilbao, L
   Munoz, R
   Goikoetxea, L
   Garcia, A
   Bustero, I
   Olalde, B
   Garagorri, N
   Obieta, I
AF Garmendia, N.
   Bilbao, L.
   Munoz, R.
   Goikoetxea, L.
   Garcia, A.
   Bustero, I.
   Olalde, B.
   Garagorri, N.
   Obieta, I.
BE Daculsi, G
   Layrolle, P
TI Nanozirconia partially coated MWNT: Nanostructural characerization and
   cytotoxicity and lixivation study
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE hip prostheses; ceramic nanocomposites; carbon nanotubes; nanozirconia;
   cytotoxicity study
AB Carbon nanotubes could avoid the crack propagation and enhance the toughness of the ceramic material used for prostheses applications. So nanozirconia partially coated carbon nanotubes have been obtained via hydrothermal synthesis of zirconia nanoparticles in presence of multiwall carbon nanotubes. The as covered nanotubes should have a better wettability in the ceramic matrix and improve the dispersion of the CNTs in the nanocomposite, which results in a new ceramic biomaterial with a longer lifetime and better reliability. The obtained product has been structurally characterized by several techniques such as FTIR, XRD, SEM, AFM, EELS, XPS and TGA. The citotoxicity of the sintered product was studied by the change in the pH and ICP-AES in in-vitro biocompatibility tests.
C1 [Garmendia, N.; Bilbao, L.; Munoz, R.; Goikoetxea, L.; Garcia, A.; Bustero, I.; Olalde, B.; Garagorri, N.; Obieta, I.] INASMET TECNALIA, Unidad Salud, San Sebastian 20009, Spain.
RP Garmendia, N (reprint author), INASMET TECNALIA, Unidad Salud, Paseo Mikeletegui 2,Parque Tecnol, San Sebastian 20009, Spain.
RI Munoz Gomez, Roberto/Q-5768-2017; Obieta, Isabel/A-7137-2011
OI Munoz Gomez, Roberto/0000-0002-7668-6681; 
CR Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   GARMENDIA N, 2007, UNPUB CARBON
   Lupo F, 2004, CARBON, V42, P1995, DOI 10.1016/j.carbon.2004.03.037
   Shan Y, 2005, NANOTECHNOLOGY, V16, P625, DOI 10.1088/0957-4484/16/6/001
NR 5
TC 7
Z9 7
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 361-363
BP 775
EP 778
DI 10.4028/www.scientific.net/KEM.361-363.775
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200192
DA 2018-10-19
ER

PT S
AU Ribeiro, C
   Bressiani, JC
   Bressiani, AHA
AF Ribeiro, C.
   Bressiani, J. C.
   Bressiani, A. H. A.
BE Daculsi, G
   Layrolle, P
TI Characterization of the calcium phosphate porous ceramic obtained by
   foam consolidation using albumin
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE porous ceramic; tricalcium phosphate; albumin; foam
AB In many in-vivo and in vitro studies, the behavior of calcium phosphate ceramics like P tricalcium phosphate in biological environments has been reported to be predictive and positive. In terms of bone tissue growth, this ceramic can be more attractive presenting a porous microstructure. To obtain biomaterial quality ceramics, in this investigation beta- TCP porous ceramics were prepared by a special consolidation method with albumin as a foam generating agent. This technique enables preparation a variety of formats with complex geometries. To obtain porous samples using albumin, heat had to be introduced into the system during the consolidation stage. After consolidation, the samples were sintered at 1250 degrees C for 30 minutes and characterized using X-ray diffractometry, scanning electron microscopy and mercury porosimetry. The foams that were obtained by this method exhibited spherical and interconnected pores, characteristics desirable in biomedical implants.
C1 [Ribeiro, C.; Bressiani, J. C.; Bressiani, A. H. A.] IPEN CNEN SP, Inst Nucl Energy Res, CCTM, Mat Technol & Sci Ctr, BR-05508000 Sao Paulo, Brazil.
RP Ribeiro, C (reprint author), IPEN CNEN SP, Inst Nucl Energy Res, CCTM, Mat Technol & Sci Ctr, Av Prof Lineu Prestes 2242, Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM cribeiro@ipen.br; jbressia@ipen.brl; abressia@ipen.br
RI Bressiani, Ana/I-1402-2012; Bressiani, Jose/I-1426-2012
CR Dhara S, 2001, J AM CERAM SOC, V84, P3048, DOI 10.1111/j.1151-2916.2001.tb01137.x
   Garrn I, 2004, J EUR CERAM SOC, V24, P579, DOI 10.1016/S0955-2219(03)00259-0
   Le Nihouannen D, 2007, J MATER SCI-MATER M, V18, P225, DOI 10.1007/s10856-006-0684-7
   LORENZO RLM, 2001, BIOMATERIALS, V22, P1847
   Lyckfeldt O, 2000, J EUR CERAM SOC, V20, P2551, DOI 10.1016/S0955-2219(00)00136-9
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Ribeiro C, 2006, MATER SCI FORUM, V530-531, P587, DOI 10.4028/www.scientific.net/MSF.530-531.587
   RIBEIRO C, 2006, AN 17 C BRAS ENG CIE, V101, P1
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014
NR 10
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 361-363
BP 971
EP 974
DI 10.4028/www.scientific.net/KEM.361-363.971
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200240
DA 2018-10-19
ER

PT S
AU Rousseau, M
   Boulzaguet, H
   Biagianti, J
   Duplat, D
   Milet, C
   Lopez, E
   Bedouet, L
AF Rousseau, Marthe
   Boulzaguet, Helene
   Biagianti, Julie
   Duplat, Denis
   Milet, Christian
   Lopez, Evelyne
   Bedouet, Laurent
BE Daculsi, G
   Layrolle, P
TI Low molecular weight molecules of oyster nacre induce mineralization of
   the MC3T3-E1
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE MC3T3-E1 pre-osteoblast; mineralization; nacre; metabolites;
   osteopontin; runx2
ID DIFFERENTIATION; CELLS; BONE
AB The nacre layer from the pearl oyster shell is considered as a promising osteoinductive biomaterial. Nacre contains one or more signal molecules capable of stimulating bone formation. The identity and the mode of action of these molecules on the osteoblast differentiation were analyzed. Water-soluble molecules from nacre were fractionated according to dialysis, solvent extraction and reversed-phase HPLC. The activity of a fraction composed of low molecular weight molecules in the mineralization of the MC3T3-E1 extracellular matrix was investigated. Mineralization of the preosteoblast cells was monitored according to alizarin red staining, Raman spectroscopy, scanning electron microscopy and quantitative RT-PCR. Molecules isolated from nacre, ranging from 50 to 235 Da, induced a red alizarin staining of the preosteoblasts extracellular matrix after 16 days of culture. Raman spectroscopy demonstrated the presence of hydroxyapatite in samples treated with these molecules. Scanning electron microscopy pictures showed at the surface of the treated cells the occurence of clusters of spherical particles ressembling to hydroxyapatite. The treatment of cells with nacre molecules accelerated expression of collagen I and increased the mRNA expression of Runx2 and osteopontin. This study indicated that the nacre molecules efficient in bone cell differentiation are certainly different from proteins, and could be useful for in vivo bone repair.
C1 [Rousseau, Marthe; Boulzaguet, Helene; Biagianti, Julie; Duplat, Denis; Milet, Christian; Lopez, Evelyne; Bedouet, Laurent] ERT Valorisat Mol Bioact Origine Marine, CNRS MNHN Biol Organ Marins & Ecosyst, UMR 5178, Dept Milieux & Peuplements Aquat, F-75231 Paris 05, France.
RP Rousseau, M (reprint author), ERT Valorisat Mol Bioact Origine Marine, CNRS MNHN Biol Organ Marins & Ecosyst, UMR 5178, Dept Milieux & Peuplements Aquat, CP 26,43 Rue Cuvier, F-75231 Paris 05, France.
RI MNHN/CNRS/UPMC/IRD, UMR BOREA/B-2312-2012
CR Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200
   Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 6
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 361-363
BP 1017
EP 1020
DI 10.4028/www.scientific.net/KEM.361-363.1017
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200251
DA 2018-10-19
ER

PT S
AU Park, SH
   Park, JM
   Lee, HS
   Min, KS
   Pae, AR
   Kang, NR
AF Park, S. H.
   Park, J. M.
   Lee, H. S.
   Min, K. S.
   Pae, A. R.
   Kang, N. R.
BE Daculsi, G
   Layrolle, P
TI Gene-expression of MC3T3-E1 osteoblast cells cultured on anodized
   titanium surface and machined titanium surface by using cDNA microarray
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE MCM-E1 osteoblast; cDNA microarray; anodized titanium; machined
   titanium; implant surface
ID IMPLANTS
AB One of the techniques for modifying Ti implant surface is all anodization. This method is an electrochemical one that forms rough, thick.. and porous oxide films. To compare the gene expression from the cells cultured on the different implant surface, cDNA microarray have been performed. MC3T3-E1 cells were cultured on titanium disks. The control groups were cultured on the machined surfaces(MS). The experimental groups cultured on the anodized titanium surfaces(AS). Microarray assay 48 hours after culturing the cells on the machined surface and anodized surface revealed that osteoinductive molecules appeared more prominent on the anodized surface, whereas the adhesion molecules oil the biomaterial were higher on the machined surface than anodized surface, which will affect the phenotype of the plated cells depending on the surface morphology.
C1 [Park, S. H.] Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea.
   [Park, J. M.] Ewha Womans Univ, Grad Sch Clin, Dept Implantol, Seoul, South Korea.
   [Lee, H. S.] Kangnung Univ, Oral anatomy Den Sch, Kangnung, South Korea.
   [Min, K. S.] Wonkwang Univ, Den Sch, Dept Conservat Dentistry, Iksan, South Korea.
   [Pae, A. R.] Ewha Womans Univ Mokdong Hosp, Dept Dentistry, Div Prosthodont, Seoul, South Korea.
   [Kang, N. R.] Ewha Womans Univ Mokdong Hosp, Dept Dentistry, Dev Oral & Maxillofac Surg, Seoul, South Korea.
RP Park, SH (reprint author), Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea.
EM shpark94@khu.ac.kr; jumi1970@naver.com; nightsu@kangnung.ac.kr;
   mksdd@wonkwang.ac.kr; ahranmine@hanmail.net; narakang@ewha.ac.kr
OI Min, Kyung-San/0000-0002-1928-3384
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Carinci Francesco, 2003, J Oral Implantol, V29, P215, DOI 10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Harris LG, 2005, J BIOMED MATER RES A, V73A, P12, DOI 10.1002/jbm.a.30276
   Isa ZM, 2006, INT J ORAL MAX IMPL, V21, P203
   Kim Y, 2004, BIOTECHNOL LETT, V26, P399, DOI 10.1023/B:BILE.0000018258.58314.5c
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Son WW, 2003, J BIOMED MATER RES B, V66B, P520, DOI 10.1002/jbm.b.10042
   Zechner W, 2003, CLIN ORAL IMPLAN RES, V14, P150, DOI 10.1034/j.1600-0501.2003.140203.x
NR 10
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1091
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1091
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200269
DA 2018-10-19
ER

PT S
AU Park, SH
   Kim, HH
   Lee, HS
   Choi, YS
   Pae, AR
   Kim, MR
AF Park, S. H.
   Kim, H. H.
   Lee, H. S.
   Choi, Y. S.
   Pae, A. R.
   Kim, M. R.
BE Daculsi, G
   Layrolle, P
TI Comparison of gene-expression of MC3T3-E1 osteoblastic cell cultured on
   machined titanium surface and resorbable blast material titanium surface
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE MC3T3-E1 osteoblast; cDNA microarray; resorbable blast material
   titanium; machined titanium; implant surface
ID REMOVAL TORQUE; IMPLANTS; GROWTH
AB Because of its high biocompatibility, hydroxyapatite(HA) has been considered as a good blasting material. DNA microarray is a new molecular technology that enables the analysis of gene expression in parallel on a very large number of genes, spanning a significant fraction of the human genome. It is a qualitive analysis (e,g. it can differentiate each single gene) and quantitative, since it has the sensitivity to detect a change of expression level in the investigated cells when compared to normal samples. The aim of this study is to define the cell attachment and the genetic effect of machined surface implant and RBM (resorbable blast media) surface implant on the osteoblastic cell (MC3T3-E1 osteoblastic cell line) by cDNA microarray slide containing 21575 genes. Cells were Cultured on machined grade 4 titanium disks(Group 1, machined surface) and disks of RBM (Group 2) and the samples were moved to new dishes and media were added and the plated disks were cultured for 24 hours. Total RNA extraction was performed with Qiagen mini kit (Qiagen, Chatsworth, CA, USA) for microarray assay. Microarray assay after culturing the cells on the machined surface and RBM surface revealed that osteoinductive molecules appeared more prominent on the RBM surface, whereas the adhesion molecules on the biomaterial were higher on the machined surface than RBM surface.
C1 [Park, S. H.] Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea.
   [Kim, H. H.] Ewha Womans Univ, Grad Sch Clin Dentistry, Dept Implantol, Seoul, South Korea.
   [Lee, H. S.] Kangnung Univ, Den Sch, Oral anatomy, Kangnung, South Korea.
   [Choi, Y. S.] Kyung Hee Univ, Dent Sch, Dept Oral Maxillofac Radiol, Seoul, South Korea.
   [Pae, A. R.] Ewha Womans Univ Mokdong Hosp, Dept Dentistry, Div Prosthodont, Seoul, South Korea.
   [Kim, M. R.] Ewha Womans Univ Mokdong Hosp, Dept Dentistry, Dev Oral & Maxillofac Surg, Seoul, South Korea.
RP Park, SH (reprint author), Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea.
EM shpark94@khu.ac.kr; sunray_kr@yahoo.co.kr; nightsu@kangnung.ac.kr;
   omrcys@khu.ac.kr; ahranmine@hanmail.net; myungrae@ewha.ac.kr
CR Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Carinci F, 2003, ORAL ONCOL, V39, P69, DOI 10.1016/S1368-8375(02)00027-1
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285, DOI 10.3109/17453678608994393
   Cho SA, 2003, BIOMATERIALS, V24, P3611, DOI 10.1016/S0142-9612(03)00218-7
   De Jong DS, 2002, J BONE MINER RES, V17, P2119, DOI 10.1359/jbmr.2002.17.12.2119
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Niimi A, 1997, CLIN ORAL IMPLAN RES, V8, P286, DOI 10.1034/j.1600-0501.1997.080406.x
   Piattelli Maurizio, 2002, J Oral Implantol, V28, P2, DOI 10.1563/1548-1336(2002)028<0002:BRTMAR>2.3.CO;2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
NR 12
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1095
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1095
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200270
DA 2018-10-19
ER

PT S
AU Maksoud, R
   Lefevbre, L
   Heinrich, L
   Gremillard, L
   Chevalier, J
   Hartmann, DJ
AF Maksoud, R.
   Lefevbre, L.
   Heinrich, L.
   Gremillard, L.
   Chevalier, J.
   Hartmann, D. J.
BE Daculsi, G
   Layrolle, P
TI Preliminary results of in vitro study of cell growth in a 45S5 bioactive
   glass as bone substitute using scanning electron and confocal
   microscopies.
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE bone substitute; porous bioglass; cell culture; scanning electron
   microscopy; confocal microscopy
ID BIOMATERIALS
AB The aim of this study was to evaluate the cytocompatibility, cell ingrowth and extracellular matrix deposition of a newly developed porous bioactive glass as a bone substitute. Two types of bioactive glass, different in their pore size (75 and 20 ppi, resp. similar to 350 and similar to 1200 mu m), were used in this study. The materials were seeded with human osteoblastic (MG63) and fibroblastic (M-228 F01 and M-191 F01) cell lines. The cells were visualized by two techniques, scanning electron microscopy and confocal microscopy. For confocal microscopy cell nuclei were labeled with propidium iodide (IP) and the extracellular matrix components (type I collagen and osteocalcin) by specific antibodies. Cells and matrix were visualized by fluorescence. The bioactive glass used in this study was shown to be non cytotoxic. Cell growth and colonization at the surface and in the depth of the material were observed. Extracellular matrix deposition was also demonstrated which proved the proper biofunctionality of the biomaterial. Scanning electron microscope allowed us to visualize cells at a high magnification at the surface of the bioglass and evidenced that the biomaterials were covered by a sheet of cells with their matrix; on the other hand, confocal microscopy permitted us to observe cell ingrowth and matrix deposition within the depth of the substitute. We showed that extracellular matrix was synthesized mainly in the upper levels where the cell population was the most confluent. In summary, this porous bioglass appears promising for bone substitution.
C1 [Maksoud, R.; Heinrich, L.; Hartmann, D. J.] Univ Lyon, Unite Reparat Tissulaire Interact Biol & Biomat, RTI2B, ISPB Fac Pharm, 8 Av Rockefeller, F-69373 Lyon 08, France.
   [Lefevbre, L.; Heinrich, L.; Gremillard, L.] INSALYON, UMR CNRS 5510, F-69621 Villeurbanne, France.
RP Maksoud, R (reprint author), Univ Lyon, Unite Reparat Tissulaire Interact Biol & Biomat, RTI2B, ISPB Fac Pharm, 8 Av Rockefeller, F-69373 Lyon 08, France.
EM rami.maksoud@univ-lyon1.fr; leila.lefebvre@insa-lyon.fr;
   laurence.heinrich@recherche.univ-lyon1.fr;
   laurent.gremillard@insa-lyon.fr; jerome.chevalier@insa-lyon.fr;
   hartmann@sante.univ-lyon1.fr
OI Gremillard, Laurent/0000-0001-7258-6483
CR Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   BUCH BE, 1990, CLIN ORTHOP RELAT R, V251, P249
   CARPENTER PR, 1986, J MATER SCI LETT, V5, P1309, DOI 10.1007/BF01729402
   Heinrich L, 2007, J BIOMED MATER RES B, V81B, P153, DOI 10.1002/jbm.b.30648
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, P SURFACES INTERFACE, P265
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   SAMUEL D, 1988, LANCET, V1, P1221
   ZENATI R, 2005, Patent No. 2005001921
NR 9
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1111
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1111
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200274
DA 2018-10-19
ER

PT S
AU Sovar, MM
   Aldea, E
   Mitran, V
   Miculescu, F
   Demetrescu, I
AF Sovar, M. M.
   Aldea, E.
   Mitran, V.
   Miculescu, F.
   Demetrescu, I.
BE Daculsi, G
   Layrolle, P
TI Cell growth on TiAlNb alloy as a function of bioactivation method
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE bioactivation; cell culture; chemical and electrochemical treatments; HA
   deposition; electrochemical measurement
ID TITANIUM
AB This paper it supposed to demonstrate how to obtain the hydroxylapatite on the surface of TiAlNb biomaterial used as dental implant. The bone-forming bioactivity of TiAlNb is associated with its chemical and structural properties, including composition, porosity, specific surface area and particle size. After different bioactivation surface treatments as chemical and electrochemical treatments, it was observed a better stability for the TiAlNb alloy that was treated electrochemically.
C1 [Sovar, M. M.; Aldea, E.; Demetrescu, I.] Univ Politecn Bucharest, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
   [Mitran, V.] Univ Bucharest, Fac Biol, Bucharest RO-76201, Romania.
   [Miculescu, F.] Univ Politecn, Bucharest Mat Sci & Engn Fac, RO-060042 Bucharest, Romania.
RP Sovar, MM (reprint author), Univ Politecn Bucharest, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
EM aldea_e@yahoo.ca
RI Miculescu, Florin/A-4524-2011; Demetrescu, Ioana/C-5325-2013
OI Miculescu, Florin/0000-0001-6757-5616; Mitran,
   Valentina/0000-0002-5192-9595
CR ALDEA E, 2006, INT C BIOM MED DEV, P128
   Barrere F, 2000, KEY ENG MAT, V192-1, P67
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Ionita D, 2007, KEY ENG MATER, V330-332, P577, DOI 10.4028/www.scientific.net/KEM.330-332.577
   Jaeggi C, 2005, SURF COAT TECH, V200, P1913, DOI 10.1016/j.surfcoat.2005.08.021
   Ng BD, 2005, BIOMATERIALS, V26, P1087, DOI 10.1016/j.biomaterials.2004.04.022
   Pihlstrom BL, 2005, J AM DENT ASSOC, V136, P728, DOI 10.14219/jada.archive.2005.0256
   POPA MV, IN PRESS MAT CORROSI
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Textor M., 2001, TITANIUM MED, P171
   Vermes C, 2001, J ARTHROPLASTY, V16, P95, DOI 10.1054/arth.2001.28719
NR 11
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1131
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1131
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200279
DA 2018-10-19
ER

PT S
AU Frayssinet, P
   Combacau, M
   Gougeon, M
   Rouquet, N
AF Frayssinet, Patrick
   Combacau, Marylene
   Gougeon, Michel
   Rouquet, Nicole
BE Daculsi, G
   Layrolle, P
TI Histological evaluation of a new biomaterial releasing magnetite
   nanoparticles inside bone metastases for thermotherapy
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE magnetite; nanoparticles; cancer
ID HYPERTHERMIA
AB Magnetite nanoparticles were used for their ability to be heated when they are put in an oscillating magnetic field. When they are located inside tumors they can eradicate the tumor cells by heating. We have developed a biomaterial constituted by a mineral degradable matrix containing magnetite nanoparticles. This material can be injected into bone metastasis in which it sets and releases magnetite particles uptaked inside the cancer cells. We have implanted this material inside rabbit bone to check by histology the fate of the nanoparticles in bone. The implant matrix was degraded within a few days releasing the nanoparticles. They were found inside monocytes and fibroblasts having ingrown the material. The nanoparticles could form aggregates which then were fragmented in micro/nanoparticles penetrating the surrounding cells. This study showed that the nanoparticles are released from the mineral matrix within a few days and penetrate the cells in their close proximity.
C1 [Frayssinet, Patrick; Combacau, Marylene; Rouquet, Nicole] Urodelia, F-31470 St Lys, France.
   [Gougeon, Michel] Univ Toulouse 3, CIRMAT, Toulouse, France.
RP Frayssinet, P (reprint author), Urodelia, F-31470 St Lys, France.
EM patrick.frayssinet@wanadoo.fr
CR Hafeli UO, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P501
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   Shimamura T, 2005, BIOMED RES-TOKYO, V26, P159, DOI 10.2220/biomedres.26.159
NR 4
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1211
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1211
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200298
DA 2018-10-19
ER

PT S
AU Daculsi, G
   Aguado, E
   Corre, P
   Bourges, X
   Baroth, S
   Goyenvalle, E
AF Daculsi, G.
   Aguado, E.
   Corre, P.
   Bourges, X.
   Baroth, S.
   Goyenvalle, E.
BE Daculsi, G
   Layrolle, P
TI Improvement of radio opacity of injectable bone substitute MBCP Gel (TM)
   for minimal invasive surgery MIS
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE biocompatibility; MBCP gel; injectable biomaterials
AB Dedicated to Minimal Invasive Surgery MIS particularly in spine for vertebroplasty, the surgeons and radiologists ask for improvement of radio opacity, to be sure of the injection site, and to prevent injection in blood vessels. MBCP Gel(R) is an Injectible biomaterial non self hardening, the biomaterials consists of BCP granules associated with a hydrosoluble polymer. These materials have been shown to be perfectly biocompatible and potentially resorbable and, thanks to their initial plasticity, they assume the shape of the bone defects very easily, eliminating the need to shape the material to adjust to the implantation site. MBCP gels do not have mechanical properties like the hydraulic bone cements. However bone cells are able to invade the spaces created by the disappearance of the polymer carrier. Bone ingrowth takes place all around the granules at the expense of the resorption of the BCP granules. In time, the mechanical property is increased due to the presence of the newly formed bone. This study demonstrates an improvement of MBCP get by freeze drying and reconstitution using iodine solution or sterile water in a classical model of rabbit bone defects.
C1 [Daculsi, G.; Corre, P.; Baroth, S.] Univ Nantes, INSERM, U791, F-44035 Nantes, France.
   [Aguado, E.; Goyenvalle, E.] Natl Vet Sch Nantes, BBTOCEx, ENVN, Nantes, France.
   [Bourges, X.; Baroth, S.] Biomatlante SAS, Vigneuxde Bretagne, France.
   [Aguado, E.; Goyenvalle, E.] INSERM, F-0335 Angers, France.
RP Daculsi, G (reprint author), Univ Nantes, INSERM, U791, F-44035 Nantes, France.
EM guy.daculsi@univ-nantes.fr; aguado@vet-nantes.fr;
   pierre.corre@univ-nantes.fr; xavierbourges@biomatlante.com;
   serge.baroth@univ-nantes.fr; goyenvalle@vet-nantes.fr
RI Daculsi, Guy/P-1320-2014; CORRE, Pierre/P-1307-2014
OI Daculsi, Guy/0000-0003-1030-3446; CORRE, Pierre/0000-0003-4587-2163
CR Daculsi G, 2005, KEY ENG MAT, V284-286, P803, DOI 10.4028/www.scientific.net/KEM.284-286.803
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   DECULSI G, 2006, ADV SCI TECHNOLOGY, V49, P9
   FABRE T, 2007, KEY ENG MAT, V333
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   MAINARD D, 2005, MONOGRAPHIE GEST
   Niwa S, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P385
   Saffarzadeh A, 2004, KEY ENG MAT, V254-2, P193, DOI 10.4028/www.scientific.net/KEM.254-256.193
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 11
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1277
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1277
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200314
DA 2018-10-19
ER

PT S
AU Fabre, T
   Chauveaux, D
   Moinard, M
   Mais, C
   Durand, M
   Pollart, C
   Daculsi, G
AF Fabre, T.
   Chauveaux, D.
   Moinard, M.
   Mais, C.
   Durand, M.
   Pollart, C.
   Daculsi, G.
BE Daculsi, G
   Layrolle, P
TI Pilot study of safety and performance of a mixture of calcium phosphate
   granules combined with cellulosic-derived gel after tunnel filling
   created during surgical treatment of femoral head aseptic osteonecrosis
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE biphasic calcium phosphate; injectable; clinical study; bone filling;
   femoral head osteonecrosis
ID IMPLANTATION
AB The biomaterial studied here is a composite associating a mineral phase of an intimate nanoscale melting of hydroxyapatite and beta tri calcium phosphate and an aqueous phase containing a synthetic polymer derived from cellulose HPMC (hydroxyl propyl methyl cellulose), marketed under name MBCP Gel (FDA approval, Biomatlante manufacturer). The present exploratory study aim was to study the safety of MBCP-gel, and to determine in the osseous healthy area the performance of MBCP gel. We expected to prove bone ingrowth into the osseous cavities created during drilling biopsy of the aseptic osteonecrosis of femoral head. The current results obtained in the first two patients with I year follow up demonstrate the resorption and bone ingrowth with trabecular bone architecture in the hole created into the femoral neck.
C1 [Fabre, T.; Chauveaux, D.; Moinard, M.] Hop Pellegrin, CHU Bordeaux, F-33000 Bordeaux, France.
   [Mais, C.; Durand, M.; Daculsi, G.] Hop Haut Leveque, CHU Bordeaux, INSERM, CIC, Pessac 33604, France.
   [Pollart, C.] Biomatlante SAS, Vigneuxde Bretagne, France.
RP Fabre, T (reprint author), Hop Pellegrin, CHU Bordeaux, F-33000 Bordeaux, France.
EM thierry.fabre@chu-bordeaux.fr; dominique.chauveaux@chu-bordeaux.fr;
   maryse.moinard@chu-bordeaux.fr; Claude.Mais@bordeaux.inserm.fr;
   marlene.durand@chu-bordeaux.fr; clairepollart@biomatlante.com;
   guy.daculsi@univ-nantes.fr
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
FU sponsor Biomatlante SAS; Vigneux de Bretagne, France [44360]
FX This study was supported by the sponsor Biomatlante SAS, 44360 Vigneux
   de Bretagne, France. Thanks for J. Demotes support for the set up of
   this clinical trial (CIC: Centre dInvestigation Clinique INSERM/
   Bordeaux University Hospital).
CR Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gauthier O, 1999, BONE, V25, p71S, DOI 10.1016/S8756-3282(99)00137-4
   Khairoun I, 2004, Provisional patent, Patent No. [11054623, 11/054 623]
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   MAINARD D, 2005, MONOGRAPHIE GEST
   Niwa S, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P385
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 9
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1295
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1295
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200318
DA 2018-10-19
ER

PT S
AU Durand, M
   Chauveaux, D
   Moinard, M
   Fabre, T
   Rouvillain, JL
   d'Arc, MB
   Daculsi, G
AF Durand, M.
   Chauveaux, D.
   Moinard, M.
   Fabre, T.
   Rouvillain, J. L.
   d'Arc, M. Bagot
   Daculsi, G.
BE Daculsi, G
   Layrolle, P
TI TricOs((TM)) and fibrin sealant combined for bone defect filling: From
   pre-clinical tests to prospective clinical study. Preliminary human data
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE TRICOS; mouldable self-hardening biodegradable bone substitute;
   tolerance histology/morphometry; X-rays and CT-scan follow up
ID SURGERY; GLUE
AB The association of TricOs (TM) (Macroporous Biphasic Ceramic Phosphate MBCP granules) and the fibrin sealant FS VH S/D 4, has been developed to answer a challenging request of orthopaedic surgeons: a biocompatible, osteogenic, mouldable, and self-hardening bone substitute able to fill randomly shaped bone defects. The aims of this study was the evaluation of the performance and safety of the bioactive bone substitute TricOS (TM) associated with a fibrin sealant in regeneration of functional bone. The pre-clinical tests were conducted to optimize MBCP granules size and ratio MBCP-FS VH S/D 4 (sheep maxillary sinus grafting, femoral epiphysis defect in rabbits, long bone defects in sheep). A clinical study design was set up as an exploratory prospective French multicentric phase II study sponsored by INSERM (Institut National de la Saute et de la Recherche Medicale). The application was the TOV (Tibial Osteotomy of Valgisation) using osteosynthesis and bone substitute: TricOs (TM) mixed with the fibrin sealant (FS VH S/D 4) for filling the space created. The follow up is 13 months with safety checks, clinical assessments, high-sensitivity X-ray, and CT-scan imaging. A bone sample will be collected from the reconstructed area at 12 months, during the osteosynthesis material removal surgery. The principal criterion is CT-scan imaging performed 12 months after TOV surgery, before material removal, to assess qualitative and quantitative bone reconstruction. Animals' studies demonstrate that the biomaterial is safe to use and shows osteoconductive properties, granules resorption and bone ingrowth at the expenses of the implants. As for clinical trial, 7 patients are today included in the study: This paper present the first results obtained from X-ray imaging during follow up.
C1 [Durand, M.] Hop Xavier Arnozan, PTIB, Ctr Innovat Technol Biomat CHU Bordeaux, F-33600 Pessac, France.
   [Chauveaux, D.; Fabre, T.] Hop Pellegrin CHU Bordeaux, Serv chirurgie orthoped, F-33076 Bordeaux, France.
   [Moinard, M.] Serv radiol CHU Bordeaux, Hop Pellegrin, F-33076 Bordeaux, France.
   [Rouvillain, J. L.] Hop Zobda Quitman, Serv Chirurgie Orthoped, F-97261 Fort, France.
   [d'Arc, M. Bagot] Baxter Biosurg, F-78311 Maurepas, France.
   [Daculsi, G.] INSERM, Ctr Invest Clin CHU Bordeaux, Hop Haut Leveque, F-33604 Pessac, France.
RP Durand, M (reprint author), Hop Xavier Arnozan, PTIB, Ctr Innovat Technol Biomat CHU Bordeaux, F-33600 Pessac, France.
EM mariene.durand@chu-bardeaux.fr; Dominique.chauveaux@chu-bordeaux.fr;
   maryse.moinard@chu-bordeaux.fr; Thierry.fabre@chu-bordeaux.fr;
   jean-louis.rouvillain@chu-fortdefrance.fr;
   maurice_bagot_d'arc@baxter.com; guy.daculsi@univ-nantes.fr
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446; ROUVILLAIN, JEAN
   LOUIS/0000-0002-9076-9096
FU French Ministry of Industry [RNTS 2002]
FX Katharina Bittner and Reiner Spaethe from Baxter BioScience BioSurgery,
   Biomatlante SAS and French Ministry of Industry grant RNTS 2002 to
   support these studies.; All scientists and technicians of INSERM EM9903
   laboratory of Materials of Biological Interest and Nantes Veterinary
   National School, LBBTO, for theirs contributions to the preclinical
   experiments.
CR Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   Bertrand B, 1996, LARYNGOSCOPE, V106, P652, DOI 10.1097/00005537-199605000-00026
   BERTRAND B, 1994, COMPT REND S ORG SER
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   D'Arc MB, 2004, ANN OTO RHINOL LARYN, V113, P711, DOI 10.1177/000348940411300907
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   Daculsi G., 1990, J BIOMED MATER RES, P24379
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
NR 8
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1335
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1335
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200328
DA 2018-10-19
ER

PT S
AU Peltola, M
   Aitasalo, K
   Tirri, T
   Rekola, J
   Puntala, A
AF Peltola, M.
   Aitasalo, K.
   Tirri, T.
   Rekola, J.
   Puntala, A.
BE Daculsi, G
   Layrolle, P
TI Long-term tissue reactions of three biomaterials in craniofacial surgery
SO BIOCERAMICS, VOL 20, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 20th International Symposium on Ceramics in Medicine
CY OCT 24-26, 2007
CL Nantes, FRANCE
SP Int Soc Ceram Med
DE long-term; clinical; tissue reactions; biomaterial
ID FRONTAL-SINUS; HYDROXYAPATITE; OBLITERATION
AB Successful craniofacial reconstruction needs both a well-known and a reliable reconstruction material. However, there is often a lack of long-term knowledge of the tissue reactions and healing process in the human body. In this study, frontal sinus obliterations with bovine bone natural hydroxyapatite derivative (BHA), synthetic bioactive glass S53P4 (BAG) and hydroxyapatite cement (HAC) were investigated with clinical, histologic, scanning electron microscopic (SEM) and energy dispersive x-ray analysis (EDXA) 27, 12 and 3 years postoperatively. The aim was to determine the long-term clinical biocompatibility of the used materials. Histologic studies revealed bone formation with BHA particles and lamellar bone with BAG granule remnants in close contact to the new bone formation. In HAC reconstruction there was scattered fibroconnective tissue growth without new bone formation in the surface of HAC implantation. Neither foreign body reaction nor any abnormal findings were seen. SEM studies revealed a CaP layer on the surface of BAG granule remnants. In EDXA studies, composition profiles showed Ca-, P- and Si- rich layers on the BAG granule surface. No differences were found in CaO and P2O5 levels between BHA granules and HAC implantation and the surrounding bone. All investigated biomaterials were well tolerated in long-term applications.
C1 [Peltola, M.; Aitasalo, K.; Rekola, J.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FI-20520 Turku, Finland.
   [Tirri, T.] Turku Univ, Inst Dent, FI-20500 Turku, Finland.
   [Puntala, A.] Turku Univ Hosp, Dept Neurosurg, FI-20500 Turku, Finland.
RP Peltola, M (reprint author), Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FI-20520 Turku, Finland.
EM matti.peltola@tyks.fi; kalle.aitasalo@tyks.fi; teemu.tirri@utu.fi;
   jami.rekola@tyks.fi; puntala@tyks.fi
CR Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Close Lanny Garth, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P67, DOI 10.1097/00020840-200502000-00015
   Metson R, 2004, OTOLARYNG CLIN N AM, V37, P411, DOI 10.1016/S0030-6665(03)00153-1
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   ROSEN G, 1995, LARYNGOSCOPE, V105, P553, DOI 10.1288/00005537-199505000-00023
   Siirala U, 1967, Int Surg, V47, P425
   Snyderman CH, 2001, OTOLARYNG CLIN N AM, V34, P179, DOI 10.1016/S0030-6665(05)70305-4
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Weber R., 1999, Rhinology (Utrecht), V37, P1
NR 9
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 361-363
BP 1343
EP +
DI 10.4028/www.scientific.net/KEM.361-363.1343
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BHJ11
UT WOS:000253480200330
DA 2018-10-19
ER

PT J
AU Granicka, L
   Kawiak, J
   Werynski, A
AF Granicka, Ludomira
   Kawiak, Jerzy
   Werynski, Andrzej
TI The biocompatibility of membranes for immunoisolation
SO BIOCYBERNETICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE encapsulation; hollow fibers; membrane stability; membrane non-toxity;
   biomaterial performance with the host
ID CELLS; BIOMATERIALS
AB The assessment of biocompatibility of systems consisting of a host, permiselective membrane and a biological material, encapsulated within may be standardized for biological material immunoisolation purposes. The procedures for evaluation of the membrane non-toxicity against the biological material, the membrane physical and chemical stability post implantation and the biomaterial ability to perform with the host are presented.
C1 [Granicka, Ludomira; Kawiak, Jerzy; Werynski, Andrzej] Polish Acad Sci, Inst Biocybernet & Biomed Engn, PL-02109 Warsaw, Poland.
RP Granicka, L (reprint author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Ul Ks Trojdena 4, PL-02109 Warsaw, Poland.
EM ludomira@ibib.waw.pl
CR Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Clark H, 2000, J BIOMED MATER RES, V52, P183, DOI 10.1002/1097-4636(200010)52:1<183::AID-JBM24>3.0.CO;2-D
   Desanctis LB, 1996, INT J ARTIF ORGANS, V19, P404
   GRANICKA L, 2006, BIOENKAPSULACJA DLA
   GRANICKA L, 2004, ARTIF CELL BLOOD SUB, V32, P1
   GRANICKA LH, 2005, MEMBR SCI TECHN C VI
   Huang TH, 2002, BIOMATERIALS, V23, P77, DOI 10.1016/S0142-9612(01)00081-3
   Nageswari K, 1998, J BIOMATER APPL, V13, P74, DOI 10.1177/088532829801300105
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Roy S, 2003, SENSOR MATER, V15, P335
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   WILIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4, P66
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 16
TC 1
Z9 1
U1 0
U2 0
PU PWN-POLISH SCIENTIFIC PUBL
PI WARSAW
PA UL KS TROJDENA 4, WARSAW, 02-109, POLAND
SN 0208-5216
J9 BIOCYBERN BIOMED ENG
JI Biocybern. Biomed. Eng.
PY 2008
VL 28
IS 2
BP 59
EP 68
PG 10
WC Engineering, Biomedical
SC Engineering
GA 326LG
UT WOS:000257659900006
DA 2018-10-19
ER

PT B
AU Ku, DN
   Fan, JW
AF Ku, David N.
   Fan, Jin Wu
BE Bastos, T
   Gamboa, H
TI Biomaterial for soft tissue replacements
SO BIODEVICES 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON
   BIOMEDICAL ELECTRONICS AND DEVICES, VOL 1
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Electronics and Devices
CY JAN 28-31, 2008
CL Funchal, PORTUGAL
SP INSTICC, Univ Madeira, IEEE EMB, Assoc Advancement Artificial Intelligence
DE biomaterial; mechanics; elasticity; strength; wear; biocompatibility;
   medical devices
AB Typical biomaterials are stiff, difficult to manufacture, and not initially developed for medical implants. A new biomaterial is proposed that is similar to human soft tissue. The biomaterial provides mechanical properties similar to soft tissue in its mechanical and physical properties. Characterization is performed for modulus of elasticity, ultimate strength and wear resistance. The material further exhibits excellent biocompatibility with little toxicity and low inflammation. The material can be molded into a variety of anatomic shapes for use as a cartilage replacement, heart valve, and reconstructive implant for trauma victims. The biomaterial may be suitable for several biodevices of the future aimed at soft-tissue replacements.
C1 [Ku, David N.; Fan, Jin Wu] Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Ku, DN (reprint author), Georgia Inst Technol, Atlanta, GA 30332 USA.
CR HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
NR 3
TC 1
Z9 1
U1 0
U2 3
PU INSTICC-INST SYST TECHNOLOGIES INFORMATION CONTROL & COMMUNICATION
PI SETUBAL
PA AVENIDA D MANUEL L, 27A 2 ESQUERDO, SETUBAL, 2910-595, PORTUGAL
BN 978-989-8111-17-3
PY 2008
BP 23
EP 29
PG 7
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Biomedical; Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BHU55
UT WOS:000256526000007
DA 2018-10-19
ER

PT B
AU Navarro, L
   Pinoli, JC
   Besset, H
   Guyonnet, R
   Vico, L
   Guignandon, A
AF Navarro, Laurent
   Pinoli, Jean-Charles
   Besset, Henri
   Guyonnet, Rene
   Vico, Laurence
   Guignandon, Alain
BE Bastos, T
   Gamboa, H
TI A new instrumented biological device designed to apply mechanical shocks
   to bone cells
SO BIODEVICES 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON
   BIOMEDICAL ELECTRONICS AND DEVICES, VOL 2
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Electronics and Devices
CY JAN 28-31, 2008
CL Funchal, PORTUGAL
SP INSTICC, Univ Madeira, IEEE EMB, Assoc Advancement Artificial Intelligence
DE mechanical shocks; biomechanical device; energy; acceleration forces;
   Fourier analysis
ID OSTEOBLASTS; PROLIFERATION; EXPRESSION; SURFACES; STRAIN
AB A new device called biomechanical stimulation device (BSD) has been recently developped and is under patenting process. This BSD allows to apply shocks to a biomaterial disc, on which bone cells have been seeded. To observe the real behaviour of the biomaterial under shock loading, the BSD is instrumented with an impact hammer and an accelerometer. Force and acceleration signals are recorded, and signal analysis can be performed, in particular Fourier analysis. The results obtained lead to a better understanding of the stimulus that the cells can perceive at the top surface of the biomaterial disc. It appears that mechanical shocks applied at 1 Hps (Hit per second) or 10 Hps generate a frequency content up to 35 kHz. The main further objective will be to characterize the influence of mechanical shocks on bone cells proliferation.
C1 [Navarro, Laurent; Pinoli, Jean-Charles] Ecole Natl Super Mines, CIS, 158 Cours Fauriel, F-42023 St Etienne 2, France.
   [Besset, Henri; Guyonnet, Rene] SPIN, F-42023 St Etienne 2, France.
   [Vico, Laurence; Guignandon, Alain] Univ Jan Monnet St Etienne, LBTO, INSERM U890, F-42023 St Etienne, France.
RP Navarro, L (reprint author), Ecole Natl Super Mines, CIS, 158 Cours Fauriel, F-42023 St Etienne 2, France.
EM navarro@emse.fr; pinoli@emse.fr
RI Vico, Laurence/O-1927-2018
OI Vico, Laurence/0000-0002-2110-287X; Navarro, Laurent/0000-0002-8788-8027
CR Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bilezikian J. P., 2002, PRINCIPLES BONE BIOL
   Flandrin P., 1993, TEMPS FREQUENCE
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Giakas G, 1996, SPINE, V21, P2235, DOI 10.1097/00007632-199610010-00011
   Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kacena MA, 2003, IN VITRO CELL DEV-AN, V39, P454
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   Tjandrawinata RR, 1997, FASEB J, V11, P493
NR 13
TC 0
Z9 0
U1 0
U2 1
PU INSTICC-INST SYST TECHNOLOGIES INFORMATION CONTROL & COMMUNICATION
PI SETUBAL
PA AVENIDA D MANUEL L, 27A 2 ESQUERDO, SETUBAL, 2910-595, PORTUGAL
BN 978-989-8111-17-3
PY 2008
BP 272
EP +
PG 2
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Biomedical; Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BHU57
UT WOS:000256526900051
DA 2018-10-19
ER

PT J
AU Marner, WD
   Shaikh, AS
   Muller, SJ
   Keasling, JD
AF Marner, Wesley D., II
   Shaikh, Afshan S.
   Muller, Susan J.
   Keasling, Jay D.
TI Morphology of artificial silica matrices formed via autosilification of
   a silaffin/protein polymer chimera
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-COMPLEMENTARY OLIGOPEPTIDE; NONPOLAR RESIDUES; PHASE-SEPARATION;
   DIATOM BIOSILICA; BIOMATERIAL; PEPTIDES; COLLAGEN; MORPHOGENESIS;
   POLYAMINES; SCAFFOLDS
AB Protein polymers (long-chain proteins in which a specific amino acid sequence "monomer" is repeated through the molecule) are found widely in nature, and these materials exhibit a diverse array of physical properties. One class of self-as.sembling proteins is hydrophobic-polar (HP) protein polymers capable of self-assembly under the appropriate solution conditions. We generated a chimeric protein consisting of an HP protein polymer monomer unit, EAK(1) (sequence n-AEAEAKAKAEAEAKAK-c), and a silaffin peptide, R5 (sequence: n-SSKKSGSYSG-SKGSKRRIL-c). First identified in diatoms, silaffins represent a class of proteins and peptides capable of directing silica precipitation in vitro at neutral pH and ambient temperatures. The EAK(1)-R5 chimera demonstrated self-assembly into hydrogels and the ability to direct silica precipitation in vitro. This chimera is capable of generating silica morphologies and feature sizes significantly different from those achievable with the R5 peptide alone, indicating that fusions of silaffins with self-assembling proteins may be a route to controlling the morphology of artificially produced silica matrices.
C1 [Marner, Wesley D., II; Shaikh, Afshan S.; Muller, Susan J.; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
   [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Keasling, Jay D.] Lawrence Berkely Natl Lab, Phys Biosci Div, Synthet Biol Dept, Berkeley, CA 94720 USA.
RP Keasling, JD (reprint author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
EM keasling@berkeley.edu
RI Keasling, Jay/J-9162-2012
OI Keasling, Jay/0000-0003-4170-6088
FU NIGMS NIH HHS [T32 GM008352]
CR Brunner E, 2004, PHYS CHEM CHEM PHYS, V6, P854, DOI 10.1039/b313261g
   Caplan MR, 2002, IND ENG CHEM RES, V41, P403, DOI 10.1021/ie010149z
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011
   Forti FL, 2006, J BIOMATER APPL, V20, P267, DOI 10.1177/0885328206054048
   Goeden-Wood NL, 2003, MACROMOLECULES, V36, P2932, DOI 10.1021/ma025952z
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497
   Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221
   Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandel-Gutfreund Y, 2002, J MOL BIOL, V323, P453, DOI 10.1016/S0022-2836(02)00973-9
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Patwardhan SV, 2006, P NATL ACAD SCI USA, V103, P9428
   Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Wang K, 2005, INT J BIOL MACROMOL, V36, P232, DOI 10.1016/j.ijbiomac.2005.06.006
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 26
TC 26
Z9 27
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2008
VL 9
IS 1
BP 1
EP 5
DI 10.1021/bm701131x
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 251ZW
UT WOS:000252415600001
PM 18092760
DA 2018-10-19
ER

PT J
AU Stamov, D
   Grimmer, M
   Salchert, K
   Pompe, T
   Werner, C
AF Stamov, Dimitar
   Grimmer, Milauscha
   Salchert, Katrin
   Pompe, Tilo
   Werner, Carsten
TI Heparin intercalation into reconstituted collagen I fibrils: Impact on
   growth kinetics and morphology
SO BIOMATERIALS
LA English
DT Article
DE collagen; heparin; glycosaminoglycan; molecular weight; ECM; charge
ID HEMATOPOIETIC PROGENITOR CELLS; RAT TAIL TENDON; ATOMIC-FORCE
   MICROSCOPY; EXTRACELLULAR-MATRIX; STEM-CELLS; MONOMERIC TROPOCOLLAGEN;
   MECHANICAL-PROPERTIES; PROTEIN INTERACTIONS; BINDING SITES;
   GLYCOSAMINOGLYCANS
AB Collagen type I fibrils, reconstituted in vitro in the presence of heparin, exhibit an unusually thick and straight shape. A detailed structural analysis by scanning force and scanning electron microscopy revealed a non-linear dependence in size distribution, width-to-length ratio, and morphology over a wide range of glycosaminoglycan (GAG) concentrations. By varying molecular weight, degree of sulphation, charge, and concentration of different GAGs we are able to correlate the morphological data with kinetic turbidimetric measurements, and quantitation of fibril-bound GAG. The experiments imply a pronounced impact of the prenucleation phase on the cofibril morphology as a result of the strong electrostatic interaction of heparin with tropocollagen. Heparin is assumed to stabilize the collagen microfibrils and to enhance their parallel accretion during cofibrillogenesis with preservation of the typical asymmetric collagen banding pattern. The heparin quantitation data show heparin to be intercalated as a linker molecule with one specific binding site inside the cofibrils. The reconstituted cofibrils with their unusual morphology and GAG intercalation-a phenomenon not reported in vivo-can be expected to exhibit interesting mechanical and biochemical behaviours as a biomaterial for extracellular matrix scaffolds. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Max Bergmann Ctr Biomat Dresden, Leibnitz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
RP Pompe, T (reprint author), Max Bergmann Ctr Biomat Dresden, Leibnitz Inst Polymer Res Dresden, Hohe Str 6, D-01069 Dresden, Germany.
EM pompe-tilo@ipfdd.de
RI Stamov, Dimitar/E-8421-2011; Werner, Carsten/F-8127-2010; Umlauf,
   Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; Pompe, Tilo/0000-0003-1508-4959;
   Stamov, Dimitar/0000-0003-3140-3235
CR Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BIRK DE, 2005, COLLAGEN PRIMER STRU, P185
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   BRUNO E, 1995, EXP HEMATOL, V23, P1212
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   CHAPMAN JA, 1989, BIOPOLYMERS, V28, P1367, DOI 10.1002/bip.360280803
   CHAPMAN JA, 1981, STRUCTURAL ASPECTS R
   Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006
   COMPER WD, 1977, BIOPOLYMERS, V16, P2133, DOI 10.1002/bip.1977.360161005
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dao MA, 1998, BLOOD, V92, P4612
   de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746
   Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015
   Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   FLINT MH, 1984, CONNECT TISSUE RES, V13, P69, DOI 10.3109/03008208409152144
   Franke K, 2007, BIOMATERIALS, V28, P836, DOI 10.1016/j.biomaterials.2006.09.031
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   GUIDRY C, 1987, J CELL BIOL, V104, P1097, DOI 10.1083/jcb.104.4.1097
   Gupta P, 1998, BLOOD, V92, P4641
   HAMANN KJ, 1995, J IMMUNOL, V154, P4073
   Hirsch M, 2001, EXP EYE RES, V72, P123, DOI 10.1006/exer.2000.0935
   Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103
   Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8
   HOLMES DF, 1992, P NATL ACAD SCI USA, V89, P9855, DOI 10.1073/pnas.89.20.9855
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KELLER KM, 1986, BIOCHIM BIOPHYS ACTA, V882, P1, DOI 10.1016/0304-4165(86)90047-4
   KREIS T, 1999, GUIDEBOOK EXTRACELLU
   Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030
   Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LILJA S, 1983, EXP PATHOL-JENA, V23, P173, DOI 10.1016/S0232-1513(83)80055-3
   LILJA S, 1981, VIRCHOWS ARCH A, V390, P325, DOI 10.1007/BF00496562
   LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, STEM CELLS, V17, P295, DOI 10.1002/stem.170295
   MATHEWS MB, 1968, BIOCHEM J, V109, P517, DOI 10.1042/bj1090517
   Matrosova VY, 2004, STEM CELLS, V22, P544, DOI 10.1634/stemcells.22-4-544
   MCPHERSON JM, 1988, COLLAGEN REL RES, V8, P65
   Milan AM, 2005, CALCIFIED TISSUE INT, V76, P127, DOI 10.1007/s00223-004-0033-0
   NEMETHCSOKA M, 1977, EXP PATHOL-JENA, V14, P40, DOI 10.1016/S0014-4908(77)80090-2
   OBRINK B, 1973, EUR J BIOCHEM, V34, P129, DOI 10.1111/j.1432-1033.1973.tb02739.x
   OBRINK B, 1973, EUR J BIOCHEM, V33, P387, DOI 10.1111/j.1432-1033.1973.tb02695.x
   ORBIEN FJ, 2007, TECHNOL HEALTH CARE, V15, P3
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Pilarski LM, 1999, BLOOD, V93, P2918
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Salchert K, 2003, J CHROMATOGR A, V1005, P113, DOI 10.1016/S0021-9673(03)00932-4
   Salchert K, 2004, BIOMACROMOLECULES, V5, P1340, DOI 10.1021/bm0499031
   Salchert K, 2005, J MATER SCI-MATER M, V16, P581, DOI 10.1007/s10856-005-0535-y
   SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179
   SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573
   SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313
   SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213
   SILVER FH, 1979, J THEOR BIOL, V81, P515, DOI 10.1016/0022-5193(79)90049-3
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   Themistocleous GS, 2004, IN VIVO, V18, P687
   TRUS BL, 1976, J MOL BIOL, V108, P705, DOI 10.1016/S0022-2836(76)80113-1
   Tsai SW, 2006, BIOPOLYMERS, V83, P381, DOI 10.1002/bip.20568
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   WOOD GC, 1960, BIOCHEM J, V75, P605, DOI 10.1042/bj0750605
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   WOOD GC, 1960, BIOCHEM J, V75, P598, DOI 10.1042/bj0750598
   YOUNG RD, 1985, J CELL SCI, V74, P95
   Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5
NR 86
TC 50
Z9 50
U1 3
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2008
VL 29
IS 1
BP 1
EP 14
DI 10.1016/j.biomaterials.2007.09.009
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 235CH
UT WOS:000251210600001
PM 17892897
DA 2018-10-19
ER

PT J
AU Sierpinski, P
   Garrett, J
   Ma, J
   Apel, P
   Klorig, D
   Smith, T
   Koman, LA
   Atala, A
   Van Dyke, M
AF Sierpinski, Paulina
   Garrett, Jeffrey
   Ma, Jianjun
   Apel, Peter
   Klorig, David
   Smith, Thomas
   Koman, L. Andrew
   Atala, Anthony
   Van Dyke, Mark
TI The use of keratin biomaterials derived from human hair for the
   promotion of rapid regeneration of peripheral nerves
SO BIOMATERIALS
LA English
DT Article
DE nerve regeneration; nerve guide; ECM; Schwann cell; keratin
ID SPONGE SCAFFOLDS; MOLECULAR-BASIS; SCHWANN-CELLS; GROWTH-FACTOR;
   EXPRESSION; DIFFERENTIATION; PROLIFERATION; CULTIVATION; FABRICATION;
   FOLLICLE
AB The management of trauma-associated nerve defects is difficult because of the absence of autologous donor motor or sensory nerves. Pre-clinical development and clinical experience has shown that damaged nerves can be surgically repaired using a tubular conduit interposed across the defect. Acceptable patient outcomes are achieved so long as the gap distance does not exceed a few centimeters. Although research in animals has demonstrated that nerve repair can be facilitated across slightly larger gaps by introducing a biomaterial filler into the conduit lumen, these biomaterials are not typically "neuroinductive" (i.e. capable of acting directly on regenerative cells to enhance nerve tissue formation beyond clinical limits). Moreover, their use does not often result in functional recovery equivalent to nerve autograft, the clinical gold standard. Here we show that a biomaterial gel made from the proteins found in human hair can mediate a robust nerve regeneration response, in part through activation of Schwann cells. In vitro, keratins extracted from human hair enhance the activity of Schwann cells by a chemotactic mechanism, increase their attachment and proliferation, and upregulate expression of important genes. Moreover, these characteristics translate to improved functional nerve recovery in an animal model. These results suggest that a biomaterial derived from human hair keratins is neuroinductive and can facilitate an outcome comparable to autograft in a nerve injury model. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Wake Forest Univ, Sch Med, Wake Forest Inst Regenet Med, Winston Salem, NC 27157 USA.
   Wake Forest Univ, Sch Med, Dept Orthopaed, Winston Salem, NC 27157 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenet Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160; Klorig, David/0000-0001-8756-771X
CR Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795
   BANSAL R, 1987, J NEUROCHEM, V49, P1902, DOI 10.1111/j.1471-4159.1987.tb02453.x
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   CORY AH, 1991, CANCER COMMUN, V3, P207
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   FELTRI ML, 1994, DEVELOPMENT, V120, P1287
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327
   HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D
   Ide C, 1996, NEUROSCI RES, V25, P101
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   Ioannidou E, 2006, CURR PHARM DESIGN, V12, P2397, DOI 10.2174/138161206777699007
   Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379
   JONES CM, 1991, DEVELOPMENT, V111, P531
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   LIU HM, 1992, ACTA NEUROPATHOL, V83, P469
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LYONS KM, 1990, DEVELOPMENT, V109, P833
   MA J, 2007, IN PRESS J ORTHOP RE
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   National Centre for Biotechnology Information (NCBI), ENTR PROT DAT
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9
   STEIN KS, 1996, DERMATOL CLIN, V14, P543
   Stenn K S, 1994, J Dermatol Sci, V7 Suppl, pS109, DOI 10.1016/0923-1811(94)90042-6
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   TOONEY PA, 1993, IMMUNOL CELL BIOL, V71, P131, DOI 10.1038/icb.1993.14
   Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168
   van de Locht M, 1987, MELLIAND TEXTILBERIC, V10, P780
   Verge VMK, 1996, PHILOS T R SOC B, V351, P423, DOI 10.1098/rstb.1996.0038
   Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902
NR 39
TC 168
Z9 176
U1 5
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2008
VL 29
IS 1
BP 118
EP 128
DI 10.1016/j.biomaterials.2007.08.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 235CH
UT WOS:000251210600013
PM 17919720
DA 2018-10-19
ER

PT J
AU Neuss, S
   Apel, C
   Buttler, P
   Denecke, B
   Dhanasingh, A
   Ding, XL
   Grafahrend, D
   Groger, A
   Hemmrich, K
   Herr, A
   Jahnen-Dechent, W
   Mastitskaya, S
   Perez-Bouza, A
   Rosewick, S
   Salber, J
   Woltje, M
   Zenke, M
AF Neuss, Sabine
   Apel, Christian
   Buttler, Patricia
   Denecke, Bernd
   Dhanasingh, Anandhan
   Ding, Xiaolei
   Grafahrend, Dirk
   Groger, Andreas
   Hemmrich, Karsten
   Herr, Alexander
   Jahnen-Dechent, Willi
   Mastitskaya, Svetlana
   Perez-Bouza, Alberto
   Rosewick, Stephanie
   Salber, Jochen
   Woeltje, Michael
   Zenke, Martin
TI Assessment of stem cell/biomaterial combinations for stem cell-based
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE mesenchymal stem cells; preadipocytes; endothelial progenitor cells;
   dental pulp stem cells; hematopoietic stem cells; embryonic stem cells
ID IN-VITRO; BIOMATERIALS; DIFFERENTIATION; MICROARRAY; OSTEOBLAST
AB Biomaterials are used in tissue engineering with the aim to repair or reconstruct tissues and organs. Frequently, the identification and development of biomaterials is an iterative process with biomaterials being designed and then individually tested for their properties in combination with one specific cell type. However, recent efforts have been devoted to systematic, combinatorial and parallel approaches to identify biomaterials, suitable for specific applications. Embryonic and adult stem cells represent an ideal cell source for tissue engineering. Since stem cells can be readily isolated, expanded and transplanted, their application in cell-based therapies has become a major focus of research. Biomaterials can potentially influence e.g. stem cell proliferation and differentiation in both, positive or negative ways and biomaterial characteristics have been applied to repel or attract stem cells in a niche-like microenvironment. Our consortium has now established a grid-based platform to investigate stem cell/biomaterial interactions. So far, we have assessed 140 combinations of seven different stem cell types and 19 different polymers performing systematic screening assays to analyse parameters such as morphology, vitality, cytotoxicity, apoptosis, and proliferation. We thus can suggest and advise for and against special combinations for stem cell-based tissue engineering. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Neuss, Sabine; Denecke, Bernd; Jahnen-Dechent, Willi; Mastitskaya, Svetlana; Rosewick, Stephanie; Woeltje, Michael] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, IZKF BIOMAT, D-52074 Aachen, Germany.
   [Neuss, Sabine; Perez-Bouza, Alberto; Rosewick, Stephanie] Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany.
   [Apel, Christian; Buttler, Patricia] Rhein Westfal TH Aachen, Dept Conservat Dent Peridontol & Prevent Dent, D-52074 Aachen, Germany.
   [Dhanasingh, Anandhan; Grafahrend, Dirk; Salber, Jochen] DWI eV, D-52074 Aachen, Germany.
   [Dhanasingh, Anandhan; Grafahrend, Dirk; Salber, Jochen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Ding, Xiaolei; Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Aachen, Germany.
   [Ding, Xiaolei; Jahnen-Dechent, Willi; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany.
   [Groger, Andreas; Hemmrich, Karsten] Rhein Westfal TH Aachen, Dept Plast Surg Hand Surg, Burn Unit, Aachen, Germany.
   [Herr, Alexander] Med Fac Carl Gustav Carus, Inst Clin Genet, Dresden, Germany.
   [Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Biointerface Grp, Inst Biomed Engn, D-52074 Aachen, Germany.
RP Neuss, S (reprint author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, IZKF BIOMAT, Pauwelstr 30, D-52074 Aachen, Germany.
EM sneuss-stein@ukaachen.de
RI Jahnen-Dechent, Willi/A-7608-2011
OI Jahnen-Dechent, Willi/0000-0003-1315-4407
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Coleman SR, 1997, CLIN PLAST SURG, V24, P347
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gasteier P, 2007, MACROMOL BIOSCI, V7, P1010, DOI 10.1002/mabi.200700064
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HEMMRICH K, IN PRESS JMSM
   Hieronymus T, 2005, J IMMUNOL, V174, P2552, DOI 10.4049/jimmunol.174.5.2552
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Kozarova A, 2006, J PROTEOME RES, V5, P1051, DOI 10.1021/pr050432e
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   NEUSS S, IN PRESS CELL TRANSP
   NEUSS S, UNPUB SECRETION FIBR
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Zhang M, 2003, PASTORAL CARE ED, V21, P10
NR 27
TC 114
Z9 116
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2008
VL 29
IS 3
BP 302
EP 313
DI 10.1016/j.biomaterials.2007.09.022
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 242CY
UT WOS:000251703300006
PM 17935776
DA 2018-10-19
ER

PT B
AU Kikuchi, M
   Suetsugu, Y
   Koyama, Y
   Sotome, S
   Itoh, S
   Takakuda, K
   Shinomiya, K
   Edamura, K
   Nagaoka, K
   Tanaka, S
AF Kikuchi, Masanori
   Suetsugu, Yasushi
   Koyama, Yoshihisa
   Sotome, Shinichi
   Itoh, Soichiro
   Takakuda, Kazuo
   Shinomiya, Kenichi
   Edamura, Kazuya
   Nagaoka, Katsuyoshi
   Tanaka, Shigeo
BE Tateishi, T
TI Bone Regeneration Materials Based on Calcium Phosphate Ceramics
SO BIOMATERIALS IN ASIA: IN COMMEMORATION OF THE 1ST ASIAN BIOMATERIALS
   CONGRESS
LA English
DT Proceedings Paper
CT Conference on Biomaterials in Asia
CY DEC 06-08, 2007
CL Tsukuba, JAPAN
ID L-LACTIDE COMPOSITES; IN-VIVO; HYDROXYAPATITE/COLLAGEN COMPOSITE; NERVE
   REGENERATION; COLLAGEN; BIOMATERIAL; MEMBRANES; CARRIER; VITRO
C1 [Kikuchi, Masanori; Suetsugu, Yasushi] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan.
   [Koyama, Yoshihisa; Takakuda, Kazuo] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Sotome, Shinichi; Itoh, Soichiro; Shinomiya, Kenichi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan.
   [Edamura, Kazuya; Nagaoka, Katsuyoshi; Tanaka, Shigeo] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.
RP Kikuchi, M (reprint author), Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan.
EM KIKUCHI.Masanori@nims.go.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
FU Research Promotion Bureau; Ministry of Education, Culture, Sports,
   Science and Technology, Japan [19-207]
FX The study is supported in part by Research Promotion Bureau, Ministry of
   Education, Culture, Sports, Science and Technology, Japan under the
   contract No.19-207.
CR Bouchard P, 1997, J CLIN PERIODONTOL, V24, P511, DOI 10.1111/j.1600-051X.1997.tb00220.x
   Cerrai P, 1999, J MATER SCI-MATER M, V10, P677, DOI 10.1023/A:1008904229292
   FLORESDEJACOBY L, 1994, J CLIN PERIODONTOL, V21, P113, DOI 10.1111/j.1600-051X.1994.tb00288.x
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P564, DOI 10.1002/jbm.1055
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Kikuchi M, 2000, J CERAM SOC JPN, V108, P642, DOI 10.2109/jcersj.108.1259_642
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kikuchi Masanori, 2006, Advances in Science and Technology, V49, P1, DOI 10.4028/www.scientific.net/AST.49.1
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Koyama Y, 2003, JSME INT J C-MECH SY, V46, P1409, DOI 10.1299/jsmec.46.1409
   KOYAMA Y, 2000, J STOMATOLOGICAL SOC, V67, P63
   Leghissa GC, 1999, CLIN ORAL IMPLAN RES, V10, P62, DOI 10.1034/j.1600-0501.1999.100108.x
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   SUDA T, 1985, HONE NO KAGAKU, P129
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   VONITOH K, 2001, J RECONSTR MICROSURG, V17, P115
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
NR 26
TC 0
Z9 0
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-283-574-1
PY 2008
BP 327
EP +
DI 10.1142/9789812835758_0021
PG 4
WC Materials Science, Biomaterials
SC Materials Science
GA BIX84
UT WOS:000263639900022
DA 2018-10-19
ER

PT S
AU Ku, DN
AF Ku, David N.
BE Fred, A
   Filipe, J
   Gamboa, H
TI New Soft Tissue Implants Using Organic Elastomers
SO BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES
SE COMMUNICATIONS IN COMPUTER AND INFORMATION SCIENCE
LA English
DT Proceedings Paper
CT International Joint Conference on Biomedical Engineering Systems and
   Technologies
CY JAN 28-31, 2008
CL Funchal, PORTUGAL
DE Biomaterial; mechanics; elasticity; strength; wear; biocompatibility;
   medical devices
ID HYDROGEL
AB Typical biomaterials are. stiff, difficult to manufacture, and not initially developed for medical implants. A new biomaterial is proposed that is similar to human soft tissue. The biomaterial provides mechanical properties similar to soft tissue in its mechanical and physical properties. Characterization is performed for modulus of elasticity, ultimate strength and wear resistance. The material further exhibits excellent biocompatibility with little toxicity and low inflammation. The material can be molded into a variety of anatomic shapes for use as a cartilage replacement, heart valve, and reconstructive implant for trauma victims. The biomaterial may be suitable for several biodevices of the future aimed at soft-tissue replacements.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Ku, DN (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
CR HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   Nakamura T, 2001, J BIOMED MATER RES, V56, P289, DOI 10.1002/1097-4636(200108)56:2<289::AID-JBM1097>3.0.CO;2-W
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
NR 4
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1865-0929
BN 978-3-540-92218-6
J9 COMM COM INF SC
PY 2008
VL 25
BP 85
EP 95
PG 11
WC Engineering, Biomedical
SC Engineering
GA BIV03
UT WOS:000262981100006
DA 2018-10-19
ER

PT J
AU Pradel, W
   Mai, R
   Hagedorn, GM
   Lauer, G
   Allegrini, S
AF Pradel, Winnie
   Mai, Ronald
   Hagedorn, Gunnar Manolo
   Lauer, Guenter
   Allegrini, Sergio, Jr.
TI The biomaterial influences the ossification after sinus floor elevation
   using tissue-engineered bone grafts
SO BIOMEDIZINISCHE TECHNIK
LA English
DT Article
DE bone augmentation surgery; bone regeneration; bone replacement material;
   dental implants
ID OSTEOBLAST-LIKE CELLS; MAXILLARY SINUS; AUTOGENOUS BONE; AUGMENTATION;
   HYDROXYAPATITE; REGENERATION; CONSTRUCTS; PLACEMENT; GROWTH
AB Sinus floor elevation is the standard procedure that allows dental implant insertion in the atrophic posterior maxilla. Instead of autogenous bone, tissue-engineered bone grafts can be used, but clear comparative clinical studies also assessing the influence of the biomaterial are missing. In six patients, tissue-engineered bone grafts were used in eight sinus floor elevations. After culturing osteoblast-like cells from biopsies of the maxilla, they were seeded on scaffolds made either from demineralised bovine bone matrix (DBBM) or from solvent-dehydrated mineralised bovine bone (SDBB), and grafted. In all patients primary wound healing was without complications, except for one patient in the SDBB group. After 12 months, implant insertion was possible only in the SDBB group; in the DBBM group, fibrous connective tissue was found in an attempt of implant insertion. After 5 months, implant placement was performed in one patient of each group. However, the two implants inserted in the DBBM group were lost after 6 weeks. Histology of the bone cores in the DBBM group at 5 months showed lamellar bone and osteoid, and at 12 months showed fibrous connective tissue. Inflammation and some resorption of the scaffold was found 5 months after SDBB grafting, and after 12 months cancellous bone formation encapsulating SDBB remnants were observed. These preliminary data suggest that the preparation method of the bovine bone matrix, in particular the mineral content, and therefore the mechanical stability may have some influence on the generation of new bone.
C1 [Pradel, Winnie; Mai, Ronald; Hagedorn, Gunnar Manolo; Lauer, Guenter] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, D-01307 Dresden, Germany.
   [Allegrini, Sergio, Jr.] Ernst Moritz Arndt Univ Greifswald, Dept Orthodont Prevent & Pediat Dent, Greifswald, Germany.
RP Pradel, W (reprint author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Oral & Maxillofacial Surg, Fetscherstr 74, D-01307 Dresden, Germany.
EM winnie.pradel@uniklinikum-dresden.de
CR Fanghanel J, 2006, ANN ANAT, V188, P261, DOI 10.1016/j.aanat.2005.11.013
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Hubner U., 1999, OSTEOLOGIE, V8, P179
   Hutmacher D.W., 2002, IMPLANTOLOGIE, V10, P143
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   Pradel W, 2005, INT J ORAL MAX IMPL, V20, P860
   Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001
   Raghoebar GM, 1997, BRIT J ORAL MAX SURG, V35, P119, DOI 10.1016/S0266-4356(97)90687-2
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   Rissolo A R, 1998, Dent Clin North Am, V42, P91
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Shimakura Y, 2003, J CRANIOFAC SURG, V14, P108, DOI 10.1097/00001665-200301000-00021
   Springer IN, 2006, TISSUE ENG, V12, P2649, DOI 10.1089/ten.2006.12.2649
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   Tolman D E, 1995, Int J Oral Maxillofac Implants, V10, P275
   Ueda M, 2005, INT J PERIODONT REST, V25, P129
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 21
TC 7
Z9 8
U1 0
U2 3
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0013-5585
J9 BIOMED TECH
JI Biomed. Tech.
PY 2008
VL 53
IS 5
BP 224
EP 228
DI 10.1515/BMT.2008.034
PG 5
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA 369MG
UT WOS:000260698000004
PM 18803528
DA 2018-10-19
ER

PT J
AU Moutos, FT
   Guilak, F
AF Moutos, Franklin T.
   Guilak, Farshid
TI Composite scaffolds for cartilage tissue engineering
SO BIORHEOLOGY
LA English
DT Article; Proceedings Paper
CT 5th Symposium on Mechanobiology of Cartilage and Chondrodcyte
CY MAY, 2007
CL Athens, GREECE
DE Articular cartilage; tissue engineering; stem cell; hydrogel; fiber;
   biomaterial
ID MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; ARTICULAR-CARTILAGE;
   IN-VITRO; OSTEOCHONDRAL DEFECTS; PART 2; REPAIR; TRANSPLANTATION;
   CONSTRUCTS; OSTEOARTHRITIS
AB Tissue engineering remains a promising therapeutic strategy for the repair or regeneration of diseased or damaged tissues. Previous approaches have typically focused on combining cells and bioactive molecules ( e. g., growth factors, cytokines and DNA fragments) with a biomaterial scaffold that functions as a template to control the geometry of the newly formed tissue, while facilitating the attachment, proliferation, and differentiation of embedded cells. Biomaterial scaffolds also play a crucial role in determining the functional properties of engineered tissues, including biomechanical characteristics such as inhomogeneity, anisotropy, nonlinearity or viscoelasticity. While single-phase, homogeneous materials have been used extensively to create numerous types of tissue constructs, there continue to be significant challenges in the development of scaffolds that can provide the functional properties of load-bearing tissues such as articular cartilage. In an attempt to create more complex scaffolds that promote the regeneration of functional engineered tissues, composite scaffolds comprising two or more distinct materials have been developed. This paper reviews various studies on the development and testing of composite scaffolds for the tissue engineering of articular cartilage, using techniques such as embedded fibers and textiles for reinforcement, embedded solid structures, multi-layered designs, or three-dimensionally woven composite materials. In many cases, the use of composite scaffolds can provide unique biomechanical and biological properties for the development of functional tissue engineering scaffolds.
C1 [Guilak, Farshid] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
OI Guilak, Farshid/0000-0001-7380-0330
FU NIA NIH HHS [AG15768, R01 AG015768-11, R01 AG015768]; NIAMS NIH HHS [R21
   AR049294-01, R01 AR048182-03, P01 AR050245, R01 AR048182, AR50245,
   AR48852, R21 AR049294, AR49294, P01 AR050245-01, R01 AR048852]
CR Alford JW, 2005, AM J SPORT MED, V33, P443, DOI 10.1177/0363546505274578
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Callaghan JJ, 1998, J BONE JOINT SURG AM, V80A, P704, DOI 10.2106/00004623-199805000-00011
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016
   Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015
   Font-Rodriguez DE, 1997, CLIN ORTHOP RELAT R, P79
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Goldberg V M, 1999, Instr Course Lect, V48, P623
   Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hannouche D, 2007, TISSUE ENG, V13, P87, DOI 10.1089/ten.2006.0067
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liao E, 2007, TISSUE ENG, V13, P537, DOI 10.1089/ten.2006.0117
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   MAROUDAS A, 1985, BIORHEOLOGY, V22, P159
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Mow Van C., 1997, P275
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   POOLE A, 2006, OSTEOARTHRITIS DIAGN, P27
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schek RM, 2006, BIOMATERIALS, V27, P1160, DOI 10.1016/j.biomaterials.2005.07.029
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Soltz MA, 2003, J BIOMECH ENG-T ASME, V125, P585, DOI 10.1115/1.1610020
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P896, DOI 10.1016/j.joca.2005.05.003
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   URBAN JPG, 1979, BIORHEOLOGY, V16, P447
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 63
TC 67
Z9 70
U1 2
U2 19
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 2008
VL 45
IS 3-4
BP 501
EP 512
DI 10.3233/BIR-2008-0491
PG 12
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 373IS
UT WOS:000260965900027
PM 18836249
DA 2018-10-19
ER

PT J
AU Kim, IY
   Seo, SJ
   Moon, HS
   Yoo, MK
   Park, IY
   Kim, BC
   Cho, CS
AF Kim, In-Yong
   Seo, Seog-Jin
   Moon, Hyun-Seuk
   Yoo, Mi-Kyong
   Park, In-Young
   Kim, Bom-Chol
   Cho, Chong-Su
TI Chitosan and its derivatives for tissue engineering applications
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE chitin; chitosan; chitosan derivatives; scaffold; tissue engineering
ID GROWTH-FACTOR-BETA; PERIPHERAL-NERVE REGENERATION; IN-VITRO;
   ARTICULAR-CARTILAGE; RAT HEPATOCYTES; CARDIOPULMONARY BYPASS; COMPOSITE
   SCAFFOLDS; HYALURONIC-ACID; TRANSFORMING GROWTH-FACTOR-BETA-1; SOMITE
   CHONDROGENESIS
AB Tissue engineering is an important therapeutic strategy for present and future medicine. Recently, functional biomaterial researches have been directed towards the development of improved scaffolds for regenerative medicine. Chitosan is a natural polymer from renewable resources, obtained from shell of shellfish, and the wastes of the seafood industry. It has novel properties such as biocompatibility, biodegradability, antibacterial, and wound-healing activity. Furthermore, recent studies suggested that chitosan and its derivatives are promising candidates as a supporting material for tissue engineering applications owing to their porous structure, gel forming properties, ease of chemical modification, high affinity to in vivo macromolecules, and so on. In this review, we focus on the various types of chitosan derivatives and their use in various tissue engineering applications namely, skin, bone, cartilage, liver, nerve and blood vessel. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Kim, In-Yong; Seo, Seog-Jin; Moon, Hyun-Seuk; Yoo, Mi-Kyong; Park, In-Young; Kim, Bom-Chol; Cho, Chong-Su] Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea.
RP Cho, CS (reprint author), Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea.
EM chocs@plaza.snu.ac.kr
RI Moon, Hyun-Seuk/G-8576-2015
OI Moon, Hyun-Seuk/0000-0002-5216-2090
CR Adams JC, 2002, J CELL SCI, V115, P257
   Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Aimin C, 1999, Clin Orthop Relat Res, P239, DOI 10.1097/00003086-199909000-00031
   ALBELDA SM, 1990, FASEB J, V4, P2868
   American Heart Association, 2004, HEART DIS STROK STAT
   ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99
   ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bannan S, 1997, ANN THORAC SURG, V63, P663, DOI 10.1016/S0003-4975(96)01054-5
   Belboul A, 1997, PERFUSION-UK, V12, P385, DOI 10.1177/026765919701200607
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bittner B, 1998, EUR J PHARM BIOPHARM, V45, P295, DOI 10.1016/S0939-6411(98)00012-5
   BODMER D, 1992, J CONTROL RELEASE, V21, P129, DOI 10.1016/0168-3659(92)90014-I
   BORDER WA, 1994, NEW ENGL J MED, V331, P1286
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P791, DOI 10.1163/1568562053992496
   Chavez-Delgado ME, 2003, J BIOMED MATER RES B, V67B, P702, DOI 10.1002/jbm.b.10059
   Chen RH, 1996, CARBOHYD POLYM, V29, P353
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   DAVIS BK, 1974, P NATL ACAD SCI USA, V71, P3120, DOI 10.1073/pnas.71.8.3120
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Eugene K., 2003, BIOMATERIALS, V24, P2339
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Fukutomi M, 1996, ARTIF ORGANS, V20, P767, DOI 10.1111/j.1525-1594.1996.tb04538.x
   GAMIAN A, 1991, CAN J MICROBIOL, V37, P233, DOI 10.1139/m91-035
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   GUTSCHE AT, 1994, BIOTECHNOL BIOENG, V43, P801, DOI 10.1002/bit.260430815
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hoekstra R, 2002, INT J ARTIF ORGANS, V25, P182
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hulth A, 1996, J ORTHOPAED RES, V14, P547, DOI 10.1002/jor.1100140408
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jenkins DW, 2001, CHEM REV, V101, P3245, DOI 10.1021/cr000257f
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Kagisaki K, 1997, ARTIF ORGANS, V21, P836, DOI 10.1111/j.1525-1594.1997.tb03753.x
   Kamiyama K, 1999, BIOL PHARM BULL, V22, P179
   Kang IK, 2005, J MATER SCI-MATER M, V16, P533, DOI 10.1007/s10856-005-0529-9
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   KAWAKAMI T, 1992, BIOMATERIALS, V13, P759, DOI 10.1016/0142-9612(92)90014-F
   KHNOR E, 2003, BIOMATERIALS, V24, P2339
   Kim Inyong, 2006, [Tissue Engineering and Regenerative Medicine, 조직공학과 재생의학], V3, P27
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kim TH, 2006, J NANOSCI NANOTECHNO, V6, P2796, DOI 10.1166/jnn.2006.434
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   KOSHER RA, 1973, DEV BIOL, V35, P210, DOI 10.1016/0012-1606(73)90018-3
   KOSHER RA, 1975, NATURE, V258, P327, DOI 10.1038/258327a0
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   LeCluyse EL, 1996, ADV DRUG DELIVER REV, V22, P133, DOI 10.1016/S0169-409X(96)00418-8
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Leroux L, 1999, BONE, V25, p31S, DOI 10.1016/S8756-3282(99)00130-1
   Li JL, 2003, J BIOMED MATER RES A, V67A, P938, DOI 10.1002/jbm.a.10076
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li XB, 2000, POLYM ADVAN TECHNOL, V11, P176, DOI 10.1002/1099-1581(200004)11:4<176::AID-PAT964>3.0.CO;2-Z
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madihally SV, 1999, STEM CELLS, V17, P295, DOI 10.1002/stem.170295
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5440, DOI 10.1021/ma00046a049
   Mao SR, 2005, BIOMATERIALS, V26, P6343, DOI 10.1016/j.biomaterials.2005.03.036
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048
   Mingyu Cheng, 2004, J Biomater Appl, V19, P59, DOI 10.1177/0885328204043450
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   MOONEY DJ, 1994, TRANSPLANT P, V26, P3425
   Morales TI, 1997, ARCH BIOCHEM BIOPHYS, V343, P164, DOI 10.1006/abbi.1997.0166
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Mori T, 1998, J BIOMED MATER RES, V43, P469
   Morita SI, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P111
   Nishikawa H, 2000, J ENDODONT, V26, P169, DOI 10.1097/00004770-200003000-00010
   Nishikawa H., 2001, SILICON BASED MAT DE, V2, P93
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   OKAMOTO Y, 1993, J VET MED SCI, V55, P739, DOI 10.1292/jvms.55.739
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   PARADOSSI G, 1992, INT J BIOL MACROMOL, V14, P73, DOI 10.1016/0141-8130(92)90002-P
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Schulz JT, 2000, ANNU REV MED, V51, P231, DOI 10.1146/annurev.med.51.1.231
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   SUH JK, 1998, 2 BIANN M TISS ENG S
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Svenmarker S, 1997, EUR J CARDIO-THORAC, V11, P957, DOI 10.1016/S1010-7940(96)01132-3
   TANIGAWA T, 1992, ADVANCES IN CHITIN AND CHITOSAN, P206
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TINGWU Q, 1993, CHINESE J REPARATIVE, V13, P31
   Tokura S, 1997, MACROMOL SYMP, V120, P1, DOI 10.1002/masy.19971200103
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Valerie D., 1998, PHARM SCI TECHNOL TO, V1, P246
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   VANDEVORD PJ, 2002, J BIOMED MATER RES, P59
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wang XH, 2005, J BIOMAT SCI-POLYM E, V16, P1063, DOI 10.1163/1568562054798554
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Watanabe J, 2003, SCI TECHNOL ADV MAT, V4, P539, DOI 10.1016/j.stam.2003.09.018
   WEIGEL PH, 1980, J CELL BIOL, V87, P855, DOI 10.1083/jcb.87.3.855
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Xu C, 1996, ENDOCRINOLOGY, V137, P3557, DOI 10.1210/en.137.8.3557
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
   Yanas I.V., 1980, J BIOMED MATER RES, V14, P65
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   ZHU H, 2003, BIOMATERIALS, V24, P2339
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 165
TC 719
Z9 790
U1 23
U2 464
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD JAN-FEB
PY 2008
VL 26
IS 1
BP 1
EP 21
DI 10.1016/j.biotechadv.2007.07.009
PG 21
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 253JA
UT WOS:000252513300001
PM 17884325
DA 2018-10-19
ER

PT S
AU Li, MC
   Xin, MH
   Su, S
   Gao, W
AF Li, Mingchun
   Xin, Meihua
   Su, Sheng
   Gao, Wei
GP IEEE
TI Novel biomaterial study I : N, N-dilong chain alkyl chitosan (NCS) for
   self-assembled nanovesicle and NCS/PLLA blend for tissue engineering
   scaffold
SO BMEI 2008: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOMEDICAL
   ENGINEERING AND INFORMATICS, VOL 1
SE International Conference on Biomedical Engineering and Informatics
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Engineering and Informatics
CY MAY 27-30, 2008
CL Sanya, PEOPLES R CHINA
SP Tianjin Univ Technol, IEEE Comp Soc
DE chitosan; alkylation; amphiphilic; self-assembled vesicle; blend
ID DRUG-DELIVERY; VESICLES
AB A novel amphiphilic chitosan, N,N-dilong chain alkyl chitosan (NCS), was applied to prepare self-assembled vesicles for DDS and NCS/PLLA blend for tissue engineering scaffold. The morphology of NCS self-assembled vesicles was investigated by SEM. Drug-releasing rates of vesicles made from longer alkyl chain and/or larger backbone molecular weight of N,N-dialkyl chitosan are slower than shorter and smaller ones, and equilibrium drug-releasing ratios as well as releasing rates. The bio-experimental results indicate that NCS/PLLA blends are biodegradable and nontoxic. NCS is benefit to improve the cell affinity of PLLA.
C1 [Li, Mingchun; Xin, Meihua; Su, Sheng; Gao, Wei] Huaqiao Univ, Coll Mat Sci & Engn, Key Lab Funct Mat Fujian Higher Educ, Quanzhou 362021, Fujian, Peoples R China.
RP Li, MC (reprint author), Huaqiao Univ, Coll Mat Sci & Engn, Key Lab Funct Mat Fujian Higher Educ, Quanzhou 362021, Fujian, Peoples R China.
EM mcli@hqu.edu.cn
CR LI M, 2005, J FUDAN U NATURAL SC, V44
   Li MC, 2006, DES MONOMERS POLYM, V9, P89, DOI 10.1163/156855506775526179
   Li MC, 2002, POLYM INT, V51, P889, DOI 10.1002/pi.911
   Li MC, 2007, J COLLOID INTERF SCI, V311, P285, DOI 10.1016/j.jcis.2006.12.082
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
NR 6
TC 0
Z9 0
U1 0
U2 5
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 1948-2914
BN 978-0-7695-3118-2
J9 INT CONF BIOMED
PY 2008
BP 748
EP 750
DI 10.1109/BMEI.2008.295
PG 3
WC Engineering, Biomedical; Mathematical & Computational Biology
SC Engineering; Mathematical & Computational Biology
GA BHW79
UT WOS:000257096000145
DA 2018-10-19
ER

PT S
AU Xin, MH
   Li, MC
   Liao, YZ
   Deng, J
   Qiao, ZY
AF Xin, Meihua
   Li, Mingchun
   Liao, Yaozu
   Deng, Jun
   Qiao, Zhiyong
GP IEEE
TI Novel biomaterial study II: O, O-dilong chain acyl chitosan (OCS) for
   self-assembled nanovesicle and OCS/PLLA blend for tissue engineering
   scaffold
SO BMEI 2008: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOMEDICAL
   ENGINEERING AND INFORMATICS, VOL 1
SE International Conference on Biomedical Engineering and Informatics
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Engineering and Informatics
CY MAY 27-30, 2008
CL Sanya, PEOPLES R CHINA
SP Tianjin Univ Technol, IEEE Comp Soc
DE chitosan; acylation; amphiphilic; self-assembled vesicle; blend
AB A novel amphiphilic chitosan, O,O-dilong chain acyl chitosan (OCS), was applied to prepare self-assembled vesicles for DDS and OCS/PLLA blend for tissue engineering scaffold. The study on morphology, drug-releasing behavior of the vesicles, and the bio-experiments of OCS vesicles and OCS/PLLA blend elucidate the relative results are similar to NCS vesicles and NCS/PLLA blend.
C1 [Xin, Meihua; Li, Mingchun; Liao, Yaozu; Deng, Jun; Qiao, Zhiyong] Huaqiao Univ, Coll Mat Sci & Engn, Key Lab Funct Mat Fujian Higher Educ, Quanzhou 362021, Fujian, Peoples R China.
RP Xin, MH (reprint author), Huaqiao Univ, Coll Mat Sci & Engn, Key Lab Funct Mat Fujian Higher Educ, Quanzhou 362021, Fujian, Peoples R China.
EM mcli@hqu.edu.cn
RI Liao, Yaozu/H-2505-2017; Liao, Yaozu/C-5305-2011
OI Liao, Yaozu/0000-0001-9263-6281; 
CR HU X, 2006, J TISSUE ENG RECONST, V2, P304
   LI Z, 2002, CHEM IND ENG PROGR, V25, P704
   Liao YZ, 2007, CHINESE CHEM LETT, V18, P213, DOI 10.1016/j.cclet.2006.12.024
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
NR 5
TC 0
Z9 0
U1 0
U2 8
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 1948-2914
BN 978-0-7695-3118-2
J9 INT CONF BIOMED
PY 2008
BP 751
EP 754
DI 10.1109/BMEI.2008.296
PG 4
WC Engineering, Biomedical; Mathematical & Computational Biology
SC Engineering; Mathematical & Computational Biology
GA BHW79
UT WOS:000257096000146
DA 2018-10-19
ER

PT B
AU Moldovan, C
   Iosub, R
   Radu, C
   Codreanu, N
   Ion, M
   Codreanu, C
   Firtat, B
   Necula, D
   Ion, A
   Ion, I
   Harvey, T
   Summersgill, P
AF Moldovan, Carmen
   Iosub, Rodica
   Radu, Cornel
   Codreanu, Nita
   Ion, Marian
   Codreanu, Cecilia
   Firtat, Bogdan
   Necula, Daniel
   Ion, Alina
   Ion, Ion
   Harvey, Thomas
   Summersgill, Phillip
GP IEEE
TI ENZYMATIC BIOSENSOR FOR INSECTICIDES DETECTION
SO CAS: 2008 INTERNATIONAL SEMICONDUCTOR CONFERENCE, PROCEEDINGS
LA English
DT Proceedings Paper
CT 31st International Semiconductor Conference
CY OCT 13-15, 2008
CL Sinaia, ROMANIA
SP IEEE
AB The detection of organophosphoric insecticides, in a simple manner was made using impedimetric enzyme biosensors, which allow determination in sub-micromolar concentration ranges. This type of measurement applies for monitoring of biocatalytic reactions based on irreversible inhibition of the enzyme (acetylcholinesterase). The reaction involves generation of charged species, which leads to a global change in the ionic composition of the tested solution.
   Our work has been focused on the development of an impedimetric microsensor for direct detection of dichorvos, because this kind of biosensor presents a number of advantages such as: miniaturized electrodes based on gold thin film; easy production using standard microtechnology; low cost; no reference electrode required; no light sensitivity, and differential mode measurements possibile allowing elimination of interferences. In addition, dichlorvos is targeted to be detected considering that the commonest poisoning today is due to: Methyl Parathion (metacid), Dichorvos (Nuvan), Zinc Phosphide and Aluminium Phosphide (Celphos).
   The biosensor with interdigitated electrodes and immobilized acetylcholinesteraze (AChE) measures the impedance of the layer adjacent to the electrode surface. The impedimetric measurement consists of determining the conductivity and capacitance of the solution between two interdigitated electrodes. The chemistry of deposited enzymatic layer (concentration, enzymatic activity measuring, deposition protocol), the immobilization technique for AChE, the fabrication technique and the electrical characteristiques of the enzymatic sensor have been studied.
   AChE immobilization was performed by ionic adsorption on polyethylenglycol (PEG) bio-polymeric substrate, by including in the gel. The functionalized electrodes deposited with biomaterial were inserted into the microfluidic channels and tested from electrical and microfluidic point of view, achieving the micro-bio integration. Insertion of electrolyte plus acetilcholine into the channels leads to activation of the enzyme and the measurements are realized under the strict control of temperature and pH. The response time is about 10 minutes.
C1 [Moldovan, Carmen; Iosub, Rodica; Radu, Cornel; Codreanu, Nita; Ion, Marian; Codreanu, Cecilia; Firtat, Bogdan; Necula, Daniel] IMT Bucharest, Bucharest, Romania.
   [Ion, Alina; Ion, Ion] Polytech Univ, Fac Chem, Bucharest, Romania.
   [Harvey, Thomas; Summersgill, Phillip] EPIGEM Ltd, Redcar, England.
RP Moldovan, C (reprint author), IMT Bucharest, Bucharest, Romania.
EM carmen.moldovan@imt.ro; tom.harvey@epigem.co.uk
FU INTEGRAMplus [FP6, IST, 027540]; IMUNOSENSE [51-083/2007]
FX This work was supported by INTEGRAMplus project (FP6, IST, 027540) and
   IMUNOSENSE project (PNII, No 51-083/2007).
CR Jaffrezic-Renault N, 2008, SENSORS-BASEL, V8, P2569, DOI 10.3390/s8042569
   Rodriguez-Mozaz S, 2004, PURE APPL CHEM, V76, P723, DOI 10.1351/pac200476040723
   Schoning MJ, 2003, SENSORS-BASEL, V3, P119, DOI 10.3390/s30600119
NR 3
TC 0
Z9 0
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-2004-9
PY 2008
BP 147
EP +
DI 10.1109/SMICND.2008.4703353
PG 2
WC Engineering, Electrical & Electronic
SC Engineering
GA BKA53
UT WOS:000267590800025
DA 2018-10-19
ER

PT J
AU Ikeda, M
   Ueno, S
   Matsumoto, S
   Shimizu, Y
   Komatsu, H
   Kusumoto, KI
   Hamachi, I
AF Ikeda, Masato
   Ueno, Shiori
   Matsumoto, Shinji
   Shimizu, Yusuke
   Komatsu, Harunobu
   Kusumoto, Ken-ichi
   Hamachi, Itaru
TI Three-Dimensional Encapsulation of Live Cells by Using a Hybrid Matrix
   of Nanoparticles in a Supramolecular Hydrogel
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE cell encapsulation; hydrogels; nanobeads; self-assembly; supramolecular
   chemistry
ID ASSEMBLING PEPTIDE SCAFFOLDS; GLYCOSYLATED AMINO-ACID; WATER GELATION;
   BIOMATERIALS; MOLECULES; COMPARTMENTALIZATION; NANOFIBERS; CULTURES;
   BINDING; DESIGN
AB From a library of glyco-lipid mimics with muconic amide as the spacer, we found that 1, a glyco-lipid that has N-acetyl glucosamine and methyl cyclohexyl groups as its hydrophilic head and hydrophobic tails, respectively, formed a stable hydrogel (0.05 wt%) through hierarchical self-assembly of the lipid molecules into supramolecular nanofibers. The formation of the supramolecular hydrogel was verified by rheological measurements, and the supramolecular nanofiber was characterized as the structural element by transmission electron microscopy and atomic force microscopy observations. Absorption and circular dichroism spectroscopic measurements revealed that the muconic amide moieties of I are arranged in a helical, stacked fashion in the self-assembled nanofibers. Moreover, we unexpectedly found that the homogeneous distribution of the supramolecular nanofibers of 1 was greatly facilitated by the addition of polystyrene nanobeads (100500 nm in diameter), as evaluated by confocal laser scanning microscopic observations. It is interesting that the obtained supramolecular hybrid matrix can efficiently encapsulate and distribute live Jurkat cells in three dimensions under physiological conditions. This supramolecular hybrid matrix is intriguing as a unique biomaterial.
C1 [Ikeda, Masato; Ueno, Shiori; Matsumoto, Shinji; Shimizu, Yusuke; Komatsu, Harunobu; Hamachi, Itaru] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan.
   [Kusumoto, Ken-ichi] Fukuoka Ind Technol Ctr, Biotechnol & Food Res Inst, Fukuoka 8390861, Japan.
RP Hamachi, I (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan.
EM ihamachi@sbchem.kyoto-u.ac.jp
RI Ikeda, Masato/D-7277-2011
OI Ikeda, Masato/0000-0003-4097-8292
FU JSPS
FX This work is partially supported by JST (PRESTO, Synthesis and Control).
   S.M. thanks JSPS for the Research Fellowship for Young Scientists for
   financial support. We thank Dr. K. Kuwata (Kyoto university) for HRMS
   measurements, the Members of Y. Aoyoma laboratory (Kyoto university) for
   the use of and kind support with the plate reader. Dr. A. Narita (Y.
   Chujo laboratory, Kyoto university) for the TEM observations, and Prof.
   T. Takigawa (Kyoto university) for the rheometer observations.
CR Alberts B., 2002, MOL BIOL CELL
   Anderson K. M., 2008, ANGEW CHEM, V120, P1074
   Anderson KM, 2008, ANGEW CHEM INT EDIT, V47, P1058, DOI 10.1002/anie.200703785
   Bhattacharya S, 2006, ANGEW CHEM INT EDIT, V45, P2934, DOI 10.1002/anie.200504461
   Bhattacharya S., 2006, ANGEW CHEM, V118, P3000
   Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Das D, 2006, CHEM-EUR J, V12, P5068, DOI 10.1002/chem.200501638
   de Loos M, 2005, EUR J ORG CHEM, P3615, DOI 10.1002/ejoc.200400723
   Deng W, 2007, ANGEW CHEM, V119, P5236, DOI DOI 10.1002/ANGE.200701272
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   HWANG I, 2006, ANGEW CHEM, V119, P214
   Hwang I, 2007, ANGEW CHEM INT EDIT, V46, P210, DOI 10.1002/anie.200603149
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Kimura M, 2004, ADV MATER, V16, P335, DOI 10.1002/adma.200305804
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e
   Kiyonaka S, 2003, CHEM-EUR J, V9, P976, DOI 10.1002/chem.200390120
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   Matsumoto S, 2008, CHEM-EUR J, V14, P3977, DOI 10.1002/chem.200701904
   Matsumoto S, 2008, CHEM COMMUN, P1545, DOI 10.1039/b719004b
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simmons B, 2002, NANO LETT, V2, P1037, DOI 10.1021/nl015691r
   Sreenivasachary N, 2008, CHEM-ASIAN J, V3, P134, DOI 10.1002/asia.200700041
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suzuki M, 2007, NEW J CHEM, V31, P69, DOI 10.1039/b612478j
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   van Herrikhuyzen J., 2007, ANGEW CHEM, V119, P1857
   van Herrikhuyzen J, 2007, ANGEW CHEM INT EDIT, V46, P1825, DOI 10.1002/anie.200604225
   Varki A, 1999, ESSENTIALS GLYCOBIOL
   WEISS RG, 2006, MOL GELS MAT SELF AS, pCH17
   Yamaguchi S, 2008, CHEM-EUR J, V14, P1891, DOI 10.1002/chem.200701285
   Yang Z, 2007, J MATER CHEM, V17, P2385, DOI 10.1039/b702493b
   Yang ZM, 2007, CHEM COMMUN, P843, DOI 10.1039/b616563
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 47
TC 27
Z9 27
U1 1
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PY 2008
VL 14
IS 34
BP 10808
EP 10815
DI 10.1002/chem.200801144
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 381SC
UT WOS:000261555200035
PM 18942699
DA 2018-10-19
ER

PT J
AU Hiebl, B
   Fuhrmann, R
   Franke, RP
AF Hiebl, B.
   Fuhrmann, R.
   Franke, R. P.
TI Characterization of cryopreserved CD14+- human monocytes after
   differentiation towards macrophages and stimulation with VEGF-A(165)
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 14th Conference of the
   European-Society-for-Clinical-Hemorheology-and-Microcirculation
CY JUN 27-30, 2007
CL Dresden, GERMANY
SP European Soc Clin Hemorheol & Microcirculat
DE VEGF; monocyte; macrophage; CD14; CD68; CD31
ID ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CELLS; ENDOMETRIOSIS;
   BIOMATERIAL
AB Monocytes are broadly discussed in the literature as cells, which can get properties of endothelial progenitor cells after angiogenic stimulation. Angiogenically stimulated monocytes can be used to promote implant vascularisation. A necessity therefore is that these cells can be stored and used after storage without a loose of their characteristic phenotype. In this study we tested, if freshly thawed cryopreserved human monocytes are positive for the mo/macrophage markers CD14 and CD68 and the endothelial marker CD31 after thawing and following angiogenic stimulation in a VEGF-A(165) enriched (10 ng/ml) angiogenic medium. Thereby the monocytes were tested before and after differentiation towards macrophages. The results revealed that freshly thawed human CD14 positive monocytes are positive for CD14, CD68 and CD31 after angiogenic stimulation. This CD specification was much more intense in the differentiated cells. The differentiation step also resulted in an increased cell count. Both results can be attributed to the method of differentiation, were cell culture bags were used instead of common cell culture dishes. Additionally the differentiation medium (X-VIVO 10 + 10% FCS) was specifically adapted to the requirements of monocytes/macrophages. The study showed that human CD14 positive monocytes can be thawed after cryopreservation without loss of their monocytes/macrophage phenotype and without loss of their ability to get angiogenically stimulated. To enhance the efficiency of both steps (thawing, angiogenic stimulation) it can be useful to differentiate the thawed cells in cell culture bags by the use of X-VIVO 10 (+ 10% FCS) before angiogenic stimulation.
C1 [Hiebl, B.] GKSS Forschungszentrum Geesthacht GmbH, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Fuhrmann, R.; Franke, R. P.] Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, Ulm, Germany.
   [Franke, R. P.] Charite Univ Med Berlin, BCRT, D-13353 Berlin, Germany.
RP Hiebl, B (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM bernhard.hiebl@gkss.de
OI Hiebl, Bernhard/0000-0002-6450-0675
CR DIPIETRO LA, 1993, BEHRING I MITT, V92, P238
   Ferrara N, 2000, RECENT PROG HORM RES, V55, P15
   Fujimoto J, 1999, GYNECOL OBSTET INVES, V48, P14, DOI 10.1159/000052864
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Kakou A, 2007, CLIN HEMORHEOL MICRO, V37, P71
   Kerdjoudj H, 2007, CLIN HEMORHEOL MICRO, V37, P89
   KREUTLE VF, 2004, THESIS U ULM
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815
   Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Schweighofer B, 2007, CLIN HEMORHEOL MICRO, V37, P57
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Xiu RJ, 2006, CLIN HEMORHEOL MICRO, V34, P81
   Zachary I, 1998, INT J BIOCHEM CELL B, V30, P1169, DOI 10.1016/S1357-2725(98)00082-X
NR 16
TC 8
Z9 9
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2008
VL 39
IS 1-4
BP 221
EP 228
DI 10.3233/CH-2008-1086
PG 8
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 322OA
UT WOS:000257384000027
PM 18503129
DA 2018-10-19
ER

PT J
AU Kirchhof, K
   Groth, T
AF Kirchhof, Kristin
   Groth, Thomas
TI Surface modification of biomaterials to control adhesion of cells
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 14th Conference of the
   European-Society-for-Clinical-Hemorheology-and-Microcirculation
CY JUN 27-30, 2007
CL Dresden, GERMANY
SP European Soc Clin Hemorheol & Microcirculat
ID MULTILAYER FILMS; POLYELECTROLYTES; ULTRATHIN
AB The layer-by-layer technique was used to build-up polyelectrolyte multilayers (PEMs) composed of heparin, an anionic glycosaminoglycan (GAG) and chitosan, a cationic biodegradable polysaccharide on model biomaterial surfaces. The surface coatings shall control adhesion of cells and thus their subsequent proliferation and differentiation. PEMs were characterized physicochemically by static contact angle and quartz crystal microbalance (QCM) measurements. Variations in procedure parameters such as the pH value of the solutions were crucial to the formation process and surface properties in terms of wettability and mass increase. Cell-surface interactions were studied with human fibroblast on PEMs. It was found that the pH value of solutions had a strong impact on cell adhesion making surfaces extremely cytophobic or moderately cytophilic. Adsorption of fibronectin to the terminal heparin layer could be used to increase cell adhesion in a concentration-dependent manner.
C1 [Kirchhof, Kristin; Groth, Thomas] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut & Biopharmaceut, Biomed Mat Grp, D-06120 Halle, Germany.
RP Groth, T (reprint author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut & Biopharmaceut, Biomed Mat Grp, Wolfgang Langenbeck Str 4, D-06120 Halle, Germany.
EM thomas.groth@pharmazie.uni-halle.de
OI Groth, Thomas/0000-0001-6647-9657
CR DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hubbell JA, 1996, J CONTROL RELEASE, V39, P305, DOI 10.1016/0168-3659(95)00162-X
   Kakou A, 2007, CLIN HEMORHEOL MICRO, V37, P71
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
NR 10
TC 14
Z9 14
U1 0
U2 10
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2008
VL 39
IS 1-4
BP 247
EP 251
DI 10.3233/CH-2008-1089
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 322OA
UT WOS:000257384000031
PM 18503133
DA 2018-10-19
ER

PT J
AU Polimeni, G
   Koo, KT
   Pringle, GA
   Agelan, A
   Safadi, FF
   Wikesjo, UME
AF Polimeni, Giuseppe
   Koo, Ki-Tae
   Pringle, Gordon A.
   Agelan, Alexis
   Safadi, Fayez F.
   Wikesjoe, Ulf M. E.
TI Histopathological observations of a polylactic acid-based device
   intended for guided bone/tissue regeneration
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bioresorbable; bone; GBR; GTR; guided bone regeneration; guided tissue
   regeneration; membranes; polylactic acid; rat; tissue engineering; wound
   healing
ID GINGIVAL RECESSION DEFECTS; FOREIGN-BODY REACTION; TISSUE REGENERATION;
   PERIODONTAL REPAIR; BONE REGENERATION; DOGS; FIXATION; IMPLANTS
AB Background: Barrier devices have been shown to support alveolar bone and periodontal regeneration, a procedure also known as guided bone/tissue regeneration (GBR/GTR). Popular demand and clinical convenience have raised an interest in bioresorbable barrier devices. Tissue reactions to such bioresorbable devices are, however, generally not well explored.
   Purpose: The objective of this study was to evaluate short- and long-term tissue reactions following implantation of a bioresorbable polylactic acid (PLA)-based barrier device using a rat model.
   Materials and methods: Twenty-one young adult male Sprague-Dawley rats were used. The animals were divided into three groups including 15 animals receiving the PLA device and animals serving as sham surgery (five) or nonoperated (one) controls. Using aseptic techniques, the PLA device was surgically implanted in direct contact with the calvarial bone. Animals receiving the PLA device were sacrificed at 3, 5, 7, and 12 months postsurgery to provide longitudinal histopathological observations of tissue and biomaterials reactions. Control animals were sacrificed at 3 months.
   Results: Animals were maintained without adverse events. Sham surgery and nonoperated control animals showed no signs of new bone formation or resorption, or signs of inflammatory reactions in adjoining soft tissues. In contrast, extensive amounts of residual biomaterial with evidence of foreign body reactions and bone resorption were observed in animals receiving the PLA device over 12 months.
   Conclusions: The results suggest that the PLA device may induce bone resorbing foreign body reactions. Importantly, the PLA device does not resorb within a 12-month healing interval. These biomaterials properties may influence new bone formation and maintenance when applying the device for GBR/GTR.
C1 [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Periodont, Lab Appl Periodontal & Craniofacial Regenerat, Augusta, GA 30912 USA.
   [Pringle, Gordon A.] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.
   [Agelan, Alexis] Temple Univ, Sch Med, Univ Lab Anim Resources, Philadelphia, PA 19122 USA.
   [Safadi, Fayez F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Oral Biol & Maxillofacial Pathol, Lab Appl Periodontal & Craniofacial Regenerat, Augusta, GA 30912 USA.
RP Wikesjo, UME (reprint author), Med Coll Georgia, Sch Dent, Dept Periodont, Lab Appl Periodontal & Craniofacial Regenerat, 1430,1120 15th St, Augusta, GA 30912 USA.
EM uwikesjo@mcg.edu
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Akimoto K, 1999, Clin Implant Dent Relat Res, V1, P98, DOI 10.1111/j.1708-8208.1999.tb00098.x
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Danesh-Meyer MJ, 2001, J PERIODONTAL RES, V36, P341, DOI 10.1034/j.1600-0765.2001.360601.x
   Fritz ME, 2000, J PERIODONTOL, V71, P1484, DOI 10.1902/jop.2000.71.9.1484
   Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Karring T, 1999, PERIODONTOL 2000, V19, P115, DOI 10.1111/j.1600-0757.1999.tb00151.x
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Mosier-LaClair S, 2001, FOOT ANKLE INT, V22, P247, DOI 10.1177/107110070102200313
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Polimeni G, 2005, J CLIN PERIODONTOL, V32, P951, DOI 10.1111/j.1600-051X.2005.00763.x
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schmitz JP, 2000, J ORAL MAXIL SURG, V58, P888, DOI 10.1053/joms.2000.8216
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Tatakis DN, 1999, J PERIODONTOL, V70, P542, DOI 10.1902/jop.1999.70.5.542
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   WIKESJO UME, 1990, J PERIODONTOL, V61, P719, DOI 10.1902/jop.1990.61.12.719
NR 25
TC 30
Z9 32
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2008
VL 10
IS 2
BP 99
EP 105
DI 10.1111/j.1708-8208.2007.00067.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 297FF
UT WOS:000255601800005
PM 18462206
DA 2018-10-19
ER

PT J
AU de la Portilla, F
   Fernandez, A
   Leon, E
   Rada, R
   Cisneros, N
   Maldonado, VH
   Vega, J
   Espinosa, E
AF de la Portilla, F.
   Fernandez, A.
   Leon, E.
   Rada, R.
   Cisneros, N.
   Maldonado, V. H.
   Vega, J.
   Espinosa, E.
TI Evaluation of the use of PTQ(TM)implants for the treatment of
   incontinent patients due to internal anal sphincter dysfunction
SO COLORECTAL DISEASE
LA English
DT Article
DE silicone; faecal incontinence; anorectal sphincter; internal anal
   sphincter augmentation
ID INJECTABLE SILICONE BIOMATERIAL; FECAL INCONTINENCE; INJECTION;
   HEMORRHOIDECTOMY; PREVALENCE; MANAGEMENT
AB Objective This study reports the results of injectable silicone PTQ(TM) implants for faecal incontinence due to internal anal sphincter (IAS) dysfunction.
   Method Twenty patients (12 women) with partial faecal incontinence aged from 55 to 65 years were treated by a PTQ(TM) implant. All patients completed the Cleveland Clinic Continence and Quality of Life questionnaire. Endoluminal ultrasound and anorectal physiological testing were performed in each patient. All implants were inserted into the submucosal plane without ultrasound guidance.
   Results Faecal continence was significantly improved up to 1 year. The Wexner continence score fell from a median of 13.05 (range, 5-20) before treatment to 4.5 (range 2-7.7) at 1 month after (P < 0.005). This rose gradually to 6.2 (range, 0-16) at one year (P = 0.02) and 9.4 (range, 1-20) at 2 years (P = 0.127). There were no differences in resting or squeeze pressure before and at 3 months after treatment (P = 0.86 and P = 0.93). Fourteen (70%) patients experienced pruritus ani during the first few weeks after the procedure and one developed infection at the implant site.
   Conclusion Silicone implantation is minimally invasive and technically simple. It is effective over 1 year in the treatment of faecal incontinence due to IAS dysfunction.
C1 Hosp Juan Ramon Jimenez, Dept Gen Surg, Coloproctol Unit, Huelva 21005, Spain.
   Hosp Valme, Dept Biostat, Res Unit, Seville, Spain.
   Hosp Valme, Dept Internal Med, Seville, Spain.
RP de la Portilla, F (reprint author), Hosp Juan Ramon Jimenez, Dept Gen Surg, Coloproctol Unit, Ronda Norte S-N, Huelva 21005, Spain.
EM delaportilla@ya.com
RI Fernandez-Palacin, Ana/M-9635-2018; MAESTRE, VICTORIA/E-9943-2015; IBIS,
   COLOPROCTOLOGIA/H-9797-2016
OI Fernandez-Palacin, Ana/0000-0002-5823-5705; Portilla de Juan, Fernando
   de la/0000-0003-0603-2911
CR Altomare DF, 2001, BRIT J SURG, V88, P1487, DOI 10.1046/j.0007-1323.2001.01898.x
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   DAVIS KJ, 2001, COLORECTAL DIS S1, V3, P21
   GIBBONS CP, 1986, LANCET, V1, P886
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lehur PA, 2000, DIS COLON RECTUM, V43, P1100, DOI 10.1007/BF02236557
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Person Benjamin, 2005, Surg Innov, V12, P7, DOI 10.1177/155335060501200103
   RAO SS, 2004, GASTROENTEROLOGY S1, V126, P14
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   SHAFIK A, 1993, INT SURG, V78, P159
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   UROPLASTY PRODUCT OV
NR 24
TC 28
Z9 28
U1 0
U2 7
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD JAN
PY 2008
VL 10
IS 1
BP 89
EP 94
DI 10.1111/j.1463-1318.2007.01276.x
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 238FE
UT WOS:000251431900016
PM 17608753
DA 2018-10-19
ER

PT B
AU Ioanid, A
   Ciuceanu, RM
AF Ioanid, Ana
   Ciuceanu, Radu Mircea
BE Iantovics, B
   Enachescu, C
   Filip, F
TI Simulation of the Growth Process of a Silicium Nanotubes Structure as
   Biomaterial in the Porozity of Zeolite AFI
SO COMPLEXITY IN ARTIFICIAL AND NATURAL SYSTEMS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Complexity and Intelligence of the
   Artificial and Natural Complex Systems - Medical Applications of the
   Compex Systems Biomedical Computing
CY NOV 08-10, 2008
CL Petu Maior Univ Tg, Mures, ROMANIA
HO Petu Maior Univ Tg
DE biomaterials; zeolite; interconnected pores; adsorption; nanotube
   structure
ID ADSORPTION
AB Hydroxyapatite (HA, Ca(10)(PO(4))(6)(OH)(2)) that the principal mineral component of the bone tissue, has remarcable precursor of growth properties in the porous structure sort with strongly interconnected pores. The interconnection of the pores is an essential condition assuring high quality of bone implants. We suggest the experimentation of a silicium nanotubes structure (SiNT) as support to enhance the growth of an high quality HA. We propose a model obtaining a silicium nanotubes structure, by silicium atoms adsorption, from vapour phase, in the pores of AlPO(4) (AFI) zeolite. A collection of 3D interconnected nanotubes of the deposited silicium can be obtained after matrix removal.
C1 [Ioanid, Ana] Univ Bucharest, Bucharest, Romania.
RP Ioanid, A (reprint author), Univ Bucharest, Bucharest, Romania.
EM ana_ioanid@yahoo.com; raduciuceanu@yahoo.com
CR ABRAHAMSON AA, 1969, PHYS REV, V178, P76, DOI 10.1103/PhysRev.178.76
   Aoyama N, 2007, FLUID PHASE EQUILIBR, V257, P212, DOI 10.1016/j.fluid.2007.01.039
   Fekkar-Nemmiche N, 2007, EUR PHYS J-SPEC TOP, V141, P45, DOI [10.1140/epjst/e2007-00014-2, 10.1141/epjst/e2007-00008-0]
   HOSONO H, 1992, J NON-CRYST SOLIDS, V139, P90, DOI 10.1016/S0022-3093(05)80810-5
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Llewellyn PL, 2005, ADSORPTION, V11, P73, DOI 10.1007/s10450-005-5901-z
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Wang N, 2000, NATURE, V408, P50, DOI 10.1038/35040702
NR 9
TC 0
Z9 0
U1 0
U2 2
PU EDITURA UNIVERSITATII PETRU MAIOR TARGU-MURES
PI TG MURES
PA STR N LORGA NR 1, TG MURES, 540088, ROMANIA
BN 978-973-7794-76-5
PY 2008
BP 309
EP 316
PG 8
WC Computer Science, Artificial Intelligence; Computer Science, Hardware &
   Architecture; Computer Science, Theory & Methods
SC Computer Science
GA BJD31
UT WOS:000264924800045
DA 2018-10-19
ER

PT J
AU Petite, H
   Bensidhoum, M
   Logeart-Avramoglou, D
   David, B
   Viateau, V
   Hannouche, D
AF Petite, H.
   Bensidhoum, M.
   Logeart-Avramoglou, D.
   David, B.
   Viateau, V.
   Hannouche, D.
TI Tissue engineering of bone using adult stem cells: what's new in 2008
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Meeting Abstract
CT 33rd Congress of the Societe-de-Biomecanique
CY SEP 01-03, 2008
CL Compiegne, FRANCE
SP Soc Biomecan
DE bone; mesenchymal stem cells; bioreactor; biomechanics; biomaterial
C1 [Petite, H.; Bensidhoum, M.; Logeart-Avramoglou, D.; David, B.; Viateau, V.; Hannouche, D.] Univ Paris 07, CNRS, B2OA UMR 7052, Paris, France.
   [Viateau, V.] Ecole Natl Vet Alfort, Maisons Alfort, France.
RP Petite, H (reprint author), Univ Paris 07, CNRS, B2OA UMR 7052, Paris, France.
EM hpetite@infobiogen.fr
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PY 2008
VL 11
SU 1
BP 17
EP 17
DI 10.1080/10255840802298745
PG 1
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA 398OZ
UT WOS:000262742700005
DA 2018-10-19
ER

PT B
AU Doshi, S
   Bell, R
AF Doshi, S.
   Bell, R.
BE Boukamel, A
   Laiarinandrasana, L
   Meo, S
   Verron, E
TI Characterization of a polyurethane biomaterial for use in non-linear
   analysis of an inverting artificial heart diaphragm
SO CONSTITUTIVE MODELS FOR RUBBER V
SE Proceedings and Monographs in Engineering, Water and Earth Sciences
LA English
DT Proceedings Paper
CT 5th European Conference on Constitute Models for Rubber
CY SEP 04-07, 2007
CL Paris, FRANCE
ID DEFORMATION; BEHAVIOR
AB The Mooney-Rivlin material model is evaluated for use in the non-linear finite element analysis of diaphragms made from biomedical grade polyurethane used in artificial hearts. Coefficients for the model are determined graphically from uniaxial and biaxial tensile data. The results are compared against published data for Biomer, a standard biomedical grade polyurethane. The evaluation shows that the Mooney-Rivlin model is inaccurate at low strains when used to represent the entire uniaxial stress-strain curve up to tensile failure. However, a more accurate representation of low strain is obtained when a specific strain range, (10% < epsilon < 50%), is used for modeling. This requirement of the model is relevant in diaphragm deformation, as strains are expected to be in this range.
C1 [Doshi, S.; Bell, R.] Carleton Univ, Ottawa, ON K1S 5B6, Canada.
RP Doshi, S (reprint author), Carleton Univ, Ottawa, ON K1S 5B6, Canada.
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   BHATE AP, 1984, POLYM ENG SCI, V24, P862, DOI 10.1002/pen.760241105
   de Vivo F, 1999, INT J ARTIF ORGANS, V22, P11
   DOSHI S, 2005, P MAT PROC MED DEV C, P230
   Gent A., 1992, ENG RUBBER DESIGN RU
   KIM HJ, 1994, BIO-MED MATER ENG, V4, P171
   Orang F, 1996, BIOMATERIALS, V17, P485, DOI 10.1016/0142-9612(96)82722-0
   Treloar LRG, 1944, T FARADAY SOC, V40, P0059, DOI 10.1039/tf9444000059
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
BN 978-0-415-45442-1
J9 PROC MONOGR ENG WATE
PY 2008
BP 367
EP 372
PG 6
WC Engineering, Environmental; Engineering, Mechanical; Materials Science,
   Composites
SC Engineering; Materials Science
GA BHA25
UT WOS:000251796000057
DA 2018-10-19
ER

PT J
AU Virtanen, S
AF Virtanen, Sannakaisa
TI Corrosion of biomedical implant materials
SO CORROSION REVIEWS
LA English
DT Article
DE corrosion; biomaterial; implant; passivity; Co-Cr-Mo; titanium; Ti-Al-V;
   magnesium
ID COMMERCIALLY PURE TITANIUM; SURFACE OXIDE-FILM; IN-VIVO CORROSION;
   BIOLOGICAL ENVIRONMENTS; PHYSIOLOGICAL SOLUTION; HYDROGEN-PEROXIDE;
   MAGNESIUM ALLOYS; ELECTROCHEMICAL CHARACTERIZATION; FRETTING-CORROSION;
   CREVICE CORROSION
AB Corrosion behavior of the most important metallic materials - mainly used in orthopaedic implants - is summarized. A focus of this review is on the comparison of the susceptibility of the different alloys (especially Ti base alloys and Co-Cr alloys) to corrosion. A short discussion on influence of surface modification on the corrosion performance of biomaterials is included. Critical factors to be considered in the experimental investigation of the corrosion behavior in view of the biomedical applications are summarized. Recent investigations on the possible exploitation of materials with a low corrosion resistance for biodegradable implants are summarized.
C1 Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Surface Sci & Corros LKO, D-91058 Erlangen, Germany.
RP Virtanen, S (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Surface Sci & Corros LKO, Martensstr 7, D-91058 Erlangen, Germany.
RI Virtanen, Sannakaisa/N-3699-2015
OI Virtanen, Sannakaisa/0000-0002-7179-7593
CR AMMAR IA, 1971, ELECTROCHIM ACTA, V16, P1539, DOI 10.1016/0013-4686(71)80024-5
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   ASK M, 1989, APPL SURF SCI, V10, P283
   ASPHAHANI AL, 1987, ASM METALS HDB, V13, P658
   Bearinger JP, 2003, J BIOMED MATER RES A, V67A, P702, DOI 10.1002/jbm.a.10116
   Bilhan H, 2007, J BIOMATER APPL, V22, P197, DOI 10.1177/0885328207072557
   Blackwood DJ, 2002, CORROS SCI, V44, P395, DOI 10.1016/S0010-938X(01)00080-4
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   BROWN BF, 1969, J ELECTROCHEM SOC, V116, P218, DOI 10.1149/1.2411799
   BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023
   DONG A, 2006, SURFACE REV LETT, V13, P3543
   ELIAZ N, 2007, BIOMEDICAL MAT RES A, V80, P621
   ELIAZ N, 2003, CORROSION REV, V21
   ELIAZ N, 2008, CORROSION SCI TECHNO, pCH18
   Fraker A. C., 1987, METALS HDB, V13, P1324
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   Gilbert JL, 1997, AM SOC TEST MATER, V1301, P45, DOI 10.1520/STP12020S
   GILBERT JL, 1993, J BIOMEDICAL MAT RES, V27, P15333
   Goldberg JR, 1997, AM SOC TEST MATER, V1301, P157, DOI 10.1520/STP12030S
   Hallab NJ, 2003, CORROS REV, V21, P183
   Hanawa T, 2004, MATER TRANS, V45, P1635, DOI 10.2320/matertrans.45.1635
   Hanawa T, 2003, CORROS REV, V21, P161
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   HIRAKAWA K, 2004, CLIN OTHOPAEDICS REL, P1
   Hiromoto S, 2006, WEAR, V261, P1002, DOI 10.1016/j.wear.2006.03.032
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   Hiromoto S, 2006, CORROS REV, V24, P323
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Hodgson AWE, 2002, ELECTROCHIM ACTA, V47, P1913, DOI 10.1016/S0013-4686(02)00029-4
   Hong SB, 2001, CORROS SCI, V43, P1781, DOI 10.1016/S0010-938X(00)00181-5
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jones LC, 2006, J HISTOTECHNOL, V29, P277, DOI 10.1179/his.2006.29.4.277
   KELLY EJ, 1982, MOD ASPECT ELECTROC, V14, pCH5
   Kocijan A, 2004, J APPL ELECTROCHEM, V34, P517, DOI 10.1023/B:JACH.0000021868.10122.96
   Kocijan A, 2003, J MATER SCI-MATER M, V14, P69, DOI 10.1023/A:1021505621388
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   Kovac S, 2006, J BONE JOINT SURG BR, V88B, P1567, DOI 10.1302/0301-620X.88B12.17796
   LAING PG, 1984, BIOMATERIALS SCI ENG
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LECLERC MF, 1994, CORROSION, P2
   LIPS K, MAT CORROSION, V55, P5
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Menini R, 2006, J ELECTROCHEM SOC, V153, pB13, DOI 10.1149/1.2128098
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Munoz AI, 2007, J ELECTROCHEM SOC, V154, pC562, DOI 10.1149/1.2764238
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Park IS, 2006, MET MATER-INT, V12, P399, DOI 10.1007/BF03027706
   Pourbaix M., 1963, ATLAS EQUILIBRES ELE
   RETTIG R, 2007, J BIOMEDICA IN PRESS
   RETTIG R, 2007, BIOMEDICAL MAT RES
   Rettig R, 2007, J MATER SCI-MATER M, V18, P1377, DOI 10.1007/s10856-007-0152-z
   RIMONDINIG L, 2002, MATERIALWISSENSCHAFT, V33, P706
   ROJAS CR, CORROSION REV, V23, P445
   RUCZICKOVA M, 2005, Z PHYS CHEM, V219, P1447
   Schmuki P, 1996, J ELECTROCHEM SOC, V143, P3997, DOI 10.1149/1.1837327
   Schmuki P, 2002, J SOLID STATE ELECTR, V6, P145, DOI 10.1007/s100080100219
   Scholl E, 2000, J ARTHROPLASTY, V15, P570, DOI 10.1054/arth.2000.6618
   Schultze JW, 2000, ELECTROCHIM ACTA, V45, P2499, DOI 10.1016/S0013-4686(00)00347-9
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   Simon M, 2005, EUR J ORAL SCI, V113, P537, DOI 10.1111/j.1600-0722.2005.00247.x
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stover M, 2006, J MATER SCI, V41, P5569, DOI 10.1007/s10853-006-0257-7
   Szklarska-Smialowska S., 1986, PITTING CORROSION ME
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Urban RM, 2006, AM SOC TEST MATER, V1471, P215, DOI 10.1520/STP37558S
   VADIRAJ A, 2005, T INDIAN I METALS, V5, P911
   VIRTANEN S, 2008, ACTA BIOMAT IN PRESS
   Waksman R., 2005, ACC REV, V14, P36
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Willert HG, 1996, CLIN ORTHOP RELAT R, P51
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V1, P99
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yan Y, 2006, J PHYS D APPL PHYS, V39, P3200, DOI 10.1088/0022-3727/39/15/S10
   Yan Y, 2006, J PHYS D APPL PHYS, V39, P3206, DOI 10.1088/0022-3727/39/15/S11
   Yan Y, 2007, TRIBOL INT, V40, P1492, DOI 10.1016/j.triboint.2007.02.019
   Yan Y, 2007, WEAR, V263, P1105, DOI 10.1016/j.wear.2007.01.114
   Yu SY, 1999, J ELECTROCHEM SOC, V146, P4429, DOI 10.1149/1.1392655
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
NR 91
TC 16
Z9 17
U1 4
U2 44
PU FREUND PUBLISHING HOUSE LTD
PI TEL AVIV
PA PO BOX 35010, TEL AVIV 61350, ISRAEL
SN 0334-6005
J9 CORROS REV
JI Corros. Rev.
PY 2008
VL 26
IS 2-3
BP 147
EP 171
DI 10.1515/corrrev.2008.147
PG 25
WC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science, Coatings & Films
SC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science
GA 312FC
UT WOS:000256653500003
DA 2018-10-19
ER

PT J
AU Manocha, B
   Margaritis, A
AF Manocha, Bhavik
   Margaritis, Argyrios
TI Production and characterization of gamma-polyglutarnic acid
   nanoparticles for controlled anticancer drug release
SO CRITICAL REVIEWS IN BIOTECHNOLOGY
LA English
DT Review
DE drug delivery; biopolymer; biomaterial; cancer chemotherapy;
   gamma-polyglutamic acid (PGA); polyglutamic acid; nanoparticles
ID CARBOHYDRATE-CARRYING POLYMERS; LIPID-COATED NANOPARTICLES;
   POLY(GLUTAMIC ACID); IN-VITRO; PACLITAXEL POLIGLUMEX;
   BACILLUS-LICHENIFORMIS; GLUTAMIC ACID; POLY(GAMMA-GLUTAMIC ACID); BATCH
   FERMENTATION; PLGA NANOPARTICLES
AB gamma-Polyglutamic acid (gamma-PGA) is a hydrophilic, biodegradable, and naturally available biopolymer produced by a number of microbial species, most commonly, the Bacillaceae family. Its biological properties such as nontoxicity, biocompatibility, and nonimmunogenicity qualify it as an important biomaterial in drug delivery applications. This review focuses mainly on the development of gamma-PGA nanoparticles as drug delivery carriers for anticancer therapeutics. We discuss various techniques for the production and characterization of gamma-PGA nanoparticles and controlled-release strategies. We also present a brief overview of the tumor physiology that forms the basis for the development of various targeted drug delivery approaches in cancer chemotherapy.
C1 [Manocha, Bhavik; Margaritis, Argyrios] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Margaritis, A (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
EM amarg@uwo.ca
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Akagi T, 2005, J CONTROL RELEASE, V108, P226, DOI 10.1016/j.jconrel.2005.08.003
   Akagi T, 2006, J BIOMAT SCI-POLYM E, V17, P875, DOI 10.1163/156856206777996871
   Albain KS, 2006, CLIN LUNG CANCER, V7, P417, DOI 10.3816/CLC.2006.n.027
   Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9
   Altundag K, 2007, J CLIN PATHOL, V60, P958, DOI 10.1136/jcp.2006.042481
   Ashiuchi M, 2004, APPL ENVIRON MICROB, V70, P4249, DOI 10.1128/AEM.70.7.4249-4255.2004
   Au JLS, 2002, J CONTROL RELEASE, V78, P81, DOI 10.1016/S0168-3659(01)00488-6
   Auzenne E, 2002, CLIN CANCER RES, V8, P573
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Bhadra D, 2002, PHARMAZIE, V57, P5
   Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Butler M., 1996, ANIMAL CELL CULTURE
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225
   Chari RVJ, 1998, ADV DRUG DELIVER REV, V31, P89, DOI 10.1016/S0169-409X(97)00095-1
   Chen Y, 2003, LETT PEPT SCI, V10, P621, DOI 10.1007/BF02442596
   CHEN Y, 1994, J CONTROL RELEASE, V31, P49, DOI 10.1016/0168-3659(94)90250-X
   Cho CS, 2001, BIOMATERIALS, V22, P45, DOI 10.1016/S0142-9612(00)00143-5
   Cho CS, 1997, BIOMATERIALS, V18, P323, DOI 10.1016/S0142-9612(96)00138-X
   Chognot D, 2003, J COLLOID INTERF SCI, V268, P441, DOI 10.1016/S0021-9797(03)00591-5
   Dipetrillo T, 2006, AM J CLIN ONCOL-CANC, V29, P376, DOI 10.1097/01.coc.0000224494.07907.4e
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Feng SS, 2003, CHEM ENG SCI, V58, P4087, DOI 10.1016/S0009-2509(03)00234-3
   Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   FRESTA M, 1995, J PHARM SCI, V84, P895, DOI 10.1002/jps.2600840721
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X
   GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111
   Govender T, 2000, INT J PHARMACEUT, V199, P95, DOI 10.1016/S0378-5173(00)00375-6
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Heiati H, 1997, INT J PHARMACEUT, V146, P123, DOI 10.1016/S0378-5173(96)04782-5
   Hezayen FF, 2001, INT J SYST EVOL MICR, V51, P1133, DOI 10.1099/00207713-51-3-1133
   Higashi N, 2006, J COLLOID INTERF SCI, V298, P118, DOI 10.1016/j.jcis.2005.12.015
   Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457
   Hitzman CJ, 2006, J PHARM SCI-US, V95, P1196, DOI 10.1002/jps.20607
   Hitzman CJ, 2006, J PHARM SCI-US, V95, P1127, DOI 10.1002/jps.20590
   Hoste K, 2000, J CONTROL RELEASE, V64, P53, DOI 10.1016/S0168-3659(99)00142-X
   Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241
   JAIN RK, 1989, JNCI-J NATL CANCER I, V81, P570, DOI 10.1093/jnci/81.8.570
   JAIN RK, 1988, CANCER RES, V48, P2641
   Jeong YI, 2005, INT J PHARM, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027
   Jeong YI, 1998, J CONTROL RELEASE, V51, P169, DOI 10.1016/S0168-3659(97)00163-6
   Jeong YI, 1999, INT J PHARM, V188, P49, DOI 10.1016/S0378-5173(99)00202-1
   Jones A, 1998, CANCER J SCI AM, V4, P209
   Kaszuba M, 1999, J NANOPART RES, V1, P405, DOI 10.1023/A:1010072129578
   Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4
   Koizumi F, 2006, CANCER RES, V66, P10048, DOI 10.1158/0008-5472.CAN-06-1605
   Kumar M.N.V. Ravi, 2004, ENCY NANOSCIENCE NAN, V9, P1
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Kumar N, 2001, ADV DRUG DELIVER REV, V53, P23, DOI 10.1016/S0169-409X(01)00219-8
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   Liang HF, 2005, J CONTROL RELEASE, V105, P213, DOI 10.1016/j.jconrel.2005.03.021
   Lin YH, 2005, BIOMACROMOLECULES, V6, P1104, DOI 10.1021/bm049312a
   LIN YH, 2007, NANOTECHNOLOGY, V18, P105
   Lin YH, 2007, BIOMACROMOLECULES, V8, P146, DOI 10.1021/bm0607776
   LINKS M, 1999, EXPERT REV MOL MED, V1, P1
   MAGENHEIM B, 1993, INT J PHARMACEUT, V94, P115, DOI 10.1016/0378-5173(93)90015-8
   Man M, 2005, IDRUGS, V8, P739
   Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Mohanraj V. J., 2006, TROP J PHARM RES, V5, P561, DOI DOI 10.4314/TJPR.V5I1.14634
   Niemetz R, 1997, EUR J BIOCHEM, V249, P905, DOI 10.1111/j.1432-1033.1997.00905.x
   Oldham EA, 2000, INT J ONCOL, V16, P125
   Panyam J, 2004, J PHARM SCI-US, V93, P1804, DOI 10.1002/jps.20094
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Peppas LB, 1995, INT J PHARMACEUT, V116, P1
   PEPPAS NA, 1984, MED APPLICATION CONT, P169
   Peracchia MT, 1997, J CONTROL RELEASE, V46, P223, DOI 10.1016/S0168-3659(96)01597-0
   Polakovic M, 1999, J CONTROL RELEASE, V60, P169, DOI 10.1016/S0168-3659(99)00012-7
   POZNANSKY MJ, 1984, PHARMACOL REV, V36, P277
   Redhead HM, 2001, J CONTROL RELEASE, V70, P353, DOI 10.1016/S0168-3659(00)00367-9
   Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P8, DOI 10.1016/j.nano.2005.12.003
   Richard A, 2004, BIOTECHNOL BIOENG, V87, P501, DOI 10.1002/bit.20156
   Richard A, 2003, BIOTECHNOL BIOENG, V82, P299, DOI 10.1002/bit.10568
   Richard A, 2003, BIOTECHNOL LETT, V25, P465, DOI 10.1023/A:1022644417429
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   Richard A, 2006, BIOCHEM ENG J, V30, P303, DOI 10.1016/j.bej.2006.05.014
   Sahli H, 1997, BIOMATERIALS, V18, P281, DOI 10.1016/S0142-9612(96)00146-9
   Shih IL, 2001, BIORESOURCE TECHNOL, V78, P267, DOI 10.1016/S0960-8524(01)00027-X
   Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033
   Singer JW, 2003, ADV EXP MED BIOL, V519, P81
   Sledge GW, 2003, EUR J CANCER, V39, P1668, DOI 10.1016/S0959-8049(03)00273-9
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   TROY FA, 1973, J BIOL CHEM, V248, P305
   Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2
   Vittaz M, 1996, BIOMATERIALS, V17, P1575, DOI 10.1016/0142-9612(95)00322-3
   WASHINGTON C, 1990, INT J PHARM, V58, P1, DOI 10.1016/0378-5173(90)90280-H
   WEBER J, 1990, J BIOL CHEM, V265, P9664
   WEIR DM, 1983, IMMUNOLOGY OUTLINE S
   Yang SC, 1999, J CONTROL RELEASE, V59, P299, DOI 10.1016/S0168-3659(99)00007-3
   Yoon SH, 2000, BIOTECHNOL LETT, V22, P585, DOI 10.1023/A:1005625026623
NR 100
TC 35
Z9 37
U1 2
U2 35
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0738-8551
J9 CRIT REV BIOTECHNOL
JI Crit. Rev. Biotechnol.
PY 2008
VL 28
IS 2
BP 83
EP 99
DI 10.1080/07388550802107483
PG 17
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 316SJ
UT WOS:000256969700001
PM 18568849
DA 2018-10-19
ER

PT J
AU Breschi, L
   Mazzoni, A
   Ruggeri, A
   Cadenaro, M
   Di Lenarda, R
   Dorigo, ED
AF Breschi, Loyenzo
   Mazzoni, Annalisa
   Ruggeri, Alessandra
   Cadenaro, Milena
   Di Lenarda, Robeyto
   Dorigo, Elettya De Stefano
TI Dental adhesion review: Aging and stability of the bonded interface
SO DENTAL MATERIALS
LA English
DT Review
DE dental bonding systems; hybrid layer; aging; dentin; resin based
   restorative materials
ID SELF-ETCH ADHESIVES; TOOTH-BIOMATERIAL INTERFACES; SINGLE-STEP
   ADHESIVES; IN-VIVO DEGRADATION; HYBRID LAYER; WATER STORAGE; MATRIX
   METALLOPROTEINASES; NANOLEAKAGE EXPRESSION; RESIN HYDROPHILICITY;
   HYDROLYTIC STABILITY
AB Objective. Most of current dental adhesive systems show favorable immediate results in terms of retention and sealing of bonded interface, thereby counteracting polymerization shrinkage that affects resin-based restorative materials. Despite immediate efficacy, there are major concerns when dentin bonded interfaces are tested after aging even for short time period, i.e. 6 months.
   Methods. This study critically discusses the latest peer-reviewed reports related to formation, aging and stability of resin bonding, focusing on the micro and nano-phenomena related to adhesive interface degradation.
   Results- Most simplified one-step adhesives were shown to be the least durable, while three-step etch-and-rinse and two-step self-etch adhesives continue to show the highest performances, as reported in the overwhelming majority of studies. In other words, a simplification of clinical application procedures is done to the detriment of bonding efficacy. Among the different aging phenomena occurring at the dentin bonded interfaces, some are considered pivotal in degrading the hybrid layer, particularly if simplified adhesives are used. insufficient resin impregnation of dentin, high permeability of the bonded interface, sub-optimal polymerization, phase separation and activation of endogenous collagenolytic enzymes are some of the recently reported factors that reduce the longevity of the bonded interface.
   Significance. In order to overcome these problems, recent studies indicated that (1) resin impregnation techniques should be improved, particularly for two-step etch-and-rinse adhesives; (2) the use of conventional multi-step adhesives is recommended, since they involve the use of a hydrophobic coating of nonsolvated resin; (3) extended curing time should be considered to reduce permeability and allow a better polymerization of the adhesive film; (4) proteases inhibitors as additional primer should be used to increase the stability of the collagens fibrils within the hybrid layer inhibiting the intrinsic collagenolytic activity of human dentin. (c) 2007 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Breschi, Loyenzo; Cadenaro, Milena; Di Lenarda, Robeyto; Dorigo, Elettya De Stefano] Univ Trieste, Dept Biomed, Unit Dent Sci & Biomat, I-34129 Trieste, Italy.
   [Mazzoni, Annalisa; Ruggeri, Alessandra] Univ Bologna, Dept SAU&FAL, Bologna, Italy.
RP Breschi, L (reprint author), Univ Trieste, Dept Biomed, Unit Dent Sci & Biomat, Via Stuparich 1, I-34129 Trieste, Italy.
EM lbreschi@units.it
OI Cadenaro, Milena/0000-0002-3755-3181; Di Lenarda,
   Roberto/0000-0002-9051-4413; Breschi, Lorenzo/0000-0001-7621-226X
CR Armstrong SR, 2001, DENT MATER, V17, P268, DOI 10.1016/S0109-5641(00)00081-6
   Armstrong SR, 2004, OPER DENT, V29, P705
   Brackett WW, 2005, OPER DENT, V30, P733, DOI 10.2341/04-152
   Brackett WW, 2002, OPER DENT, V27, P218
   BRACKETT WW, IN PRESS OPER DENT
   Breschi L, 2006, J DENT RES, V85, P1092, DOI 10.1177/154405910608501205
   Breschi L, 2004, OPER DENT, V29, P538
   Breschi L, 2003, J BIOMED MATER RES A, V67A, P11, DOI 10.1002/jbm.a.10048
   Breschi L, 2002, J BIOMED MATER RES, V61, P40, DOI 10.1002/jbm.10102
   Breschi L, 1999, J BIOMED MATER RES, V46, P315, DOI 10.1002/(SICI)1097-4636(19990905)46:3<315::AID-JBM2>3.0.CO;2-6
   BRESCHI L, 2001, J DENT RES, V80, P249
   Buonocore MG., 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801
   Burrow MF, 1996, DENT MATER, V12, P302, DOI 10.1016/S0109-5641(96)80038-8
   Cadenaro M, 2006, EUR J ORAL SCI, V114, P257, DOI 10.1111/j.1600-0722.2006.00351.x
   Cadenaro M, 2005, EUR J ORAL SCI, V113, P525, DOI 10.1111/j.1600-0722.2005.00251.x
   Carrilho MRO, 2007, J DENT RES, V86, P90, DOI 10.1177/154405910708600115
   Carrilho MRO, 2005, AM J DENT, V18, P315
   Cheng H, 1999, CONNECT TISSUE RES, V40, P37, DOI 10.3109/03008209909005276
   Chersoni S, 2004, DENT MATER, V20, P796, DOI 10.1016/j.dental.2003.11.010
   Chersoni S, 2004, J DENT RES, V83, P459, DOI 10.1177/154405910408300605
   CHIARI M, 1994, ELECTROPHORESIS, V15, P177, DOI 10.1002/elps.1150150131
   Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025
   De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204
   De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212
   De Munck J, 2005, BIOMATERIALS, V26, P1145, DOI 10.1016/j.biomaterials.2004.04.013
   De Munck J, 2005, EUR J ORAL SCI, V113, P77, DOI 10.1111/j.1600-0722.2004.00185.x
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades G, 2001, DENT MATER, V17, P277, DOI 10.1016/S0109-5641(00)00082-8
   Embery G, 2001, CRIT REV ORAL BIOL M, V12, P331, DOI 10.1177/10454411010120040401
   Ferrari M, 2003, OPER DENT, V28, P3
   Finer Y, 2004, J DENT RES, V83, P22, DOI 10.1177/154405910408300105
   Gale MS, 1999, J DENT, V27, P89, DOI 10.1016/S0300-5712(98)00037-2
   GARCIAGODOY F, IN PRESS AM J DENT
   Gendron R, 1999, CLIN DIAGN LAB IMMUN, V6, P437
   GOLDBERG M, 1993, HISTOCHEM J, V25, P781
   GWINNETT AJ, 1995, AM J DENT, V8, P109
   Hall R C, 1997, Adv Dent Res, V11, P478
   Hashimoto M, 2002, J BIOMED MATER RES, V63, P306, DOI 10.1002/jbm.10208
   Hashimoto M, 2003, J BIOMED MATER RES B, V66B, P287, DOI 10.1002/jbm.b.10560
   Hashimoto M, 2005, J BIOMED MATER RES B, V74B, P699, DOI 10.1002/jbm.b.30301
   Hashimoto M, 2004, OPER DENT, V29, P416
   Hashimoto M, 2003, BIOMATERIALS, V24, P3795, DOI 10.1016/S0142-9612(03)00262-X
   Hashimoto M, 2000, J DENT RES, V79, P1385, DOI 10.1177/00220345000790060601
   Hebling J, 2005, J DENT RES, V84, P741, DOI 10.1177/154405910508400811
   HEDBOM E, 1993, J BIOL CHEM, V268, P27307
   Inoue S, 2001, J Adhes Dent, V3, P237
   Ito S, 2005, J ADHES DENT, V7, P133
   Ito S, 2005, BIOMATERIALS, V26, P6449, DOI 10.1016/j.biomaterials.2005.04.052
   Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8
   King NM, 2005, AM J DENT, V18, P126
   KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197
   KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6
   Koshiro K, 2005, EUR J ORAL SCI, V113, P341, DOI 10.1111/j.1600-0722.2005.00222.x
   LEE W, 1995, J PERIODONTAL RES, V30, P23, DOI 10.1111/j.1600-0765.1995.tb01249.x
   LIN CP, 1993, J HISTOCHEM CYTOCHEM, V41, P381, DOI 10.1177/41.3.8429200
   Malacarne J, 2006, DENT MATER, V22, P973, DOI 10.1016/j.dental.2005.11.020
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Mazzoni A, 2006, BIOMATERIALS, V27, P4470, DOI 10.1016/j.biomaterials.2006.01.040
   MAZZONI A, IN PRESS J DENT RES
   Mjor IA, 2002, OPER DENT, V27, P117
   Mjor IA, 2002, OPER DENT, V27, P528
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   Nishitani Y, 2006, J DENT RES, V85, P1016, DOI 10.1177/154405910608501108
   Nishitani Y, 2006, EUR J ORAL SCI, V114, P160, DOI 10.1111/j.1600-0722.2006.00342.x
   Oyarzun A, 2000, EUR J ORAL SCI, V108, P546, DOI 10.1034/j.1600-0722.2000.00912.x
   Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306
   PASHLEY DH, IN PRESS AM J DENT
   Pashley EL, 2002, J DENT, V30, P83, DOI 10.1016/S0300-5712(02)00002-7
   Pasquantonio G, 2007, DENT MATER, V23, P513, DOI 10.1016/j.dental.2006.03.009
   Perdigao J, 1996, DENT MATER, V12, P262, DOI 10.1016/S0109-5641(96)80033-9
   PERDIGAO J, 1995, THESIS CATHOLIC U LE
   RAHARIMALALA V, 1994, IEEE T DIELECT EL IN, V1, P1094, DOI 10.1109/94.368653
   SADEK FT, IN PRESS J BIOMED A
   SANO H, 1995, OPER DENT, V20, P160
   SANO H, 1994, OPER DENT, V19, P59
   Sano H, 1999, J DENT RES, V78, P906, DOI 10.1177/00220345990780041101
   SANO H, 1995, OPER DENT, V20, P18
   Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401
   SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313
   SHONO Y, 1999, J ADHES DENT, P211
   SimoAlfonso E, 1996, ELECTROPHORESIS, V17, P732, DOI 10.1002/elps.1150170419
   Spencer P, 1999, QUINTESSENCE INT, V30, P501
   Spencer P, 2004, J ADHES DENT, V6, P91
   Sulkala M, 2002, J DENT RES, V81, P603, DOI 10.1177/154405910208100905
   Sulkala M, 2007, ARCH ORAL BIOL, V52, P121, DOI 10.1016/j.archoralbio.2006.08.009
   Suppa P, 2005, J BIOMED MATER RES B, V73B, P7, DOI 10.1002/jbm.b.30217
   Tanaka J, 1999, Dent Mater J, V18, P11
   Tay FR, 2003, AM J DENT, V16, P6
   Tay FR, 2002, J DENT RES, V81, P472, DOI 10.1177/154405910208100708
   Tay FR, 2002, J DENT, V30, P371, DOI 10.1016/S0300-5712(02)00064-7
   Tay FR, 2005, OPER DENT, V30, P561
   Tay FR, 2003, J DENT RES, V82, P537, DOI 10.1177/154405910308200710
   Tay FR, 2003, J ADHES DENT, V5, P91
   Tay FR, 2006, J ENDODONT, V32, P862, DOI 10.1016/j.joen.2006.04.005
   Tay Franklin R, 2002, J Adhes Dent, V4, P255
   Tay Franklin R, 2003, J Can Dent Assoc, V69, P726
   Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001
   van Dijken JWV, 2000, DENT MATER, V16, P285, DOI 10.1016/S0109-5641(00)00019-1
   Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Van Meerbeek B, 2000, AM J DENT, V13, p3D
   van Strijp AJP, 2003, CARIES RES, V37, P58, DOI 10.1159/000068223
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   Vargas MA, 1997, DENT MATER, V13, P316, DOI 10.1016/S0109-5641(97)80102-9
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VONDERMARK K, 1981, INT REV CONNECT TISS, V9, P265
   Wang Y, 2002, J BIOMED MATER RES, V59, P46, DOI 10.1002/jbm.1215
   Watanabe I, 1993, Quintessence Int, V24, P335
   Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Yoshida Y, 1999, J BIOMED MATER RES, V47, P85, DOI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
NR 113
TC 544
Z9 587
U1 5
U2 113
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 2008
VL 24
IS 1
BP 90
EP 101
DI 10.1016/j.dental.2007.02.009
PG 12
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 259BO
UT WOS:000252914300013
PM 17442386
DA 2018-10-19
ER

PT J
AU Reis, CP
   Ribeiro, AJ
   Veiga, F
   Neufeld, RJ
   Damge, C
AF Reis, Catarina Pinto
   Ribeiro, Antonio J.
   Veiga, Francisco
   Neufeld, Ronald J.
   Damge, Christiane
TI Polyelectrolyte biomaterial interactions provide nanoparticulate carrier
   for oral insulin delivery
SO DRUG DELIVERY
LA English
DT Article
DE nanospheres; insulin; polyelectrolyte complexes; oral delivery
ID DEXTRAN SULFATE NANOPARTICLES; ALGINATE GEL BEADS; CHITOSAN-ALGINATE;
   SODIUM ALGINATE; RELEASE CHARACTERISTICS; POLYION COMPLEXES;
   SUSTAINED-RELEASE; MOLECULAR-WEIGHT; MICROCAPSULES; ABSORPTION
AB Nanospheres are being developed for the oral delivery of peptide-based drugs such as insulin. Mucoadhesive, biodegradable, biocompatible, and acid-protective biomaterials are described using a combination of natural polyelectrolytes, with particles formulated through nanoemulsion dispersion followed by triggered in situ gel complexation. Biomaterials meeting these criteria include alginate, dextran, chitosan, and albumin in which alginate/dextran forms the core matrix complexed with chitosan and albumin coat. Smaller size and higher albumin-based acid-protective formulation was orally administered to diabetic rats and glucose reduction and physiological response analyzed. Insulin encapsulation efficiency was 90, 82, and 66% for uncoated, chitosan-coated, and albumin-chitosan-coated alginate nanospheres, respectively. The choice of coating polymer seems to influence insulin release profile and to be crucial to prevent peptic digestion. Physiological response following oral delivery showed that insulin albumin-chitosan-coated alginate nanospheres reduced glycemia similar to 72% of basal values. Albumin serves as an important enteric coating providing acid- and protease protection enabling uptake of active drug following oral dosage.
C1 [Reis, Catarina Pinto; Ribeiro, Antonio J.; Veiga, Francisco] Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, P-3000295 Coimbra, Portugal.
   [Neufeld, Ronald J.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Damge, Christiane] Univ Strasbourg, Fac Med, Inst Physiol, Strasbourg, France.
RP Reis, CP (reprint author), Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, Rua Norte, P-3000295 Coimbra, Portugal.
EM catarinareis@ci.uc.pt
RI iMed.ULisboa, NanoBB/B-5393-2014; Veiga, Francisco/L-4884-2014; Ribeiro,
   Antonio/K-4072-2013; Reis, Catarina/M-8132-2013; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014
OI Veiga, Francisco/0000-0002-1041-0068; Ribeiro,
   Antonio/0000-0002-1399-8944; Reis, Catarina/0000-0002-1046-4031; 
CR Becheran-Maron L, 2004, INT J BIOL MACROMOL, V34, P127, DOI 10.1016/j.ijbiomac.2004.03.010
   Boonsongrit Y, 2006, EUR J PHARM BIOPHARM, V62, P267, DOI 10.1016/j.ejpb.2005.09.002
   BURTIN P., 2003, ELECT J ENV AGR FOOD, V2, P498
   Chen Y, 2003, LETT PEPT SCI, V10, P621, DOI 10.1007/BF02442596
   Chien YW, 1996, DRUG DEV IND PHARM, V22, P753, DOI 10.3109/03639049609065908
   Coppi G, 2001, DRUG DEV IND PHARM, V27, P393, DOI 10.1081/DDC-100104314
   DAMGE C, 1988, DIABETES, V37, P246, DOI 10.2337/diabetes.37.2.246
   Damge C, 2007, J CONTROL RELEASE, V117, P163, DOI 10.1016/j.jconrel.2006.10.023
   Donini C, 2002, INT J PHARM, V245, P83, DOI 10.1016/S0378-5173(02)00335-6
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Gursoy A, 2000, J MICROENCAPSUL, V17, P565
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Hasegawa M, 2001, JPN J CANCER RES, V92, P459, DOI 10.1111/j.1349-7006.2001.tb01116.x
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Jerry N, 2001, DRUG DELIV, V8, P19
   Lee DW, 2003, J MICROENCAPSUL, V20, P179, DOI 10.1080/0265204021000058393
   Lee KY, 1997, J APPL POLYM SCI, V63, P425, DOI 10.1002/(SICI)1097-4628(19970124)63:4<425::AID-APP3>3.0.CO;2-T
   LERCO MM, 2003, ACTA CIR BRAS, V18, P136
   Mesiha MS, 2005, INT J PHARM, V288, P289, DOI 10.1016/j.ijpharm.2004.10.003
   MURATA Y, 1993, INT J PHARM, V96, P139, DOI 10.1016/0378-5173(93)90221-Z
   Murata Y, 1996, J CONTROL RELEASE, V38, P101, DOI 10.1016/0168-3659(95)00098-4
   Norris DA, 1998, ADV DRUG DELIVER REV, V34, P135, DOI 10.1016/S0169-409X(98)00037-4
   Ohta A, 1997, INT J VITAM NUTR RES, V67, P55
   POLK A, 1994, J PHARM SCI, V83, P178, DOI 10.1002/jps.2600830213
   PRISTA L. N., 1995, TECNOLOGIA FARMACEUT
   Quong D, 1998, BIOTECHNOL BIOENG, V60, P124, DOI 10.1002/(SICI)1097-0290(19981005)60:1<124::AID-BIT14>3.0.CO;2-Q
   Quong D, 1998, BIOTECHNOL BIOENG, V57, P438
   Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P53, DOI 10.1016/j.nano.2006.04.009
   Reis CP, 2007, EUR J PHARM SCI, V30, P392, DOI 10.1016/j.ejps.2006.12.007
   Reis CP, 2007, BIOTECHNOL BIOENG, V96, P977, DOI 10.1002/bit.21164
   Reis CP, 2006, CHEM IND CHEM ENG Q, V12, P47
   Saez A, 2000, EUR J PHARM BIOPHARM, V50, P379, DOI 10.1016/S0939-6411(00)00125-9
   Sajeesh S, 2006, INT J PHARM, V325, P147, DOI 10.1016/j.ijpharm.2006.06.019
   Sankalia MG, 2007, EUR J PHARM BIOPHARM, V65, P215, DOI 10.1016/j.ejpb.2006.07.014
   Sezer AD, 1999, J MICROENCAPSUL, V16, P687
   Shechter Y, 2005, BIOCONJUGATE CHEM, V16, P913, DOI 10.1021/bc050055w
   Shen WH, 2000, COMP BIOCHEM PHYS A, V125, P389, DOI 10.1016/S1095-6433(00)00169-0
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   TAKAHASHI T, 1990, INT J PHARM, V61, P35, DOI 10.1016/0378-5173(90)90041-2
   Tapia C, 2004, EUR J PHARM BIOPHARM, V57, P65, DOI 10.1016/S0939-641(03)00153-X
   Tiyaboonchai W, 2003, INT J PHARM, V255, P139, DOI 10.1016/S0378-5173(03)00055-3
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 44
TC 47
Z9 48
U1 1
U2 35
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PY 2008
VL 15
IS 2
BP 127
EP 139
DI 10.1080/10717540801905165
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 267LD
UT WOS:000253509600007
PM 18293199
OA Bronze
DA 2018-10-19
ER

PT S
AU Edwards, HK
   Coe, SC
   Fay, MW
   Scotchford, CA
   Grant, DM
   Brown, PD
AF Edwards, H. K.
   Coe, S. C.
   Fay, M. W.
   Scotchford, C. A.
   Grant, D. M.
   Brown, P. D.
BE Baker, RT
   Mobus, G
   Brown, PD
TI Site-speciric, cross-sectional imaging of biomaterials and the
   cell/biomaterial interface using focused ion beam/scanning electron
   microscopy
SO EMAG: ELECTRON MICROSCOPY AND ANALYSIS GROUP CONFERENCE 2007
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT Electron Microscopy and Analysis Group Conference
CY SEP 03-07, 2007
CL Glasgow Caledonian Univ, Glasgow, SCOTLAND
SP Univ Glasgow
HO Glasgow Caledonian Univ
ID FOCAL ADHESION SITES; BONE; CELLS
AB Focused ion beam / scanning electron microscopy (FIBSEM) procedures are examined for the sectioning of biological cell / biomedical implant materials. Conventional site-specific lift-out techniques enable the structural characterisation of hydroxyapatite/Ti coatings. Cryo-FIBSEM procedures, as used to investigate human osteoblasts/hydroxyapatite/Ti structures, emphasise the need for the repeated deposition of coating layers to protect such delicate structures and to minimise beam curtaining effects.
C1 [Edwards, H. K.; Coe, S. C.; Scotchford, C. A.; Grant, D. M.; Brown, P. D.] Univ Nottingham, Sch Mech Mat & Mfg Engn, Univ Pk, Nottingham NG7 2RD, England.
RP Edwards, HK (reprint author), Univ Nottingham, Sch Mech Mat & Mfg Engn, Univ Pk, Nottingham NG7 2RD, England.
EM Hannah.Edwards@nottingham.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692; Brown, Paul/0000-0002-1911-5225;
   Fay, Michael/0000-0003-0017-5196; Grant, David/0000-0002-6786-7720
FU ESPRC [EP/E015379/1]
FX This work was supported by the ESPRC under grant EP/E015379/1.
CR BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   Iliescu M, 2004, SURF COAT TECH, V187, P131, DOI 10.1016/j.surfcoat.2004.01.022
   Milani M, 2006, SCANNING, V28, P148, DOI 10.1002/sca.4950280303
   Owen GRH, 2001, CELL BIOL INT, V25, P1251, DOI 10.1006/cbir.2001.0846
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   Stokes DJ, 2006, J PHYS CONF SER, V26, P50, DOI 10.1088/1742-6596/26/1/012
NR 11
TC 2
Z9 2
U1 4
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2008
VL 126
AR 012097
DI 10.1088/1742-6596/126/1/012097
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA BIX01
UT WOS:000263476400096
OA Bronze
DA 2018-10-19
ER

PT J
AU Astel, A
   Astel, K
   Biziuk, M
AF Astel, Aleksander
   Astel, Karolina
   Biziuk, Marek
TI PCA and multidimensional visualization techniques united to aid in the
   bioindication of elements from transplanted Sphagnum Palustre moss
   exposed in the Gdansk city area
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE air pollution; bioindication; chemometrics; Gdansk city; kriging maps;
   moss; Sphagnum Palustre
ID PRINCIPAL COMPONENT ANALYSIS; AIRBORNE PARTICULATE MATTER; HEAVY-METAL
   CONCENTRATIONS; ATMOSPHERIC DEPOSITION; POLLUTION; THESSALONIKI;
   OUTLIERS; SAMPLES; SWEDEN; GREECE
AB Goal, Scope and Background. During the last decades, a technique for assessing atmospheric deposition of heavy elements was developed based on the principle that samples of moss are able to accumulate elements and airborne particles from rain, melting snow and dry deposition. Despite a broad interest in bioindication there are still ongoing works aimed at the preparation of a standard procedure allowing for a comparison of research carried out in various areas. This is why the comparison of living and dry moss of the same species and growth site seems to be interesting, logical and promising. A most reliable approach seems to be the application of bioindication connected with multivariate statistics and efficient visualization techniques in the interpretation of monitoring data. The aim of this study was: (i) to present cumulative properties of transplanted Sphagnum palustre moss with differentiation into dry and living biomaterial; (ii) to determine and geographically locate types of pollution sources responsible for a structure of the monitoring data set; (iii) to visualize geographical distribution of analytes in the Gdansk metropolitan area and to identify the high-risk areas which can be targeted for environmental hazards and public health.
   Materials and Methods. A six month air pollution study based on Sphagnum palustre bioindication is presented and a simplified procedure of the experiment is given. The study area was located at the mouth of the Vistula River on the Baltic Sea, in Gdansk City (Poland). Sphagnum palustre was selected for research because of its extraordinary morphological properties and its ease in being raised. The capability of dry and living moss to accumulate elements characteristic for anthropogenic and natural sources was shown by application of Principal Component Analysis. The high-risk areas and pollution profiles are detected and visualized using surface maps based on Kriging algorithm.
   Results. The original selection of elements included all those that could be reliably determined by Neutron Activation Analysis in moss samples. Elimination of variables covered the elements whose concentrations in moss were lower than the reported detection limits for INAA for most observations or in cases where particular elements did not show any variation. Eighteen elements: Na, Ca, Sc, Fe, Co, Zn, As, Br, Mo, Sb, Ba, La, Ce, Sm, Yb, Lu, Hf, Th, were selected for the research presented.
   Discussion. Two runs of PCA were performed since, in the first-run a heavy polluted location (Stogi - 'Sto') understood as outlier in the term of PCA approach was detected and results in the form of block diagrams and surface maps were presented. As ensues from the first-run PCA analysis, the factor layout for both indicators is similar but not identical due to the differences in the elements accumulation mechanism. Three latent factors ('phosphatic fertilizer plant impact', 'urban impact' and 'marine impact') explain over 89% and 82% of the total variance for dry and living moss respectively. In the second-run PCA three latent factors are responsible for the data structure in both moss materials. However, in the case of dry moss analysis these factors explain 85% of the total variance but they are rather hard to interpret. On the other hand living moss shows the same pattern as in first-run PCA. Three latent factors explain over 84% of the total variance in this case. The pollution profiles extracted in PCA of dry moss data differ tremendously between both runs, while no deterioration was found after removal of Stogi from data set in case of living moss. Performance of the second-run PCA with exception of Stogi as a heavy polluted location has led to the conclusion that living moss shows better indication properties than dry one.
   Conclusions. While using moss as wet and dry deposition sampler it is not possible to calculate deposition values since the real volume of collected water and dust is hard to estimate due to a splash effect and irregular surface. Therefore, accumulation values seam to be reasonable for moss-based air pollution surveys. Both biomaterials: dry and living Sphagnum palustre show cumulative properties relative to elements under interest. Dry moss has a very loose collection of the atmospheric particles, which can also easily get lost upon rinsing with rainwater running through exposed dry moss material. The living moss may, on the contrary, incorporate the elements in its tissue, thus being less susceptible to rinsing and thus better reflecting the atmospheric conditions. Despite the differences in element uptake and uphold capabilities dry and living moss reflect characteristic anthropogenic and natural profiles. Visible differences in impacts' map coverage exist mostly due to the accumulation mechanisms differentiating dry from living moss. However, in case of each indicator 'phosphatic fertilizer plant impact' is recognized as the strongest pollution source present in examined region.
   Recommendations and Perspectives. General types of pollution sources responsible for a structure of monitoring data set were determined as high-risk/low-risk areas and visualized in form of geographic distribution maps. These locations can be targeted for environmental hazards and public health. Chemometric results in the form of easy defined surface maps can became a powerful instrument in hands of decision-makers working in the field of sustainable development implementation.
C1 [Astel, Aleksander] Pomeranian Acad, Biol & Environm Protect Inst, Environm Chem Res Unit, PL-76200 Slupsk, Poland.
   [Astel, Karolina; Biziuk, Marek] Gdansk Univ Technol, Dept Analyt Chem, Fac Chem, PL-80952 Gdansk, Poland.
RP Astel, A (reprint author), Pomeranian Acad, Biol & Environm Protect Inst, Environm Chem Res Unit, 22A Arciszewskiego Str, PL-76200 Slupsk, Poland.
EM astel@pap.edu.pl
CR Astel A, 2004, ADV ENVIRON RES, V8, P337, DOI 10.1016/S1093-0191(02)00107-7
   BALLACH HJ, 1997, ENVIRON SCI POLLUT R, V1, P37
   BERG T, 1995, ENVIRON POLLUT, V88, P67, DOI 10.1016/0269-7491(95)91049-Q
   BODE P, 1994, J RADIOAN NUCL CH AR, V179, P141, DOI 10.1007/BF02037934
   Bode P, 2000, J RADIOANAL NUCL CH, V245, P127, DOI 10.1023/A:1006777230207
   BODE P, 1994, TRANSACT AM NUCL SOC, V71, P46
   Burns DT, 2002, PURE APPL CHEM, V74, P2201, DOI 10.1351/pac200274112201
   Coskun M, 2005, B ENVIRON CONTAM TOX, V74, P201, DOI 10.1007/s00128-004-0569-8
   Couto JA, 2004, SCI TOTAL ENVIRON, V324, P211, DOI 10.1016/j.scitotenv.2003.10.024
   DIJNGOVA R, 2003, SCI TOTAL ENVIRON, V308, P235
   Djingova R, 2004, ECOL RES, V19, P3, DOI 10.1111/j.1440-1703.2003.00602.x
   DRAGAN G, 1996, ENVIRON SCI POLLUT R, V4, P224
   Einax JW, 1997, CHEMOMETRICS ENV ANA
   Fernandez JA, 2004, ECOTOX ENVIRON SAFE, V59, P76, DOI 10.1016/j.ecoenv.2004.01.007
   Gerdol R, 2000, ENVIRON POLLUT, V108, P201, DOI 10.1016/S0269-7491(99)00189-X
   Giordano S, 2005, ENVIRON POLLUT, V136, P431, DOI 10.1016/j.envpol.2005.01.017
   *GOLD SOFTW INC, SURF VER 8 04 GUID B
   Grunfeld K, 2005, SCI TOTAL ENVIRON, V347, P1, DOI 10.1016/j.scitotenv.2004.12.054
   HARNISH J, 1995, ENVIRON SCI POLLUT R, V3, P161
   HELMERS E, 1998, ENVIRON SCI POLLUT R, V1, P29
   Manning W. J., 1980, BIOMONITORING AIR PO
   MASSART DL, 1983, INTERPRETATION ANAL
   Miranda J, 2000, ENVIRON SCI POLLUT R, V7, P14, DOI 10.1065/espr199910.006
   PAIS I, 1997, BOCA RATON, P153
   PANTELICA A, 1997, J RADIOANAL NUCL CH, V216, P216
   Pesch R, 2006, ECOL INDIC, V6, P137, DOI 10.1016/j.ecolind.2005.08.018
   Poikolainen J, 2004, SCI TOTAL ENVIRON, V318, P171, DOI 10.1016/S0048-9697(03)00396-6
   Ruhling A, 2004, ENVIRON POLLUT, V131, P417, DOI 10.1016/j.envpol.2004.03.005
   Ruhling A., 1994, ATMOSPHERIC HEAVY ME
   SAMARA C, 1990, TOXICOL ENVIRON CHEM, V29, P107, DOI 10.1080/02772249009357625
   SAMARA C, 1994, TOXICOL ENVIRON CHEM, V44, P147, DOI 10.1080/02772249409358054
   SANESI G, 1999, CHEMOSPHERE, V39, P343
   SCHAUG J, 1990, ATMOS ENVIRON A-GEN, V24, P2625, DOI 10.1016/0960-1686(90)90141-9
   Schintu M, 2005, CHEMOSPHERE, V60, P610, DOI 10.1016/j.chemosphere.2005.01.050
   Simeonov V, 2000, CHEMOSPHERE, V41, P1411, DOI 10.1016/S0045-6535(99)00540-8
   Singh A, 1996, CHEMOMETR INTELL LAB, V33, P75, DOI 10.1016/0169-7439(95)00087-9
   Stanimirova I, 2007, TALANTA, V72, P172, DOI 10.1016/j.talanta.2006.10.011
   *STATSOFT INC, 2001, STATISTICA DAT AN SO
   Szczepaniak K, 2006, J RADIOANAL NUCL CH, V270, P35, DOI 10.1007/s10967-006-0418-9
   Szczepaniak K, 2003, ENVIRON RES, V93, P221, DOI 10.1016/S0013-9351(03)00141-5
   THURSTON GD, 1985, ATMOS ENVIRON, V19, P9, DOI 10.1016/0004-6981(85)90132-5
   TYLER G, 1984, AMBIO, V13, P18
   Tyler G, 1970, P 2 INT CLEAN AIR C, P129
   VANDEGINSTE BGM, 1998, HDB CHEMOMETRICS QUA
   Zechmeister HG, 2005, ENVIRON POLLUT, V138, P238, DOI 10.1016/j.envpol.2005.04.005
   ZECHMEISTER HG, 2006, ENVIRON SCI POLLUT R, V6, P398
   Zereini F, 1998, ENVIRON SCI POLLUT R, V5, P223, DOI 10.1007/BF02986405
NR 47
TC 16
Z9 16
U1 1
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JAN
PY 2008
VL 15
IS 1
BP 41
EP 50
DI 10.1065/espr2007.05.422
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 267EV
UT WOS:000253493200009
PM 18306887
DA 2018-10-19
ER

PT J
AU Kaihara, S
   Matsumura, S
   Fisher, JP
AF Kaihara, Sachiko
   Matsumura, Shuichi
   Fisher, John P.
TI Synthesis and characterization of cyclic acetal based degradable
   hydrogels
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE cyclic acetal; hydrogel; biomaterial; swelling; hydrolytic degradation
ID POLY(ETHYLENE OXIDE); SCAFFOLDS; POLYMERS; SURFACES; GLYCOL); CELLS;
   WATER
AB While many synthetic, hydrolytically degradable hydrogels have been developed for biomedical applications, there are only a few examples whose polymer backbone does not form acidic products upon degradation. In order to address this concern, we proposed to develop a hydrogel based on a cyclic acetal unit that produces diols and propanals upon hydrolytic degradation. In particular, we proposed the fabrication of hydrogels formed by the free radical polymerization of two diacrylate monomers, 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD), a cyclic acetal having two acryl groups, and poly(ethylene glycol)diacrylate (PEGDA). However, the hydrophobicity of the EHD monomer inhibits hydrogel fabrication. Therefore this work develops a strategy to form hydrogels with a co-monomer system, one of which is hydrophobic, and subsequently describes the properties of the resulting hydrogel. Using benzoyl peroxide as an initiator and N,N-dimethyl-p-toluidine as an accelerator, the EHD and PEGDA monomers were reacted in an acetone/water co-solvent system. The chemical structure of the resulting EH-PEG [5-ethyl-5-(hydroxymethyl)beta,beta-dimethyl-1,3-dioxane-2-ethanol-co-PEG] hydrogel was then characterized by FT-IR. Physicochemical properties of the EH-PEG hydrogel, including swelling degree, sol fraction, and contact angle, were determined so as to characterize the properties of these materials and ultimately investigate their use in drug delivery and tissue engineering applications. Results showed that EH-PEG hydrogel may be formed using the co-solvent system. Further results indicated that swelling degree is dependent upon initiator concentration, monomer concentration, and molar ratios of monomers, while sol fraction significantly depended on initiator concentration and monomer concentration, only. These results demonstrate the ability to fabricate hydrogels using EHD and PEGDA system as well as to control the properties of the resulting hydrophilic networks. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Kaihara, Sachiko; Matsumura, Shuichi] Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 223, Japan.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H King Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Erdodi G, 2006, PROG POLYM SCI, V31, P1, DOI 10.1016/j.progpolymsci.2005.11.001
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   LENTZ BR, 1994, CHEM PHYS LIPIDS, V73, P91, DOI 10.1016/0009-3084(94)90176-7
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   MOREAU JL, 2006, J BIOMED MATER RES A, V81, P594
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang CQ, 2002, J APPL POLYM SCI, V86, P3120, DOI 10.1002/app.10950
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yang Y, 2004, MACROMOL BIOSCI, V4, P1113, DOI 10.1002/mabi.200400125
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 24
TC 32
Z9 34
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD JAN
PY 2008
VL 68
IS 1
BP 67
EP 73
DI 10.1016/j.ejpb.2007.05.019
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 260VK
UT WOS:000253038300009
PM 17888640
DA 2018-10-19
ER

PT J
AU Bettini, R
   Rornani, AA
   Morganti, MM
   Borghetti, AF
AF Bettini, Ruggero
   Rornani, Antonello A.
   Morganti, Marina M.
   Borghetti, Angelo F.
TI Physicochemical and cell adhesion properties of chitosan films prepared
   from sugar and phosphate-containing solutions
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE chitosan film; sugars; swelling index; surface characterization;
   mechanical properties; human cell culture; cytocompatibility; cell
   proliferation
ID IN-VITRO; DRUG-DELIVERY; N-ACETYLATION; POLYSACCHARIDE; DEGRADATION;
   PROTEIN; CHITIN; SCAFFOLDS; CHEMISTRY; TITANIUM
AB This work was aimed at investigating a series of chitosan films obtained from chitosan, chitosan-phosphate, chitosan-phosphate-D(+)raffinose or chitosan-phosphate-D-(+) sucrose solutions to preliminarily select a suitable biomaterial for developing a cell substrate for tissue engineering. The prepared films were characterized in terms of physicochemical properties (FT-IR, XRD, optical microscopy, wettability, water absorption, and tensile stress) and effects on proliferation of different types of human cells (endothelial, HUVEC fibroblast, WI-38).
   The obtained results indicated that the presence of sucrose or raffinose at high concentration along with phosphate salts in the chitosan film-forming solution affords smooth, amorphous and highly hydrophilic materials in the form of soft and elastic film with optimal cytocompatibility.
   Owing to improved physicochemical and mechanical properties as well as affinity for differentiated human cells, these novel chitosan films appear as promising candidate biomaterials for tissue regeneration and repair.
   The major finding is the possibility to improve the biocompatibility of chitosan films by simply modifying their solid state characteristics. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Bettini, Ruggero] Univ Parma, Dept Pharm, I-43100 Parma, Italy.
   [Rornani, Antonello A.; Morganti, Marina M.; Borghetti, Angelo F.] Univ Parma, Sect Mol Pathol & Immunol, Dept Expt Med, I-43100 Parma, Italy.
RP Bettini, R (reprint author), Univ Parma, Dept Pharm, I-43100 Parma, Italy.
EM bettini@unipr.it
RI Bettini, Ruggero/O-2693-2013
OI Bettini, Ruggero/0000-0002-3857-7476
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Bonelli MA, 1999, EXP CELL RES, V252, P20, DOI 10.1006/excr.1999.4614
   Bugay D.E., 1999, PHARM EXCIPIENTS CHA
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Cheng WT, 2006, CARBOHYD POLYM, V64, P212, DOI 10.1016/j.carbpol.2005.11.024
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Fini A., 2003, AM J DRUG DELIV, V1, P43
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LANGER R, 1993, VACANTI TISSUE ENG S, V260, P920
   MARTIN A., 1993, PHYS PHARM
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
NR 23
TC 20
Z9 20
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD JAN
PY 2008
VL 68
IS 1
BP 74
EP 81
DI 10.1016/j.ejpb.2007.03.026
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 260VK
UT WOS:000253038300010
PM 17881204
DA 2018-10-19
ER

PT J
AU Potter, W
   Kalil, RE
   Kao, WJ
AF Potter, Wyatt
   Kalil, Ronald E.
   Kao, Weiyuan J.
TI Biomimetic material systems for neural progenitor cell-based therapy
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Review
DE CNS regeneration; neural stem cells; neural progenitor nanofiber
   scaffolds; hydrogel photoencapsulation; protein coated polymers; review
ID EMBRYONIC STEM-CELLS; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM;
   IN-VITRO DIFFERENTIATION; ADULT-RAT; FUNCTIONAL RECOVERY; PRECURSOR
   CELLS; SENSORY AXONS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX
AB Reconstruction and regeneration of the central nervous system (CNS) following injury is a formidable task. However, cell replacement with transplanted neural progenitor cells (NPC) is a promising technique that has resulted in various levels of functional recovery in animals that had experienced an experimental injury of the brain or spinal cord. Unfortunately, CNS injury often leads to significant tissue damage and loss, limiting the survival and integration of transplanted NPC. In response, researchers have developed many biomaterial substrates that have been used to culture, transplant, and influence the differentiation and integration of transplanted NPC. Biomaterial scaffolds are a three-dimensional lattice that can be engineered to support NPC in vitro as well as serving as a temporary extracellular matrix (ECM) after transplantation. Scaffold modification with bioactive components, such as proteins, adhesive peptide sequences, and growth factors, allow researchers to modulate NPC responses as well as the local environment of the transplantation site. Biomimetic approaches also can include materials that recapitulate the structural dimensions of the ECM, namely self-assembling nanofibers. These materials can be useful for altering the tissue microenvironment by reducing inflammation and glial scarring, which may further enhance NPC survival and integration into functional neural circuitry. This review describes various biomaterial constructs, with a focus on biomimetic systems that have been used in modulating NPC behavior in culture and/or in transplanting NPC to the CNS.
C1 [Kao, Weiyuan J.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   [Potter, Wyatt; Kao, Weiyuan J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA.
   [Kalil, Ronald E.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [R01EB6613]
CR Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Asher RA, 2000, J NEUROSCI, V20, P2427
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5
   Bin Kim J, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cai Y, 2006, NEUROSCIENCE, V138, P133, DOI 10.1016/j.neuroscience.2005.11.041
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Chipperfield H, 2005, BRAIN RES PROTOC, V14, P146, DOI 10.1016/j.brainresport.2004.12.003
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007
   Desai AR, 2000, DEVELOPMENT, V127, P2863
   Drury JL, 2005, J BIOMECH ENG-T ASME, V127, P220, DOI 10.1118/1.1865194
   Fennis JPM, 2005, TISSUE ENG, V11, P1045, DOI 10.1089/ten.2005.11.1045
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   Goh ELK, 2003, J HEMATOTH STEM CELL, V12, P671, DOI 10.1089/15258160360732696
   Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRIMPE B, 2003, SOC NEUR ABSTR, V880, P2
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Homer P. J., 2000, J NEUROSCI, V20, P2218
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Iwai M, 2003, J CEREBR BLOOD F MET, V23, P331, DOI 10.1097/01.WCB.0000050060.57184.E7
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9
   Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999
   KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037
   Laywell ED, 2005, J COMP NEUROL, V493, P321, DOI 10.1002/cne.20722
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Li XJ, 2006, METH MOL B, V331, P169
   Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3
   Nakano I, 2003, NEURAL STEM CELLS: DEVELOPMENT AND TRANSPLANTATION, P95
   Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463
   OLSON L, 1994, J NEUROL, V241, pS12
   Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6
   Oudega M, 1996, EXP NEUROL, V140, P218, DOI 10.1006/exnr.1996.0131
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pean JM, 1998, J CONTROL RELEASE, V56, P175, DOI 10.1016/S0168-3659(98)00086-8
   Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149
   PINSKE GG, 2004, LIVER INT, V3, P218
   Plant GW, 1998, CELL TRANSPLANT, V7, P381, DOI 10.1016/S0963-6897(98)00016-5
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   RAO AJ, 2004, SOC NEUROSCI ABSTR, V30
   REIER PJ, 1983, SPINAL CORD RECONSTR, P163
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053
   Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003
   SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   Snyder EY, 1998, NEUROSCIENTIST, V4, P408, DOI 10.1177/107385849800400613
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Sultana S, 2000, GLIA, V30, P143, DOI 10.1002/(SICI)1098-1136(200004)30:2<143::AID-GLIA4>3.0.CO;2-Z
   Surini S, 2003, J CONTROL RELEASE, V90, P291, DOI 10.1016/S0168-3659(03)00196-2
   Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9
   Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Terris DJ, 2001, ARCH OTOLARYNGOL, V127, P294, DOI 10.1001/archotol.127.3.294
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3
   WALDECK HAS, J BIOMED MAT RES A, P1549
   Wang ZX, 2005, BIOMATERIALS, V26, P7387, DOI 10.1016/j.biomaterials.2005.05.058
   Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016
   WIDERA D, 2006, BMC NEUROSCI, V7, P1
   WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Woerly S., 2001, BIOMATERIALS, V20, P2213
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   Wu W, 1999, NATURE, V400, P331
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2005, J BIOMAT SCI-POLYM E, V16, P1193, DOI 10.1163/156856205774269485
   YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016
   Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x
   ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   ZIV Y, 2005, NATURE, V9, P268
NR 120
TC 70
Z9 79
U1 0
U2 33
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2008
VL 13
BP 806
EP 821
DI 10.2741/2721
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 299SQ
UT WOS:000255775700065
PM 17981590
DA 2018-10-19
ER

PT S
AU Nakai, M
   Niinomi, M
   Akahori, T
AF Nakai, M.
   Niinomi, M.
   Akahori, T.
BE Fujikawa, Y
   Nakajima, K
   Sakurai, T
TI Mechanically Multifunctional Properties and Microstructure of New
   Beta-Type Titanium Alloy, Ti-29Nb-13Ta-4.6Zr, for Biomedical
   Applications
SO FRONTIERS IN MATERIALS RESEARCH
SE Advances in Materials Research
LA English
DT Proceedings Paper
CT International Workshop on Advanced Materials
CY MAR 01, 2007
CL Inst Med Res, Sendai, JAPAN
HO Inst Med Res
ID METAL PLATES
AB A new biomedical titanium alloy, Ti-29Nb-13Ta-4.6Zr, composed of nontoxic elements like Nb, Ta, and Zr, has recently been developed in order to achieve a lower Young's modulus Similar to that of human hard tissues in addition to excellent mechanical properties for use as structural biomaterials. The characteristics of this material depend oil the microstructures obtained by heat treatments or thermomechanical treatments. Therefore, the relationship between microstructures and basic mechanical properties, the Young's modulus, tensile and fatigue properties, etc., has been investigated with respect to Ti-29Nb-13Ta-4.6Zr. Further, the practical performance of this alloy as a metallic biomaterial has been evaluated via animal experiments. Moreover, the mechanical functionalities of this alloy, such as superelasticity, were reported recently. In the present paper, the accumulated reports oil Ti-29Nb-13Ta-4.6Zr were summarized and the mechanical properties of this alloy were mainly reviewed in order to evaluate its potential for biomedical applications.
C1 [Nakai, M.; Niinomi, M.; Akahori, T.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808579, Japan.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2005, J JPN I MET, V69, P530, DOI 10.2320/jinstmet.69.530
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   *ASTM, 2006, ANN BOOK ASTM STAND, P63
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Hattori T., 2002, J JPN CLIN BIOMECH, V23, P299
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Morinaga M., 1992, J JILM, V42, P614
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   NIINIMI M, 2005, J AM SOC TESTING MAT, V2
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   NIINOMI M, 2004, ENCY BIOMATERIALS BI
   PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   UHTHOFF HK, 1983, J BONE JOINT SURG BR, V65, P66
NR 19
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1435-1889
BN 978-3-540-77967-4
J9 ADV MATERIALS RES
PY 2008
VL 10
BP 167
EP 183
PG 17
WC Environmental Sciences; Materials Science, Multidisciplinary
SC Environmental Sciences & Ecology; Materials Science
GA BIU96
UT WOS:000262978700014
DA 2018-10-19
ER

PT S
AU Tian, JM
   Dong, LM
   Wang, C
   Guo, ZP
   Zhang, CZ
   Zan, QF
   Wang, XA
AF Tian, Jiemo
   Dong, Limin
   Wang, Chen
   Guo, Zhiping
   Zhang, Chaozong
   Zan, Qingfen
   Wang, Xiangang
BE Pan, W
   Gong, JH
TI Tissue engineering scaffolds of bioceramics and new bone growth
SO HIGH-PERFORMANCE CERAMICS V, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 5th China International Conference on High-Performance Ceramics (CICC-5)
CY MAY 10-13, 2007
CL Changsha, PEOPLES R CHINA
SP Chinese Ceram Soc
DE tissue engineering scaffolds; bioceramics; bone
AB The paper describes beta-TCP/DCHA and mineral phase structural bioceramics(CHA) as well as their 3-D structures, bioactivity, degradability and introducing new bone growth. FT-IR, XRD, SEM and Micro-CT were used to evaluate beta-TCP/DCHA and mineral phase structural ceramics before and after implantation. Osteoblasts were immersed in the bioceramics and implanted in the rabbit femora. The experimental results showed that new bone grown in beta-TCP/DCHA, and scaffolds were degraded with new bone formation and growth. The results indicated that beta-TCP/DCHA was a better tissue engineering material. A kind of biomaterial (beta-TCP/CHA) can be used for in situ formation or in vitro individuation formation. The experimental results indicated that beta-TCP/CHA possessed better osteoblast affinity. Osteoblasts can adhere, proliferate and grow better on the material. The experiments in vivo showed the materials bonded with osseous tissue. The implants were degraded obviously after 6 months, and new bone replaced degradation materials.
C1 [Tian, Jiemo; Dong, Limin; Wang, Chen; Guo, Zhiping; Zhang, Chaozong; Zan, Qingfen; Wang, Xiangang] Tsinghua Univ, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
RP Tian, JM (reprint author), Tsinghua Univ, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
CR Bandyopadhyay A, 2006, J AM CERAM SOC, V89, P2675, DOI 10.1111/j.1551-2916.2006.01207.x
   Mastrogiacomo Maddalena, 2003, Tissue Engineering, V9, P818
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   TIAN J, 2002, KEY ENG MATER, V224, P443
   Tian JM, 2002, CERAM INT, V28, P299, DOI 10.1016/S0272-8842(01)00094-3
NR 6
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 368-372
BP 1161
EP 1165
DI 10.4028/www.scientific.net/KEM.368-372.1161
PN 1-2
PG 5
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA BHO67
UT WOS:000254883200364
DA 2018-10-19
ER

PT S
AU Lin, JL
   Cai, K
   Zou, YW
   Gou, L
   Ran, JG
   Yin, GF
AF Lin Jiangli
   Cai Ke
   Zou Yuanwen
   Gou Li
   Ran Junguo
   Yin Guangfu
BE Pan, W
   Gong, JH
TI Improved principal component analysis on the comprehensive
   hemocompatibility evaluation of biomaterials
SO HIGH-PERFORMANCE CERAMICS V, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 5th China International Conference on High-Performance Ceramics (CICC-5)
CY MAY 10-13, 2007
CL Changsha, PEOPLES R CHINA
SP Chinese Ceram Soc
DE hemocompatibility; comprehensive evaluation; biomaterial; image analysis
AB Hemocompatibility of a biomaterial is determined by the interactions between its surface and blood. Due to the complicated action mechanism, various effective ways and the multiple affective factors of the hemocompatibility, a comprehensive evaluation needs to be built instead of single index. Therefore, the platelet consumption ratio of 10 kinds of biomaterials including Ti6Al4V-TiC-DLC gradient coat material was studied based on image analysis method. Combined with the kinetic clotting time and the hemolysis ratio, the comprehensive hemocompatibility evaluation of the material is carried out based on the improved principal component analysis. First, linear transformation of negative index is carried out. Second, index is under a dimensionless using the logarithmic treatment, then to acquire all variants' principal component and their characteristic vectors. Finally, comprehensive evaluation index of hemocompatibility is constructed. The improved principal component analysis avoids the effect of correlativity among indexes during anaphase evaluation, and can more correctly maintain the original information of indexes. Thus, the research provides a new idea to the comprehensive evaluation of Hemocompatibility.
C1 [Lin Jiangli; Cai Ke; Zou Yuanwen; Gou Li; Ran Junguo; Yin Guangfu] Sichuan Univ, Sch Mat Sci & Engn, Chengdu 610065, Peoples R China.
RP Lin, JL (reprint author), Sichuan Univ, Sch Mat Sci & Engn, Chengdu 610065, Peoples R China.
CR LU WW, 2002, FOREIGN MED SCI BIOM, V25, P230
   YAO H, 2005, GEOMATICS INFORM SCI, V30, P732
   Ye Z. Y., 2004, STAT INFORM FORUM, V19, P29
NR 3
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2008
VL 368-372
BP 1231
EP 1234
DI 10.4028/www.scientific.net/KEM.368-372.1231
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA BHO67
UT WOS:000254883200386
DA 2018-10-19
ER

PT J
AU Karp, FB
   Bemotski, NA
   Valdes, TI
   Bohringer, KF
   Ratner, BD
AF Karp, Floyd B.
   Bemotski, Neil A.
   Valdes, Thelma I.
   Bohringer, Karl F.
   Ratner, Buddy D.
TI Foreign body response investigated with an implanted biosensor by in
   situ electrical impedance spectroscopy
SO IEEE SENSORS JOURNAL
LA English
DT Article
DE biosensor; chorio-allantoic membrane; electrical impedance spectroscopy;
   foreign body response; implanted medical device; wound healing
ID TISSUE
AB One of the principal challenges for the long-term implantation of biosensors is that the normal physiological response of the body creates a fibrotic capsule of scar tissue surrounding the implanted sensor (the foreign body response). This dense, collagenous capsule isolates the device from the local environment, causing a time-dependent degradation of the signal. We utilize this degradation or change to an electrical signal as an indicator of the physiological responses to the implantation of the biomaterial device. We thus track the foreign body response electronically, an important analytical method for our program that aims to reduce the foreign body response. We applied electrical impedance spectroscopy (EIS) to track changes of the electrical signal behavior over time between micro-electrode arrays. We have performed experiments both in vitro and ex ova. In vitro, we used a reservoir of phosphate buffered saline into which selected proteins were introduced that adsorb onto the electrode surface. Three proteins were studied and each was found to affect the EIS results differently. We have investigated the foreign body response ex ova using the chick chorio-allantoic membrane (CAM) model. Following implantation of the electrode array the chick CAM exhibited a response similar to the mammalian foreign body response. We report that the electrical signal degrades with tissue growth during the healing and remodeling following the traumatic implantation of the electrode needle through the ectoderm side of the CAM tissue.
C1 [Karp, Floyd B.; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Bemotski, Neil A.; Bohringer, Karl F.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.
   [Valdes, Thelma I.] Becton Dickinson & Co, Franklin Lakes, NJ 07417 USA.
   [Ratner, Buddy D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Karp, FB (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM floyd@uwashington.edu; nber-nots@u.washington.edu; Thelma_Valdes@bd.com;
   karl@ee.washington.edu; ratner@uweb.engr.washington.edu
CR Alikacem N, 1999, ARTIF ORGANS, V23, P910, DOI 10.1046/j.1525-1594.1999.06231.x
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, P1, DOI 10.1002/0471716243
   Duan YY, 2001, P SOC PHOTO-OPT INS, V4235, P498, DOI 10.1117/12.420893
   GRILL WM, 1994, ANN BIOMED ENG, V22, P23, DOI 10.1007/BF02368219
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   HETKE, 2003, HDB NEUROPROSTHETIC
   Ho DQ, 2000, DERMATOL SURG, V26, P42, DOI 10.1046/j.1524-4725.2000.99143.x
   MCADAMS ET, 1995, PHYSIOL MEAS, V16, pA1, DOI 10.1088/0967-3334/16/3A/001
   SCHWAN HP, 1957, ADV BIOL MED PHYS, V5
   SCHWAN HP, 1963, PHYS TECHNIQUES BIOL, V6
   Tait W. S, 1994, INTRO ELECTROCHEMICA
   Webster JG, 1990, ELECT IMPEDANCE TOMO
NR 12
TC 13
Z9 14
U1 0
U2 11
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1530-437X
EI 1558-1748
J9 IEEE SENS J
JI IEEE Sens. J.
PD JAN-FEB
PY 2008
VL 8
IS 1-2
BP 104
EP 112
DI 10.1109/JSEN.2007.912550
PG 9
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Physics, Applied
SC Engineering; Instruments & Instrumentation; Physics
GA 254XO
UT WOS:000252621500014
DA 2018-10-19
ER

PT J
AU Shikha, D
   Jha, U
   Sinha, SK
   Barhai, PK
   Kalavathy, S
   Nair, KGM
   Dash, S
   Tyagi, AK
   Kothari, DC
AF Shikha, Deep
   Jha, Usha
   Sinha, S. K.
   Barhai, P. K.
   Kalavathy, S.
   Nair, K. G. M.
   Dash, S.
   Tyagi, A. K.
   Kothari, D. C.
TI Improvement in corrosion resistance of biomaterial alumina after 60 keV
   nitrogen ion implantation
SO INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY
LA English
DT Article
ID BEHAVIOR
AB Surface modification of polycrystalline alpha-alumina is carried out using ion implantation. Samples were implanted at 60 keV N+ ions with different ion doses ranging from 1 x 10(15) to 1 x 10(17) ions/cm(2). Corrosion resistance is studied in a Ringer solution. The increase in corrosion resistance is due to the compound formation studied using Fourier transform infrared spectroscopy and glancing-angle X-ray diffraction techniques. Nanohardness is more at a lower ion dose and decreases at a higher ion dose. Microstrutural investigation shows that the decrease in corrosion resistance and nanohardness at a higher ion dose is due to the damage accumulation at the surface.
C1 [Shikha, Deep; Jha, Usha] BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
   [Sinha, S. K.; Barhai, P. K.] BIT Mesra, Dept Appl Phys, Ranchi 835215, Jharkhand, India.
   [Kalavathy, S.; Nair, K. G. M.; Dash, S.; Tyagi, A. K.] Indira Gandhi Ctr Atom Res, Div Mat Sci, Kalpakkam 603102, Tamil Nadu, India.
   [Kothari, D. C.] Univ Bombay, Dept Phys, Bombay 400098, Maharashtra, India.
RP Shikha, D (reprint author), BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
EM sksinha@bitmesra.ac.in
RI Jha, Usha/L-9583-2017
OI Jha, Usha/0000-0001-9033-6517; Kothari, Dushyant/0000-0003-0448-4164
CR AZEVEDO AF, 2005, SURF COAT TECH, V94, P271
   Delgado-Alvarado C, 2006, ACTA BIOMATER, V2, P701, DOI 10.1016/j.actbio.2006.05.012
   DOBBS HS, 1992, J MATER SCI, V17, P2398
   Halitim F, 1997, J PHYS D APPL PHYS, V30, P330, DOI 10.1088/0022-3727/30/3/004
   Karimi MV, 2002, SURF COAT TECH, V158, P609
   Liu ZS, 2006, MATER CHEM PHYS, V99, P75, DOI 10.1016/j.matchemphys.2005.09.088
   Man HH, 1996, J MAGN MAGN MATER, V152, P47, DOI 10.1016/0304-8853(95)00454-8
   MECHIM G, 1973, J BIOMED MATER RES, V7, P555
   Park JB, 1992, BIOMATERIALS INTRO
   Sinha SK, 2002, SURF COAT TECH, V158, P214, DOI 10.1016/S0257-8972(02)00210-4
   Thair L, 2002, CORROS SCI, V44, P2439, DOI 10.1016/S0010-938X(02)00034-3
   THAMPI NS, 1989, INDIAN J PURE AP PHY, V27, P638
   Tian J, 2000, J MATER CHEM, V10, P565, DOI 10.1039/a905551g
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
   Zeigler J. F., 2003, SRIM COM
   Zhao Q, 1999, BIOMATERIALS, V20, P595, DOI 10.1016/S0142-9612(98)00218-X
NR 17
TC 5
Z9 5
U1 0
U2 6
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1546-542X
J9 INT J APPL CERAM TEC
JI Int. J. Appl. Ceram. Technol.
PY 2008
VL 5
IS 1
BP 44
EP 48
DI 10.1111/j.1744-7402.2008.02184.x
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 266ZV
UT WOS:000253478500006
DA 2018-10-19
ER

PT J
AU Koumanova, B
   Achova, B
   Allen, SJ
AF Koumanova, B.
   Achova, B.
   Allen, S. J.
TI Biosorption of acid dye on Pueraria lobata ohwi. Equilibrium and kinetic
   modelling
SO INTERNATIONAL JOURNAL OF ENVIRONMENT AND POLLUTION
LA English
DT Article
DE kudzu; acid dye Erionil Marine Blau; biosorption; equilibrium; kinetics
ID GRANULAR ACTIVATED CARBON; SPHAGNUM MOSS PEAT; AQUEOUS-SOLUTION;
   PSEUDO-ISOTHERMS; TREE FERN; ADSORPTION; SORPTION; REMOVAL; IONS;
   PHENOLS
AB The applicability of the biomaterial kudzu (Pueraria lobata ohwi) for the removal of the acid dye Erionil Marine Blau (EMB) from aqueous medium was investigated. The equilibrium results were described by the Langmuir and Freundlich models and the isotherms parameters were calculated. The experimental data were correlated better by the Freundlich model (R-2 = 0.9029). The effect of the system variables, initial sorbate concentration, mass of biosorbent, agitation rate and particle size, were examined. It was established that the biosorption of EMB on kudzu followed pseudo second order kinetics. The intraparticle diffusion model was also applied to explain the mechanism of dye molecules diffusion through the non-living biomass. The comparative estimation of the results proved the feasibility of using kudzu as an effective biosorbent for the removal of the acid dye EMB from aqueous phase. The highest obtained percent uptake of dye was 93%.
C1 [Koumanova, B.; Achova, B.] Univ Chem Technol & Met, Dept Chem Engn, BU-1756 Sofia, Bulgaria.
   [Allen, S. J.] Queens Univ Belfast, Sch Chem Engn, Belfast, Antrim, North Ireland.
RP Koumanova, B (reprint author), Univ Chem Technol & Met, Dept Chem Engn, 8 Kliment Ohridski Blvd, BU-1756 Sofia, Bulgaria.
EM bogdana@uctm.edu; S.Allen@Queens-Belfast.AC.UK
CR ALLEN SJ, 1995, J CHEM TECHNOL BIOT, V62, P17, DOI 10.1002/jctb.280620103
   ALLEN SJ, 1989, ENVIRON POLLUT, V56, P39, DOI 10.1016/0269-7491(89)90120-6
   Baup S, 2000, ADSORPTION, V6, P219, DOI 10.1023/A:1008937210953
   Brown PA, 2001, BIORESOURCE TECHNOL, V78, P195, DOI 10.1016/S0960-8524(00)00144-9
   Demirbas O, 2002, ADSORPTION, V8, P341, DOI 10.1023/A:1021589514766
   Dogan M, 2000, WATER AIR SOIL POLL, V120, P229, DOI 10.1023/A:1005297724304
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   FURUSAWA T, 1973, IND ENG CHEM FUND, V12, P179
   Garcia A, 1999, ADSORPTION, V5, P359, DOI 10.1023/A:1008904631147
   Ho Y.S., 1998, T ICHEME B, V76, P332
   Ho YS, 2004, ADSORPTION, V10, P151, DOI 10.1023/B:ADSO.0000039870.28835.09
   Ho YS, 2004, PROCESS BIOCHEM, V39, P759, DOI 10.1016/S0032-9592(03)00184-5
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Ho YS, 1999, ADSORPTION, V5, P409, DOI 10.1023/A:1008921002014
   Ho YS, 2001, ADSORPTION, V7, P139, DOI 10.1023/A:1011652224816
   Ho YS, 2001, SEPAR SCI TECHNOL, V36, P2473, DOI 10.1081/SS-100106104
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   Juang RS, 2000, J COLLOID INTERF SCI, V227, P437, DOI 10.1006/jcis.2000.6912
   Juang RS, 2001, ADSORPTION, V7, P65, DOI 10.1023/A:1011225001324
   Kircheva-Yaneva Z., 2004, J U CHEM TECHNOL MET, V39, P343
   Ko DCK, 2002, ADSORPTION, V8, P171, DOI 10.1023/A:1021283731952
   Koumanova B, 2002, J CHEM TECHNOL BIOT, V77, P539, DOI 10.1002/jctb.601
   Koumanova B, 2002, J HAZARD MATER, V90, P229, DOI 10.1016/S0304-3894(01)00365-X
   KOUMANOVA B, 2003, U CHEM TECHNOL MET S, V38, P735
   KOUMANOVA B, 2003, J U CHEM TECHNOL MET, V1, P71
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Ozer A, 2004, ADSORPTION, V10, P317
   PEEVAANTOVA P, 2001, J U CHEM TECHNOL MET, V36, P73
   Sharma A, 2004, ADSORPTION, V10, P327
   Singh S, 2004, WATER AIR SOIL POLL, V156, P275, DOI 10.1023/B:WATE.0000036821.39350.5f
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yapar S, 2004, ADSORPTION, V10, P287
   Zhang SJ, 2003, BIOTECHNOL LETT, V25, P1479, DOI 10.1023/A:1025036407588
NR 34
TC 0
Z9 0
U1 0
U2 3
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA
PA WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 896, CH-1215
   GENEVA, SWITZERLAND
SN 0957-4352
J9 INT J ENVIRON POLLUT
JI Int. J. Environ. Pollut.
PY 2008
VL 34
IS 1-4
BP 151
EP 163
DI 10.1504/IJEP.2008.020789
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 371PF
UT WOS:000260842700012
DA 2018-10-19
ER

PT J
AU Di Vita, G
   Patti, R
   Sparacello, M
   Balistreri, CR
   Candore, G
   Caruso, C
AF Di Vita, G.
   Patti, R.
   Sparacello, M.
   Balistreri, C. R.
   Candore, G.
   Caruso, C.
TI Impact of different texture of polypropylene mesh on the inflammatory
   response
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE hernioplasty; monofilament polypropylene; multifilament polypropylene;
   mesh
ID INGUINAL-HERNIA REPAIR; RANDOMIZED CLINICAL-TRIAL; ABDOMINAL-WALL;
   BIOMATERIALS; INTERLEUKIN-1; HERNIOPLASTY; LIGHTWEIGHT; INCREASE;
   SURGERY; MARKERS
AB Over the past decade, hernia surgery has undergone a considerable transformation with the use of prosthetic materials. The most used polypropylene meshes induce a rapid acute inflammatory response followed by chronic foreign body reaction. Many factors influence this response such as density, size, physical characteristics, different texture and porosity of each biomaterial. The aim of this study is to assess whether the implant of monofilament or multifilament meshes, in the inguinal hernioplasty, determine a different inflammatory response. Thirty-two male patients were included in the study and were randomly divided into two groups. In the first group (MO) inguinal hernioplasty was performed using monofilament polypropylene mesh, while in the second one (MU) multifilament prosthesis was used. Peripheral venous blood samples were collected 24 hours before surgery and then 6, 24, 48 and 168 hours posto-peratively. Modifications in leukocyte count, C-reactive protein (CRP), alpha-1 antitrypsin (alpha 1-AT), interleukin (IL)-1, IL-6, IL-1 ra and IL-10 serum levels were recorded at all sampling times. We present evidence that serum levels of CRP, (alpha 1-AT), leukocytes and cytokines were significantly increased post-operatively in both groups, returning to basal values 168 hours afterwards. In particular, the production of all pro-inflammatory mediators was higher in the MU group, whereas the anti-inflammatory cytokine (IL-10, IL-1ra) production was higher in MO patients. Our results indicate that polypropylene multifilament mesh allows a higher intense acute inflammatory response as compared to monofilament mesh implantation.
C1 [Di Vita, G.; Patti, R.; Sparacello, M.] Univ Palermo, Div Gen Surg, Dept Surg & Oncol Sci, I-90143 Palermo, Italy.
   [Balistreri, C. R.; Candore, G.; Caruso, C.] Univ Palermo, Dept Pathobiol & Biomed Methodol, Immunosenescence Unit, Palermo, Italy.
RP Di Vita, G (reprint author), Univ Palermo, Div Gen Surg, Dept Surg & Oncol Sci, Via Autonomia Siciliana 70, I-90143 Palermo, Italy.
EM divitagaetano@libero.it
RI Balistreri, Carmela Rita/K-9495-2016
OI Balistreri, Carmela Rita/0000-0002-5393-1007
CR Amid P, 1997, HERNIA, V1, P5
   AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   AMID PK, 1994, ANN SURG, V220, P735, DOI 10.1097/00000658-199412000-00004
   Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27
   ARNAUD JP, 1978, INT SURG, V63, P7
   Azouz Abdallah, 2004, Medical Electron Microscopy, V37, P141
   BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bogusiewicz M, 2006, EUR J OBSTET GYN R B, V124, P106, DOI 10.1016/j.ejogrb.2005.04.020
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Condon RE, 1994, SEMIN LAPAROSC SURG, V1, P75
   Conze J, 2004, Hernia, V8, P365, DOI 10.1007/s10029-004-0268-8
   Di Vita G, 2005, LANGENBECK ARCH SURG, V390, P306, DOI 10.1007/s00423-004-0534-3
   Di Vita G, 2001, AM J SURG, V181, P487, DOI 10.1016/S0002-9610(01)00637-7
   Di Vita G, 2000, AM J SURG, V180, P203, DOI 10.1016/S0002-9610(00)00445-1
   DIANNARELLO CA, 1998, ANN NY ACAD SCI, V856, P1
   Gurleyik E, 1998, AM J SURG, V175, P179, DOI 10.1016/S0002-9610(97)00293-6
   HILL ADK, 1995, SURG ENDOSC-ULTRAS, V9, P695
   Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   Klinge U, 2002, J BIOMED MATER RES, V63, P765, DOI 10.1002/jbm.10449
   Klinge U, 1996, CHIRURG, V67, P229
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Lawrence K, 1997, ANN ROY COLL SURG, V79, P40
   Marois Y, 2000, ARTIF ORGANS, V24, P533, DOI 10.1046/j.1525-1594.2000.06547.x
   Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x
   NYHUS LM, 1993, SURGERY, V114, P1
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Papadimitriou John, 2005, Hernia, V9, P75, DOI 10.1007/s10029-004-0286-6
   Post S, 2004, BRIT J SURG, V91, P44, DOI 10.1002/bjs.4387
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Schumpelick V, 1996, CHIRURG, V67, P1028, DOI 10.1007/s001040050099
   USHER FC, 1958, ARCH SURG-CHICAGO, V76, P997, DOI 10.1001/archsurg.1958.01280240155026
   WALKER AP, 1995, HERNIA, P534
   WHITE RA, 1988, T AM SOC ART INT ORG, V34, P95
NR 36
TC 13
Z9 14
U1 0
U2 4
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN-MAR
PY 2008
VL 21
IS 1
BP 207
EP 214
DI 10.1177/039463200802100123
PG 8
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 284DT
UT WOS:000254686700023
PM 18336747
OA Bronze
DA 2018-10-19
ER

PT J
AU Cong, CB
   Wang, HS
   Xu, RW
   Lu, WC
   Yu, DS
AF Cong, Chuanbo
   Wang, Haosheng
   Xu, Riwei
   Lu, Weichuan
   Yu, Dingsheng
TI A study on properties of poly(3-hydroxylbutyrate-co-4-hydroxylbutyrate)
   with various 4HB contents and triethyl citrate plasticization
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE biomaterial; crystal structures; mechanical properties; wide-angle X-ray
   diffraction; thermal properties
ID MICROBIAL SYNTHESIS; RALSTONIA-EUTROPHA; POLYHYDROXYALKANOATE SYNTHASE;
   MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; BIOSYNTHESIS;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE);
   POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); POLY(3-HYDROXYBUTYRATE);
   DEGRADATION
AB Sheets of poly(3-hydroxylbutyrate-co-4-hydroxylbutyrate)[P(3HB-co-4HB)] with various 4HB contents and triethyl citrate (TEC) plasticization are prepared by melt mixing and compression moulding. The thermal, crystalline and mechanical properties of these sheets are evaluated. Furthermore, fracture surfaces of samples plasticized by TEC are examined by scanning electron microscope (SEM). The results show that the increase of 4HB content can lead to the decrease of thermal parameters of samples such as melting temperature, glass transition temperature, crystalline temperature and crystallinity. However, the elongation-at-break of samples increases with the 4HB content increasing, and the strength-at-break decreases as a whole. The incorporation of 4HB units can improve the thermal stability of copolymer. The effect of TEC on the thermal and mechanical properties of samples is similar with that of 4HB unit. In contrast to 4HB unit, the increase of TEC content can worsen the thermal stability of samples. In addition, the copolymer of P(3HB-co-4HB) is compatible with TEC and its ductility can be improved by incorporation of TEC.
C1 [Cong, Chuanbo; Wang, Haosheng; Xu, Riwei; Yu, Dingsheng] Beijing Univ Chem Technol, Sch Mat Sci & Engn, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   [Lu, Weichuan] Tianjin Green Biosci Ltd Co, Tianjin 300457, Peoples R China.
RP Yu, DS (reprint author), Beijing Univ Chem Technol, Sch Mat Sci & Engn, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
EM yuds@mail.buct.edu.cn
OI Xu, Riwei/0000-0003-2203-3033
CR ABE H, 1994, MACROMOLECULES, V27, P6012, DOI 10.1021/ma00099a012
   Cao A, 1996, POLYM J, V28, P1096, DOI 10.1295/polymj.28.1096
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Choi JS, 2004, POLYM TEST, V23, P455, DOI 10.1016/j.polymertesting.2003.09.005
   Choi MH, 2003, BIOMACROMOLECULES, V4, P38, DOI 10.1021/bm025596s
   DOI Y, 1990, INT J BIOL MACROMOL, V12, P106, DOI 10.1016/0141-8130(90)90061-E
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Fraga A, 2005, POLYM TEST, V24, P526, DOI 10.1016/j.polymertesting.2004.11.013
   Ishida K, 2001, BIOMACROMOLECULES, V2, P1285, DOI 10.1021/bm010115a
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   Lee SN, 2002, J APPL POLYM SCI, V83, P2945, DOI 10.1002/app.10318
   Loo CY, 2007, INT J BIOL MACROMOL, V40, P466, DOI 10.1016/j.ijbiomac.2006.11.003
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Park SK, 1997, J MICROBIOL, V35, P127
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   Satoh Y, 2005, J BIOSCI BIOENG, V99, P508, DOI 10.1263/jbb.99.508
   Savenkova L, 2000, PROCESS BIOCHEM, V35, P573, DOI 10.1016/S0032-9592(99)00107-7
   Shang LG, 2003, BIOTECHNOL LETT, V25, P1415, DOI 10.1023/A:1025047410699
   Tabandeh F, 2003, IRAN POLYM J, V12, P37
   Trotsenko YA, 2000, MICROBIOLOGY+, V69, P635, DOI 10.1023/A:1026641821583
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Tsuge T, 2004, SCI TECHNOL ADV MAT, V5, P449, DOI 10.1016/j.stam.2004.01.013
   WEI W, 2007, IRAN POLYM J, V16, P195
   YOSHIE N, 1995, MACROMOLECULES, V28, P6516, DOI 10.1021/ma00123a018
NR 25
TC 3
Z9 3
U1 0
U2 13
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JAN
PY 2008
VL 17
IS 1
BP 49
EP 59
PG 11
WC Polymer Science
SC Polymer Science
GA 268UY
UT WOS:000253606500004
DA 2018-10-19
ER

PT J
AU Sousa, C
   Teixeira, P
   Bordeira, S
   Fonseca, J
   Oliveira, R
AF Sousa, C.
   Teixeira, P.
   Bordeira, S.
   Fonseca, J.
   Oliveira, R.
TI Staphylococcus epidermidis adhesion to modified polyearbonate surfaces:
   Gold and SAMs coated
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE adhesion; calix-crown; polycarbonate; self-assembled monolayers;
   Staphylococcus epidermidis
ID SELF-ASSEMBLED-MONOLAYERS; PROTEIN ADSORPTION; CELL-ADHESION; BACTERIAL
   ADHESION; AUREUS ADHESION; GROWTH; MODEL; ALKANETHIOLS; ATTACHMENT;
   WETTABILITY
AB Bacterial adhesion to a biomaterial surface is thought to be the key step in the infection of indwelling medical devices and constitutes an object of study in the demand to reduce nosocomial infections. In this work, specific modifications on polycarbonate outer layer were utilized as model surfaces for the study of the adhesion of Staphylococcus epidermidis, one of the main microorganisms responsible for nosocomial infections. The effect of gold coating on staphylococcal adhesion was assessed, as well as of subsequent coverage with different self-assembled monolayers (SAMs): two SAMs with a methyl terminal group and hydrophobic character and two hydrophilic SAMs with a carboxylic acid terminal group. Variations in the aliphatic chain length were also tested. A SAM with a calix-crown molecule was also created to immobilize a specific protein and its antibody. The extent of staphylococcal adhesion to methyl terminated SAMS was reduced compared to the number of cells adhered to the carboxyl acid terminated SAMs, demonstrating that methyl terminated SAMs constituted more suitable surfaces in preventing bacterial adhesion. The calix-crown molecule favours high levels of adhesion due to its non-specific bonding nature and geometrical configuration. However, when a specific protein is linked to calix-crown, bacterial adhesion occurs to a much lower extent. The results obtained in this work have a potential practical significance showing that the use of certain SAMs as surface modifiers may constitute a successful method in the reduction of bacterial adhesion to biomedical surfaces. (C) Koninklijke Brill NV, Leiden, 2008.
C1 [Sousa, C.; Teixeira, P.; Oliveira, R.] Univ Minho, Ctr Engn Biol, IBB, P-4710057 Braga, Portugal.
   [Bordeira, S.; Fonseca, J.] Univ Lisbon, Ctr Fis Mat Condensada, P-1649003 Lisbon, Portugal.
RP Sousa, C (reprint author), Univ Minho, Ctr Engn Biol, IBB, Campus Gualtar, P-4710057 Braga, Portugal.
EM claudiasousa@deb.uminho.pt
RI Teixeira, Pilar/C-9931-2012; Sousa, Claudia/B-5314-2016
OI Teixeira, Pilar/0000-0003-2735-6608; Sousa, Claudia/0000-0003-4259-1251
CR Andrews CS, 2001, BIOMATERIALS, V22, P3225, DOI 10.1016/S0142-9612(01)00160-0
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   Barbosa JN, 2005, BIOMATERIALS, V26, P3021, DOI 10.1016/j.biomaterials.2004.09.002
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Cerca N, 2004, RES MICROBIOL, V155, P755, DOI 10.1016/j.resmic.2004.06.005
   Chen HX, 2007, SENSORS-BASEL, V7, P1091, DOI 10.3390/s7071091
   Cooper E, 2000, J MATER CHEM, V10, P133, DOI 10.1039/a903210j
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Haddow DB, 1999, J BIOMED MATER RES, V47, P379, DOI 10.1002/(SICI)1097-4636(19991205)47:3<379::AID-JBM13>3.0.CO;2-#
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lin JC, 2000, J BIOMED MATER RES, V51, P413, DOI 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   Miller WJ, 1997, LANGMUIR, V13, P7106, DOI 10.1021/la970621e
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Oliveira R, 2003, BIOFILMS WASTEWATER, P211
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Rios PF, 2007, J ADHES SCI TECHNOL, V21, P227, DOI 10.1163/156856107780684567
   Saygun O, 2006, J SURG RES, V131, P73, DOI 10.1016/j.jss.2005.06.020
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Teixeira P, 1999, J ADHES SCI TECHNOL, V13, P1287, DOI 10.1163/156856199X00190
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Tsai MY, 2001, J BIOMED MATER RES, V55, P554, DOI 10.1002/1097-4636(20010615)55:4<554::AID-JBM1049>3.0.CO;2-V
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VITALII S, 1997, J COLLOID INTERF SCI, V185, P94
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang H, 2006, J BIOMED MATER RES A, V77A, P672, DOI 10.1002/jbm.a.30586
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
NR 37
TC 7
Z9 7
U1 0
U2 6
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2008
VL 22
IS 7
BP 675
EP 686
DI 10.1163/156856108X309657
PG 12
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 330NI
UT WOS:000257949700001
DA 2018-10-19
ER

PT J
AU Koller, G
   Roether, J
   Bruce, K
   Deb, S
AF Koller, G.
   Roether, J.
   Bruce, K.
   Deb, S.
TI Antimicrobial potential of bioactive bone cements
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE bioactive bone cements; bacteriostatic bone cements; bioactive glass;
   poly(methylmethacrylate)
ID BIOMATERIAL-CENTERED INFECTION; ANTIBACTERIAL ACTIVITY; MICROBIAL
   ADHESION; TISSUE INTEGRATION; IN-VITRO; SILVER
AB Poly(methyl methacrylate) (PMMA) based bone cement is widely used to anchor artificial joints. In recent years, antibiotics have been incorporated in bone cements and administered systemically to either prevent or reduce the severity of infections. Certain antibiotics, such as tobramycin or vancomycin antibiotics have been incorporated at high concentrations into PMMA bone cements when dealing with infected hip joints, however, the inclusion of some antibiotics adversely affect the mechanical properties of the cement. Furthermore, studies have indicated that the incorporation of gentamicin in PMMA cements does not have a statistically significant effect on the biofilm formation of species such as Staphylococcus aureus (S. aureus). Bioactive glasses have been shown to have numerous applications in the biomedical field because of their properties in bonding to both hard and soft tissues. Bioglass(R) undergoes surface dissolution in a physiological environment forming a hydroxycarbonate apatite layer and, in addition, exhibits the anti-inflammatory properties. Recent studies have shown that two paste bioactive bone cement systems that use Bioglass(R) as filler exhibit physical and mechanical properties comparable to PMMA cements with low polymerization exotherm and better mechanical properties with improved adhesion to bone and implant surfaces. In this study, Bioglass(R) containing two paste bone cements were investigated for their potential bacteriostatic properties and compared with PMMA cements with and without antibiotics. The results of this study indicated that the PMMA cement containing the antibiotic, gentamycin and the Bioglass(R) containing cements both pre- and post-immersion in simulated body fluid (SBF) for brief periods showed the inhibition zones were not statistically significantly different in their average size for any of the three bacterial species, namely Pseudomonas aeruginosa, S. aureus and Staphylococcus epidermidis. However, the PMMA cement without any antibiotic, namely gentamycin (CMW1) did not show any inhibition zones around the specimens for any of the three bacterial species. It was also noted that both Bioglass(R) filled bioactive cements immersed in SBF showed statistically significant increases in inhibition zones for all three specimens compared to specimens that were not immersed (p<0.001).
C1 [Koller, G.; Roether, J.; Deb, S.] Guys Hosp, Univ London Kings Coll, Inst Dent, Dept Biomat, London SE1 9RT, England.
   [Bruce, K.] Kings Coll London, Dept Biochem, Mol Biol Drug Delivery Grp, London, England.
   [Roether, J.; Deb, S.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Deb, S (reprint author), Guys Hosp, Univ London Kings Coll, Inst Dent, Dept Biomat, London SE1 9RT, England.
EM sanjukta.deb@kcl.ac.uk
RI Koller, Garrit/F-9986-2012
CR Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P43, DOI 10.1093/jac/48.suppl_1.43
   Bourne RB, 2004, J ARTHROPLASTY, V19, P69, DOI 10.1016/j.arth.2004.03.005
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   Deb S, 2005, BIOMATERIALS, V26, P3713, DOI 10.1016/j.biomaterials.2004.09.065
   Gristina A, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000145156.89115.12
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   HALL FJ, 1977, LANCET, V2, P455
   Hanssen AD, 2004, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000143806.72379.7d
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Heatley NG, 1944, BIOCHEM J, V38, P61, DOI 10.1042/bj0380061
   Hench Larry L., 2001, P INT C GLASS, V226-233, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5
   Kwon SY, 1997, BIO-MED MATER ENG, V7, P129
   Lieberman P, 2002, J ALLERGY CLIN IMMUN, V110, pS64, DOI 10.1067/mai.2002.124970
   Morita S, 1998, BIOMATERIALS, V19, P1601, DOI 10.1016/S0142-9612(97)00120-8
   Mulligan AM, 2003, BIOMATERIALS, V24, P1797, DOI 10.1016/S0142-9612(02)00577-X
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
NR 23
TC 6
Z9 6
U1 0
U2 6
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD JAN-APR
PY 2008
VL 6
IS 1
BP 16
EP 22
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 299AB
UT WOS:000255727100003
PM 20740442
DA 2018-10-19
ER

PT J
AU Nair, K
   Yan, KC
   Sun, W
AF Nair, K.
   Yan, K. C.
   Sun, W.
TI A computational modeling approach for the characterization of mechanical
   properties of 3D alginate tissue scaffolds
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE scaffold; stress-strain; Ogden; numerical
ID PERIPHERAL-NERVE REGENERATION; CELL-MOVEMENT; IN-VIVO; CALCIUM;
   CARTILAGE; DELIVERY; MOTILITY; BIOMATERIALS; CHONDROCYTES; FABRICATION
AB Scaffold guided tissue engineering is an innovative approach wherein cells are seeded onto biocompatible and biodegradable materials to form 3-dimensional (3D) constructs that, when implanted in the body facilitate the regeneration of tissue. Tissue scaffolds act as artificial extracellular matrix providing the environment conducive for tissue growth. Characterization of scaffold properties is necessary to understand better the underlying processes involved in controlling cell behavior and formation of functional tissue. We report a computational modeling approach to characterize mechanical properties of 3D gel-like biomaterial, specifically, 3D alginate scaffold encapsulated with cells. Alginate inherent nonlinearity and variations arising from minute changes in its concentration and viscosity make experimental evaluation of its mechanical properties a challenging and time consuming task. We developed an in silico model to determine the stress-strain relationship of alginate based scaffolds from experimental data. In particular, we compared the Ogden hyperelastic model to other hyperelastic material models and determined that this model was the most suitable to characterize the nonlinear behavior of alginate. We further propose a mathematical model that represents the alginate material constants in Ogden model as a function of concentrations and viscosity. This study demonstrates the model capability to predict mechanical properties of 3D alginate scaffolds.
C1 [Nair, K.; Sun, W.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
   [Yan, K. C.] Coll New Jersey, Ewing, NJ USA.
RP Sun, W (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM sunwei@drexel.edu
CR Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771
   Boyce MC, 2000, RUBBER CHEM TECHNOL, V73, P504, DOI 10.5254/1.3547602
   BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117
   BROWN PJ, 2005, NATL TEXTILE CTR RES
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   Dos Santos LA, 1999, BONE, V25, p99S, DOI 10.1016/S8756-3282(99)00143-X
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   Favre E, 2001, COLLOID SURFACE A, V194, P197, DOI 10.1016/S0927-7757(01)00789-0
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   HARRIS A, 1973, EXP CELL RES, V77, P285, DOI 10.1016/0014-4827(73)90579-X
   *HIBB KARL SOR INC, 2002, ABAQUS US MAN THEOR
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   KHALIL S, 2006, THESIS DREXEL U PHIL
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JW, 2002, J ORTHOPAED RES, V20, P66, DOI 10.1016/S0736-0266(01)00073-0
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lowe B, 1997, J EXP BIOL, V200, P1593
   Marcotte M, 2001, FOOD RES INT, V34, P695, DOI 10.1016/S0963-9969(01)00091-6
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Nair K, 2007, J MECH MATER STRUCT, V2, P1121, DOI 10.2140/jomms.2007.2.1121
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   Pettit EJ, 1998, PHYSIOL REV, V78, P949
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Sugiura S, 2005, BIOMATERIALS, V26, P3327, DOI 10.1016/j.biomaterials.2004.08.029
   Sugiyama S, 2004, INORG CHEM COMMUN, V7, P569, DOI 10.1016/j.inoche.2004.02.021
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   van Osch GJVM, 2001, BIOCHEM BIOPH RES CO, V280, P806, DOI 10.1006/bbrc.2000.4168
   VOZZI G, MAT RES SOC S P 2004
   Yoshioka Y, 2003, BIOCHEM BIOPH RES CO, V305, P353, DOI 10.1016/S0006-291X(03)00761-7
   ZIMMERMANN U, 1992, ELECTROPHORESIS, V13, P69
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 50
TC 10
Z9 10
U1 2
U2 8
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD JAN-APR
PY 2008
VL 6
IS 1
BP 35
EP 46
PG 12
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 299AB
UT WOS:000255727100006
PM 20740445
DA 2018-10-19
ER

PT J
AU Chen, HQ
   Fan, MW
AF Chen, Huangqin
   Fan, Mingwen
TI Novel thermally sensitive pH-dependent chitosan/carboxymethyl cellulose
   hydrogels
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE chitosan; carboxymethyl cellulose; thermally responsive material; pH
   dependent
ID DRUG-DELIVERY SYSTEMS; BIORESORBABLE MEMBRANE; SODIUM HYALURONATE;
   IN-VIVO; CHITOSAN; CARBOXYMETHYLCELLULOSE; COMPLEX; BIOCOMPATIBILITY;
   PERSPECTIVES; TRANSFECTION
AB Temperature-responsive polymers are attractive candidates for applications related to injectable delivery of biologically active therapeutics. In this study, a novel approach to provide thermally sensitive neutral solutions based on chitosan/carboxymethyl cellulose (Ch/CMC) combinations is described. The potential of thermosensitive Ch/CMC as a biomaterial is evaluated for the culture of chondrocytes, with the goal of using the Ch/CMC polymer as an injectable matrix/cell therapeutic. These formulations possess a physiological pH and can be held as liquid below room temperature for encapsulating living cells. At body temperature they form monolithic gels, thus injected in vivo, the liquid formulations turn into gel implants in situ. The sols/gels have been thoroughly characterized for rheology and morphology analysis. The use of Ch/CMC aqueous solutions as gelling systems is a new discovery of a new family of thermosetting gels highly compatible with biological compounds.
C1 [Chen, Huangqin; Fan, Mingwen] Wuhan Univ, Minist Educ, Sch Stomatol, Key Lab Oral Biomed Engn, Wuhan 430072, Peoples R China.
RP Fan, MW (reprint author), Wuhan Univ, Minist Educ, Sch Stomatol, Key Lab Oral Biomed Engn, Wuhan 430072, Peoples R China.
EM kqyywjtx@public.wh.hb.cn
CR Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Denkbas EB, 2006, J BIOACT COMPAT POL, V21, P351, DOI 10.1177/0883911506066930
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lee SC, 2005, J BIOACT COMPAT POL, V20, P5, DOI 10.1177/0883911505049652
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Moreira H, 2000, DIS COLON RECTUM, V43, P182, DOI 10.1007/BF02236979
   Paneva D, 2005, J BIOACT COMPAT POL, V20, P133, DOI 10.1177/0883911505051855
   Park K., 2001, ADV DRUG DELIV REV, V53, P321
   Rosca C, 2005, CARBOHYD POLYM, V62, P35, DOI 10.1016/j.carbpol.2005.07.004
   Salum MR, 2001, DIS COLON RECTUM, V44, P706, DOI 10.1007/BF02234571
   Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006
   Yu X, 2005, J BIOACT COMPAT POL, V20, P15, DOI 10.1177/0883911505049653
   Zhang J, 2007, J BIOACT COMPAT POL, V22, P207, DOI 10.1177/0883911506076046
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 24
TC 37
Z9 37
U1 5
U2 58
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2008
VL 23
IS 1
BP 38
EP 48
DI 10.1177/0883911507085070
PG 11
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 249SW
UT WOS:000252251000003
DA 2018-10-19
ER

PT J
AU Liu, L
   Liu, JY
   Wang, MQ
   Min, SJ
   Cai, YR
   Zhu, LJ
   Yao, JM
AF Liu, Lin
   Liu, Jinying
   Wang, Mingqi
   Min, Sijia
   Cai, Yurong
   Zhu, Liangjun
   Yao, Juming
TI Preparation and characterization of nano-hydroxyapatite/silk fibroin
   porous scaffolds
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomineralization; hydroxyapatite; silk fibroin; composite; porous
   scaffold; biocompatibility
ID SOLID-STATE NMR; SILK FIBROIN; BOMBYX-MORI; PHYSICOCHEMICAL PROPERTIES;
   MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; IN-VITRO; NANOCOMPOSITE;
   APATITE; MICROSTRUCTURE
AB Novel tissue engineering scaffold materials of nano-hydroxyapatite (nHA)/silk fibroin (SF) biocomposite were prepared by freeze-drying. The needle-like nHA crystals of about 10 nm in diameter by 50-80 nm in length, which were uniformly distributed in the porous nHA/SF scaffolds, were prepared by a co-precipitation method with a size. The as-prepared nHA/SF scaffolds showed good homogeneity, interconnected pores and high porosity. XRD and FT-IR analysis suggested that the silk fibroin was in beta-sheet structure, which usually provides outstanding mechanical properties for silk materials. In this work, composite scaffolds containing as high as 70% (w/w) nHA were prepared, which had excellent compressive modulus and strength, higher than the scaffolds at low nHA content level and other porous biodegradable polymeric scaffolds often considered in bone-related tissue engineering reported previously. The cell compatibility of composite scaffolds was evaluated through cell viability by MTT assay. All these results indicated that these nHA/SF scaffold materials may be a promising biomaterial for bone tissue engineering.
C1 [Liu, Lin; Liu, Jinying; Wang, Mingqi; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Textile, Key Lab Adv Textile Mat & Mfg Technol, Minist Educ, Hangzhou 310018, Peoples R China.
   [Min, Sijia; Zhu, Liangjun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Textile, Key Lab Adv Textile Mat & Mfg Technol, Minist Educ, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   [Jin Zhengguo 靳正国], 2003, [硅酸盐学报, Journal of the Chinese Silicate Society], V31, P608
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   LI L, 2007, IN PRES J MAT SCI MA
   LI YB, 1994, J MATER SCI-MATER M, V5, P326
   Liu HC, 2004, BIOMATERIALS, V25, P4047, DOI 10.1016/j.biomaterials.2003.10.098
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Rhee SH, 2002, J MATER SCI-MATER M, V13, P597, DOI 10.1023/A:1015135112302
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Teng SH, 2007, J INORG BIOCHEM, V101, P686, DOI 10.1016/j.jinorgbio.2006.11.018
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
   Wu C., 2004, CHIN J CLIN REHABIL, V8, P929
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Yao JM, 2004, BIOMACROMOLECULES, V5, P680, DOI 10.1021/bm034285u
   Zhang Li, 2007, High Technology Letters (English Language Edition), V13, P31
NR 37
TC 62
Z9 67
U1 3
U2 48
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 3
BP 325
EP 338
DI 10.1163/156856208783721010
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 284BX
UT WOS:000254681300004
PM 18325234
DA 2018-10-19
ER

PT J
AU Luo, LH
   Wang, XM
   Zhang, YF
   Liu, YM
   Chang, PR
   Wang, Y
   Chen, Y
AF Luo, Li-Hua
   Wang, Xiao-Mei
   Zhang, Yu-Feg
   Liu, Yong-Ming
   Chang, Peter R.
   Wang, Yan
   Chen, Yun
TI Physical properties and biocompatibility of cellulose/soy protein
   isolate membranes coagulated from acetic aqueous solution
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE cellulose; soy protein isolate; blend; membrane; biocompatibility
ID IN-VIVO BIOCOMPATIBILITY; BLEND MEMBRANES; BIODEGRADABLE POLYMERS;
   FIBROIN BLEND; FILMS; VITRO; IMMOBILIZATION; HEMODIALYSIS; FRACTIONS;
   COMPOSITE
AB Aseries of cellulose/soy protein isolate (SPI) membranes was prepared from cellulose and SPI solution by casting and coagulation from 5 wt% acetic acid and 5 wt% sulphuric acid aqueous solution, respectively. The structure and properties of the membranes were characterized by Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy and tensile testing. The effects of SPI content (W-SPI) and the coagulants on the structure and properties of the membranes were investigated. The membranes exhibited porous structure. The pore size in the surfaces and cross-sections of the membranes increased with an increase of WSPI regardless of the coagulants. The membranes containing 10 wt% WSPI showed higher tensile strength and elongation at break than other membranes. The membranes with the same WSPI coagulated from acetic acid solution exhibited higher values of tensile strength, elongation at break and pore size in the surfaces and cross-sections than those corresponding membranes coagulated from sulphuric acid. The biocompatibility of the acetic acid-coagulated membranes was preliminarily evaluated by cell culture and in vivo implantation experiments. The results revealed that human umbilical vein endothelial cells (ECV304) grew well on this biomaterial. In comparison with the pure cellulose membrane, because of the incorporation of SPI and the resultant alteration of microstructure, the SPI-modified membranes showed an improved in vivo biocompatibility and biodegradability in the implantation experiments. These cellulose/SPI membranes warrant further explorations in biomedical fields.
C1 [Luo, Li-Hua; Wang, Xiao-Mei; Liu, Yong-Ming; Wang, Yan; Chen, Yun] Wuhan Univ, Res Ctr Med & Struct Biol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.
   [Zhang, Yu-Feg] Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Sch Stomatol, Wuhan 430079, Peoples R China.
   [Chang, Peter R.; Chen, Yun] Agr & Agri Food Canada, Bioprod & Bioproc Natl Sci Program, Saskatoon, SK S7N 0X2, Canada.
RP Chen, Y (reprint author), Wuhan Univ, Res Ctr Med & Struct Biol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.
EM yunchen@whu.edu.cn
RI chen, yun/C-8105-2014
OI chen, yun/0000-0002-5984-7455; Chang, Peter R./0000-0002-9497-5540
CR Abe Y, 2003, J APPL POLYM SCI, V89, P1671, DOI 10.1002/app.12439
   ANDERSON RL, 1992, CANCER LETT, V63, P83, DOI 10.1016/0304-3835(92)90057-3
   Bartouilh de Taillac L, 2004, COMPOS SCI TECHNOL, V64, P827, DOI 10.1016/j.compscitech.2003.09.011
   Bryjak J, 2007, CARBOHYD RES, V342, P1105, DOI 10.1016/j.carres.2007.02.014
   Cai J, 2005, MACROMOL BIOSCI, V5, P539, DOI 10.1002/mabi.200400222
   Chen H, 2004, J BIOMAT SCI-POLYM E, V15, P841, DOI 10.1163/1568562041271138
   Chen P, 2005, MACROMOL BIOSCI, V5, P237, DOI 10.1002/mabi.200400179
   Chen Y, 2004, J MEMBRANE SCI, V241, P393, DOI 10.1016/j.memsci.2004.06.009
   Chen Y, 2004, J APPL POLYM SCI, V94, P748, DOI 10.1002/app.20956
   Chun BH, 2007, BIORESOURCE TECHNOL, V98, P1000, DOI 10.1016/j.biotrech.2006.04.012
   DIAMANTOGLOU M, 1994, INT J ARTIF ORGANS, V17, P385
   Donaldson MS, 1998, BIOTECHNOL PROGR, V14, P573, DOI 10.1021/bp9800541
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Franek F, 2000, BIOTECHNOL PROGR, V16, P688, DOI 10.1021/bp0001011
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   GERLACH J, 1990, INT J ARTIF ORGANS, V13, P436
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   Hishikawa Y, 2005, BIOMACROMOLECULES, V6, P2468, DOI 10.1021/bm050032k
   Kasai W, 2004, MACROMOL BIOSCI, V4, P17, DOI 10.1002/mabi.200300054
   Kino Y, 1998, J SURG RES, V79, P71, DOI 10.1006/jsre.1998.5389
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kumar V, 2002, J BIOMAT SCI-POLYM E, V13, P273, DOI 10.1163/156856202320176529
   Marsano E, 2007, J APPL POLYM SCI, V104, P2187, DOI 10.1002/app.24856
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Murakami Y, 2003, J BIOMAT SCI-POLYM E, V14, P1255, DOI 10.1163/156856203322553473
   Romero-Bastida CA, 2004, J AGR FOOD CHEM, V52, P2230, DOI 10.1021/jf0350414
   Schmidt V, 2005, POLYM DEGRAD STABIL, V87, P25, DOI 10.1016/j.polymdegradstab.2004.07.003
   Sharma J. B., 2007, Archives of Gynecology and Obstetrics, V275, P231, DOI 10.1007/s00404-006-0256-6
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Subirade M, 1998, INT J BIOL MACROMOL, V23, P241, DOI 10.1016/S0141-8130(98)00052-X
   Suzuki S, 2005, BIOMATERIALS, V26, P5303, DOI 10.1016/j.biomaterilas.2005.01.061
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   Vaz CM, 2003, BIOMACROMOLECULES, V4, P1520, DOI 10.1021/bm034050i
   Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang G, 2001, J APPL POLYM SCI, V81, P3260, DOI 10.1002/app.1781
   Ye SH, 2004, J BIOMAT SCI-POLYM E, V15, P981, DOI 10.1163/1568562041526450
   Yi F, 2006, J APPL POLYM SCI, V99, P1340, DOI 10.1002/app.22222
   Zhang L, 2005, IND ENG CHEM RES, V44, P522, DOI 10.1021/ie0491802
NR 42
TC 24
Z9 26
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 4
BP 479
EP 496
DI 10.1163/156856208783719491
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 284BZ
UT WOS:000254681500006
PM 18318960
DA 2018-10-19
ER

PT J
AU Liu, Y
   Chen, JR
   Yang, Y
   Wu, F
AF Liu, Yun
   Chen, Jie-Rong
   Yang, Yun
   Wu, Feng
TI Improved blood compatibility of poly(ethylene terephthalate) films
   modified with L-arginine
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyethylene terephthalate; L-arginine; protein adsorption; platelet
   adhesion; thrombus formation; blood compatibility
ID NITRIC-OXIDE; IMPROVED HEMOCOMPATIBILITY; PLATELET-AGGREGATION; SURFACE
   MODIFICATION; PROTEIN ADSORPTION; ACTIVATION; POLYMERS; CHITOSAN; ACID
AB In order to improve the blood compatibility of the commonly used blood- contacting biomaterial poly(ethylene terephthalate) (PET), in this study PET films were chemically modified with L-arginine (L-Arg) by a three-step-procedure using glutaraldehyde (GA) as a cross-linker. The composition and chemical structure of PET and its change with surface modification were examined by X-ray photoelectron spectroscopy (XPS) and attenuated total reflection Fourier transform infrared (ATR-FT-IR) spectroscopy, while the change in hydrophilicity was judged by water contact angles measurement. The result of water contact measurement indicated that the modified films became more hydrophilic than PET with the contact angle decreasing from 78.5. for PET to 43.7. for PET-Arg. The protein adsorption on the film surface was evaluated by bicinchoninic acid assay (BCA) method, and the result showed that the L-Arg-modified films decreased the amount of protein adsorption by about 25%. The in vitro blood compatibility such as platelet adhesion (observed by scanning electron microscopy) and thrombus formation was also investigated, and the results demonstrated that the L-Arg-modified films significantly suppressed platelet adhesion and aggregation and reduced the thrombus formation by about 67% compared with PET.
C1 [Liu, Yun] Xian Jiaotong Univ, Sch Life & Technol, Xian 710049, Peoples R China.
   [Liu, Yun; Yang, Yun] Xian Jiaotong Univ, Dept Chem, Sch Sci, Xian 710049, Peoples R China.
   [Chen, Jie-Rong] Xian Jiaotong Univ, Dept Environm Sci & Engn, Xian 710065, Peoples R China.
   [Wu, Feng] Xian Jiaotong Univ, Ctr Blood Res, Coll Med, Xian 710065, Peoples R China.
RP Liu, Y (reprint author), Xian Jiaotong Univ, Sch Life & Technol, Xian 710049, Peoples R China.
EM liuy@tgrc.org
CR DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602
   Gappa-Fahlenkamp H, 2005, BIOMATERIALS, V26, P3479, DOI 10.1016/j.biomaterials.2004.09.028
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Jee KS, 2003, BIOMATERIALS, V24, P3409, DOI 10.1016/S0142-9612(03)00204-7
   Kidane A, 2000, COLLOID SURFACE B, V18, P347, DOI 10.1016/S0927-7765(99)00160-5
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee WK, 2002, J BIOMAT SCI-POLYM E, V13, P1153, DOI 10.1163/156856202320813855
   Li ZF, 2004, J COLLOID INTERF SCI, V269, P62, DOI 10.1016/S0021-9797(03)00606-4
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319
   Marietta M, 1997, THROMB RES, V88, P229, DOI 10.1016/S0049-3848(97)00233-8
   MARLETTA MA, 1993, J BIOL CHEM, V268, P12231
   MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536
   Ratner BD, 1996, BIOMATERIALS SCI, P133
   SALVEMINI D, 1990, BRIT J PHARMACOL, V101, P991, DOI 10.1111/j.1476-5381.1990.tb14194.x
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stief TW, 2001, THROMB RES, V104, P265, DOI 10.1016/S0049-3848(01)00368-1
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Udvardy M, 1997, THROMB RES, V87, P75, DOI 10.1016/S0049-3848(97)00106-0
   Yamasaki A, 2003, COLLOID SURFACE B, V28, P53, DOI 10.1016/S0927-7765(02)00130-3
NR 23
TC 17
Z9 19
U1 1
U2 15
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 4
BP 497
EP 507
DI 10.1163/156856208783719545
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 284BZ
UT WOS:000254681500007
PM 18318961
DA 2018-10-19
ER

PT J
AU Nisbet, DR
   Yu, LMY
   Zahir, T
   Forsythe, JS
   Shoichet, MS
AF Nisbet, D. R.
   Yu, L. M. Y.
   Zahir, T.
   Forsythe, J. S.
   Shoichet, M. S.
TI Characterization of neural stem cells on electrospun
   poly(epsilon-caprolactone) submicron scaffolds: evaluating their
   potential in neural tissue engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE electrospinning; neural tissue engineering; nerve regeneration; neural
   stem cells; oligodendrocyte
ID EMBRYONIC CORTICAL-NEURONS; PRECURSOR CELLS; SPINAL-CORD; NANOFIBERS;
   NEUROGENESIS; REGENERATION; BEHAVIOR
AB Development of biomaterials with specific characteristics to influence cell behaviour has played an important role in exploiting strategies to promote nerve regeneration. The effect of three-dimensional (3D) non-woven electrospun poly(epsilon-caprolactone) (PCL) scaffolds on the behaviour of rat brain-derived neural stem cells (NSCs) is reported. The interaction of NSCs on the randomly orientated submicron (PCL) fibrous scaffolds, with an average fibre diameter of 750 +/- 100 nm, was investigated. The PCL scaffolds were modified with ethylenediamine (ED) to determine if amino functionalisation and changes in surface tension of the fibrous scaffolds affected the proliferation and differentiation characteristics of NSCs. Surface tension of the fibrous scaffold increased upon treatment with ED which was attributed to amine moieties present on the surface of the fibres. Although surface treatment did not change the differentiation of the NSCs, the modified scaffolds were more hydrophilic, resulting in a significant increase in the number of adhered cells, and increased spreading throughout the entirety of the scaffold. When the NSCs were seeded on the PCL scaffolds in the presence of 10% FBS, the stem cells differentiated primarily into oligodendrocytes, indicating that electrospun PCL has the capacity to direct the differentiation of NSCs towards a specific lineage. The data presented here is useful for the development of electrospun biomaterial scaffolds for neural tissue engineering, to regulate the proliferation and differentiation of NSCs.
C1 [Yu, L. M. Y.; Zahir, T.; Shoichet, M. S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   [Nisbet, D. R.; Forsythe, J. S.] Monash Univ, Dept Mat Engn, Div Biol Engn, CRC Polymers, Clayton, Vic 3800, Australia.
   [Yu, L. M. Y.; Zahir, T.; Shoichet, M. S.] Univ Toronto, Inst Biomat & Biomed Engn, Terrence Donnelly Ctr Cellular & Biomol REs, Toronto, ON M5S 3E1, Canada.
   [Shoichet, M. S.] Univ Toronto, Dept Chem, Toronto, ON M5S 3E1, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
EM moily@chem-eng.utoronto.ca
OI Forsythe, John/0000-0003-2849-229X; Nisbet, David/0000-0002-1343-0769
CR ASPLER JS, 1993, NORD PULP PAP RES J, V8, P68
   Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083
   Chiu JB, 2005, J BIOMED NANOTECHNOL, V1, P115, DOI 10.1166/jbn.2005.018
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Harrison J, 2004, BIOMATERIALS, V25, P4963, DOI 10.1016/j.biomaterials.2004.01.054
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Kim HS, 2005, MACROMOL SYMP, V224, P145, DOI 10.1002/masy.200550613
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LESVESQUE SG, 2006, BIOMATERIALS, V27, P5277
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   McDonald John W., 1999, Scientific American, V281, P65
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Nisbet DR, 2007, J NEURAL ENG, V4, P35, DOI 10.1088/1741-2560/4/2/004
   Nisbet DR, 2006, J COLLOID INTERF SCI, V299, P647, DOI 10.1016/j.jcis.2006.02.057
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016
   Wang TY, 2006, BRAIN RES, V1107, P82, DOI 10.1016/j.brainres.2006.05.110
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   ZAHIR T, 2007, CELL TRANSP IN PRESS
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100
NR 28
TC 72
Z9 76
U1 3
U2 50
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 5
BP 623
EP 634
DI 10.1163/156856208784089652
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 310LL
UT WOS:000256531000005
PM 18419941
DA 2018-10-19
ER

PT J
AU Liu, LY
   Chen, G
   Chao, T
   Ratner, BD
   Sage, EH
   Jiang, SY
AF Liu, Lingyun
   Chen, Gang
   Chao, Timothy
   Ratner, Buddy D.
   Sage, E. Helene
   Jiang, Shaoyi
TI Reduced foreign body reaction to implanted biomaterials by surface
   treatment with oriented osteopontin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Biomaterials from 2D to 3D to Larger than Life
CY DEC 14-17, 2006
CL Maui, HI
DE orientation; osteopontin; surface charge; foreign body reaction; capsule
ID GIANT-CELL FORMATION; METHACRYLATE) HYDROGELS; MICE LACKING;
   ANGIOGENESIS; ORIENTATION; ADHESION; PROTEINS; SCIENCE; SPARC
AB The foreign body reaction (FBR), which leads to the encapsulation of implanted biomaterials, has been implicated in the failure of many medical devices. The protein layer that is non-specifically adsorbed onto the implant surface immediately after implantation is thought to dictate this reaction. It is hypothesized that biomaterial surfaces having specific proteins with precisely controlled orientations will decrease the FBR. Previously, we have reported that osteopontin (OPN) adsorbed on positively charged surfaces has a preferable orientation for in vitro cell adhesion and spreading as compared to negatively charged surfaces. It is expected that coating a layer of OPN in its prefer-red orientation on an implant surface will decrease the FBR. In this work, in vivo studies were performed to test this hypothesis. A positively charged polymer (p(HEMA-co-AEMA)) and a negatively charged polymer (p(HEMA-co-CEA)) coated with OPN were implanted subcutaneously in wild-type mice for 7 or 28 days. Uncoated polymers were used as control. For the 7-day implants, cells on OPN-coated p(HEMA-co-AEMA) spread more than cells on the other three materials. Following 28 days of implantation the implants were explanted and the capsule thickness and vascularity around the implants were characterized. Additionally, the macrophage and foreign body giant cells (FBGCs) around the implants were quantified. It was found in this study that the modification of the positively charged polymer surface with OPN in a controlled orientation led to a reduction in the foreign body reaction as determined by capsule thickness. Our finding provides valuable information for designing better biocompatible biomaterials with improved in vivo performance.
C1 [Liu, Lingyun; Chao, Timothy; Ratner, Buddy D.; Jiang, Shaoyi] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Chen, Gang; Ratner, Buddy D.; Jiang, Shaoyi] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu; hsage@benoyaresearch.org;
   sjiang@u.washington.edu
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v
   Ende MTA, 1996, J APPL POLYM SCI, V59, P673, DOI 10.1002/(SICI)1097-4628(19960124)59:4<673::AID-APP13>3.3.CO;2-6
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Liaw L, 1998, J CLIN INVEST, V101, P1468
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Ohri R, 2005, CALCIFIED TISSUE INT, V76, P307, DOI 10.1007/s00223-004-0071-7
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   WANG H, 2005, J BIOMED MATER RES A, V77, P672
   WOODWARD SC, 1982, DIABETES CARE, V5, P278, DOI 10.2337/diacare.5.3.278
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 19
TC 31
Z9 34
U1 0
U2 17
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 6
BP 821
EP 835
DI 10.1163/156856208784522083
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 319WM
UT WOS:000257195700007
PM 18534099
DA 2018-10-19
ER

PT J
AU Bosetti, M
   Boccafoschi, F
   Calarco, A
   Leigheb, M
   Gatti, S
   Piffanelli, V
   Peluso, G
   Cannas, M
AF Bosetti, M.
   Boccafoschi, F.
   Calarco, A.
   Leigheb, M.
   Gatti, S.
   Piffanelli, V.
   Peluso, G.
   Cannas, M.
TI Behaviour of human mesenchymal stem cells on a polyelectrolyte-modified
   HEMA hydrogel for silk-based ligament tissue engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Human stem cells; silk; ligament; tissue engineering
ID ANTERIOR CRUCIATE-LIGAMENT; RECONSTRUCTION; PROLIFERATION; BIOMATERIALS;
   TENDONS; MATRIX; DIFFERENTIATION; SELECTION
AB The aim of this study was to design a functional bio-engineered material to be used as scaffold for autologous mesenchymal stem cells in ligament tissue engineering. Polyelectrolyte-modified HEMA hydrogel (HEMA-co-METAC), applied as coating on silk fibroin fibres, has been formulated in order to take advantage of the biocompatibility of the polyelectrolyte by increasing its mechanical properties with silk fibres. Human bone marrow mesenchymal stem cells behaviour on such reinforced polyelectrolyte has been studied by evaluating cell morphology, cell number, attachment, spreading and proliferation together with collagen matrix production and its mRNA expression. Silk fibroin fibres matrices with HEMA-co-METAC coating exhibited acceptable mechanical behaviour compared to the natural ligament, good human mesenchymal stem cell adhesion and with mRNA expression studies higher levels of collagen types I and III expression when compared to control cells on polystyrene. These data indicate high expression of mRNA for proteins responsible for the functional characteristics of the ligaments and suggest a potential for use of this biomaterial in ligament tissue-engineering applications.
C1 [Boccafoschi, F.; Leigheb, M.; Gatti, S.; Piffanelli, V.; Cannas, M.] Univ Piemonte Orientale, Dept Clin & Expt Pharmacol, Human Anat Lab, I-28100 Novara, Italy.
   [Bosetti, M.] Univ Piemonte Orientale, DiSCAFF, Novara, Italy.
   [Calarco, A.; Peluso, G.] CNR, Inst Prot & Biochem, I-80125 Naples, Italy.
   [Leigheb, M.] Azienda Osped Maggiore Carita, SCO, Novara, Italy.
RP Cannas, M (reprint author), Univ Piemonte Orientale, Dept Clin & Expt Pharmacol, Human Anat Lab, Via Solaroli 17, I-28100 Novara, Italy.
EM cannas@med.unipmn.it
OI Bosetti, Michela/0000-0002-3682-8702; Boccafoschi,
   Francesca/0000-0002-6734-5447
FU Fondazione Cariplo [2002.1952/11.9974]
FX The authors are indebted to dr. G. Freddi, Stazione Sperimentale della
   Seta, Milano, who furnished the raw Bombyx mori silkworm fibres, of size
   20/22, used in the experiments. This work was funded in part by
   Fondazione Cariplo, project "La ricostruzione legamentosa con uso di
   cellule staminali: studio sperimentale" (to M. C., contract no.
   2002.1952/11.9974).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Deie M, 1997, MECH AGEING DEV, V97, P121, DOI 10.1016/S0047-6374(97)00049-3
   DUNN MG, 1994, J ORTHOPAED RES, V12, P128, DOI 10.1002/jor.1100120116
   Goh JCH, 2003, TISSUE ENG, V9, pS31, DOI 10.1089/10763270360696969
   Goulet F, 1997, PRINCIPLES TISSUE EN, P633
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   IRIE K, 1992, J ORTHOPAED RES, V10, P886, DOI 10.1002/jor.1100100618
   JACKSON DW, 1994, ARTHROSCOPY, V10, P442, DOI 10.1016/S0749-8063(05)80197-5
   Kartus J, 2001, ARTHROSCOPY, V17, P971, DOI 10.1053/jars.2001.28979
   Lalan S, 2001, WORLD J SURG, V25, P1458
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Margevicius KJ, 1996, J BIOMED MATER RES, V31, P319, DOI 10.1002/(SICI)1097-4636(199607)31:3<319::AID-JBM5>3.0.CO;2-P
   MARKOLF KL, 1989, J BONE JOINT SURG AM, V71A, P887, DOI 10.2106/00004623-198971060-00013
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Savarese A, 1993, Ital J Orthop Traumatol, V19, P79
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   West RV, 2005, J AM ACAD ORTHOP SUR, V13, P197, DOI 10.5435/00124635-200505000-00006
   Woo S L, 2000, J Am Acad Orthop Surg, V8, P364
   Woo SLY, 2004, ANN BIOMED ENG, V32, P342, DOI 10.1023/B:ABME.0000017551.93144.1a
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 31
TC 11
Z9 13
U1 1
U2 22
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 9
BP 1111
EP 1123
DI 10.1163/156856208785540145
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 391XL
UT WOS:000262267400001
PM 18727855
DA 2018-10-19
ER

PT J
AU Liu, Q
   Chen, GQ
AF Liu, Qian
   Chen, Guo-Qiang
TI In vitro biocompatibility and degradation of terpolyester
   3HB-co-4HB-co-3HHx, consisting of 3-hydroxybutyrate, 4-hydroxybutyrate
   and 3-hydroxyhexanoate
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PHB; polyhydroxyalkanoates; PHBHHx; terpolymer; biocompatibility; tissue
   engineering
ID BIODEGRADABLE POLYMER BLENDS; SURFACE-ROUGHNESS; BACTERIAL
   POLYHYDROXYALKANOATES; BETA-HYDROXYBUTYRATE; CELL-ADHESION;
   PROLIFERATION; VIVO; POLY(3-HYDROXYBUTYRATE);
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); HYDROXYAPATITE
AB A terpolyester consisting of 3-hydroxybutyrate (3HB), 4-hydroxybutyrate (4HB) and 3-hydroxyhexanoate (3HHx), abbreviated as P(3HB-co-4HB-co-3HHx), was studied for possible application as an implant biomaterial. L929 mouse fibroblasts, MC3T3-E1 murine osteoblasts and a human cell line of immortalized human keratinocyte (HaCat cells) were used to study the biocompatibility of P(3HB-co-4HB-co-3HHx). Cell morphology and cell activity were studied using scanning electron microscopy (SEM) and the MTT assay, respectively. All three cell types showed higher activities when grown on films of P(3HB-co-4HB-co-3HHx) compared with their growth on poly(lactic acid) (PLA), co-polyester PHBHHx films and on polylysine-coated plates (blank), respectively. The three cell types grown on the terpolyester also demonstrated a well-spread cell shape and large number of pseudopods due to strong cell-cell and cell-material interactions. It was clearly observed that P(3HB-co-4HB-co-3HHx) had a much faster degradation rate than PHBHHx after 15 weeks of incubation in phosphate-buffered saline under dynamic conditions. The results proved that the terpolyester had favorable biocompatibility and biodegradability compared with the well-studied polyesters PLA and PHBHHx.
C1 [Liu, Qian; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
FU Li Ka Shing Foundation; Natural Science Foundation of China [20334020];
   National High Tech 863 [2006AA02Z242]; National Basic Science Foundation
   [2007CB707804]
FX This research was supported by Li Ka Shing Foundation and Natural
   Science Foundation of China key project (Grant No. 20334020). The
   National High Tech 863 Grant (Project No. 2006AA02Z242) and National
   Basic Science Foundation 973 (2007CB707804) also contributed to this
   research.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Andrade J D, 1973, Med Instrum, V7, P110
   BARBARA DB, 1996, BIOMATERIALS, V17, P137
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BYROM D, 1992, FEMS MICROBIOL LETT, V103, P247, DOI 10.1111/j.1574-6968.1992.tb05844.x
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chen GQ, 1997, BIOTECHNOL TECH, V11, P347, DOI 10.1023/A:1018435815864
   CHEN GQ, 1991, ANTON LEEUW INT J G, V60, P61, DOI 10.1007/BF00580443
   Chen GQ, 2000, PROG NAT SCI, V10, P843
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   HISHATSKAYA EI, 2005, J BIOMAT SCI-POLYM E, V16, P643
   Kunze C, 2006, BIOMATERIALS, V27, P192, DOI 10.1016/j.biomaterials.2005.05.095
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Rivard CH, 1996, ANN CHIR, V50, P651
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   Tsai CC, 2001, BIOMATERIALS, V22, P523, DOI 10.1016/S0142-9612(00)00206-4
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Xie WP, 2008, BIOCHEM ENG J, V38, P384, DOI 10.1016/j.bej.2007.08.002
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
   Zhang LL, 1997, J APPL POLYM SCI, V65, P1849, DOI 10.1002/(SICI)1097-4628(19970906)65:10<1849::AID-APP1>3.0.CO;2-F
   Zhang LL, 1997, POLYM INT, V44, P104
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 44
TC 9
Z9 10
U1 1
U2 8
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2008
VL 19
IS 11
BP 1521
EP 1533
DI 10.1163/156856208786140391
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 391XS
UT WOS:000262268100008
PM 18973727
DA 2018-10-19
ER

PT J
AU Matsusaki, M
   Omichi, M
   Maruyama, I
   Akashi, M
AF Matsusaki, Michiya
   Omichi, Masaaki
   Maruyama, Ikuro
   Akashi, Mitsuru
TI Physical adsorption of human thrombomodulin (ART-123) onto polymeric
   biomaterials for developing an antithrombogenic blood-contacting
   material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE thrombomodulin; anticoagulant; physical adsorption; surface
   modification; proteins
ID ANTICOAGULANT ACTIVITY; SERUM-ALBUMIN; IMMOBILIZATION; THROMBIN;
   PARTICLES; RESONANCE; FRAGMENT; COMPLEX; FILMS
AB Human thrombomodulin (hTM) is an endothelial cell-associated protein with potent natural anticoagulant activity by converting thrombin from a procoagulant protease to an anticoagulant. ART-123 is a recombinant soluble hTM (amino acid residues 1-498), and we focused on the physical adsorption of ART-123 onto a polymeric biomaterial surface to develop an antithrombogenic blood-contacting material with preventing the denaturation of hTM and the remaining chemical reagents. The adsorption of hTM onto polysulfone (PSF) films was analyzed quantitatively by quartz crystal microbalance analysis. The adsorption constant and the maximum adsorption amount, calculated by the assumption of a Langmuir-type adsorption, showed that hTM adsorbed with a relatively weak interaction onto the PSF film. The hydrophilic protein lysozyme also showed a Langmuir-type monolayer adsorption, although hydrophobic catalase and fibrinogen showed multilayer adsorption accompanying the denaturation. The physically adsorbed hTM showed high coenzymatic activity for the activation of protein C, as well as anticoagulant activity. Furthermore, the surface, wettability of the PSF film was easily controllable by the physical adsorption of hydrophobic and hydrophilic bioactive proteins. The physical adsorption of hTM or bioactive proteins onto polymeric biomaterials will be instrumental for developing an antithrombogenic blood-contacting biomaterial, and for controlling the surface properties of biomaterials. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 84A: 1-9, 2008.
C1 Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.
   Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 8908520, Japan.
RP Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1Yamadaoka, Suita, Osaka 5650871, Japan.
EM akashi@chem.eng.osaka-u.ac.jp
RI Matsusaki, Michiya/E-2476-2011
OI Matsusaki, Michiya/0000-0003-4294-9313
CR AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   AKASHI M, 1989, J BIOACT COMPAT POL, V4, P4
   Bhatia RB, 2000, CHEM MATER, V12, P2434, DOI 10.1021/cm000260f
   BOS OJM, 1989, J BIOL CHEM, V264, P953
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   DANGELO SV, 1986, J CLIN INVEST, V77, P416
   Hamada K, 2003, J POLYM SCI POL CHEM, V41, P1807, DOI 10.1002/pola.10699
   Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X
   Hong J, 2007, J BIOTECHNOL, V128, P597, DOI 10.1016/j.jbiotec.2006.11.016
   Kishida A, 1994, ASAIO J, V40, pM840, DOI 10.1097/00002480-199407000-00116
   KISHIDA A, 1995, ASAIO J, V41, pM369, DOI 10.1097/00002480-199507000-00033
   Kishida A, 2000, AM J HEMATOL, V63, P136, DOI 10.1002/(SICI)1096-8652(200003)63:3<136::AID-AJH5>3.0.CO;2-I
   KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8
   KOGA J, 1984, BIOTECHNOL BIOENG, V26, P100, DOI 10.1002/bit.260260118
   Lai ZF, 2006, J BIOMED MATER RES A, V76A, P81, DOI 10.1002/jbm.a.30500
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   MARUYAMA I, 1985, J BIOL CHEM, V260, P5432
   Nakashima M, 1998, J CLIN PHARMACOL, V38, P40, DOI 10.1002/j.1552-4604.1998.tb04375.x
   Nelson JM, 1916, J AM CHEM SOC, V38, P1109, DOI 10.1021/ja02262a018
   SALEM HH, 1984, J BIOL CHEM, V259, P2246
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Suh CW, 2003, BIOTECHNOL APPL BIOC, V37, P149, DOI 10.1042/BA20020049
   SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x
   Thorslund S, 2005, COLLOID SURFACE B, V46, P240, DOI 10.1016/j.colsurfb.2005.10.009
   Wang AF, 2005, COLLOID SURFACE B, V43, P245, DOI 10.1016/j.colsurfb.2005.04.015
   WATANABE J, 2005, HDB NANOSTRUCTURED B, P129
NR 26
TC 10
Z9 10
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2008
VL 84A
IS 1
BP 1
EP 9
DI 10.1002/jbm.a.31460
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239MF
UT WOS:000251521700001
PM 17584906
DA 2018-10-19
ER

PT J
AU Dimitrievska, S
   Petit, A
   Ajji, A
   Bureau, MN
   Yahia, L
AF Dimitrievska, Sashka
   Petit, Alain
   Ajji, Abdellah
   Bureau, Martin N.
   Yahia, L'Hocine
TI Biocompatibility of novel polymer-apatite nanocomposite fibers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; inflammatory response; polymer fibers; nanocomposites;
   hydroxyapatite
ID STARCH-BASED POLYMERS; IN-VITRO; BIOLOGICAL RESPONSE; HYDROXYAPATITE
   COMPOSITES; POLYETHYLENE; PARTICLES; PROLIFERATION; FIBROBLASTS;
   SECRETION; TITANIUM
AB On the basis of the bioactivity of hydroxyapatite (HA) and the excellent mechanical and biocompatible performance of polyethylene terephthalate (PET), composite microfibers made of nanograde HA with PET was designed and fabricated to mimic the structure of biological bone, which exhibits a composite of nanograde apatite crystals and natural polymer. The PET/HA nanocomposite was molded into fibers so that the bulk structures' mechanical properties can be custom tailored by changing the final 3D orientation of the fibbers. This study focused on the in vitro biocompatibility evaluation of the PET/HA composite fibers as potential bone fixation biomaterial for total hip replacement prosthesis surfaces. The MTT assay was performed with the extracts of the composite fibers in order to evaluate the short-term effects of the degradation products. The cell morphology of L929 mouse fibroblast cell line was analyzed after direct contact with the fiber scaffolds for different time periods, and the cell viability was also analyzed by the Alamar Blue assay. The release of the inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), from RAW 264.7 macrophages in the presence of fiber extracts and fibers was used as a measure of the inflammatory response. The ability of the fiber matrices to support L929 attachment, spreading, and growth in vitro, combined with the compatible degradation extracts and low inflammation potential of the fibers and extracts, suggests potential use of these fibers as load-baring bone fixation biomaterial structures. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 84A: 44-53,2008.
C1 Ecole Polytech, LIAB, Inst Genie Biomed, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Jewish Gen Hosp, Div Orthopaed Surg, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.
   Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
RP Bureau, MN (reprint author), Ecole Polytech, LIAB, Inst Genie Biomed, Montreal, PQ H3C 3A7, Canada.
EM martin.bureau@cnrc-nrc.gc.ca
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   AJJI A, 2006, ANN TECHN C ANTEC 20
   *ANSI AAMI ISO, 1999, 109935 ANSI AAMI ISO
   Bandyopadhyay-Ghosh S, 2007, J BIOMED MATER RES A, V80A, P175, DOI 10.1002/jbm.a.30878
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Bukata SV, 2004, J ORTHOPAED RES, V22, P6, DOI 10.1016/S0736-0266(03)00153-0
   Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x
   Catelas I, 2003, BIOMATERIALS, V24, P383, DOI 10.1016/S0142-9612(02)00351-4
   Cheang P, 2003, MAT SCI ENG A-STRUCT, V345, P47, DOI 10.1016/S0921-5093(02)00284-8
   Curran JM, 2005, BIOMATERIALS, V26, P5313, DOI [10.1016/j.biomaterials.2005.01.065, 10.1016/.jbiomaterials.2005.01.065]
   Dalby MJ, 2002, BIOMATERIALS, V23, P681, DOI 10.1016/S0142-9612(01)00156-9
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Gonzales JB, 1996, CLIN ORTHOP RELAT R, P244
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V6, P799
   Juhasz JA, 2004, BIOMATERIALS, V25, P949, DOI 10.1016/j.biomaterials.2003.07.005
   LIMIN S, 2001, J BIOMED MATER RES, V58, P570
   Liming F., 2006, BIOMATERIALS, V27, P3701
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MATHEWS RG, 1999, POLYM ENG SCI, V39, P2377
   Metzger A., 1975, J AM PODIATRY ASS, V65, P1
   MOLDAWER LL, 1994, CRIT CARE MED, V22, P3
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   MOSCATO S, 2005, J BIOMED MATER RES A, V76, P214
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Petit A, 2002, J ORTHOP RES, V20, P9, DOI 10.1016/S0736-0266(01)00077-8
   SABOKAR A, 1996, ACTA ORTHOP SCAND, V6, P593
   Salgado AJ, 2005, J MATER SCI-MATER M, V16, P267, DOI 10.1007/s10856-005-6689-9
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
NR 36
TC 21
Z9 22
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2008
VL 84A
IS 1
BP 44
EP 53
DI 10.1002/jbm.a.31338
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239MF
UT WOS:000251521700005
PM 17600325
DA 2018-10-19
ER

PT J
AU Laure, B
   Besnier, JM
   Bergemer-Fouquet, AM
   Marquet-Van Der Mee, N
   Damie, F
   Quentin, R
   Favard, L
   Rosset, P
AF Laure, Boris
   Besnier, Jean-Marc
   Bergemer-Fouquet, Anne-Marie
   Marquet-Van Der Mee, Nathalie
   Damie, Frederik
   Quentin, Roland
   Favard, Luc
   Rosset, Philippe
TI Effect of hydroxyapatite coating and polymethylmethacrylate on stainless
   steel implant-site infection with Staphylococcus epidermidis in a sheep
   model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE sheep; animal model; infection; hydroxyapatite; stainless steel;
   Staphylococcus epidermidis
ID TOTAL HIP-ARTHROPLASTY; RABBIT MODEL; IN-VITRO; STRAINS; BIOMATERIALS;
   ADHERENCE; SURFACE; AUREUS
AB We aimed to study the influence of hydroxyapatite (HA) coating and polymethylmethacrylate (PMMA) cement on the risk of development of stainless steel implant-site infection with Staphylococcus epidermidis in a sheep model. Uncoated, HA-coated, and PMMA-cemented stainless steel implants were inserted in the left femur of 30 sheep. For each type of implant, sheep were inoculated with S. epidermidis in the intramedullary canal and one non-inoculated group was used as control. After 6 weeks, infection was evaluated using clinical, radiological, bacteriological, and histological criteria. Radiological and clinical results were normal. Cultures were negative in the control sheep. In the inoculated sheep, interposition tissue and bone cultures were positive in 2 of 6 uncoated, 6 of 6 HA, and 6 of 6 PMMA implants with a mean bacteria count of 5.2 +/- 1.17, 3.5 +/- 0.7, and 3.9 +/- 0.9 loglo cfu/g, respectively (NS), for interposition tissue, and 4 +/- 0.01, 2.9 +/- 0.6, and 2.5 +/- 1.3 log(10) cfu/g, respectively (NS) for bone. The polymorphonuclear leukocyte (PMN) score (mean number of PMN per 10 different microscopic high-power fields >= 5) in interposition tissue was >= 3 in 6 of 6 HA, significantly different from uncoated (3 of 6) and PMMA (2 of 6) groups (p = 0.04). The HA and PMMA inoculated groups had a higher infection rate than the uncoated inoculated group (p = 0.06). In this experimental sheep model of S. epidermidis infection at the bone-biomaterial interface, HA seems to be at higher risk of infection compared with uncoated or PMMA-cemented stainless steel, when inoculation is intramedullary and contemporary with implantation. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 84A: 92-98, 2008.
C1 Univ Tours, Fac Med Tours, F-37000 Tours, France.
   Ctr Hosp Reg & Univ, Hop Trousseau, Serv Chirurg Maxillofaciale, F-37044 Tours, France.
   Ctr Hosp Reg & Univ, Hop Bretonneau, Serv Malad Infect, F-37044 Tours, France.
   Ctr Hosp Reg & Univ, Hop Bretonneau, Serv Anat Pathol, F-37044 Tours, France.
   Ctr Hosp Reg & Univ, Hop Trousseau, Bacteriol Lab, F-37044 Tours, France.
   Ctr Hosp Reg & Univ, Hop Trousseau, Serv Chirurg Orthoped, F-37044 Tours, France.
RP Laure, B (reprint author), Univ Tours, Fac Med Tours, 2bis Blvd Tonnelle, F-37000 Tours, France.
EM laure@med.univ-tours.fr
CR Allignet J, 1999, MICROBIOL-UK, V145, P2033, DOI 10.1099/13500872-145-8-2033
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   ATHANASOU NA, 1995, J BONE JOINT SURG BR, V77B, P28
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Blom AW, 1998, J HOSP INFECT, V40, P79, DOI 10.1016/S0195-6701(98)90029-9
   Cordero J, 1996, INJURY, V27, P34
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Johansson A, 1999, INJURY, V30, P587, DOI 10.1016/S0020-1383(99)00153-9
   Johansson A, 1999, INJURY, V30, P651, DOI 10.1016/S0020-1383(99)00152-7
   Konig DP, 2000, J HOSP INFECT, V44, P75
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   MARQUETVANDERMEE N, 1995, FEMS MICROBIOL LETT, V128, P39
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Monzon M, 2002, ACTA ORTHOP SCAND, V73, P11, DOI 10.1080/000164702317281341
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   Oosterbos CJM, 2002, J BIOMED MATER RES, V60, P339, DOI 10.1002/jbm.1288
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   SOBALLE K, 1992, ACTA ORTHOP SCAND, V63, P128, DOI 10.3109/17453679209154808
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P989, DOI 10.1002/jbm.820200713
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
NR 24
TC 4
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2008
VL 84A
IS 1
BP 92
EP 98
DI 10.1002/jbm.a.31376
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239MF
UT WOS:000251521700010
PM 17600319
DA 2018-10-19
ER

PT J
AU Hamada, K
   Hirose, M
   Yamashita, T
   Ohgushil, H
AF Hamada, Kazunori
   Hirose, Motohiro
   Yamashita, Toshihiko
   Ohgushil, Hajime
TI Spatial distribution of mineralized bone matrix produced by marrow
   mesenchymal stem cells in self-assembling peptide hydrogel scaffold
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cells; osteogenic differentiation; mineralization;
   three-dimensional visualization; self-assembling peptide hydrogels
ID STROMAL CELLS; IN-VITRO; COMPLEMENTARY OLIGOPEPTIDE; OSTEOBLAST GROWTH;
   PROGENITOR CELLS; DIFFERENTIATION; MODULATION; ADHESION; VISUALIZATION;
   FABRICATION
AB We evaluated the osteogenic differentiation of mesenchymal stem cells (MSCs) using a new class of synthetic self-assembling peptide hydrogels, RADA 16, as a scaffold for three-dimensional culture. MSCs derived from rat bone marrow were culture-expanded and seeded into the hydrogel and further cultured in osteogenic medium containing P-glycerophosphate, ascorbic acid, and dexamethasone for 2 - 4 weeks. High alkaline phosphatase activity and osteocalcin (OC) contents were detected at both the protein and gene expression levels during the culture periods. Both calcium and the OC contents increased over time, indicating the growth of a mineralized extracellular matrix within the hydrogel. Moreover, the process of the growth of the mineralized matrix determined by three-dimensional microarchitecture images was obtained by confocal laser scanning microscopy. The findings show that MSCs can differentiate into mature osteoblasts to form mineralized matrices within the hydrogel scaffold. Importantly, the differentiation can occur three dimensionally within the hydrogel, indicating that RADA 16 can be considered attractive synthetic biomaterial for use in bone tissue engineering. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 84A: 128-136,2008.
C1 Natl Inst Adv Ind Sci & Technol, RICE, Amagasaki, Hyogo 6610974, Japan.
   Sapporo Med Univ, Dept Orthoped Surg, S1W17 Chuo Ku, Sapporo, Hokkaido 0608556, Japan.
RP Hirose, M (reprint author), Natl Inst Adv Ind Sci & Technol, RICE, 3-11-46 Nakoji, Amagasaki, Hyogo 6610974, Japan.
EM motohiro-hirose@aist.go.jp
RI Hirose, Motohiro/M-4959-2018
OI Hirose, Motohiro/0000-0001-9010-0125
CR Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   Hasegawa Y, 1999, CLIN ORTHOP RELAT R, P235
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kihara T, 2004, BIOCHEM BIOPH RES CO, V316, P943, DOI 10.1016/j.bbrc.2004.02.134
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   OWEN M, 1988, CIBA F SYMP, V136, P42
   PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154
   Sammarco V James, 2002, Foot Ankle Clin, V7, P19, DOI 10.1016/S1083-7515(01)00003-1
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Uchimura E, 2003, CALCIFIED TISSUE INT, V73, P575, DOI 10.1007/s00223-002-1052-3
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao XJ, 2004, TRENDS BIOTECHNOL, V22, P470, DOI 10.1016/j.tibech.2004.07.011
NR 47
TC 57
Z9 63
U1 2
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2008
VL 84A
IS 1
BP 128
EP 136
DI 10.1002/jbm.a.31439
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239MF
UT WOS:000251521700014
PM 17600333
DA 2018-10-19
ER

PT J
AU Jones, JA
   McNally, AK
   Chang, DT
   Qin, LA
   Meyerson, H
   Colton, E
   Kwon, ILK
   Matsuda, T
   Anderson, JM
AF Jones, Jacqueline A.
   McNally, Amy K.
   Chang, David T.
   Qin, L. Abigail
   Meyerson, Howard
   Colton, Erica
   Kwon, I. L. Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Matrix metalloproteinases and their inhibitors in the foreign body
   reaction on biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophages; foreign body giant cells; fusion matrix metalloproteinases;
   tissue inhibitors of matrix metalloproteinases
ID TRANSCRIPTION FACTORS; TISSUE INHIBITORS; SURFACE-CHEMISTRY;
   GENE-EXPRESSION; MACROPHAGE; ADHESION; PATHWAYS; MONOCYTE; CELLS
AB Matrix metalloproteinases (MMPs) can degrade structural components within the extracellular matrix and at the cellular surface producing changes in cellular behavior (i.e., adhesion and migration) and subsequent pathological responses (i.e., the foreign body reaction and wound healing). We continue to study the foreign body reaction that occurs following biomaterial implantation by investigating secretory responses of biomaterial-adherent macrophages and foreign body giant cells (FBGCs) as directed by material surface chemistry and further this research by determining whether secreted MMPs, play a role in macrophage adhesion and fusion. We have identified numerous MMPs and their tissue inhibitors (TIMPs) in in vitro cell-culture supernatants using antibody arrays and quantified select MMP/TIMPs with ELISAs. MMP-9 concentrations were significantly greater than both TIMP-1 and TIMP-2 on all materials. The ratios of MMP-9/TIMP-1 and MMP-9/TIMP-2 increased with time because of an increase in MMP-9 concentrations over time, while the TIMP concentrations remained constant. Total MMP-9 concentrations in the supernatants were comparable on all materials at each timepoint, while TIMP-1 and TIMP-2 concentrations tended to be greater on hydrophilic/anionic surfaces. Analysis of the MMP/TIMP quantities produced per cell revealed that the hydrophilic/neutral surfaces, which inhibited macrophage adhesion, activated the adherent macrophages/FBGCs to produce a greater quantity of MMP-9, TIMP-1, and TIMP-2 per cell. Pharmacological inhibition of MMP-1,-8,-13, and -18 reduced macrophage fusion without affecting adhesion, while inhibitors of MMP-2,-3,-9, and -12 did not affect adhesion or fusion. These findings demonstrate that material surface chemistry does modulate macrophage/FBGC-derived MMP/TIMP secretion and implicates MMP involvement in macrophage fusion. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 84A: 158-166, 2008.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Room 5105,Wolstein Res Bldg, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB-00275]; NCATS NIH HHS [TL1 TR000441]; NIGMS NIH HHS
   [T32 GM007250]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JP, 1994, BIOPOLYMERS, V34, P1049, DOI 10.1002/bip.360340808
   Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063
   Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809
   John M, 2002, EXP LUNG RES, V28, P55, DOI 10.1080/019021402753355535
   JONES J, 2006, IN PRESS J BIOMED MA
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Klein SA, 2002, J INVEST SURG, V15, P199, DOI 10.1080/08941930290085976
   Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1
   Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MEZNARICH N, 2004, J UNDERGRADUATE RES, V4, P84
   Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002
   Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769
   Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
NR 26
TC 59
Z9 60
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2008
VL 84A
IS 1
BP 158
EP 166
DI 10.1002/jbm.a.31220
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239MF
UT WOS:000251521700017
PM 17607751
DA 2018-10-19
ER

PT J
AU Xu, JL
   Khor, KA
   Lu, YW
   Chen, WN
   Kumar, R
AF Xu, J. L.
   Khor, Khiam Aik
   Lu, Y. W.
   Chen, W. N.
   Kumar, R.
TI Osteoblast interactions with various hydroxyapatite based biomaterials
   consolidated using a spark plasma sintering technique
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; osteoblast; proliferation; differentiation; osteocalcin
ID IN-VITRO; SUBSTITUTED HYDROXYAPATITE; HUMAN BONE; DIFFERENTIATION;
   CELLS; PROLIFERATION; ADHESION; CALCIUM; APATITE; SILICON
AB This study investigated the osteoblast behaviors on various hydroxyapatite based biomaterials that were consolidated at 1100 degrees C for 3 min by a spark plasma sintering technique. The osteoblasts from human fetal osteoblast cell line were cultured in the medium on the various biomaterials surfaces (HA, RF21, 1SiHA, and 5SiHA) to assess the cell morphology and proliferation as well as cell differentiation (alkaline phosphatase activity). Moreover, the bone gamma-carboxyglutamic protein or osteocalcin in the medium were determined at different periods of culture. The present results indicated that the amount of osteocalcin in the medium decreased during the periods of culture. The highest osteocalcin production obtained from the biomaterial 5SiHA after cell culture for 2 days demonstrated that the presence of silica in the biomaterials enhanced the cell differentiation by the rapid release of silicate and calcium ions. (c) 2007 Wiley Periodicals, Inc.
C1 [Xu, J. L.; Khor, Khiam Aik] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Lu, Y. W.; Chen, W. N.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Kumar, R.] Univ Montana, Dept Environm Engn, Missoula, MT 59701 USA.
RP Xu, JL (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM jlxu@ntu.edu.sg
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Black L, 2006, CEMENT CONCRETE RES, V36, P1023, DOI 10.1016/j.cemconres.2006.03.018
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Eklou-Kalonji E, 1998, CELL TISSUE RES, V292, P163, DOI 10.1007/s004410051046
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   MARIE PJ, 1995, CALCIF TISSUE INT S, V56, P13
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Rea SM, 2004, BIOMATERIALS, V25, P4503, DOI 10.1016/j.biomaterials.2003.11.016
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ruys AJ, 1993, J AUST CERAM SOC, V29, P71
   Sahai N, 2000, J PHYS CHEM B, V104, P4322, DOI 10.1021/jp9935889
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Xu JL, 2005, BIOMATERIALS, V26, P2197, DOI 10.1016/j.biomaterials.2004.06.042
   Zhao ZY, 2004, DEV BIOL, V275, P183, DOI 10.1016/j.ydbio.2004.08.002
NR 26
TC 6
Z9 7
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2008
VL 84B
IS 1
BP 224
EP 230
DI 10.1002/jbm.b.30864
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243MV
UT WOS:000251802900026
PM 17631676
DA 2018-10-19
ER

PT J
AU Ishii, S
   Miyata, S
   Hotta, Y
   Yamamoto, K
   Unno, H
   Hori, K
AF Ishii, Shun'ichi
   Miyata, Shunsuke
   Hotta, Yasuaki
   Yamamoto, Koji
   Unno, Hajime
   Hori, Katsutoshi
TI Formation of filamentous appendages by Acinetobacter sp Tol 5 for
   adhering to solid surfaces
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE acinetobacter; cell appendage; adhesion; biofilm; anchor
ID MOTILE ESCHERICHIA-COLI; BACTERIAL ADHESION; IONIC-STRENGTH; BIOMATERIAL
   SURFACES; CELL APPENDAGES; HYDROPHOBICITY; MECHANISMS; TRANSPORT;
   POLYMERS; PILI
AB The toluene-degrading bacterium Acinetobacter sp. Tol 5 is highly adhesive to solid surfaces owing to two filamentous cell appendages, namely, anchors and peritrichate fibrils. When growing this bacterium in the presence of a carrier made of polyurethane foam, almost all the cells adhered to the surface of the carrier. In contrast, when Tol 5 cells were grown in the absence of the polyurethane carrier, the cells were suspended as aggregated cells or individually dispersed cells. The aggregated cells possessed the cell appendages and showed an adhesiveness similar to that of cells grown in the presence of the carrier, while the dispersed cells scarcely produced the cell appendages and showed a low level of adhesiveness. The dispersed cells started to adhere to the polyurethane carrier by producing the filamentous appendages within 30 min of the addition of the carrier as a substratum and toluene as a carbon source. Peritrichate fibrils just sprouting and growing anchors longer than 3 pm were observed when the cells started to adhere. This suggests that the presence of surface areas sufficient for adhesion might trigger cell appendage formation in Tol 5 cells for adhesion by increasing the amount of cell contact with the surfaces.
C1 [Ishii, Shun'ichi; Unno, Hajime; Hori, Katsutoshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
   [Miyata, Shunsuke; Hori, Katsutoshi] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   [Hotta, Yasuaki] Asahi Univ, Dept Operat Dent, Gifu 5010296, Japan.
RP Hori, K (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B-29, Yokohama, Kanagawa 2268501, Japan.
EM hori.katsutoshi@nitech.ac.jp
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124; Ishii,
   Shun'ichi/0000-0002-0203-8569
CR Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114
   Bolster CH, 2001, J CONTAM HYDROL, V50, P287, DOI 10.1016/S0169-7722(01)00106-1
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUNT CR, 1995, INT J PHARM, V113, P257, DOI 10.1016/0378-5173(94)00205-J
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Handley P. S., 1990, BIOFOULING, V2, P239
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Hori K, 2001, J CHEM ENG JPN, V34, P1120, DOI 10.1252/jcej.34.1120
   Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004
   Ishii SI, 2006, BIOSCI BIOTECH BIOCH, V70, P2635, DOI 10.1271/bbb.602336
   JEWETT DG, 1995, WATER RES, V29, P1673, DOI 10.1016/0043-1354(94)00338-8
   JONES GW, 1983, CRC CR REV MICROBIOL, V10, P229
   Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   Morisaki H, 1999, MICROBIOL-SGM, V145, P2797, DOI 10.1099/00221287-145-10-2797
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Ohshima H, 1995, ADV COLLOID INTERFAC, V62, P189, DOI 10.1016/0001-8686(95)00279-Y
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   RUTTER P R, 1984, P21
   Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANLOOSDRECHT MCM, 1990, EXPERIENTIA, V46, P817
   Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474
   Vigeant MAS, 2002, APPL ENVIRON MICROB, V68, P2794, DOI 10.1128/AEM.68.6.2794-2801.2002
   ZITA A, 1994, APPL ENVIRON MICROB, V60, P3041
NR 31
TC 15
Z9 15
U1 0
U2 3
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JAN
PY 2008
VL 105
IS 1
BP 20
EP 25
DI 10.1263/jbb.105.20
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 277JP
UT WOS:000254208800003
PM 18295715
DA 2018-10-19
ER

PT J
AU Baillif, S
   Ecochard, R
   Casoli, E
   Freney, J
   Burillon, C
   Kodjikian, L
AF Baillif, Stephanie
   Ecochard, Rene
   Casoli, Ernmanuelle
   Freney, Jean
   Burillon, Carole
   Kodjikian, Laurent
TI Adherence and kinetics of biofilm formation of Staphylococcus
   epidermidis to different types of intraocular lenses under dynamic flow
   conditions
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY APR 30-MAY 04, 2006
CL Ft Lauderdale, FL
SP Assoc Res Vis & Ophthalmol
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SCANNING-ELECTRON-MICROSCOPY;
   POLYMER-ASSOCIATED INFECTIONS; IN-VITRO ADHESION; BACTERIAL ADHESION;
   CATARACT-SURGERY; SURFACE-PROPERTIES; ESCHERICHIA-COLI; CELL-SURFACES;
   RISK-FACTORS
AB PURPOSE: To compare the adherence and biofilm formation of Staphylococcus epidermidis under in vitro flow conditions on intraocular lenses (IOLs) made of 4 biomaterials: poly(methyl methacrylate) (PMMA), silicone, hydrophilic acrylic, and hydrophobic acrylic.
   SETTING: Department of Ophthalmology, Croix-Rousse University Hospital and University Research Laboratory, Lyon, France.
   METHODS: Intraocular lenses were placed in a bioreactor designed to replicate intraocular conditions. The model consisted of Tygon tubing connected to a vial. Three septa allowed the entry and elimination of the artificial aqueous humor and inoculation of the bacterial suspension. The first of 2 pumps moved the aqueous humor along the circuit; the second pump regulated the flow at which the nutritive environment was regenerated. At various times (12, 16, 24, 40, 48, 60, and 72 hours), IOLs were taken from this environment and the bound bacteria were removed and counted. The distribution of bacterial adhesion on the IOLs was modeled using polynomial Poisson regression. To test the effect of the IOL biomaterial on bacterial adhesion, likelihood ratio tests were performed.
   RESULTS: The model provided the kinetics of S epidermidis biofilm growth on IOLs. The biofilm growth on each of the 4 biomaterials occurred in 3 phases: latent, dynamic or accelerated growth, and linear growth. The extent of bacterial binding to IOLs increased from hydrophilic acrylic polymer to PMMA, hydrophobic acrylic, and silicone. The differences were statistically significant.
   CONCLUSION: Bacterial adhesion to and biofilm development on the IOL surface depended on the characteristics of the biomaterial.
C1 [Baillif, Stephanie; Kodjikian, Laurent] Croix Rousse Univ Hosp, Dept Ophthalmol, F-69004 Lyon, France.
   [Baillif, Stephanie; Casoli, Ernmanuelle; Freney, Jean; Burillon, Carole; Kodjikian, Laurent] Bernard Lyon 1 Univ, UMR MA, Lab Biomed Med Devices & Matrix Remodeling, Lyon, France.
   [Baillif, Stephanie; Burillon, Carole; Kodjikian, Laurent] Edouard Herriot Univ Hosp, Dept Ophthalmol, Lyon, France.
   [Ecochard, Rene] Claude Bernard Lyon 1 Univ, CNRS, UMR 5558, Dept Biostat, Lyon, France.
RP Kodjikian, L (reprint author), Croix Rousse Univ Hosp, Dept Ophthalmol, 103 Grande Rue Croix Rousse, F-69004 Lyon, France.
EM kodjikian.laurent@wanadoo.fr
OI baillif, stephanie/0000-0003-1700-8570
CR ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   An Y. H, 2000, HDB BACTERIAL ADHESI, P1
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Baillif S, 2006, INVEST OPHTH VIS SCI, V47, P3410, DOI 10.1167/iovs.05-1070
   Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032
   Burillon C, 2002, DRUG DEV IND PHARM, V28, P95, DOI 10.1081/DDC-120001490
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P449
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Costerton JW, 2003, J CLIN INVEST, V112, P1466
   Cramton SE, 2004, MICROBIAL BIOFILMS, P64
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   Dick HB, 2001, OPHTHALMIC RES, V33, P303, DOI 10.1159/000055685
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   GILBERT P, 1991, J APPL BACTERIOL, V71, P72
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   GRIFFITHS PG, 1989, BRIT J OPHTHALMOL, V73, P402, DOI 10.1136/bjo.73.6.402
   Han DP, 1996, AM J OPHTHALMOL, V122, P1
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   KATSIKOGIANNI M, 2007, CONCISE REV MECHANIS
   KATTAN HM, 1991, OPHTHALMOLOGY, V98, P227
   KESLOFF MS, 1998, SURV OPHTHALMOL, V42, P193
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4382, DOI 10.1167/iovs-03-0185
   KREKELER C, 1989, EXPERIENTIA, V45, P1047, DOI 10.1007/BF01950157
   Legeais JM, 2002, TXB OPHTHALMOLOGY, P1880
   Miller JJ, 2005, AM J OPHTHALMOL, V139, P983, DOI 10.1016/j.ajo.2005.01.025
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Neumann A W, 1979, Cell Biophys, V1, P79
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   OKAKJIMA Y, 2006, INVEST OPHTH VIS SCI, V47, P2971
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Pinna A, 2000, OPHTHALMOLOGY, V107, P2162, DOI 10.1016/S0161-6420(00)00408-5
   Rutter P. R., 1980, MICROBIAL ADHESION S, P79
   Schauersberger J, 2003, J CATARACT REFR SURG, V29, P361, DOI 10.1016/S0886-3350(02)01741-8
   Tehrani M, 2004, OPHTHALMOLOGICA, V218, P57, DOI 10.1159/000074568
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   Verwey E. J. W., 1955, J COLLOID SCI, V10, P224, DOI DOI 10.1016/0095-8522(55)90030-1
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   Wejde G, 2005, ACTA OPHTHALMOL SCAN, V83, P7, DOI 10.1111/j.1600-0420.2004.00377.x
   Wong TY, 2004, BRIT J OPHTHALMOL, V88, P29, DOI 10.1136/bjo.88.1.29
   Yamakawa N, 2003, J CATARACT REFR SURG, V29, P367, DOI 10.1016/S0886-3350(02)01459-1
NR 60
TC 20
Z9 21
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JAN
PY 2008
VL 34
IS 1
BP 153
EP 158
DI 10.1016/j.jcrs.2007.07.058
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 250HR
UT WOS:000252291100036
PM 18165096
DA 2018-10-19
ER

PT J
AU Park, D
   Yun, YS
   Park, JM
AF Park, Donghee
   Yun, Yeoung-Sang
   Park, Jong Moon
TI XAS and XPS studies on chromium-binding groups of biomaterial during
   Cr(VI) biosorption
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE biosorption; hexavalent chromium; Ecklonia; adsorption-coupled reduction
ID HEXAVALENT CHROMIUM; BROWN SEAWEED; ACTIVATED CARBONS; ECKLONIA BIOMASS;
   TREATED BIOMASS; REDUCTION; REMOVAL; MECHANISM; TRIVALENT; CHROMATE
AB The reduction of toxic Cr(VI) to the less or nontoxic Cr(III) may be an useful detoxification technique for the treatment of Cr(VI)-contaminated waters. Recently, the protonated biomass of brown seaweed, Ecklonia, was shown to completely reduce Cr(VI) to Cr(III) in the pH range 1-5. The reduction of Cr(VI) to Cr(III) appeared to occur at the surface of the biomass. In this study, abiotic Cr(VI) reduction by the biomass was performed with various contact times, pHs and initial Cr(VI) concentrations, and surface and bulk characteristics of the Cr-laden biomass was then investigated using X-ray photoelectron spectroscopy (XPS) and X-ray absorption spectroscopy (XAS). The XPS spectra indicated that the Cr(VI) bound to the biomass was completely reduced to Cr(III) at tested various conditions. XANES and EXAFS spectra of the Cr-laden biomass were very similar to those of Cr(Ill)-acetate, which means that the Cr bound to the biomass during Cr(VI) reduction had an octahedral geometrical arrangement. The bonding distance of the chromium oxygen atoms was approximately 1.97-1.99 angstrom. In conclusion, it was obvious that oxygen containing groups, such as carboxyl and phenolic groups, play a major role in the binding of the Cr(III) resulting from the abiotic reduction of Cr(VI) by the biomass. (c) 2007 Elsevier Inc. All rights reserved.
C1 Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Sch Environm Sci & Engn, Dept Chem Engn, Pohang 790784, South Korea.
   Chonbuk Natl Univ, Res Inst Ind Technol, Div Environm & Chem Engn, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Sch Environm Sci & Engn, Dept Chem Engn, San 31, Pohang 790784, South Korea.
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
CR Anderson RA, 1997, REGUL TOXICOL PHARM, V26, pS35, DOI 10.1006/rtph.1997.1136
   Baral A., 2002, ENVIRON SCI POLICY, V5, P121, DOI DOI 10.1016/S1462-9011(02)00028-X
   Barnhart J., 1997, REGUL TOXICOL PHARM, V26, P3
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   Cheung KH, 2007, INT BIODETER BIODEGR, V59, P8, DOI 10.1016/j.ibiod.2006.05.002
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Costa M, 2003, TOXICOL APPL PHARM, V188, P1, DOI 10.1016/S0041-008X(03)00011-5
   Dambies L, 2001, COLLOID SURFACE A, V177, P203, DOI 10.1016/S0927-7757(00)00678-6
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Deng SB, 2004, WATER RES, V38, P2424, DOI 10.1016/j.watres.2004.02.024
   Dupont L, 2002, ENVIRON SCI TECHNOL, V36, P5062, DOI 10.1021/es025764o
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Gardea-Torresdey JL, 2002, MICROCHEM J, V71, P157, DOI 10.1016/S0026-265X(02)00007-3
   Lu AH, 2006, ENVIRON SCI TECHNOL, V40, P3064, DOI 10.1021/es052057x
   Lytle CM, 1998, ENVIRON SCI TECHNOL, V32, P3087, DOI 10.1021/es980089x
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Neal AL, 2002, APPL SURF SCI, V202, P150, DOI 10.1016/S0169-4332(02)00550-0
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, J MICROBIOL BIOTECHN, V15, P780
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2004, IND ENG CHEM RES, V43, P8226, DOI 10.1021/ie049323k
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Parsons JG, 2002, MICROCHEM J, V71, P211, DOI 10.1016/S0026-265X(02)00013-9
   Shi XL, 1999, J TOXICOL ENV HEAL B, V2, P87, DOI 10.1080/109374099281241
   Yun YS, 2003, ENVIRON SCI TECHNOL, V37, P3601, DOI 10.1021/es011454e
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
NR 28
TC 137
Z9 141
U1 4
U2 74
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JAN 1
PY 2008
VL 317
IS 1
BP 54
EP 61
DI 10.1016/j.jcis.2007.09.049
PG 8
WC Chemistry, Physical
SC Chemistry
GA 236DL
UT WOS:000251283100007
PM 17935729
DA 2018-10-19
ER

PT J
AU Martinez, B
   Zapatel, C
   Caride, F
   Caride, E
   Laguens, M
   Nacucchio, M
AF Martinez, B.
   Zapatel, C.
   Caride, F.
   Caride, E.
   Laguens, M.
   Nacucchio, M.
TI An anorganic bioceramic matrix for use as scaffold in bone regeneration:
   pharmaceutical development and preliminary biological evaluation
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Article
DE bioceramic; bone; regenerative medicine; scaffold; osteogenesis;
   hydroxyapatite
ID MEMBRANE TECHNIQUE; HYDROXYAPATITE; DEFECTS
AB Regenerative medicine is an interdisciplinary field involving biology, medicine and engineering. It is focused on the repair, regeneration or replacement of cells, tissues or organs in order to restore their biological functionality to improve patients' quality of life. The purpose of this work was to develop an anorganic bioceramic matrix obtained from natural and traceable bovine bones capable of acting as a scaffold and as a mineral reservoir for guided bone heating. The manufacturing process used went through several stages in order to assure the removal of all organic components. The products obtained were analyzed and a biological evaluation performed. An anorganic matrix derived from bovine bones with morphology similar to human cancellous bone was obtained. The biological evaluation has shown that the material was well integrated to the tissue with no signs of inflammation and the beginning of new bone formation. This biomaterial appears to be a promising candidate for future applications in tissue engineering and drug delivery as a scaffold with a porous structure.
C1 [Martinez, B.; Zapatel, C.; Nacucchio, M.] Pharmatrix Lab, R&D Dept, RA-1704 Ramos Mejia, Pcia De Bs As, Argentina.
   [Caride, F.; Caride, E.] Natl Univ La Plata, Sch Dent, Dept Periodontol, RA-1900 La Plata, Pcia De Bs As, Argentina.
   Natl Univ La Plata, Sch Med, Dept Pathol, RA-1900 La Plata, Pcia De Bs As, Argentina.
   [Nacucchio, M.] Univ Buenos Aires, Sch Pharm, Dept Pharmaceut Technol, RA-1113 Buenos Aires, DF, Argentina.
RP Nacucchio, M (reprint author), Pharmatrix Lab, R&D Dept, Arenales 259, RA-1704 Ramos Mejia, Pcia De Bs As, Argentina.
EM mnacucchio@fibertel.com.ar
CR ABDELFATTAH W, 2007, ACTA BIOMATER, P503
   Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   *ASTM, 1999, F1581926928 ASTM
   Brunel G, 1996, J PERIODONTOL, V67, P1342, DOI 10.1902/jop.1996.67.12.1342
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Cochran D, 2001, J PERIODONTOL, V72, P834, DOI 10.1902/jop.2001.72.6.834
   *CPMP, 2001, 41001 EMEA
   DAHLIN C, 1991, J NEUROSURG, V74, P487, DOI 10.3171/jns.1991.74.3.0487
   DORMONT D, 2000, 27 P INT S CONTR REL
   FANOVICH MA, 1999, THESIS U NACL MAR PL
   Greenwood HL, 2006, PLOS MED, V3, P1496, DOI 10.1371/journal.pmed.0030381
   HABERKO K, 2006, J EUROPEAN CERAMIC S, P537
   HISLOP WS, 1993, BRIT J ORAL MAX SURG, V31, P149, DOI 10.1016/0266-4356(93)90113-B
   *ICH EXP WORK GROU, 2000, GOOD MAN PRACT GUID
   *INT COMM WORLD OR, 2006, 74 ANN GEN SESS INT
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   MOSS ML, 1954, AM J ANAT, V94, P333, DOI 10.1002/aja.1000940302
   NASR HF, 1999, PERIODONTOLOGY, V2000, P74
   *PICS, 0091 PE
   ROSE F, 2001, BUSINESS BRIEFING PH, P189
   SANDBURG E, 1993, INT J ORAL MAXILLOF, P234
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   SKELTON KL, 2007, ACTA BIOMATER, P563
   Smiler D G, 2001, Implant Dent, V10, P139
   VACANTI AC, 1997, PRINCIPLES TISSUE EN, P619
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   *WHO, 2003, GOOD MAN CONTR PRACT
   WILLIAMS MJ, 2005, BIOMATERIALS, P4817
NR 30
TC 0
Z9 0
U1 0
U2 4
PU EDITIONS SANTE
PI PARIS
PA 47 RUE GALILEE, 75116 PARIS, FRANCE
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD JAN-FEB
PY 2008
VL 18
IS 1
BP 73
EP 78
DI 10.1016/S1773-2247(08)50010-4
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 283LC
UT WOS:000254636700010
DA 2018-10-19
ER

PT J
AU McManus, MC
   Sell, SA
   Bowen, WC
   Koo, HP
   Simpson, DG
   Bowlin, GL
AF McManus, Michael C.
   Sell, Scott A.
   Bowen, Whitney C.
   Koo, Harry P.
   Simpson, David G.
   Bowlin, Gary L.
TI Electrospun Fibrinogen-Polydioxanone Composite Matrix: Potential for In
   Situ Urologic Tissue Engineering
SO JOURNAL OF ENGINEERED FIBERS AND FABRICS
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; POLY(GLYCOLIC ACID); COLLAGEN; SCAFFOLD;
   FIBRONECTIN; GEL; BIOCOMPATIBILITY; REPLACEMENT; NANOFIBERS; MIGRATION
AB Our objective is to demonstrate an electrospun fibrinogen-PDO (polydioxanone) composite scaffold will retain the superior cellular interaction of fibrinogen while producing a product with the functional strength needed for direct implantation. Fibrinogen-PDO composite scaffolds were electrospun with PDO ratios of 0% (pure fibrinogen), 10%, 20%, 30%, 40%, 50% and 100% (pure PDO) and disinfected using standard methods. Scaffolds were seeded with human BSM (bladder smooth muscle cells) and incubated with twice weekly media changes. Samples were removed at 7, 14 and 21 days for evaluation by collagen assay, scanning electron microscopy and histology. Cell seeding and culture demonstrated human BSM readily migrate throughout and remodel electrospun fibrinogen-PDO composite scaffolds with deposition of native collagen. Cell migration and collagen deposition increased with increasing fibrinogen concentration while scaffold integrity increased with increasing PDO concentration. Electrospun fibrinogen-PDO composite structures promote rapid cellular in-growth by human BSM while maintaining structural integrity. The fibrinogen to PDO ratio can be adjusted to achieve the desired properties required for a specific tissue engineering application. Our ultimate objective is to utilize this innovative biomaterial technology to produce an acellular, bioresorbable product that enables in situ tissue regeneration. While there is still much work to be done, these initial findings indicate fibrinogen-PDO composite scaffolds deserve further investigation.
C1 [Sell, Scott A.; Bowen, Whitney C.; Bowlin, Gary L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23298 USA.
   [McManus, Michael C.; Koo, Harry P.] Virginia Commonwealth Univ, Dept Surg, Div Urol, Richmond, VA 23298 USA.
   [Simpson, David G.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA.
RP Bowlin, GL (reprint author), Virginia Commonwealth Univ, Dept Biomed Engn, POB 980694, Richmond, VA 23298 USA.
EM glbowlin@vcu.edu
RI Bowlin, Gary/E-8617-2010; Sell, Scott/I-5731-2012
OI Sell, Scott/0000-0002-6785-3193
CR Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   BOWLIN G, 2002, TISSUE ENG BIODEGRAD
   Bowlin GL, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P165
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   ERBAN JK, 1993, BEHRING I MITT, V92, P248
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   MCMANUS M, 2004, AM UR ASS ANN M 2004
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   MCMANUS MC, J BIOMEDICA IN PRESS
   MCMANUS MC, 2005, AUA MID SECT ANN M 2
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   MOONEY DJ, 1995, BIOMEDICAL ENG HDB, P1609
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Peretti GM, 2001, ANN PLAS SURG, V46, P533, DOI 10.1097/00000637-200105000-00013
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   Shreiber DI, 2001, EXP CELL RES, V266, P155, DOI 10.1006/excr.2001.5208
   STITZEL JD, 2001, J BIOMATER APPL, V15, P1
   Underwood S, 2001, BIOTECHNOL BIOENG, V73, P295, DOI 10.1002/bit.1062
   Underwood S, 1999, BIOPROCESS ENG, V20, P239, DOI 10.1007/s004490050586
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 42
TC 5
Z9 5
U1 0
U2 4
PU INDA
PI CARY
PA PO BOX 1288, CARY, NC 27512-1288 USA
SN 1558-9250
J9 J ENG FIBER FABR
JI J. Eng. Fiber Fabr.
PY 2008
VL 3
IS 2
PG 10
WC Materials Science, Textiles
SC Materials Science
GA 423YB
UT WOS:000264531600002
DA 2018-10-19
ER

PT J
AU Israeli, Y
   Frezet, L
   Rivaton, A
AF Israeli, Y.
   Frezet, L.
   Rivaton, A.
TI Photochemical Processes Involved in a Biopolymer Doped by Chromium(VI)
   during Hologram Recording
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE dichromated agar; hologram formation; mechanism; crosslinking
ID DICHROMATED POLY(VINYL ALCOHOL); CR-VI; PHOTOSENSITIVE MATERIAL;
   POLY(ACRYLIC ACID); REAL-TIME; AGAR; MECHANISM; OXIDATION;
   POLYSACCHARIDES; PHOTOOXIDATION
AB This paper is devoted to the study of the photochemical processes occurring during hologram formation in a biopolymer, agar doped by chromium(VI). The evolution of both the absorbing chromium species and the polymer allowed elucidating the reactions taking place during irradiation in conditions representative of hologram formation. As previously observed with dichromated poly(vinyl alcohol) (PVA), polymer containing hydroxyl groups as agar, irradiation of dichromated agar provoked a two step reduction of chromium species and the crosslinking of the host polymer. But agar has a rather complex chemical structure and the photoproducts formed along the polymeric chains throughout the photoredox process were different in agar and in PVA. The photostability of the matrix, that has been proven, coupled with the possibility to record good quality holograms, allowed us to propose dichromated agar as a new natural photosensitive biomaterial.
C1 [Israeli, Y.; Frezet, L.; Rivaton, A.] Univ Clermont Ferrand, CNRS, Photochim Mol & Macromol Lab, UMR 6505, F-63177 Aubiere, France.
RP Rivaton, A (reprint author), Univ Clermont Ferrand, CNRS, Photochim Mol & Macromol Lab, UMR 6505, 24 Ave Landais, F-63177 Aubiere, France.
EM agnes.rivaton@univ-bpclermont.fr
CR ALLEN NS, 1986, CHEM SOC REV, V15, P373, DOI 10.1039/cs9861500373
   ARMINSEN R, PRODUCTION PROPERTIE, pCH1
   AVRAM M, 1966, SPECTROSCOPIE INFRAR, P474
   Barichard A, 2008, J POLYM SCI POL CHEM, V46, P636, DOI 10.1002/pola.22411
   Bolte M, 1998, P SOC PHOTO-OPT INS, V3417, P2, DOI 10.1117/12.323477
   Bolte M, 2005, P SOC PHOTO-OPT INS, V5742, P195, DOI 10.1117/12.590395
   Bolte M, 2004, P SOC PHOTO-OPT INS, V5290, P298, DOI 10.1117/12.529102
   Bolte M, 2002, P SOC PHOTO-OPT INS, V4833, P555, DOI 10.1117/12.474364
   BOLTE M, 2006, P SPIE HOLOGRAPHY 20
   BOLTE M, 2006, P SPIE INT SOC OPT E
   Daier V, 1999, CAN J CHEM, V77, P57, DOI 10.1139/cjc-77-1-57
   Djouani F, 2006, J POLYM SCI POL CHEM, V44, P1317, DOI 10.1002/pola.21243
   El Hafidi I, 2005, OPT LASER TECHNOL, V37, P503, DOI 10.1016/j.optlastec.2004.06.008
   HASAN F, 1976, J AM CHEM SOC, V98, P6574, DOI 10.1021/ja00437a027
   Lafond C, 2000, OPT ENG, V39, P610, DOI 10.1117/1.602405
   Lahaye M, 2001, J APPL PHYCOL, V13, P173, DOI 10.1023/A:1011142124213
   LINVIEN D, 1991, HDB INFRARED RAMAN C, P133
   Lopez T, 2004, INT J THERMOPHYS, V25, P1483, DOI 10.1007/s10765-004-5753-x
   MANIVANNAN G, 1993, J PHYS CHEM-US, V97, P7228, DOI 10.1021/j100130a017
   Marinho-Soriano E, 2005, BIORESOURCE TECHNOL, V96, P379, DOI 10.1016/j.biortech.2004.04.012
   Melo MRS, 2002, CARBOHYD POLYM, V49, P491, DOI 10.1016/S0144-8617(02)00006-1
   Mollet JC, 1998, J APPL PHYCOL, V10, P59, DOI 10.1023/A:1008051528443
   Montano NE, 1999, J APPL PHYCOL, V11, P27, DOI 10.1023/A:1008084228609
   Morlat S, 2001, POLYMER, V42, P6071, DOI 10.1016/S0032-3861(01)00084-2
   OLVERABAUTISTA I, 2006, P SPIE INT SOC OPTIC
   Pereira L, 2003, BIOMOL ENG, V20, P223, DOI 10.1016/S1389-0344(03)00058-3
   Pizzocaro C, 2002, J PHOTOCH PHOTOBIO A, V151, P221, DOI 10.1016/S1010-6030(02)00170-3
   Pizzocaro C, 1998, CAN J CHEM, V76, P1746, DOI 10.1139/cjc-76-11-1746
   PONCELEE EL, 2006, OPTICAL MAT, V26, P5
   Ramanujam PS, 2005, OPT MATER, V27, P1175, DOI 10.1016/j.optmat.2004.08.079
   Rizzotto M, 1996, POLYHEDRON, V15, P1517, DOI 10.1016/0277-5387(95)00392-4
   Roldan V, 2002, CAN J CHEM, V80, P1676, DOI 10.1139/V02-187
   Savic S, 2002, APPL OPTICS, V41, P4484, DOI 10.1364/AO.41.004484
   Signorella S, 1999, CARBOHYD RES, V316, P14, DOI 10.1016/S0008-6215(99)00012-9
   Usov AI, 1998, FOOD HYDROCOLLOID, V12, P301, DOI 10.1016/S0268-005X(98)00018-6
   Verhoef R, 2003, CARBOHYD RES, V338, P1851, DOI 10.1016/S0008-6215(03)00261-1
   VOLLHARDT KPC, 1990, TRAITE CHIMIE ORGANI, P323
   Wang KP, 1996, APPL OPTICS, V35, P6369, DOI 10.1364/AO.35.006369
   WHYTE JNC, 1985, CARBOHYD RES, V140, P336, DOI 10.1016/0008-6215(85)85135-1
NR 39
TC 0
Z9 0
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PY 2008
VL 45
IS 12
BP 1039
EP 1048
AR PII 905014198
DI 10.1080/10601320802457840
PG 10
WC Polymer Science
SC Polymer Science
GA 368FA
UT WOS:000260605800010
DA 2018-10-19
ER

PT J
AU Lim, YB
   Lee, M
AF Lim, Yong-Beom
   Lee, Myongsoo
TI Nanostructures of beta-sheet peptides: steps towards bioactive
   functional materials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID ELASTIN-LIKE POLYPEPTIDES; SUPRAMOLECULAR STRUCTURES; MULTIVALENT
   LIGANDS; CARBON NANOTUBES; SELF-ASSEMBLE; PROTEIN; NANOFIBERS;
   MOLECULES; FIBRILS; DESIGN
AB The design and construction of synthetic self-assembled nanostructures is, in a large part, inspired from elaborate nanostructures in biological systems. If we look at it from another angle, the self-assembled nanostructures are excellent scaffolds for exploring and modulating biological phenomena when they are suitably functionalized with bioactive molecules. Of the many types of molecular building blocks for self-assembly, peptide-based building blocks have the advantage in that their constituent amino acids are biocompatible and the sequence space of peptide chains is vast. This contribution highlights an emerging approach to the biomaterial application of artificially designed and functional beta-sheet peptide self-assemblies.
C1 [Lim, Yong-Beom; Lee, Myongsoo] Yonsei Univ, Ctr Supramol Nanoassembly, Seoul 120749, South Korea.
   [Lim, Yong-Beom; Lee, Myongsoo] Yonsei Univ, Dept Chem, Seoul 120749, South Korea.
RP Lee, M (reprint author), Yonsei Univ, Ctr Supramol Nanoassembly, Seoul 120749, South Korea.
EM mslee@yonsei.ac.kr
RI Lim, Yong-beom/D-3603-2011; Lee, Myongsoo/A-8106-2011
CR Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820
   Binder WH, 2006, ANGEW CHEM INT EDIT, V45, P7324, DOI 10.1002/anie.200602001
   Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q
   Burkoth TS, 1998, J AM CHEM SOC, V120, P7655, DOI 10.1021/ja980566b
   Chen DY, 2005, ACCOUNTS CHEM RES, V38, P494, DOI 10.1021/ar040113d
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Choi S. -K, 2004, SYNTHETIC MULTIVALEN
   Collier JH, 2004, ADV MATER, V16, P907, DOI 10.1002/adma.200306379
   DICHER DE, 2002, SCIENCE, V297, P967
   Dolphin GT, 2006, ANGEW CHEM INT EDIT, V45, P2699, DOI 10.1002/anie.200600395
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V
   Eckhardt D, 2005, CHEM COMMUN, P2814, DOI 10.1039/b503275j
   Elemans JAAW, 2003, J MATER CHEM, V13, P2661, DOI 10.1039/b304972h
   Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601
   Fishwick CWG, 2003, NANO LETT, V3, P1475, DOI 10.1021/nl034095p
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Ghosh S, 2007, ANGEW CHEM INT EDIT, V46, P2002, DOI 10.1002/anie.200604383
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Hadley EB, 2006, J AM CHEM SOC, V128, P16444, DOI 10.1021/ja067178r
   Harris SL, 2001, J BACTERIOL, V183, P4099, DOI 10.1128/JB.183.13.4099-4102.2001
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hentschel J, 2006, J AM CHEM SOC, V128, P7722, DOI 10.1021/ja060759w
   Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t
   Holowka EP, 2007, NAT MATER, V6, P52, DOI 10.1038/nmat1794
   Janek K, 1999, BIOCHEMISTRY-US, V38, P8246, DOI 10.1021/bi990510+
   Kim BS, 2005, J AM CHEM SOC, V127, P16333, DOI 10.1021/ja055999a
   Kim BS, 2005, CHEM COMMUN, P2035, DOI 10.1039/b419258c
   Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812
   Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r
   KINGERYWOOD JE, 1992, J AM CHEM SOC, V114, P7303, DOI 10.1021/ja00044a057
   Kodama H, 2004, CHEM COMMUN, P2876, DOI 10.1039/b409641j
   LARSEN MB, 2006, CARBOHYD RES, V341, P1209
   Lee M, 2001, CHEM REV, V101, P3869, DOI 10.1021/cr0001131
   Lee Y, 2007, J AM CHEM SOC, V129, P5362, DOI 10.1021/ja071090b
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599
   Leman LJ, 2007, J AM CHEM SOC, V129, P2959, DOI 10.1021/ja068052x
   Lim YB, 2007, CHEM-ASIAN J, V2, P1363, DOI 10.1002/asia.200700163
   Lim YB, 2007, BIOMACROMOLECULES, V8, P1404, DOI 10.1021/bm0700901
   Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P3475, DOI 10.1002/anie.200604576
   Lim Y, 2007, ORG BIOMOL CHEM, V5, P401, DOI 10.1039/b615744k
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Mimna R, 2007, ANGEW CHEM INT EDIT, V46, P2681, DOI 10.1002/anie.200603681
   Mueller A, 2002, CHEM REV, V102, P727, DOI 10.1021/cr000071g
   Nesloney CL, 1996, BIOORGAN MED CHEM, V4, P739, DOI 10.1016/0968-0896(96)00051-X
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Ryu JH, 2007, J AM CHEM SOC, V129, P4808, DOI 10.1021/ja070173p
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   Shao H, 2007, J AM CHEM SOC, V129, P1884, DOI 10.1021/ja068154n
   Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smeenk JM, 2005, ANGEW CHEM INT EDIT, V44, P1968, DOI 10.1002/anie.200462415
   Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8
   Stevens MM, 2004, ADV MATER, V16, P915, DOI 10.1002/adma.200306430
   Sung M, 2006, BBA-BIOMEMBRANES, V1758, P355, DOI 10.1016/j.bbamem.2005.11.016
   Thoma G, 2002, ANGEW CHEM INT EDIT, V41, P3195, DOI 10.1002/1521-3773(20020902)41:17<3195::AID-ANIE3195>3.0.CO;2-X
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   Valiaev A, 2007, J AM CHEM SOC, V129, P6491, DOI 10.1021/ja070147r
   van Maarseveen JH, 2005, ORG LETT, V7, P4503, DOI 10.1021/010518028
   Wang HF, 2006, J AM CHEM SOC, V128, P13364, DOI 10.1021/ja065455o
   Ye SX, 2004, LANGMUIR, V20, P5897, DOI 10.1021/la0363884
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 72
TC 38
Z9 38
U1 4
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2008
VL 18
IS 7
BP 723
EP 727
DI 10.1039/b711188f
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 259IP
UT WOS:000252933300001
DA 2018-10-19
ER

PT J
AU Schneider, OD
   Loher, S
   Brunner, TJ
   Schmidlin, P
   Stark, WJ
AF Schneider, Oliver D.
   Loher, Stefan
   Brunner, Tobias J.
   Schmidlin, Patrick
   Stark, Wendelin J.
TI Flexible, silver containing nanocomposites for the repair of bone
   defects: antimicrobial effect against E. coli infection and comparison
   to tetracycline containing scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENTS; THERMODYNAMIC ANALYSIS;
   ANTIBIOTIC-RESISTANCE; FLAME SYNTHESIS; PARTICLE-SIZE; ION RELEASE;
   NANOPARTICLES; BIOACTIVITY; FIBERS; BIOMATERIALS
AB Bone regeneration in infected tissue or areas with high bacteria concentrations such as the oral cavity requires combining disinfection with biomaterial properties. Classical antibiotics typically provide excellent short term protection against re-infection of a defect but are typically washed out of an operation site within days. The present work investigates the use of silver on amorphous tricalcium phosphate (TCP) nanoparticles for electrospun, highly porous poly(lactide-co-glyclolide) (PLGA) fibrous composites. In vitro bioactivity tests of the wool-like composite PLGA/Ag-TCP (80 : 20) containing 0.5 wt% silver showed rapid hydroxyapatite deposition on the nanocomposite within 2 days. Antibacterial tests using E. coli demonstrated a strongly prolonged antibacterial effect of the scaffolds containing finely dispersed silver on TCP if compared to current clinically used methods based on soaking the scaffolds with a tetracycline solution prior to implantation.
C1 [Schneider, Oliver D.; Loher, Stefan; Brunner, Tobias J.; Stark, Wendelin J.] ETH, Inst Chem & Bioengn, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Schmidlin, Patrick] Univ Zurich, Clin Prevent Dent Periodontol & Cariol, CH-8028 Zurich, Switzerland.
RP Stark, WJ (reprint author), ETH, Inst Chem & Bioengn, Dept Chem & Appl Biosci, HCI E107, CH-8093 Zurich, Switzerland.
EM wendelin.stark@chem.ethz.ch
RI Stark, Wendelin/A-8680-2008
CR BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   Brunner TJ, 2007, J BIOMED MATER RES B, V83B, P400, DOI 10.1002/jbm.b.30809
   Brunner TJ, 2007, J MATER CHEM, V17, P4072, DOI 10.1039/b707171j
   Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i
   Cavalu S, 2007, J OPTOELECTRON ADV M, V9, P690
   Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380
   Damm C, 2005, POLYM POLYM COMPOS, V13, P649, DOI 10.1177/096739110501300701
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Ergun C, 2008, J BIOMED MATER RES A, V85A, P236, DOI 10.1002/jbm.a.31555
   Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x
   Ho CH, 2004, ADV MATER, V16, P957, DOI 10.1002/adma.200306253
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jin WJ, 2007, SYNTHETIC MET, V157, P454, DOI 10.1016/j.synthmet.2007.05.011
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kim TS, 2004, J CLIN PERIODONTOL, V31, P286, DOI 10.1111/j.1600-051X.2004.00494.x
   Larsen G, 2004, ADV MATER, V16, P166, DOI 10.1002/adma.200306021
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Loher S, 2005, CHEM MATER, V17, P36, DOI 10.1021/cm048776c
   Loher S, 2008, SMALL, V4, P824, DOI 10.1002/smll.200800047
   Loher S, 2006, NANOTECHNOLOGY, V17, P2054, DOI 10.1088/0957-4484/17/8/044
   Madler L, 2002, J AEROSOL SCI, V33, P369, DOI 10.1016/S0021-8502(01)00159-8
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   MEYER JL, 1978, CALC TISS RES, V25, P209, DOI 10.1007/BF02010771
   MEYER JL, 1978, CALC TISS RES, V25, P59, DOI 10.1007/BF02010752
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nelson M, 2006, INT J NANOMED, V1, P339
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Schneider OD, 2008, J BIOMED MATER RES B, V84B, P350, DOI 10.1002/jbm.b.30878
   Simonet M, 2007, POLYM ENG SCI, V47, P2020, DOI 10.1002/pen.20914
   Stark WJ, 2003, CHEM COMMUN, P588, DOI 10.1039/b211831a
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   STARK WJ, 2006, Patent No. 000589
   STARK WJ, 2005, Patent No. 087660
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Wenzel RP, 2000, NEW ENGL J MED, V343, P1961, DOI 10.1056/NEJM200012283432610
   Williams RJ, 1998, SCIENCE, V279, P1153, DOI 10.1126/science.279.5354.1153
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Zuo WW, 2005, POLYM ENG SCI, V45, P704, DOI 10.1002/pen.20304
NR 46
TC 52
Z9 54
U1 3
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2008
VL 18
IS 23
BP 2679
EP 2684
DI 10.1039/b800522b
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 309HI
UT WOS:000256450900009
DA 2018-10-19
ER

PT J
AU Cai, YR
   Tang, RK
AF Cai, Yurong
   Tang, Ruikang
TI Calcium phosphate nanoparticles in biomineralization and biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; DRUG-DELIVERY SYSTEMS; NANOCRYSTALLINE
   HYDROXYAPATITE; HIERARCHICAL STRUCTURE; DENTAL ENAMEL; IN-VITRO;
   BIOMIMETIC MINERALIZATION; ORIENTED AGGREGATION; COMPOSITE SCAFFOLDS;
   CARBONATE APATITE
AB Recent developments in biomineralization and biomaterials have demonstrated that nano-calcium phosphate particles play an important role in the formation of hard tissues in nature. It is suggested that the basic inorganic building blocks of bone and enamel are nanosized apatite although their hierarchical structures differ. Nanoparticles can confer on biominerals remarkable physical and chemical characteristics such as enhanced mechanical strength and self-preservation in biological fluids. In living organisms, tens to hundreds of nano-blocks, under the control of an organic matrix, combine into self-assembled biominerals. It is also confirmed experimentally that enamel- or bone-like apatite can be achieved by oriented aggregation by using nano-calcium phosphates as the raw materials, determined by the biomolecules. Interestingly, features of smaller hydroxyapatite (HAP) nanoparticles may more closely approximate features of HAP during biomineralization than features of the larger HAP particles that are conventionally used. The application and prospective use of nano-calcium phosphate in the biological repair of bone and enamel are also introduced. It is emphasized that the cell experiments reveal improved cytophilicity of nanophase calcium phosphate minerals. Greater cell viability and proliferation of bone marrow mesenchymal stem cells are measured on smaller calcium phosphates. Furthermore, studies of amorphous calcium phosphate and crystallized HAP particles are used to investigate the effect of crystallinity of nanoparticles on living cells, and show that the differentiation of stem cells is promoted significantly by nano-HAP. It is suggested that nano-HAP may be the ideal biomaterial due to its good biocompatibility and bone/enamel integration. Lots of studies of calcium phosphates are expected in the nano-zone such as for drug delivery systems and resorbable scaffolds. In this feature article, a new view on calcium phosphates highlights the importance of size and phase controls in the application of biomedical materials.
C1 [Cai, Yurong; Tang, Ruikang] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China.
   [Cai, Yurong; Tang, Ruikang] Zhejiang Univ, Ctr Biopathways & Biomat, Hangzhou 310027, Zhejiang, Peoples R China.
   [Cai, Yurong] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Zhejiang, Peoples R China.
RP Tang, RK (reprint author), Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China.
EM rtang@zju.edu.cn
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   BAER E, 1991, PURE APPL CHEM, V63, P961, DOI 10.1351/pac199163070961
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751
   BARAL S, 1993, CHEM MATER, V5, P145, DOI 10.1021/cm00026a001
   Barralet J, 2000, J BIOMED MATER RES, V49, P176, DOI 10.1002/(SICI)1097-4636(200002)49:2<176::AID-JBM4>3.3.CO;2-#
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Boskey A, 2003, OSTEOPOROSIS INT, V14, pS16, DOI 10.1007/s00198-003-1468-2
   BOULDIN D. R., 1959, SOIL SCI SOC AMER PROC, V23, P276
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BROWN WE, 1983, J DENT RES, V62, P672
   BURTON WK, 1949, NATURE, V163, P398, DOI 10.1038/163398a0
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Cai YR, 2007, CHEM MATER, V19, P3081, DOI 10.1021/cm070298t
   Carpick RW, 1997, CHEM REV, V97, P1163, DOI 10.1021/cr960068q
   Chen H, 2003, J DENT RES, V82, P443, DOI 10.1177/154405910308200608
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen HM, 2006, J AM CHEM SOC, V128, P13348, DOI 10.1021/ja064864h
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Chen JF, 2004, BIOMATERIALS, V25, P723, DOI 10.1016/S0142-9612(03)00566-0
   Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s
   Chowdhury EH, 2004, GENE, V341, P77, DOI 10.1016/j.gene.2004.07.015
   Christian RC, 1999, CURR OPIN NEPHROL HY, V8, P443, DOI 10.1097/00041552-199907000-00008
   CHRISTOFFERSEN J, 1992, J CRYST GROWTH, V121, P608, DOI 10.1016/0022-0248(92)90568-4
   Colfen H, 2007, TOP CURR CHEM, V271, P1, DOI 10.1007/128_056
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Cui FZ, 2007, J TISSUE ENG REGEN M, V1, P185, DOI 10.1002/term.21
   CUI FZ, 2007, MAT SCI ENG R, V5, P1
   Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954
   DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364
   de Leeuw NH, 2004, J PHYS CHEM B, V108, P1809, DOI 10.1021/jp036784v
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   FABRIZIO E, 2006, MICROELECTRON ENG, V83, P1598
   Feng QL, 2000, J CRYST GROWTH, V210, P735, DOI 10.1016/S0022-0248(99)00502-3
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   Fowler CE, 2005, J MATER CHEM, V15, P3317, DOI 10.1039/b503312h
   FREUNDLICH H, 1923, COLLOID CAPILLARY CH, P153
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gao ZG, 2005, J CONTROL RELEASE, V102, P203, DOI 10.1016/j.jconrel.2004.09.021
   Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8
   Gilbert B, 2005, REV MINERAL GEOCHEM, V59, P109, DOI 10.2138/rmg.2005.59.6
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   GUA YW, 2003, BIOMATERIALS, V23, P1603
   Guo HB, 2003, BIOMATERIALS, V24, P667, DOI 10.1016/S0142-9612(02)00381-2
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   GUPTA HS, 2006, P NATL ACAD SCI USA, V103, P17743
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   He LH, 2007, J DENT, V35, P431, DOI 10.1016/j.jdent.2006.12.002
   Hilton TJ, 2002, AM J DENT, V15, P198
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Huang F, 2003, NANO LETT, V3, P373, DOI 10.1021/nl025836+
   Ingert D, 2001, ADV FUNCT MATER, V11, P136, DOI 10.1002/1616-3028(200104)11:2<136::AID-ADFM136>3.0.CO;2-3
   JA C, 1998, J BIOMED MATER RES, V40, P341
   Ji BH, 2006, COMPOS SCI TECHNOL, V66, P1212, DOI 10.1016/j.compscitech.2005.10.017
   Kim HJ, 2006, ADV MATER, V18, P3083, DOI 10.1002/adma.200600387
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   Kirsch T, 2006, CURR OPIN RHEUMATOL, V18, P174, DOI 10.1097/01.bor.0000209431.59226.46
   Koinkar VN, 1996, J VAC SCI TECHNOL A, V14, P2378, DOI 10.1116/1.580026
   Kreilgaard M., 2002, ADV DRUG DEL REV, V54, P77
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lasaga AC, 2001, SCIENCE, V291, P2400, DOI 10.1126/science.1058173
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lieber R, 1992, SKELETAL MUSCLE STRU
   Mann S., 2001, BIOMINERALIZATION PR
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Narayan RJ, 2004, JOM-US, V56, P38, DOI 10.1007/s11837-004-0289-x
   Oaki Y, 2006, SMALL, V2, P66, DOI 10.1002/smll.200500246
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Penn RL, 2004, J PHYS CHEM B, V108, P12707, DOI [10.1021/jp036490+, 10.1021/jp036490]
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Perkin KK, 2005, NANO LETT, V5, P1457, DOI 10.1021/nl050817w
   Porter AE, 2005, BIOMATERIALS, V26, P7650, DOI 10.1016/j.biomaterials.2005.05.059
   RAISZ LG, 1981, ANNU REV PHYSIOL, V43, P225, DOI 10.1146/annurev.ph.43.030181.001301
   Raskin A, 1999, J DENT, V27, P13, DOI 10.1016/S0300-5712(98)00026-8
   Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f
   Roschger P, 2001, J STRUCT BIOL, V136, P126, DOI 10.1006/jsbi.2001.4427
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Sethmann I, 2005, AM MINERAL, V90, P1213, DOI 10.2138/am.2005.1833
   Shchukin DG, 2003, CHEM MATER, V15, P3947, DOI 10.1021/cm0341585
   Shenton W, 1997, NATURE, V389, P585
   Shenton W, 1999, ADV MATER, V11, P253, DOI 10.1002/(SICI)1521-4095(199903)11:3<253::AID-ADMA253>3.0.CO;2-7
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P385, DOI 10.1023/A:1013231529439
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Sun YX, 2006, J PHYS CHEM SOLIDS, V68, P373, DOI 10.1016/j.jpcs.2006.11.026
   TANG R, 2005, MRS B
   Tang RK, 2000, J CRYST GROWTH, V212, P261, DOI 10.1016/S0022-0248(00)00022-1
   Tang RK, 2004, J MATER CHEM, V14, P2341, DOI 10.1039/b401097c
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   Tang RK, 2002, PURE APPL CHEM, V74, P1851, DOI 10.1351/pac200274101851
   Tang RK, 2003, J PHYS CHEM B, V107, P10653, DOI 10.1021/jp0346312
   Tang RK, 2001, LANGMUIR, V17, P3480, DOI 10.1021/la001730n
   Tao JH, 2007, J PHYS CHEM B, V111, P13410, DOI 10.1021/jp0732918
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tesch W, 2001, CALCIFIED TISSUE INT, V69, P147, DOI 10.1007/s00223-001-2012-z
   TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059
   TRAUBE I, 1927, SOLUBILITY SURFACE B, V60, P1808
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang LJ, 2007, J PHYS CHEM C, V111, P6398, DOI 10.1021/jp0675429
   Wang LJ, 2006, BIOINTERPHASES, V1, P106, DOI 10.1116/1.2354575
   Wang LJ, 2006, J DENT RES, V85, P359, DOI 10.1177/154405910608500415
   Wang TX, 2005, J AM CHEM SOC, V127, P3246, DOI 10.1021/ja045331g
   Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Wilson NHF, 2000, J DENT, V28, P15, DOI 10.1016/S0300-5712(99)00055-X
   Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114
   WONG SYP, 1985, J BONE JOINT SURG AM, V67A, P274, DOI 10.2106/00004623-198567020-00015
   Wu WJ, 1999, ADV COLLOID INTERFAC, V79, P229, DOI 10.1016/S0001-8686(98)00072-4
   Xu AW, 2006, ADV FUNCT MATER, V16, P903, DOI 10.1002/adfm.200500716
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yang HG, 2004, ANGEW CHEM, V116, P6056
   Yoon BH, 2005, BIOMATERIALS, V26, P2957, DOI 10.1016/j.biomaterials.2004.07.062
   YOREO D, 2003, MINERAL GEOCHEM, V54, P57
   You LC, 2006, J AM CHEM SOC, V128, P13336, DOI 10.1021/ja064569x
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zhang B, 2003, NANOTECHNOLOGY, V14, P443, DOI 10.1088/0957-4484/14/4/307
   Zhang BJ, 2000, CHEM COMMUN, P781, DOI 10.1039/b001528h
   Zhang LJ, 2004, LANGMUIR, V20, P2243, DOI 10.1021/la035381j
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhang ZP, 2005, ADV MATER, V17, P42, DOI 10.1002/adma.200400401
NR 144
TC 173
Z9 175
U1 25
U2 259
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2008
VL 18
IS 32
BP 3775
EP 3787
DI 10.1039/b805407j
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 334LD
UT WOS:000258222400006
DA 2018-10-19
ER

PT J
AU Andrade, GI
   Barbosa-Stancioli, EF
   Mansur, AAP
   Vasconcelos, WL
   Mansur, HS
AF Andrade, Giovanna I.
   Barbosa-Stancioli, Edel Figueiredo
   Mansur, Alexandra A. Piscitelli
   Vasconcelos, W. L.
   Mansur, Herman Sander
TI Small-angle X-ray scattering and FTIR characterization of nanostructured
   poly (vinyl alcohol)/silicate hybrids for immunoassay applications
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th Meeting of the Brazilian-Society-for-Materials-Research
CY OCT 08-12, 2006
CL Florianopolis, BRAZIL
SP Brazilian Soc Mat Res
ID PROTEIN IMMOBILIZATION; BOVINE HERPESVIRUS-5; BIOMATERIAL SURFACES;
   NETWORKS; NANOCOMPOSITES; SPECTROSCOPY; COMPOSITES; ADSORPTION;
   HYDROGELS; DESIGN
AB In the present work we aimed to develop and characterize hybrid organic-inorganic materials based on poly(vinyl alcohol) (PVA) polymer chemically modified by organosilanes and crosslinked network to be tested as solid support on immunoassay application. Hybrids were synthesized by reacting PVA with 5 different alkoxysilanes modifying chemical groups: tetraethoxysilane (TEOS), 3-mercaptopropyltriethoxysilane (MPTES), 3-glycidoxypropyltrimethoxysilane (GPTMS), 3-(triethoxysilyl)propylisocyanate (TESPI), and 3-aminopropyltriethoxysilane (APTES). PVA-derived hybrids were also modified by chemically crosslinking with glutaraldehyde (GA) during the synthesis reaction. In order to investigate the structure in the nanometer-scale, PVA-derived hybrids were characterized by using small-angle X-ray scattering synchrotron radiation (SAXS). Fourier transform infrared spectroscopy (FTIR) was used to investigate PVA hybrids chemical functionalities and their interaction with bovine herpesviruses. The morphology of silane modified PVA films were also analyzed by SEM coupled to EDX. The bioactivity assays were tested through Enzyme Linked Immunosorbent Assay (ELISA) with bovine herpesvirus (BoHV). SAXS results have indicated nano-ordered disperse domains for PVA hybrids with different X-ray scattering patterns for PVA polymer and PVA-derived hybrids. FTIR spectra have clearly showed that the proposed modifications of PVA by organosilanes were obtained. The chemical crosslinking of PVA polymer chain by GA was verified by FTIR. The immunoassay results have showed that PVA hybrids with chemically functionalized structures have played an important role on regulating to some extent the interaction of herpesvirus and solid substrate at the interface. These results have given strong evidence that PVA-derived hybrid nanocomposites were successfully formed with GA crosslinked network. Also, such PVA based material could be advantageously used in immunoassays with enhanced specificity for diagnosis.
C1 [Mansur, Alexandra A. Piscitelli; Vasconcelos, W. L.; Mansur, Herman Sander] Univ Fed Minas Gerais, Sch Engn, Dept Met & Mat Engn, Biomat & Tissue Engn Lab, BR-30160030 Belo Horizonte, MG, Brazil.
   [Andrade, Giovanna I.; Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Sch Engn, Dept Met & Mat Engn, Biomat & Tissue Engn Lab, Rua Espirito Santo 35-2andar, BR-30160030 Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
CR Ahmad Z, 2001, CHEM MATER, V13, P3320, DOI 10.1021/cm010175n
   Bandyopadhyay A, 2006, J MATER SCI, V41, P5981, DOI 10.1007/s10853-006-0254-x
   Carlos LD, 1999, CHEM MATER, V11, P581, DOI 10.1021/cm980373n
   Chaker JA, 2000, J APPL CRYSTALLOGR, V33, P700, DOI 10.1107/S0021889899013254
   Chiavacci LA, 2003, J APPL CRYSTALLOGR, V36, P405, DOI 10.1107/S0021889803000517
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Choi J, 2001, J AM CHEM SOC, V123, P11420, DOI 10.1021/ja010720l
   Chowdhury SI, 2002, J VIROL, V76, P3839, DOI 10.1128/JVI.76.8.3839-3851.2002
   Dominguez L, 2002, REACT FUNCT POLYM, V53, P205, DOI 10.1016/S1381-5148(02)00174-8
   G Andrade, 2006, BIOMED MATER, V1, P2214
   Goncalves MC, 2004, CHEM MATER, V16, P2530, DOI 10.1021/cm0348848
   Habsuda J, 2002, POLYMER, V43, P4123, DOI 10.1016/S0032-3861(02)00209-4
   Innocenzi P, 2001, J SOL-GEL SCI TECHN, V20, P293, DOI 10.1023/A:1008782203971
   Kickelbick G, 2003, PROG POLYM SCI, V28, P83, DOI 10.1016/S0079-6700(02)00019-9
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   MALMSTEN M, 1998, PROTEIN SURFACES, P143
   Mansur H, 2002, SPECTROSC-INT J, V16, P351, DOI 10.1155/2002/183053
   Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Mansur HS, 2000, BIOMACROMOLECULES, V1, P789, DOI 10.1021/bm0056198
   Mansur HS, 2000, J NON-CRYST SOLIDS, V273, P109, DOI 10.1016/S0022-3093(00)00150-2
   Mark JE, 1996, POLYM ENG SCI, V36, P2905, DOI 10.1002/pen.10692
   Mark JE, 1999, CURR OPIN SOLID ST M, V4, P565, DOI 10.1016/S1359-0286(00)00007-3
   Matejka L, 2003, MACROMOLECULES, V36, P7977, DOI 10.1021/ma034234p
   Meyer G, 1999, J GEN VIROL, V80, P2849, DOI 10.1099/0022-1317-80-11-2849
   Meyers R.A., 2000, INTERPRETATION INFRA, P10815
   Patwardhan SV, 2006, EUR POLYM J, V42, P167, DOI 10.1016/j.eurpolymj.2005.09.016
   PEPPAS NA, 1977, POLYMER, V18, P403, DOI 10.1016/0032-3861(77)90090-8
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PEPPAS NA, 1977, MAKROMOL CHEM, V178, P595
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Riet-Correa G, 2006, PESQUISA VET BRASIL, V26, P44, DOI 10.1590/S0100-736X2006000100009
   Sanchez C, 2000, J SOL-GEL SCI TECHN, V19, P31, DOI 10.1023/A:1008753919925
   Sarmento VHV, 2003, J APPL CRYSTALLOGR, V36, P473, DOI 10.1107/S0021889803000384
   WANG SH, 1994, CHEM MATER, V6, P943, DOI 10.1021/cm00043a013
   WILCOX WC, 1988, J VIROL, V62, P1941
   Wild P, 1998, J VIROL, V72, P9561
   Yano S, 2003, POLYMER, V44, P3515, DOI 10.1016/S0032-3861(03)00281-7
   Yeun JH, 2006, J APPL POLYM SCI, V101, P591, DOI 10.1002/app.23372
   YOU CH, 2005, KEY ENG MATER, V17, P469
   Zelazowska E, 2005, OPT APPL, V35, P887
NR 41
TC 48
Z9 49
U1 0
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2008
VL 43
IS 2
BP 450
EP 463
DI 10.1007/s10853-007-1953-7
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 241GF
UT WOS:000251644200005
DA 2018-10-19
ER

PT J
AU Costa, HS
   Rocha, MF
   Andrade, GI
   Barbosa-Stancioli, EF
   Pereira, MM
   Orefice, RL
   Vasconcelos, WL
   Mansur, HS
AF Costa, Hermes S.
   Rocha, Magda F.
   Andrade, Giovanna I.
   Barbosa-Stancioli, Edel F.
   Pereira, Marivalda M.
   Orefice, Rodrigo L.
   Vasconcelos, Wander L.
   Mansur, Herman S.
TI Sol-gel derived composite from bioactive glass-polyvinyl alcohol
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th Meeting of the Brazilian-Society-for-Materials-Research
CY OCT 08-12, 2006
CL Florianopolis, BRAZIL
SP Brazilian Soc Mat Res
ID BONE; BIOMATERIAL; SCAFFOLDS; CERAMICS; POLYMERS; HYBRIDS
AB Investigation of novel biomaterials for bone engineering is based on the development of porous scaffolds, which should match the properties of the tissue that is to be replaced. These materials need to be biocompatible, ideally osteoinductive, osteoconductive, and mechanically well-matched. In the present paper, we report the preparation and characterization of hybrid macroporous scaffold of polyvinyl alcohol (PVA)/bioactive glass through the sol-gel route. Hybrids containing PVA (80, 70 and 60 wt%) and bioactive glass with composition 58SiO(2)-33CaO-9P(2)O(5) were synthesized by foaming a mixture of polymer solution and bioactive glass via sol-gel precursor solution. PVA with two different degree of hydrolysis (DH), 98.5% (high degree) and 80% (low degree) were also investigated, in order to evaluate the influence of residual acetate group present in polymer chain on the final structure and properties of 3D porous composite produced. The microstructure, morphology and crystallinity of the hybrid porous scaffolds were characterized by X-ray diffraction (XRD), Infrared Fourier Transform spectrometry (FTIR) and Scanning electron microscopy (SEM/EDX) analysis. In addition, specific surface area was assessed by B.E.T. nitrogen adsorption method and mechanical behavior was evaluated by compression tests. Preliminary cytotoxicity and cell viability were also performed by the MTT assay. VERO cell monolayers were grown in 96-well microtiter plates. The results have clearly showed that hybrid foams of polyvinyl alcohol/bioactive glass (PVA/BG) with interconnected macroporous 3D structure were successfully produced. All the tested hybrids of PVA/BG have showed adequate cell viability properties for potential biological applications.
C1 [Costa, Hermes S.; Rocha, Magda F.; Pereira, Marivalda M.; Orefice, Rodrigo L.; Vasconcelos, Wander L.; Mansur, Herman S.] Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   [Andrade, Giovanna I.; Barbosa-Stancioli, Edel F.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, R Espirito Santo 35, BR-30160030 Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Mansur, Herman/0000-0002-3032-495X
CR ALMEIDA RM, 1990, J APPL PHYS, V68, P4225, DOI 10.1063/1.346213
   Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Coates J., 2000, ENCY ANAL CHEM, V12, P10815, DOI DOI 10.1002/9780470027318.A5606
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   JONES RJ, 2005, BIOMATERIALS, V27, P964, DOI DOI 10.1016/J.BIOMATERIALS.2005.07.017
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   Pereira MM, 2005, J MATER SCI-MATER M, V16, P1045, DOI 10.1007/s10856-005-4758-8
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roman J, 2003, CHEM MATER, V15, P798, DOI 10.1021/cm021325c
   Shi DL, 1998, MAT SCI ENG C-BIO S, V6, P175, DOI 10.1016/S0928-4931(98)00048-4
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   YAMAOKA T, 1995, J PHARM PHARMACOL, V47, P479, DOI 10.1111/j.2042-7158.1995.tb05835.x
NR 27
TC 36
Z9 38
U1 2
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2008
VL 43
IS 2
BP 494
EP 502
DI 10.1007/s10853-007-1875-4
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 241GF
UT WOS:000251644200011
DA 2018-10-19
ER

PT J
AU Tarallo, L
   Zaffe, D
   Adani, R
   Krajewski, A
   Ravaglioli, A
AF Tarallo, Luigi
   Zaffe, Davide
   Adani, Roberto
   Krajewski, Adriano
   Ravaglioli, Antonio
TI Extracorporeal hydroxyapatite-chamber for bone and biomaterial studies
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GRAFTS; IMPLANTATION; RABBITS; SCREWS; PLATES; MODEL
AB Hydroxyapatite (HA) spherules and autologous bone (AB) with a central vascular pedicle were housed inside an HA-chamber to form the skeletal segment of specific shape. Experimental chambers were then inserted in a pocket between medial thigh muscles in 13 New Zealand male rabbits for 3 months. Three graft group were scheduled: (A) HA and AB without vascular pedicle, (B) HA with vascular pedicle, (C) HA and AB with vascular pedicle. At term, histology showed tissue and cellular degeneration in group A chambers. Due to spherules coalescence, fibrous tissue is formed in group B chambers. Group C chambers contained living osteocytes in the implanted bone, several newly formed vessels in soft tissue, bone and partial hydroxyapatite erosions. New bone was formed in apposition to both autologous bone and hydroxyapatite. Our study suggests that this experimental model could be used to grow adequately sized vascularized skeletal segments.
C1 [Zaffe, Davide] Univ Modena & Reggio Emilia, Sect Human Anat, Dept Anat & Histol, Policlin, I-41100 Modena, Italy.
   [Tarallo, Luigi; Adani, Roberto] Univ Modena & Reggio Emilia, Sect Orthopaed Clin, Dept Emergency Urgency, Policlin, I-41100 Modena, Italy.
   [Krajewski, Adriano; Ravaglioli, Antonio] ISTEC, I-48018 Faenza, RA, Italy.
RP Zaffe, D (reprint author), Univ Modena & Reggio Emilia, Sect Human Anat, Dept Anat & Histol, Policlin, Via Pozzo 71, I-41100 Modena, Italy.
EM zaffe@unimore.it
RI Zaffe, Davide/G-1181-2016
OI Zaffe, Davide/0000-0003-1241-385X
CR Bertoldi C, 2005, J MATER SCI-MATER M, V16, P857, DOI 10.1007/s10856-005-3575-4
   Busa R, 1999, MICROSURG, V19, P289, DOI 10.1002/(SICI)1098-2752(1999)19:6<289::AID-MICR7>3.0.CO;2-#
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Celik M, 2000, J ORAL MAXIL SURG, V58, P292, DOI 10.1016/S0278-2391(00)90056-9
   CIGADA A, 1993, J APPL BIOMATER, V4, P39, DOI 10.1002/jab.770040105
   Ferretti Marzia, 2002, Anatomy and Embryology, V206, P21, DOI 10.1007/s00429-002-0265-6
   Gamradt SC, 2003, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000096814.78689.77
   Gartsman G M, 1985, J Reconstr Microsurg, V1, P215, DOI 10.1055/s-2007-1007077
   Gill DRJ, 1998, J HAND SURG-AM, V23A, P312, DOI 10.1016/S0363-5023(98)80133-0
   Grauer JN, 2003, BIODRUGS, V17, P391, DOI 10.2165/00063030-200317060-00002
   Guo JH, 1996, ANN PLAS SURG, V36, P133, DOI 10.1097/00000637-199602000-00005
   Herath H M T U, 2005, J Appl Biomater Biomech, V3, P192
   HORY Y, 1979, J HAND SURG, V4, P23
   Isogai N, 1999, J BONE JOINT SURG AM, V81A, P306, DOI 10.2106/00004623-199903000-00002
   Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N
   Kasashima T, 2000, J RECONSTR MICROSURG, V16, P121, DOI 10.1055/s-2000-7546
   Lin CC, 1996, BIOMATERIALS, V17, P1133, DOI 10.1016/0142-9612(96)85916-3
   MIZUMOTO S, 1992, J RECONSTR MICROSURG, V8, P325, DOI 10.1055/s-2007-1006716
   MIZUMOTO S, 1993, J RECONSTR MICROSURG, V9, P441, DOI 10.1055/s-2007-1006754
   MORONI A, 1990, BIOCERAMICS, V2, P125
   NETTELBLAD H, 1985, PLAST RECONSTR SURG, V76, P851, DOI 10.1097/00006534-198512000-00008
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   UPTON J, 1994, PLAST RECONSTR SURG, V94, P573, DOI 10.1097/00006534-199410000-00001
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
   ZAFFE D, 1992, BIOCERAMICS AND THE HUMAN BODY, P388
   ZAFFE D, 1992, BIOSIS INT SOC BIOAN, P63
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2008
VL 19
IS 1
BP 159
EP 166
DI 10.1007/s10856-006-0102-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 250CW
UT WOS:000252278600021
PM 17597378
DA 2018-10-19
ER

PT J
AU Bernhardt, A
   Lode, A
   Boxberger, S
   Pompe, W
   Gelinsky, M
AF Bernhardt, Anne
   Lode, Anja
   Boxberger, Sabine
   Pompe, Wolfgang
   Gelinsky, Michael
TI Mineralised collagen - an artificial, extracellular bone matrix -
   improves osteogenic differentiation of bone marrow stromal cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOBLASTIC DIFFERENTIATION;
   PERFUSION CULTURE; ALKALINE-PHOSPHATASE; SCAFFOLDS; GROWTH;
   HYDROXYAPATITE; PROLIFERATION; CONSTRUCTS
AB In the field of bone tissue engineering there is a high demand on bone graft materials which promote bone formation. By combination of collagen type I with nanocrystalline hydroxyapatite (HA) we generated a resorbable material which structure and composition is close to those of the extracellular bone matrix. This nanocomposit material was produced in a biomimetic process in which collagen fibril assembly and mineralisation with hydroxyapatite occur simultaneously. In this study the proliferation and osteogenic differentiation of human bone marrow-derived stromal cells (hBMSC) on membranes of biomimetically mineralised collagen type I was investigated. To this end, we optimised biochemical assays for determination of cell number and alkaline phosphatase activity corresponding to the special properties of this biomaterial. For cell experiments hBMSC were seeded on the mineralised collagen membranes and cultivated over 35 days, both in static and perfusion culture, in the presence and absence of dexamethasone, beta-glycerophosphate and ascorbate. Compared to cells grown on tissue culture polystyrene we found attenuated proliferation rates, but markedly increased activity of alkaline phosphatase on the mineralised collagen indicating its promoting effect on the osteogenic differentiation of hBMSC. Therefore this bone-like material may act as a suitable artificial extracellular matrix for bone tissue engineering. Perfusion of the 2D cell matrix constructs with cell culture medium did not improve proliferation and osteogenic differentiation of the hBMSC.
C1 [Bernhardt, Anne; Lode, Anja; Pompe, Wolfgang; Gelinsky, Michael] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Boxberger, Sabine] Univ Hosp Carl, Med Klin & Poliklin 1, D-01307 Dresden, Germany.
RP Bernhardt, A (reprint author), Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM bernhard@tmfs.mpgfk.tu-dresden.de
RI Gelinsky, Michael/A-9680-2012; Bernhardt, Anne/O-1242-2015
OI Gelinsky, Michael/0000-0001-9075-5121; Bernhardt,
   Anne/0000-0002-1903-1929
CR Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Berube P, 2005, J PERIODONTOL, V76, P1697, DOI 10.1902/jop.2005.76.10.1697
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   BURTH R, 1999, TECH TEXTILE, V8, P20
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Domaschke H, 2006, TISSUE ENG, V12, P949, DOI 10.1089/ten.2006.12.949
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Fuss M, 2000, ANN ANAT, V182, P303
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   George J, 2006, BIOTECHNOL BIOENG, V95, P404, DOI 10.1002/bit.20938
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Hosseinkhani H, 2005, TISSUE ENG, V11, P1476, DOI 10.1089/ten.2005.11.1476
   Jager M, 2005, ANN BIOMED ENG, V33, P1319, DOI 10.1007/s10439-005-5889-2
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   MCCULLOCH CAG, 1986, ANAT RECORD, V215, P397, DOI 10.1002/ar.1092150410
   Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   Nordstrom E, 1999, BIO-MED MATER ENG, V9, P21
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
NR 40
TC 58
Z9 58
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2008
VL 19
IS 1
BP 269
EP 275
DI 10.1007/s10856-006-0059-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 250CW
UT WOS:000252278600034
PM 17597360
DA 2018-10-19
ER

PT J
AU Vitale-Brovarone, C
   Verne, E
   Robiglio, L
   Martinasso, G
   Canuto, RA
   Muzio, G
AF Vitale-Brovarone, Chiara
   Verne, Enrica
   Robiglio, Lorenza
   Martinasso, Germana
   Canuto, Rosa A.
   Muzio, Giuliana
TI Biocompatible glass-ceramic materials for bone substitution
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOACTIVE GLASS; OSTEOBLASTS; SCAFFOLDS; COATINGS; HYDROXYAPATITE;
   MINERALIZATION; TI6AL4V; ALUMINA; MATRIX; CELLS
AB A new bioactive glass composition (CEL2) in the SiO(2)-P(2)O(5)-CaO-MgO-K(2)O-Na(2)O system was tailored to control pH variations due to ion leaching phenomena when the glass is in contact with physiological fluids. CEL2 was prepared by a traditional melting-quenching process obtaining slices that were heat-treated to obtain a glass-ceramic material (CEL2GC) that was characterized thorough SEM analysis. Pre-treatment of CEL2GC with SBF was found to enhance its biocompatibility, as assessed by in vitro tests. CEL2 powder was then used to synthesize macroporous glass-ceramic scaffolds. To this end, CEL2 powders were mixed with polyethylene particles within the 300-600 mu m size-range and then pressed to obtain crack-free compacted powders (green). This was heat-treated to remove the organic phase and to sinter the inorganic phase, leaving a porous structure. The biomaterial thus obtained was characterized by X-ray diffraction, SEM equipped with EDS, density measurement, image analysis, mechanical testing and in vitro evaluation, and found to be a glass-ceramic macroporous scaffold with uniformly distributed and highly interconnected porosity. The extent and size-range of the porosity can be tailored by varying the amount and size of the polyethylene particles.
C1 [Vitale-Brovarone, Chiara; Verne, Enrica; Robiglio, Lorenza] Politecn Torino, Mat Sci & Chem Engn Dept, I-10128 Turin, Italy.
   [Martinasso, Germana; Canuto, Rosa A.; Muzio, Giuliana] Univ Turin, Dept Expt Med & Oncol, Turin, Italy.
RP Vitale-Brovarone, C (reprint author), Politecn Torino, Mat Sci & Chem Engn Dept, I-10128 Turin, Italy.
EM chiara.vitale@polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Muzio,
   Giuliana/0000-0003-2730-1957; Verne, Enrica/0000-0002-8649-4739
CR Brandao-Burch A, 2005, CALCIFIED TISSUE INT, V77, P167, DOI 10.1007/s00223-004-0285-8
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   DUCHEYNE P, 1992, REV CLIN ORTHO REL R, V277, P102
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Frick KK, 1997, AM J PHYSIOL-CELL PH, V272, pC1450
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Jun IK, 2006, J AM CERAM SOC, V89, P391, DOI 10.1111/j.1551-2916.2005.00707.x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6
   VALLETREGI M, 2001, J CHEM SOC DA, V5, P97
   Verne E, 2004, J EUR CERAM SOC, V24, P2699, DOI 10.1016/j.jeurceramsoc.2003.09.004
   Verne E, 2003, J EUR CERAM SOC, V23, P675, DOI 10.1016/S0955-2219(02)00164-4
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
   Vitale-Brovarone C, 2005, J MATER SCI-MATER M, V16, P863, DOI 10.1007/s10856-005-3583-4
   Vitale-Brovarone C, 2004, J MATER SCI-MATER M, V15, P209, DOI 10.1023/B:JMSM.0000015480.49061.e1
   VITALEBROVARONE C, 2006, J MATER SCI-MATER M, V17, P1069, DOI DOI 10.1007/S10856-006-0533-8
NR 24
TC 56
Z9 56
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2008
VL 19
IS 1
BP 471
EP 478
DI 10.1007/s10856-006-0111-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 250CW
UT WOS:000252278600059
PM 17607523
DA 2018-10-19
ER

PT J
AU Dass, CR
   Friedhuber, AM
   Khachigian, LM
   Dunstan, DE
   Choong, PFM
AF Dass, Crispin R.
   Friedhuber, Anna M.
   Khachigian, Levon M.
   Dunstan, Dave E.
   Choong, Peter F. M.
TI Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological
   activity
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE chitosan; c-jun; cancer; apoptosis; deoxyribozyme; nanoparticle; bone
ID C-JUN; MURINE MODEL; OSTEOSARCOMA; DNA; DEOXYRIBOZYMES; MOLECULES;
   DELIVERY
AB DNAzymes are oligonucleotides capable of specific catalysis of target mRNA. To date, a delivery vehicle for DNAzymes has not been developed. Chitosan is a biomaterial obtained abundantly in nature. A biocompatible c-jun (an oncogene) DNAzyme nanoparticle formulated from chitosan was found to be more active against osteosarcoma (bone cancer) cells, inducing apoptotic cell death in these cells. The formulation was stable in serum for a week and at room temperature for a month. Clinically, knockdown of c-jun gene expression with chitosan nanobiotechnology may improve treatment outcome for tumours growing in bone.
C1 [Dass, Crispin R.; Choong, Peter F. M.] Univ Melbourne, St Vincents Hosp, Dept Orthopaed, Fitzroy, Vic 3065, Australia.
   [Friedhuber, Anna M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.
   [Dunstan, Dave E.] Univ Melbourne, Dept Chem & Biomol Engn, Fitzroy, Vic 3065, Australia.
RP Dass, CR (reprint author), Univ Melbourne, St Vincents Hosp, Dept Orthopaed, POB 2900, Fitzroy, Vic 3065, Australia.
EM crispin.dass@svhm.org.au
RI Choong, Peter/F-1109-2014; Dunstan, Dave/B-8936-2014
OI Choong, Peter/0000-0002-3522-7374; Dunstan, Dave/0000-0002-9931-010X;
   Choong, Peter/0000-0001-7333-7665; Khachigian, Levon/0000-0003-3446-0323
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276
   Dass CR, 2007, BIOMATERIALS, V28, P3026, DOI 10.1016/j.biomaterials.2007.03.016
   Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6
   Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225
   Franchi A, 1998, VIRCHOWS ARCH, V432, P515, DOI 10.1007/s004280050199
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Isaka Y, 2007, CURR OPIN MOL THER, V9, P132
   Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005
   MIRKIN CA, 1996, NATURE, V382, P609
   Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7
   Roy K, 1999, NAT MED, V5, P387
   Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262
   Zhang GS, 2004, J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120
NR 14
TC 21
Z9 21
U1 1
U2 7
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0265-2048
J9 J MICROENCAPSUL
JI J. Microencapsul.
PY 2008
VL 25
IS 6
BP 421
EP 425
DI 10.1080/02652040802033673
PG 5
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA 335BD
UT WOS:000258264900006
PM 18465314
DA 2018-10-19
ER

PT J
AU Ehrlich, H
   Janussen, D
   Simon, P
   Bazhenov, VV
   Shapkin, NP
   Erler, C
   Mertig, M
   Born, R
   Heinemann, S
   Hanke, T
   Worch, H
   Vournakis, JN
AF Ehrlich, Hermann
   Janussen, Dorte
   Simon, Paul
   Bazhenov, Vasily V.
   Shapkin, Nikolay P.
   Erler, Christiane
   Mertig, Michael
   Born, Rene
   Heinemann, Sascha
   Hanke, Thomas
   Worch, Hartmut
   Vournakis, John N.
TI Nanostructural organization of naturally occurring composites - Part II:
   Silica-chitin-based biocomposites
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID ALPHA-CHITIN; MARINE SPONGES; SILICIFIED COLLAGEN; ELECTRON-MICROSCOPY;
   MOLECULAR-BIOLOGY; 1ST EVIDENCE; GLASS; PORIFERA; CHITOSAN;
   POLYSACCHARIDES
AB Investigations of the micro- and nanostructures and chemical composition of the sponge skeletons as examples for natural structural biocomposites are of fundamental scientific relevance. Recently, we show that some demosponges (Verongula gigantea, Aplysina sp.) and glass sponges (Farrea occa, Euplectella aspergillum) possess chitin as a component of their skeletons. The main practical approach we used for chitin isolation was based on alkali treatment of corresponding external layers of spicules sponge material with the aim of obtaining alkali-resistant compounds for detailed analysis. Here, we present a detailed study of the structural and physicochemical properties of spicules of the glass sponge Rossella fibulata. The structural similarity of chitin derived from this sponge to invertebrate alpha chitin has been confirmed by us unambiguously using physicochemical and biochemical methods. This is the first report of a silica-chitin composite biomaterial found in Rossella species. Finally, the present work includes a discussion related to strategies for the practical application of silica-chitin-based composites as biomaterials. Copyright (C) 2008 Hermann Ehrlich et al.
C1 [Ehrlich, Hermann; Erler, Christiane; Mertig, Michael; Born, Rene; Heinemann, Sascha; Hanke, Thomas; Worch, Hartmut] Tech Univ Dresden, Max Bergmam Ctr Biomat, D-01069 Dresden, Germany.
   [Ehrlich, Hermann; Erler, Christiane; Mertig, Michael; Born, Rene; Heinemann, Sascha; Hanke, Thomas; Worch, Hartmut] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Janussen, Dorte] Forschung Inst & Naturmuseum Senckenberg, D-60325 Frankfurt, Germany.
   [Simon, Paul] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany.
   [Bazhenov, Vasily V.; Shapkin, Nikolay P.] Far Eastern Natl Univ, Inst Chem & Appl Ecol, Vladivostok 690650, Russia.
   [Vournakis, John N.] Marine Polymer Technol Inc, Danvers, MA 01923 USA.
RP Ehrlich, H (reprint author), Tech Univ Dresden, Max Bergmam Ctr Biomat, D-01069 Dresden, Germany.
EM hermann.ehrlich@tu-dresden.de
RI Ehrlich, Hermann/I-5481-2015; Ehrlich, Hermann/J-6698-2012; Born,
   Rene/D-8798-2011; Bazhenov, Vasilii/J-6065-2012
OI Ehrlich, Hermann/0000-0003-3654-0810; Ehrlich,
   Hermann/0000-0003-3654-0810; Born, Rene/0000-0001-6793-2273; Bazhenov,
   Vasilii/0000-0002-1346-1151; Shapkin, Nikolay/0000-0001-7602-156X
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   ATKINS E, 1985, J BIOSCIENCE, V8, P375, DOI 10.1007/BF02703990
   BACHMED K, 2005, PROGR BIOCH, V40, P2523
   BODEN N, 1985, INSECT BIOCHEM, V15, P19, DOI 10.1016/0020-1790(85)90039-3
   Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102
   Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2
   BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505
   Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647
   CARLSTROM D, 1957, J BIOPHYS BIOCHEM CY, V3, P669, DOI 10.1083/jcb.3.5.669
   CUTTANEOVIETTI R, 1996, NATURE, V383, P397
   Darder M, 2003, CHEM MATER, V15, P3774, DOI 10.1021/cm0343047
   De La Rocha CL, 2003, GEOLOGY, V31, P423, DOI 10.1130/0091-7613(2003)031<0423:SIFBMS>2.0.CO;2
   Ehrlich H., 2006, RUSS J MAR BIOL, V32, P217
   EHRLICH H, 2007, HDB BIOMINERALIZATIO, V1
   EHRLICH H, IN PRESS J NANOMATER
   EHRLICH H, 2007, PORIFERA RES BIODIVE
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P473, DOI 10.1002/jez.b.21174
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Einbu A, 2004, BIOMACROMOLECULES, V5, P2048, DOI 10.1021/bm049710d
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   GEMPERLE A, 1982, BIOPOLYMERS, V21, P1, DOI 10.1002/bip.360210102
   Giraud-Guille MM, 1998, CURR OPIN SOLID ST M, V3, P221, DOI 10.1016/S1359-0286(98)80094-6
   GIRAUDGUILLE MM, 1990, J STRUCT BIOL, V103, P232, DOI 10.1016/1047-8477(90)90041-A
   Goodrich JD, 2007, BIOMACROMOLECULES, V8, P252, DOI 10.1021/bm0603589
   Heinemann S, 2007, INT J MATER RES, V98, P603, DOI 10.3139/146.101519
   Heinemann S, 2007, ADV ENG MATER, V9, P1061, DOI 10.1002/adem.200700219
   Helbert W, 1998, CELLULOSE, V5, P113, DOI 10.1023/A:1009272814665
   Kang QK, 2005, KEY ENG MAT, V288-289, P83, DOI 10.4028/www.scientific.net/KEM.288-289.83
   Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2
   MAITAN J, 2007, INT J BIOL MACROMOL, V40, P237
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Muller WEG, 2006, BIOSENS BIOELECTRON, V21, P1149, DOI 10.1016/j.bios.2005.04.017
   NEVILLE AC, 1976, J CELL SCI, V21, P73
   Ogasawara W, 2000, CHEM MATER, V12, P2835, DOI 10.1021/cm0004376
   Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002
   REISWIG HM, 1991, ZOOMORPHOLOGY, V110, P301, DOI 10.1007/BF01668020
   Reitner Joachim, 1995, Geologisch-Palaeontologische Mitteilungen, V20, P335
   Reitner Joachim, 1996, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V36, P5
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198
   Schroder HC, 2007, NATURWISSENSCHAFTEN, V94, P339, DOI 10.1007/s00114-006-0192-0
   Schulze F. E, 1904, WISSENSCHAFTLICHE ER, V1898-1899, P1
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Shchipunov YA, 2005, J COLLOID INTERF SCI, V287, P373, DOI 10.1016/j.jcis.2005.02.004
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Tabachnick K.R., 1991, P378
   TRAVIS DF, 1967, J ULTRA MOL STRUCT R, V18, P519, DOI 10.1016/S0022-5320(67)80201-6
   Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395
   Vournakis J, 1997, US patent, Patent No. [5,623,064, 5623064]
   VOURNAKIS JN, 2004, Patent No. 6686342
   Walter SL, 2007, MAT SCI ENG C-BIO S, V27, P570, DOI 10.1016/j.msec.2006.05.020
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Weaver JC, 2003, MICROSC RES TECHNIQ, V62, P356, DOI 10.1002/jemt.10401
NR 56
TC 35
Z9 36
U1 0
U2 16
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
J9 J NANOMATER
JI J. Nanomater.
PY 2008
AR 670235
DI 10.1155/2008/670235
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 299UT
UT WOS:000255781200001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cui, FZ
   Jiao, YP
   Lee, IS
AF Cui, Fu-Zhai
   Jiao, Yan-Peng
   Lee, In-Seop
TI Functionalization of polymer surface for nerve repair
SO JOURNAL OF PHOTOPOLYMER SCIENCE AND TECHNOLOGY
LA English
DT Review
DE polymer; surface; nerve repair; plasma treatment; bioactive molecules
ID NEGATIVE-ION-IMPLANTATION; HYALURONIC-ACID HYDROGELS; L-LACTIC ACID;
   INCORPORATED COLLAGEN TUBES; TRAUMATIC BRAIN-INJURY; GUIDE CONDUIT
   MATERIAL; TENDON CHITOSAN TUBES; IN-VIVO EVALUATION;
   EXTRACELLULAR-MATRIX; PLASMA TREATMENT
AB Surfaces play an important role in biological system for most biological reactions occurring at surfaces and interfaces. One of the emphasis of developing biomaterials for nerve repair is to create perfect surfaces which can provoke specific cellular responses and direct new nerve tissue regeneration. The improvement in biocompatibility of biomaterials for nerve repair by directed surface functionalization is an important contribution to biomaterial development. In this paper, recent advance in polymer surface functionalization for nerve repair is reviewed. Various methods for polymer surface functionalization are introduced for developing nerve repair biomaterials, such as plasma treatment, ion implantation, hydroxyapatite coating, incorporation of bioactive molecules, micropatterning of surface, and their combinations.
C1 [Cui, Fu-Zhai; Jiao, Yan-Peng] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
   [Lee, In-Seop] Yonsei Univ, Inst Phys & Appl Phys, Seoul 120749, South Korea.
   [Lee, In-Seop] Yonsei Univ, Atom Scale Surface Sci Res Ctr, Seoul 120749, South Korea.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
CR Ahmed MR, 2005, J PERIPHER NERV SYST, V10, P17, DOI 10.1111/j.1085-9489.2005.10105.x
   Ahmed MR, 2004, BIOMATERIALS, V25, P2585, DOI 10.1016/j.biomaterials.2003.09.075
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Bryan DJ, 2004, J NEURAL ENG, V1, P91, DOI 10.1088/1741-2560/1/2/004
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang YC, 2007, J BIOMED MATER RES A, V82A, P842, DOI 10.1002/jbm.a.31036
   Ishikawa J, 2007, SURF COAT TECH, V201, P8083, DOI 10.1016/j.surfcoat.2006.01.073
   Itoh S, 2005, J BIOMED MATER RES B, V73B, P375, DOI 10.1002/jbm.b.30224
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Khang G, 2000, POLYM-KOREA, V24, P869
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4
   Li XK, 2007, COLLOID SURFACE B, V57, P198, DOI 10.1016/j.colsurfb.2007.02.010
   Lin Y, 2006, ACTA BIOMATER, V2, P155, DOI 10.1016/j.actbio.2005.10.002
   Ma J, 2006, TISSUE ENG, V12, P1017
   Ma J, 2005, COLLOID SURFACE B, V44, P152, DOI 10.1016/j.colsurfb.2005.06.009
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Nam YS, 1999, J BIOMAT SCI-POLYM E, V10, P1145
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ozgenel GY, 2004, J RECONSTR MICROSURG, V20, P153
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Rafiuddin M, 2003, BRAIN RES, V993, P208, DOI 10.1016/j.brainres.2003.08.057
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Ring A, 2007, EUR SURG RES, V39, P75, DOI 10.1159/000099146
   Sailynoja E, 1999, J MATER SCI-MATER M, V10, P703, DOI 10.1023/A:1008962719355
   Sakai Y, 2007, BIO-MED MATER ENG, V17, P191
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   Sommani P, 2007, NUCL INSTRUM METH B, V257, P118, DOI 10.1016/j.nimb.2006.12.159
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tsuji H, 2007, SURF COAT TECH, V201, P8123, DOI 10.1016/j.surfcoat.2006.01.074
   Tsuji H, 2005, NUCL INSTRUM METH B, V237, P459, DOI 10.1016/j.nimb.2005.05.020
   Tsuji H, 2004, APPL SURF SCI, V235, P182, DOI 10.1016/j.apsusc.2004.05.121
   Tsuji H, 2003, NUCL INSTRUM METH B, V206, P507, DOI 10.1016/S0168-583X(03)00809-7
   Tsuji H, 2002, NUCL INSTRUM METH B, V191, P815, DOI 10.1016/S0168-583X(02)00659-6
   Tsuji H, 2002, SURF COAT TECH, V158, P620, DOI 10.1016/S0257-8972(02)00316-X
   Tsuji H, 2000, NUCL INSTRUM METH B, V166, P815, DOI 10.1016/S0168-583X(99)01055-1
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   WU ZR, 2007, BIOMEDICAL MAT RES A, V81, P355
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   YAMAGUCHI ST, 2004, J ARTIF ORGANS, V7, P187
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 71
TC 2
Z9 3
U1 1
U2 19
PU TECHNICAL ASSOC PHOTOPOLYMERS,JAPAN
PI CHIBA
PA CHIBA UNIV, FACULTY ENGINEERING, YAYOICHO, CHIBA, 263-8522, JAPAN
SN 0914-9244
J9 J PHOTOPOLYM SCI TEC
JI J. Photopolym Sci. Technol.
PY 2008
VL 21
IS 2
BP 231
EP 244
DI 10.2494/photopolymer.21.231
PG 14
WC Polymer Science
SC Polymer Science
GA 323WY
UT WOS:000257480300013
OA Bronze
DA 2018-10-19
ER

PT J
AU Tuan, RS
   Lee, FYI
   Konttinen, YT
   Wilkinson, JM
   Smith, RL
AF Tuan, Rocky S.
   Lee, Francis Young-In
   Konttinen, Yrjoe T.
   Wilkinson, J. Mark
   Smith, Robert Lane
CA Implant Wear Symposium 2007 Biolog
TI What are the local and systemic biologic reactions and mediators to wear
   debris, and what host factors determine or modulate the biologic
   response to wear particles?
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Article; Proceedings Paper
CT AAOS/NIH Osteolysis and Implant Wear: Biological, Biomedical
   Engineering, and Surgical Principles
CY SEP 09-11, 2007
CL Austin, TX
SP Amer Adad Orthopaed Surg, Nat Inst Hlth
ID TOTAL HIP-REPLACEMENT; MESENCHYMAL STEM-CELLS; ORTHOPEDIC BIOMATERIAL
   PARTICLES; WEIGHT POLYETHYLENE PARTICLES; SYNOVIAL-LIKE MEMBRANE; HUMAN
   TRABECULAR BONE; TITANIUM PARTICLES; IN-VITRO; PERIPROSTHETIC
   OSTEOLYSIS; FACTOR-ALPHA
AB New clinical and basic science data on the cellular and molecular mechanisms by which wear particles stimulate the host inflammatory response have provided deeper insight into the pathophysiology of periprosthetic bone loss. Interactions among wear particles, macrophages, osteoblasts, bone marrow-derived mesenchymal stem cells, fibroblasts, endothelial cells, and T cells contribute to the production of pro-inflammatory and proosteoclastogenic cytokines such as TNF-alpha, RANKL, M-SCF, PGE(2), IL-1, IL-6, and IL-8. These cytokines not only promote osteoclastogenesis but interfere with osteogenesis led by osteoprogenitor cells. Recent studies indicate that genetic variations in TNF-alpha, IL-1, and FRZB can result in subtle changes in gene function, giving rise to altered susceptibility or severity for periprosthetic inflammation and bone loss. Continuing research on the biologic effects and mechanisms of action of wear particles will provide a rational basis for the development of novel and effective ways of diagnosis, prevention, and treatment of periprosthetic inflammatory bone loss.
C1 [Tuan, Rocky S.] NIAMSD, NIH, Cartilage Biol & Orthopaed Branch, Bethesda, MD 20892 USA.
   [Lee, Francis Young-In] Columbia Univ, Dept Orthopaed Surg, New York, NY USA.
   [Konttinen, Yrjoe T.] Univ Helsinki, Inst Clin Med, Helsinki, Finland.
   [Wilkinson, J. Mark] Univ Sheffield, No Gen Hosp, Acad Unit Bone Metab, Sheffield S10 2TN, S Yorkshire, England.
   [Smith, Robert Lane] Stanford Univ, Med Ctr, Dept Orthopaed Surg, Stanford, CA 94305 USA.
RP Tuan, RS (reprint author), NIAMSD, NIH, Cartilage Biol & Orthopaed Branch, Bethesda, MD 20892 USA.
FU Intramural NIH HHS [Z01 AR041131-06]
CR Al-Saffar N, 2000, J ORTHOP RES, V18, P800, DOI 10.1002/jor.1100180518
   Brown C, 2006, P I MECH ENG H, V220, P355, DOI 10.1243/095441105X63291
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Childs LM, 2001, J BONE MINER RES, V16, P338, DOI 10.1359/jbmr.2001.16.2.338
   Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004
   Chiu R, 2006, J BIOMED MATER RES A, V77A, P850, DOI 10.1002/jbm.a.30697
   Chiu R, 2007, J ORTHOP RES, V25, P450, DOI 10.1002/jor.20328
   Clarke SA, 2001, J BIOMED MATER RES, V57, P84, DOI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5
   Clohisy JC, 2003, J ORTHOPAED RES, V21, P202, DOI 10.1016/S0736-0266(02)00133-X
   Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004
   Fritz EA, 2006, J BIOMED MATER RES A, V77A, P192, DOI 10.1002/jbm.a.30609
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Goodman SB, 2005, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01/blo.0000149998.88218.05
   Gordon A, 2007, J ORTHOP RES, V25, P1665, DOI 10.1002/jor.20446
   Granchi D, 2005, BIOMATERIALS, V26, P2371, DOI 10.1016/j.biomaterials.2004.07.0145
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   Hart AJ, 2006, J BONE JOINT SURG BR, V88B, P449, DOI 10.1302/0301-620X.88B4
   Horiki M, 2004, J BONE MINER METAB, V22, P346, DOI 10.1007/s00774-003-0493-8
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Kaufman AM, 2008, J BIOMED MATER RES A, V84A, P464, DOI 10.1002/jbm.a.31467
   Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da
   Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134
   Kwon SY, 2001, BIORHEOLOGY, V38, P161
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Mandelin J, 2005, J BIOMED MATER RES B, V74B, P582, DOI 10.1002/jbm.b.30244
   Mandelin J, 2005, J RHEUMATOL, V32, P713
   Minematsu H, 2007, ANN NY ACAD SCI, V1117, P143, DOI 10.1196/annals.1402.026
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Ramage SC, 2007, J BONE JOINT SURG AM, V89A, P841, DOI 10.2106/JBJS.F.00655
   Santavirta S, 1996, ARCH ORTHOP TRAUM SU, V115, P286, DOI 10.1007/BF00439055
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   Seo SW, 2007, ANN NY ACAD SCI, V1117, P151, DOI 10.1196/annals.1402.027
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   Shanbhag AS, 2007, J BONE JOINT SURG AM, V89A, P1081, DOI 10.2106/JBJS.F.00330
   Solovieva SA, 1996, CLIN ORTHOP RELAT R, P158
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Trindade MCD, 2000, J BIOMED MATER RES, V51, P360, DOI 10.1002/1097-4636(20000905)51:3<360::AID-JBM9>3.0.CO;2-E
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Wang ML, 2003, J ORTHOPAED RES, V21, P697, DOI 10.1016/S0736-0266(02)00241-3
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wilkinson JM, 2003, J BONE MINER RES, V18, P1995, DOI 10.1359/jbmr.2003.18.11.1995
   Xu JW, 1997, CLIN RHEUMATOL, V16, P243, DOI 10.1007/BF02238958
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yaszay B, 2001, J ORTHOPAED RES, V19, P970, DOI 10.1016/S0736-0266(01)00003-1
NR 56
TC 70
Z9 71
U1 0
U2 8
PU AMER ACAD ORTHOPAEDIC SURGEONS
PI ROSEMENT
PA 6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA
SN 1067-151X
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PY 2008
VL 16
SU 1
BP S42
EP S48
DI 10.5435/00124635-200800001-00010
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 323UT
UT WOS:000257474600010
PM 18612013
DA 2018-10-19
ER

PT J
AU Park, SH
   Kim, TI
   Ku, Y
   Chung, CP
   Han, SB
   Yu, JH
   Lee, SP
   Kim, HW
   Lee, HH
AF Park, Sun-Hye
   Kim, Tae-Il
   Ku, Young
   Chung, Chong-Pyoung
   Han, Soo-Boo
   Yu, Ji-Hee
   Lee, Seung-Pyo
   Kim, Hae-Won
   Lee, Hae-Hyoung
TI Effect of hydroxyapatite-coated nanofibrous membrane on the responses of
   human periodontal ligament fibroblast
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE biomaterial; hydroxyapatite; membrane; periodontal ligament fibroblast;
   periodontal tissue regeneration
ID GUIDED TISSUE REGENERATION; BONE; DEFECTS; CELLS
AB In this study, hydroxyapatite-coated biopolymer nanofibrous membrane was synthesized by mineralizing the electrospun polycaprolactone nanofiber. The effect of the hydroxyapatite-coated nanofibrous membrane was mainly investigated on the proliferation and differentiation of human periodontal ligament fibroblast, which is necessary for periodontal tissue regeneration. Scanning electron microscopy revealed favorable cell attachment and spreading appearance on 1 d and MTS assay showed increased cell proliferation on the hydroxyapatite-coated nanofiber membrane during 14 d. From 7 to 14 d, alkaline phosphatase activity of the hydroxyapatite-coated nanofiber was significantly increased when compared to that of control group. Hydroxyapatite-coated nanofibrous membrane showed prominent mineral formation on day 14. As a result, it was clarified that the developed hydroxyapatite-coated nanofibrous membrane had favorable effects on the proliferation and differentiation of human periodontal ligament fibroblast and might be a good candidate material for periodontal tissue regeneration.
C1 [Park, Sun-Hye; Kim, Tae-Il; Ku, Young; Chung, Chong-Pyoung; Han, Soo-Boo] Seoul Natl Univ, Dept Periodontol, Dent Res Inst, Sch Dent,Chongno Ku, Seoul 110749, South Korea.
   [Yu, Ji-Hee; Lee, Seung-Pyo] Seoul Natl Univ, Dept Oral Anat, Sch Dent, Chongno Ku, Seoul 110749, South Korea.
   [Kim, Hae-Won; Lee, Hae-Hyoung] Sch Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
   [Kim, Hae-Won; Lee, Hae-Hyoung] Sch Dent, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea.
RP Kim, TI (reprint author), Seoul Natl Univ, Dept Periodontol, Dent Res Inst, Sch Dent,Chongno Ku, 28 Yeongon Dong, Seoul 110749, South Korea.
EM periopf@snu.ac.kr
OI KIM, TAE-IL/0000-0003-4087-8021
CR Caffesse RG, 2002, AM J DENT, V15, P339
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Isaka J, 2001, J PERIODONTOL, V72, P314, DOI 10.1902/jop.2001.72.3.314
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   PONTORIERO R, 1995, J CLIN PERIODONTOL, V22, P810, DOI 10.1111/j.1600-051X.1995.tb00265.x
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   WASI S, 1984, CAN J BIOCHEM CELL B, V62, P470, DOI 10.1139/o84-064
   YU HS, IN PRESS J BIOMED MA
NR 15
TC 10
Z9 10
U1 0
U2 0
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2008
VL 116
IS 1349
BP 31
EP 35
DI 10.2109/jcersj2.116.31
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 254ZP
UT WOS:000252626800008
OA Bronze
DA 2018-10-19
ER

PT J
AU Nakamura, A
   Shishido, A
   Kishida, I
   Okada, M
   Furuzono, T
   Yokogawa, Y
AF Nakamura, Atsutomo
   Shishido, Atsumasa
   Kishida, Ippei
   Okada, Masahiro
   Furuzono, Tsutomu
   Yokogawa, Yoshiyuki
TI TEM observation of hydroxyapatite nanocrystals ionically-bonded onto the
   graftpolymer-modified PET substrate
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE hydroxyapatite; composite; biomaterial; interface; transmission electron
   microscopy
ID SILK FIBROIN FIBERS; IMPLANT MATERIAL; COMPOSITE; PARTICLES; CRYSTAL
AB The crystallographic orientation relationship between hydroxyapatite (HAp) nanocrystals and poly (acrylic acid) (PAA) graftpolymer-modified poly (ethylene terephthalate) (PET) substrate was studied using transmission electron microscopy (TEM). We observed the microstructure of fabricated rod-like HAp nanocrystals and the interface of HAp/PET composite where, the HAp nanocrystals are bonded onto PAA graftpolymer-modified PET substrate. The selected-area electron diffraction (SAED) pattern of interface of the HAp/PET composite indicated! that some low index planes in HAp prism plane tended to be contact plane with the PET substrate surface. In particular, the {11 (2) over bar0} plane was distinctly found as the contact plane with PET substrate. In this material, it has been reported that the carboxyl groups of PAA graft-polymer are ionically-bonded with Ca ions on surface of the HAp nanocrystal. It was suggested that the periodic ionic arrangements of the {11 (2) over bar0} plane play an important role on the bonding between the HAp nanocrystals and the carboxyl groups of graft-polymer on the PET substrate.
C1 [Nakamura, Atsutomo; Shishido, Atsumasa; Kishida, Ippei; Okada, Masahiro; Furuzono, Tsutomu; Yokogawa, Yoshiyuki] Osaka City Univ, Grad Sch Mech & Phys Engn, Sumiyoshi Ku, Osaka 5588585, Japan.
   [Okada, Masahiro; Furuzono, Tsutomu] Natl Cardiovasc Ctr, Res Inst, Dept Bioengn, Osaka 5658565, Japan.
RP Nakamura, A (reprint author), Osaka City Univ, Grad Sch Mech & Phys Engn, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
RI Nakamura, Atsutomo/H-3335-2012
OI Nakamura, Atsutomo/0000-0002-4324-1512; Okada,
   Masahiro/0000-0001-9441-3284
CR DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Furuzono T, 2006, ASAIO J, V52, P315, DOI 10.1097/01.mat.0000214860.08820.f9
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Furuzono T, 2003, J BIOMED MATER RES B, V65B, P217, DOI 10.1002/jbm.b.10002
   Furuzono T, 2001, J BIOMED MATER RES, V56, P9, DOI 10.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-2
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Korematsu A, 2005, J MATER SCI-MATER M, V16, P67, DOI 10.1007/s10856-005-6448-y
   LEGEROS RZ, 1965, NATURE, V206, P403, DOI DOI 10.1038/206403A0
   Okada M, 2007, J NANOPART RES, V9, P807, DOI 10.1007/s11051-006-9126-1
   Sato K, 2000, J COLLOID INTERF SCI, V224, P23, DOI 10.1006/jcis.1999.6623
   SATO K, 2001, J COLLOID INTERF SCI, V240, P33
   Suvorova EI, 1999, J MICROSC-OXFORD, V196, P46
NR 15
TC 1
Z9 1
U1 0
U2 12
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2008
VL 116
IS 1349
BP 100
EP 104
DI 10.2109/jcersj2.116.100
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 254ZP
UT WOS:000252626800022
OA Bronze
DA 2018-10-19
ER

PT J
AU Ainslie, KM
   Desai, TA
AF Ainslie, Kristy M.
   Desai, Tejal A.
TI Microfabricated implants for applications in therapeutic delivery,
   tissue engineering, and biosensing
SO LAB ON A CHIP
LA English
DT Review
ID TRANSDERMAL DRUG-DELIVERY; SMOOTH-MUSCLE-CELLS; BIOMATERIAL
   SURFACE-CHEMISTRY; FUNCTIONALIZED POROUS SILICON; NANO-STRUCTURED
   POLYMERS; IN-VITRO; CONTROLLED-RELEASE; POLY(EPSILON-CAPROLACTONE)
   FILMS; POLY(LACTIC-CO-GLYCOLIC ACID); BIOCOMPATIBILITY ASSESSMENT
AB By adapting microfabrication techniques originally developed in the microelectronics industry novel devices for drug delivery, tissue engineering and biosensing have been engineered for in vivo use. Implant microfabrication uses a broad range of techniques including photolithography, and micromachining to create devices with features ranging from 0.1 to hundreds of microns with high aspect ratios and precise features. Microfabrication offers device feature scale that is relevant to the tissues and cells to which they are applied, as well as offering ease of en masse fabrication, small device size, and facile incorporation of integrated circuit technology. Utilizing these methods, drug delivery applications have been developed for in vivo use through many delivery routes including intravenous, oral, and transdermal. Additionally, novel microfabricated tissue engineering approaches propose therapies for the cardiovascular, orthopedic, and ocular systems, among others. Biosensing devices have been designed to detect a variety of analytes and conditions in vivo through both enzymatic-electrochemical reactions and sensor displacement through mechanical loading. Overall, the impact of microfabricated devices has had an impact over a broad range of therapies and tissues. This review addresses many of these devices and highlights their fabrication as well as discusses materials relevant to microfabrication techniques.
C1 [Ainslie, Kristy M.; Desai, Tejal A.] Univ Calif San Francisco, Dept Physiol, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.
RP Desai, TA (reprint author), Univ Calif San Francisco, Dept Physiol, Dept Bioengn & Therapeut Sci, Box 2520,Byers Hall Rm 203C, San Francisco, CA 94158 USA.
EM Tejal.Desai@ucsf.edu
OI Ainslie, Kristy/0000-0002-1820-8382
FU NIBIB NIH HHS [R01 EB002687-03, R01 EB002687]
CR Ahmed A, 2002, J CONTROL RELEASE, V81, P291, DOI 10.1016/S0168-3659(02)00074-3
   Ainslie KM, 2005, NANO LETT, V5, P1852, DOI 10.1021/nl051117u
   Ainslie KM, 2008, LAB CHIP, V8, P1042, DOI 10.1039/b800604k
   Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Amirpour ML, 2001, ANAL CHEM, V73, P1560, DOI 10.1021/ac000907f
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   BALARIN A, 2007, J MOL STRUCT, V834, P465, DOI DOI 10.1016/J.MOLSTRUC.2006.12.010
   BIRD RL, 1988, THROMB RES, V51, P471
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Bosetti M, 2002, J BIOMED MATER RES, V60, P79, DOI 10.1002/jbm.1282
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3
   CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588
   Chambon E, 2005, MICROELECTRON J, V36, P514, DOI 10.1016/j.mejo.2005.02.072
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Chang S, 2003, J VASC SURG, V37, P1082, DOI 10.1067/mva.2003.160
   Chen JK, 1997, IEEE T BIO-MED ENG, V44, P760, DOI 10.1109/10.605435
   Chen SQ, 2004, APPL SURF SCI, V230, P418, DOI 10.1016/j.apsusc.2004.03.203
   Cheney CP, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2400104
   Chow AY, 2001, IEEE T NEUR SYS REH, V9, P86, DOI 10.1109/7333.918281
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Daniel KD, 2007, LAB CHIP, V7, P1288, DOI 10.1039/b705143c
   Dario P, 2000, J MICROMECH MICROENG, V10, P235, DOI 10.1088/0960-1317/10/2/322
   De Stefano L, 2006, BIOSENS BIOELECTRON, V21, P1664, DOI 10.1016/j.bios.2005.08.012
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   Desai TA, 2000, BIOSENS BIOELECTRON, V15, P453, DOI 10.1016/S0956-5663(00)00088-9
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Desai TA, 2004, ADV DRUG DELIVER REV, V56, P1661, DOI 10.1016/j.addr.2003.11.006
   Desai TA, 2002, EXPERT OPIN BIOL TH, V2, P633, DOI 10.1517/14712598.2.6.633
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Eaimtrakarn S, 2001, INT J PHARM, V224, P61, DOI 10.1016/S0378-5173(01)00738-4
   Edquist BT, 2006, ABSTR PAP AM CHEM S, V231
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Fahr A, 2007, EXPERT OPIN DRUG DEL, V4, P403, DOI 10.1517/17425247.4.4.403
   Ferrara LA, 2003, BIOMED MICRODEVICES, V5, P297, DOI 10.1023/A:1027305729456
   Fulmer GR, 2005, ABSTR PAP AM CHEM S, V229, pU514
   Gardner Phyllis, 2006, Expert Opin Drug Deliv, V3, P479, DOI 10.1517/17425247.3.4.479
   Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003
   GRATTON SE, 2007, CONTR REL SOC LONG B
   Grayson ACR, 2005, BIOMATERIALS, V26, P2137, DOI 10.1016/j.biomaterials.2004.06.033
   Hallow DM, 2007, J CONTROL RELEASE, V118, P285, DOI 10.1016/j.jconrel.2006.12.029
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Henry S, 1999, J PHARM SCI, V88, P948
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Hollenberg BA, 2006, J NEUROSCI METH, V153, P147, DOI 10.1016/j.jneumeth.2005.10.016
   Jelinek I, 2005, CHIMIA, V59, P222, DOI 10.2533/000942905777676498
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jiang J, 2007, INVEST OPHTH VIS SCI, V48, P4038, DOI 10.1167/iovs.07-0066
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Coltro WKT, 2007, LAB CHIP, V7, P931, DOI 10.1039/b702931d
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kulkarni SS, 2004, BIOSENS BIOELECTRON, V19, P1401, DOI 10.1016/j.bios.2003.12.020
   La Flamme Kristen E, 2005, Diabetes Technol Ther, V7, P684
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Leoni L, 2004, ADV DRUG DELIVER REV, V56, P211, DOI 10.1016/j.addr.2003.08.014
   Leoni L, 2002, SENSORS, V2, P111, DOI 10.3390/s20300111
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   Leoni L, 2001, IEEE T BIO-MED ENG, V48, P1335, DOI 10.1109/10.959329
   Lesinski GB, 2005, BIOMED MICRODEVICES, V7, P71, DOI 10.1007/s10544-005-6174-8
   Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043
   Lillis B, 2005, BIOSENS BIOELECTRON, V21, P282, DOI 10.1016/j.bios.2004.09.031
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   LOEB GE, 1990, ANNU REV NEUROSCI, V13, P357, DOI 10.1146/annurev.neuro.13.1.357
   Lopez CA, 2006, BIOMATERIALS, V27, P3075, DOI 10.1016/j.biomaterials.2005.12.017
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002
   Ma B, 2006, MICROFLUID NANOFLUID, V2, P417, DOI 10.1007/s10404-006-0083-x
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Madou MJ, 2002, FUNDAMENTALS MICROFA, P723
   Martin F, 2005, J CONTROL RELEASE, V102, P123, DOI 10.1016/j.jconrel.2004.09.024
   Mata A, 2007, INT J NANOMED, V2, P389
   Maynard EM, 2001, ANNU REV BIOMED ENG, V3, P145, DOI 10.1146/annurev.bioeng.3.1.145
   McAllister DV, 2000, ANNU REV BIOMED ENG, V2, P289, DOI 10.1146/annurev.bioeng.2.1.289
   McAllister DV, 2003, P NATL ACAD SCI USA, V100, P13755, DOI 10.1073/pnas.2331316100
   MENDELSOHN A, INORGANIC NANOPOROUS
   MENZ W, 1994, MINIM INVAS NEUROSUR, V37, P21, DOI 10.1055/s-2008-1053444
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mokwa W, 2007, MEAS SCI TECHNOL, V18, pR47, DOI 10.1088/0957-0233/18/5/R01
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Motlagh D, 2003, J BIOMED MATER RES A, V67A, P148, DOI 10.1002/jbm.a.10083
   Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0
   Motlagh D, 2002, J MOL CELL CARDIOL, V34, pA32, DOI 10.1016/S0022-2828(02)90184-7
   Mustata G, 2006, CRIT REV THER DRUG, V23, P111, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i2.20
   Nagarajan S, 2008, CHEM MATER, V20, P604, DOI 10.1021/cm702397b
   Natarajan B, 2006, SURF REV LETT, V13, P351, DOI 10.1142/S0218625X0600830X
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Norman JJ, 2005, TISSUE ENG, V11, P378, DOI 10.1089/ten.2005.11.378
   NORMAN JJ, 2007, TISSUE ENG
   OGURA E, 1991, IEEE T BIO-MED ENG, V38, P721, DOI 10.1109/10.83583
   Oh SJ, 2006, IEEE T BIO-MED ENG, V53, P351, DOI 10.1109/TBME.2005.862568
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   PANUSH RS, 1981, J CLIN LAB IMMUNOL, V5, P113
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Park IY, 2007, BIOSENS BIOELECTRON, V22, P2065, DOI 10.1016/j.bios.2006.09.017
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103
   Peng KQ, 2006, ADV FUNCT MATER, V16, P387, DOI 10.1002/adfm.200500392
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Polla DL, 2000, ANNU REV BIOMED ENG, V2, P551, DOI 10.1146/annurev.bioeng.2.1.551
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Pope-Harman A, 2007, MED CLIN N AM, V91, P899, DOI 10.1016/j.mcna.2007.05.008
   Razzacki SZ, 2004, ADV DRUG DELIVER REV, V56, P185, DOI 10.1016/j.addr.2003.08.012
   Receveur RAM, 2007, J MICROMECH MICROENG, V17, pR50, DOI 10.1088/0960-1317/17/5/R02
   Reddy RRK, 2001, BIOSENS BIOELECTRON, V16, P313, DOI 10.1016/S0956-5663(01)00129-4
   Reed ML, 1998, J PHARM SCI-US, V87, P1387, DOI 10.1021/js980085q
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427
   Ryu WH, 2007, BIOMED MICRODEVICES, V9, P845, DOI 10.1007/s10544-007-9097-8
   Ryu WH, 2007, J CONTROL RELEASE, V124, P98, DOI 10.1016/j.jconrel.2007.08.024
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Santiesteban FMM, 2006, IEEE T BIO-MED ENG, V53, P547, DOI 10.1109/TBME.2005.864497
   Santini JT, 1999, NATURE, V397, P335
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Schurr MO, 2007, MINIM INVASIV THER, V16, P75, DOI 10.1080/13645700701266909
   Seo HK, 2007, IEEE SENS J, V7, P945, DOI 10.1109/JSEN.2007.895972
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sharma S, 2005, J NANOSCI NANOTECHNO, V5, P235, DOI 10.1166/jnn.2005.030
   Smith LJ, 2007, INT J NANOMED, V2, P493
   Smith LL, 2007, INT J NANOMED, V2, P383
   Snyder JD, 2001, J BIOMAT SCI-POLYM E, V12, P921, DOI 10.1163/156856201753113105
   STAPLES M, 2006, PHARM RES
   Steeves CA, 2007, J MATER SCI-MATER M, V18, P25, DOI 10.1007/s10856-006-0659-8
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tan W, 2003, BIOMED MICRODEVICES, V5, P235, DOI 10.1023/A:1025764310391
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Tao SL, 2006, NAT PROTOC, V1, P3153, DOI 10.1038/nprot.2006.451
   Tao SL, 2005, J CONTROL RELEASE, V109, P127, DOI 10.1016/j.jconrel.2005.09.019
   Tao SL, 2005, DRUG DISCOV TODAY, V10, P909, DOI 10.1016/S1359-6446(05)03489-6
   Tao SL, 2005, ADV MATER, V17, P1625, DOI 10.1002/adma.200500017
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Tao SL, 2003, J BIOMED MATER RES A, V67A, P369, DOI 10.1002/jbm.a.10047
   Tao SL, 2003, J CONTROL RELEASE, V88, P215, DOI 10.1016/S0168-3659(03)00005-1
   Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P585
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Thornberry DR, 2005, ABSTR PAP AM CHEM S, V229, pU679
   Tsai NC, 2007, SENSOR ACTUAT A-PHYS, V134, P555, DOI 10.1016/j.sna.2006.06.014
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Vora KD, 2007, MICROSYST TECHNOL, V13, P487, DOI 10.1007/s00542-006-0201-4
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wallrabe U, 1998, INT J ARTIF ORGANS, V21, P137
   Wang YL, 2006, LANGMUIR, V22, P2719, DOI 10.1021/la053188e
   Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435
   Weis RP, 2002, DIS MARKERS, V18, P159, DOI 10.1155/2002/727014
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Whitaker TC, 2006, APPLYING EQUINE SCIENCE: RESEARCH INTO BUSINESS, P231
   Wilk SJ, 2007, BIOSENS BIOELECTRON, V23, P183, DOI 10.1016/j.bios.2007.03.030
   Wilson BS, 2003, ANNU REV BIOMED ENG, V5, P207, DOI 10.1146/annurev.bioeng.5.040202.121645
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129
NR 170
TC 64
Z9 66
U1 3
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2008
VL 8
IS 11
BP 1864
EP 1878
DI 10.1039/b806446f
PG 15
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 383PS
UT WOS:000261686100020
PM 18941687
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Yang, YQ
   Huang, YL
   Wu, WH
AF Yang, Yongqiang
   Huang, Yanlu
   Wu, Weihui
BE Deng, SS
   Matsunawa, A
   Zhur, X
TI One-step shaping of NiTi biomaterial by selective laser melting
SO LASERS IN MATERIAL PROCESSING AND MANUFACTURING III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Material Processing and Manufacturing III
CY NOV 12-14, 2007
CL Beijing, PEOPLES R CHINA
SP SPIE, Chinese Opt Soc
DE selective laser melting; NiTi alloy; microstructure; artificial implant
ID MEMORY ALLOY
AB NiTi alloy has excellent biocompatibility. This paper presents a novel technology of direct shaping of this promising biomaterial with selective laser melting (SLM). The frequently encountered defects of the SLM metal alloy parts such as non-fully melting, thermal deformation and balling were analyzed theoretically and experimentally, and the microstructure of the parts was analyzed on microscope. The results show that an appropriate selection of laser mode and scanning strategy assures a satisfying quality of the final parts; they also reveal that the SLM technology can be expected as a potential technology to directly manufacture the artificial implant of NiTi alloys.
C1 [Yang, Yongqiang; Huang, Yanlu; Wu, Weihui] S China Univ Technol, Sch Mech Engn, Guangzhou 510641, Peoples R China.
RP Yang, YQ (reprint author), S China Univ Technol, Sch Mech Engn, Guangzhou 510641, Peoples R China.
EM meyqyang@scut.edu.cn
CR ABE F, 2003, MECH ENG SCI, V217, P119
   [程艳阶 Cheng Yanjie], 2004, [机械科学与技术, Mechanical Science and Technology], V23, P1072
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   *FLEX MAN, FLEX MAN MET PROD SE
   GIL FJ, 1998, J BIOMECH, V31, P135
   KRUTH JP, 2004, J MATER PROCESS TECH, V616, P149
   LU K, 2000, MAT RES B, V1555, P35
   Man HC, 2001, SCRIPTA MATER, V45, P1447, DOI 10.1016/S1359-6462(01)01182-4
   Man HC, 2002, J LASER APPL, V14, P242, DOI 10.2351/1.1514236
   NIKOLAY K, 2004, RAPID PROTOTYPING J, V10, P78
   REHME O, 2008, P 3 INT WLT C LAS MA, P1
   SIMSKE SJ, 1994, P 1 INT C SHAP MEM S, P449
   WANG CL, 2007, PROCESS STUDY SELECT
   WEVER DJ, 1997, BIOMATERIALS, P1120
   ZHAO JF, 2003, CHINESE J LASERS, V1130, P30
NR 15
TC 2
Z9 2
U1 3
U2 23
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7000-3
J9 P SOC PHOTO-OPT INS
PY 2008
VL 6825
AR 68250C
DI 10.1117/12.757753
PG 7
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Optics; Physics, Applied
SC Engineering; Materials Science; Optics; Physics
GA BHL77
UT WOS:000254149500011
DA 2018-10-19
ER

PT S
AU Shimada, J
   Kato, D
   Terauchi, K
   Itoh, K
   Yanada, M
   Shimomura, M
   Tsuneduka, H
   Kawakami, Y
AF Shimada, Jun-ichi
   Kato, Daishiro
   Terauchi, Kunihiko
   Itoh, Kazuhiro
   Yanada, Masashi
   Shimomura, Masanori
   Tsuneduka, Hiroaki
   Kawakami, Yoichi
BE Streubel, KP
   Jean, H
TI Surgical retractor with RGB-WHITE LEDs
SO LIGHT-EMITTING DIODES: RESEARCH, MANUFACTURING, AND APPLICATIONS XII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 12th Conference on Light-Emitting Diodes - Research, Manufacturing, and
   Applications XI
CY JAN 22-24, 2008
CL San Jose, CA
SP SPIE
DE RGB LED module; medical lighting; VATS lobectomy; lymph node dissection;
   visual performance
AB Sufficient lighting is sometimes required when surgeons watch the mediastinum through the 7x7cm thoracic window in video-assisted thoracoscopic (VATS) lobectomy. It is thus important to develop the "ultimately localized solid-state-lighting" because the distance between the window and the surface of the lung is as short as 4-5 cm. Our new idea was to place the module composed of red, green and blue light emitting diodes (RGB LEDs) at the tip of the retractor. Compared to a conventional endoscopic lighting consisting of halogen lamp, this method has lead to the bright and shadowless illumination within the entire thoracic cavity since the white RGB LEDs are emitted unidirectionally from the cylinder-shaped camera component, moving the shadows from the surgical instruments to the side of the incision. It also should be noted that we found an effective principle for controlling the color rendering of each biomaterial through the synthesis of LED lighting spectra, by which the visual performance of surgeons can be coordinated. Therefore, we believe that "medical RGB LEDs" will contribute to the safe operation, and will be developed to a standard lighting system in clinical settings with bright surgical fields in the near future.
C1 [Shimada, Jun-ichi; Kato, Daishiro; Terauchi, Kunihiko; Itoh, Kazuhiro; Yanada, Masashi; Shimomura, Masanori; Tsuneduka, Hiroaki] Kyoto Prefectural Univ Med, Dept Thorac Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto, Japan.
   [Kawakami, Yoichi] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto, Japan.
RP Shimada, J (reprint author), Kyoto Prefectural Univ Med, Dept Thorac Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto, Japan.
FU Ministry of Education, Culture, Sports, Science and Technology; Nichia
   Chemical Industries Co. Ltd. (Anan, Japan);  [19591639]
FX We acknowledge the financial support of the grant of Creation and
   support Program for Grant-in-Aid for Scientific Research (C) (No.
   19591639) and Start-ups from Universities from the Ministry of
   Education, Culture, Sports, Science and Technology. This research
   received generous support from Nichia Chemical Industries Co. Ltd.
   (Anan, Japan) for special made R, G, B, LED chips.
CR KAWAKAMI Y, P SPIE, V4445, P71103
   SHIMADA J, 2003, P SPIE, V4996, P71103
   SHIMADA J, 2001, P SPIE, V4278, P71103
   SHIMADA JI, 2005, P SPIE, P71103
   SHIMADA Y, P SPIE, V4445, P71103
NR 5
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7085-0
J9 PROC SPIE
PY 2008
VL 6910
AR UNSP 69100T
DI 10.1117/12.761979
PG 9
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BHN18
UT WOS:000254451900014
DA 2018-10-19
ER

PT J
AU Shisatskaya, EI
AF Shisatskaya, Ekaterina I.
TI Biomedical investigations of biodegradable PHAs
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 4th European Symposium on Biopolymers
CY OCT 02-04, 2007
CL Kusadasi, TURKEY
DE biodegradable polymers; PHA; biomedical investigations
ID IN-VITRO; POLYHYDROXYALKANOATES; BIOMATERIAL; POLYESTERS; PHB
AB This work is a review of the results of biomedical studies of polymer devices (films, fibers, microparticles, 3D implants) made from resorbable PHAs synthesized by the bacterium Wautersia (Ralstonia) eutropha B5786, using the technology developed at the institute of Biophysics of the Siberian Branch of the Russian Academy of Sciences. Two types of PHAs - polyhydroxybutyrate (PHB) and a hydroxybutyrate/hydroxyvalerate copolymer (PHB/PHV) - have been proven to be biocompatible in vitro in cultures of fibroblasts, endothelial cells, hepatocytes, and osteoblasts, and in short- and long-duration experiments on animals. Polymer films and membranes have been found to be usable as scaffolds for functioning cells and monofilament suture fibers-for stitching muscular-fascial wounds and in abdominal surgery. Ectopic bone formation assay and experiments with the model of segmental osteotomy showed that 3D PHB and PHB/HA implants can be used for reparative osteogenesis. The paper reports beneficial results of using polymers to repair bone defects in oral surgery.
C1 [Shisatskaya, Ekaterina I.] Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk 660036, Russia.
   [Shisatskaya, Ekaterina I.] Siberian Fed Univ, Krasnoyarsk 660148, Russia.
RP Shisatskaya, EI (reprint author), Russian Acad Sci, Inst Biophys, Siberian Branch, Akad Gorodok 50, Krasnoyarsk 660036, Russia.
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   [Anonymous], 109931 ISO
   ASRAR J, 2002, BIOPOLYMERS, P55
   EGOR, 2003, MACROMOLECULAR APPRO, V15
   FREIER T, 1994, MICROBIOLOGY, V63, P78
   GOVORUKHINA N I, 1991, Prikladnaya Biokhimiya i Mikrobiologiya, V27, P98
   Hasirci V, 2006, J BIOMAT SCI-POLYM E, V17, P1241, DOI 10.1163/156856206778667442
   HASIRCI V, 2000, BIOMATERIALS BIOENGI, P141
   KAMENDOV IV, 2007, NEW TECHNOLOGIES PRE, V53
   KAMENDOV IV, 1913, BICOMPATIBLE MAT SHA, V13
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   Kozlovskii A. G., 1999, Mikrobiologiya, V68, P340
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   *RF STAT STAND, 2000, ASSESSMENT
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   SEVASTIANOV VI, 2001, ADV MATER, V5, P47
   [Шишацкая Е.И Shishatskaya E.I.], 2007, [Клеточная трансплантология и тканевая инженерия, Cellular Transplantaition and Tissue Engineering, Kletochnaya transplantologiya i tkanevaya inzheneriya], V2, P68
   Shishatskaya EI, 2006, J BIOMAT SCI-POLYM E, V17, P481, DOI 10.1163/156856206776986242
   Shishatskaya EI, 2005, J BIOMAT SCI-POLYM E, V16, P643, DOI 10.1163/1568562053783678
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   SHISHATSKAYA EI, 2007, BIOTECHNOLOGY, V131, P50
   SHISHATSKAYA EI, 2006, J MAT SCI MAT MED
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   Volova T, 2003, BIOCHEM ENG J, V16, P125, DOI 10.1016/S1369-703X(03)00038-X
   Volova TG, 2007, MICROBIOLOGY+, V76, P704, DOI 10.1134/S0026261707060082
   VOLOVA T G, 1992, Prikladnaya Biokhimiya i Mikrobiologiya, V28, P221
   Volova T. G., 2004, MICROBIAL POLYHYDROX
   VOLOVA TG, 2005, ADV MATER, V3, P50
   VOLOVA TG, 2006, BIOTECHNOLOGY, V6, P28
   VOLOVA TG, 1996, Patent No. 2051967
   VOLOVA TG, 2003, Patent No. 2207375
   VOLOVA TG, 2006, ADV MATER, V3, P2
   VOLOVA TG, 2006, POLYHYDROXYALKANOATE, P280
   Williams S.F., 2002, BIOPOLYMERS, P91
   1950, RUSSIAN
   1996, GUIDE CARE USE LAB A
   2001, AVIATSIONNAYA EKOLOG, V35, P14
   GUIDELINES CARE USE
NR 40
TC 12
Z9 16
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2008
VL 269
BP 65
EP 81
DI 10.1002/masy.200850909
PG 17
WC Polymer Science
SC Polymer Science
GA 344EM
UT WOS:000258909100010
DA 2018-10-19
ER

PT J
AU Ozcan, C
   Zorlutuna, P
   Hasirci, V
   Hasirci, N
AF Ozcan, Canturk
   Zorlutuna, Pinar
   Hasirci, Vasif
   Hasirci, Nesrin
TI Influence of oxygen plasma modification on surface free energy of PMMA
   films and cell attachment
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 4th European Symposium on Biopolymers
CY OCT 02-04, 2007
CL Kusadasi, TURKEY
DE contact angle; modification; PMMA; surface free energy; surfaces
ID GLOW-DISCHARGE; POLYMERIZATION; POLYPROPYLENE; WETTABILITY; POLYMERS; AR
AB For any biomaterial placed into a biological medium, the surface properties of the material, such as porosity, crystallinity, presence and distribution of electrical charge and functional groups are very critical parameters that determine the acceptance or rejection of the material. Applications, especially tissue engineering require some surface modifications at the molecular level without disturbing the bulk properties of the implants in order to enhance the cell attachment on the material. An appropriate technique is the application of glow discharge plasma which employs no solvents, takes place at ambient temperatures, and alterations take place only at the surface by changing the surface chemistry along with surface free energy (SFE) and efficiency for cell-material interaction. In this study, poly(methyl methacrylate) (PMMA) film surfaces were modified with oxygen plasma. SFE and its dispersive and polar (acidic-basic) components of the modified surfaces were calculated by means of several theoretical approaches including geometric mean, harmonic mean and acid-base equations. The relation between SFE and its dispersive and polar components and cell attachment on surfaces were studied. The highest 3T3 cell attachment was obtained for the surface with the total SFE of 61.77 mJ/m(2) and polar component of 50.91 mJ/m(2) according to Geometric mean. The total SFE of this surface was calculated to be 61.06 mJ/m(2) and the polar component as 40.96 mJ/m(2) using the Harmonic mean method.
C1 [Ozcan, Canturk; Hasirci, Nesrin] Middle E Tech Univ, Dept Chem, BIOMAT, TR-06531 Ankara, Turkey.
   [Zorlutuna, Pinar; Hasirci, Vasif; Hasirci, Nesrin] Middle E Tech Univ, Grad Dept Biotechnol, BIOMAT, TR-06531 Ankara, Turkey.
   [Hasirci, Vasif] Middle E Tech Univ, Dept Biol Sci, BIOMAT, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   [Hasirci, Vasif; Hasirci, Nesrin] Middle E Tech Univ, Grad Dept Biomed Engn, BIOMAT, TR-06531 Ankara, Turkey.
RP Hasirci, N (reprint author), Middle E Tech Univ, Dept Chem, BIOMAT, TR-06531 Ankara, Turkey.
RI Zorlutuna, Pinar/A-7208-2015
OI Zorlutuna, Pinar/0000-0002-3122-7553; HASIRCI,
   Nesrin/0000-0002-4497-0194
CR AKOVALI G, 1984, J APPL POLYM SCI, V29, P2617, DOI 10.1002/app.1984.070290816
   CANTIN S, 2005, COLLOID SURFACE A, V276, P107
   Chai JN, 2004, LANGMUIR, V20, P10919, DOI 10.1021/la048947s
   Choi HS, 2006, SURF COAT TECH, V200, P4479, DOI 10.1016/j.surfcoat.2005.03.037
   Combe EC, 2004, DENT MATER, V20, P262, DOI 10.1016/S0109-5641(03)00102-7
   Della Volpe C, 2004, J COLLOID INTERF SCI, V271, P434, DOI 10.1016/j.jcis.2003.09.049
   Duca MD, 1998, POLYM DEGRAD STABIL, V61, P65, DOI 10.1016/S0141-3910(97)00130-4
   Kwon OJ, 2006, J COLLOID INTERF SCI, V295, P409, DOI 10.1016/j.jcis.2005.11.007
   Lin YS, 2006, SURF COAT TECH, V200, P3355, DOI 10.1016/j.surfcoat.2005.07.052
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Ozcan C, 2007, J BIOMAT SCI-POLYM E, V18, P759, DOI 10.1163/156856207781034124
   Ozdemir Y, 2002, J MATER SCI-MATER M, V13, P1147, DOI 10.1023/A:1021185803716
   Park SJ, 2001, J COLLOID INTERF SCI, V244, P336, DOI 10.1006/jcis.2001.7920
   Said A, 1997, COLLOID SURFACE B, V8, P227, DOI 10.1016/S0927-7765(96)01326-4
   Schulz U, 2001, SURF COAT TECH, V142, P507, DOI 10.1016/S0257-8972(01)01202-6
   Shimizu RN, 2000, J APPL POLYM SCI, V76, P1831, DOI 10.1002/(SICI)1097-4628(20000620)76:12<1831::AID-APP14>3.0.CO;2-Q
   Siboni S, 2004, J COLLOID INTERF SCI, V271, P454, DOI 10.1016/j.jcis.2003.09.050
   Sidouni FZ, 2001, SURF SCI, V491, P355, DOI 10.1016/S0039-6028(01)01299-7
   ULUBAYRAM K, 1993, COLLOID SURFACE B, V1, P261
   You ZZ, 2006, J COLLOID INTERF SCI, V300, P697, DOI 10.1016/j.jcis.2006.04.014
NR 20
TC 20
Z9 21
U1 2
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2008
VL 269
BP 128
EP 137
DI 10.1002/masy.200850916
PG 10
WC Polymer Science
SC Polymer Science
GA 344EM
UT WOS:000258909100017
DA 2018-10-19
ER

PT J
AU Fatimi, A
   Axelos, MAV
   Tassin, JF
   Weiss, P
AF Fatimi, Ahmed
   Axelos, Monique A. V.
   Tassin, Jean Francois
   Weiss, Pierre
TI Rheological characterization of self-hardening hydrogel for tissue
   engineering applications: Gel point determination and viscoelastic
   properties
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Congress on Biohydrogels
CY NOV 14-18, 2007
CL Vlareggio, ITALY
DE biomaterials; cellulose; gelation; hydrogels; rheology
ID HYDROXYPROPYL METHYLCELLULOSE; COMPOSITE; BONE
AB Silated hydroxypropylmethylcellulose (Si-HPMC) is a modified biopolymer used in biomaterial's domain. A hydroxypropylmethylcellulose (HPMC) was functionalised with silane groups. The macromolecular solution of Si-HPMC (pH 12.9) generates an elastic state at physiological pH (similar to 7.4). in this work we present the gel formation of Si-HPMC resulting from the condensation of silanol groups. The crosslinked hydrogel was characterized using rheological techniques. With the scalar percolation model the gelation time was determined as a function of Si-HPMC concentration at 37 degrees C.
C1 [Fatimi, Ahmed; Weiss, Pierre] Univ Nantes, INSERM, U791, Lab Ingn Osteo Articulaire & Dent, F-44042 Nantes 01, France.
   [Axelos, Monique A. V.] INRA, UR1268, F-44316 Nantes, France.
   [Tassin, Jean Francois] Univ Maine, CNRS, UMR Polymeres Colloides Interfaces 6120, F-72085 Le Mans 9, France.
RP Fatimi, A (reprint author), Univ Nantes, INSERM, U791, Lab Ingn Osteo Articulaire & Dent, 1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Weiss, Pierre/P-1372-2014; Fatimi, Ahmed/F-2936-2012
OI Weiss, Pierre/0000-0002-6159-8590; 
CR Audebrand M, 2006, BIOMACROMOLECULES, V7, P2811, DOI 10.1021/bm060297e
   AXELOS MAV, 1990, PHYS REV LETT, V64, P1457, DOI 10.1103/PhysRevLett.64.1457
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   CLARK AH, 1987, ADV POLYM SCI, V83, P57
   Coffey Donald G., 1995, V67, P123
   Desbrieres J, 2000, POLYMER, V41, P2451, DOI 10.1016/S0032-3861(99)00413-9
   FATIMI A, BIOMATERIAL IN PRESS
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   WEISS P, 2004, KEY ENG MATER, P254
NR 11
TC 8
Z9 8
U1 0
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2008
VL 266
BP 12
EP 16
DI 10.1002/masy.200850603
PG 5
WC Polymer Science
SC Polymer Science
GA 325AS
UT WOS:000257561100004
DA 2018-10-19
ER

PT J
AU Pasqui, D
   Danieli, E
   Leone, G
   Torricelli, P
   Barbucci, R
AF Pasqui, Daniela
   Danieli, Elisa
   Leone, Gemma
   Torricelli, Paola
   Barbucci, Rolando
TI A new phosphorylated polysaccharide for biomedical applications:
   Generation of 3D scaffolds with osteogenic activity and coating of
   titanium oxide surfaces
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Congress on Biohydrogels
CY NOV 14-18, 2007
CL Vlareggio, ITALY
DE 3D scaffolds; biomedical applications; osteogenic activity
ID SELF-ASSEMBLED MONOLAYERS; IMPLANTS
AB A new phosphorylated derivative of carboxymethylcellulose and amidic carboxymethylcellulose containing one phosphate group for each disaccharide unit was synthesized using sodium trimetaphospahte (STMP) as the phosphating agent. The new polysaccharide was characterized by infrared spectroscopy (FT-IR) and the amount of phosphate groups was determined by elemental analysis. These modified polysaccharides were used both to prepare 3D scaffolds and functionalize titanium oxide surfaces with the aim to improve the osseointegration with the host tissue. The presence of phosphate groups modify the physical-chemical properties of the hydrogels with respect to the native ones. The evaluation of the bioactivity of the phosphorylated carboxymethylcellulose hydrogels towards osteoblast-like cells showed a significant increase in the osteocalcin production. The modified surfaces were chemically characterized by means of X-ray photoelectron spectroscopy (XPS) and FT-IR, whereas the surface topography was analysed by Atomic Force Measurements (AFM) measurements before and after the polysaccharide coating. In vitro biological tests using osteoblast-like cells demonstrated that phosphorylated carboxymethylcellulose functionalized TiO2 surfaces promoted better cell adhesion and significantly enhanced their proliferation. These findings suggest that the phosphate polysaccharide both as a 3D scaffold and as a surface coating promotes osteoblast growth potentially improving the biomaterial osseointegration rate.
C1 [Pasqui, Daniela; Leone, Gemma; Barbucci, Rolando] Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
   [Pasqui, Daniela; Leone, Gemma; Barbucci, Rolando] Univ Siena, CRISMA, I-53100 Siena, Italy.
   [Danieli, Elisa; Barbucci, Rolando] BioSuMa Srl, Siena, Italy.
   [Torricelli, Paola] Rizzoli Ortopead Inst, Dept Expt Surg, Res Inst Codivilla Putti, Bologna, Italy.
RP Pasqui, D (reprint author), Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RI TORRICELLI, PAOLA/J-5298-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970
CR Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   Cacciafesta P, 2002, CHEM MATER, V14, P777, DOI 10.1021/cm0112183
   Chiesa R, 2007, ORAL SURG ORAL MED O, V103, P745, DOI 10.1016/j.tripleo.2006.09.025
   Conforto E, 2004, MAT SCI ENG C-BIO S, V24, P611, DOI 10.1016/j.msec.2004.08.004
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Lack S, 2007, CARBOHYD RES, V342, P943, DOI 10.1016/j.carres.2007.01.011
   PASQUI D, BIOMAMACRO IN PRESS
   Ratner B. D., 2001, TITANIUM MED, P2
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Thomas TR., 1982, ROUGH SURFACES
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   VACANTI P, 1999, LANCET, V354, P32
NR 12
TC 0
Z9 0
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2008
VL 266
BP 23
EP 29
DI 10.1002/masy.200850605
PG 7
WC Polymer Science
SC Polymer Science
GA 325AS
UT WOS:000257561100006
DA 2018-10-19
ER

PT J
AU Weiss, P
   Vinatier, C
   Sohier, J
   Fatimi, A
   Layrolle, P
   Demais, V
   Atmani, H
   Basle, MF
   Guicheux, J
AF Weiss, Pierre
   Vinatier, Claire
   Sohier, Jerome
   Fatimi, Ahmed
   Layrolle, Pierre
   Demais, Valerie
   Atmani, Hassan
   Basle, Michel-Felix
   Guicheux, Jerome
TI Self-hardening hydrogel for bone tissue engineering
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Congress on Biohydrogels
CY NOV 14-18, 2007
CL Vlareggio, ITALY
DE biomaterials; cellulose; hydrogels; tissue engineering
ID HYDROXYPROPYL METHYLCELLULOSE HYDROGEL; CALCIUM-PHOSPHATE BIOMATERIAL;
   GENERAL-PROPERTIES; STROMAL CELLS; CHONDROCYTES; INGROWTH; REPAIR;
   MARROW
AB We have developed a self-reticulating polymer based on silanized hydroxypropylmethylcellulose (Si-HPMC). The aim of this study was to determine whether this Si-HPMC hydrogel with or without calcium phosphate granules could represent a potential scaffold for bone tissue engineering.
   This study showed that Si-HPMC hydrogel didn't affect SaOS-2 and rat bone marrow cells viability. in addition, SaOS-2 cells are able to proliferate within Si-HPMC hydrogel containing or not calcium phosphate granules whereas Rat bone marrow cells proliferate only at the surface of calcium phosphate granules contained within Si-HPMC hydrogel. Finally, SaOS-2 cells seeded at the surface of reticulated Si-HPMC were not able to penetrate the hydrogel, while J774, a macrophage cells line, were able to move into the Si-HPMC hydrogel. These data indicate that Si-HPMC is a promissing scaffold for tissue engineering.
C1 [Weiss, Pierre; Vinatier, Claire; Sohier, Jerome; Fatimi, Ahmed; Layrolle, Pierre; Demais, Valerie; Guicheux, Jerome] Univ Nantes, INSERM, U791, Lab Ingn Osteo Articulaire & Dent, F-44042 Nantes 01, France.
   [Atmani, Hassan; Basle, Michel-Felix] Univ Angers, INSERM, EMI 0335, LHEA,Fac Med, F-49045 Nantes, France.
RP Weiss, P (reprint author), Univ Nantes, INSERM, U791, Lab Ingn Osteo Articulaire & Dent, 1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Fatimi, Ahmed/F-2936-2012; Weiss, Pierre/P-1372-2014; Vinatier,
   Claire/P-1686-2014; Layrolle, Pierre/K-9257-2015; guicheux,
   Jerome/F-7767-2013; Sohier, Jerome/O-1923-2017
OI Weiss, Pierre/0000-0002-6159-8590; Vinatier, Claire/0000-0002-6063-9901;
   Layrolle, Pierre/0000-0001-9800-5210; guicheux,
   Jerome/0000-0003-2754-3024; 
CR Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   FATIMI A, BIOMATERIAL IN PRESS
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Vinatier C, 2006, BIOMED MAT ENG, V16, P107
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
NR 14
TC 3
Z9 3
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2008
VL 266
BP 30
EP 35
DI 10.1002/masy.200850606
PG 6
WC Polymer Science
SC Polymer Science
GA 325AS
UT WOS:000257561100007
DA 2018-10-19
ER

PT S
AU Guan, SK
   Peng, L
   Wen, CL
   Luo, Q
AF Guan, Shaokang
   Peng, Li
   Wen, Cuilian
   Luo, Qun
BE Pekguleryuz, MO
   Neelameggham, NR
   Beals, RS
   Nyberg, EA
TI Electrochemical fabrication and biocompatibility of the hydroxyapatite
   coating on magnesium alloy for implanted applications
SO MAGNESIUM TECHNOLOGY 2008
SE Magnesium Technology Series
LA English
DT Proceedings Paper
CT Magnesium Technology Symposium 2008
CY MAR 09-13, 2008
CL New Orleans, LA
SP Minerals, Met & Mat Soc, Magnesium Comm, Light Met Div
DE magnesium alloy; hydroxyapatite; biocompatibility; corrosion;
   resistance; implanted
ID BONE; DEFICIENCY; CORROSION; TITANIUM; ADHESION
AB Magnesium alloy is a potential implant material due toits high load bearing, good biocompatibility and biodegradable properties. But the use as a biomaterial is limited due to its poor corrosion resistance. In this paper, hydroxyapatite (HAP) coating was fabricated on magnesium alloy substrate by cathodic electro-deposition method to improve the corrosion resistance and biocompatibility. XRD, EDS and SEM were used to investigate the structure, composition and morphology of the coating. The result showed that the post-treated coating was composed of needle-like hydroxyapatite, containing Na, Mg, C, Ca, P elements, and can be called chemically similar to bone. The biocompatibility of the coating was investigated by in vitro test. There were obvious Ca-P-Mg depositions on the coating, which can inhibit the further corrosion of magnesium alloy. From the results of this study, there is a strong rationale that needle-like HAP can be coated on magnesium and it can improve the biocompatibility of magnesium alloy effectively.
C1 [Guan, Shaokang; Peng, Li; Wen, Cuilian; Luo, Qun] Zhengzhou Univ, Sch Mat Sci & Engn, Zhengzhou 450002, Peoples R China.
RP Guan, SK (reprint author), Zhengzhou Univ, Sch Mat Sci & Engn, Zhengzhou 450002, Peoples R China.
CR CHANG CS, 1983, J ORAL MAXILLOFAC SU, V47, P729
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   EVANS GP, 1990, J MATER SCI-MATER M, V1, P38, DOI 10.1007/BF00705352
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Percival M., 1999, APPL NUTR SCI REP, V5, P1
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   REVELL PA, 1954, KEY ENG MATER, P254
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 21
TC 2
Z9 3
U1 0
U2 6
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
SN 1545-4150
BN 978-0-87339-711-7
J9 MAGNESIUM TECHNOLOGY
PY 2008
BP 367
EP 371
PG 5
WC Metallurgy & Metallurgical Engineering; Materials Science,
   Characterization & Testing; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHR19
UT WOS:000255592000066
DA 2018-10-19
ER

PT J
AU Jalota, S
   Bhaduri, SB
   Tas, AC
AF Jalota, Sahil
   Bhaduri, Sarit B.
   Tas, A. Cuneyt
TI Using a synthetic body-fluid (SBF) solution of 27 mM HCO3- to make bone
   substitutes more osteointegrative
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE bone substitute; calcium phosphate; biomaterial; synthesis; body fluid;
   biomimetic
ID CALCIUM HYDROXYAPATITE WHISKERS; DIAMETRAL TENSILE-STRENGTH; SULFATE
   DIHYDRATE MIXTURES; ALPHA-TRICALCIUM PHOSPHATE; IN-VITRO; PHYSIOLOGICAL
   SOLUTION; COMPRESSIVE STRENGTH; BIOMIMETIC PROCESS; TITANIUM SURFACES;
   COLLAGEN MOLECULE
AB A Tris-HCl-buffered synthetic body fluid (SBF) solution, mimicking the human blood plasma, with the following ion concentrations of 27 mM HCO3- 2.5 mM Ca2+, 1.0 mM HPO42-, 142 mM Na+, 125 mM Cl-, 5 mM K+, 1.5 mM Mg2+ and 0.5 mM SO42- was used as an aqueous medium to process a number of bone substitute materials under the so-called biomimetic conditions of 37 degrees C and pH 7.4. This solution was named as Tris-SBF-27 mM. Firstly, collagen sponges were soaked in Tris-SBF-27 mM solution at 37 degrees C and were found to be fully covered with nanoporous apatitic calcium phosphate (Ap-CaP). The composites of collagen-Ap-CaP biomaterials are expected to be used in orthopedic and dental surgery. Secondly, Ap-CaP short whiskers or microrods with a novel nanotexture and surface areas higher than 45 m(2)/g were synthesized in Tris-SBF-27 mM solution. Thirdly, calcium sulfate cements doped with CaHPO4 (monetite), were shown to have apatite-inducing ability upon ageing in Tris-SBF-27 mM. CaHPO4 addition in calcium sulfate was found to improve its mechanical strength, measured after cement setting reaction. Pure calcium sulfate cement pellets were not stable in Tris-SBF-27 mM solutions and crumbled into a powder. All the samples were characterized by SEM, XRD, FTIR, surface area and mechanical strength measurements. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Tas, A. Cuneyt] Yeditepe Univ, Dept Biomed Engn, TR-34755 Istanbul, Turkey.
   [Jalota, Sahil; Bhaduri, Sarit B.] Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.
RP Tas, AC (reprint author), Yeditepe Univ, Dept Biomed Engn, TR-34755 Istanbul, Turkey.
EM actas@yeditepe.edu.tr
RI Tas, A. Cuneyt/B-1966-2008
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Bayraktar D, 2001, J MATER SCI LETT, V20, P401, DOI 10.1023/A:1010929825557
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Carlson J, 2003, BIOMATERIALS, V24, P71, DOI 10.1016/S0142-9612(02)00253-3
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   COETZEE AS, 1980, ARCH OTOLARYNGOL, V106, P405
   De la Torre AG, 2004, POWDER DIFFR, V19, P240, DOI 10.1154/1.1725254
   Devreker F, 2001, HUM REPROD, V16, P749, DOI 10.1093/humrep/16.4.749
   Dreesmann H, 1892, BEITR KLIN CHIR, V9, P804
   DRIESSENS FCM, 1990, BIOMINERALS, P37
   Earle WR, 1943, J NATL CANCER I, V4, P165
   Fernandez E, 2005, BIOMATERIALS, V26, P3395, DOI 10.1016/j.biomaterials.2004.09.023
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   Garcia C, 2006, J NON-CRYST SOLIDS, V352, P3488, DOI [10.1016/j.jnoncrysol.2006.02.110, 10.1016/j.jnoncrysol.2006.02.010]
   Girija EK, 2002, CHEM LETT, P702, DOI 10.1246/cl.2002.702
   Grondahl L, 2003, J MATER SCI-MATER M, V14, P503, DOI 10.1023/A:1023403929496
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   Hina A, 2001, J CRYST GROWTH, V223, P213, DOI 10.1016/S0022-0248(00)01026-5
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   HUMMEL HU, 2001, J STARK ZKG INT, V54, P458
   Iizuka T, 1998, J CERAM SOC JPN, V106, P820, DOI 10.2109/jcersj.106.820
   Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1
   Jalota S, 2004, J MATER RES, V19, P1876, DOI 10.1557/JMR.2004.0230
   JALOTA S, 2006, MAT SCI ENG C-BIO S, V27, P432
   Jalota S, 2006, J BIOMED MATER RES A, V78A, P481, DOI 10.1002/jbm.a.30851
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Karamalegos C, 1999, HUM REPROD, V14, P1842, DOI 10.1093/humrep/14.7.1842
   KELLY CM, 2001, CLIN ORTHOP RELAT R, V382, P42
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Krumgalz BS, 1999, J SOLUTION CHEM, V28, P667, DOI 10.1023/A:1021711926908
   Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010
   Lebugle A, 1999, J MATER CHEM, V9, P2511, DOI 10.1039/a902469g
   Liang C, 2004, MATER CHEM PHYS, V88, P285, DOI 10.1016/j.matchemphys.2004.06.044
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Ling YB, 2005, IND ENG CHEM RES, V44, P715, DOI 10.1021/ie049316w
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Martin RI, 1998, J CRYST GROWTH, V183, P417, DOI 10.1016/S0022-0248(97)00420-X
   MCDOWELL H, 1971, INORG CHEM, V10, P1638
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Murashima Y, 2002, INT ENDOD J, V35, P768, DOI 10.1046/j.1365-2591.2002.00565.x
   Niedhart C, 2004, J BIOMED MATER RES B, V71B, P123, DOI 10.1002/jbm.b.30071
   Nilsson M, 2003, J MATER SCI-MATER M, V14, P399, DOI 10.1023/A:1023254632704
   Nilsson M, 2002, J BIOMED MATER RES, V61, P600, DOI 10.1002/jbm.10268
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Ooms EM, 2003, J BIOMED MATER RES B, V66B, P447, DOI 10.1002/jbm.b.10039
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   PELTIER L F, 1961, Clin Orthop, V21, P1
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Rhee SH, 1998, J AM CERAM SOC, V81, P3029
   Ringer S, 1882, J Physiol, V3, P380
   Santos GC, 2004, J PROSTHET DENT, V91, P335, DOI 10.1016/j.prosdent.2004.01.017
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   Singh NB, 2005, J AM CERAM SOC, V88, P196, DOI 10.1111/j.1551-2916.2004.00020.x
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   STRAUSS A, 1999, BIOMATERIALIEN MED, P105
   SWAINTEK JN, 2005, ADV BIOCERAMICS BIOC, P79
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   Tas AC, 2001, POWDER DIFFR, V16, P102, DOI 10.1154/1.1330273
   Tas AC, 2001, J AM CERAM SOC, V84, P295
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Tortet L, 1997, J SOLID STATE CHEM, V132, P6, DOI 10.1006/jssc.1997.7383
   Treboux G, 2000, J PHYS CHEM A, V104, P5111, DOI 10.1021/jp994399t
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   VITAGLIANO L, 1995, J MOL BIOL, V247, P69, DOI 10.1006/jmbi.1994.0123
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
NR 83
TC 67
Z9 67
U1 8
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2008
VL 28
IS 1
BP 129
EP 140
DI 10.1016/j.msec.2007.10.058
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 257JL
UT WOS:000252795000018
DA 2018-10-19
ER

PT J
AU Yang, JM
   Yang, SJ
   Lin, HT
   Wu, TH
   Chen, HJ
AF Yang, Jen Ming
   Yang, Shu Jyuan
   Lin, Hao Tzu
   Wu, Te-Hsing
   Chen, Haw-Jan
TI Chitosan containing PU/Poly(NIPAAm) thermosensitive membrane for wound
   dressing
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE polyurethane; poly(N-isopropyl acrylamide); thermo-sensitivity; cell
   culture; antibacterial assessment; wound dressing
ID SBS-G-VP; HTPB-BASED POLYURETHANE; DMAEMA COPOLYMER MEMBRANE;
   WATER-VAPOR TRANSMISSION; POLY(N-ISOPROPYLACRYLAMIDE)-GRAFTED SURFACES;
   BIOMATERIAL USAGE; IN-VITRO; HEALING ACCELERATOR; CULTURED-CELLS;
   RADIATION
AB Hydroxyl-terminated polybutadiene (HTPB) based polyurethane (PU) solution was prepared and then the PU solution was modified with N-isopropyl acrylamide by UV radiation without degassing to get thermo-sensitive membrane (PUNIPAAm). Then chitosan was impregnated onto the PUNIPAAm surface and treated by freeze-drying to get chitosan containing PUNIPAAm (PUNIPAAm-chi). Wettability on the various membranes was determined. The measurement of water vapor transmission rate on membranes and the antibacterial assessment were also evaluated. In order to evaluate the biocompatibility of these membranes, a cytotoxicity test and cell adhesion and proliferation assay were conducted in cell culture. The results showed that these thermo-sensitive PUNIPAAm membranes exhibited very low cytotoxicity and could support cell adhesion and growth. As having the antibacterial ability and the values of WVTR, permeance and permeability of the various PUNIPAAm-chi membranes are comparable to the commercial products, the PUNIPAAm-chi may be considered for wound dressing. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Yang, Jen Ming; Yang, Shu Jyuan; Lin, Hao Tzu] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan, Taiwan.
   [Wu, Te-Hsing; Chen, Haw-Jan] Inst Nucl Energy Res, Lungtan 32500, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan, Taiwan.
EM jmyang@mail.cgu.edu.tw
CR Amiji MM, 1996, J BIOMAT SCI-POLYM E, V8, P281, DOI 10.1163/156856296X00309
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   HIRANO S, 1978, AGR BIOL CHEM TOKYO, V42, P1938
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   KIFUNE K, 1992, ADVANCES IN CHITIN AND CHITOSAN, P9
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Lim YH, 1997, J APPL POLYM SCI, V64, P2647
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Minami S, 1996, CARBOHYD POLYM, V29, P295, DOI 10.1016/S0144-8617(96)00078-1
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1992, ADVANCES IN CHITIN AND CHITOSAN, P70
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Okamoto Y., 1982, BIOMATERIALS, V11, P430
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   TAKEI YG, 1995, BIOMATERIALS, V16, P667, DOI 10.1016/0142-9612(95)99692-F
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yang JM, 2007, J BIOMED MATER RES B, V80B, P43, DOI 10.1002/jbm.b.30566
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 2002, J MEMBRANE SCI, V208, P105, DOI 10.1016/S0376-7388(02)00180-1
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 2003, J BIOMED MATER RES A, V64A, P138, DOI 10.1002/jbm.a.10245
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 2005, J MEMBRANE SCI, V258, P97, DOI 10.1016/j.memsci.2005.02.033
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
   YANO H, 1985, Mie Medical Journal, V35, P53
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhou SQ, 1998, J PHYS CHEM B, V102, P1364, DOI 10.1021/jp972990p
NR 53
TC 43
Z9 44
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2008
VL 28
IS 1
BP 150
EP 156
DI 10.1016/j.msec.2007.01.011
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 257JL
UT WOS:000252795000020
DA 2018-10-19
ER

PT J
AU Akahori, T
   Niinomi, M
   Nakai, M
   Nishimura, H
   Takei, Y
   Fukui, H
   Ogawa, M
AF Akahori, Toshikazu
   Niinomi, Mitsuo
   Nakai, Masaaki
   Nishimura, Hideki
   Takei, Yukiko
   Fukui, Hisao
   Ogawa, Michiharu
TI Wear and mechanical properties, and cell viability of gas-nitrided
   beta-type Ti-Nb-Ta-Zr system alloy for biomedical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-29 mass%niobium-13 mass%tantalum-4.6 mass%zirconium; gas
   nitriding; surface modification; frictional wear; mechanical properties;
   run out; cell viability; metallic biomaterial
AB Frictional wear resistance is one of the important properties of metallic biomaterials. Surface hardening treatments such as oxidizing, nitriding and ion implantation tend to be applied for improving the wear resistance of titanium and its alloys. The simple gas nitriding process is expected to further improve the wear resistance of newly developed beta-type Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) for biomedical applications. However, there is a possibility for the mechanical properties such as tensile and fatigue strength of TNTZ to be degraded through gas nitriding process. Therefore, the gas nitriding process was carried out in this study to improve the wear resistance of TNTZ and alpha+beta-type Ti-6Al-4V ELI alloy (Ti64), which is one of the representative titanium alloys practically applied for biomedical applications, in simulated body fluid (Ringer's solution). Their tensile and fatigue properties and cell viability was also investigated in order to confirm the reliability as biomedical materials.
   The Vickers hardness near the specimen surface of nitrided TNTZ and Ti64, where TiN and Ti2N forms. increases significantly as compared to that of their matrices. The wear resistances of TNTZ and Ti64 are improved significantly in Ringer's solution by nitriding process as compared to those of as-solutionized TNTZ (TNTZ(ST)) and Ti64 (Ti64(ST)). The tensile strength of nitrided TNTZ increases by around 90 MPa as compared to that of TNTZST. The tensile strength of nitrided Ti64 does not change significantly at all nitriding temperatures. On the other hand, the elongation decreases with increasing the nitriding temperature. The run out (plain fatigue limit) of TNTZ subjected to a nitriding process at 1123 K, which has relatively good balance between wear resistance and tensile properties, is around 300 MPa, and is nearly equal to that of Ti64 subjected to a nitriding process at 1123 K, although the tensile strength of the nitrided TNTZ is around 200 MPa smaller than that of the nitrided Ti64. The cell viabilities of nitrided TNTZ and Ti64 range from 1.4 to 1.6 against that of control (cell disc), and are a little higher than that of TNTZ(ST) and Ti64(ST). The cell viabilities of nitrided TNTZ and Ti64 after removing the oxide layer on their surfaces are similar to that of control and are not significantly degraded.
C1 [Akahori, Toshikazu; Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Nishimura, Hideki] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
   [Takei, Yukiko; Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   [Ogawa, Michiharu] Daido Steel Co Ltd, R&D Lab, Nagoya, Aichi 4578584, Japan.
RP Akahori, T (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
CR AKAGIH, 2000, J JPN SOC DENTAL MAT, V19, P179
   Akahori T., 2005, Journal of Japan Institute of Light Metals, V55, P575, DOI 10.2464/jilm.55.575
   AKAHORI T, 2007, J JAPAN I METALS, V70, P295
   Akahori T, 2007, J JPN I MET, V71, P407, DOI 10.2320/jinstmet.71.407
   Bloyce A., 1997, SURFACE PERFORMANCE, P155
   Hanawa T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P145
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   NAKAI M, 2007, J JAPAN I METALS, V71, P414
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   NIINOMI M, 2002, COMMUNICATION, V88, P567
   Niinomi M., 2001, METALL MATER TRANS A, V32A, P477
   Yan X, 2001, J SOC MATER SCI JPN, V50, P764
NR 13
TC 8
Z9 8
U1 1
U2 13
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JAN
PY 2008
VL 49
IS 1
BP 166
EP 174
DI 10.2320/matertrans.MRA2007210
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 266NF
UT WOS:000253442100029
OA Bronze
DA 2018-10-19
ER

PT B
AU Koike, M
   Okabe, T
AF Koike, M.
   Okabe, T.
BE Gilbert, J
TI Properties Characterization of Cast Ti-Al-Cu Alloys for Dental
   Applications
SO MEDICAL DEVICE MATERIALS IV
LA English
DT Proceedings Paper
CT 4th Materials and Processes for Medical Devices
CY SEP 23-27, 2007
CL Palm Desert, CA
SP ASM Int, Mat Informat Soc
ID TITANIUM; WEAR
AB The use of titanium for medical and dental prostheses began with commercially pure titanium (CP Ti) some 15 years ago. Depending on applications, however, stronger alloys are demanded. Thus, a well accepted, industrial titanium alloy, Ti-6Al-4V, has been widely tested and used for various biomedical applications. On the other hand, the use of V as a biomaterial has been questioned from the standpoint of biocompatibility. Although an alternative alloy, Ti-6Al-7Nb, was introduced, a more economical alloy would be preferable. Therefore, we evaluated the Ti-Al + Cu alloy system by using Cu in the place of V in Ti-6Al-4V. Four experimental alloys, one binary Ti-5% (mass) Al and three ternary Ti-5%Al alloys with 1, 3 and 5% Cu were prepared by melting high-purity Al and Cu together with a Ti sponge in an argon-arc melting furnace. Specimens were made by casting these alloys and commercial Ti-6Al-4V into MgO-based investment molds in a centrifugal casting machine. The yield and tensile strengths and the percent elongation of the Ti-5Al-5Cu were found to be comparable to those of the Ti-6Al-4V (p > 0.05). The strength was increased by increasing Cu contents along with the reduction in elongation. The anodic polarization results in an artificial saliva revealed that all metals tested completely passivated in the normal intnaoral potential range (-58 to 212 mV). The grindability of Ti-5Al-5Cu, tested using a SiC wheel, was statistically better than that of Ti-6Al-4V and the other tested alloys (p < 0.01). The wear resistance of the Ti-5Al-5Cu, tested in an equipment that simulated chewing action, was statistically better than that of the Ti-6Al-4V (p < 0.01). With further refinements, the Ti-Al-Cu alloy could be a good candidate for some dental applications.
C1 [Koike, M.; Okabe, T.] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomat Sci, Dallas, TX 75246 USA.
RP Koike, M (reprint author), Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomat Sci, Dallas, TX 75246 USA.
CR [Anonymous], 2006, 22674 ISO
   Chan KS, 2006, METALL MATER TRANS A, V37A, P1323, DOI 10.1007/s11661-006-1084-9
   Chan KS, 2007, ACTA BIOMATER, V3, P383, DOI 10.1016/j.actbio.2006.10.007
   Collings E.W., 1984, PHYS METALLURGY TI A, P66
   Craig R. G., 2001, RESTORATIVE DENT MAT
   Donachie M. J., 2000, TITANIUM TECHNICAL G
   EWERS GJ, 1985, J ORAL REHABIL, V12, P469, DOI 10.1111/j.1365-2842.1985.tb01293.x
   GUY AG, 1962, PHYS METALLURGY ENG
   *ICDD, 1998, POW DIFFR FIL SET 1
   JAFFEE RI, 1958, PROG MET PHYS, V7, P65, DOI 10.1016/0502-8205(58)90004-2
   KOBAYASHI E, 1995, J JPN SOC DENT MAT D, V15, P406
   Koike M, 2005, MAT SCI ENG C-BIO S, V25, P349, DOI 10.1016/j.msec.2005.04.002
   Koike M, 2003, BIOMATERIALS, V24, P4541, DOI 10.1016/S0142-9612(03)00063-2
   KOIKE M, 2007, J DENT RES, V86
   KOIKE M, 2007, EVALUATION CAST TI A, P1567
   KOIKE M, 2007, DENT TITANIUM CASTIN, P199
   MCCABE JF, 1985, ANDERSONS APPL DENT
   MURRAY JL, 1978, PHASE DIAGRAMS BINAR, P99
   Ohkubo C, 2000, BIOMATERIALS, V21, P421, DOI 10.1016/S0142-9612(99)00206-9
   Ohkubo C, 2003, BIOMATERIALS, V24, P3377, DOI 10.1016/S0142-9612(03)00157-1
   OKABE T, 1995, CELL MATER, V5, P211
   SHIMIZU H, 2006, MODELING CASTING WEL, V11, P143
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Takada Y, 2001, Dent Mater J, V20, P34
   Watanabe I, 1997, J DENT RES, V76, P773, DOI 10.1177/00220345970760031001
NR 25
TC 1
Z9 1
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-861-8
PY 2008
BP 109
EP 113
DI 10.1361/cp2007mpmd109
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BUH12
UT WOS:000289268700017
DA 2018-10-19
ER

PT J
AU Mareci, D
   Chelariu, R
   Carcea, I
   Gordin, DM
   Gloriant, T
AF Mareci, Daniel
   Chelariu, Romeu
   Carcea, Ioan
   Gordin, Doina-Margareta
   Gloriant, Thierry
TI Preliminary testing of corrosion behaviour of Ti6Al7Nb and Ti30Ta alloys
   in artificial saliva with additions of fluoride ions and lactic acid
SO METALURGIA INTERNATIONAL
LA English
DT Article
ID TI-TA ALLOYS; POLARIZATION RESISTANCE MEASUREMENTS; TITANIUM-ALLOYS;
   MECHANICAL-PROPERTIES; DENTAL MATERIALS; BIOMEDICAL APPLICATIONS; TAFEL
   SLOPES; IN-VITRO; RATES; MEDIA
AB Recently, titanium is the most use metal for manufacturing dental implants. In the last decade, new titanium alloys have been developed in different areas of dentistry. Concurrently, oral treatments using gels containing fluoride have also been widely used in odontology. The aim of this study is to investigate the electrochemical behavior of a new titanium alloy containing Ta, in four different media based on the artificial saliva having different fluoride ions and lactic acid contents, and compare it with the behaviour of Ti6Al7Nb alloy used frequently as biomaterial. To investigate the electrochemical behavior of two titanium alloys the open circuit potential recording and linear sweep voltametric analysis were used. Our results have shown that Ti20Ta alloy have corresion resistance as good as that of Ti6Al7Nb in artifical saliva (pH = 8.0), acidified saliva (9.8 g/l lactic acid, pH = 2.5) and fluoridated saliva (1.0 g/l F; pH = 8.0). The corrosion of Ti6Al7Nb and Ti30Ta alloys is enhanced in fluoridated acidified saliva (9.8 g/l lactic acid, 1.0 g/l F, pH = 2.5).
C1 [Mareci, Daniel] Gh Asachi Tech Univ Iasi, Fac Chem Engn, Iasi, Romania.
   [Chelariu, Romeu; Carcea, Ioan] Gh Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi, Romania.
   [Gordin, Doina-Margareta; Gloriant, Thierry] CNRS, INSA Rennes, UMR 6226, F-75700 Paris, France.
RP Mareci, D (reprint author), Gh Asachi Tech Univ Iasi, Fac Chem Engn, Iasi, Romania.
OI Gordin, Doina Margareta/0000-0003-2200-9930; Mareci,
   Daniel/0000-0002-5859-1996
FU Romanian Government, National Centre for Programmes Management, Romania
   [CEEX 245/2006]
FX The work was partially supported from research contract CEEX 245/2006
   funding by Romanian Government, National Centre for Programmes
   Management, Romania.
CR Bard J.A., 1976, ENCY ELECTROCHEMISTR, V5
   BAYRAMOGLU G, 2000, J ORAL REHABIL, V27, P274
   Evans U.R., 1960, CORROSION OXIDATION, P898
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Gioka C, 2004, DENT MATER, V20, P693, DOI 10.1016/j.dental.2004.02.008
   GRIMSDOTTIR MR, 1993, SCAND J DENT RES, V101, P229
   Kedici SP, 1998, J ORAL REHABIL, V25, P800, DOI 10.1046/j.1365-2842.1998.00305.x
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1
   MANSFELD F, 1973, J ELECTROCHEM SOC, V120, P515, DOI 10.1149/1.2403489
   MANSFELD F, 1973, CORROSION, V29, P397, DOI 10.5006/0010-9312-29.10.397
   MERRITT K, 1981, SYSTEMIC ASPECTS BIO, V2, P33
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   Rao S, 1997, MAT SCI ENG C-BIO S, V4, P311, DOI 10.1016/S0928-4931(97)00016-7
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Strang R, 1998, J DENT, V26, P273, DOI 10.1016/S0300-5712(97)00064-X
   Strang R, 1998, J DENT, V26, P191, DOI 10.1016/S0300-5712(97)00063-8
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   Wagner C, 1938, Z ELKTROCHEM ANGEW P, V44, P391
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
   1993, ASM HDB CORROSION, V13
NR 30
TC 1
Z9 1
U1 2
U2 6
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2008
VL 13
IS 12
BP 82
EP 90
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 338GI
UT WOS:000258494000011
DA 2018-10-19
ER

PT S
AU Debus, C
   Bolivar, PH
AF Debus, Christian
   Bolivar, Peter Haring
BE Johnson, NP
   Ozbay, E
   Zheludev, NI
   Ziolkowski, RW
TI Terahertz biosensors based on double split ring arrays
SO METAMATERIALS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Metamaterials III
CY APR 07-10, 2008
CL Strasbourg, FRANCE
SP SPIE Europe, Alsace Int, Conseil General BasRhin, Region Alsace, Communaute Urbaine Strasbourg
DE Terahertz; biosensing; split ring; array; substrate
ID SPECTROSCOPY; FILTERS
AB Terahertz biosensors are used for sensing chemical and biochemical material. In order to sense small material quantities, such as DNA strands, sensors with a high sensitivity are needed. Our recent approach applies asymmetric double-split ring resonators (aDSR) in a two-dimensional array. Interaction of resonances within the structure results in a steep flank in the frequency response which is sensitively shifted by small amounts of biomolecules loaded on the sensor surface. Additionally a high E-field concentration connected to the split ring resonances is used to maximize the frequency shift induced by biomaterial covering only a small fraction of the sensor area. Minutes amounts of biomaterial can therefore be detected. In this presentation, the approach is analyzed with numerical simulation. We demonstrate the functionality and optimization of the aDSR array structures, and the capability to detect submicrometer layers of dielectric material with a spatially selective deposition on the resonant structures. A measurement of the complementary structure is presented as proof of principle.
C1 [Debus, Christian; Bolivar, Peter Haring] Univ Siegen, Inst High Frequency & Quantum Elect, D-57076 Siegen, Germany.
RP Debus, C (reprint author), Univ Siegen, Inst High Frequency & Quantum Elect, Holderlinstr 3, D-57076 Siegen, Germany.
CR Bolivar PH, 2004, PHILOS T ROY SOC A, V362, P323, DOI 10.1098/rsta.2003.1318
   Brucherseifer M, 2000, APPL PHYS LETT, V77, P4049, DOI 10.1063/1.1332415
   Debus C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805016
   Driscoll T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768300
   Falcone F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.197401
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   MacDonald ME, 2000, IEEE T MICROW THEORY, V48, P712, DOI 10.1109/22.841963
   Munk B. A., 2000, FREQUENCY SELECTIVE
   Nagai M, 2006, INT J INFRARED MILLI, V27, P505, DOI 10.1007/s10762-006-9098-3
   Nagel M, 2005, SEMICOND SCI TECH, V20, pS281, DOI 10.1088/0268-1242/20/7/019
   Nagel M, 2006, INT J INFRARED MILLI, V27, P517, DOI [10.1007/s10762 006-9104-9, 10.1007/s10762-006-9104-9]
   O'Hara JF, 2008, OPT EXPRESS, V16, P1786, DOI 10.1364/OE.16.001786
   Rau C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1940127
   Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847
   Stewing F, 2004, MICROW OPT TECHN LET, V41, P79, DOI 10.1002/mop.20053
   Tanaka T, 2004, JPN J APPL PHYS 2, V43, pL287, DOI 10.1143/JJAP.43.L287
   Wu Q, 1996, APPL PHYS LETT, V68, P2924, DOI 10.1063/1.116356
   Yoshida H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825411
NR 18
TC 3
Z9 3
U1 0
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7185-7
J9 PROC SPIE
PY 2008
VL 6987
AR 69870U
DI 10.1117/12.786069
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BIA05
UT WOS:000257877700016
DA 2018-10-19
ER

PT J
AU Uklejewski, R
   Winiecki, M
   Mielniczuk, J
   Rogala, P
   Auguscinski, A
AF Uklejewski, R.
   Winiecki, M.
   Mielniczuk, J.
   Rogala, P.
   Auguscinski, A.
TI THE POROACCESSIBILITY PARAMETERS FOR THREE-DIMENSIONAL CHARACTERIZATION
   OF ORTHOPAEDIC IMPLANTS POROUS COATINGS
SO METROLOGY AND MEASUREMENT SYSTEMS
LA English
DT Article
DE Surface topography; joint replacement; biologic fixation of implants;
   bone tissue ingrowth; porous coating poroaccessibility
ID TITANIUM IMPLANTS; BONE; FIXATION; SURFACE; PROSTHESIS; SUBSTRATE;
   STRENGTH; INGROWTH; TISSUE; SHEEP
AB The ability of formation of the proper bone-porous implant fixation depends, among others, on the structural-osteoinductive properties of the porous coating covering the orthopaedic implant surface. These properties, describing the poroaccessibility of porous biomaterial, are one of co-factors conditioning the promotion of bone tissue ingrowth into pore space of implant porous coating. So far the structural-osteoinductive properties of implants porous coatings are described by the traditional two-dimensional roughness parameters obtained with contact or non-contact roughness profile measurement (mostly standard surface roughness amplitude parameters e.g.: R(a), R(q), R(max)) or with the average pore size, which is, in the authors opinion, inadequate and unsatisfactory for porous coating characterization in respect of its poroaccessibility. The lack of proper directives on porous structure characterization of titanium and hydroxyapatite coatings on orthopaedic implants is the reason to work them out. In connection with the development of methods for surface texture analysis in three dimensions, the authors have perceived new possibilities for porous coatings microstructure analysis and on this base a set of parameters of poroaccessibility of implant porous coating for bone tissue ingrowth has been proposed: the effective volumetric porosity phi(Vef), the index of the porous coating space capacity V(PM), the representative surface porosity phi(Srep), the representative pore size P(Srep), the representative angle of the poroaccessibility Omega(rep) and the bone-implant interface adhesive surface enlargement index psi. With this set of parameters one can characterize the structural-osteoinductive properties of porous biomaterial. In this paper a new set of poroaccessibility parameters of implant porous coatings and a method of calculation of these parameters on the basis of three-dimensional roughness measurements are presented.
C1 [Uklejewski, R.; Winiecki, M.] Kazimierz Wielki Univ, Dept Fundamental Med Bioengn, Bydgoszcz, Poland.
   [Mielniczuk, J.; Auguscinski, A.] Poznan Tech Univ, Chair Machine Design Fundamentals, Poznan, Poland.
   [Rogala, P.] Karol Marcinkowski Univ Med Sci, Dept Spin Surg Orthopaed & Traumatol, Poznan, Poland.
RP Uklejewski, R (reprint author), Kazimierz Wielki Univ, Dept Fundamental Med Bioengn, Bydgoszcz, Poland.
EM uklejewski@ukw.edu.pl; winiecki@ukw.edu.pl;
   janusz.mielniczuk@put.poznan.pl; progala@orsk.ump.edu.pl;
   andrzej.auguseinski@put.poznan.pl
RI Winiecki, Mariusz/J-4565-2013
OI Winiecki, Mariusz/0000-0002-3568-2473
FU  [4 T0/C 056 29]
FX This work was financed by research project no 4 T0/C 056 29.
CR AN YH, 2000, MECH TESTING BONE BO, P439
   Bragdon CR, 2004, J BONE JOINT SURG AM, V86A, P105, DOI 10.2106/00004623-200412002-00015
   BROOKER AF, 1984, J BONE JOINT SURG AM, V66A, P619, DOI 10.2106/00004623-198466040-00021
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Cameron H. U., 1994, BONE IMPLANT INTERFA, P121
   CAMERON HU, 1994, BONE IMPLANT INTERFA, P145
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   Charnley J., 1970, ACRYLIC CEMENT ORTHO
   COOK SD, 1985, CLIN ORTHOP RELAT R, P271
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   GALANTE J, 1973, J BIOMED MATER RES, V7, P43, DOI 10.1002/jbm.820070305
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Grook K, 1987, J BIOMED MATER RES, V21, P1375
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Overgaard S, 1999, J BONE JOINT SURG BR, V81B, P725, DOI 10.1302/0301-620X.81B4.9282
   Overgaard Soren, 2000, Acta Orthopaedica Scandinavica, V71, P1, DOI 10.1080/000164700753759574
   Park J. B., 2003, BIOMATERIALS PRINCIP
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Rogala P., 2007, P 11 INT C METR PROP, P241
   Rogala P., 2007, P 6 SEM SURF STER ME, P61
   Rogala P., 2006, ENG BIOMAT, V54-55, P1
   Rogala P., 2006, J BIOMECH S1, V39, pS14
   Rogala Piotr, 2002, Chir Narzadow Ruchu Ortop Pol, V67, P309
   Rogala Piotr, 2002, Chir Narzadow Ruchu Ortop Pol, V67, P395
   Soballe K, 1991, J Arthroplasty, V6, P307, DOI 10.1016/S0883-5403(06)80181-6
   SOBALLE K, 1992, CLIN ORTHOP RELAT R, P282
   Soballe K., 1993, ACTA ORTHOP SCAND S, V64, P1
   Stout K. J, 2000, DEV METHODS CHARACTE
   Stryla W, 2004, INT J REHABIL RES, V27, P175
   Sun LM, 2002, J BIOMED MATER RES, V62, P228, DOI 10.1002/jbm.10315
   Svehla M, 2002, J ARTHROPLASTY, V17, P304, DOI 10.1054/arth.2002.30410
   Teloken MA, 2002, J BONE JOINT SURG AM, V84A, P2140, DOI 10.2106/00004623-200212000-00003
   UKLEJEWSKI R, 1992, IPPT PAN REPORTS, V16
   Whitehouse D.J., 1994, HDB SURFACE METROLOG
   WIECZOROWSKI M, 1996, P 3 INT S MEAS TECHN, P209
   WINIECKI M, 2006, THESIS POZNAN U TECH
   Yang YC, 2001, BIOMATERIALS, V22, P1827, DOI 10.1016/S0142-9612(00)00364-1
NR 39
TC 4
Z9 4
U1 0
U2 2
PU POLISH ACAD SCIENCES COMMITTEE METROLOGY & RES EQUIPMENT
PI WARSAW
PA UL MIODOWA 10, WARSAW, 00251, POLAND
SN 0860-8229
J9 METROL MEAS SYST
JI Metrol. Meas. Syst.
PY 2008
VL 15
IS 2
BP 215
EP 226
PG 12
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA 380WO
UT WOS:000261497000008
DA 2018-10-19
ER

PT S
AU Cunningham, BT
AF Cunningham, Brian T.
BE George, T
   Cheng, Z
TI Photonic crystals utilized for label-free and amplified fluorescence
   biodetection - art. no. 695910
SO MICRO (MEMS) AND NANOTECHNOLOGIES FOR SPACE, DEFENSE, AND SECURITY II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 2nd Conference on Micro (MEMS) and Nanotechnologies for Space, Defense,
   and Security
CY MAR 18-20, 2008
CL Orlando, FL
SP SPIE
DE label-free biosensors; optical biosensors; fluorescence enhancement;
   photonic crystal
ID SURFACE-PLASMON RESONANCE; PORCINE ROTAVIRUS; BIOMOLECULAR INTERACTIONS;
   OPTICAL BIOSENSOR; UNITED-STATES; VP7 GENES; ASSAY; VIRUSES; SYSTEM;
   CONTAMINATION
AB Photonic crystals are fabricated on plastic surfaces, producing narrow bandwidth resonances at any desired wavelength. While shifts in the resonant wavelength quantify the density of adsorbed biomaterial, the resonances also enhance the output of adsorbed fluorophores. The combined attributes of photonic crystals enable highly sensitive label-free detection and greatly amplified sensitivity of any fluorescence-based assay for applications in life science research, drug discovery, and environmental pathogen detection. Applications for label-free selective detection of viral pathogens with sensitivity of similar to 30 focal forming units, and detection of spore pathogens with single-unit resolution are highlighted. Amplified fluorescence, meanwhile, enables gene expression detection of DNA at concentrations similar to 2 orders of magnitude lower than detection on optically passive surfaces.
C1 Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
RP Cunningham, BT (reprint author), Univ Illinois, Dept Elect & Comp Engn, 1406 W Green St, Urbana, IL 61801 USA.
CR Abbaszadegan M, 1999, APPL ENVIRON MICROB, V65, P444
   Amano Y, 2005, ANAL BIOANAL CHEM, V381, P156, DOI 10.1007/s00216-004-2927-0
   Arakawa T, 1999, ANAL BIOCHEM, V271, P119, DOI 10.1006/abio.1999.4132
   Atreya C D, 2004, Foodborne Pathog Dis, V1, P89, DOI 10.1089/153531404323143602
   AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335
   Block ID, 2007, MICROELECTRON ENG, V84, P603, DOI 10.1016/j.mee.2006.12.011
   Block ID, 2006, SENSOR ACTUAT B-CHEM, V120, P187, DOI 10.1016/j.snb.2006.02.006
   Boltovets PM, 2004, J VIROL METHODS, V121, P101, DOI 10.1016/j.jviromet.2004.06.019
   Borchardt MA, 2004, APPL ENVIRON MICROB, V70, P5937, DOI 10.1128/AEM.70.10.5937-5946.2004
   Boroditsky M, 1999, J LIGHTWAVE TECHNOL, V17, P2096, DOI 10.1109/50.803000
   BRESEE J, 2002, METHODS DETECTION RO, P17
   Budach W, 1999, ANAL CHEM, V71, P3347, DOI 10.1021/ac990092e
   Budach W, 2003, ANAL CHEM, V75, P2571, DOI 10.1021/ac026390k
   Chan LL, 2007, APOPTOSIS, V12, P1061, DOI 10.1007/s10495-006-0031-y
   Chan LL, 2007, SENSOR ACTUAT B-CHEM, V120, P392, DOI 10.1016/j.snb.2006.02.047
   Chan LL, 2006, IEEE SENS J, V6, P1551, DOI 10.1109/JSEN.2006.884547
   CHAN LL, 2007, SENSORS ACTU B UNPUB
   Choi CJ, 2007, LAB CHIP, V7, P550, DOI 10.1039/b618584c
   Choi CJ, 2006, LAB CHIP, V6, P1373, DOI 10.1039/b603514k
   Cooper MA, 2001, NAT BIOTECHNOL, V19, P833, DOI 10.1038/nbt0901-833
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V87, P365, DOI 10.1016/S0925-4005(02)00273-3
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V85, P219, DOI 10.1016/S0925-4005(02)00111-9
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V81, P316, DOI 10.1016/S0925-4005(01)00976-5
   Cunningham BT, 2006, EXPERT REV PROTEOMIC, V3, P271, DOI 10.1586/14789450.3.3.271
   Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604
   Feldstein M. J., 1999, J BIOMED MICRODEVICE, V1, P139
   Gallay A, 2006, CLIN MICROBIOL INFEC, V12, P561, DOI 10.1111/j.1469-0691.2006.01441.x
   Ganesh N, 2007, NAT NANOTECHNOL, V2, P515, DOI 10.1038/nnano.2007.216
   GELLBERG HB, 1991, VET MICROBIOL, V28, P231
   Glass RI, 2006, SCI AM, V294, P46, DOI 10.1038/scientificamerican0406-46
   GLASS RI, 2006, SCI AM, V294, P54
   Hennings V. P., 1903, HEDWIGIA, V42, pS107
   HOPKINS RS, 1985, AM J PUBLIC HEALTH, V75, P254, DOI 10.2105/AJPH.75.3.254
   HURST CJ, 1980, APPL ENVIRON MICROB, V39, P1
   KAPIKIAN AZ, 2001, FIELDS VIROLOGY, P1787
   Li PY, 2004, SENSOR ACTUAT B-CHEM, V99, P6, DOI 10.1016/S0925-4005(03)00604-X
   Lin B, 2006, SENSOR ACTUAT B-CHEM, V114, P559, DOI 10.1016/j.snb.2005.04.022
   LIVINSTON M, 2004, OCS04DO2
   Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005
   MARA DD, 2006, J WATER HEALTH, V5, P39
   Mateus CFR, 2004, IEEE PHOTONIC TECH L, V16, P1712, DOI 10.1109/LPT.2004.828851
   Miles MR, 2003, SOYBEAN RUST IS US C
   Pacradouni V, 2000, PHYS REV B, V62, P4204, DOI 10.1103/PhysRevB.62.4204
   Pontes L, 2001, J MOL BIOL, V307, P1171, DOI 10.1006/jmbi.2001.4512
   ROLSMA MD, 1994, J VIROL, V68, P258
   Rolsma MD, 1998, J VIROL, V72, P9079
   ROSEN BI, 1994, J CLIN MICROBIOL, V32, P311
   Rosenblatt D, 1997, IEEE J QUANTUM ELECT, V33, P2038, DOI 10.1109/3.641320
   Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A
   Schofield DJ, 1996, J VIROL METHODS, V62, P33, DOI 10.1016/0166-0934(96)02086-1
   Teodoroff TA, 2005, J CLIN MICROBIOL, V43, P1377, DOI 10.1128/JCM.43.3.1377-1384.2005
   Timenetsky MDST, 1996, J DIARRHOEAL DIS RES, V14, P71
   *USDA, 2007, PEST INF PLATF EXT E
   Voss EW, 1984, FLUORESCEIN HAPTEN I
   Winiarczyk S, 2002, J VET MED B, V49, P373, DOI 10.1046/j.1439-0450.2002.00572.x
   NIKON TIRF MICROSCOP
NR 56
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-7150-5
J9 P SOC PHOTO-OPT INS
PY 2008
VL 6959
BP 95910
EP 95910
DI 10.1117/12.773626
PG 12
WC Nanoscience & Nanotechnology; Optics
SC Science & Technology - Other Topics; Optics
GA BHY70
UT WOS:000257465900025
DA 2018-10-19
ER

PT J
AU Gatti, R
   Orlandini, G
   Uggeri, J
   Belletti, S
   Galli, C
   Raspanti, M
   Scandroglio, R
   Guizzardi, S
AF Gatti, R.
   Orlandini, G.
   Uggeri, J.
   Belletti, S.
   Galli, C.
   Raspanti, M.
   Scandroglio, R.
   Guizzardi, S.
TI Analysis of living cells grown on different titanium surfaces by
   time-lapse confocal microscopy
SO MICRON
LA English
DT Review
DE osteoblast; titanium; CLSM; calcein; 3D reconstruction
ID OSTEOBLASTIC CELLS; 3-DIMENSIONAL RECONSTRUCTION; LASER MICROSCOPY;
   BONE-CELLS; CALCEIN-AM; IN-VITRO; ADHESION; BEHAVIOR; BIOMATERIALS;
   ATTACHMENT
AB In this study we have combined fluorescence- and reflection-confocal laser scanning microscopy for the simultaneous visualization of living cells and surface topography beneath them. To this purpose we have designed a specific flow chamber and we have tested it with osteoblasts grown on an opaque, thick support, made of smooth or sandblasted titanium. Cells were loaded with Calcein-AM or tetramethylrhodamine methyl ester (TMRM), two probes employed as indicators of cell viability/morphology and mitochondrial membrane potential, respectively. Besides the acquisition of stacks of confocal sections, the system allowed also vertical views and faithful three-dimensional reconstruction of the samples. Confocal microscope implemented with our flow chamber proved to be a promising tool for time-lapse investigation of cell-biomaterial interactions. (C) 2007 Published by Elsevier Ltd.
C1 [Gatti, R.; Orlandini, G.; Uggeri, J.; Belletti, S.; Galli, C.; Scandroglio, R.; Guizzardi, S.] Univ Parma, Sect Histol, Dept Expt Med, I-43100 Parma, Italy.
   [Raspanti, M.] Univ Varese, Luigi Cattaneo Lab Human Morphol, Varese, Italy.
RP Guizzardi, S (reprint author), Univ Parma, Sect Histol, Dept Expt Med, Via Volturno 39, I-43100 Parma, Italy.
EM stefano.guizzardi@unipr.it
OI Guizzardi, Stefano/0000-0003-2395-8767
CR BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   Baschong W, 2001, MICRON, V32, P33, DOI 10.1016/S0968-4328(00)00025-1
   BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   DURREMBERGER M, 2001, EUR CELLS MATER, V1, P10
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   Galli C, 2005, J PERIODONTOL, V76, P364, DOI 10.1902/jop.2005.76.3.364
   Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804
   Goto T, 2004, BIO-MED MATER ENG, V14, P537
   Guizzardi S, 2004, J PERIODONTOL, V75, P273, DOI 10.1902/jop.2004.75.2.273
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kapanen A, 2002, BIOMATERIALS, V23, P3733, DOI 10.1016/S0142-9612(02)00107-2
   Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   Orlandini G, 1999, METHOD ENZYMOL, V307, P340
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Siggelkow H, 1998, CLIN CHIM ACTA, V272, P111, DOI 10.1016/S0009-8981(98)00007-2
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Suba C, 2005, J CRANIOFAC SURG, V16, P31, DOI 10.1097/00001665-200501000-00008
   Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008
   Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y
   Voros J, 2000, BIOSENS BIOELECTRON, V15, P423, DOI 10.1016/S0956-5663(00)00102-0
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 27
TC 12
Z9 12
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PY 2008
VL 39
IS 2
BP 137
EP 143
DI 10.1016/j.micron.2006.11.009
PG 7
WC Microscopy
SC Microscopy
GA 285OQ
UT WOS:000254786500010
PM 17223563
DA 2018-10-19
ER

PT J
AU Simon, P
   Lichte, H
   Formanek, P
   Lehmann, M
   Huhle, R
   Carrillo-Cabrera, W
   Harscher, A
   Ehrlich, H
AF Simon, P.
   Lichte, H.
   Formanek, P.
   Lehmann, M.
   Huhle, R.
   Carrillo-Cabrera, W.
   Harscher, A.
   Ehrlich, H.
TI Electron holography of biological samples
SO MICRON
LA English
DT Review
DE S-layer protein; collagen; tobacco mosaic virus; ferritin; biominerals;
   magnetotactic bacteria; biological objects; transmission electron
   microscopy; magnetic and electric dipole fields; off-axis electron
   holography; in-line electron holography
ID ATOMIC-FORCE MICROSCOPY; COLLAGEN FIBRILS; RADIATION-DAMAGE;
   SURFACE-LAYER; ANGSTROM RESOLUTION; GELATIN-COMPOSITES; CONTRAST
   TRANSFER; IMAGE-FORMATION; SPECIMENS; PROTEIN
AB In this paper, we summarise the development of off-axis electron holography on biological samples starting in 1986 with the first results on ferritin from the group of Tonomura. In the middle of the 1990s strong interest was evoked, but then stagnation took place because the results obtained at that stage did not reach the contrast and the resolution achieved by conventional electron microscopy.
   To date, there exist only a few (similar to 12) publications on electron holography of biological objects, thus this topic is quite small and concise. The reason for this could be that holography is mostly established in materials science by physicists. Therefore, applications for off-axis holography were powerfully pushed forward in the area of imaging, e.g. electric or magnetic micro- and nanofields. Unstained biological systems investigated by means of off-axis electron holography up to now are ferritin, tobacco mosaic virus, a bacterial flagellum, T5 bacteriophage Virus, hexagonal packed intermediate layer of bacteria and the Semliki Forest virus. New results of the authors on collagen fibres and surface layer of bacteria, the so-called S-layer 2D crystal lattice are presented in this review. For the sake of completeness, we will shortly discuss in-line holography of biological samples and off-axis holography of materials related to biological systems, such as biomaterial composites or magnetotactic bacteria. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Simon, P.; Carrillo-Cabrera, W.] Max Planck Inst Chem Phys Fester Stoffe, D-01187 Dresden, Germany.
   [Lichte, H.; Formanek, P.; Lehmann, M.; Huhle, R.] Dresden Univ, Inst Struct Phys, Triebenberg Lab, D-01062 Dresden, Germany.
   [Harscher, A.] Retina Implant GmbH, D-72770 Reutlingen, Germany.
   [Ehrlich, H.] Dresden Univ, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Ehrlich, H.] Dresden Univ, Inst Mat Sci, D-01069 Dresden, Germany.
   [Lehmann, M.] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany.
RP Simon, P (reprint author), Max Planck Inst Chem Phys Fester Stoffe, Nothnitzer Str 40, D-01187 Dresden, Germany.
EM simon@cpfs.mpg.de
RI Ehrlich, Hermann/J-6698-2012; Formanek, Petr/H-2553-2013; Ehrlich,
   Hermann/I-5481-2015
OI Ehrlich, Hermann/0000-0003-3654-0810; Ehrlich,
   Hermann/0000-0003-3654-0810
CR Angert I, 2000, ULTRAMICROSCOPY, V81, P203, DOI 10.1016/S0304-3991(99)00190-4
   AOYAMA K, 1991, J ELECTRON MICROSC, V40, P235
   AOYAMA K, 1994, J ELECTRON MICROSC, V43, P39
   Aoyama K, 1996, J MICROSC-OXFORD, V182, P177, DOI 10.1046/j.1365-2818.1996.133413.x
   Asawa Y, 2004, J ELECTRON MICROSC, V53, P423, DOI 10.1093/jmicro/dfh057
   BAUMEISTER W, 1986, J MOL BIOL, V187, P241, DOI 10.1016/0022-2836(86)90231-7
   Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230
   BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8
   Brink J, 1998, J MICROSC-OXFORD, V191, P67
   BROWNING ND, 2006, P INT C MICR IMC SAP, V1
   Busch S, 1999, EUR J INORG CHEM, P1643
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Cheong GW, 1996, J STRUCT BIOL, V117, P138, DOI 10.1006/jsbi.1996.0078
   Danev R, 2002, J BIOL PHYS, V28, P627, DOI 10.1023/A:1021234621466
   Danev R, 2001, J PHYS SOC JPN, V70, P696, DOI 10.1143/JPSJ.70.696
   Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868
   Ehrlich H, 2005, Z ANORG ALLG CHEM, V631, P1825, DOI 10.1002/zaac.200500195
   Ehrlich H., 2005, BIOMATERIALIEN, V6, P297
   Fink HW, 1997, J OPT SOC AM A, V14, P2168, DOI 10.1364/JOSAA.14.002168
   FRANK J, 2006, 3 DIMENSIONAL ELECT
   FUJIYOSHI Y, 1981, ULTRAMICROSCOPY, V7, P189, DOI 10.1016/0304-3991(81)90009-7
   GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0
   GELMAN RA, 1978, BIOPHYS J, V21, pA39
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   GLAESER RM, 1978, J MICROSC-OXFORD, V112, P127, DOI 10.1111/j.1365-2818.1978.tb01160.x
   GRUBB DT, 1984, ULTRAMICROSCOPY, V12, P279, DOI 10.1016/0304-3991(83)90241-3
   Guille MMG, 2005, MICRON, V36, P602, DOI 10.1016/j.micron.2005.07.005
   Gutsmann T, 2003, BIOPHYS J, V84, P2593, DOI 10.1016/S0006-3495(03)75064-4
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   HAN KF, 1995, J MICROSC-OXFORD, V178, P107, DOI 10.1111/j.1365-2818.1995.tb03586.x
   HANDLIN DL, 1983, MACROMOLECULES, V16, P1514, DOI 10.1021/ma00243a019
   Harris JR, 2002, MICRON, V33, P461, DOI 10.1016/S0968-4328(01)00039-7
   HARRIS JR, 1991, MICRON MICROSC ACTA, V22, P341, DOI 10.1016/0739-6260(91)90053-3
   HARSCHER A, 1999, THESIS U TUBINGEN GE
   He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200
   Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8
   HUHLE R, 2001, DREI EL INNSB AUSTR, P76
   Kaneko Y, 2006, J BACTERIOL, V188, P805, DOI 10.1128/JB.188.2.805-808.2006
   Kaneko Y, 2005, J ELECTRON MICROSC, V54, P79, DOI 10.1093/jmicro/dfh105
   KAWASAKI T, 1986, J ELECTRON MICROSC, V35, P211
   KELLENBERGER E, 1986, MICRON MICROSC ACTA, V17, P107, DOI 10.1016/0739-6260(86)90041-9
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   KNAPEK E, 1982, ULTRAMICROSCOPY, V10, P71, DOI 10.1016/0304-3991(82)90189-9
   Lednicky F, 2003, J MACROMOL SCI PHYS, VB42, P1039, DOI 10.1081/MB-120023556
   Lehmann M, 2002, MICROSC MICROANAL, V8, P447, DOI 10.1017/S1431927602020147
   Lichte H, 2002, PHILOS T R SOC A, V360, P897, DOI 10.1098/rsta.2001.0973
   LICHTE H, 1998, P INT C EL MICR ICEM, V14, P559
   LICHTE H, 2002, ELECT HOLOGRAPHY POW, V123, P225
   LICHTE H, 1988, I PHYS C SER, V93, P325
   Lichte H, 2007, ANNU REV MATER RES, V37, P539, DOI 10.1146/annurev.matsci.37.052506.084232
   Lin AC, 2002, PROTEINS, V49, P378, DOI 10.1002/prot.10224
   Massover WH, 2001, ULTRAMICROSCOPY, V90, P7, DOI 10.1016/S0304-3991(01)00131-0
   Massover WH, 2007, J SYNCHROTRON RADIAT, V14, P116, DOI 10.1107/S0909049506052307
   MATSUMOTO T, 1995, OPTIK, V100, P71
   Mertig M, 2001, EUR PHYS J D, V16, P317, DOI 10.1007/s100530170119
   MILES MJ, 2006, P INT C MICR IMC16 S, V1, P1800
   Ono T, 2005, MATRIX BIOL, V24, P239, DOI 10.1016/j.matbio.2005.02.001
   Osawa T, 2002, J ELECTRON MICROSC, V51, P341, DOI 10.1093/jmicro/51.5.341
   Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1
   Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1
   PETERMANN J, 1975, PHILOS MAG, V31, P929, DOI 10.1080/14786437508229642
   Prigent M, 2001, J PHYS D APPL PHYS, V34, P1167, DOI 10.1088/0022-3727/34/8/307
   Prostak KS, 1996, CALCIFIED TISSUE INT, V59, P474, DOI 10.1007/BF00369213
   REIMER L, 1989, SPRINGER SEREIS OPTI
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   Shindo D, 2007, J ELECTRON MICROSC, V56, P1, DOI 10.1093/jmicro/dfl039
   Simon P, 2006, ANGEW CHEM INT EDIT, V45, P1911, DOI 10.1002/anie.200504465
   Simon P, 2005, Z ANORG ALLG CHEM, V631, P983, DOI 10.1002/zaac.200400560
   Simon P, 2005, J APPL POLYM SCI, V96, P1573, DOI 10.1002/app.21600
   Simon P, 2004, J MATER CHEM, V14, P2218, DOI 10.1039/b402627f
   Simon P, 2004, BBA-BIOMEMBRANES, V1663, P178, DOI 10.1016/j.bbamem.2004.03.005
   Simon P, 2003, ADV MATER, V15, P1475, DOI 10.1002/adma.200301645
   Simon P, 2002, CHEM MATER, V14, P1505, DOI 10.1021/cm011140q
   SLEYTR UB, 1996, CRYSTALLINE BACTERIA, P5
   Snoeck E., 2006, P IMC16 INT MICR C I, V2, P730
   Spence JCH, 1997, MICRON, V28, P101, DOI 10.1016/S0968-4328(97)00008-5
   Stark H, 1996, ULTRAMICROSCOPY, V63, P75, DOI 10.1016/0304-3991(96)00045-9
   SUGINAGA N, 2006, P INT C MICR IMC 16, V1, P78
   Takai Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357564
   Takaoka A, 2006, J ELECTRON MICROSC, V55, P157, DOI [10.1093/jmicro/dfl016, 10.1093/jmicro/df1016]
   Thalhammer S, 2001, J ARCHAEOL SCI, V28, P1061, DOI 10.1006/jasc.2000.0644
   TROTTER JA, 1989, CELL TISSUE RES, V258, P527
   Tzaphlidou M, 2005, MICRON, V36, P593, DOI 10.1016/j.micron.2005.05.009
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   Volkl E., 1999, INTRO ELECT HOLOGRAP
   Vyalikh DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238103
   WADE RH, 1992, ULTRAMICROSCOPY, V46, P145, DOI 10.1016/0304-3991(92)90011-8
   WAHL R, 2003, THESIS TU DRESDEN GE
   Wang YC, 1998, MICROSC MICROANAL, V4, P146, DOI 10.1017/S143192769898014X
   Weierstall U, 1999, MICRON, V30, P335, DOI 10.1016/S0968-4328(99)00022-0
   Weierstall U, 1996, ULTRAMICROSCOPY, V65, P13, DOI 10.1016/S0304-3991(96)00050-2
   WOODCOCK CL, 1990, EUR J CELL BIOL, V51, P45
   Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398
   Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127
   2000, WORKSH HIGH RES EL M
NR 96
TC 24
Z9 24
U1 2
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PY 2008
VL 39
IS 3
BP 229
EP 256
DI 10.1016/j.micron.2006.11.012
PG 28
WC Microscopy
SC Microscopy
GA 282XT
UT WOS:000254601500002
PM 17374487
DA 2018-10-19
ER

PT S
AU Chattopadhyay, B
   Biswas, M
   Mandal, S
   Jonkers, HM
   Ye, G
AF Chattopadhyay, Brajadulal
   Biswas, Mousurni
   Mandal, Saroj
   Jonkers, Henk M.
   Ye, Guang
BE Sun, W
   VanBreugel, K
   Miao, C
   Ye, G
   Chen, H
TI EFFECT OF MICROBIAL PROTEIN ADDITIVE ON MICOSTRUCTURAL CHARACTERISTICS
   OF CONCRETE
SO MICROSTRUCTURE RELATED DURABILITY OF CEMENTITIOUS COMPOSITES, VOLS 1 AND
   2
SE RILEM Proceedings
LA English
DT Proceedings Paper
CT 1st International Conference on Microstructure Related Durability of
   Cementitious Composites
CY OCT 13-15, 2008
CL Nanjing, PEOPLES R CHINA
SP SE Univ, TUDelft, JSRIBS, CAE, Chinese Ceram Soc, Rilem, ACI
AB Reinforcement corrosion and crack formation are the major causes of limiting the durability or lifetime of concrete structures. A variety of additives or replacements of cement can be applied in order to improve the durability of the concrete. Cracking causes early deterioration of concrete what can be minimized by microbial - induced sealing or plugging of the cracks. This study was designed to describe the impact of a novel microbial protein on strength and microstructure characteristics of cement paste and mortar. The results presented in this article suggest that the novel microbial protein isolated from a Hot spring bacterium can be effective to increase the compressive strength and other physical properties of the cement paste and mortar. Microstructure analysis by ESEM and EDX show more hydration of the cement particles and increase of the calcium/silicon ratio of the CSH gel within the matrix in presence of the protein. The observed changes in micro-structural characteristics of the protein-amended cement paste, particularly with respect to increased uniformity of the matrix components, is reflected by strength improvement. This protein-amended cement-based biomaterial may be used for increasing durability and crack healing of concrete constructions in the future.
C1 [Chattopadhyay, Brajadulal; Biswas, Mousurni] Jadavpur Univ, Dept Phys, Kolkata, India.
   [Mandal, Saroj] Jadavpur Univ, Dept Civil Engn, Kolkata, India.
   [Ye, Guang] Delft Univ Technol, Dept Civil Engn & Geosci, Microlab, Delft, Netherlands.
RP Chattopadhyay, B (reprint author), Jadavpur Univ, Dept Phys, Kolkata, India.
RI ye, guang/F-1204-2014
OI ye, guang/0000-0001-8566-3863
FU Department of Biotechnology (DBT), New Delhi [BT/PR/5022 /
   BCE/08/338/2004]; Defence Research & Development Organization (DRDO),
   New Delhi [ERIP/ER/0403462/M/01]; DBT, New Delhi, through the Overseas
   Research Award; cooperation of Microlab; TU-Delft, Netherlands
FX The financial assistance to this experimental study received from
   Department of Biotechnology (DBT), New Delhi and their R & D grant and
   fileno BT/PR/5022 / BCE/08/338/2004 dated 29.03.2005 and Defence
   Research & Development Organization (DRDO), New Delhi and their R & D
   grant and file no ERIP/ER/0403462/M/01 dated 23.03.2005 are gratefully
   acknowledged. B.D. Chattopadhyay is gratefully acknowledged the
   financial assistance of DBT, New Delhi, through the Overseas Research
   Award and the cooperation of Microlab, TU-Delft, The Netherlands for
   carry out part of the work there.
CR Bang SS, 2001, ENZYME MICROB TECH, V28, P404, DOI 10.1016/S0141-0229(00)00348-3
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   CHATTOPADHYAY BD, 2008, P INT C MICR REL DUR
   De Graef B, 2005, MATER STRUCT, V38, P875, DOI 10.1617/14254
   De Muynck W, 2005, P INT C CONCR REP RE, P296
   Dick J, 2006, BIODEGRADATION, V17, P357, DOI 10.1007/s10532-005-9006-x
   Edvardsen C, 1999, ACI MATER J, V96, P448
   Ghosh P, 2005, CEMENT CONCRETE RES, V35, P1980, DOI 10.1016/j.cemconres.2005.03.005
   Ghosh P., 2006, Indian Journal of Experimental Biology, V44, P336
   GHOSH S, IND J CONCR RES
   Jonkers HM, 2007, SPRINGER SER MATER S, V100, P195, DOI 10.1007/978-1-4020-6250-6_9
   Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6
   MEHETA PK, 1993, CONCRETE MICROSTRUCT
   Ramachandran SK, 2001, ACI MATER J, V98, P3
   Rodriguez-Navarro C, 2003, APPL ENVIRON MICROB, V69, P2182, DOI 10.1128/AEM.69.4.2182-2193.2003
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
NR 16
TC 0
Z9 0
U1 0
U2 7
PU R I L E M PUBLICATIONS
PI BAGNEUX
PA 157 RUE DES BLAINS, 92220 BAGNEUX, FRANCE
SN 1461-1147
BN 978-2-35158-065-3
J9 RILEM PROC
PY 2008
VL 61
BP 263
EP +
PG 3
WC Materials Science, Composites
SC Materials Science
GA BIQ82
UT WOS:000262079600030
DA 2018-10-19
ER

PT J
AU Proudana, M
   Bojin, D
   Ionita, D
   Popa, M
   Vasilescu, E
   Drob, P
AF Proudana, M.
   Bojin, D.
   Ionita, D.
   Popa, M.
   Vasilescu, E.
   Drob, P.
TI Biomimetic hybrid inorganic/organic coatings in the increasing of the
   integration capacity of TiAlVZr bioalloy
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Frontiers of Polymers and Advanced
   Materials
CY JUL 08-12, 2007
CL Cracow, POLAND
DE albumin; bioalloy; hybrid materials; hydroxyapatite (HA)
ID TREATED TITANIUM; ALLOY
AB This paper will address key issues related to the synthesis, characterization and utilization of inorganic/organic hybrid coatings on TiAlVZr bioalloy to control adsorption at interface and the integration capacity of the implant. To enhance the integration capacity function of the biomaterial is necessary to control the composition and structure via the use of hybrid materials consisting of organic and inorganic biomimetic phases [1,2]. Such composite coatings mimic the structure of natural materials of tissues, in our case hydroxyapatite (HA) by association of bovine serum albumin (BSA) with calcium phosphates matrices. Calcium phosphate coating have been deposited on metal substrates by electrochemical method.
C1 [Proudana, M.; Bojin, D.; Ionita, D.] Polytechn Univ Bucharest, Fac Appl Chem & Mat Sci, Dept Gen Chem, Bucharest 011061, Romania.
   [Popa, M.; Vasilescu, E.; Drob, P.] Romania Acad, Inst Phys Chem, Bucharest, Romania.
RP Proudana, M (reprint author), Polytechn Univ Bucharest, Fac Appl Chem & Mat Sci, Dept Gen Chem, Str Polizu 1, Bucharest 011061, Romania.
EM prodana_mariana@yahoo.com
RI Popa, Monica/C-4370-2011; Vasilescu, Ecaterina/C-5129-2013; Drob,
   Paula/C-5170-2013; Bojin, Dionezie/C-6759-2012
OI Popa, Monica/0000-0002-5661-5931; Drob, Paula/0000-0001-7556-7018;
   Vasilescu, Ecaterina/0000-0002-0295-1585
CR Cheng XL, 2004, BIOMATERIALS, V25, P5395, DOI 10.1016/j.biomaterials.2003.12.045
   Demetrescu I, 2004, MOL CRYST LIQ CRYST, V418, P999, DOI 10.1080/15421400490479433
   IBREKTSSON T, 1998, J ORAL MAXILLOFAC SU, V56, P1312
   Ionita D, 2007, KEY ENG MATER, V330-332, P545, DOI 10.4028/www.scientific.net/KEM.330-332.545
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Lim YJ, 2001, INT J ORAL MAX IMPL, V16, P333
   MANSFELD F, 1991, CORROS SCI, V32, P247, DOI 10.1016/0010-938X(91)90072-W
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wu Y, 2007, KEY ENG MATER, V330-332, P581, DOI 10.4028/www.scientific.net/KEM.330-332.581
NR 9
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2008
VL 486
BP 1175
EP 1181
DI 10.1080/15421400801917890
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 305NV
UT WOS:000256186000013
DA 2018-10-19
ER

PT J
AU Sovar, MM
   Man, I
   Demetrescu, I
AF Sovar, M. M.
   Man, I.
   Demetrescu, I.
TI Enhancing corrosion resistance of CoCr alloy using bioactive phosphate
   deposition
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Frontiers of Polymers and Advanced
   Materials
CY JUL 08-12, 2007
CL Cracow, POLAND
DE biocompatibility; chemical phosphate deposition; CoCr alloy;
   electrochemical behaviour; surface analysis
ID CR-MO
AB The present study focused on the connection between biocompatibility and corrosion resistance for a CoCr alloy. The behavior of a CoCr biomaterial was studied by electrochemical (cyclic voltametry), Fourier transform infra-red spectroscopy (FTIR), surface analysis techniques as scanning electronic microscope (SEM) and X-ray diftractometer (XRD). The surface analysis confirms electrochemical data and the effect of bioactive film on stability.
C1 [Sovar, M. M.; Man, I.; Demetrescu, I.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Sovar, MM (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Str Polizu 1, Bucharest 011061, Romania.
EM ela_magda@yahoo.com
CR Aionicesei E, 2006, REV CHIM-BUCHAREST, V57, P813
   Bocardo J. C. E, 2005, ADV TECHNOL MAT MAT, V7, P141
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Ionita D, 2007, KEY ENG MATER, V330-332, P545, DOI 10.4028/www.scientific.net/KEM.330-332.545
   Li F, 2002, SURF COAT TECH, V154, P88, DOI 10.1016/S0257-8972(01)01710-8
   Marti A, 2000, INJURY, V31, P18, DOI [10.1016/S0020-1383(00)80018-2), DOI 10.1016/S0020-1383(00)80018-2]
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   Thamaraiselvi TV, 2005, TRENDS BIOMATER ARTI, V18, P242
   YASZEMSKI MJ, 2003, BIOMATERIALS ORTHOPE, P72
NR 9
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1542-1406
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2008
VL 486
BP 1182
EP 1188
DI 10.1080/15421400801917924
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 305NV
UT WOS:000256186000014
DA 2018-10-19
ER

PT J
AU Oyen, ML
AF Oyen, Michelle L.
TI The materials science of bone: Lessons from nature for biomimetic
   materials synthesis
SO MRS BULLETIN
LA English
DT Article
ID MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; BIOPHYSICAL PRINCIPLES;
   CORTICAL BONE; BIOLOGICAL-MATERIALS; COLLAGEN FIBRILS; TISSUE;
   SCAFFOLDS; COMPOSITES; BIOMINERALIZATION
AB There has been considerable recent interest in natural bone as a material, due in part to its interesting combination of mechanical properties: bone is stiff and tough but lightweight. This unusual combination of properties results from a nanocomposite structure of approximately equal volumes of mineral and hydrated organic matter. Much recent effort has been focused on the structure, properties, and performance at different length scales relative to the hierarchical organization of bone. Historically, such bone research has emphasized clinical and medical aspects, including engineering materials for bone augmentation or replacement, bone-biomaterial interactions and interfaces, and more recently, scaffolds for bone tissue engineering. However, within the fast-growing biomimetics field, the bone extracellular matrix is taken as a model for materials development. Efforts have been made both to mimic the bony material itself as well as to mimic the process by which bone forms.
RI Oyen, Michelle/B-1600-2008
OI Oyen, Michelle/0000-0002-3428-748X
CR Ager JW, 2006, J MATER RES, V21, P1878, DOI 10.1557/JMR.2006.0242
   Alberts B, 1994, MOL BIOL CELL
   An KN, 2004, BIORHEOLOGY, V41, P239
   An Y. H., 2000, MECH TESTING BONE BO
   Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102
   Becker R O, 1982, ELECTROMAGNETISM LIF
   Bembey AK, 2006, J MATER RES, V21, P1962, DOI 10.1557/JMR.2006.0237
   BERNHARDT A, 2007, J MAT SCI MAT M 0628
   BONUCCI E, 2000, MECH TESTING BONE BO, P3
   Boskey A L, 1998, J Cell Biochem Suppl, V30-31, P83
   Boskey AL, 1998, CALCIFIED TISSUE INT, V63, P179, DOI 10.1007/s002239900511
   Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007
   Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   CLARKE DR, 1992, J AM CERAM SOC, V75, P739, DOI 10.1111/j.1151-2916.1992.tb04138.x
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   COWIN SC, 2001, BONE MECH HDB
   Currey J. D., 2002, BONES STRUCTURE MECH
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954
   Deer W. A., 1966, INTRO ROCK FORMING M
   Donnelly E, 2006, J MATER RES, V21, P2106, DOI 10.1557/JMR.2006.0259
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   FRATZL P, 2007, R SOC INTERFACE, V4, P637
   Freeman JW, 2004, J THEOR BIOL, V229, P371, DOI 10.1016/j.jtbi.2004.04.018
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hellmich C, 2002, J BIOMECH, V35, P1199, DOI 10.1016/S0021-9290(02)00080-5
   Hellmich C, 2004, BIOMECH MODEL MECHAN, V2, P219, DOI 10.1007/S10237-004-0040-0
   Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4
   Holland F., 2003, BIOGEOCHEIMISTRY, V8, P117
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huiskes R, 2005, BASIC ORTHOPAEDIC BI, P123
   Jaasma MJ, 2002, J BIOMECH, V35, P237, DOI 10.1016/S0021-9290(01)00193-2
   Jaeger C, 2005, CHEM MATER, V17, P3059, DOI 10.1021/cm050492k
   Jager I, 2000, BIOPHYS J, V79, P1737
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Karp JM, 2003, MRS BULL, V28, P301, DOI 10.1557/mrs2003.85
   KATZ JL, 1971, J BIOMECH, V4, P455, DOI 10.1016/0021-9290(71)90064-9
   Ko CC, 2006, J MATER RES, V21, P3090, DOI 10.1557/JMR.2006.0394
   Kotha SP, 2002, J THEOR BIOL, V219, P269, DOI 10.1006/yjtbi.3120
   Lagziel-Simis S, 2006, CURR OPIN BIOTECH, V17, P569, DOI 10.1016/j.copbio.2006.10.005
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010
   Leventouri T, 2006, BIOMATERIALS, V27, P3339, DOI 10.1016/j.biomaterials.2006.02.021
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mann S, 1999, J STRUCT BIOL, V126, P179, DOI 10.1006/jsbi.1999.4131
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P635, DOI 10.1016/j.ijom.2004.04.006
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P325, DOI 10.1016/S0901-5027(03)00199-1
   Noris-Suarez K, 2007, BIOMACROMOLECULES, V8, P941, DOI 10.1021/bm060828z
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Oyen ML, 2007, J MATER SCI-MATER M, V18, P623, DOI 10.1007/s10856-007-2311-7
   Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033
   Rho JY, 1999, BONE, V25, P295, DOI 10.1016/S8756-3282(99)00163-5
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sanford K, 2005, CURR OPIN BIOTECH, V16, P416, DOI 10.1016/j.copbio.2005.06.002
   SASAKI N, 1995, J BIOMECH, V28, P809, DOI 10.1016/0021-9290(94)00130-V
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   Song J, 2005, J AM CHEM SOC, V127, P3366, DOI 10.1021/ja043776z
   Subburaman K, 2006, P NATL ACAD SCI USA, V103, P14672, DOI 10.1073/pnas.0602952103
   Tai K, 2007, NAT MATER, V6, P454, DOI 10.1038/nmat1911
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
   Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 85
TC 16
Z9 16
U1 3
U2 15
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2008
VL 33
IS 1
BP 49
EP 55
DI 10.1557/mrs2008.14
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 257ZW
UT WOS:000252839200016
DA 2018-10-19
ER

PT S
AU Yang, CW
   Lui, TS
AF Yang, Chung-Wei
   Lui, Truan-Sheng
BE Lau, AKT
   Lu, J
   Varadan, VK
   Chang, FK
   Tu, JP
   Lam, PM
TI Statistical analysis on bonding strength and failure mechanism of
   plasma-sprayed HA coating with reinforced intermediate layers
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2
SE ADVANCED MATERIALS RESEARCH
LA English
DT Proceedings Paper
CT International Conference on Multifunctional Materials and Structures
CY JUL 28-31, 2008
CL Hong Kong, PEOPLES R CHINA
DE biomaterial; composite coating; strength; failure mechanism; statistics;
   Weibull model
ID COMPOSITE COATINGS; HYDROXYAPATITE; MICROSTRUCTURE; PHASE
AB Experimental results showed that both of commercial pure titanium (CP-Ti) and yttria-stabilized zirconia (YSZ) intermediate layers significantly enhanced the bonding strength of HACs (one-way ANOVA test, p 0.05). On the basis of fracture morphologies and bonding strength data fluctuation, the Weibull model provided a powerful statistical analysis for assessing the failure mechanism and the reliability of composite coatings. Plasma-sprayed HACs were reliable materials with a right shift wear-out failure model (m > 3) of increasing failure rate (IFR). The HA composite coatings remained in tack on the substrate, which represented better reliability and less dissociation for further applications. The measured bonding strength of HACs was a combination of adhesive and cohesive strength of a coating layer. The area fraction of adhesive failure tended to decrease with introducing the reinforced intermediate layer, especially for the HA/YSZ composite coating. The decrease of adhesive failure area fraction represented good interlocking between the coating/substrate interfaces. The knowledge of fracture behaviour in HACs with reinforced intermediate layers will be very helpful for the understanding and prediction of the bonding strength.
C1 [Yang, Chung-Wei; Lui, Truan-Sheng] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.
RP Yang, CW (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, 1 Univ Rd, Tainan 70101, Taiwan.
CR Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   CRIST BV, 2000, HDB MONOCHROMATIC XP, P49
   Fu L, 2001, SURF COAT TECH, V140, P263, DOI 10.1016/S0257-8972(01)01168-9
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V276, P160, DOI 10.1016/S0921-5093(99)00495-5
   Kurzweg H, 1998, J MATER SCI-MATER M, V9, P9, DOI 10.1023/A:1008822309486
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   Lamy D, 1996, J MATER RES, V11, P680
   Lima RS, 2001, SURF COAT TECH, V135, P166, DOI 10.1016/S0257-8972(00)00997-X
   MUNTING E, 1990, CRC HDB BIOACTIVE CE, P143
   TRUSTRUM K, 1983, J MATER SCI, V18, P2765, DOI 10.1007/BF00547593
   Villora JM, 2004, J EUR CERAM SOC, V24, P589, DOI 10.1016/S0955-2219(03)00245-0
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Yang CW, 2007, MATER TRANS, V48, P211, DOI 10.2320/matertrans.48.211
   YANG CW, 2008, J EUR CERAM IN PRESS
NR 14
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-378-4
J9 ADV MAT RES
PY 2008
VL 47-50
BP 1007
EP 1010
DI 10.4028/www.scientific.net/AMR.47-50.1007
PN 1-2
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BID78
UT WOS:000258807900247
DA 2018-10-19
ER

PT S
AU Kim, YK
   Lee, MH
   Prasad, MN
   Park, IS
   Lee, MH
   Seol, KW
   Bae, TS
AF Kim, Yu Kyong
   Lee, Man Hyung
   Prasad, Madhav Nepane
   Park, Il Song
   Lee, Min Ho
   Seol, Kyeong Won
   Bae, Tae Sung
BE Lau, AKT
   Lu, J
   Varadan, VK
   Chang, FK
   Tu, JP
   Lam, PM
TI Surface characteristics of magnesium alloys treated by anodic oxidation
   using pulse power
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Multifunctional Materials and Structures
CY JUL 28-31, 2008
CL Hong Kong, PEOPLES R CHINA
DE magnesium oxidation; pulse supply; AZ91D; AZ31B
ID MICROARC OXIDATION; TITANIUM-ALLOYS; COATINGS; CORROSION; ELECTROLYTES;
   SILICATE; ALUMINUM
AB Magnesium has been proposed as an implant metal due to its low weight and inherent biocompatibility. However, it use as a biomaterial is seriously limited by its poor corrosion n resistance. Die-cast AZ91D and rolled AZ31B alloys, which are commercial magnesium alloys, were used in this study. After plasma anodization, SEM showed that the surface had a relatively high porosity with some micro-cracks. EDX revealed Mg, Al and Zn on the surface of the samples before anodization. After anodization, there was an increase in the oxygen EDX peak intensity with a concomitant decrease in the magnesium intensity. Anodized AZ91D had the best corrosion resistance according to the potentiodynamic polarization curves. After immersion in Hanks solution for 10 days, the untreated AZ31B sample had the highest pH value due to formation of OH- on the film surface.
C1 [Kim, Yu Kyong; Park, Il Song; Lee, Min Ho; Bae, Tae Sung] Chonbuk Natl Univ, Sch Dent, Jeon Ju 561756, South Korea.
   [Lee, Man Hyung; Prasad, Madhav Nepane; Park, Il Song; Seol, Kyeong Won] Chonbuk Natl Univ, Ctr Ind Technol, Div Adv Mat Engn & Res, Jeonju 561756, South Korea.
RP Kim, YK (reprint author), Chonbuk Natl Univ, Sch Dent, Jeon Ju 561756, South Korea.
EM merrywido@nate.com; mc911k@chonbuk.ac.kr; neumadhav@yahoo.com;
   ilsong@chonbuk.ac.kr; LMH@chonbuk.ac.kr; kwseol@chonbuk.ac.kr;
   bts@chonbuk.ac.kr
FU Korea Research Foundation Grant funded the Korean Government(MOEHRD)
   [KRF-2007-313-E00471]
FX This work was supported by the Korea Research Foundation Grant funded
   the Korean Government(MOEHRD) (KRF-2007-313-E00471).
CR BECK TR, 1983, J ELECTROCHEM SOC, V130, P1289, DOI 10.1149/1.2119940
   Cai QZ, 2006, SURF COAT TECH, V200, P3727, DOI 10.1016/j.surfcoat.2005.05.039
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Guo XW, 2004, SURF COAT TECH, V183, P359, DOI 10.1016/j.surfcoat.2003.09.045
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li WP, 2006, SURF COAT TECH, V201, P2505, DOI 10.1016/j.surfcoat.2006.04.024
   Rudnev VS, 2001, J ELECTROANAL CHEM, V497, P150, DOI 10.1016/S0022-0728(00)00483-6
   Shi ZM, 2006, CORROS SCI, V48, P1939, DOI 10.1016/j.corsci.2005.08.004
   TIMONOVA MA, 1972, METAL NEMETAL POKRYT, V81, P6
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   Xue WB, 2000, THIN SOLID FILMS, V372, P114, DOI 10.1016/S0040-6090(00)01026-9
   Yerokhin AL, 2002, APPL SURF SCI, V200, P172, DOI 10.1016/S0169-4332(02)00848-6
NR 12
TC 5
Z9 5
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-378-4
J9 ADV MATER RES-SWITZ
PY 2008
VL 47-50
BP 1290
EP +
DI 10.4028/www.scientific.net/AMR.47-50.1290
PN 1-2
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BID78
UT WOS:000258807900317
DA 2018-10-19
ER

PT S
AU Zhao, Y
   Yin, P
   Wang, ZY
   Ren, L
   Zhang, QQ
AF Zhao, Yang
   Yin, Pei
   Wang, Zu-Yong
   Ren, Lei
   Zhang, Qi-qing
BE Lau, AKT
   Lu, J
   Varadan, VK
   Chang, FK
   Tu, JP
   Lam, PM
TI Novel organic-inorganic hybrid nanoparticles as non-viral gene vector
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2
SE ADVANCED MATERIALS RESEARCH
LA English
DT Proceedings Paper
CT International Conference on Multifunctional Materials and Structures
CY JUL 28-31, 2008
CL Hong Kong, PEOPLES R CHINA
DE gene therapy; non-viral vector; hybrid; gelatin; siloxane
ID DNA DELIVERY; PLASMID DNA; POLYMERS; THERAPY
AB Novel hybrid biomaterial of gelatin-siloxane nanoparticles (GS NPs), with positive surface potential and lower cytotoxicity, was synthesized through a 2-step sol-gel process. The pDNA-GS NPs complex was formulated with high encapsulation efficiency, and exhibited and efficient transfection in vitro. We thus envision that the GS NPs material could serve as non-viral gene vectors for gene therapy.
C1 [Zhao, Yang; Yin, Pei; Wang, Zu-Yong; Ren, Lei; Zhang, Qi-qing] Xiamen Univ, Mat Coll, Biomed Engn Res Ctr, Xiamen 361005, Peoples R China.
RP Zhao, Y (reprint author), Xiamen Univ, Mat Coll, Biomed Engn Res Ctr, Xiamen 361005, Peoples R China.
RI Wang, Zuyong/J-6140-2017; ren, lei/G-3459-2010; Zhang, QQ/G-3361-2010;
   Zhao, Yang/J-2690-2014
OI Wang, Zuyong/0000-0003-0136-6402; ren, lei/0000-0003-2131-1601; 
CR Bloquel C, 2006, ADV DRUG DELIVER REV, V58, P1224, DOI 10.1016/j.addr.2006.07.023
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Kiuru M, 2008, GENE THER, V15, P329, DOI 10.1038/sj.gt.3303100
   Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637
   Kushibiki T, 2006, J CONTROL RELEASE, V112, P249, DOI 10.1016/j.jconrel.2006.02.003
   Liu SH, 2005, ADV MATER, V17, P1862, DOI 10.1002/adma.200500124
   Luten J, 2008, J CONTROL RELEASE, V126, P97, DOI 10.1016/j.jconrel.2007.10.028
   Ren L, 2001, J SOL-GEL SCI TECHN, V21, P115, DOI 10.1023/A:1011226104173
   Wood KC, 2008, BIOCONJUGATE CHEM, V19, P403, DOI 10.1021/bc700408r
NR 9
TC 1
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-378-4
J9 ADV MAT RES
PY 2008
VL 47-50
BP 1319
EP 1322
DI 10.4028/www.scientific.net/AMR.47-50.1319
PN 1-2
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BID78
UT WOS:000258807900324
DA 2018-10-19
ER

PT S
AU Sun, J
   Mu, XN
   Ding, TT
AF Sun, Jiao
   Mu, Xinning
   Ding, Tingting
BE Lau, AKT
   Lu, J
   Varadan, VK
   Chang, FK
   Tu, JP
   Lam, PM
TI Activation of MAPK and NF-kappa B induced by biomaterials in vascular
   endothelial cells
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2
SE ADVANCED MATERIALS RESEARCH
LA English
DT Proceedings Paper
CT International Conference on Multifunctional Materials and Structures
CY JUL 28-31, 2008
CL Hong Kong, PEOPLES R CHINA
DE endothelial cells (ECs); biomaterials; hemocompatibility; NF-kappa B;
   MAPK
ID EXPRESSION; INHIBITION
AB Materials used to make artificial vessels and hearts can cause thrombosis, thus hindering the development of these therapeutic aids. Endothelial cells (ECs) play a key role in thrombosis, so in this study, we used human umbilical vein endothelial cells (HUVEC) and tested the hemocompatibility of different biomaterials. We then measured the signal proteins MAPK (mitogen-activated protein kinase) and Nuclear Factor- kB (NF-kappa B) to investigate the correlation between their expression and the degree of hemocompatibility. The results showed that ECs in the polyurethane (PU-60) group had significantly more NF-kappa B than the negative control (P<0.5), To identify whether the increased expression of NF-kappa B was induced by MAPK activation, we investigated changes in phosphorylated MAPK. We found both MAPK and NF-kappa B are ideal indicators for evaluating the hemocompatibility of biomaterial.
C1 [Sun, Jiao; Mu, Xinning; Ding, Tingting] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Shanghai Biomat Res & Testing Ctr, Shanghai 200023, Peoples R China.
RP Sun, J (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Shanghai Biomat Res & Testing Ctr, Shanghai 200023, Peoples R China.
CR Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1
   Lin CW, 2007, BIOMATERIALS, V28, P1355, DOI 10.1016/j.biomaterials.2006.11.006
   Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Sun J, 2005, KEY ENG MAT, V288-289, P507, DOI 10.4028/www.scientific.net/KEM.288-289.507
   Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200
NR 6
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-378-4
J9 ADV MAT RES
PY 2008
VL 47-50
BP 1335
EP 1338
DI 10.4028/www.scientific.net/AMR.47-50.1335
PN 1-2
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BID78
UT WOS:000258807900328
DA 2018-10-19
ER

PT S
AU Wang, M
   Liu, Y
   Au, CL
   Lai, PK
   Leung, LY
   Chua, BH
AF Wang, Min
   Liu, Ya
   Au, Chun-Ling
   Lai, Pik-Ki
   Leung, Lai-Yee
   Chua, Boon-Heng
BE Lau, AKT
   Lu, J
   Varadan, VK
   Chang, FK
   Tu, JP
   Lam, PM
TI Deformation and fracture of bone analogue biomaterials having different
   polymer matrices
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Multifunctional Materials and Structures
CY JUL 28-31, 2008
CL Hong Kong, PEOPLES R CHINA
DE hydroxyapatite; tricalcium phosphate; Bioglass (R); polyethylene;
   polysulfone; polyhydroxybutyrate; composite; bone analogue; biomaterial
ID POLYETHYLENE; REPLACEMENT; HAPEX(TM); COMPOSITE
AB By mimicking the microstructure of human cortical bone, a variety of bioactive particle reinforced polymer composites have been developed for hard tissue repair. Apart from biological assessments, these composites must be fully evaluated in terms of their mechanical performance before they can be used in patients. The bioactive particles in these composites are normally hard (relative to matrix materials) and brittle bioceramics such as hydroxyapatite (HA), tricalcium phosphate (TCP), Bioglass (R), etc. The matrices can be either "biostable" polymers such as high density polyethylene (HDPE) and polysulfone (PSU) or biodegradable polymers such as polyhydroxybutyrate (PHB) and poly(L-lactide) (PLLA). These polymers on their own possess different mechanical properties and display different deformation behaviours. With the incorporation of various amounts of particulate HA, TCP or Bioglass (R), the bone analogue polymeric composites exhibit a spectrum of deformation and fracture characteristics. In our systematic studies of HA/HDPE, Bioglass (R)/HDPE, HA/PSU, HA/PHB, TCP/PHB and a few other bone analogues biomaterials over the past fifteen years, mechanical tests were conducted under a variety of loading conditions (tension, compression, bending, torsion, etc.). Comparisons of deformation and fracture behaviours of these composites were made and presented. The insights that have been gained are important for developing other bioactive ceramic-polymer composites.
C1 [Wang, Min; Liu, Ya; Au, Chun-Ling] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Min; Lai, Pik-Ki; Leung, Lai-Yee] Hong Kong Polytech Univ, Jockey Club Rehabil Engn Ctr, Hong Kong, Peoples R China.
   [Wang, Min; Chua, Boon-Heng] Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore, Singapore.
RP Wang, M (reprint author), Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM memwang@hku.hk
RI Leung, Lai Yee/H-8204-2013
FU UK; USA; Singapore; Hong Kong
FX Funding for our research on biomedical composites from various sources
   (UK, USA, Singapore, Hong Kong) is gratefully acknowledged. The
   assistance provided by technical staff in the University of London, UK,
   Nanyang Technological University, Singapore, the Hong Kong Polytechnic
   University and the University of Hong Kong, Hong Kong, is gratefully
   acknowledged.
CR Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Guild FJ, 1998, J MATER SCI-MATER M, V9, P497, DOI 10.1023/A:1008831720198
   Swain R. E., 1999, BIOMED ENG-APP BAS C, V11, P315
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   2006, 5 AS AUSTR C COMP MA
   2004, 7 WORLD BIOM C SYDN
NR 9
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-378-4
J9 ADV MATER RES-SWITZ
PY 2008
VL 47-50
BP 1391
EP +
DI 10.4028/www.scientific.net/AMR.47-50.1391
PN 1-2
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BID78
UT WOS:000258807900342
DA 2018-10-19
ER

PT S
AU Nikkola, L
   Vapalahti, K
   Harlin, A
   Seppala, J
   Ashammakhi, N
AF Nikkola, L.
   Vapalahti, K.
   Harlin, A.
   Seppala, J.
   Ashammakhi, N.
BE Paulino, GH
   Pindera, MJ
   Dodds, RH
   Rochinha, FA
   Dave, EV
   Chen, L
TI Nanostructured diclofenac sodium releasing material
SO MULTISCALE AND FUNCTIONALLY GRADED MATERIALS
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 9th International Conference on Multiscale and Functionally Graded
   Materials
CY OCT 15-18, 2006
CL Oahu, HI
SP Univ Illinois, Urbana Champaign, Univ Virginia, Fed Univ Rio de Janeiro
DE nano-fibers; electrospinning; drug release
ID NANOFIBROUS SCAFFOLD; DRUG-DELIVERY; STEM-CELLS; TISSUE; FIBERS; NANO
AB Various techniques have been developed to produce second generation biomaterials for tissue repair. These include extrusion, molding, salt leaching, spinning etc, but success in regenerating tissues has been limited. It is important to develop porous material, yet with a fibrous structure for it to be biomimetic. To mimic biological tissues, the extra-cellular matrix usually contains fibers in nano scale. To produce nanostructures, self-assembly or electrospinning can be used. Adding a drug release function to such a material may advance applications further for use in controlled tissue repair. This turns the resulting device into a multifunctional porous, fibrous structure to support cells and drug releasing properties in order to control tissue reactions. A bioabsorbable poly(epsilon-caprolactone-co-D,L lactide) 95/5 (PCL) was made into diluted solution using a solvent, to which was added 2w-% of diclofenac sodium (DS). Nano-fibers were made by electrospinning onto substrate. Microstructure of the resulting nanomat was studied using SEM and drug release profiles with UV/VIS spectroscopy. Thickness of the electrospun nanomat was about 2 mm. SEM analysis showed that polymeric nano-fibers containing drug particles form a highly interconnected porous nano structure. Average diameter of the nano-fibers was 130nm. There was a high burst peak in drug release, which decreased to low levels after one day. The used polymer has slow a degradation rate and though the nanomat was highly porous with a large surface area, drug release rule is slow. It is feasible to develop a nano-fibrous porous structure of bioabsorbable polymer, which is loaded with test drug. Drug release is targeted at improving the properties of biomaterial for use in controlled tissue repair and regeneration.
C1 [Nikkola, L.; Vapalahti, K.; Ashammakhi, N.] Tampere Univ Technol, Inst Biomat, POB 589, FIN-33101 Tampere, Finland.
   [Harlin, A.] Tampere Univ Technol, Inst Fiber Mat Sci, FIN-33101 Tampere, Finland.
   [Seppala, J.] Aalto Univ, FIN-02150 Espoo, Finland.
RP Nikkola, L (reprint author), Tampere Univ Technol, Inst Biomat, POB 589, FIN-33101 Tampere, Finland.
RI Seppala, Jukka/G-7698-2012
FU European Commission [NMP3-CT-2004-500283]; Technology Development Center
   in Finland (TEKES); Academy of Finland [73948]
FX Research funds from the European Commission (EXPERTISSUES Project
   NMP3-CT-2004-500283), Technology Development Center in Finland (TEKES)
   and the Academy of Finland (Center of Excellence 73948) are greatly
   appreciated.
CR *ESA, 2003, ESA NEWSL, V166
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   TAE HK, 2003, BIOMATERIALS, V24, P801
   TUAN, 2005, BIOMATERIALS, V26, P599
   USHIKI T, 1992, Acta Anatomica Nipponica, V67, P186
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092
   Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/0l.sla.0000143302.48223.7e
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 18
TC 1
Z9 1
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0492-2
J9 AIP CONF PROC
PY 2008
VL 973
BP 901
EP +
PG 3
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Mathematics, Applied; Materials Science, Characterization & Testing
SC Engineering; Materials Science; Mathematics
GA BHN30
UT WOS:000254471400144
DA 2018-10-19
ER

PT B
AU Singh, KA
   Brott, LL
   Grote, JG
   Naik, RR
AF Singh, Kristi A.
   Brott, Lawrence L.
   Grote, James G.
   Naik, Rajesh R.
GP IEEE
TI Inkjet Printing of DNA for Use in Bioelectronic Applications
SO NAECON 2008 - IEEE NATIONAL AEROSPACE AND ELECTRONICS CONFERENCE
LA English
DT Proceedings Paper
CT IEEE National Aerospace and Electronics Conference (NAECON 2008)
CY JUL 16-18, 2008
CL Dayton, OH
SP IEEE
ID FILMS
AB Biopolymers have received much attention lately for use in electronic applications. Salmon DNA complexed with cetyltrimethyl ammonium chloride (DNA-CTMA) produces a material soluble in organic solvents, enhancing the ease of processing. DNA-CTMA has shown promise as an electron blocking layer in organic light emitting diodes (OLEDs) and potential as a gate insulating material in field effect transistors (FETs). To realize an all bio-based FET, we are continuing to investigate the use of DNA as the semiconducting layer. In addition to tailoring the properties of the biomaterial to increase the conductivity, we are also trying to better characterize these materials and explore different deposition techniques. Inkjet printing offers an unique ability to reproducibly deposit materials in a spatially controlled fashion, using picoliter amounts with high throughput. This paper will present how parameters such as solvent evaporation rate and substrate influence film properties. The characterization of the resulting DNA films includes atomic force microscopy (AFM) and white light interferometry.
C1 [Singh, Kristi A.; Brott, Lawrence L.; Grote, James G.; Naik, Rajesh R.] USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
RP Singh, KA (reprint author), USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
CR BARTSCH CM, 2007, P SPIE, V6646
   Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   GARNETT E, 2006, ELECT MORPHOLOGICAL
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   GROVE M, 1999, P DISPL WORKS 99 SAN
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hagen JA, 2007, NANO LETT, V7, P133, DOI 10.1021/nl062342u
   Heckman EM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135205
   HECKMAN EM, 2006, ORGANIC PHOTONIC MAT, V6117
   Heckman EM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378400
   *MICROFAB, 1999, 9902 MICROFAB
   MOLESA S, 2003, MAT RES SOC S P, V769
   Singh B, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220488
   Soltman D, 2008, LANGMUIR, V24, P2224, DOI 10.1021/la7026847
   Steckl J., 2007, NATURE PHOTONICS, V1, P3
   Yu Z, 2007, APPL OPTICS, V46, P1507, DOI 10.1364/AO.46.001507
NR 17
TC 1
Z9 1
U1 2
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-2615-7
PY 2008
BP 107
EP 109
DI 10.1109/NAECON.2008.4806527
PG 3
WC Engineering, Aerospace; Engineering, Electrical & Electronic
SC Engineering
GA BKN28
UT WOS:000268668000022
DA 2018-10-19
ER

PT S
AU Sun, JY
   Tong, J
   Zhang, ZJ
AF Sun, J. Y.
   Tong, J.
   Zhang, Z. J.
BE Zhu, X
   Chou, SY
   Arakawa, Y
TI The specimen preparation methods for nanoindentation testing of
   biomaterials: a review
SO NANOPHOTONICS, NANOSTRUCTURE, AND NANOMETROLOGY II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 2nd Conference on Nanophotonics, Nanostructure and Nanometrology
CY NOV 12-14, 2007
CL Beijing, PEOPLES R CHINA
SP SPIE, Chinese Opt Soc
DE specimen preparation; nanoindentation; biomaterials
ID MECHANICAL-PROPERTIES; ELASTIC-MODULUS; CUTICLE; BONE; INDENTATION;
   HARDNESS
AB Nanoindenter provides an approach for assessing mechanical properties in micro-electronics devices and films based on quantitative, controlled nanoindentation of surfaces, with the convenience of modem automation. It is also suitable to measure mechanical properties of biomaterials. Nanoindenter for biomaterial testing in bone and dentin was widely used. Recently some studies of nanoindentation properties in insect were carried out. While the surface roughness of natural biomaterials problem should not to be ignored in nanoindentation testing. The surface roughness will critically affect the precision of result of nanoindentation testing and caused error data. In this paper, the biomaterials specimen preparation methods for nanoindentation testing will be reviewed.
C1 [Sun, J. Y.; Tong, J.] Jilin Univ, Coll Mech Sci & Engn, Key Lab Terrain Machine Bion Engn, Minist Educ, Changchun 130023, Jilin Province, Peoples R China.
   [Zhang, Z. J.] Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China.
   [Zhang, Z. J.] Jilin Univ, Coll Mech Sci & Engn, Changchun, Jilin, Peoples R China.
RP Sun, JY (reprint author), Jilin Univ, Coll Mech Sci & Engn, Key Lab Terrain Machine Bion Engn, Minist Educ, Changchun 130023, Jilin Province, Peoples R China.
FU National Natural Science Foundation of China [30600131, 50675087];
   National Science Fund for Distinguished Young Scholars of China
   [50025516]; Special Research Fund for the Doctoral Program of High
   Education of China [20060183067]; "Project 985" of Jilin University
FX This work was supported by National Natural Science Foundation of China
   (grant no. 30600131, 50675087), National Science Fund for Distinguished
   Young Scholars of China (grant no. 50025516) by Special Research Fund
   for the Doctoral Program of High Education of China (grant no.
   20060183067) and by Project 985 of Jilin University.
CR ANTHONY CFC, 2000, INTRO CONTACT MECH
   Arzt E, 2002, Z METALLKD, V93, P345, DOI 10.3139/146.020345
   Barbakadze N, 2006, J EXP BIOL, V209, P722, DOI 10.1242/jeb.02065
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Enders S, 2004, J MATER RES, V19, P880, DOI 10.1557/jmr.2004.19.3.880
   Fan Z, 2002, J ORTHOPAED RES, V20, P806, DOI 10.1016/S0736-0266(01)00186-3
   GEORGE M, 2004, EXP MECH, V42, P395
   Habelitz S, 2002, J BIOMECH, V35, P995, DOI 10.1016/S0021-9290(02)00039-8
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Haque F, 2003, SURF ENG, V19, P255, DOI 10.1179/026708403225007464
   HAY JL, 2000, ASM HDB MAT TESTING, V8
   Jamsa T, 2002, J BIOMECH, V35, P161, DOI 10.1016/S0021-9290(01)00203-2
   Kohane M, 2003, J BIOMED MATER RES A, V66A, P633, DOI 10.1002/jbm.a.10028
   Miyajima T, 2003, KEY ENG MAT, V240-2, P927, DOI 10.4028/www.scientific.net/KEM.240-242.927
   Ngan AHW, 2002, J MATER RES, V17, P2604, DOI 10.1557/JMR.2002.0377
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Povolo F, 2000, J ALLOY COMPD, V310, P392, DOI 10.1016/S0925-8388(00)00970-1
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Rho JY, 2001, ANN BIOMED ENG, V29, P1082, DOI 10.1114/1.1424913
   SALLY JM, 2003, J EUR CERAM SOC, V23, P2897
   Sarikaya M., 2002, 15 ASCE ENG MECH C J
   SCHERGE M, 2002, BIOL MICRO NANOTRIBI
   Sun JY, 2006, IEE P-NANOBIOTECHNOL, V153, P129, DOI [10.1049/ip-nbt:20050050, 10.1049/jp-nbt:20050050]
   SUN JY, UNPUB INFLUENCE WATE
   Tong J., 2004, J BIONIC ENG, V1, P221
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 27
TC 0
Z9 0
U1 1
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-0-8194-7006-5
J9 PROC SPIE
PY 2008
VL 6831
AR UNSP 68310H
DI 10.1117/12.756306
PG 6
WC Nanoscience & Nanotechnology; Instruments & Instrumentation; Optics
SC Science & Technology - Other Topics; Instruments & Instrumentation;
   Optics
GA BHN51
UT WOS:000254506100011
DA 2018-10-19
ER

PT J
AU Kumari, P
   Srivastava, MM
AF Kumari, Pushpa
   Srivastava, M. M.
TI Characterization of protein content of shelled Moringa oleifera seeds
   used for decontamination of arsenic from water bodies
SO NATIONAL ACADEMY SCIENCE LETTERS-INDIA
LA English
DT Article
DE biomaterial; arsenic; Moringa oleifera; cationic polypeptide; gel
   electrophoresis
ID AQUEOUS-SOLUTION; REMOVAL; BIOSORPTION; BIOMASS; CHROMIUM; POWDER;
   SYSTEM; ADSORBENTS; ADSORPTION
AB Shelled Moringa oleifera seeds (SMOS) has been explored as biomaterial for the decontamination of arsenic from waste water. SMOS derived protein is proposed as bioactive principle. Derived protein has been characterized for its electrophoretic nature [79.3% cationic and 20.7% anionic polypeptide]. Cationic polypeptide of the molecular weight (6-16kDa) seems to be a major contributor.
C1 [Kumari, Pushpa; Srivastava, M. M.] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282005, Uttar Pradesh, India.
RP Kumari, P (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282005, Uttar Pradesh, India.
EM smohanm@rediffmail.com
CR Abdel-Ghani NT, 2007, INT J ENVIRON SCI TE, V4, P67, DOI 10.1007/BF03325963
   Basu Arindam, 2003, Indian J Environ Health, V45, P143
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CACERES A, 1992, J ETHNOPHARMACOL, V36, P233, DOI 10.1016/0378-8741(92)90049-W
   Chandrashekar K., 2001, INT J MINER PROCESS, V68, P37
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Dangi SY, 2002, PHARM BIOL, V40, P144, DOI 10.1076/phbi.40.2.144.5847
   GONZALEZ RL, 2006, BIORESOURCE TECHNOL, V97, P178
   Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Goyal P, 2007, ARCH ENVIRON PROT, V33, P35
   Kumari P, 2005, J IND MICROBIOL BIOT, V32, P521, DOI 10.1007/s10295-005-0042-7
   Kumari P, 2006, INT J MINER PROCESS, V78, P131, DOI 10.1016/j.minpro.2005.10.001
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Martins RJE, 2004, WATER RES, V38, P693, DOI 10.1016/j.watres.2003.10.013
   MARUGANDAN S, 2001, J MED AROM PLANTS SC, V22, P56
   Pagnanelli F, 2003, CHEM ENG SCI, V58, P4709, DOI 10.1016/j.ces.2003.08.001
   Pagnanelli F, 2000, ENVIRON SCI TECHNOL, V34, P2773, DOI 10.1021/es99127g
   Sawalha MF, 2005, MICROCHEM J, V81, P122, DOI 10.1016/j.microc.2005.01.008
   Sharma P, 2006, BIORESOURCE TECHNOL, V97, P299, DOI 10.1016/j.biortech.2005.02.034
   Sharma P, 2007, BIORESOURCE TECHNOL, V98, P474, DOI 10.1016/j.biortech.2005.12.016
   Sharma P, 2007, CHEM SPEC BIOAVAILAB, V19, P175, DOI 10.3184/095422907X255938
   Srivastava M.M., 2005, ARCH ENVIRON PROT, V31, P59
   Ucun H, 2002, BIORESOURCE TECHNOL, V85, P155, DOI 10.1016/S0960-8524(02)00086-X
NR 23
TC 0
Z9 0
U1 1
U2 2
PU NATL ACAD SCIENCES INDIA
PI ALLAHABAD
PA 5 LAJPATRAI RD, ALLAHABAD 211002, INDIA
SN 0250-541X
J9 NATL ACAD SCI LETT
JI Natl. Acad. Sci. Lett.-India
PY 2008
VL 31
IS 5-6
BP 191
EP 195
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 331OB
UT WOS:000258020400008
DA 2018-10-19
ER

PT J
AU Scarcelli, G
   Yun, SH
AF Scarcelli, Giuliano
   Yun, Seok Hyun
TI Confocal Brillouin microscopy for three-dimensional mechanical imaging
SO NATURE PHOTONICS
LA English
DT Article
ID HIGH-RESOLUTION; BIOLOGICAL TISSUES; ELASTIC PROPERTIES;
   LIGHT-SCATTERING; SPECTROSCOPY; COLLAGEN; LENS; EYE
AB Acoustically induced inelastic light scattering, first reported in 1922 by Brillouin(1), allows non-contact, direct readout of the viscoelastic properties of a material and has widely been investigated for material characterization 2, structural monitoring 3 and environmental sensing'. Extending the Brillouin technique from point sampling spectroscopy to imaging modality(5) would open up new possibilities for mechanical imaging, but has been challenging because rapid spectrum acquisition is required. Here, we demonstrate a confocal Brillouin microscope based on a fully parallel spectrometer-a virtually imaged phased array-that improves the detection efficiency by nearly 100-fold over previous approaches. Using the system, we show the first cross-sectional Brillouin imaging based on elastic properties as the contrast mechanism and monitor fast dynamic changes in elastic modulus during polymer crosslinking. Furthermore, we report the first in situ biomechanical measurement of the crystalline lens in a mouse eye. These results suggest multiple applications of Brillouin microscopy in biomedical and biomaterial science.
C1 [Scarcelli, Giuliano; Yun, Seok Hyun] Harvard Univ, Wellman Ctr Photomed, Boston, MA 02114 USA.
   [Scarcelli, Giuliano; Yun, Seok Hyun] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Scarcelli, Giuliano; Yun, Seok Hyun] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02114 USA.
RP Yun, SH (reprint author), Harvard Univ, Wellman Ctr Photomed, 55 Fruit St, Boston, MA 02114 USA.
EM syun@hms.harvard.edu
OI scarcelli, giuliano/0000-0002-1736-077X
FU NIBIB NIH HHS [R21 EB008472, R21 EB008472-01A1]
CR Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Benassi P, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1832173
   Brillouin L., 1922, Annales de Physique, V17, P88
   Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241
   Comoglio PM, 2005, NAT MED, V11, P1156, DOI 10.1038/nm1105-1156
   Culshaw B, 1996, P IEEE, V84, P78, DOI 10.1109/5.476028
   DANIELMEYER HG, 1970, J ACOUST SOC AM, V47, P151, DOI 10.1121/1.1911448
   Diddams SA, 2007, NATURE, V445, P627, DOI 10.1038/nature05524
   DIL JG, 1982, REP PROG PHYS, V45, P285, DOI 10.1088/0034-4885/45/3/002
   Eloranta E., 2005, LIDAR RANGE RESOLVED, P143
   Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055
   FARIS GW, 1993, J OPT SOC AM B, V10, P587, DOI 10.1364/JOSAB.10.000587
   Fung YC, 1993, BIOMECHANICS MECH PR
   Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623
   HARLEY R, 1977, NATURE, V267, P285, DOI 10.1038/267285a0
   Heys KR, 2004, MOL VIS, V10, P956
   Itoh S, 1998, JPN J APPL PHYS 1, V37, P3134, DOI 10.1143/JJAP.37.3134
   Koski KJ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999857
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LEES S, 1990, CONNECT TISSUE RES, V24, P187, DOI 10.3109/03008209009152148
   LINDSAY SM, 1981, REV SCI INSTRUM, V52, P1478, DOI 10.1063/1.1136479
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   RANDALL J, 1982, PROC R SOC SER B-BIO, V214, P449, DOI 10.1098/rspb.1982.0021
   RANDALL J, 1979, PHILOS T R SOC A, V293, P341, DOI 10.1098/rsta.1979.0101
   Shirasaki M, 1996, OPT LETT, V21, P366, DOI 10.1364/OL.21.000366
   TANAKA H, 1995, PHYS REV LETT, V74, P1609, DOI 10.1103/PhysRevLett.74.1609
   VAUGHAN JM, 1980, NATURE, V284, P489, DOI 10.1038/284489a0
   Wang TD, 2003, OPT LETT, V28, P414, DOI 10.1364/OL.28.000414
   Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142
NR 30
TC 153
Z9 156
U1 3
U2 55
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-4885
J9 NAT PHOTONICS
JI Nat. Photonics
PD JAN
PY 2008
VL 2
IS 1
BP 39
EP 43
DI 10.1038/nphoton.2007.250
PG 5
WC Optics; Physics, Applied
SC Optics; Physics
GA 254OL
UT WOS:000252595800018
PM 19812712
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yamashita, T
   Zhang, HZ
   Deguchi, K
   Oota, K
   Tuchiya, A
   Lukic, V
   Nagotani, S
   Kamiya, T
   Abe, K
AF Yamashita, Toru
   Zhang, HanZhe
   Deguchi, Kentaro
   Oota, Kentaro
   Tuchiya, Atsushi
   Lukic, Violeta
   Nagotani, Shoko
   Kamiya, Tatsushi
   Abe, Koji
TI Vascular endothelial growth factor promotes brain tissue regeneration
   with a biomaterial polydimethylsiloxane-tetraethoxysilane
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Yamashita, Toru; Zhang, HanZhe; Deguchi, Kentaro; Oota, Kentaro; Tuchiya, Atsushi; Lukic, Violeta; Nagotani, Shoko; Kamiya, Tatsushi; Abe, Koji] Okayama Univ, Dept Neurol, Okayama, Japan.
NR 0
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2008
VL 61
BP S133
EP S133
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 381PJ
UT WOS:000261548100795
DA 2018-10-19
ER

PT B
AU Xu, T
   Yoo, JJ
AF Xu, Tao
   Yoo, James J.
BE SchulzeHagenest, D
TI Inkjet Printing Technology for Regenerative Medicine
SO NIP24/DIGITAL FABRICATION 2008: 24TH INTERNATIONAL CONFERENCE ON DIGITAL
   PRINTING TECHNOLOGIES, TECHNICAL PROGRAM AND PROCEEDINGS
LA English
DT Proceedings Paper
CT 24th Internationational Conference on Digital Printing
   Technologies/Digital Fabrication 2008
CY SEP 06-11, 2008
CL Pittsburgh, PA
SP Soc Imaging Sci & Technol, Imaging Soc Japan
ID COLLAGEN MATRIX; REPAIR
AB Tissue engineering and regenerative medicine has emerged as an innovative scientific field that focuses on development of new approaches for repairing cells, tissues and organs. While the current paradigm of utilizing combinations of biomaterial scaffolds and cells for tissue construction has shown to be effective, only a limited number of these technologies have been successfully translated to patients. This is due to various issues that are encountered in the tissue building process. Recent development of novel biomaterials, the discovery of new sources of cells, and advances in scaffold fabrication strategies are being applied to address these challenges. One of the challenges that hinder clinical translation is the inefficiency of current cell delivery methods. Living tissues maintain inherent multi-cellular heterogeneous structures, and rebuilding of such complex structures requires subtle arrangements of different cell types and extracellular matrix components at specific anatomical target sites. Inkjet printing technology has been proposed as a tool to address cell delivery concerns. In this session, this versatile method of building complex tissue structures will be discussed.
C1 [Xu, Tao; Yoo, James J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Xu, T (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RI Yoo, James/L-4850-2017
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   XU T, TISSUE ENG IN PRESS
   XU T, 2008, T ASME, V130
NR 8
TC 0
Z9 0
U1 0
U2 3
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 978-0-89208-279-7
PY 2008
BP 7
EP 9
PG 3
WC Computer Science, Hardware & Architecture; Imaging Science &
   Photographic Technology
SC Computer Science; Imaging Science & Photographic Technology
GA BIK55
UT WOS:000260411500002
DA 2018-10-19
ER

PT B
AU Chernoff, DA
AF Chernoff, Donald A.
BE Laudon, M
   Romanowicz, B
TI Atomic Force Microscopy of Pharmaceutical and Biological Materials
SO NSTI NANOTECH 2008, VOL 2, TECHNICAL PROCEEDINGS: LIFE SCIENCES,
   MEDICINE, AND BIO MATERIALS
LA English
DT Proceedings Paper
CT Nanotechnology Conference and Trade Show (Nanotech 2008)
CY JUN 01-05, 2008
CL Boston, MA
SP Accelrys Software, Ace Glass, Advance Reprod Corp, Adv Mat Technolog Pte Ltd, Agilent Technol, AIXTRON AG, AJA Int, ALM, Amuneal Mfg Corp, ANSYS, Anton Paar, Appl MicroStruct, Appl Surface Technol, Arkalon Chem Technolog, LLC, Arkema Grp, Artech House Publishers, Asemblon, ASML, Asylum Res, AZoNano, Banner & Witcoff, Beckman Coulter, Bio Nano Counsulting, BioForce Nanosci, Boneer Corp, Birck Nanotechnol Ctr, Purdue Univ, Discovery Pk, Brookhaven Instruments Corp, Buchanan Ingersoll & Rooney PC, Buhler AG, Business Week, Calif NanoSyst Inst, Capovani Brothers, Los Alamos, Ctr Integrated Nanotechnologies, Sandia Natl Labs, Ctr Integrated Nanotechnologies, Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Argonne Natl Lab, Ctr Nanoscale Mat, Cheap tubes, Clean Technol & Sustainable Ind Org, COMSOL, Cooley Godward Kronish LLP, Core Technol Grp, CRESTEC Corp, CSEM, CVI Melles Griot, Dept Innovat, Ind, Sci & Res, Digital Matrix, Draiswerke, ETH Zurich, Eulitha AG, Marks & Clerk, Marubent Techno Syst Corp, Massachusetts Technol Transfer Ctr, Mat Res Soc, Merck & Co, Microfluidics, Micromerit Instrument Corp, Microtrac, MINAT 2008, Messe Stuttgart, Minus K Technol, Misonix, Lawrence Berkeley Natl Lab, Mol Foundry, Motorola, Nano Korea 2008, Nano Sci & Technol Inst, nano tech 2009 Japan, Nano Technol Res Assoc Korea, NanoAndMore USA, NanoDynamics, NanoEurope 2008, NanoInk, Nanomotion, Nanon Imaging Ltd, NANOSENSORS, Nanosyst Initiat Munich, Nanotech No Europe 2008, nano Tox, Nano World AG, NCI, Natl Inst Stand & Technol, NIH, Natl Nanomfg Network, Natl Nanotechnol Infrastruct, GATech, Microelect Res Ctr, Nat Nano, Nat Publishing Grp, NETZSCH Fine Particle Technol LLC, NIL Technol ApS, Novomer, NTT Adv Technol Corp, Olympus Ind Amer, OSEC, Business Network Switzerland, Oxford Instruments, Particle Technol Labs, Penn State Univ, Photon Spectra, Physik Instrumente LP, picoDrill SA, Piezo Inst, PVD Prod, Q Sense, Quantum Analyt, Raith USA, European Patent Off, Evans Analyt Grp, EXAKT Technologies, First Nano, Flow Sci, FDA, Goodwin Procter LLP, Greater Houston Partnership, Greenberg Traurig LLP, Halcyonics, Headwaters Technol Innovat LLC, Heidelberg Instruments, Hielscher USA, HighNano Analyti, Hiscock & Barclay LLP, Hitachi High Technologies Amer, Hochschule Offenburg Univ Appl Sci, HOCKMEYER Equipment Corp, HORIBA Jobin Yvon, IBU-tec adv mat GmbH, IDA Ireland, ImageXpert, Inspec, Inc, IEEE, Inst Nanoscale & Quantum Sci & Technol Adv Res, IntelliSense Software Corp, Invest Germany, IOP Publishing, Italian Trade Commiss, JENOPTIK, Justus Liebig Univ, KAUST, Keithley Instruments, Kelvin Nanotechnol Ltd, Kodak, Kotobuki Ind Co, Ltd, Lake Shore Cryotron, MACRO M, NanoClay, Res Germany Land Ideas, RKS Legal Solut LLC, Dandia Natl Labs, Scottish Enterprise, SEMTech Solut, Serendip, Silvix Corp, SNS Nano Fiber Technol LLC, SoftMEMS LLC, Son & Mat, SW Nano Technologies, Specialty Coating Syst, Spectrum Labs, SPEX SamplePrep LLC, Springer, Sterne, Kessler, Goldstein & Fox PLLC, Strem Chem, Sukgyung A T Co, Lts, Surrey NanoSyst, SUSS MicroTec, Swissnanotech Pavilion, Taylor & Francis Grp LLC, CRC Press, TechConnect, Technovel Corp, Tekna Plasma Syst, Thinky Corp, Thomas Swan & Co Ltd, UGL Unicco, UK Trade & Investment, UniJet, Univ Munster, Univ Appl Sci, Univ Duisburg, Ctr Nanointegrat Duisburg, Vecco Instruments, Wasatch Mol Inc, Weidmann Plast Technol, Whiteman Osterman & Hanna LLP, Willy A Bachofen AG, WITec GmbH, World Gold Council
DE amorphous and crystalline particles; collagen; DNA; autoimmune diseases;
   AFM
AB We give four case studies showing how Atomic Force Microscopy is used in the pharmaceutical industry and in medical research. We look at structures on length scales from I nm to many pm. Lactose is perfectly stable until you look closely. Molecules diffuse on particle surfaces over time in response to temperature and humidity, causing unanticipated physical changes in bulk materials. Polymer microspheres are not spherical at all. More importantly, the crystalline vs amorphous form of tiny particles on the microsphere surface can affect flowability. Collagen is a monodisperse polymer when first synthesized, but is crosslinked when incorporated into living tissue. When tissue is processed to make an injectable biomaterial, it is helpful to see and measure the now-complex molecular structure. In the hunt for the molecular basis of disease, clinical, cellular, and chemical studies are essential. AFM visualization of a key peptide-DNA complex completed the picture for psoriasis.
C1 [Chernoff, Donald A.] Adv Surface Microscopy Inc, 3250 North Post Rd,Ste 120, Indianapolis, IN 46226 USA.
RP Chernoff, DA (reprint author), Adv Surface Microscopy Inc, 3250 North Post Rd,Ste 120, Indianapolis, IN 46226 USA.
EM donc@asmicro.com
CR Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228
   CHERNOFF D, 2003, COMPREHENSIVE DESK R
   CHERNOFF E, 1993, P 51 ANN M MICR SOC, P518
   Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116
   Price R, 2005, MICRON, V36, P519, DOI 10.1016/j.miccron.2005.04.003
NR 5
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4200-8504-4
PY 2008
BP 700
EP +
PG 2
WC Nanoscience & Nanotechnology; Medicine, General & Internal; Medicine,
   Research & Experimental; Materials Science, Biomaterials
SC Science & Technology - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine; Materials Science
GA BMF49
UT WOS:000272169900190
DA 2018-10-19
ER

PT J
AU Singh, M
   Mishra, AK
   Misra, NK
   Tandon, P
   Kunimoto, KK
   Gupta, VD
AF Singh, Mahendra
   Mishra, Abhishek K.
   Misra, Navnit K.
   Tandon, Poonain
   Kunimoto, Ko-Ki
   Gupta, V. D.
TI Phonon dispersion and heat capacity in microbial
   poly(epsilon-L-lysine)(M-epsilon-PL)
SO POLYMER JOURNAL
LA English
DT Article
DE microbial poly(epsilon-L-lysine); density-of-states; phonon dispersion;
   heat capacity
ID INELASTIC NEUTRON-SCATTERING; VIBRATIONAL DYNAMICS; L-LYSINE;
   NORMAL-MODES; STREPTOMYCES; CONFORMATION; SPECTROSCOPIES; POLYLYSINE;
   FORM; IR
AB Microbial poly(epsilon-L-lysine)(M-epsilon-PL) is a naturally occurring biomaterial which is water soluble, biodegradable, edible and non-toxic towards humans and environment. Normal mode analysis including phonon dispersion has been performed to understand completely the vibrational spectra of this polymer. Various characteristic features of the dispersion curves have been reported. The heat capacity is calculated as a function of temperature via, density-of-states in the range 1-450K.
C1 [Tandon, Poonain; Gupta, V. D.] Univ Lucknow, Dept Phys, Lucknow 226007, Uttar Pradesh, India.
   [Kunimoto, Ko-Ki] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan.
   [Mishra, Abhishek K.] Amity Univ, Amity Sch Engn, Dept Phys, Noida 201301, India.
   [Singh, Mahendra; Misra, Navnit K.] Brahmanand PG Coll, Kanpur 224008, Uttar Pradesh, India.
RP Tandon, P (reprint author), Univ Lucknow, Dept Phys, Lucknow 226007, Uttar Pradesh, India.
EM poonam_tandon@yahoo.co.uk
RI Tandon, Poonam/G-2247-2010; MISHRA, ABHISHEK/F-1329-2011
OI MISHRA, ABHISHEK/0000-0002-6129-5653
CR Agarwal R, 2004, POLYMER, V45, P5307, DOI 10.1016/j.polymer.2004.05.014
   ARVANITOYANNIS I, 1995, POLYMER, V36, P857, DOI 10.1016/0032-3861(95)93118-6
   Burman L, 1996, BIOPOLYMERS, V38, P53, DOI 10.1002/(SICI)1097-0282(199601)38:1<53::AID-BIP5>3.3.CO;2-N
   FUKUSHI H, 1993, CHEM EXPRESS, V8, P745
   GAYMANS RJ, 1993, POLYMER, V34, P4360, DOI 10.1016/0032-3861(93)90202-L
   Gupta A, 1997, POLYMER, V38, P2389, DOI 10.1016/S0032-3861(96)01000-2
   HIGGS PW, 1953, PROC R SOC LON SER-A, V220, P472, DOI 10.1098/rspa.1953.0200
   Ho YT, 2000, FOOD CHEM, V68, P449, DOI 10.1016/S0308-8146(99)00220-4
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   KUSHWAHA DRS, 1980, BIOPOLYMERS, V19, P219, DOI 10.1002/bip.1980.360190202
   Lee H. H., 1991, CHEM EXPRESS, V6, P683
   LEE HH, 1995, SPECTROSC LETT, V28, P177, DOI 10.1080/00387019508010070
   Maeda S, 2003, J MOL STRUCT, V655, P149, DOI 10.1016/S0022-2860(03)00218-7
   Misra NK, 1997, POLYM J, V29, P914, DOI 10.1295/polymj.29.914
   Misra NK, 2000, POLYMER, V41, P2095, DOI 10.1016/S0032-3861(99)00395-X
   Misra RM, 2004, EUR POLYM J, V40, P1787, DOI 10.1016/j.eurpolymj.2004.04.022
   Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0
   Papanek P, 1996, MACROMOLECULES, V29, P2253, DOI 10.1021/ma9512420
   Papanek P, 2002, MACROMOLECULES, V35, P4175, DOI 10.1021/ma011218o
   Porwal V, 2004, INDIAN J BIOCHEM BIO, V41, P34
   Sasaki S., 2001, POLYM PREP JPN, V50, P2003
   Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012
   SHIMA S, 1982, AGR BIOL CHEM TOKYO, V46, P1917, DOI 10.1080/00021369.1982.10865352
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2497, DOI 10.1080/00021369.1981.10864929
   SHIMA S, 1977, AGR BIOL CHEM TOKYO, V41, P1807, DOI 10.1080/00021369.1977.10862764
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2503, DOI 10.1080/00021369.1981.10864930
   Shukla SK, 2007, POLYM J, V39, P359, DOI 10.1295/polymj.PJ2006103
   TASUMI M, 1962, J MOL SPECTROSC, V9, P261, DOI 10.1016/0022-2852(62)90236-9
   Wilson EB, 1980, MOL VIBRATIONS THEOR
NR 29
TC 0
Z9 0
U1 0
U2 1
PU SOC POLYMER SCIENCE JAPAN
PI TOKYO
PA TSUKIJI DAISAN NAGAOKA BLDG, 2-4-2 TSUKIJI, CHUO-KU, TOKYO, 104, JAPAN
SN 0032-3896
J9 POLYM J
JI Polym. J.
PY 2008
VL 40
IS 6
BP 503
EP 512
DI 10.1295/polymj.PJ2007184
PG 10
WC Polymer Science
SC Polymer Science
GA 335LP
UT WOS:000258292400004
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhou, ZH
   Ruan, JM
   Zhou, ZC
   Zou, JP
AF Zhou Zhihua
   Ruan Jianming
   Zhou Zhongcheng
   Zou Jianpeng
TI Synthesis and properties of composite biomaterials based on
   hydroxyapatite and poly(L-lactide)
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE biocompatibility; composite; hydroxyapatite; poly(L-lactide);
   properties; synthesis
ID SOFT-TISSUE; DEGRADATION; LACTIDE; MATRIX
AB Composite biomaterial composed of poly(L-lactide) (PLLA) and hydroxyapatite (HA) was obtained by using the combination of solvent evaporation technique and hot pressing. HA particles in the PLLA matrix were homogeneously dispersed. A typical morphology of brittle failure with a smooth fracture surface was observed. The addition of HA particles changed significantly the appearance of the impact fracture surface to a pattern of multiple cracks. With the increasing of the amount of the HA, the bending strength of composite decreases while the bending modulus increases. The PLLA/HA composite exhibits improved cell compatibility due to the good biocompatibility of the HA particles.
C1 [Zhou Zhihua] Hunan Univ Sci & Technol, Coll Chem & Chem Engn, Xiangtan, Peoples R China.
   [Ruan Jianming; Zhou Zhongcheng; Zou Jianpeng] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
RP Zhou, ZH (reprint author), Hunan Univ Sci & Technol, Coll Chem & Chem Engn, Xiangtan, Peoples R China.
EM zhou7381@sohu.com
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   Ho MH, 2006, DESALINATION, V200, P501, DOI 10.1016/j.desal.2006.03.411
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Hu FX, 2006, BIOMATERIALS, V27, P5725, DOI 10.1016/j.biomaterials.2006.07.014
   Kang M. H., 1999, POLYMER, V40, P6147
   Niemela T, 2004, KEY ENG MAT, V254-2, P509, DOI 10.4028/www.scientific.net/KEM.254-256.509
   Peltoniemi HH, 1998, PLAST RECONSTR SURG, V101, P123, DOI 10.1097/00006534-199801000-00021
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Sakai W, 2002, POLYMER, V43, P6231, DOI 10.1016/S0032-3861(02)00443-3
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P57, DOI 10.1016/0278-2391(94)90016-7
   STAMBOULIS A, 2001, KEY ENG MATER, V192, P729
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   ZHANG HP, 2005, J CENTRAL S U TECHNO, V12, P113
   Zhou ZH, 2006, J CENT SOUTH UNIV T, V13, P608, DOI 10.1007/s11771-006-0001-0
   Zou JP, 2004, J CENT SOUTH UNIV T, V11, P113, DOI 10.1007/s11771-004-0024-3
NR 19
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2008
VL 47
IS 5
BP 496
EP 501
DI 10.1080/03602550801952300
PG 6
WC Polymer Science
SC Polymer Science
GA 292NZ
UT WOS:000255274700008
DA 2018-10-19
ER

PT J
AU Tan, HP
   Lao, LH
   Wu, JD
   Gong, YH
   Gao, CY
AF Tan, Huaping
   Lao, Lihong
   Wu, Jindan
   Gong, Yihong
   Gao, Changyou
TI Biomimetic modification of chitosan with covalently grafted lactose and
   blended heparin for improvement of in vitro cellular interaction
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE chitosan; lactose; heparin; chondrocytes; cell culture
ID FIBROBLAST-GROWTH-FACTOR; ARTICULAR-CARTILAGE; SURFACE MODIFICATION;
   SCAFFOLD; CHONDROCYTES; COLLAGEN; MICROSPHERES; MATRIX; ATTACHMENT;
   ADHESION
AB Lactose- and heparin-modified chitosan films were prepared and their physical and biological properties were compared with chitosan, chitosan-g-heparin, and chitosan-g-lactose films. Atomic force microscopy (AFM) measurement showed that all these films in the dry state were rather flat with a roughness smaller than 20 nm. While the chitosan-g-lactose/heparin and chitosan-g-lactose films have the highest swelling and weight loss ratios, the chitosan and chitosan-g-heparin films have the lowest. The chitosan-g-lactose/heparin film showed stronger ability to induce chondrocyte attachment, proliferation, viability, and glycosaminoglycan (GAG) secretion than that of the chitosan, chitosan-g-heparin, and chitosan-g-lactose films. Chondrocyte aggregates and nodules were observed on the chitosan-g-lactose/heparin and chitosan-g-lactose films, which still preserved viable metabolic ability. These results show that the lactose-modified and heparin-incorporated chitosan film can enhance the cell-biomaterial interaction synchronously. The resulting chitosan-g-lactose/heparin material is more bioactive that might be applicable as promising scaffold for chondrogenesis. Copyright (C) 2007 John Wiley & Sons, Ltd.
C1 [Tan, Huaping; Lao, Lihong; Wu, Jindan; Gong, Yihong; Gao, Changyou] Zhejiang Univ, Dept Polymer Sci & Engn, Key Lab Macromole Synth & Funct, Minist Educ, Hangzhou 310027, Peoples R China.
   [Tan, Huaping; Lao, Lihong; Wu, Jindan; Gong, Yihong; Gao, Changyou] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Key Lab Macromole Synth & Funct, Minist Educ, Hangzhou 310027, Peoples R China.
EM cygao@mail.hz.zj.cn
OI Gao, Changyou/0000-0001-5084-7208
CR Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   JASON AB, 2005, BIOMACROMOLECULES, V6, P386
   Kato Y, 2001, J CONTROL RELEASE, V70, P295, DOI 10.1016/S0168-3659(00)00356-4
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Ma L, 2004, J BIOMED MATER RES A, V71A, P334, DOI 10.1002/jbm.a.30170
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Marcon P, 2005, BIOMATERIALS, V26, P4975, DOI 10.1016/j.biomaterials.2005.01.044
   Narita T, 2000, BIOMACROMOLECULES, V1, P162, DOI 10.1021/bm9900085
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Sato T, 2001, MAT SCI ENG C-BIO S, V17, P83, DOI 10.1016/S0928-4931(01)00313-7
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUNIL S, 2003, BIOTECHNOL PROGR, V19, P510
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yasuda T, 2003, ARTHRITIS RHEUM, V48, P1271, DOI 10.1002/art.10951
NR 32
TC 25
Z9 25
U1 2
U2 17
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD JAN
PY 2008
VL 19
IS 1
BP 15
EP 23
DI 10.1002/pat.962
PG 9
WC Polymer Science
SC Polymer Science
GA 265TW
UT WOS:000253384800003
DA 2018-10-19
ER

PT S
AU Henderson, LA
   Kipper, MJ
   Chiang, MYM
AF Henderson, Lori A.
   Kipper, Matt J.
   Chiang, Martin Y. M.
BE Mahapatro, A
   Kulshrestha, AS
TI Beyond Trial and Error: Tools to Advance the Engineering of Biomaterials
SO POLYMERS FOR BIOMEDICAL APPLICATIONS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT International Symposium on Polymers for Biomedical Applications/232nd
   National Meeting of the American-Chemical-Society (ACS)
CY SEP 10-14, 2006
CL San Francisco, CA
SP Amer Chem Soc (ACS)
ID LAMININ ALPHA-1 CHAIN; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX;
   ENDOTHELIAL-CELLS; HUMAN-NEUTROPHILS; STOCHASTIC-MODEL; SINGLE-CELL;
   MIGRATION; GRADIENTS; CHEMOTAXIS
AB Tissue engineering and advanced medical technologies have the potential to dramatically improve the quality of human life. In order to move beyond empirical trial and error into design, biomaterials development is in urgent need of reliable measurement tools and techniques to engineer structures that meet specific physiological requirements for clinical use. This requires the development of design principles based on the physical understanding of how cells respond to molecular signals and integrate multiple inputs to generate a given biological response to their environment. Biomaterial scaffolds, for example, support cells, give tissues their form, and are an important source of information that drives cell fate. The definition and quantification of the type of relationships that trigger specific cell response to polymer composition and structure will enhance the rational design of tissue-engineered products. To meet this need, NIST is developing instruments, methodologies, and standards for the measurement of materials properties and cell response to properties on surfaces and in 3D scaffolds. Many tools and techniques were adapted (e.g., combinatorial libraries, biochemical assays, electron-, atomic force-, and fluorescence microscopy, etc.) to examine cell characteristics like adhesion, morphology, and migration as a function of the physical properties of biomaterials. This chapter introduces the characterization techniques and modeling tools used to obtain chemical, physical, and structural information that describe cell morphology and migration on different polymeric surfaces. The results identified key variables that impact the engineering and design of biomaterials.
C1 [Henderson, Lori A.; Kipper, Matt J.; Chiang, Martin Y. M.] Natl Inst Stand & Technol, Div Polymers, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
RI Kipper, Matt/B-6941-2013
OI Kipper, Matt/0000-0002-8818-745X
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   ALT W, 1980, J MATH BIOL, V9, P147, DOI 10.1007/BF00275919
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Bhat RR, 2005, J POLYM SCI POL PHYS, V43, P3384, DOI 10.1002/polb.20640
   BOAL DH, 2002, MECH CELL, P23
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Chesnoy S, 2000, ANNU REV BIOPH BIOM, V29, P27, DOI 10.1146/annurev.biophys.29.1.27
   DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   DEVANEY JE, 2005, SCI SPEED THOUGHT
   DICKINSON RB, 1995, SIAM J APPL MATH, V55, P1419, DOI 10.1137/S003613999223733X
   DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Dunkers JP, 2003, OPT EXPRESS, V11, P3074, DOI 10.1364/OE.11.003074
   Dunn G A, 1987, J Cell Sci Suppl, V8, P81
   Dunn G A, 1983, Agents Actions Suppl, V12, P14
   FARRELL BE, 1990, CELL MOTIL CYTOSKEL, V16, P279, DOI 10.1002/cm.970160407
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Gunawan RC, 2005, LANGMUIR, V21, P3061, DOI 10.1021/la048303k
   HADDOX JL, 1991, J IMMUNOL METHODS, V141, P41, DOI 10.1016/0022-1759(91)90208-W
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hypolite CL, 1997, BIOCONJUGATE CHEM, V8, P658, DOI 10.1021/bc9701252
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   KIPPER MJ, 2006, ANAL BIOCH UNPUB
   KIPPER MJ, 2006, BIOPHYS J UNPUB
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Malinda KM, 1999, FASEB J, V13, P53
   MCINTYRE LV, 2002, WTEC PANEL REPORT TI
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   NI Y, 2006, BIOPHYS J UNPUB
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Quist AP, 2005, ANAL BIOANAL CHEM, V381, P591, DOI 10.1007/s00216-004-2847-z
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   SALTZMAN MW, 2002, NAT REV DRUG DISCOV, V1, P177
   SHOICHET MS, 1998, POLYM TISSUE ENG, P19
   Smith AP, 2001, J POLYM SCI POL PHYS, V39, P2141, DOI 10.1002/polb.1188
   STOKES CL, 1991, J CELL SCI, V99, P419
   Suresh S, 2006, J MATER RES, V21, P1871, DOI 10.1557/JMR.2006.0260
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Van Vliet KJ, 2003, ACTA MATER, V51, P5881, DOI 10.1016/j.actamat.2003.09.001
   Walmod PS, 2004, EXP CELL RES, V295, P407, DOI 10.1016/j.yexcr.2004.01.011
   Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   WU P, 1994, ANN BIOMED ENG, V22, P144, DOI 10.1007/BF02390372
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723
   Zhang Y, 2003, POLYMER, V44, P3327, DOI 10.1016/S0032-3861(03)00185-X
NR 65
TC 1
Z9 1
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-3966-1
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2008
VL 977
BP 118
EP 152
PG 35
WC Chemistry, Multidisciplinary; Engineering, Biomedical; Materials
   Science, Biomaterials; Polymer Science
SC Chemistry; Engineering; Materials Science; Polymer Science
GA BUT01
UT WOS:000290249500010
DA 2018-10-19
ER

PT S
AU Nederberg, F
   Atthoff, B
   Bowden, T
   Welch, K
   Stromme, M
   Hilborn, J
AF Nederberg, Fredrik
   Atthoff, Bjorn
   Bowden, Tim
   Welch, Ken
   Stromme, Maria
   Hilborn, Jons
BE Mahapatro, A
   Kulshrestha, AS
TI Biodegradable Ionomers for the Loading and Release of Proteins:
   Formation, Characterization, Mechanism, and Consequence of Water Uptake
SO POLYMERS FOR BIOMEDICAL APPLICATIONS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT International Symposium on Polymers for Biomedical Applications/232nd
   National Meeting of the American-Chemical-Society (ACS)
CY SEP 10-14, 2006
CL San Francisco, CA
SP Amer Chem Soc (ACS)
ID POLYMERS
AB The increased understanding of proteins and the human genome point towards a future in which selective proteins may replace synthetic drugs in the general cure of disease. In this scenario the ability of controlled and gentle release of proteins provide the key for successful treatment. To address the ability of full protein delivery we have developed a series of telechelic biodegradable ionomers based on poly (trimethylene carbonate) carrying zwitterionic, anionic or cationic functional groups. The introduction of polar end-groups provides a material with unique properties that directs the introduced functionality within the material bulk but also to the material surface if water is introduced. Bulk aggregation provide a low elastic modulus material and the ability to surface enrich provide the on-set of water swelling. The latter finally results in a co-continuous water-ionomer structure that engulfs and stores proteins simply by soaking the material in an aqueous protein solution. Following protein loading the material can be dried and re-immersed in water so that release occurs. Our results, including both the careful synthesis and the ability to load and release proteins, provides new possibilities for full protein delivery.
   In this chapter the increased understanding of the water swelling properties and the subsequent formation of bulk water domains in biodegradable poly (trimethylene carbonate) (PTMC) ionomers is presented. The recent discovery that A functional PTMC may be functionalized with polar co-phosphoryl choline (PC) end groups and that the resulting telechelic zwitter ionomer forms an interesting low elastic modulus material has encouraged and directed the use of biodegradable ionomers in new areas of biomaterial research (I). Present findings now suggest that the scope of the synthesis may be broadened to provide telechelic ionomers with additional functionalities (2) and also that the water absorbing properties of such ionomers indicate their potential to serve as novel carriers for the loading and release of proteins (3).
C1 [Nederberg, Fredrik; Atthoff, Bjorn; Bowden, Tim; Hilborn, Jons] Uppsala Univ, Dept Chem Mat, Angstrom Lab, Uppsala, Sweden.
   [Welch, Ken; Stromme, Maria] Uppsala Univ, Dept Engn Sci, Angstrom Lab, Uppsala, Sweden.
OI Hilborn, Jons/0000-0001-6947-9601; Melander Bowden,
   Tim/0000-0003-0851-4316
CR Atthoff B, 2006, MACROMOLECULES, V39, P3907, DOI 10.1021/ma0603783
   Atthoff B, 2006, BIOMACROMOLECULES, V7, P2401, DOI 10.1021/bm060396s
   BERG JM, 2002, BIOCHEMISTRY-US, P304
   EISENBERG A, 1971, MACROMOLECULES, V4, P125, DOI 10.1021/ma60019a026
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Nederberg F, 2005, POLYM ADVAN TECHNOL, V16, P108, DOI 10.1002/pat.556
   Nederberg F, 2005, BIOMACROMOLECULES, V6, P3088, DOI 10.1021/bm0504173
   Nederberg F, 2004, J AM CHEM SOC, V126, P15350, DOI 10.1021/ja0457314
   Nederberg F, 2004, MACROMOLECULES, V37, P954, DOI 10.1021/ma035433b
   Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640
   SZEBENI J, 1985, BIOCHEMISTRY-US, V24, P2827, DOI 10.1021/bi00333a003
   WELCH K, 2006, UNPUB
NR 12
TC 1
Z9 1
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-3966-1
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2008
VL 977
BP 250
EP 266
PG 17
WC Chemistry, Multidisciplinary; Engineering, Biomedical; Materials
   Science, Biomaterials; Polymer Science
SC Chemistry; Engineering; Materials Science; Polymer Science
GA BUT01
UT WOS:000290249500017
DA 2018-10-19
ER

PT B
AU Levine, B
AF Levine, B.
BE Lefebvre, LP
   Banhart, J
   Dunand, DC
TI A New Era in Porous Metals: Applications in Orthopaedics
SO POROUS METALS AND METALLIC FOAMS: METFOAM 2007
LA English
DT Proceedings Paper
CT 5th Biennial International Conference on Porous Metals and Metallic
   Foams (MetFoam 2007)
CY SEP 05-07, 2007
CL Montreal, CANADA
SP Natl Res Council Canada, Quebec Mat Network, NW Univ, Hahn Meitner Inst, McGill Univ, Inco, Quebec Met Powders, CQRDA, Fraunhofer IFAM, MetSoc, Adv Engn Mat Journal, US Natl Sci Fdn
ID BONE INGROWTH; TANTALUM; ATTACHMENT; IMPLANTS; FIXATION
AB The development of porous metals and coatings has revolutionized the field of orthopaedics. However, most implants are fabricated utilizing traditional materials (i.e. sintered beads, fiber metal, plasma spray), which have several inherent limitations. Several new porous metals have been recently introduced to improve upon the biomaterial properties of these traditional metals. Tritanium (Stryker, Mahwah, NJ), Regenerex (Biomet, Warsaw, IN), and Trabecular Metal (Zimmer, Warsaw, IN) are currently available for use in orthopaedic surgery, all with a characteristic appearance similar to cancellous bone. The open-cell structure of these materials affords several intriguing properties, including; high volumetric porosity (60-80%), low modulus of elasticity, and high frictional characteristics. The following represents a review of the biomaterial properties and applications in orthopaedic surgery for this new class of highly porous metals.
C1 Midwest Orthopaed Ctr, Peoria, IL 61615 USA.
RP Levine, B (reprint author), Midwest Orthopaed Ctr, 6000 N Allen Rd, Peoria, IL 61615 USA.
CR *BIOM INC, BENCH TEST RES AR NO
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GREENFIELD E, 2009, MOUNTING ARTIFICIAL
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   *NC, S03001 NC
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 13
TC 0
Z9 0
U1 0
U2 3
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-932078-28-2
PY 2008
BP 251
EP 254
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BIU80
UT WOS:000262963600062
DA 2018-10-19
ER

PT B
AU Lemaire, V
   Sicotte, B
   Allard, S
AF Lemaire, V.
   Sicotte, B.
   Allard, S.
BE Lefebvre, LP
   Banhart, J
   Dunand, DC
TI Surface Modification Treatments to Reduce Ni Leaching from Porous
   Nitinol
SO POROUS METALS AND METALLIC FOAMS: METFOAM 2007
LA English
DT Proceedings Paper
CT 5th Biennial International Conference on Porous Metals and Metallic
   Foams (MetFoam 2007)
CY SEP 05-07, 2007
CL Montreal, CANADA
SP Natl Res Council Canada, Quebec Mat Network, NW Univ, Hahn Meitner Inst, McGill Univ, Inco, Quebec Met Powders, CQRDA, Fraunhofer IFAM, MetSoc, Adv Engn Mat Journal, US Natl Sci Fdn
ID SHAPE-MEMORY ALLOYS
AB Porous Nitinol has been implanted with success as orthopaedic devices for bone attachment or replacement for over two decades. However, because of the presence of nickel in Nitinol, its use in biomaterial applications has been controversial due to the possible release of nickel (Ni) ions. The objective of the study was therefore to determine the effect of surface modification treatments in order to minimize the nickel ion release from porous Nitinol. Different treatments have been studied: annealing, TiN coating, TiO(2) coating, and pre-treatments in SBF solutions.
   The results show that surface modification treatments can have the most desirable effect on the release of nickel ions from porous nitinol. Compared to non-annealed porous Nitinol, annealing reduces the Ni leaching by a factor of 3, bringing the nickel lifetime release for an average size spinal implant to the same quantity of nickel absorbed in one day from a normal diet. Compared to non-annealed porous Nitinol, TiN coating reduces the Ni leaching by a factor of 10, TiO(2) coating by a factor of 14, and SBF pre-treatments by a factor of 12. The best results have been obtained by combining a TiN coating with the SBF pre-treatment: the release of Ni ions was 24 times lower than for the non-amlealed condition.
C1 [Lemaire, V.; Sicotte, B.; Allard, S.] Biorthex Inc, Boucherville, PQ J4B 6Y4, Canada.
RP Lemaire, V (reprint author), Biorthex Inc, 75 Boul Mortagne,CP 120, Boucherville, PQ J4B 6Y4, Canada.
CR Bencko V, 1983, J Hyg Epidemiol Microbiol Immunol, V27, P237
   Cui ZD, 2005, SURF COAT TECH, V192, P347, DOI 10.1016/j.surfcoat.2004.06.033
   FLYVHOLM MA, 1984, Z LEBENSM UNTERS FOR, V179, P427, DOI 10.1007/BF01043419
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HAUSINGER RP, 1994, BIOCH ELEMENTS, V12
   Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441
   SHABALOVSKAYA SA, 1995, J VAC SCI TECHNOL A, V13, P2624, DOI 10.1116/1.579461
NR 7
TC 1
Z9 1
U1 0
U2 1
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-932078-28-2
PY 2008
BP 291
EP 294
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BIU80
UT WOS:000262963600072
DA 2018-10-19
ER

PT J
AU Lysiak-Drwal, K
   Dominiak, M
   Solski, L
   Zywicka, B
   Pielka, S
   Konopka, T
   Gerber, H
AF Lysiak-Drwal, Katarzyna
   Dominiak, Marzena
   Solski, Leszek
   Zywicka, Boguslawa
   Pielka, Stanislaw
   Konopka, Tomasz
   Gerber, Hanna
TI Early histological evaluation of bone defect healing with and without
   guided bone regeneration techniques: Experimental animal studies
SO POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ
LA English
DT Article
DE intraosseus defects; healing process; guided bone regeneration; animal
   studies
ID HUMAN INFRABONY DEFECTS; PERIODONTAL REGENERATION; GROWTH-FACTOR;
   MEMBRANES
AB Introductions: To obtain osseous tissue regeneration, treatment methods referred to as guided bone regeneration are used which utilize the mechanical, chemical, and biological properties of materials.
   Material/Methods: Eighteen white rabbits were used. Under general anesthesia, a 5 mm in diameter defect was created transcutaneously in the femur trochanter major. The rabbits were divided into three groups depending on the type of the intraosseous defect (ID) treatment: in group I (C) the control IDs were left to heal spontaneously, in II (BOC+BG) the IDs were filled with Bio-Oss Collagen (R) and Bio Gide Perio (R) membrane, and in III (PRP) the IDs were filled with BOC (R) and platelet-rich plasma (Curasan Centrifuge (R)). The animals were sacrificed 1 and 3 months after the surgical procedure. The histological material was stained with hematoxylin and eosin and using the van Gieson method.
   Results and Conclusions: In the earlier histological examinations (1 and 3 months after the procedures), resorption of the biomaterial and the formation of new bone trabeculas were observed in both groups II and III. At the first observation the extent of biomaterial resorption and the intensity of the osteogenic process were greater in group III, but after 3 months group II had a slight advantage. Fragmented remnants of the biomaterial in both groups were surrounded by newly formed bone and locally by fibrous connective tissue. At both observation times the number of bone trabeculas after implantation in groups II and III was greater than in the control group.
C1 [Lysiak-Drwal, Katarzyna; Dominiak, Marzena] Wroclaw Med Univ, Dept Oral Surg, PL-50424 Wroclaw, Poland.
   [Solski, Leszek; Zywicka, Boguslawa; Pielka, Stanislaw] Wroclaw Med Univ, Dept Expt Surg & Biomat Res, PL-50424 Wroclaw, Poland.
   [Konopka, Tomasz] Wroclaw Med Univ, Dept Oral Pathol, PL-50424 Wroclaw, Poland.
   [Gerber, Hanna] Wroclaw Med Univ, Dept Maxillofacial Surg, PL-50424 Wroclaw, Poland.
RP Dominiak, M (reprint author), Wroclaw Med Univ, Dept Oral Surg, Ul Krakowska 26, PL-50424 Wroclaw, Poland.
EM marzena.dominiak@wp.pl
RI Konopka, Tomasz/S-9535-2018
OI Konopka, Tomasz/0000-0002-8808-2893
CR Arm DM, 1996, BIOMATERIALS, V17, P703, DOI 10.1016/0142-9612(96)86740-8
   Bolouri A, 2001, Compend Contin Educ Dent, V22, P955
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   Christgau M, 1997, J CLIN PERIODONTOL, V24, P17, DOI 10.1111/j.1600-051X.1997.tb01179.x
   Cieslik-Balicka A., 2006, CZAS STOMAT, V59, P510
   CORTELLINI P, 1993, J PERIODONTOL, V64, P261, DOI 10.1902/jop.1993.64.4.261
   CORTELLINI P, 1993, J PERIODONTOL, V64, P254, DOI 10.1902/jop.1993.64.4.254
   Doblin J M, 1996, Int J Periodontics Restorative Dent, V16, P120
   DOMINIAK M, 2004, PORADNIK STOMAT, V7, P5
   Dominiak M., 2005, DENT MED PROBL, V42, P341
   ERPSTEIN H, 1992, DTSCH ZAHNARZTL, V47, P282
   Hockers T, 1999, CLIN ORAL IMPLAN RES, V10, P487, DOI 10.1034/j.1600-0501.1999.100607.x
   JANCZUK Z, 1998, PERIODONTOLOGIA WSPO, P39
   Kay S A, 1997, Pract Periodontics Aesthet Dent, V9, P185
   KONOPKA T, 1996, MAGAZYN STOMAT, V8, P26
   KONOPKA T, 2001, WROCL STOMAT, P79
   KOZAKIEWICZ M, 2003, MAGAZYN STOMAT, V13, P74
   KRYST L, 1997, CHIRURG STOMATOLOGIC, P211
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Sato N., 2000, PERIODONTAL SURG CLI, P247
   Simion M, 1999, CLIN ORAL IMPLAN RES, V10, P73, DOI 10.1034/j.1600-0501.1999.100201.x
   Thaller S R, 1994, J Craniofac Surg, V5, P242, DOI 10.1097/00001665-199409000-00009
   WENZ B, 1995, S DIFF TREATM OPT BO
   WOJTOWICZ A, 2001, PROT STOMAT, V51, P274
   WYCHOWANSKI P, 2000, NOWA STOM, V13, P23
NR 26
TC 14
Z9 16
U1 0
U2 8
PU POLISH ACAD SCIENCES, INST IMMUNOL & EXP THERAPY
PI WROCLAW
PA RUDOLF WEIGL 12, WROCLAW, 53-114, POLAND
SN 0032-5449
J9 POSTEP HIG MED DOSW
JI Postep. Hig. Med. Dosw.
PY 2008
VL 62
BP 282
EP 288
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 464LU
UT WOS:000267507200031
PM 18583951
OA DOAJ Gold
DA 2018-10-19
ER

PT B
AU Sabet, A
   Genin, GM
   Zatlin, B
   Christoforou, E
   Bayly, PV
AF Sabet, A.
   Genin, G. M.
   Zatlin, B.
   Christoforou, E.
   Bayly, P. V.
GP ASME
TI Transient shear wave propagation in a viscoelastic gel cylinder:
   Comparison of theory to MRI-based measurements
SO PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL
   CONFERENCE AND INFORMATION IN ENGINEERING CONFERENCE, VOL 1, PTS A-C
LA English
DT Proceedings Paper
CT ASME International Design Engineering Technical Conferences/Computers
   and Information in Engineering Conference
CY SEP 04-07, 2007
CL Las Vegas, NV
SP ASME, Design & Engn Div, ASME, Comp & Informat Engn Div
ID MOTION
AB Shear strain patterns in a cylindrical gelatin sample under transient angular acceleration were measured by tagged magnetic resonance imaging (MRI). Measured strain fields were compared to theoretical strain fields obtained by finite element (FE) simulation. Agreement between theory and experiment is very good. The current results support the utility of the experimental approach for tasks such as measurement of shear waves in brain tissue during angular acceleration of the skull. The results also show that a simple viscoelastic model is suitable to describe rapid shear deformation of a gel biomaterial.
C1 [Sabet, A.; Genin, G. M.; Zatlin, B.; Christoforou, E.; Bayly, P. V.] Washington Univ, Dept Mech & Aerosp Engn, St Louis, MO 63130 USA.
RP Sabet, A (reprint author), Washington Univ, Dept Mech & Aerosp Engn, Box 1185,1 Brookings Dr, St Louis, MO 63130 USA.
OI Bayly, Philip/0000-0003-4303-0704
CR AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762
   Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845
   *COSMOL, 2006, COSMOL SOL MECH US G
   GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x
   Margulies SS, 1998, HDB BIOMATERIAL PROP, P70
   MARGULIES SS, 1990, J BIOMECH, V23, P832, DOI DOI 10.1016/0021-9290(90)90029-3
   Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177
   RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885
NR 8
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4802-9
PY 2008
BP 649
EP 652
PG 4
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BHM90
UT WOS:000254391800074
DA 2018-10-19
ER

PT B
AU Sundararaghavan, HG
   Shreiber, DI
AF Sundararaghavan, Harini G.
   Shreiber, David I.
GP ASME
TI Gradients of stiffness guide neurite growth in 3D collagen gels
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2007, VOL 2: BIOMEDICAL AND BIOTECHNOLOGY ENGINEERING
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 11-15, 2007
CL Seattle, WA
SP Amer Soc Mech Engineers
ID CELLS; REGENERATION; SUBSTRATE; PROLIFERATION; GUIDANCE; RIGIDITY
AB One approach to enhance nerve and spinal cord regeneration following injury is to implant a biomaterial scaffold to "bridge" the gap of the injury. Structural/mechanical anisotropy has been suggested as a means of orienting this growth axially. We have spatially varied the mechanical properties of a 3D collagen gel to direct growth axially and unidirectionally. Gradients of mechanical properties were generated in collagen gels by exposing the collagen to a 0-1mM gradient of genipin, a cell-tolerated crosslinking agent, for 12hrs via microfluidics. The gradient of stiffness was confirmed via a gradient of genipin-induced fluorescence intensity, which we have previously correlated to the storage modulus of collagen gels. The growth of neurites from isolated chick embryo dorsal root ganglia (DRG) in the presence of these gradients was evaluated after 5 days in culture. In control cases, neurites grew into the collagen gel and up either side of the cross-channel to approximately equal lengths. A 20% difference in differential growth was observed in control experiments. In contrast, when presented a gradient of shear modulus from similar to 365Pa - 60Pa, neurites elected to grow down the gradient of stiffness to the compliant side, with an almost 300% difference. Interestingly, the length of neurites in gels with gradients was significantly greater than the length of those grown in gels with uniform, untreated gels with high compliance. Control of neurite growth, cell migration, and other aspects of cell behavior in 3D scaffolds via mechanical properties offers vast potential for tissue engineering and other regenerative therapies.
C1 [Sundararaghavan, Harini G.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Sundararaghavan, HG (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
OI Shreiber, David/0000-0001-8248-419X
CR Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Enever PAJ, 2002, J SURG RES, V105, P160, DOI 10.1006/jsre.2002.6372
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Fry EJ, 2001, CLIN EXP PHARMACOL P, V28, P253, DOI 10.1046/j.1440-1681.2001.03417.x
   Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lin DC, 2005, J BIOMECH ENG-T ASME, V127, P571, DOI 10.1115/1.1933981
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Rosner BI, 2003, ANN BIOMED ENG, V31, P1383, DOI 10.1114/1.1626118
   Ryan AF, 2006, AUDIOL NEURO-OTOL, V11, P134, DOI 10.1159/000090686
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SHREIBER D, 2005, FALL S MAT RES SOC M
   Shreiber DI, 2001, EXP CELL RES, V266, P155, DOI 10.1006/excr.2001.5208
   SUNDARARAGHAVAN HG, UNPUB J BIOMED MAT R
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125
   Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8
   Vogel V, 2001, TRENDS BIOTECHNOL, V19, P416, DOI 10.1016/S0167-7799(01)01737-1
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
NR 22
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4296-6
PY 2008
BP 113
EP 119
PG 7
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BHN23
UT WOS:000254463900017
DA 2018-10-19
ER

PT B
AU Shanjani, Y
   Toyserkani, E
   Wei, C
AF Shanjani, Yaser
   Toyserkani, Ehsan
   Wei, Christina
GP ASME
TI Modeling and characterization of biomaterials spreading properties in
   powder-based rapid prototyping techniques
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2007, VOL 2: BIOMEDICAL AND BIOTECHNOLOGY ENGINEERING
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 10-16, 2007
CL Seattle, WA
SP Amer Soc Mech Engineers
AB In this work, the spreading properties of biomaterials, while a counter-rotating roller is used in rapid prototyping machines, are modeled and characterized. For modeling, the slab method is used in which biomaterial geometrical properties are incorporated into the model. A pressure dependent plasticity model is used as a constitutive model for biomaterial powders. In addition, the coulomb friction law for the powder-roller interface boundary is incorporated into the model. Size and shape of powder particles as well as roller rotational and linear velocities are considered within the friction coefficient.
   Powder bed parameters such as compaction pressure, stress distribution and relative density are predicted using the simulation.
C1 [Shanjani, Yaser; Toyserkani, Ehsan; Wei, Christina] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada.
RP Shanjani, Y (reprint author), Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada.
EM yshanian@uwaterloo.ca; etoyserk@uwaterloo.ca; ywei@uwaterloo.ca
CR CLEYNENBREUGEL VT, 2002, J MATER SCI-MATER M, V13, P1245
   CUNNINGHAM JC, 2005, THESIS DREXEL U PHIL, P13
   JOHANSON JR, 1965, J APPL MECH, V32, P842, DOI 10.1115/1.3627325
   KATASHINSKII VP, 1983, POWDER METALL MET C+, V22, P972
   KATASHINSKII VP, 1983, POWER METALLURGY MET, V22, P882
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Shtern M. B., 1982, POWDER METALL MET C, V21, P169
   Upcraft S, 2003, ASSEMBLY AUTOM, V23, P318, DOI 10.1108/01445150310698634
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 9
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4296-6
PY 2008
BP 135
EP 143
PG 9
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BHN23
UT WOS:000254463900020
DA 2018-10-19
ER

PT B
AU Liang, LF
   Liu, T
AF Liang, Lie-feng
   Liu, Tao
GP ZSTU/SU
TI The Degradation of Poly (Vinyl Alcohol)/Chitosan Blend Membranes with
   Introduction to Silk Sericin
SO PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ADVANCED TEXTILE
   MATERIALS & MANUFACTURING TECHNOLOGY
LA English
DT Proceedings Paper
CT International Conference on Advanced Textile Materials and Manufacturing
   Technology
CY OCT 15-19, 2008
CL Hangzhou, PEOPLES R CHINA
SP Zhejiang Sci Tech Univ, Key Lab Adv Textile Mat & Mfg Technol, Minist Educ China, Shinshu Univ, Global Ctr Excellence, Minist Educ, Culture, Sports, Sci & Technol Japan
DE Chitosan; Polyvinylalcohol; Sericin; Biomaterial; Composite membrane;
   Degradation
AB Chitosan is a natural amino polysaccharide and has perfect biocompatibility and antibacterial function with broad-spectrum. Variational characteristics of glutinosity in chitosan/ acetic acid gel polymer blending with a certain concentration of polyvinylalcohol (PVA) in different condition were measured. Sericin is soluble polypeptide macromolecular compound dissolving in warm water, being high chemical characteristics, and having some kinds of necessary amino acids, high moisture permeability, high moisture retention and with better human affinity, people can use the mixture blending silk sericin with PVA and chitosan to manufacture valuable composite materials. In the experiment, the degradation of the mixture membrane in simulated body fluid (SBF) was measured. The results showed that the speed of degradation of the film can be adjusted by using different concentration of PVA and chitosan and/or sericin.
C1 [Liang, Lie-feng; Liu, Tao] Southwest Univ, Coll Text & Garment, Chongqing 400716, Peoples R China.
RP Liang, LF (reprint author), Southwest Univ, Coll Text & Garment, Chongqing 400716, Peoples R China.
CR Ching C, 1993, BIODEGRADABLE POLYM
   HATAKEYAMA H, 2001, KEY ENG MATER, P47
   Lang K, 1996, DESALINATION, V104, P185, DOI 10.1016/0011-9164(96)00041-0
   LLANOS GR, 1993, COSMET TOILETRIES, V108, P101
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 7
TC 0
Z9 0
U1 0
U2 7
PU ZHEJIANG UNIV PRESS
PI HANGZHOU
PA YUGU ROAD 20,, HANGZHOU, ZHEJIANG 310027, PEOPLES R CHINA
BN 978-7-89490-517-8
PY 2008
BP 406
EP 408
PG 3
WC Engineering, Manufacturing; Materials Science, Textiles
SC Engineering; Materials Science
GA BIT56
UT WOS:000262623900075
DA 2018-10-19
ER

PT S
AU Cadieux, PA
   Wignall, GR
   Carriveau, R
   Denstedt, JD
AF Cadieux, Peter A.
   Wignall, Geoffrey R.
   Carriveau, Rupp
   Denstedt, John D.
BE Evan, AP
   Lingeman, JE
   McAteer, JA
   Williams, JC
TI Implications of Biofilm Formation on Urological Devices
SO RENAL STONE DISEASE 2
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 2nd International Urolithiasis Research Symposium
CY APR 17-18, 2008
CL Indianapolis, IN
SP Int Kidney Stone Inst
DE ureteral stent; uropathogen; conditioning film; biofilm; adhesion;
   persister; antibiotic resistance
ID URINARY-TRACT-INFECTION; CRYSTALLINE BACTERIAL BIOFILMS; URETERAL
   STENTS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; URETHRAL CATHETERS;
   CYSTIC-FIBROSIS; IN-VITRO; TRICLOSAN; PREVENTION
AB Despite millions of dollars and several decades of research targeted at their prevention and eradication, biofilm-associated infections remain the major cause of urological device failure. Numerous strategies have been aimed at improving device design, biomaterial composition, surface properties and drug delivery, but have been largely circumvented by microbes and their plethora of attachment, host evasion, antimicrobial resistance, and dissemination strategies. This is not entirely surprising since natural biofilm formation has been going on for millions of years and remains a major part of microorganism survival and evolution. Thus, the fact that biofilms develop on and in the biomaterials and tissues of humans is really an extension of this natural tendency and greatly explains why they are so difficult for us to combat. Firstly, biofilm structure and composition inherently provide a protective environment for microorganisms, shielding them from the shear stress of urine flow, immune cell attack and some antimicrobials. Secondly, many biofilm organisms enter a metabolically dormant state that renders them tolerant to those antibiotics and host factors able to penetrate the biofilm matrix. Lastly, the majority of organisms that cause biofilm-associated urinary tract infections originate from our own oral cavity, skin, gastrointestinal and urogenital tracts and therefore have already adapted to many of our host defenses. Ultimately, while biofilms continue to hold an advantage with respect to recurrent infections and biomaterial usage within the urinary tract, significant progress has been made in understanding these dynamic microbial communities and novel approaches offer promise for their prevention and eradication. These include novel device designs, antimicrobials, anti-adhesive coatings, biodegradable polymers and biofilm-disrupting compounds and therapies.
C1 [Cadieux, Peter A.; Wignall, Geoffrey R.; Denstedt, John D.] Univ Western Ontario, Dept Surg, Div Urol, 1151 Richmond St,Suite 2, London, ON N6A 5B8, Canada.
   Univ Western Ontario, Dept Microbiol & Immunol, 1151 Richmond St,Suite 2, London, ON N6A 5B8, Canada.
   [Cadieux, Peter A.; Denstedt, John D.] Lawson Hlth Res Inst, London, ON N5A 4V2, Canada.
   [Carriveau, Rupp] Univ Windsor, Dept Civil & Environm Engn, Windsor, ON N9B3P46, Canada.
RP Cadieux, PA (reprint author), Univ Western Ontario, Dept Surg, Div Urol, 1151 Richmond St,Suite 2, London, ON N6A 5B8, Canada.
FU Boston Scientific (Natick, MA, USA); Lawson Health Research Institute;
   Nerites Corporation Limited (Madison, WI, USA)
FX Peter Cadieux is an American Urological Association Foundation Research
   Scholar. Scanning electron micrographs were imaged by Ross Davidson and
   Wayne Chang at Surface Science Western at the University of Western
   Ontario (www.uwo.ca/ssw). Work involving triclosan was supported through
   grants from Boston Scientific (Natick, MA, USA) and the Lawson Health
   Research Institute, while that involving PEG-DOPA based anti-fouling
   coatings was funded by Nerites Corporation Limited (Madison, WI, USA).
CR Abraham WR, 2006, CURR MED CHEM, V13, P1509, DOI 10.2174/092986706777442039
   Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   ALLISON DG, 1995, J IND MICROBIOL, V15, P311, DOI 10.1007/BF01569985
   Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000
   ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647
   Balaban N, 2005, CLIN ORTHOP RELAT R, P48, DOI 10.1097/01.blo.0000175889.82865.67
   Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6
   BOYARSKY S, 1971, HYDRODYNAMICS URETER
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06
   Bykova AA, 2005, FLUID DYNAM+, V40, P1, DOI 10.1007/s10697-005-0039-y
   Cadieux PA, 2006, J UROLOGY, V175, P2331, DOI 10.1016/S0022-5347(06)00252-7
   CADIEUX PA, 2008, J ENDOUROLOGY UNPUB
   Chew BH, 2006, J ENDOUROL, V20, P949, DOI 10.1089/end.2006.20.949
   Choisy C, 1998, B ACAD NAT MED PARIS, V182, P1709
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001
   Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07
   Costerton J W, 2007, BIOFILM PRIMER
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cummings LJ, 2004, J MATH BIOL, V49, P56, DOI 10.1007/s00285-003-0252-4
   Davenport K, 2005, J HOSP INFECT, V60, P298, DOI 10.1016/j.jhin.2005.01.026
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Elwood CN, 2007, J ENDOUROL, V21, P1217, DOI 10.1089/end.2007.9903
   Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002
   Evans-Pughe C., 2005, IEE Review, V51, P40, DOI 10.1049/ir:20050205
   Gradisar H, 2007, J MED CHEM, V50, P264, DOI 10.1021/jm060817o
   Hafron J, 2006, UROLOGY, V68, P911, DOI 10.1016/j.urology.2006.05.025
   Hansen MC, 2000, J MICROBIOL METH, V40, P233, DOI 10.1016/S0167-7012(00)00126-3
   Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06
   Jackson G, 2001, J MICROBIOL METH, V47, P1, DOI 10.1016/S0167-7012(01)00280-9
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   John T, 2007, J ENDOUROL, V21, P1211, DOI 10.1089/end.2007.9904
   Jones GL, 2006, J ANTIMICROB CHEMOTH, V57, P266, DOI 10.1093/jac/dki447
   Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018
   KO R, 2008, J ENDOUROL
   Laube N, 2007, J UROLOGY, V177, P1923, DOI 10.1016/j.juro.2007.01.016
   Laux DC, 2002, MICROBIOL-SGM, V148, P1709, DOI 10.1099/00221287-148-6-1709
   Lecamwasam HS, 1999, NEUROUROL URODYNAM, V18, P521, DOI 10.1002/(SICI)1520-6777(1999)18:5<521::AID-NAU15>3.0.CO;2-0
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Lifshitz DA, 1999, J ENDOUROL, V13, P735, DOI 10.1089/end.1999.13.735
   Lojanapiwat B, 2006, WORLD J UROL, V24, P681, DOI 10.1007/s00345-006-0135-6
   Maeyama R, 2005, J BIOMED MATER RES A, V75A, P146, DOI 10.1002/jbm.a.30346
   Meijman F J, 2001, Ned Tijdschr Geneeskd, V145, P716
   Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159
   Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518
   Norris P, 2005, ANTIMICROB AGENTS CH, V49, P4272, DOI 10.1128/AAC.49.10.4272-4279.2005
   Otto K, 2004, J BACTERIOL, V186, P226, DOI 10.1128/JB.186.1.226-234.2004
   Park K, 2004, UROL RES, V32, P416, DOI 10.1007/s00240-004-0442-6
   PECHEY A, 2008, J UROL UNPUB
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pugach JL, 1999, J UROLOGY, V162, P883, DOI 10.1097/00005392-199909010-00084
   PURVEDORJ B, 2002, APPL ENVIRON MICROB, V68, P8
   Rahav G, 2003, AGE AGEING, V32, P670, DOI 10.1093/ageing/afg096
   Raju GS, 2006, GASTROINTEST ENDOSC, V63, P317, DOI 10.1016/j.gie.2005.07.053
   RAMPHAL R, 1988, J ANTIMICROB CHEMOTH, V22, P483, DOI 10.1093/jac/22.4.483
   Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   Reid G, 2001, INT J ANTIMICROB AG, V17, P317, DOI 10.1016/S0924-8579(00)00353-8
   Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329
   Rotariu P, 2001, J ENDOUROL, V15, P979, DOI 10.1089/089277901317203047
   Saravanan P, 2006, BIOFOULING, V22, P371, DOI 10.1080/08927010601029103
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Schierholz JM, 2001, J CHEMOTHERAPY, V13, P239, DOI 10.1179/joc.2001.13.Supplement-2.239
   SHICK R, 1998, J ENDOUROL, V12, P37
   SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stickler D, 1999, CURR OPIN MICROBIOL, V2, P270, DOI 10.1016/S1369-5274(99)80047-2
   Stickler D, 1998, EUR J CLIN MICROBIOL, V17, P649, DOI 10.1007/BF01708349
   Stickler DJ, 1996, BIOFOULING, V9, P293, DOI 10.1080/08927019609378311
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Stoodley P, 2001, APPL ENVIRON MICROB, V67, P5608, DOI 10.1128/AEM.67.12.5608-5613.2001
   STRAMER SL, 1978, MICROBIOS, V23, P193
   SURMAN S, 2003, MED BIOFILMS DETECTI, P1
   TACK KJ, 1985, CHEMOTHERAPY, V31, P204, DOI 10.1159/000238337
   Tligui M, 2000, PROG UROL, V10, P92
   TONG JCK, 2007, J BIOMECH ENG, V129, P6
   VAHIDI B, 2007, P 29 ANN INT C IEEE
   VIGEANT M, 2005, AICHE ANN M C P AM I
   Waites KB, 2004, J SPINAL CORD MED, V27, P448, DOI 10.1080/10790268.2004.11752236
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
NR 87
TC 1
Z9 1
U1 2
U2 12
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0577-6
J9 AIP CONF PROC
PY 2008
VL 1049
BP 147
EP +
PG 4
WC Biochemistry & Molecular Biology; Physics, Applied; Urology & Nephrology
SC Biochemistry & Molecular Biology; Physics; Urology & Nephrology
GA BIN28
UT WOS:000261024700014
DA 2018-10-19
ER

PT S
AU Razvi, H
AF Razvi, Hassan
BE Evan, AP
   Lingeman, JE
   McAteer, JA
   Williams, JC
TI Ureteral Stent Coatings: What's Here and What's Coming
SO RENAL STONE DISEASE 2
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 2nd International Urolithiasis Research Symposium
CY APR 17-18, 2008
CL Indianapolis, IN
SP Int Kidney Stone Inst
DE Biomimetics; stent coatings
ID BIOMATERIAL; CATHETER; SURFACES; POLYMERS; TRIAL
AB Ureteral stents have become an indispensable tool to the urologist in the management of various disorders afflicting the urinary tract. While the ideal stent remains elusive, novel technical advances in stent coating technology offer the potential of enhancing stent biocompatibility and clinical application. Currently available stent coatings as well as new and emerging devices will be reviewed.
C1 Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.
RP Razvi, H (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.
CR CAUDA F, 2008, J ENDOUROL, V23, P465
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Granada Juan F, 2003, Curr Atheroscler Rep, V5, P308, DOI 10.1007/s11883-003-0054-6
   Jones DS, 2006, J BIOMED MATER RES B, V78B, P230, DOI 10.1002/jbm.b.30474
   KO R, 2008, J ENDOUROL IN PRESS
   Laube N, 2007, J UROLOGY, V177, P1923, DOI 10.1016/j.juro.2007.01.016
   MAKI DG, 1988, JAMA-J AM MED ASSOC, V127, P267
   Mittelman MW, 2004, J UROLOGY, V171, P443
   MONAGHAN DP, 1993, MATER WORLD, V1, P347
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Vapnek JM, 2003, J UROLOGY, V169, P994, DOI 10.1097/01.ju.0000051160.72187.e9
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
NR 17
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0577-6
J9 AIP CONF PROC
PY 2008
VL 1049
BP 182
EP 185
PG 4
WC Biochemistry & Molecular Biology; Physics, Applied; Urology & Nephrology
SC Biochemistry & Molecular Biology; Physics; Urology & Nephrology
GA BIN28
UT WOS:000261024700017
DA 2018-10-19
ER

PT S
AU Dhitiseith, D
   Honsawek, S
AF Dhitiseith, D.
   Honsawek, S.
BE Tunkasiri, T
TI Differential Expression of Osteogenic Differentiation in Human Umbilical
   Cord Wharton's Jelly-derived Mesenchymal Stem Cells Treated with
   Demineralized Bone
SO SMART MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Smart Materials-Smart/Intelligent Materials
   and Nanotechnology/2nd Int Workshop on Functional Materials and
   Nanomaterials
CY APR 22-25, 2008
CL Chiang Mai, THAILAND
SP USCB, ICMR, NSTDA, NECTEC, MTEC, TRF, QES, Coax Grp Corp Ltd
DE Demineralized bone matrix; gene expression; mesenchymal stem cells;
   osteoblast; RT-PCR
ID GENE-EXPRESSION; OSTEOBLAST
AB Mesenchymal stem cells are multipotential cells capable of differentiating into osteoblasts, chondrocytes, adipocytes, tenocytes, and myoblasts. Wharton's jelly consists of stem cells that are a rich Source of primitive multipotent mesenchymal cells. Demineralized bone matrix (DBM) has been widely utilized as a biomaterial to promote new bone formation. We isolate and characterize umbilical cord Wharton's Jelly-derived mesenchymal stem (UCMS) cells derived from Wharton's jelly and examine the biological activity of DBM in this cell line. Osteoblast differentiation of the UCMS cells was determined using alkaline phosphatase (ALP) activity assay. To examine differential gene expression during osteogenic differentiation, total RNA was isolated from UCMS cells in the absence or presence of DBM on day7 and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase-polymerase chain reaction (RT-PCR) analyses. Wharton's jelly derived cells could differentiate along ail osteogenic lineage after treatment of DBM The ALP activity assay showed that human UCMS cells Could differentiate into osteogenic lineage. Gene expression of human UCMS cells treated with DBM for 7 days was analyzed by using cDNA array and RT-PCR analyses. We round that expression of RUNX2 and SMAD2 was upregulated whereas SMAD7 expression was downregulated as confirmed by RT-PCR. UCMS cells from a Wharton's jelly of human Umbilical cord Could express osteogenesis genes for treatment with DBM. Wharton's jelly front Umbilical cord is a new Source of mesenchymal stem cells that are readily available for application to bone tissue engineering.
C1 [Dhitiseith, D.; Honsawek, S.] Chulalongkorn Univ, Fac Med, Dept Biochem, Bone & Musculoskeletal Biol Lab, Bangkok 10330, Thailand.
RP Dhitiseith, D (reprint author), Chulalongkorn Univ, Fac Med, Dept Biochem, Bone & Musculoskeletal Biol Lab, Bangkok 10330, Thailand.
EM Dhakoon.D@student.chula.ac.th; fmedshs@md.chula.ac.th
CR Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Hishikawa K, 2004, BIOCHEM BIOPH RES CO, V317, P1103, DOI 10.1016/j.bbrc.2004.03.165
   HONSAWEK S, 2006, J MED ASS THAI, pS189
   Honsawek Sittisak, 2005, J Med Assoc Thai, V88 Suppl 4, pS260
   Honsawek S, 2007, ASIAN BIOMED, V1, P229
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   Huang WB, 2001, BIOCHEM BIOPH RES CO, V281, P1120, DOI 10.1006/bbrc.2001.4458
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raouf A, 2002, BONE, V30, P463, DOI 10.1016/S8756-3282(01)00699-8
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393
NR 13
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-356-2
J9 ADV MAT RES
PY 2008
VL 55-57
BP 697
EP 700
DI 10.4028/www.scientific.net/AMR.55-57.697
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BIT84
UT WOS:000262689600172
DA 2018-10-19
ER

PT S
AU Campbell, D
   Tighe, BJ
AF Campbell, D.
   Tighe, B. J.
BE Tunkasiri, T
TI Zwitterionic and Charge-balanced Polyampholyte Copolymer Hydrogels
SO SMART MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Smart Materials-Smart/Intelligent Materials
   and Nanotechnology/2nd Int Workshop on Functional Materials and
   Nanomaterials
CY APR 22-25, 2008
CL Chiang Mai, THAILAND
SP USCB, ICMR, NSTDA, NECTEC, MTEC, TRF, QES, Coax Grp Corp Ltd
DE zwitterionic; copolymers; hydrogel; biomaterial
ID POLYMER
AB Zwitterionic copolymers were synthesised from N,N-dimethyl-N-(2-acryloylethyl)-N-(3-sulfopropyl) ammonium betaine (SPDA) and 2-hydroxyethyl methacrylate (HEMA) produce a series of polyzwitterion hydrogels. For the synthesis of the charge-balanced copolymer hydrogels, two cationic monomers were selected: 2-(diethylamino) ethyl methacrylate (DMAEMA) and 3-(dimethylamino) propyl methacrylamide (DMAPMA), and an anionic monomer; 2-acrylamido-2-methylpropane sulphonic acid (AMPS). Two series of charge-balanced copolymers were synthesized from stoichiometrically equivalent ratios of DMAEMA or DMAPMA and AMPS with HEMA as a termonomer. All synthesized copolymers produced clear and cohesive hydrogels. The zwitterionic and charge-balanced copolymers displayed similar equilibrium water contents together with similar mechanical and Surface energy properties. The swelling of the zwitterionic and the charge-balanced copolymers shows some features of antipolyelectrolyte behavior.
C1 [Campbell, D.; Tighe, B. J.] Aston Univ, Biomat Res Unit, Birmingham B4 7ET, W Midlands, England.
RP Campbell, D (reprint author), Aston Univ, Biomat Res Unit, Birmingham B4 7ET, W Midlands, England.
EM campbeld@aston.ac.uk; b.j.tighe@aston.ac.uk
CR CORKHILL PH, 1990, CRIT REV BIOCOMPAT, V5, P363
   French K., 2005, OPTICIAN, V230, P16
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   MAHOMED A, 2005, OPHTHALMOL RES S1, V37, P27
   MAHOMED A, 2005, OPHTHALMOL RES S1, V37, P161
   Tighe B.J., 1990, T BR CONT LENS ASS, V13, P57
   ZHANG Z, 2006, P 2006 AICHE ANN M
NR 8
TC 1
Z9 1
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-356-2
J9 ADV MAT RES
PY 2008
VL 55-57
BP 729
EP 732
DI 10.4028/www.scientific.net/AMR.55-57.729
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BIT84
UT WOS:000262689600180
DA 2018-10-19
ER

PT B
AU Denton, M
   Earthman, JC
AF Denton, M.
   Earthman, J. C.
BE Berg, B
   Mitchell, MR
   Proft, J
TI ELECTROCHEMICAL CORROSION CHARACTERIZATION OF NITINOL MARTENSITE AND
   AUSTENITE PHASES
SO SMST 2006: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MEMORY
   AND SUPERELASTIC TECHNOLOGIES
LA English
DT Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
CY MAY 07-11, 2006
CL Pacific Grove, CA
SP Admedes Schussler GmbH, Boston Sci, Dearborn Precis Tubular Prod, Edwards Lifesciences, Ft Wayne Met Res Prod Corp, Guidant Endovasc Solut, Johnson Matthey, Kemac Technologies, Mech & Mat Consulting, Medtron Vasc, MeKo Laser Mat Proc, Memry Corp, Minitubes, Nitinol Devices & components, SAES Getters Grp, Special Met Corp, Shape Mem Alloys Div, Ulbrich Stainless Steels & Special Met
AB Corrosion resistance is one of the key requirements for a successful biomaterial. Nitinol is being considered for biomedical applications, where both the austenite and martensite phases are exposed to the biological environment throughout the service life of the device. Although the corrosion behavior of austenite has been well established, the corrosion of martensite has not been fully characterized. A detailed corrosion comparison between the different nitinol phases was conducted and the results were evaluated. The purpose of this study is to understand the electrochemical behavior of both phases of nitinol relating to the breakdown potential and repassivation tendencies.
   The material specimens were thermally treated to ensure that one was austenite, and the other was martensite at 22 degrees C. DSC, or differential scanning calorimetry confirmed the material phases of each sample. Cyclic potentiodynamic polarization measurements yield information on corrosion rates, passivation abilities, and pitting tendencies. Therefore, these curves were obtained for the austenite, stress-induced martensite, and thermally-induced martensite phases in Hank's simulated physiological solution. The breakdown potential was similar for the thermally-induced martensite and austenite phases with high noble potentials. While the stress-induced martensite had a lower breakdown. In addition, the stress-induced martensite phase produced a higher corrosion rate compared to the thermally-induced martensite and austenite phases. The corrosion performance observed was due to the changes in surface morphology where the stress initiated microdefects naturally lowered the corrosion rate.
C1 [Denton, M.; Earthman, J. C.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
RP Denton, M (reprint author), Univ Calif Irvine, Dept Chem Engn & Mat Sci, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
CR [Anonymous], G5 ASTM
   *ASTM, F212904 ASTM
   DUERIG T, 1999, MATER SCI ENG, pA273
   Krishnan M, 2005, SCRIPTA MATER, V53, P875, DOI 10.1016/j.scriptamat.2005.05.031
   Otsuka K., 1998, SHAPE MEMORY MAT, P1
   THIERRY B, 2000, EFFECT SURFACE TREAT
   TREPANIER C, 1998, EFFECT MODIFICATION
NR 7
TC 1
Z9 1
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-862-5
PY 2008
BP 295
EP 302
DI 10.1361/cp2006smst295
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BQI76
UT WOS:000281128400028
DA 2018-10-19
ER

PT S
AU Viitala, R
   Areva, S
   Jokinen, M
   Koskinen, M
AF Viitala, Reeta
   Areva, Sami
   Jokinen, Mika
   Koskinen, Mika
BE Innocenzi, P
   Zub, YL
   Kessler, VG
TI About interactions between sol-gel derived silica, titania and living
   organisms
SO SOL-GEL METHODS FOR MATERIALS PROCESSING: FOCUSING ON MATERIALS FOR
   POLLUTION CONTROL, WATER PURIFICATION, AND SOIL REMEDIATION
SE NATO Science for Peace and Security Series C-Environmental Security
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Sol-Gel Approaches to Materials for
   Pollution Control, Water Purification and Soil Remediation
CY OCT 25-27, 2007
CL Kyiv, UKRAINE
SP NATO Sci Comm
DE sol-gel method; silica; titania; biomaterials; virus delivery; tissue
   bonding
ID CALCIUM-PHOSPHATE FORMATION; VITRO APATITE DEPOSITION; PLASMA-SPRAYED
   COATINGS; SIMULATED BODY-FLUID; IN-VITRO; HYDROGEN-PEROXIDE;
   HYDROXYAPATITE COATINGS; NANOPHASE CERAMICS; TRABECULAR BONE; TIO2
   COATINGS
AB Sol-gel derived silica and titania have a specific interaction with many biological molecules, microbes, algae, cells and living tissue. The specific interactions mean that they differ from common reactions between non-viable materials and biomolecules or living tissues and the interactions are mostly beneficial from the viewpoint of biotechnical applications. Pepetides and proteins may preserve their activity and bacteria, algae and cells may preserve their viability and viruses their infectivity as encapsulated in sol-gel derived silica. Silica and titania are known to form a direct bond with living tissue which can be utilized in the biomaterial applications. Other application areas of silica and titania are in biosensing, tissue engineering, gene therapy, controlled delivery of therapeutic agents and environmental protection.
C1 [Viitala, Reeta; Areva, Sami] Univ Turku, Turku Biomat Ctr, Itainen Pitkakatu 4 B, FI-20520 Turku, Finland.
   [Jokinen, Mika; Koskinen, Mika] DelSiTech Ltd, FI-20520 Turku, Finland.
RP Viitala, R (reprint author), Univ Turku, Turku Biomat Ctr, Itainen Pitkakatu 4 B, FI-20520 Turku, Finland.
EM reeta.viitala@utu.fi
FU Academy of Finland [114117]
FX This research is financially supported by Academy of Finland grant no:
   114117
CR Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   AREVA S, 2006, THESIS ABO AKAD U AB
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BODYN JD, 1930, CLIN ORTHOP RELAT R, V150, P263
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   COMBE EC, 1999, DENT BIOMATERIALS
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DAY RE, 1967, T FARADAY SOC, V63, P708, DOI 10.1039/tf9676300708
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Gan L, 2004, BIOMATERIALS, V25, P5303, DOI 10.1016/j.biomaterials.2003.12.038
   GANONG WA, 1987, MED BOOK REV MED PHY
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Gordon JE, 1976, NEW SCI STRONG MAT W
   Gross KA, 1998, J MATER SCI-MATER M, V9, P839, DOI 10.1023/A:1008948228880
   Haddow DB, 1996, J MATER SCI-MATER M, V7, P255, DOI 10.1007/BF00058562
   Hayakawa T, 2002, BIOMATERIALS, V23, P1025, DOI 10.1016/S0142-9612(01)00214-9
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Iler R.K., 1979, CHEM SILICA SOLUBILI
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   JOKINEN M, 2007, Patent No. 2007135224
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   KNIENAPFEL H, 1999, J ARTHOPLASTY, V14, P355
   Kortesuo P, 2000, BIOMATERIALS, V21, P193, DOI 10.1016/S0142-9612(99)00148-9
   KOSKINEN M, 2002, Patent No. 0280977
   KOSKINER M, 2005, MOL THER, V11, pS422
   Lalor P. A., 1993, Clinical Materials, V12, P57, DOI 10.1016/0267-6605(93)90028-6
   LEWIS KE, 1966, T FARADAY SOC, V62, P204, DOI 10.1039/tf9666200204
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Livage J, 2001, J PHYS-CONDENS MAT, V13, pR673, DOI 10.1088/0953-8984/13/33/202
   Mann S., 2001, BIOMINERALIZATION
   MONTERRA C, 1988, J CHEM SOC F1, P1617
   Moritz N, 2005, BIOMATERIALS, V26, P4460, DOI 10.1016/j.biomaterials.2004.11.020
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   MORITZ N, 2003, MAT TECH ADV PERF MA, V1, P29
   Ogiso M, 1998, J BIOMED MATER RES, V39, P364
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   Pelli S, 1996, OPT MATER, V5, P119, DOI 10.1016/0925-3467(95)00049-6
   PELLI S, 1994, SPIE P, V2288, P573
   Peltola T, 2000, J BIOMED MATER RES, V51, P200, DOI 10.1002/(SICI)1097-4636(200008)51:2<200::AID-JBM8>3.0.CO;2-Z
   Peltola T, 2002, KEY ENG MAT, V218-2, P207, DOI 10.4028/www.scientific.net/KEM.218-220.207
   Peltola T, 1998, J BIOMED MATER RES, V41, P504, DOI 10.1002/(SICI)1097-4636(19980905)41:3<504::AID-JBM22>3.0.CO;2-G
   PELTOLA T, 2000, THESIS U TURKU
   QIU Q, 1993, CELL MATER, V3, P351
   SAKKA S, 2005, SOL GEL PROCESSING
   TAYLOR DJ, 1995, J MATER RES, V10, P1429, DOI 10.1557/JMR.1995.1429
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Viitala R, 2005, J NON-CRYST SOLIDS, V351, P3225, DOI 10.1016/j.jnoncrysol.2005.08.023
   Viitala R, 2007, INT J PHARM, V336, P382, DOI 10.1016/j.ijpharm.2006.12.008
   vonSchroeder HP, 1996, J ARTHROPLASTY, V11, P620, DOI 10.1016/S0883-5403(96)80120-3
   WADE WH, 1961, J PHYS CHEM-US, V65, P1681, DOI 10.1021/j100827a004
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x
   Wu JM, 2002, SCRIPTA MATER, V46, P101, DOI 10.1016/S1359-6462(01)01207-6
NR 72
TC 4
Z9 4
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1871-4668
BN 978-1-4020-8521-5
J9 NATO SCI PEACE SECUR
JI NATO Sci. Peace Secur. Ser. C- Environ. Secur.
PY 2008
BP 251
EP +
DI 10.1007/978-1-4020-8514-7_15
PG 6
WC Ecology; Environmental Sciences; Materials Science, Multidisciplinary;
   Soil Science; Water Resources
SC Environmental Sciences & Ecology; Materials Science; Agriculture; Water
   Resources
GA BIC25
UT WOS:000258329100015
DA 2018-10-19
ER

PT J
AU Trottier, V
   Marceau-Fortier, G
   Germain, L
   Vincent, C
   Fradette, J
AF Trottier, Valerie
   Marceau-Fortier, Guillaume
   Germain, Lucie
   Vincent, Caroline
   Fradette, Julie
TI IFATS Collection: Using Human Adipose-Derived Stem/Stromal Cells for the
   Production of New Skin Substitutes
SO STEM CELLS
LA English
DT Article; Proceedings Paper
CT 5th Annual Scientific Meeting of the
   International-Federation-of-Adipose-Therapeutics-and-Science
CY OCT, 2007
CL Indianapolis, IN
SP Int Federat Adipose Therapet & Sci
DE Mesenchymal stem cells; Tissue engineering; Skin; Cell differentiation;
   Fibroblasts; Adipose tissue
ID VITRO RECONSTRUCTED SKIN; EPIDERMAL STEM-CELLS; GEL MATRIX CULTURE;
   IN-VITRO; BURN WOUNDS; REGENERATIVE MEDICINE; DERMAL FIBROBLASTS;
   STROMAL CELLS; DONOR AGE; TISSUE
AB The ability to harvest and culture stem cell populations from various human postnatal tissues is central to regenerative medicine applications, including tissue engineering. The discovery of multipotent mesenchymal stem cells within the stromal fraction of adipose tissue prompted their use for the healing and reconstruction of many tissues. Here, we examined the influence of adipose-derived stem/stromal cells (ASCs) on skin's regenerative processes, from a tissue engineering perspective. Using a self-assembly approach, human skin substitutes were produced. They featured a stromal compartment containing human extracellular matrix endogenously produced from either dermal fibroblasts or adipose-derived stem/stromal cells differentiated or not toward the adipogenic lineage. Human keratinocytes were seeded on each stroma and cultured at the air-liquid interface to reconstruct a bilayered skin substitute. These new skin substitutes, containing an epidermis and a distinctive stroma devoid of synthetic biomaterial, displayed characteristics similar to human skin. The influence of the type of stromal compartment on epidermal morphogenesis was assessed by the evaluation of tissue histology, the expression of key protein markers of the epidermal differentiation program ( keratin [ K] 14, K10, transglutaminase), the expression of dermo-epidermal junction components (laminins, collagen VII), and the presence of basement membrane and hemidesmosomes. Our findings suggest that adipose-derived stem/stromal cells could usefully substitute dermal fibroblasts for skin reconstruction using the self-assembly method. Finally, by exploiting the adipogenic potential of ASCs, we also produced a more complete trilayered skin substitute consisting of the epidermis, the dermis, and the adipocyte-containing hypodermis, the skin's deepest layer. STEM CELLS 2008; 26: 2713-2723
C1 [Trottier, Valerie; Marceau-Fortier, Guillaume; Germain, Lucie; Vincent, Caroline; Fradette, Julie] CHAUQ Hop St Sacrement, Lab Organogenese Expt LOEX, Quebec City, PQ G1S 4L8, Canada.
   [Trottier, Valerie; Marceau-Fortier, Guillaume; Germain, Lucie; Vincent, Caroline; Fradette, Julie] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ G1K 7P4, Canada.
RP Fradette, J (reprint author), CHAUQ Hop St Sacrement, Lab Organogenese Expt LOEX, 1050 Chem St Foy, Quebec City, PQ G1S 4L8, Canada.
EM julie.fradette@chg.ulaval.ca
CR Aoki S, 2004, MOL BIOL CELL, V15, P4647, DOI 10.1091/mbc.E04-01-0038
   Auger FA, 2004, BIOTECHNOL APPL BIOC, V39, P263
   BELL E, 1991, J BIOMECH ENG-T ASME, V113, P113, DOI 10.1115/1.2891224
   Bellemare J, 2005, J PATHOL, V206, P1, DOI 10.1102/path.1737
   Berthod F, 1997, BRIT J DERMATOL, V136, P809, DOI 10.1111/j.1365-2133.1997.tb03917.x
   Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012
   Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc
   BUXMAN MM, 1975, J INVEST DERMATOL, V65, P107, DOI 10.1111/1523-1747.ep12598072
   CARVER N, 1991, INT J DERMATOL, V30, P540
   COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   Damour O, 1998, MED BIOL ENG COMPUT, V36, P825, DOI 10.1007/BF02518890
   Donjacour A A, 1991, Cancer Treat Res, V53, P335
   El-Ghalbzouri A, 2004, BRIT J DERMATOL, V150, P444, DOI 10.1046/j.1365-2133.2004.05830.x
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   GERMAIN L, 1995, BURNS, V21, P175, DOI 10.1016/0305-4179(95)80004-8
   Germain L, 2000, J INVEST DERMATOL, V115, P860, DOI 10.1046/j.1523-1747.2000.00024.x
   GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Huh CH, 2007, J DERMATOL SCI, V46, P217, DOI 10.1016/j.jdermsci.2007.01.005
   Kanitakis J, 2002, EUR J DERMATOL, V12, P390
   Kanitakis J, 2002, EUR J DERMATOL, V12, P400
   Kaur P, 2006, J INVEST DERMATOL, V126, P1450, DOI 10.1038/sj.jid.5700184
   KUMAGAI N, 1988, PLAST RECONSTR SURG, V82, P99, DOI 10.1097/00006534-198882010-00017
   Lamme EN, 2000, J PATHOL, V190, P595, DOI 10.1002/(SICI)1096-9896(200004)190:5<595::AID-PATH572>3.0.CO;2-V
   Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com
   LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342
   Mansbridge J, 2002, EXPERT OPIN BIOL TH, V2, P25, DOI 10.1517/14712598.2.1.25
   Michel M, 1999, IN VITRO CELL DEV-AN, V35, P318
   Michel M, 1996, J CELL SCI, V109, P1017
   Michel M, 1997, J CELL PHYSIOL, V171, P179, DOI 10.1002/(SICI)1097-4652(199705)171:2<179::AID-JCP8>3.0.CO;2-L
   Moulin V, 1997, J CELL PHYSIOL, V171, P1
   Pouliot R, 2002, TRANSPLANTATION, V73, P1751, DOI 10.1097/00007890-200206150-00010
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   SUGIHARA H, 1991, IN VITRO CELL DEV B, V27, P142
   Sugihara H, 2001, BRIT J DERMATOL, V144, P244, DOI 10.1046/j.1365-2133.2001.04008.x
   TEEPE RGC, 1990, J TRAUMA, V30, P269, DOI 10.1097/00005373-199003000-00004
   VALLEE M, PATHOL BIOL PARIS
   van den Bogaerdt AJ, 2002, ARCH DERMATOL RES, V294, P135, DOI 10.1007/s00403-002-0305-3
   Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030
   Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 45
TC 110
Z9 114
U1 0
U2 24
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PY 2008
VL 26
IS 10
BP 2713
EP 2723
DI 10.1634/stemcells.2008-0031
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 362DH
UT WOS:000260177900029
PM 18617689
OA Bronze
DA 2018-10-19
ER

PT S
AU Zeng, RC
   Dietzel, W
   Chen, J
   Huang, WJ
   Wang, J
AF Zeng, Rongchang
   Dietzel, Wolfgang
   Chen, Jun
   Huang, Weijiu
   Wang, Jun
BA Xu, BS
BF Xu, BS
BE Lei, MK
   Zhu, XP
   Xu, KW
TI Corrosion behavior of TiO2 coating on magnesium alloy AM60 in hank's
   solution
SO SURFACE ENGINEERING (ICSE 2007)
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th International Conference on Surface Engineering
CY JUL 07-10, 2007
CL Dalian Univ Technol, Dalian, PEOPLES R CHINA
SP Chinese Mech Engn Soc, Surface Eng Branch, Natl Nat Sci Fdn China, Dalian Assoc Sci & Technol
HO Dalian Univ Technol
DE magnesium alloy; coating; corrosion; implant; biomaterial; plasma
   spraying
AB As magnesium is an essential element for the human body, magnesium alloys are expected to be promising implant materials despite their lower corrosion resistance. The most potential advantages of magnesium lie on both excellent biocompatibility and good mechanical properties. A TiO2 coating had been successfully deposited on the surface of AM60 samples by using a thermal spray technique and was then sealed with sodium silicate. The corrosion behavior was investigated by using the potentiodynamic electrochemical technique. The experimental results demonstrated that the TiO2 coating had a porous ceramic structure. The thickness and micro hardness of the layer reached 40 mu m, and 886 HV, respectively. After additional sealing with sodium silicate, TiO2 coating on magnesium alloy improved corrosion resistance in Hank's solution.
C1 [Zeng, Rongchang; Chen, Jun; Huang, Weijiu; Wang, Jun] Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
   [Dietzel, Wolfgang] GKSS Forschungszentrum Geesthacht GmbH, D-21502 Geesthacht, Germany.
RP Zeng, RC (reprint author), Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
EM rczeng2001@yahoo.com.cn; Wolfgang.Dietzel@gkss.de; chenjun@cqit.edu.cn;
   huangweijiu@cqit.edu.cn; hnwangjun@cqit.edu.cn
FU National Natural Science Foundation [50405005]; Natural Science
   Foundation of Chongqing Science and Technology Commission of China
   [8655]; Program for New Century Excellent Talents in University
   [NCET-05-0777]
FX This work is supported by the National Natural Science Foundation
   (No.50405005) and the Natural Science Foundation (No.8655) of Chongqing
   Science and Technology Commission of China and the Program for New
   Century Excellent Talents in University (No.NCET-05-0777).
CR ABDULLAT YA, 2001, MAT T, V42, P1777
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   [黄伟九 Huang Weijiu], 2004, [武汉理工大学学报, Journal of wuhan university of technology], V26, P23
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Zeng RC, 2005, ACTA METALL SIN, V41, P307
   Zeng RC, 2007, J MATER SCI TECHNOL, V23, P353
   [曾荣昌 Zeng Rongchang], 2005, [材料研究学报, Chinese Journal of Materials Research], V19, P1
   [曾荣昌 Zeng Rongchang], 2003, [材料研究学报, Chinese Journal of Materials Research], V17, P241
NR 10
TC 6
Z9 9
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2008
VL 373-374
BP 609
EP +
DI 10.4028/www.scientific.net/KEM.373-374.609
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Materials
   Science, Coatings & Films
SC Engineering; Materials Science
GA BHS23
UT WOS:000255930200145
DA 2018-10-19
ER

PT J
AU Cristino, S
   Piacentini, A
   Manferdini, C
   Codeluppi, K
   Grassi, F
   Facchini, A
   Lisignoli, G
AF Cristino, Sandra
   Piacentini, Anna
   Manferdini, Cristina
   Codeluppi, Katia
   Grassi, Francesco
   Facchini, Andrea
   Lisignoli, Gina
TI Expression of CXC chemokines and their receptors is modulated during
   chondrogenic differentiation of human mesenchymal stem cells grown in
   three-dimensional scaffold: Evidence in native cartilage
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; HUMAN CHONDROCYTES; ARTICULAR-CARTILAGE; FACTOR-I;
   TGF-BETA-1; MIGRATION; MATRIX; BETA; EXPANSION; ADHESION
AB Chemokines contribute to the maintenance of cartilage homeostasis. To evaluate the role of CXC chemokines CXCL8 (interleukin-8), CXCL10 (interferon-gamma-inducible protein-10), CXCL12 (stroma-derived factor-1) and CXCL13 (B-cell attracting chemokine-1) and their receptors, respectively CXCR1-2, CXCR3, CXCR4, and CXCR5, during chondrogenic differentiation of human mesenchymal stromal cells (h-MSCs), we used a well-defined in vitro model. Chondrogenic differentiation was analyzed on h-MSCs grown on hyaluronic acid-based biomaterial in the presence or absence of transforming growth factor-beta, and the expression and modulation of CXC chemokines and receptors were evaluated at different time points. Real-time polymerase chain reaction was performed to analyze their expression at the messenger ribonucleic acid (mRNA) level, and immunohistochemistry and enzyme-linked immunosorbent assay were used to evaluate their expression at the protein level. Human articular cartilage biopsies were used to evaluate chemokine and receptor expression in normal tissue. We found no expression of CXCR1, CXCR2, CXCR3, or CXCL10 at the mRNA level. CXCL8 mRNA was down-modulated, whereas at the protein level, we found greater release of this chemokine. CXCR4 and its ligand CXCL12 were down-modulated during chondrogenesis. By contrast, CXCR5 was up-regulated, whereas its ligand CXCL13 was lower. These data were also confirmed on human articular cartilage. These findings show that, during in vitro h-MSC chondrogenic differentiation, chemokine and receptor expression was specifically induced or repressed. This was in line with what the authors also found in normal articular cartilage, suggesting a role in differentiation and maturation of a cartilage-like structure in vitro and consequently the regulation of cartilage homeostasis.
C1 [Cristino, Sandra; Piacentini, Anna; Manferdini, Cristina; Codeluppi, Katia; Grassi, Francesco; Facchini, Andrea; Lisignoli, Gina] Ist Ortoped Rizzoli, Lab Immunol & Genet, I-40136 Bologna, Italy.
   [Facchini, Andrea] Univ Bologna, Dept Internal Med & Gastroenterol, Bologna, Italy.
RP Lisignoli, G (reprint author), Ist Ortoped Rizzoli, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM labimge@alma.unibo.it
OI manferdini, cristina/0000-0002-6648-6061
CR ASARI A, 1994, J HISTOCHEM CYTOCHEM, V42, P513, DOI 10.1177/42.4.8126377
   Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x
   Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B
   Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200
   Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Fukuyama S, 2006, J IMMUNOL, V177, P4276, DOI 10.4049/jimmunol.177.7.4276
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hering Thomas M., 1999, Frontiers in Bioscience, V4, pd743, DOI 10.2741/Hering
   Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1046/j.1365-2249.2003.02323.x
   Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319
   Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3
   Kanbe K, 2002, ARTHRITIS RHEUM, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D
   Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825
   Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572
   Lisignoli G, 2006, J CELL PHYSIOL, V206, P78, DOI 10.1002/jcp.20435
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Pulsatelli L, 1999, J RHEUMATOL, V26, P1992
   Qi W, 2006, AM J PHYSIOL-RENAL, V290, pF703, DOI 10.1152/ajprenal.00254.2005
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285
   SOLCHAGA LA, 1999, J ORTHOP RES, V17, P215
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Walsh S, 2003, CELL TISSUE RES, V311, P187, DOI 10.1007/s00441-002-0679-8
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190
   Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435
   Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239
   Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X
NR 40
TC 19
Z9 20
U1 1
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2008
VL 14
IS 1
BP 97
EP 105
DI 10.1089/ten.a.2007.0121
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 273VV
UT WOS:000253960900010
PM 18333808
DA 2018-10-19
ER

PT J
AU Helmus, MN
   Gibbons, DF
   Cebon, D
AF Helmus, Michael N.
   Gibbons, Donald F.
   Cebon, David
TI Biocompatibility: Meeting a Key Functional Requirement of Next-
   Generation Medical Devices
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE Biomaterial; biocompatibility; bioactive; biostable; biodegradable; drug
   eluting; implant; database
ID LINKING AGENT GENIPIN; IN-VITRO EVALUATION; PYROLYTIC CARBON;
   CORONARY-ARTERIES; ENDOTHELIAL-CELLS; SURFACE-TREATMENT; TISSUE
   REACTION; COATED STENTS; HEART-VALVES; HEMOCOMPATIBILITY
AB The array of polymeric, biologic, metallic, and ceramic biomaterials will be reviewed with respect to their biocompatibility, which has traditionally been viewed as a requirement to develop a safe medical device. With the emergence of combination products, a paradigm shift is occurring that now requires biocompatibility to be designed into the device. In fact, next-generation medical devices will require enhanced biocompatibility by using, for example, pharmacological agents, bioactive coatings, nano-textures, or hybrid systems containing cells that control biologic interactions to have desirable biologic outcomes. The concept of biocompatibility is moving from a "do no harm" mission (i.e., nontoxic, nonantigenic, nonmutagenic, etc.) to one of doing "good," that is, encouraging positive healing responses. These new devices will promote the formation of normal healthy tissue as well as the integration of the device into adjacent tissue. In some contexts, biocompatibility can become a disruptive technology that can change therapeutic paradigms (e. g., drug-coated stents). New database tools to access biocompatibility data of the materials of construction in existing medical devices will facilitate the use of existing and new biomaterials for new medical device designs.
C1 [Helmus, Michael N.] Med Devices Biomat Drug Delivery & Nanotechnol, Worcester, MA 01609 USA.
   [Gibbons, Donald F.] 3M Corp, N Oaks, MN USA.
   [Cebon, David] Granta Design Ltd, Cambridge, England.
RP Helmus, MN (reprint author), Med Devices Biomat Drug Delivery & Nanotechnol, 2 Jamesbury Dr, Worcester, MA 01609 USA.
EM Mhelmus571@aol.com
CR AMMAR A, 1984, ACTA NEUROCHIR, V72, P45, DOI 10.1007/BF01406813
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   Armani DL, 2001, ANN NY ACAD SCI, V936, P566
   *ASM INT GRANT DES, 2007, MAT MED DEV DAT MMD
   BARENBERG SA, 1990, DEGRADABLE MAT PERSP, P641
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   BONCHEK LI, 1969, J SURG RES, V9, P229, DOI 10.1016/0022-4804(69)90058-4
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   BORETOS JW, 1984, CONT BIOMATERIALS MA, P27
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   CARPENTIER AF, 2007, Patent No. 7214344
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chang Y, 2001, J THORAC CARDIOV SUR, V122, P1208, DOI 10.1067/mtc.2001.117624
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   Chowdhury SKR, 2004, WEAR, V256, P1026, DOI 10.1016/S0043-1648(03)00535-0
   COOK SD, 1991, BLOOD COMPATIBLE MAT, P279
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V31, P134, DOI 10.1016/0030-4220(71)90044-2
   DE SI, 1997, CIRCULATION, V95, P1549
   De Somer F, 2002, PERFUSION-UK, V17, P39, DOI 10.1191/0267659102pf526oa
   EBERHART RC, 1981, MRS BULL, V16, P50
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Galli M, 2001, CATHETER CARDIO INTE, V53, P182, DOI 10.1002/ccd.1145
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   Goreish HH, 2004, J BIOMED MATER RES A, V68A, P1, DOI 10.1002/jbm.a.10141
   GRANSTROM L, 1986, BIOMATERIALS, V7, P455, DOI 10.1016/0142-9612(86)90034-7
   GRISS P, 1981, ARCH ORTHOP TRAUM SU, V98, P157, DOI 10.1007/BF00632972
   Hao L, 2005, J BIOMED MATER RES B, V73B, P148, DOI 10.1002/jbm.b.30194
   Harmand MF, 1999, BIOMATERIALS, V20, P1561, DOI 10.1016/S0142-9612(99)00051-4
   HAUBOLD AD, 1981, BIOCOMPATIBILITY CLI, V2, P4
   HELMUS M, 1986, ASTM SPEC TECH PUBL, V898, P236
   Helmus M, 2007, NAT NANOTECHNOL, V2, P333, DOI 10.1038/nnano.2007.165
   HELMUS MN, 1993, CARDIOVASC PATHOL, V2, pS53
   HELMUS MN, 2003, BIOMATERIALS DESIGN
   HELMUS MN, 1995, ENCY HDB BIOMATERIAL, pCH2
   HELMUS MN, 1999, Patent No. 9938547
   HENCH LL, 2004, CERAMICS GLASSES GLA, P153
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Indolfi C, 2000, BASIC RES CARDIOL, V95, P179, DOI 10.1007/s003950050180
   IOMHAIR MM, 1996, TECHNOL HEALTH CARE, V4, P385
   KOHN J, 2004, BIOMATERIALS SCI INT, P115
   Lazar HL, 1999, ANN THORAC SURG, V67, P446, DOI 10.1016/S0003-4975(98)01139-4
   Levy RJ, 2003, J HEART VALVE DIS, V12, P209
   Malik N, 2001, J Invasive Cardiol, V13, P193
   Mantero S, 2002, J BIOMED MATER RES, V59, P329, DOI 10.1002/jbm.1249
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   MAROPIS PS, 1977, ORAL SURG ORAL MED O, V43, P506, DOI 10.1016/0030-4220(77)90098-6
   MCCOY TJ, 1989, BIOMATERIALS, V10, P243, DOI 10.1016/0142-9612(89)90100-2
   Mirzadeh H, 2003, J BIOMED MATER RES A, V67A, P727, DOI 10.1002/jbm.a.10107
   Neuhauser B, 2003, CARDIOVASC SURG, V11, P465, DOI 10.1016/S0967-2109(03)00109-1
   Nguyen KT, 2003, BIOMATERIALS, V24, P5191, DOI 10.1016/S0142-9612(03)00451-4
   Nitsch A, 2005, AESTHET PLAST SURG, V29, P53, DOI 10.1007/s00266-004-0096-3
   Novello WP, 2000, ARTIF ORGANS, V24, P182, DOI 10.1046/j.1525-1594.2000.06523.x
   RADOMSKI JS, 1987, J SURG RES, V42, P133, DOI 10.1016/0022-4804(87)90110-7
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Ranade SV, 2004, J BIOMED MATER RES A, V71A, P625, DOI 10.1002/jbm.a.30188
   RASHKIND WJ, 1981, VASCULAR CATHETER DE
   RICHARDSON WC, 1975, J BIOMED MATER RES, V9, P73, DOI 10.1002/jbm.820090411
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Rose SF, 2004, BIOMATERIALS, V25, P5125, DOI 10.1016/j.biomaterials.2003.12.016
   Sangiorgi Giuseppe, 2007, Ann Ist Super Sanita, V43, P89
   SELVADURAY GS, 2004, C P ASM INT, P69
   SHIMIZU T, 1989, TRANSFUSION, V29, P292, DOI 10.1046/j.1537-2995.1989.29489242792.x
   Silber Sigmund, 2003, J Interv Cardiol, V16, P485, DOI 10.1046/j.1540-8183.2003.01065.x
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   SNYDER RW, 1988, ENCY MED DEVICES INS, V4, P2839
   Sousa JE, 2001, CIRCULATION, V103, P192
   SPECTOR M, 1990, INT SAMPE TECH CONF, V25, P1119
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   STOKES K, 1987, T SOC BIOMATERIALS, P52
   Su SH, 2003, ANN BIOMED ENG, V31, P667, DOI 10.1114/1.1575756
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   SWART IGN, 1987, DENT IMPLANTS, P97
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   Takami Y, 1997, J BIOMED MATER RES, V36, P381, DOI 10.1002/(SICI)1097-4636(19970905)36:3<381::AID-JBM12>3.0.CO;2-H
   Tamai H, 2000, CIRCULATION, V102, P399
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   Tonda R, 2005, J BIOMED MATER RES A, V75A, P192, DOI 10.1002/jbm.a.30401
   Tweden K S, 1995, J Heart Valve Dis, V4 Suppl 1, pS90
   Urayama H, 1996, ARTIF ORGANS, V20, P24, DOI 10.1111/j.1525-1594.1996.tb04414.x
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   VANDOMAEL M, 1986, PRACTICE CORONARY AN, P93
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V2, P3
   Yang YQ, 1996, J HEART VALVE DIS, V5, P532
   Yannas I., 2004, BIOMATERIALS SCI INT, P127
NR 92
TC 52
Z9 53
U1 1
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD JAN
PY 2008
VL 36
IS 1
BP 70
EP 80
DI 10.1177/0192623307310949
PG 11
WC Pathology; Toxicology
SC Pathology; Toxicology
GA 463UF
UT WOS:000267456900008
PM 18337223
OA Bronze
DA 2018-10-19
ER

PT B
AU Watari, F
   Inoue, S
   Takashi, N
   Totsuka, Y
   Yokoyama, A
AF Watari, Fumio
   Inoue, Saori
   Takashi, Noriyuki
   Totsuka, Yasunori
   Yokoyama, Atsuro
BE Somiya, S
   Doyama, M
TI Reaction of cells and tissue to material nanosizing
SO TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN, VOL 33, NO 2
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposium of the Materials-Research-Society-of-Japan
CY DEC 07-09, 2007
CL Tokyo, JAPAN
SP Mat Res Soc Japan
DE nanosizing; biomaterial; tissue regeneration; inflammation;
   nanotoxicology; titanium; apatite
ID RESISTANT IMPLANT MATERIALS; QUANTITATIVE-ANALYSIS; NITRIDED TITANIUM;
   CARBON NANOTUBES; BIOCOMPATIBILITY; MICROSCOPY; MORPHOLOGY; SCAFFOLDS;
   CULTURE; NICKEL
AB Micro/nanosizing effect of materials onto biological organism was investigated by both in vitro biochemical cell functional test and in vivo animal implantation test. Dependence of reaction of cells and tissue, and that of bone fori-nation of apatite on particle size were studied. The increase of specific surface area causes the enhancement of chemical reactivity and therefore toxicity in many cases, This is the most usually and easily recognizable and strongest effect in most cases. However there is the other effect which becomes prominent especially for biocompatible materials such as Ti and TiO(2). Stimulus was increased with the decrease of particle size and pronounced below 3 mu m by inducing phagocytosis to cells and inflammation to tissue. For the size below 50nm, particles invade into the internal body through the respiratory or digestive system and diffuse inside body. For bone, synthetic hydroxyapatite exhibits excellent osteoconductivity but it is not substituted with natural bone and remains permanently in the body, When the composite with collagen and nanoapatite synthesized in the biomimetic aspects is implanted, resorption of nanocomposite through phagocytosis by osteoclasts and new bone formation by osteoblasts occurred simultaneously after inflammation. Nanocomposite leads to the bone substitutional properties, which resembles the remodeling process in natural bone. Thus nanosizing induces the intrinsic functions of biological organism and results in the conversion of functions such as from biocompatibility to stimulus and from osteoconductivity but non-bone substitutional to bone substitutional properties through biological process.
C1 [Watari, Fumio; Inoue, Saori; Takashi, Noriyuki; Totsuka, Yasunori; Yokoyama, Atsuro] Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido 0608586, Japan.
RP Watari, F (reprint author), Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido 0608586, Japan.
EM watari@den.hokudai.ac.jp
CR Aoki N, 2007, DENT MATER J, V26, P178, DOI 10.4012/dmj.26.178
   Aoki N, 2005, J BIOMED NANOTECHNOL, V1, P402, DOI 10.1166/jbn.2005.048
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Liao S, 2007, ACTA BIOMATER, V3, P669, DOI [10.1016/j.actbio.2007.03.007, 10.1016/j.aetbio.2007.03.007]
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Tamura K, 2002, MATER TRANS, V43, P3052, DOI 10.2320/matertrans.43.3052
   Tamura Y, 2002, DENT MATER J, V21, P355, DOI 10.4012/dmj.21.355
   Tamura Y, 2002, MATER TRANS, V43, P3043, DOI 10.2320/matertrans.43.3043
   Uo M, 2004, J BIOMED MATER RES B, V70B, P146, DOI 10.1002/jbm.b.30024
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   Ushiro M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144103
   Watari F, 2005, J ELECTRON MICROSC, V54, P299, DOI 10.1093/jmicro/dfi056
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   WATARI F, 2006, P 6 AS BIOCERAMICS S, P142
   WATARI F, 2007, HDB BIOMINERALIZATIO, V3, P127
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zhu YH, 2007, DENT MATER J, V26, P245, DOI 10.4012/dmj.26.245
NR 19
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY JAPAN-MRS-J
PI TOKYO
PA C/O SOCIETY NON-TRADITIONAL TECHNOLOGY, SAKURA BLDG 9F, 2-5-5,
   TORANOMON, MINATO-KU, TOKYO, 105-0001, JAPAN
J9 T MRS JAP
PY 2008
VL 33
IS 2
BP 209
EP 214
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BIZ29
UT WOS:000263941500004
DA 2018-10-19
ER

PT B
AU Kitano, K
   Matsuno, R
   Konno, T
   Takai, M
   Ishihara, K
AF Kitano, Kazuhiko
   Matsuno, Ryosuke
   Konno, Tomohiro
   Takai, Madoka
   Ishihara, Kazuhiko
BE Somiya, S
   Doyama, M
TI Nanoscale Structured Phospholipid Polymer Brush for Biointerface
SO TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN, VOL 33, NO 3
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposium of the Materials-Research-Society-of-Japan
CY DEC 07-09, 2007
CL Tokyo, JAPAN
SP Mat Res Soc Japan
DE phospholipid polymer; polymer brush; atom transfer radical
   polymerization; atomic force microscopy; lubricity
ID RADICAL POLYMERIZATION; POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE);
   PROTEIN ADSORPTION; FRICTION; SURFACES; PLASMA; BLOOD
AB To prepare the biomaterial surface having both lubricity and biocompatibility, we aimed to prove the mechanism of the resistance of friction and protein adsorption with grafting polymer. We prepared poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) grafted layer using an atom transfer radical polymerization (ATRP) method, which had the advantage of controlling surface structures oil nanoscale. From the results Of Surface characterization, it was confirmed that the thickness of the PMPC grafted layer was 4-10 nm and the conformation of the PMPC grafted layer was brushlike. We investigated the friction properties in air and in water with an atomic force microscopy (AFM). The friction coefficients of the PMPC brush layers were decreased dramatically in water and the resistance of friction depended on the thickness of the PMPC brush layer. We also investigated the protein adhesion properties by measuring the force-distance curves using the AFM cantilever immobilized with a bovine serum albumin (BSA). The adhesion force between the BSA and the PMPC brush layers were markedly reduced and the resistance of the BSA adhesion depended on the thickness of the PMPC brush layer. For resisting both friction and protein adsorption in water, it was a key factor to keep the thick hydrated layer made by the elongated hydrophilic PMPC brush chains.
C1 [Kitano, Kazuhiko; Ishihara, Kazuhiko] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Kitano, K (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM kitano@mpc.t.u-tokyo.ac.jp
CR CHANG PC, J BONE MINER RES, V39, P380
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   GODA T, 2007, COLLOIDS B IN PRESS
   Gong J, 1998, J CHEM PHYS, V109, P8062, DOI 10.1063/1.477453
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   KOBAYASHI M, 2007, SOFT MATTER, V3, P1
   Kyomoto M, 2007, J BIOMED MATER RES A, V82A, P10, DOI 10.1002/jbm.a.31134
   Li JW, 1999, LANGMUIR, V15, P7662, DOI 10.1021/la981750d
   Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o
   LWEIS AL, 2002, BIOMATERIALS, V23, P1697
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Ramakrishnan A, 2002, MACROMOL RAPID COMM, V23, P612, DOI 10.1002/1521-3927(20020701)23:10/11<612::AID-MARC612>3.0.CO;2-9
   Sawada SI, 2006, J BIOMED MATER RES A, V79A, P476, DOI 10.1002/jbm.a.30820
   Sibarani J, 2007, COLLOID SURFACE B, V54, P88, DOI 10.1016/j.colsurfb.2006.09.024
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
NR 21
TC 0
Z9 0
U1 1
U2 3
PU MATERIALS RESEARCH SOCIETY JAPAN-MRS-J
PI TOKYO
PA C/O SOCIETY NON-TRADITIONAL TECHNOLOGY, SAKURA BLDG 9F, 2-5-5,
   TORANOMON, MINATO-KU, TOKYO, 105-0001, JAPAN
J9 T MRS JAP
PY 2008
VL 33
IS 3
BP 771
EP 774
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BIZ20
UT WOS:000263875800059
DA 2018-10-19
ER

PT J
AU Rosales-Cortes, M
   Peregrina-Sandoval, J
   Hernandez-Mercado, J
   Nolasco-Rodriguez, G
   Chavez-Delgado, ME
   Gomez-Pinedo, U
   Albarran-Rodriguez, E
AF Rosales-Cortes, Manuel
   Peregrina-Sandoval, Jorge
   Hernandez-Mercado, Jorge
   Nolasco-Rodriguez, Guillermo
   Chavez-Delgado, Maria Estela
   Gomez-Pinedo, Ulises
   Albarran-Rodriguez, Esther
TI Regeneration of the dog's axotomized sciatic nerve with preg
   nenolone-saturated chitosan prosthesis implanted through the
   tubulization technique
SO VETERINARIA MEXICO
LA English
DT Article
DE biomaterial; chitosan; axotomized sciatic nerve; regeneration;
   peripheral nerves and pregnenolone
ID PERIPHERAL-NERVE; WALLERIAN DEGENERATION; AXONAL REGENERATION; PROMOTING
   FACTORS; DRUG-DELIVERY; SCHWANN-CELLS; REPAIR; PREGNENOLONE; GROWTH;
   MYELIN
AB Peripheral nerves can be injured by traumatisms or mechanical causes, and thermal, ischemic or tumoral damage, this could present inconveniences of the mobility, sensibility and loss of motor function at the denervated area. The surgical techniques applied to repair nerves have gone through several phases of evolution such as the tubulization technique which consists of a prosthesis with a pipe shape at the segment injured. In this work the biomaterial utilized to manufacture the prosthesis was chitosan, since this compound allows to incorporate to its matrix promoting nervous growing substances that are released in situ for a long time while being degraded by titular lysosomes of organic origin. It is known, by diverse studies, that several neurosteroids are involved during the regeneration process of peripheral nerves, which functions are already described, as pregnenolone. In order to determine if there was or not regeneration and the degree of maturity of this,12 young French Poodle female dogs of 1 to 1.5 years old were used (four were used as intact control group, four were subjected to tubulization technique with chitosan, and four went into tubulization technique with chitosan and pregnenolone neurosteroid, which is a stem hormone), in order to correct 15 mm of axotomized segment. The regenerated nerves were evaluated by means of electronic microscopy of transmission and light, performing cross cuts of 60-70 nm and 1 mu m in thickness for their histological analysis. The morphological findings showed a similar structure to that of an intact nerve, since the number of myelinated axons, not myelinated and the proportion "g" (which indicates the ripening degree of the axon), were similar, indicating that the regeneration of the axotomized nerves and tubulization was achieved, independently of the administered treatment.
C1 [Rosales-Cortes, Manuel; Hernandez-Mercado, Jorge; Nolasco-Rodriguez, Guillermo; Albarran-Rodriguez, Esther] Univ Guadalajara, Ctr Univ Ciencias Biol & Agropecuarias, Dept Vet Med, Lab Morfofisiol,Div Ciencias Vet, Zapopan 45110, Jalisco, Mexico.
   [Peregrina-Sandoval, Jorge] Univ Guadalajara, Ctr Univ Ciencias Biol Agropecuarias, Dept Biol Mol, Lab Inmunol,Div Ciencias Biol & Ambientales, Zapopan, Jalisco, Mexico.
   [Chavez-Delgado, Maria Estela] Inst Mexicano Seguro Social, Dept Otorrinolaringol, Hosp Gen Zona 89, Guadalajara, Jalisco, Mexico.
   [Gomez-Pinedo, Ulises] Antiguo Hosp Civil Guadalajara, OPD, AC & Lab Patol Clin,Div Patol & Biotecnol Ambient, Ctr Invest & Asistencia & Tecnol & Diseno Estado, Guadalajara, Jalisco, Mexico.
RP Rosales-Cortes, M (reprint author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agropecuarias, Dept Vet Med, Lab Morfofisiol,Div Ciencias Vet, Kilometro 15-5,Carretera Guadalajara Nogales, Zapopan 45110, Jalisco, Mexico.
EM mrosales@cucba.udg.mx
OI , ulises.gomez-pinedo/0000-0003-3097-5557
CR AFIFI AK, 1999, NEUROANATOMIA FUNCTI
   AGUAYO AJ, 1982, ADV CELL NEUROBIOL, V3, P215
   AKAWA SN, 1993, REGULATION CELL DENS, V121, P135
   Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X
   AYALA H, 1997, REV ORTOP TRAUM, V2, P3
   BALEY S, 1993, J NEUROCYTOL, V22, P176
   Barakat-Walter I, 1999, J NEUROBIOL, V40, P541, DOI 10.1002/(SICI)1097-4695(19990915)40:4<541::AID-NEU10>3.0.CO;2-Q
   BRAUN RM, 1966, SURG GYNECOL OBSTETR, V122, P15
   BROUSSIGNAC P, 1968, CHIMIE IND GENIE CHI, V99, P241
   CAMPBELL JB, 1961, J TRAUMA, V11, P139
   CHAUDHRY V, 1992, NEUROL CLIN, V10, P613
   CHEN ZW, 1995, MICROSURG, V16, P547, DOI 10.1002/micr.1920160808
   DAVIS GE, 1985, TRENDS NEUROSCI, V8, P528, DOI 10.1016/0166-2236(85)90189-4
   DUMITRU D, 1994, REACTION PERIPHERAL
   GABRIELSON G, 1996, PLAST RECONSTR SURG, V38, P68
   Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0
   Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3
   GIL J, 1997, PROTOCOLO DISECCION
   Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x
   HIRANO S, 1998, BIOMATERIALS, V19, P3293
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   JONES KJ, 1993, BRAIN RES BULL, V30, P491, DOI 10.1016/0361-9230(93)90283-H
   JONES KJ, 1993, ADV NEUROL, V59, P227
   JUNGTESTAS I, 1994, J STEROID BIOCHEM, V48, P145, DOI 10.1016/0960-0760(94)90261-5
   KABBADJ K, 1993, GLIA, V7, P170, DOI 10.1002/glia.440070206
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P273, DOI 10.1016/0266-7681(94)90068-X
   MORFIN R, 1992, P NATL ACAD SCI USA, V89, P6790, DOI 10.1073/pnas.89.15.6790
   Mueller Hans Werner, 1998, Current Opinion in Neurology, V11, P557
   PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x
   PHAM HN, 1991, J RECONSTR MICROSURG, V7, P31, DOI 10.1055/s-2007-1006762
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SALONEN V, 1987, J NEUROCYTOL, V16, P713, DOI 10.1007/BF01637662
   Shepherd R, 1997, GLYCOCONJUGATE J, V14, P535, DOI 10.1023/A:1018524207224
   SISSON S, 1994, ANATOMIA ANIMALES DO
   Smith KJ, 2001, ANN NEUROL, V49, P470
   SPECTOR G, 1992, LARYNGOSCOPE, V102, P784
   SPENCER PS, 1979, BRAIN RES, V165, P119, DOI 10.1016/0006-8993(79)90049-0
   Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3
   TERRIS DJ, 1993, ARCH OTOLARYNGOL, V119, P725
   VARUM K, 1996, BIOCHIM BIOPHYS ACTA, V5, P1291
   VARUM K, 1996, BIOCHIM BIOPHYS ACTA, V1297, P5
   VASSILIS EK, 1986, CELL DEATH DIS NERVO
   Weiss P, 1944, J NEUROSURG, V1, P400, DOI 10.3171/jns.1944.1.6.0400
   WILLIAMS LR, 1993, EXP NEUROL, V120, P49, DOI 10.1006/exnr.1993.1039
   WONG BJF, 1991, OTOLARYNG CLIN N AM, V24, P739
   Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0
NR 50
TC 0
Z9 0
U1 3
U2 7
PU UNIV NACIONAL AUTONOMA MEXICO FACULTAD MEDICINA VETERINARIA ZOOTECNIA
PI MEXICO
PA CIRCUITO EXTERIOR, CIUDAD UNIVERSITARIA, MEXICO 04510, DF, MEXICO
SN 0301-5092
J9 VET MEXICO
JI Vet. Mexico
PD JAN-MAR
PY 2008
VL 39
IS 1
BP 55
EP 66
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 299GQ
UT WOS:000255744500005
DA 2018-10-19
ER

PT B
AU Lu, L
   Zhou, J
   Mondrinos, M
   Lelkes, P
   Wootton, D
AF Lu, L.
   Zhou, J.
   Mondrinos, M.
   Lelkes, P.
   Wootton, D.
BE Bartolo, PJ
   Mateus, AJ
   Batista, FDC
   Almeida, HA
   Matias, JM
   Vasco, JC
   Gaspar, JB
   Correia, MA
   Andre, NC
   Alves, NF
   Novo, PP
   Martinho, PG
   Carvalho, RA
TI Porogen based solid freeform fabrication of polycaprolactone-calcium
   phosphate scaffolds for tissue engineering
SO VIRTUAL AND RAPID MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
SE Proceedings and Monographs in Engineering Water and Earth Sciences
LA English
DT Proceedings Paper
CT 3rd International Conference on Advanced Research in Virtual and Rapid
   Prototyping
CY SEP 24-29, 2007
CL Leiria, PORTUGAL
SP Polytech Inst Leiria, Sch Technol & Management, Ctr Rapid & Sustainable Prod Dev, Int Acad Prod Engn, Global Alliance Rapid Prototyping Assoc, Portuguese Rapid Prototyping Assoc, HUNTSMAN
ID RESORBABLE POLYMERS; COMPOSITE SCAFFOLD; BONE; CHEMISTRY; ACID)
AB This research integrates biomimetic modeling, solid freeform fabrication, systems and control, and tissue engineering in one intelligent system for structured, highly porous biomaterials, which will be applied to bone scaffolds. Currently we are developing a solid freeform fabrication system to make highly biocompatible and water soluble sucrose porogens. This research has conducted material studies on modified sucrose as a porogen material in its fluidity, viscosity, melting temperature, mechanical strength, and manufacturability. A new SFF-based manufacturing system using pressure based extrusion to print sucrose bone scaffold porogens has been developed. Porogen structure can be built by this system. In parallel we are utilizing a commercial Rapid Prototyping (RP) machine to fabricate thermoplastic porogens of various designs to determine the feasibility of injecting a highly viscous scaffold material into porogens. Materials which have been successfully used to make scaffolds by injection include CPC bone cement, molten poly-caprolactone (PCL), 90/10 and 80/20 percent by mass composite of poly-caprolactone (PCL) and calcium phosphate(CaPO4,). Results presented for the injection method include characterization of attainable feature resolution of the RP machine, as well as preliminary cell-biomaterial interaction data demonstrating biocompatibility of CPC scaffolds. The preliminary results using a commercial rapid prototyping machine have demonstrated that the indirect porogen technique can improve the resolution of SFF system by 2-4 times in fabricating bone scaffolds. The resultant scaffolds demonstrate that the defined porous structure will be suitable for tissue engineering applications.
C1 [Lu, L.; Zhou, J.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
   [Mondrinos, M.; Lelkes, P.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   [Wootton, D.] Cooper Union Adv Sci & Art, Mech Engn, New York, NY USA.
RP Lu, L (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHEN CS, 1995, BIOMATERIALS, V16, P777, DOI 10.1016/0142-9612(95)99640-8
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   COOMBES AGA, 1992, BIOMATERIALS, V13, P297, DOI 10.1016/0142-9612(92)90053-Q
   COOMBES AGA, 1992, BIOMATERIALS, V13, P217, DOI 10.1016/0142-9612(92)90187-S
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   HAINES AH, 1981, ADV CARBOHYD CHEM BI, V39, P13
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KELLY EB, NEW FRONTIERS BONE G
   KHAN R, 1984, PURE APPL CHEM, V56, P833, DOI 10.1351/pac198456070833
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LANGE AE, 1994, SAMPE J, V30, P46
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nikolaychik VV, 1996, J BIOMAT SCI-POLYM E, V7, P881, DOI 10.1163/156856296X00057
   Nikolaychik VV, 1996, ASAIO J, V42, pM487, DOI 10.1097/00002480-199609000-00035
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   PORTER NL, FABRICATION POROUS C
   RUBIO E, 1991, J AM CHEM SOC, V113, P695, DOI 10.1021/ja00002a060
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Singhal A R, 1996, Tissue Eng, V2, P197, DOI 10.1089/ten.1996.2.197
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
NR 32
TC 1
Z9 1
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
BN 978-0-415-41602-3
J9 PROC MONOGR ENG WATE
PY 2008
BP 87
EP +
PG 3
WC Engineering, Manufacturing; Engineering, Civil; Engineering, Electrical
   & Electronic; Engineering, Mechanical
SC Engineering
GA BHA08
UT WOS:000251781800012
DA 2018-10-19
ER

PT J
AU Cecchini, M
   Bumma, G
   Serresi, M
   Beltram, F
AF Cecchini, Marco
   Bumma, Giorgia
   Serresi, Michela
   Beltram, Fabio
TI PC12 diiierentiation on biopolymer nanostructures
SO NANOTECHNOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX; CONTACT GUIDANCE; NANOIMPRINT LITHOGRAPHY;
   HIPPOCAMPAL-NEURONS; AXONAL OUTGROWTH; GROWTH; CELLS; NETWORKS;
   SURFACES; BIOMATERIAL
AB The study of nervous system regeneration and axonal outgrowth control are relevant in several research areas, like neurophysiology or biomedical engineering. Among the elements that control neuron dynamics, the host substrate topography is a key parameter in determining cell differentiation. We present time-lapse experiments to analyze the differentiation dynamics of PC 12 cells on nanopatterned biocompatible substrates. 200 nm depth gratings were fabricated on tissue-culture polystyrene substrates by nanoimprint lithography; different linewidths and pitches were compared down to 500 nm and 1000 nm, respectively. PC12 cells were cultured on these substrates and, following NGF administration to the medium, body morphology, cell movement and neuritogenesis were monitored at different time periods. In addition to demonstrating guided differentiation, our studies show complex time variations in body morphology and axon length, and guided cell movement. We show unstable synaptic connections and cell-body polarization, and the competition between topographical guidance and cell-cell interactions.
C1 [Cecchini, Marco; Bumma, Giorgia; Serresi, Michela; Beltram, Fabio] Scuola Normale Super Pisa, Pisa, Italy.
   [Cecchini, Marco; Beltram, Fabio] INFM, CNR, NEST, Pisa, Italy.
   [Cecchini, Marco; Bumma, Giorgia; Serresi, Michela; Beltram, Fabio] Italian Inst Technol, Pisa, Italy.
RP Cecchini, M (reprint author), Scuola Normale Super Pisa, Pisa, Italy.
EM m.cecchini@sns.it
RI Beltram, Fabio/F-2920-2013
OI Beltram, Fabio/0000-0002-6081-436X; Cecchini, Marco/0000-0002-9688-2356
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   Beck M, 2002, MICROELECTRON ENG, V61-2, P441, DOI 10.1016/S0167-9317(02)00464-1
   Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605
   CLARK P, 1993, J CELL SCI, V105, P203
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729
   James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kam L, 2001, BIOMATERIALS, V22, P1049, DOI 10.1016/S0142-9612(00)00352-5
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Mofrad MRK, 2005, ACTA BIOMATER, V1, P281, DOI 10.1016/j.actbio.2005.02.008
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Schmalenberg KE, 2004, BIOMATERIALS, V25, P1851, DOI 10.1016/j.biomaterials.2003.08.048
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Vogt AK, 2005, BIOMATERIALS, V26, P2549, DOI 10.1016/j.biomaterials.2004.07.031
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 30
TC 28
Z9 28
U1 0
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD DEC 19
PY 2007
VL 18
IS 50
AR 505103
DI 10.1088/0957-4484/18/50/505103
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 256QV
UT WOS:000252745600003
DA 2018-10-19
ER

PT J
AU Isenhath, SN
   Fukano, Y
   Usui, ML
   Underwood, RA
   Irvin, CA
   Marshall, AJ
   Hauch, KD
   Ratner, BD
   Fleckman, P
   Olerud, JE
AF Isenhath, S. N.
   Fukano, Y.
   Usui, M. L.
   Underwood, R. A.
   Irvin, C. A.
   Marshall, A. J.
   Hauch, K. D.
   Ratner, B. D.
   Fleckman, P.
   Olerud, J. E.
TI A mouse model to evaluate the interface between skin and a percutaneous
   device
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE wound healing; poly(HEMA); implant; biointegration; biomaterial
ID OCTYLCYANOACRYLATE TISSUE ADHESIVE; BLOOD-STREAM INFECTION; WOUND
   TREATMENT FILMS; SURFACE-TOPOGRAPHY; CONNECTIVE-TISSUE; ACCESS DEVICE;
   IMPLANTS; LACERATIONS; ATTACHMENT; MANAGEMENT
AB Percutaneous medical devices are integral in the management and treatment of disease. The space created between the skin and the device becomes a haven for bacterial invasion and biofilm formation and results in infection. We hypothesize that sealing this space via integration of the skin into the device will create a barrier against bacterial invasion. The purpose of this study was to develop an animal model in which the interaction between skin and biomaterials can be evaluated. Porous poly(2-hydroxyethyl methacrylate) [poly(HEMA)l rods were implanted for 7 days in the dorsal skin of C57 BL/6 mice. The porous poly(HEMA) rods were surface-modified with carbonyldiimidazole (CDI) or CDI plus laminin 5; unmodified rods served as control. Implant sites were sealed with 2-octyl cyanoacrylate; corn pads and adhesive dressings were tested for stabilization of implants. All rods remained intact for the duration of the study. There was histological evidence of both epidermal and dermal integration into all poly(HEMA) rods regardless of treatment. This in vivo model permits examination of the implant/skin interface and will be useful for future studies designed to facilitate skin cell attachment where percutaneous devices penetrate the skin. (c) 2007 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Dermatol Med, Seattle, WA 98195 USA.
   Univ Washington, Dept BioEngn, Seattle, WA 98195 USA.
RP Olerud, JE (reprint author), Univ Washington, Dept Dermatol Med, Seattle, WA 98195 USA.
EM olerudje@u.washington.edu
FU NIDDK NIH HHS [DK59221]
CR Bhende Shubhangi, 2002, Surg Infect (Larchmt), V3, P251, DOI 10.1089/109629602761624216
   Blondeel PNV, 2004, AM J SURG, V188, P307, DOI 10.1016/j.amjsurg.2004.04.006
   Bruns TB, 2000, AM FAM PHYSICIAN, V61, P1383
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Deporter D A, 1985, Prog Clin Biol Res, V187, P353
   Fitton JH, 1998, CORNEA, V17, P108, DOI 10.1097/00003226-199801000-00016
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Gesler W, 2004, ASAIO J, V50, P349, DOI 10.1097/01.MAT.0000131248.70074.E3
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Hollander JE, 1999, ANN EMERG MED, V34, P356, DOI 10.1016/S0196-0644(99)70131-9
   HOWELL JM, 1995, ANTIMICROB AGENTS CH, V39, P559, DOI 10.1128/AAC.39.2.559
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P1535, DOI 10.1002/jbm.820251210
   Kim H, 2006, INT J ORAL MAX IMPL, V21, P354
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   KUNZKER JF, 1995, CHEM IND, V16, P56
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Mertz PM, 2003, J CUTAN MED SURG, V7, P1, DOI 10.1007/s10227-002-1154-6
   Narang U, 2003, J CUTAN MED SURG, V7, P13, DOI 10.1007/s10227-002-1155-5
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   Pachulski Roman, 2005, J Interv Cardiol, V18, P185, DOI 10.1111/j.1540-8183.2005.04048.x
   Quinn J, 1997, SURGERY, V122, P69, DOI 10.1016/S0039-6060(97)90266-X
   Quinn J, 1997, JAMA-J AM MED ASSOC, V277, P1527
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Safdar N, 2002, MEDICINE, V81, P466, DOI 10.1097/00005792-200211000-00007
   Singer AJ, 1997, NEW ENGL J MED, V337, P1142, DOI 10.1056/NEJM199710163371607
   Singer AJ, 2003, ACAD EMERG MED, V10, P1134, DOI 10.1197/S1069-6563(03)00376-2
   Snik AFM, 2004, AUDIOL NEURO-OTOL, V9, P190, DOI 10.1159/000078388
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   Trott AT, 1997, JAMA-J AM MED ASSOC, V277, P1559
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Yu C, 1999, ASAIO J, V45, P531, DOI 10.1097/00002480-199911000-00005
NR 37
TC 29
Z9 30
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2007
VL 83A
IS 4
BP 915
EP 922
DI 10.1002/jbm.a.31391
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 235XN
UT WOS:000251267700003
PM 17567856
DA 2018-10-19
ER

PT J
AU Lally, S
   Mackenzie, P
   LeMaitre, CL
   Freemont, TJ
   Saunders, BR
AF Lally, Sarah
   Mackenzie, Paul
   LeMaitre, Christine L.
   Freemont, Tony J.
   Saunders, Brian R.
TI Microgel particles containing methacrylic acid: pH-triggered swelling
   behaviour and potential for biomaterial application
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE microgel; responsive polymer; gel; biocolloid; intervertebral disc
ID SYSTEMS; DISPERSIONS; TRANSITIONS; FLUID
AB pH-responsive microgels are crosslinked polymer particles that swell when the pH approaches the pK(a) of the ionic monomer incorporated within the particles. In recent work from our group it was demonstrated that the mechanical properties of degenerated intervertebral discs (IVDs) could be restored to normal values by injection of poly (EA/MAA/BDDA) (ethylacrylate, methacrylic acid and butanediol diacrylate) microgel dispersions [J.M. Saunders, T. Tong, C.L. Le Maitre, T.J. Freemont, B.R. Saunders, Soft Matter 3 (2007) 486]. In this work we report the pH dependent swelling and rheological properties of poly (MMA/MAA/EGDMA) (methyl methacrylate and ethyleneglycol dimethacrylate) microgel dispersions. This system was investigated because it contains monomers that are already used as biomaterials. The poly(MMA/MAA/EGDMA) particles exhibit pH-triggered volume swelling ratios of up to ca. 250. The swelling onset for these particles occurs at pH values greater than ca. 6.0. A pK(a) for these particles of ca. 6.7 is consistent with titration and swelling data. Fluid-to-gel phase diagrams for concentrated poly(MMA/MAA/EGDMA) dispersions were determined as a function of polymer volume fi-action and pH using tube-inversion measurements. The rheological properties for the gelled microgel dispersions were investigated using dynamic rheology measurements. The elastic modulus data for the poly(MMA/MAA/EGDMA) gelled dispersions were compared to data for poly(EA/MAA/BDDA) microgels. A similar pH-dependence for the elastic modulus was apparent. The maximum elastic modulus was achieved at a pH of about 7.0. The elastic modulus is an exponentially increasing function of polymer volume fraction at pH 7.0. Preliminary cell challenge experimental data are reported that indicate that gelled poly(MMA/MAA/EGDMA) microgel dispersions are biocompatible with cells from human intervertebral discs. However, the duration over which these experiments could be performed was limited by gradual redispersion of the gelled microgel dispersions. Based on the results presented it is suggested that poly(MMA/MAA/EGDMA) microgel would be a good candidate as a biomaterial for structural support of soft connective tissues. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Manchester, Sch Mat, Manchester Mat Sci Ctr, Manchester M1 7HS, Lancs, England.
   Univ Manchester, Sch Med, Tissue Injury & Repair Grp, Stopford Bldg, Manchester M13 9PT, Lancs, England.
RP Saunders, BR (reprint author), Univ Manchester, Sch Mat, Manchester Mat Sci Ctr, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM brian.saunders@umist.ac.uk
RI Freemont, Tony/A-9000-2015
OI Freemont, Tony/0000-0002-9780-208X; Saunders, Brian/0000-0003-1410-2967;
   Le Maitre, Christine/0000-0003-4489-7107
CR Brandrup J., 1999, POLYM HDB
   BUSCALL R, 1982, COLLOID SURFACE, V5, P269, DOI 10.1016/0166-6622(82)80040-1
   Chen WC, 2001, J APPL POLYM SCI, V79, P853, DOI 10.1002/1097-4628(20010131)79:5<853::AID-APP100>3.0.CO;2-I
   English RJ, 1999, J RHEOL, V43, P1175, DOI 10.1122/1.551026
   Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7
   Hoare T, 2006, LANGMUIR, V22, P7342, DOI 10.1021/la0608718
   Kim JY, 2003, COLLOID POLYM SCI, V281, P614, DOI 10.1007/s00396-002-0808-7
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   Prasad V, 2003, FARADAY DISCUSS, V123, P1, DOI 10.1039/b211107c
   RODRIGUEZ BE, 1994, MACROMOLECULES, V27, P6642, DOI 10.1021/ma00100a058
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   SAUNDERS BR, 2002, ENCY SURFACE COLLOID, P4544
   Saunders JM, 2007, SOFT MATTER, V3, P486, DOI 10.1039/b613943d
   SPENCER HG, 1962, J POLYM SCI, V56, pS25, DOI 10.1002/pol.1962.1205616337
   Tan BH, 2005, ADV COLLOID INTERFAC, V113, P111, DOI 10.1016/j.cis.2005.01.002
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VINCENT B, 1973, J COLLOID INTERF SCI, V42, P270, DOI 10.1016/0021-9797(73)90290-7
   Zhang XS, 1999, J BIOMED MATER RES, V46, P279, DOI 10.1002/(SICI)1097-4636(199908)46:2<279::AID-JBM18>3.0.CO;2-M
NR 19
TC 32
Z9 33
U1 0
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD DEC 15
PY 2007
VL 316
IS 2
BP 367
EP 375
DI 10.1016/j.jcis.2007.08.030
PG 9
WC Chemistry, Physical
SC Chemistry
GA 231ZK
UT WOS:000250987500019
PM 17765913
DA 2018-10-19
ER

PT J
AU Zawrah, MF
   El-Gazery, M
AF Zawrah, M. F.
   El-Gazery, M.
TI Mechanical properties of SiC ceramics by ultrasonic nondestructive
   technique and its bioactivity
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE SiC; mechanical properties; ultrasonic; bioactivity
ID BIOMORPHIC SILICON-CARBIDE; MICROSTRUCTURE; PHASE; GLASS; WOOD
AB Two SiC ceramics samples sintered at different firing temperatures, i.e. 1750, 1800 and 1900 degrees C were investigated through their mechanical properties using ultrasonic nondestructive technique. The velocity of longitudinal and shear ultrasonic waves were measured and used to calculate the longitudinal modulus (L), shear modulus (G), Young's modulus (E), bulk modulus (K) and Poisson's ratio (v). An attempt was done to use these materials as biomaterials. Simulated body fluids (SBF) containing inorganic concentrations close to human blood plasma was used to study the bioactivity of this material. The microstructure of SiC samples after immersion in SBF was investigated using scanning electron microscope (SEM). The results revealed that the longitudinal and shear ultrasonic velocities increase with increasing the sintering temperature in S1 and S2 and consequently increasing the mechanical properties. Generally, S I exhibited higher mechanical properties than S2 at 1900 degrees C. This is attributed to rigid framework, higher density and lower porosity. The obtained mechanical properties are favorable as compared with human cancellous bone and titanium for biomedical applications. It is then possible to conclude that SiC biomaterial implants appear as quite interesting alternative to Ti implants, by showing higher mechanical properties and lower density. Moreover, taking into account the biomechanical requirements (density, elastic modulus, strain to failure, etc.) of a particular type of bone in the body that should be repaired, bio SiC ceramics can be selected according the above properties. (c) 2007 Elsevier B.V. All rights reserved.
C1 Natl Res Ctr, Dept Ceram, Cairo 12622, Egypt.
   Natl Inst Stand, Ultrasonic Metrol Dept, Cairo, Egypt.
RP Zawrah, MF (reprint author), Natl Res Ctr, Dept Ceram, Cairo 12622, Egypt.
EM mzawrah@hotmail.com
OI Zawrah, Mahmoud/0000-0001-5172-7304
CR [Anonymous], 2001, E49401 ASTM
   Brunette D. M., 2001, TITANIUM MED
   CARRY C, 1984, MATER SCI RES, V18, P391
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   EVANS AG, 1975, J MATER SCI, V10, P1659, DOI 10.1007/BF00554926
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   Green R. E., 1973, ULTRASONIC INVESTIGA
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   Greil P, 1999, MATER CHEM PHYS, V61, P64, DOI 10.1016/S0254-0584(99)00115-7
   HENCH LL, 1993, INTRO BIO CERAMICS
   Martinez-Fernandez J, 2000, SCRIPTA MATER, V43, P813, DOI 10.1016/S1359-6462(00)00494-2
   Martinez-Fernandez J, 2000, ENVIRONMENT CONSCIOUS MATERIALS - ECOMATERIALS, P733
   MOUSSA R, 1982, P BR CERAM SOC, V32, P261
   MUNOZ A, 2000, JOINING ADV SPECIALI, V3, P7
   NarcisoRomero FJ, 1996, J MATER SCI, V31, P779, DOI 10.1007/BF00367899
   NOSE T, 1989, MRS INT M ADV MAT, V7, P293
   PAPADAKIS E, 1990, MEASUREMENT ULTRASON, V19
   SCHREIDER E, 1973, ELASTIC CONSTANTS TH
   Sieber H, 2000, ADV ENG MATER, V2, P105, DOI 10.1002/(SICI)1527-2648(200003)2:3<105::AID-ADEM105>3.0.CO;2-P
   SIEBER H, 2000, CERAMIC T, V110, P81
   SIEBER H, 2000, CERAM FORUM INT CFI, V77, P1
   Singh M, 2002, J EUR CERAM SOC, V22, P2709, DOI 10.1016/S0955-2219(02)00136-X
   SINGH M, 1994, J MATER RES, V9, P1701, DOI 10.1557/JMR.1994.1701
   SINGH M, 2001, P 11 INT S ULTR HIGH, P58
   SINGH M, 1993, ADV CERAMIC MATRIX C, P349
   Singh M., 2000, CERAM SCI ENG P, V21, P39
   Singh M., 2001, CERAM ENG SCI P, V22, P135
   SINGH M, 2001, 2001210605 NASA TM
   Truel R., 1969, ULTRASONIC METHODS S
   Varela-Feria FM, 2002, J EUR CERAM SOC, V22, P2719, DOI 10.1016/S0955-2219(02)00137-1
   Yamamuro T., 1990, HDB BIOACTIVE CERAMI
   YOSHIZAWA Y, 1990, J AM CERAM SOC, V73, P3069, DOI 10.1111/j.1151-2916.1990.tb06718.x
   Zawrah MF, 2004, CERAM INT, V30, P721, DOI 10.1016/j.ceramint.2003.07.017
NR 33
TC 32
Z9 33
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD DEC 15
PY 2007
VL 106
IS 2-3
BP 330
EP 337
DI 10.1016/j.matchemphys.2007.06.010
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 234ZI
UT WOS:000251202900031
DA 2018-10-19
ER

PT J
AU Asakura, T
   Sato, H
   Moro, F
   Yang, MY
   Nakazawa, Y
   Collins, AM
   Knight, D
AF Asakura, Tetsuo
   Sato, Hirohiko
   Moro, Fumika
   Yang, Mingying
   Nakazawa, Yasumoto
   Collins, Andrew M.
   Knight, David
TI Solid-state NMR analysis of
   (GA)(3)S(AG)(3)D(GA)(3)S(AG)(3)D(GA)(3)S(AG)(3), a peptide with a
   lamellar structure and a calcium binding site, and production of
   TS[(AG)(3)D(GA)(3)S](16) in Escherichia coli
SO MACROMOLECULES
LA English
DT Article
ID SAMIA-CYNTHIA-RICINI; MORI SILK FIBROIN; NUCLEAR-MAGNETIC-RESONANCE;
   SPIDER DRAGLINE SILK; C-13 CHEMICAL-SHIFTS; BOMBYX-MORI; CELL ADHESIVE;
   C-ALPHA; H-2 NMR; PROTEIN
AB In an attempt to produce mineralized composite materials with potential use as biomaterials or scaffolds for tissue engineering, we designed silklike peptides based on Ala-Gly repeated sequences with a lamellar structure and Asp as a Ca binding site in the turn part as in Tirrell's work (for example: Macromolecules 1996, 29, 1540-1553). We further modified the design of the lamella structure by introducing a Ser residue between (GlyAla)(3) and (AlaGly)(3) sequences. At first, we synthesized three labeled versions of 41SDSDS, (GlyAla)(3)Ser(AlaGly)(3)Asp(GlyAla)(3)Ser(AlaGly)(3)Asp(GlyAla)(3)Ser(AlaGly)(3), with (13)C labeling in different positions to characterize the lamellar structure using (13)C CP/MAS and spin-diffusion solid-state NMR. The beta-sheet fraction in Ala residues increased with increased distance from the Asp residue in the turn part. The introduced Ser residue took almost 100% beta-sheet structure probably because it forms an extra hydrogen bond stabilizing the stem part of (AlaGly). Thus, position-selective and sensitive information useful to characterize the detailed lamella structure; with heterogeneous local conformations, can be obtained by (13)C selective labeling of the peptide and determining (13)C conformation-dependent NMR chemical shifts. We then produced an analogous recombinant. protein, 14DS16, ThrSer[(AlaGly)(3)Asp(GlyAla)3Ser]16 in Escherichia coli as a possible biomaterial. Films of this protein treated with simulated body fluid were rapidly mineralized with hydroxyapatite.
C1 Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
   Univ Bristol, Dept Chem, Bristol BS8 1TS, Avon, England.
RP Asakura, T (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
EM asakura@cc.tuat.ac.jp
RI Nakazawa, Yasumoto/B-9981-2013; Asakura, Tetsuo/B-9970-2013
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k
   Asakura T, 2005, PROTEIN SCI, V14, P2654, DOI 10.1110/ps.051525505
   Asakura T, 2002, BIOCHEMISTRY-US, V41, P4415, DOI 10.1021/bi0119013
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   Asakura T, 2002, PROTEIN SCI, V11, P2706, DOI 10.1110/ps.0221702
   ASAKURA T, 1984, MACROMOLECULES, V17, P1075, DOI 10.1021/ma00135a017
   Asakura T, 1999, INT J BIOL MACROMOL, V24, P167, DOI 10.1016/S0141-8130(98)00082-8
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Asakura T, 2007, J AM CHEM SOC, V129, P5703, DOI 10.1021/ja070128h
   DAL PI, 2006, INT J MOL MED, V18, P241
   Demura M, 1998, J AM CHEM SOC, V120, P1300, DOI 10.1021/ja972069l
   GILLESPIE DB, 1994, ACS SYM SER, V544, P155
   HARRIS RK, 2006, FURTHER CONVENTIONS
   Iwadate M, 1999, J BIOMOL NMR, V13, P199, DOI 10.1023/A:1008376710086
   Kameda T, 1999, MACROMOLECULES, V32, P7166, DOI 10.1021/ma990554q
   Kino R, 2006, J APPL POLYM SCI, V99, P2822, DOI 10.1002/app.22910
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liivak O, 1997, MACROMOLECULES, V30, P7127, DOI 10.1021/ma970834a
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Miranda DAO, 2005, J PERIODONTOL, V76, P210, DOI 10.1902/jop.2005.76.2.210
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nemoto R, 2001, J SOL-GEL SCI TECHN, V21, P7, DOI 10.1023/A:1011245213742
   Ohta K, 2004, KEY ENG MAT, V254-2, P15, DOI 10.4028/www.scientific.net/KEM.254-256.15
   Panitch A, 1997, MACROMOLECULES, V30, P42, DOI 10.1021/ma961059m
   Parkhe AD, 1998, INT J BIOL MACROMOL, V23, P251, DOI 10.1016/S0141-8130(98)00054-3
   SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sinsawat A, 2002, POLYMER, V43, P1323, DOI 10.1016/S0032-3861(01)00696-6
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   TSUJIMOTO Y, 1979, CELL, V18, P591, DOI 10.1016/0092-8674(79)90075-8
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Vincent JVF, 1992, BIOMECHANICS MAT PRA
   Wang JX, 1996, MACROMOLECULES, V29, P1548, DOI 10.1021/ma9512972
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yang MY, 2005, J BIOCHEM, V137, P721, DOI 10.1093/jb/mvi090
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Zhao CH, 2001, PROG NUCL MAG RES SP, V39, P301, DOI 10.1016/S0079-6565(01)00039-5
NR 47
TC 12
Z9 12
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 11
PY 2007
VL 40
IS 25
BP 8983
EP 8990
DI 10.1021/ma0713759
PG 8
WC Polymer Science
SC Polymer Science
GA 238BK
UT WOS:000251422100024
DA 2018-10-19
ER

PT J
AU Fathima, NN
   Ansari, T
   Rao, JR
   Nair, BU
AF Fathima, Nishtar Nishad
   Ansari, Thamimul
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Role of green tea polyphenol crosslinking alleviating
   ultraviolet-radiation effects on in collagen
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE antioxidants; fluorescence; irradiation; proteins; UV-vis spectroscopy
ID TOTAL ANTIOXIDANT CAPACITY; INHIBITION; (+)-CATECHIN; FILMS; ACID; SKIN
AB The widespread application of collagen warrants studies on the effects of ultraviolet (UV) radiation on stabilized collagen. The negative impact of UV radiation is well known. Because collagen is used as a biomaterial in various biomedical applications, knowing the effects of UV irradiation on stabilized collagen has become essential. In this study, the effects of UV irradiation on collagen stabilized with green tea polyphenols, that is, Acacia mearnsii (wattle), and catechin has been studied. The fluorescence intensity has been found to decrease with irradiation for native and wattle-treated collagen. Spectral studies have indicated that the photo-degradation products increase after irradiation for native collagen, whereas collagen treated with catechin or A. mearnsii exhibits different responses depending on the duration of the irradiation. The duration of the irradiation has a significant influence on polyphenol-treated collagen. (c) 2007 Wiley Periodicals, Inc.
C1 Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Nair, BU (reprint author), Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM clrichem@mailcity.com
RI Fathima, Nishad/B-7919-2009; Rao, Jonnalagadda/B-8486-2009; Nair,
   Balachandran/D-1508-2010
CR CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   CHAQOUR B, 1995, J PHOTOCH PHOTOBIO B, V28, P125, DOI 10.1016/1011-1344(94)07080-8
   FUJIMORI E, 1988, FEBS LETT, V235, P98, DOI 10.1016/0014-5793(88)81241-9
   Henning SA, 2005, J NUTR BIOCHEM, V16, P610, DOI 10.1016/j.jnutbio.2005.03.003
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Moncheva S, 2004, ESTUAR COAST SHELF S, V59, P475, DOI 10.1016/j.ecss.2003.10.006
   Vaquero MJR, 2007, FOOD CONTROL, V18, P93, DOI 10.1016/j.foodcont.2005.08.010
   ROUX DG, 1972, PHYTOCHEMISTRY, V11, P219
   Serafini M, 2000, J NUTR BIOCHEM, V11, P585, DOI 10.1016/S0955-2863(00)00124-8
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V82, P9, DOI 10.1016/j.photobiol.2005.08.003
   Sionkowska A, 2004, SURF SCI, V566, P608, DOI 10.1016/j.susc.2004.05.114
   SIONKOWSKA A, 2004, INT J BIOL MACROMOL, V84, P9
   SWALLOW AJ, 1973, RAD CHEM, P243
   Tichopad A, 2005, J ETHNOPHARMACOL, V99, P221, DOI 10.1016/j.jep.2005.02.021
   Toyoshima M, 2004, J PHOTOCH PHOTOBIO B, V73, P59, DOI 10.1016/j.jphotobiol.2003.09.005
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wu WB, 2006, LIFE SCI, V79, P801, DOI 10.1016/j.lfs.2006.02.028
NR 20
TC 10
Z9 10
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2007
VL 106
IS 5
BP 3382
EP 3386
DI 10.1002/app.26973
PG 5
WC Polymer Science
SC Polymer Science
GA 223XW
UT WOS:000250410500068
DA 2018-10-19
ER

PT J
AU Eisenbarth, E
AF Eisenbarth, E.
TI Biomaterials for tissue engineering
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID IN-SITU PHOTOPOLYMERIZATION; CELL SEEDING DENSITY; ARTICULAR-CARTILAGE;
   INJECTABLE CARTILAGE; TRANSDERMAL PHOTOPOLYMERIZATION;
   EXTRACELLULAR-MATRIX; HYDROGEL BARRIERS; SKIN SUBSTITUTES; ALGINATE
   BEADS; ACID-SOLUTION
AB Tissue engineering needs a biomaterial as a framework for single cells to build a vital and well functioning tissue. A future challenge is to modify biomaterials used this purpose in a way that they imitate in their composition and/or structure the native and physiological conditions for the tissue specific cells. This review gives a survey about types of the used biomaterials, processing techniques and biomimetic aspects.
C1 Hamburg Univ Technol Biomech Sect, D-21073 Hamburg, Germany.
   [Eisenbarth, E.] FH Sudwestfalen Biotechnol & Biomat, D-58644 Iserlohn, Germany.
RP Eisenbarth, E (reprint author), Hamburg Univ Technol Biomech Sect, D-21073 Hamburg, Germany.
EM eisenbarth@fh-swf.de
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   BELL E, 1991, J CELL BIOCHEM, V45, P239, DOI 10.1002/jcb.240450302
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   Bucheler M, 2000, LARYNGO RHINO OTOL, V79, P160
   BURG IKJ, 2000, BIOMATER, V23, P2347
   Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dulong V, 2004, CARBOHYD POLYM, V57, P1, DOI 10.1016/j.carbpol.2003.12.006
   Eisenbarth E, 2006, J BIOMED MATER RES A, V79A, P166, DOI 10.1002/jbm.a.30823
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   FEDOROVICH NE, 2007, TISSUE ENG, V13, P1
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   GONZALES AL, 2004, TISSUE ENG, V10, P491
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hauselmann H. J., 1996, AM J PHYSIOL, V271, P742
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Helgerson S., 2004, ENCY BIOMATERIALS BI, P603
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HGUYEN T, 2002, BIOMATER, V23, P4307
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   Hoerstrup SP, 2002, CIRCULATION S1, V106
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   ITAY S, 1987, CLIN ORTHOP RELAT R, P284
   Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kim B, 2005, MATER LETT, V59, P829, DOI 10.1016/j.matlet.2004.11.032
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   KJAERGARD HK, 1994, EUR SURG RES, V26, P273, DOI 10.1159/000129346
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LANZA RP, 1995, TRANSPLANTATION, V59, P1377, DOI 10.1097/00007890-199505270-00003
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   LAUSMAA J, 1994, ENVIRON HEALTH PER S, V102, P41
   Lee KH, 2000, YONSEI MED J, V41, P774, DOI 10.3349/ymj.2000.41.6.774
   Loeser RF, 2000, BIORHEOLOGY, V37, P109
   LU L, 2001, J BONE JOINT SU A S1, V83, P282
   Mahmood TA, 2002, KEY ENG MAT, V218-2, P257, DOI 10.4028/www.scientific.net/KEM.218-220.257
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MAUCK RL, 2002, ANN BIOMED ENG, V30, P3046
   MINUTH WW, 2005, TISSUE ENG CELL BIOL, P1
   MURUGAN R, 2007, TISSUE ENG, P1
   Nagel-Heyer S, 2005, BIOTECHNOL LETT, V27, P187, DOI 10.1007/s10529-004-7859-4
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Ochoa ER, 2002, ANN NY ACAD SCI, V979, P10, DOI 10.1111/j.1749-6632.2002.tb04863.x
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   PAYUMO FC, 2002, CLIN ORTHOP RELAT R, V4, P228
   Pelham R., 1997, P NATL ACAD SCI USA, V94, P1366
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Salter DM, 2004, BIORHEOLOGY, V41, P273
   Samuel RE, 2002, HUM GENE THER, V13, P791, DOI 10.1089/10430340252898975
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Sidelmann JJ, 2000, SEMIN THROMB HEMOST, V26, P605, DOI 10.1055/s-2000-13216
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Smith P, 2000, ARTHRITIS RHEUM, V43, P1156, DOI 10.1002/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M
   Smith RL, 2004, CLIN ORTHOP RELAT R, V427, P89
   Spector M, 2002, TISSUE ENG, V8, P351, DOI 10.1089/107632702760184628
   Sperinde JJ, 1997, MACROMOLECULES, V30, P5255, DOI 10.1021/ma970345a
   Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VACANTI CA, 1993, SCI, V260, P920
   VONDERMARK K, 1977, EUR RESPIR J, V276, P531
   Vunjak-Novakovic Gordana, 2003, Novartis Found Symp, V249, P34
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   WINTERMANTEL E, 1996, SPRINGER VERLAG BERL
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yuan XY, 2004, POLYM INT, V53, P1704, DOI 10.1002/pi.1538
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 100
TC 44
Z9 44
U1 1
U2 37
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD DEC
PY 2007
VL 9
IS 12
BP 1051
EP 1060
DI 10.1002/adem.200700287
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 252WZ
UT WOS:000252479300007
DA 2018-10-19
ER

PT J
AU Trabuco, EC
   Zobitz, ME
   Klingele, CJ
   Gebhart, JB
AF Trabuco, Emanuel C.
   Zobitz, Mark E.
   Klingele, Christopher J.
   Gebhart, John B.
TI Effect of host response (incorporation, encapsulation, mixed
   incorporation and encapsulation, or resorption) on the tensile strength
   of graft-reinforced repair in the rat ventral hernia model
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article; Proceedings Paper
CT 33rd Annual Meeting of the Society-of-Gynecological-Surgeons
CY APR 13, 2007
CL Orlando, FL
SP Soc Gynecol Surg
DE biomaterial; dermal collagen; heterologous transplantation; porcine
   dermis; small intestine submucosa; surgical mesh; tensile strength
ID SMALL-INTESTINAL SUBMUCOSA; PORCINE DERMAL COLLAGEN; ABDOMINAL-WALL
   DEFECTS; RECONSTRUCTION; POLYPROPYLENE; IMPLANTS; SURGERY; TISSUE
AB OBJECTIVE: The objective of the study was to determine whether the elicited histologic response to synthetic and xenograft materials affected the tensile strength of mesh-reinforced repairs in the rat ventral hernia model.
   STUDY DESIGN: Hernias were repaired with Gynemesh, Pelvicol, Pelvisoft, or Surgisis ( representing incorporation, encapsulation, mixed incorporation and encapsulation, or resorption responses) and were compared with a suture-plicated control. Six animals per group were killed at 1 and 3 months after graft implantation. Preimplantation tensile strength was also measured for each graft material and native rat abdominal wall.
   RESULTS: Before implantation, Pelvicol had significantly higher adjusted tensile strength when compared with the rat abdominal wall (P < .001) or the other graft materials ( P <= .05). However, no difference in adjusted tensile strength was observed among the groups at 1 and 3 months after implantation.
   CONCLUSION: The elicited histologic response did not affect the adjusted tensile strength of xenograft or synthetic mesh-reinforced repairs when compared with suture controls.
C1 [Trabuco, Emanuel C.; Klingele, Christopher J.; Gebhart, John B.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA.
   [Zobitz, Mark E.] Mayo Clin, Biomech Lab, Rochester, MN 55905 USA.
   [Gebhart, John B.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA.
RP Gebhart, JB (reprint author), Mayo Clin, Dept Obstet & Gynecol, 200 First St SW, Rochester, MN 55905 USA.
EM gebhart.john@mayo.edu
CR Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Birch C, 2002, CURR OPIN OBSTET GYN, V14, P527, DOI 10.1097/00001703-200210000-00015
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Cole E, 2003, J UROLOGY, V170, P1950, DOI 10.1097/01.ju.0000086484.41789.b7
   Gandhi S, 2005, AM J OBSTET GYNECOL, V192, P1643, DOI 10.1016/j.ajog.2004.11.044
   Iglesia C B, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P105, DOI 10.1007/BF02764826
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Moalli PA, 2005, AM J OBSTET GYNECOL, V192, P80, DOI 10.1016/j.ajog.2004.07.008
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   TRABUCO EC, 2006, INT UROGYNECOL J, V17, pS266
   Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2
   Zheng F, 2005, NEUROUROL URODYNAM, V24, P362, DOI 10.1002/nau.20148
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
NR 17
TC 7
Z9 8
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2007
VL 197
IS 6
AR 638.e1
DI 10.1016/j.ajog.2007.08.049
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 241SI
UT WOS:000251675700031
PM 18060961
DA 2018-10-19
ER

PT J
AU De Giglio, E
   Cometa, S
   Cioffi, N
   Torsi, L
   Sabbatini, L
AF De Giglio, E.
   Cometa, S.
   Cioffi, N.
   Torsi, L.
   Sabbatini, L.
TI Analytical investigations of poly(acrylic acid) coatings
   electrodeposited on titanium-based implants: a versatile approach to
   biocompatibility enhancement
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE titanium; PAA; electrosynthesis; corrosion protection; biomaterial;
   surface modification
ID QUARTZ-CRYSTAL MICROBALANCE; WATER-SOLUBLE CARBODIIMIDES; CELL
   VIABILITY; ACRYLIC-ACID; METAL; IMMOBILIZATION; RELEASE; ALLOY;
   POLYMERIZATION; ARTHROPLASTY
AB A polyacrylic acid film was synthesized on titanium substrates from aqueous solutions via an electroreductive process for the first time. This work was done in order to develop a versatile coating for titanium-based orthopaedic implants that acts as both an effective bioactive surface and an effective anti-corrosion barrier. The chemical structure of the PAA coating was investigated by X-ray photoelectron spectroscopy (XPS). Scanning electron microscopy (SEM) was employed to evaluate the effect of annealing treatment on the morphology of the coatings in terms of their uniformity and porosity. Inductively coupled plasma mass spectrometry was used to measure ion concentrations in ion release tests performed on Ti-6Al-4V sheets modified with PAA coatings (annealed and unannealed). Results indicate that the annealing process produces coatings that possess considerable anti-corrosion performance. Moreover, the availability and the reactivity of the surface carboxylic groups were exploited in order to graft biological molecules onto the PAA-modified titanium implants. The feasibility of the grafting reaction was tested using a single aminoacid residue. A fluorinated aminoacid was selected, and the grafting reaction was monitored both by XPS, using fluorine as a marker element, and via quartz crystal microbalance (QCM) measurements. The success of the grafting reaction opens the door to the synthesis of a wide variety of PAA-based coatings that are functionalized with selected bioactive molecules and promote positive reactions with the biological system interfacing the implant while considerably reducing ion release into surrounding tissues.
C1 Univ Bari, Dept Chem, I-70126 Bari, Italy.
RP De Giglio, E (reprint author), Univ Bari, Dept Chem, Via E Orabona 4, I-70126 Bari, Italy.
RI Torsi, Luisa/G-9065-2011
OI Torsi, Luisa/0000-0002-0798-0780; De Giglio, Elvira/0000-0001-9387-6201;
   Sabbatini, Luigia/0000-0002-5099-2242
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Asberg P, 2005, LANGMUIR, V21, P7292, DOI 10.1021/la050479e
   Carrigan SD, 2005, LANGMUIR, V21, P5966, DOI 10.1021/la0503294
   CHOLOD MS, 1987, POLYMERIC MAT ENCY
   De Giglio E, 2005, ANAL BIOANAL CHEM, V381, P626, DOI 10.1007/s00216-004-2801-0
   GOODMAN M, 1957, ADV PROTEIN CHEM, V12, P488
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 2002, ENCY SURFACE COLLOID, P774
   Jabbour GE, 2000, IEEE J QUANTUM ELECT, V36, P12, DOI 10.1109/3.817633
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   Kawahata NH, 2002, TETRAHEDRON LETT, V43, P7221, DOI 10.1016/S0040-4039(02)01657-X
   Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n
   Leadley SR, 1997, J ELECTRON SPECTROSC, V85, P107, DOI 10.1016/S0368-2048(97)00028-5
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Okazaki Y, 2000, MATER T JIM, V41, P1247, DOI 10.2320/matertrans1989.41.1247
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 1998, MATER T JIM, V39, P1053, DOI 10.2320/matertrans1989.39.1053
   Peppas NA, 2004, INT J PHARMACEUT, V277, P11, DOI 10.1016/j.ipharm.2003.03.001
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rie KT, 1995, SURF COAT TECH, V74-75, P973, DOI 10.1016/0257-8972(95)08316-2
   Roberts NB, 1998, J INORG BIOCHEM, V69, P171, DOI 10.1016/S0162-0134(97)10015-0
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600
   Su XD, 2005, J COLLOID INTERF SCI, V287, P35, DOI 10.1016/j.jcis.2005.01.089
   TENG FS, 1977, J ELECTROCHEM SOC, V124, P995, DOI 10.1149/1.2133515
   TENG FS, 1979, J APPL POLYM SCI, V23, P101, DOI 10.1002/app.1979.070230109
   TRAPP GA, 1978, BIOL PSYCHIAT, V13, P709
   Ulbricht M, 1998, BIOMATERIALS, V19, P1229, DOI 10.1016/S0142-9612(98)00029-5
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
   Xu YP, 1998, J ORG CHEM, V63, P4314, DOI 10.1021/jo980063o
   Yessine MA, 2004, ADV DRUG DELIVER REV, V56, P999, DOI 10.1016/j.addr.2003.10.039
NR 37
TC 50
Z9 51
U1 1
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD DEC
PY 2007
VL 389
IS 7-8
BP 2055
EP 2063
DI 10.1007/s00216-007-1299-7
PG 9
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 236RC
UT WOS:000251320100002
PM 17516054
DA 2018-10-19
ER

PT J
AU Honsawek, S
   Dhitiseith, D
   Phupong, V
AF Honsawek, Sittisak
   Dhitiseith, Dhakoon
   Phupong, Vorapong
TI Gene expression characteristics of osteoblast differentiation in human
   umbilical cord mesenchymal stem cells induced by demineralized bone
   matrix
SO ASIAN BIOMEDICINE
LA English
DT Article
DE demineralized bone matrix; gene expression; mesenchymal stem cells;
   osteoblast; RT-PCR
ID TGF-BETA RECEPTOR; MORPHOGENETIC PROTEINS; SIGNAL-TRANSDUCTION; CBFA1
AB Background: Mesenchymal stem cells are multipotential cells capable of differentiating into osteoblasts, chondrocytes, adipocytes, tenocytes, and myoblasts. Wharton's jelly contains stem cells that are a rich source of primitive multipotent mesenchymal cells. Demineralized bone matrix (DBM) has been extensively utilized as a biomaterial to promote new bone formation.
   Objective: To isolate and characterize umbilical cord mesenchymal stem (UCMS) cells derived from Wharton's jelly and examine the biological activity of DBM in this cell line.
   Methods: Osteoblast differentiation of the UCMS cells was determined using alkaline phosphatase activity assay. To examine differential gene expression during osteoblast differentiation, total RNA was isolated from UCMS cells in the absence or presence of D,BM on day 7 and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase-polymerase chain. reaction (RT-PCR) analysis.
   Results: Wharton's jelly derived cells could differentiate along an osteogenic lineage after treatment of DBM. Alkaline phosphatase activity assay showed that human UCMS cells could differentiate into osteogenic lineage. Gene expression of human UCMS cells treated with DBM for 7 days was analyzed by using cDNA array and RT-PCR analyses. We found that expression of runx2 and smad2 was upregulated whereas smad7 expression was downregulated as confirmed by RT-PCR.
   Conclusion: UCMS cells from a Wharton's jelly of human umbilical cord could express osteogenesis genes for treatment with DBM. Wharton's jelly from umbilical cord is a new source of mesenchymal stem cells that are readily available for application to bone tissue engineering.
C1 [Honsawek, Sittisak; Dhitiseith, Dhakoon] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand.
   [Phupong, Vorapong] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand.
RP Honsawek, S (reprint author), Chulalongkorn Univ & Hosp, Fac Med, Dept Biochem, Rama 4 Rd, Bangkok 10330, Thailand.
EM fmedshs@md.chula.ac.th
CR Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026
   BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Hishikawa K, 2004, BIOCHEM BIOPH RES CO, V317, P1103, DOI 10.1016/j.bbrc.2004.03.165
   Honsawek Sittisak, 2005, J Med Assoc Thai, V88 Suppl 4, pS260
   Honsawek Sittisak, 2006, J Med Assoc Thai, V89 Suppl 3, pS189
   Honsawek S, 2007, ASIAN BIOMED, V1, P229
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   Huang WB, 2001, BIOCHEM BIOPH RES CO, V281, P1120, DOI 10.1006/bbrc.2001.4458
   Inman Gareth J, 2005, Biochem J, V386, pe1
   Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raouf A, 2002, BONE, V30, P463, DOI 10.1016/S8756-3282(01)00699-8
   Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   van Driel M, 2004, CURR PHARM DESIGN, V10, P2535
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang Yuntao, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P68
   Warner DR, 2003, BIOCHEM BIOPH RES CO, V312, P1185, DOI 10.1016/j.bbrc.2003.11.049
   WOLFINBARGER L, 1993, IN VITRO CELL DEV-AN, V29A, P914
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393
   Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0
NR 33
TC 2
Z9 3
U1 0
U2 8
PU CHULALONGKORN UNIV, FAC MED
PI BANGKOK
PA CHULALONGKORN UNIV, FAC MED, 1873, RAMA 4, BANGKOK, 10330, THAILAND
SN 1905-7415
J9 ASIAN BIOMED
JI Asian Biomed.
PD DEC
PY 2007
VL 1
IS 4
BP 383
EP 391
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 318UQ
UT WOS:000257118700005
DA 2018-10-19
ER

PT J
AU Amsden, BG
   Sukarto, A
   Knight, DK
   Shapka, SN
AF Amsden, Brian G.
   Sukarto, Abby
   Knight, Darryl K.
   Shapka, Stephen N.
TI Methacrylated glycol chitosan as a photopolymerizable biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID IN-VIVO DEGRADATION; ARTICULAR-CARTILAGE; BIODEGRADABLE ELASTOMER;
   DELIVERY APPLICATIONS; CHONDROITIN SULFATE; INDENTATION TESTS; PROTEIN
   DELIVERY; GROWTH-FACTORS; HYDROGELS; DERIVATIVES
AB Glycol chitosan is a derivative of chitosan that is soluble at neutral pH and possesses potentially useful biological properties. With the goal of obtaining biocompatible hydrogels for use as tissue engineering scaffolds or drug delivery depots, glycol chitosan was converted to a photopolymerizable prepolymer through graft methacrylation using glycidyl methacrylate in aqueous media at pH 9. N-Methacrylation was verified by both H-1 NMR and C-13 NMR. The degree of N-methacrylation, measured via H-1 NMR, was easily varied from 1.5% to approximately 25% by varying the molar ratio of glycidyl methacrylate to glycol chitosan and the reaction time. Using a chondrocyte cell line, the N-methacrylated glycol chitosan was found to be noncytotoxic up to a concentration of 1 mg/mL. The prepolymer was cross-linked in solution using UV light and Irgacure 2959 photoinitiator under various conditions to yield gels of low sol content (similar to 5%), high equilibrium water content (85-95%), and thicknesses of up to 6 mm. Cross-polarization magic-angle spinning C-13 solid state NMR verified the complete conversion of the double bonds in the gel. Chondrocytes seeded directly onto the gel surface, populated the entirety of the gel and remained viable for up to one week. The hydrogels degraded slowly in vitro in the presence of lysozyme at a rate that increased as the cross-link density of the gels decreased.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM brian.amsden@chee.queensu.ca
RI Amsden, Brian/L-6387-2013; Knight, Darryl/A-7949-2013
CR ABOSHOSHA MHH, 1987, ANGEW MAKROMOL CHEM, V152, P93, DOI 10.1002/apmc.1987.051520109
   An YJ, 2000, J CONTROL RELEASE, V64, P205, DOI 10.1016/S0168-3659(99)00143-1
   Bae K, 2006, CLIN ORAL INVEST, V10, P102, DOI 10.1007/s00784-006-0038-3
   Baroli B, 2003, J PHARM SCI, V92, P1186, DOI 10.1002/jps.10378
   BOURKE SL, 2003, AAPS PHARM SCI, V5
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   Cha SY, 2001, J POLYM SCI POL CHEM, V39, P880, DOI 10.1002/1099-0518(20010315)39:6<880::AID-POLA1062>3.0.CO;2-K
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Chowdhury SM, 1996, J SURG RES, V61, P58, DOI 10.1006/jsre.1996.0081
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
   Flores-Ramirez N, 2005, J BIOMAT SCI-POLYM E, V16, P473, DOI 10.1163/1568562053700174
   Goldsmith AAJ, 1998, J BIOMECH ENG-T ASME, V120, P362, DOI 10.1115/1.2798003
   Gu F, 2006, PHARM RES, V23, P782, DOI 10.1007/s11095-006-9750-6
   Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020
   HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   HORI RY, 1976, J BIOMECH, V9, P259, DOI 10.1016/0021-9290(76)90012-9
   Hsu SC, 2002, POLYM DEGRAD STABIL, V75, P73, DOI 10.1016/S0141-3910(01)00205-1
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI [10.1115/1.1688772, 10.1115/1/.1688772]
   Kim B, 2003, BIOMED MICRODEVICES, V5, P333, DOI 10.1023/A:1027313931273
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Mi FL, 2006, POLYMER, V47, P4348, DOI 10.1016/j.polymer.2006.04.005
   Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   NORDTVEIT RJ, 1994, CARBOHYD POLYM, V23, P253, DOI 10.1016/0144-8617(94)90187-2
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Renbutsu E, 2005, BIOMACROMOLECULES, V6, P2385, DOI 10.1021/1bm0500796
   Sashiwa H, 2003, MACROMOL BIOSCI, V3, P231, DOI 10.1002/mabi.200390029
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senkoylu A, 2001, J BIOACT COMPAT POL, V16, P136, DOI 10.1106/3EH5-2R73-RC4V-Y9L7
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
NR 53
TC 98
Z9 98
U1 4
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2007
VL 8
IS 12
BP 3758
EP 3766
DI 10.1021/bm700691e
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 239VY
UT WOS:000251547600012
PM 18031015
DA 2018-10-19
ER

PT J
AU Pasqui, D
   Rossi, A
   Di Cintio, F
   Barbucci, R
AF Pasqui, Daniela
   Rossi, Antonella
   Di Cintio, Federica
   Barbucci, Rolando
TI Functionalized titanium oxide surfaces with phosphated carboxymethyl
   cellulose: Characterization and bonelike cell behavior
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TI-SURFACES; IMPLANTS; PROTEIN; GROWTH;
   LAYERS; ACIDS
AB The performance of dental or orthopedic implants is closely dependent on surface properties in terms of topography and chemistry. A phosphated carboxymethylcellulose containing one phosphate group for each disaccharide unit was synthesized and used to functionalize titanium oxide surfaces with the aim to improve osseointegration with the host tissue. The modified surfaces were chemically characterized by means of X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy. The investigation of the surface topography was performed by atomic force microscopy measurements before and after the polysaccharide coating. In vitro biological tests using osteoblast-like cells demonstrated that functionalized TiO2 surfaces modulated cell response, in terms of adhesion, proliferation, and morphology. Phosphated carboxymethylcellulose promoted better cell adhesion and significantly enhanced their proliferation. The morphology of cells was polygonal and more spread on this type of modified surface. These findings suggest that the presence of a phosphate polysaccharide coating promotes osteoblast growth on the surface potentially improving biomaterial osseointegration.
C1 [Pasqui, Daniela; Barbucci, Rolando] Univ Siena, CRISMA, I-53100 Siena, Italy.
   [Pasqui, Daniela; Barbucci, Rolando] Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
   [Rossi, Antonella; Di Cintio, Federica] Univ Siena, Dept Neurosci, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, CRISMA, Via A Moro 2, I-53100 Siena, Italy.
EM barbucci@unisi.it
OI Rossi, Antonella/0000-0002-5151-2634
CR Baker KC, 2006, MAT SCI ENG C-BIO S, V26, P1351, DOI 10.1016/j.msec.2005.08.015
   BAN S, 2006, DENT MATER, V22, P12
   Barbucci R, 2002, INTEGRATED BIOMATERI
   Cacciafesta P, 2002, CHEM MATER, V14, P777, DOI 10.1021/cm0112183
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chiesa R, 2007, ORAL SURG ORAL MED O, V103, P745, DOI 10.1016/j.tripleo.2006.09.025
   Conforto E, 2004, MAT SCI ENG C-BIO S, V24, P611, DOI 10.1016/j.msec.2004.08.004
   de Kerchove AJ, 2006, MACROMOLECULES, V39, P6558, DOI 10.1021/ma0527606
   Dubruel P, 2006, SURF SCI, V600, P2562, DOI 10.1016/j.susc.2006.04.021
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Lausmaa J., 2001, TITANIUM MED, P231
   LEONE G, UNPUB NEW PHOSPHORIL
   PASQUI D, BIOMACROMOLECULES
   Pisarek M, 2007, MATER CHEM PHYS, V104, P93, DOI 10.1016/j.matchemphys.2007.02.088
   RANDON J, 1995, J MEMBRANE SCI, V98, P119, DOI 10.1016/0376-7388(94)00183-Y
   RATNER BD, 2001, TITANIUM MED MAT SCI, V2
   SOUSA SR, 2004, LANGMUIR, V20, P22
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P12
   Thomas TR., 1982, ROUGH SURFACES
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   Wu JM, 2002, SCRIPTA MATER, V46, P101, DOI 10.1016/S1359-6462(01)01207-6
   XIAO SJ, 1998, LANGMUIR, V14, P19
NR 22
TC 10
Z9 10
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2007
VL 8
IS 12
BP 3965
EP 3972
DI 10.1021/bm701033u
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 239VY
UT WOS:000251547600040
PM 18020417
DA 2018-10-19
ER

PT J
AU Davies, JE
AF Davies, John E.
TI Bone bonding at natural and biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE bone bonding; cement line; biomineralisation; calcium phosphate;
   bioactive; implant
ID RABBIT TIBIAL CORTEX; ELECTRON-MICROSCOPY; IN-VIVO; INTERFACE;
   RESORPTION; NEOOSTEOGENESIS; OSTEOCLASTS; DEPOSITION; EVOLUTION;
   STRENGTH
AB Bone bonding is occurring in each of us and all other terrestrial vertebrates throughout life at bony remodeling sites. The surface created by the bone-resorbing osteoclast provides a three-dimensionally complex surface with which the cement line, the first matrix elaborated during de novo bone formation, interdigitates and is interlocked. The structure and composition of this interfacial bony matrix has been conserved during evolution across species: and we have known for over a decade that this interfacial matrix can be recapitulated at a biomaterial surface implanted in bone, given appropriate healing conditions. No evidence has emerged to suggest that bone bonding to artificial materials is any different from this natural biological process. Given this understanding it is now possible to explain why bone-bonding biomaterials are not restricted to the calcium-phosphate-based bioactive materials as was once thought. Indeed. in the absence of surface porosity, calcium phosphate biomaterials are not bone bonding. On the contrary, non-bonding materials can be rendered bone bonding by modifying their surface topography. This paper argues that the driving force for bone bonding is bone formation by contact osteogenesis, but that this has to occur on a sufficiently stable recipient surface which has micronscale surface topography with undercuts in the sub-micron scale-range. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM davies@ecf.utoronto.ca
CR Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.mathbio.2004.02.001
   Barringer Kerry, 1993, Novon, V3, P15, DOI 10.2307/3391410
   BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   CURRY JD, 2002, BONES, P26
   Davies J.E., 2000, BONE ENG, P1
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P285
   Davies JE, 1996, ANAT REC, V245, P426
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P214
   Davies John E, 2003, J Dent Educ, V67, P932
   de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841
   DEBRUIJN JD, 1992, MATER RES SOC SYMP P, V252, P63
   Dziedzic DM, 1996, MATER RES SOC SYMP P, V414, P147
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910
   GLOWACKI J, 1986, P NATL ACAD SCI USA, V83, P4104, DOI 10.1073/pnas.83.11.4104
   GUO P, 1996, THESIS U TORONTO
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1970, 1 US ARM MED R D
   Hill P A, 1998, Br J Orthod, V25, P101
   HONG L, 1998, J BIOMED MATER RES B, V42, P113
   Hosseini M. M., 1996, Cells and Materials, V6, P233
   HOSSEINI MM, 2002, THESIS U TORONTO
   HOSSEINI MM, 2000, BONE ENG, P295
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kolliker A., 1873, NORMALE RESORPTION K
   Kolliker A, 1859, P R SOC LOND, V9, P656
   Liang B, 2003, BIOMATERIALS, V24, P4959, DOI 10.1016/S0142-9612(03)00421-6
   Masuda T, 1998, INT J ORAL MAX IMPL, V13, P17
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   MCKEE MD, 1993, CELL MATER, V3, P219
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   PARKER E, 2000, BONE ENG, P63
   PILLIAR RM, 1991, MRS BULL, V16, P55
   PIOROWSKI G, 1975, J BIOMED MAT RES S, V6, P47
   PRICE PA, 1977, CALCIUM BINDING PROT, P333
   Rennert J, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-4
   RUBEN JA, 1987, EVOLUTION, V41, P1187, DOI 10.1111/j.1558-5646.1987.tb02460.x
   Russell RGG, 2006, CURR OPIN RHEUMATOL, V18, pS3, DOI 10.1097/01.bor.0000229521.95384.7d
   Skedros JG, 2005, ANAT REC PART A, V286A, P781, DOI 10.1002/ar.a.20214
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   VONEBNER V, 1875, AKAD WISS WIEN MATH, V72, P49
   WEINMANN JP, 1955, BONE BONES FUNDAMENT
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P48
   WINET H, 1988, J ORTHOPAED RES, V6, P531, DOI 10.1002/jor.1100060409
   WINET H, 1990, CALCIFIED TISSUE INT, V47, P24, DOI 10.1007/BF02555862
   ZHOU H, 1994, J BONE MINER RES, V9, P367
   ZHOU H, 1993, CELL MATER, V3, P141
   ZHOU H, 1993, CEMENT LINE FORMATIO
NR 55
TC 157
Z9 167
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5058
EP 5067
DI 10.1016/j.biomaterials.2007.07.049
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100008
PM 17697711
DA 2018-10-19
ER

PT J
AU Anderson, JM
   Jones, JA
AF Anderson, James M.
   Jones, Jacqueline A.
TI Phenotypic dichotomies in the foreign body reaction
SO BIOMATERIALS
LA English
DT Article
DE macrophages; adhesion; activation; hydrophilic; hydrophobic; ionic
   surface chemistry
ID BIOMATERIAL SURFACE-CHEMISTRY; MACROPHAGE ACTIVATION; HUMAN MONOCYTES;
   IN-VITRO; EXPRESSION; GAMMA; INTERLEUKIN-4; POLARIZATION; APOPTOSIS;
   IL-10
AB To better understand the relationship between macrophage/foreign body giant cell adhesion and activation on surface-modified biomaterials. quantitative assessment of adherent cell density (cells per mm(2)) and cytokine production (pgs per mL) were determined by ELISA. Further analysis to identify cellular activation was carried out by normalizing the cytokine concentration data to provide a measure of cellular activation. This method of analysis demonstrated that hydrophobic surfaces provided statistically significantly greater adherent cell densities than hydrophilic/neutral surfaces. However, when cell activation parameters were determined by normalization to the adherent cell density, the hydrophilic/neutral surfaces demonstrated statistically significantly greater levels of activation and production of IL-10, IL-1 beta, IL-6. IL-8, and MIP-1 beta. With increasing time, production of the anti-inflammatory cytokine IL-10 increased, whereas IL-1 beta, IL-6, and IL-8 decreased and MIP-1 beta was relatively constant over the culture time period. This observed dichotomy or disparity between adhesion and activation may be related to surface-induced adherent cell apoptosis. Further evaluation of macrophage activation on biomaterial surfaces indicated that an apparent phenotypic switch in macrophage phenotype occurred over the course of the in vitro culture. Analysis of cytokine/chemokine profiles with surface-modified biomaterials revealed similarities between the classically activated macrophages and the biomaterial-adherent macrophages early (day 3) in culture, while at later timepoints the biomaterial-adherent macrophages produced profiles similar to alternatively activated macrophages. Classically activated macrophages are those commonly activated by lipopolysaccharide (LPS) or interferon-gamma (IFN-gamma) and alternatively activated macrophages are those activated by IL-4/IL-13 or IL-10. Surface modification of biotnaterials offer an opportunity to control cellular activation and cytokine profiles in the phenotypic switch, and may provide a means by which macrophages can be induced to regulate particular secretory proteins that direct inflammation, the foreign body reaction, wound healing, and ultimately biocompatibility. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 2103 Cornell Rd,Room W5106,Wolstein Res Bldg, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [R01 EB000279, R01 EB000279-13A1, R37 EB000275, EB-000275,
   R01 EB000275, R01 EB000275-22, R01 EB000282, R01 EB000282-12]
CR Bonder CS, 1999, IMMUNOLOGY, V96, P529
   Bonecchi R, 1998, BLOOD, V92, P2668
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Bzowska M, 2002, EUR J IMMUNOL, V32, P2011, DOI 10.1002/1521-4141(200207)32:7<2011::AID-IMMU2011>3.0.CO;2-L
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE K, 1997, J IMMUNOL, P158
   DONNELLY RP, 1990, J IMMUNOL, V145, P569
   FENTON MJ, 1992, J IMMUNOL, V149, P1283
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   JONES J, 2007, IN PRESS J BIOMED MA
   Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407
   Kopydlowski KM, 1999, J IMMUNOL, V163, P1537
   MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   OSWALD I, 1992, P NATL ACAD SCI USA, V88, P8676
   STEIN M, 1992, J EXP MED, P176
NR 21
TC 53
Z9 55
U1 3
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5114
EP 5120
DI 10.1016/j.biornaterials.2007.07.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100015
PM 17706278
DA 2018-10-19
ER

PT J
AU Gersbach, CA
   Coyer, SR
   Le Doux, JM
   Garcia, AJ
AF Gersbach, Charles A.
   Coyer, Sean R.
   Le Doux, Joseph M.
   Garcia, Andres J.
TI Biomaterial-mediated retroviral gene transfer using self-assembled
   monolayers
SO BIOMATERIALS
LA English
DT Article
DE fibroblast; genetic engineering; gene therapy; gene transfer;
   self-assembly; alkanethiol
ID IN-VIVO; DNA DELIVERY; INTEGRIN BINDING; MAMMALIAN-CELLS; FIBRONECTIN
   CONFORMATION; RECOMBINANT ADENOVIRUS; NEURITE EXTENSION; BONE-FORMATION;
   PLASMID DNA; SURFACE
AB Biomaterial-mediated gene delivery has recently emerged as a promising alternative to conventional gene transfer technologies that focus on direct delivery of viral vectors or DNA-polymer/matrix complexes. However, biomaterial-based strategies have primarily targeted transient gene expression vehicles, including plasmid DNA and adenovirus particles. This study expands on this work by characterizing biomaterial properties conducive to the surface immobilization of retroviral particles and subsequent transduction of mammalian cells at the cell-material interface. Self-assembled monolayers (SAMs) of functionally-terminated alkanethiols on gold were used to establish biomaterial surfaces of defined chemical composition. Gene transfer was observed to be greater than 90% on NH2-terminated surfaces, approximately 50% on COOH-functionalized surfaces, and undetectable on CH3-terminated SAMs, similar to controls of tissue culture-treated polystyrene. Gene delivery via the NH2-SAM was further characterized as a function of retrovirus coating time, virus concentration, and cell seeding density. Finally, SAM-mediated gene delivery was comparable to fibronectin- and poly-L-lysine-based methods for gene transfer. This work is significant to establishing safe and effective gene therapy strategies, developing efficient methods for gene delivery, and supporting recent progress in the field of biomaterial-mediated gene transfer. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Emory Univ, Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Georgia Tech Emory Ctr Engn Living Tissue, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Petit Inst Bioengn & Biosci, 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Le Doux, Joseph/D-4876-2018
OI Le Doux, Joseph/0000-0002-6506-3905
FU NIBIB NIH HHS [R01-EB003364, R01 EB003364-04, R01 EB003364]; NIGMS NIH
   HHS [T32 GM008433, T32-GM08433]
CR Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Galipeau J, 1999, CANCER RES, V59, P2384
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949
   GONSHO A, 1994, BIOL PHARM BULL, V17, P275
   Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142
   Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876
   Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193
   Hennemann B, 2000, BLOOD, V96, P2432
   Hennemann B, 2000, HUM GENE THER, V11, P43, DOI 10.1089/10430340050016148
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim A, 2003, J CONTROL RELEASE, V90, P81, DOI 10.1016/S0168-3659(03)00175-5
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Kuhlcke K, 2002, MOL THER, V5, P473, DOI 10.1006/mthe.2002.0566
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Landazuri N, 2004, J GENE MED, V6, P1304, DOI 10.1002/jgm.618
   Le Doux JM, 1999, BIOTECHNOL BIOENG, V63, P654, DOI 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1
   Le Doux JM, 2001, HUM GENE THER, V12, P1611, DOI 10.1089/10430340152528110
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Matthews CB, 1999, GENE THER, V6, P1558, DOI 10.1038/sj.gt.3300978
   MURPHY TJ, 2002, METHOD ENZYMOL, DOI UNSP 345539-551
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Rundle CH, 2003, BONE, V32, P591, DOI 10.1016/S8756-3282(03)00096-6
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2003, J CONTROL RELEASE, V86, P339, DOI 10.1016/S0168-3659(02)00354-1
   Themis M, 1998, GENE THER, V5, P1180, DOI 10.1038/sj.gt.3300715
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Xu LF, 2004, MOL THER, V10, P37, DOI 10.1016/j.tmthe.2004.04.010
   Xu LF, 2003, BLOOD, V101, P3924, DOI 10.1182/blood-2002-10-3050
   Yamauchi F, 2006, BIOMATERIALS, V27, P3497, DOI 10.1016/j.biomaterials.2006.02.004
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zheng J, 2000, BIOTECHNOL PROGR, V16, P254, DOI 10.1021/bp990150h
NR 55
TC 27
Z9 26
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5121
EP 5127
DI 10.1016/j.biomaterials.2007.07.047
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100016
PM 17698189
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kim, MS
   Ahn, HH
   Shin, YN
   Cho, MH
   Khang, G
   Lee, HB
AF Kim, Moon Suk
   Ahn, Hyun Hee
   Shin, Yu Na
   Cho, Mi Hee
   Khang, Gilson
   Lee, Hai Bang
TI An in vivo study of the host tissue response to subcutaneous
   implantation of PLGA- and/or porcine small intestinal submucosa-based
   scaffolds
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; scaffold; PLGA; small intestinal submucosa; inflammation
ID MESENCHYMAL STEM-CELLS; ENGINEERED BONE; ACID); BIOCOMPATIBILITY;
   MICROSPHERES; BIOMATERIALS; DEGRADATION; MECHANISMS; POLYMERS; COLLAGEN
AB An innate immune response is often found at the site of biomaterial implantation. Since the effective use of biomaterials in vivo requires good biocompatibility and biofanetionality, it is vital that we assess and compare the inflammatory reactions provoked by various implanted biomaterials in vivo. In the present study, we assessed the host tissue response to poly(lactic-co-glycolic acid) (PLGA)and small intestinal submucosa (SIS)-based scaffolds subcutaneously implanted in Fischer rats. Our results revealed that the PLGAbased scaffolds resulted in severe post-implantation inflammation, whereas the SIS-based scaffolds induced only a slight past implantation inflammation and a PLGA/SIS-based copolymer yielded intermediate results. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Korea Res Inst Chem Technol, Fus Biotechnol Res Ctr, Taejon 305600, South Korea.
   Chonbuk Natl Univ, Polymer BIN Fus Res Team BK 21, Duckjin 561756, Jeonju, South Korea.
RP Lee, HB (reprint author), Korea Res Inst Chem Technol, Fus Biotechnol Res Ctr, POB 107, Taejon 305600, South Korea.
EM hblee@krict.re.kr
RI Khang, Gilson/B-2109-2013
OI ahn, hyunhee/0000-0003-0126-6014
CR ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   BABA Y, 2005, EXP MOL PATHOL, V9, P229
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Choi B. S., 2006, TISSUE ENG REGEN MED, V3, P295
   Cimini M, 2005, J BIOMED MATER RES A, V75A, P895, DOI 10.1002/jbm.a.30493
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Fox DB, 2004, TISSUE ENG, V10, P129, DOI 10.1089/107632704322791772
   FRANCESCHI LD, 2005, J BIOMED MATER RES, V75, P612
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   HUNT JA, 1993, BIOMATERIALS, V14, P378, DOI 10.1016/0142-9612(93)90058-A
   HUNT JA, 1995, BIOMATERIALS, V16, P167, DOI 10.1016/0142-9612(95)92113-K
   Jilek S, 2004, J ALLERGY CLIN IMMUN, V114, P943, DOI 10.1016/j.jaci.2004.05.065
   Kim SH, 2006, POLYM-KOREA, V30, P14
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Long RA, 2006, BIOMATERIALS, V27, P2398, DOI 10.1016/j.biomaterials.2005.10.011
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MILLER ND, 1984, BIOMATERIALS, V5, P365, DOI 10.1016/0142-9612(84)90037-1
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Ong SY, 2006, BIOMATERIALS, V27, P4087, DOI 10.1016/j.biomaterials.2006.03.022
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Prokop A, 1989, Adv Biochem Eng Biotechnol, V39, P29
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WILLIAMS DF, 1981, BIOMATERIALS, V2, P133, DOI 10.1016/0142-9612(81)90039-9
   WILLIAMS DF, 1975, BIOMED ENG, V10, P207
   WILLIAMS DF, 1976, MED PROG TECHNOL, V20, P31
   Yoon SJ, 2007, TISSUE ENG, V13, P1125, DOI 10.1089/ten.2006.0287
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
NR 38
TC 106
Z9 124
U1 5
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5137
EP 5143
DI 10.1016/j.biomaterials.2007.08.014
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100019
PM 17764737
DA 2018-10-19
ER

PT J
AU Ratner, BD
AF Ratner, Buddy D.
TI The catastrophe revisited: Blood compatibility in the 21st century
SO BIOMATERIALS
LA English
DT Article
DE coagulation; endothelium; non-thrombogenic surfaces; platelets; blood
   compatibility
ID VON-WILLEBRAND-FACTOR; PLATELET-ADHESION; PROTEIN ADSORPTION; ARTIFICIAL
   SURFACES; FIBRINOGEN; POLYMER; BINDING; BIOMATERIALS; ACTIVATION;
   THROMBOSIS
AB The biomaterials community has been unable to accurately assign the term "blood compatible" to a biomaterial in spite of 50 years of intensive research on the subject. There is no clear consensus as to which materials are "blood compatible." There are no standardized methods to assess blood compatibility. Since we use millions of devices in contact with blood each year, it is imperative we give serious thought to this intellectual catastrophe. In this perspective, I consider five hypotheses as to why progress has been slow in evolving a clear understanding of blood compatibility: Hypothesis 1-It is impossible to make a blood compatible material. Hypothesis 2-We do not understand the biology behind blood compatibility. Hypothesis 3-We do not understand how to test for or evaluate blood compatibility. Hypothesis 4-Certain materials of natural origin seem to show better blood compatibility but we do not know how to exploit this concept. Hypothesis 5-We now have better blood compatible materials but the regulatory and economic climate prevent adoption in clinical practice. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Washington, UWEB, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, UWEB, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU NHLBI NIH HHS [R24 HL064387-04, R01 HL067923-04, R01 HL064387,
   R01HL67923, 5R01HL064387, R01 HL067923]
CR Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Cao L, 2007, J BIOMED MATER RES A, V81A, P827, DOI 10.1002/jbm.a.31091
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HARKER LA, 1974, THROMB DIATH HAEMOST, V31, P188, DOI 10.1055/s-0038-1649157
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1982, ACS ADV CHEM SERIES, V199, P59
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   KIM DD, 1998, PHARM RES, V15, P5
   Kim JK, 2005, J BIOMED MATER RES A, V75A, P199, DOI 10.1002/jbm.a.30424
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   Lee YK, 2007, BIOMATERIALS, V28, P1523, DOI 10.1016/j.biomaterials.2006.11.020
   Oh BK, 2003, J AM CHEM SOC, V125, P9552, DOI 10.1021/ja035775x
   Ratner B. D., 1984, CONT BIOMATERIALS MA, P193
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   REYNOLDS LO, 1993, J BIOMAT SCI-POLYM E, V4, P451
   Skarja GA, 1998, BIOMATERIALS, V19, P2129, DOI 10.1016/S0142-9612(98)00045-3
   Stephen R, 2004, BIOMATERIALS SCI INT, P367
   TAKENO M, 2005, THESIS U WASHINGTON
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Wagner WR, 2000, J BIOMAT SCI-POLYM E, V11, P1239, DOI 10.1163/156856200744183
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yuan JA, 2004, COLLOID SURFACE B, V36, P27, DOI [10.1016/j.colsurfc.2004.03.017, 10.1016/j.colsurfb.2004.03.017]
NR 23
TC 226
Z9 233
U1 4
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5144
EP 5147
DI 10.1016/j.biomaterials.2007.07.035
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100020
PM 17689608
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kuijer, R
   Jansen, EJP
   Emans, PJ
   Bulstra, SK
   Riesle, J
   Pieper, J
   Grainger, DW
   Busscher, HJ
AF Kuijer, Roel
   Jansen, Edwin J. P.
   Emans, Pieter J.
   Bulstra, Sjoerd K.
   Riesle, Jens
   Pieper, Jeroen
   Grainger, David W.
   Busscher, Henk J.
TI Assessing infection risk in implanted tissue-engineered devices
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; infection; scaffold; pathology
ID TOTAL KNEE REPLACEMENT; TOTAL HIP; IN-VIVO; PEOT/PBT SCAFFOLDS; BONE;
   CARTILAGE; PEGT/PBT; BEHAVIOR; MODEL; BIOCOMPATIBILITY
AB Peri-operative contamination is the major cause of biomaterial-associated infections, highly complicating surgical patient outcomes. While this risk in traditional implanted biomaterials is well-recognised, newer cell-seeded, biologically conducive tissue-engineered (TE) constructs now targeted for human use have not been assessed for this possibility. We investigated infection incidence of implanted, degradable polyester TE scaffold biomaterials in rabbit knee osteochondral defects. Sterile, polyester copolymer scaffolds of different compositions and cell-accessible pore volumes were surgically inserted into rabbit osteochondral defects for periods of 3 weeks up to 9 months. either with or without initial seeding with autologous or allogeneic chondrocytes. Infection assessment included observation of pus or abscesses in or near the knee joint and post-mortem histological evaluation. Of 228 implanted TE scaffolds, 10 appeared to be infected: 6 scaffolds without cell seeding (3.6%) and 4 cell-seeded scaffolds (6.3%). These infections were evident across all scaffold types, independent of polymer composition or available pore volume, and up to 9 months. We conclude that infections in TE implants pose a serious problem with incidences similar to current biomaterials-associated infections. Infection control measures should be developed in tissue engineering to avoid further complications when TE devices emerge clinically. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   Univ Hosp Maastricht, Dept Orthopaed Surg, NL-6202 AZ Maastricht, Netherlands.
   Univ Med Ctr Groningen, Dept Orthopaed Surg, NL-9700 RB Groningen, Netherlands.
   IsoTis SA, NL-3723 MB Bilthoven, Netherlands.
   Iso Tis Orthobiol Inc, Irvine, CA 92618 USA.
   Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Kuijer, R (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM r.kuijer@med.umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
CR An YH, 2006, INT J ARTIF ORGANS, V29, P407
   ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Borzsei L, 2006, CHEMOTHERAPY, V52, P73, DOI 10.1159/000092371
   Bouwmeester SJM, 1998, J MATER SCI-MATER M, V9, P181, DOI 10.1023/A:1008875821298
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   El Ghalbzouri A, 2004, BIOMATERIALS, V25, P2987, DOI 10.1016/j.biomaterials.2003.09.098
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Emans PJ, 2006, TISSUE ENG, V12, P1699, DOI 10.1089/ten.2006.12.1699
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GAILLARD ML, 1994, J MATER SCI-MATER M, V5, P424, DOI 10.1007/BF00058977
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HESSLING SC, 1992, REF TYPE GENERIC
   Hill EE, 2006, CLIN MICROBIOL INFEC, V12, P5, DOI 10.1111/j.1469-0691.2005.01289.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5
   Maathuis PGM, 2005, CLIN ORTHOP RELAT R, P136, DOI 10.1097/01.blo.0000149997.14631.0c
   Makinen TJ, 2005, J ANTIMICROB CHEMOTH, V56, P1063, DOI 10.1093/jac/dki366
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   NORD WR, 1988, RES ORGAN BEHAV, V10, P1
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Poelstra KA, 2000, SPINE, V25, P406, DOI 10.1097/00007632-200002150-00003
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   Rissing J P, 1990, Infect Dis Clin North Am, V4, P377
   Smith MK, 2006, TISSUE ENG, V12, P235, DOI 10.1089/ten.2006.12.235
   VACANTI JP, 1999, LANCET S1, V354, P132
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P23
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 50
TC 26
Z9 27
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5148
EP 5154
DI 10.1016/j.biomaterials.2007.06.003
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100021
PM 17597202
DA 2018-10-19
ER

PT J
AU Montanaro, L
   Campoccia, D
   Arciola, CR
AF Montanaro, Lucio
   Campoccia, Davide
   Arciola, Carla Renata
TI Advancements in molecular epidemiology of implant infections and future
   perspectives
SO BIOMATERIALS
LA English
DT Review
DE implant infection; strain genotyping; ica genes; adhesins; MSCRAMMs;
   gene therapy
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; STAPHYLOCOCCUS-EPIDERMIDIS
   BIOFILMS; BIOMATERIAL-ASSOCIATED INFECTIONS; FIBRONECTIN-BINDING
   PROTEINS; QUORUM SENSING INHIBITORS; AUREUS COLLAGEN ADHESIN;
   ANTIBIOTIC-RESISTANCE; SLIME PRODUCTION; IMMUNE EVASION; IN-VITRO
AB Implant infection remains the major and often irreducible complication in clinical use of biomaterials, demanding new therapeutic and preventive strategies. Etio-pathogenesis of biomaterials-related infections is being more and more studied, and various virulence bacterial factors have progressively been identified, but little is still known about the weight of the distinct molecules in the context of specific peri-implant infection sites. Molecular epidemiology has become recently integrated into the research on implant infections. What distinguishes molecular epidemiology from the simple molecular biology is that the use of molecular techniques is applied to the study of the distribution and prevalence of virulence and resistance genes in collections of bacterial clinical isolates from implant infections. Here, the authors comment on the range of molecular techniques available, reviewing the various applications of molecular epidemiology to the study of implant infections and providing some experimental examples related to the field of orthopaedic implant infections. They highlight the new opportunities arising from molecular epidemiology of designing measures useful to prevent and treat implant infections. The knowledge of the relative weight of virulence factors and of their regulatory mechanisms at molecular level can open the way to new strategies also including gene therapies aimed at silencing or knocking out crucial genes responsible for the aggressive tools (adhesins, biofilm production, antibiotic resistance) of the aetiological agents of implant-related infections. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR Ammendolia MG, 1999, J CLIN MICROBIOL, V37, P3235
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   Arciola CR, 2007, BIOMATERIALS, V28, P3987, DOI 10.1016/j.biomaterials.2007.05.013
   Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1119
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Baldassarri L, 2006, INT J ARTIF ORGANS, V29, P402
   Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003
   Beech IB, 2006, INT J ARTIF ORGANS, V29, P443
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chan WC, 2004, J MED CHEM, V47, P4633, DOI 10.1021/jm0400754
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004
   Darouiche RO, 1997, J MED MICROBIOL, V46, P75, DOI 10.1099/00222615-46-1-75
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Donabedian H, 2003, J INFECTION, V46, P207, DOI 10.1053/jinf.2002.1120
   Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   Elliott TSJ, 2001, J CHEMOTHERAPY, V13, P234, DOI 10.1179/joc.2001.13.Supplement-2.234
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079
   Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016
   Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307.3316.2003
   Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098
   Flock JI, 1999, MOL MED TODAY, V5, P532, DOI 10.1016/S1357-4310(99)01597-X
   Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Garaizar J, 2006, FEMS IMMUNOL MED MIC, V47, P178, DOI 10.1111/j.1574-695X.2006.00081.x
   Gauduchon V, 2004, J INFECT DIS, V189, P346, DOI 10.1086/380909
   GILLESPIE W A, 1959, J Med Lab Technol, V16, P52
   Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Hanssen AD, 2002, J ARTHROPLASTY, V17, P98, DOI 10.1054/arth.2002.32458
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308
   Hu DL, 2006, MICROBES INFECT, V8, P2841, DOI 10.1016/j.micinf.2006.09.001
   Huang XW, 2007, J PEPT SCI, V13, P220, DOI 10.1002/psc.835
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Ishida T, 2007, APPL ENVIRON MICROB, V73, P3183, DOI 10.1128/AEM.02233-06
   Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6
   Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kaplan JB, 2005, EXPERT OPIN THER PAT, V15, P955, DOI 10.1517/13543776.15.8.955
   Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006
   MACK D, 1994, INFECT IMMUN, V62, P3244
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Marculescu CE, 2005, INFECT DIS CLIN N AM, V19, P931, DOI 10.1016/j.idc.2005.07.002
   Maslow J, 1996, INFECT CONT HOSP EP, V17, P595
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   MONTANARO L, 2007, J BIOMED MAT RES A
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morschhauser J, 2000, PHILOS T R SOC B, V355, P695, DOI 10.1098/rstb.2000.0609
   Musk DJ, 2006, CURR MED CHEM, V13, P2163, DOI 10.2174/092986706777935212
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Olive DM, 1999, J CLIN MICROBIOL, V37, P1661
   Otsuka T, 2006, BIOCHEM BIOPH RES CO, V346, P1234, DOI 10.1016/j.bbrc.2006.06.038
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   Patti JM, 2005, INT J ARTIF ORGANS, V28, P1157
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Peacock SJ, 1999, MICROBIOL-UK, V145, P3477, DOI 10.1099/00221287-145-12-3477
   Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005
   Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X
   Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0
   Ray A, 2000, FASEB J, V14, P1041
   RICHARDS GK, 1989, ADV PERIT D, V5, P133
   Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Sabat A, 2006, J CLIN MICROBIOL, V44, P3804, DOI 10.1128/JCM.00395-06
   Sarno R, 2003, ANTIMICROB AGENTS CH, V47, P3296, DOI 10.1128/AAC.47.10.3296-3304.2003
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micnif.2006.03.011
   Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042
   Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005
   Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426
   Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vadyvaloo V, 2005, INT J ARTIF ORGANS, V28, P1069
   van Belkum A, 2006, CURR OPIN INFECT DIS, V19, P339, DOI 10.1097/01.qco.0000235159.40184.61
   van der Mei HC, 2001, APPL ENVIRON MICROB, V67, P491, DOI 10.1128/AEM.67.2.491-494.2001
   van Merode AEJ, 2006, J BACTERIOL, V188, P2421, DOI 10.1128/JB.188.7.2421-2426.2006
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Walsh S, 2003, ANTIMICROB AGENTS CH, V47, P554, DOI 10.1128/AAC.47.2.554-558.2003
   Wei W, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-112
   White DG, 1997, ANTIMICROB AGENTS CH, V41, P2699, DOI 10.1128/AAC.41.12.2699
   Winzer K, 2001, INT J MED MICROBIOL, V291, P131, DOI 10.1078/1438-4221-00110
   Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102
   Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851
   Zaidi N, 2003, ARCH PATHOL LAB MED, V127, P1098
   Zhou H, 2006, VACCINE, V24, P4830, DOI 10.1016/j.vaccine.2006.03.020
   Ziebuhr W, 2000, INT J MED MICROBIOL, V290, P115
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 128
TC 72
Z9 84
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5155
EP 5168
DI 10.1016/j.biomaterials.2007.08.003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100022
PM 17764738
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Fuchs, S
   Hermanns, MI
   Peters, K
   Unger, RE
AF Kirkpatrick, Charles James
   Fuchs, Sabine
   Hermanns, Maria Iris
   Peters, Kirsten
   Unger, Ronald E.
TI Cell culture models of higher complexity in tissue engineering and
   regenerative medicine
SO BIOMATERIALS
LA English
DT Article
DE 3D-cell culture; co-cultures; vascularization; barrier models; Scaffold
ID HUMAN ENDOTHELIAL-CELLS; HUMAN PERIPHERAL-BLOOD; HEAVY-METAL IONS;
   IN-VITRO; PROGENITOR CELLS; GENE-REGULATION; BIOMATERIALS; EXPRESSION;
   ANGIOGENESIS; INTERFACE
AB Cell culture techniques have tended to be used in biomaterial research as a screening method prior to embarking on specific in vivo experimentation. This presentation aims at showing that it is possible to develop more sophisticated in vitro systems using primary human cells in co-culture with other cell types and biomaterials in a three-dimensional setting. While the predictive value of such systems is still not proven these models can be employed to unravel the complexity of biological systems in order to understand molecular mechanisms of cell-cell and cell-material interactions. The brief overview is under the headings of basic principles of relevant culture systems, the study of inflammation and the healing response, scenarios for specific biomaterial applications and future directions. How human endothelial cells can be usefully incorporated into more complex cell culture models is presented as an example of how relevant questions in tissue engineering and regenerative medicine can be addressed. The central tenet of this paper is that it is possible to refine in vitro methodology using cells of human origin to establish relevant assay systems that more closely simulate the cellular and molecular microenvironment encountered in a specific situation of regeneration using biomaterials. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-55101 Mainz, Germany.
EM kirkpatrick@repair-lab.org
RI Peters, Kirsten/S-3484-2016
CR BASSON CT, 1990, J CELL BIOL, V110, P789, DOI 10.1083/jcb.110.3.789
   Bluff JE, 2007, EXP HEMATOL, V35, P500, DOI 10.1016/j.exphem.2006.10.016
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Dalby MJ, 2007, BIOMATERIALS, V28, P1761, DOI 10.1016/j.biomaterials.2006.11.049
   Fuchs S, 2006, CELL TISSUE RES, V326, P79, DOI 10.1007/s00441-006-0222-4
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fujiyoshi K, 2006, BIOMATERIALS, V27, P3888, DOI 10.1016/j.biomaterials.2006.02.047
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   Hasirci V, 2006, J BIOMAT SCI-POLYM E, V17, P1241, DOI 10.1163/156856206778667442
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Holtorf HL, 2006, ADV EXP MED BIOL, V585, P225
   Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707
   Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509
   Kaps C, 2006, BIOMATERIALS, V27, P3617, DOI 10.1016/j.biomaterials.2006.02.017
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096
   Kirkpatrick CJ, 2006, ARTIF ORGANS, V30, P822, DOI 10.1111/j.1525-1594.2006.00306.x
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KLEIN CL, 1995, PATHOBIOLOGY, V63, P83, DOI 10.1159/000163938
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Mehrad B, 2007, THROMB HAEMOSTASIS, V97, P755, DOI 10.1160/TH07-01-0040
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376
   Peters K, 2005, MOL CELL BIOCHEM, V270, P157, DOI 10.1007/s11010-005-4504-z
   Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   PETERS K, 2004, J MATER SCI-MATER M, V15, P319
   PETERS K, 2007, IN PRESS J MAT SCI M
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
NR 46
TC 47
Z9 47
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 34
BP 5193
EP 5198
DI 10.1016/j.biomaterials.2007.08.012
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 227NJ
UT WOS:000250663100026
PM 17761278
DA 2018-10-19
ER

PT J
AU Lovett, M
   Cannizzaro, C
   Daheron, L
   Messmer, B
   Vunjak-Novakovic, G
   Kaplan, DL
AF Lovett, Michael
   Cannizzaro, Christopher
   Daheron, Laurence
   Messmer, Brady
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
TI Silk fibroin microtubes for blood vessel engineering
SO BIOMATERIALS
LA English
DT Article
DE silk fibroin; vascular grafts; arterial tissue engineering; porosity;
   endothelial cells; bioreactor
ID IN-VITRO; STEM-CELLS; GRAFTS; BIOMATERIALS; SCAFFOLDS; BYPASS
AB Currently available synthetic grafts demonstrate moderate success at the macrovascular level, but fail at the microvascular scale ( <6 mm inner diameter). We report on the development of silk fibroin microtubes for blood vessel repair with several advantages over existing scaffold materials/designs. These microtubes were prepared by dipping straight lengths of stainless steel wire into aqueous silk fibroin, where the addition of poly(ethylene oxide) (PEO) enabled control of microtube porosity. The microtube properties were characterized in terms of pore size, burst strength, protein permeability, enzymatic degradation, and cell migration. Low porosity microtubes demonstrated superior mechanical properties in terms of higher burst pressures, but displayed poor protein permeability; whereas higher porosity tubes had lower burst strengths but increased permeability and enhanced protein transport. The microtubes also exhibited cellular barrier functions as low porosity tubes prevented outward migration of GFP-transduced HUVECs, while the high porosity microtubes allowed a few cells per tube to migrate outward during perfusion. When combined with the biocompatible and suturability features of silk fibroin, these results suggest that silk microtubes, either implanted directly or preseeded with cells, are an attractive biomaterial for microvascular grafts. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA.
   Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI vunjak-novakovic, gordana/J-9279-2012
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [R01 EB003210, P41 EB002520, P41 EB002520-06A1, R01
   EB003210-06, EB002520]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Bosiers M, 2006, J VASC SURG, V43, P313, DOI 10.1016/j.jvs.2005.10.037
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Harris JR, 2002, J OTOLARYNGOL, V31, P89, DOI 10.2310/7070.2002.18928
   Heyligers JMM, 2006, J VASC SURG, V43, P587, DOI 10.1016/j.jvs.2005.10.038
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   HUXLEY VH, 1987, AM J PHYSIOL, V252, pH188
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   L'Heureux N, 1998, FASEB J, V12, P47
   Lambert AW, 1999, CARDIOVASC SURG, V7, P491, DOI 10.1016/S0967-2109(99)00012-5
   Lewus KE, 2005, TISSUE ENG, V11, P1015, DOI 10.1089/ten.2005.11.1015
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   SOFFER L, IN PRESS J BIOMATER
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WILLIAMS SA, 1988, CLIN SCI, V74, P507, DOI 10.1042/cs0740507
   2004, STAT FACT SHEET MISC
NR 27
TC 164
Z9 181
U1 5
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 35
BP 5271
EP 5279
DI 10.1016/j.biomterials.2007.08.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 230EW
UT WOS:000250860000007
PM 17727944
DA 2018-10-19
ER

PT J
AU Mauney, JR
   Nguyen, T
   Gillen, K
   Kirker-Head, C
   Gimble, JM
   Kaplan, DL
AF Mauney, Joshua R.
   Nguyen, Trang
   Gillen, Kelly
   Kirker-Head, Carl
   Gimble, Jeffrey M.
   Kaplan, David L.
TI Engineering adipose-like tissue in vitro and in vivo utilizing human
   bone marrow and adipose-derived mesenchymal stem cells with silk fibroin
   3D scaffolds
SO BIOMATERIALS
LA English
DT Article
DE adipose; stem cells; silk; tissue
ID FIBROBLAST-GROWTH-FACTOR; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION;
   ADIPOGENIC DIFFERENTIATION; STROMAL CELLS; PREADIPOCYTES; PROTEIN;
   RECONSTRUCTION; RECEPTORS; PATHWAY
AB Biomaterials derived from silk fibroin prepared by aqueous (AB) and organic (HFIP) solvent-based processes, along with collagen (COL) and poly-lactic acid (PLA)-based scaffolds were studied in vitro and in vivo for their utility in adipose tissue engineering strategies. For in vitro studies, human bone marrow and adipose-derived mesenchymal stem cells (hMSCs and hASCs) were seeded on the various biomaterials and cultured for 21 days in the presence of adipogenic stimulants (AD) or maintained as noninduced controls. Alamar Blue analysis revealed each biomaterial supported initial attachment of hMSCs and hASCs to similar levels for all matrices except COL in which higher levels were observed. hASCs and hMSCs cultured on all biomaterials in the presence of AD showed significant upregulation ;of adipogenic mRNA transcript levels (LPL, GLUT4, FABP4, PPAR-gamma, adipsin, ACS) to similar extents when compared to noninduced controls. Similarly Oil-Red 0 analysis of hASC or hMSC-seeded scaffolds displayed substantial amounts of lipid accumulating adipocytes following cultivation with AD. The data revealed AB and HFIP scaffolds supported similar extents of lipid accumulating cells while PLA and COL scaffolds qualitatively displayed lower and higher extents by comparison, respectively. Following a 4-week implantation period in a rat muscle pouch defect model, both AB and HFIP scaffolds supported in vivo adipogenesis either alone or seeded with hASCs or hMSCs as assessed by Oil-Red 0 analysis, however the presence of exogenous cell sources substantially increased the extent and frequency of adipogenesis observed. In contrast, COL and PLA scaffolds underwent rapid scaffold degradation and were irretrievable following the implantation period. The results suggest that macroporous 3D AB and HFIP silk fibroin scaffolds offer an important platform for cell-based adipose tissue engineering applications, and in particular, provide longer-term structural integrity to promote the maintenance of soft tissue in vivo. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn & Chem, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Bioengn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Medford, MA 02155 USA.
   Tufts Cummings Sch Vet Med, North Grafton, MA 01536 USA.
   Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn & Chem, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIBIB NIH HHS [P41 EB002520-06A1, P41 EB002520, R01 EB003210, R01
   EB003210-04]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman Greg, 2002, FASEB Journal, V16, P270
   Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276
   Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865
   DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Fischbach C, 2004, TISSUE ENG, V10, P215, DOI 10.1089/107632704322791862
   Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kang XH, 2005, TISSUE ENG, V11, P458, DOI 10.1089/ten.2005.11.458
   Kim CS, 2003, FEBS LETT, V548, P125, DOI 10.1016/S0014-5793(03)00728-2
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021
   Lee K., 2000, PRINCIPLES TISSUE EN, P409
   Makowski L., 2004, J NUTR, V134, P2464
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mauney JR, 2005, BIOMATERIALS, V26, P6167, DOI 10.1016/j.biomaterials.2005.03.024
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Miner JL, 2004, J ANIM SCI, V82, P935
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Patrick C.W.J., 1998, FRONTIERS TISSUE ENG, P369
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Powers MP, 1996, J ORAL MAXIL SURG, V54, P934, DOI 10.1016/S0278-2391(96)90386-9
   Rooney DP, 2006, DIABETIC MED, V23, P436, DOI 10.1111/j.1464-5491.2006.01855.x
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x
   Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5
   SHILLABEER G, 1989, J CLIN INVEST, V84, P381, DOI 10.1172/JCI114177
   SHIMOMURA I, 1992, BIOCHIM BIOPHYS ACTA, V1124, P112, DOI 10.1016/0005-2760(92)90086-B
   Tzikas Thomas L, 2004, Facial Plast Surg, V20, P135, DOI 10.1055/s-2004-861754
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   Walton RL, 2004, MICROSURG, V24, P378, DOI 10.1002/micr.20056
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   WHITE RT, 1992, J BIOL CHEM, V267, P9210
   Zimmer JSD, 2004, J LIPID RES, V45, P2138, DOI 10.1194/jlr.M400240-JLR200
NR 54
TC 228
Z9 241
U1 6
U2 82
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 35
BP 5280
EP 5290
DI 10.1016/j.biomaterials.2007.08.017
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 230EW
UT WOS:000250860000008
PM 17765303
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Morgan, SM
   Tilley, S
   Perera, S
   Ellis, MJ
   Kanczler, J
   Chaudhuri, JB
   Oreffo, ROC
AF Morgan, Suzanne M.
   Tilley, Simon
   Perera, Semali
   Ellis, Marianne J.
   Kanczler, Janos
   Chaudhuri, Julian B.
   Oreffo, Richard O. C.
TI Expansion of human bone marrow stromal cells on
   poly-(DL-lactide-co-glycolide) (P(DL)LGA) hollow fibres designed for use
   in skeletal tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; poly-(DL-lactide-co-glycolide); hollow fibre;
   human bone marrow stromal cells; osteogenesis; wet-spin phase-inversion
   technique and biodegradable scaffolds
ID MESENCHYMAL STEM-CELLS; IN-VITRO; BIODEGRADABLE POLYMER; MORPHOGENETIC
   PROTEIN-2; POLYLACTIDE FOAMS; SCAFFOLDS; DIFFERENTIATION; OSTEOBLASTS;
   VIVO; TRANSPLANTATION
AB Strategies to expand human bone marrow stromal cells (HBMSC) for bone tissue engineering are a key to revolutionising the processes involved in three-dimensional skeletal tissue reconstruction. To facilitate this process we believe the use of biodegradable porous poly (DL-lactide-co-glycolide) (P(DL)LGA) hollow fibres as a scaffold used in combination with HBMSC to initiate natural bone repair and regeneration offers a potential solution. In this study, the biocompatibility of 75:25 P(DL)LGA fibres with HBMSC and the capacity of a PDLLGA fibre-associated HBMSC-monolayer to establish an osteogenic phenotype in vivo was examined. A high proportion of HBMSC survived when expanded on PDLLGA fibres for 6 days, with only 10% of the propidium iodide (pI)-labelled population represented in the sub-G1 DNA peak on analysis by flow cytometry. Tracking carboxy-fluorescein diacetate, succinimidyl ester (CFSE)labelled HBMSC by flow cytometry indicated that HBMSC attachment to the PDLLGA fibres does not interfere with their rate of proliferation. Furthermore, in response to osteogenic stimuli, HBMSC expanded on P(DL)LGA fibres can differentiate, as expected, along the osteogenic lineage with associated alkaline phosphatase activity. Following implantation into SCID mice, osteogenic-conditioned PDLLGA fibre-HBMSC graft resulted in type I collagen deposition and associated bone mineralisation and osteoid formation, as evidenced by immunohistochemistry and histology. These studies provide evidence that porous PDLLGA hollow fibre-HBMSC graft is an innovative biomaterial that offers new approaches to mesenchymal cell expansion, which could be utilised as a scaffold for skeletal tissue generation. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England.
   Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England.
   Univ Bath, Dept Chem Engn, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
RP Oreffo, ROC (reprint author), Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England.
EM roco@soton.ac.uk
RI Oreffo, Richard/A-4615-2011; Chaudhuri, julian/F-5032-2012
OI Oreffo, Richard/0000-0001-5995-6726; Ellis, Marianne/0000-0003-4155-0853
FU Biotechnology and Biological Sciences Research Council [BBS/B/17271]
CR Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Christie K, 2003, INT AFF, V79, P929
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Dalby MJ, 2002, BIOMATERIALS, V23, P681, DOI 10.1016/S0142-9612(01)00156-9
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093
   Eser H, 2006, J APPL POLYM SCI, V102, P2426, DOI 10.1002/app.24516
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jordan KM, 2002, BEST PRACT RES CL RH, V16, P795, DOI 10.1053/berh.2002.0264
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Li K, 1999, AICHE J, V45, P1211, DOI 10.1002/aic.690450607
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Olsen BR, 1996, CURR BIOL, V6, P645, DOI 10.1016/S0960-9822(09)00438-2
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623
   Petricca SE, 2006, ACTA BIOMATER, V2, P277, DOI 10.1016/j.actbio.2005.12.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 2001, SCIENCE, V293, P211
   *ROAYL COLL PHYS, 1999, OST CLIN GUID PREV T
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Thomson R. C., 1995, V122, P245
   TILLEY S, 2006, REGEN MED, V1, P1
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Wang DL, 1996, J MEMBRANE SCI, V115, P85, DOI 10.1016/0376-7388(95)00312-6
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   WONG WH, 1997, SYNTHETIC BIODEGRADA, P58
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 63
TC 34
Z9 36
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 35
BP 5332
EP 5343
DI 10.1016/j.biomaterials.2007.08.029
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 230EW
UT WOS:000250860000013
PM 17822756
DA 2018-10-19
ER

PT J
AU Yang, Y
   Ding, F
   Wu, H
   Hu, W
   Liu, W
   Liu, H
   Gu, X
AF Yang, Yumin
   Ding, Fel
   Wu, Han
   Hu, Wen
   Liu, Wei
   Liu, He
   Gu, Xiaosong
TI Development and evaluation of silk fibroin-based nerve grafts used for
   peripheral nerve regeneration
SO BIOMATERIALS
LA English
DT Article
DE silk fibroin; nerve graft; nerve guidance conduit; biomimetic design;
   rat sciatic nerve defect; peripheral nerve regeneration
ID IN-VIVO; BIOMATERIALS; CELLS; SCAFFOLDS; RESPONSES; DELIVERY; DEFECTS;
   RELEASE; PROTEIN; FIBERS
AB Silk fibroin (SF), derived from natural silk long used as a textile material, has recently become an important biomaterial for tissue engineering applications. We have previously reported on good in vitro biocompatibility of SF fibers with peripheral nerve tissues and cells. In the present study, we developed a novel biomimetic design of the SF-based nerve graft (SF graft) which was composed of a SF-nerve guidance conduit (NGC) inserted with oriented SF filaments. The SF-NGC prepared via well-established procedures exhibits an eggshell-like microstructure that is responsible for its superior mechanical and permeable properties beneficial to nerve regeneration. The SF graft was used for bridge implantation across a 10-mm long sciatic nerve defect in rats, and the outcome of peripheral nerve repair at 6 months post-implantation was evaluated by a combination of electrophysiological assessment, FluoroGold retrograde tracing and histological investigation. The examined functional and morphological parameters show that SF grafts could promote peripheral nerve regeneration with effects approaching those elicited by nerve autografts which are generally considered as the gold standard for treating large peripheral nerve defects, thus raising a potential possibility of using these newly developed nerve grafts as a promising alternative to nerve autografts. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, JS, Peoples R China.
RP Gu, X (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, JS, Peoples R China.
EM neurongu@public.nt.js.cn
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Beris A, 2007, J NEUROTRAUM, V24, P909, DOI 10.1089/neu.2006.0165
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   COBIN AS, 2006, TISSUE ENG, V12, P3383
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DUCKER TB, 1970, J NEUROSURG, V32, P236, DOI 10.3171/jns.1970.32.2.0236
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Ijkema-Paassen J, 2001, Equine Vet J Suppl, P41
   Jiang BG, 2007, EUR NEUROL, V58, P12, DOI 10.1159/000102161
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Krekoski CA, 2001, J NEUROSCI, V21, P6206
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lorenz M., 2005, BIOMATERIALS, V26, P147
   LV Q, 2004, J MATER SCI-MATER M, V159, P1193
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0
   Toba T, 2002, INT J ARTIF ORGANS, V25, P230
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wurm FM, 2003, NAT BIOTECHNOL, V21, P34, DOI 10.1038/nbt0103-34
   Yamada N, 2004, WOMAN ART J, V25, P3, DOI 10.2307/3566510
   Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang M, 2005, ADV BIOCHEM ENG BIOT, V94, P67, DOI 10.1007/b100000
NR 44
TC 178
Z9 200
U1 4
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2007
VL 28
IS 36
BP 5526
EP 5535
DI 10.1016/j.biomaterials.2007.09.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 237FG
UT WOS:000251359000014
PM 17884161
DA 2018-10-19
ER

PT J
AU Aliev, MKH
   Saboor, A
AF Aliev, M. K. H.
   Saboor, A.
TI Pulsed nanocrystalline plasma electrolytic boriding as a novel method
   for corrosion protection of CP-Ti (Part 1: Different frequency and duty
   cycle)
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE titanium; pulsed plasma electrolytic boriding; corrosion;
   nanocrystalline
ID TITANIUM; ALLOYS
AB Potentiodynamic polarization and electrochemical impedance spectroscopy were employed to test borided CP-Ti, treated by a relatively new method called pulsed plasma electrolytic boriding. The results show excellent corrosion resistance for modified CP-Ti. The effect of frequency and duty cycle of pulsed current was investigated. It was found that pulse frequency and duty cycle affect the size and porosity of nanocrystalline borides and by controlling these effective parameters, surface modification can render the CP-Ti material extremely corrosion resistant as a biomaterial.
C1 [Aliev, M. K. H.; Saboor, A.] Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, Tehran, Iran.
RP Saboor, A (reprint author), Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, POB 14115-143, Tehran, Iran.
EM sabour02@yahoo.com
CR Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023
   Cai Z, 2001, BIOMATERIALS, V22, P979, DOI 10.1016/S0142-9612(00)00263-5
   Donachie M. J., 2000, TITANIUM TECHNICAL G
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   LUTJERING G, 2004, TI 2003 SCI TECHNOLO
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   TAHERI P, 2007, PLASMA PROCESS POLYM, V4, P4
   Vanzillotta PS, 2006, DENT MATER, V22, P275, DOI 10.1016/j.dental.2005.03.012
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 10
TC 11
Z9 13
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD DEC
PY 2007
VL 30
IS 6
BP 601
EP 605
DI 10.1007/s12034-007-0095-5
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 252VG
UT WOS:000252474200012
DA 2018-10-19
ER

PT J
AU Park, D
   Lim, SR
   Yun, YS
   Park, JM
AF Park, Donghee
   Lim, Seong-Rin
   Yun, Yeoung-Sang
   Park, Jong Moon
TI Reliable evidences that the removal mechanism of hexavalent chromium by
   natural biomaterials is adsorption-coupled reduction
SO CHEMOSPHERE
LA English
DT Article
DE biosorption; mechanism; hexavalent chromium; adsorption-coupled
   reduction
ID DEAD FUNGAL BIOMASS; LOW-COST ADSORBENTS; ACTIVATED CARBONS;
   WASTE-WATER; BIOSORPTION; CR(VI); CHROMATE; SORPTION; WASTEWATERS;
   KINETICS
AB For the last few decades, over 200 papers have been published in the Cr(VI) biosorption research field. Most early studies have claimed that Cr(VI) was removed from aqueous phase through an anionic adsorption, but this approach has been lost old original position. It has been newly explained that these findings were misinterpreted due to errors in measuring the concentrations of different chromium species in the aqueous phase, insufficient contact time required for equilibrium and the lack of information about the oxidation state of the chromium bound to biomaterials. Although 'adsorption-coupled reduction' is now widely accepted as the mechanism of Cr(VI) biosorption by natural biomaterials, a number of researchers still believe that Cr(VI) is removed by anionic adsorption onto the biomaterials. Therefore, the objective of this study was to show reliable evidences that the removal mechanism of Cr(VI) by natural biomaterials is 'adsorption-coupled reduction'. Sixteen natural biomaterials were used to study the Cr(VI) biosorption. Not only Cr(VI) but also total Cr in the aqueous phase were analyzed. X-ray photoelectron spectroscope was also used to verify the oxidation state of the chromium bound to the biomaterials. Finally, the removal behavior of Cr(VI) by each biomaterial was described by a kinetic model based on a redox reaction. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Park, Donghee; Lim, Seong-Rin; Park, Jong Moon] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Pohang 790784, South Korea.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Res Inst Ind Technol, Div Environm & Chem Engn, Duckjin Dong 561756, Jeonju, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, San 31 Hyoja Dong, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278; Lim, Seong-Rin/0000-0002-5192-0486
CR Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Baral A., 2002, ENVIRON SCI POLICY, V5, P121, DOI DOI 10.1016/S1462-9011(02)00028-X
   BARAL SS, 2006, BIOCH ENG J, V13, P216
   Barnhart J., 1997, REGUL TOXICOL PHARM, V26, P3
   Barrera H, 2006, J HAZARD MATER, V136, P846, DOI 10.1016/j.jhazmat.2006.01.021
   Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575
   Chen GQ, 2006, J HAZARD MATER, V135, P249, DOI 10.1016/j.jhazmat.2005.11.060
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032
   Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056
   Kiran B, 2007, J HAZARD MATER, V141, P662, DOI 10.1016/j.jhazmat.2006.07.026
   Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q
   MALKOC E, 2007, THERMODYNAMIC KINETI, V54, P291
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Sankararamakrishnan N, 2006, BIORESOURCE TECHNOL, V97, P2377, DOI 10.1016/j.biortech.2005.10.024
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Sawalha MF, 2007, CHEMOSPHERE, V66, P1424, DOI 10.1016/j.chemosphere.2006.09.028
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V49, P31, DOI 10.1016/0960-8524(94)90170-8
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Verma A, 2006, SEP PURIF TECHNOL, V50, P336, DOI 10.1016/j.seppur.2005.12.007
   Ziagova M, 2007, BIORESOURCE TECHNOL, V98, P2859, DOI 10.1016/j.biortech.2006.09.043
NR 36
TC 148
Z9 158
U1 1
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
J9 CHEMOSPHERE
JI Chemosphere
PD DEC
PY 2007
VL 70
IS 2
BP 298
EP 305
DI 10.1016/j.chemosphere.2007.06.007
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 242DS
UT WOS:000251705300016
PM 17644158
DA 2018-10-19
ER

PT J
AU Roy, ME
   Whiteside, LA
   Katerberg, BJ
   Steiger, JA
   Nayfeh, TA
AF Roy, Marcel E.
   Whiteside, Leo A.
   Katerberg, Brian J.
   Steiger, Jerry A.
   Nayfeh, Tariq A.
TI Not all zirconia femoral heads degrade in vivo
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT Open Meeting of the Hip-Society
CY 2007
CL San Diego, CA
ID POLYETHYLENE ACETABULAR CUPS; CERAMICS; WEAR; SURFACE
AB Degradation of yttria-stabilized zirconia femoral heads in vivo has been linked to increased roughening and even fracture of the femoral head. To determine whether magnesia-stabilized zirconia is better suited to resist degradation, we characterized the monoclinic phase concentration, surface topography, and microhardness of retrieved zirconia femoral heads. From previous work, we expected yttria-stabilized zirconia heads to undergo considerable tetragonal-to-monoclinic phase transformation in vivo, leading to considerably increased roughness and decreased microhardness, whereas magnesia-stabilized zirconia heads would not experience phase transformation and thus would not roughen or exhibit decreased microhardness. We studied seven yttria-stabilized zirconia and 12 magnesia-stabilized zirconia femoral heads. Yttria-stabilized zirconia heads explanted after 5 years exhibited a rough orange peel-like surface under light microscopy and were rougher than magnesia-stabilized zirconia heads (average roughness approximately 20 nm versus 7.5 nm, respectively), likely attributable to increased monoclinic phase transformation (approximately 37% by weight) caused by low-temperature aging. The microhardness of yttria-stabilized zirconia heads decreased with age, but the relationship was not noteworthy. In contrast, magnesia-stabilized zirconia retrievals showed no change in monoclinic phase concentration, surface roughness, or microhardness with age. The properties of the yttria-stabilized zirconia evaluated in our study deteriorated in vivo, whereas magnesia-stabilized zirconia did not degrade and appears to be a superior biomaterial for bearing in total joint arthroplasty.
C1 Missouri Bone & Joint Res Fdn, St Louis, MO 63131 USA.
   Whiteside Biomech Inc, St Louis, MO USA.
RP Roy, ME (reprint author), Missouri Bone & Joint Res Fdn, 1000 Des Peres Rd,Suite 150, St Louis, MO 63131 USA.
EM mroy@mobojo.org
CR Amer T. S., 1993, Journal of Information Systems, V7, P1
   American Society for Testing Materials, 1998, F187398 ASTM
   [Anonymous], 2003, C132703 ASTM
   Barbour PSM, 2000, P I MECH ENG H, V214, P569, DOI 10.1243/0954411001535598
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   Cawley J.D., 1994, MAT SCI TECHNOLOGY, V11, P49
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   Kim YH, 2005, J BONE JOINT SURG AM, V87A, P1769, DOI 10.2106/JBJS.D.02572
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   McKellop H, 1999, CLIN ORTHOP RELAT R, P73
   ROY ME, 2007, J BIOMED MAT RES A
   Santos EM, 2004, J ARTHROPLASTY, V19, P30, DOI 10.1016/j.arth.2004.06.017
   *US FDA, 2001, MED DEV REC REC ZIRC
NR 21
TC 20
Z9 20
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD DEC
PY 2007
IS 465
BP 220
EP 226
DI 10.1097/BLO.0b013e318158b4d3
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 238JV
UT WOS:000251444600037
PM 17828030
DA 2018-10-19
ER

PT J
AU Emmambux, MN
   Stading, M
AF Emmambux, M. Naushad
   Stading, Mats
TI In situ tensile deformation of zein films with plasticizers and filler
   materials
SO FOOD HYDROCOLLOIDS
LA English
DT Article
DE biomaterial; zein films; tensile deformation and fracture; CLSM; local
   deformation
ID WATER-VAPOR PERMEABILITY; FOOD MATERIALS; FRACTURE; CELLULOSE
AB Material deformation is a dynamic process. Visualisation of this deformation can help to understand the local deformation and fracture behaviour. Zein (the prolamin protein from maize) films with different amount of plasticizers (0-25%) and different filler materials (maize oil, Dimodan (R), Vestosint (R)), at 25% (w/w) to protein) were deformed under tension and observed at micron scale in real time by a confocal laser scanning microscope (CLSM). The addition of plasticizers increased strain and decreased stress of zein films. At low level of plasticizers (6.25% and 12%), zein films deformed and fracture through micro-crack formation and propagation normal the tensile axis. At high Plasticization, only micro-pores were observed during tensile deformation. The filler material oil and Dimodan (R)( increased, but Vestosint (R)) decreased tensile strain in comparison to the control. This shows that the fracture dynamic is affected by the filler materials and is indeed observed by the CLSM. Analysis of local strain by Fluospheres (R) as particle tracking showed a good linear correlation with the tensile strain of the plasticized zein films. The local strains of filler materials and zein matrix in the films were different from the overall tensile strain. The combination of CLSM with a fluospheres (R) as particle tracking is a good method to study local deformation in biomaterials to understand the deformation and fracture behaviour of biomaterials. (C) 2006 Elsevier Ltd. All rights reserved.
C1 Swedish Inst Food & Biotechnol, Struct & Mat Design, S-40229 Gothenburg, Sweden.
   Chalmers, Dept Mat Sci & Engn, S-41296 Gothenburg, Sweden.
RP Emmambux, MN (reprint author), Univ Pretoria, Dept Food Sci, Lynwood Rd, ZA-0002 Pretoria, South Africa.
EM naushad.emmambux@up.ac.za; ms@sik.se
RI Emmambux, Mohammad/A-5862-2011
CR Anker M., 2002, Innovative Food Science and Emerging Technologies, V3, P81, DOI 10.1016/S1466-8564(01)00051-0
   Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8
   Arvanitoyannis I, 1999, CARBOHYD POLYM, V38, P47, DOI 10.1016/S0144-8617(98)00087-3
   Damodaran S., 1996, FOOD CHEM, P321
   DeFrate LE, 2006, J BIOMECH, V39, P399, DOI 10.1016/j.jbiomech.2004.12.021
   DEROSE RT, 1989, PLANT MOL BIOL, V12, P245, DOI 10.1007/BF00043202
   Emmambux NM, 2003, J SCI FOOD AGR, V83, P402, DOI 10.1002/jsfa.1379
   Kinloch A. J., 1983, FRACTURE BEHAV POLYM
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lawton JW, 2004, CEREAL CHEM, V81, P1, DOI 10.1094/CCHEM.2004.81.1.1
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Lillford PJ, 2001, J TEXTURE STUD, V32, P397, DOI 10.1111/j.1745-4603.2001.tb01244.x
   Marissen R, 2000, POLYMER, V41, P1119, DOI 10.1016/S0032-3861(99)00234-7
   Nicolas Y, 2003, FOOD HYDROCOLLOID, V17, P907, DOI 10.1016/S0268-005X(03)00113-9
   PARK HJ, 1994, T ASAE, V37, P1281
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Plucknett KP, 2001, J MICROSC-OXFORD, V201, P279, DOI 10.1046/j.1365-2818.2001.00837.x
   Sears J.K., 1982, TECHNOLOGY PLASTICIZ
   STANLEY DW, 1994, FOOD RES INT, V27, P135, DOI 10.1016/0963-9969(94)90155-4
   Thiel BL, 1998, ANN BOT-LONDON, V82, P727, DOI 10.1006/anbo.1998.0732
   VANECK HM, 2004, THESIS U PRETORIA PR
   Xiao CB, 2003, J APPL POLYM SCI, V89, P3500, DOI 10.1002/app.12509
   Zebarjad SM, 2004, J MATER PROCESS TECH, V155, P1459, DOI [10.1016/j.jmatprotec.2004.04.187, 10.1016/j.matprotec.2004.04.187]
   Zioupos P, 1998, MAT SCI ENG C-BIOMIM, V6, P33, DOI 10.1016/S0928-4931(98)00033-2
NR 24
TC 25
Z9 27
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-005X
J9 FOOD HYDROCOLLOID
JI Food Hydrocolloids
PD DEC
PY 2007
VL 21
IS 8
BP 1245
EP 1255
DI 10.1016/j.foodhyd.2006.09.013
PG 11
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 177YQ
UT WOS:000247188800002
DA 2018-10-19
ER

PT J
AU Salido, M
   Vilches, JI
   Gutierrez, JL
   Vilches, J
AF Salido, M.
   Vilches, J. I.
   Gutierrez, J. L.
   Vilches, J.
TI Actin cytoskeletal organization in human osteoblasts grown on different
   dental titanium implant surfaces
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE osteoblasts; cytoskeleton; dental implants; titanium; microtopography
ID CELL-ADHESION; IN-VITRO; BONE; ATTACHMENT; ROUGHNESS; PROLIFERATION;
   DYNAMICS
AB The understanding of the cellular basis of osteoblastic cell-biomaterial interaction is crucial to the analysis of the mechanism of osseointegration. Cell adhesion is a complex process that is dependent on the cell types and on the surface microtopography and chemistry of the substrate.
   We have studied the role of microtopography in modulating cell adhesion, in vitro, using a human osteoblastic cell line for the assessment of actin cytoskeletal organization. Through application of CLSM combining reflection and fluorescence, 2D or 3D images of cytoskeleton were obtained.
   On smooth surfaces, Ti CP machined, predominantly planar bone cells with an axial ratio of 1.1 were randomly oriented, with stress fibers running in all directions, and thin filopodia.
   On TiCP Osseotite((R)) surfaces the osteoblastic cells conformed to the irregular terrain of the sustrate with focal adhesion sites only established on the relative topographical peaks separated for a longer distance than in the machined surface, and defined wide lamellopodia and long filopodia, with enhanced expression of stress fibers, forming large clear focal contacts with the rough surface. The cytoskeletal organization of cells cultured on rough titanium supports an active role for the biomaterial surface in the events that govern osteoblastic cell adhesion. The results enforce the role of the rough sustrate surface in affecting osteoblastic cell adhesion and provide valuable information for the design of material surfaces that are required for the development of an appropriate osteogenic surface for osteoblastic anchorage, compared to machined surface, in dental implants.
C1 Univ Cadiz, Sch Med, Dept Histol, Serv Cent Invest Ciencias Salud, Cadiz 11002, Spain.
   Univ Seville, Sch Dent, Dept Oral Surg, Seville, Spain.
RP Salido, M (reprint author), Univ Cadiz, Sch Med, Dept Histol, Serv Cent Invest Ciencias Salud, C Dr Maranon 3, Cadiz 11002, Spain.
EM mercedes.salido@uca.es
CR Al-Nawas Bila, 2003, Clin Implant Dent Relat Res, V5, P176, DOI 10.1111/j.1708-8208.2003.tb00200.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Ivanoff CJ, 2001, CLIN ORAL IMPLAN RES, V12, P128, DOI 10.1034/j.1600-0501.2001.012002128.x
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   MUSTAFA K, 2001, CLIN ORAL IMPLAN RES, V12, P15
   Papalexiou V, 2004, CLIN ORAL IMPLAN RES, V15, P44, DOI 10.1111/j.1600-0501.2004.00995.x
   Pierres A., 2002, European Cells & Materials, V3, P31
   Rodriguez- Rius D, 2005, MED ORAL PATOL ORAL, V10, P58
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   Ronold HJ, 2003, J MATER SCI-MATER M, V14, P843, DOI 10.1023/A:1025622407727
   Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Torensma R, 2003, CLIN ORAL IMPLAN RES, V14, P569, DOI 10.1034/j.1600-0501.2003.00949.x
   Veis AA, 2004, CLIN ORAL IMPLAN RES, V15, P54, DOI 10.1111/j.1600-0501.2004.01004.x
   Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0
   Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 28
TC 18
Z9 20
U1 0
U2 2
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD DEC
PY 2007
VL 22
IS 12
BP 1355
EP 1364
PG 10
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 200FN
UT WOS:000248749400006
PM 17701915
DA 2018-10-19
ER

PT J
AU Carinci, F
   Piattelli, A
   Degidi, M
   Palmieri, A
   Perrotti, V
   Scapoli, L
   Martinelli, M
   Zuccarino, L
   Pezzetti, F
AF Carinci, Francesco
   Piattelli, Andriano
   Degidi, Marco
   Palmieri, Annalisa
   Perrotti, Vittoria
   Scapoli, Luca
   Martinelli, Marcella
   Zuccarino, Luca
   Pezzetti, Furio
TI Effects of dernineralized freeze-dried bone allograft on gene expression
   of osteoblastlike MG63 cells
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID BENIGN EPIDERMOLYSIS-BULLOSA; APOPTOSIS-INDUCING FACTOR;
   RETINOBLASTOMA-BINDING PROTEIN; HUMAN INTERLEUKIN-13 RECEPTOR;
   CENTRAL-NERVOUS-SYSTEM; FC-RECEPTOR; CHROMOSOMAL LOCALIZATION;
   CLINICAL-EVALUATION; NEGATIVE REGULATOR; IGA NEPHROPATHY
AB Demineralized freeze-dried bone allograft (DFDBA) is widely used in periodontal regeneration procedures as a scaffold for new bone formation in periodontal defects. How this biomaterial alters osteoblast activity to promote bone formation is poorly understood. We therefore attempted to address this question by using microarray techniques to identify genes that are differently regulated in osteoblasts exposed to DFDBA. By using DNA microarrays containing 20,000 genes, the authors identified in an osteablastlike cell line (MG-63) cultured with DFDBA (Allogro, Dentsply/Friadent-Ceramed) several genes whose expression was significantly up-regulated or down-regulated. The differently expressed genes cover a broad range of functional activities: (1) cell cycle regulation, (2) immunity, (3) vesicular transport, (4) production of cytoskeletal elements, and (5) bone remodeling. The data reported are, to the authors' knowledge, the first genetic portrait of DFDBA effects. They can be relevant to a better understanding of the molecular mechanism of bone regeneration and as a model for comparing other materials with similar clinical effects.
C1 [Carinci, Francesco] Univ Ferrara, I-44100 Ferrara, Italy.
   [Piattelli, Andriano] Univ G dAnnunzio, Pescara, Italy.
   [Degidi, Marco] Univ Bologna, Dent Clin, I-40126 Bologna, Italy.
   [Scapoli, Luca; Pezzetti, Furio] Univ Bologna, Hist Inst, I-40126 Bologna, Italy.
   [Scapoli, Luca; Pezzetti, Furio] CARISBO Fdn, Ctr Mol Genet, Bologna, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Scapoli, Luca/C-6152-2008
OI Scapoli, Luca/0000-0003-4006-9910
CR Aichelmann-Reidy ME, 2004, J PERIODONTOL, V75, P340, DOI 10.1902/jop.2004.75.3.340
   Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265
   BIEGEL JA, 1990, J NEUROSURG, V73, P710, DOI 10.3171/jns.1990.73.5.0710
   BIEGEL JA, 1992, GENE CHROMOSOME CANC, V5, P104, DOI 10.1002/gcc.2870050203
   BONNIN JM, 1984, CANCER-AM CANCER SOC, V54, P2137, DOI 10.1002/1097-0142(19841115)54:10<2137::AID-CNCR2820541014>3.0.CO;2-D
   Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007
   Carinci F, 2003, J DENT RES, V82, P551, DOI 10.1177/154405910308200713
   Carinci F, 2003, ORAL ONCOL, V39, P69, DOI 10.1016/S1368-8375(02)00027-1
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Chavanas S, 1997, J INVEST DERMATOL, V109, P74, DOI 10.1111/1523-1747.ep12276614
   Clancy BM, 2003, BONE, V33, P46, DOI 10.1016/S8756-3282(03)00116-9
   COPELAND NG, 1993, GENOMICS, V15, P180, DOI 10.1006/geno.1993.1027
   Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022
   Darling TN, 1998, J INVEST DERMATOL, V110, P165, DOI 10.1046/j.1523-1747.1998.00103.x
   Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338
   Darling TN, 1998, J INVEST DERMATOL, V110, P170, DOI 10.1046/j.1523-1747.1998.00101.x
   DEWIT TPM, 1995, J IMMUNOL, V155, P1203
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368
   Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.3.CO;2-X
   Guo JA, 1997, GENOMICS, V42, P141, DOI 10.1006/geno.1997.4628
   Gurinsky BS, 2004, J PERIODONTOL, V75, P1309, DOI 10.1902/jop.2004.75.10.1309
   Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549
   Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4
   Herold RW, 2002, J PERIODONTOL, V73, P213, DOI 10.1902/jop.2002.73.2.213
   Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   JUST W, 1993, HUM GENET, V92, P516, DOI 10.1007/BF00216462
   KIMATA K, 1981, J BIOL CHEM, V256, P6961
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   Klepp M, 2004, J CLIN PERIODONTOL, V31, P534, DOI 10.1111/j.1600-051X.2004.00520.x
   KREMER EJ, 1992, HUM GENET, V89, P107, DOI 10.1007/BF00207054
   Lamb JW, 2001, J PERIODONTOL, V72, P1580, DOI 10.1902/jop.2001.72.11.1580
   Landi L, 2000, Int J Periodontics Restorative Dent, V20, P574
   Li S, 2000, NATURE, V406, P210
   MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665
   Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412
   MONTEIRO RC, 1993, J CLIN INVEST, V92, P1681, DOI 10.1172/JCI116754
   Narita I, 2001, J HUM GENET, V46, P694, DOI 10.1007/s100380170002
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   NOMURA T, IN PRESS J BIOMED MA
   Paul BF, 2001, J PERIODONTOL, V72, P1064, DOI 10.1902/jop.2001.72.8.1064
   Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933
   Pleass RJ, 1996, BIOCHEM J, V318, P771, DOI 10.1042/bj3180771
   QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0
   QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507
   Shimokawa T, 2000, IMMUNOGENETICS, V51, P945, DOI 10.1007/s002510000226
   Smiler D G, 2001, Implant Dent, V10, P139
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Tsuge T, 2001, HUM GENET, V108, P128, DOI 10.1007/s004390100458
   WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154
   Welsh GI, 1999, EXP CELL RES, V250, P62, DOI 10.1006/excr.1999.4505
   Wilkins RM, 1999, ANN CHIR GYNAECOL FE, V88, P180
   YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62
   Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221
   Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16
   ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665
NR 57
TC 8
Z9 8
U1 0
U2 0
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD DEC
PY 2007
VL 27
IS 6
BP 596
EP 601
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 240LP
UT WOS:000251589400010
PM 18092454
DA 2018-10-19
ER

PT J
AU Foroutan, H
   Khodabakhsh, M
   Rabbani, M
AF Foroutan, H.
   Khodabakhsh, M.
   Rabbani, M.
TI Investigation of synthesis of PVP hydrogel by irradiation
SO IRANIAN JOURNAL OF RADIATION RESEARCH
LA English
DT Article
DE hydrogel; biomaterial; radiation polymerization; electron beams; wound
   dressing
ID POLY(N-VINYLPYRROLIDONE) HYDROGELS
AB Background: A dressing often covers the wound to accelerate its healing. Hydrocolloid-type dressing to give better conditions for healing has been developed consisting of gelatin, pectin, water and hydrophilic polymer which promote healing. In recent years, much attention has been focused on the research and development of polymer hydrogels as biomaterials, such as contact lenses, wound dressing and drug-delivery systems. Materials and Methods: Hydrogels, as wound dressing were prepared with composite poly (N-vinyl-2-pyrolidone) (PVP) with several additives such as agar and polyethylenglycol (PEG) and by electron-beam. Electron beam was applied as a tool for initiation of crosslinking and sterilization of these materials. The effects of irradiation dose at the range of 10-40 KGy and various concentration of components on the characterizes of hydrogel such as gel content, degree of swelling (DS), equilibrium water content (EWC) and dehydration properties, transparency and microbial test were investigated. Results: After irradiation, the achieved gel content of hydrogels was obtained higher than 25%. Gels' degree of swelling with different concentrations was changed from 35 to 20 at the range of irradiation dose of 10-40 KGy. Also, at the same range of irradiation and concentration, EWC of gels was found to be 98 to 94 %. The dehydration results did not show variation with the tested parameters. Conclusion: Results showed that hydrogels membrane with composition PVP (10% w/w), agar and PEG (1-3%w/w) at the dose of 25 KGy had the amount of gel content 80-85%. Their IDS and EWC were respectively obtained 30% and 96.5%. They were elastic, transparent, flexible, sterile and impermeable for bacteria. They absorbed a high capacity of water, attached to healthy skin, and they were easy to remove. It was concluded that the network was solely composed of crosslinked PVP plasticized by other compounds.
C1 [Foroutan, H.; Khodabakhsh, M.; Rabbani, M.] Nucl Sci Res Sch, Inst Nucl Sci & Technol, Tehran, Iran.
RP Foroutan, H (reprint author), Nucl Sci Res Sch, Inst Nucl Sci & Technol, POB 11365-3486, Tehran, Iran.
EM halehfroutan@yahoo.com
CR Brasch U, 1996, MACROMOL CHEM PHYSIC, V197, P223, DOI 10.1002/macp.1996.021970117
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   DARWIS D, 1993, RADIAT PHYS CHEM, V42, P907, DOI 10.1016/0969-806X(93)90399-F
   GUVEN O, 1992, J WOUND CARE, V1, P3
   HILMY N, 1993, RADIAT PHYS CHEM, V42, P911
   Ju HK, 2001, POLYMER, V42, P6851, DOI 10.1016/S0032-3861(01)00143-4
   Lugao AB, 1998, RADIAT PHYS CHEM, V52, P319, DOI 10.1016/S0969-806X(98)00160-1
   Rosiak J., 1989, Patent US, Patent No. [4871490 A, 4871490, 4,871,490]
   Rosiak JM, 1991, ACS BOOK SERIES, V475
   SCHIPUNOV YA, 2003, J COLLOID INTERF SCI, V268, P69
NR 10
TC 2
Z9 2
U1 0
U2 10
PU IJRR-IRANIAN JOURNAL RADIATION RES
PI TEHRAN
PA NO 29, 4TH FL, CHAMRAN MEDICAL BLDG, PARVANEH ST, ALE-AHMAD HWY, TEHRAN,
   00000, IRAN
SN 1728-4554
J9 IRAN J RADIAT RES
JI Iran. J. Radiat. Res.
PD WIN
PY 2007
VL 5
IS 3
BP 131
EP 136
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 338KF
UT WOS:000258505900005
DA 2018-10-19
ER

PT J
AU Jones, JA
   Chang, DT
   Meyerson, H
   Colton, E
   Kwon, IK
   Matsuda, T
   Anderson, JM
AF Jones, Jacqueline A.
   Chang, David T.
   Meyerson, Howard
   Colton, Erica
   Kwon, Il Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Proteomic analysis and quantification of cytokines and chemokines from
   biomaterial surface-adherent macrophages and foreign body giant cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophages; cytokine and chemokine production; macrophage adhesion;
   activation and fusion; hydrophilic; hydrophobic; and ionic surface
   chemistry; foreign body giant cells
ID CLASSICALLY ACTIVATED MACROPHAGES; IN-VITRO; BIOMEDICAL POLYMERS;
   HUMAN-MONOCYTES; INTERLEUKIN-1 GENERATION; ADHESION; INFLAMMATION;
   EXPRESSION; CHEMISTRY; APOPTOSIS
AB Implantation of biomaterial devices results in the well-known foreign body reaction consisting of monocytes, macrophages, and foreign body giant cells (FBGCs) at the material/tissue interface. We continue to address the hypothesis that material surface chemistry modulates the phenotypic expression of these cells. Utilizing our human monocyte culture system, we have used surface-modified polymers displaying hydrophobic, hydrophilic, and/or ionic chemistries to determine the cytokines/chemokines released from biomaterial-adherent macrophages/FBGCs. This study broadens our approach by using proteomic analysis to identify important factors expressed by these cells and further quantifies these molecules with ELISAs. Proteomic profiles changed over time suggesting that the adherent macrophages underwent a phenotypic switch. Macrophage/FBGC-derived proinflammatory cytokines, IL-1 beta and IL-6, decreased with time, while the anti-inflammatory cytokine, IL-10, gradually increased with time. Resolution of the inflammatory response was also demonstrated by a decrease in chemoattractant IL-8 and MIP-1 beta production with time. Material-dependent macrophage/FBGC activation was analyzed using cytokine/chemokine production and cellular adhesion. Monocyte/macrophage adhesion was similar on all surfaces, except for the hydrophilic /neutral surfaces that showed a significant decrease in cellular density and minimal FBGC formation. Normalizing the ELISA data based on the adherent cell population provided cytokine/chemokine concentrations produced per cell. This analysis showed that although there were fewer cells on the hydrophilic /neutral surface, these adherent cells were further activated to produce significantly greater amounts of each cytokine/chemokine tested than the other surfaces. This study clearly presents evidence that material surface chemistry can differentially affect monocyte/ macrophage/FBGC adhesion and cytokine/chemokine profiles derived from activated macrophages/FBGCs adherent to biomaterial surfaces. (C) 2007 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Univ Hosp, Dept Pathol, Cleveland, OH 44106 USA.
   Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Jones, JA (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jaj17@case.edu
FU NIGMS NIH HHS [T32 GM007250]; NCATS NIH HHS [TL1 TR000441]; NIBIB NIH
   HHS [EB-00275]
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANDERSON JM, 1988, ASAIO, V11, P101
   Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675
   Bonder CS, 1999, IMMUNOLOGY, V96, P529
   Bonecchi R, 1998, BLOOD, V92, P2668
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   De Waal Malefyt Rene, 1993, Journal of Immunology, V151, P6370
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DONNELLY RP, 1990, J IMMUNOL, V145, P569
   FENTON MJ, 1992, J IMMUNOL, V149, P1283
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gosain A, 2005, J BURN CARE REHABIL, V26, P7, DOI 10.1097/01.BCR.0000150214.72984.44
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   Kalasinsky KS, 2005, SPECTROCHIM ACTA A, V61, P1707, DOI 10.1016/j.saa.2004.12.048
   Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407
   Kopydlowski KM, 1999, J IMMUNOL, V163, P1537
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MILLER K, 1989, J BIOMED MATER RES, V23, P1009
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   Mirzadeh H, 2002, J APPL POLYM SCI, V86, P3191, DOI 10.1002/app.10775
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   OSWALD I, 1992, P NATL ACAD SCI USA, V88, P8676
   ROLLINS BJ, 1997, CHEMOKINES BLOOD, V90, P909
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   Walduck A, 2004, CURR OPIN MICROBIOL, V7, P33, DOI 10.1016/j.mib.2003.12.010
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zhu H, 2002, CURR OPIN CELL BIOL, V14, P173, DOI 10.1016/S0955-0674(02)00315-0
NR 46
TC 137
Z9 139
U1 3
U2 43
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2007
VL 83A
IS 3
BP 585
EP 596
DI 10.1002/jbm.a.31221
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 228PT
UT WOS:000250742700002
PM 17503526
DA 2018-10-19
ER

PT J
AU Schmidt, DR
   Kao, WJ
AF Schmidt, David Richard
   Kao, Weiyuan John
TI Monocyte activation in response to polyethylene glycol hydrogels grafted
   with RGD and PHSRN separated by interpositional spacers of various
   lengths
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibronectin; IL-1 beta; TNF-alpha; GM-CSF; matrix metalloproteinase
ID PROTEIN ADSORPTION; CELL-ADHESION; POLY(ETHYLENE GLYCOL); MACROPHAGE
   ADHESION; POLYMERIC NANOPARTICLES; FIBRINOGEN ADSORPTION; SYNERGISTIC
   SITE; FBGC FORMATION; ACTIVE-SITE; IN-VITRO
AB Polyethylene glycol (PEG) is often cited as a "stealth" polymer, capable of resisting both protein adsorption and cell adhesion. By extension, PEG would then be expected to limit the host response. Monocyte-derived macrophages play an integral role in inflammation, and thus their response to a material can potentially dictate the overall host response to a biomaterial. In the present study, monocyte responses following interaction with a photopolymerized PEG hydrogel were compared with those from standard tissue culture polystyrene (TCPS). Additionally, the effect of the spacing between RGD and PHSRN, the corresponding synergy sequence on fibronectin (FN), was evaluated using peptides with differing spacer lengths grafted to the PEG hydrogel. Monocyte adherent density on the PEG-only hydrogel was comparable with that of TCPS; however, the secretion of the proinflammatory molecules interleukin-1 beta (IL-1 beta), tumor necrosis factor-a (TNF-alpha), and granulocyte-macrophage colony stimulating factor (GM-CSF) increased dramatically following monocyte interaction with PEG-only hydrogels as compared with TCPS. The matrix metalloproteinase-2 (MMP-2) concentration was similar for all surfaces, while both the matrix metalloproteinase-9 (MMP-9) and FN concentrations were above the range of the assay for all substrates. Cell density was higher on the PHSRNG(13)RGD grafted substrate as compared with PHSRNG(6)RGD, but neither sequence increased cell density versus RGD alone. Although protein concentration did sometimes vary with different peptides, this variation was minimal in comparison with the surface effects between TCPS and the PEG-only hydrogel. This study explores the roles of PEG and FN-derived peptides on monocyte activation. (C) 2007 Wiley Periodicals, Inc.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NHLBI NIH HHS [R01 HL 77825]; NIBIB NIH HHS [R01 EB6613]
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   CHEM CS, 2006, J POLYM RES, V13, P247
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hojo K, 2001, BIOORG MED CHEM LETT, V11, P1429, DOI 10.1016/S0960-894X(01)00225-6
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Hsieh MF, 2005, J CHIN INST CHEM ENG, V36, P609
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kao WJ, 2001, FRONT BIOSCI, V6, pD992, DOI 10.2741/Kao
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WJ, 2003, BIOMATERIALS, V24, P1183, DOI 10.1016/S0142-9612(02)00489-1
   Kao WUJ, 2002, J BIOMED MATER RES, V62, P478, DOI 10.1002/jbm.10317
   Kao WYJ, 2002, J CONTROL RELEASE, V78, P219, DOI 10.1016/S0168-3659(01)00503-X
   Kim TI, 2004, J PERIODONTOL, V75, P925, DOI 10.1902/jop.2004.75.7.925
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   MACNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   PALSON BO, 2004, TISSUE ENG, P252
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Susuki Y, 2002, CHEM PHARM BULL, V50, P1229, DOI 10.1248/cpb.50.1229
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Vermette P, 2003, COLLOID SURFACE B, V28, P153, DOI 10.1016/S0927-7765(02)00160-1
   Yamada KM, 2000, J CLIN INVEST, V105, P1507, DOI 10.1172/JCI10119
NR 43
TC 48
Z9 49
U1 2
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2007
VL 83A
IS 3
BP 617
EP 625
DI 10.1002/jbm.a.31270
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 228PT
UT WOS:000250742700005
PM 17503491
DA 2018-10-19
ER

PT J
AU Ernsting, MJ
   Labow, RS
   Santerre, JP
AF Ernsting, Mark J.
   Labow, Rosalind S.
   Santerre, J. Paul
TI Human monocyte adhesion onto RGD and PHSRN peptides delivered to the
   surface of a polycarbonate polyurethane using bioactive fluorinated
   surface modifiers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fluoropolymer; monocyte; RGD; peptides; cell adhesion; surface
   modification; polyurethanes
ID ENZYME-INDUCED BIODEGRADATION; MODIFYING MACROMOLECULES;
   PLATELET-ADHESION; SEGMENTED POLYURETHANES; CHOLESTEROL ESTERASE;
   CELL-ADHESION; FIBRONECTIN; DEPENDENCE; URETHANE; BINDING
AB Fluorinated oligomers, when blended into polyurethane, have been shown to migrate to the surface and generate an interface that minimizes protein denaturation and reduces cell activation. This type of surface modification can be achieved with ppm quantities of a bioactive fluorinated surface modifier (BFSM), enabling the introduction of bioactive agents onto a surface in one manufacturing step. In the current study, two BFSMs were synthesized with covalently conjugated RGD and PHSRN peptides near the fluorine terminal groups, and were shown to be surface active in polyurethane blends. CyQuant cell enumeration, scanning electron microscopy, and cell viability assays all indicated that the bioactive (and fluorinated) substrates supported enhanced monocyte interaction. The simplicity of the surface modification technique and the demonstrated ability of the peptide BFSMs to influence cell attachment and spreading indicate the potential benefits and practical value of the BFSM technology in tailoring surfaces for biomaterial applications. This was specifically highlighted for human blood monocytes, a key cell involved in the early stages of wound healing. (C) 2007 Wiley Periodicals, Inc.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
   Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM paul.santerre@dentistry.utoronto.ca
CR Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200
   Antal-Szalmas P, 2000, CYTOMETRY, V41, P279, DOI 10.1002/1097-0320(20001201)41:4<279::AID-CYTO6>3.0.CO;2-B
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   BRASH J, 1994, PROTEINS INTERFACES, V2, P1
   Chen KY, 2002, J MATER SCI-MATER M, V13, P37, DOI 10.1023/A:1013678301050
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Ernsting MJ, 2005, BIOMATERIALS, V26, P6536, DOI 10.1016/j.biomaterials.2005.04.047
   Ernsting MJ, 2003, J BIOMAT SCI-POLYM E, V14, P1411, DOI 10.1163/156856203322599743
   GRANT R, 1997, J BIOL CHEM, V265, P565
   GRIESSER H, 2001, BIOMEDICAL APPL POLY
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho JY, 2000, J BIOMAT SCI-POLYM E, V11, P1085
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Jahangir R, 2003, BIOMATERIALS, V24, P121, DOI 10.1016/S0142-9612(02)00269-7
   Kang IK, 1998, J POLYM SCI POL CHEM, V36, P2331, DOI 10.1002/(SICI)1099-0518(19980930)36:13<2331::AID-POLA20>3.3.CO;2-D
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   McCloskey CB, 2002, MACROMOLECULES, V35, P924, DOI 10.1021/ma010283v
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   ORLIARUSO M, 1991, SYNTHESIS CARBOXYLIC
   RICHES DWH, 1996, MOL CELLULAR BIOL WO, P95
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Tselepis VH, 1997, J BIOL CHEM, V272, P21341, DOI 10.1074/jbc.272.34.21341
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   Yee KO, 2000, THROMB RES, V97, P39
NR 33
TC 11
Z9 11
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2007
VL 83A
IS 3
BP 759
EP 769
DI 10.1002/jbm.a.31370
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 228PT
UT WOS:000250742700021
PM 17559113
DA 2018-10-19
ER

PT J
AU Knight, DK
   Shapka, SN
   Amsden, BG
AF Knight, Darryl K.
   Shapka, Stephen N.
   Amsden, Brian G.
TI Structure, depolymerization, and cytocompatibility evaluation of glycol
   chitosan
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glycol chitosan; depolymerization; potassium persulfate; cytotoxicity;
   NMR
ID MOLECULAR-WEIGHT MANIPULATION; N-ACETYLATED CHITOSAN; WATER-SOLUBLE
   CHITIN; CONTROLLED-RELEASE; BIOLOGICAL-PROPERTIES; NITROUS-ACID;
   IN-VITRO; DELIVERY; NANOPARTICLES; CHONDROCYTES
AB Glycol chitosan, a water soluble chitosan derivative being investigated as a new biomaterial, was fractionated via two different methods. Initial characterization of the glycol chitosan with H-1 NMR spectroscopy illustrated the presence of both secondary and tertiary amine groups, contradictory to its widely accepted structure. Fractionation of glycol chitosan with nitrous acid resulted in a significant reduction in the number average molecular weight, specifically, from 170 to similar to 7 kDa for a pH 3 and below. However, the reaction altered its chemical structure, as the secondary amine groups were converted to N-nitrosamines, which are potentially carcinogenic. An increase in the pH of the reaction limited this formation, but not entirely. Free radical degradation initiated with potassium persulfate was not as effective at reducing the molecular weight as the nitrous acid approach, yielding molecular weights around 12 kDa under the same molar ratio of degrading species, but did retain the structural integrity of the glycol chitosan. Additionally, control of the molecular weight appears feasible with potassium persulfate. When assessed in vitro for cytocompatibility, the polymer exhibited no toxicity on monolayer-cultured chondrocytes, and in fact stimulated cell growth at low concentrations. (C) 2007 Wiley Periodicals, Inc.
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM brian.amsden@chee.queensu.ca
RI Knight, Darryl/A-7949-2013; Amsden, Brian/L-6387-2013
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B
   ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   AMIJI MM, 1995, CARBOHYD POLYM, V26, P211, DOI 10.1016/0144-8617(94)00095-B
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Bae K, 2006, CLIN ORAL INVEST, V10, P102, DOI 10.1007/s00784-006-0038-3
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DIGENIS GA, 1979, BIOORG CHEM, V8, P97, DOI 10.1016/0045-2068(79)90041-5
   Duplan-Perrat F, 2000, J INVEST DERMATOL, V114, P365, DOI 10.1046/j.1523-1747.2000.00885.x
   Goycoolea FM, 2003, MACROMOL BIOSCI, V3, P612, DOI 10.1002/mabi.200300011
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsu SC, 2002, POLYM DEGRAD STABIL, V75, P73, DOI 10.1016/S0141-3910(01)00205-1
   Hu YQ, 2005, CARBOHYD POLYM, V61, P472, DOI 10.1016/j.carbpol.2005.06.022
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kubota N, 1997, POLYM J, V29, P123, DOI 10.1295/polymj.29.123
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   LEDUNG P, 1994, CARBOHYD POLYM, V24, P209, DOI 10.1016/0144-8617(94)90132-5
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lee M, 2001, PHARMACEUT RES, V18, P427, DOI 10.1023/A:1011037807261
   Liao IC, 2005, J CONTROL RELEASE, V104, P347, DOI 10.1016/j.jconrel.2005.02.013
   LIJINSKY W, 1972, J NATL CANCER I, V49, P1239
   LIJINSKY W, 1972, CANCER RES, V32, P893
   Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Mi FL, 2006, POLYMER, V47, P4348, DOI 10.1016/j.polymer.2006.04.005
   Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002
   MUZZARELLI RAA, 1987, CARBOHYD RES, V164, P433, DOI 10.1016/0008-6215(87)80146-5
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Sato M, 1996, BIOL PHARM BULL, V19, P241
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senkoylu A, 2001, J BIOACT COMPAT POL, V16, P136, DOI 10.1106/3EH5-2R73-RC4V-Y9L7
   SHECHTER L, 1956, IND ENG CHEM, V48, P94, DOI 10.1021/ie50553a029
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Sugimoto M, 1998, CARBOHYD POLYM, V36, P49, DOI 10.1016/S0144-8617(97)00235-X
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   Wang W, 2001, LANGMUIR, V17, P631, DOI 10.1021/la001078w
NR 56
TC 30
Z9 30
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2007
VL 83A
IS 3
BP 787
EP 798
DI 10.1002/jbm.a.31430
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 228PT
UT WOS:000250742700024
PM 17559127
DA 2018-10-19
ER

PT J
AU Watanabe, J
   Kashii, M
   Hirao, M
   Oka, K
   Sugamoto, K
   Yoshikawa, H
   Akashi, M
AF Watanabe, Junji
   Kashii, Masafumi
   Hirao, Makoto
   Oka, Kunihiro
   Sugamoto, Kazuomi
   Yoshikawa, Hideki
   Akashi, Mitsuru
TI Quick-forming hydroxyapatite/agarose gel composites induce bone
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE agarose gel; hydroxyapatite; injectable biomaterials; bone regeneration;
   osteoconductivity
ID ALCOHOL) HYDROGEL MATRICES; ALTERNATE SOAKING PROCESS; ON/IN
   AGAROSE-GEL; IN-VIVO; APATITE FORMATION; GRAFTING MATERIAL
AB We investigated the fundamental properties of quick-forming hydroxyapatite (HAp)/agarose gel composites, and evaluated their potential as an injectable bone substitute. From scanning electron microscope observations, the HAp/agarose gel composites produced by an innovative electrophoretic process showed an interconnecting structure with the HAp particles. The diameter of the HAp particles was roughly 1 mu m, and the total amount of HAp particles was estimated by a quantification of the calcium ions. In the case of 1 mg of dry composite, 10 mu g of HAp was formed in the agarose gel. Moreover, X-ray diffraction analysis revealed that the HAp particles had an amorphous structure, so the HAp particles were expected to dissolve under physiological conditions relative to the HAp with higher crystallinity. The advantages of the resultant HAp/agarose gel composites are ease of handling, close contact with the surrounding tissues, and ease of use as an injectable material. As a preliminary animal study, the composites were implanted into the medial femoral condyle of rabbits. After implantation, the process of bone regeneration was evaluated by microfocus-computed tomography (mu CT) and histological analysis. At 2 weeks postoperatively, newly-formed bone was observed at the edge of the bone defect site, and at 4 weeks postoperatively, excellent bone regeneration was observed. The implanted composite gradually degraded, and disappeared at 8 weeks postoperatively. This result indicated that the composite dissolved rapidly, and was replaced by newly-formed bone. Quick-forming HAp/agarose gel composites may be a good candidate as an injectable biomaterial, particularly in the fields of orthopedic, oral, and maxillofacial surgery. (c) 2007 Wiley Periodicals, Inc.
C1 Osaka Univ, Grad Sch Engn, Dept Appl Chem, Osaka 5650871, Japan.
   Osaka Univ, 21st COE Ctr Integrated Cell & Tissue Regulat, Osaka 5650871, Japan.
   Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka 5650871, Japan.
RP Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Osaka 5650871, Japan.
EM akashi@chem.eng.osaka-u.ac.jp
CR BERG HC, 1993, RANDOM WALKS BIOL
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P795, DOI 10.1163/156856299X00883
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Watanabe J, 2006, BIOMACROMOLECULES, V7, P3008, DOI 10.1021/bm060488h
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
NR 13
TC 39
Z9 41
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2007
VL 83A
IS 3
BP 845
EP 852
DI 10.1002/jbm.a.31435
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 228PT
UT WOS:000250742700031
PM 17559128
DA 2018-10-19
ER

PT J
AU Sitharaman, B
   Wilson, LJ
AF Sitharaman, Balaji
   Wilson, Lon J.
TI Gadofullerenes and gadonanotubes: A new paradigm for high-performance
   magnetic resonance imaging contrast agent probes
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Gd@C(60); gadofullerenes; single-walled carbon nanotube; US-tubes;
   gadonanotubes; molecular imaging; NMRD; contrast agents; magnetic
   resonance imaging (MRI); biomedical applications
ID WATER-SOLUBLE GADOFULLERENES; PROTON RELAXATION TIMES; WALL CARBON
   NANOTUBES; ENDOHEDRAL METALLOFULLERENES; PARAMAGNETIC SOLUTIONS;
   HIGH-RELAXIVITY; MRI; PH; NANOSCALE; TRANSLOCATION
AB In this review, the physicochemical properties and biomedical applications of Gd@C(60) (gado-fullerenes) and Gd@ Ultra-short Single-walled carbon nanotubes (gadonanotubes) are discussed, especially in regard to the unique benefits of this novel class of materials for Magnetic Resonance Imaging (MRI). The introduction of carbon nanotechnology into biomaterial science has created great opportunity for improving medical diagnostics and therapeutics. In this regard, derivatized gadofullerenes and gadonanotubes offer a new nanoscale paradigm for the design of high-performance MRI contrast agent (CA) probes with efficacies up to 100 times greater than current clinical CAs. Studies show that such CAs are well suited for both passive (magnetic labels for cells) and active (pH-sensitive probes) MRI-based molecular imaging. This capability might lead, for example, to the detection of molecular components or processes that are at the cause of disease. The various important physicochemical factors or parameters discussed in this work provide valuable insight into the development of not only other carbon nanostructure-based MRI contrast agents, but for any fullerene-based biomedical application.
C1 [Sitharaman, Balaji; Wilson, Lon J.] Rice Univ, Dept Chem, Richard E Smalley Inst Nanoscale Sci & Technol, Houston, TX 77251 USA.
   [Sitharaman, Balaji; Wilson, Lon J.] Rice Univ, Ctr Biol & Environm Nanotechnol, Houston, TX 77251 USA.
RP Wilson, LJ (reprint author), Rice Univ, Dept Chem, Richard E Smalley Inst Nanoscale Sci & Technol, MS 60, Houston, TX 77251 USA.
OI Sitharaman, Balaji/0000-0001-8391-8076
CR Anderson SA, 2006, INVEST RADIOL, V41, P332, DOI 10.1097/01.rli.0000192420.94038.9e
   BLOEMBERGEN N, 1957, J CHEM PHYS, V27, P572, DOI 10.1063/1.1743771
   BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679
   BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684
   Bolskar RD, 2003, J AM CHEM SOC, V125, P5471, DOI 10.1021/ja03400984
   Brucher E, 2002, TOP CURR CHEM, V221, P103
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Caravan P, 2002, J AM CHEM SOC, V124, P3152, DOI 10.1021/ja017168k
   CONNICK RE, 1966, J CHEM PHYS, V44, P4103, DOI 10.1063/1.1726589
   Dellago C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.105902
   Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434
   Fatouros PP, 2006, RADIOLOGY, V240, P756, DOI 10.1148/radiol.2403051341
   Gu Z, 2002, NANO LETT, V2, P1009, DOI 10.1021/nl025675+
   Hall J, 1998, NEW J CHEM, V22, P627, DOI 10.1039/a709264d
   Hartman KB, 2007, SMALL, V3, P1496, DOI 10.1002/smll.200700153
   Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kato H, 2003, J AM CHEM SOC, V125, P4391, DOI 10.1021/ja027555+
   Kissell KR, 2006, J PHYS CHEM B, V110, P17425, DOI 10.1021/jp060899s
   KOWALEWSKI J, 1996, ENCY NUCL MAGNETIC R, P3456
   Krause W, 2002, TOPICS CURRENT CHEM, V221
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LAUS S, 2005, UNPUB J AM CHEM SOC
   Laus S, 2007, J PHYS CHEM C, V111, P5633, DOI 10.1021/jp070458o
   Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j
   Mackeyev YA, 2005, J PHYS CHEM B, V109, P5482, DOI 10.1021/jp0456436
   Mann DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195503
   Mansfield P, 2004, ANGEW CHEM INT EDIT, V43, P5456, DOI 10.1002/anie.200460078
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Mashl RJ, 2003, NANO LETT, V3, P589, DOI 10.1021/nl0340226
   May P.M., 1977, J CHEM SOC DA, V6, P588
   McDermott R, 2004, P NATL ACAD SCI USA, V101, P7857, DOI 10.1073/pnas.0402382101
   McDevitt MR, 2007, J NUCL MED, V48, P1180, DOI 10.2967/jnumed.106.039131
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   MICSKEI K, 1993, INORG CHEM, V32, P3844, DOI 10.1021/ic00070a013
   Mikawa M, 2000, J BIOMED MATER RES, V49, P390, DOI 10.1002/(SICI)1097-4636(20000305)49:3<390::AID-JBM12>3.0.CO;2-Q
   Mikawa M, 2001, BIOCONJUGATE CHEM, V12, P510, DOI 10.1021/bc000136m
   Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785
   Noon WH, 2002, CHEM PHYS LETT, V355, P445, DOI 10.1016/S0009-2614(02)00209-9
   Nunn A D, 1997, Q J Nucl Med, V41, P155
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Porter AE, 2006, ACTA BIOMATER, V2, P409, DOI 10.1016/j.actbio.2006.02.006
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Shinohara H, 2000, REP PROG PHYS, V63, P843, DOI 10.1088/0034-4885/63/6/201
   Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a
   Sitharaman B, 2004, NANO LETT, V4, P2373, DOI 10.1021/nl0485713
   Sitharaman B, 2007, CONTRAST MEDIA MOL I, V2, P139, DOI 10.1002/cmmi.140
   Sithararnan B, 2006, INT J NANOMED, V1, P291
   SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559
   SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867
   Stevenson S, 1999, NATURE, V401, P55
   Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9
   Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280
   Tagmatarchis N., 2001, Mini-Reviews in Medicinal Chemistry, V1, P339, DOI 10.2174/1389557013406693
   TANNOCK IF, 1989, CANCER RES, V49, P4373
   Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h
   WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8
   Wilson L. J., 1999, Electrochemical Society Interface, V8, P24
   Zhu FQ, 2003, BIOPHYS J, V85, P236, DOI 10.1016/S0006-3495(03)74469-5
NR 59
TC 54
Z9 54
U1 1
U2 30
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD DEC
PY 2007
VL 3
IS 4
BP 342
EP 352
DI 10.1166/jbn2007.043
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 251WF
UT WOS:000252406100004
DA 2018-10-19
ER

PT J
AU Sullivan, SR
   Underwood, RA
   Sigle, RO
   Fukano, Y
   Muffley, LA
   Usui, ML
   Gibran, NS
   Antezana, MA
   Carter, WG
   Olerud, JE
AF Sullivan, Stephen R.
   Underwood, Robert A.
   Sigle, Randall O.
   Fukano, Yuko
   Muffley, Lara A.
   Usui, Marcia L.
   Gibran, Nicole S.
   Antezana, Marcos A.
   Carter, William G.
   Olerud, John E.
TI Topical application of laminin-332 to diabetic mouse wounds
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Article
DE laminin; laminin-332; laminin 5; db/db; mouse; wound heating;
   keratinocyte; diabetes mellitus; diabetic
ID ALPHA-3-BETA-1 INTEGRIN; KERATINOCYTE MIGRATION; OBESITY SYNDROMES;
   EPITHELIAL-CELLS; ADHESION; MICE; DEPOSITION; ALPHA-6-BETA-4; SKIN;
   DIFFERENTIATION
AB Background: Keratinocyte migration is essential for wound heating and diabetic wound keratinocytes migrate poorly. Keratinocyte migration and anchorage appears to be mediated by laminin-332 (LM-332). Impaired diabetic wound heating may be due to defective LM-332 mediated keratinocyte migration.
   Objective: To evaluate LM-332 expression in diabetic (db/db) and control (db/-) mice and to test LM-332 wound heating effects when applied to mouse wounds.
   Methods: LM-332 expression in mouse wounds was evaluated using immunohistochemistry. LM-332 wound heating effects were evaluated by directly applying soluble LM-332, a LM-332 biomaterial, or a control to mouse wounds. Percent wound closure and histology score, based on heating extent, were measured.
   Results: Precursor LM-332 expression was markedly reduced in db/db when compared to db/- mice. In vitro, soluble LM-332 and LM-332 biomaterial demonstrated significant keratinocyte adhesion. In vivo, soluble LM-332 treated wounds had the highest histology score, but significant differences were not found between wound treatments (p > 0.05). No differences in percentage wound closure between treatment and control wounds were found (p > 0.05).
   Conclusion: The db/db wounds express less precursor LM-332 when compared to db/-. However, LM-332 application did not improve db/db wound heating. LM-332 purified from keratinocytes was primarily physiologically cleaved LM-332 and may not regulate keratinocyte migration. Application of precursor LM-332 rather than cleaved LM-332 may be necessary to improve wound heating, but this isoform is not currently available in quantities sufficient for testing. (c) 2007 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA.
   Univ Washington, Dept Surg Plast & Reconstruct Surg, Seattle, WA 98195 USA.
   Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA.
   Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
RP Olerud, JE (reprint author), Univ Washington, Dept Med Dermatol, 1959 NE Pacific St,Box 356524, Seattle, WA 98195 USA.
EM oterudje@u.washington.edu
RI Sullivan, Stephen/C-6389-2013
FU NIGMS NIH HHS [R01 GM56483, R01 GM056483]; NIAID NIH HHS [R01 AI043006];
   NIAMS NIH HHS [R01 AR43006]; NIDDK NIH HHS [R01 DK059221-05, R01
   DK58007, R01 DK058007]
CR American Diabetes Association, 1999, DIABETES CARE, V22, P1354, DOI DOI 10.2337/DIACARE.22.8.1354
   Andriessen MPN, 1995, ACTA DERM-VENEREOL, V75, P459
   Antezana MA, 2002, J INVEST DERMATOL, V119, P1400, DOI 10.1046/j.1523-1747.2002.19618.x
   Baker SE, 1996, J CELL SCI, V109, P2509
   BOYCE ST, 1983, J INVEST DERMATOL S, V81, P33
   BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8
   CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D
   CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141
   COLEMAN DL, 1982, DIABETES, V31, P1
   COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772
   Crowe MJ, 1999, J BURN CARE REHABIL, V20, P155, DOI 10.1097/00004630-199903000-00032
   DEBRAYSACHS M, 1983, DIABETES, V32, P1048, DOI 10.2337/diabetes.32.11.1048
   Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003
   Fujita M, 1999, J INVEST DERMATOL, V112, P626
   Gil SG, 2002, METHOD CELL BIOL, V69, P27, DOI 10.1016/S0091-679X(02)69006-5
   GIL SG, 1994, J INVEST DERMATOL, V103, P31
   Goldfinger LE, 1999, J CELL SCI, V112, P2615
   Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255
   GREENHALGH DG, 1990, AM J PATHOL, V136, P1235
   Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465
   MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695
   Martson M, 1999, WOUND REPAIR REGEN, V7, P119, DOI 10.1046/j.1524-475X.1999.00119.x
   MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496
   MORDES JP, 1981, AM J MED, V70, P353, DOI 10.1016/0002-9343(81)90772-5
   Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200
   Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200
   Olerud J. E., 2000, Journal of Investigative Dermatology, V114, P857
   OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586
   PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513
   Reiber GE, 1996, DIABETIC MED, V13, pS6, DOI 10.1002/dme.1996.13.s1.6
   Ring BD, 2000, ENDOCRINOLOGY, V141, P446, DOI 10.1210/en.141.1.446
   ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6
   Shang ML, 2001, J BIOL CHEM, V276, P33045, DOI 10.1074/jbc.M100798200
   Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310
   Spenny ML, 2002, WOUND REPAIR REGEN, V10, P295, DOI 10.1046/j.1524-475X.2002.10504.x
   STENN KS, 1988, MOL CELLULAR BIOL WO, P321
   Sullivan KE, 2004, CLIN IMMUNOL, V113, P3, DOI 10.1016/j.clim.2004.04.004
   Tanaka M, 1996, CLIN EXP DERMATOL, V21, P23, DOI 10.1111/j.1365-2230.1996.tb00006.x
   Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P673
   VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
   Woodley DT, 2005, J INVEST DERMATOL, V124, P958, DOI 10.1111/j.0022-202X.2005.23702.x
   Xia YP, 1996, J CELL BIOL, V132, P727, DOI 10.1083/jcb.132.4.727
   Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51
   Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280
NR 47
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0923-1811
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD DEC
PY 2007
VL 48
IS 3
BP 177
EP 188
DI 10.1016/j.jdermsci.2007.07.002
PG 12
WC Dermatology
SC Dermatology
GA 235WV
UT WOS:000251265900003
PM 17719208
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Salengke, S
   Sastry, SK
AF Salengke, S.
   Sastry, S. K.
TI Models for ohmic heating of solid-liquid mixtures under worst-case
   heating scenarios
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE ohmic heating; solid liquid mixtures; multiphase heat transfer;
   continuous sterilization
ID LOW-ACID FOOD; SAFETY CONSIDERATIONS; PARTICULATE FOODS; CONDUCTIVITY;
   GENERATION; VALIDATION; SIMULATION; PRODUCTS; SYSTEM
AB Sterilization of solid-liquid mixtures by ohmic heating requires the assurance that all parts of the food or biomaterial in question is treated adequately to ensure inactivation of pathogenic sporeforniers. Previous work has identified worst-case scenarios as being associated with a single solid piece (inclusion particle) of substantially different electrical conductivity than its surroundings. Two potentially hazardous situations were modeled, both involving an inclusion particle, but one involving a static medium surrounding the solid; and the other involving a mixed fluid, with a circuit theory analysis for the electric field. Results indicate that the mixed fluid model provides a more conservative prediction of mixture cold-spot temperatures than the static model when the cold-spot occurs within the particle; typically occurring when the medium is more conductive than the solid. However, the static fluid model provides more conservative prediction of the mixture cold-spot temperatures when the cold-spot is within the fluid; typically when the solid is more conductive than the medium. Our results underline the need to evaluate both scenarios in evaluating the potential for an underprocessed region. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Ohio State Univ, Dept Food Agr & Biol Engn, Columbus, OH 43210 USA.
RP Sastry, SK (reprint author), Ohio State Univ, Dept Food Agr & Biol Engn, 590 Woody Hayes Dr, Columbus, OH 43210 USA.
EM Sastry.2@osu.edu
OI Salengke, Salengke/0000-0001-7777-2971
CR BERNARD DT, 1990, FOOD TECHNOL-CHICAGO, V44, P119
   Davies LJ, 1999, J FOOD ENG, V40, P245, DOI 10.1016/S0260-8774(99)00061-8
   DEALWIS AAP, 1989, CHEM ENG RES DES, V67, P159
   DEALWIS AAP, 1992, ADVANCES IN ASEPTIC PROCESSING TECHNOLOGIES, P103
   DEALWIS AAP, 1990, CHEM ENG SCI, V45, P1547, DOI 10.1016/0009-2509(90)80006-Z
   DIGNAN DM, 1989, FOOD TECHNOL-CHICAGO, V43, P118
   FRYER PJ, 1993, J FOOD ENG, V18, P101, DOI 10.1016/0260-8774(93)90031-E
   Khalaf WG, 1996, J FOOD ENG, V27, P145, DOI 10.1016/0260-8774(94)00090-5
   Kim HJ, 1996, J FOOD PROCESS PRES, V20, P41, DOI 10.1111/j.1745-4549.1996.tb00339.x
   Kim HJ, 1996, FOOD TECHNOL-CHICAGO, V50, P253
   Larkin JW, 1996, FOOD TECHNOL-CHICAGO, V50, P242
   Murakami E. G., 1997, C FOOD ENG COFE 97 L
   Orangi S, 1998, INT J HEAT MASS TRAN, V41, P2211, DOI 10.1016/S0017-9310(97)00291-3
   Palaniappan S., 1991, Journal of Food Process Engineering, V14, P221, DOI 10.1111/j.1745-4530.1991.tb00093.x
   PFLUG IJ, 1990, J FOOD PROTECT, V53, P312, DOI 10.4315/0362-028X-53.4.312
   Salengke S, 2007, J FOOD ENG, V83, P324, DOI 10.1016/j.jfoodeng.2007.02.060
   Salengke S, 2000, THESIS OHIO STATE U
   Sastry S. K., 1995, 9 WORLD C FOOD SCI T
   Sastry SK, 1996, FOOD TECHNOL-CHICAGO, V50, P246
   Sastry SK, 1998, J FOOD PROCESS ENG, V21, P441, DOI 10.1111/j.1745-4530.1998.tb00463.x
   Sastry SK, 1992, J FOOD PROCESS ENG, V15, P241, DOI 10.1111/j.1745-4530.1992.tb00155.x
   Sastry SK, 1992, J FOOD PROCESS ENG, V15, P263, DOI 10.1111/j.1745-4530.1992.tb00156.x
   Sastry SK, 1992, J FOOD PROCESS ENG, V15, P213, DOI 10.1111/j.1745-4530.1992.tb00153.x
   SEGNER WP, 1989, J FOOD PROCESS PRES, V13, P257, DOI 10.1111/j.1745-4549.1989.tb00105.x
   Ye XF, 2004, LEBENSM-WISS TECHNOL, V37, P49, DOI 10.1016/S0023-6438(03)00133-6
   Ye XF, 2003, J FOOD ENG, V59, P143, DOI 10.1016/S0260-8774(02)00450-8
   ZHANG L, 1993, CHEM ENG SCI, V48, P633, DOI 10.1016/0009-2509(93)80132-A
   Zitoun KB, 2001, INT J MULTIPHAS FLOW, V27, P1397, DOI 10.1016/S0301-9322(01)00011-8
   ZURITZ CA, 1989, T ASAE, V32, P711
NR 29
TC 23
Z9 25
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
J9 J FOOD ENG
JI J. Food Eng.
PD DEC
PY 2007
VL 83
IS 3
BP 337
EP 355
DI 10.1016/j.jfoodeng.2007.02.026
PG 19
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 198RH
UT WOS:000248644700003
DA 2018-10-19
ER

PT J
AU Hu, XL
   Chen, XS
   Xie, ZG
   Liu, S
   Jing, XB
AF Hu, Xiuli
   Chen, Xuesi
   Xie, Zhigang
   Liu, Shi
   Jing, Xiabin
TI Synthesis and characterization of amphiphilic block copolymers with
   allyl side-groups
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE allyl; amphiphilic; polycarbonates; polyesters; ring-opening
   polymerization
ID RING-OPENING POLYMERIZATION; DRUG-DELIVERY; EPSILON-CAPROLACTONE;
   POLY(ETHYLENE GLYCOL); CHEMICAL-MODIFICATION; ALIPHATIC POLYESTERS;
   REACTIVE MICELLES; ACID); CARBONATE; SURFACES
AB The synthesis of a new cyclic carbonate monomer containing an allyl group was reported and its biodegradable amphiphilic block copolymer, poly(ethylene glycol)-block-poly(L-lactide-co-5-methyl-5-allyloxycarbonyl-propylene carbonate) [PEG-b-P(LA-co-MAC)] was synthesized by ring-opening polymerization (ROP) of L-lactide (LA) and 5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one (MAC) in the presence of poly (ethylene glycol) as a macroinitiator, with diethyl zinc as a catalyst. C-13 NMR and H-1 NMR were used for microstructure identification of the copolymers. The copolymer could form micelles in aqueous solution. The core of the micelles is built of the hydrophobic P(LA-co-MAC) chains, whereas the shell is set up by the hydrophilic PEG blocks. The micelles exhibited a homogeneous spherical morphology and unimodal size distribution. By using the cyclic carbonate monomer containing allyl side-groups, crosslinking of the PEG-b-P(LA-co-MAC) inner core was possible. The adhesion and spreading of ECV-304 cells on the copolymer were better than that on PLA films. Therefore, this biodegradable amphiphilic block copolymer is expected to be used as a biomaterial for drug delivery and tissue engineering. (c) 2007 Wiley Periodicals, Inc.
C1 [Hu, Xiuli; Chen, Xuesi; Xie, Zhigang; Liu, Shi; Jing, Xiabin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Hu, Xiuli; Xie, Zhigang] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Jing, XB (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM xbjing@ciac.jl.cn
OI Xie, Zhigang/0000-0003-2974-1825
CR ALFONSO R, 2006, J POLYM SCI A, V44, P993
   Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Arimura H, 2005, BIOMACROMOLECULES, V6, P720, DOI 10.1021/bm0494491
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Cheng SX, 2003, MACROMOL RAPID COMM, V24, P1066, DOI 10.1002/marc.200300085
   Consantin M, 1999, MACROMOL RAPID COMM, V20, P91, DOI 10.1002/(SICI)1521-3927(19990201)20:2<91::AID-MARC91>3.0.CO;2-E
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Detrembleur C, 2000, MACROMOLECULES, V33, P7751, DOI 10.1021/ma000488o
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Emoto K, 2000, J AM CHEM SOC, V122, P2653, DOI 10.1021/ja993821g
   Emoto K, 1999, LANGMUIR, V15, P5212, DOI 10.1021/la980918s
   GELBIN ME, 1992, J AM CHEM SOC, V114, P3962, DOI 10.1021/ja00036a051
   Guan HL, 2005, J POLYM SCI POL CHEM, V43, P4771, DOI 10.1002/pola.20942
   Guan HL, 2005, POLYMER, V46, P2817, DOI 10.1016/j.polymer.2005.01.072
   Hany R, 2004, BIOMACROMOLECULES, V5, P1452, DOI 10.1021/bm049962e
   Hany R, 2004, MACROMOLECULES, V37, P385, DOI 10.1021/ma0304426
   HOON H, 2006, J POLYM SCI A, V44, P4235
   Hruby M, 2005, J CONTROL RELEASE, V103, P137, DOI 10.1016/j.jconrel.2004.11.017
   Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962
   JAMIE M, 2006, J POLYM SCI A, V44, P6817
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083
   Kratz F, 2000, J MED CHEM, V43, P1253, DOI 10.1021/jm9905864
   KUMURA Y, 1998, MACROMOLECULES, V21, P3338
   Kurth N, 2002, POLYMER, V43, P1095, DOI 10.1016/S0032-3861(01)00692-9
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Lee H, 2005, BIOMACROMOLECULES, V6, P3119, DOI 10.1021/bm050451h
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Lee MY, 2000, MACROMOL CHEM PHYSIC, V201, P2771, DOI 10.1002/1521-3935(20001201)201:18<2771::AID-MACP2771>3.3.CO;2-M
   Lee MY, 2000, POLYMER, V41, P1703, DOI 10.1016/S0032-3861(99)00347-X
   Lee RS, 2004, J POLYM SCI POL CHEM, V42, P2303, DOI 10.1002/pola.20052
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Li SM, 2002, BIOMACROMOLECULES, V3, P525, DOI 10.1021/bm010168s
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Ouchi T, 2004, J POLYM SCI POL CHEM, V42, P453, DOI 10.1002/pola.10848
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1426, DOI 10.1002/pola.10226
   PIOTR D, 2006, J POLYM SCI A, V44, P9
   PIOTR D, 2006, J POLYM SCI A, V44, P3184
   Rieger J, 2005, CHEM COMMUN, P274, DOI 10.1039/b411565a
   Sanda F, 2001, MACROMOLECULES, V34, P1564, DOI 10.1021/ma0013307
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   TOSHIFUMI S, 2006, J POLYM SCI A, V44, P406
   Wan T, 2006, J POLYM SCI POL CHEM, V44, P6688, DOI 10.1002/pola.21793
   Wang H, 1998, J POLYM SCI POL CHEM, V36, P695, DOI 10.1002/(SICI)1099-0518(19980415)36:5<695::AID-POLA3>3.0.CO;2-L
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Xiong XY, 2004, MACROMOLECULES, V37, P3425, DOI 10.1021/ma049662p
   ZHOU QX, 1990, MACROMOLECULES, V23, P3399, DOI 10.1021/ma00216a002
NR 51
TC 47
Z9 49
U1 1
U2 53
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
EI 1099-0518
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD DEC 1
PY 2007
VL 45
IS 23
BP 5518
EP 5528
DI 10.1002/pola.22297
PG 11
WC Polymer Science
SC Polymer Science
GA 241BE
UT WOS:000251631100015
DA 2018-10-19
ER

PT J
AU Barradas, S
   Guipont, V
   Molins, R
   Jeandin, M
   Arrigoni, M
   Boustie, M
   Bolis, C
   Berthe, L
   Ducos, M
AF Barradas, S.
   Guipont, V.
   Molins, R.
   Jeandin, M.
   Arrigoni, M.
   Boustie, M.
   Bolis, C.
   Berthe, L.
   Ducos, M.
TI Laser shock flier impact simulation of particle-substrate interactions
   in cold spray
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE adhesion of TS coatings; coatings for gas turbine components; cold gas
   dynamic spraying; friction and wear; hydroxyapatite biomaterial; laser
   deposited materials; laser surface treatment; plasma spray forming;
   porosity of coatings; spray deposition
ID SELF-DIFFUSION; LIQUID-METALS; ALUMINUM; COPPER; DEPOSITION; VISCOSITY;
   MECHANISM; COATINGS; ADHESION
AB Coating-substrate adhesion in cold spray is a paramount property, the mechanisms of which are not yet well elucidated. To go into these mechanisms, due to the intrinsic characteristics of the cold spray process (particle low-temperature and high velocity) direct observation and control of inflight particles and related phenomena cannot be done easily. For this reason, an experimental simulation of the particle-substrate reactions at the particle impingement was developed. This simulation is based on original flier impact experiments from laser shock acceleration. Relevant interaction phenomena were featured and studied as a function of shearing, plastic deformation, phase transformation primarily. These phenomena were shown to he similar to those involved in cold spray. This was ascertained by the study of the Cu-Al metallurgically reactive system using SEM, TEM, EPMA, and energy balance and diffusion calculations. This simulation could also be used to feed finite element modeling of cold spray and laser shock flier impact.
C1 [Barradas, S.; Guipont, V.; Jeandin, M.] Mines Paris ParisTech, Competence Ctr Spray Proc C2P, CNRS 7633, Ctr Mat, Evry, France.
   [Arrigoni, M.; Boustie, M.] ENSMA, LCD, CNRS, UPR 9028, Futuroscope, France.
   [Bolis, C.; Berthe, L.] CNRS, LALP, UPR 1578, Arcueil, France.
RP Barradas, S (reprint author), Mines Paris ParisTech, Competence Ctr Spray Proc C2P, CNRS 7633, Ctr Mat, Evry, France.
EM michel.jeandin@ensmp.fr
RI berthe, laurent/E-6573-2010
OI BERTHE, Laurent/0000-0002-9978-9843
CR ADDA Y, 1966, DIFFUSION SOLIDES, V2
   Akbari-Mousavi AA, 2005, INT J IMPACT ENG, V31, P719
   Assadi H, 2003, ACTA MATER, V51, P4379, DOI 10.1016/S1359-6465(03)00274-X
   Barradas S, 2005, SURF COAT TECH, V197, P18, DOI 10.1016/j.surfcoat.2004.08.222
   BARRADAS S, 2002, INT THERM SPRAY C IT, P592
   BLAZYNSKI TZ, 1989, EXPLOSIVE WELDING FO, P189
   Bolis C, 2004, AIP CONF PROC, V706, P1373
   BOUSTIE M, 2006, SURFACE MODIDICATION, P271
   Brandes E. A., 1992, SMITHELLS METALS REF
   CALVO FA, 1988, J MATER SCI, V23, P2273, DOI 10.1007/BF01115800
   Chauhan AS, 2000, CHEM PHYS, V252, P227, DOI 10.1016/S0301-0104(99)00345-6
   DUBRUJEAUD B, 1994, J MATER SCI LETT, V13, P773, DOI 10.1007/BF00271317
   DUCOS M, 2004, THERMAL SPRAY 2004 A
   Dykhuizen RC, 1999, J THERM SPRAY TECHN, V8, P559, DOI 10.1361/105996399770350250
   FUKANUMA H, 2004, THERMAL SPRAY 2004 A
   GARTNER F, 2006, SURFACE MODIFICATION, P35
   Grujicic M, 2004, MATER DESIGN, V25, P681, DOI 10.1016/j.matdes.2004.03.008
   Grujicic M, 2003, APPL SURF SCI, V219, P211, DOI 10.1016/S0169-4332(03)00643-3
   HUTCHINGS IM, 1981, WEAR, V70, P269, DOI 10.1016/0043-1648(81)90347-1
   Jayaram C, 2001, CHEM PHYS LETT, V341, P179, DOI 10.1016/S0009-2614(01)00427-4
   Johnson G.R., 1983, 7TH P INT S BALL HAG, P541
   Klinkov SV, 2005, AEROSP SCI TECHNOL, V9, P582, DOI 10.1016/j.ast.2005.03.005
   KREYE H, 2006, ITSC 2006 BUILDING 1
   LI CJ, 2004, THERMAL SPRAY 2004 A
   McCure RC, 1995, ADVANCES IN THERMAL SPRAY SCIENCE AND TECHNOLOGY, P1
   Schmidt T, 2006, ACTA MATER, V54, P729, DOI 10.1016/j.actamat.2005.10.005
   SCHMIDT T, 2003, ADV SCI APPL TECHNOL, P9
   SCHMIDT T, 2004, COLD SPRAY 2004 EMER
   Sobolev VV, 1997, INT MATER REV, V42, P117, DOI 10.1179/imr.1997.42.3.117
   Stoltenhoff T, 2002, J THERM SPRAY TECHN, V11, P542, DOI 10.1361/105996302770348682
   TYRRELL HJV, 1981, SCI PROG, V67, P271
   Van Steenkiste TH, 1999, SURF COAT TECH, V111, P62, DOI 10.1016/S0257-8972(98)00709-9
NR 32
TC 22
Z9 22
U1 3
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD DEC
PY 2007
VL 16
IS 4
BP 548
EP 556
DI 10.1007/s11666-007-9069-9
PG 9
WC Materials Science, Coatings & Films
SC Materials Science
GA 241HS
UT WOS:000251648100011
DA 2018-10-19
ER

PT J
AU Ye, FX
   Ohmori, A
   Tsumura, T
   Nakata, K
   Li, CJ
AF Ye, F. -X.
   Ohmori, A.
   Tsumura, T.
   Nakata, K.
   Li, C. -J.
TI Microstructural analysis and photocatalytic activity of plasma-sprayed
   titania-hydroxyapatite coatings
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Thermal Spray Conference (ITSC 2007)
CY MAY 14-16, 2007
CL Beijing, PEOPLES R CHINA
SP ASM Thermal Spray Soc, German Welding Soc, Int Inst Welding
DE hydroxyapatite; photocatalyst; plasma spray; TiO2
ID AIR PURIFICATION; POWDER; WATER; PHOSPHATE
AB Hydroxyapatite (HAp Ca-10(PO4)(6)(OH)(2)) is known to be a biomaterial and an adsorbent for chromatography. In this study, HAp was agglomerated with anatase TiO2 to manufacture thermal-spray powders to improve the adsorption activity of TiO2, and then to improve its photocatalytic activity. The microstructures, compositions and photocatalytic activity of plasma-sprayed TiO2, TiO2-10%HAp, TiO2-30% HAp, and HAp coatings were investigated. Due to the low thermal conductivity of HAp compound, not all HAp particles fully melted even under the arc current of 800 A. The addition of HAp inhibited the phase transformation of anatase TiO2 to rutile. Under the arc current of 600 A, the anatase content in the TiO2, TiO2-10%HAp and TiO2-30%HAp coatings was 11, 20 and 42%, respectively. With the increasing of the spraying distance from 70 to 110 mm, the anatase content in the TiO2-30%HAp coatings decreased from 34 to 17% under arc current of 700 A. Furthermore, a slight decomposition of HAp to alpha-Ca-3(PO4)(2) was found in the TiO2-30%HAp coatings, it did not decompose to CaO and P2O5 according to the XRD and EDAX analysis. The addition of the secondary gas of helium had no significant influence on the melting state of the TiO2-HAp feedstock powders. Moreover, the HAp in the TiO2-10%HAp and TiO2-30%HAp coatings had adsorption characteristic to acetaldehyde. The photocatalytic activity of TiO2-10%HAp coating was highest among TiO2, TiO2-10%HAp, and TiO2-30%HAp coatings sprayed under the arc current of 600 A for the optimum adsorption property and anatase content.
C1 [Ye, F. -X.] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   [Ohmori, A.] TOCALO Co Ltd, Akashi, Hyogo, Japan.
   [Tsumura, T.; Nakata, K.] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan.
   [Li, C. -J.] Xian Jiaotong Univ, Sch Mat Sci & Engn, Welding Res Inst, Xian, Shaanxi, Peoples R China.
RP Ye, FX (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Weijin Rd 92, Tianjin 300072, Peoples R China.
EM yefx@tju.edu.cn
OI Li, Chang-Jiu/0000-0001-9814-064X
CR Cheang P, 1996, J THERM SPRAY TECHN, V5, P310, DOI 10.1007/BF02645883
   Choi D, 2007, MAT SCI ENG C-BIO S, V27, P377, DOI 10.1016/j.msec.2006.05.035
   Dyshlovenko S, 2004, SURF COAT TECH, V179, P110, DOI 10.1016/S0257-8972(03)00799-0
   Fernandez-Ibanez P, 1999, CATAL TODAY, V54, P329, DOI 10.1016/S0920-5861(99)00194-7
   Fujishima A., 1972, NATURE, V238, P5358
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   Herrmann JM, 1999, CATAL TODAY, V53, P115, DOI 10.1016/S0920-5861(99)00107-8
   Khor KA, 1997, J THERM SPRAY TECHN, V6, P109, DOI 10.1007/BF02646320
   Malato S, 2002, APPL CATAL B-ENVIRON, V37, P1, DOI 10.1016/S0926-3373(01)00315-0
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   Nakajima A, 2006, J PHOTOCH PHOTOBIO A, V177, P94, DOI 10.1016/j.jphotochem.2005.05.019
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   OHMORI A, 2002, INT THERM SPRAY C, P165
   Pirkanniemi K, 2002, CHEMOSPHERE, V48, P1047, DOI 10.1016/S0045-6535(02)00168-6
   Ryu HS, 2002, BIOMATERIALS, V23, P909, DOI 10.1016/S0142-9612(01)00201-0
   SPURR RA, 1957, ANAL CHEM, V29, P760, DOI 10.1021/ac60125a006
   TRIBUTSCH H, 1995, J ELECTROANAL CHEM, V396, P53, DOI 10.1016/0022-0728(95)04057-U
   Wang Y, 1998, J THERM SPRAY TECHN, V7, P50, DOI 10.1007/s11666-006-5003-9
   Ye FX, 2004, SURF COAT TECH, V184, P233, DOI 10.1016/j.surfcoat.2003.11.012
   Ye FX, 2002, SURF COAT TECH, V160, P62, DOI 10.1016/S0257-8972(02)00377-8
   Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3
NR 22
TC 18
Z9 18
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD DEC
PY 2007
VL 16
IS 5-6
BP 776
EP 782
DI 10.1007/s11666-007-9126-4
PG 7
WC Materials Science, Coatings & Films
SC Materials Science
GA 246XN
UT WOS:000252041800024
DA 2018-10-19
ER

PT J
AU Yamamoto, H
   Almeras, T
AF Yamamoto, Hiroyuki
   Almeras, Tancred
TI A mathematical verification of the reinforced-matrix hypothesis using
   the Mori-Tanaka theory
SO JOURNAL OF WOOD SCIENCE
LA English
DT Article
DE wood cell wall; composite material; micromechanics; inhomogeneities;
   biomaterial
ID MOISTURE-CONTENT; GROWTH STRESSES; CELL-WALLS; WOOD; MATURATION;
   GENERATION; MICROFIBRIL; SHRINKAGE; BEHAVIOR; MODEL
AB This article presents a theoretical verification of the reinforced-matrix hypothesis derived from tensor equations, sigma(W) = sigma(f) + sigma(m) and epsilon(W) = epsilon(f) = epsilon(m) ( Wood Sci Technol 32:171-182, 1998; Wood Sci Technol 33:311-325, 1999; J Biomech Eng 124:432-440, 2002), using classical Mori-Tanaka theory on the micromechanics of fiber-reinforced materials ( Acta Metall 21:571-574, 1973; Micromechanics-dislcation and inclusions ( in Japanese), pp 141-147, 1976). The Mori-Tanaka theory was applied to a small fragment of the cell wall undergoing changes in its physical state, such as those arising from sorption of moisture, maturation of wall components, or action of an external force, to obtain <sigma(A)>(D) = phi.<sigma (F)>(I) + (1 - phi) .<sigma(M)>(D-I). When the constitutive equation of each constituent material was applied to the equation <sigma(A)>(D) = phi.<sigma(F)>(I) + (1 - phi).<sigma(M)>(D-I), the equations sigma(W) = sigma(f) + sigma(m) and epsilon(W) = epsilon(f) = epsilon(m) were derived to lend support to the concept that two main phases, the reinforcing cellulose microfibril and the lignin - hemicellulose matrix, coexist in the same domain. The constitutive equations for the cell wall fragment were obtained without recourse to additional parameters such as Eshelby's tensor S and Hill's averaged concentration tensors A(F) and A(M). In our previous articles, the coexistence of two main phases and sigma(W) = sigma(f) + sigma(m) and epsilon(W) = epsilon(f) = epsilon(m) had been taken as our starting point to formulate the behavior of wood fiber with multilayered cell walls. The present article provides a rational explanation for both concepts.
C1 [Yamamoto, Hiroyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.
   [Almeras, Tancred] ENGREF, CIRAD, CNRS,INRA,Unite Mixte Rech Ecol Forets Guyane, Kourou 97387, French Guiana.
RP Yamamoto, H (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.
EM hiro@agr.nagoya-u.ac.jp
CR Almeras T, 2005, HOLZFORSCHUNG, V59, P347, DOI 10.1515/HF.2005.057
   Barber N. F., 1964, Holzforschung, V18, P146, DOI 10.1515/hfsg.1964.18.5.146
   CAVE ID, 1972, WOOD SCI TECHNOL, V6, P157, DOI 10.1007/BF00350828
   CAVE ID, 1972, WOOD SCI TECHNOL, V6, P284, DOI 10.1007/BF00357050
   CAVE ID, 1978, WOOD SCI TECHNOL, V12, P75, DOI 10.1007/BF00390012
   Clair B, 2006, BIOPHYS J, V91, P1128, DOI 10.1529/biophysj.105.078485
   ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173
   ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Kojima Y, 2005, J WOOD SCI, V51, P462, DOI 10.1007/s10086-004-0676-5
   MEYLAN BA, 1972, WOOD SCI TECHNOL, V6, P293, DOI 10.1007/BF00357051
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   MURA T, 1976, MICROMECHANICS DISLO, P141
   PAGE DH, 1977, TAPPI, V60, P114
   SALMEN L, 1985, WOOD FIBER SCI, V17, P336
   Yamamoto H, 1998, WOOD SCI TECHNOL, V32, P171
   YAMAMOTO H, 1988, MOKUZAI GAKKAISHI, V34, P788
   Yamamoto H, 2002, J BIOMECH ENG-T ASME, V124, P432, DOI 10.1115/1.1485751
   Yamamoto H, 1999, WOOD SCI TECHNOL, V33, P311, DOI 10.1007/s002260050118
NR 19
TC 4
Z9 4
U1 0
U2 11
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 1435-0211
J9 J WOOD SCI
JI J. Wood Sci.
PD DEC
PY 2007
VL 53
IS 6
BP 505
EP 509
DI 10.1007/s10086-007-0897-5
PG 5
WC Forestry; Materials Science, Paper & Wood
SC Forestry; Materials Science
GA 264JT
UT WOS:000253284300007
DA 2018-10-19
ER

PT J
AU Chen, L
   Yan, YH
   Li, JH
   Li, SP
AF Chen Lei
   Yan Yuhua
   Li Jianhua
   Li Shipu
TI Preparation and degradation characteristics of poly (d, l-lactide)
   composite films
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE poly (d l-lactic acid) (PDLLA); chitosan (CHI); beta-TCP; nerve growth
   factor (NGF); degradation characteristics
ID HYDROLYTIC DEGRADATION
AB PDLLA/CHI/beta-TCP/NGF composite films were prepared by a solvent evaporation method. The degradation characteristics of the poly (d, l-lactide) composite films were studied in vitro and in vivo. The acidity produced by poly (d, l-lactide) materials was not obvious. Adding chitosan and beta-TCP can relieve the acidity problem and improve strength performance of films. The NGF has influences on the degradation characteristics of films. It is verified that PDLLA/CHI/beta-TCP/NGF composite films prepared by solvent evaporation method have excellent degradation characteristics. It can be used as a perfect biomaterial for repairing nerve injuries.
C1 [Chen Lei; Yan Yuhua; Li Jianhua; Li Shipu] Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Li, SP (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
EM chenlei19811114@sohu.com; lishipu46@126.com
CR Chen YH, 2004, ROBOT CIM-INT MANUF, V20, P237, DOI 10.1016/j.rcim.2003.09.002
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 1999, BIOMATERIALS, V20, P35, DOI 10.1016/S0142-9612(97)00226-3
   LUO YF, 2005, HIGHLY TECHNOLOGY CO, V15, P55
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   ZHANG Y, 1999, ORAL DIS, V5, P3
NR 7
TC 0
Z9 0
U1 0
U2 3
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD DEC
PY 2007
VL 22
IS 4
BP 691
EP 694
DI 10.1007/s11595-006-4691-9
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 246ZH
UT WOS:000252046400026
DA 2018-10-19
ER

PT J
AU Ning, J
   Yao, A
   Wang, DP
   Huang, WH
   Fu, HL
   Liu, X
   Jiang, XQ
   Zhang, XL
AF Ning, Jia
   Yao, Aihua
   Wang, Deping
   Huang, Wenhai
   Fu, Hailuo
   Liu, Xin
   Jiang, Xinquan
   Zhang, Xiuli
TI Synthesis and in vitro bioactivity of a borate-based bioglass
SO MATERIALS LETTERS
LA English
DT Article
DE glasses; biomaterials; X-ray techniques
ID GLASSES; 45S5
AB A bioactive borate glass was synthesized through normal melting-derived route in this letter. The degradation and bioactivity of the glass were studied by the immersion of glass microspheres in a dilute K2HPO4 solution. The cell growth inhibition rate of the borate glass was examined by MTT assay. The conversion product of the borate glass was identified by XRD, SEM. It was confirmed that the borate glass had a rapid degradation rate, comparing with the silicate-based bioglass, 45S5 glass. HA formed from the borate glass, that is an indication of bioactive potential in vivo. MTT assay results demonstrate that the inhibition effect of B ions released from the borate glass on cell proliferation can be alleviated by diluting extract solution to a certain concentration (v/v ratio: 1:4, [B] < 1.792 mM). It is believed that the borate glass could be a desirable biomaterial for preparing scaffold of tissue engineering. (c) 2007 Elsevier B.V All rights reserved.
C1 Tongji Univ, Sch Mat Sci & Engn, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.
   Shanghai Nith Peoples Hosp, Shanghai 200011, Peoples R China.
RP Ning, J (reprint author), Tongji Univ, Sch Mat Sci & Engn, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.
EM whhuang@mail.tongji.edu.cn
CR Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Day DE, 2003, GLASS TECHNOL, V44, P75
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Huang Wen-hai, 2005, Journal of Tongji University (Natural Science), V33, P88
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   MANADOUCH M, 2001, J BIOMED MATER RES, V54, P560
   MARION NW, 2005, MECH ADV MATER STRUC, V12, P1
   Ning Jia, 2006, Journal of the Chinese Ceramic Society, V34, P1326
   Pernice P, 1999, J NON-CRYST SOLIDS, V258, P1, DOI 10.1016/S0022-3093(99)00554-2
   RICHARD MNC, 2000, THESIS U MISSOURIROL, P68
NR 10
TC 33
Z9 36
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC
PY 2007
VL 61
IS 30
BP 5223
EP 5226
DI 10.1016/j.matlet.2007.04.089
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 234ZF
UT WOS:000251202600012
DA 2018-10-19
ER

PT J
AU Wu, EY
   Ou, KL
   Pan, YN
AF Wu, En-Yu
   Ou, Keng-Liang
   Pan, Yung-Ning
TI Enhancement of biocompatibility on bioactive Ti-Nb-based alloy by
   high-density plasma modification
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-niobium-hafnium alloy; plasma treatment; oxidation;
   biocompatibility; osseointegration
ID BARRIER CAPABILITY; JUNCTION DIODES; CU DIFFUSION; OXIDE-FILMS;
   TITANIUM; SURFACE; BIOMATERIAL; STERILIZATION; TANTALUM; NIOBIUM
AB The formations and characteristics of oxides on the surfaces of the plasma-treated Ti-Nb-Hf alloys were investigated by employing X-ray photoelectron spectroscopy, X-ray powder diffractometer and scanning electron microscopy. Further, the non-treated and plasma-treated specimens were incubated in phosphate-buffered saline (PBS) containing albumin to evaluate their biocompatibility. The results indicate that through O-2-plasma treatment, the thickness of the oxide layer increases, and the surface roughness improves, exhibiting little protuberances and numerous micropores and cavities on the treated surface. The compositions of the oxide layers in the specimen without O-2-plasma treatment consist of TiO, Ti2O3 and TiO2, and the oxides transform to mainly TiO2 as the specimen is treated with O-2-plasma. In addition, the formation of nitrides by allylamine plasma treatment can provide amino-group linkings for the attachment of albumin. Plasma oxidation and polymerization are believed to improve biocompatibility and therefore promote osseointegration.
C1 [Wu, En-Yu; Pan, Yung-Ning] Natl Taiwan Univ, Dept Mech Engn, Taipei 106, Taiwan.
   [Ou, Keng-Liang] Taipei Med Univ, Grad Inst Oral Sci, Taipei 110, Taiwan.
RP Wu, EY (reprint author), Natl Taiwan Univ, Dept Mech Engn, Taipei 106, Taiwan.
EM enyu.wu@gmail.com
CR Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Barrett N, 2007, MICROELECTRON ENG, V84, P2302, DOI 10.1016/j.mee.2007.04.131
   Cheng HC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2361279
   Cheng HC, 2006, ELECTROCHEM SOLID ST, V9, pD25, DOI 10.1149/1.2335940
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   Lee TM, 2000, J BIOMED MATER RES, V50, P499, DOI 10.1002/(SICI)1097-4636(20000615)50:4<499::AID-JBM5>3.0.CO;2-U
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   Lin CC, 2005, JPN J APPL PHYS 1, V44, P8590, DOI 10.1143/JJAP.44.8590
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Ou KL, 2005, MICROELECTRON ENG, V81, P44, DOI 10.1016/j.mee.2005.03.001
   Ou KL, 2005, J ELECTROCHEM SOC, V152, pG138, DOI 10.1149/1.1850367
   Ou KL, 2002, J VAC SCI TECHNOL B, V20, P2154, DOI 10.1116/1.1511214
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Shibata Y, 2002, J DENT RES, V81, P841, DOI 10.1177/154405910208101209
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Sonoda T, 1998, SURF SCI, V402, P241, DOI 10.1016/S0039-6028(98)00032-6
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Yang WL, 2001, SOLID STATE ELECTRON, V45, P149, DOI 10.1016/S0038-1101(00)00228-8
NR 27
TC 1
Z9 1
U1 0
U2 15
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2007
VL 48
IS 12
BP 3164
EP 3169
DI 10.2320/matertrans.MER2007160
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 255OC
UT WOS:000252666300021
OA Bronze
DA 2018-10-19
ER

PT J
AU Missirlis, YF
   Katsikogianni, M
AF Missirlis, Y. F.
   Katsikogianni, M.
TI Theoretical and experimental approaches of bacteria-biomaterial
   interactions
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article; Proceedings Paper
CT International Symposium on Biomaterials
CY SEP 05-06, 2006
CL Essen, GERMANY
SP Germany Soc Biomat
ID ATOMIC-FORCE MICROSCOPY; SURFACE FREE-ENERGY; MEDIATED CELL ATTACHMENT;
   FLOW DETACHMENT ASSAY; SLOW VISCOUS MOTION; STAPHYLOCOCCUS-EPIDERMIDIS;
   FLUID SHEAR; MICROBIAL ADHESION; HYDRODYNAMIC SHEAR; ESCHERICHIA-COLI
AB Bacterial adhesion to surfaces is a complicated process influenced by many factors including the bacteria (surface energy and charge, molecular details), the substratum surface (chemical composition, roughness, configuration, surface energy and charge) and environmental factors (serum proteins, flow conditions, temperature, bacterial concentration, time of exposure, antibiotics). The models that have been proposed for the quantitative prediction of bacteria-material interactions are based on colloidal theories and macromolecular binding considerations. Two categories of techniques used in calculating bacterial adhesion strength and bacteria-material interactions have been proposed: those that utilize fluid flowing against adherent bacteria and those that manipulate single bacteria (atomic force microscopy and optical tweezers), and are concisely reviewed.
C1 [Missirlis, Y. F.; Katsikogianni, M.] Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26500, Greece.
RP Missirlis, YF (reprint author), Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26500, Greece.
EM misirlis@mech.upatras.gr
OI Katsikogianni, Maria/0000-0002-1560-3993
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Abu-Lail NI, 2006, LANGMUIR, V22, P7296, DOI 10.1021/la0533415
   Afrin R, 2004, ULTRAMICROSCOPY, V100, P187, DOI 10.1016/j.ultramic.2004.01.013
   Amanatides E, 2006, SURF COAT TECH, V200, P6331, DOI 10.1016/j.surfcoat.2005.11.002
   Bakker DP, 2003, APPL ENVIRON MICROB, V69, P6280, DOI 10.1128/AEM.69.10.6280-6287.2003
   Bayoudh S, 2005, COLLOID SURFACE A, V266, P160, DOI 10.1016/j.colsurfa.2005.06.025
   Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Boonaert CJP, 2001, COLLOID SURFACE B, V22, P171, DOI 10.1016/S0927-7765(01)00196-5
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   BUNT CR, 1993, INT J PHARMACEUT, V99, P93, DOI 10.1016/0378-5173(93)90350-O
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CHANG HT, 1991, BIOTECHNOL BIOENG, V38, P499, DOI 10.1002/bit.260380508
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CHARACKLIS WG, 1973, WATER RES, V7, P1113, DOI 10.1016/0043-1354(73)90066-3
   CHAUDHURY MK, 1984, THESIS U NEW YORK BU
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P841, DOI 10.1016/S0006-3495(90)82430-9
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DAHAL EN, 1987, LANGMUIR, V3, P1009
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   Dickinson RB, 1997, J COLLOID INTERF SCI, V190, P142, DOI 10.1006/jcis.1997.4882
   DUDDRIDGE JE, 1982, BIOTECHNOL BIOENG, V24, P153, DOI 10.1002/bit.260240113
   Dufrene YF, 2001, MICRON, V32, P153, DOI 10.1016/S0968-4328(99)00106-7
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116
   FOWKES FM, 1962, J PHYS CHEM-US, V66, P382, DOI 10.1021/j100808a524
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   FOWKES FM, 1980, J COLLOID INTERF SCI, V78, P200, DOI 10.1016/0021-9797(80)90508-1
   GABORIAND F, 2006, COLLOID SURFACE B, V54, P10
   GANNON JT, 1991, APPL ENVIRON MICROB, V57, P190
   GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2
   GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031
   Hubble J, 1996, J THEOR BIOL, V182, P169, DOI 10.1006/jtbi.1996.0151
   Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Kamusewitz H, 2003, APPL PHYS A-MATER, V76, P899, DOI 10.1007/s00339-002-1972-9
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   KATSIKOGIANNI M, UNPUB
   KATSIKOGIANNI MG, 2007, PLASMA PROCESS POLYM, V4, P1046
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376
   Kuo SC, 1997, BIOPHYS J, V73, P517, DOI 10.1016/S0006-3495(97)78090-1
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7
   Liu YT, 2007, LANGMUIR, V23, P7134, DOI 10.1021/la700575u
   Lower SK, 2000, GEOCHIM COSMOCHIM AC, V64, P3133, DOI 10.1016/S0016-7037(00)00430-0
   Ma HL, 2004, J THEOR BIOL, V226, P237, DOI 10.1016/j.jtbi.2003.09.008
   Mack D., 1999, J HOSP INFECT, V43, P113
   Mascari L, 2003, BIOTECHNOL BIOENG, V83, P65, DOI 10.1002/bit.10650
   Mascari L, 2001, ANN BIOMED ENG, V29, P956, DOI 10.1114/1.1415527
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   NORDE W, 1989, COLLOID SURFACE, V38, P1, DOI 10.1016/0166-6622(89)80138-6
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Prince JL, 2003, LANGMUIR, V19, P154, DOI 10.1021/1a026072g
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Robichon D, 1999, CR ACAD SCI III-VIE, V322, P687, DOI 10.1016/S0764-4469(99)80108-5
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Sharma PK, 2005, APPL ENVIRON MICROB, V71, P3668, DOI 10.1128/AEM.71.7.3668-3673.2005
   Sharp JM, 2005, LANGMUIR, V21, P8198, DOI 10.1021/la046765s
   Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1995, MOL IMMUNOL, V32, P199, DOI 10.1016/0161-5890(94)00124-J
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VANOSS CJ, 1984, COLLOID SURFACE, V8, P373, DOI 10.1016/0166-6622(84)80131-6
   VANOSS CJ, 1989, SCI TECH, V23, P15
   Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6
   Visser J, 1997, EXP THERM FLUID SCI, V14, P407, DOI 10.1016/S0894-1777(96)00142-2
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   WU S, 1971, J COLLOID INTERF SCI, V37, P686, DOI 10.1016/0021-9797(71)90347-X
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
NR 95
TC 9
Z9 9
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2007
VL 38
IS 12
BP 983
EP 994
DI 10.1002/mawe.200700240
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 250GS
UT WOS:000252288600007
DA 2018-10-19
ER

PT J
AU Jennissen, HP
   Laub, M
AF Jennissen, H. P.
   Laub, M.
TI Development of an universal affinity fusion tag (Poly-DOPA) for
   immobilizing recombinant proteins on biomaterials
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article; Proceedings Paper
CT International Symposium on Biomaterials
CY SEP 05-06, 2006
CL Essen, GERMANY
SP Germany Soc Biomat
DE bMP-2; mussel adhesive; DOPA; dihydroxy phenylalanine; Mytilus edulis;
   poly-Tyr tag; poly-DOPA tag
ID BONE MORPHOGENETIC PROTEIN-2; MYTILUS-EDULIS-L; ADHESIVE PROTEIN;
   MC3T3-E1 CELLS; MUSSEL; SURFACES; IMPLANTS; POLYPEPTIDES; PURIFICATION;
   MOLECULES
AB The covalent and non-covalent immobilization of growth factors such as recombinant human bone morphogenetic protein 2 (rhBMP-2) on metals and bone replacement materials in bioactive form is a recent development. Up to now the immobilization technology usually involved the chemical modification and activation of the biomaterial surface followed by attachment of the bioactive protein. Here we suggest an alternative method in which an affinity tag fused to an active protein will allow immobilization without additional chemistry. For biomaterials such as minerals, metals (titanium, steel, CoCrMo), glass ceramics, teflon and possibly bone and teeth ideal adhesion molecules would be the foot proteins (Mefps) of the mussel M. edulis which contain the rare amino acid dihydroxy phenylalanine (DOPA). Recently it could be shown by Messersmith's group that a single DOPA-molecule can be non-covalently bound to titanium dioxide surface with a dissociation energy of 22.2 kcal/mol (Lee, H.; Scherer, N. E; Messersmith, P. B. Proc. Natl. Acad. Sci. U. S. A 2006, 103, 12999-13003). We therefore propose the DOPA-tag as a general and versatile affinity tag for the immobilization of proteins on biomaterials.
C1 [Jennissen, H. P.; Laub, M.] Univ Essen Gesamthsch, Univ Klinikum Essen, Inst Physiol Chem, D-45122 Essen, Germany.
RP Jennissen, HP (reprint author), Univ Essen Gesamthsch, Univ Klinikum Essen, Inst Physiol Chem, Hufelandstr 55, D-45122 Essen, Germany.
EM hpjennissen@uni-duisburg-essen.de
CR Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   Chen C, 2000, J ORG CHEM, V65, P2574
   Chung CY, 1999, BIOCHEM BIOPH RES CO, V265, P246, DOI 10.1006/bbrc.1999.1639
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Halliwell CM, 2001, ANAL BIOCHEM, V295, P257, DOI 10.1006/abio.2001.5182
   HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321
   Jennissen HP, 1999, MATERIALWISS WERKST, V30, P838, DOI 10.1002/(SICI)1521-4052(199912)30:12<838::AID-MAWE838>3.0.CO;2-W
   Jennissen HP, 2002, ANN NY ACAD SCI, V961, P139, DOI 10.1111/j.1749-6632.2002.tb03067.x
   Kodama H., 1981, JPN J ORAL BIOL, V23, P899
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAUB M, 2007, IN PRESS MATERIALWIS, V38
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   LEHRER RI, 2003, INTEGR COMP BIOL, P313
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MRABET NT, 2002, BIOCHROMATOGRAPHY TH
   PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0
   Rodgers KJ, 2004, FREE RADICAL BIO MED, V37, P1756, DOI 10.1016/j.freeradbiomed.2004.08.009
   Rumpf HM, 2003, MATERIALWISS WERKST, V34, P1101, DOI 10.1002/mawe.200300711
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413
   Sambrook J, 1989, MOL CLONING LAB MANU
   SMITH JC, 1984, GENE, V32, P321, DOI 10.1016/0378-1119(84)90007-6
   Statz A, 2006, BIOFOULING, V22, P391, DOI 10.1080/08927010601004890
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   Taylor SW, 1995, ARCH BIOCHEM BIOPHYS, V324, P228, DOI 10.1006/abbi.1995.0035
   Taylor SW, 2002, ANAL BIOCHEM, V302, P70, DOI 10.1006/abio.2001.5522
   Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Wiemann M, 2001, MATERIALWISS WERKST, V32, P931, DOI 10.1002/1521-4052(200112)32:12<931::AID-MAWE931>3.0.CO;2-H
   Zurlinden K, 2005, MATERIALWISS WERKST, V36, P820, DOI 10.1002/mawe.200500978
   ZURLINDEN K, 2005, BIOMATERIALIEN, V6, P214
NR 40
TC 10
Z9 10
U1 0
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2007
VL 38
IS 12
BP 1035
EP 1039
DI 10.1002/mawe.200700247
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 250GS
UT WOS:000252288600015
DA 2018-10-19
ER

EF